FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Puskas, BL
   Menke, NE
   Huie, P
   Song, Y
   Ecklund, K
   Trindade, MCD
   Smith, RL
   Goodman, SB
AF Puskas, BL
   Menke, NE
   Huie, P
   Song, Y
   Ecklund, K
   Trindade, MCD
   Smith, RL
   Goodman, SB
TI Expression of nitric oxide, peroxynitrite, and apoptosis in loose total
   hip replacements
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nitric oxide; peroxynitrite; apoptosis; osteolysis; wear debris
ID PARTICLES IN-VITRO; BONE-RESORPTION ACTIVITY; WEAR DEBRIS; SYNTHASE;
   MACROPHAGES; INDUCTION; RELEASE; TISSUE; CELLS; ARTHROPLASTY
AB Nitric oxide (NO) is an effector molecule associated with inflammation, immune function, bone metabolism, and the induction of apoptosis. This study examined the role of NO, peroxynitrite (ONOO-), and apoptosis in cases of revision total hip replacements (THRs). We hypothesized that apoptosis and excess production of NO contribute to the inflammatory reaction to orthopedic biomaterial wear debris that is associated with loosening and osteolysis. Periprosthetic membranous specimens were collected from revised cemented acetabular components with simple loosening and ballooning osteolysis. Synovial samples from patients undergoing primary THR were used as controls. The presence of macrophages (CD68(+)) and levels of inducible nitric oxide svnthase (INOS), endothelial nitric oxide synthase (EcNOS), ONOO- (Nitro, assayed by the amount of nitrated tyrosine residues), and apoptosis (TUNEL staining) were examined using immunohistochemistry. Increased expression for INOS, EcNOS, and ONOO- in both the loose/ osteolytic and the loose /non-osteolytic groups was observed when compared to the synoviurn group. There were no significant differences between the loose/ osteolytic group and loose /non-osteolytic group for these biologic markers. TUNEL staining showed a significant increase in apoptosis in the loose/osteolytic group compared to the loose/non-osteolytic group and synovial tissues. These findings suggest that NO and NO-derived molecules, such as ONOO-, may be involved in sustaining the foreign-body reaction to wear debris. NO and ONOO- may prove to be useful markers of prosthetic loosening whereas apoptosis may be a marker distinguishing ballooning from simple osteolysis.
C1 Stanford Univ, Ctr Med, Div Orthopaed Surg, Stanford, CA 94305 USA.
   Stanford Univ, Ctr Med, Dept Pathol, Stanford, CA USA.
RP Goodman, SB (reprint author), Stanford Univ, Ctr Med, Div Orthopaed Surg, 300 Pasteur Dr,R144, Stanford, CA 94305 USA.
EM goodbone@stanford.edu
CR Bauer G, 2000, ANTICANCER RES, V20, P4115
   BRODBECK WG, 2001, 27 ANN M SOC BIOM ST
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   Catelas I, 1999, BIOMATERIALS, V20, P625, DOI 10.1016/S0142-9612(98)00214-2
   Catelas I, 1999, J BONE JOINT SURG BR, V81B, P516, DOI 10.1302/0301-620X.81B3.8737
   CHIBA J, 1994, CLIN ORTHOP RELAT R, V300, P304
   Ciapetti G, 2000, J BIOMED MATER RES, V52, P338, DOI 10.1002/1097-4636(200011)52:2<338::AID-JBM13>3.3.CO;2-C
   Evans C H, 1995, Clin Orthop Relat Res, P275
   Fabre T, 1999, J BIOMED MATER RES, V44, P429, DOI 10.1002/(SICI)1097-4636(19990315)44:4<429::AID-JBM9>3.0.CO;2-C
   Ghafourifar P, 2001, BIOL SIGNAL RECEPT, V10, P57
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   Granchi D, 2000, J BIOMAT SCI-POLYM E, V11, P633, DOI 10.1163/156856200743913
   Hua LL, 1998, ANN NEUROL, V43, P384, DOI 10.1002/ana.410430317
   HUGHES DE, 1995, J BONE MINER RES, V10, P1478
   Hukkanen M, 1997, J BONE JOINT SURG BR, V79B, P467, DOI 10.1302/0301-620X.79B3.7469
   ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W
   KASTEN TP, 1994, P NATL ACAD SCI USA, V91, P3569, DOI 10.1073/pnas.91.9.3569
   Kim MS, 2001, BIOCHEM PHARMACOL, V61, P779, DOI 10.1016/S0006-2952(01)00541-X
   Kim PKM, 2001, INT IMMUNOPHARMACOL, V1, P1421, DOI 10.1016/S1567-5769(01)00088-1
   Liu ZP, 2001, J COMP NEUROL, V432, P35, DOI 10.1002/cne.1087
   MACAULAY W, 1995, T ORTHOP RES SOC, V20, P221
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   Murrell GAC, 1996, J BONE JOINT SURG AM, V78A, P265, DOI 10.2106/00004623-199602000-00014
   Perry MJ, 1997, J ARTHROPLASTY, V12, P670, DOI 10.1016/S0883-5403(97)90140-6
   PIZZOFERRATO A, 1991, Clinical Materials, V7, P51, DOI 10.1016/0267-6605(91)90057-M
   PRAEMER A, 1999, MUSCULOSKELETAL COND
   Reiff DA, 2001, J TRAUMA, V50, P433, DOI 10.1097/00005373-200103000-00006
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   Shanbhag AS, 1998, J BIOMED MATER RES, V41, P497, DOI 10.1002/(SICI)1097-4636(19980905)41:3<497::AID-JBM21>3.3.CO;2-G
   Shida J, 2000, CALCIFIED TISSUE INT, V67, P151, DOI 10.1007/s00223001125
   Sit KH, 1997, ANAT RECORD, V248, P149, DOI 10.1002/(SICI)1097-0185(199706)248:2<149::AID-AR1>3.0.CO;2-O
   Stea S, 1999, J BIOMAT SCI-POLYM E, V10, P247, DOI 10.1163/156856299X00162
   Stea S, 2000, BIOMATERIALS, V21, P1393, DOI 10.1016/S0142-9612(00)00041-7
   vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7
   Wink DA, 1997, J BIOL CHEM, V272, P11147
   Yaszay B, 2001, J ORTHOPAED RES, V19, P970, DOI 10.1016/S0736-0266(01)00003-1
NR 37
TC 13
Z9 14
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2003
VL 66A
IS 3
BP 541
EP 549
DI 10.1002/jbm.a.10010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717RV
UT WOS:000185104800014
PM 12918037
DA 2018-10-19
ER

PT J
AU Parl, HD
   Lee, WK
   Ooya, T
   Park, KD
   Kim, YH
   Yui, N
AF Parl, HD
   Lee, WK
   Ooya, T
   Park, KD
   Kim, YH
   Yui, N
TI In vitro biocompatibility assessment of sulfonated
   polyrotaxane-immobilized polyurethane surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE surface modification; sulfonated polyrotaxane; polyurethane;
   biocompatibility; biomaterials
ID PROTEIN ADSORPTION; BIODEGRADABLE POLYROTAXANES; POLY(ETHYLENE OXIDE);
   BACTERIAL ADHESION; DRUG-DELIVERY; POLYMERS; CYCLODEXTRINS; TISSUES
AB Sulfonated polyrotaxanes (PRx-SO3's), in which sulfonated alpha-cyclodextrins (alpha-CDs) were threaded onto the poly(ethylene glycol) (PEG) segments in a PEG-b-poly(propyleneglycol) (PPG)-b-PEG triblock copolymer (Pluronic) capped with benzyloxycarbonyl (Z)-L-phenylalanine (Z-L-Phe), were prepared as a novel surface-modifying biomaterial. Surface modification of the polyurethane (PU) was carried out by blending the PRx-SO3's with a PU solution, followed by solution casting. The incorporated PRx-SO3's led to the enhanced hydrophilicity by changing the surface properties of the PU matrix. Modified PUs showed the stable entrapment of the PRx-SO3's with little extraction into water and enhanced mechanical properties after exposure to water compared to the PU control. The incorporated PRx-SO3's repelled the proteins and kept them from closely approaching the surface areas, prevented platelet activation by thrombin, and effectively repelled bacteria. These results suggest that both the supramolecular structure of the polyrotaxanes and exposure of the sulfonated groups onto the surfaces contribute to these phenomena. Thus, surface modification with PRx-SO3's is suggested to be useful for the fabrication of biocompatible medical devices.
C1 Japan Adv Inst Sci & Technol, Sch Mat Sci, Tatsunokuchi, Ishikawa 9231292, Japan.
   Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, South Korea.
   Korea Inst Sci & Technol, Biomat Res Ctr, Seoul 130650, South Korea.
RP Yui, N (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahidai, Tatsunokuchi, Ishikawa 9231292, Japan.
RI Kobe Univ, Engineering/D-2028-2017; Ooya, Tooru/C-5573-2012
CR Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAIER RE, 1978, ARTIF ORGANS, V2, P422
   BRASH JL, 1987, PROTEINS INTERFACES
   Dal Park H, 2002, J BIOMED MATER RES, V60, P186
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   FOLKMAN J, 1989, SCIENCE, V243, P1490, DOI 10.1126/science.2467380
   Freij-Larsson C, 2000, BIOMATERIALS, V21, P307, DOI 10.1016/S0142-9612(99)00195-7
   FUJITA H, 1996, MACROMOL RAPID COMM, V171, P509
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   HARADA A, 1995, MACROMOLECULES, V28, P8406, DOI 10.1021/ma00128a060
   HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   KAMATH KR, 1994, COLLOID SURFACE B, V2, P471
   Kim YH, 1997, MACROMOL SYMP, V118, P565, DOI 10.1002/masy.19971180174
   Li J, 2001, MACROMOLECULES, V34, P7236, DOI 10.1021/ma010742s
   Li JT, 1996, COLLOID SURFACE B, V7, P9, DOI 10.1016/0927-7765(96)01269-6
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   Ooya T, 1998, J BIOMAT SCI-POLYM E, V9, P313, DOI 10.1080/09205063.1998.9753058
   Ooya T, 1999, CRIT REV THER DRUG, V16, P289
   Ooya T, 2001, BIOMACROMOLECULES, V2, P200, DOI 10.1021/bm005618f
   OOYA T, 1995, MACROMOL RAPID COMM, V16, P259, DOI 10.1002/marc.1995.030160405
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Park KD, 1997, BIOMATERIALS, V18, P47, DOI 10.1016/S0142-9612(96)00096-8
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   PARK KD, 1996, ASAIO J, V42, P876
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Yui N, 1998, BIOCONJUGATE CHEM, V9, P118, DOI 10.1021/bc970189c
NR 30
TC 14
Z9 14
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2003
VL 66A
IS 3
BP 596
EP 604
DI 10.1002/jbm.a.10505
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717RV
UT WOS:000185104800020
PM 12918043
DA 2018-10-19
ER

PT J
AU Lu, XY
   Huang, Y
   Qian, WP
   Tang, ZM
   Lu, ZH
AF Lu, XY
   Huang, Y
   Qian, WP
   Tang, ZM
   Lu, ZH
TI An effective method for quantitative evaluation of proteins adsorbed on
   biomaterial surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE quantitative evaluation; reflectometry interference; spectroscopy/atomic
   force microscope; protein adsorption; polystyrene
ID INTERFERENCE SPECTROSCOPY; ALBUMIN ADSORPTION; PLASMON RESONANCE;
   INTERFEROMETRY; DESORPTION; POLYMER; ANTIGEN; OXIDE; SPR
AB An effective method for the quantitative evaluation of proteins adsorbed on biomaterial surfaces has been developed. First, the kinetic behavior of a range of human fibrinogen (Fib) adsorbed onto polystyrene (PS) films was investigated by using a reflectometry interference spectroscopy setup. The specific molecular number of adsorbed proteins, N-p, was then defined. According to the definition, the numbers of Fib molecules adsorbed on PS films were calculated. An atomic force microscope (AFM) was used to scan the lateral distribution of the Fib molecules adsorbed on the PS films. From the AFM images, the practical specific molecular numbers were obtained by direct counting of the molecules. In order that the adsorbed number of Fib molecules on a unit area of the PS films could be counted easily, the solution concentration of proteins was reduced to 5 ag/mL (10(-18)g/mL). There was good consistency between the numbers calculated with the formula defined by us and the numbers counted from AFM images. Therefore, the results of the present study prove the validity of our definition of the specific molecular number of adsorbed proteins and the effectiveness of the reflectometry interference spectroscopy-based method for quantitative evaluation of adsorptive proteins.
C1 SE Univ, Minist Educ, Key Lab Mol & Biomol Elect, Nanjing 210096, Peoples R China.
RP Lu, XY (reprint author), SE Univ, Minist Educ, Key Lab Mol & Biomol Elect, Nanjing 210096, Peoples R China.
RI Lu, Zuhong/A-5448-2013
CR Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   Bender SA, 2000, BIOMATERIALS, V21, P299, DOI 10.1016/S0142-9612(99)00183-0
   BRECHT A, 1992, SENSOR ACTUAT B-CHEM, V6, P96, DOI 10.1016/0925-4005(92)80038-Y
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   GAUGLITZ G, 1993, SENSOR ACTUAT B-CHEM, V11, P21, DOI 10.1016/0925-4005(93)85234-2
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Kandori K, 1998, COLLOID SURFACE B, V11, P313, DOI 10.1016/S0927-7765(98)00053-8
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Klomp AJA, 1999, BIOMATERIALS, V20, P1203, DOI 10.1016/S0142-9612(99)00009-5
   LU XY, 2001, SENSORS, V1, P148
   LU XY, 2001, P BMES IEEE, V23, P25
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   Ortega-Vinuesa JL, 1998, BIOMATERIALS, V19, P251, DOI 10.1016/S0142-9612(97)00206-8
   Park K, 1998, BIOMATERIALS, V19, P387, DOI 10.1016/S0142-9612(97)00111-7
   Pavey KD, 1999, BIOMATERIALS, V20, P885, DOI 10.1016/S0142-9612(98)00245-2
   Piehler J, 1997, BIOSENS BIOELECTRON, V12, P531, DOI 10.1016/S0956-5663(97)00010-9
   Piehler J, 1999, COLLOID SURFACE B, V13, P325, DOI 10.1016/S0927-7765(99)00046-6
   POOT AA, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P29
   QIAN WP, 2000, AACCS OAK RIDG C BOS
   RATHGEB E, 1998, ANAL CHIM ACTA, V372, P333
   Sauer M, 1999, ANAL CHEM, V71, P2850, DOI 10.1021/ac981057v
   Schmitt HM, 1997, BIOSENS BIOELECTRON, V12, P809, DOI 10.1016/S0956-5663(97)00046-8
   SHARMA CP, 1990, BIOMATERIALS, V11, P255, DOI 10.1016/0142-9612(90)90006-C
   Silin V, 1997, J COLLOID INTERF SCI, V185, P94, DOI 10.1006/jcis.1996.4586
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   XIAO CD, 2000, CHINESE J BIOMEDICAL, V19, P60
   Yu F, 2000, CLIN CHEM, V46, P1489
   YU F, 2000, THESIS BIOMEDICAL EN
   Zeng HT, 1999, BIOMATERIALS, V20, P377, DOI 10.1016/S0142-9612(98)00184-7
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   ZHANG SJ, 1999, CHIN C BIOM PAN CHIN
NR 34
TC 17
Z9 17
U1 1
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2003
VL 66A
IS 3
BP 722
EP 727
DI 10.1002/jbm.a.10014
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 717RV
UT WOS:000185104800033
PM 12918056
DA 2018-10-19
ER

PT J
AU Kurimoto, A
   Tanabe, T
   Tachibana, A
   Yamauchi, K
AF Kurimoto, A
   Tanabe, T
   Tachibana, A
   Yamauchi, K
TI Keratin sponge: Immobilization of lysozyme
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE keratin; sponge; disulfide bond; thioether bond; lysozyme
ID SCAFFOLDS
AB A porous wool keratin sponge was used for immobilization of lysozyme, a model bioactive substance and was demonstrated to be a unique biomaterial in terms that the activity of lysozyme linked to the sponge through disulfide bond was gradually released, while lysozyme through thioether bond was stably maintained.
C1 Osaka City Univ, Grad Sch Engn, Dept Appl & Bioappl Chem, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Yamauchi, K (reprint author), Osaka City Univ, Grad Sch Engn, Dept Appl & Bioappl Chem, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
EM yamauchi@bioa.eng.osaka-cu.ac.jp
CR AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4579, DOI 10.1021/bi00839a052
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gorham S. D., 1991, BIOMATERIALS, P55
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Sabolinski ML, 1996, BIOMATERIALS, V17, P311, DOI 10.1016/0142-9612(96)85569-4
   STUCHBURY T, 1975, Biochemical Journal, V151, P417
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tournier EJM, 1998, ANAL CHIM ACTA, V361, P33, DOI 10.1016/S0003-2670(98)00008-7
   van Wachem PB, 1999, J BIOMED MATER RES, V47, P270, DOI 10.1002/(SICI)1097-4636(199911)47:2<270::AID-JBM18>3.0.CO;2-D
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
NR 15
TC 32
Z9 35
U1 1
U2 14
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
EI 1347-4421
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD SEP
PY 2003
VL 96
IS 3
BP 307
EP 309
DI 10.1263/jbb.96.307
PG 3
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 744ER
UT WOS:000186615400017
PM 16233527
DA 2018-10-19
ER

PT J
AU Miyanishi, K
   Trindade, MCD
   Ma, T
   Goodman, SB
   Schurman, DJ
   Smith, RL
AF Miyanishi, K
   Trindade, MCD
   Ma, T
   Goodman, SB
   Schurman, DJ
   Smith, RL
TI Periprosthetic osteolysis: Induction of vascular endothelial growth
   factor from human monocyte/macrophages by orthopedic biomaterial
   particles
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Article; Proceedings Paper
CT 49th Annual Meeting of the Orthopaedic-Research-Society
CY FEB 02-05, 2003
CL NEW ORLEANS, LA
SP Orthopaed Res Soc
DE implants; cytokines; growth factors; molecular pathways; osteolysis
ID TOTAL HIP-ARTHROPLASTY; NECROSIS-FACTOR-ALPHA; OSTEOCLASTIC
   BONE-RESORPTION; COLONY-STIMULATING FACTOR; PRIMARY HUMAN MONOCYTES;
   TITANIUM-ALLOY; FACTOR VEGF; IN-VITRO; RHEUMATOID-ARTHRITIS; ADHESION
   MOLECULES
AB Introduction: Periprosthetic osteolysis after total hip arthroplasty occurs in association with formation of a vascularized granulomatous tissue in response to particulate debris.
   Materials and Methods: This study examined expression of vascular endothelial growth factor (VEGF) and the VEGF receptor in 10 periprosthetic tissues from loosened prostheses and quantified effects of titanium particles on VEGF release, intracellular signaling, and VEGF-dependent chemotaxis in primary cultures of human monocyte/macrophages.
   Results: Double immunofluorescent staining showed that VEGF and Flt-1 co-localized with cells positive for the macrophage marker, CD11b, in the periprosthetic tissues. Monocyte/macrophages challenged with titanium particles showed a dose- and time-dependent release of VEGF ranging from 2.8- to 3.1-fold and exhibited increased expression of VEGF121 and VEGF165 mRNAs, reaching levels up to 5.0- and 8.6-fold, respectively, by 48 h (p < 0.01). Exposure of monocyte/macrophages to titanium particles upregulated phosphorylated-p44/42 mitogen-activated protein kinase (MAPK) within 30 minutes. Particle-induced activation of p44/42 MAPK and release of VEGF were dose-dependently suppressed by pretreatment of cells with PD98059, a specific inhibitor of p44/42 MAPK. Monocyte/macrophages challenged with titanium particles also showed a time-dependent activation of AP-1, a transcription factor associated with VEGF expression (p < 0.01). Supernatants from particle-challenged monocyte/macrophages increased macrophage chemotactic activity by 30%, which was significantly inhibited by anti-VEGF neutralizing antibody (p < 0.01).
   Conclusions: This study suggests that induction of VEGF release from monocyte/macrophages in response to orthopaedic biomaterial wear debris may contribute to periprosthetic osteolysis and implant loosening.
C1 Stanford Univ, Sch Med, Orthopaed Res Lab, Stanford, CA 94305 USA.
RP Smith, RL (reprint author), Stanford Univ, Sch Med, Orthopaed Res Lab, 300 Pasteur Dr,R-144, Stanford, CA 94305 USA.
EM smith@rrdmail.stanford.edu
CR AlSaffar N, 1996, AM J CLIN PATHOL, V105, P628
   ALSAFFAR N, 1995, ANN RHEUM DIS, V54, P201, DOI 10.1136/ard.54.3.201
   ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9
   Archibeck MJ, 2000, J BONE JOINT SURG AM, V82A, P1478, DOI 10.2106/00004623-200010000-00014
   ARNAOUT MA, 1990, BLOOD, V75, P1037
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Goodman SB, 1997, CLIN ORTHOP RELAT R, P149, DOI 10.1097/00003086-199704000-00017
   Goodman SB, 1998, J BONE JOINT SURG BR, V80B, P531, DOI 10.1302/0301-620X.80B3.8158
   Itaya H, 2001, THROMB HAEMOSTASIS, V85, P171
   Koch AE, 1998, ARTHRITIS RHEUM, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D
   Konttinen YT, 1997, J RHEUMATOL, V24, P694
   Lee SS, 2001, CLIN EXP RHEUMATOL, V19, P321
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   Maloney WJ, 1998, J BIOMED MATER RES, V41, P371, DOI 10.1002/(SICI)1097-4636(19980905)41:3<371::AID-JBM5>3.3.CO;2-A
   Matsumoto Y, 2002, J IMMUNOL, V168, P5824, DOI 10.4049/jimmunol.168.11.5824
   Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Nakashima Y, 1999, J BONE JOINT SURG BR, V81B, P155, DOI 10.1302/0301-620X.81B1.8884
   Nawrocki B, 1999, J BONE MINER RES, V14, P288, DOI 10.1359/jbmr.1999.14.2.288
   Neufeld G, 1999, FASEB J, V13, P9
   Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Renard P, 2001, Nucleic Acids Res, V29, pE21, DOI 10.1093/nar/29.4.e21
   Rezzonico R, 2000, BLOOD, V95, P3868
   Rezzonico R, 2001, BLOOD, V97, P2932, DOI 10.1182/blood.V97.10.2932
   ROBERTS WG, 1995, J CELL SCI, V108, P2369
   Robertsson O, 1997, ACTA ORTHOP SCAND, V68, P231, DOI 10.3109/17453679708996690
   Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Shida J, 2000, CALCIFIED TISSUE INT, V67, P151, DOI 10.1007/s00223001125
   Somasundaram S, 2002, CANCER RES, V62, P3868
   TISCHER E, 1991, J BIOL CHEM, V266, P11947
   Trindade MCD, 1999, J ORTHOP RES, V17, P797, DOI 10.1002/jor.1100170602
   Urata Y, 2002, FREE RADICAL BIO MED, V32, P688, DOI 10.1016/S0891-5849(01)00823-1
   Waris V, 1996, SCAND J RHEUMATOL, V25, P257, DOI 10.3109/03009749609069995
   Wellmann S, 2001, CLIN CHEM, V47, P654
   Xu JW, 1996, CLIN EXP RHEUMATOL, V14, P643
NR 40
TC 41
Z9 48
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD SEP
PY 2003
VL 18
IS 9
BP 1573
EP 1583
DI 10.1359/jbmr.2003.18.9.1573
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 714YY
UT WOS:000184943900003
PM 12968666
OA Bronze
DA 2018-10-19
ER

PT J
AU Wollensak, G
   Spoerl, E
   Seiler, T
AF Wollensak, G
   Spoerl, E
   Seiler, T
TI Stress-strain measurements of human and porcine corneas after
   riboflavin-ultraviolet-A-induced cross-linking
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID BIOMECHANICAL PROPERTIES; ARCHITECTURE; KERATOCONUS; INDUCTION;
   COLLAGEN; STROMA
AB Purpose. To evaluate the biomechanical effect of combined riboflavin-ultraviolet A (UVA) treatment on porcine and human corneas.
   Setting: Department of Ophthalmology, Technical University of Dresden, Dresden, Germany.
   Methods: Corneal strips from 5 human enucleated eyes and 20 porcine cadaver corneas were treated with the photosensitizer riboflavin and irradiated with 2 double UVA diodes (370 nm, irradiance = 3 mW/cm(2)) for 30 minutes. After cross-linking, static stress-strain measurements of the treated and untreated corneas were performed using a microcomputer-controlled biomaterial tester with a prestress of 5 x 10(3) Pa.
   Results: There was a significant increase in corneal rigidity after cross-linking, indicated by a rise in stress in treated porcine corneas (by 71.9%) and human corneas (by 328.9%) and in Young's modulus by the factor 1.8 in porcine corneas and 4.5 in human corneas. The mean central corneal thickness was 850 mum +/- 70 (SD) in porcine corneas and 550 +/- 40 mum in human corneas.
   Conclusions: Riboflavin-UVA-induced collagen cross-linking led to an increase in mechanical rigidity in porcine corneas and an even greater increase in human corneas. As collagen cross-linking is maximal in the anterior 300 mum of the cornea, the greater stiffening effect in human corneas can be explained by the relatively larger portion of the cornea being cross-linked in the overall thinner human cornea.
C1 Tech Univ Dresden, Dept Ophthalmol, D-8027 Dresden, Germany.
   Univ Zurich, Dept Ophthalmol, Zurich, Switzerland.
RP Wollensak, G (reprint author), Univ Dresden, Eye Clin, Fetscherstr 74, D-01307 Dresden, Germany.
CR ANDREASSEN TT, 1980, EXP EYE RES, V31, P435, DOI 10.1016/S0014-4835(80)80027-3
   Argento C, 2001, J CATARACT REFR SURG, V27, P1440, DOI 10.1016/S0886-3350(01)00799-4
   Bron AJ, 2001, BRIT J OPHTHALMOL, V85, P379, DOI 10.1136/bjo.85.4.379
   Kampmeier J, 2000, CORNEA, V19, P355, DOI 10.1097/00003226-200005000-00020
   Kim WS, 2001, CORNEA, V20, P394, DOI 10.1097/00003226-200105000-00011
   MAURICE D M, 1988, P187
   Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437
   Schnitzler E, 2000, KLIN MONATSBL AUGENH, V217, P190, DOI 10.1055/s-2000-10344
   Seiler T, 1999, J CATARACT REFR SURG, V25, P1307, DOI 10.1016/S0886-3350(99)00250-3
   Spoerl E, 1998, EXP EYE RES, V66, P97, DOI 10.1006/exer.1997.0410
   Spoerl E, 1999, J REFRACT SURG, V15, P711
   SPOERL E, IN PRESS CURR EYE RE
   Spoerl E, 2000, OPHTHALMOLOGE, V97, P203, DOI 10.1007/s003470050515
   Sporl E, 1997, OPHTHALMOLOGE, V94, P902, DOI 10.1007/s003470050219
   Wollensak G, 2003, J CATARACT REFR SURG, V29, P1786, DOI 10.1016/S0886-3350(03)00343-2
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   WOLLENSAK G, IN PRESS CORNEA
   Zeng YJ, 2001, J BIOMECH, V34, P533, DOI 10.1016/S0021-9290(00)00219-0
NR 18
TC 567
Z9 591
U1 1
U2 47
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD SEP
PY 2003
VL 29
IS 9
BP 1780
EP 1785
DI 10.1016/S0886-3350(03)00407-3
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 727WY
UT WOS:000185684900026
PM 14522301
DA 2018-10-19
ER

PT J
AU Jain, R
   von Recum, AF
AF Jain, R
   von Recum, AF
TI Effect of titanium surface texture on the cell-biomaterial interface
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Article
DE cell density and morphology; cp-titanium; microtexture; PET; SEM
ID QUANTITATIVE-ANALYSIS; IMPLANTS; MICROMORPHOLOGY; FIBROBLASTS;
   SUBSTRATA; POLYESTER; GROWTH; TISSUE
AB To improve the in vivo performance of engineered implants, this study examines the independent effects of surface chemistry and topography on fibroblast morphology and density in vitro. Titanium (Ti) was sputter-coated onto smooth and microtextured polyethylene terephthalate (PET). Test specimens were evaluated in 24-h, fibroblast cultures and assessed with scanning electron microscopy (SEM) for cellular morphology and density. Fibroblast density increased, as the Ti film thickness increased. The fibroblasts exhibited contact guidance on the textured test specimens. The greatest cellular density was found on the Ti-coated, textured test specimens. In conclusion, Ti and surface texture appeared to strongly influence fibroblast density and morphology as compared to PET and smooth surfaces.
C1 Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43220 USA.
   Ohio State Univ, Coll Engn, Ctr Biomed Engn, Columbus, OH 43210 USA.
   Ohio State Univ, Coll Med & Publ Hlth, Columbus, OH 43210 USA.
RP von Recum, AF (reprint author), Ohio State Univ, Coll Vet Med, Dept Vet Biosci, 127N Vet Med Acad Bldg,1900 Coffey Rd, Columbus, OH 43220 USA.
EM vonrecum.1@osu.edu
CR BONZON N, 1995, BIOMATERIALS, V16, P747, DOI 10.1016/0142-9612(95)99636-Z
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   Chinn JA, 1998, J BIOMED MATER RES, V39, P130, DOI 10.1002/(SICI)1097-4636(19980101)39:1<130::AID-JBM15>3.0.CO;2-J
   CLARK P, 1992, J CELL SCI, V103, P287
   CLARK P, 1987, DEVELOPMENT, V99, P439
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   HOLGERS KM, 1995, BIOMATERIALS, V16, P611, DOI 10.1016/0142-9612(95)93858-B
   JAIN R, 2002, BIOL INTERACTIONS FI
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MEYLE J, 1991, J APPL BIOMATER, V2, P273, DOI 10.1002/jab.770020409
   Meyle J, 1993, J Biomater Appl, V7, P362, DOI 10.1177/088532829300700404
   ONEILL C, 1990, J CELL SCI, V95, P577
   PACQUY YCG, 1996, BIOMATERIALS, V17, P1251
   PRATT KJ, 1989, J BIOMED MATER RES, V23, P1131, DOI 10.1002/jbm.820231004
   ROWLAND SA, 1995, J APPL BIOMATER, V6, P1, DOI 10.1002/jab.770060102
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1095
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   VONRECUM AF, 1990, ADV BIOMAT, V9, P297
   VONRECUM AF, 1992, MUSCULOSKELETAL INFE, P191
   WALBOOMERS XF, 1999, J BIOMED MATER RES, V47, P202
NR 25
TC 12
Z9 12
U1 0
U2 1
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0894-1939
J9 J INVEST SURG
JI J. Invest. Surg.
PD SEP-OCT
PY 2003
VL 16
IS 5
BP 263
EP 273
DI 10.1080/08941930390230388
PG 11
WC Surgery
SC Surgery
GA 728MV
UT WOS:000185721700004
PM 14527884
DA 2018-10-19
ER

PT J
AU Sabokbar, A
   Pandey, R
   Athanasou, NA
AF Sabokbar, A
   Pandey, R
   Athanasou, NA
TI The effect of particle size and electrical charge on
   macrophage-osteoclast differentiation and bone resorption
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TOTAL HIP ARTHROPLASTIES; IN-VITRO; WEAR DEBRIS; POLYETHYLENE PARTICLES;
   PARTICULATE DEBRIS; RESORBING CELLS; PERIPROSTHETIC OSTEOLYSIS;
   SURFACE-AREA; PHAGOCYTOSIS; CYTOKINES
AB In aseptic loosening, there is commonly periprosthetic bone loss and a heavy macrophage infiltrate in response to biomaterial wear particles generated from the implant materials. Macrophages which have phagocytosed wear particles are known to be capable of differentiation into bone resorbing osteoclasts. In this investigation we determine the role of particle size and particle charge on this process. Mouse monocytes and macrophages were co-cultured with osteoblast-like UMR106 cells and 1,25 dihydroxyvitamin D3 in the presence or the absence of (i) various sizes of latex beads (0.1, 1, 10 and 100 mum) and (ii) uncharged, positively- or negatively-charged sephadex beads of uniform shape and composition. The extent of osteoclast differentiation by monocytes or foreign body macrophages was determined by the expression of the osteoclast-associated enzyme tartrate-resistant acid phosphatase and lacunar bone resorption. No significant difference in the extent of osteoclast formation and bone resorption was noted in response to particle size. Osteoclast formation was also not significantly different in the presence of positively/negatively charged and uncharged particles. These findings indicate that osteoclast formation is not significantly influenced by particle characteristics, such as particle size. They also add support to the hypothesis that macrophage involvement in periprosthetic osteolysis is not dependent on particle phagocytosis and that it may be induced by particle contact. (C) 2003 Kluwer Academic Publishers.
C1 Univ Oxford, Nuffield Dept Orthopaed Surg, Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.
   Nuffield Orthopaed Ctr, Dept Pathol, Oxford OX3 7LD, England.
RP Sabokbar, A (reprint author), Univ Oxford, Nuffield Dept Orthopaed Surg, Nuffield Orthopaed Ctr, Oxford OX3 7LD, England.
CR AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   Athanasou NA, 1996, J BONE JOINT SURG AM, V78A, P1096, DOI 10.2106/00004623-199607000-00016
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Brodner W, 1997, J BONE JOINT SURG BR, V79B, P316, DOI 10.1302/0301-620X.79B2.7326
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P304
   Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058
   Galiano RD, 1996, ANN PLAS SURG, V36, P608, DOI 10.1097/00000637-199606000-00008
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   Glant TT, 1996, AM J THER, V3, P27, DOI [10.1097/00045391-199601000-00006, DOI 10.1097/00045391-199601000-00006]
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   HERMAN JH, 1989, J BONE JOINT SURG AM, V71A, P1530, DOI 10.2106/00004623-198971100-00012
   HOROWITZ SM, 1991, J ORTHOPAED RES, V9, P406, DOI 10.1002/jor.1100090313
   Ingham E, 2000, P I MECH ENG H, V214, P21, DOI 10.1243/0954411001535219
   Itonaga I, 2000, ANN RHEUM DIS, V59, P26, DOI 10.1136/ard.59.1.26
   JASTY M, 1994, CLIN ORTHOP RELAT R, P111
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   KRUKOWSKI M, 1990, J ORAL MAXIL SURG, V48, P468, DOI 10.1016/0278-2391(90)90233-R
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1994, J BONE JOINT SURG AM, V76, P1664
   Matthews JB, 2000, BIOMATERIALS, V21, P2033, DOI 10.1016/S0142-9612(00)00089-2
   MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Neale SD, 2000, J ARTHROPLASTY, V15, P654, DOI 10.1054/arth.2000.6622
   Pandey R, 1996, ANN RHEUM DIS, V55, P388, DOI 10.1136/ard.55.6.388
   QUINN J, 1992, J BONE JOINT SURG BR, V74, P652
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   REVELL PA, 1982, CURRENT TRENDS PATHO, P73
   Sabokbar A, 1997, ANN RHEUM DIS, V56, P414, DOI 10.1136/ard.56.7.414
   Sabokbar A, 1997, J BONE JOINT SURG BR, V79B, P129, DOI 10.1302/0301-620X.79B1.6966
   SABOKBAR A, 1998, ARCH ORTHOP TRAUMA S, V184, P31
   Schwarz EM, 2000, J ORTHOPAED RES, V18, P472, DOI 10.1002/jor.1100180321
   SHAHBANG AS, 1995, J ARTHROPLASTY, V10, P498
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   SUDA T, 1995, BONE, V17, pS87, DOI 10.1016/8756-3282(95)00185-G
   Voronov I, 1998, J BIOMED MATER RES, V39, P40, DOI 10.1002/(SICI)1097-4636(199801)39:1<40::AID-JBM6>3.3.CO;2-Y
   Wang W, 1997, J PATHOL, V182, P92
   Wang W, 1997, J BONE JOINT SURG BR, V79B, P849, DOI 10.1302/0301-620X.79B5.7780
   WILLERT HG, 1996, CLIN ORTHOP S, V329, pS160
   WRIGHT T, 1995, IMPLANT WEAR FUTURE
NR 44
TC 36
Z9 37
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2003
VL 14
IS 9
BP 731
EP 738
DI 10.1023/A:1025088418878
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 709HH
UT WOS:000184619400001
PM 15348391
DA 2018-10-19
ER

PT J
AU Tyan, YC
   Liao, JD
   Lin, SP
AF Tyan, YC
   Liao, JD
   Lin, SP
TI Surface properties and in vitro analyses of immobilized chitosan onto
   polypropylene nonwoven fabric surface using antenna-coupling microwave
   plasma
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ANTICOAGULANT ACTIVITY; POLY(ETHYLENE OXIDE); BLOOD COMPATIBILITY;
   COPOLYMER MEMBRANE; POLY(ACRYLIC ACID); ACRYLIC-ACID; HEPARIN;
   BIOMATERIAL; POLYURETHANES; COMPLEX
AB Antenna coupling microwave plasma enables a highly efficient and oxidative treatment of the outermost surface of polypropylene (PP) non-woven fabric within a short time period. Subsequently, grafting copolymerization with acrylic acid (AAc) makes the plasma-treated fabric durably hydrophilic and excellent in water absorbency. With high grafting density and strong water affinity, the pAAc-grafted fabric greatly becomes feasible as an intensive absorbent and as a support to promote chitosan-immobilization through amide bonds. Experimental result demonstrated that surface analyses by FTIR-ATR have shown that R-CONH-R', amide binding were emerged between pAAc and chitosan. The XPS measurements on C-1s 286.0 eV (C-OH), 286.5 eV (C-N) and 288.1 eV (O=C-NH) also could be found. Bioactivity assessments on the chitosan-immobilized surfaces were anticipated by activated partial thromboplastin time (aPTT), thrombin time (TT), and fibrinogen concentration. By means of cell counter we counted the ratio of blood cell adhesion on the modified fabric matrix. After human plasma incubated with the chitosan-immobilized PP fabrics, the required time for aPTT and blood cell adhesion increased significantly, while fibrinogen concentration and TT did not change. Due to the capability of anticoagulation and cell adhesion, the chitosan-immobilized PP fabric can be used as the substrate for cell culturing and then developed the wound-dressing substitute for second-degree burn. (C) 2003 Kluwer Academic Publishers.
C1 Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.
   Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 701, Taiwan.
   Chung Yuan Christian Univ, Dept Biomed Engn, Taoyuan 320, Taiwan.
RP Tyan, YC (reprint author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, 1 Univ Rd, Tainan 70101, Taiwan.
EM mpad73@hotmail.com; jdliao@mail.ncku.edu.tw
CR AMIJI MM, 1995, BIOMATERIALS, V16, P593, DOI 10.1016/0142-9612(95)93856-9
   Beamson G., 1992, HIGH RESOLUTION XPS, P110
   Benesch J, 2002, BIOMATERIALS, V23, P2561, DOI 10.1016/S0142-9612(01)00391-X
   BRANDENBERG G, 1984, NEUROSURGERY, V15, P9, DOI 10.1227/00006123-198407000-00004
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   CHAVASIT V, 1988, POLYM BULL, V19, P223
   Chen-Yang YW, 2000, MACROMOLECULES, V33, P5638, DOI 10.1021/ma990065q
   Dutkiewicz J, 1990, J BIOACT COMPAT POL, V5, P293, DOI 10.1177/088391159000500305
   GRILL A, 1993, COLD PLASMA MAT FABR, P129
   HAN DK, 1995, BIOMATERIALS, V16, P467, DOI 10.1016/0142-9612(95)98819-Z
   HEMKER HC, 1991, THROMB RES, P1
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   HIRANO S, 1987, ADV BIOMEDICAL POLYM, P285
   HOFFMAN AS, 1990, J APPL POLYM SCI APP, V46, P341
   IKADA Y, 1993, LUBRICATING POLYM SU, P73
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   Kane J. B., 1996, BIOMATERIALS SCI INT, P360
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Klokkevold PR, 1999, J ORAL MAXIL SURG, V57, P49, DOI 10.1016/S0278-2391(99)90632-8
   LEE RE, 1993, SCANNING ELECT MICRO, P272
   Lee SD, 1996, J POLYM SCI POL CHEM, V34, P141, DOI 10.1002/(SICI)1099-0518(19960115)34:1<141::AID-POLA15>3.0.CO;2-L
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Liao JD, 2002, J PHYS CHEM B, V106, P77, DOI [10.1021/jp011119c, 10.1021/jp01119c]
   LIAO JD, 1998, Patent No. 325210
   LIAO JD, 1997, P SOC MAT SCI, V1, P13
   LIAO JD, 1999, CHUNG YUAN J, V27, P89
   Lin JC, 1999, BIOMATERIALS, V20, P1439, DOI 10.1016/S0142-9612(98)00200-2
   MANNHALTER C, 1993, SENSOR ACTUAT B-CHEM, V11, P273, DOI 10.1016/0925-4005(93)85265-C
   Minami S, 1998, CARBOHYD POLYM, V36, P151, DOI 10.1016/S0144-8617(98)00015-0
   Moharram MA, 1996, J APPL POLYM SCI, V59, P987
   MOLDER JF, 1995, HDB XRAY PHOTOELECTR, P42
   Murata J, 1996, CARBOHYD POLYM, V29, P69, DOI 10.1016/0144-8617(95)00144-1
   MUZZARELLI RAA, 1983, CARBOHYD POLYM, V3, P53
   Nam SY, 1997, J MEMBRANE SCI, V135, P161, DOI 10.1016/S0376-7388(97)00144-0
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   Patel VR, 1996, ACS SYM SER, V627, P209
   Pawloski JR, 1998, CIRCULATION, V97, P263, DOI 10.1161/01.CIR.97.3.263
   Pugnaloni A, 1986, CLIN LAB ROME, V10, P151
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   RIGBY AJ, 1996, TECH TEXTILES IN OCT, P24
   RIGBY AJ, 1996, ECH TEXTILES INT, P22
   SANDFORD PA, 1991, ACS SYM SER, V467, P430
   Tyan YC, 2002, J BIOMATER APPL, V17, P153, DOI 10.1106/088532802030478
   Tyan YC, 2002, BIOMATERIALS, V23, P65, DOI 10.1016/S0142-9612(01)00080-1
   TYAN YC, 2000, CHIN J MED BIOL ENG, V20, P25
   Vasilets VN, 1997, BIOMATERIALS, V18, P1139, DOI 10.1016/S0142-9612(97)00045-8
   WEI P, 1995, THESIS PENNSYLVANIA
   Welle A, 1997, APPL SURF SCI, V119, P185, DOI 10.1016/S0169-4332(97)00216-X
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yasuda H. K., 1985, PLASMAS POLYM, P73
   ZHANG SK, 1995, J APPL POLYM SCI, V56, P687, DOI 10.1002/app.1995.070560606
NR 54
TC 18
Z9 19
U1 3
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2003
VL 14
IS 9
BP 775
EP 781
DI 10.1023/A:1025036421604
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 709HH
UT WOS:000184619400007
PM 15348397
DA 2018-10-19
ER

PT J
AU Al Saffar, N
AF Al Saffar, N
TI Selective chemokine expression and the link between local and systemic
   immune responses to orthopaedic biomaterial
SO JOURNAL OF PATHOLOGY
LA English
DT Meeting Abstract
CT 2nd Joint Meeting of the British Division of the
   International-Academy-of-Pathology/185th Meeting of the
   Pathological-Society-of-Great-Britian-and-Ireland
CY JUL 01-04, 2003
CL UNIV BRISTOL, BRISTOL, ENGLAND
SP Int Acad Path, Britian Div, Pathol Soc Great Britan & Ireland
HO UNIV BRISTOL
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, Tissue Engn Ctr, London SW7 2AZ, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0022-3417
J9 J PATHOL
JI J. Pathol.
PD SEP
PY 2003
VL 201
SU S
BP 56A
EP 56A
PG 1
WC Oncology; Pathology
SC Oncology; Pathology
GA 721XX
UT WOS:000185344700224
DA 2018-10-19
ER

PT J
AU Okumoto, Y
   Fujiki, H
   Kawakami, J
   Nakashima, S
   Nakano, S
   Ohmichi, T
   Miyoshi, D
   Sugimoto, N
AF Okumoto, Y
   Fujiki, H
   Kawakami, J
   Nakashima, S
   Nakano, S
   Ohmichi, T
   Miyoshi, D
   Sugimoto, N
TI Novel biomaterials derived from deoxyribozyme and NAPzyme
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT IUPAC Polymer Conference on Mission and Challenges of Polymer Science
   and Technology (IUPAC PC2002)
CY DEC 02-05, 2002
CL KYOTO, JAPAN
DE biomaterials; deoxyribozyme; enzymes; metal ion; NAPzyme (nucleic acid
   peptide deoxyribozyme)
ID CLEAVAGE REACTION; RIBONUCLEASE-A; RNA CLEAVAGE; DNA ENZYME; SUBSTRATE;
   SEQUENCE; RIBOZYME; MONOVALENT; STABILITY; CATIONS
AB We report the potential of a small Ca2+-dependent deoxyribozyme as a novel biomaterial to distinguish RNA foldings. It is found that an immobilized deoxyribozyme using avidin-biotin interaction cleaves the target site within only single-stranded RNAs. The RNA cleavage reaction is also detected using the deoxyribozyme SPR sensor chip. Furthermore, we develop a novel NAPzyme (nucleic acid peptide deoxyribozyme) with its RNA cleavage function in the absence of divalent metal ions.
C1 Konan Univ, Dept Chem, Fac Sci & Engn, Higashinada Ku, Kobe, Hyogo 6588501, Japan.
RP Sugimoto, N (reprint author), Konan Univ, Dept Chem, Fac Sci & Engn, Higashinada Ku, 8-9-1 Okamoto, Kobe, Hyogo 6588501, Japan.
OI Miyoshi, Daisuke/0000-0002-4308-0499
CR Barrette I, 2001, NUCLEIC ACIDS RES, V29, P753, DOI 10.1093/nar/29.3.753
   BEVILACQUA PC, 1992, SCIENCE, V258, P1355, DOI 10.1126/science.1455230
   CECH TR, 1999, RNA WORLD, P265
   Curtis EA, 2001, RNA, V7, P546, DOI 10.1017/S1355838201002357
   Dale T, 2000, RNA, V6, P608, DOI 10.1017/S1355838200992495
   Debouck C, 1999, NAT GENET, V21, P48, DOI 10.1038/4475
   Kawakami J, 2001, CHEM LETT, P258, DOI 10.1246/cl.2001.258
   KAWAKAMI J, UNPUB
   O'Rear JL, 2001, RNA, V7, P537, DOI 10.1017/S1355838201002461
   Ohmichi T, 1997, BIOCHEMISTRY-US, V36, P3514, DOI 10.1021/bi962030d
   Ohmichi T, 2002, J AM CHEM SOC, V124, P10367, DOI 10.1021/ja0255406
   Ohmichi T, 1998, NUCLEIC ACIDS RES, V26, P5655, DOI 10.1093/nar/26.24.5655
   Ohmichi T, 2000, J AM CHEM SOC, V122, P11286, DOI 10.1021/ja001779f
   Okumoto Y, 2002, BIOCHEMISTRY-US, V41, P2769, DOI 10.1021/bi011909c
   Okumoto Y, 2000, J INORG BIOCHEM, V82, P189, DOI 10.1016/S0162-0134(00)00159-8
   OKUMOTO Y, 2003, IN PRESS BIOCHEMISTR, V42
   Park C, 2001, BIOCHEMISTRY-US, V40, P4949, DOI 10.1021/bi0100182
   Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h
   RICHARDS EG, 1975, HDB BIOCH MOL BIOL N, V1, P597
   Santoro SW, 2000, J AM CHEM SOC, V122, P2433, DOI 10.1021/ja993688s
   Santoro SW, 1998, BIOCHEMISTRY-US, V37, P13330, DOI 10.1021/bi9812221
   Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367
   Smith TH, 1996, NUCLEOS NUCLEOT, V15, P1581, DOI 10.1080/07328319608002458
   SUGIMOTO N, 1988, BIOCHEMISTRY-US, V27, P6384, DOI 10.1021/bi00417a029
   SUGIMOTO N, 1999, J CHEM SOC P2, P1382
NR 25
TC 0
Z9 0
U1 1
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD SEP
PY 2003
VL 201
BP 245
EP 252
DI 10.1002/masy.200351127
PG 8
WC Polymer Science
SC Polymer Science
GA 742JJ
UT WOS:000186513400028
DA 2018-10-19
ER

PT J
AU Andersson, J
   Ekdahl, KN
   Nilsson, B
AF Andersson, J
   Ekdahl, KN
   Nilsson, B
TI Complement activation on a model biomaterial surface. Binding of C3B via
   the alternative pathway amplification loop to plasma proteins adsorbed
   to the surface
SO MOLECULAR IMMUNOLOGY
LA English
DT Meeting Abstract
CT 9th European Meeting on Complement in Human Disease
CY SEP 06-09, 2003
CL TRIESTE, ITALY
DE biocompatibility; protein adsorption
C1 Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden.
NR 0
TC 0
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD SEP
PY 2003
VL 40
IS 2-4
BP 199
EP 199
PG 1
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 715MJ
UT WOS:000184975900070
DA 2018-10-19
ER

PT J
AU Nakashima, M
   Reddi, AH
AF Nakashima, M
   Reddi, AH
TI The application of bone morphogenetic proteins to dental tissue
   engineering
SO NATURE BIOTECHNOLOGY
LA English
DT Review
ID HUMAN OSTEOGENIC PROTEIN-1; GROWTH-FACTOR-BETA; MEDIATED GENE DELIVERY;
   IN-VITRO; REPARATIVE DENTIN; PULP CELLS; GROWTH/DIFFERENTIATION
   FACTOR-11; PERIODONTAL REGENERATION; EXTRACELLULAR-MATRIX; SUPERFAMILY
   MEMBERS
AB Progress in understanding the role of bone morphogenetic proteins (BMPs) in craniofacial and tooth development, the demonstration of stem cells in dental pulp and accumulating knowledge on biomaterial scaffolds have set the stage for tissue engineering and regenerative therapy of the craniofacial complex. Furthermore, the recent approval by the US Food and Drug Administration (FDA; Rockville, MD, USA) of recombinant human BMPs for accelerating bone fusion in slow-healing fractures indicates that this protein family may prove useful in designing regenerative treatments in dental applications. In the near term, these advances are likely to be applied to endodontics and periodontal surgery; ultimately, they may facilitate approaches to regenerating whole teeth for use in tooth replacement.
C1 Univ Calif Davis, Sch Med, Dept Orthoped Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA.
   Kyushu Univ, Fac Dent Sci, Fukuoka 8128582, Japan.
RP Reddi, AH (reprint author), Univ Calif Davis, Sch Med, Dept Orthoped Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA.
RI U-ID, Kyushu/C-5291-2016
FU NIAMS NIH HHS [1R01 AR47345]
CR BEGUEKIRN C, 1992, INT J DEV BIOL, V36, P491
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309
   Bostrom MPG, 1998, CLIN ORTHOP RELAT R, pS116, DOI 10.1097/00003086-199810001-00013
   Boyne PJ, 2001, J BONE JOINT SURG AM, V83A, pS146
   Chai Y, 2003, MICROSC RES TECHNIQ, V60, P469, DOI 10.1002/jemt.10287
   Cheng SL, 2001, CALCIFIED TISSUE INT, V68, P87, DOI 10.1007/BF02678146
   CHO MI, 1988, J PERIODONTAL RES, V23, P268, DOI 10.1111/j.1600-0765.1988.tb01371.x
   Cho MI, 2000, PERIODONTOL 2000, V24, P9, DOI 10.1034/j.1600-0757.2000.2240102.x
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Cochran DL, 1997, INT J ORAL MAX IMPL, V12, P739
   Cook S D, 1995, J Oral Implantol, V21, P281
   Couble ML, 2000, CALCIFIED TISSUE INT, V66, P129, DOI 10.1007/PL00005833
   Franceschi RT, 2000, J CELL BIOCHEM, V78, P476, DOI 10.1002/1097-4644(20000901)78:3<476::AID-JCB12>3.0.CO;2-5
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Gu K, 1996, ARCH ORAL BIOL, V41, P919, DOI 10.1016/S0003-9969(96)00052-0
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P604
   Harle J, 2001, ULTRASOUND MED BIOL, V27, P579, DOI 10.1016/S0301-5629(00)00326-4
   Helder MN, 1998, J DENT RES, V77, P545, DOI 10.1177/00220345980770040701
   Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6
   Jin QM, 2003, J PERIODONTOL, V74, P202, DOI 10.1902/jop.2003.74.2.202
   Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103
   Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Lee JY, 2001, J BONE JOINT SURG AM, V83A, P1032, DOI 10.2106/00004623-200107000-00008
   Lu LC, 2001, J BONE JOINT SURG AM, V83A, pS82
   Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   NAKASE T, 1994, J BONE MINER RES, V9, P651
   NAKASHIMA M, 1994, ARCH ORAL BIOL, V39, P1085, DOI 10.1016/0003-9969(94)90062-0
   NAKASHIMA M, 1994, DEV BIOL, V162, P18, DOI 10.1006/dbio.1994.1063
   Nakashima M, 1998, ARCH ORAL BIOL, V43, P745, DOI 10.1016/S0003-9969(98)00046-6
   Nakashima M, 2003, HUM GENE THER, V14, P591, DOI 10.1089/104303403764539369
   NAKASHIMA M, 1990, ARCH ORAL BIOL, V35, P493, DOI 10.1016/0003-9969(90)90078-O
   NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601
   Nakashima M, 2002, GENE THER, V9, P814, DOI 10.1038/sj/gt/3301692
   Nevins M, 1996, Int J Periodontics Restorative Dent, V16, P8
   Olmsted EA, 2001, J CELL BIOCHEM, V82, P11, DOI 10.1002/jcb.1106
   Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200
   PARALKAR VM, 1990, J BIOL CHEM, V265, P17281
   POLSON AM, 1983, J PERIODONTOL, V54, P141, DOI 10.1902/jop.1983.54.3.141
   Reddi A H, 1974, Adv Biol Med Phys, V15, P1
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   REDDI AH, 1974, P NATL ACAD SCI USA, V71, P1648, DOI 10.1073/pnas.71.5.1648
   Reddi AH, 2001, ARTHRITIS RES, V3, P1
   REDDI AH, 1973, P SOC EXP BIOL MED, V143, P634
   Ripamonti U, 1996, GROWTH FACTORS, V13, P273, DOI 10.3109/08977199609003228
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   Ripamonti U, 1998, PLAST RECONSTR SURG, V101, P227, DOI 10.1097/00006534-199801000-00040
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   Ripamonti U, 2001, J BONE JOINT SURG AM, V83A, pS116
   RUTHERFORD RB, 1994, ARCH ORAL BIOL, V39, P833, DOI 10.1016/0003-9969(94)90014-0
   RUTHERFORD RB, 1993, ARCH ORAL BIOL, V38, P571, DOI 10.1016/0003-9969(93)90121-2
   RUTHERFORD RB, 2000, PRINCIPLES TISSUE EN, P847
   Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   Saygin NE, 2000, PERIODONTOL 2000, V24, P73, DOI 10.1034/j.1600-0757.2000.2240105.x
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Sigurdsson TJ, 1997, CLIN ORAL IMPLAN RES, V8, P367, DOI 10.1034/j.1600-0501.1997.080503.x
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Sun Y, 1995, Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi, V11, P8
   Sykaras N, 2001, CLIN ORAL IMPLAN RES, V12, P339, DOI 10.1034/j.1600-0501.2001.012004339.x
   TAKEDA K, 1994, BONE, V15, P467, DOI 10.1016/8756-3282(94)90268-2
   Thesleff I, 1997, MECH DEVELOP, V67, P111, DOI 10.1016/S0925-4773(97)00115-9
   Thomadakis G, 1999, EUR J ORAL SCI, V107, P368, DOI 10.1046/j.0909-8836.1999.eos107508.x
   Toyono T, 1997, ARCH ORAL BIOL, V42, P481, DOI 10.1016/S0003-9969(97)00041-1
   Tziafas D, 2000, J DENT, V28, P77, DOI 10.1016/S0300-5712(99)00047-0
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Unger EC, 2001, PROG CARDIOVASC DIS, V44, P45, DOI 10.1053/pcad.2001.26443
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2
   VEIS A, 1985, J DENT RES, V64, P552, DOI 10.1177/002203458506400409
   WIENTROUB S, 1988, CALCIFIED TISSUE INT, V42, P255, DOI 10.1007/BF02553752
   Yokose S, 2000, CALCIFIED TISSUE INT, V66, P139, DOI 10.1007/s002230010028
NR 75
TC 242
Z9 257
U1 4
U2 71
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1087-0156
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD SEP
PY 2003
VL 21
IS 9
BP 1025
EP 1032
DI 10.1038/nbt864
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 716VV
UT WOS:000185051000034
PM 12949568
DA 2018-10-19
ER

PT J
AU Yamada, K
   Tsuboi, Y
   Itaya, A
AF Yamada, K
   Tsuboi, Y
   Itaya, A
TI AFM observation of silk fibroin on mica substrates: morphologies
   reflecting the secondary structures
SO THIN SOLID FILMS
LA English
DT Article
DE biomaterial; beta-sheet; crystallization; heat treatment; monolayers;
   random coil
ID ATOMIC-FORCE MICROSCOPY; PHYSICAL-PROPERTIES; MOLECULAR-CONFORMATION;
   SOLID-STATE; CRYSTALLIZATION; INTERFACE; FILMS; SPECTROSCOPY;
   DIFFRACTION; TRANSITION
AB Bombyx mori silk fibroin was fixed on mica substrates by cast of aqueous fibroin solutions, and the microscopic morphologies of the samples were revealed by means of atomic force microscopy. By adjusting the method used to prepare the solution, we succeeded in forming quasi-2-dimensional thin films in which a network of fibroin molecules developed over the substrate. The film network consisted of fibroin in a random coil structure. The morphology of the network changed after thermal or methanol treatments, which are known to convert the secondary structure of fibroin from the random coil to the beta-sheet type. In both of these cases, the network morphology disappeared and characteristic island-like morphologies appeared. On the other hand, temporally evolving gelation occurred in a fibroin solution due to the formation of beta-sheet crystals. Such islands were also observable in a specimen prepared by the cast of the gel-containing solution. Based on these results, it was concluded that the islands consist of beta-sheet crystals. Of particular interest is the observation that all of the islands had a common thickness value of 1.3 nm. These morphologies are discussed in terms of the secondary structure of fibroin. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Kyoto Inst Technol, Dept Polymer Sci & Engn, Sakyo Ku, Kyoto 6068585, Japan.
   Japan Sci & Technol Corp, PRESTO, Struct & Transformat, Kawaguchi, Japan.
RP Tsuboi, Y (reprint author), Hokkaido Univ, Div Chem, Grad Sch Sci, Sapporo, Hokkaido 0600810, Japan.
OI Yamada, Kazushi/0000-0003-3623-9833
CR Anselmetti D., 2000, Single Molecules, V1, P53, DOI 10.1002/(SICI)1438-5171(200004)1:1<53::AID-SIMO53>3.3.CO;2-L
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Asakura T., 1994, ENCY AGR SCI, V4, P1
   ASAKURA T, 1987, BIOINDUSTRY, V4, P36
   Demura M, 1998, J AM CHEM SOC, V120, P1300, DOI 10.1021/ja972069l
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Egawa H, 1999, LANGMUIR, V15, P1660, DOI 10.1021/la980923w
   Freddi G, 1997, J POLYM SCI POL PHYS, V35, P841, DOI 10.1002/(SICI)1099-0488(19970415)35:5<841::AID-POLB13>3.0.CO;2-A
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Hossain KS, 1999, LANGMUIR, V15, P4114, DOI 10.1021/la981221+
   Inoue SI, 2000, J POLYM SCI POL PHYS, V38, P1436, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1436::AID-POLB30>3.0.CO;2-8
   Kaplan D, 1994, SILK POLYM MAT SCI B
   KASAI H, 1980, STRUCTURE SILK FIBER, P198
   Li L, 2001, MACROMOLECULES, V34, P316, DOI 10.1021/ma000273e
   Liu ZD, 2001, J VAC SCI TECHNOL B, V19, P111, DOI 10.1116/1.1340663
   LOTZ B, 1979, BIOCHIMIE, V61, P205, DOI 10.1016/S0300-9084(79)80067-X
   Mackie AR, 2000, LANGMUIR, V16, P2242, DOI 10.1021/la990711e
   MAGOSHI J, 1981, J POLYM SCI POL PHYS, V19, P185, DOI 10.1002/pol.1981.180190117
   Magoshi J, 2000, THERMOCHIM ACTA, V352, P165, DOI 10.1016/S0040-6031(99)00462-1
   MAGOSHI J, 1975, J APPL POLYM SCI, V19, P1013, DOI 10.1002/app.1975.070190410
   MAGOSHI J, 1974, KOBUNSHI RONBUNSHU, V31, P463
   MAGOSHI J, 1974, KOBUNSHI RONBUNSHU, V31, P765
   MAGOSHI J, 1994, ACS SYM SER, V544, P292
   MAGOSHI J, 1985, J APPL POLYM SCI APP, V41, P187
   MAGOSHI J, 1997, SEN-I GAKKAISHI, V53, P87
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   Ono SS, 1999, J PHYS CHEM B, V103, P6909, DOI 10.1021/jp990735u
   Rinia HA, 2000, BIOCHEMISTRY-US, V39, P5852, DOI 10.1021/bi000010c
   Shen Y, 1998, MACROMOLECULES, V31, P8857, DOI 10.1021/ma980281j
   Sohn D, 1999, LANGMUIR, V15, P1698, DOI 10.1021/la980885g
   TANAKA K, 1999, BIOCHIM BIOPHYS ACTA, V92, P1432
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P243, DOI 10.1002/polb.1994.090320205
   TSUKADA M, 1995, J POLYM SCI POL PHYS, V33, P1995, DOI 10.1002/polb.1995.090331402
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P237, DOI 10.1016/S0141-8130(99)00002-1
   Willcox PJ, 1996, MACROMOLECULES, V29, P5106, DOI 10.1021/ma960588n
   Zhang WK, 2000, LANGMUIR, V16, P4305, DOI 10.1021/la991230y
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 40
TC 26
Z9 26
U1 1
U2 25
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD SEP 1
PY 2003
VL 440
IS 1-2
BP 208
EP 216
DI 10.1016/S0040-6090(03)00460-7
PG 9
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 715BU
UT WOS:000184951300032
DA 2018-10-19
ER

PT J
AU Eurell, TE
   Brown, DR
   Gerding, PA
   Hamor, RE
AF Eurell, TE
   Brown, DR
   Gerding, PA
   Hamor, RE
TI Alginate as a new biomaterial for the growth of porcine retinal pigment
   epithelium
SO VETERINARY OPHTHALMOLOGY
LA English
DT Article
DE alginate; melanosomes; porcine; retinal pigment epithelium; tissue
   culture; transdifferentiation
ID DENSITY-DEPENDENT GROWTH; HUMAN BRUCHS MEMBRANE; CELLS IN-VITRO; MACULAR
   DEGENERATION; RPE CELLS; CULTURE; MATRIX; TRANSDIFFERENTIATION;
   TRANSPLANTATION; NUMBER
AB Objective Determine the effect of a 3-dimensional alginate matrix on the growth and differentiation of cells isolated from porcine retinal pigment epithelium (RPE).
   Procedures Porcine RPE cells were harvested from enucleated eyecups, isolated by differential gravity sedimentation and cultured in either alginate alone (Group 1) or on plastic tissue culture plates followed by alginate (Group 2). Group 1 cells were cultured in alginate to evaluate the efficacy of the matrix as a culture medium. Group 2 cells were initially cultured on plastic to induce dedifferentiation. The cells were then harvested, suspended in alginate beads, and incubated for a second culture period to determine if the induced dedifferentiation was reversible.
   Results The number of Group 1 cells was significantly greater (Pless than or equal to0.01) at the end of the culture period. The amount of pigment and cell morphology of Group 1 cells at the end of the culture period was similar to that seen at initial cell isolation. The initial culture of Group 2 cells on plastic showed characteristic features of dedifferentiation marked by the loss of pigment and alterations in microscopic appearance. Secondary culture of dedifferentiated Group 2 cells in alginate beads resulted in a return to pigmentation and characteristic morphology for a majority of the cultured cells.
   Conclusions Porcine RPE cells can be propagated in alginate culture with a significant increase in cell numbers while maintaining normal morphology. Under the conditions described in the present study, the dedifferentiation of porcine RPE induced by standard in vitro culture methods is reversible.
C1 Univ Illinois, Coll Vet Med, Dept Vet Biosci, Urbana, IL 61801 USA.
RP Eurell, TE (reprint author), Univ Illinois, Coll Vet Med, Dept Vet Biosci, Urbana, IL 61801 USA.
CR Algvere PV, 1997, GRAEF ARCH CLIN EXP, V235, P149, DOI 10.1007/BF00941722
   BHATT NS, 1994, AM J OPHTHALMOL, V117, P214, DOI 10.1016/S0002-9394(14)73079-X
   Burke JM, 1996, EXP EYE RES, V62, P63, DOI 10.1006/exer.1996.0008
   Campbell CH, 2002, FASEB J, V16, P1917, DOI 10.1096/fj.02-0182com
   CAMPOCHIARO PA, 1993, EXP EYE RES, V57, P539, DOI 10.1006/exer.1993.1158
   CASOROLIMARANO RP, 1999, INVEST OPHTHALMOL, V40, P2062
   Delori FC, 2000, INVEST OPHTH VIS SCI, V41, P496
   DELPRIORE LV, 1988, ARCH OPHTHALMOL-CHIC, V106, P1286
   DOREY CK, 1990, EXP EYE RES, V50, P1, DOI 10.1016/0014-4835(90)90003-D
   Durlu YK, 1997, CELL TRANSPLANT, V6, P149, DOI 10.1016/S0963-6897(96)00142-X
   Gettins PGW, 2002, BIOL CHEM, V383, P1677, DOI 10.1515/BC.2002.188
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   GRIERSON I, 1994, EYE, V8, P255
   GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X
   Ho TC, 1997, INVEST OPHTH VIS SCI, V38, P1110
   Ishida M, 1998, CURR EYE RES, V17, P392, DOI 10.1080/02713689808951220
   KENNEDY A, 1993, CURR EYE RES, V12, P693, DOI 10.3109/02713689308995764
   Kim KS, 1998, CURR EYE RES, V17, P962, DOI 10.1076/ceyr.17.10.962.5243
   Lee SC, 2001, OPHTHALMIC RES, V33, P80, DOI 10.1159/000055648
   Marmor M, 1998, RETINAL PIGMENT EPIT, P3
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   MAYERSON PL, 1985, INVEST OPHTH VIS SCI, V26, P1599
   MAZURE A, 1992, INVEST OPHTH VIS SCI, V33, P3407
   Perka C, 2000, J BIOMED MATER RES, V49, P305, DOI 10.1002/(SICI)1097-4636(20000305)49:3<305::AID-JBM2>3.3.CO;2-0
   Peters S, 2000, OPHTHALMIC RES, V32, P52, DOI 10.1159/000055589
   REH TA, 1987, NATURE, V330, P68, DOI 10.1038/330068a0
   Schraermeyer U, 1999, PIGM CELL RES, V12, P219, DOI 10.1111/j.1600-0749.1999.tb00755.x
   Schraermeyer U, 1999, EXP EYE RES, V68, P237, DOI 10.1006/exer.1998.0596
   SIEVING PA, 1999, OPHTHALMOLOGY
   SONG MK, 1990, J CELL PHYSIOL, V143, P196, DOI 10.1002/jcp.1041430127
   Tezel TH, 1996, GRAEF ARCH CLIN EXP, V234, pS89, DOI 10.1007/BF02343054
   Tezel TH, 1999, INVEST OPHTH VIS SCI, V40, P467
   Tezel TH, 1999, OPHTHALMIC RES, V31, P192, DOI 10.1159/000055532
   Tezel TH, 1997, CURR EYE RES, V16, P802, DOI 10.1076/ceyr.16.8.802.8981
   TEZEL TH, 1996, GRAEFES ARCH CLIN S, V234, P89
   TOTH CA, 1995, OPHTHALMOLOGY, V102, P272
   VIELKIND U, 1988, PIGM CELL RES, V1, P419, DOI 10.1111/j.1600-0749.1988.tb00146.x
   YAGI K, 1993, ARTIF ORGANS, V17, P929
   Zhao SL, 1997, INT REV CYTOL, V171, P225
   Zhu M, 1998, AUST NZ J OPHTHALMOL, V26, pS50, DOI 10.1111/j.1442-9071.1998.tb01371.x
NR 42
TC 5
Z9 5
U1 0
U2 7
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1463-5216
J9 VET OPHTHALMOL
JI Vet. Ophthalmol.
PD SEP
PY 2003
VL 6
IS 3
BP 237
EP 243
DI 10.1046/j.1463-5224.2003.00300.x
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA 725JT
UT WOS:000185540900008
PM 12950655
DA 2018-10-19
ER

PT J
AU Carrilho, ENVM
   Nobrega, JA
   Gilbert, TR
AF Carrilho, ENVM
   Nobrega, JA
   Gilbert, TR
TI The use of silica-immobilized brown alga (Pilayella littoralis) for
   metal preconcentration and determination by inductively coupled plasma
   optical emission spectrometry
SO TALANTA
LA English
DT Article
DE Pilayella littoralis; biosorbent; metal preconcentration; flow
   injection; ICP-OES; GFAAS
ID ATOMIC-ABSORPTION SPECTROMETRY; FLOW-INJECTION ANALYSIS;
   CHLORELLA-VULGARIS; MARINE-ALGAE; HEAVY-METALS; TRACE-METALS;
   BIOSORPTION; SYSTEM; BIOMASS; BINDING
AB The brown alga Pilayella littoralis was used as a new biosorbent in an on-line metal preconcentration procedure in a flow-injection system. Al, Co, Cu and Fe were determined in lake water samples by inductively coupled plasma optical emission spectrometry (ICP-OES) after preconcentration in a silica-immobilized alga column. Like other algae, P. littoralis exhibited strong affinity for these metals proving to be an effective accumulation medium. Metals were bound at pH 5.5 and were displaced at pH < 2 with diluted HCl. The enrichment factors for Cu-II, Fe-III, Al-III and Co-II were 13, 7, 16 and 11, respectively. Metal sorption efficiency ranged from 86 to 90%. The method accuracy was assessed by using drinking water certified reference material and graphite furnace atomic absorption spectrometry (GFAAS) as a comparison technique. The column procedure allowed a less time consuming, easy regeneration of the biomaterial and rigidity of the alga provided by its immobilization on silica gel. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Fed Sao Carlos, Dept Quim, BR-13560970 Sao Carlos, SP, Brazil.
   Northeastern Univ, Dept Chem, Boston, MA 02115 USA.
   Northeastern Univ, Barnett Inst, Boston, MA 02115 USA.
RP Carrilho, ENVM (reprint author), UNESP, FCAV, Depto Zootecnia Nutricao Anim, Via Acesso Prof Paulo D Castellane S-N, BR-14884900 Jaboticabal, SP, Brazil.
OI Nobrega, Joaquim/0000-0001-9134-9547
CR BARKLEY NP, 1991, J AIR WASTE MANAGE, V41, P1387, DOI 10.1080/10473289.1991.10466935
   Carrilho ENVM, 2000, J ENVIRON MONITOR, V2, P410, DOI 10.1039/b004128i
   Carrilho ENVM, 2002, ENVIRON SCI TECHNOL, V36, P2003, DOI 10.1021/es0107834
   Commission on Spectrochemical and Other Optical Procedures for Analysis, 1978, SPECTROCHIM ACTA B, V33, P241
   DARNALL D W, 1986, P1
   ELMAHADI HAM, 1991, J ANAL ATOM SPECTROM, V6, P643, DOI 10.1039/ja9910600643
   FANG ZL, 1984, ANAL CHIM ACTA, V164, P23, DOI 10.1016/S0003-2670(00)85614-7
   FANG ZL, 1989, J ANAL ATOM SPECTROM, V4, P543, DOI 10.1039/ja9890400543
   FANG ZL, 1991, SPECTROCHIM ACTA REV, V14, P235
   Figueira MM, 2000, WATER RES, V34, P196, DOI 10.1016/S0043-1354(99)00120-7
   GARNHAM GW, 1992, ENVIRON SCI TECHNOL, V26, P1764, DOI 10.1021/es00033a008
   Gupta VK, 2001, WATER RES, V35, P4079, DOI 10.1016/S0043-1354(01)00138-5
   Hamdy AA, 2000, CURR MICROBIOL, V41, P232, DOI 10.1007/s002840010126
   HARRIS PO, 1990, ENVIRON SCI TECHNOL, V24, P220, DOI 10.1021/es00072a011
   HARTENSTEIN SD, 1985, ANAL CHEM, V57, P21, DOI 10.1021/ac00279a010
   HOLAN ZR, 1993, BIOTECHNOL BIOENG, V41, P819, DOI 10.1002/bit.260410808
   KRUG FJ, 1986, ANAL CHIM ACTA, V179, P103, DOI 10.1016/S0003-2670(00)84457-8
   LIU Y, 1989, ANAL CHEM, V61, P520, DOI 10.1021/ac00181a004
   Lopez-Suarez CE, 2000, TALANTA, V50, P1313, DOI 10.1016/S0039-9140(99)00214-3
   MAHAN CA, 1992, SPECTROCHIM ACTA B, V47, P1483, DOI 10.1016/0584-8547(92)80138-7
   MAHAN CA, 1992, ANAL CHEM, V64, P1933, DOI 10.1021/ac00041a031
   MALAMAS F, 1984, ANAL CHIM ACTA, V160, P1, DOI 10.1016/S0003-2670(00)84503-1
   MILLER JC, 1988, ANALYST, V113, P1351, DOI 10.1039/an9881301351
   Palmieri MC, 2000, PROCESS BIOCHEM, V36, P441, DOI 10.1016/S0032-9592(00)00236-3
   Romero-Gonzalez ME, 2000, J ANAL ATOM SPECTROM, V15, P1009
NR 25
TC 35
Z9 35
U1 2
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-9140
J9 TALANTA
JI Talanta
PD AUG 29
PY 2003
VL 60
IS 6
BP 1131
EP 1140
DI 10.1016/S0039-9140(03)00217-0
PG 10
WC Chemistry, Analytical
SC Chemistry
GA 716RB
UT WOS:000185041200006
PM 18969139
DA 2018-10-19
ER

PT J
AU Svedhem, S
   Dahlborg, D
   Ekeroth, J
   Kelly, J
   Hook, F
   Gold, J
AF Svedhem, S
   Dahlborg, D
   Ekeroth, J
   Kelly, J
   Hook, F
   Gold, J
TI In situ peptide-modified supported lipid bilayers for controlled cell
   attachment
SO LANGMUIR
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; SELF-ASSEMBLED MONOLAYERS; PROTEIN
   ADSORPTION; VESICLE ADSORPTION; SYNTHETIC PEPTIDE; NEURITE OUTGROWTH;
   A-CHAIN; ADHESION; MEMBRANES; POLYMER
AB The control of cellular interactions with engineered materials is critical for the development of cell-integrated biochips used in cell-based sensors, "lab-on-a-chip" bioanalytical systems, and artificial neuronal networks, as well as medical implants and functional biomaterial scaffolds for tissue engineering. Supported lipid bilayers offer efficient reduction of nonspecific cell and protein binding and, if selectively functionalized, constitute one attractive approach to surface modification strategies of materials used in such devices. The present work describes the in situ modification of supported lipid bilayers through the coupling of a cysteine-terminated peptide to thiol-reactive maleimido lipids incorporated in the bilayer. The accumulation of peptide at the lipid bilayer interface was monitored by the quartz crystal microbalance technique with dissipation monitoring (QCM-D). Coupling of the peptide could be detected by QCM-D with a high signal-to-noise ratio despite its low molecular weight (2 kDa), primarily because the mass uptake included both peptide and the water associated to it. Lipid bilayers that were modified with the cysteine-terminated IKVAV-containing peptide promoted the binding of anti-IKVAV antibodies, as well as the attachment of PC 12 cells, which express a membrane receptor for the IKVAV sequence. Very low nonspecific binding of peptides, proteins, and the cells was observed on nonfunctionalized lipid bilayers. Similarly, IKVAV-functionalized lipid bilayers were resistant to serum protein adsorption as well as the binding of non-IKVAV-specific antibodies. QCM-D and fluorescence recovery after photobleaching revealed that the lipid bilayers persisted under all the experimental conditions used for cell attachment, including staining and fixation. Thus, the described lipid-based surface modification is highly relevant for the development of controlled cell-attachment substrates and can even be applicable for patterning cell attachment because lipid-bilayer formation by vesicle fusion is material-specific.
C1 Chalmers Univ Technol, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
   Univ Gothenburg, S-41296 Gothenburg, Sweden.
   Linkoping Univ, Dept Phys & Measurement Technol, SE-58183 Linkoping, Sweden.
RP Gold, J (reprint author), Chalmers Univ Technol, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
RI Hook, Fredrik/F-6701-2010
CR Andersson AS, 2003, J BIOMED MATER RES A, V64A, P622, DOI 10.1002/jbm.a.10442
   Chalazonitis A, 1997, J NEUROBIOL, V33, P118, DOI 10.1002/(SICI)1097-4695(199708)33:2<118::AID-NEU2>3.0.CO;2-5
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   Dori Y, 2000, J BIOMED MATER RES, V50, P75, DOI 10.1002/(SICI)1097-4636(200004)50:1<75::AID-JBM11>3.0.CO;2-A
   EGGER M, 1992, BIOCHIM BIOPHYS ACTA, V1104, P45, DOI 10.1016/0005-2736(92)90130-E
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Fang Y, 2002, J AM CHEM SOC, V124, P2394, DOI 10.1021/ja017346+
   Glasmastar K, 2002, J COLLOID INTERF SCI, V246, P40, DOI 10.1006/jcis.2001.8060
   Groves JT, 2002, ACCOUNTS CHEM RES, V35, P149, DOI 10.1021/ar950039m
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   Hook F, 2001, LANGMUIR, V17, P8305, DOI 10.1021/la0107704
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Houseman BT, 2003, LANGMUIR, V19, P1522, DOI 10.1021/la0262304
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Hyun JH, 2002, LANGMUIR, V18, P2975, DOI 10.1021/la015712x
   ISHIHARA K, 1993, J BIOMED MATER RES, V27, P1309, DOI 10.1002/jbm.820271011
   Jenkins ATA, 2000, LANGMUIR, V16, P6381, DOI 10.1021/la991649o
   Kam L, 2001, J BIOMED MATER RES, V55, P487, DOI 10.1002/1097-4636(20010615)55:4<487::AID-JBM1041>3.0.CO;2-7
   Keller CA, 2000, PHYS REV LETT, V84, P5443, DOI 10.1103/PhysRevLett.84.5443
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Patel N, 1998, FASEB J, V12, P1447
   Powell SK, 2000, J NEUROSCI RES, V61, P302, DOI 10.1002/1097-4547(20000801)61:3<302::AID-JNR8>3.0.CO;2-G
   Reimhult E, 2002, J CHEM PHYS, V117, P7401, DOI 10.1063/1.1515320
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Ross EE, 2001, LANGMUIR, V17, P2305, DOI 10.1021/la010752
   Ruiz L, 1999, J BIOMAT SCI-POLYM E, V10, P931, DOI 10.1163/156856299X00540
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   SEPHEL GC, 1989, BIOCHEM BIOPH RES CO, V162, P821, DOI 10.1016/0006-291X(89)92384-X
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Viitala T, 2000, LANGMUIR, V16, P4953, DOI 10.1021/la990817+
   Vikholm I, 1999, BBA-BIOMEMBRANES, V1421, P39, DOI 10.1016/S0005-2736(99)00112-1
   Vikholm I, 1998, THIN SOLID FILMS, V327, P643, DOI 10.1016/S0040-6090(98)00731-7
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
NR 39
TC 76
Z9 78
U1 2
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 19
PY 2003
VL 19
IS 17
BP 6730
EP 6736
DI 10.1021/la034172w
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 711YL
UT WOS:000184768600029
DA 2018-10-19
ER

PT J
AU Lewis, G
   Daniels, AU
AF Lewis, G
   Daniels, AU
TI Use of isothermal heat-conduction microcalorimetry (IHCMC) for the
   evaluation of synthetic biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE isothermal heat-conduction microcalorimetry; degradation rate,
   ultra-high-molecular-weight; polyethylene; calcium sulfate; macrophage
   response
ID SOLID-STATE STABILITY; IN-VITRO; METABOLISM; CELLS; DECOMPOSITION;
   POLYETHYLENE; CALORIMETRY; PARTICLES
AB Isothermal heat-conduction microcalorimetry (IHCMC) allows measurement of extremely small rates of heat flow-on the order of 0.1 microwatt. This provides, for example, the ability to directly observe-and quantitate in a few days-rates of degradation as low as 1% per year at body temperature, in solid material samples of a few grams. Also, one method of IHCMC data analysis allows direct determination of the reaction-rate constant at the temperature of interest, thereby avoiding possible errors due to rate mechanism changes with temperature, an issue that needs to be considered when the Arrhenius method is used. IHCMC can also be used to measure transient phenomena, such as heat of adsorption, and initial metabolic responses of cellular entities to biomaterials. The purposes of this review article are to (a) explain the basic principles, attractive features, limitations, and methods of IHCMC; (b) describe biomaterials applications to date-including studies of the stability of ultra-high-molecular-weight polyethylene and implant-grade calcium sulfate, setting reactions of dental adhesives, and macrophage response to biomaterial particles; (c) provide a discussion of issues and concerns that should be addressed in order to maximize the utility of IHCMC in biomaterials studies; and (d) suggest a number of possible future biomaterials applications for this technique. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Memphis, Dept Mech Engn, Memphis, TN 38152 USA.
   Univ Basel, Orthopaed Biomech Lab, Basel, Switzerland.
RP Lewis, G (reprint author), Univ Memphis, Dept Mech Engn, Memphis, TN 38152 USA.
CR ANGBERG M, 1988, ACTA PHARM SUEC, V25, P307
   BACKMAN P, 1992, J CELL PHYSIOL, V150, P99, DOI 10.1002/jcp.1041500114
   BANYAN PF, 1999, THERMOCHIM ACTA, V327, P109
   Charlebois SJ, 2002, J BIOMED MATER RES, V59, P166, DOI 10.1002/jbm.1230
   CHARLEBOIS SJ, 1999, THESIS U MEMPHIS MEM
   *CSC, 1995, CSC 4400 IS MICR US
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   DANIELS AU, 1998, T 24 ANN M SOC BIOM, P348
   DANIELS AU, 2000, T 46 ANN M ORTH RES, P2
   DANIELS AU, 1998, T 14 EUR C BIOM
   DANIELS AU, 1998, MED PLAST BIOMATER, V5, P50
   DANIELS AU, 1998, T 44 ANN M ORTH RES, P101
   DANIELS AU, 1998, T 24 ANN M SOC BIOM, P27
   Forsstrom D, 2000, POLYM DEGRAD STABIL, V67, P263, DOI 10.1016/S0141-3910(99)00123-8
   HANSEN LD, 1990, CAN J CHEM, V68, P2111, DOI 10.1139/v90-321
   HANSEN LD, 1996, PHARM TECHNOL, V20, P64
   HANSEN LD, 2001, THERMOCHIM ACTA, V382, P161
   HARDISON A, 2001, T 27 SOC BIOM ST PAU, P82
   HARDISON A, 2001, THESIS U MEMPHIS MEM
   IKOMIKUMM J, 1991, BLOOD PURIFICAT, V9, P177, DOI 10.1159/000170015
   KEMP RB, 1990, THERMOCHIM ACTA, V172, P61, DOI 10.1016/0040-6031(90)80559-H
   KOENIGBAUER MJ, 1992, PHARMACEUT RES, V9, P939, DOI 10.1023/A:1015865319250
   KUHN KD, 2000, BONE CEMENTS UP TO D
   LEWIS EA, 1997, COMMUNICATION    SEP
   Lewis G, 2001, BIOMATERIALS, V22, P371, DOI 10.1016/S0142-9612(00)00195-2
   Lewis G, 1998, BIO-MED MATER ENG, V8, P285
   MICHAELS AS, 1961, J POLYM SCI, V50, P393, DOI 10.1002/pol.1961.1205015411
   Mohsen NM, 1998, J BIOMED MATER RES, V40, P224, DOI 10.1002/(SICI)1097-4636(199805)40:2<224::AID-JBM7>3.3.CO;2-I
   NASSBERGER L, 1987, HUM TOXICOL, V6, P223, DOI 10.1177/096032718700600309
   NG WL, 1975, AUST J CHEM, V28, P1169, DOI 10.1071/CH9751169
   PARSSON H, 1995, J BIOMED MATER RES, V29, P519, DOI 10.1002/jbm.820290412
   Phipps Mark A., 2000, Pharmaceutical Science and Technology Today, V3, P9, DOI 10.1016/S1461-5347(99)00227-8
   PIKAL MJ, 1989, INT J PHARM, V50, P233, DOI 10.1016/0378-5173(89)90127-0
   Spink C, 1976, Methods Biochem Anal, V23, P1, DOI 10.1002/9780470110430.ch1
   TAN XY, 1992, PHARMACEUT RES, V9, P1203, DOI 10.1023/A:1015816225127
   THOMAS A, 1999, STUDY VARIOUS BONE C
   THOREN SA, 1990, BIOCHIM BIOPHYS ACTA, V1033, P305, DOI 10.1016/0304-4165(90)90138-M
   Wadso I, 2000, THERMOCHIM ACTA, V347, P73, DOI 10.1016/S0040-6031(99)00418-9
   WILLSON RJ, 1995, J PHYS CHEM-US, V99, P7108, DOI 10.1021/j100018a051
   Zimehl R, 2002, THERMOCHIM ACTA, V382, P161, DOI 10.1016/S0040-6031(01)00726-2
NR 40
TC 16
Z9 16
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG 15
PY 2003
VL 66B
IS 2
BP 487
EP 501
DI 10.1002/jbm.b.10044
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 707TE
UT WOS:000184525300001
PM 12861599
DA 2018-10-19
ER

PT J
AU Cirioni, O
   Giacometti, A
   Ghiselli, R
   Dell'Acqua, G
   Gov, Y
   Kamysz, W
   Lukasiak, J
   Mocchegiani, F
   Orlando, F
   D'Amato, G
   Balaban, N
   Saba, V
   Scalise, G
AF Cirioni, O
   Giacometti, A
   Ghiselli, R
   Dell'Acqua, G
   Gov, Y
   Kamysz, W
   Lukasiak, J
   Mocchegiani, F
   Orlando, F
   D'Amato, G
   Balaban, N
   Saba, V
   Scalise, G
TI Prophylactic efficacy of topical temporin A and RNAIII-inhibiting
   peptide in a subcutaneous rat pouch model of graft infection
   attributable to staphylococci with intermediate resistance to
   glycopeptides
SO CIRCULATION
LA English
DT Article
DE vasculature; grafting; infection; peptides
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; ANTIMICROBIAL PEPTIDES; VANCOMYCIN
   RESISTANCE; ANTIBIOTIC-RESISTANCE; AUREUS PATHOGENESIS; BIOFILM
   FORMATION; EPIDERMIDIS; PREVENTION; CATHETERS; TARGET
AB Background-Bacteria that adhere to implanted medical devices play an important role in industry and in modern medicine. Staphylococci are among the most common pathogens that cause biomaterial infections. Vascular prosthetic graft infection is one of the most feared complications that the vascular surgeon treats, frequently resulting in prolonged hospitalization, organ failure, amputation, and death. A rat model was used to investigate the topical efficacies of temporin A and the quorum-sensing inhibitor RNAIII-inhibiting protein ( RIP) as prophylactic agents of vascular prosthetic graft infections caused by Staphylococcus aureus and Staphylococcus epidermidis with intermediate resistance to glycopeptides.
   Methods and Results-Graft infections were established in the back subcutaneous tissue of adult male Wistar rats by implantation of Dacron prostheses 1 cm(2) followed by topical inoculation with 2 x 10(7) colony-forming units of bacterial strains. The study included, for each staphylococcal strain, a control group ( no graft contamination), a contaminated group that did not receive antibiotic prophylaxis, and 6 contaminated groups that received grafts soaked with temporin A, RIP, rifampin, temporin A plus RIP, RIP plus rifampin, or temporin A plus RIP. The infection was evaluated by quantitative agar culture. When tested alone, temporin A and RIP showed comparable efficacies, and their efficacies were significantly higher than that of rifampin against both strains. All combinations showed efficacies significantly higher than that of each single compound. The combinations of temporin A and RIP exerted the strongest antistaphylococcal efficacies, eliminating infection by 100%.
   Conclusions-The results of the present study make these molecules potentially useful for antimicrobial chemoprophylaxis in vascular surgery.
C1 Univ Ancona, Inst Infect Dis & Publ Hlth, I-60128 Ancona, Italy.
   Univ Ancona, Dept Gen Surg, I-60128 Ancona, Italy.
   Univ Ancona, Ctr Biotechnol, Dept Res, I-60128 Ancona, Italy.
   Arval Biol Labs, Conthey, Switzerland.
   Tel Aviv Univ, Dept Human Microbiol, Sackler Sch Med, IL-69978 Tel Aviv, Israel.
   Med Univ Gdansk, Fac Pharm, Gdansk, Poland.
RP Giacometti, A (reprint author), Osped Reg, Clin Malattie Infett, Via Conca, I-60200 Torrette Ancona, Italy.
OI Kamysz, Wojciech/0000-0001-5335-3043; MOCCHEGIANI,
   FEDERICO/0000-0002-8833-5360; Orlando, Fiorenza/0000-0001-7351-4430
CR Balaban N, 2000, PEPTIDES, V21, P1301, DOI 10.1016/S0196-9781(00)00272-2
   Balaban N, 2003, J INFECT DIS, V187, P625, DOI 10.1086/345879
   Balaban N, 2003, KIDNEY INT, V63, P340, DOI 10.1046/j.1523-1755.2003.00733.x
   Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438
   Balaban N, 2001, J BIOL CHEM, V276, P2658, DOI 10.1074/jbc.M005446200
   Barie PS, 1998, WORLD J SURG, V22, P118, DOI 10.1007/s002689900359
   BERGAMINI TM, 1994, J SURG RES, V56, P393
   BERGAMINI TM, 1995, ARCH SURG-CHICAGO, V130, P1345
   BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.biochem.59.1.395
   Biavasco F, 2000, EUR J CLIN MICROBIOL, V19, P403, DOI 10.1007/s100960000299
   CHERVU A, 1991, J VASC SURG, V14, P521, DOI 10.1016/0741-5214(91)90246-Q
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DASCHNER FD, 1995, EUR J CLIN MICROBIOL, V14, pS12
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Douglas J.L., 1992, INFECT ENDOCARDITIS, P375
   GHISELLI R, 2002, J VASC SURG, V36, P1
   Gov Y, 2001, PEPTIDES, V22, P1609, DOI 10.1016/S0196-9781(01)00496-X
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856
   HANCOCK REW, 1994, HEART ARTERIES VEINS, P1539
   Harjunpaa I, 1999, FEBS LETT, V449, P187, DOI 10.1016/S0014-5793(99)00406-8
   Henke PK, 1998, AM SURGEON, V64, P39
   Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   MAKI DG, 1994, INFECT ASS INDWELLIN, P1552
   McManus AT, 1998, ARCH SURG-CHICAGO, V133, P1207, DOI 10.1001/archsurg.133.11.1207
   *NAT COMM CLIN LAB, 2001, M7A5 NAT COMM CLIN L
   National Committee for Clinical Laboratory Standards, 2001, M2A7 NAT COMM CLIN L
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Raad I, 1998, CLIN INFECT DIS, V26, P1182, DOI 10.1086/520285
   Sardelic F, 1996, Cardiovasc Surg, V4, P389, DOI 10.1016/0967-2109(95)00075-5
   Schroder JM, 1999, CELL MOL LIFE SCI, V56, P32, DOI 10.1007/s000180050004
   SCHWALBE RS, 1987, NEW ENGL J MED, V316, P927, DOI 10.1056/NEJM198704093161507
   Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x
   Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#
   Srinivasan A, 2002, CLIN MICROBIOL REV, V15, P430, DOI 10.1128/CMR.15.3.430-438.2002
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Veenstra DL, 1999, JAMA-J AM MED ASSOC, V281, P261, DOI 10.1001/jama.281.3.261
   VONEIFF C, 1999, EUR J CLIN MICROBIOL, V18, P853
   Wade D, 2000, FEBS LETT, V479, P6, DOI 10.1016/S0014-5793(00)01754-3
   Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9
   Zhao HX, 2002, BIOCHEMISTRY-US, V41, P4425, DOI 10.1021/bi011929e
NR 42
TC 57
Z9 59
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD AUG 12
PY 2003
VL 108
IS 6
BP 767
EP 771
DI 10.1161/01.CIR.0000083717.85060.16
PG 5
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 710ZM
UT WOS:000184712700025
PM 12885754
OA Bronze
DA 2018-10-19
ER

PT J
AU Thakar, RG
   Ho, F
   Huang, NF
   Liepmann, D
   Li, S
AF Thakar, RG
   Ho, F
   Huang, NF
   Liepmann, D
   Li, S
TI Regulation of vascular smooth muscle cells by micropatterning
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE smooth muscle cells; morphology; phenotype; micropatterning;
   proliferation; PLGA
ID SOFT LITHOGRAPHY; GENE-EXPRESSION; BLOOD-VESSELS; DIFFERENTIATION;
   PROLIFERATION; RESTENOSIS; CULTURE; TISSUES; BIOLOGY
AB Vascular smooth muscle cells (SMCs) undergo morphological and phenotypic changes when cultured in vitro. To investigate whether SMC morphology regulates SMC functions, bovine aortic SMCs were grown on micropatterned collagen strips (50-, 30-, and 20-mum wide). The cell shape index and proliferation rate of SMCs on 30- and 20-mum strips were significantly lower than those on non-patterned collagen (control), and the spreading area was decreased only for cells patterned on the 20-mum strips, suggesting that SMC proliferation is dependent on cell shape index. The formation of actin stress fibers and the expression of alpha-actin were decreased in SMCs on the 20- and 30-mum collagen strips. SMCs cultured on micropatterned biomaterial poly-(D,L-lactide-co-glycolide) (PLGA) with 30-mum wide grooves also showed lower proliferation rate and less stress fibers than SMCs on non-patterned PLGA. Our findings suggest that micropatterned matrix proteins and topography can be used to control SMC morphology and that elongated cell morphology decreases SMC proliferation but is not sufficient to promote contractile phenotype. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Ctr Tissue Engn, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Joint Grad Program Bioengn, Berkeley, CA 94720 USA.
   Univ Calif San Francisco, Joint Grad Program Bioengn, San Francisco, CA 94143 USA.
RP Li, S (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
OI Huang, Ngan/0000-0003-2298-6790
CR Bauters C, 1997, PROG CARDIOVASC DIS, V40, P107, DOI 10.1016/S0033-0620(97)80003-5
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Folch A, 1998, BIOTECHNOL PROGR, V14, P388, DOI 10.1021/bp980037b
   GILBERTSONBEADLING SK, 1993, LAB INVEST, V69, P203
   Hadlock T, 1999, LARYNGOSCOPE, V109, P1412, DOI 10.1097/00005537-199909000-00010
   Halayko AJ, 2001, J APPL PHYSIOL, V90, P358
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Li S, 2001, BIORHEOLOGY, V38, P101
   Li Song, 2003, FASEB Journal, V17, P97
   Libby P, 1997, PROG CARDIOVASC DIS, V40, P97, DOI 10.1016/S0033-0620(97)80002-3
   Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005
   Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200
   Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   Musey PI, 2002, ANN NY ACAD SCI, V961, P279, DOI 10.1111/j.1749-6632.2002.tb03102.x
   Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303
   OWENS GK, 1995, PHYSIOL REV, V75, P487
   Reusch P, 1996, CIRC RES, V79, P1046, DOI 10.1161/01.RES.79.5.1046
   Shanahan CM, 1998, ARTERIOSCL THROM VAS, V18, P333, DOI 10.1161/01.ATV.18.3.333
   Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170
   Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Thyberg J, 1996, INT REV CYTOL, V169, P183, DOI 10.1016/S0074-7696(08)61987-7
   UGLOW EB, 2003, CIRC RES
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
NR 28
TC 129
Z9 133
U1 5
U2 26
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 8
PY 2003
VL 307
IS 4
BP 883
EP 890
DI 10.1016/S0006-291X(03)01285-3
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 707KP
UT WOS:000184510100021
PM 12878194
DA 2018-10-19
ER

PT J
AU Park, JH
   Bae, YH
AF Park, JH
   Bae, YH
TI Hydrogels based on poly(ethylene oxide) and poly(tetramethylene oxide)
   or poly(dimethyl siloxane). II. Physical properties and bacterial
   adhesion
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE hydrogels; physical properties; biocompatibility; biomaterials
ID POLYURETHANE SURFACES; MULTIBLOCK COPOLYMERS; FIBRINOGEN ADSORPTION;
   BIOMATERIAL SURFACES; THROMBUS COMPONENTS; DIBLOCK COPOLYMERS;
   ATTACHMENT; POLYMERS; SEGMENTS
AB To investigate the effects of polymer chemistry and topology on physical properties and bacterial adhesion, various hydrogels composed of short hydrophilic [poly(ethylene oxide) (PEO)] and hydrophobic blocks were synthesized by polycondensation reactions. Differential scanning calorimetry and X-ray diffraction analysis confirmed that all of the hydrogels were strongly phase-separated due to incompatibility between PEO and hydrophobic blocks such as poly(tetramethylene oxide) (PTMO) and poly(dimethyl siloxane) (PDMS). The crystallization of PEO in the hydrogels was enhanced by the incorporation of longer PEO chains, the adoption of PDMS as a hydrophobic block, and the grafting of monomethoxy poly(ethylene oxide) (MPEO). Compared to Pellethane, the control polymer, the hydrogels exhibited higher Young's moduli and elongations at break, which was attributed to the crystalline domains of PEO and the flexible characteristics of the hydrophobic blocks. The mechanical properties of the hydrogels, however, significantly deteriorated when they were hydrated in distilled water; this was primarily ascribed to the disappearance of PEO crystallity. The water capacity of hydrogels at 37degreesC in phosphate-buffered saline (PBS) (pH = 7.4) was dominantly dependant on PEO content, which also influenced the thermonegative swelling behavior. From the bacterial adhesion tests, it was evident that both S. epidermidis and E. coli adhered to Pellethane much greater than to the hydrogels, regardless of the preadsorption of albumin. Better resistance to bacterial adhesion was observed in hydrogels with longer PEO chains, with PTMO as a hydrophobic block, and with MPEO grafts. The least bacterial adhesion for both species was achieved on MPEO(2k)-PTMO, a hydrogel with MPEO grafts. (C) 2003 Wiley Periodicals, Inc.
C1 Kwangju Inst Sci & Technol, Ctr Biomat & Biotechnol, Dept Mat Sci & Engn, Puk Gu, Kwangju 500712, South Korea.
RP Bae, YH (reprint author), Kwangju Inst Sci & Technol, Ctr Biomat & Biotechnol, Dept Mat Sci & Engn, Puk Gu, 1 Oryong Dong, Kwangju 500712, South Korea.
EM you.bae@m.cc.utah.edu
RI byun, jaehyun/G-5584-2014; Park, Jae Hyung/B-5967-2018
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Antonsen K.P, 1992, POLYETHYLENE GLYCOL, P15
   ANTTIPOIKA I, 1990, ACTA ORTHOP SCAND, V61, P163, DOI 10.3109/17453679009006513
   Baumgartner JN, 1998, J BIOMED MATER RES, V40, P660, DOI 10.1002/(SICI)1097-4636(19980615)40:4<660::AID-JBM18>3.0.CO;2-J
   Baumgartner JN, 1996, ASAIO J, V42, pM476, DOI 10.1097/00002480-199609000-00033
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   Chang Y, 2000, MACROMOLECULES, V33, P4496, DOI 10.1021/ma9908853
   Cho CS, 2000, POLYMER, V41, P5185, DOI 10.1016/S0032-3861(99)00746-6
   CHU JH, 1995, POLYMER, V36, P1569, DOI 10.1016/0032-3861(95)99001-B
   Deslandes Y, 1998, POLYMER, V39, P2361, DOI 10.1016/S0032-3861(97)00533-8
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   FLETCHER M, 1982, APPL ENVIRON MICROB, V44, P184
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Graham N. B., 1992, POLYETHYLENE GLYCOL, P263
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1996, BIOMATERIALS SCI INT, P205
   Huh KM, 1999, POLYMER, V40, P6147, DOI 10.1016/S0032-3861(98)00822-2
   Iza M, 1998, J CONTROL RELEASE, V52, P41, DOI 10.1016/S0168-3659(97)00191-0
   Kong XH, 2000, EUR POLYM J, V36, P1085, DOI 10.1016/S0014-3057(99)00186-X
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PASQUALE GD, 1997, MACROMOL RAPID COMM, V18, P267
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   PEPPAS NA, 1987, HYDROGELS MED PHARMA, V3
   Petrova T, 1998, POLYM INT, V45, P419
   PEZRON E, 1988, MACROMOLECULES, V21, P1121, DOI 10.1021/ma00182a045
   PRINGLE JH, 1986, APPL ENVIRON MICROB, V51, P1321
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   SLACK SM, 1991, J BIOMAT SCI-POLYM E, V3, P49
   TANAKA F, 1992, MACROMOLECULES, V25, P1516, DOI 10.1021/ma00031a024
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   Youxin L., 1993, J CONTROL RELEASE, V27, P247
NR 36
TC 7
Z9 7
U1 1
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 8
PY 2003
VL 89
IS 6
BP 1505
EP 1514
DI 10.1002/app.12217
PG 10
WC Polymer Science
SC Polymer Science
GA 687BK
UT WOS:000183355800008
DA 2018-10-19
ER

PT J
AU Tang, YW
   Labow, RS
   Santerre, JP
AF Tang, YW
   Labow, RS
   Santerre, JP
TI Isolation of methylene dianiline and aqueous-soluble biodegradation
   products from polycarbonate-polyurethanes
SO BIOMATERIALS
LA English
DT Article
DE biodegradation; polyurethanes; polycarbonate-urethanes; enzymes;
   methylene dianiline; macrophages; cholesterol esterase
ID ENZYME-INDUCED BIODEGRADATION; CHOLESTEROL ESTERASE; BIOSTABILITY;
   DEGRADATION; DEPENDENCE; URETHANES
AB Polycarbonate-polyurethanes (PCNUs) have provided the medical device industry with practical alternatives to oxidation-sensitive polyether-urethanes (PEUs). To date, many studies have focused on PCNUs synthesized with 4,4'-methylene diphenyl-diisocyanate (MDI). The relative hydrolytic stability of this class of polyurethanes is actually quite surprising given the inherent hydrolytic potential of the aliphatic carbonate group. Yet, there has been little information reporting on the rationale for the material's demonstrated hydrolytic stability. Recent work has shown that PCNU materials have a strong sensitivity towards hydrolysis when changes are made to their hard segment content and/or chemistry. However, knowledge is specifically lacking in regards of the identification of cleavage sites and the specific nature of the biodegradation products. Using high-performance liquid chromatography. radiolabel tracers and mass spectrometry, the current study provides insight into the distribution of biodegradation products from the enzyme-catalyzed hydrolysis of five different PCNUs. The hydrolytic sensitivity of the materials is shown to be related to the distribution of products, which itself is a direct consequence of unique micro-structures formed within the different materials. While an MDI-based polymer was shown to be the most hydrolytically stable material, it was the only PCNU that produced its diamine analog, in this case 4,4'-methylene dianiline (MDA), as a degradation product. Given the concern over aromatic diamine toxicity, this finding is important and highlights the fact that relative biostability is a distinct issue from that of degradation product toxicity, and that both must be considered separately when assessing the impact of biodegradation on biomaterial in vivo compatibility. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Toronto, Fac Dent, Dept Biomat, Toronto, ON M5G 1G6, Canada.
   Univ Ottawa, Inst Heart, Div Cardiovasc, Ottawa, ON K1Y 4W7, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biomat, 124 Edward St, Toronto, ON M5G 1G6, Canada.
CR AMIN P, 1993, J BIOMED MATER RES, V27, P655, DOI 10.1002/jbm.820270513
   Anderson JM, 1998, POLYM INT, V46, P163, DOI 10.1002/(SICI)1097-0126(199807)46:3<163::AID-PI972>3.0.CO;2-9
   BENOIT FM, 1993, J BIOMED MATER RES, V27, P1341, DOI 10.1002/jbm.820271014
   CHAPMAN TM, 1989, J POLYM SCI POL CHEM, V27, P1993, DOI 10.1002/pola.1989.080270620
   COOPER SL, 1976, ENCY POLYM SCI TECHN, V1, P521
   DARBY TD, 1978, TOXICOL APPL PHARM, V46, P449, DOI 10.1016/0041-008X(78)90090-X
   Feaster SR, 1996, BIOCHEMISTRY-US, V35, P16723, DOI 10.1021/bi961677v
   FINER Y, 1999, P 25 ANN M SOC BIOM, P318
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   MAZZU AL, 1984, J BIOMED MATER RES, V18, P961, DOI 10.1002/jbm.820180810
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   Suyama T, 1997, ENZYME MICROB TECH, V20, P122, DOI 10.1016/S0141-0229(96)00084-1
   Szycher M, 1991, J Biomater Appl, V5, P323, DOI 10.1177/088532829100500404
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   Vermette P, 1999, J BIOMAT SCI-POLYM E, V10, P729, DOI 10.1163/156856299X00612
   WANG FGB, 1997, P 23 AM SOC BIOM M N, P451
   WANG FGB, 1998, P 24 ANN M SOC BIOM, P393
   Wang GB, 1997, J BIOMED MATER RES, V36, P407, DOI 10.1002/(SICI)1097-4636(19970905)36:3<407::AID-JBM16>3.3.CO;2-U
NR 24
TC 41
Z9 44
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2003
VL 24
IS 17
BP 2805
EP 2819
DI 10.1016/S0142-9612(03)00081-4
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 679TD
UT WOS:000182937300001
PM 12742719
DA 2018-10-19
ER

PT J
AU Cheng, MY
   Deng, JU
   Yang, F
   Gong, YD
   Zhao, NM
   Zhang, XF
AF Cheng, MY
   Deng, JU
   Yang, F
   Gong, YD
   Zhao, NM
   Zhang, XF
TI Study on physical properties and nerve cell affinity of composite films
   from chitosan and gelatin solutions
SO BIOMATERIALS
LA English
DT Article
DE chitosan; gelatin; composite film; mechanical property; nerve cell
   affinity; nerve regeneration
ID SYNTHETIC HYDROGELS; SURFACE WETTABILITY; PROTEIN ADSORPTION;
   MISCIBILITY; BLEND
AB A series of chitosan-gelatin composite films was prepared by varying the ratio of constituents. FT-IR and X-ray analysis showed good compatibility between these two biopolymers. Differential scanning calorimetry (DSC) analysis indicated that the water take-up of chitosan film increased when blended with gelatin. Composite film exhibited a lower Young's modulus and a higher percentage of elongation-at-break compared with chitosan film, especially in wet state. All composite films were hydrophilic materials with water contact angles ranging from 55degrees to 65degrees. The results obtained from ELISA indicated the adsorption amount of fibronectin oil composite films was much higher than on chitosan film. PC 12 cells culture was used to evaluate the nerve cell affinity of materials. The cells cultured on the composite film with 60wt% gelatin differentiated more rapidly and extended longer neurites than on chitosan film. The results suggest that the soft and elastic complex of chitosan and gelatin, which has better nerve cell affinity compared to chitosan, is a promising candidate biomaterial for nerve regeneration. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
RP Zhang, XF (reprint author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.
CR BARNES A, 1988, POLYMER, V29, P2191, DOI 10.1016/0032-3861(88)90111-5
   Borkenhagen M, 1998, J BIOMED MATER RES, V40, P392, DOI 10.1002/(SICI)1097-4636(19980603)40:3<392::AID-JBM8>3.0.CO;2-C
   BULTER BL, 1996, J FOOD SCI, V61, P953
   Burns NL, 1996, J COLLOID INTERF SCI, V178, P116, DOI 10.1006/jcis.1996.0099
   CORKHILL PH, 1990, POLYMER, V31, P1526, DOI 10.1016/0032-3861(90)90161-Q
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   GEORGIEV IL, 2000, WATER RES, V34, P1503
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   HUNG TK, 1980, J BIOMECH, V14, P269
   KIM JH, 1993, POLYMER, V34, P1952, DOI 10.1016/0032-3861(93)90441-C
   Kuo SW, 2001, POLYMER, V42, P9843, DOI 10.1016/S0032-3861(01)00526-2
   KWUNCHIT O, 1997, INT J PHARM, V156, P229
   LEE YM, 1992, POLYM BULL, V29, P423, DOI 10.1007/BF00944840
   LI JC, 1999, TSINGHUA SCI TECHNOL, V4, P1515
   MILLARUELO AI, 1988, BRAIN RES, V466, P219
   NIELSEN LE, 1994, MECH PROPERTIES POLY, P299
   NYGREN H, 1994, BIOPHYS CHEM, V49, P263, DOI 10.1016/0301-4622(93)E0090-R
   Pan Y, 2001, EUR POLYM J, V37, P247, DOI 10.1016/S0014-3057(00)00117-8
   Peppas NA, 1996, BIOMATERIALS SCI, P63
   RUEGG UT, 1984, NEUROSCI LETT, V49, P319, DOI 10.1016/0304-3940(84)90309-4
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   Tokura S, 1996, MACROMOL SYMP, V101, P389, DOI 10.1002/masy.19961010144
   VANWEEME.BK, 1971, FEBS LETT, V15, P232, DOI 10.1016/0014-5793(71)80319-8
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Xu J, 1996, MACROMOLECULES, V29, P3436, DOI 10.1021/ma951638b
   Yin YJ, 1999, POLYM INT, V48, P429, DOI 10.1002/(SICI)1097-0126(199906)48:6<429::AID-PI160>3.3.CO;2-T
NR 26
TC 278
Z9 299
U1 4
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2003
VL 24
IS 17
BP 2871
EP 2880
DI 10.1016/S0142-9612(03)00117-0
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 679TD
UT WOS:000182937300007
PM 12742725
DA 2018-10-19
ER

PT J
AU Thapa, A
   Miller, DC
   Webster, TJ
   Haberstroh, KM
AF Thapa, A
   Miller, DC
   Webster, TJ
   Haberstroh, KM
TI Nano-structured polymers enhance bladder smooth muscle cell function
SO BIOMATERIALS
LA English
DT Article
DE nano-structured; poly(lactide-co-glycolide); poly(ether urethane);
   bladder; cell function
ID POLY(ETHERURETHANE UREA) ELASTOMERS; SURFACE HYDROLYSIS; IN-VITRO;
   ADHESION; SCAFFOLDS; TISSUE; CANCER; BIODEGRADATION; PROLIFERATION;
   STAGE
AB It is the hypothesis of the present study that a biocompatible material which mimics the nanometer topography of native bladder tissue will enhance cellular responses and lead to better tissue integration in vivo. Previous in vitro studies have verified the ability to successfully reduce the surface feature dimensions of poly(lactic-co-glycolic acid) (PLGA) and poly(ether urethane) (PU) films into the nanometer regime via chemical etching procedures. Results from these studies also provided the first evidence that bladder smooth muscle cell adhesion was enhanced on chemically treated nano-structured polymeric surfaces compared to their conventional counterparts. Although cell adhesion is necessary for a biomaterial's success, subsequent cell functions (such as long-term cell growth and proliferation) are also critical for tissue ingrowth and long-term implant survival. The present in vitro study, therefore. investigated the function of bladder smooth muscle cells on these novel, nano-structured polymers over the expanded periods of 1, 3 and 5 days. Results indicated that cell number was influenced by both surface roughness and surface chemistry changes: the important contributor, however, was increased nanometer surface roughness. This claim is supported by the fact that cell number was enhanced on nano-structured compared to conventional PLGA and PU once chemistry changes were eliminated using casting techniques. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Haberstroh, KM (reprint author), Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
FU NCRR NIH HHS [RR01296]
CR Andriano KP, 1999, J BIOMED MATER RES, V48, P602, DOI 10.1002/(SICI)1097-4636(1999)48:5<602::AID-JBM3>3.0.CO;2-6
   ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   AYAD S, 1994, EXTRACELLULAR MATRIX
   Bianco FJ, 1998, CLIN CANCER RES, V4, P3011
   BRAUKER J, 1992, TRANSPLANT P, V24, P2924
   CONLEY MW, 1998, BIOMATERIALS, V19, P1255
   Dalbagni G, 2000, UROL CLIN N AM, V27, P137, DOI 10.1016/S0094-0143(05)70241-X
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   DUNN GA, 1986, J CELL SCI, V83, P313
   Fleshner NE, 1996, CANCER, V78, P1505, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1505::AID-CNCR19>3.0.CO;2-3
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   GOLDHABER P, 1961, P AM ASSOC CANC RES, V3, P28
   Haberstroh KM, 1999, J UROLOGY, V162, P2114, DOI 10.1016/S0022-5347(05)68136-0
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Lebret T, 2000, J UROLOGY, V163, P63, DOI 10.1016/S0022-5347(05)67973-6
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   *NIH, 2001, NIH PUBL
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   RATNER B, 1996, BIOMATERIALS SCI
   SCHMIDT JA, 1991, BIOMATERIALS, V12, P385, DOI 10.1016/0142-9612(91)90006-V
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   THAPA A, IN PRESS J BIOMED MA
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304
NR 29
TC 193
Z9 198
U1 0
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2003
VL 24
IS 17
BP 2915
EP 2926
DI 10.1016/S0142-9612(03)00123-6
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 679TD
UT WOS:000182937300013
PM 12742731
DA 2018-10-19
ER

PT J
AU Hong, JY
   Kim, YJ
   Lee, HW
   Lee, WK
   Ko, JS
   Kim, HM
AF Hong, JY
   Kim, YJ
   Lee, HW
   Lee, WK
   Ko, JS
   Kim, HM
TI Osteoblastic cell response to thin film of poorly crystalline calcium
   phosphate apatite formed at low temperatures
SO BIOMATERIALS
LA English
DT Article
DE apatite; thin film; osteoblast; differentiation; biomaterial
ID TRANSFORM INFRARED-SPECTROSCOPY; ELECTRON-MICROSCOPY; IN-VITRO;
   ADHESION; HYDROXYAPATITE; GROWTH; BONE; DIFFERENTIATION; PROLIFERATION;
   PAXILLIN
AB The response of osteoblastic cells to a thin film of poorly crystalline Calcium phosphate apatite crystals (PCA) was examined in vitro. The PCA thin film was prepared on polystyrene Culture dishes using highly metastable calcium phosphate ion Solution at low temperatures. The PCA thin film was formed through fusion and transformation of granular calcium phosphate particles which had initially formed on the surface, into a film of calcium phosphate apatite crystal. The PCA thin film was used for cell culture without additional surface treatment. The osteoblastic cell behaviors including adhesion, proliferation, expression of the marker genes and calcified matrix formation were examined on the PCA thin film using primary osteoblasts or MC3T3-E1 cells. The cells were well attached and had spread in a slender shape over the PCA thin film. The extent of cell proliferation oil the PCA thin film is as much as on the plain dishes. In addition, a much larger number of calcified nodules had formed on the PCA thin film than on the plain dish. The expression of the marker genes such as alkaline phosphatase, osteocalcin, osteopontin, osteonectin was apparent. These results demonstrate that the osteoblasts exhibit a full spectrum of cellular activity including the adequate differentiation on the PCA thin film. Therefore a PCA thin film can be used as a coating material for biomaterials where the surface is not adequate for inducing the full activity of bone cells. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Seoul Natl Univ, Intellectual Biointerface Engn Ctr, ChongRo Ku, Seoul 110749, South Korea.
EM jeasko@snu.ac.kr; hyunmkim@plaza.snu.ac.kr
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR AMLER MH, 1988, J PERIODONTOL, V58, P759
   BAGAMBISA F B, 1990, International Journal of Oral and Maxillofacial Implants, V5, P217
   Blanchard JM, 2000, PATHOL BIOL, V48, P318
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   Cornell C. N., 1998, CLIN ORTHOP S, V355, pS267
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   GALGUT P N, 1990, Clinical Materials, V6, P105, DOI 10.1016/0267-6605(90)90002-D
   Gregorie M., 1990, J BIOMED MATER RES, V24, P163
   Han JW, 2001, J BIOL CHEM, V276, P40903, DOI 10.1074/jbc.M102665200
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   Juliano R.L., 2002, ANN REV PHARM TOXICO, V42, P223
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kim HM, 1996, CALCIFIED TISSUE INT, V59, P58, DOI 10.1007/s002239900086
   KIM HM, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P331
   Kim HM, 2001, J BIOMED MATER RES, V56, P250, DOI 10.1002/1097-4636(200108)56:2<250::AID-JBM1092>3.0.CO;2-S
   Kim HM, 2000, BIOMATERIALS, V21, P1129, DOI 10.1016/S0142-9612(99)00265-3
   KIM HM, 1995, J BONE MINER RES, V10, P1589
   Kuhn-Spearing L, 1996, P ANN M MIN MET MAT, P815
   Lacefield W R, 1998, Implant Dent, V7, P315, DOI 10.1097/00008505-199807040-00010
   Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200
   Lee YJ, 2003, BIOMATERIALS, V24, P1059, DOI 10.1016/S0142-9612(02)00439-8
   LEES SL, 1983, CALCIFIED TISSUE INT, V35, P815
   LEGEROS RZ, 1991, CALCIUM PHOSPHATES O, P108
   Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264
   Liu SC, 2001, J BIOL CHEM, V276, P37086, DOI 10.1074/jbc.M105114200
   LUBEN RA, 1976, ENDOCRINOLOGY, V99, P526, DOI 10.1210/endo-99-2-526
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   REY C, 1992, INT CONGR SER, V1002, P5
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   REY C, 1995, J BONE MINER RES, V10, P1577
   Rosa Adalberto Luiz, 2002, Pesqui Odontol Bras, V16, P209, DOI 10.1590/S1517-74912002000300005
   Shi DL, 2002, J BIOMED MATER RES, V63, P71, DOI 10.1002/jbm.10087
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   WELSH CF, 2000, BIOCHIM BIOPHYS ACTA, V31, P1471
NR 41
TC 28
Z9 28
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2003
VL 24
IS 18
BP 2977
EP 2984
DI 10.1016/S0142-9612(02)00121-2
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682NG
UT WOS:000183097900001
PM 12895569
DA 2018-10-19
ER

PT J
AU Panilaitis, B
   Altman, GH
   Chen, JS
   Jin, HJ
   Karageorgiou, V
   Kaplan, DL
AF Panilaitis, B
   Altman, GH
   Chen, JS
   Jin, HJ
   Karageorgiou, V
   Kaplan, DL
TI Macrophage responses to silk
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; sericin; tissue engineering; scaffold; biomaterial;
   macrophage; inflammation; TNF
ID IN-VITRO; PARTICULATE DEBRIS; FIBROBLAST CELLS; BONE-FORMATION;
   BIOMATERIALS; FIBROIN; ATTACHMENT; GROWTH
AB Silk fibers have potential biomedical applications beyond their traditional use as Sutures. The physical properties of silk fibers and films make it a promising candidate for tissue engineering scaffold applications, particularly where high mechanical loads or tensile forces are applied or in cases where low rates of degradation Lire desirable. A critical issue for biomaterial scaffolds is biocompatibility. The direct inflammatory potential of intact silk fibers as well as extracts was studied in an in vitro system. Tile results indicate that silk fibers are largely immunologically inert in short- and long-term culture with RAW 264.7 murine macrophage cells while insoluble fibroin particles induced significant TNF release. Soluble sericin proteins extracted front native silk fibers did not induce significant macrophage activation. While sericin did not activate macrophages by itself, it demonstrated a synergistic effect with bacterial lipopolysaccharide. The low level of inflammatory potential of silk fibers makes them promising candidates in future biomedical applications. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Tufts Univ, Dept Biomed Engn, Ctr Bioengn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Ctr Bioengn, 4 Colby St, Medford, MA 02155 USA.
OI Karageorgiou, Vassilis/0000-0002-0892-510X
FU NIDCR NIH HHS [R01 DE13405-01]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   ASAKURA T, 1984, MACROMOLECULES, V17, P1075, DOI 10.1021/ma00135a017
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   HOWIE DW, 1993, ORTHOP CLIN N AM, V24, P571
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Jones LC, 1999, J BIOMED MATER RES, V48, P889
   Kadoya Y, 1996, J ORTHOPAED RES, V14, P473, DOI 10.1002/jor.1100140318
   Kaplan D., 1994, ACS SYM SER, P544
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   Shanbhag AS, 2000, J BIOMED MATER RES, V53, P100, DOI 10.1002/(SICI)1097-4636(2000)53:1<100::AID-JBM14>3.0.CO;2-4
   Shibata Y, 1997, INFECT IMMUN, V65, P1734
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   Voronov I, 1998, J BIOMED MATER RES, V39, P40, DOI 10.1002/(SICI)1097-4636(199801)39:1<40::AID-JBM6>3.3.CO;2-Y
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wooley PH, 2002, BIOMATERIALS, V23, P517, DOI 10.1016/S0142-9612(01)00134-X
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
NR 27
TC 317
Z9 329
U1 12
U2 94
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2003
VL 24
IS 18
BP 3079
EP 3085
DI 10.1016/S0142-9612(03)00158-3
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682NG
UT WOS:000183097900012
PM 12895580
DA 2018-10-19
ER

PT J
AU Di Palma, F
   Douet, M
   Boachon, C
   Guignandon, A
   Peyroche, S
   Forest, B
   Alexandre, C
   Chamson, A
   Rattner, A
AF Di Palma, F
   Douet, M
   Boachon, C
   Guignandon, A
   Peyroche, S
   Forest, B
   Alexandre, C
   Chamson, A
   Rattner, A
TI Physiological strains induce differentiation in human osteoblasts
   cultured on orthopaedic biomaterial
SO BIOMATERIALS
LA English
DT Article
DE osteoblasts; mechanical strain; titanium alloy; differentiation device
ID BONE-DERIVED CELLS; ALKALINE-PHOSPHATASE ACTIVITY; IN-VITRO
   BIOMINERALIZATION; PROTEIN-KINASE-A; MECHANICAL STRAIN;
   SURFACE-ROUGHNESS; MESSENGER-RNA; CYCLE NUMBER; TITANIUM; PROLIFERATION
AB We have developed an in vitro mechanical stretching model of osteoblastic cells cultured on metallic biomaterials in order to study the effects of mechanical strain on osteointegration of orthopaedic implants. Titanium alloy discs coated with alumina or hydroxyapatite were used as substrates. Three Dynacell(R) devices were especially designed to apply cyclic strains on rigid biomaterials. The regimen (600 muepsilon strains, 0.25 Hz) was defined on the basis of physiological data and estimated deformation on hip stern prostheses. The performances of these apparatus were reproducible and provided controlled deformations. Human osteosarcoma cell line MG-63, human osteoblasts obtained from primary Cultures and ROS 17/2.8 rat osteosarcoma cells were used as cell models. Cell behaviour was assessed in terms of growth and alkaline phosphatase (ALP) activity by in situ assays for two regimens: 15-min deformations repeated three times a day to mimic rehabilitation exercises and 24-h continuous deformations. We demonstrated that continuous deformation did not affect the growth and ALP activity of MG-63 cells, in contrast with sequential deformations which had no effect on cell number, but which stimulated ALP activity after 5 days of stretching. This sequential regimen can also modify the behaviour of human bone-derived cells resulting in increased proliferation after 5 days and stimulation of ALP activity after 15 days. ROS 17/2.8 rat osteosarcoma cells submitted to sequential deformations responded faster than other cell lines by increasing their ALP activity only after I day of stretching. Like MG-63 cells, proliferation of the ROS 17/2.8 rat osteosarcoma cell line was not affected by sequential deformations. This study suggests that short, repeated deformations defined to mimic rehabilitation exercises recommended after prostheses implantation are more likely to exert beneficial effects on implanted bone than continuous strains. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ St Etienne, Lab Biol & Biochim Tissu Osseux, Fac Med, INSERM,Equipe Rech 9901, F-42023 St Etienne 02, France.
   Ecole Natl Super Mines, Lab Mecan Biomat & Traitement Surface, F-42023 St Etienne 02, France.
RP Rattner, A (reprint author), Univ St Etienne, Lab Biol & Biochim Tissu Osseux, Fac Med, INSERM,Equipe Rech 9901, 15 Rue Ambroise Pare, F-42023 St Etienne 02, France.
EM aline.rattner@univ-st-etienne.fr
CR Ahmad M, 1999, J BIOMED MATER RES, V46, P121, DOI 10.1002/(SICI)1097-4636(199907)46:1<121::AID-JBM14>3.0.CO;2-P
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   Aubin JE, 1999, J CELL BIOCHEM, V72, P396, DOI 10.1002/(SICI)1097-4644(19990301)72:3<396::AID-JCB9>3.3.CO;2-Y
   Ball MD, 2001, BIOMATERIALS, V22, P337, DOI 10.1016/S0142-9612(00)00189-7
   Bennett JH, 2001, HISTOL HISTOPATHOL, V16, P603, DOI 10.14670/HH-16.603
   Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9
   Boyan BD, 2001, J BIOMED MATER RES, V55, P350, DOI 10.1002/1097-4636(20010605)55:3<350::AID-JBM1023>3.0.CO;2-M
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Brand R A, 2001, J Orthop Sci, V6, P295, DOI 10.1007/s007760100051
   BRIGHTON CT, 1991, J BONE JOINT SURG AM, V73A, P320, DOI 10.2106/00004623-199173030-00002
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   Burr DB, 1996, BONE, V18, P405, DOI 10.1016/8756-3282(96)00028-2
   Cai Z, 1999, BIOMATERIALS, V20, P183, DOI 10.1016/S0142-9612(98)00160-4
   Carmeliet G, 1997, J BONE MINER RES, V12, P786, DOI 10.1359/jbmr.1997.12.5.786
   CARVALHO RS, 1995, ARCH ORAL BIOL, V40, P257, DOI 10.1016/0003-9969(95)98814-F
   Carvalho RS, 1996, EUR J ORTHODONT, V18, P227, DOI 10.1093/ejo/18.1.227
   Castellani R, 1999, CLIN ORAL IMPLAN RES, V10, P369, DOI 10.1034/j.1600-0501.1999.100504.x
   CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0
   Cullen DM, 2001, J APPL PHYSIOL, V91, P1971
   Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169
   Fermor B, 1998, BONE, V22, P637, DOI 10.1016/S8756-3282(98)00047-7
   FRANCESCHI RT, 1990, J BONE MINER RES, V5, P1157
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HEREMANS H, 1978, ONCOLOGY, V35, P216
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   JONES D, 1995, CELL BIOL, P525
   JONES DB, 1991, BIOMATERIALS, V12, P101, DOI 10.1016/0142-9612(91)90186-E
   Kapanen A, 2002, BIOMATERIALS, V23, P3341, DOI 10.1016/S0142-9612(02)00023-6
   Kaspar D, 2002, J BIOMECH, V35, P873, DOI 10.1016/S0021-9290(02)00058-1
   Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2
   LABAT B, 1995, J BIOMED MATER RES, V29, P1397, DOI 10.1002/jbm.820291111
   Labat B, 2000, BIOMATERIALS, V21, P1275, DOI 10.1016/S0142-9612(00)00013-2
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0
   Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   MAJESKA RJ, 1980, ENDOCRINOLOGY, V107, P1494, DOI 10.1210/endo-107-5-1494
   MALIK MA, 1992, BIOMATERIALS, V13, P123, DOI 10.1016/0142-9612(92)90008-C
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   Meazzini MC, 1998, J ORTHOP RES, V16, P170, DOI 10.1002/jor.1100160204
   Morais S, 1998, BIOMATERIALS, V19, P13, DOI 10.1016/S0142-9612(97)00149-X
   Morais S, 1998, BIOMATERIALS, V19, P23, DOI 10.1016/S0142-9612(97)00150-6
   Ohgushi H, 1999, J BIOMED MATER RES, V44, P381, DOI 10.1002/(SICI)1097-4636(19990315)44:4<381::AID-JBM3>3.0.CO;2-E
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   Peake MA, 2000, J APPL PHYSIOL, V89, P2498
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Ramires PA, 2002, BIOMATERIALS, V23, P397, DOI 10.1016/S0142-9612(01)00118-1
   Rattner A, 2000, CALCIFIED TISSUE INT, V66, P35, DOI 10.1007/s002230050007
   RAWLINSON SCF, 1995, J BONE MINER RES, V10, P1225
   Schwartz Z, 2001, J BIOMED MATER RES, V56, P417, DOI 10.1002/1097-4636(20010905)56:3<417::AID-JBM1111>3.0.CO;2-K
   Schwartz Z, 2001, BIOMATERIALS, V22, P731, DOI 10.1016/S0142-9612(00)00241-6
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Vico L, 2001, CALCIFIED TISSUE INT, V68, P1, DOI 10.1007/BF02684996
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731
   YANAGISAWA I, 1999, EFFECTS WETTABILITY, P168
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 61
TC 37
Z9 36
U1 2
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2003
VL 24
IS 18
BP 3139
EP 3151
DI 10.1016/S0142-9612(03)00152-2
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 682NG
UT WOS:000183097900019
PM 12895587
DA 2018-10-19
ER

PT J
AU Henno, S
   Lambotte, JC
   Glez, D
   Guigand, M
   Lancien, G
   Cathelineau, G
AF Henno, S
   Lambotte, JC
   Glez, D
   Guigand, M
   Lancien, G
   Cathelineau, G
TI Characterisation and quantification of angiogenesis in beta-tricalcium
   phosphate implants by immunohistochemistry and transmission electron
   microscopy
SO BIOMATERIALS
LA English
DT Article
DE angiogenesis; immunohistochemistry; TEM; quantification; tricalcium
   phosphate
ID ENDOTHELIAL GROWTH-FACTOR; MICROVESSEL DENSITY; BREAST-CANCER;
   PROGNOSTIC VALUE; BONE SUBSTITUTE; RABBIT MODEL; HYDROXYAPATITE; CELLS;
   BIOCOMPATIBILITY; BIOMATERIALS
AB The aim of this study is the histological characterisation of angiogenesis in a macroporous biomaterial with quantification techniques used in oncology. Porous tricalcium phosphate implants were seated in the tibias of 12 rabbits. This work allows (1) morphological study with photonic microscopy, transmission electron microscopic and immunohistochemistry labelling for (2) quantification Of vascularisation using anti-C-D31 monoclonal antibody (3) quantification of proliferation using anti-PCNA polyclonal antibody (4) study of two angiogenic growth factors: VEGF and FGF-2.
   Quantification of angiogenesis revealed an outbreak kinetic with early vascular growth in first several days and a second growth phase after 4 weeks. This study reveals in macropores many isolated cells without adjacent vascular lumen, with endothelial phenotype. Expression Of angiogenic growth factors reveals that all endothelial cells were VEGF-negative throughout the test period. FGF-2 expression by endothelial cells began 2 weeks post-implantation. Osteoblasts strongly expressed two markets throughout the test period.
   Furthermore. the procedure described here can be used to compare angiogenesis in different biomaterials or in the same biomaterial with the influence of macroporosities. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Rennes 1, Equipe Biomat Site Osseux, CNRS, UMR 6511, F-35000 Rennes, France.
RP Cathelineau, G (reprint author), Univ Rennes 1, Equipe Biomat Site Osseux, CNRS, UMR 6511, 2 Pl Pasteur, F-35000 Rennes, France.
EM guy.cathelineau@univ-rennes1.fr
CR ALBERTS B, 1994, MOL BIOL CELL, V5, P573
   Amoroso A, 1997, Eur Rev Med Pharmacol Sci, V1, P17
   BARBARESCHI M, 1995, BREAST CANCER RES TR, V36, P181, DOI 10.1007/BF00666039
   Bland YS, 1995, ACTA ORTHOP SCAND, V66, P543, DOI 10.3109/17453679509002313
   BREM S, 1972, J NATL CANCER I, V48, P347
   Bush D, 1995, Biomed Sci Instrum, V31, P147
   Butler K, 2001, PATHOL RES PRACT, V197, P29, DOI 10.1078/0344-0338-00005
   Carlile MJ, 2000, HISTOCHEM J, V32, P239, DOI 10.1023/A:1004055118334
   Chang CS, 1999, J BIOMED MATER RES, V48, P411, DOI 10.1002/(SICI)1097-4636(1999)48:4<411::AID-JBM3>3.0.CO;2-H
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Craig LE, 1998, MICROVASC RES, V55, P65, DOI 10.1006/mvre.1997.2045
   DACULSI G, 1989, REV CHIR ORTHOP, V75, P65
   Daculsi G, 1996, J BIOMED MATER RES, V31, P495, DOI 10.1002/(SICI)1097-4636(199608)31:4<495::AID-JBM9>3.0.CO;2-G
   DAMORE PA, 1993, GROWTH FACTORS, V8, P61, DOI 10.3109/08977199309029135
   DECKER B, 1995, ANAT REC, V242, P310, DOI 10.1002/ar.1092420304
   Dejana E, 2001, THROMB HAEMOSTASIS, V86, P308
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   FOX SB, 1995, J PATHOL, V177, P275, DOI 10.1002/path.1711770310
   Gunther KP, 1998, ORTHOPADE, V27, P105
   Hagerty RD, 2000, J BIOMED MATER RES, V49, P489, DOI 10.1002/(SICI)1097-4636(20000315)49:4<489::AID-JBM7>3.0.CO;2-2
   Hansen S, 1998, LAB INVEST, V78, P1563
   Kato T, 1999, BREAST CANCER RES TR, V53, P19, DOI 10.1023/A:1006193024382
   King TW, 2000, J BIOMED MATER RES, V51, P383, DOI 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Lambotte J C, 1998, Chirurgie, V123, P572, DOI 10.1016/S0001-4001(99)80006-3
   Lind M, 2001, BIOMATERIALS, V22, P189, DOI 10.1016/S0142-9612(00)00165-4
   MAROTTI G, 1980, ACTA ANAT, V106, P84
   Mompeo B, 1999, ULTRASTRUCT PATHOL, V23, P25, DOI 10.1080/019131299281806
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   Ortega N, 1997, AM J PATHOL, V151, P1215
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Richard M, 1998, CALCIFIED TISSUE INT, V62, P437, DOI 10.1007/s002239900456
   RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1
   Rubin PAD, 1997, OPHTHALMIC PLAST REC, V13, P8, DOI 10.1097/00002341-199703000-00002
   Saadeh PB, 2000, ENDOCRINOLOGY, V141, P2075, DOI 10.1210/en.141.6.2075
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x
   Schroeder JA, 1999, J BIOMED MATER RES, V48, P309, DOI 10.1002/(SICI)1097-4636(1999)48:3<309::AID-JBM15>3.0.CO;2-Z
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Thomas KA, 1996, J BIOL CHEM, V271, P603, DOI 10.1074/jbc.271.2.603
   TRECANT M, 1994, CLIN MATER, V15, P233, DOI 10.1016/0267-6605(94)90051-5
   VERNON RB, 1995, AM J PATHOL, V147, P873
   Vogely HC, 2000, J ORTHOPAED RES, V18, P485, DOI 10.1002/jor.1100180323
   WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038
   WILLIAMS DF, 1990, INTERDISCIPL SCI REV, V15, P20
   WINCT H, 1995, J ORTHOPAED RES, V13, P679
   WINET H, 1993, J BIOMED MATER RES, V27, P667, DOI 10.1002/jbm.820270514
NR 47
TC 17
Z9 20
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2003
VL 24
IS 19
BP 3173
EP 3181
DI 10.1016/S0142-9612(03)00149-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687UQ
UT WOS:000183395700001
PM 12763444
DA 2018-10-19
ER

PT J
AU Ramage, G
   Tunney, MM
   Patrick, S
   Gorman, SP
   Nixon, JR
AF Ramage, G
   Tunney, MM
   Patrick, S
   Gorman, SP
   Nixon, JR
TI Formation of Propionibacterium acnes biofilms on orthopaedic
   biomaterials and their susceptibility to antimicrobials
SO BIOMATERIALS
LA English
DT Article
DE Propionibacterium acnes; bacterial adherence; biofilm;
   polymethylmethacrylate; titanium alloy
ID POLYMETHYLMETHACRYLATE BONE CEMENTS; STAPHYLOCOCCUS-EPIDERMIDIS;
   ANTIBIOTIC-RESISTANCE; ADHERENCE; SURFACES; BACTERIA; SURGERY
AB Failure to treat and eradicate prosthetic hip infection with systemic antibiotic regimens is usually due to the fact that the infection is associated with biofilm formation and that bacterial cells growing within a biofilm exhibit increased resistance to antimicrobial agents. In this in vitro study, we investigated the susceptibility of prosthetic hip Propionibacterium acnes and Staphylococcus spp. isolates growing within biofilms on polymethylmethacrylate (PMMA) bone cement to a range of antibiotics. All P. acnes isolates in the biofilm mode of growth demonstrated considerably greater resistance to cefamandole, ciprofloxacin and vancomycin. In contrast. only four of the eight P. acnes isolates demonstrated an increase in resistance to gentamicin. All ten Staphylococcus spp. isolates in the biofilm mode of growth exhibited large increases in resistance to gentamicin and cefamandole with eight of the ten isolates also exhibiting an increase in resistance to vancomycin. However, only three of the ten Staphylococcus spp. isolates exhibited an increase in resistance to ciprofloxacin. Biofilms were also formed on three different titanium alloys and on PMMA bone cement using P. acnes. Staphylococcus epidermidis and Staphylococcus aureus strains to determine if the underlying biomaterial surface had an effect on biofilm formation and the antimicrobial susceptibility of the bacteria growing within biofilms. Although differences in the rate at which the three strains adhered to the different biomaterials were apparent, no differences in biofilm antibiotic resistance between the biomaterials were observed. In the light of these results, it is important that the efficacy of other antibiotics against P. acnes and Staphylococcus spp. prosthetic hip isolates growing within biofilms on orthopaedic biomaterials be determined to ensure optimal treatment of orthopaedic implant infection. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, Belfast BT9 7BL, Antrim, North Ireland.
   Queens Univ Belfast, Sch Med, Dept Microbiol & Immunobiol, Belfast BT12 6BN, Antrim, North Ireland.
   Musgrave Pk Hosp, Withers Orthopaed Ctr, Belfast BT9 7JB, Antrim, North Ireland.
RP Tunney, MM (reprint author), Queens Univ Belfast, Sch Pharm, Clin & Practice Res Grp, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
OI TUNNEY, MICHAEL/0000-0002-7433-7074
CR CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   CHUARD C, 1993, ANTIMICROB AGENTS CH, V37, P625, DOI 10.1128/AAC.37.4.625
   Goto T, 1999, UROLOGY, V53, P1058, DOI 10.1016/S0090-4295(98)00649-9
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813
   HEDGES AJ, 1978, J APPL BACTERIOL, V45, P57, DOI 10.1111/j.1365-2672.1978.tb04198.x
   HENRY SL, 1995, CLIN PHARMACOKINET, V29, P36, DOI 10.2165/00003088-199529010-00005
   NAYLOR PT, 1990, CLIN ORTHOP RELAT R, P126
   OGA M, 1988, BIOMATERIALS, V9, P285, DOI 10.1016/0142-9612(88)90100-7
   Polonio RE, 2001, ANTIMICROB AGENTS CH, V45, P3262, DOI 10.1128/AAC.45.11.3262-3266.2001
   Preston CAK, 1996, INT J ANTIMICROB AG, V7, P251, DOI 10.1016/S0924-8579(96)00330-5
   PROSSER BL, 1987, ANTIMICROB AGENTS CH, V31, P1502, DOI 10.1128/AAC.31.10.1502
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   Tunney MM, 1998, ANTIMICROB AGENTS CH, V42, P3002, DOI 10.1128/AAC.42.11.3002
   TUNNEY MM, 2001, PROGR ABSTR BRIT PHA, P111
   van de Belt H, 2000, ACTA ORTHOP SCAND, V71, P625, DOI 10.1080/000164700317362280
   van de Belt H, 2001, BIOMATERIALS, V22, P1607, DOI 10.1016/S0142-9612(00)00313-6
   WEBB LX, 1994, J ORTHOP TRAUMA, V8, P28, DOI 10.1097/00005131-199402000-00007
NR 18
TC 118
Z9 121
U1 3
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2003
VL 24
IS 19
BP 3221
EP 3227
DI 10.1016/S0142-9612(03)00173-X
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687UQ
UT WOS:000183395700006
PM 12763449
DA 2018-10-19
ER

PT J
AU Kasuga, T
   Maeda, H
   Kato, K
   Nogami, M
   Hata, K
   Ueda, M
AF Kasuga, T
   Maeda, H
   Kato, K
   Nogami, M
   Hata, K
   Ueda, M
TI Preparation of poly(lactic acid) composites containing calcium carbonate
   (vaterite)
SO BIOMATERIALS
LA English
DT Article
DE poly(lactic acid); calcium carbonate; hydroxyapatite; composite;
   simulated body fluid; Young's modulus
ID SIMULATED BODY-FLUID; APATITE FORMATION; CERAMICS; POLYMERS
AB A new type of ceramic-polymer biomaterial having excellent apatite-forming ability in simulated body fluid was prepared by hot-pressing a mixture of poly(-L-lactic acid) (PLA) and calcium carbonate (vaterite). After PLA dissolved in methylene chloride was mixed with calcium carbonate consisting of vaterite, the mixture was dried completely and subsequently hot-pressed uniaxially under a pressure of 40 MPa at 180degreesC. When 30 wt% vaterite was introduced, the modulus of elasticity was effectively improved by 3.5-6GPa. which was about twice higher than the modulus of PLA. The composite showed no brittle fracture behavior and a comparably high bending strength of similar to50MPa. The composite containing 30wt%, vaterite formed a 5-15-mum-thick bonelike apatite layer on its surface after soaking in SBF at 37degreesC even for 1-3d. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
   Nagoya Univ Hosp, Genet Regenerat Med Ctr, Showa Ku, Nagoya, Aichi 4668550, Japan.
   Nagoya Univ, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
CR AOKI H, 1994, MED APPL HYDROXYAPAT, P286
   ASADA M, 1991, J MOL STRUCT, V244, P237, DOI 10.1016/0022-2860(91)80159-2
   CHO S, 1997, KEY ENG MATER, V132, P802
   DE GROOT K., 1996, PHOSPHORUS RES B, V6, P71
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   Doi Yutaka, 1997, Cells and Materials, V7, P111
   FUJIMOR Y, 1997, SEITAIZAIRYO, V15, P277
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   HYON SH, 1985, KOBUNSHI RONBUNSHU, V42, P771, DOI 10.1295/koron.42.771
   JONES SJ, 1984, ANAT EMBRYOL, V170, P247, DOI 10.1007/BF00318728
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Maeda H, 2002, J MATER RES, V17, P727, DOI 10.1557/JMR.2002.0104
   MAEDA H, 2002, KEY ENG MATER, V240, P163
   NAKAMAE K, 1985, NIHON SETTYAKUKYOUKA, V21, P414
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
NR 23
TC 123
Z9 128
U1 5
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2003
VL 24
IS 19
BP 3247
EP 3253
DI 10.1016/S0142-9612(03)00190-X
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 687UQ
UT WOS:000183395700009
PM 12763452
DA 2018-10-19
ER

PT J
AU Riminucci, M
   Bianco, P
AF Riminucci, M
   Bianco, P
TI Building bone tissue: matrices and scaffolds in physiology and
   biotechnology
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Proceedings Paper
CT International Symposium on Extracellular Matrix (SIMEC 2002)
CY OCT 07-10, 2002
CL ANGRA REIS, BRAZIL
DE extracellular matrix; bone matrix; bone formation; biomaterials; tissue
   engineering
ID MARROW STROMAL CELLS; HUMAN BREAST-CANCER; SMALL PROTEOGLYCAN-I; POROUS
   HYDROXYAPATITE; GRAFT SUBSTITUTE; SIALOPROTEIN BSP; STEM-CELLS; DEFECTS;
   EXPRESSION; REPAIR
AB Deposition of bone in physiology involves timed secretion, deposition and removal of a complex array of extracellular matrix proteins which appear in a defined temporal and spatial sequence. Mineralization itself plays a role in dictating and spatially orienting the deposition of matrix. Many aspects of the physiological process are recapitulated in systems of autologous or xenogeneic transplantation of osteogenic precursor cells developed for tissue engineering or modeling. For example, deposition of bone sialoprotein, a member of the small integrin-binding ligand, N-linked glycoprotein family, represents the first step of bone formation in ectopic transplantation systems in vivo. The use of mineralized scaffolds for guiding bone tissue engineering has revealed unexpected manners in which the scaffold and cells interact with each other, so that a complex interplay of integration and disintegration of the scaffold ultimately results in efficient and desirable, although unpredictable, effects. Likewise, the manner in which biomaterial scaffolds are "resorbed" by osteoclasts in vitro and in vivo highlights more complex scenarios than predicted from knowledge of physiological bone resorption per se. Investigation of novel biomaterials for bone engineering represents an essential area for the design of tissue engineering strategies.
C1 Univ Roma La Sapienza, Dipartimento Med Sperimetale & Patol, I-00161 Rome, Italy.
   Univ Aquila, Dipartimento Med Sperimentale, Rome, Italy.
   Parco Sci Biomed San Raffaele, Rome, Italy.
RP Bianco, P (reprint author), Univ Roma La Sapienza, Dipartimento Med Sperimetale & Patol, Viale Regina Elena 324, I-00161 Rome, Italy.
CR Bellahcene A, 1996, INT J CANCER, V69, P350
   BELLAHCENE A, 1994, CANCER RES, V54, P2823
   Bellahcene A, 1996, J BONE MINER RES, V11, P665
   Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413
   Bianco P, 1998, J CLIN INVEST, V101, P1737, DOI 10.1172/JCI2361
   Bianco P, 1998, MATRIX BIOL, V17, P185, DOI 10.1016/S0945-053X(98)90057-9
   BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P183, DOI 10.1177/41.2.8419458
   BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P193, DOI 10.1177/41.2.8419459
   BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bianco P., 1992, MINERALIZATION BIOL, P243
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   BUCHOLZ RW, 1989, CLIN ORTHOP RELAT R, P53
   CAMERON HU, 1977, J BIOMED MATER RES, V11, P179, DOI 10.1002/jbm.820110204
   CAPANNA R, 1991, Chirurgia degli Organi di Movimento, V76, P245
   Chappard D, 1993, Bull Assoc Anat (Nancy), V77, P59
   Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   DUMBACH J, 1994, J CRANIO MAXILL SURG, V22, P151, DOI 10.1016/S1010-5182(05)80381-6
   Elsinger E C, 1996, J Foot Ankle Surg, V35, P396
   FISHER LW, 1983, J BIOL CHEM, V258, P2723
   FISHER LW, 1987, J BIOL CHEM, V262, P9702
   FISHER LW, 1989, J BIOL CHEM, V264, P4571
   FISHER LW, 1990, J BIOL CHEM, V265, P23447
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDENSTEIN AJ, 1982, EXP HEMATOL, V10, P217
   Giannini S, 1992, Ital J Orthop Traumatol, V18, P431
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   HEISE U, 1990, INT ORTHOP, V14, P329
   HOLMES R, 1988, J CRANIO MAXILL SURG, V16, P199, DOI 10.1016/S1010-5182(88)80047-7
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   JONES SJ, 1993, BONE, V14, P455, DOI 10.1016/8756-3282(93)90179-E
   KERR JM, 1993, GENOMICS, V17, P408, DOI 10.1006/geno.1993.1340
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Krebsbach PH, 1999, CRIT REV ORAL BIOL M, V10, P165, DOI 10.1177/10454411990100020401
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Riminucci M, 1998, J BONE MINER RES, V13, P1852, DOI 10.1359/jbmr.1998.13.12.1852
   RIMINUCCI M, 1995, CALCIFIED TISSUE INT, V57, P277, DOI 10.1007/BF00298883
   ROBEY PG, 2002, DISORDERS BONE MINER, P199
   TERMINE JD, 1981, J BIOL CHEM, V256, P403
   TERMINE JD, 1980, J BIOL CHEM, V255, P9769
NR 50
TC 29
Z9 30
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD AUG
PY 2003
VL 36
IS 8
BP 1027
EP 1036
DI 10.1590/S0100-879X2003000800008
PG 10
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 716DE
UT WOS:000185012900009
PM 12886456
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Kuniyasu, H
   Hirose, Y
   Ochi, M
   Yajima, A
   Sakaguchi, K
   Murata, M
   Pohl, F
AF Kuniyasu, H
   Hirose, Y
   Ochi, M
   Yajima, A
   Sakaguchi, K
   Murata, M
   Pohl, F
TI Bone augmentation using rhGDF-5-collagen composite
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE recombinant; growth differentiation factor-5; bone augmentation;
   collagen; rat calvaria
ID TGF-BETA-SUPERFAMILY; COLLAGEN; FACTOR-5; DIFFERENTIATION;
   CHONDROGENESIS; IMPLANTS; GROWTH; MEMBER; RAT
AB The aim of this study was to evaluate the effectiveness of local application of growth differentiation factor-5 (GDF-5)-collagen composite on bone augmentation on the rat calvaria. GDF-5-collagen composite is made from recombinant human GDF-5 (rhGDF-5) and purified bovine type I atelocollagen. The GDF-5 solution was mixed with 0.3% atelocollagen acid solution, and the mixture was lyophilized. The spongy Iyophilized material was pressed into the shape of a minidisk to make the GDF-5-collagen composite. The GDF-5-collagen composite contained 1, 10, or 100-mug rhGDF-5. The control collagen composite contained 0-mug rhGDF-5. The GDF-5-collagen composite or control collagen composite was inserted beneath the calvarial periosteum of 4-week-old rats. At 3 weeks after implantation, the implants containing 1-mug rhGDF-5 had mostly induced new bone formation on the cranial side. In the implants containing 10-mug rhGDF-5, bone formation had proceeded to the center of the GDF-5-collagen composite from the periosteal and the cranial sides, and bone marrow was seen focally. The augmented bone showed a connected trabecular structure with abundant vascularization. The implants containing 100-mug rhGDF-5 were nearly entirely replaced by new bone with bone marrow, and the augmented bone was firmly connected with the original bone. Neither cartilage nor bone formation was found in the control collagen composite. Thus, we conclude that the GDF-5-collagen composite may be a superior biomaterial for bone augmentation and this composite could be useful as a local osteoinductive device.
C1 Hlth Sci Univ Hokkaido, Sch Dent, Dept Fixed Prosthodont, Ishikari, Hokkaido 0610293, Japan.
   Hlth Sci Univ Hokkaido, Sch Dent, Dept Oral Surg 2, Ishikari, Hokkaido 0610293, Japan.
   Biopharm GMBH, D-69115 Heidelberg, Germany.
RP Hirose, Y (reprint author), Hlth Sci Univ Hokkaido, Sch Dent, Dept Fixed Prosthodont, 1757 Kanazawa, Ishikari, Hokkaido 0610293, Japan.
CR Aspenberg P, 1999, ACTA ORTHOP SCAND, V70, P51, DOI 10.3109/17453679909000958
   Bahat O, 2000, Int J Oral Maxillofac Implants, V15, P646
   CHANG SC, 1994, J BIOL CHEM, V269, P28227
   HJORTING-HANSEN E, 1990, International Journal of Oral and Maxillofacial Implants, V5, P255
   HOTTEN G, 1994, BIOCH BIOPHYSICAL RE, V204, P645
   Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567
   Howell TH, 1997, INT J PERIODONT REST, V17, P125
   JENSEN J, 1990, J ORAL MAXIL SURG, V48, P27, DOI 10.1016/0278-2391(90)90175-2
   Kuboki Y, 1995, CONNECT TISSUE RES, V32, P219, DOI 10.3109/03008209509013726
   LORD CF, 1988, J BONE JOINT SURG AM, V70A, P369, DOI 10.2106/00004623-198870030-00008
   Majzoub Z, 1999, J PERIODONTOL, V70, P1501, DOI 10.1902/jop.1999.70.12.1501
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   RAGHOEBAR GM, 1993, J ORAL MAXIL SURG, V51, P1198, DOI 10.1016/S0278-2391(10)80288-5
   Rompen EH, 1999, CLIN ORAL IMPLAN RES, V10, P85, DOI 10.1034/j.1600-0501.1999.100202.x
   Spiro RC, 2000, BIOCHEM SOC T, V28, P362, DOI 10.1042/0300-5127:0280362
   STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0
   TAKAOKA K, 1991, J ORTHOPAED RES, V9, P902, DOI 10.1002/jor.1100090617
   TALLENTS RH, 2001, J PROSTHET DENT, V87, P45
   Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315
   Weibel ER, 1980, STEREOLOGICAL METHOD
   Yamashita H, 1997, EXP CELL RES, V235, P218, DOI 10.1006/excr.1997.3664
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 22
TC 29
Z9 30
U1 0
U2 3
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD AUG
PY 2003
VL 14
IS 4
BP 490
EP 499
DI 10.1034/j.1600-0501.2003.00817.x
PG 10
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 710QE
UT WOS:000184690300014
PM 12869012
DA 2018-10-19
ER

PT J
AU Neut, D
   van Horn, JR
   van Kooten, TG
   van der Mei, HC
   Busscher, HJ
AF Neut, D
   van Horn, JR
   van Kooten, TG
   van der Mei, HC
   Busscher, HJ
TI Detection of biomaterial-associated infections in orthopaedic joint
   implants
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; REVISION; MICROSCOPY; DIAGNOSIS; SEPSIS
AB Biomaterial-associated infection of orthopaedic joint replacements is the second most common cause of implant failure. Yet, the microbiologic detection rate of infection is relatively low, probably because routine hospital cultures are made only of swabs or small pieces of excised tissue and not of the surfaces of potentially infected implants. Joint replacements from patients in whom infection was suspected, after clinical, radiologic, and biochemical examinations, were used in this study. The aim of the current study was to compare the detection rate of infection in total joint replacements based on cultures of the excised tissue and scrapings from the biomaterial surface. Joint prostheses were retrieved from 22 patients requiring orthopaedic revision surgery because of suspected infection of their prostheses. Routine hospital culturing of tissue only showed bacterial growth in nine patients (41%). However, after prolonged culturing, bacterial growth was observed in 14 patients (64%), whereas extensive culturing of scrapings from the biomaterial surface indicated bacterial growth in 19 of the 22 patients (86%). In addition, confocal laser scanning microscopy enabled observation of biofilm bacteria on the surfaces of the explanted prostheses. Diagnosis in orthopaedic revision surgery should consider using a microbial or microscopic analysis of the surface of an explanted prosthesis, where the biofilm mode of growth firmly anchors and protects the infecting organisms. Improved detection of infection by analysis of the implant surface is expected to yield ameliorated therapy and a reduced need for revision surgery.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Dept Orthopaed Surg, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR ANTTIPOIKA I, 1990, ACTA ORTHOP SCAND, V61, P163, DOI 10.3109/17453679009006513
   Atkins BL, 1998, J HOSP INFECT, V40, P263, DOI 10.1016/S0195-6701(98)90302-4
   Barrack RL, 1999, CLIN ORTHOP RELAT R, P175
   Fitzgerald RH, 1995, J AM ACAD ORTHOP SUR, V3, P249
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   Lai KA, 1996, ACTA ORTHOP SCAND, V67, P325, DOI 10.3109/17453679609002324
   Lawrence JR, 1999, METHOD ENZYMOL, V310, P131
   MADERAZO EG, 1988, CLIN ORTHOP RELAT R, P131
   NELSON CL, 1993, CLIN ORTHOP RELAT R, P96
   Powles JW, 1998, J BONE JOINT SURG BR, V80B, P607, DOI 10.1302/0301-620X.80B4.8555
   PRAEMER A, 1992, MUSCULOSKELETAL COND, P27
   Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008
   Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   WEBER FA, 1986, CLIN ORTHOP RELAT R, P108
NR 16
TC 125
Z9 135
U1 0
U2 23
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD AUG
PY 2003
IS 413
BP 261
EP 268
DI 10.1097/01.blo.0000073345.50837.84
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 710TP
UT WOS:000184697700030
PM 12897618
DA 2018-10-19
ER

PT J
AU Mao, C
   Zhu, AP
   Qiu, YZ
   Shen, J
   Lin, SCC
AF Mao, C
   Zhu, AP
   Qiu, YZ
   Shen, J
   Lin, SCC
TI Introduction of O-butyrylchitosan with a photosensitive
   hetero-bifunctional crosslinking reagent to silicone rubber film by
   radiation grafting and its blood compatibility
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE surface modification; radiation grafting; O-butyrylchitosan; silicone
   rubber; blood compatibility; platelet adhesion
ID IN-VITRO; CHITOSAN; SURFACE; POLYMERIZATION; DERIVATIVES
AB Based on an in vitro test for an improvement of the blood compatibility of silicone rubber (SR) films by grafting O-butyrylchitosan (OBCS), OBCS was covalently immobilized onto SR film surface using the photosensitive heterobifunctional crosslinking reagent, 4-azidobenzoic acid, which was previously bonded to OBCS by reaction between an acid group of the crosslinking reagent and a free amino group of OBCS. Surface properties of SR film were investigated by attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR), electron spectroscopy for chemical analysis (ESCA) and the water contact angle measurements. The blood compatibility of SR film was evaluated by platelet rich plasma (PRP) contacting experiments and the results were observed by scanning electron microscopy (SEM). The state of platelet adhesion was described. The suitable modifications could be carried out to tailor SR films biomaterial to meet the specific needs of different biomedical applications. These results suggest that the blood compatible of SR films/OBCS films show their suitability as potential biomaterials. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Shen, J (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
CR Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   DAASETAN M, 2001, J BIOMED MATER RES, V54, P540
   FOSTER A, 1998, P NOBCCHE, V25, P127
   GRANT S, 1988, POLYM COMMUN, V29, P342
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   HAYASHI A, 1992, MACROMOLECULES, V25, P5094, DOI 10.1021/ma00045a041
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   MARIKA K, 1997, ANAL CHIM ACTA, V353, P281
   Nho YC, 2002, RADIAT PHYS CHEM, V64, P67, DOI 10.1016/S0969-806X(01)00281-X
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   POPOWICZ P, 1985, BIOMED BIOCHIM ACTA, V44, P1329
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Sugiyama K, 1998, MACROMOL CHEM PHYSIC, V199, P1201, DOI 10.1002/(SICI)1521-3935(19980601)199:6<1201::AID-MACP1201>3.3.CO;2-Y
   Yang MR, 1997, MATER CHEM PHYS, V48, P71, DOI 10.1016/S0254-0584(97)80081-8
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 21
TC 7
Z9 11
U1 3
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD AUG 1
PY 2003
VL 30
IS 4
BP 299
EP 306
DI 10.1016/S0927-7765(03)00115-2
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 707HY
UT WOS:000184506300005
DA 2018-10-19
ER

PT J
AU Rebaudi, A
   Silvestrini, P
   Trisi, P
AF Rebaudi, A
   Silvestrini, P
   Trisi, P
TI Use of a resorbable hydroxyapatite-collagen chondroitin sulfate material
   on immediate postextraction sites: A clincial and histologic study
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID GUIDED BONE REGENERATION; COMMERCIALLY PURE TITANIUM; COATED DENTAL
   IMPLANTS; OSSEOINTEGRATED IMPLANTS; TISSUE REGENERATION; EXTRACTION
   SOCKETS; TOOTH EXTRACTION; CLINICAL REPORT; LONG-TERM; PLACEMENT
AB This study looked at a bone-substitute biomaterial (Biostite) used to fill bone defects around immediate implants in humans. Ninety-six peri-implant bone defects were treated without the use of membranes, comparing two groups: group A = filling the defect with Biostite, and group B = no defect fill. After 4 to 6 months of healing, group A revealed higher percentages of implants covered by new, bone-like tissue (67% in group A, 34% in group B). Endochondral osteogenesis was demonstrated histologically in the regenerated tissues in alveolar sites treated, allowing the hypothesis of bone induction from the filling material used.
C1 BioCRA, Biomat Clin Res Assoc, Pescara, Italy.
RP Rebaudi, A (reprint author), Via Fieschi 3-1, I-16121 Genoa, Italy.
EM al.reb@tin.it
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Akimoto K, 1999, INT J ORAL MAX IMPL, V14, P351
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Becker BE, 1998, J PERIODONTOL, V69, P920, DOI 10.1902/jop.1998.69.8.920
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   BECKER W, 1991, J PERIODONTOL, V62, P703, DOI 10.1902/jop.1991.62.11.703
   Becker W, 1996, J PERIODONTOL, V67, P1025, DOI 10.1902/jop.1996.67.10.1025
   BECKER W, 1990, INT J PERIODONT REST, V10, P377
   BECKER W, 1994, INT J ORAL MAXILLOF, V9, P389
   Benque E, 1999, INT J ORAL MAX IMPL, V14, P258
   Benque E, 1997, J CLIN PERIODONTOL, V24, P550, DOI 10.1111/j.1600-051X.1997.tb00228.x
   BENQUE EP, 1992, J PARODONTOL, V11, P67
   BLOCK MS, 1991, J ORAL MAXIL SURG, V49, P1269, DOI 10.1016/0278-2391(91)90302-3
   BOUVIER M, 1990, ARCH ORAL BIOL, V35, P301, DOI 10.1016/0003-9969(90)90047-E
   BOUVIER M, 1990, DIFFERENTIATION, V45, P128, DOI 10.1111/j.1432-0436.1990.tb00466.x
   BOYNE PJ, 1984, J ORAL MAXIL SURG, V42, P589, DOI 10.1016/0278-2391(84)90089-2
   BRUNEL G, 1992, J PARODONTOL, V11, P419
   Buser D, 1993, Int J Periodontics Restorative Dent, V13, P29
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x
   CARLSSON L, 1988, ACTA ORTHOP SCAND, V59, P272, DOI 10.3109/17453678809149361
   Corrente G, 1997, INT J PERIODONT REST, V17, P171
   Corrente G, 2000, INT J PERIODONT REST, V20, P391
   Dahlin C, 1989, Int J Oral Maxillofac Implants, V4, P19
   Dahlin C, 1991, CLIN ORAL IMPLAN RES, V2, P159, DOI 10.1034/j.1600-0501.1991.020401.x
   EVIAN CI, 1994, J PERIODONTOL, V65, P201, DOI 10.1902/jop.1994.65.3.201
   GHER ME, 1994, J PERIODONTOL, V65, P881, DOI 10.1902/jop.1994.65.9.881
   Graves S L, 1994, Aust Prosthodont J, V8, P31
   Ivanoff CJ, 1999, INT J ORAL MAX IMPL, V14, P173
   Knox R, 1991, Int J Periodontics Restorative Dent, V11, P364
   Landsberg CJ, 1997, INT J PERIODONT REST, V17, P141
   Lazzara RJ, 1999, INT J PERIODONT REST, V19, P117
   Lazzere RJ, 1989, INT J PERIODONT REST, V9, P333
   LEE DR, 1989, T SOC BIOMATER, V9, P14
   LUNDGREN D, 1994, CLIN ORAL IMPLAN RES, V5, P177, DOI 10.1034/j.1600-0501.1994.050309.x
   MELVIN JW, 1993, J BIOMECH ENG-T ASME, V115, P549, DOI 10.1115/1.2895538
   Milano F, 1997, INT J PERIODONT REST, V17, P417
   MISCH C. E., 1993, CONT IMPLANT DENT, P259
   MOZZATI M, 1997, QUINTESSENCE INT DEN, V5, P179
   MOZZATI M, 1996, QUINTESSENCE INT DEN, V8, P447
   Piattelli A, 1998, INT J ORAL MAX IMPL, V13, P805
   Rosenquist B, 1996, Int J Oral Maxillofac Implants, V11, P205
   Salata LA, 1998, INT J ORAL MAX IMPL, V13, P44
   Santarelli G, 1996, INT J PERIODONT REST, V16, P69
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   Stentz WC, 1997, J PERIODONTOL, V68, P933, DOI 10.1902/jop.1997.68.10.933
   Stentz WC, 1997, J PERIODONTOL, V68, P199, DOI 10.1902/jop.1997.68.3.199
   TISDEL CL, 1994, J BONE JOINT SURG AM, V76A, P159, DOI 10.2106/00004623-199402000-00001
   Trisi P, 1999, INT J ORAL MAX IMPL, V14, P689
   TRISI P, 2000, 7 INT S PER RES DENT
NR 50
TC 15
Z9 15
U1 0
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD AUG
PY 2003
VL 23
IS 4
BP 371
EP 379
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 723JF
UT WOS:000185428700008
PM 12956481
DA 2018-10-19
ER

PT J
AU Damien, E
   Hing, K
   Saeed, S
   Revell, PA
AF Damien, E
   Hing, K
   Saeed, S
   Revell, PA
TI A preliminary study on the enhancement of the osteointegration of a
   novel synthetic hydroxyapatite scaffold in vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 27th Annual Meeting of the Society-for-Biomaterials
CY APR 24-29, 2001
CL ST PAUL, MN
SP Soc Biomat
DE biomaterial; bone; hydroxyapatite implant; IGF-I; osteoblasts;
   osteointegration
ID GROWTH-FACTOR-I; POROUS HYDROXYAPATITE; DISTRACTION OSTEOGENESIS;
   GRINDING TECHNIQUE; MECHANICAL STRAIN; BONE; OSTEOPOROSIS; IMPLANTS;
   DEFECTS
AB Synthetic hydroxyapatite, a bioactive calcium phosphate, is clinically used as a bone replacement bioceramic because of its similarity in composition to bone mineral, biocompatibility, and osteoconductive nature. The aim of this study was to evaluate the bioactivity of a novel synthetic porous hydroxyapatite (PHA) in vivo in rabbit and to investigate the enhancement of its bioactivity and osteointegration. In the investigation reported here, insulin-like growth factor-I (IGF-I) has been used to enhance the bioactivity of PHA. Cylindrical PHA implants with or without IGF-I were implanted bilaterally in rabbit femurs. Fluorochrome bone markers were administered at 7-day intervals. The implants with the attached bone were retrieved at postmortem, 1 and 3 weeks after implantation, for histological and histomorphometric analysis. Undecalcified sections stained with toluidine blue showed new bone formation. Mineralization of the new bone formed in the interface, surrounding trabecular bone, and within the pores of the implants was studied. Lamellar bone mineral apposition rate (MAR) was assessed and compared among treatment groups, sham, PHA alone, and PHA with IGF-I (500 ng/implant), by fluorochrome label incorporation using UVL microscopy. We report for the first time, that the supplementation of PHA implants with IGF-I significantly increased new bone formation and MAR (6.58 +/- 0.08 mum/day) compared with implantation of PHA alone (4.08 +/- 0.05 mum/day) or sham operation (3.11 +/- 0.12 mum/day). These results suggest that synthetic PHA might provide a delivery system for bioactive agents to accelerate bone healing in orthopedic procedures. (C) 2003 Wiley Periodicals, Inc.
C1 UCL, Dept Histol, Osteoarticular Res & IRC Biomed Mat, London WC1E 7HU, England.
   Univ London, IRC Biomed Mat, London, England.
RP Damien, E (reprint author), UCL, Dept Histol, Osteoarticular Res & IRC Biomed Mat, Royal Free Campus, London WC1E 7HU, England.
EM edamien@rfc.ucl.ac.uk
CR Canalis E, 1997, BONE, V21, P215, DOI 10.1016/S8756-3282(97)00150-6
   Damien E, 1998, J BONE MINER RES, V13, P1275, DOI 10.1359/jbmr.1998.13.8.1275
   Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169
   DAMIEN E, 1996, J BONE MINER RES, V11, P9
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Farhadieh RD, 1999, J CRANIOFAC SURG, V10, P80, DOI 10.1097/00001665-199901000-00016
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   HING KA, 1999, Patent No. 9903283
   HOCK JM, 1988, ENDOCRINOLOGY, V122, P254, DOI 10.1210/endo-122-1-254
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Khan SN, 2000, ORTHOP CLIN N AM, V31, P375, DOI 10.1016/S0030-5898(05)70157-7
   Kurland ES, 1997, J CLIN ENDOCR METAB, V82, P2799, DOI 10.1210/jc.82.9.2799
   Lind M, 1998, Acta Orthop Scand Suppl, V283, P2
   Poiraudeau S, 1997, OSTEOPOROSIS INT, V7, P463, DOI 10.1007/s001980050034
   PRISELL PT, 1993, CALCIFIED TISSUE INT, V53, P201, DOI 10.1007/BF01321838
   Raschke MJ, 1999, BONE, V24, P81, DOI 10.1016/S8756-3282(98)00158-6
   RIPAMONTI U, 1992, PLAST RECONSTR SURG, V90, P382, DOI 10.1097/00006534-199209000-00004
   ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F
   Toussirot E, 1998, REV MED INTERNE, V19, P479, DOI 10.1016/S0248-8663(99)80003-4
   UCHIDA A, 1990, J BONE JOINT SURG BR, V72, P298
   Yamamoto T, 2000, J BONE JOINT SURG BR, V82B, P1117, DOI 10.1302/0301-620X.82B8.11194
   Yudell RM, 2000, J ORAL MAXIL SURG, V58, P761, DOI 10.1053/joms.2000.7261
   Ziegler J, 2002, J BIOMED MATER RES, V59, P422, DOI 10.1002/jbm.1258
NR 23
TC 54
Z9 64
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2003
VL 66A
IS 2
BP 241
EP 246
DI 10.1002/jbm.a.10564
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 707RV
UT WOS:000184524400005
PM 12888993
DA 2018-10-19
ER

PT J
AU Keselowsky, BG
   Collard, DM
   Garcia, AJ
AF Keselowsky, BG
   Collard, DM
   Garcia, AJ
TI Surface chemistry modulates fibronectin conformation and directs
   integrin binding and specificity to control cell adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fibronectin; integrin; cell adhesion; conformation; self-assembled
   monolayers
ID SELF-ASSEMBLED MONOLAYERS; OSTEOBLAST-LIKE CELLS; PROTEIN ADSORPTION;
   BIOLOGICAL-ACTIVITY; MONOCLONAL-ANTIBODIES; COMPETITIVE BEHAVIOR;
   HYDROPHOBIC SURFACES; ADSORBED FIBRONECTIN; RELAXATION KINETICS;
   GENE-EXPRESSION
AB Integrin-mediated cell adhesion to proteins adsorbed onto synthetic surfaces anchors cells and triggers signals that direct cell function. In the case of fibronectin (Fn), adsorption onto substrates of varying properties alters its conformation/structure and its ability to support cell adhesion. In the present study, self-assembled monolayers (SAMs) of alkanethiols on gold were used as model surfaces to investigate the effects of surface chemistry on Fn adsorption, integrin binding, and cell adhesion. SAMs presenting terminal CH3, OH, COOH, and NH2 functionalities modulated adsorbed Fn conformation as determined through differences in the binding affinities of monoclonal antibodies raised against the central cell-binding domain (OH > COOH = NH2 > CH3). Binding of alpha(5)beta(1) integrin to adsorbed Fn was controlled by SAM surface chemistry in a manner consistent with antibody binding (OH > COOH = NH2 > CH3), whereas alpha(nu) integrin binding followed the trend: COOH much greater than OH = NH2 = CH3, demonstrating alpha(5)beta(1) integrin specificity for Fn adsorbed onto the NH2 and OH SAMs. Cell adhesion strength to Fn-coated SAMs correlated with alpha(5)beta(1) integrin binding (OH > COOH = NH2 > CH3), and experiments with function-perturbing antibodies demonstrated that this receptor provides the dominant adhesion mechanism in this cell model. This work establishes an experimental framework to analyze adhesive mechanisms controlling cell-surface interactions and provides a general strategy of surface-directed control of adsorbed protein activity to manipulate cell function in biomaterial and biotechnological applications. (C) 2003 Wiley Periodicals, Inc.
C1 Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
RI Keselowsky, Benjamin/A-8000-2009
CR ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BOWDITCH RD, 1991, J BIOL CHEM, V266, P23323
   BRASH JL, 1987, PROTEINS INTERFACES, P490
   ENOMOTOIWAMOTO M, 1993, CELL ADHES COMMUN, V1, P191, DOI 10.3109/15419069309097253
   Franco M, 2000, J BIOMED MATER RES, V52, P261, DOI 10.1002/1097-4636(200011)52:2<261::AID-JBM4>3.0.CO;2-2
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Latour RA, 2002, J BIOMED MATER RES, V60, P564, DOI 10.1002/jbm.10052
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2
   PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sayre CN, 1997, LANGMUIR, V13, P714, DOI 10.1021/la960420v
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   SHARMA SK, 1980, J CHROMATOGR, V184, P471, DOI 10.1016/S0021-9673(00)93875-5
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SILVER JH, 1993, J BIOMED MATER RES, V27, P735, DOI 10.1002/jbm.820270606
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   ULMAN A, 1989, LANGMUIR, V5, P1147, DOI 10.1021/la00089a003
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
NR 60
TC 591
Z9 602
U1 14
U2 162
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2003
VL 66A
IS 2
BP 247
EP 259
DI 10.1002/jbm.a.10537
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 707RV
UT WOS:000184524400006
PM 12888994
DA 2018-10-19
ER

PT J
AU Simon, JL
   Roy, TD
   Parsons, JR
   Rekow, ED
   Thompson, VP
   Kemnitzer, J
   Ricci, JL
AF Simon, JL
   Roy, TD
   Parsons, JR
   Rekow, ED
   Thompson, VP
   Kemnitzer, J
   Ricci, JL
TI Engineered cellular response to scaffold architecture in a rabbit
   trephine defect
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE scaffold architecture; porous scaffold; poly(DTE carbonate); solid
   freeform fabrication; 3-D printing
ID TYROSINE-DERIVED POLYCARBONATES; 3-DIMENSIONAL PRINTING(TM); POROUS
   HYDROXYAPATITE; BONE-FORMATION; PORE-SIZE; METAL; INGROWTH
AB Tight control of pore architecture in porous scaffolds for bone repair is critical for a fully elucidated tissue response. Solid freeform fabrication (SFF) enables construction of scaffolds with tightly controlled pore architecture. Four types of porous scaffolds were constructed using SFF and evaluated in an 8-mm rabbit trephine defect at 8 and 16 weeks (n = 6): a lacticle/glycolide (50:50) copolymer scaffold with 20% w/w tri-calcium phosphate and random porous architecture (Group 1); another identical design made from poly(desaminotyrosyl-tyrosine ethyl ester carbonate) [poly(DTE carbonate)], a tyrosine-derived pseudo-polyamino acid (Group 2); and two poly(DTE carbonate) scaffolds containing 500 mum pores separated by 500-mum thick walls, one type with solid walls (Group 3), and one type with microporous walls (Group 4). A commercially available coralline scaffold (Interpore) with a 486-mum average pore size and empty defects were used as controls. There was no significant difference in the overall amount of bone ingrowth in any of the devices, as found by radiographic analysis, but patterns of bone formation matched the morphology of the scaffold. These results suggest that controlled scaffold architecture can be superimposed on biomaterial composition to design and construct scaffolds with improved fill time. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Med & Dent New Jersey, Dept Orthopaed, Newark, NJ 07103 USA.
   Rutgers State Univ, Dept Biochem Engn, New Brunswick, NJ 08903 USA.
   Integra Lifsci Inc, Plainsboro, NJ 08536 USA.
RP Parsons, JR (reprint author), Univ Med & Dent New Jersey, Dept Orthopaed, Newark, NJ 07103 USA.
EM parsonjr@umdnj.edu
OI Thompson, Van P/0000-0003-0033-0344
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   DAMIEN CJ, 1990, J BIOMED MATER RES, V24, P639, DOI 10.1002/jbm.820240602
   DAMIEN CJ, 1994, J BIOMED MATER RES, V28, P553, DOI 10.1002/jbm.820280505
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   HAMMERLE CHF, 1995, J ORAL MAXIL SURG, V53, P167, DOI 10.1016/0278-2391(95)90396-8
   Hooper KA, 1997, J APPL POLYM SCI, V63, P1499, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1499::AID-APP12>3.0.CO;2-Y
   Katstra WE, 2000, J CONTROL RELEASE, V66, P1, DOI 10.1016/S0168-3659(99)00225-4
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   KUHNE JH, 1994, ACTA ORTHOP SCAND, V65, P246, DOI 10.3109/17453679408995448
   LINDHOLM TC, 1994, INT J ORAL MAX SURG, V23, P306, DOI 10.1016/S0901-5027(05)80116-X
   MAINARD D, 1997, J BONE JOINT SURG S, V79, P4
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   RASMUSSEN P, 1975, SCAND J DENT RES, V83, P233
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Ripamonti U., 2000, BONE ENG, P215
   Rowe CW, 2000, J CONTROL RELEASE, V66, P11, DOI 10.1016/S0168-3659(99)00224-2
   ROY TD, 2001, T SOC BIOM 27 ANN M, P282
   ROY TD, 2001, T 47 ANN M ORTH RES, P196
   SCHLIEPHAKE H, 1991, INT J ORAL MAX SURG, V20, P52, DOI 10.1016/S0901-5027(05)80698-8
   SUZUKI HK, 1966, STAIN TECHNOL, V41, P57, DOI 10.3109/10520296609116280
   VANEEDEN SP, 1994, PLAST RECONSTR SURG, V93, P959, DOI 10.1097/00006534-199404001-00010
   WHITE E, 1986, DENT CLIN N AM, V30, P49
   WHITE RA, 1972, SCIENCE, V176, P922, DOI 10.1126/science.176.4037.922
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
NR 26
TC 59
Z9 62
U1 1
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2003
VL 66A
IS 2
BP 275
EP 282
DI 10.1002/jbm.a.10569
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 707RV
UT WOS:000184524400009
PM 12888997
DA 2018-10-19
ER

PT J
AU Suzuki, R
   Muyco, J
   McKittrick, J
   Frangos, JA
AF Suzuki, R
   Muyco, J
   McKittrick, J
   Frangos, JA
TI Reactive oxygen species inhibited by titanium oxide coatings
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE titanium dioxide; silicone; anti-inflammatory; oxide coating;
   peroxynitrite
ID TOTAL HIP-REPLACEMENT; NITRIC-OXIDE; SUPEROXIDE-DISMUTASE;
   HYDROGEN-PEROXIDE; PEROXYNITRITE FORMATION; INFLAMMATORY RESPONSE;
   DIOXIDE; IMPLANTS; NITRATION; MODEL
AB Titanium is a successful biomaterial that possesses good biocompatibility. It is covered by a surface layer of titanium dioxide, and this oxide may play a critical role in inhibiting reactive oxygen species, such as peroxynitrite, produced during the inflammatory response. In the present study, titanium dioxide was coated onto silicone substrates by radio-frequency sputtering. Silicone coating with titanium dioxide enhanced the breakdown of peroxynitrite by 79%. At physiologic pH, the peroxynitrite donor 3-morpholinosydnonimine-N-ethylcarbamide (SIN-1) was used to nitrate 4-hydroxyphenylacetic acid (4-HPA) to form 4-hydroxy-3-nitrophenyl acetic acid (NHPA). Titanium dioxide-coated silicone inhibited the nitration of 4-HPA by 61% compared to aluminum oxide-coated silicone and 55% compared to uncoated silicone. J774A.1 mouse macrophages were plated on oxide-coated silicone and polystyrene and stimulated to produce superoxide and interleukin-6. Superoxide production was measured by the chemiluminescent reaction with 2-methyl-6-[p-methoxyphenyll-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (MCLA). Titanium dioxide-coated silicone exhibited a 55% decrease in superoxide compared to uncoated silicone and a 165% decrease in superoxide compared to uncoated polystyrene. Titanium dioxide-coated silicone inhibited IL-6 production by 77% compared to uncoated silicone. These results show that the anti-inflammatory properties of titanium dioxide can be transferred to the surfaces of silicone substrates. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA.
   Univ Calif San Diego, Mat Sci & Engn Program, Dept Mech & Aerosp Engn, La Jolla, CA 92037 USA.
   La Jolla Bioeng Inst, La Jolla, CA 92037 USA.
RP Frangos, JA (reprint author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92037 USA.
OI McKittrick, Joanna/0000-0002-1442-3472
FU NIAMS NIH HHS [AR47032]; NIBIB NIH HHS [EB00823]
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   Anderson James M., 1996, P165
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BARTEAU MA, 1993, J VAC SCI TECHNOL A, V11, P2162, DOI 10.1116/1.578386
   BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620
   Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V
   BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229
   CAREY JH, 1976, B ENVIRON CONTAM TOX, V16, P697, DOI 10.1007/BF01685575
   Crow J P, 1995, Adv Pharmacol, V34, P17
   CUCKLER JM, 1992, AM SOC TEST MATER, V1144, P118, DOI 10.1520/STP14858S
   Eriksson AS, 1996, J CELL PHYSIOL, V166, P138, DOI 10.1002/(SICI)1097-4652(199601)166:1<138::AID-JCP16>3.0.CO;2-B
   HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868
   Hukkanen M, 1998, CLIN ORTHOP RELAT R, P53
   Hukkanen M, 1997, J BONE JOINT SURG BR, V79B, P467, DOI 10.1302/0301-620X.79B3.7469
   ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U
   KAUR H, 1994, FEBS LETT, V350, P9, DOI 10.1016/0014-5793(94)00722-5
   KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017
   KRAEUTLER B, 1978, J AM CHEM SOC, V100, P5985, DOI 10.1021/ja00487a001
   MATTHEWS RW, 1992, J PHOTOCH PHOTOBIO A, V64, P231, DOI 10.1016/1010-6030(92)85110-G
   MATTHEWS RW, 1987, J PHYS CHEM-US, V91, P3328, DOI 10.1021/j100296a044
   MEACHIM G, 1973, J BIOMED MATER RES, V7, P555, DOI 10.1002/jbm.820070607
   MILLER MJS, 1995, GASTROENTEROLOGY, V109, P1475, DOI 10.1016/0016-5085(95)90633-9
   NAIR M, 1993, IND ENG CHEM RES, V32, P2318, DOI 10.1021/ie00022a015
   NISHIDA A, 1989, CLIN CHIM ACTA, V179, P177, DOI 10.1016/0009-8981(89)90164-2
   Oosthuizen MMJ, 1997, J BIOLUM CHEMILUM, V12, P277, DOI 10.1002/(SICI)1099-1271(199711/12)12:6<277::AID-BIO455>3.3.CO;2-2
   Overgaard L, 1998, J BONE JOINT SURG BR, V80B, P888, DOI 10.1302/0301-620X.80B5.8101
   PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699
   RACHMILEWITZ D, 1993, GASTROENTEROLOGY, V105, P1681, DOI 10.1016/0016-5085(93)91063-N
   Salvemini D, 1996, EUR J PHARMACOL, V303, P217, DOI 10.1016/0014-2999(96)00140-9
   Sampson JB, 1996, METHOD ENZYMOL, V269, P210
   Sen CK, 1996, FASEB J, V10, P709
   SIBUM H, 1985, ULLMANS ENCY IND CHE, P95
   Suzuki R, 2000, CLIN ORTHOP RELAT R, P280
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   THOMSEN P, 1986, SCAND J PLAST RECONS, V20, P173, DOI 10.3109/02844318609006316
   Thomsen P, 1990, BONE BIOMATERIAL INT, P153
   TRILLAS M, 1992, J CHEM TECHNOL BIOT, V55, P85
   Udipi K, 2000, J BIOMED MATER RES, V51, P549, DOI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
   UEHARA K, 1993, FEBS LETT, V335, P167, DOI 10.1016/0014-5793(93)80722-7
   Ying JY, 1996, CHEM ENG J, V64, P225, DOI 10.1016/S0923-0467(96)03142-9
NR 43
TC 35
Z9 35
U1 1
U2 10
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2003
VL 66A
IS 2
BP 396
EP 402
DI 10.1002/jbm.a.10001
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 707RV
UT WOS:000184524400022
PM 12889010
DA 2018-10-19
ER

PT J
AU Broberg, M
   Nygren, H
AF Broberg, M
   Nygren, H
TI Exposure of fibrinogen-adherent platelets to plasma proteins: A new
   method for studying protein interactions with platelets
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE platelets; plasma proteins; activation; release; mediators
ID VON-WILLEBRAND-FACTOR; ACTIVATED PLATELETS; WHOLE-BLOOD;
   VONWILLEBRAND-FACTOR; MONOCLONAL-ANTIBODY; ADHESION RECEPTORS; TITANIUM
   SURFACES; GLYCOPROTEIN-IB; GLASS SURFACES; THROMBIN
AB To understand the effects of mediators in coagulating blood at biomaterial surfaces, it is important to use methods that resemble the normal sequence of events in wound healing around implants. The initial adhesion of platelets from whole blood onto material surfaces is mediated by the fibrinogen receptor glycoprotein IIb/IIIa, as shown in a previous study (Broberg et al., J Lab Clin Med 2002; 139:163-172). In this study, isolated platelets were adhered to fibrinogen and exposed to IgG, von Willebrand factor, or thrombin. The response was detected as the number of adherent platelets, the spreading of platelets, the exposure of CD62P (P-selectin), and the release of platelet factor 4 (PF4), ADP, and ATP. These results were compared to the response of platelets adhering to surfaces coated with the same proteins. Fibrinogen-adherent platelets exposed to thrombin generated the significantly highest exposure of CD62P and release of PF4, ADP, and ATP. When platelets were adhered to different protein coatings, von Willebrand factor generated the most CD62P exposure, IgG generated the most PF4 release, and thrombin generated the highest concentration of ADP. These results indicate that protein interactions with platelets may generate different results, depending on the mode of protein exposure. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Gothenburg, Dept Anat & Cell Biol, SE-40530 Gothenburg, Sweden.
RP Broberg, M (reprint author), Univ Gothenburg, Dept Anat & Cell Biol, Box 420, SE-40530 Gothenburg, Sweden.
CR Aziz KA, 1997, J LEUKOCYTE BIOL, V61, P322
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   Broberg M, 2002, J LAB CLIN MED, V139, P163, DOI 10.1067/mlc.2002.121604
   Broberg M, 1998, COLLOID SURFACE B, V11, P123, DOI 10.1016/S0927-7765(98)00024-1
   Broberg M, 1998, COLLOID SURFACE B, V10, P251, DOI 10.1016/S0927-7765(98)00011-3
   BROBERG M, 2001, BIOMATERIALS, P2403
   BUSCH C, 1980, THROMB RES, V19, P129, DOI 10.1016/0049-3848(80)90412-0
   CAPITANIO AM, 1985, BIOCHIM BIOPHYS ACTA, V839, P161, DOI 10.1016/0304-4165(85)90033-9
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   Eriksson C, 2001, J LAB CLIN MED, V137, P296, DOI 10.1067/mlc.2001.114066
   FERAUDI M, 1981, INT J SPORTS MED, V2, P106, DOI 10.1055/s-2008-1034592
   GEORGE JN, 1982, BLOOD, V59, P194
   Greco NJ, 1996, BIOCHEMISTRY-US, V35, P906, DOI 10.1021/bi951503y
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868
   Haimovich B, 1996, J BIOL CHEM, V271, P16332, DOI 10.1074/jbc.271.27.16332
   Heemskerk JWM, 1997, BLOOD, V90, P2615
   HOLMSEN H, 1979, ANNU REV MED, V30, P119, DOI 10.1146/annurev.me.30.020179.001003
   HSULIN SC, 1984, J BIOL CHEM, V259, P9121
   IKEDA Y, 1991, J CLIN INVEST, V87, P1234, DOI 10.1172/JCI115124
   Ji P, 1999, BBA-MOL CELL RES, V1448, P543, DOI 10.1016/S0167-4889(98)00160-8
   KAPLAN KL, 1979, BLOOD, V53, P604
   KLINGER MHF, 1995, INT ARCH ALLERGY IMM, V107, P541, DOI 10.1159/000237097
   LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4
   MASON RG, 1971, P SOC EXP BIOL MED, V137, P680
   MCEVER RP, 1984, J BIOL CHEM, V259, P9799
   NIEWIAROWSKI S, 1969, NATURE, V222, P1269, DOI 10.1038/2221269a0
   NIEWIAROWSKI S, 1987, HEMOSTASIS THROMBOSI, P618
   NYDAHL S, 1992, THROMB RES, V65, P365, DOI 10.1016/0049-3848(92)90167-9
   Nygren H, 1998, J BIOMAT SCI-POLYM E, V9, P817, DOI 10.1163/156856298X00172
   Nygren H, 1997, J VAC SCI TECHNOL A, V15, P768, DOI 10.1116/1.580705
   NYGREN H, 1997, WEIRS HDB IMMUNOLOGY
   OSTERMAN DG, 1982, BIOCHEM BIOPH RES CO, V107, P130, DOI 10.1016/0006-291X(82)91679-5
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686
   ROSENFELD SI, 1985, J CLIN INVEST, V76, P2317, DOI 10.1172/JCI112242
   SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M
   Sanders MW, 1998, HAEMOSTASIS, V28, P289
   SAVAGE B, 1992, J BIOL CHEM, V267, P11300
   STANFORD MF, 1983, ANN NY ACAD SCI, V416, P504, DOI 10.1111/j.1749-6632.1983.tb35208.x
   STENBERG M, 1982, ANAL BIOCHEM, V127, P183, DOI 10.1016/0003-2697(82)90163-4
   Stenberg M, 1983, J PHYS C S12, VC10, P83
   STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880
   TEDDER TF, 1995, FASEB J, V9, P866
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   WERTHEN M, 1990, PROG COLL POL SCI S, V82, P349
   ZUCKER MB, 1969, P SOC EXP BIOL MED, V131, P318
NR 46
TC 4
Z9 4
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG 1
PY 2003
VL 66A
IS 2
BP 403
EP 410
DI 10.1002/jbm.a.10554
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 707RV
UT WOS:000184524400023
PM 12889011
DA 2018-10-19
ER

PT J
AU Wikesjo, UME
   Xiropaidis, AV
   Thomson, RC
   Cook, AD
   Selvig, KA
   Hardwick, WR
AF Wikesjo, UME
   Xiropaidis, AV
   Thomson, RC
   Cook, AD
   Selvig, KA
   Hardwick, WR
TI Periodontal repair in dogs: space-providing ePTFE devices increase
   rhBMP-2/ACS-induced bone formation
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE tissue engineering; periodontal regeneration; wound healing; seroma
ID REGENERATION IN-VIVO; BABOON PAPIO-URSINUS; MORPHOGENETIC PROTEIN-2;
   MANDIBULAR RECONSTRUCTION; FENESTRATION DEFECTS; ENDOSSEOUS IMPLANTS;
   RIDGE AUGMENTATION; DELIVERY SYSTEMS; DENTAL IMPLANTS; CANINE MODEL
AB Background: Recombinant human bone morphogenetic protein-2 (rhBMP-2) technologies have been shown to enhance alveolar bone formation significantly. Biomaterial (carrier) limitations, however, have restricted their biologic potential for indications where compressive forces may limit the volume of bone formed. The objective of this proof-of-principle study was to evaluate the potential of a space-providing, macroporous ePTFE device to define rhBMP-2-induced alveolar bone formation using a discriminating onlay defect model.
   Methods: Routine, critical size, 5-6 mm, supra-alveolar, periodontal defects were created around the third and fourth mandibular premolar teeth in four young adult Hound Labrador mongrel dogs. All jaw quadrants received rhBMP-2 (0.4 mg) in an absorbable collagen sponge (ACS) carrier. Contralateral jaw quadrants in subsequent animals were randomly assigned to receive additionally the dome-shaped, macroporous ePTFE device over the rhBMP-2/ACS implant or no additional treatment. The gingival flaps were advanced to cover the ePTFE device and teeth, and sutured. Animals were scheduled for euthanasia to provide for histologic observations of healing at 8 weeks postsurgery.
   Results: Healing was uneventful without device exposures. New bone formation averaged (+/-SD) 4.7+/-0.2 mm (98%) and 4.5+/-0.4 mm (94%) of the defect height, respectively, for jaw quadrants receiving rhBMP-2/ACS with the ePTFE device or rhBMP-2/ACS alone (p >0.05). In contrast, the regenerated bone area was significantly enhanced in jaw quadrants receiving rhBMP-2/ACS with the ePTFE device compared to rhBMP-2/ACS alone (9.3+/-2.7 versus 5.1+/-1.1 mm(2) ; p <0.05). Cementum formation was similar for both treatment groups. Ankylosis compromised periodontal regeneration in all sites.
   Conclusions: The results suggest that the novel space-providing, macroporous ePTFE device appears suitable as a template to define rhBMP-2/ACS-induced alveolar bone formation.
C1 Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA 19140 USA.
   WL Gore & Assoc Inc, Med Prod Div, Res & Dev, Flagstaff, AZ USA.
   Univ Bergen, Sch Dent, Dept Dent Res, Bergen, Norway.
RP Wikesjo, UME (reprint author), Temple Univ, Sch Dent, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, 3223 N Broad St, Philadelphia, PA 19140 USA.
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
CR Barboza EP, 2000, J PERIODONTOL, V71, P488, DOI 10.1902/jop.2000.71.3.488
   Boyne PJ, 2001, INT J PERIODONT REST, V21, P333
   Boyne PJ, 1999, BRIT J ORAL MAX SURG, V37, P344, DOI 10.1054/bjom.1999.0205
   Boyne PJ, 1998, BRIT J ORAL MAX SURG, V36, P84, DOI 10.1016/S0266-4356(98)90173-5
   Boyne PJ, 1996, BONE, V19, P83
   CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843
   Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Cochran DL, 1997, INT J ORAL MAX IMPL, V12, P739
   Giannobile WV, 1998, J PERIODONTOL, V69, P129, DOI 10.1902/jop.1998.69.2.129
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P604
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P785
   HANISCH O, 2003, IN PRESS J PERIODONT
   Howell T. H., 1997, INT J PERIODONT REST, V17, P124
   Hunt DR, 2001, J PERIODONTOL, V72, P651, DOI 10.1902/jop.2001.72.5.651
   Ishikawa I, 1994, DENT JAPAN, V31, P141
   JOVANOVIC SA, 2003, IN PRESS CLIN ORAL I
   King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801
   King GN, 1998, J PERIODONTOL, V69, P561, DOI 10.1902/jop.1998.69.5.561
   King GN, 1999, J PERIODONTOL, V70, P1125, DOI 10.1902/jop.1999.70.10.1125
   King GN, 1998, J PERIODONTAL RES, V33, P226, DOI 10.1111/j.1600-0765.1998.tb02194.x
   Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103
   KirkerHead CA, 1997, INT J ORAL MAX IMPL, V12, P403
   Koempel JA, 1998, J BIOMED MATER RES, V41, P359, DOI 10.1002/(SICI)1097-4636(19980905)41:3<359::AID-JBM3>3.0.CO;2-B
   Kuboki Y, 1998, EUR J ORAL SCI, V106, P197, DOI 10.1111/j.1600-0722.1998.tb02176.x
   Mayer M, 1996, PLAST RECONSTR SURG, V98, P247, DOI 10.1097/00006534-199608000-00006
   Nevins M, 1996, Int J Periodontics Restorative Dent, V16, P8
   OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x
   Ripamonti U, 1996, ARCH ORAL BIOL, V41, P121, DOI 10.1016/0003-9969(95)00110-7
   RIPAMONTI U, 1994, J PERIODONTAL RES, V29, P439, DOI 10.1111/j.1600-0765.1994.tb01246.x
   Selvig KA, 2002, J PERIODONTOL, V73, P1020, DOI 10.1902/jop.2002.73.9.1020
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P511, DOI 10.1902/jop.1995.66.6.511
   Sigurdsson TJ, 1997, CLIN ORAL IMPLAN RES, V8, P367, DOI 10.1034/j.1600-0501.1997.080503.x
   Sigurdsson TJ, 2001, INT J PERIODONT REST, V21, P461
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Steinberg B, 1999, J CRANIOFAC SURG, V10, P338, DOI 10.1097/00001665-199907000-00011
   Sykaras N, 2001, CLIN ORAL IMPLAN RES, V12, P339, DOI 10.1034/j.1600-0501.2001.012004339.x
   Talwar R, 2001, J CLIN PERIODONTOL, V28, P340, DOI 10.1034/j.1600-051x.2001.028004340.x
   Tatakis DN, 2002, J PERIODONTAL RES, V37, P93, DOI 10.1034/j.1600-0765.2002.00021.x
   TORIUMI DM, 1991, ARCH OTOLARYNGOL, V117, P1101
   Toriumi DM, 1999, LARYNGOSCOPE, V109, P1481, DOI 10.1097/00005537-199909000-00023
   URIST MR, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P315
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
   Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x
   WIKESJO UME, 2003, IN PRESS J PERIODONT
   WIKESJO UME, 2003, IN PRESS CLIN IMPLAN
   WIKESJO UME, 2003, IN PRESS CLIN ORAL I
   WIKESJO UME, 2003, IN PRESS J CLIN PERI
   WIKESJO UME, 2002, CLIN IMPLANT DENT R, V4, P173
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yudell RM, 2000, J ORAL MAXIL SURG, V58, P761, DOI 10.1053/joms.2000.7261
   Zellin G, 1997, J BIOMED MATER RES, V35, P181
NR 57
TC 25
Z9 25
U1 1
U2 6
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD AUG
PY 2003
VL 30
IS 8
BP 715
EP 725
DI 10.1034/j.1600-051X.2003.00364.x
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 704JJ
UT WOS:000184336300006
PM 12887340
DA 2018-10-19
ER

PT J
AU Song, F
   Bai, YL
AF Song, F
   Bai, YL
TI Effects of nanostructures on the fracture strength of the interfaces in
   nacre
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID DEFORMATION; COMPOSITES; STRATEGIES; DESIGN
AB A strengthening mechanism arising from the mineral bridges in the organic matrix layers of nacre (mother of pearl) is presented by studying the structural and mechanical properties of the interfaces in nacre. This mechanism not only increases the average fracture strength of the organic matrix interfaces by about five times, but also effectively arrests the cracks in the organic matrix layers and causes the crack deflection in this biomaterial. The present investigation shows that the main mechanism governing the strength of the organic matrix layers of nacre relies on the mineral bridges rather than the organic matrix. This study provides a guide to the interfacial design of synthetic materials.
C1 Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech, Beijing 100080, Peoples R China.
RP Song, F (reprint author), Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech, Beijing 100080, Peoples R China.
RI Bai, Yilong/B-7781-2013
CR Almqvist N, 1999, MAT SCI ENG C-BIO S, V7, P37, DOI 10.1016/S0928-4931(98)00072-1
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Kaplan DL, 1998, CURR OPIN SOLID ST M, V3, P232, DOI 10.1016/S1359-0286(98)80096-X
   Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P
   Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5
   Okumura K, 2001, EUR PHYS J E, V4, P121, DOI 10.1007/s101890170150
   Sarikaya M, 1995, BIOMIMETICS DESIGN P, P35
   Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Song F, 2002, J MATER RES, V17, P1567, DOI 10.1557/JMR.2002.0233
   WANG RZ, 1995, J MATER SCI, V30, P2299, DOI 10.1007/BF01184577
   Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340
NR 15
TC 60
Z9 70
U1 3
U2 26
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD AUG
PY 2003
VL 18
IS 8
BP 1741
EP 1744
DI 10.1557/JMR.2003.0239
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 709EF
UT WOS:000184611200001
OA Green Published
DA 2018-10-19
ER

PT J
AU Brodbeck, WG
   Colton, E
   Anderson, JM
AF Brodbeck, WG
   Colton, E
   Anderson, JM
TI Effects of adsorbed heat labile serum proteins and fibrinogen on
   adhesion and apoptosis of monocytes/macrophages on biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT International Conference on Advances of Biomaterials for Reconstructive
   Medicine
CY JUN 09-14, 2002
CL CAPRI, ITALY
ID MULTINUCLEATED GIANT-CELLS; SURFACE-CHEMISTRY; MACROPHAGES; FUSION;
   MONOCYTES; CRACKING; INVIVO
AB A previously established human monocyte culture protocol was used to determine the effects of varying adsorbed proteins on monocyte/macrophage adhesion and survival on dimethyl-silane (DM) or RGD modified glass coverslips. Cells were allowed to adhere for 2 h in the absence of protein or in the presence of serum, fibrinogen (Fg), heat inactivated serum (HIS), serum supplemented with Fg or HIS with Fg. Cell adhesion and apoptosis rates were determined on days 0 (2 h), 3, 7 and 10 of culture. The presence of serum alone in the initial culture was sufficient to optimize monocyte/macrophage adhesion and survival rates. Adding Fg to serum did not increase adhesion nor decrease apoptotic rates. No protein or the addition of HIS during the initial incubation period significantly decreased monocyte/ macrophage adhesion and survival on both surfaces, however, the addition of Fg to HIS restored adhesion and survival rates to those seen with in the presence of serum alone on RGD surfaces. These studies demonstrate that monocyte/macrophage adhesion and survival on biomaterial surfaces are optimized by adsorbed heat labile serum proteins while adsorbed Fg plays a surface property-dependent role. (C) 2003 Kluwer Academic Publishers
C1 Case Western Reserve Univ, Sch Med, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Sch Med, Inst Pathol, Rm 306, Cleveland, OH 44106 USA.
EM wgb2@po.cwru.edu
CR ANDERSON JM, 1996, BIOMATERIALS SCI, P451
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   SLACK SM, 1987, ANN NY ACAD SCI, V516, P223, DOI 10.1111/j.1749-6632.1987.tb33044.x
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   TANG L, 1998, J BIOMED MATER RES, P156
   TANG L, 1996, J EXP MED, V178, P2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 17
TC 33
Z9 36
U1 1
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2003
VL 14
IS 8
BP 671
EP 675
DI 10.1023/A:1024951330265
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 704VC
UT WOS:000184360500003
PM 15348406
DA 2018-10-19
ER

PT J
AU Kirkpatrick, CJ
   Unger, RE
   Krump-Konvalinkova, V
   Peters, K
   Schmidt, H
   Kamp, G
AF Kirkpatrick, CJ
   Unger, RE
   Krump-Konvalinkova, V
   Peters, K
   Schmidt, H
   Kamp, G
TI Experimental approaches to study vascularization in tissue engineering
   and biomaterial applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT International Conference on Advances of Biomaterials for Reconstructive
   Medicine
CY JUN 09-14, 2002
CL CAPRI, ITALY
ID ANGIOGENESIS INVITRO; ENDOTHELIAL-CELLS; QUANTIFICATION; IONS
AB The success of tissue engineering and biomaterial applications is not only dependent on the growth and functioning of the organ- or tissue-specific cells on the biomaterial but is entirely dependent in most cases on a successful vascularization after implantation. The process of vascularization involves angiogenesis; the formation of new blood vessels which spread into the implant material and supply the existing cells with the nutrients to survive. We have established in vitro methods using human microvascular endothelial cells to evaluate novel biomaterials for endothelial cell attachment, cytotoxicity, growth, angiogenesis and the effects on gene regulation. These in vitro studies can be used to rapidly evaluate the potential success of a new biomaterial and for the development of matrix scaffolds which will promote a physiological vascularization response. (C) 2003 Kluwer Academic Publisher
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   Univ Mainz, AMP Lab GmbH, D-55099 Mainz, Germany.
RP Kirkpatrick, CJ (reprint author), Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RI Peters, Kirsten/S-3484-2016
CR BATTEGAY EJ, 1995, J MOL MED-JMM, V73, P333
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   MONTESANO R, 1992, EUR J CLIN INVEST, V22, P504, DOI 10.1111/j.1365-2362.1992.tb01498.x
   NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Peters K, 2001, J MATER SCI-MATER M, V12, P955, DOI 10.1023/A:1012852814570
   UNGER RE, IN PRESS MICROVASC R
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
NR 10
TC 28
Z9 28
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2003
VL 14
IS 8
BP 677
EP 681
DI 10.1023/A:1024903514335
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 704VC
UT WOS:000184360500004
PM 15348407
DA 2018-10-19
ER

PT J
AU Paradossi, G
   Cavalieri, F
   Chiessi, E
   Spagnoli, C
   Cowman, MK
AF Paradossi, G
   Cavalieri, F
   Chiessi, E
   Spagnoli, C
   Cowman, MK
TI Poly(vinyl alcohol) as versatile biomaterial for potential biomedical
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT International Conference on Advances of Biomaterials for Reconstructive
   Medicine
CY JUN 09-14, 2002
CL CAPRI, ITALY
ID CONTRAST AGENTS; ULTRASOUND; HYDROGELS
AB In this paper, we present some new case examples where the chemical versatility of poly (vinyl alcohol) (PVA) can be used for potential biomedical applications. PVA, the polymeric material used for designing new nanostructured devices, is water soluble, biocompatible and has excellent physical properties. We point out the possibility of obtaining wall-to-wall chemical hydrogels as well as microgels without diminishing the biocompatibility available in the starting PVA material. Injectability is another important factor to take into account in controlled drug delivery for gene therapy. In this respect, in this paper, established and more innovative methods are prospected in order to obtain particles with dimensions suitable for these applications. (C) 2003 Kluwer Academic Publisher
C1 Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy.
   Univ Roma Tor Vergata, INFM, Sect B, Rome, Italy.
   Polytech Univ Brooklyn, Dept Chem Engn Chem & Mat Sci, Brooklyn, NY USA.
RP Paradossi, G (reprint author), Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy.
EM paradossi@stc.uniroma2.it
RI Paradossi, Gaio/B-8330-2014
OI Paradossi, Gaio/0000-0003-3051-3811; CAVALIERI,
   FRANCESCA/0000-0001-5391-5069; Chiessi, Ester/0000-0001-7529-2755
CR DE SMEDT SC, 1995, MACROMOLECULES, V28, P5082, DOI 10.1021/ma00118a042
   ERMA B, 1997, STRUCTURE PROPERTIES
   Finch C. A., 1973, POLYVINYL ALCOHOL PR
   FLORY PJ, 1948, J POLYM SCI, V3, P880, DOI 10.1002/pol.1948.120030608
   Keresztes Z, 2001, APPL PHYS A-MATER, V72, pS113, DOI 10.1007/s003390100680
   Klibanov AL, 1999, ADV DRUG DELIVER REV, V37, P139, DOI 10.1016/S0169-409X(98)00104-5
   Koda S, 1996, ULTRASON SONOCHEM, V3, pS91, DOI 10.1016/1350-1477(96)00008-2
   MACKENNA G, 1994, POLYMER, V35, P5737
   OPHIR J, 1989, ULTRASOUND MED BIOL, V15, P319, DOI 10.1016/0301-5629(89)90044-6
   Paradossi G, 1999, J POLYM SCI POL PHYS, V37, P1225, DOI 10.1002/(SICI)1099-0488(19990615)37:12<1225::AID-POLB4>3.3.CO;2-G
   PEPPAS NA, 1992, J CONTROL RELEASE, V18, P95, DOI 10.1016/0168-3659(92)90178-T
NR 11
TC 157
Z9 157
U1 3
U2 43
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2003
VL 14
IS 8
BP 687
EP 691
DI 10.1023/A:1024907615244
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 704VC
UT WOS:000184360500006
PM 15348409
DA 2018-10-19
ER

PT J
AU Zavan, B
   Cortivo, R
   Tonello, C
   Abatangelo, G
AF Zavan, B
   Cortivo, R
   Tonello, C
   Abatangelo, G
TI Gland cell cultures into 3D hyaluronan-based scaffolds
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT International Conference on Advances of Biomaterials for Reconstructive
   Medicine
CY JUN 09-14, 2002
CL CAPRI, ITALY
ID GROWTH
AB In this study we report a preliminary investigation of the feasibility of non-woven/sponge fabrics of a hyaluronan derived biomaterials (benzyl ester of HA (HYAFF-11(TM) FAB, Abano Terme, Italy) for the in vitro culture of rat hepatocytes and rat beta cells. Cell growth on hyaluronan derived biomaterials were tested in the presence of complete medium and in the presence of ECM (extracellular matrix) secreted by fibroblasts previously cultured into the scaffold. Hepatocytes and beta cells were extracted from rat liver/pancreas and seeded either on the HYAFF-11(TM) scaffold alone, or on HYAFF-11(TM) scaffold containing ECM. Direct assay of cell proliferation was performed with MTT test. For morphological observations samples were stained with hematoxylin and eosin. The results obtained by MTT test showed that hepatocytes cultivated in both the above described conditions were able to proliferate up to 14 days and Langerhans islet up to 21 days. After this time, cells started to undergo apoptosis. The morphological analyses showed cell aggregation in three-dimensional structures promoted by the fibers of the biomaterial.
   Our results confirmed that HYAFF-11(TM) meshes represent a suitable scaffold for hepatocyte adhesion/Langerhans islet organization and proliferation. In particular, the presence of a fibroblast secreted extracellular matrix improves the biological property of the scaffold. (C) 2003 Kluwer Academic Publishers
C1 Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
RP Zavan, B (reprint author), Univ Padua, Dept Histol Microbiol & Med Biotechnol, I-35100 Padua, Italy.
CR Brun P, 1999, J MATER SCI-MATER M, V10, P1
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   Kolff WJ, 2002, NAT MED, V8, P1063, DOI 10.1038/nm771
   KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201
   MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Zacchi V, 1998, J BIOMED MATER RES, V40, P187, DOI 10.1002/(SICI)1097-4636(199805)40:2<187::AID-JBM3>3.0.CO;2-H
NR 7
TC 13
Z9 14
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2003
VL 14
IS 8
BP 727
EP 729
DI 10.1023/A:1024971902040
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 704VC
UT WOS:000184360500013
PM 15348416
DA 2018-10-19
ER

PT J
AU Artzi, Z
   Givol, N
   Rohrer, MD
   Nemcovsky, CE
   Prasad, HS
   Tal, H
AF Artzi, Z
   Givol, N
   Rohrer, MD
   Nemcovsky, CE
   Prasad, HS
   Tal, H
TI Qualitative and quantitative expression of bovine bone mineral in
   experimental bone defects. Part 1: Description of a dog model and
   histological observations
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE animal studies; bone regeneration; collagen; follow-up studies; grafts,
   bone; membranes, barrier; osteogenesis; wound healing
ID ALVEOLAR RIDGE AUGMENTATION; HUMAN EXTRACTION SOCKETS; MAXILLOFACIAL
   SURGERY; BIO-OSS; DISTRACTION OSTEOGENESIS; GRINDING TECHNIQUE; OSSEOUS
   RESPONSE; PTFE MEMBRANE; GUIDED BONE; REGENERATION
AB Background: The purpose of this study was to evaluate histologically the contribution of inorganic bovine bone biomaterial in a new experimental bone defect in dogs at different healing periods and to examine newly formed bone around the grafted mineral particles and their relationship in membrane-protected (test) and non-protected intrabony (control) defects.
   Methods: Four round intrabony defects, 5 x 4 mm were made bilaterally (at different times) on the lateral bony mandibular angle in eight dogs. Two defects were filled with bovine bone mineral (BBM) particles and two remained non-grafted but were blood clotted. A Collagen membrane covered each defect type (n = 4). This procedure was repeated on the contralateral side at a different given time to obtain two different healing periods in each dog. Thus, four specimens were obtained at 3, 6, 12, and 24 months post-operatively for each healing period. The non-decalcification method (Donath technique) with Stevenel's blue and van Gieson's picro fuchsin staining was used for histological examination.
   Results: Newly formed bone was observed at all examined defect types. The BBM particles were clearly evident regardless of the healing period. At 3 and 6 months, newly formed bone, woven in nature, was incorporated with the grafted particles. High cellular bone with occasional osteoclasts was noted towards the surface of the mineral particles. No substantial difference was observed between the protected and the non-protected defects except for higher ossified centers around the membrane-protected defects. At the non-grafted sites, the membrane-protected defect showed newly formed bone near the bony walls, and particularly under the membrane, establishing a bony bridge over the defect at the healing periods. The non-grafted unprotected defect (control) showed bone formation only at the base and close to the bony walls leaving a healed concave configuration. At 1 and 2 years, the grafted sites showed full bone healing configuration. However, the grafted particles still dominated the previous defect area and were completely surrounded by the newly formed bone. Osteons and lamellar bone arrangement were established but the bone was still highly cellular and osteoclasts could still be identified. The non-grafted membrane-protected sites showed excellent bone healing although areas of non-mineralized soft tissue were often seen. The control sites healed but still presented with a concave surface configuration.
   Conclusions: BBM biornaterial is a highly osteoconductive material. In a 4-wall bony defect, newly formed bone was well evident in establishing excellent bone healing configuration with or without a regenerative biological barrier. The grafted material dominated the experimental sites with no substantial resorption at any healing period up to 2 years observation.
C1 Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Periodontol, Tel Aviv, Israel.
   Chaim Sheba Med Ctr, Dept Oral & Maxillofacial Surg, IL-52621 Tel Hashomer, Israel.
   Univ Minnesota, Sch Dent, Div Oral & Maxillofacial Pathol, Minneapolis, MN 55455 USA.
   Univ Minnesota, Hard Tissue Res Lab, Minneapolis, MN 55455 USA.
RP Artzi, Z (reprint author), Tel Aviv Univ, Sch Dent Med, Dept Periodontol, Tel Aviv, Israel.
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P233
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Artzi Z, 2003, J PERIODONTOL, V74, P1153, DOI 10.1902/jop.2003.74.8.1153
   Artzi Z, 1998, J PERIODONTOL, V69, P1062, DOI 10.1902/jop.1998.69.9.1062
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Artzi Z, 2001, J PERIODONTOL, V72, P152, DOI 10.1902/jop.2001.72.2.152
   Becker W, 1998, J PERIODONTOL, V69, P414, DOI 10.1902/jop.1998.69.4.414
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BOYNE PJ, 1997, OSSEOUS RECONSTRUCTI, P27
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   CALLAN DP, 1993, J PERIODONTOL, V64, P575, DOI 10.1902/jop.1993.64.6.575
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   Chin M, 1996, J ORAL MAXIL SURG, V54, P45, DOI 10.1016/S0278-2391(96)90303-1
   Chin MT, 1998, J ORAL MAXIL SURG, V56, P805, DOI 10.1016/S0278-2391(98)90844-8
   COHEN RE, 1994, J PERIODONTOL, V65, P1008, DOI 10.1902/jop.1994.65.11.1008
   Dahlin C, 1989, Int J Oral Maxillofac Implants, V4, P19
   DAHLIN C, 1990, SCAND J PLAST RECONS, V24, P13, DOI 10.3109/02844319009004514
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   FROST DE, 1982, J ORAL MAXIL SURG, V40, P353, DOI 10.1016/0278-2391(82)90253-1
   Fukuta K, 1992, J Craniofac Surg, V3, P25, DOI 10.1097/00001665-199207000-00010
   Hammerle CHF, 1997, CLIN ORAL IMPLAN RES, V8, P198, DOI 10.1034/j.1600-0501.1997.080306.x
   Hammerle CHF, 1998, CLIN ORAL IMPLAN RES, V9, P151, DOI 10.1034/j.1600-0501.1998.090302.x
   HISLOP WS, 1993, BRIT J ORAL MAX SURG, V31, P149, DOI 10.1016/0266-4356(93)90113-B
   Hockers T, 1999, CLIN ORAL IMPLAN RES, V10, P487, DOI 10.1034/j.1600-0501.1999.100607.x
   Isaksson S, 1992, Swed Dent J Suppl, V84, P1
   ISAKSSON S, 1992, J CRANIO MAXILL SURG, V20, P2, DOI 10.1016/S1010-5182(05)80187-8
   Jensen O T, 1995, Int J Oral Maxillofac Implants, V10, P335
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   KARNOVSKY MJ, 1965, J CELL BIOL, V3, P112
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   LEAKE DL, 1976, J ORAL SURG, V34, P940
   MANDELKOW HK, 1990, UNFALLCHIRURG, V93, P376
   Ohnishi H, 2000, J PERIODONTOL, V71, P341, DOI 10.1902/jop.2000.71.3.341
   PEETZ M, 1997, OSSEOUS RECONSTRUCTI, P87
   PINHOLT EM, 1991, SCAND J DENT RES, V99, P154
   ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Schenk R K, 1994, Int J Oral Maxillofac Implants, V9, P13
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Schmitt JM, 1997, J PERIODONTOL, V68, P1043, DOI 10.1902/jop.1997.68.11.1043
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Schwartz Z, 2000, J PERIODONTOL, V71, P1258, DOI 10.1902/jop.2000.71.8.1258
   SEIBERT J, 1990, J PERIODONTOL, V61, P157, DOI 10.1902/jop.1990.61.3.157
   SIMION M, 1994, INT J PERIODONT REST, V14, P497
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   SPECTOR M, 1994, CLIN PLAST SURG, V21, P437
   Spector M, 1999, TISSUE ENGINEERING, P3
   Thaller S R, 1993, J Craniofac Surg, V4, P79, DOI 10.1097/00001665-199304000-00005
   Tinti C, 1996, Int J Periodontics Restorative Dent, V16, P220
   Young C, 1999, INT J ORAL MAX IMPL, V14, P72
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
NR 53
TC 23
Z9 23
U1 0
U2 4
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD AUG
PY 2003
VL 74
IS 8
BP 1143
EP 1152
DI 10.1902/jop.2003.74.8.1143
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 754KK
UT WOS:000187315400006
PM 14514227
DA 2018-10-19
ER

PT J
AU Sheikh, N
AF Sheikh, N
TI The effect of radiosterilization on cytotoxicity of polyurethane film
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Ionizing Radiation and Polymers (IRaP
   2002)
CY SEP 21-26, 2002
CL ST ADELE, CANADA
SP Rech, Sci & Technol Quebec, Ecole Polytech Montreal, DSM DRECAM CEA/Saclay, IOM, IAEA Vienna, Grp COGETEFI, CTT Grp, GEX Corp, Nissin NHV Amer Inc, IBA, Promerus
DE sterilization; gamma-ray; polyurethane film; SEM; porosity; cytotoxicity
AB Nowadays a sequence of tests for evaluation of sterilized biomaterial includes an initial set of tests in vitro, both biological (cell culture) and non-biological (mechanical tests). In this paper the cytotoxicity of a sterilized polyurethane film, in order to use as biomaterial, has been investigated. For this purpose NCO-terminated urethane prepolymer in medical quality was synthesized without ingredients beside monomers (polyethylene glycol/castor oil and toluene diisocyanate). The cured prepolymer films were prepared under ambient conditions due to the reaction of free NCO-groups of prepolymer with air moisture. The polyurethane films were sterilized by gamma-ray (25 kGy). The surface structure of sterilized polyurethane film was observed by SEM and compared to that of the unsterilized film. Also, the in vitro interaction of fibroblast cells and sterilized polyurethane film in culture medium containing serum was evaluated in comparison with control samples. Results showed no signs of cell toxicity. (C) 2003 Elsevier B.V. All rights reserved.
C1 Atom Energy Org Iran, Gamma Irradiat Ctr, Tehran, Iran.
RP Sheikh, N (reprint author), Atom Energy Org Iran, Gamma Irradiat Ctr, POB 11365-3486, Tehran, Iran.
CR AUTIAN J, 1977, ARTIF ORGANS, V1, P53
   Corneillie S, 1998, POLYM INT, V46, P251, DOI 10.1002/(SICI)1097-0126(199807)46:3<251::AID-PI6>3.0.CO;2-Z
   Donkerwolcke M, 1998, BIOMATERIALS, V19, P1461, DOI 10.1016/S0142-9612(98)00059-3
   KLEMCHUK PP, 1993, RADIAT PHYS CHEM, V41, P165, DOI 10.1016/0969-806X(93)90052-V
   LALEH MD, 1986, POLYURETHANE MED, P103
   Sheikh N, 2000, INT J ADHES ADHES, V20, P299, DOI 10.1016/S0143-7496(99)00060-3
   1994, PLASTICS DESIGN LIB, pR4
NR 7
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD AUG
PY 2003
VL 208
BP 215
EP 219
DI 10.1016/S0168-583X(03)01107-8
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 707LT
UT WOS:000184512700036
DA 2018-10-19
ER

PT J
AU Rosiak, JM
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Stasica, P
   Ulanski, P
AF Rosiak, JM
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Stasica, P
   Ulanski, P
TI Nano-, micro- and macroscopic hydrogels synthesized by radiation
   technique
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Ionizing Radiation and Polymers (IRaP
   2002)
CY SEP 21-26, 2002
CL ST ADELE, CANADA
SP Rech, Sci & Technol Quebec, Ecole Polytech Montreal, DSM DRECAM CEA/Saclay, IOM, IAEA Vienna, Grp COGETEFI, CTT Grp, GEX Corp, Nissin NHV Amer Inc, IBA, Promerus
DE ionizing radiation; hydrogel; biomaterial; drug delivery; implant
ID POLYMERIC NANOGELS; PULSE-RADIOLYSIS; AQUEOUS-SOLUTION
AB Radiation techniques, due to the additive-free initiation and easy process control, are very suitable tools for synthesis of biomaterials, especially hydrogels. In our group, a number of techniques have been elaborated allowing for targeted synthesis of gels of various size ranges, from internally crosslinked individual macromolecules, via microgels to macroscopic hydrogels. An example of a mature technology of this kind are hydrogel wound dressings, being now produced on large scale in Poland and other countries. Current research projects include: hydrogel-based system for anticancer therapy due to local drug delivery, systems for encapsulation of living cells, new approach to the synthesis of polymeric material for intervertebral discs implant, temperature-sensitive membranes, hydrogel phantoms of 3D radiation dosimeter for radiotherapy, degradation-resistant nanogels and microgels for biomedical purposes (e.g. synovial fluid substitute), hydrogel-based dietary products and adjustment of the molecular weight of biopolymers. (C) 2003 Elsevier B.V. All rights reserved.
C1 Tech Univ Lodz, Inst Appl Radiat Chem, PL-93590 Lodz, Poland.
RP Rosiak, JM (reprint author), Tech Univ Lodz, Inst Appl Radiat Chem, Wroblewskiego 15, PL-93590 Lodz, Poland.
EM rosiakjm@mitr.p.lodz.pl
RI Kujawa, Piotr/D-5142-2013; Kozicki, Marek/M-2744-2018; Ulanski,
   Piotr/S-9103-2018
OI Kozicki, Marek/0000-0002-8396-4344; Ulanski, Piotr/0000-0002-4310-3574;
   Kadlubowski, Slawomir/0000-0003-0648-5208
CR Charlesby A, 1960, ATOMIC RAD POLYM
   Darwis D, 2002, RADIAT PHYS CHEM, V63, P539, DOI 10.1016/S0969-806X(01)00636-3
   DeRossi D, 1991, POLYM GELS FUNDAMENT
   Funke W, 1998, ADV POLYM SCI, V136, P139
   Goosen M. F. A., 1997, APPL CHITIN CHITOSAN
   GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002
   Janik I, 2000, J CHEM SOC PERK T 2, P2041, DOI 10.1039/b004777p
   KOLODZIEJCZYK M, 2001, 9 BRG WORKSH 62 ICB
   Kozicki M, 2002, RADIAT PHYS CHEM, V65, P133, DOI 10.1016/S0969-806X(02)00209-8
   Kozicki M, 1999, ENG BIOMATER, V2, P11
   KUJAWA P, 1997, 6 INT WORKSH BIOENC
   MARYANSKI MJ, 1993, MAGN RESON IMAGING, V11, P253, DOI 10.1016/0730-725X(93)90030-H
   MUZZARELLI RAA, 1977, CHITIN
   Peppas N. A., 1986, HYDROGELS MED PHARM, V2
   ROSIAK J, 1992, J RADIOAN NUCL CH AR, V159, P87, DOI 10.1007/BF02041021
   Rosiak J. M., 1989, US patent, Patent No. [US4871490, 4871490]
   ROSIAK JM, 1994, J CONTROL RELEASE, V31, P9, DOI 10.1016/0168-3659(94)90246-1
   Rosiak JM, 1999, RADIAT PHYS CHEM, V55, P139, DOI 10.1016/S0969-806X(98)00319-3
   ROSIAK JM, 1988, RADIAT PHYS CHEM, V52, P307
   ROSIAK JM, 1991, ACS SYM SER, V475, P271
   ROSIAK JM, 1996, MED SCI MONIT, V2, P78
   Sabharwal S, 1999, RADIAT PHYS CHEM, V54, P643, DOI 10.1016/S0969-806X(98)00299-0
   Spohr R., 1998, New Astronomy Reviews, V42, P189, DOI 10.1016/S1387-6473(98)00004-9
   Stasica P, 2000, ENG BIOMATER, V3, P9
   Ulanski P, 1999, NUCL INSTRUM METH B, V151, P356, DOI 10.1016/S0168-583X(99)00085-3
   Ulanski P, 1998, RADIAT PHYS CHEM, V52, P289, DOI 10.1016/S0969-806X(98)00155-8
   Ulanski P, 2000, J CHEM SOC PERK T 2, P2022, DOI 10.1039/b003952g
   Ulanski P, 2002, RADIAT PHYS CHEM, V63, P533, DOI 10.1016/S0969-806X(01)00549-7
   ULANSKI P, 1994, CHITIN WORLD, P572
   ULANSKI P, 2000, ADV CHITIN SCI, V4, P429
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
NR 31
TC 37
Z9 42
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
EI 1872-9584
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD AUG
PY 2003
VL 208
BP 325
EP 330
DI 10.1016/s0168-583X(03)00672-X
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 707LT
UT WOS:000184512700057
DA 2018-10-19
ER

PT J
AU Marmey, P
   Porte, MC
   Baquey, C
AF Marmey, P
   Porte, MC
   Baquey, C
TI PVDF multifilament yarns grafted with polystyrene induced by
   gamma-irradition: Influence of the grafting parameters on the mechanical
   properties
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 5th International Symposium on Ionizing Radiation and Polymers (IRaP
   2002)
CY SEP 21-26, 2002
CL ST ADELE, CANADA
SP Rech, Sci & Technol Quebec, Ecole Polytech Montreal, DSM DRECAM CEA/Saclay, IOM, IAEA Vienna, Grp COGETEFI, CTT Grp, GEX Corp, Nissin NHV Amer Inc, IBA, Promerus
DE poly(vinylidene fluoride); heparin-like; gamma-rays; polystyrene
   grafting
ID SWIFT HEAVY-ION; INSOLUBLE MATERIALS; BIOMATERIALS
AB The development of alternative prosthetic materials for cardiovascular applications has found growing interest due to the failure to date to be able to implement functional patent small diameter vascular grafts (mt-set < 5 mm). For instance, the successful implantation of small diameter polyester (PET) and expanded polytetrafluoroethylene (PTFEe) vascular grafts has not been achieved in humans. Our stategy is to work with a new multifilament yarns biomaterial, produced from polyvinylidene fluoride (PVDF), which shows suitable mechanical properties, such as a lower tensile modulus than PET and PTFEe. The required biological properties sought for (i.e. low thrombogenicity) could be achieved by "heparin-like" surface modification treatments in order to modify the thrombogenicity levels of the polymeric materials [Ann. Biomed. Eng. 7 (1979) 429]. A four step method is necessary to achieve this "heparin-like" surface transformation [J. Biomed. Mater. Res. 52 (2000) 119]. The first step consists in grafting polystyrene onto the PVDF surface by gamma irradiation. The purpose of this study was to evaluate the influence of grafting parameters on the mechanical properties: (i) gamma-ray irradiation time and (ii) grafting time of styrene monomers, which polymerize and form polystyrene bound to the PVDF surface. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Victor Segalen Bordeaux 2, INSERM, U577, F-33076 Bordeaux, France.
RP Marmey, P (reprint author), Univ Victor Segalen Bordeaux 2, INSERM, U577, 146 Rue Leo Saignat, F-33076 Bordeaux, France.
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289
CR Betz N, 1996, NUCL INSTRUM METH B, V116, P207, DOI 10.1016/0168-583X(96)00125-5
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P441, DOI 10.1007/BF02364220
   FOUGNOT C, 1979, ANN BIOMED ENG, V7, P429, DOI 10.1007/BF02364219
   KROSCHWITZ JI, 1998, CONCISE ENCY POLYM S, P1117
   MIGONNEY V, 1988, BIOMATERIALS, V9, P145, DOI 10.1016/0142-9612(88)90113-5
   Porte-Durrieu MC, 2000, J BIOMED MATER RES, V52, P119, DOI 10.1002/1097-4636(200010)52:1<119::AID-JBM15>3.0.CO;2-Q
   Porte-Durrieu MC, 1999, NUCL INSTRUM METH B, V151, P404, DOI 10.1016/S0168-583X(99)00105-6
   PorteDurrieu MC, 1997, NUCL INSTRUM METH B, V131, P364, DOI 10.1016/S0168-583X(97)00341-8
   SCHEIRS J, 1997, MODERN FLUOROPOLYMER, V1, P335
NR 9
TC 17
Z9 18
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD AUG
PY 2003
VL 208
BP 429
EP 433
DI 10.1016/S0168-583X(03)00887-5
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 707LT
UT WOS:000184512700076
DA 2018-10-19
ER

PT J
AU Feng, ZG
   Zhao, SP
AF Feng, ZG
   Zhao, SP
TI Synthesis and characterization of biodegradable hydrogels based on
   photopolymerizable acrylate-terminated CL-PEG-CL macromers with
   supramolecular assemblies of alpha-cyclodextrins
SO POLYMER
LA English
DT Article
DE supramolecular structured hydrogel; photopolymerization; cyclodextrins
ID POLY(ETHYLENE GLYCOL); INCLUSION COMPLEXES; POLYMERS
AB A series of polypseudorotaxanes were synthesized from alpha-cyclodextrins (alpha-CDs) threaded onto photopolymerizable CL-PEG-CL oligomers bearing acrylate terminals. The corresponding supramolecular structured hydrogels were prepared from these polypseudorotaxanes in a mixed solvent of H2O and DMSO via in situ photopolymerization under UV irradiation. The structure and properties of the gels were characterized by FTIR, TGA-DTG and WAXD. The results show that alpha-CDs are threaded and immobilized onto the network chains of the hydrogel with crosslinking junctions as stoppers topologically, and the feed molar ratio of alpha-CDs to the macromers affects the hydrogel structure and the water distribution in the hydrogel. These supramolecular structured hydrogels may be good candidates for biomaterial applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Beijing Inst Technol, Sch Mat Sci & Engn, Dept Mat Phys & Chem, Beijing 100081, Peoples R China.
RP Feng, ZG (reprint author), Beijing Inst Technol, Sch Mat Sci & Engn, Dept Mat Phys & Chem, 5 S St Zhongguancun, Beijing 100081, Peoples R China.
CR Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Ciferri A, 2002, MACROMOL RAPID COMM, V23, P511, DOI 10.1002/1521-3927(20020601)23:9<511::AID-MARC511>3.0.CO;2-F
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   HARADA A, 1993, MACROMOLECULES, V26, P5698, DOI 10.1021/ma00073a026
   HARADA A, 1990, MACROMOLECULES, V23, P2821, DOI 10.1021/ma00212a039
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   ITO K, 1992, MACROMOLECULES, V25, P1534, DOI 10.1021/ma00031a027
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li X, 2003, MACROMOLECULES, V36, P1209, DOI 10.1021/ma0213347
   LIU J, 2000, POLYMER, V41, P5871
   OOYA T, 1995, MACROMOL RAPID COMM, V16, P259, DOI 10.1002/marc.1995.030160405
   SAWHNEY AS, 1994, J BIOMED MATER RES, V28, P831, DOI 10.1002/jbm.820280710
   SCOTT RA, 1999, BIOMATERIALS, V20, P65
   Tamura M, 2000, B CHEM SOC JPN, V73, P147, DOI 10.1246/bcsj.73.147
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Zhao SP, 2003, ACTA POLYM SIN, P201
NR 18
TC 21
Z9 23
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD AUG
PY 2003
VL 44
IS 18
BP 5177
EP 5186
DI 10.1016/S0032-3861(03)00505-6
PG 10
WC Polymer Science
SC Polymer Science
GA 710CL
UT WOS:000184663200015
DA 2018-10-19
ER

PT J
AU Zdeblick, TA
   Phillips, FM
AF Zdeblick, TA
   Phillips, FM
TI Interbody cage devices
SO SPINE
LA English
DT Article
DE interbody; cage; fusion
ID CERVICAL FUSION CAGE; LUMBAR SPINE; POSTERIOR INSTRUMENTATION; TITANIUM
   CAGES; COMPLICATIONS; MULTICENTER; STRATEGIES; DESIGN; MODEL; ACID)
AB Study Design. A literature review was conducted of basic science research and clinical experiences describing the use of interbody cage devices for the management of degenerative spinal abnormalities.
   Objectives. To summarize current knowledge regarding the use of interbody fusion cages.
   Summary of Background Data. Degenerative conditions of the lumbar and cervical spine are a major societal expense and a leading cause of disability. Fusion surgery may be used to treat patients with some of these conditions. During the past decade, interbody cages have been popularized as a useful fusion technique with high rates of clinical and radiographic success reported. Cages may be implanted using a variety of surgical approaches to the disc space and can be used alone or with supplemental posterior fixation.
   Methods. A literature review of biomechanical, biologic, and clinical studies of threaded interbody cages was performed.
   Results. Interbody cages have been shown to successfully promote fusion in a variety of animal models. In biomechanical studies, anteriorly placed threaded cages significantly stabilize the motion segment in all directions except extension. Posteriorly placed cages provide less stability as a result of the facetectomy required for placement of an appropriately sized device. Successful clinical and radiographic results have been reported with the use of interbody cages. Most reported cage failures are the result of technical difficulties with implantation or poor patient selection. Accurate radiographic assessment of fusion in the presence of a metal interbody cage remains and studies evaluating alternate biomaterial cages are underway.
   Conclusion. Interbody cages are a useful technique for achieving spinal fusion and have been shown to have an acceptable clinical success rate in appropriately selected patients.
C1 Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53792 USA.
   Univ Chicago, Dept Surg, Chicago, IL 60637 USA.
RP Zdeblick, TA (reprint author), Univ Wisconsin, Dept Orthoped & Rehabil, 600 Highland Ave,K4-739 CSC, Madison, WI 53792 USA.
CR AGAZZI S, 1999, J NEUROSURG, V91, P92
   Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020
   Brantigan JW, 2000, SPINE, V25, P1437, DOI 10.1097/00007632-200006010-00017
   Brodke DS, 1997, SPINE, V22, P26, DOI 10.1097/00007632-199701010-00005
   CUNNINGHAM BW, 1998, ANN M ORTH RES SOC N
   ELIAS WJ, 2000, J NEUROSURG S, V93, P52
   Hacker RJ, 2000, SPINE, V25, P2646, DOI 10.1097/00007632-200010150-00017
   Heim SE, 2002, ORTHOP CLIN N AM, V33, P393, DOI 10.1016/S0030-5898(01)00007-4
   Kandziora F, 2002, J NEUROSURG, V96, P321, DOI 10.3171/spi.2002.96.3.0321
   Kandziora F, 2002, SPINE, V27, P1644, DOI 10.1097/00007632-200208010-00010
   Kandziora F, 2001, SPINE, V26, P1850, DOI 10.1097/00007632-200109010-00007
   KETTLER A, 2000, J NEUROSURG S, V92
   Klemme WR, 2001, SPINE, V26, P534
   Kuslich SD, 2000, SPINE, V25, P2656, DOI 10.1097/00007632-200010150-00018
   Lenke LG, 2002, CLIN ORTHOP RELAT R, P98
   Lieberman IH, 2000, SPINE, V25, P509, DOI 10.1097/00007632-200002150-00019
   Lund T, 1998, J BONE JOINT SURG BR, V80B, P351, DOI 10.1302/0301-620X.80B2.7693
   Matge G, 2002, ACTA NEUROCHIR, V144, P539, DOI 10.1007/s00701-002-0939-0
   McAfee PC, 1999, SPINE, V24, P2147, DOI 10.1097/00007632-199910150-00015
   McAfee PC, 2002, CLIN ORTHOP RELAT R, P55
   ODOWD JD, 1998, NASS 13 ANN M OCT 29
   Oxland TR, 2000, J BONE JOINT SURG AM, V82A, P383, DOI 10.2106/00004623-200003000-00009
   PHILLIPS FM, IN PRESS EFFECTS SUP
   Profeta G, 2000, SURG NEUROL, V53, P417, DOI 10.1016/S0090-3019(00)00207-X
   Rathonyi G C, 1998, Eur Spine J, V7, P400, DOI 10.1007/s005860050097
   Ray CD, 1997, SPINE, V22, P667, DOI 10.1097/00007632-199703150-00019
   Regan JJ, 1999, SPINE, V24, P402, DOI 10.1097/00007632-199902150-00023
   Rosenberg WS, 2001, NEUROSURGERY, V48, P569, DOI 10.1097/00006123-200103000-00022
   Shimamoto N, 2001, Spine (Phila Pa 1976), V26, pE432, DOI 10.1097/00007632-200110010-00008
   Staelin ST, 2000, J LAPAROENDOSC ADV A, V10, P297, DOI 10.1089/lap.2000.10.297
   TENCER AF, 1995, SPINE, V20, P2408, DOI 10.1097/00007632-199511001-00007
   Togawa D, 2001, SPINE, V26, P2744, DOI 10.1097/00007632-200112150-00025
   van Dijk M, 2002, SPINE, V27, P682, DOI 10.1097/00007632-200204010-00003
   Whitecloud TS, 1998, J SPINAL DISORD, V11, P479
   Wilke HJ, 2000, SPINE, V25, P2762, DOI 10.1097/00007632-200011010-00008
   Zdeblick TA, 2000, SPINE, V25, P2682, DOI 10.1097/00007632-200010150-00023
NR 36
TC 69
Z9 80
U1 1
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
J9 SPINE
JI SPINE
PD AUG 1
PY 2003
VL 28
IS 15
SU S
BP S2
EP S7
DI 10.1097/00007632-200308011-00002
PG 6
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 710ZK
UT WOS:000184712500002
PM 12897467
OA Bronze
DA 2018-10-19
ER

PT J
AU Dvir-Ginzberg, M
   Gamlieli-Bonshtein, I
   Agbaria, R
   Cohen, S
AF Dvir-Ginzberg, M
   Gamlieli-Bonshtein, I
   Agbaria, R
   Cohen, S
TI Liver tissue engineering within alginate scaffolds: Effects of
   cell-seeding density on hepatocyte viability, morphology, and function
SO TISSUE ENGINEERING
LA English
DT Article
ID ADULT-RAT HEPATOCYTES; POLYMER MATRICES; NONPARENCHYMAL CELLS; CULTURE;
   SPHEROIDS; GROWTH; APOPTOSIS; MECHANISM; SYSTEM; MODEL
AB Tissue engineering with three-dimensional biomaterials represents a promising approach for developing hepatic tissue to replace the function of a failing liver. Herein, we address cell seeding and distribution within porous alginate scaffolds, which represent a new type of porous biomaterial for tissue engineering. The hydrophilic nature of the alginate scaffold as well as its pore structure and interconnectivity enabled the efficient seeding of hepatocytes into the scaffolds, that is, 70-90% of the initial cells depending on the seeding method. Utilization of centrifugal force during seeding enhanced cell distribution in the porous scaffolds, consequently enabling the seeding of concentrated cell suspensions (>1 X 10(7) cells/mL). Cell density in scaffolds affected hepatocyte viability as judged by MTT assay. At a cell density of 0.28 X 10(6) cells/cm(3) scaffold, the number of viable hepatocytes decreased to 33% of its initial value within 7 days, whereas at the denser cultures, 5.7 X 10(6) cells/cm(3) scaffold and higher, the cells maintained higher viability while forming a network of connecting spheroids. In the high-density cellular constructs, hepatocellular functions such as albumin and urea secretion, and detoxification (cytochrome P-450 and phase II conjugating enzyme activities), remained high during the 7-day culture. Collectively, the results of the present study highlight the importance of cell density on the hepatocellular functions of three-dimensional hepatocyte constructs as well as the advantages of alginate matrices as scaffoldings.
C1 Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Inst Appl Biosci, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.
   Ben Gurion Univ Negev, Dept Clin Pharmacol, IL-84105 Beer Sheva, Israel.
RP Cohen, S (reprint author), Ben Gurion Univ Negev, Dept Biotechnol Engn, Bldg 39,Room 222, IL-84105 Beer Sheva, Israel.
RI COHEN, SMADAR/F-1901-2012
OI Dvir-Ginzberg, Mona/0000-0003-3089-6875
CR BEHINIA K, 2000, TISSUE ENG, V6, P467
   Bergin E, 2000, AM J PHYSIOL-RENAL, V278, pF758
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   DRISCOLL JL, 1982, IN VITRO CELL DEV B, V18, P835
   DUNN JCY, 1989, FASEB J, V3, P174
   Falasca L, 2001, CELLS TISSUES ORGANS, V168, P126, DOI 10.1159/000047828
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Hansen LK, 1998, TISSUE ENG, V4, P65, DOI 10.1089/ten.1998.4.65
   Hsiao CC, 1999, TISSUE ENG, V5, P207, DOI 10.1089/ten.1999.5.207
   Kaufmann PM, 1997, CELL TRANSPLANT, V6, P463, DOI 10.1016/S0963-6897(97)00052-3
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Kim SS, 2000, TISSUE ENG, V6, P39, DOI 10.1089/107632700320874
   Kneser U, 1999, J BIOMED MATER RES, V47, P494, DOI 10.1002/(SICI)1097-4636(19991215)47:4<494::AID-JBM5>3.3.CO;2-C
   KOIDE N, 1990, EXP CELL RES, V186, P227, DOI 10.1016/0014-4827(90)90300-Y
   KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201
   LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Michalopoulos GK, 1999, HEPATOLOGY, V29, P90, DOI 10.1002/hep.510290149
   Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103
   Peluso JJ, 1997, BIOCHEM PHARMACOL, V54, P847, DOI 10.1016/S0006-2952(97)00118-4
   PETERS T, 1972, J BIOL CHEM, V247, P3858
   Ranucci CS, 2000, BIOMATERIALS, V21, P783, DOI 10.1016/S0142-9612(99)00238-0
   Rodwell V. W., 1993, HARPERS BIOCH, P293
   Selden C, 1998, ARTIF ORGANS, V22, P308
   SHAPIRO L, 1997, BIOMATERIALS, V18, P581
   Tzanakakis ES, 2001, CELL TRANSPLANT, V10, P329, DOI 10.3727/000000001783986783
   Vacanti JP, 1999, LANCET S1, V354, pSi32
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Wagner WR, 1997, TISSUE ENG, V3, P289, DOI 10.1089/ten.1997.3.289
   WORTELBOER HM, 1991, BIOCHEM PHARMACOL, V42, P381, DOI 10.1016/0006-2952(91)90726-L
NR 32
TC 150
Z9 159
U1 2
U2 51
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD AUG
PY 2003
VL 9
IS 4
BP 757
EP 766
DI 10.1089/107632703768247430
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 715QL
UT WOS:000184983700017
PM 13678452
DA 2018-10-19
ER

PT J
AU Covert, RJ
   Ott, RD
   Ku, DN
AF Covert, RJ
   Ott, RD
   Ku, DN
TI Friction characteristics of a potential articular cartilage biomaterial
SO WEAR
LA English
DT Article; Proceedings Paper
CT 14th International Conference on Wear of Materials
CY MAR 30-APR 03, 2003
CL WASHINGTON, D.C.
DE friction; cartilage; poly(vinyl-alcohol); biomaterials
ID KNEE; JOINTS; LUBRICATION; WALKING
AB Many biomaterials are being developed to repair or replace articular cartilage. One of these materials, a poly(vinyl-alcohol) cryogel (PVA-c) may exhibit the mechanical properties required to withstand the harsh environment of diarthrodial joints. To better understand how PVA-c friction is affected by different variables employed in bench top testing to simulate joint conditions, a six-factor, two-level fractional-factorial experiment was developed. Factors included temperature, lubricant, material stiffness, load, sliding speed, and surface roughness. Static and dynamic friction were found to depend significantly on material stiffness and roughness, increasing as material stiffness and roughness increased. Dynamic friction was also inversely proportional to sliding speed. Overall static and dynamic friction for all variables was 0.285 +/- 0.091 and 0.143 +/- 0.066 (average +/- S.D.), respectively. Material deformation and other factors may have contributed to the higher than expected friction levels. Frictional behavior of this PVA-c against stainless steel does not follow Amonton's friction law, nor does it follow friction models based on repulsion and adsorption theories. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Georgia Inst Technol, GWW Sch Mech Engn, Atlanta, GA 30332 USA.
   Oak Ridge Natl Lab, High Temp Mat Lab, Oak Ridge, TN 37831 USA.
   SaluMedica LLC, Atlanta, GA USA.
RP Ku, DN (reprint author), Georgia Inst Technol, GWW Sch Mech Engn, 315 Ferst Dr, Atlanta, GA 30332 USA.
CR ASTM (American Society for Testing and Materials), 2000, ANN BOOK ASTM STAND, V4.08
   FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887
   Gong J, 1998, J CHEM PHYS, V109, P8062, DOI 10.1063/1.477453
   Gong JP, 1997, J PHYS CHEM B, V101, P5487, DOI 10.1021/jp9713118
   KAWANABE K, 2000, J BIOMED MATER RES, V54, P400
   Ku DN, 1999, [US Patent, Poly(vinyl alcohol) Cryogel Patent], Patent No. 5981826
   LAFORTUNE MA, 1992, J BIOMECH, V25, P347, DOI 10.1016/0021-9290(92)90254-X
   LIAO Y, 2001, T ORTHOP RES SOC, V26, P222
   LINN F C, 1968, Journal of Biomechanics, V1, P193, DOI 10.1016/0021-9290(68)90004-3
   LINN FC, 1967, J BONE JOINT SURG AM, VA 49, P1079, DOI 10.2106/00004623-196749060-00005
   MORRISON JB, 1970, J BIOMECH, V3, P51, DOI 10.1016/0021-9290(70)90050-3
   MORRISON JB, 1968, BIOMED ENG, V3, P164
   MOW VC, 1997, LUBRICATION WEAR DIA, P514
   Murakami T, 1998, P I MECH ENG H, V212, P23, DOI 10.1243/0954411981533791
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   OONISHI H, 1999, T ORTHOP RES SOC, V24, P50
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Stone KR, 1996, CLIN SPORT MED, V15, P557
   UNSWORTH A, 1975, J LUBR TECHNOL, V97, P360
   Walker PS, 2000, CLIN ORTHOP RELAT R, P290
   WALKER PS, 1997, BIOMECHANICAL PRINCI, P514
NR 21
TC 61
Z9 66
U1 2
U2 21
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD AUG-SEP
PY 2003
VL 255
BP 1064
EP 1068
DI 10.1016/S0043-1648(03)00113-3
PN 2
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 733YB
UT WOS:000186027300037
DA 2018-10-19
ER

PT J
AU Henry, M
   Dupont-Gillain, C
   Bertrand, P
AF Henry, M
   Dupont-Gillain, C
   Bertrand, P
TI Conformation change of albumin adsorbed on polycarbonate membranes as
   revealed by ToF-SIMS
SO LANGMUIR
LA English
DT Article
ID ION MASS-SPECTROMETRY; PROTEIN ADSORPTION; SURFACES; FILMS
AB The adsorption of proteins at biomaterial surfaces depends on the properties of the substrate and can cause changes in protein conformation. Time-of-flight secondary ion mass spectroscopy (ToF-SIMS) was used in this study to characterize human serum albumin (HSA) adsorption on two different polyearbonate surfaces: a native membrane and a hydrophilic treated one. The amount adsorbed as a function of HSA concentration in solution was compared for the two substrates. The treated membrane was found to have a lower affinity for albumin than the native one. Principal component analysis was used to reveal changes in albumin conformation as a function of albumin concentration in solution and to compare the conformations adopted on the two substrates. The albumin conformation was different on the two substrates, and in every case, the protein lost its native structure. A correlation was found between the amount adsorbed on the hydrophilic surface and the albumin conformation on this surface.
C1 Univ Catholique Louvain, Unite Phys Chim & Phys Mat, B-1348 Louvain, Belgium.
   Univ Catholique Louvain, Unite Chim Interfaces, B-1348 Louvain, Belgium.
RP Bertrand, P (reprint author), Univ Catholique Louvain, Unite Phys Chim & Phys Mat, 1 Croix Sud, B-1348 Louvain, Belgium.
CR *BARP, BMH4CT989516 BARP
   Bartiaux S., 1995, THESIS U CATHOLIQUE
   Brash J. L., 1995, ACS SYM SER, V602, P1
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CASTNER DG, CHARACTERIZATION PRO
   CHILKOTI A, 2001, TOF SIMS SURFACE ANA, pCH23
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Delcorte A, 1997, LANGMUIR, V13, P5125, DOI 10.1021/la970105o
   DUPONTGILLAIN CC, IN PRESS J BIOMED MA
   HORBETT TA, 1996, BIOMATERIALS SCI INT, pCH3
   Kingshott P, 2002, BIOMATERIALS, V23, P4775, DOI 10.1016/S0142-9612(02)00228-4
   LEGEAY G, 2002, Patent No. 2820057
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   LHOEST JB, 1997, THESIS U CATHOLIQUE
   MANTUS DS, 1993, ANAL CHEM, V65, P1431, DOI 10.1021/ac00058a021
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   NORDE W, 1995, CELL MATER, V5, P97
   Robinson S, 2002, LANGMUIR, V18, P8743, DOI 10.1021/la020376l
   SCHMIDT R, 1999, COMPORTEMENT MAT SYS, pCH7
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   Vanden-Eynde X, 1997, SURF INTERFACE ANAL, V25, P878
   VANDULM P, 1983, J COLLOID INTERF SCI, V91, P248, DOI 10.1016/0021-9797(83)90329-6
   VICKERMAN JC, 1997, STATIC SIMS LIB
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   Xia N, 2002, LANGMUIR, V18, P4090, DOI 10.1021/la020022u
NR 26
TC 59
Z9 60
U1 2
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 22
PY 2003
VL 19
IS 15
BP 6271
EP 6276
DI 10.1021/la034081z
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 702WM
UT WOS:000184247800042
DA 2018-10-19
ER

PT J
AU Maccabee, MS
   Trune, DR
   Hwang, PH
AF Maccabee, MS
   Trune, DR
   Hwang, PH
TI Effects of topically applied biomaterials on paranasal sinus mucosal
   healing
SO AMERICAN JOURNAL OF RHINOLOGY
LA English
DT Article
ID ACID
AB Background: Recently, nasal packing made of absorbable biomaterial has become increasingly popular. Although absorbable packs are effective for hemostasis, their impact on healing mucosa is unknown. Some have felt that a biocompatible sinus dressing actually may enhance healing, particularly in areas where the mucosa has been stripped. The aim of this study was to determine the effect of topical MeroGel and FloSeal on paranasal sinus mucosal healing in a rabbit model.
   Methods: Bilateral maxillary sinuses of 12 New Zealand white rabbits were surgically opened and stripped of mucosa. The left maxillary sinus of six rabbits had sterile saline-soaked MeroGel placed in the antrum, and the other six rabbits received FloSeal. The right maxillary sinuses of all 12 animals were stripped and otherwise untreated to serve as stripped controls. The animals were killed at 2 weeks and specimens were examined by light microscopy.
   Results: MeroGel-treated mucosa showed extensive fibrosis of the basal lamina and lamina propria, complete loss of surface epithelium, and loss of the mucociliary blanket. There was minimal resorption of the MeroGel, and MeroGel fibers were frankly incorporated into the regenerated epithelium, associated with an exuberant lymphocytic infiltrate. FloSeal-treated mucosa showed similar fibrosis of the basal lamina and lamina propria with loss of the mucociliary blanket, although to a lesser degree than the MeroGel- treated group. FloSeal showed similar incorporation into the healed mucosa with lymphocytosis. Controls showed expected submucosal gland reduction, lamina propria fibrosis, and loss of cilia, but the lamina propria fibrosis seen in the MeroGel and FloSeal groups was markedly more prominent.
   Conclusion: In a rabbit model, MeroGel and FloSeal appear to increase reactionary fibrosis of healing mucosa. These agents also appear to be incompletely resorbed and grossly incorporated into healing tissue. Mucosal healing may be impaired by the application of these agents.
C1 Oregon Hlth Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97239 USA.
RP Hwang, PH (reprint author), Oregon Hlth Sci Univ, Dept Otolaryngol Head & Neck Surg, 3181 SW Sam Jackson Pk Rd,PV-01, Portland, OR 97239 USA.
CR Chandra RK, 2003, AM J RHINOL, V17, P51, DOI 10.1177/194589240301700109
   Jacob A, 2002, LARYNGOSCOPE, V112, P37, DOI 10.1097/00005537-200201000-00007
   JOHANSSON P, 1988, ACTA OTO-LARYNGOL, V106, P460, DOI 10.3109/00016488809122271
   KUMLIEN J, 1985, ACTA OTO-LARYNGOL, V99, P630, DOI 10.3109/00016488509182270
   Maccabee MS, 2003, AM J RHINOL, V17, P133, DOI 10.1177/194589240301700304
   McIntosh D, 2002, AM J RHINOL, V16, P85, DOI 10.1177/194589240201600203
   POPESKO P, 1990, COLOUR ATLAS ANATOMY, V1, P1
   WATELET JB, AM J RHINOL, V16, P77
NR 8
TC 63
Z9 64
U1 0
U2 1
PU OCEAN SIDE PUBLICATIONS INC
PI PROVIDENCE
PA 95 PITMAN ST, PROVIDENCE, RI 02906 USA
SN 1050-6586
J9 AM J RHINOL
JI Am. J. Rhinol.
PD JUL-AUG
PY 2003
VL 17
IS 4
BP 203
EP 207
DI 10.1177/194589240301700405
PG 5
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 717CL
UT WOS:000185068000005
PM 12962189
DA 2018-10-19
ER

PT J
AU Collier, JH
   Messersmith, PB
AF Collier, JH
   Messersmith, PB
TI Enzymatic modification of self-assembled peptide structures with tissue
   transglutaminase
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID EXTRACELLULAR-MATRIX PRODUCTION; CATALYZED CROSS-LINKING; NONPOLAR
   AMINO-ACIDS; BETA-SHEET PEPTIDE; COMPLEMENTARY OLIGOPEPTIDE; SYSTEMATIC
   VARIATION; SECONDARY STRUCTURE; GLUTAMINE REPEATS; BIOMATERIAL;
   HYDROGELS
AB A de novo peptide that self-assembles into fibrillar structures and serves as a substrate for the cross-linking enzyme tissue transglutaminase was developed (Ac-QQKFQFQFEQQ-Am). Congo red staining, circular dichroism, and FTIR spectroscopy showed that this 11-amino acid peptide produced predominantly beta-sheet structures. TEM with negative staining and quick-freeze deep etch (QFDE) TEM showed that the peptide structures were composed of a highly entangled fibrillar network. These beta-sheet fibrillar nanostructures were then covalently coupled to pendant amine-containing biomolecules via tissue transglutaminase. MALDI-TOF mass spectrometry and HPLC were utilized to monitor the extent of the transglutaminase modification of the peptide, showing that as many as five glutamines in the peptide were reactive via transglutaminase for covalent conjugation. This strategy, based on the post-assembly modification of a self-assembling peptide, has potential applications for tailoring supramolecular structures for drug delivery, tissue engineering, or other biomedical applications.
C1 Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Messersmith, PB (reprint author), Northwestern Univ, Dept Biomed Engn, 2145 Sheridan Rd,Room E310, Evanston, IL 60208 USA.
RI Messersmith, Phillip/F-3433-2013; Liu, Yifei/L-7828-2014; Messersmith,
   Phil/B-6695-2009
OI Liu, Yifei/0000-0002-1087-9827; Messersmith, Phillip/0000-0002-1197-333X
FU NIDCR NIH HHS [R01 DE 13030, T32 DE 07042]
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Aggeli A, 1997, J MATER CHEM, V7, P1135, DOI 10.1039/a701088e
   Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407
   BRACK A, 1975, NATURE, V256, P383, DOI 10.1038/256383a0
   Caplan MR, 2002, IND ENG CHEM RES, V41, P403, DOI 10.1021/ie010149z
   Caplan MR, 2002, J BIOMAT SCI-POLYM E, V13, P225, DOI 10.1163/156856202320176493
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Clark TD, 1999, CHEM-EUR J, V5, P782, DOI 10.1002/(SICI)1521-3765(19990201)5:2<782::AID-CHEM782>3.0.CO;2-A
   Collier JH, 2001, J AM CHEM SOC, V123, P9463, DOI 10.1021/ja011535a
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   DUDEK SM, 1994, BRAIN RES, V651, P129, DOI 10.1016/0006-8993(94)90688-2
   Fields GB, 1998, BIOPOLYMERS, V47, P143, DOI 10.1002/(SICI)1097-0282(1998)47:2<143::AID-BIP3>3.3.CO;2-P
   GREENBERG CS, 1991, FASEB J, V5, P3071
   GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031
   GROSS M, 1977, J BIOL CHEM, V252, P3752
   HARIS PI, 1995, BIOPOLYMERS, V37, P251, DOI 10.1002/bip.360370404
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Jao SC, 1997, AMYLOID, V4, P240, DOI 10.3109/13506129709003835
   Jeitner TM, 2001, ANAL BIOCHEM, V292, P198, DOI 10.1006/abio.2001.5040
   JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145
   Kahlem P, 1996, P NATL ACAD SCI USA, V93, P14580, DOI 10.1073/pnas.93.25.14580
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Lashuel HA, 2000, J AM CHEM SOC, V122, P5262, DOI 10.1021/ja9937831
   LORAND L, 1979, ANAL BIOCHEM, V93, P453, DOI 10.1016/S0003-2697(79)80107-4
   LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602
   Lynn DG, 2000, J STRUCT BIOL, V130, P153, DOI 10.1006/jsbi.2000.4287
   MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Pears A.G.E., 1960, HISTOCHEMISTRY THEOR
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Trask BC, 2001, BIOCHEMISTRY-US, V40, P4372, DOI 10.1021/bi002738z
   Valnickova Z, 1998, J BIOL CHEM, V273, P27220, DOI 10.1074/jbc.273.42.27220
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   WEST MW, 1995, PROTEIN SCI, V4, P2032, DOI 10.1002/pro.5560041008
   XIONG HY, 1995, P NATL ACAD SCI USA, V92, P6349, DOI 10.1073/pnas.92.14.6349
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang ZY, 2002, BIOCONJUGATE CHEM, V13, P640, DOI 10.1021/bc015580j
   Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217
NR 52
TC 98
Z9 98
U1 4
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD JUL-AUG
PY 2003
VL 14
IS 4
BP 748
EP 755
DI 10.1021/bc034017t
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 703LK
UT WOS:000184280700008
PM 12862427
DA 2018-10-19
ER

PT J
AU Li, J
   Kao, WJ
AF Li, J
   Kao, WJ
TI Synthesis of polyethylene glycol (PEG) derivatives and PEGylated-peptide
   blopolymer conjugates
SO BIOMACROMOLECULES
LA English
DT Article
ID WATER-SOLUBLE POLYMERS; POLY(ETHYLENE GLYCOL); MACROPHAGE ADHESION;
   CELL-ADHESION; CHEMICAL MODIFICATION; SUPEROXIDE-DISMUTASE; SURFACE
   MODIFICATION; COVALENT ATTACHMENT; AVAILABLE LYSINE; FBGC FORMATION
AB We synthesized a library of 50 poly(ethylene glycol) (PEG) derivatives to expand the extent of conjugation with biologically active molecules (biopolymers, peptides, drugs, etc.) and biomaterial substrates. The formation of PEG derivatives was confirmed with HPLC, (1)H and (13)C NMR. PEG derivatives were polymerized into networks in order to study the role of PEG and terminal functional groups in modulating the hydrophilicity of biomaterials and cell-biomaterial interaction. The resulting surface hydrophilicity and the number of adhered fibroblasts were primarily dependent on the PEG concentration with the molecular weight and the terminal functional group of PEG derivatives being less important. One of PEG derivatives, PEG-bisglutarate, was utilized to link peptide sequences to gelatin backbone in the formation of novel biomedical hydrogels. PEG-peptide conjugates were characterized by mass spectroscopy. PEG-peptide modified gelatins were characterized by gel permeation chromatography.
C1 Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA.
   Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
   Albertsson P. A., 1986, PARTITION CELL PARTI
   *AM CYAN CO, 1959, CHEM ACR, P17
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   ANDERSON GW, 1964, J AM CHEM SOC, V86, P1839, DOI 10.1021/ja01063a037
   Belcheva N, 1998, J BIOMAT SCI-POLYM E, V9, P207, DOI 10.1163/156856298X00613
   BENTLEY DM, 2001, Patent No. 0100246
   Bogdansky S., 1990, BIODEGRADABLE POLYM, P231
   Bohl KS, 2000, BIOMATERIALS, V21, P2273, DOI 10.1016/S0142-9612(00)00153-8
   Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   BROWN RD, 1985, J AM CHEM SOC, V107, P4109, DOI 10.1021/ja00300a001
   BRUSON HA, 1949, ORG REACTIONS, V5, P79
   BUECKMANN F, 1981, MAKROMOL CHEM, V182, P1379
   Caldwell KD, 1997, ACS SYM SER, V680, P400
   CARELLI V, 1995, J CONTROL RELEASE, V33, P153, DOI 10.1016/0168-3659(94)00081-5
   CHUN PW, 1967, ANAL BIOCHEM, V19, P481, DOI 10.1016/0003-2697(67)90239-4
   CIUFFARIN E, 1981, J ORG CHEM, V46, P3064, DOI 10.1021/jo00328a015
   CLARK MA, 2002, Patent No. 0244360
   Cox JD, 2002, BIOMATERIALS, V23, P929, DOI 10.1016/S0142-9612(01)00205-8
   DAI WG, 1994, BIO-TECHNOL, V12, P797, DOI 10.1038/nbt0894-797
   Deible CR, 1999, BIOMATERIALS, V20, P101, DOI 10.1016/S0142-9612(98)00001-5
   DELGADO C, 1992, CRIT REV THER DRUG, V9, P249
   Desai NP, 2000, J MICROENCAPSUL, V17, P677
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Djagny KB, 2001, CRIT REV FOOD SCI, V41, P481, DOI 10.1080/20014091091904
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   DUNN SE, 1994, PHARMACEUT RES, V11, P1016, DOI 10.1023/A:1018939521589
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   Fares HM, 1999, J COSMET SCI, V50, P133
   FUJITA Y, 1974, Patent No. 49012920
   Gao CY, 2001, J APPL POLYM SCI, V81, P3523, DOI 10.1002/app.1808
   GIAMMONA G, 2000, P 27 INT S CONTR REL, P640
   HALL RJ, 1973, ANALYST, V98, P673, DOI 10.1039/an9739800673
   Harris J. M., 1989, AM CHEM SOC POLYM PR, V30, P356
   HARRIS JM, 1984, J POLYM SCI POL CHEM, V22, P341, DOI 10.1002/pol.1984.170220207
   HARRIS JM, 1985, J MACROMOL SCI R M C, VC25, P325, DOI 10.1080/07366578508081960
   Hatanaka K, 2001, MACROMOL BIOSCI, V1, P397, DOI 10.1002/1616-5195(20011201)1:9<397::AID-MABI397>3.0.CO;2-0
   Hempenius MA, 1997, MACROMOLECULES, V30, P266, DOI 10.1021/ma9608784
   Hooper R, 1999, ORGANOMETALLICS, V18, P3249, DOI 10.1021/om990261l
   HOSTE K, 1994, MACROMOL RAPID COMM, V15, P697, DOI 10.1002/marc.1994.030150906
   Houben-Weyl H., 1970, METHOD ORGANISCHEN C, VXIII, P377
   Hurwitz E, 2000, CANCER IMMUNOL IMMUN, V49, P226, DOI 10.1007/s002620000112
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   JOHANSSON G, 1974, P INT SOLV EXTR C 1, P927
   KAKADE ML, 1969, ANAL BIOCHEM, V27, P273, DOI 10.1016/0003-2697(69)90032-3
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kao WUJ, 2002, J BIOMED MATER RES, V62, P478, DOI 10.1002/jbm.10317
   Kao WYJ, 1998, BIOTECHNOL BIOENG, V59, P2, DOI 10.1002/(SICI)1097-0290(19980705)59:1<2::AID-BIT2>3.0.CO;2-G
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   Karakecili AG, 2002, J BIOMAT SCI-POLYM E, V13, P185, DOI 10.1163/156856202317414366
   KATRE NV, 1987, P NATL ACAD SCI USA, V84, P1487, DOI 10.1073/pnas.84.6.1487
   KERN W, 1979, MAKROMOL CHEM, V180, P2539
   Khang G, 2002, J APPL POLYM SCI, V85, P1253, DOI 10.1002/app.10680
   Khang G, 2000, POLYM-KOREA, V24, P869
   KIM JS, 2001, P 28 INT S CONTR REL, V1, P321
   KLECH CM, 1988, ENCY PHARM TECHNOLOG, P415
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   MARTINEK K, 1977, BIOCHIM BIOPHYS ACTA, V485, P1, DOI 10.1016/0005-2744(77)90188-7
   MELLOTT M, 2000, P 27 INT S CONTR REL, P980
   MOK KL, 2001, J RUBBER RES KUOLA L, V4, P205
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Mutter M, 1978, TETRAHEDRON LETT, V31, P2839
   Nakaoka R, 1997, J CONTROL RELEASE, V46, P253, DOI 10.1016/S0168-3659(96)01605-7
   NATHAN A, 1994, J BIOACT COMPAT POL, V9, P239, DOI 10.1177/088391159400900301
   Nichifor M, 1997, J CONTROL RELEASE, V48, P165, DOI 10.1016/S0168-3659(97)00048-5
   Nixon PG, 2000, CHEM MATER, V12, P3108, DOI 10.1021/cm000339k
   OKUYAMA T, 1960, J BIOCHEM-TOKYO, V47, P454, DOI 10.1093/oxfordjournals.jbchem.a127083
   Ouchi T, 1997, ACS SYM SER, V680, P284
   Pendri A, 1996, J BIOACT COMPAT POL, V11, P122, DOI 10.1177/088391159601100204
   PETERSON SL, 2002, 223 ACS NAT M APR 7
   POLSON A, 1964, BIOCHIM BIOPHYS ACTA, V82, P463, DOI 10.1016/0304-4165(64)90438-6
   Rochev Y, 2001, PROG COLL POL SCI S, V118, P153
   SAIKI I, 1993, JPN J CANCER RES, V84, P558, DOI 10.1111/j.1349-7006.1993.tb00176.x
   SASAKI DY, 2000, 219 ACS NAT M MARCH
   Scott RA, 1999, BIOMATERIALS, V20, P1371, DOI 10.1016/S0142-9612(99)00040-X
   SIMIONESCU CI, 1983, POLYM BULL, V10, P311, DOI 10.1007/BF00281941
   SMITH LL, MAT RES SOC S P, V609
   SUN Y, 1987, POLYM PREPR AM CHEM, V28, P292
   Tan YY, 1998, PROTEIN EXPRES PURIF, V12, P45, DOI 10.1006/prep.1997.0805
   TOPCHIEVA IN, 1988, EUR POLYM J, V24, P899, DOI 10.1016/0014-3057(88)90166-8
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Veis A., 1964, MACROMOLECULAR CHEM
   Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9
   VESTLING MM, 1993, DRUG METAB DISPOS, V21, P911
   WIRTH P, 1991, BIOORG CHEM, V19, P133, DOI 10.1016/0045-2068(91)90029-O
   WORLEY SD, 1997, 213 ACS NAT M SAN FR
   YOKOYAMA M, 1992, BIOCONJUGATE CHEM, V3, P275, DOI 10.1021/bc00016a003
   YOSHIMOTO T, 1986, BIOTECHNOL LETT, V8, P771, DOI 10.1007/BF01020820
   ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2
   ZALIPSKY S, 1995, ADV DRUG DELIVER REV, V16, P157, DOI 10.1016/0169-409X(95)00023-Z
   ZEPPEZAU.M, 1965, BIOCHIM BIOPHYS ACTA, V94, P581, DOI 10.1016/0926-6585(65)90069-5
   Zhao X, 1997, ACS SYM SER, V680, P458
NR 94
TC 84
Z9 86
U1 1
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL-AUG
PY 2003
VL 4
IS 4
BP 1055
EP 1067
DI 10.1021/bm034069l
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 704VB
UT WOS:000184360400028
PM 12857092
DA 2018-10-19
ER

PT J
AU Gottenbos, B
   van der Mei, HC
   Klatter, F
   Grijpma, DW
   Feijen, J
   Nieuwenhuis, P
   Busscher, HJ
AF Gottenbos, B
   van der Mei, HC
   Klatter, F
   Grijpma, DW
   Feijen, J
   Nieuwenhuis, P
   Busscher, HJ
TI Positively charged biomaterials exert antimicrobial effects on
   gram-negative bacilli in rats
SO BIOMATERIALS
LA English
DT Article
DE biomaterial-centered infection; E. coli; Pseudomonas aeruginosa; rat
   model; antimicrobial biomaterials
ID BACTERIAL BIOFILMS; INITIAL ADHESION; ESCHERICHIA-COLI; SURFACE GROWTH;
   INFECTIONS; POLY(METHACRYLATES); RESISTANCE
AB Biomaterial-centered infection is a much-dreaded complication associated with the use of biomedical implants. Although positively charged biomaterial surfaces stimulate bacterial adhesion, it has been suggested that surface growth of adhering Gram-negative bacilli is inhibited on positively charged surfaces. In the present paper, we determined the infection rate of differently charged poly(methacrylates) in rats. To this end, 2 x 10(6)/cm(2) Escherichia coli O2K2 or 2 x 10(4)/cm(2) Pseudomonas aeruginosa AK1 were seeded on glass discs coated with three differently charged poly(methacrylates) coatings in a parallel plate flow chamber. Three rats received six subcutaneous discs (two discs of each charge variant) seeded with E coli, while three other rats received discs seeded with P. aeruginosa. The numbers of viable bacteria on the surfaces were determined 48 h after implantation. On 50% of all positively charged discs viable E. coli were absent, while the negatively charged discs were all colonized by E coli. P. aeruginosa, however, were isolated from both positively and negatively charged discs. Probably, P. aeruginosa can circumvent the antimicrobial effect of the positive charge through the formation of extracellular polysacharides. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, Dept Cell Biol, Immunol Sect, NL-9713 AV Groningen, Netherlands.
   Univ Twente, Dept Chem Technol, NL-7500 AE Enschede, Netherlands.
   Univ Twente, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Gottenbos B, 1999, J MATER SCI-MATER M, V10, P853, DOI 10.1023/A:1008989416939
   Gottenbos B, 1999, METHODS ENZYMOL, V310, P523
   Gould IM, 1999, J ANTIMICROB CHEMOTH, V43, P459, DOI 10.1093/jac/43.4.459
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   HARKES G, 1991, BIOMATERIALS, V12, P853, DOI 10.1016/0142-9612(91)90074-K
   NICKEL JC, 1994, J ANTIMICROB CHEMOTH, V33, P31, DOI 10.1093/jac/33.suppl_A.31
   VANWAGENEN RA, 1980, J COLLOID INTERF SCI, V76, P305, DOI 10.1016/0021-9797(80)90374-4
   Verkerke GJ, 1997, ARTIF ORGANS, V21, P413
   Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219
NR 14
TC 41
Z9 42
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2003
VL 24
IS 16
BP 2707
EP 2710
DI 10.1016/S0142-9612(03)00083-8
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 679HB
UT WOS:000182913700004
PM 12711516
DA 2018-10-19
ER

PT J
AU Gomathi, K
   Gopinath, D
   Ahmed, MR
   Jayakumar, R
AF Gomathi, K
   Gopinath, D
   Ahmed, MR
   Jayakumar, R
TI Quercetin incorporated collagen matrices for dermal wound healing
   processes in rat
SO BIOMATERIALS
LA English
DT Article
DE quercetin; collagen; wound healing; antioxidant enzymes
ID OXIDATIVE STRESS; HUMAN SKIN; FLAVONOIDS; ANTIOXIDANTS; SCAVENGERS;
   OXYGEN; DAMAGE; DNA
AB We have been developing antioxidants incorporated collagen matrix as a novel biomaterial for various biomedical applications. In this study we made use of quercetin incorporated collagenous matrix for dermal wound healing in rat. Quercetin incorporated collagen (QIC) treated groups were compared with control and collagen (CS) treated animals. QIC treated animal showed a better healing when compared to control and CS treated wound. The biochemical parameters like hydroxyproline, protein, uronic acid content in the healing wound, revealed that there is an increase in proliferation of cells in quercetin treated groups when compared to CS group and there is considerable increase in wound contraction when compared to CS treated group. In addition we adapted the antioxidant assay using 2,2'-azobisisobutryonitrile (AIBN) to assess in vitro antioxidant activity of QIC. The antioxidant studies indicate QIC quench the radicals more efficiently. These results suggested that quercetin incorporated collagen matrix could be a novel dressing material for dermal wound healing. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Cent Leather Res Inst, Bioorgan Lab, Madras 600020, Tamil Nadu, India.
RP Jayakumar, R (reprint author), Cent Leather Res Inst, Bioorgan Lab, Madras 600020, Tamil Nadu, India.
RI KANNAYIRAM, GOMATHI/I-3910-2017; hari, Rajeswary/I-3950-2017
OI KANNAYIRAM, GOMATHI/0000-0002-6247-0070; hari,
   Rajeswary/0000-0002-6247-0070; Damodaran, Gopinath/0000-0002-1697-0357
CR Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596
   Bergmeyer H.U., 1974, METHOD ENZYMAT AN, P438
   BINYANG AK, 2001, ANAL SCI, V17, P987
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Burek AA, 2000, CURR OPIN ORTHOP, V11, P92
   Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200
   CHEN YT, 1990, FREE RADICAL BIO MED, V9, P19, DOI 10.1016/0891-5849(90)90045-K
   Cohen I.K., 1995, WOUND HEALING SKIN P, P27
   DECHARNEUX T, 1992, BIOCHEM PHARMACOL, V44, P1243, DOI 10.1016/0006-2952(92)90521-J
   GASPAR J, 1994, MUTAGENESIS, V9, P445, DOI 10.1093/mutage/9.5.445
   Ignjatovic LM, 2002, J SERB CHEM SOC, V67, P53, DOI 10.2298/JSC0201053I
   IISHIKAWA T, 2000, BIOSCI BIOTECH BIOCH, V64, P173
   JOVANOVIC SV, 1994, J AM CHEM SOC, V116, P4846, DOI 10.1021/ja00090a032
   KATO K, 1988, J MED CHEM, V31, P793, DOI 10.1021/jm00399a019
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Martin A, 1996, DERMATOL SURG, V22, P156, DOI 10.1111/j.1524-4725.1996.tb00499.x
   MERODIEWA D, 1999, FREE RADIC BIOL, V26, P107
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1
   Musonda CA, 1998, CARCINOGENESIS, V19, P1583, DOI 10.1093/carcin/19.9.1583
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   NOSTRO PL, 2000, LANGMUIR, V16, P1744
   NUTTING GC, 1948, J AM LEATHER CHEM AS, V44, P831
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Pawlak W, 1998, J GRAVIT PHYSL, V5, P131
   POLAZZA P, 1991, FREE RADIC BIOL MED, V11, P407
   RAO CN, 1981, INDIAN J BIOCHEM BIO, V18, P224
   SAIJA A, 1995, FREE RADICAL BIO MED, V19, P481, DOI 10.1016/0891-5849(94)00240-K
   Skaper SD, 1997, FREE RADICAL BIO MED, V22, P669, DOI 10.1016/S0891-5849(96)00383-8
   Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291
   Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017
NR 31
TC 66
Z9 67
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2003
VL 24
IS 16
BP 2767
EP 2772
DI 10.1016/S0142-9612(03)00059-0
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 679HB
UT WOS:000182913700011
PM 12711523
DA 2018-10-19
ER

PT J
AU Evans, BR
   O'Neill, HM
   Malyvanh, VP
   Lee, I
   Woodward, J
AF Evans, BR
   O'Neill, HM
   Malyvanh, VP
   Lee, I
   Woodward, J
TI Palladium-bacterial cellulose membranes for fuel cells
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE bacterial cellulose; palladium deposition; membrane electrode assembly
ID ACID; POLYMERS
AB Bacterial cellulose is a versatile renewable biomaterial that can be used as a hydrophilic matrix for the incorporation of metals into thin, flexible, thermally stable membranes. In contrast to plant cellulose, we found it catalyzed the deposition of metals within its structure to generate a finely divided homogeneous catalyst layer. Experimental data suggested that bacterial cellulose possessed reducing groups capable of initiating the precipitation of palladium, gold, and silver from aqueous solution. Since the bacterial cellulose contained water equivalent to at least 200 times the dry weight of the cellulose, it was dried to a thin membranous structure suitable for the construction of membrane electrode assemblies (MEAs). Results of our study with palladium-cellulose showed that it was capable of catalyzing the generation of hydrogen when incubated with sodium dithionite and generated an electrical current from hydrogen in an MEA containing native cellulose as the polyelectrolyte membrane (PEM). Advantages of using native and metallized bacterial cellulose membranes in an MEA over other PEMs such as Nafion 117(R) include its higher thermal stability to 130 degreesC and lower gas crossover. Published by Elsevier Science B.V.
C1 Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA.
   Maryville Coll, Maryville, TN 37804 USA.
   Univ Tennessee, Dept Elect Engn, Knoxville, TN 37916 USA.
RP Evans, BR (reprint author), Oak Ridge Natl Lab, Div Chem Sci, 4500N Bethel Valley Rd, Oak Ridge, TN 37831 USA.
OI O'Neill, Hugh/0000-0003-2966-5527
CR AMMON HPT, 1995, ANAL CHEM, V67, P466, DOI 10.1021/ac00098a036
   Brown A. J., 1886, J CHEM SOC, V49, P432, DOI DOI 10.1039/CT8864900432
   Buchanan Rita, 1987, WEAVERS GARDEN
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Cotton FA, 1988, ADV INORGANIC CHEM
   Farah L. F., 1990, US Patent, Patent No. [4.912.049, 4912049]
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Franz G., 1990, METHODS PLANT BIOCH, V2, P291
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   GREENBAUM E, 1984, PHOTOBIOCH PHOTOBIOP, V8, P323
   Heinze T, 1998, MACROMOL CHEM PHYSIC, V199, P2341, DOI 10.1002/macp.1998.021991101
   HEINZE T, 1996, DAS PAPIER, V12, P721
   HESTRIN S, 1947, NATURE, V159, P64, DOI 10.1038/159064a0
   HON DNS, 1994, CELLULOSE, V1, P1, DOI 10.1007/BF00818796
   LASSIG JP, 1995, ARCH BIOCHEM BIOPHYS, V322, P119, DOI 10.1006/abbi.1995.1443
   Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   ONG E, 1993, ACS SYM SER, V516, P185
   SCHRAMM S, 1954, BIOCHEM J, V57, P345
   SHULTZ MD, 1995, BIOCHEM BIOPH RES CO, V209, P1046, DOI 10.1006/bbrc.1995.1603
   Stephens RS, 1990, Production of cholesterol-absorbing bacterial cellulose for use as dietary fiber, Patent No. [4960763, US 4960763 A, CAN 114:60730]
   Tiller J, 1999, BIOTECHNOL APPL BIOC, V30, P155
   Yamada Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1244, DOI 10.1271/bbb.61.1244
NR 23
TC 119
Z9 124
U1 6
U2 52
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JUL
PY 2003
VL 18
IS 7
BP 917
EP 923
AR PII S0956-5663(02)00212-9
DI 10.1016/S0956-5663(02)00212-9
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 693TW
UT WOS:000183735300009
PM 12713915
DA 2018-10-19
ER

PT J
AU Yuan, J
   Zhang, J
   Zang, XP
   Shen, J
   Lin, SC
AF Yuan, J
   Zhang, J
   Zang, XP
   Shen, J
   Lin, SC
TI Improvement of blood compatibility on cellulose membrane surface by
   grafting betaines
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE cellulose membrane; blood compatibility; sulfobetaine; carboxybetaine;
   surface modification
ID PLATELET-ADHESION; PHOSPHOLIPID POLYMER; 2-METHACRYLOYLOXYETHYL
   PHOSPHORYLCHOLINE; POLYURETHANE FILM; DIALYSIS MEMBRANE; COPOLYMERS;
   MONOMER
AB Cellulose is widely used as hemodialysis biomaterials due to their good permeability of water and solutes and mechanical strength. Nevertheless, their blood compatibility is still not adequate for blood purification. Surface modification is an effective way to improve the blood compatibility and remain the bulk properties of biomaterials. The purpose of this study was to design and synthesize a novel nonthrombogenic biomaterial by modifying the surface of cellulose with zwitterionic monomer. In this study, betaines (carboxybetaine and sulfobetaine) were grafted onto cellulose membrane respectively by a three-step procedure. In the first step, the membrane was treated with hexamethylene diisocyanate in toluene at 50 degreesC in the presence of di-n-butyltin dilaurate as a catalyst. The extent of the reaction was measured by ATR-IR spectra; a maximum number of free NCO group was obtained after a reaction time of 2.5 h. In the second step, the hydroxyl groups of N,N-dimethylethylethanolamine (DMEA) or 4-dimethylamino-1-butanol (DMAB) were allowed to react in toluene with isocyanate groups bound on surface. In the third step, betaines were formed on the surface through the ring-opening reaction between tertiary amine of DMEA or DMAB with 1,3-propanesultone (PS) or beta-propiolactone (PL). It was characterized by ATR-IR and XPS that the grafted surfaces were composed sulfobetaine or carboxybetaine. The platelet adhesion test showed that membranes-grafted betaines have excellent blood compatibility feature by the low platelet adhesion. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn, Nanjing 210093, Peoples R China.
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Chen Z, 2000, J APPL POLYM SCI, V76, P382, DOI 10.1002/(SICI)1097-4628(20000418)76:3<382::AID-APP13>3.0.CO;2-A
   CHRISTINA FL, 1993, J APPL POLYM SCI, V50, P345
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P271, DOI 10.1163/156856299X00342
   ISHIHARA K, 1992, BIOMATERIALS, V13, P235, DOI 10.1016/0142-9612(92)90190-Y
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   LIAW DJ, 1985, J APPL POLYM SCI, V30, P4697, DOI 10.1002/app.1985.070301216
   LIAW DJ, 1987, J APPL POLYM SCI, V34, P999, DOI 10.1002/app.1987.070340311
   Liaw DJ, 2000, POLYMER, V41, P6123, DOI 10.1016/S0032-3861(99)00824-1
   Lin JC, 2001, J MATER SCI-MATER M, V12, P827, DOI 10.1023/A:1017937304964
   Lin S. C., 1998, CHIN POLYM B, V1, P1
   MCCORMICK CL, 1992, POLYMER, V33, P4617, DOI 10.1016/0032-3861(92)90422-S
   Monroy V.M., 1984, POLYMER, V25, P121
   MONROYSOTO VM, 1984, POLYMER, V25, P254
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   SALAMONE JC, 1977, POLYMER, V18, P1058, DOI 10.1016/0032-3861(77)90013-1
   SURUTA T, 1993, BIOMEDICAL APPL POLY
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   WANG DA, 2001, BIOMATERIALS, V221, P549
   Yuan YL, 2002, J BIOMAT SCI-POLYM E, V13, P1081, DOI 10.1163/156856202320813800
   YUAN YL, IN PRESS POLYM INTER
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   Zhou J, 2002, CHEM J CHINESE U, V23, P2393
NR 32
TC 69
Z9 75
U1 4
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2003
VL 30
IS 1-2
BP 147
EP 155
DI 10.1016/S0927-7765(03)00082-1
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 689YP
UT WOS:000183520800017
DA 2018-10-19
ER

PT J
AU Katz, E
   Willner, I
AF Katz, E
   Willner, I
TI Probing biomolecular interactions at conductive and semiconductive
   surfaces by impedance spectroscopy: Routes to impedimetric
   immunosensors, DNA-Sensors, and enzyme biosensors
SO ELECTROANALYSIS
LA English
DT Review
DE impedance spectroscopy; biosensor; immunosensor; DNA sensor; enzyme;
   field-effect transistor; capacitance; bioelectronics
ID SELF-ASSEMBLED MONOLAYERS; ANTIGEN-ANTIBODY INTERACTIONS;
   CRYSTAL-MICROBALANCE ANALYSES; FIELD-EFFECT TRANSISTORS; MODIFIED GOLD
   ELECTRODES; ELECTROCHEMICAL IMPEDANCE; INSOLUBLE PRODUCT; PLASMON
   RESONANCE; CYTOCHROME-C; CAPACITANCE MEASUREMENTS
AB Impedance spectroscopy is a rapidly developing electrochemical technique for the characterization of biomaterial-functionalized electrodes and biocatalytic transformations at electrode surfaces, and specifically for the transduction of biosensing events at electrodes or field-effect transistor devices. The immobilization of biomaterials, e.g., enzymes, antigens/antibodies or DNA on electrodes or semiconductor surfaces alters the capacitance and interfacial electron transfer resistance of the conductive or semiconductive electrodes. Impedance spectroscopy allows analysis of interfacial changes originating from biorecognition events at electrode surfaces. Kinetics and mechanisms of electron transfer processes corresponding to biocatalytic reactions occurring at modified electrodes can be also derived from Faradaic impedance spectroscopy. Different immunosensors that use impedance measurements for the transduction of antigen-antibody complex formation on electronic transducers were developed. Similarly, DNA biosensors using impedance measurements as readout signals were developed. Amplified detection of the analyte DNA using Faradaic impedance spectroscopy was accomplished by the coupling of functionalized liposomes or by the association of biocatalytic conjugates to the sensing interface providing biocatalyzed precipitation of an insoluble product on the electrodes. The amplified detections of viral DNA and single-base mismatches in DNA were accomplished by similar methods. The changes of interfacial features of gate surfaces of field-effect transistors (FET) upon the formation of antigen-antibody complexes or assembly of protein arrays were probed by impedance measurements and specifically by transconductance measurements. Impedance spectroscopy was also applied to characterize enzyme-based biosensors. The reconstitution of apo-enzymes on cofactor-functionalized electrodes and the formation of cofactor-enzyme affinity complexes on electrodes were probed by Faradaic impedance spectroscopy. Also biocatalyzed reactions occurring on electrode surfaces were analyzed by impedance spectroscopy. The theoretical background of the different methods and their practical applications in analytical procedures were outlined in this article.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RP Katz, E (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
EM ekatz@vms.huji.ac.il; willnea@vms.huji.ac.il
CR Abdelghani A, 2002, MAT SCI ENG C-BIO S, V22, P67, DOI 10.1016/S0928-4931(01)00344-7
   Alfonta L, 2001, ANAL CHEM, V73, P5287, DOI 10.1021/ac010542e
   Alfonta L, 2001, ANAL CHEM, V73, P91, DOI 10.1021/ac00819v
   Alfonta L, 2000, ANAL CHEM, V72, P927, DOI 10.1021/ac990439d
   Alfonta L, 2001, BIOSENS BIOELECTRON, V16, P675, DOI 10.1016/S0956-5663(01)00231-7
   Alfonta L, 2001, CHEM COMMUN, P1492, DOI 10.1039/b104335h
   AMADOR SM, 1993, LANGMUIR, V9, P812, DOI 10.1021/la00027a034
   Ameur S, 2000, APPL BIOCHEM BIOTECH, V89, P161, DOI 10.1385/ABAB:89:2-3:161
   Antonisse MMG, 2000, ANAL CHEM, V72, P343, DOI 10.1021/ac990721k
   Anzai J, 1998, ANAL CHEM, V70, P811, DOI 10.1021/ac970536b
   ARMSTRONG RD, 1990, ELECTROCHIM ACTA, V35, P1, DOI 10.1016/0013-4686(90)85028-L
   ATHEY D, 1995, ELECTROANAL, V7, P270, DOI 10.1002/elan.1140070313
   Bard A. J., 1980, ELECTROCHEMICAL METH
   Bardea A, 1999, CHEM COMMUN, P21, DOI 10.1039/a808319c
   Bardea A, 1998, CHEM COMMUN, P839, DOI 10.1039/a800215k
   Bardea A, 2000, ELECTROANAL, V12, P1097, DOI 10.1002/1521-4109(200010)12:14<1097::AID-ELAN1097>3.3.CO;2-O
   Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   BARTLETT P N, 1991, Progress in Reaction Kinetics, V16, P55
   BATAILLARD P, 1988, ANAL CHEM, V60, P2374, DOI 10.1021/ac00172a011
   BATAILLARD P, 1987, SENSOR ACTUATOR, V12, P245, DOI 10.1016/0250-6874(87)80038-0
   BenDov I, 1997, ANAL CHEM, V69, P3506, DOI 10.1021/ac970216s
   Berggren C, 2001, ELECTROANAL, V13, P173, DOI 10.1002/1521-4109(200103)13:3<173::AID-ELAN173>3.0.CO;2-B
   BERGVELD P, 1991, BIOSENS BIOELECTRON, V6, P55, DOI 10.1016/0956-5663(91)85009-L
   BERGVELD P, 1989, SENSOR ACTUATOR, V18, P309, DOI 10.1016/0250-6874(89)87038-6
   Berney H, 1997, SENSOR ACTUAT B-CHEM, V44, P578, DOI 10.1016/S0925-4005(97)00239-6
   BILLARD V, 1991, ANAL CHIM ACTA, V249, P367, DOI 10.1016/S0003-2670(00)83008-1
   Blonder R, 1996, ANAL CHEM, V68, P3151, DOI 10.1021/ac960290v
   Blonder R, 1997, J AM CHEM SOC, V119, P10467, DOI 10.1021/ja971980z
   Bonazzola C, 1998, J ELECTROANAL CHEM, V449, P111, DOI 10.1016/S0022-0728(98)00047-3
   BOURDILLON C, 1994, J AM CHEM SOC, V116, P10328, DOI 10.1021/ja00101a074
   BOURDILLON C, 1993, J AM CHEM SOC, V115, P12264, DOI 10.1021/ja00079a005
   Bourdillon C, 1996, ACCOUNTS CHEM RES, V29, P529, DOI 10.1021/ar960137n
   BOUSSE L, 1983, J ELECTROANAL CHEM, V152, P25, DOI 10.1016/S0022-0728(83)80030-8
   BRESLER HS, 1992, ACS SYM SER, V511, P89
   Brett CMA, 1999, ELECTROCHIM ACTA, V44, P4233, DOI 10.1016/S0013-4686(99)00138-3
   Calvo EJ, 1996, ANAL CHEM, V68, P4186, DOI 10.1021/ac960170n
   Campas M, 2002, ANAL LETT, V35, P1875, DOI 10.1081/AL-120014280
   Campbell CN, 2002, ANAL CHEM, V74, P158, DOI 10.1021/ac015602v
   Caruana DJ, 1999, J AM CHEM SOC, V121, P769, DOI 10.1021/ja983328p
   CHAMPAGNE GY, 1989, BIOELECTROCH BIOENER, V22, P159, DOI 10.1016/0302-4598(89)80048-0
   CHOVELON JM, 1991, SENSOR ACTUAT B-CHEM, V3, P43, DOI 10.1016/0925-4005(91)85006-5
   Cloarec JP, 2002, BIOSENS BIOELECTRON, V17, P405, DOI 10.1016/S0956-5663(01)00282-2
   Cloarec JP, 1999, SENSOR ACTUAT B-CHEM, V58, P394, DOI 10.1016/S0925-4005(99)00102-1
   DEMOZ A, 1995, J ELECTROANAL CHEM, V389, P71, DOI 10.1016/0022-0728(95)03836-6
   DESILVA MS, 1995, BIOSENS BIOELECTRON, V10, P675, DOI 10.1016/0956-5663(95)96958-2
   DIOT JL, 1985, J ELECTROANAL CHEM, V193, P75, DOI 10.1016/0022-0728(85)85053-1
   ELDEFRAWI ME, 1988, ANAL LETT, V21, P1665, DOI 10.1080/00032718808066519
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   ERSHLER B, 1947, DISCUSS FARADAY SOC, V1, P269, DOI 10.1039/df9470100269
   Farace G, 2002, BIOELECTROCHEMISTRY, V55, P1, DOI 10.1016/S1567-5394(01)00166-9
   Fare TL, 1998, BIOSENS BIOELECTRON, V13, P459, DOI 10.1016/S0956-5663(97)00091-2
   FENG CD, 1996, SENSOR ACTUAT B-CHEM, V35, P431
   Finklea HO, 1996, ELECTROANAL CHEM, V19, P109
   Friebe A., 1993, Sensors and Materials, V5, P65
   GARDIES F, 1989, SENSOR ACTUATOR, V17, P461, DOI 10.1016/0250-6874(89)80032-0
   GEBBERT A, 1992, ANAL CHEM, V64, P997, DOI 10.1021/ac00033a007
   GHINDILIS AL, 1994, BIOSENS BIOELECTRON, V9, P353, DOI 10.1016/0956-5663(94)80035-9
   Gooding JJ, 2002, ELECTROANAL, V14, P1149, DOI 10.1002/1521-4109(200209)14:17<1149::AID-ELAN1149>3.0.CO;2-8
   GOPEL W, 1995, BIOSENS BIOELECTRON, V10, P853, DOI 10.1016/0956-5663(95)99225-A
   Gu JG, 2000, J POLYM ENVIRON, V8, P167, DOI 10.1023/A:1015293626335
   HARDEMAN S, 1995, SENSOR ACTUAT B-CHEM, V24, P98, DOI 10.1016/0925-4005(95)85021-X
   Hason S, 2002, CRIT REV ANAL CHEM, V32, P167, DOI 10.1080/10408340290765515
   Hason S, 2002, TALANTA, V56, P905, DOI 10.1016/S0039-9140(01)00664-6
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   Ho WO, 1999, ANAL CHEM, V71, P1940, DOI 10.1021/ac981367d
   HOBARA D, 1994, COLLOID SURFACE A, V93, P241, DOI 10.1016/0927-7757(94)02959-8
   IANNIELLO RM, 1982, ANAL CHEM, V54, P1980, DOI 10.1021/ac00249a015
   Ichiki T, 2002, J PHOTOPOLYM SCI TEC, V15, P487, DOI 10.2494/photopolymer.15.487
   Ivnitski D, 2000, ELECTROANAL, V12, P317, DOI 10.1002/(SICI)1521-4109(20000301)12:5<317::AID-ELAN317>3.0.CO;2-A
   Jaffrezic-Renault N, 1997, SYNTHETIC MET, V90, P205, DOI 10.1016/S0379-6779(98)80008-8
   Janata J, 2002, CRIT REV ANAL CHEM, V32, P109, DOI 10.1080/10408340290765470
   Jie M, 1999, ELECTROCHEM COMMUN, V1, P425, DOI 10.1016/S1388-2481(99)00071-5
   Jordan CE, 1997, ANAL CHEM, V69, P1449, DOI 10.1021/ac961012z
   Jossinet J, 2002, PHYS MED BIOL, V47, P2189, DOI 10.1088/0031-9155/47/13/301
   Katz E, 2001, SENSOR ACTUAT B-CHEM, V76, P134, DOI 10.1016/S0925-4005(01)00606-2
   KATZ E, 1994, J ELECTROANAL CHEM, V367, P59, DOI 10.1016/0022-0728(93)03010-M
   Kazanskaya N, 1996, BIOSENS BIOELECTRON, V11, P253, DOI 10.1016/0956-5663(96)88412-0
   Kharitonov AB, 2000, SENSOR ACTUAT B-CHEM, V70, P222, DOI 10.1016/S0925-4005(00)00573-6
   Kharitonov AB, 2001, J PHYS CHEM B, V105, P4205, DOI 10.1021/jp0045383
   Kharitonov AB, 2000, J ELECTROANAL CHEM, V487, P133, DOI 10.1016/S0022-0728(00)00178-9
   KNICHEL M, 1995, SENSOR ACTUAT B-CHEM, V28, P85, DOI 10.1016/0925-4005(94)01543-Q
   Lafargue AL, 2002, BIOELECTROMAGNETICS, V23, P450, DOI 10.1002/bem.10034
   Laureyn W, 2000, SENSOR ACTUAT B-CHEM, V68, P360, DOI 10.1016/S0925-4005(00)00489-5
   LIEDBERG B, 1995, BIOSENS BIOELECTRON, V10, pR1, DOI 10.1016/0956-5663(95)96965-2
   LIEDBERG B, 1995, BIOSENS BIOELECTRON, V10, P1
   Lillie G, 2001, SENSOR ACTUAT B-CHEM, V78, P249, DOI 10.1016/S0925-4005(01)00821-8
   LionDagan M, 1997, COLLOID SURFACE B, V8, P251, DOI 10.1016/S0927-7765(97)00008-8
   Lisdat F, 2001, ELECTROANAL, V13, P1225, DOI 10.1002/1521-4109(200110)13:15<1225::AID-ELAN1225>3.0.CO;2-5
   Luo LQ, 2001, BIOPHYS CHEM, V94, P11, DOI 10.1016/S0301-4622(01)00204-6
   Luong JHT, 2001, ANAL CHEM, V73, P1844, DOI 10.1021/ac0011585
   Luppa PB, 2001, CLIN CHIM ACTA, V314, P1, DOI 10.1016/S0009-8981(01)00629-5
   Lust E, 1998, J ELECTROANAL CHEM, V449, P153, DOI 10.1016/S0022-0728(98)00057-6
   Marquette CA, 2002, TALANTA, V56, P763, DOI 10.1016/S0039-9140(01)00633-6
   Maupas H, 1997, J ELECTROANAL CHEM, V421, P165, DOI 10.1016/S0022-0728(96)04837-1
   Maupas H, 1996, J ELECTROANAL CHEM, V406, P53, DOI 10.1016/0022-0728(95)04443-4
   MCNEIL CJ, 1995, ANAL CHEM, V67, P3928, DOI 10.1021/ac00117a018
   Mikkelsen Susan R., 1996, Electroanalysis, V8, P15, DOI 10.1002/elan.1140080104
   MILLAN KM, 1993, ANAL CHEM, V65, P2317, DOI 10.1021/ac00065a025
   Mirsky VM, 1997, BIOSENS BIOELECTRON, V12, P977, DOI 10.1016/S0956-5663(97)00053-5
   Moore JE, 2002, J FOOD PROTECT, V65, P1660, DOI 10.4315/0362-028X-65.10.1660
   Mullett WM, 2000, METHODS, V22, P77, DOI 10.1006/meth.2000.1039
   Nacke T, 2002, TECH MESS, V69, P12, DOI 10.1524/teme.2002.69.1.012
   Nahir TM, 1996, J ELECTROANAL CHEM, V410, P9, DOI 10.1016/0022-0728(96)04551-2
   O'Sullivan CK, 1999, ANAL LETT, V32, P2353, DOI 10.1080/00032719908542975
   Oliveira-Brett AM, 2002, BIOELECTROCHEMISTRY, V56, P33, DOI 10.1016/S1567-5394(02)00017-8
   Oliveira-Brett AM, 2002, LANGMUIR, V18, P2326, DOI 10.1021/la010980g
   Ong KG, 2001, BIOSENS BIOELECTRON, V16, P305, DOI 10.1016/S0956-5663(01)00131-2
   Otero A, 1998, MEAT SCI, V49, pS179, DOI 10.1016/S0309-1740(98)00083-7
   Ouerghi O, 2002, BIOELECTROCHEMISTRY, V56, P131, DOI 10.1016/S1567-5394(02)00029-4
   Ouerghi O, 2001, J ELECTROANAL CHEM, V501, P62, DOI 10.1016/S0022-0728(00)00485-X
   Pak SC, 2001, BIOSENS BIOELECTRON, V16, P371, DOI 10.1016/S0956-5663(01)00152-X
   Pardo-Yissar V, 2003, J AM CHEM SOC, V125, P622, DOI 10.1021/ja028922k
   Pardo-Yissar V, 2000, FARADAY DISCUSS, V116, P119, DOI 10.1039/b001508n
   Patolsky F, 2000, ANGEW CHEM INT EDIT, V39, P940, DOI 10.1002/(SICI)1521-3773(20000303)39:5<940::AID-ANIE940>3.3.CO;2-P
   Patolsky F, 1998, J PHYS CHEM B, V102, P10359, DOI 10.1021/jp983700n
   Patolsky F, 1999, LANGMUIR, V15, P3703, DOI 10.1021/la981682v
   Patolsky F, 1999, ANAL CHEM, V71, P3171, DOI 10.1021/ac9901541
   Patolsky F, 2002, ANGEW CHEM INT EDIT, V41, P3398, DOI 10.1002/1521-3773(20020916)41:18<3398::AID-ANIE3398>3.0.CO;2-W
   Patolsky F, 2001, J AM CHEM SOC, V123, P5194, DOI 10.1021/ja0036256
   Patolsky F, 2001, ANGEW CHEM INT EDIT, V40, P2261, DOI 10.1002/1521-3773(20010618)40:12<2261::AID-ANIE2261>3.0.CO;2-P
   Patolsky F, 2001, NAT BIOTECHNOL, V19, P253, DOI 10.1038/85704
   Pei RJ, 2001, BIOMACROMOLECULES, V2, P463, DOI 10.1021/bm0001289
   Pei RJ, 2001, BIOSENS BIOELECTRON, V16, P355, DOI 10.1016/S0956-5663(01)00150-6
   Pravda M, 2002, ANAL LETT, V35, P1, DOI 10.1081/AL-120002357
   Prokhorov E, 2002, MED BIOL ENG COMPUT, V40, P323, DOI 10.1007/BF02344214
   Raitman OA, 2002, J AM CHEM SOC, V124, P6487, DOI 10.1021/ja012680r
   Raitman OA, 2002, CHEM COMMUN, P1936, DOI 10.1039/b205393d
   RANDLES JEB, 1947, DISCUSS FARADAY SOC, V1, P11, DOI 10.1039/df9470100011
   Reininger-Mack A, 2002, TRENDS BIOTECHNOL, V20, P56, DOI 10.1016/S0167-7799(01)01880-7
   Rickert J, 1996, BIOSENS BIOELECTRON, V11, P757, DOI 10.1016/0956-5663(96)85927-6
   Rogers KR, 2000, MOL BIOTECHNOL, V14, P109, DOI 10.1385/MB:14:2:109
   Ruan CM, 2002, ANAL CHEM, V74, P4814, DOI 10.1021/ac025647b
   SABY C, 1993, SENSOR ACTUAT B-CHEM, V16, P458, DOI 10.1016/0925-4005(93)85228-3
   Sadik OA, 2002, ANAL CHEM, V74, P3142, DOI 10.1021/ac0156722
   Sallacan N, 2002, ANAL CHEM, V74, P702, DOI 10.1021/ac0109873
   Saoudi B, 2000, SENSOR ACTUAT B-CHEM, V62, P35, DOI 10.1016/S0925-4005(99)00356-1
   Sapsford KE, 2002, ANAL CHEM, V74, P1061, DOI 10.1021/ac0157268
   Sargent A, 1999, J ELECTROANAL CHEM, V470, P144, DOI 10.1016/S0022-0728(99)00231-4
   Saum AGE, 2000, BIOSENS BIOELECTRON, V15, P305, DOI 10.1016/S0956-5663(00)00068-3
   Saum AGE, 1998, BIOSENS BIOELECTRON, V13, P511, DOI 10.1016/S0956-5663(97)00129-2
   Savitri D, 1999, BIOELECTROCH BIOENER, V48, P163, DOI 10.1016/S0302-4598(98)00227-X
   Schoning MJ, 2002, ANALYST, V127, P1137, DOI 10.1039/b204444g
   Schroth P, 2001, ELECTROCHIM ACTA, V47, P293, DOI 10.1016/S0013-4686(01)00568-0
   SCHYBERG C, 1995, SENSOR ACTUAT B-CHEM, V27, P457, DOI 10.1016/0925-4005(94)01639-Y
   Sergeyeva TA, 1998, BIOSENS BIOELECTRON, V13, P359, DOI 10.1016/S0956-5663(97)00117-6
   Sergeyeva TA, 1996, SENSOR ACTUAT B-CHEM, V34, P283, DOI 10.1016/S0925-4005(97)80006-8
   SETHI RS, 1994, BIOSENS BIOELECTRON, V9, P243, DOI 10.1016/0956-5663(94)80127-4
   Sibai A, 1996, SENSOR ACTUAT B-CHEM, V31, P125, DOI 10.1016/0925-4005(96)80028-1
   Souteyrand E, 1997, J PHYS CHEM B, V101, P2980, DOI 10.1021/jp963056h
   SOUTEYRAND E, 1994, SENSOR ACTUAT B-CHEM, V20, P63, DOI 10.1016/0925-4005(93)01165-Z
   Souteyrand E, 2000, APPL BIOCHEM BIOTECH, V89, P195, DOI 10.1385/ABAB:89:2-3:195
   Stoynov ZB, 1991, ELECTROCHEMICAL IMPE
   Strasak L, 2002, BIOELECTROCHEMISTRY, V56, P37, DOI 10.1016/S1567-5394(02)00019-1
   TAIRA H, 1993, ANAL SCI, V9, P199, DOI 10.2116/analsci.9.199
   TAYLOR RF, 1991, ANAL CHIM ACTA, V249, P67, DOI 10.1016/0003-2670(91)87009-V
   Vagin MY, 2002, BIOELECTROCHEMISTRY, V56, P91, DOI 10.1016/S1567-5394(01)00142-6
   VALDES JJ, 1988, J HOPKINS APL TECH D, V9, P4
   Van Gerwen P, 1998, SENSOR ACTUAT B-CHEM, V49, P73, DOI 10.1016/S0925-4005(98)00128-2
   Wang G, 2002, ELECTROCHEM COMMUN, V4, P506, DOI 10.1016/S1388-2481(02)00360-0
   Wang J, 2000, NUCLEIC ACIDS RES, V28, P3011, DOI 10.1093/nar/28.16.3011
   Wang J, 1996, J AM CHEM SOC, V118, P7667, DOI 10.1021/ja9608050
   Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   WILLNER I, 1993, J AM CHEM SOC, V115, P4937, DOI 10.1021/ja00064a084
   WILLNER I, 1994, J AM CHEM SOC, V116, P9365, DOI 10.1021/ja00099a078
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   WILLNER I, 1992, J AM CHEM SOC, V114, P10965, DOI 10.1021/ja00053a045
   Willner I, 2002, SCIENCE, V298, P2407, DOI 10.1126/science.298.5602.2407
   Willner I, 1999, BIOTECHNOL PROGR, V15, P991, DOI 10.1021/bp990115a
   Willner I, 2000, BIOSENSORS THEIR APP, P47
   WILLNER I, 2002, ELECTROANALYTICAL ME, P43
   Wilson EK, 1998, CHEM ENG NEWS, V76, P47, DOI 10.1021/cen-v076n021.p047
   Yan F, 2001, ANAL CHEM, V73, P5272, DOI 10.1021/ac015516v
   Yan F, 2001, J AM CHEM SOC, V123, P11335, DOI 10.1021/ja005719l
   Yang MS, 1997, ANAL CHIM ACTA, V346, P259
   Yoon HC, 2002, ANALYST, V127, P1082, DOI 10.1039/b203299f
   Zayats M, 2002, J AM CHEM SOC, V124, P14724, DOI 10.1021/ja027919y
   Zayats M, 2002, ANAL CHEM, V74, P4763, DOI 10.1021/ac020312f
   Zayats M, 2000, BIOSENS BIOELECTRON, V15, P671, DOI 10.1016/S0956-5663(00)00120-2
   Zhao YD, 1999, ANAL CHIM ACTA, V388, P93, DOI 10.1016/S0003-2670(99)00065-3
   ZHONG CJ, 1995, ANAL CHEM, V67, P709
NR 181
TC 955
Z9 966
U1 40
U2 699
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1040-0397
J9 ELECTROANAL
JI Electroanalysis
PD JUL
PY 2003
VL 15
IS 11
BP 913
EP 947
DI 10.1002/elan.200390114
PG 35
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 705DL
UT WOS:000184380400001
DA 2018-10-19
ER

PT J
AU Rosales-Cortes, M
   Peregrina-Sandoval, J
   Banuelos-Pineda, J
   Sarabia-Estrada, R
   Gomez-Rodiles, CC
   Albarran-Rodriguez, E
   Zaitseva, GP
   Pita-Lopez, ML
AF Rosales-Cortes, M
   Peregrina-Sandoval, J
   Banuelos-Pineda, J
   Sarabia-Estrada, R
   Gomez-Rodiles, CC
   Albarran-Rodriguez, E
   Zaitseva, GP
   Pita-Lopez, ML
TI Immunological study of a chitosan prosthesis in the sciatic nerve
   regeneration of the axotomized dog
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE biomaterial; chitosan; sciatic nerve; immunological study; humoral
   immune response; cellular immune response
ID REPAIR; DELIVERY; PRODUCTS; POLYMER
AB This study demonstrated that when the regeneration of the axotomized sciatic nerve is induced through tubulization with chitosan, this biomaterial does not induce immunostimulation or immunodepression in the dog. Canine females were distributed among three groups: an intact control group which was only isolated, an axotomized control group, and an axotomized group which was tubulized with 3% chitosan prostheses. In vitro culture and phagocytosis tests, as well as IgG and IgM serum concentrations, were determined in peripheral blood on days 0, 15, 30 and 60. The results showed that chitosan implants did not importantly affect the immune response.
C1 UdeG, CUCBA, Dpto Neuromorfol, Div Med Vet, Mexico City, DF, Mexico.
   UdeG, CUCBA, Dpto Biol Celular & Mol, Div Ciencias Biol & Ambientales, Mexico City, DF, Mexico.
CR BRAUN RM, 1966, SURG GYNECOL OBSTETR, V122, P15
   BRIAN J, 1991, OTOLARYNGOL CLIN N A, V24, P739
   Bukovsky M, 2001, Bratisl Lek Listy, V102, P314
   CAMPBELL I, 1961, J TRAUMA, V11, P139
   Chang KLB, 2001, J AGR FOOD CHEM, V49, P4845, DOI 10.1021/jf001469g
   CHAVEZDELGADO E, 2001, ORL MEX, V46, P128
   Dornish M, 2001, ANN NY ACAD SCI, V944, P388
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   GABRIELSON G, 1996, PLAST RECONSTR SURG, V38, P68
   GEMMA E, 1995, INFECT IMMUN, V63, P4770
   GOMEZPINEDO U, 2001, ARCH NEUROSCIENCIAS, V6, P184
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Jameela SR, 1998, J CONTROL RELEASE, V52, P17, DOI 10.1016/S0168-3659(97)00187-9
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   Laplante AF, 2001, FASEB J, V15, P2377, DOI 10.1096/fj.01-0250com
   LUNDBORG G, 1994, J HAND SURG-BRIT EUR, V19B, P273, DOI 10.1016/0266-7681(94)90068-X
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   PHAM HN, 1991, J RECONSTR MICROSURG, V7, P31, DOI 10.1055/s-2007-1006762
   ROSALESCORTES M, 2000, CUCCBA, V2, P19
   SAINTIGNY G, 1993, ACTA DERM-VENEREOL, V73, P175
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   TERRIS DJ, 1993, ARCH OTOLARYNGOL, V119, P725
   Wang DA, 2001, J BIOMED MATER RES, V58, P372, DOI 10.1002/jbm.1031
   WILLIAMS LR, 1993, EXP NEUROL, V120, P49, DOI 10.1006/exnr.1993.1039
   Yoshii S, 2001, BRAIN RES, V888, P158, DOI 10.1016/S0006-8993(00)03025-0
   Yoshimoto H, 1995, Nihon Yakurigaku Zasshi, V106, P113
NR 27
TC 23
Z9 28
U1 0
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2003
VL 18
IS 1
BP 15
EP 23
DI 10.1177/088532803033204
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 697NY
UT WOS:000183950900002
PM 12873072
DA 2018-10-19
ER

PT J
AU Gauthier, O
   Khairoun, I
   Bosco, J
   Obadia, L
   Bourges, X
   Rau, C
   Magne, D
   Bouler, JM
   Aguado, E
   Daculsi, G
   Weiss, P
AF Gauthier, O
   Khairoun, I
   Bosco, J
   Obadia, L
   Bourges, X
   Rau, C
   Magne, D
   Bouler, JM
   Aguado, E
   Daculsi, G
   Weiss, P
TI Noninvasive bone replacement with a new injectable calcium phosphate
   biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; calcium phosphate; bone cement; ceramics; composite
ID IN-VITRO; CEMENT; INGROWTH; MACROPOROSITY; SUBSTITUTION; INJECTION;
   CERAMICS; SURGERY; RABBIT; DOGS
AB The use of injectable calcium phosphate (CaP) biomaterials in noninvasive surgery should provide efficient bone colonization and implantation. Two different kinds of injectable biomaterials are presently under development: ionic hydraulic bone cements that harden in vivo after injection, and an association of biphasic calcium phosphate (BCP) ceramic granules and a water-soluble polymer vehicle (a technique particularly investigated by our group), providing an injectable CaP bone substitute (IBS). In our study, we compared these two approaches, using physicochemical characterizations and in vivo evaluations in light microscopy, scanning electron microscopy, and three-dimensional microtomography with synchrotron technology. Three weeks after implantation in rabbit bone, both biomaterials showed perfect biocompatibility and bioactivity, but new bone formation and degradation of the biomaterial were significantly greater for BCP granules than for ionic cement. Newly formed bone developed, binding the BCP granules together, whereas new bone grew only on the surface of the cement, which remained dense, with no obvious degradation 3 weeks after implantation. This study confirms that BCP granules carried by a cellulosic polymer conserve bioactivity and are conducive to earlier and more extensive bone substitution than a carbonated-hydroxyapatite bone cement. The presence of intergranular spaces in the BCP preparation, as shown on microtomography imaging, seems particularly favorable, allowing body fluids to reach each BCP granule immediately after implantation. Thus, the IBS functions as a completely interconnected ceramic with total open macroporosity. This new bone replacement approach should facilitate microinvasive bone surgery and local delivery of bone therapy agents. (C) 2003 Wiley Periodicals, Inc.
C1 Fac Chirurg Dent, Lab Rech Mat Interet Biol, INSERM 99 03, F-44042 Nantes 01, France.
   Ecole Natl Vet Nates, Lab Chirurg, F-44307 Nantes 03, France.
   ESRF, F-38043 Grenoble, France.
RP Weiss, P (reprint author), Fac Chirurg Dent, Lab Rech Mat Interet Biol, INSERM 99 03, 1 Pl Alexis Ricord, F-44042 Nantes 01, France.
EM pweiss@sante.univ-nantes.fr
RI Gauthier, Olivier/A-4639-2015; Weiss, Pierre/P-1372-2014; Daculsi,
   Guy/P-1320-2014
OI Weiss, Pierre/0000-0002-6159-8590; Daculsi, Guy/0000-0003-1030-3446;
   BOULER, Jean-Michel/0000-0001-9784-5584
CR ADAMSBAUM C, 1993, SKELETAL RADIOL, V22, P317
   Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   BROWN WE, 1983, J DENT RES, V62, P672
   Chauveaux D., 1990, CLIN MAT, V5, P251
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   DACULSI G, 1994, CNRS PATENT BIOMATER
   Daculsi G, 1999, BONE, V25, P59
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DEGROOT K, 1980, BIOMATERIALS, V1, P47, DOI 10.1016/0142-9612(80)90059-9
   DELECRIN J, 1994, CELL MATER, V4, P51
   DELRIO MS, 1998, M CRYST MULT OPT
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GAUTHIER O, 1999, BONE, V25, P71
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   GROSS U, 1992, 4 WORLD BIOM C BERL
   Guicheux J, 1998, J BONE MINER RES, V13, P739, DOI 10.1359/jbmr.1998.13.4.739
   JUST EK, 1985, ENCY POLYM SCI ENG, P226
   KAEMMERLEN P, 1989, NEW ENGL J MED, V321, P121
   Khairoun I, 1997, J BIOMED MATER RES, V38, P356, DOI 10.1002/(SICI)1097-4636(199724)38:4<356::AID-JBM8>3.0.CO;2-N
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   Lacout JL, 1996, J MATER SCI-MATER M, V7, P371, DOI 10.1007/BF00154552
   Lemaitre J, 1992, Rev Stomatol Chir Maxillofac, V93, P163
   MYAMOTO T, 1989, J BIOMED MATER RES, V23, P125
   Pasquier G, 1996, J MATER SCI-MATER M, V7, P683, DOI 10.1007/BF00123407
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   PASSUTI N, 1995, INNOV TECH BIOL MED, V16, P20
   RAVEN C, 1998, MICROIMAGING TOMOGRA
   Takechi M, 1996, J MATER SCI-MATER M, V7, P317, DOI 10.1007/BF00154542
   Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
   Turczyn R, 2000, J BIOMAT SCI-POLYM E, V11, P217, DOI 10.1163/156856200743661
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
   Weitkamp T, 1999, P SOC PHOTO-OPT INS, V3772, P311, DOI 10.1117/12.363734
NR 39
TC 51
Z9 51
U1 2
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2003
VL 66A
IS 1
BP 47
EP 54
DI 10.1002/jbm.a.10506
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 697NQ
UT WOS:000183950000006
PM 12833430
DA 2018-10-19
ER

PT J
AU Wettero, J
   Askendal, A
   Tengvall, P
   Bengtsson, T
AF Wettero, J
   Askendal, A
   Tengvall, P
   Bengtsson, T
TI Interactions between surface-bound actin and complement, platelets, and
   neutrophils
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE reactive oxygen species; aggregation; biomaterials; cytoskeleton; plasma
   proteins
ID D-BINDING PROTEIN; F-ACTIN; ARTIFICIAL SURFACES; METHYLATED SILICON;
   PLASMA GELSOLIN; NADPH OXIDASE; GC-GLOBULIN; LUNG INJURY; HUMAN-BLOOD;
   IN-VITRO
AB Actin exists as globular (G) monomers or polymeric filaments (F) in the cytoplasm of eukaryotic cells, mediating cell morphologic changes and motility. Large amounts of this protein may be released out to the extracellular compartment during tissue injury, but little is known about its role in biomaterial-related inflammation. We immobilized actin to methylated glass, methylated and aminated silicon, and gold model surfaces and studied the subsequent blood serum deposition and complement activation, generation of reactive oxygen species (ROS), and adhesion and aggregation of neutrophils and platelets. Null ellipsometry showed that approximately one monolayer of G-actin can be immobilized onto the model surfaces and that actin in buffer polymerized on top of this by the addition of K+ and Mg2+ ions to form a thicker layer of firmly bound F-actin. After serum incubation, F-actin bound low amounts of anti-complement factor 1q (anti-C1q). Cell responses upon contact with actin-coated surfaces were analyzed by luminol-amplified chemiluminescence, lumi-aggregometry, and fluorescence microscopy. It was shown that surface-triggered aggregation, spreading, and generation of ROS are down-regulated and comparable to the response by adsorbed albumin. However, F-actin on gold surfaces recruited platelets in a C1q-dependent manner. We conclude that in vitro adsorbed actin is a weak complement, platelet, and neutrophil activator, but that F-actin associates with both C1q and platelets. (C) 2003 Wiley Periodicals, Inc.
C1 Linkoping Univ, Div Med Microbiol, Dept Mol & Clin Med, Fac Hlth Sci, SE-58185 Linkoping, Sweden.
   Linkoping Univ, Div Appl Phys, Dept Phys & Measurement Technol Biol & Chem, SE-58185 Linkoping, Sweden.
RP Wettero, J (reprint author), Linkoping Univ, Div Med Microbiol, Dept Mol & Clin Med, Fac Hlth Sci, 85 Linkoping, SE-58185 Linkoping, Sweden.
EM jonwe@ifm.liu.se
RI Wettero, Jonas/C-9578-2009
OI Wettero, Jonas/0000-0002-6916-5490
CR Babior BM, 1999, BLOOD, V93, P1464
   BENGTSSON T, 1993, EUR J CELL BIOL, V62, P49
   BENGTSSON T, 1994, EUR J CELL BIOL, V63, P345
   BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   CHENOWETH DE, 1987, ANN NY ACAD SCI, V516, P306, DOI 10.1111/j.1749-6632.1987.tb33051.x
   CHEUNG AK, 1989, KIDNEY INT, V36, P257, DOI 10.1038/ki.1989.188
   Comut AA, 2000, BIOMATERIALS, V21, P1887, DOI 10.1016/S0142-9612(00)00066-1
   COOPER NR, 1999, INFLAMMATION BASIC P, P281
   Dahl B, 2001, INTENS CARE MED, V27, P394, DOI 10.1007/s001340000837
   DAHLGREN C, 1991, TRENDS PHOTOCHEM PHO, V2, P427
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   ELWING H, 1987, J COLLOID INTERF SCI, V119, P203, DOI 10.1016/0021-9797(87)90260-8
   Erukhimov JA, 2000, AM J RESP CRIT CARE, V162, P288, DOI 10.1164/ajrccm.162.1.9806088
   FECHHEIMER M, 1979, MOL IMMUNOL, V16, P881, DOI 10.1016/0161-5890(79)90086-5
   FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8
   GHEBREHIWET B, 1998, COMPLEMENT SYSTEM, P188
   HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8
   HAGMANN J, 1993, P NATL ACAD SCI USA, V90, P3280, DOI 10.1073/pnas.90.8.3280
   HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421
   HERMANSSON GT, 1992, IMMOBILIZED AFFINITY
   JANMEY PA, 1995, CURR OPIN CELL BIOL, V7, P111, DOI 10.1016/0955-0674(95)80052-2
   JANMEY PA, 1987, BLOOD, V70, P524
   JANMEY PA, 1992, BLOOD, V80, P928
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   KERN W, 1970, RCA REV, V31, P187
   Klickstein LB, 1997, IMMUNITY, V7, P345, DOI 10.1016/S1074-7613(00)80356-8
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429
   Loos M., 1998, COMPLEMENT SYSTEM, P1
   McCrackin F. L., 1969, 479 NBS
   McGrath JL, 2000, BIOPHYS J, V79, P3258, DOI 10.1016/S0006-3495(00)76558-1
   Morimatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P206, DOI 10.1006/bbrc.1996.5881
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   NISHIOKA M, 1982, BIOCHEM BIOPH RES CO, V108, P1307, DOI 10.1016/0006-291X(82)92142-8
   PEERSCHKE EIB, 1994, SEMIN HEMATOL, V31, P320
   Peerschke EIB, 2001, IMMUNOL REV, V180, P56, DOI 10.1034/j.1600-065X.2001.1800105.x
   PEERSCHKE EIB, 1990, J IMMUNOL, V145, P2984
   PETERS DA, 1979, J ELECTROCHEM SOC, V126, P883, DOI 10.1149/1.2129162
   Renault A, 1999, BIOPHYS J, V76, P1580, DOI 10.1016/S0006-3495(99)77317-0
   SAHU A, 1994, J BIOL CHEM, V269, P28997
   Seno T, 2001, THROMB RES, V103, P399, DOI 10.1016/S0049-3848(01)00341-3
   SMITH DB, 1988, AM J PATHOL, V130, P261
   SMITH DB, 1987, J LAB CLIN MED, V110, P189
   STOSSEL TP, 1999, INFLAMMATION BASIC P, P663
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Tengvall P, 1996, BIOMATERIALS, V17, P1001, DOI 10.1016/0142-9612(96)84675-8
   Tengvall P, 1996, J BIOMED MATER RES, V31, P305, DOI 10.1002/(SICI)1097-4636(199607)31:3<305::AID-JBM3>3.0.CO;2-Q
   VASCONCELLOS CA, 1993, BLOOD, V82, P3648
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   WALDECK DH, 1985, SURF SCI, V158, P103, DOI 10.1016/0039-6028(85)90290-0
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   WEETALL HH, 1993, APPL BIOCHEM BIOTECH, V41, P157, DOI 10.1007/BF02916421
   Wettero J, 2003, BIOMATERIALS, V24, P1559, DOI 10.1016/S0142-9612(02)00543-4
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Wettero J, 2001, J BIOMED MATER RES, V57, P550, DOI 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   Zalavary S, 1996, J LEUKOCYTE BIOL, V60, P58
NR 60
TC 11
Z9 12
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2003
VL 66A
IS 1
BP 162
EP 175
DI 10.1002/jbm.a.10591
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 697NQ
UT WOS:000183950000019
PM 12833443
DA 2018-10-19
ER

PT J
AU Fini, M
   Giavaresi, G
   Greggi, T
   Martini, L
   Aldini, NN
   Parisini, P
   Giardino, R
AF Fini, M
   Giavaresi, G
   Greggi, T
   Martini, L
   Aldini, NN
   Parisini, P
   Giardino, R
TI Biological assessment of the bone-screw interface after insertion of
   uncoated and hydroxyapatite-coated pedicular screws in the osteopenic
   sheep
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE osteoporosis; pedicular fixation; hydroxyapatite; sheep; bone healing
ID LOADED PEDICLE SCREWS; IN-VIVO; OSTEOPOROSIS INFLUENCES; IMPLANT
   INTEGRATION; PROSTHETIC DEVICES; INTERNAL-FIXATION; SPINAL FIXATION;
   TITANIUM-ALLOY; MODEL; BIOMATERIALS
AB The sheep seems to be a promising model of osteoporosis and biomaterial osteointegration in osteopenic bone. The long-term ovariectomized sheep model was used for the biological investigation of bone healing around uncoated and hydroxyapatite (HA)-coated pedicle screws in osteopenic bone. Four sheep were ovariectomized and four sheep were sham-operated. Twenty-four months after surgery, the animals were implanted with uncoated and HA-coated stainless steel screws in the lumbar vertebral pedicles. Four months later, bone-to-implant contact, bone ingrowth, and bone hardness were measured around screws. Uncoated stainless steel presented significantly (p < 0.0005) lower bone-to-implant contact in healthy and osteopenic bone compared with HA-coated stainless steel. HA significantly improved bone ingrowth in healthy bone (p < 0.05) compared with uncoated stainless steel. Osteopenia significantly (p < 0.05) reduced the area of bone ingrowth around the screw threads for both types of implants. In the inner thread area, bone microhardness significantly increased (p < 0.05) in HA-coated surface versus uncoated for healthy and osteopenic bone. HA coating significantly enhances bone-to-implant contact also in osteopenic bone in comparison with uncoated stainless steel surfaces. Bone ingrowth and mineralization are ameliorated by the osteoconductive HA coating. However, osteopenia seems to greatly influence bone ingrowth processes around the implanted screws regardless of the characteristics of the material surface. (C) 2003 Wiley Periodicals, Inc.
C1 Rizzoli Orthopaed Inst, Dept Expt Surg, Res Inst Codivilla Putti, I-40136 Bologna, Italy.
   Rizzoli Orthopaed Inst, Dept Spinal Surg, I-40136 Bologna, Italy.
   Univ Bologna, Fac Med, Chair Surg Pathophysiol, I-40100 Bologna, Italy.
RP Fini, M (reprint author), Rizzoli Orthopaed Inst, Dept Expt Surg, Res Inst Codivilla Putti, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570; Giavaresi,
   Gianluca/0000-0001-7843-5969
CR ALBREKTSSON T, 1991, BONE-BIOMATERIAL INTERFACE, P357
   ALDINI NN, IN PRESS J ORTHOP RE
   An YH, 1999, ANIMAL MODELS ORTHOP, P85
   BARRIOS C, 1993, J ORTHOP TRAUMA, V7, P438, DOI 10.1097/00005131-199310000-00006
   BELLINO FL, 1998, LAB ANIM SCI, V48, P623
   Blomqvist JE, 1996, INT J ORAL MAX SURG, V25, P63, DOI 10.1016/S0901-5027(96)80015-4
   Brayda-Bruno M, 2001, INT J ARTIF ORGANS, V24, P41
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Chang YL, 1999, J ORAL MAXIL SURG, V57, P1096
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   Fini M, 2000, INT J ARTIF ORGANS, V23, P275
   Fini M, 2002, INT J ORAL MAX IMPL, V17, P28
   Giavaresi G, 2001, INT J ARTIF ORGANS, V24, P814
   HALVORSON TL, 1994, SPINE, V19, P2415, DOI 10.1097/00007632-199411000-00008
   Hu SS, 1997, SPINE, V22, p43S, DOI 10.1097/00007632-199712151-00008
   Huja SS, 2000, MECH TESTING BONE BO, P247
   *INT SOC FRACT REP, 2002, OSTEOPOROS INT S2, V13, pS1
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   Kanayama M, 1999, SPINE, V24, P1058, DOI 10.1097/00007632-199906010-00003
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Kubo T, 1999, J STEROID BIOCHEM, V68, P197, DOI 10.1016/S0960-0760(99)00032-1
   Matsuzaki H, 1999, ANIMAL MODELS ORTHOP, P539
   Moroni A, 2001, J BONE JOINT SURG AM, V83A, P717, DOI 10.2106/00004623-200105000-00010
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   NEWMAN E, 1995, BONE, V16, P277
   Ozawa S, 2002, BONE, V30, P137, DOI 10.1016/S8756-3282(01)00646-9
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rocca M, 2000, INT J ARTIF ORGANS, V23, P824
   Sanden B, 2001, SPINE, V26, P2673, DOI 10.1097/00007632-200112150-00008
   Sanden B, 2001, EUR SPINE J, V10, P334, DOI 10.1007/s005860100291
   Sandhu HS, 1999, ANIMAL MODELS ORTHOP, P505
   Seeger LL, 1997, SPINE, V22, p49S, DOI 10.1097/00007632-199712151-00009
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Torricelli P, 2000, J BIOMED MATER RES, V52, P177, DOI 10.1002/1097-4636(200010)52:1<177::AID-JBM23>3.0.CO;2-F
   Walsh WR, 2000, CLIN ORTHOP RELAT R, P258
   Walsh WR, 1997, CLIN ORTHOP RELAT R, P218
NR 36
TC 49
Z9 56
U1 0
U2 5
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2003
VL 66A
IS 1
BP 176
EP 183
DI 10.1002/jbm.a.10605
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 697NQ
UT WOS:000183950000020
PM 12833444
DA 2018-10-19
ER

PT J
AU Icenogle, T
   Sandler, D
   Puhlman, M
   Himley, S
   Sato, DJ
   Schaefer, S
AF Icenogle, T
   Sandler, D
   Puhlman, M
   Himley, S
   Sato, DJ
   Schaefer, S
TI Intraperitoneal pocket for left ventricular assist device placement
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Article
AB Background: Implantation of the HeartMate Implanted Pneumatic or Vented Electric Ventricular Assist Device requires that the pump be implanted either in the peritoneal cavity or in the abdominal wall. Both sites have been problematic.
   Methods: We describe a new technique in which an intraperitoneal pocket is created, using Gore-Tex Dual Mesh Plus Biomaterial with Holes, to contain the ventricular assist device. This shields the ventricular assist device from the peritoneal contents and avoids abdominal wall dissection. Thirty consecutive patients who underwent implantation using this technique were compared with 16 patients who underwent implantation before this technique was in use.
   Results: Thirty consecutive patients underwent implantation, and 2 of those patients underwent re-implantation because of device failure (16/30 HeartMate Implanted Pneumatic, 14/30 HeartMate Vented Electric, and 2/14 HeartMate Vented Electric replaced with the HeartMate Implanted Pneumatic). Twenty-five patients have undergone explantation. Pocket infections in patients who have had implanted devices for >1 month decreased from 4 of 13 before the pockets were used to 1 of 25 with the intraperitoneal pockets (Fisher's exact test p = 0.038). Two hernia repairs were required after explantation when the biomaterial pocket was used. A decrease in return to surgery for bleeding was noted after the pocket was used (7/16 without the pocket and 3/32 with the pocket; Fisher's exact test, p = 0.010).
   Conclusions: Bleeding complications and pocket infections decreased in this early experience. Further study is necessary to confirm the apparent decrease in complication rate by using this new technique in this small cohort of patients.
C1 Heart Inst Spokane, Inland NW Thorac Organ Transplant Program, Sacred Heart Med Ctr, Spokane, WA USA.
   Int Heart Inst Montana, Missoula, MT USA.
RP Icenogle, T (reprint author), NW Cardiothorac & Transplant Surg, Suite 532,W 105 8th Ave, Spokane, WA 99204 USA.
CR FRAZIER OH, 1992, ANN THORAC SURG, V53, P1080, DOI 10.1016/0003-4975(92)90393-I
   Goldstein DJ, 1998, NEW ENGL J MED, V339, P1522, DOI 10.1056/NEJM199811193392107
   MCCARTHY PM, 1994, ANN THORAC SURG, V57, P634, DOI 10.1016/0003-4975(94)90557-6
   PHILLIPS WS, 1992, ANN THORAC SURG, V53, P482, DOI 10.1016/0003-4975(92)90273-7
   Wasler A, 1996, ASAIO J, V42, pM573, DOI 10.1097/00002480-199609000-00052
NR 5
TC 9
Z9 9
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD JUL
PY 2003
VL 22
IS 7
BP 818
EP 821
DI 10.1016/S1053-2498(02)00644-7
PG 4
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA 702QZ
UT WOS:000184235800015
PM 12873551
DA 2018-10-19
ER

PT J
AU Wikesjo, UME
   Lim, WH
   Razi, SS
   Sigurdsson, TJ
   Lee, MB
   Tatakis, DN
   Hardwick, WR
AF Wikesjo, UME
   Lim, WH
   Razi, SS
   Sigurdsson, TJ
   Lee, MB
   Tatakis, DN
   Hardwick, WR
TI Periodontal repair in dogs: A bioabsorbable calcium carbonate coral
   implant enhances space provision for alveolar bone regeneration in
   conjunction with guided tissue regeneration
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE alveolar bone; bone regeneration; calcium carbonate; dental cementum;
   guided bone regeneration; membranes; bioabsorbable
ID TITANIUM-REINFORCED MEMBRANES; CEMENTUM REGENERATION;
   CLINICAL-EVALUATION; INTRABONY DEFECTS; FOLLOW-UP; HYDROXYAPATITE;
   THERAPY
AB Background: Collapse or compression of a barrier device into a periodontal defect or onto the root surface compromises outcomes following guided tissue regeneration (GTR). Bone biomaterials have been suggested to support regeneration of alveolar bone and to improve space provision with GTR devices. The objective of this study was to evaluate space provision, alveolar bone, and cementum regeneration following use of a bioabsorbable, calcium carbonate biomaterial in conjunction with GTR.
   Methods: Routine, critical size, 5 to 6 mm, supraalveolar, periodontal defects were created in 5 young adult beagle dogs. Alternate jaw quadrants in consecutive animals received GTR and the coral biomaterial (cGTR) or GTR alone. The animals were euthanized 4 weeks postsurgery and tissue blocks processed for histometric analysis.
   Results: The coral implant particles were surrounded by newly-formed bone or immersed in connective tissue and appeared to resorb and be replaced by bone. There was limited, if any, appreciable cementum regeneration. Space provision was enhanced in cGTR compared to GTR sites (6.1 +/- 1.6 versus 2.4 +/- 0.8 mm(2); P<0.05). Bone regeneration (height) was significantly increased in cGTR compared to GTR sites averaging 1.9 +/- 0.6 and 1.2 +/- 0.6 mm, respectively (P<0.05). Bone regeneration (area) was 2-fold greater in cGTR sites compared to the GTR control (3.3 +/- 1.8 versus 1.4 +/- 0.5 mm(2)), however the difference was not statistically significant (P >0.05).
   Conclusions: The coral implant significantly enhanced space provision for GTR while alveolar bone formation appeared to be enhanced by its use. Increased healing intervals are needed to fully understand the biologic value of the coral implant as an adjunct to GTR.
C1 Temple Univ, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA 19122 USA.
   Univ Akureyri, Akureyri, Iceland.
   Loma Linda Univ, Dept Periodontol, Loma Linda, CA 92350 USA.
   Ohio State Univ, Dept Periodontol, Columbus, OH 43210 USA.
   WL Gore & Assoc Inc, Flagstaff, AZ USA.
RP Wikesjo, UME (reprint author), Temple Univ, Dept Periodontol, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA 19122 USA.
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
CR BODEN SD, 1997, SPINAL DISORD, V10, P1
   CORTELLINI P, 1995, J PERIODONTOL, V66, P797, DOI 10.1902/jop.1995.66.9.797
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   HARDWICK R, 1995, J PERIODONTOL, V66, P495, DOI 10.1902/jop.1995.66.6.495
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   Kim CK, 1996, J PERIODONTOL, V67, P1301, DOI 10.1902/jop.1996.67.12.1301
   Mellonig JT, 1996, CLIN ORTHOP RELAT R, P116
   Moon IS, 1996, J CLIN PERIODONTOL, V23, P945, DOI 10.1111/j.1600-051X.1996.tb00516.x
   MORA F, 1995, J CLIN PERIODONTOL, V22, P877, DOI 10.1111/j.1600-051X.1995.tb01787.x
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P511, DOI 10.1902/jop.1995.66.6.511
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   Tatakis DN, 2000, J CLIN PERIODONTOL, V27, P698, DOI 10.1034/j.1600-051x.2000.027009698.x
   TINTI C, 1994, J PERIODONTOL, V65, P1088, DOI 10.1902/jop.1994.65.11.1088
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   Wikesjo UME, 1998, J CLIN PERIODONTOL, V25, P475, DOI 10.1111/j.1600-051X.1998.tb02476.x
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   WIKESJO UME, 2003, IN PRESS J CLIN PERI
   YUKNA RA, 1994, J PERIODONTOL, V65, P177, DOI 10.1902/jop.1994.65.2.177
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 27
TC 26
Z9 26
U1 1
U2 3
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD JUL
PY 2003
VL 74
IS 7
BP 957
EP 964
DI 10.1902/jop.2003.74.7.957
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 754KJ
UT WOS:000187315200003
PM 12931757
DA 2018-10-19
ER

PT J
AU Moire, L
   Rezzonico, E
   Poirier, Y
AF Moire, L
   Rezzonico, E
   Poirier, Y
TI Synthesis of novel biomaterials in plants
SO JOURNAL OF PLANT PHYSIOLOGY
LA English
DT Article
DE PHA; plastic; polyhydroxyalkanoate; polymer; silk; biomaterial
ID PROTEIN-BASED POLYMER; TRANSGENIC PLANTS; SPIDER SILK; BETA-OXIDATION;
   BIODEGRADABLE PLASTICS; PICHIA-PASTORIS; MUSSEL BYSSUS;
   POLYHYDROXYALKANOATES; ARABIDOPSIS; EXPRESSION
AB Metabolic engineering of plants allows the possibility of using crops for the synthesis of novel polymers having useful material properties. Strong and flexible protein-based polymers, which are based on the structure of silk and elastin have been synthesized in transgenic plants. A wide range of polyhydroxyalkanoates having properties ranging from stiff plastics to soft elastomers and glues have been synthesized in various compartments of plants, such as the cytoplasm, plastid and peroxisome. These plant biomaterials could replace, in part, the synthetic plastics, fibers and elastomers produced from petroleum, thus offering the advantage of renewability, sustainability and biodegradability.
C1 Univ Lausanne, Inst Ecol, Lab Biotechnol Vegetale, CH-1015 Lausanne, Switzerland.
RP Poirier, Y (reprint author), Univ Lausanne, Inst Ecol, Lab Biotechnol Vegetale, Batiment Biol, CH-1015 Lausanne, Switzerland.
CR Bohmert K, 2000, PLANTA, V211, P841, DOI 10.1007/s004250000350
   Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830
   Daniell H, 1997, Methods Mol Biol, V63, P359
   DEKONING G, 1995, CAN J MICROBIOL, V41, P303, DOI 10.1139/m95-201
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fukui T, 1998, J BACTERIOL, V180, P667
   GUDA C, 1995, BIOTECHNOL LETT, V17, P745, DOI 10.1007/BF00130362
   Guda C, 2000, PLANT CELL REP, V19, P257, DOI 10.1007/s002990050008
   Hahn JJ, 1999, BIOTECHNOL PROGR, V15, P1053, DOI 10.1021/bp990118n
   Herzog RW, 1997, APPL MICROBIOL BIOT, V47, P368, DOI 10.1007/s002530050942
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Houmiel KL, 1999, PLANTA, V209, P547, DOI 10.1007/s004250050760
   Jendrossek D, 2001, ADV BIOCHEM ENG BIOT, V71, P293
   John ME, 1996, P NATL ACAD SCI USA, V93, P12768, DOI 10.1073/pnas.93.23.12768
   John ME, 1997, CRIT REV BIOTECHNOL, V17, P185, DOI 10.3109/07388559709146613
   Kim YB, 2001, ADV BIOCHEM ENG BIOT, V71, P51
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Mitsky T. A., 2000, PCT application, Patent No. [WO00/52183, 0052183]
   Mittendorf V, 1999, PLANT J, V20, P45, DOI 10.1046/j.1365-313X.1999.00572.x
   Mittendorf V, 1998, P NATL ACAD SCI USA, V95, P13397, DOI 10.1073/pnas.95.23.13397
   Nakashita H, 1999, BIOSCI BIOTECH BIOCH, V63, P870, DOI 10.1271/bbb.63.870
   NAWRATH C, 1995, MOL BREEDING, V1, P105, DOI 10.1007/BF01249696
   NAWRATH C, 1994, P NATL ACAD SCI USA, V91, P12760, DOI 10.1073/pnas.91.26.12760
   Poirier Y, 1999, PLANT PHYSIOL, V121, P1359, DOI 10.1104/pp.121.4.1359
   Poirier Y, 1999, CURR OPIN BIOTECH, V10, P181, DOI 10.1016/S0958-1669(99)80032-9
   POIRIER Y, 1992, SCIENCE, V256, P520, DOI 10.1126/science.256.5056.520
   Poirier Y, 2002, FEMS MICROBIOL LETT, V207, P97, DOI 10.1111/j.1574-6968.2002.tb11035.x
   Poirier Y, 2001, ADV BIOCHEM ENG BIOT, V71, P209
   POIRIER Y, 1995, BIO-TECHNOL, V13, P142, DOI 10.1038/nbt0295-142
   Poirier Y, 2001, BIOPOLYESTERS, V3A, P401
   POIRIER Y, 2001, APPL ENVIRON MICROB, V67, P5253
   Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Slater S, 1999, NAT BIOTECHNOL, V17, P1011, DOI 10.1038/13711
   Slater S, 1998, J BACTERIOL, V180, P1979
   Steinbuchel A, 2001, ADV BIOCHEM ENG BIOT, V71, P81
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuchel A., 1991, NOVEL BIOMATERIALS B, P123
   URRY DW, 1996, POLYM MAT ENCY SYNTH, P7263
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Yamamoto H, 1996, BIOTECHNOL GENET ENG, V13, P133, DOI 10.1080/02648725.1996.10647926
   Zhang XR, 1996, PLANT CELL REP, V16, P174, DOI 10.1007/BF01890861
NR 43
TC 17
Z9 18
U1 0
U2 18
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0176-1617
J9 J PLANT PHYSIOL
JI J. Plant Physiol.
PD JUL
PY 2003
VL 160
IS 7
BP 831
EP 839
DI 10.1078/0176-1617-01030
PG 9
WC Plant Sciences
SC Plant Sciences
GA 709UV
UT WOS:000184643500011
PM 12940550
DA 2018-10-19
ER

PT J
AU Yao, FL
   Bai, Y
   Zhou, YT
   Liu, C
   Wang, H
   Yao, KD
AF Yao, FL
   Bai, Y
   Zhou, YT
   Liu, C
   Wang, H
   Yao, KD
TI Synthesis and characterization of multiblock copolymers based on
   L-lactic acid, citric acid, and poly(ethylene glycol)
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE synthesis; block copolymers; biodegradable; poly(L-lactic acid); citric
   acid
ID POLY(L-LACTIDE) BONE PLATES; BLOCK-COPOLYMERS; DEGRADATION; FIXATION;
   SCREWS
AB Because poly(L-lactic acid) (PLLA) is a biodegradable polyester with low immunogenicity and good biocompatibility, it is used as a biomaterial. However, hydrophobic PLLA does not have any reactive groups. Thus, its application is limited. To increase the hydrophilicity of PLLA and accelerate its degradation rate, functionalized pendant groups and blocks were introduced through copolymerization with citric acid and poly(ethylene glycol) (PEG), respectively. This article describes the synthesis and characterization Of poly(L-lactic-co-citric acid) (PLCA)-PLIA and PLCA-PEG multiblock copolymers. The results indicated that the hydrolysis rate was enhanced, and the hydrophilicity was improved because of the incorporation of carboxyl groups in PLCA-PLLA. The joining of the PEG block led to improved hydrophilicity of PLCA, and the degradation rate of PLCA-PEG accelerated as compared with that of PLCA-PLLA. (C) 2003 Wiley Periodicals, Inc.
C1 Tianjin Univ, Sch Chem Technol & Engn, Dept Polymer Sci & Engn, Tianjin 300072, Peoples R China.
   Tianjin Univ, Res Inst Polymer Mat, Tianjin 300072, Peoples R China.
RP Yao, FL (reprint author), Tianjin Univ, Sch Chem Technol & Engn, Dept Polymer Sci & Engn, Tianjin 300072, Peoples R China.
CR BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   DANIELS AU, 1990, J APPL BIOMATER, V1, P57, DOI 10.1002/jab.770010109
   DIETER B, 1998, POLYM DEGRAD STABIL, V59, P129
   ESPARTERO JL, 1996, MACROMOLECULES, V29, P35
   GAVAERT MR, 2001, Patent No. 2001079315
   INERJIT JG, 2001, ADV DRUG DELIVERY RE, V51, P97
   JOENG JH, 2001, BIOCONJUGATE CHEM, V12, P917
   Lee SH, 2002, MACROMOL RES, V10, P85, DOI 10.1007/BF03218295
   Luo WJ, 2002, J APPL POLYM SCI, V84, P1729, DOI 10.1002/app.10580
   OKEEFE BJ, 2001, J CHEM SOC DA, V15, P2215
   Park SY, 2001, MACROMOLECULES, V34, P8821, DOI 10.1021/ma010789d
   Qian HT, 2000, POLYM DEGRAD STABIL, V68, P423, DOI 10.1016/S0141-3910(00)00031-8
   RYPACEK F, 2001, POLYM MAT SCI ENG, V84, P817
   SHAH SS, 1994, J BIOMAT SCI-POLYM E, V5, P421, DOI 10.1163/156856294X00121
   Tasaka F, 2001, MACROMOLECULES, V34, P5494, DOI 10.1021/ma010067m
   VELD PJAI, 1992, MAKROMOL CHEM, V193, P2713
   YAO FL, 2003, UNPUB J APPL POLYM S
NR 18
TC 25
Z9 27
U1 3
U2 20
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD JUL 1
PY 2003
VL 41
IS 13
BP 2073
EP 2081
DI 10.1002/pola.10756
PG 9
WC Polymer Science
SC Polymer Science
GA 690TB
UT WOS:000183564300020
DA 2018-10-19
ER

PT J
AU Sara, N
   Kresalkova, M
   Saha, L
   Kolomaznik, K
AF Sara, N
   Kresalkova, M
   Saha, L
   Kolomaznik, K
TI The effect of anaerobic digestion on chrome sludge - A by-product of
   tanned leather waste
SO JOURNAL OF THE AMERICAN LEATHER CHEMISTS ASSOCIATION
LA English
DT Article
AB The leather industry is environmentally important as a user of a by-product of the meat industry. It is perceived as a consumer of resources and a producer of pollutants. The most serious problem is chrome tanned solid wastes, which are now under control through alkali-enzymatic hydrolysis treatment of chrome shavings. The main products of this hydrolytic reaction are gelable protein hydrolysate, enzymatic hydrolysate, and chrome sludge. In chrome sludge, the rest of the biomaterial is collagen protein. Approximately 20-40 % (on free moisture basis) is strongly bound as co-ordinate complex with chromium, which creats serious problems for further treatment of it to recover tanning salt. One possible solution is to decrease the content of collagen protein by anaerobic digestion, which is presented in this paper.
   The effect of anaerobic digestion on chrome sludge was observed under controlled conditions using different fermentation compositions of broth at 50degreesC for a 15 day incubation period. Sludge, inoculum and water at 3: 1:1 ratio was determined to be the optimum fermentation composition from the bioconversion point-of-view. During anaerobic digestion, the content of biomaterial associated with the chrome sludge decreased while the quantity of free chromium increased. These observations were confirmed by attenuated total reflectance (ATR) using FTIR spectophotometric and scanning electron microscopic (SEM) analysis.
C1 Tomas Bata Univ Zlin, Fac Technol, CZ-76272 Zlin, Czech Republic.
RP Sara, N (reprint author), Tomas Bata Univ Zlin, Fac Technol, TGM 275, CZ-76272 Zlin, Czech Republic.
OI SAHA, NABANITA/0000-0002-7549-2260
CR *ADH PAN ADV COMM, 1977, METH GEN HUM AN AGR
   ALOY M, 1986, ANAEROBIC DIGESTION
   BECKERS GH, 1986, ANAEROBIC DIGESTION
   Brown EM, 1996, J AM LEATHER CHEM AS, V91, P270
   Cabeza LF, 1998, J AM LEATHER CHEM AS, V93, P299
   FERRY JG, 1976, ARCH MICROBIOL, V107, P33, DOI 10.1007/BF00427864
   GHOSH S, 2002, P ANN GEN M SBAOI ED, P182
   HOBSON PN, 1984, ANAEROBIC DIGESTION
   Kolomaznik K, 2000, J AM LEATHER CHEM AS, V95, P55
   KOLOMAZNIK K, 2002, SWITZ PEAK 6 WORLD C
   Langmaier F, 1999, J SOC LEATH TECH CH, V83, P187
   Poulopoulou VG, 1998, J AIR WASTE MANAGE, V48, P846, DOI 10.1080/10473289.1998.10463735
   SAHA N, 1999, P R 99 REC REC REINT, V4, P38
   SAHA N, 2002, INDIAN CHEM ENG A, V44, P3
   SAHA N, 1998, ADV BIOTECHNOL, P503
NR 15
TC 5
Z9 5
U1 0
U2 2
PU AMER LEATHER CHEMISTS ASSN
PI LUBBOCK
PA TEXAS TECH UNIV, BOX 45300, LUBBOCK, TX 79409-5300 USA
SN 0002-9726
J9 J AM LEATHER CHEM AS
JI J. Am. Leather Chem. Assoc.
PD JUL
PY 2003
VL 98
IS 7
BP 256
EP 262
PG 7
WC Chemistry, Applied; Materials Science, Textiles
SC Chemistry; Materials Science
GA 698FB
UT WOS:000183986200002
DA 2018-10-19
ER

PT J
AU Kawashima, A
   Watanabe, S
   Asami, K
   Hanada, S
AF Kawashima, A
   Watanabe, S
   Asami, K
   Hanada, S
TI XPS study of corrosion behavior of Ti-18Nb-4Sn shape memory alloy in a
   0.05 mass % HCl solution
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE Ti-18Nb-4Sn shape memory alloy; biomaterial; X-ray photoelectron
   spectroscopy; surface composition; passive film; 0.05 mass % HCl
   solution
ID CHROMIUM; SURFACES; TITANIUM; GROWTH; OXIDES; IRON; SN; FE; NI; CO
AB The Ti-18Nb-4Sn alloy has been confirmed to possess much higher corrosion resistance compared to the NiTi alloy throughout immersion time up to 604.8 ks in a 0.05 mass% HCl at 310K open to air. TheTi-18Nb-4Sn alloy shows higher open circuit potential, compared to titanium metal and NiTi alloy. The higher open circuit potential results in an increase in the thickness of the passive film formed on the alloy. The passive film on the Ti-18Nb-4Sn alloy is rich in niobium as well as tin due to preferential dissolution of titanium. The degree of enrichment of niobium and tin in the film increases with an increase in immersion time. On the other hand, the passive film on the NiTi alloy consists exclusively of titanium. The angle-resolved XPS analysis reveals that the outer part of the passive film on the Ti-18Nb-4Sn alloy is rich in niobium and deficient in titanium. Furthermore, the passive film on the Ti-18Nb-4Sn alloy is composed of a double oxyhydroxide containing titanium, niobium and tin cations. It can, therefore, be said that the formation of the thick and homogeneous double oxyhydroxide film whose outer part is rich in niobium seems responsible for the excellent corrosion resistance of the Ti-18Nb-4Sn alloy.
C1 Tohoku Univ, Inst Mat Res, Oarai Branch, Oarai, Ibaraki 3111313, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Kawashima, A (reprint author), Tohoku Univ, Inst Mat Res, Oarai Branch, Oarai, Ibaraki 3111313, Japan.
CR AKIYAMA E, 1994, MAT SCI ENG A-STRUCT, V181, P1128, DOI 10.1016/0921-5093(94)90816-8
   ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   ASAMI K, 1990, CORROS SCI, V31, P727, DOI 10.1016/0010-938X(90)90188-B
   ASAMI K, 1993, CORROS SCI, V35, P43, DOI 10.1016/0010-938X(93)90131-Y
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   BLACKWOOD DJ, 1989, ELECTROCHIM ACTA, V34, P875, DOI 10.1016/0013-4686(89)87123-3
   Castleman L.S., 1981, CRC SERIES BIOCOMPAT
   HIROTA E, 1991, CORROS SCI, V32, P1213, DOI 10.1016/0010-938X(91)90133-A
   International Agency for Research on Cancer, 1996, MON EV CARC RISK CHE
   KAWASHIMA A, 2002, P 15 INT CORR C
   LU S, 1990, ENG ASPECTS SHAPE ME, P445
   Melton K. N, 1990, ENG ASPECTS SHAPE ME, P21
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Okazaki Y, 1996, J JPN I MET, V60, P902, DOI 10.2320/jinstmet1952.60.9_902
   Oshida Y, 1990, MATER SCI FORUM, V56, P705
   SARKAR NK, 1983, J ORAL REHABIL, V10, P121, DOI 10.1111/j.1365-2842.1983.tb00106.x
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Tsunekawa S, 2002, APPL SURF SCI, V201, P69, DOI 10.1016/S0169-4332(02)00516-0
   Yamamoto A, 1999, J BIOMED MATER RES, V47, P396, DOI 10.1002/(SICI)1097-4636(19991205)47:3<396::AID-JBM15>3.0.CO;2-R
NR 23
TC 14
Z9 15
U1 0
U2 5
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2003
VL 44
IS 7
BP 1405
EP 1411
DI 10.2320/matertrans.44.1405
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 707UR
UT WOS:000184528700032
OA Bronze
DA 2018-10-19
ER

PT J
AU VandeVondele, S
   Voros, J
   Hubbell, JA
AF VandeVondele, S
   Voros, J
   Hubbell, JA
TI RGD-Grafted poly-l-lysine-graft-(polyethylene glycol) copolymers block
   non-specific protein adsorption while promoting cell adhesion
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE biomaterials; protein adsorption; adhesion; peptide; cell adhesion
ID SURFACE MODIFICATION; SPECTROSCOPY; PLASMA; FIBRINOGEN; ATTACHMENT;
   POLYMERS
AB A novel class of surface-active copolymers is described, designed to protect surfaces from nonspecific protein adsorption while still inducing specific cell attachment and spreading. A graft copolymer was synthesized, containing poly-(L-lysine) (PLL) as the backbone and substrate binding and poly(ethylene glycol) (PEG) as protein adsorption-resistant pendant side chains. A fraction of the grafted PEG was pendantly functionalized by covalent conjugation to the peptide motif RGD to induce cell binding. The graft copolymer spontaneously adsorbs from dilute aqueous solution onto negatively charged surfaces. The performance of RGD-modified PLL-g-PEG copolymers was analyzed in protein adsorption and cell culture assays. These coatings efficiently blocked the adsorption of serum proteins to Nb2O5 and tissue culture polystyrene while specifically supporting attachment and spreading of human dermal fibroblasts. This surface functionalization technology is expected to be valuable in both the biomaterial and biosensor fields, because different signals can easily be combined, and sterilization and application are straightforward and cost-effective. (C) 2003 Wiley Periodicals, Inc.
C1 Swiss Fed Inst Technol, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
   Univ Zurich, CH-8044 Zurich, Switzerland.
   Swiss Fed Inst Technol, Surface Sci & Technol Lab, CH-8044 Zurich, Switzerland.
RP Hubbell, JA (reprint author), Swiss Fed Inst Technol, Inst Biomed Engn, Moussonstr 18, CH-8044 Zurich, Switzerland.
RI Hubbell, Jeffrey/A-9266-2008; Zhou, Feng/E-9510-2011
OI Hubbell, Jeffrey/0000-0003-0276-5456; 
CR Amanda A, 2001, BIOTECHNOL PROGR, V17, P917, DOI 10.1021/bp0100631
   Barghi N, 2000, Compend Contin Educ Dent, V21, P659
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   Elbert DL, 1998, CHEM BIOL, V5, P177, DOI 10.1016/S1074-5521(98)90062-X
   Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   Holland NB, 1998, NATURE, V392, P799
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kurrat R, 1998, COLLOID SURFACE B, V11, P187, DOI 10.1016/S0927-7765(98)00039-3
   Kurrat R, 1997, REV SCI INSTRUM, V68, P2172, DOI 10.1063/1.1148069
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Matsuda T, 1992, ASAIO J, V38, pM154, DOI 10.1097/00002480-199207000-00008
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Nikolova AN, 1998, BBA-BIOMEMBRANES, V1372, P237, DOI 10.1016/S0005-2736(98)00061-3
   Park S, 2000, J BIOMED MATER RES, V53, P568, DOI 10.1002/1097-4636(200009)53:5<568::AID-JBM17>3.0.CO;2-8
   PASCHE S, 2002, NANO7ECOSS21
   Scott MD, 1998, CURR PHARM DESIGN, V4, P423
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Wellings DA, 1997, METHOD ENZYMOL, V289, P44
   Winblade ND, 2000, BIOMACROMOLECULES, V1, P523, DOI 10.1021/bm000040v
   Zalipsky S, 1992, POLYETHYLENE GLYCOL, P347
NR 23
TC 216
Z9 219
U1 7
U2 83
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUN 30
PY 2003
VL 82
IS 7
BP 784
EP 790
DI 10.1002/bit.10625
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 679GX
UT WOS:000182913300004
PM 12701144
DA 2018-10-19
ER

PT J
AU Sanders, JE
   Cassisi, DV
   Neumann, T
   Golledge, SL
   Zachariah, SG
   Ratner, BD
   Bale, SD
AF Sanders, JE
   Cassisi, DV
   Neumann, T
   Golledge, SL
   Zachariah, SG
   Ratner, BD
   Bale, SD
TI Relative influence of polymer fiber diameter and surface charge on
   fibrous capsule thickness and vessel density for single-fiber implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE N,N-dimethylaminoethyl methacrylate; methacrylic acid;
   hexafluoropropylene; fibrous capsule; microfiber; vessel density
ID TISSUE-RESPONSE
AB Single polypropylene microfibers plasma-coated with polymers of different surface charge [N,N-dimethyl-aminoethyl methacrylate (NN) (positive charge), methacrylic acid (MA) (negative charge), and hexafluoropropylene (HF) (neutral)] were implanted in the subcutaneous dorsum of Sprague-Dawley rats for 5-week intervals. Thee groups of fiber diameters were used: (I) 1.0 to 5.9 mum; (II) 6.0 to 10.9 mum; and (III) 11.0 to 15.9 mum. Fibrous capsule thickness and blood-vessel density (number of vessels within 100 mum of the fiber) were assessed in tissue sections in the planes of microfiber cross-sections. Results from a multifactorial analysis of variance demonstrated statistically significant main effects (p < 0.05) for microfiber diameter but not for surface-charge coating. The mean differences in capsule thickness among the microfiber diameter groups were: between groups II and I: 5.4 mum; between groups III and I: 10.2 mum; and between groups III and II: 4.7 mum. The mean differences in capsule thickness among surface-charge coatings were: between MA and NN: 0.7 mum; between MA and HE 1.4 mum; and between NN and HF 0.7 mum. Many of the 1.0 to 5.9 mum-in-diameter fibers had no capsule and no sign of a foreign-body reaction. For the vessel density analysis, neither microfiber diameter nor surface-charge coating had a statistically significant effect. Thus the geometric feature of microfiber diameter was more important than was surface charge relative to fibrous capsule formation but not relative to local vessel density. This ranking of the relative influence of design features in relation to tissue response provides useful information for prioritization in biomaterial design. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Bioengn 357962, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, Dept Bioengn 357962, Seattle, WA 98195 USA.
FU NICHD NIH HHS [R01 HD038554-01, HD-38554, R01 HD038554]; NCRR NIH HHS
   [RR-01296]
CR HATTORI S, 1985, J COLLOID INTERF SCI, V104, P72, DOI 10.1016/0021-9797(85)90010-4
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Sanders JE, 2002, J BIOMED MATER RES, V62, P222, DOI 10.1002/jbm.10285
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
NR 7
TC 19
Z9 19
U1 0
U2 7
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2003
VL 65A
IS 4
BP 462
EP 467
DI 10.1002/jbm.a.10525
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 685WA
UT WOS:000183285700008
PM 12761836
DA 2018-10-19
ER

PT J
AU Silva, SN
   Pereira, MM
   Goes, AM
   Leite, MF
AF Silva, SN
   Pereira, MM
   Goes, AM
   Leite, MF
TI Effect of biphasic calcium phosphate on human macrophage functions in
   vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bioceramics; biphasic calcium phosphate; macrophage; secretion
ID HUMAN OSTEOBLASTIC CELLS; INDUCED ATP RELEASE; NITRIC-OXIDE; BIOACTIVE
   GLASS; IN-VITRO; BONE RESPONSE; HYDROXYAPATITE; CERAMICS; INDUCTION;
   ADHESION
AB Bioceramics may initiate several and complex biological reactions in host tissues. The cell-biomaterial interaction can determine macrophage activation that may elicit and sustain inflammatory response at the implant site. The current study describes some of the in vitro phenomena regarding the effect of surface reactivity of biphasic calcium phosphate (BCP) granules on human macrophages locomotion and secretion. X-ray diffraction analysis indicated that the synthesized ceramic presented 80% hydroxyapatite and 20% tricalcium phosphate. When BCP was put in contact with human macrophage cells, we observed that cells and BCP granules attached to each other. Cells attached to BCP presented a higher intracellular free Ca2+-concentration compared with nonattached neighbors and secreted calcium phosphate particles into the medium. Energy dispersive Xray analysis showed that the secreted particles presented a calcium/phosphorus ratio of 1.64 +/- 0.05, similar to hydroxyapatite. We propose that the secreted particles create a transition zone that allows further macrophage adhesion. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, BR-30160030 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Biochem & Immunol, BR-30160030 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Phys & Biophys, BR-30160030 Belo Horizonte, MG, Brazil.
RP Pereira, MM (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Rua Espirito Santo 35,Sala 206, BR-30160030 Belo Horizonte, MG, Brazil.
CR ANDERSON JM, 1998, BIOCERAMICS, V11, P13
   Benahmed M, 1996, BIOMATERIALS, V17, P2173, DOI 10.1016/0142-9612(96)00046-4
   BINDERMAN I, 1990, HDB BIOACTIVE CERAMI, V2, P45
   Bosetti M, 1999, BIOMATERIALS, V20, P363, DOI 10.1016/S0142-9612(98)00177-X
   Catelas I, 1999, BIOMATERIALS, V20, P625, DOI 10.1016/S0142-9612(98)00214-2
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DAMOULIS PD, 1994, BIOCHEM BIOPH RES CO, V201, P924, DOI 10.1006/bbrc.1994.1790
   Di AK, 2001, J BIOL CHEM, V276, P37124, DOI 10.1074/jbc.M105038200
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   DUCHEYNE P, 1992, J BIOMED MATER RES, V26, P147, DOI 10.1002/jbm.820260203
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x
   Foglieni C, 2001, HISTOCHEM CELL BIOL, V115, P223
   Gauthier O, 1999, BONE, V25, p71S, DOI 10.1016/S8756-3282(99)00137-4
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Hayakawa T, 2002, BIOMATERIALS, V23, P1025, DOI 10.1016/S0142-9612(01)00214-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Higashi S, 1998, Dent Mater J, V17, P186
   HYAKUNA K, 1989, J BIOMED MATER RES, V23, P1049, DOI 10.1002/jbm.820230906
   Ishikawa K, 2002, BIOMATERIALS, V23, P423, DOI 10.1016/S0142-9612(01)00121-1
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LEGEROS RZ, 1992, BONE BONDING BIOMATE, P201
   Liu HS, 1997, CERAM INT, V23, P19, DOI 10.1016/0272-8842(95)00135-2
   Mancini L, 2000, BIOCHEM BIOPH RES CO, V274, P477, DOI 10.1006/bbrc.2000.3164
   NEBE B, 1995, EXP CELL RES, V218, P479, DOI 10.1006/excr.1995.1181
   Oliveira DM, 1998, NITRIC OXIDE-BIOL CH, V2, P57, DOI 10.1006/niox.1997.0164
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   RICCI JL, 1992, J ORAL MAXIL SURG, V50, P969, DOI 10.1016/0278-2391(92)90058-8
   Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124
   Sabirov RZ, 2001, J GEN PHYSIOL, V118, P251, DOI 10.1085/jgp.118.3.251
   Schlosser SF, 1996, P NATL ACAD SCI USA, V93, P9948, DOI 10.1073/pnas.93.18.9948
   Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200
   van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 35
TC 21
Z9 22
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN 15
PY 2003
VL 65A
IS 4
BP 475
EP 481
DI 10.1002/jbm.a.10544
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 685WA
UT WOS:000183285700010
PM 12761838
DA 2018-10-19
ER

PT J
AU Chiba, A
   Kimura, S
   Raghukandan, K
   Morizono, Y
AF Chiba, A
   Kimura, S
   Raghukandan, K
   Morizono, Y
TI Effect of alumina addition on hydroxyapatite biocomposites fabricated by
   underwater-shock compaction
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT Symposium on High-Speed Plastic Deformation
CY JAN 09-11, 2002
CL HIROSHIMA, JAPAN
DE hydroxyapatite; alumina; biomaterial; shock compaction; underwater-shock
   wave
ID MECHANICAL-PROPERTIES; SINTERED HYDROXYAPATITE; COMPOSITES
AB Hydroxyapatite [HAp; Ca-10(PO4)(6)(OH)(2)] biocomposites are ceramic materials that exhibit excellent bioactivity, but their inherent low fracture strength and toughness render them unusable for practical applications. Alumina (Al2O3) is added to improve in mechanical properties without diminution of biocompatibility. Powder mixtures of HAp and Al2O3 in various volume ratios (90:10, 80:20, and 70:30) were compacted by underwater shock waves generated by explosives. High explosives of 6900 m s(-1) detonation velocity served as the energy generators. The compacts were sintered at 1473, 1573, and 1673 K in order to investigate the influence of sintering temperature. All compacts were found to be free of defects and to have undergone continuous compositional changes to a tricalcium phosphate and tetracalcium phosphate. K-1c showed maximum value with HAp-30vol.% Al2O3 that have been sintered at 1673 K for 7.2 ks, and the value of 3.0 MPa m(-1/2) is 2.5 times that of HAp monolithic material. The results of optical microscopy, scanning electron microscopy, X-ray diffraction, and other analyses are reported. (C) 2002 Published by Elsevier Science B.V.
C1 Kumamoto Univ, Fac Engn, Kumamoto 8608555, Japan.
RP Chiba, A (reprint author), Kumamoto Univ, Fac Engn, 2-39-1 Kurokami, Kumamoto 8608555, Japan.
EM chiba@gpo.kumamoto-u.ac.jp
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF00552220
   CHIBA A, 1992, SHOCK WAVE HIGH STRA, P415
   CHIBA A, 1998, SHOCK WAVES, P1225
   DEWITH G, 1981, J MATER SCI, V16, P1592
   HAMANO K, 1984, FINE CERAMICS HDB, P410
   JUANG HY, 1994, MAT SCI ENG C-BIO S, V2, P77
   Kikuchi M, 2000, J CERAM SOC JPN, V108, P642, DOI 10.2109/jcersj.108.1259_642
   KIM HM, 2001, J CERAM SOC JPN, V199, pS49
   KRAJEWSKI A, 1981, BIOMATERIALS, V2, P105, DOI 10.1016/0142-9612(81)90007-7
   MATSUMOTO H, 1988, J JPN I MET, V52, P810, DOI 10.2320/jinstmet1952.52.8_810
   Metsger DS, 1999, J MATER SCI-MATER M, V10, P9, DOI 10.1023/A:1008883809160
   NOMA T, 1993, NIPPON SERAM KYO GAK, V101, P923
   Suchanek W, 1997, J AM CERAM SOC, V80, P2805, DOI 10.1111/j.1151-2916.1997.tb03197.x
   TOMOSHIGE R, 1992, NIPPON SERAM KYO GAK, V100, P1230
   ZHOU JM, 1993, J MATER SCI-MATER M, V4, P83, DOI 10.1007/BF00122983
NR 15
TC 41
Z9 41
U1 1
U2 1
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JUN 15
PY 2003
VL 350
IS 1-2
BP 179
EP 183
AR PII S0921-5093(02)00718-9
DI 10.1016/S0921-5093(02)00718-9
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 678BK
UT WOS:000182845000031
DA 2018-10-19
ER

PT J
AU Yamauchi, K
   Hojo, H
   Yamamoto, Y
   Tanabe, T
AF Yamauchi, K
   Hojo, H
   Yamamoto, Y
   Tanabe, T
TI Enhanced cell adhesion on RGDS-carrying keratin film
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE keratin; RGDS; cell adhesion; cell substrate; biomaterial; modification
ID CULTIVATION; PEPTIDES
AB Keratin, which was extracted from wool as a reduced form, was subjected to modification with cell adhesion peptide, Arg-Gly-Asp-Ser (RGDS), at free cysteine residues. L929 mouse fibroblast cells were cultured on micro cover glasses coated with various amounts of keratin or RGDS-carrying keratin. One hour after cell inoculation, more cells adhered on RGDS-carrying keratin-coated surface than on a plain glass or untreated keratin-coated glass surfaces. The cell number adhered on RGDS-carrying keratin-coated surface increased with an increasing amount of coated proteins, while that on keratin-coated glass was unaffected by the amount of coated proteins. Significant number of cells with spindle-shape morphology was observed on RGDS-carrying keratin-coated surface, while the cells on a plain glass or keratin-coated glass surfaces had round morphology. Upon cultivation for 24 h, the cells on RGDS-carrying keratin-coated glass proliferated well to reach confluence, while cells on keratin-coated or untreated glasses remained sparse. Thus, RGDS-carrying keratin was found to be a good substrate for mammalian cells because of their high cell adhesive property. And keratin was demonstrated to be potential biomaterials applicable to versatile purposes by introducing modifications to abundantly present cysteine residues. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Osaka City Univ, Dept Bioappl Chem, Grad Sch Engn, Sumiyoshi Ku, Osaka 5588585, Japan.
RP Yamauchi, K (reprint author), Osaka City Univ, Dept Bioappl Chem, Grad Sch Engn, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.
CR KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6
   KONIG W, 1970, CHEM BER-RECL, V103, P788, DOI 10.1002/cber.19701030319
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   SCHNAAR RL, 1978, J BIOL CHEM, V253, P7940
   STEWART JM, 1984, SOLID PHASE PEPTIDE, P76
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
NR 8
TC 33
Z9 37
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JUN 10
PY 2003
VL 23
IS 4
BP 467
EP 472
DI 10.1016/S0928-4931(02)00280-1
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 696ZU
UT WOS:000183918400001
DA 2018-10-19
ER

PT J
AU Fallahi, D
   Mirzadeh, H
   Khorasani, MT
AF Fallahi, D
   Mirzadeh, H
   Khorasani, MT
TI Physical, mechanical, and biocompatibility evaluation of three different
   types of silicone rubber
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE blends; silicones; poly(acrylamide); hydrophilicity; biocompatibility
ID ENTANGLEMENT SPACING VARIABILITY; INDUCED GRAFT-POLYMERIZATION;
   LASER-SURFACE MODIFICATION; IN-VITRO; POLYETHYLENE TEREPHTHALATE;
   HYDROGEL COMPOSITES; POLYMERS; BIOMATERIALS; POLYSTYRENES; ACRYLAMIDE
AB Silicone rubber as a valuable biomaterial is widely used in medical applications, but its surface properties and low wettability make serious problems in long-term implants. This work was undertaken to evaluate the biocompatibility of modified silicone rubber using two different techniques. A blend of poly(acrylamide) and silicone rubber was compared with virgin silicone surfaces as well as with those modified by laser treatment. Physical and mechanical properties of the samples were examined using different techniques. The hydrophilicity of the silicone rubber increased with increasing hydrogel content and decreased as a result of laser treatment. Both fibroblast cell (L929) and platelet behavior in contact with these surfaces were evaluated in vitro. The morphology of fibroblast cells that adhered to the blends was similar to the control. In contrast, on the laser-treated surfaces fibroblast cells showed different proliferation. On the other hand, fewer platelets adhered to the laser-treated surface than adhered to the blend and the unmodified PDMS surfaces. (C) 2003 Wiley Periodicals, Inc.
C1 IPI, Polymer Biomat Dept, Tehran, Iran.
RP Mirzadeh, H (reprint author), IPI, Polymer Biomat Dept, POB 14965-115, Tehran, Iran.
CR Cherrys B, 1981, POLYM SURFACES, P161
   CIFKOVA I, 1990, BIOMATERIALS, V11, P393, DOI 10.1016/0142-9612(90)90093-6
   Dadsetan M, 2001, J BIOMED MATER RES, V57, P183, DOI 10.1002/1097-4636(200111)57:2<183::AID-JBM1157>3.0.CO;2-M
   Dadsetan M, 2000, IRAN POLYM J, V9, P203
   DARVISHI M, 1998, IRAN J POLYM SCI TEC, V11, P155
   DOLEZEL B, 1989, BIOMATERIALS, V10, P387, DOI 10.1016/0142-9612(89)90130-0
   FALENDER JR, 1976, POLYM ENG SCI, V16, P54, DOI 10.1002/pen.760160109
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   HORN P, 1997, BIOMATERIALS, V18, P1069
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   IWATA H, 1993, J APPL POLYM SCI, V49, P1041, DOI 10.1002/app.1993.070490610
   Kamijo Y, 1996, POLYM J, V28, P309, DOI 10.1295/polymj.28.309
   KAWAGUSHI H, 1998, POLYM J, V20, P903
   KHORASANI M, 1996, SURFACE MODIFICATION, P499
   Khorasani MT, 1996, RADIAT PHYS CHEM, V47, P881, DOI 10.1016/0969-806X(95)00166-U
   LEE SD, 1994, J APPL POLYM SCI, V54, P1279, DOI 10.1002/app.1994.070540909
   LISS B, 1972, POLYM PREPRINT, V13, P390
   LOPOUR P, 1990, BIOMATERIALS, V11, P397, DOI 10.1016/0142-9612(90)90094-7
   Mirzadeh H, 1998, IRAN POLYM J, V7, P5
   Mirzadeh H., 1994, Clinical Materials, V16, P177, DOI 10.1016/0267-6605(94)90115-5
   OKADA T, 1991, MAKROMOL CHEM, V192, P1705
   POLMANTEER KE, 1988, RUBBER CHEM TECHNOL, V61, P470, DOI 10.5254/1.3536197
   POLYZOIS GL, 1991, BIOMATERIALS, V12, P79, DOI 10.1016/0142-9612(91)90137-Y
   POTTER DK, 1992, MACROMOLECULES, V25, P238, DOI 10.1021/ma00027a040
   POTTER DK, 1991, MACROMOLECULES, V24, P213, DOI 10.1021/ma00001a034
   QUINN KJ, 1988, BRIT POLYM J, V20, P25, DOI 10.1002/pi.4980200106
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   SELDON HL, 1994, BIOMATERIALS, V15, P1161, DOI 10.1016/0142-9612(94)90237-2
   VONDRACEK P, 1984, BIOMATERIALS, V5, P209, DOI 10.1016/0142-9612(84)90017-6
NR 30
TC 28
Z9 28
U1 3
U2 18
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 6
PY 2003
VL 88
IS 10
BP 2522
EP 2529
DI 10.1002/app.11952
PG 8
WC Polymer Science
SC Polymer Science
GA 660ZF
UT WOS:000181865400021
DA 2018-10-19
ER

PT J
AU Lutolf, MP
   Raeber, GP
   Zisch, AH
   Tirelli, N
   Hubbell, JA
AF Lutolf, MP
   Raeber, GP
   Zisch, AH
   Tirelli, N
   Hubbell, JA
TI Cell-responsive synthetic hydrogels
SO ADVANCED MATERIALS
LA English
DT Article
ID MIGRATION; MATRIX; BIOMATERIALS; ANGIOGENESIS; PROTEOLYSIS; POLYMERS;
   PEPTIDES; DELIVERY; ADHESIVE; RELEASE
AB Synthetic biomaterial matrices have been formed in the presence of cells by a Michael-type addition reaction between a difunctional protease substrate peptide, a monofunctional cell adhesion peptide, and a tetrafunctional poly(ethylene glycol). These materials locally degrade in response to cell-surface proteases, allowing cells to create paths for 3D cell migration (see Figure).
C1 Swiss Fed Inst Technol ETHZ, Inst Biomed Engn, CH-8044 Zurich, Switzerland.
   Swiss Fed Inst Technol ETHZ, Dept Mat Sci, CH-8044 Zurich, Switzerland.
   Univ Zurich, CH-8044 Zurich, Switzerland.
RP Hubbell, JA (reprint author), Swiss Fed Inst Technol ETHZ, Inst Biomed Engn, Moussonstr 18, CH-8044 Zurich, Switzerland.
RI Lutolf, Matthias/E-5914-2010; Hubbell, Jeffrey/A-9266-2008; Tirelli,
   Nicola/P-3604-2018; Tirelli, Nicola/P-7210-2014
OI Hubbell, Jeffrey/0000-0003-0276-5456; Tirelli,
   Nicola/0000-0002-4879-3949; Tirelli, Nicola/0000-0002-4879-3949
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
   BRANNONPEPPAS L, 1989, J CONTROL RELEASE, V8, P267, DOI 10.1016/0168-3659(89)90048-5
   BROWNLEE M, 1979, SCIENCE, V206, P1190, DOI 10.1126/science.505005
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Freedman SB, 2002, ANN INTERN MED, V136, P54, DOI 10.7326/0003-4819-136-1-200201010-00011
   FRIEDMAN M, 1965, J AM CHEM SOC, V87, P3672, DOI 10.1021/ja01094a025
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Han YP, 2001, J CELL SCI, V114, P131
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Kataoka K, 1998, J AM CHEM SOC, V120, P12694, DOI 10.1021/ja982975d
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   LUTOLF MP, 2003, IN PRESS NAT BIOTECH
   LUTOLF MP, 2003, IN PRESS BIOMACROMOL
   LUTOLF MP, 2003, IN PRESS P NATL ACAD
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   MOGHADDAM MJ, 1993, J POLYM SCI POL CHEM, V31, P1589, DOI 10.1002/pola.1993.080310629
   Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8
   Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Woessner J.F., 2000, MATRIX METALLOPROTEI
   YEH PY, 1995, MACROMOL CHEM PHYS, V196, P2183, DOI 10.1002/macp.1995.021960709
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
NR 37
TC 344
Z9 350
U1 10
U2 125
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD JUN 5
PY 2003
VL 15
IS 11
BP 888
EP +
DI 10.1002/adma.200304621
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 693GF
UT WOS:000183708200004
DA 2018-10-19
ER

PT J
AU Stary, V
   Bacakova, L
   Hornik, J
   Chmelik, V
AF Stary, V
   Bacakova, L
   Hornik, J
   Chmelik, V
TI Bio-compatibility of the surface layer of pyrolytic graphite
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on Thin Films
CY SEP 15-20, 2002
CL BRATISLAVA, SLOVAKIA
DE biomaterial surface; pyrolytic graphite; carbon-carbon composites
ID SMOOTH-MUSCLE CELLS; CARBON COMPOSITES; ADHESION
AB Carbon materials are generally well tolerated by animal cells, so biomaterials of this type have come into routine use for constructing medical implants. The formation of surface layer makes them attractive for coating implants, e.g. in orthopaedic and dental surgery. The system biocompatibility is controlled mainly by its surface properties. The chemical state of the surface is given mainly by the material and by the method of surface preparation. On the other hand, biocompatibility can be improved by a suitable change of the surface morphology, e.g. by influencing the surface roughness. We prepared a surface coating of carbon fibre reinforced carbon composite using a layer of pyrolytic graphite and we used grinding and polishing of the layer for roughness control. The purpose of this article is to define the surface and surface roughness of carbon fibre reinforced carbon composite with and without a pyrolytic graphite layer and after defined surface treatment, and to correlate the results with several parameters of tissue cell growth. The main result of this work shows that, using the proper characterisation of the surface parameters, there is a statistically significant correlation with biocompatibility, especially, with adhesion and proliferation of cells. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Czech Tech Univ, Fac Mech Engn, Prague, Czech Republic.
   Acad Sci Czech Republic, Inst Physiol, Prague 14120 4, Czech Republic.
RP Stary, V (reprint author), Czech Tech Univ, Fac Mech Engn, Karlovo Nam 13, Prague, Czech Republic.
EM stary@fsik.cvut.cz
RI Bacakova, Lucie/C-2664-2012
OI Bacakova, Lucie/0000-0002-1818-9484
CR Bacakova L, 1996, BIOMATERIALS, V17, P1121
   Bacakova L, 2001, J BIOMED MATER RES, V54, P567
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   Bosdorf K, 1995, BIOMED TECH, V40, P356, DOI 10.1515/bmte.1995.40.12.356
   Dobiasova L, 1999, CARBON, V37, P421, DOI 10.1016/S0008-6223(98)00207-3
   FITZER E, 1987, CARBON, V25, P163, DOI 10.1016/0008-6223(87)90116-3
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Pesakova V, 1992, Acta Chir Orthop Traumatol Cech, V59, P302
   Pesakova V, 2000, J MATER SCI-MATER M, V11, P793, DOI 10.1023/A:1008953529111
   Silver FH., 1994, BIOMATERIALS MED DEV
   Thomas C. R., 1993, ESSENTIALS CARBON CA, P1
   Whitehouse D.J., 1994, HDB SURFACE METROLOG
NR 12
TC 43
Z9 45
U1 5
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD JUN 2
PY 2003
VL 433
IS 1-2
BP 191
EP 198
AR PII S0040-6090(03)00309-2
DI 10.1016/S0040-6090(03)00309-2
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 693KN
UT WOS:000183716900035
DA 2018-10-19
ER

PT J
AU Itescu, S
   John, R
AF Itescu, S
   John, R
TI Interactions between the recipient immune system and the left
   ventricular assist device surface: immunological and clinical
   implications
SO ANNALS OF THORACIC SURGERY
LA English
DT Article; Proceedings Paper
CT Heart Failure and Circulatory Support Summit
CY AUG 22-25, 2002
CL CLEVELAND, OHIO
SP Soc Thorac Surgeons, Cleveland Clin Fdn
ID ACTIVATION-INDUCED APOPTOSIS; T-CELL HYBRIDOMAS; INTRAVENOUS
   IMMUNOGLOBULIN; LUPUS-ERYTHEMATOSUS; HEART-TRANSPLANTATION;
   ALLOGRAFT-REJECTION; FAS CD95; IVIG; CYCLOPHOSPHAMIDE; AUTOANTIBODIES
AB The unquestionable clinical success of left ventricular assist device (LVAD) implantation has, nevertheless, been accompanied by complications arising from interactions between the implanted biomaterial and the host immune system. The aberrant state of monocyte and T-cell activation resulting from these host/device interactions is accompanied by two parallel processes: (1) selective loss of Th1 cytokine producing CD4 T-cells through activation-induced cell death; and (2) unopposed activation of Th2 cytokine producing CM T-cells resulting in B-cell hyperreactivity and dysregulated immunoglobulin synthesis through Th2 cytokines and heightened CD40 ligand-CD40 interactions. The net results of these events is that, on the one hand, the LVAD recipient develops progressive defects in cellular immunity and is at increased risk of serious infection, and, on the other hand, is more likely to develop allosensitization, posing a significant risk to successful transplant outcome. Intravenous immunoglobulin therapy is an effective and safe modality for sensitized LVAD recipients awaiting cardiac transplantation, reducing serum anti-human lymphoicyte antigen (HLA) alloreactivity and shortening the duration to transplantation. The therapeutic and safety profile of intravenous immunoglobulin would appear to be superior to plasmapheresis. Immunosuppression incorporating intravenous cyclophosphamide before and after transplantation is safe and highly effective in sensitized LVAD recipients of cardiac transplantation. When used after transplantation as part of triple immunosuppressive regimens, cyclophosphamide is superior to mycophenolate mofetil in reducing episodes of allograft rejection in these patients. Because these immune dysfunctions appear to be related to the effects of excessive biomaterial-associated T-cell activation, future efforts will need to be directed at either altering the physical properties of the materials interacting with the host circulation or pharmacological intervention aimed more selectively at inhibiting T-cell activation. (C) 2003 by The Society of Thoracic Surgeons.
C1 Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA.
RP Itescu, S (reprint author), Columbia Univ Coll Phys & Surg, Dept Surg, 622 W 168th St,P&S 14-402, New York, NY 10032 USA.
CR BACH JF, 1997, LANCET, V350, P11
   BLASCZYK R, 1993, LANCET, V341, P789, DOI 10.1016/0140-6736(93)90563-V
   BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0
   Brunner T, 1996, INT IMMUNOL, V8, P1017, DOI 10.1093/intimm/8.7.1017
   CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624
   Casiano CA, 1996, J EXP MED, V184, P765, DOI 10.1084/jem.184.2.765
   Ciubotariu R, 1998, J CLIN INVEST, V101, P398, DOI 10.1172/JCI1117
   DASSE KA, 1987, T AM SOC ART INT ORG, V33, P418
   DeMarco T, 1997, J HEART LUNG TRANSPL, V16, P360
   DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0
   Didisheim P, 1994, ASAIO J, V40, P230, DOI 10.1097/00002480-199404000-00020
   DIETRICH G, 1992, BLOOD, V79, P2946
   DWYER JM, 1992, NEW ENGL J MED, V326, P107
   FRAZIER OH, 1992, ANN THORAC SURG, V53, P1080, DOI 10.1016/0003-4975(92)90393-I
   Funauchi M, 1998, SCAND J RHEUMATOL, V27, P219
   GLOTZ D, 1993, TRANSPLANTATION, V56, P335, DOI 10.1097/00007890-199308000-00015
   HOGNES JR, 1991, ARTIFICIAL HEART PRO, P1
   Horwitz DA, 1998, ARTHRITIS RHEUM, V41, P838, DOI 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S
   Hurez V, 1994, Ther Immunol, V1, P269
   Itescu S, 1998, CIRCULATION, V98, P786, DOI 10.1161/01.CIR.98.8.786
   Itescu S, 2002, CIRCULATION, V105, P1214, DOI 10.1161/hc1002.105128
   John R, 1999, CIRCULATION, V100, P229
   JOYSEY VC, 1993, BRIT J BIOMED SCI, V50, P272
   JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0
   LAM L, 1993, LANCET, V342, P678, DOI 10.1016/0140-6736(93)91784-J
   Ledru E, 1998, J IMMUNOL, V160, P3194
   LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0
   Liu ZR, 1996, J CLIN INVEST, V98, P1150, DOI 10.1172/JCI118898
   MAMULA MJ, 1993, IMMUNOL TODAY, V14, P151, DOI 10.1016/0167-5699(93)90274-O
   MCCARTHY PM, 1991, J THORAC CARDIOV SUR, V102, P578
   McIntyre JA, 1996, TRANSPLANTATION, V62, P691, DOI 10.1097/00007890-199609150-00027
   MENCONI MJ, 1992, J CARDIAC SURG, V7, P177, DOI 10.1111/j.1540-8191.1992.tb00794.x
   Oz MC, 1997, CIRCULATION, V95, P1844
   Peraldi MN, 1996, TRANSPLANTATION, V62, P1670, DOI 10.1097/00007890-199612150-00024
   RATKOVEC RM, 1992, TRANSPLANTATION, V54, P651, DOI 10.1097/00007890-199210000-00017
   REED EF, 1996, TRANSPLANTATION, V61, P556
   ROSE EA, 1994, CIRCULATION, V50, P1187
   ROSSI F, 1989, J IMMUNOL, V143, P4104
   Smith J D, 1993, Transpl Immunol, V1, P60, DOI 10.1016/0966-3274(93)90060-L
   Spanier T, 1996, J THORAC CARDIOV SUR, V112, P1090, DOI 10.1016/S0022-5223(96)70111-3
   SPANIER TB, 1996, CIRCULATION S8, V94, P170
   SPANIER TB, 1997, J HEART LUNG TRANSPL, V17, P80
   Tugulea S, 1997, TRANSPLANTATION, V64, P842, DOI 10.1097/00007890-199709270-00009
   TYAN DB, 1994, TRANSPLANTATION, V57, P553
   *US DEP HHS, 1990, ANN REP US SCI REG O
   Vanderlugt CJ, 1996, CURR OPIN IMMUNOL, V8, P831, DOI 10.1016/S0952-7915(96)80012-4
   VASSILEV T, 1993, CLIN EXP IMMUNOL, V92, P369
   WAGNER WR, 1993, CIRCULATION, V88, P2023, DOI 10.1161/01.CIR.88.5.2023
NR 48
TC 50
Z9 51
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD JUN
PY 2003
VL 75
IS 6
SU S
BP S58
EP S65
AR PII S0003-4975(03)00480-6
DI 10.1016/S0003-4975(03)00480-6
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 687XR
UT WOS:000183402700010
PM 12820736
DA 2018-10-19
ER

PT J
AU James, NR
   Jayakrishnan, JA
AF James, NR
   Jayakrishnan, JA
TI Surface thiocyanation of plasticized poly(vinyl chloride) and its effect
   on bacterial adhesion
SO BIOMATERIALS
LA English
DT Article
DE poly(vinyl chloride); bacterial adhesion and retention; surface
   modification; phase transfer catalysis; thiocyanation; S. epidermidis;
   S. aureus
ID BIOMATERIAL SURFACES; ESCHERICHIA-COLI; INFECTIONS; PREVENTION;
   ADHERENCE
AB Thiocyanates, especially bis-alkylthiocyanates are highly effective in killing a number of bacterial strains and are reported to be potent biocides at ppm concentrations. In order to examine whether a covalently bound and immobilized thiocyanate group on a biomaterial surface is still effective as a bactericide, plasticized poly(vinyl chloride) (PVC) was thiocyanated using sodium thiocyanate in the presence of a phase transfer catalyst in aqueous media leading to the nucleophilic substitution of chlorine by thiocyanate on the PVC surface. Thiocyanation imparted hydrophilicity to the surface in comparison with bare PVC. Control and thiocyanated PVC surfaces were exposed to two strains of bacteria commonly implicated in device-associated infections, such as Staphylococcus aureus and Staphylococcus epidermidis. Bacterial adhesion and colonization was quantitated by counting the viable organisms on the adhered surface as well as by optical and scanning electron microscopy. Significantly reduced retention of S. epidermidis and S. aureus was seen on the thiocyanated PVC surface. Immobilized thiocyanate was non-cytotoxic in a preliminary cell culture assay. The study thus showed that even though an immobilized thiocyanate moiety on the polymer surface was not as effective as a bactericide unlike soluble thiocyanates, it prevented the retention and colonization of the bacteria to a considerable extent. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Div Polymer Chem, Trivandrum 695012, Kerala, India.
RP Jayakrishnan, JA (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Div Polymer Chem, Satelmond Palace Campus,Biomed Technol Wing, Trivandrum 695012, Kerala, India.
OI Athipettah, Jayakrishnan/0000-0003-2738-6161
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An Yuehuei H., 1996, P19
   BISNO AL, 1989, INFECT ASS INDWELLIN
   BRONSEMA DA, 1993, J UROLOGY, V150, P414, DOI 10.1016/S0022-5347(17)35497-6
   Craven D E, 1990, Semin Respir Infect, V5, P157
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dunkirk S G, 1991, J Biomater Appl, V6, P131, DOI 10.1177/088532829100600203
   FRIEND PL, 1980, DEV IND MICROBIOL, V21, P123
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   IKEDA T, 1991, HIGH PERFORMANCE BIO, P743
   ISO 10993-5, 1999, 109935 ISO
   Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   LAKSHMI S, 2002, J BIOMED MATER RES, V62, P26
   MARSHALL VME, 1980, J GEN MICROBIOL, V120, P513
   MICKELSON MN, 1979, APPL ENVIRON MICROB, V38, P821
   MODI S, 1991, BIOCHIM BIOPHYS ACTA, V1080, P45, DOI 10.1016/0167-4838(91)90110-L
   NISHIKUBO T, 1997, ACS SYM SER, V659, P215
   OKAWARA M, 1985, ACS SYM SER, V121, P45
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Park JH, 2002, BIOMATERIALS, V23, P3991, DOI 10.1016/S0142-9612(02)00144-8
   ROSSMOORE HW, 1983, DISINFECTION STERILI, P271
   Stamm WE, 1991, AM J MED S3B, V91, P65
   STICKLER DJ, 1995, CELL MATER, V5, P167
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639
   Zdanowski Z, 1997, J BIOMAT SCI-POLYM E, V8, P825, DOI 10.1163/156856297X00029
NR 26
TC 47
Z9 51
U1 2
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2003
VL 24
IS 13
BP 2205
EP 2212
DI 10.1016/S0142-9612(03)00022-X
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 668FV
UT WOS:000182280400009
PM 12699656
DA 2018-10-19
ER

PT J
AU Young, TH
   Hsu, JP
   Nien, TW
AF Young, TH
   Hsu, JP
   Nien, TW
TI Kinetic modelling of blood glucose variation in a bioartificial pancreas
SO BIOMATERIALS
LA English
DT Article
DE bioartificial pancreas; performance of biomaterials; kinetic model
ID ALCOHOL HYDROGEL TUBE; ISLETS; CYTOKINES; CELLS
AB Methods are presented for assessing the performance of biomaterials for a bioartificial pancreas using a kinetic model of blood glucose variation. The model is composed of simultaneous differential equations that simulate variation of blood glucose concentration of rats outside the biomaterial and decrease of islet number inside the biomaterial. The resulting calculations agree well with the in vivo experimental data and indicate that the characteristics of bioartificial pancreas can be expressed as the actually working number of islets from the viewpoint of rats, regardless of the functioning of the bioartificial pancreas. The contributions of the capability of a biomaterial permeable to insulin and against immune rejection, and other factors that may induce cell death were involved in the actually working number of islets, i.e., the model used a lumped-parameter expression for assessment of the performance of biomaterials for a bioartificial pancreas. This model would be useful as a research tool for analysis of clinical investigation of bioartificial pancreas and physiological significance of blood glucose Variation dynamics. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10016, Taiwan.
   Natl Taiwan Univ, Coll Engn, Taipei 10016, Taiwan.
   Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10016, Taiwan.
CR ALTMAN JJ, 1986, DIABETES, V35, P625, DOI 10.2337/diabetes.35.6.625
   Aung T, 1993, ASAIO J, V39, P93, DOI 10.1097/00002480-199304000-00004
   AUNG T, 1995, TRANSPLANT P, V27, P619
   BERGEN JF, 1978, ARTIF ORGANS, V172, P144
   Delaney CA, 1997, ENDOCRINOLOGY, V138, P2610, DOI 10.1210/en.138.6.2610
   JAFFRIN MY, 1988, J BIOMECH ENG-T ASME, V110, P1, DOI 10.1115/1.3108400
   KRAEGEN EW, 1981, HORM METAB RES, V13, P365, DOI 10.1055/s-2007-1019271
   LACY PE, 1991, SCIENCE, V254, P1782, DOI 10.1126/science.1763328
   LANZA RP, 1994, TRANSPLANTATION, V57, P1371, DOI 10.1097/00007890-199405150-00015
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   REACH G, 1990, COMPUT METH PROG BIO, V32, P277, DOI 10.1016/0169-2607(90)90110-U
   SORENSEN JT, 1982, DIABETES CARE, V5, P148, DOI 10.2337/diacare.5.3.148
   SuarezPinzon WL, 1996, ENDOCRINOLOGY, V137, P5290, DOI 10.1210/en.137.12.5290
   SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124
   Young TH, 1998, J BIOMED MATER RES, V40, P385, DOI 10.1002/(SICI)1097-4636(19980605)40:3<385::AID-JBM7>3.0.CO;2-B
   YOUNG TH, 1996, BIOMATERIALS, V17, P2131
   YOUNG TH, 2002, BIOMATERIALS, V23, P3301
NR 17
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2003
VL 24
IS 13
BP 2251
EP 2256
DI 10.1016/S0142-9612(03)00032-2
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 668FV
UT WOS:000182280400014
PM 12699661
DA 2018-10-19
ER

PT J
AU Khor, E
   Lim, LY
AF Khor, E
   Lim, LY
TI Implantable applications of chitin and chitosan
SO BIOMATERIALS
LA English
DT Article
DE chitin; chitosan; implants; biomedical applications; dental materials;
   bone substitute materials; wound healing; tissue engineering; drug
   delivery
ID CALCIUM-PHOSPHATE CEMENTS; DRUG-RELEASE BEHAVIOR; IN-VITRO; COMPOSITE
   SCAFFOLDS; PHOTOCROSSLINKABLE CHITOSAN; PHOSPHORYLATED CHITOSAN;
   HISTOLOGICAL-EVALUATION; BLOOD COMPATIBILITY; PHYSICAL-PROPERTIES;
   ENDOTHELIAL-CELLS
AB Chitin, extracted primarily from shellfish sources, is a unique biopolymer based on the N-acetyl-glucosamine monomer. More than 40 years have lapsed since this biopolymer had aroused the interest of the scientific community around the world for its potential biomedical applications. Chitin, together with its variants, especially its deacetylated counterpart chitosan, has been shown to be useful as a wound dressing material, drug delivery vehicle and increasingly a candidate for tissue engineering. The promise for this biomaterial is vast and will continue to increase as the chemistry to extend its capabilities and new biomedical applications are investigated. It is interesting to note that a majority of this work has come from Asia. Japan has been the undisputed leader, but other Asian nations, namely Korea, Singapore, Taiwan and Thailand have also. made notable contributions. More recently, China has joined the club to become an increasingly major research source for chitin and chitosan in Asia, This review surveys select works of key groups in Asia developing chitin and chitosan materials for implantable biomedical applications. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.
   Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore.
RP Khor, E (reprint author), Natl Univ Singapore, Dept Chem, 3 Sci Dr 3,Kent Ridge, Singapore 117543, Singapore.
RI Lim, Lee Yong/C-6144-2013
OI Lim, Lee Yong/0000-0002-7307-0742
CR Ahn JS, 2002, BIOMATERIALS, V23, P1411, DOI 10.1016/S0142-9612(01)00261-7
   Ahn JS, 2001, BIOMATERIALS, V22, P923, DOI 10.1016/S0142-9612(00)00256-8
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Chow KS, 2001, J POLYM RES, V8, P27
   Chow KS, 2000, BIOMACROMOLECULES, V1, P61, DOI 10.1021/bm005503b
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Dung PL, 2001, CHITIN CHITOSAN CHIT, P27
   Gupta KC, 2001, J MATER SCI-MATER M, V12, P753, DOI 10.1023/A:1017976014534
   Gupta KC, 2000, BIOMATERIALS, V21, P1115, DOI 10.1016/S0142-9612(99)00263-X
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Hata H, 2000, BIOMATERIALS, V21, P1779, DOI 10.1016/S0142-9612(00)00069-7
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   Hirano S, 1998, BIOMATERIALS, V19, P293, DOI 10.1016/S0142-9612(97)00216-0
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   Hirano S, 2001, J BIOMED MATER RES, V56, P556, DOI 10.1002/1097-4636(20010915)56:4<556::AID-JBM1127>3.0.CO;2-O
   Hu Y, 2002, BIOMATERIALS, V23, P3193, DOI 10.1016/S0142-9612(02)00071-6
   Hung WS, 2001, J BIOMED MATER RES, V56, P93, DOI 10.1002/1097-4636(200107)56:1<93::AID-JBM1072>3.0.CO;2-B
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   ITO M, 1991, BIOMATERIALS, V12, P41, DOI 10.1016/0142-9612(91)90130-3
   Ito M, 1999, J BIOMED MATER RES, V45, P204, DOI 10.1002/(SICI)1097-4636(19990605)45:3<204::AID-JBM7>3.0.CO;2-4
   Kam HM, 1999, J BIOMED MATER RES, V48, P881, DOI 10.1002/(SICI)1097-4636(1999)48:6<881::AID-JBM18>3.0.CO;2-2
   Kawamata Y, 2002, BIOMATERIALS, V23, P4573, DOI 10.1016/S0142-9612(02)00203-X
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Khor E., 2001, CHITIN FULFILLING BI
   Kuen YL, 1995, BIOMATERIALS, V16, P1211
   Lee YM, 2000, J MATER SCI-MATER M, V11, P817, DOI 10.1023/A:1008961730929
   Lee YM, 1997, J MATER SCI-MATER M, V8, P537, DOI 10.1023/A:1018594614087
   Li F, 2002, BIOMATERIALS, V23, P343, DOI 10.1016/S0142-9612(01)00111-9
   Lim L. Y., 1998, P C CHALL DRUG DEL P, P196
   Lim LY, 1999, J BIOMED MATER RES, V48, P111
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Mi FL, 1999, BIOMATERIALS, V20, P1603, DOI 10.1016/S0142-9612(99)00064-2
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Mi FL, 2002, BIOMATERIALS, V23, P3257, DOI 10.1016/S0142-9612(02)00084-4
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Okamoto Y, 2002, BIOMATERIALS, V23, P1975, DOI 10.1016/S0142-9612(01)00324-6
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Park SB, 2001, BIOMATERIALS, V22, P323, DOI 10.1016/S0142-9612(00)00187-3
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Risbud M, 2001, J BIOMED MATER RES, V56, P120, DOI 10.1002/1097-4636(200107)56:1<120::AID-JBM1076>3.0.CO;2-W
   Risbud MV, 2001, J BIOMED MATER RES, V57, P300, DOI 10.1002/1097-4636(200111)57:2<300::AID-JBM1171>3.0.CO;2-Q
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Shi XY, 2002, BIOMATERIALS, V23, P4469, DOI 10.1016/S0142-9612(02)00165-5
   Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3
   Su CH, 1999, BIOMATERIALS, V20, P61, DOI 10.1016/S0142-9612(98)00139-2
   Sunny MC, 2002, J MATER SCI-MATER M, V13, P623, DOI 10.1023/A:1015709705074
   Takechi M, 2002, J MATER SCI-MATER M, V13, P973, DOI 10.1023/A:1019816830793
   Takechi M, 2001, J MATER SCI-MATER M, V12, P597, DOI 10.1023/A:1011285509391
   Takechi M, 1998, BIOMATERIALS, V19, P2057, DOI 10.1016/S0142-9612(98)00114-8
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tanaka Y, 1997, BIOMATERIALS, V18, P591, DOI 10.1016/S0142-9612(96)00182-2
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4
   Ueno H, 2001, BIOMATERIALS, V22, P1667, DOI 10.1016/S0142-9612(00)00328-8
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Usami Y, 1998, J BIOMED MATER RES, V42, P517
   Wan ACA, 1998, J BIOMED MATER RES, V41, P541, DOI 10.1002/(SICI)1097-4636(19980915)41:4<541::AID-JBM5>3.0.CO;2-C
   Wan ACA, 1998, BIOMATERIALS, V19, P1309
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   Wan ACA, 1997, J BIOMED MATER RES, V38, P235, DOI 10.1002/(SICI)1097-4636(199723)38:3<235::AID-JBM8>3.0.CO;2-Q
   Wang LH, 2001, J PHARM SCI-US, V90, P1134, DOI 10.1002/jps.1067
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang XH, 2002, BIOMATERIALS, V23, P4591, DOI 10.1016/S0142-9612(02)00205-3
   Wang XH, 2002, BIOMATERIALS, V23, P4167, DOI 10.1016/S0142-9612(02)00153-9
   Wang XH, 2001, BIOMATERIALS, V22, P2247, DOI 10.1016/S0142-9612(00)00413-0
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.3.CO;2-6
   Yan XL, 2001, J BIOMED MATER RES, V58, P358, DOI 10.1002/jbm.1029
   Yan XL, 2000, CHEM PHARM BULL, V48, P941
   Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6
   Yusof NLBM, 2001, J BIOMED MATER RES, V54, P59, DOI 10.1002/1097-4636(200101)54:1<59::AID-JBM7>3.0.CO;2-U
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
   Zhao HR, 2002, BIOMATERIALS, V23, P4459, DOI 10.1016/S0142-9612(02)00162-X
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
NR 90
TC 984
Z9 1060
U1 26
U2 456
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2003
VL 24
IS 13
BP 2339
EP 2349
DI 10.1016/S0142-9612(03)00026-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 668FV
UT WOS:000182280400025
PM 12699672
DA 2018-10-19
ER

PT J
AU Hudon, V
   Berthod, F
   Black, AF
   Damour, O
   Germain, L
   Auger, FA
AF Hudon, V
   Berthod, F
   Black, AF
   Damour, O
   Germain, L
   Auger, FA
TI A tissue-engineered endothelialized dermis to study the modulation of
   angiogenic and angiostatic molecules on capillary-like tube formation in
   vitro
SO BRITISH JOURNAL OF DERMATOLOGY
LA English
DT Article
DE basic fibroblast growth factor; endothelial cells; extracellular matrix;
   tissue engineering; vascular endothelial growth factor
ID FIBROBLAST-GROWTH-FACTOR; CELL-ADHESION MOLECULE; HUMAN BLOOD-VESSEL;
   LONG-TERM CULTURE; EXTRACELLULAR-MATRIX; SKIN EQUIVALENT; COLLAGEN
   SPONGE; LUMEN FORMATION; PECAM-1 CD31; INVITRO
AB Background Because angiogenesis is a major feature of different physiological and pathological situations, the identification of factors that stimulate or inhibit this process and the elucidation of their mechanisms of action are most certainly of clinical relevance. We have produced a new model of endothelialized reconstructed dermis that promotes the spontaneous formation of a human capillary-like network and its stabilization in vitro for a period longer than 1 month.
   Objectives The aim of this work was to describe the three-dimensional structure of the capillary-like network. Thereafter we strove to study, quantitatively and qualitatively, the influence of angiogenic and angiostatic drugs on capillary-like tube (CLT) formation in vitro in the model.
   Methods The endothelialized dermis was prepared by coculturing two human cell types, dermal fibroblasts and umbilical vein endothelial cells, in a collagen sponge biomaterial.
   Results The visualization by confocal microscopy of the tubes present in the model showed that the endothelial structures were not cord-like but rather CLTs with well-defined lumina. Moreover, these tubes were organized in a complex network of branching structures. When angiogenic factors (vascular endothelial growth factor 10 ng mL(-1) or basic fibroblast growth factor 10 ng mL(-1)) were added to the model, 1-8 and 1-4 times more capillaries, respectively, were observed, whereas the addition of progesterone (10 mug mL(-1)) reduced by 2.4 times the number of tubes compared with the control.
   Conclusions These results suggest that this model is a highly efficient assay for the screening of potentially angiogenic and angiostatic compounds.
C1 Univ Laval, CHA, Hop St Sacrement, Dept Chirurg,Lab Organogenese Expt, Quebec City, PQ G1S 4L8, Canada.
   Hop Edouard Herriot, CNRS, UPR 412, Lab Substituts Cutanes, Lyon, France.
RP Auger, FA (reprint author), Univ Laval, CHA, Hop St Sacrement, Dept Chirurg,Lab Organogenese Expt, 1050 Chemin St Foy, Quebec City, PQ G1S 4L8, Canada.
CR ALBELDA SM, 1990, J CELL BIOL, V110, P1227, DOI 10.1083/jcb.110.4.1227
   AUGER FA, 1995, IN VITRO CELL DEV-AN, V31, P432
   Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844
   Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9
   Berthod F, 1996, J BIOMED MATER RES, V32, P87, DOI 10.1002/(SICI)1097-4636(199609)32:1<87::AID-JBM10>3.0.CO;2-F
   Berthod F, 1997, J INVEST DERMATOL, V108, P737, DOI 10.1111/1523-1747.ep12292122
   BERTHOD F, 1993, BIOMATERIALS, V14, P749, DOI 10.1016/0142-9612(93)90039-5
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Bhushan M, 2002, BRIT J DERMATOL, V147, P418, DOI 10.1046/j.1365-2133.2002.05003.x
   BIKFALVI A, 1991, BIOL CELL, V72, P275, DOI 10.1016/0248-4900(91)90298-2
   Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398
   Black AF, 1998, FASEB J, V12, P1331
   Brooks PC, 1996, EUR J CANCER, V32A, P2423, DOI 10.1016/S0959-8049(96)00381-4
   Chen CS, 1997, IN VITRO CELL DEV-AN, V33, P796
   COCKERILL GW, 1995, INT REV CYTOL, V159, P113, DOI 10.1016/S0074-7696(08)62106-3
   Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109
   DIAZFLORES L, 1992, J MORPHOL, V213, P33, DOI 10.1002/jmor.1052130105
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   FOLKMAN J, 1992, ADV EXP MED BIOL, V313, P355
   Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608
   Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055
   GERMAIN L, 1993, BURNS, V19, P99, DOI 10.1016/0305-4179(93)90028-7
   GORDON PB, 1983, IN VITRO CELL DEV B, V19, P661
   GU XH, 1995, BRIT J DERMATOL, V132, P376, DOI 10.1111/j.1365-2133.1995.tb08670.x
   Haas TL, 1999, TRENDS CARDIOVAS MED, V9, P70, DOI 10.1016/S1050-1738(99)00014-6
   Hirschi K K, 1997, EXS, V79, P419
   Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6
   HUDLICKA O, 1998, INTRO VASCULAR BIOL, P3
   Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889
   Jaggers DC, 1996, J ENDOCRINOL, V150, P457, DOI 10.1677/joe.0.1500457
   Kanda S, 1999, EXP CELL RES, V248, P203, DOI 10.1006/excr.1999.4400
   KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   L'Heureux N, 1998, FASEB J, V12, P47
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   Madri JA, 1997, TRANSPL IMMUNOL, V5, P179, DOI 10.1016/S0966-3274(97)80035-4
   MAUGER A, 1984, J EXP ZOOL, V232, P343, DOI 10.1002/jez.1402320221
   Mignatti P., 1996, MOL CELLULAR BIOL WO, P427
   MONTESANO R, 1993, J CELL SCI, V105, P1013
   MONTESANO R, 1992, EUR J CLIN INVEST, V22, P504, DOI 10.1111/j.1365-2362.1992.tb01498.x
   Neufeld G, 1999, FASEB J, V13, P9
   Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129
   NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453
   PEPPER MS, 1992, BIOCHEM BIOPH RES CO, V189, P824, DOI 10.1016/0006-291X(92)92277-5
   PEPPER MS, 1990, J CELL BIOL, V111, P743, DOI 10.1083/jcb.111.2.743
   Polverini Peter J, 2002, J Dent Educ, V66, P962
   Ribatti D, 2001, MECH DEVELOP, V100, P157, DOI 10.1016/S0925-4773(00)00522-0
   Ribatti D, 1997, TISSUE CELL, V29, P131, DOI 10.1016/S0040-8166(97)80014-6
   RIBBATI D, 1999, INT J BIOL MARKER, V14, P207
   RISAU W, 1995, FASEB J, V9, P926
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   SAGE H, 1994, J HYPERTENSION S10, V12, pS145
   SAINTIGNY G, 1993, ACTA DERM-VENEREOL, V73, P175
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   SCHIMMENTI LA, 1992, J CELL PHYSIOL, V153, P417, DOI 10.1002/jcp.1041530222
   SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844
   SIMIONESCU N, 1988, CELL TISSUE BIOL, P355
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247
   Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122
   VILLASCHI S, 1994, LAB INVEST, V71, P291
   Yang S, 1999, AM J PATHOL, V155, P887, DOI 10.1016/S0002-9440(10)65188-7
NR 63
TC 80
Z9 83
U1 1
U2 12
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0007-0963
J9 BRIT J DERMATOL
JI Br. J. Dermatol.
PD JUN
PY 2003
VL 148
IS 6
BP 1094
EP 1104
DI 10.1046/j.1365-2133.2003.05298.x
PG 11
WC Dermatology
SC Dermatology
GA 701GH
UT WOS:000184159500002
PM 12828735
DA 2018-10-19
ER

PT J
AU Yeo, JH
   Lee, KG
   Lee, YW
   Kim, SY
AF Yeo, JH
   Lee, KG
   Lee, YW
   Kim, SY
TI Simple preparation and characteristics of silk fibroin microsphere
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE silk fibroin; gel filtration chromatography; spray drying
ID ORAL DOSAGE FORM; STATE N-15 NMR; STRUCTURAL-ANALYSIS; ELDERLY PATIENTS;
   IN-VITRO; POLYMERS; RELEASE; CELLS; GEL
AB We investigated the biomaterial and pharmaceutical utility of pure silk fibroin (SF) protein as a possible for separation, using Sephadex G-25 gel filtration chromatography and simply preparing SF microsphere particles (SFMP) by spray dryer. Also, some of its physicochemical properties and morphology were investigated. Obtaining microspheres and/or submicronic particles by spray dryer method was accelerated or completed with the transition from the random coil to the beta-sheet structure during spray dryer treatment. It was identified by the basic Fourier transform infrared spectroscopy of SFMP. The various pH range of SFMP's swelling ratio is dependent on the pH of the solution, not on the occurred gelation. Morphologically, SFMP was spherical in shape, and particles, average 2 +/- 10 mum in size, were observed by scanning electron microscope and particle analyzer, respectively. The average molecular weight (M-W) of pure SF protein dissolved in calcium chloride is about 61,500 g/mol as measured by gel permeation chromatography. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Kyung Hee Univ, Grad Sch EW Med Sci, Tongdaemun Ku, Seoul 130701, South Korea.
   Natl Inst Agr Sci & Technol, Dept Sericulture & Entomol, Suwon 441100, South Korea.
RP Kim, SY (reprint author), Kyung Hee Univ, Grad Sch EW Med Sci, Tongdaemun Ku, 1 Hoegi Dong, Seoul 130701, South Korea.
CR ASAKURA T, 1993, MACROMOLECULES, V26, P6660, DOI 10.1021/ma00076a056
   CANETTI M, 1989, BIOPOLYMERS, V28, P1613, DOI 10.1002/bip.360280910
   CANETTI M, 1989, BIOPOLYMERS, V41, P173
   CHEN K, 1991, Journal of Sericultural Science of Japan, V60, P402
   Cho CS, 1997, BIOMATERIALS, V18, P323, DOI 10.1016/S0142-9612(96)00138-X
   Hagel L, 1998, PROTEIN PURIFICATION
   HANAWA T, 1995, CHEM PHARM BULL, V43, P872
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Jeong YI, 1998, J CONTROL RELEASE, V51, P169, DOI 10.1016/S0168-3659(97)00163-6
   Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7
   MAEDA H, 1992, BIOCONJUGATE CHEM, V3, P351, DOI 10.1021/bc00017a001
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SHIMURA K, 1973, TANPAKUSITSU NO KAGA
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   YEO JH, 1994, KOBUNSHI RONBUNSHU, V51, P47, DOI 10.1295/koron.51.47
   Yeo JH, 2000, BIOL PHARM BULL, V23, P1220
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P127, DOI 10.1002/app.1990.070400111
NR 19
TC 68
Z9 75
U1 2
U2 43
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
J9 EUR POLYM J
JI Eur. Polym. J.
PD JUN
PY 2003
VL 39
IS 6
BP 1195
EP 1199
DI 10.1016/S0014-3057(02)00359-2
PG 5
WC Polymer Science
SC Polymer Science
GA 677CA
UT WOS:000182788300013
DA 2018-10-19
ER

PT J
AU Shi, J
   Le Maguer, M
AF Shi, J
   Le Maguer, M
TI Mass transfer flux at solid-liquid contacting interface
SO FOOD SCIENCE AND TECHNOLOGY INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT International Iberdesh 2002 Conference
CY SEP 25-27, 2002
CL VALENCIA, SPAIN
DE cellular tissue; osmotic dehydration; interface; mass transfer
ID OSMOTIC DEHYDRATION PROGRESSION; TRANSPORT; EQUATIONS
AB When cellular materials are immersed in a solution of high concentration, the mass transfer is considered a multi-component transport process in which simultaneous and countercurrent flows occur in the biological tissue. The mass transfer process of each component in the solid-liquid system is affected not only by operational parameters, but also by the presence of other components. The main driving force for the mass transfer phenomena is attributed to the concentration gradient between external and internal solid material, and the interaction among fluxes and tissue matrix. Matrix deformation and tissue shrinkage are important characteristics influencing mass transfer. The coupled mass transfer fluxes across the interface in an isothermal solid-liquid system were analysed by means of a film model as a function of the concentration gradients, based on the generalised multi-component mass transfer theories. Several possible situations of cell structure changes are discussed, and the effect of structural shrinkage on mass transfer is modelled in this study. The mass transfer model and parameters proposed in the present study is applicable to the unit operation such as osmotic treatment of cellular porous biomaterial.
C1 Agr & Agri Food Canada, Food Res Ctr, Guelph, ON N1G 5C9, Canada.
   Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada.
RP Shi, J (reprint author), Agr & Agri Food Canada, Food Res Ctr, Guelph, ON N1G 5C9, Canada.
CR Bird R. B., 1965, TRANSPORT PHENOMENA
   BISWAL RN, 1989, ENG DEV EC ANAL DEHY
   BOLIN HR, 1983, J FOOD SCI, V48, P202, DOI 10.1111/j.1365-2621.1983.tb14823.x
   CHANDRASEKARAN SK, 1972, AICHE J, V18, P513, DOI 10.1002/aic.690180309
   Cussler E. L., 1984, DIFFUSION MASS TRANS
   FITO P, 1995, ISOPOW PRACTICUM, V2
   FITO P, 1997, FOOD ENG 2000
   Hawkes J., 1978, Journal of Food Processing and Preservation, V2, P265, DOI 10.1111/j.1745-4549.1978.tb00562.x
   KRISHNA R, 1986, HDB HEAT MASS TRANSF
   LEMAGUER M, 1988, MASS TRANSFER OSMOTI
   LEMAGUER M, 1995, ISOPOW PRACTICUMN MO, V2
   LENART A, 1984, J FOOD TECHNOL, V19, P45
   Nobel PS, 1983, BIOPHYSICAL PLANT PH
   RAOULTWACK AL, 1991, DRY TECHNOL, V9, P589, DOI 10.1080/07373939108916698
   ROBARDS AW, 1990, ANNU REV PLANT PHYS, V41, P369, DOI 10.1146/annurev.pp.41.060190.002101
   Salvatori D, 1999, J FOOD ENG, V42, P133, DOI 10.1016/S0260-8774(99)00084-9
   Salvatori D, 1999, J FOOD ENG, V42, P125, DOI 10.1016/S0260-8774(99)00083-7
   SHI J, 1997, P 5 C FOOD ENG LOS A, P157
   TOOR HL, 1964, AICHE J, V10, P448, DOI 10.1002/aic.690100408
   TYREE MT, 1970, J THEOR BIOL, V26, P181, DOI 10.1016/S0022-5193(70)80012-1
   Yao ZM, 1996, J FOOD ENG, V29, P349, DOI 10.1016/0260-8774(95)00045-3
NR 21
TC 6
Z9 6
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND
SN 1082-0132
J9 FOOD SCI TECHNOL INT
JI Food Sci. Technol. Int.
PD JUN
PY 2003
VL 9
IS 3
BP 193
EP 199
DI 10.1177/108201303035261
PG 7
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA 713WQ
UT WOS:000184881300010
DA 2018-10-19
ER

PT J
AU Sun, W
   Sacks, MS
   Sellaro, TL
   Slaughter, WS
   Scott, MJ
AF Sun, W
   Sacks, MS
   Sellaro, TL
   Slaughter, WS
   Scott, MJ
TI Biaxial mechanical response of bioprosthetic heart valve biomaterials to
   high in-plane shear
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
ID STRUCTURAL CONSTITUTIVE MODEL; BOVINE PERICARDIUM; CROSS-LINKING;
   TISSUES; STABILIZATION; STRAIN; FORM
AB Utilization of novel biologically-derived biomaterials in bioprosthetic heart valves (BHV) requires robust constitutive models to predict the mechanical behavior under generalized loading states. Thus, it is necessary to perform rigorous experimentation involving all functional deformations to obtain both the form and material constants of a strain-energy density function. In this study, we generated a comprehensive experimental biaxial mechanical dataset that included high in-plane shear stresses using glutaraldehyde treated bovine pericardium (GLBP) as the representative BHV biomaterial. Compared to our previous study (Sacks, JBME, v.121, pp. 551-555, 1999), GLBP demonstrated a substantially different response under high shear strains. This finding was underscored by the inability of the standard Fung model, applied successfully in our previous GLBP study, to fit the high-shear data. To develop an appropriate constitutive model, we utilized an interpolation technique for the pseudo-elastic response to guide modification of the final model form. An eight parameter modified Fung model utilizing additional quartic terms was developed, which fitted the complete dataset well. Model parameters were also constrained to satisfy physical plausibility of the strain energy function. The results of this study underscore the limited predictive ability of current soft tissue models, and the need to collect experimental data for soft tissue simulations over the complete functional range.
C1 Univ Pittsburgh, Engn Tissue Mech Lab, Dept Bioengn, Pittsburgh, PA 15260 USA.
   Univ Pittsburgh, Dept Mech Engn, Pittsburgh, PA USA.
   Edwards Lifesci, Irvine, CA USA.
RP Sacks, MS (reprint author), Univ Pittsburgh, Engn Tissue Mech Lab, Dept Bioengn, Pittsburgh, PA 15260 USA.
EM msacks@pitt.edu
CR Aupart MR, 1996, J HEART VALVE DIS, V5, P312
   BENGTSSON LA, 1995, ANN THORAC SURG, V60, pS365, DOI 10.1016/0003-4975(95)00316-D
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158
   BLACK MM, 1991, J BIOMECH, V24, P793, DOI 10.1016/0021-9290(91)90304-6
   Brossollet LJ, 1996, J BIOMECH ENG-T ASME, V118, P433, DOI 10.1115/1.2796028
   Cosgrove D M, 1996, Semin Thorac Cardiovasc Surg, V8, P269
   CURNIER A, 1995, J ELASTICITY, V37, P1, DOI 10.1007/BF00043417
   FERRANS VJ, 1991, CARDIOVASC PATHOL, P373
   Frater RWM, 1998, J HEART VALVE DIS, V7, P48
   Fung Y.-C., 1993, BIOMECHANICS MECH PR, P568, DOI [10.1007/978-1-4757-2257-4, DOI 10.1007/978-1-4757-2257-4]
   Grunkemeier G L, 1995, J Heart Valve Dis, V4, P49
   HARASAKI H, 1990, T SOC BIOMAT, V13, P25
   HUMPHREY JD, 1992, J BIOMECH ENG-T ASME, V114, P461, DOI 10.1115/1.2894095
   HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P333
   KRUCINSKI S, 1993, J BIOMECH, V26, P929, DOI 10.1016/0021-9290(93)90055-J
   Langdon SE, 1999, BIOMATERIALS, V20, P137, DOI 10.1016/S0142-9612(98)00142-2
   Lanir Y, 1996, J BIOMECH ENG-T ASME, V118, P10, DOI 10.1115/1.2795935
   LANIR Y, 1994, ASME, V61, P695
   Marsden J., 1983, MATH FDN ELASTICITY
   Moore MA, 1997, ASAIO J, V43, P23, DOI 10.1097/00002480-199701000-00006
   MOORE MA, 1994, J BIOMED MATER RES, V28, P611, DOI 10.1002/jbm.820280511
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   PELLETIER LC, 1995, ANN THORAC SURG, V60, pS297
   PEREIRA CA, 1990, J BIOMED MATER RES, V24, P345, DOI 10.1002/jbm.820240307
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   RIVLIN RS, 1951, PHILOS TR R SOC S-A, V243, P251, DOI 10.1098/rsta.1951.0004
   ROUSSEEUW PJ, 1987, WILEY SERIES PROBABI, V14
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 2000, COMPUT MECH, V26, P243, DOI 10.1007/s004660000175
   Sacks MS, 1999, J BIOMECH ENG-T ASME, V121, P551, DOI 10.1115/1.2835086
   Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671
   SACKS MS, IN PRESS J BIOMECH
   Schoen FJ, 1998, J HEART VALVE DIS, V7, P174
   SCHOEN FJ, 1994, J CARDIAC SURG, V9, P222, DOI 10.1111/j.1540-8191.1994.tb00932.x
   SCHOEN FJ, 1991, REPLACEMENT CARDIAC, P125
   SPENCER AJM, 1980, CONTINUUM MECH
   Truesdell C., 1965, HDB PHYSIK, P119
   Vasudev SC, 1997, J BIOMED MATER RES, V35, P357, DOI 10.1002/(SICI)1097-4636(19970605)35:3<357::AID-JBM10>3.0.CO;2-C
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
NR 39
TC 66
Z9 67
U1 0
U2 17
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD JUN
PY 2003
VL 125
IS 3
BP 372
EP 380
DI 10.1115/1.1572518
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 701PT
UT WOS:000184176500009
PM 12929242
DA 2018-10-19
ER

PT J
AU Pelsoczi, I
   Turzo, K
   Gergely, C
   Elkaim, R
   Fazekas, A
   Cuisinier, FJG
AF Pelsoczi, I.
   Turzo, K.
   Gergely, C.
   Elkaim, R.
   Fazekas, A.
   Cuisinier, F. J. G.
TI Coating biomaterial surfaces with polypeptide films suitable for
   promoting cell growth.
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
C1 Univ Strasbourg 1, Strasbourg, France.
   Univ Szeged, Szeged, Hungary.
   Med Univ, Strasbourg, France.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD JUN
PY 2003
VL 82
SI B
MA 2096
BP B273
EP B273
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA V42UY
UT WOS:000202893602531
DA 2018-10-19
ER

PT J
AU Watterson, JD
   Cadieux, PA
   Beiko, DT
   Cook, AJ
   Burton, JP
   Harbottle, RR
   Lee, C
   Rowe, E
   Sidhu, H
   Reid, G
   Denstedt, JD
AF Watterson, JD
   Cadieux, PA
   Beiko, DT
   Cook, AJ
   Burton, JP
   Harbottle, RR
   Lee, C
   Rowe, E
   Sidhu, H
   Reid, G
   Denstedt, JD
TI Oxalate-degrading enzymes from Oxalobacter formigenes: A novel device
   coating to reduce urinary tract biomaterial-related encrustation
SO JOURNAL OF ENDOUROLOGY
LA English
DT Article
ID URETERAL STENTS; BACTERIUM; DECARBOXYLASE; HYPEROXALURIA; PURIFICATION;
   EXPRESSION; ABSENCE; CLONING; THERAPY
AB Background and Purpose: The long-term placement of biomaterials within the urinary tract is limited by the development of encrustation. In a noninfected urinary environment, encrustation often results from the deposition of calcium oxalate on the biomaterial surface. There is an association between the absence of Oxalobacter formigenes, a commensal colonic bacterium capable of degrading oxalate, and calcium oxalate stone formation. This pilot study was designed to evaluate several oxalate-degrading enzymes produced by O. formigenes as a potential biomaterial coating to reduce urinary tract encrustation.
   Materials and Methods: Circular silicone disks of 6-mm diameter were incubated for 48 hours in oxalyl-coenzyme A decarboxylase (OXC), formyl-coenzyme A transferase (FRC), and coenzyme A, while control disks were incubated in distilled water. The adsorption of OXC and FRC was assessed using enhanced chemiluminescence (ECL) and atomic force microscopy (AFM). Coated and uncoated disks (20 of each) were implanted in the bladders of 40 female New Zealand White rabbits. After 30 days, the disks were recovered, and the degree of encrustation on the polymer surface was evaluated utilizing dry weight measurement, calcium atomic absorption spectroscopy (AAS), and scanning electron microscopy/energy-dispersive X-ray analysis (SEM/EDX).
   Results: Both ECL and AFM demonstrated coating of the silicone disks with OXC and FRC. The mean dry weights of the coated and control disks following explantation were 0.591 +/- 0.438 g and 0.747 +/- 0.428 g, respectively (P = 0.307). The mean weight of calcium on the coated and control disks, as determined by AAS, was 154.1 +/- 96.25 mg and 258 +/- 181.35 mg, respectively (P = 0.008).
   Conclusions: The use of oxalate-degrading enzymes from O. formigenes to coat urinary biomaterials represents a novel paradigm to reduce biomaterial-related encrustation. Coating of silicone with oxalate-degrading enzymes from O. formigenes results in a modest reduction in encrustation with no apparent toxicity. Further studies are warranted.
C1 Ix Biotechnol Inc, Div Oxalate Res, Alachua, FL USA.
   Univ Western Ontario, Lawson Hlth Res Inst, Dept Microbiol & Immunol, London, ON N6A 3K7, Canada.
   Univ Western Ontario, Dept Pathol, London, ON, Canada.
   Univ Western Ontario, Dept Chem, London, ON, Canada.
   Univ Western Ontario, Div Urol, London, ON, Canada.
RP Denstedt, JD (reprint author), St Josephs Hlth Care, Div Urol, London, ON N6A 4V2, Canada.
OI Burton, Jeremy/0000-0002-3591-6436
CR Abe K, 1996, J BIOL CHEM, V271, P6789, DOI 10.1074/jbc.271.12.6789
   ALLISON MJ, 1985, ARCH MICROBIOL, V14, P1
   BAETZ AL, 1990, J BACTERIOL, V172, P3537, DOI 10.1128/jb.172.7.3537-3540.1990
   BAETZ AL, 1989, J BACTERIOL, V171, P2605, DOI 10.1128/jb.171.5.2605-2608.1989
   Choong SKS, 2000, J ENDOUROL, V14, P19, DOI 10.1089/end.2000.14.19
   Denstedt JD, 2000, WORLD J UROL, V18, P237, DOI 10.1007/PL00007074
   Han J Z, 1995, J Tongji Med Univ, V15, P249
   HUKINS DWL, 1983, BRIT J UROL, V55, P304, DOI 10.1111/j.1464-410X.1983.tb03304.x
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   LUNG HY, 1991, AM J KIDNEY DIS, V17, P381, DOI 10.1016/S0272-6386(12)80627-5
   MOBLEY HLT, 1995, TRENDS MICROBIOL, V3, P280, DOI 10.1016/S0966-842X(00)88945-3
   Neuhaus TJ, 2000, ARCH DIS CHILD, V82, P322, DOI 10.1136/adc.82.4.322
   Sidhu H, 1998, LANCET, V352, P1026, DOI 10.1016/S0140-6736(98)03038-4
   Sidhu H, 2001, J UROLOGY, V166, P1487, DOI 10.1016/S0022-5347(05)65817-X
   Sidhu H, 1999, J AM SOC NEPHROL, V10, pS334
   Sidhu H, 1999, J CLIN MICROBIOL, V37, P1503
   Tieszer C, 1998, J BIOMED MATER RES, V43, P321, DOI 10.1002/(SICI)1097-4636(199823)43:3<321::AID-JBM14>3.0.CO;2-I
NR 17
TC 38
Z9 38
U1 0
U2 5
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD JUN
PY 2003
VL 17
IS 5
BP 269
EP 274
DI 10.1089/089277903322145431
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 697NE
UT WOS:000183948800001
PM 12885351
DA 2018-10-19
ER

PT J
AU Grondahl, L
   Cardona, F
   Chiem, K
   Wentrup-Byrne, E
   Bostrom, T
AF Grondahl, L
   Cardona, F
   Chiem, K
   Wentrup-Byrne, E
   Bostrom, T
TI Calcium phosphate nucleation on surface-modified PTFE membranes
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ACRYLIC-ACID; GROWTH; HYDROXYAPATITE; POLYMER; GEL; DEPOSITION; COTTON;
   FIBERS; FILMS
AB Highly porous PTFE membranes are currently being used in facial reconstructive surgery. The present study aims at improving this biomaterial through creating a more bioactive surface by introducing ionic groups onto the surface. The unmodified PTFE membrane does not induce inorganic growth after immersion in simulated body fluid (SBF) for up to 4 weeks. Copolymeric grafting with acrylic acid (AAc) by means of gamma irradiation and subsequent in vitro testing in SBF reveals that this copolymer initially acts as an ion-exchange material and subsequently induces growth of a calcium phosphate phase (Ca/P=2.7) when large amounts (15%) of pAAc are introduced onto the membrane surface. This copolymer is not expected to function well from a biomaterials perspective since SEM showed the pores on the surface to be partly blocked. In contrast, the surface of monoacryloxyethyl phosphate (MAEP)-modified samples is altered at a molecular level only. Yet the modified materials are able to induce calcium phosphate nucleation when the external surface coverage is 44% or above. The initial inorganic growth on these membranes in SBF has a (Ca + Mg)/P ratio of 1.1 (presumably Brushite or Monetite). The secondary growth, possibly calcium-deficient apatite or tricalcium phosphate, has a (Ca + Mg)/P ratio of 1.5. This result is a promising indicator of a bioactive biomaterial. (C) 2003 Kluwer Academic Publishers.
C1 Queensland Univ Technol, Ctr Instrumental & Dev Chem, Brisbane, Qld 4001, Australia.
RP Wentrup-Byrne, E (reprint author), Queensland Univ Technol, Ctr Instrumental & Dev Chem, GPO Box 2434, Brisbane, Qld 4001, Australia.
OI Grondahl, Lisbeth/0000-0001-6012-9808
CR Barbe AM, 1998, J MEMBRANE SCI, V145, P67, DOI 10.1016/S0376-7388(98)00055-6
   Beamson G., 1992, SCI ESCA300 DATABASE
   DALAS E, 1991, LANGMUIR, V7, P1822, DOI 10.1021/la00056a040
   FOWLER BO, 1966, ARCH ORAL BIOL, V11, P477, DOI 10.1016/0003-9969(66)90154-3
   Grondahl L, 2002, J APPL POLYM SCI, V86, P2550, DOI 10.1002/app.11177
   Hamadouche M, 2000, J BIOMED MATER RES, V52, P422, DOI 10.1002/1097-4636(200011)52:2<422::AID-JBM24>3.3.CO;2-G
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   ISHIGAKI I, 1978, POLYM J, V10, P513, DOI 10.1295/polymj.10.513
   James K, 1999, BIOMATERIALS, V20, P2203, DOI 10.1016/S0142-9612(99)00151-9
   Kamei S, 1997, J BIOMED MATER RES, V37, P384
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LI P, 1993, J MATER SCI-MATER M, V4, P127, DOI 10.1007/BF00120381
   Li SH, 1997, BIOMATERIALS, V18, P389, DOI 10.1016/S0142-9612(96)00122-6
   LIANG CY, 1956, J CHEM PHYS, V25, P563, DOI 10.1063/1.1742964
   MAAS CS, 1993, ARCH OTOLARYNGOL, V119, P1008
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P658, DOI 10.1007/BF00123448
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P597, DOI 10.1007/BF00121284
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P409, DOI 10.1007/BF00120283
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   Park CH, 2000, J MEMBRANE SCI, V164, P121, DOI 10.1016/S0376-7388(99)00208-2
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Piattelli A, 1996, BIOMATERIALS, V17, P1725, DOI 10.1016/0142-9612(96)87653-8
   Ratzsch M, 2000, J APPL POLYM SCI, V77, P711, DOI 10.1002/(SICI)1097-4628(20000725)77:4<711::AID-APP1>3.0.CO;2-Y
   Reis RL, 1997, J MATER SCI-MATER M, V8, P897, DOI 10.1023/A:1018514107669
   Tamada Y, 1999, J BIOMAT SCI-POLYM E, V10, P787, DOI 10.1163/156856299X00649
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   TRETINNIKOV ON, 1994, J BIOMED MATER RES, V28, P1365, DOI 10.1002/jbm.820281115
   Turmanova S, 1997, J MEMBRANE SCI, V127, P1, DOI 10.1016/S0376-7388(96)00277-3
   Yokogawa Y, 1997, J MATER SCI-MATER M, V8, P407, DOI 10.1023/A:1018549404092
NR 32
TC 45
Z9 45
U1 1
U2 13
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2003
VL 14
IS 6
BP 503
EP 510
DI 10.1023/A:1023403929496
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671KB
UT WOS:000182463000004
PM 15348434
DA 2018-10-19
ER

PT J
AU Milleding, P
   Karlsson, S
   Nyborg, L
AF Milleding, P
   Karlsson, S
   Nyborg, L
TI On the surface elemental composition of non-corroded and corroded dental
   ceramic materials in vitro
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; DEGRADATION; BIOMATERIAL; DURABILITY; ADSORPTION; CORROSION;
   ADHESION; GLASSES
AB Dental ceramics are traditionally looked upon as inert materials. As many are glass phased, it may be hypothesized that they will be subjected to glass corrosion in aqueous environments. The aim of the study was therefore to analyze the surface elemental composition of glass-phased and all-crystalline ceramics, before and after low- and high-intensity, in vitro corrosion (milli-Q-water at 37 +/- 2 degreesC for 18 h and 4% acetic acid at 80 +/- 2 degreesC for 18 h, respectively). The analysis of the surface elemental composition was performed using ESCA.
   The hypothesis was confirmed. After high-intensity corrosion, the complete wash out of alkali ions, alkaline-earth ions and elemental alumina was found, leaving behind a surface totally dominated by silica. The all-crystalline ceramics, densely sintered alumina and yttria-partially stabilized tetragonal zirconia, displayed only minor surface changes, even after high-intensity corrosion. In comparison to the corrosion testing in acid, the corrosion process in milli-Q-water did not produce different results in principle, except for the lower magnitude of the depletion of alkali ions and the virtually unchanged level of elemental alumina. Unexpectedly, no substantial difference in surface degradation was found between the glass ceramic and the ordinary porcelain-fused-to-metal ceramic or between ceramics of higher sintering temperature and those of low or ultra-low sintering temperature. The composition and microstructure alone did not appear to provide a full explanation for the inter-individual differences in surface corrosion when exposed to comparable environmental conditions. (C) 2003 Kluwer Academic Publishers.
C1 Univ Gothenburg, Fac Odontol, Dept Prosthet Dent Dent Mat Sci, SE-40530 Gothenburg, Sweden.
   Chalmers Univ Technol, S-41296 Gothenburg, Sweden.
RP Milleding, P (reprint author), Univ Gothenburg, Fac Odontol, Dept Prosthet Dent Dent Mat Sci, Box 450, SE-40530 Gothenburg, Sweden.
OI Nyborg, Lars/0000-0002-1726-5529
CR Abrahamsson I, 1998, J CLIN PERIODONTOL, V25, P721, DOI 10.1111/j.1600-051X.1998.tb02513.x
   Anusavice K J, 1992, Adv Dent Res, V6, P82
   ANUSAVICE KJ, 1993, MRS B            SEP, P64
   AXELSSON KO, 1985, DISSTERTATION INFLUE, P52
   BARREIRO MM, 1989, DENT MATER, V5, P51, DOI 10.1016/0109-5641(89)90094-8
   BAUMANN W, 1992, THESIS AACHEN
   CALES B, 1998, P 6 BIOM S GOTT 1994, P2
   CARLSSON R, 1988, DURABILITY BUILD MAT, V5, P421
   CARLSSON R, 1980, 8015 SKBF SWED CORR
   CHEVALIER J, 1998, P 10 INT S CER MED P, P9
   DERIJK WG, 1985, P BIOM ENG C, P152
   Eppler R.A., 1992, CORROSION GLASS CERA, P372
   HENCH LL, 1978, J NON-CRYST SOLIDS, V28, P83, DOI 10.1016/0022-3093(78)90077-7
   HENCH LL, 1977, P 11 INT C GLASS, V2, P343
   Hohmann W., 1993, DENTALKERAMIK BASIS
   HOLLAND L, 1964, PROPERTIES GLASS SUR
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   KINGERY WD, 1965, INTRO CERAMICS
   Krajewski A, 1996, BIOMATERIALS, V17, P53, DOI 10.1016/0142-9612(96)80755-1
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LAUSMAA J, 1988, SURFACE CHARACTERIZA, P161
   Lepisto T., 1989, CERAM ENG SCI P, V10, P658
   LEPISTO TT, 1992, CORROSION GLASS CERA, P492
   Levin E.M., 1964, PHASE DIAGRAMS CERAM, V1
   Li J., 1993, Clinical Materials, V12, P197, DOI 10.1016/0267-6605(93)90073-G
   MATTSON S, 1934, SOIL SCI, V38, P229
   MCCRACKEN WJ, 1992, CORROSION GLASS CERA, P432
   Milleding P, 1999, BIOMATERIALS, V20, P733, DOI 10.1016/S0142-9612(98)00223-3
   MORENO R, 1987, BOL SOC ESP CERAM V, V26, P335
   NEWTON RG, 1985, GLASS TECHNOL, V26, P21
   OCONNOR DJ, 1956, T FARADAY SOC, V52, P229, DOI 10.1039/tf9565200229
   Oda K, 1997, J AM CERAM SOC, V80, P3233
   PARKS GA, 1965, CHEM REV, V65, P171
   PAUL A, 1977, J MATER SCI, V12, P2246, DOI 10.1007/BF00552247
   PAUL A, 1978, J MATER SCI, V13, P1399
   *PERK ELM, ESCA HDB
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Raisanen L, 2000, J BIOMED MATER RES, V49, P79
   ROBINSON M, 1964, J AM CERAM SOC, V47, P516, DOI 10.1111/j.1151-2916.1964.tb13801.x
   ROHLE M, 1984, ADV CERAM, V12, P352
   SCHAFER R, 1993, ZAHNARZTL, V48, P626
   SCHAIRER JF, 1955, AM J SCI, V253, P681, DOI 10.2475/ajs.253.12.681
   Schmid M, 1992, Schweiz Monatsschr Zahnmed, V102, P1046
   Takami Y, 1998, J BIOMED MATER RES, V40, P24, DOI 10.1002/(SICI)1097-4636(199804)40:1<24::AID-JBM3>3.3.CO;2-U
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   TINSCHERT J, 1995, DTSCH ZAHNARZTL Z, V50, P31
   White WB, 1992, CORROSION GLASS CERA, P2
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
   1995, INT STANDARDS DENT C
NR 51
TC 20
Z9 21
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2003
VL 14
IS 6
BP 557
EP 566
DI 10.1023/A:1023416232222
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671KB
UT WOS:000182463000010
PM 15348440
DA 2018-10-19
ER

PT J
AU Inoue, K
   Sassa, K
   Yokogawa, Y
   Sakka, Y
   Okido, M
   Asai, S
AF Inoue, K
   Sassa, K
   Yokogawa, Y
   Sakka, Y
   Okido, M
   Asai, S
TI Control of crystal orientation of hydroxyapatite by imposition of a high
   magnetic field
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE bioceramics; crystal orientation; crystalline orientation;
   electromagnetic processing of materials; high magnetic field;
   hydroxyapatite
ID AQUEOUS-SOLUTION; ALIGNMENT; SUBSTRATE; COATINGS; TITANIUM; BONE
AB A hydroxyapatite is most suitable biomaterial for clinical application, because it is a main component which constitutes bones and teeth of an organism. Since the hydroxyapatite has different biocompatibility and absorptive activity of proteins for its crystal plane, it is necessary to use the appropriate crystal plane for use in vivo. Thus, the crystal orientation of the hydroxyapatite is one of the very crucial subjects in biomaterials processing. In this study, the control of crystal orientation of the hydroxyapatite has been conducted in the colloidal filtration (slip casting) process under a high magnetic field and a new process where the high magnetic field is introduced in the heat substrate method developed by Okido et al. The usefulness of the processes has been confirmed through the orientation index evaluated by X-ray diffraction patterns and scanning electron microscope (SEM) images of hydroxyapatite crystals. The crystal axis of hydroxyapatite aligned by a magnetic field was determined.
C1 Natl Inst Adv Ind Sci & Technol, Nagoya, Aichi 4638565, Japan.
   Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
   Nagoya Univ, Grad Sch, Dept Mat Proc Engn, Nagoya, Aichi 4648603, Japan.
RP Inoue, K (reprint author), Toyota Ind Co, Kariya, Aichi 4488671, Japan.
OI Sakka, Yoshio/0000-0001-8357-5843
CR AKAZAWA T, 1996, PHOSPHORUS LETT, V36, P601
   Aoki H, 1989, SURF SCI, V10, P96
   KAWASAKI T, 1990, J CHROMATOGR, V515, P125, DOI 10.1016/S0021-9673(01)89307-9
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kuroda K, 2002, J BIOMED MATER RES, V59, P390, DOI 10.1002/jbm.10002
   Morikawa H, 1998, MATER T JIM, V39, P814, DOI 10.2320/matertrans1989.39.814
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   Okido M, 2000, MATER RES SOC SYMP P, V599, P153
   OSADA Y, 2001, BIOMIMETICS HDB, P62
   ROOME CM, 1995, BIOMATERIALS, V16, P691, DOI 10.1016/0142-9612(95)99696-J
   SAKKA S, 1989, CERAMICS JAPAN, V24, P601
   Sakka Y, 2002, JPN J APPL PHYS 2, V41, pL1416, DOI 10.1143/JJAP.41.L1416
   Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244
   SATA T, 1990, FINE CERAMICS ENG, P256
   Suzuki TS, 2002, JPN J APPL PHYS 2, V41, pL1272, DOI 10.1143/JJAP.41.L1272
   Tahashi M, 2000, MATER T JIM, V41, P985, DOI 10.2320/matertrans1989.41.985
   TAHASHI M, 2002, T MAT RES SOC JAP, V27, P31
   Taniguchi T, 2000, MATER T JIM, V41, P981, DOI 10.2320/matertrans1989.41.981
   Tong WD, 1996, J MATER SCI, V31, P3739, DOI 10.1007/BF00352788
   Willson K. S., 1964, TECH P AM ELECTROPLA, V51, P92
NR 20
TC 81
Z9 81
U1 4
U2 26
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUN
PY 2003
VL 44
IS 6
BP 1133
EP 1137
DI 10.2320/matertrans.44.1133
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 697UG
UT WOS:000183961200012
OA Bronze
DA 2018-10-19
ER

PT J
AU Khitrov, G
AF Khitrov, G
TI Hybrid electroactive biomaterial synthesized
SO MRS BULLETIN
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0883-7694
J9 MRS BULL
JI MRS Bull.
PD JUN
PY 2003
VL 28
IS 6
BP 409
EP +
DI 10.1557/mrs2003.114
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 688RU
UT WOS:000183450400004
OA Bronze
DA 2018-10-19
ER

PT J
AU Tsao, BA
   Stevens, GR
   Antonelli, PJ
AF Tsao, BA
   Stevens, GR
   Antonelli, PJ
TI Opening plugged tympanostomy tubes: Effect of tube composition
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Article; Proceedings Paper
CT 107th Annual Meeting of the
   American-Academy-of-Otolaryngology-Head-and-Neck-Surgery
CY SEP 21-24, 2003
CL ORLANDO, FLORIDA
SP Amer Acad Otolaryngol Head & Neck Surg
ID BACTERIAL BIOFILM FORMATION; RESISTANCE; VENTILATION
AB OBJECTIVE. We sought to determine if tympanostomy tube (TT) composition impacts the rate of clearing mucoid plugs.
   DESIGN: The study used an ex vivo model.
   METHODS: TTs with a standard shaft length and inner diameter, varying only by composition materials, were studied. Thirty TTs of each biomaterial (stainless steel, titanium, silicone, fluoroplastic, ion-bombarded silicone, and phosphorylcholine-coated fluoroplastic) were plugged with middle-ear mucus and placed in a model ear chamber. Ofloxacin otic solution was instilled into the chamber to cover the plugged TT. Time to clear each plug was recorded.
   RESULTS. Ion-bombarded silicone TTs cleared more rapidly than plain silicone TTs (P = 0.0042), but no other statistically significant difference among TT materials was observed.
   CONCLUSIONS. TT composition does not significantly affect the rate or "ease" with which TTs may be opened after they become plugged with mucus ex vivo. The higher rate of plug clearance observed with ion-bombarded silicone relative to untreated silicone suggests that improvements may be possible with alterations in either TT composition or surface preparations.
C1 Univ Florida, Dept Otolaryngol, Gainesville, FL 32610 USA.
   Univ Florida, Dept Biostat, Gainesville, FL 32610 USA.
RP Antonelli, PJ (reprint author), Univ Florida, Dept Otolaryngol, Box 100264,1600 SW Archer Rd, Gainesville, FL 32610 USA.
CR ARMSTRON.BW, 1968, LARYNGOSCOPE, V78, P1303, DOI 10.1288/00005537-196808000-00004
   Berry JA, 2000, OTOLARYNG HEAD NECK, V123, P246, DOI 10.1067/mhm.2000.107458
   Biedlingmaier JF, 1998, OTOLARYNG HEAD NECK, V118, P444, DOI 10.1177/019459989811800403
   CHOLE RA, 1995, ARCH OTOLARYNGOL, V121, P562
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   HANDLER SD, 1988, INT J PEDIATR OTORHI, V16, P55, DOI 10.1016/0165-5876(88)90100-0
   HANDLER SD, 1986, INT J PEDIATR OTORHI, V12, P33, DOI 10.1016/S0165-5876(86)80054-4
   KARLAN MS, 1980, OTOLARYNG HEAD NECK, V88, P783, DOI 10.1177/019459988008800628
   KARLAN MS, 1981, OTOLARYNG HEAD NECK, V89, P528, DOI 10.1177/019459988108900404
   Kay DJ, 2001, OTOLARYNG HEAD NECK, V124, P374, DOI 10.1067/mhn.2001.113941
   Kinnari TJ, 2001, INT J PEDIATR OTORHI, V58, P107, DOI 10.1016/S0165-5876(01)00413-X
   Post JC, 2001, LARYNGOSCOPE, V111, P2083, DOI 10.1097/00005537-200112000-00001
   Saidi IS, 1999, OTOLARYNG HEAD NECK, V120, P621, DOI 10.1053/hn.1999.v120.a94162
   TAMI TA, 1987, ARCH OTOLARYNGOL, V113, P979
   WEIGEL MT, 1989, LARYNGOSCOPE, V99, P252
   Westine JG, 2002, LARYNGOSCOPE, V112, P1342, DOI 10.1097/00005537-200208000-00004
   Westine JG, 2002, LARYNGOSCOPE, V112, P951, DOI 10.1097/00005537-200206000-00003
NR 17
TC 9
Z9 10
U1 0
U2 1
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0194-5998
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD JUN
PY 2003
VL 128
IS 6
BP 870
EP 874
DI 10.1016/S0194-5998(03)00470-4
PG 5
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA 694CC
UT WOS:000183755400015
PM 12825039
DA 2018-10-19
ER

PT J
AU Sujovrujic, E
   Ignjatovic, N
   Uskokovic, D
AF Sujovrujic, E
   Ignjatovic, N
   Uskokovic, D
TI Gamma irradiation processing of hydroxyapatite/poly-L-lactide composite
   biomaterial
SO RADIATION PHYSICS AND CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 10th Tihany Symposium on Radiation Chemistry
CY AUG 31-SEP 05, 2002
CL SOPRON, HUNGARY
DE composite biomaterial; gamma irradiation; calcium hydroxyapatite;
   poly-L-lactide
ID MICROSPHERES; POLYMERS
AB Effects of gamma irradiation on structure and physicochemical properties of the hydroxyapatite/poly-L-lactide (HAp/PLLA) composite were studied in this paper. Since the morphology of HAp/PLLA is very sensitive to gamma irradiation, surface microstructure was analyzed by scanning electron microscopy. Structural changes occurring in the material, mostly changes in PLLA which is more sensitive to irradiation than HAp, were studied by wide angle X-ray structural analyses and infrared spectroscopy. Differential scanning calorimetry measurements were used to study the changes in thermal behavior and crystallinity. Conclusions derived according to different methods were compared. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Vinca Inst Nucl Sci, YU-11001 Belgrade, Yugoslavia.
   Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Yugoslavia.
RP Sujovrujic, E (reprint author), Vinca Inst Nucl Sci, POB 522, YU-11001 Belgrade, Yugoslavia.
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968; Suljovrujic, Edin/0000-0001-8774-4341
CR ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Ignjatovic N., 2002, Science of Sintering, V34, P79, DOI 10.2298/SOS0201079I
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Ignjatovic N, 2001, KEY ENG MATER, V192-195, P737
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Nijsen JFW, 2001, BIOMATERIALS, V22, P3073, DOI 10.1016/S0142-9612(01)00055-2
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   SINGH A, 1991, RAD PROCESSING POLYM, P9
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Sosnowski S, 2001, POLYMER, V42, P637, DOI 10.1016/S0032-3861(00)00362-1
   Tsuji H, 2000, POLYMER, V41, P3621, DOI 10.1016/S0032-3861(99)00545-5
NR 11
TC 1
Z9 1
U1 1
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0969-806X
J9 RADIAT PHYS CHEM
JI Radiat. Phys. Chem.
PD JUN
PY 2003
VL 67
IS 3-4
BP 375
EP 379
DI 10.1016/S0969-806X(03)00070-7
PG 5
WC Chemistry, Physical; Nuclear Science & Technology; Physics, Atomic,
   Molecular & Chemical
SC Chemistry; Nuclear Science & Technology; Physics
GA 693ZX
UT WOS:000183749200035
DA 2018-10-19
ER

PT J
AU Chen, M
   Li, MQ
   Shang, DS
   Chen, HT
AF Chen, M
   Li, MQ
   Shang, DS
   Chen, HT
TI Study on the subsonic speed flame spraying coating of hydroxyapatite
SO RARE METALS
LA English
DT Article
DE metal matrix composites; bio-ceramics; subsonic speed flame spraying;
   hydroxyapatite coating
AB A new method of preparation of biomaterial composite coating by the technique of subsonic thermal spraying was discussed in this paper. Ti6Al4V and pure Ti were chosen as substrate and sublayer material respectively and the working layer was sprayed with biomaterial hydroxyapatite (HAP), forming the composite coating. The experiments of heat shock and tensile strength showed that the bonding strength between coating and substrate is almost as same as that of specimen in which Ni/Al powder was adopted as sublayer. The phases of TiN, TiO2, and Ti2O3 were formed in the sublayer, which are free of toxic and have no side effects. The powder of working layer HAP was decomposed partly during spraying, but it can be solved by later treatment.
C1 Jiamusi Univ, Key Lab Biomat, Jiamusi 154007, Heilongjiang Pr, Peoples R China.
RP Chen, M (reprint author), Jiamusi Univ, Key Lab Biomat, Heilongjiang Province, Jiamusi 154007, Heilongjiang Pr, Peoples R China.
CR GAO JC, 1998, CHINESE J MAT RES, V12, P95
   Gledhill HC, 2001, BIOMATERIALS, V22, P695, DOI 10.1016/S0142-9612(00)00232-5
   Huang L Y, 1999, J CHINESE CERAMIC SO, V27, P351
   Kim HM, 2000, BIOMATERIALS, V21, P353, DOI 10.1016/S0142-9612(99)00190-8
   XI YX, 1999, DEV APPL MAT, V14, P41
   YUAN RZ, 1994, RES DEV TECHNIQUE SE
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 7
TC 6
Z9 6
U1 0
U2 2
PU NONFERROUS METALS SOCIETY CHINA
PI BEIJING
PA NO. 30 XUEYUAN RD, BEIJING 100083, PEOPLES R CHINA
SN 1001-0521
J9 RARE METALS
JI Rare Metals
PD JUN
PY 2003
VL 22
IS 2
BP 116
EP 120
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 695XK
UT WOS:000183855500009
DA 2018-10-19
ER

PT J
AU Vasin, SL
   Titushkin, IA
   Sevast'yanov, VI
AF Vasin, SL
   Titushkin, IA
   Sevast'yanov, VI
TI Analysis of the interactions of platelets with biomaterial surfaces by
   electron microscopy
SO RUSSIAN JOURNAL OF PHYSICAL CHEMISTRY
LA English
DT Article
AB A SEM-based experimental method was developed to estimate the interactions of platelets with biomaterial surfaces. The effects of biomaterials on platelets in vitro were compared in terms of the kinetic model of platelet adhesion and an independent quantitative parameter considering the number of adhered cells and their morphology. The approach proposed was used to study the character of the interactions of platelets with carbon coatings on medical polyethylene.
C1 Minist Hlth Russian Federat, Ctr Biomat Res, Moscow Transplantol & Artificial Organ Res Inst, Moscow 123182, Russia.
RP Vasin, SL (reprint author), Minist Hlth Russian Federat, Ctr Biomat Res, Moscow Transplantol & Artificial Organ Res Inst, Ul Shchukinskaya 1, Moscow 123182, Russia.
OI Sevastianov, Victor/0000-0003-1995-3373
CR *GUP INF TSENTR VN, 1999, BIOS
   SEVASTYANOV VI, 1981, VYSOKOMOL SOEDIN A+, V23, P1864
   TITUSHKIN IA, 2003, ZH FIZ KHIM, V77
   TITUSHKIN IA, 1999, PERSPEKT MAT, P43
NR 4
TC 0
Z9 0
U1 0
U2 3
PU INTERPERIODICA
PI BIRMINGHAM
PA PO BOX 1831, BIRMINGHAM, AL 35201-1831 USA
SN 0036-0244
J9 RUSS J PHYS CHEM+
JI Russ. J. Phys. Chem.
PD JUN
PY 2003
VL 77
IS 6
BP 1012
EP 1016
PG 5
WC Chemistry, Physical
SC Chemistry
GA 692ZD
UT WOS:000183689400030
DA 2018-10-19
ER

PT J
AU Hiraishi, K
   Takeda, Y
   Shiobara, N
   Shibusawa, H
   Jimma, F
   Kashiwagi, N
   Saniabadi, AR
   Adachi, M
AF Hiraishi, K
   Takeda, Y
   Shiobara, N
   Shibusawa, H
   Jimma, F
   Kashiwagi, N
   Saniabadi, AR
   Adachi, M
TI Studies on the mechanisms of leukocyte adhesion to cellulose acetate
   beads: An in vitro model to assess the efficacy of cellulose acetate
   carrier-based granulocyte and monocyte adsorptive apheresis
SO THERAPEUTIC APHERESIS AND DIALYSIS
LA English
DT Article
DE adsorptive apheresis; cellulose acetate; complement; Fc gamma R;
   granulocytes and monocytes; IgG, TNF receptors
ID DEPENDENT PHAGOCYTOSIS; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; HUMAN
   NEUTROPHILS; RECEPTORS; TNF; INFLAMMATION; CYTOKINES; RELEASE; CD32
AB Granulocyte and monocyte adsorptive apheresis (GMA) using a column filled with cellulose acetate (CA) beads (carriers) has been associated with a significant clinical efficacy in patients with rheumatoid arthritis and ulcerative colitis. To obtain further understanding on the mechanisms of disease modification by cellulose acetate-carrier-based GMA, in the present study, we investigated the mechanisms of granulocyte and monocyte adhesion to CA beads following exposure of human peripheral blood to the carriers at 37degreesC for up to 60 min under controlled conditions. Cellulose acetate beads selectively adsorbed granulocytes, monocytes, CD19(+) (B cells) and CD56(+) (NK cells) lymphocyte subpopulations. The granulocyte and monocyte adsorption was inhibited by heat-inactivated plasma and EDTA, indicating that the adsorption was plasma protein (immunoglobulin, complement) and calcium dependent. Accordingly, granulocyte and monocyte adsorption was markedly enhanced by coating the carriers with IgG. Similarly, C3b was adsorbed onto the CA beads as a marker of complement activation. The results indicated that IgG and active complement fragments mediated leukocyte adhesion to CA beads via the FcgammaR and/or leukocyte complement receptor like CR3. Additionally, CA beads induced loss of expression of TNF receptors on CD16(+) granulocytes and CD14(+) monocytes, but not on CD3(+) lymphocytes. In conclusion, CA beads might be an appropriate biomaterial for inducing extracorporeal immunomodulation as a treatment for auto-immune diseases which are associated with pathological leukocyte activity.
C1 Japan Immunores Labs, Takasaki, Gumma 3700021, Japan.
RP Hiraishi, K (reprint author), Japan Immunores Labs, 351-1 Nishiyokote Cho, Takasaki, Gumma 3700021, Japan.
CR Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536
   Dallegri F, 1997, INFLAMM RES, V46, P382, DOI 10.1007/s000110050208
   de Andres B, 1998, BLOOD, V92, P2823
   Dri P, 2000, J IMMUNOL, V165, P2165, DOI 10.4049/jimmunol.165.4.2165
   Edwards SW, 1997, IMMUNOL TODAY, V18, P320, DOI 10.1016/S0167-5699(97)01087-6
   HOENICH NA, 1994, NEPHROL DIAL TRANSPL, V9, P60
   Ivanovich P, 1984, Contrib Nephrol, V37, P78
   Jablonska E, 1999, IMMUNOL LETT, V70, P191
   Kashiwagi N, 1998, Ther Apher, V2, P134, DOI 10.1111/j.1744-9987.1998.tb00091.x
   Kashiwagi N, 2002, DIGEST DIS SCI, V47, P1334, DOI 10.1023/A:1015330816364
   KASUKAWA R, 1997, JAP J INFLAMMATION, V47, P57
   KRAUSS JC, 1994, J IMMUNOL, V153, P1769
   Lampinen M, 2001, DIGEST DIS SCI, V46, P2004, DOI 10.1023/A:1010659803912
   LANTZ M, 1994, J IMMUNOL, V152, P1362
   Mahida YR, 2000, INFLAMM BOWEL DIS, V6, P21, DOI 10.1097/00054725-200002000-00004
   Matata BM, 1996, INT J ARTIF ORGANS, V19, P582
   Moldovan I, 1999, IMMUNOL LETT, V68, P125, DOI 10.1016/S0165-2478(99)00041-3
   Nikolaus S, 1998, GUT, V42, P470, DOI 10.1136/gut.42.4.470
   Ohara M, 1997, ARTIF ORGANS, V21, P989
   OHKURO M, 1995, FEBS LETT, V373, P189, DOI 10.1016/0014-5793(95)01036-E
   PORTEU F, 1990, J EXP MED, V172, P599, DOI 10.1084/jem.172.2.599
   Shimoyama T, 2001, J CLIN APHERESIS, V16, P1
   Sulica A, 2001, Int Rev Immunol, V20, P371, DOI 10.3109/08830180109054414
   Taniai N, 2001, HEPATO-GASTROENTEROL, V48, P133
   Worth RC, 1996, J IMMUNOL, V157, P5660
NR 25
TC 85
Z9 86
U1 0
U2 5
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 1091-6660
J9 THER APHER DIAL
JI Ther. Apher. Dial.
PD JUN
PY 2003
VL 7
IS 3
BP 334
EP 340
DI 10.1046/j.1526-0968.2003.00049.x
PG 7
WC Hematology; Urology & Nephrology
SC Hematology; Urology & Nephrology
GA 716HN
UT WOS:000185022900011
PM 12924609
DA 2018-10-19
ER

PT J
AU Borges, J
   Tegtmeier, FT
   Padron, NT
   Mueller, MC
   Lang, EM
   Stark, GB
AF Borges, J
   Tegtmeier, FT
   Padron, NT
   Mueller, MC
   Lang, EM
   Stark, GB
TI Chorioallantoic membrane angiogenesis model for tissue engineering: A
   new twist on a classic model
SO TISSUE ENGINEERING
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; CHICK CHORIOALLANTOIS; DIFFERENTIATION;
   VASCULARIZATION; VASCULOGENESIS; PROLIFERATION; PATTERN; CELLS; CAM
AB Tissue-engineering (TE) applications include the isolation, culture, and seeding of cells into a suitable matrix or scaffold before in vivo transplantation. After transplantation, vascularization of the scaffold is a principal limiting factor for cell viability for the first 6-8 days posttransplantation. A model for systematic analysis of this process has been developed. Fertilized White Leghorn eggs were incubated (at 37.8degreesC in 60% relative humidity) and opened on day 3 of incubation. Preadipocyte-seeded fibrin constructs were implanted in a specially designed plastic cylinder and placed through the opening on the surface of the chorioallantoic membrane (CAM) on day 8 of incubation. Vascularization of the constructs by chorioallantoic blood vessels was assessed for up to 8 days posttransplantation. The survival rate for embryos receiving transplanted constructs was about 90%. Histology confirmed transplant cell viability at day 4 posttransplantation and vascularization of the constructs by avian endothelial cells began at this time. A new in vivo model to study the effect of angiogenesis in TE constructs, including assessments of viability, proliferation, and differentiation of transplanted cells and biomaterial properties, is presented. Advantages include easy access to the vascular network of the CAM, lack of immunocompetence, low costs, and avoidance of animal experiments.
C1 Univ Freiburg, Med Ctr, Dept Plast & Hand Surg, D-79106 Freiburg, Germany.
RP Borges, J (reprint author), Univ Freiburg, Med Ctr, Dept Plast & Hand Surg, Hugstetter Str 55, D-79106 Freiburg, Germany.
CR AUSPRUNK DH, 1986, AM J ANAT, V177, P313, DOI 10.1002/aja.1001770304
   AUSPRUNK DH, 1975, AM J PATHOL, V79, P597
   AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9
   FITZEGSCHWIND V, 1973, ADV ANAT EMBRYOL CEL, V47, P1
   Folkman J, 1974, Adv Cancer Res, V19, P331, DOI 10.1016/S0065-230X(08)60058-5
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   KURZ H, 1995, DEV DYNAM, V203, P174, DOI 10.1002/aja.1002030206
   LEESON TS, 1964, J ANAT, V79, P585
   Maas JWM, 1999, GYNECOL OBSTET INVES, V48, P108, DOI 10.1159/000010150
   MARAGOUDAKIS ME, 1988, TISSUE CELL, V20, P531, DOI 10.1016/0040-8166(88)90055-9
   MAUERSBERGER B, 1979, EXP PATHOL-JENA, V17, P18, DOI 10.1016/S0014-4908(79)80005-8
   MISSIRLIS E, 1990, TISSUE CELL, V22, P419, DOI 10.1016/0040-8166(90)90071-G
   PATAN S, 1993, ANAT EMBRYOL, V187, P121
   POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210
   Ribatti D, 1998, J SUBMICR CYTOL PATH, V30, P127
   RIBATTI D, 1995, DEV BIOL, V170, P39, DOI 10.1006/dbio.1995.1193
   Ribatti D, 1997, TISSUE CELL, V29, P131, DOI 10.1016/S0040-8166(97)80014-6
   Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445
   RIZZO V, 1995, TISSUE CELL, V27, P159, DOI 10.1016/S0040-8166(95)80018-2
   RIZZO V, 1993, TISSUE CELL, V25, P847, DOI 10.1016/0040-8166(93)90033-H
   Romanoff A. L., 1960, THE AVIAN EMBRYO
   ROMANOFF AL, 1952, ANN NY ACAD SCI, V55, P288, DOI 10.1111/j.1749-6632.1952.tb26545.x
   SETO F, 1981, POULTRY SCI, V60, P1981, DOI 10.3382/ps.0601981
   WILTING J, 1993, CELL TISSUE RES, V274, P163, DOI 10.1007/BF00327997
   WILTING J, 1993, ACTA ANAT, V147, P207
   WILTING J, 1991, ANAT EMBRYOL, V183, P259
   YANG EY, 1990, J CELL BIOL, V111, P731, DOI 10.1083/jcb.111.2.731
NR 27
TC 60
Z9 65
U1 1
U2 17
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2003
VL 9
IS 3
BP 441
EP 450
DI 10.1089/107632703322066624
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 692VP
UT WOS:000183681200006
PM 12857412
DA 2018-10-19
ER

PT J
AU Li, SH
   de Wijn, JR
   Li, JP
   Layrolle, P
   de Groot, K
AF Li, SH
   de Wijn, JR
   Li, JP
   Layrolle, P
   de Groot, K
TI Macroporous biphasic calcium phosphate scaffold with high
   permeability/porosity ratio
SO TISSUE ENGINEERING
LA English
DT Article
ID CANCELLOUS BONE; CERAMICS; DEFECTS; MARROW; TISSUE; BIOMATERIAL;
   INTERFACE; IMPLANTS; CELLS; SITE
AB Macroporous biphasic calcium phosphate (BCP) with channel-shaped pores was produced by a novel dual-phase mixing method. The processing route includes mixing water-based BCP slurry and polymethylmethacrylate resin; shaping in a mold; and polymerization, drying, pyrolyzing, and sintering. After comparison with two other commercial macroporous BCP materials, which were produced along different routes, it was found that conventional parameters such as porosity and pore size cannot describe a macroporous structure precisely enough for the application as tissue-engineering scaffold. Instead, permeability can be seen as an intrinsic and quantitative parameter to describe the macroporous structure of various scaffolds, because it is independent of sample size and fluid used in the test. Another parameter, the permeability/porosity ratio, provides an indication of the percolative efficiency per unit porous volume of a scaffold. Structural characterizations and permeability studies of other macroporous scaffold materials were also performed, and it was found that permeability could reflect a combination of five important parameters for scaffold: (1) porosity, (2) pore size and distribution, (3) interconnectivity, (4) fenestration size and distribution, and (5) orientation of pores. Finally, the implications of relating permeability with biological performances are also discussed.
C1 IsoTis NV, NL-3723 MB Bilthoven, Netherlands.
   Leiden Univ, Biomat Res Grp, Bilthoven, Netherlands.
RP Li, SH (reprint author), IsoTis NV, Prov Bronkhorstlaan 10-D, NL-3723 MB Bilthoven, Netherlands.
RI Layrolle, Pierre/K-9257-2015
OI Layrolle, Pierre/0000-0001-9800-5210
CR Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   Darcy H., 1856, FONTAINES PUBLIQUES
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   DYTECH CORPORATION L, Patent No. 0598783
   Ellinger R F, 1986, Int J Periodontics Restorative Dent, V6, P22
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GENDLER E, 1986, J BIOMED MATER RES, V20, P687, DOI 10.1002/jbm.820200603
   Gibson LJ, 1988, CELLULAR SOLIDS STRU
   Grimm MJ, 1997, J BIOMECH, V30, P743, DOI 10.1016/S0021-9290(97)00016-X
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, P244
   Guicheux J, 1998, J BIOMED MATER RES, V40, P79, DOI 10.1002/(SICI)1097-4636(199804)40:1<79::AID-JBM9>3.0.CO;2-O
   HASHIMOTOUOSHIMA M, 1995, INT J PERIODONT REST, V15, P205
   Hollister SJ, 2000, INT J ORAL MAX SURG, V29, P67, DOI 10.1034/j.1399-0020.2000.290115.x
   HUBBARD W, 1974, THESIS MARUETTE U MI, P169
   Hui PW, 1996, J BIOMECH, V29, P123, DOI 10.1016/0021-9290(95)00010-0
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Innocentini MDM, 1998, J AM CERAM SOC, V81, P3349, DOI 10.1111/j.1151-2916.1998.tb02782.x
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kohles SS, 2001, J BIOMECH, V34, P1197, DOI 10.1016/S0021-9290(01)00082-3
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   LEVIN MP, 1975, J BIOMED MATER RES, V9, P183, DOI 10.1002/jbm.820090207
   Li SH, 2002, KEY ENG MAT, V218-2, P25, DOI 10.4028/www.scientific.net/KEM.218-220.25
   Lin FH, 2000, J BIOMED MATER RES, V51, P157, DOI 10.1002/(SICI)1097-4636(200008)51:2<157::AID-JBM3>3.0.CO;2-R
   MISchenk R, 1994, BONE FORMATION REPAI, P117
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   Nauman EA, 1999, ANN BIOMED ENG, V27, P517, DOI 10.1114/1.195
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   Oda Shigeru, 1997, Journal of Medical and Dental Sciences, V44, P53
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   REJDA BV, 1977, J BIOENG, V1, P93
   Richart O., 2001, KEY ENG MATER, V192, P425
   Rohanizadeh R, 1999, CALCIFIED TISSUE INT, V64, P430, DOI 10.1007/PL00005825
   SPRINGFIELD DS, 1987, ORTHOP CLIN N AM, V18, P249
   TOTH JM, 1995, SPINE, V20, P2203, DOI 10.1097/00007632-199510001-00005
   Wang JX, 1998, BIOMATERIALS, V19, P1387, DOI 10.1016/S0142-9612(98)00014-3
   WEBER JN, 1971, NATURE, V233, P337, DOI 10.1038/233337a0
   WOYANSKY JS, 1992, AM CERAM SOC B, V71, P1674
NR 38
TC 131
Z9 138
U1 3
U2 28
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2003
VL 9
IS 3
BP 535
EP 548
DI 10.1089/107632703322066714
PG 14
WC Cell & Tissue Engineering
SC Cell Biology
GA 692VP
UT WOS:000183681200015
PM 12857421
DA 2018-10-19
ER

PT J
AU Williams, PA
   Rayson, GD
AF Williams, PA
   Rayson, GD
TI Simultaneous multi-element detection of metal ions bound to a Datura
   innoxia material
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE metal binding; biosorbent; D. innoxia; metal ion removal; affinity
   chromatography
ID AFFINITY-CHROMATOGRAPHY; BINDING; BIOSORPTION; BIOMASS; ADSORPTION;
   BIOMATERIAL; EU(III); CADMIUM; MODELS; IMPACT
AB An on-line detection scheme has been developed for the determination of metal ion affinities for binding to a plant-based substrate. This involves monitoring the effluent of a column packed with cell-wall fragments from the plant Datura innoxia for 27 different elements simultaneously by coupling the column to an ICP emission spectrometer. Previously accepted procedures for removing native metal ions from biological materials by washing the material with a pH 2 solution were found to be insufficient for this material. Measurable amounts of Na, Mg, Al, Ca, Mn, Fe, Ni, Cr, Zn, Cd, Pb, Ba, Sr, and Si were all detected in an effluent from the introduction of 1.0 M HCl following washing the material in a pH 2 solution. Metal ion breakthrough curves for Cd2+, Zn2+, Ni2+, Cu2+, and Pb2+ were found to exhibit an affinity order of Pb2+ > Cu2+ much greater than Zn2+ congruent to Cd2+ > Ni2+ for an equimolar mixture of these metal ions. This configuration also enabled the displacement of metal ions to be detected as the breakthrough curve for a subsequent metal ion was monitored. Comparison of Ni and Zn binding indicates a simple ion exchange model is insufficient to explain sequential binding of these metal ions. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.
RP Rayson, GD (reprint author), New Mexico State Univ, Dept Chem & Biochem, POB 30001,MSC 3C, Las Cruces, NM 88003 USA.
EM garayson@nmsu.edu
CR Bedell G. W., 1990, IMMOBILIZATION NONVI, P313
   BENEDETTI MF, 1995, ENVIRON SCI TECHNOL, V29, P446, DOI 10.1021/es00002a022
   Chang JS, 1998, SEPAR SCI TECHNOL, V33, P611, DOI 10.1080/01496399808544779
   DARNALL DW, 1986, ENVIRON SCI TECHNOL, V20, P206, DOI 10.1021/es00144a018
   Delgado A, 1998, WATER ENVIRON RES, V70, P370, DOI 10.2175/106143098X125019
   Drake LR, 1996, ANAL CHEM, V68, pA22, DOI 10.1021/ac9618029
   DZOMBAK DA, 1986, ENVIRON SCI TECHNOL, V20, P669, DOI 10.1021/es00149a004
   Fourest E, 1996, ENVIRON SCI TECHNOL, V30, P277, DOI 10.1021/es950315s
   GOLSHANSHIRAZI S, 1988, ANAL CHEM, V60, P2630, DOI 10.1021/ac00174a019
   JAULMES A, 1989, ADV CHROMATOGR, V28, P1
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   Kelley C, 1999, ENVIRON SCI TECHNOL, V33, P1439, DOI 10.1021/es9807789
   Klimmek S, 2001, ENVIRON SCI TECHNOL, V35, P4283, DOI 10.1021/es010063x
   Kratochvil D, 1997, WATER RES, V31, P2327, DOI 10.1016/S0043-1354(97)00071-7
   Lin S, 1998, ENVIRON SCI TECHNOL, V32, P1488, DOI 10.1021/es970843z
   Lin S, 1996, ANAL CHEM, V68, P4087, DOI 10.1021/ac960569b
   MONCRIEF RM, 1995, SEPAR SCI TECHNOL, V30, P2421, DOI 10.1080/01496399508013120
   Sarret G, 2001, ENVIRON SCI TECHNOL, V35, P2854, DOI 10.1021/es000219d
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   Terry PA, 2002, CHEMOSPHERE, V47, P249, DOI 10.1016/S0045-6535(01)00303-4
   Tiemann KJ, 2000, ENVIRON SCI TECHNOL, V34, P693, DOI 10.1021/es9909071
   van der Lelie D, 2001, ENVIRON SCI TECHNOL, V35, p446A
   Williams P, COMMUNICATION
   WIT JD, 1993, ENVIRON SCI TECHNOL, V27, P2015
   Xia HY, 2000, ADV ENVIRON RES, V4, P69
NR 25
TC 6
Z9 6
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD MAY 30
PY 2003
VL 99
IS 3
BP 277
EP 285
DI 10.1016/S0304-3894(03)00005-0
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 684PD
UT WOS:000183215000004
PM 12758012
DA 2018-10-19
ER

PT J
AU Allen, LT
   Fox, EJP
   Blute, I
   Kelly, ZD
   Rochev, Y
   Keenan, AK
   Dawson, KA
   Gallagher, WM
AF Allen, LT
   Fox, EJP
   Blute, I
   Kelly, ZD
   Rochev, Y
   Keenan, AK
   Dawson, KA
   Gallagher, WM
TI Interaction of soft condensed materials with living cells:
   Phenotype/transcriptome correlations for the hydrophobic effect
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID BIOMATERIALS; SURFACES; BIOCOMPATIBILITY; PROLIFERATION; FIBRONECTIN;
   EXPRESSION; RESPONSES; MIGRATION; ADHESION
AB The assessment of biomaterial compatibility relies heavily on the analysis of macroscopic cellular responses to material interaction. However, new technologies have become available that permit a more profound understanding of the molecular basis of cell-biomaterial interaction. Here, both conventional phenotypic and contemporary transcriptomic (DNA microarray-based) analysis techniques were combined to examine the interaction of cells with a homologous series of copolymer films that subtly vary in terms of surface hydrophobicity. More specifically, we used differing combinations of N-isopropylacrylamide, which is presently used as an adaptive cell culture substrate, and the more hydrophobic, yet structurally similar, monomer N-tert-butylacrylamide. We show here that even discrete modifications with respect to the physiochemistry of soft amorphous materials can lead to significant impacts on the phenotype of interacting cells. Furthermore, we have elucidated putative links between phenotypic responses to cell-biomaterial interaction and global gene expression profile alterations. This case study indicates that high-throughput analysis of gene expression not only can greatly refine our knowledge of cell-biomaterial interaction, but also can yield novel biomarkers for potential use in biocompatibility assessment.
C1 Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dept Pharmacol, Dublin 4, Ireland.
   Univ Coll Dublin, Irish Ctr Colloid Sci & Biomat, Dept Chem, Dublin 4, Ireland.
   Ytkemiska Inst, Inst Surface Chem, SE-11486 Stockholm, Sweden.
RP Gallagher, WM (reprint author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dept Pharmacol, Dublin 4, Ireland.
RI Fox, Edward/A-4675-2011; Dawson, Kenneth A./L-2540-2016; Rochev,
   Yury/M-9077-2014
OI Fox, Edward/0000-0002-3740-651X; Dawson, Kenneth A./0000-0002-0568-6588;
   Rochev, Yury/0000-0003-4213-9476; Gallagher, William/0000-0002-4307-5999
CR Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8
   CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179
   Dawson KA, 2002, CURR OPIN COLLOID IN, V7, P218, DOI 10.1016/S1359-0294(02)00052-3
   Doorty KB, 2003, CARDIOVASC PATHOL, V12, P105, DOI 10.1016/S1054-8807(02)00165-5
   EDWARDS JG, 1993, J CELL SCI, V104, P399
   Grill V, 2000, J BIOMED MATER RES, V52, P479, DOI 10.1002/1097-4636(20001205)52:3<479::AID-JBM5>3.0.CO;2-X
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   Kato S, 2000, BIOMATERIALS, V21, P521, DOI 10.1016/S0142-9612(99)00214-8
   Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037
   Kikuchi A, 1998, J BIOMAT SCI-POLYM E, V9, P1331, DOI 10.1163/156856298X00424
   Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5
   Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Moriyama K, 2002, J CELL SCI, V115, P1591
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Rochev Y, 2001, PROG COLL POL SCI S, V118, P153
   ROLLASON G, 1993, BIOMATERIALS, V14, P153, DOI 10.1016/0142-9612(93)90230-Y
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3
NR 22
TC 61
Z9 62
U1 0
U2 11
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 27
PY 2003
VL 100
IS 11
BP 6331
EP 6336
DI 10.1073/pnas.1031426100
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 684DT
UT WOS:000183190700010
PM 12746496
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Meyer-Plath, AA
   Schroder, K
   Finke, B
   Ohl, A
AF Meyer-Plath, AA
   Schroder, K
   Finke, B
   Ohl, A
TI Current trends in biomaterial surface functionalization -
   nitrogen-containing plasma assisted processes with enhanced selectivity
SO VACUUM
LA English
DT Article; Proceedings Paper
CT Symposium on Plasma Surface Engineering held at the Spring Meeting of
   the German-Physical-Society
CY MAR 11-15, 2002
CL REGENSBURG, GERMANY
SP German Physical Soc
DE low pressure plasma; grafting; polymers; amino group; surface analysis
ID RAY PHOTOELECTRON-SPECTROSCOPY; AMMONIA GASEOUS PLASMA;
   CHEMICAL-ANALYSIS; POLYMER SURFACES; IMMOBILIZATION; POLYETHYLENE;
   POLYSTYRENE; FTIR; POLY(ETHYLENE); ADHESION
AB Low-pressure gas-discharge plasmas are widely used for polymer surface functionalization on industrial scale. For biomaterial applications, the density and selectivity of the functionalization are of particular importance, because functional groups control the immobilization of biomolecules. Therefore, surface modification of biomaterials is a challenging task for low-pressure plasma technique, Plasma processes have been successfully applied to various polymer types in order to generate multifunctional surfaces. This paper discusses the present state and the prospects of noncoating plasma processes to generate mono functional surfaces of controlled amino group density. Such surfaces appear most desirable for many applications. The results of various microwave- and radio-frequency- excited plasma processes reported in the literature are reviewed and compared to a sequence of experiments that was conducted in a UHV reaction environment. Non-thermal plasmas are especially well suited for thermally damageable polymers. The effect of hydrogen admixture to discharges in nitrogen and ammonia is discussed in detail. The optimization of process parameters lead to highly selective amino functionalization of high density. The selectivity reached 100% -NH2/N at a surface density of amino groups of 3% -NH2/C. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Inst Neidertemp Plasma Phys, D-17489 Greifswald, Germany.
RP Ohl, A (reprint author), Inst Neidertemp Plasma Phys, Friedrich Ludwig Jahn Str 19, D-17489 Greifswald, Germany.
RI Meyer-Plath, Asmus/E-4573-2011
OI Meyer-Plath, Asmus/0000-0001-9037-7706; Finke,
   Birgit/0000-0002-5941-0376
CR Alami M., 1996, Plasmas and Polymers, V1, P113, DOI 10.1007/BF02532822
   Arefi-Khonsari F, 2001, SURF COAT TECH, V142, P437, DOI 10.1016/S0257-8972(01)01240-3
   BARBUCCI R, 1994, BIOMATERIALS, V15, P955, DOI 10.1016/0142-9612(94)90075-2
   Butoi C I, 1999, PLASMAS POLYM, V4, P77
   Cicala G, 1999, APPL PHYS LETT, V75, P37, DOI 10.1063/1.124269
   CORNELL DW, 1966, J AM CHEM SOC, V88, P544, DOI 10.1021/ja00955a028
   DUAN X, 2001, THESIS ERNST MORITZ
   DUNN TS, 1984, Patent No. 4452679
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   EVERHART DS, 1981, ANAL CHEM, V53, P665, DOI 10.1021/ac00227a022
   Favia P, 1997, J PHYS IV, V7, P199, DOI 10.1051/jp4:1997415
   Favia P, 1996, PLASMAS POLYM, V1, P91, DOI DOI 10.1007/BF02532821
   FOERCH R, 1990, J APPL POLYM SCI, V40, P1903, DOI 10.1002/app.1990.070401109
   Fozza AC, 1999, MATER RES SOC SYMP P, V544, P109
   GENGENBACH TR, 1994, J ADHES SCI TECHNOL, V8, P305, DOI 10.1163/156856194X00267
   Girardeaux C., 1996, PLASMAS POLYM, V1, P327, DOI DOI 10.1007/BF02532829
   HAYAT U, 1992, BIOMATERIALS, V13, P801, DOI 10.1016/0142-9612(92)90022-G
   HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419
   HOLLANDER A, 1993, J APPL POLYM SCI, V49, P1857, DOI 10.1002/app.1993.070491016
   KELLER D, 1997, POLYM PREPR AM CHEM, V38, P1043
   KELLER D, 1999, THESIS ERNST MORITZ
   KLEMBERGSAPIEHA JE, 1991, J VAC SCI TECHNOL A, V9, P2975, DOI 10.1116/1.577158
   KRISHNAMURTHY V, 1989, J POLYM SCI POL CHEM, V27, P1211, DOI 10.1002/pola.1989.080270409
   Kuhn G, 2001, SURF COAT TECH, V142, P494, DOI 10.1016/S0257-8972(01)01056-8
   Lee JH, 1998, SCIENCE AND TECHNOLOGY OF POLYMERS AND ADVANCED MATERIALS, P535
   Lhoest JB, 1996, J BIOMAT SCI-POLYM E, V7, P1039, DOI 10.1163/156856296X00534
   LUB J, 1989, POLYMER, V30, P40, DOI 10.1016/0032-3861(89)90380-7
   Martinez AJ, 2000, J BIOMAT SCI-POLYM E, V11, P415, DOI 10.1163/156856200743797
   MEYERPLATH A, 2002, THESIS ERNST MORITZ
   NAKAYAMA Y, 1988, J POLYM SCI POL CHEM, V26, P559, DOI 10.1002/pola.1988.080260219
   Nitschke M, 1997, J APPL POLYM SCI, V65, P381
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   OHL A, 1999, J SURF COAT TECHNOL, V116, P1006
   Retzko I, 2001, J ELECTRON SPECTROSC, V121, P111, DOI 10.1016/S0368-2048(01)00330-9
   SAFRANY DR, 1968, J PHYS CHEM-US, V72, P518, DOI 10.1021/j100848a022
   Schroder K, 2001, CONTRIB PLASM PHYS, V41, P562, DOI 10.1002/1521-3986(200111)41:6<562::AID-CTPP562>3.0.CO;2-Y
   Schroder K., 2000, MAT MED ENG, P161
   SHAHIDZADEHAHMA.N, 1996, J PLASMAS POLYM, V1, P27
   SIPEHIA R, 1988, J BIOMED MATER RES, V22, P417, DOI 10.1002/jbm.820220505
   SIPEHIA R, 1986, BIOMATERIALS, V7, P471, DOI 10.1016/0142-9612(86)90038-4
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P647, DOI 10.3109/10731199309117389
   TAKAHARA A, 1989, Journal of Biomaterials Science Polymer Edition, V1, P17, DOI 10.1163/156856289X00037
   TERLINGEN JGA, 1993, J BIOMAT SCI-POLYM E, V4, P165, DOI 10.1163/156856293X00500
   von Keudell A, 2000, APPL PHYS LETT, V76, P676, DOI 10.1063/1.125858
   WESSLEN B, 1994, BIOMATERIALS, V15, P278, DOI 10.1016/0142-9612(94)90052-3
   Williams D, 1988, ADV BIOMATER, V8, P11
   Zabeida O, 1999, MATER RES SOC SYMP P, V544, P233
NR 47
TC 136
Z9 140
U1 0
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD MAY 19
PY 2003
VL 71
IS 3
BP 391
EP 406
DI 10.1016/S0042-207X(02)00766-2
PG 16
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 674DQ
UT WOS:000182622100005
DA 2018-10-19
ER

PT J
AU Chu, CL
   Zhu, JC
   Yin, ZD
   Lin, PH
AF Chu, CL
   Zhu, JC
   Yin, ZD
   Lin, PH
TI Optimal design and fabrication of hydroxyapatite-Ti asymmetrical
   functionally graded biomaterial
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE functionally graded biomaterial; optimal design; titanium;
   hydroxyapatite
AB Hydroxyapatite (HA)-Ti asymmetrical functionally graded biomaterial (FGM) combining the excellent biocompatible properties of HA ceramic and the good mechanical properties of titanium metal was designed optimally and fabricated in this paper. The thermo-elastic properties of the uniform HA-Ti composites with various mixing ratios corresponding to each graded layer of the FGM were tested firstly. The experimental results show thermal expansion coefficients of HA-Ti composites increase with the rise of testing temperature or the content of HA ceramic and aren't affected by the allotropic transformation of alpha --> beta-Ti phase at 882.5 degreesC, while there is no a direct corresponding relationship between elastic modulus and the mixing ratio of HA-Ti composites. Then the optimal graded compositional distribution exponent n for HA-Ti asymmetrical FGM is acquired by the thermal stress relaxation design and structure optimization, which is 0.9. Finally the perfect HA-Ti asymmetrical FGM with the optimum graded composition was fabricated by hot pressing successfully. The tested values of residual thermal stress in the sintered FGM samples by X-ray stress analyzer are basically consistent with the theoretically calculated ones. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 SE Univ, Dept Engn Mech, Nanjing 210018, Peoples R China.
   Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Chu, CL (reprint author), SE Univ, Dept Engn Mech, Nanjing 210018, Peoples R China.
RI Zhu, Jingchuan/B-3573-2018
OI Zhu, Jingchuan/0000-0002-6075-2373
CR BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   Chu CL, 1999, J INORG MATER, V14, P775
   Chu CL, 2001, MAT SCI ENG A-STRUCT, V316, P205, DOI 10.1016/S0921-5093(01)01239-4
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   Chu CL, 2000, T NONFERR METAL SOC, V10, P505
   CHU CL, 2000, THESIS HARBIN I TECH
   CHU CL, 1999, T NONFERROUS METALS, V9, P57
   Neubrand A, 1997, Z METALLKD, V88, P358
   Suresh S, 1997, INT MATER REV, V42, P85, DOI 10.1179/imr.1997.42.3.85
   Tang X.F., 1994, J CHINESE CERAMIC SO, V22, P44
   Watari F, 1998, J JPN I MET, V62, P1095, DOI 10.2320/jinstmet1952.62.11_1095
NR 11
TC 27
Z9 34
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAY 15
PY 2003
VL 348
IS 1-2
BP 244
EP 250
AR PII S0921-5093(02)00738-4
DI 10.1016/S0921-5093(02)00738-4
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 654QZ
UT WOS:000181508700028
DA 2018-10-19
ER

PT J
AU dos Santos, LA
   Carrodeguas, RG
   Boschi, AO
   de Arruda, ACF
AF dos Santos, LA
   Carrodeguas, RG
   Boschi, AO
   de Arruda, ACF
TI Dual-setting calcium phosphate cement modified with ammonium
   polyacrylate
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 2nd Latin American Congress of Artificial Organs and Biomaterials (2nd
   COLAOB)
CY DEC 05-08, 2001
CL MINAS GERAIS, BRAZIL
DE calcium phosphate cement; calcium phosphate; alpha-tricalcium phosphate;
   bioceramic; biomaterial; medical devices
ID STRENGTH; TEMPERATURE
AB alpha-Tricalcium phosphate bone cement, as formerly designed and developed by Driessens et al., consists of a powder composed by alpha-tricalcium phosphate (alpha-TCP) and hydroxyapatite (HA) seeds, and an aqueous solution of Na-2 HPO4 as mixing liquid. After mixing powder and liquid, alpha-TCP dissolves into the liquid and calcium deficient hydroxyapatite (CDHA), more insoluble than the former, precipitates as an entanglement of crystals, which causes the setting and hardening of the cement. alpha-TCP bone cement offers several advantages in comparison to calcium phosphate bioceramics and acrylic bone cements as bone graft and repairing material, like perfect adaptability to the defect size and shape, osteotransductibility, and absence of thermal effect during setting. The main handicap is its low mechanical strength. Therefore, approaching its mechanical strength to that of human bone could considerably extend its applications. In the present work, an in situ polymerization system based on acrylamide (AA) and ammonium polyacrylate (PA) as liquid reducer was added to alpha-TCP cement to increase its mechanical strength. The results showed that the addition of 20 wt% of acrylamide and 1 wt% AP to the liquid increased the compressive and tensile strength of alpha-TCP bone cement by 149 and 69% (55 and 21 MPa), respectively. The improvement in mechanical strength seems to be caused by a decrease of porosity and the reinforcing effect of a polyacrylamide network coexisting with the entanglement of CDHA crystals. The studied additives do not affect the nature of the final product of the setting reaction, CDHA, but promote the reduction of its crystal size.
C1 Univ Estadual Campinas, Fac Engn Mecan, Campinas, SP, Brazil.
   Univ La Habana, Ctr Biomat, Havana, Cuba.
   Univ Fed Sao Carlos, Dept Mat Engn, BR-13560 Sao Carlos, SP, Brazil.
RP dos Santos, LA (reprint author), Univ Fed Rio Grande Sul, Escola Engn, Av Osvaldo Aranha,99 Sala 711, BR-90035190 Porto Alegre, RS, Brazil.
RI BOSCHI, Anselmo/K-7091-2013; Garcia Carrodeguas, Raul/E-5087-2012
OI Garcia Carrodeguas, Raul/0000-0002-4379-4598; Loureiro dos Santos, Luis
   Alberto/0000-0002-9099-9748
CR BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P144, DOI 10.1007/BF00053334
   CARRODEGUAS RG, 1999, REV CNIC CQ CUBA, V30, P153
   Cherng A, 1997, J BIOMED MATER RES, V35, P273, DOI 10.1002/(SICI)1097-4636(19970605)35:3<273::AID-JBM1>3.0.CO;2-E
   Chow LC, 2000, J BIOMED MATER RES, V53, P511, DOI 10.1002/1097-4636(200009)53:5<511::AID-JBM10>3.3.CO;2-5
   Driessens FCM, 1997, AN QUIM-INT, V93, pS38
   FAMERY R, 1994, CERAM INT, V20, P327, DOI 10.1016/0272-8842(94)90050-7
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   GINEBRA MP, 1995, J MATER SCI-MATER M, V6, P612, DOI 10.1007/BF00121286
   Ginebra MP, 1995, J MATER SCI-MATER M, V6, P857, DOI 10.1007/BF00134332
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   GINEBRA MP, 1998, BIOCERAMICS, V11, P243
   GRUNINGER SE, 1984, J DENT RES, V63, P200
   ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210
   JENKINS R, 1971, INTRO XRAY POWDER DI
   LeGeros R.Z., 1991, CALCIUM PHOSPHATES O, V15
   Matsuya Y, 1996, DENT MATER, V12, P2, DOI 10.1016/S0109-5641(96)80056-X
   Miyamoto Y, 1998, BIOMATERIALS, V19, P707, DOI 10.1016/S0142-9612(97)00186-5
   MIYAZAKI K, 1993, DENT MATER, V9, P41, DOI 10.1016/0109-5641(93)90104-X
   Monma H, 1984, GYPSUM LIME, V188, P11
   Santos L.A., 1999, BONE, V25, p99S
   SAWAMURA T, 1999, Patent No. 5993535
   SAWAMURA T, 1999, Patent No. 5980625
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
NR 24
TC 25
Z9 25
U1 1
U2 9
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAY
PY 2003
VL 27
IS 5
BP 412
EP 418
DI 10.1046/j.1525-1594.2003.07248.x
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 674RY
UT WOS:000182650800004
PM 12752199
DA 2018-10-19
ER

PT J
AU Rogero, SO
   Malmonge, SM
   Lugao, AB
   Ikeda, TI
   Miyamaru, L
   Cruz, AS
AF Rogero, SO
   Malmonge, SM
   Lugao, AB
   Ikeda, TI
   Miyamaru, L
   Cruz, AS
TI Biocompatibility study of polymeric biomaterials
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 2nd Latin American Congress of Artificial Organs and Biomaterials (2nd
   COLAOB)
CY DEC 05-08, 2001
CL MINAS GERAIS, BRAZIL
DE polymeric biomaterial; hydrogel; biocompatibility; cytotoxicity assay;
   dermal irritability assay
ID HYDROGELS
AB Polymeric hydrogels are used as wound dressing material since these materials show advantages such as pain relief, exudates absorption, barrier to microorganisms, permeability, and others. This article shows the results obtained in a study aiming to know the biological performance of different polymeric materials to be used in contact with skin: PVP hydrogels and acrylate adhesive. The biocompatibility was determined by in vitro assay of cytotoxicity and in vivo assay by using the contact test of irritability in rabbits. All the tested samples presented no toxicity and no dermal irritation.
C1 IPEN, BR-05422970 Sao Paulo, Brazil.
   Univ Metodista Piracicaba, Sao Paulo, Brazil.
   Inst Adolfo Lutz Registro, Sao Paulo, Brazil.
RP Rogero, SO (reprint author), IPEN, Av Lineu Prestes 2242,Cidade Univ, BR-05422970 Sao Paulo, Brazil.
EM sorogero@net.ipen.br
RI Lugao, Ademar/B-6847-2013; Malmonge, Sonia/I-4610-2012
CR *AM SOC TEST MAT, 1996, 71981 ASTMF
   Ciapetti G, 1996, BIOMATERIALS, V17, P1259, DOI 10.1016/0142-9612(96)88670-4
   Draize J. H., 1959, DERMAL TOXICITY APPR
   Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
   *INT ORG STAND, 1995, 10993 ISO
   International Organization for Standardization, 1992, 10993 ISO
   Lugao AB, 2002, RADIAT PHYS CHEM, V63, P543, DOI 10.1016/S0969-806X(01)00551-5
   LUGAO AB, 2001, RADIAT PHYS CHEM, V63, P37
   *QUAL HLTH CONTR N, 1999, 653330003 QUAL HLTH
   Rosiak J. M., 1989, US patent, Patent No. [US4871490, 4871490]
   Rosiak JM, 1995, NUCL INSTRUM METH B, V105, P335, DOI 10.1016/0168-583X(95)00550-1
   Ulanski P, 1999, NUCL INSTRUM METH B, V151, P356, DOI 10.1016/S0168-583X(99)00085-3
   WILLIAMS DF, 1986, PROGR BIOMEDICAL ENG
NR 13
TC 41
Z9 44
U1 2
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAY
PY 2003
VL 27
IS 5
BP 424
EP 427
DI 10.1046/j.1525-1594.2003.07249.x
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 674RY
UT WOS:000182650800006
PM 12752201
DA 2018-10-19
ER

PT J
AU Legendre, D
   da Silva, OL
   Andrade, A
   Fonseca, J
   Nicolosi, D
   Biscegli, J
AF Legendre, D
   da Silva, OL
   Andrade, A
   Fonseca, J
   Nicolosi, D
   Biscegli, J
TI Endurance test on a textured diaphragm for the auxiliary total
   artificial heart (ATAH)
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 2nd Latin American Congress of Artificial Organs and Biomaterials (2nd
   COLAOB)
CY DEC 05-08, 2001
CL MINAS GERAIS, BRAZIL
DE artificial heart; biomaterial; polyurethane; durability; endurance test
AB We performed an endurance test on a textured diaphragm made of polyurethane (BioSpan, The Polymer Technology Group, San Francisco, CA, U.S.A.) to be used in the auxiliary total artificial heart (ATAH), an electromechanical device that can be totally implantable without removing the natural heart due to the device's reduced dimension. The objective of this endurance test was to predict whether this diaphragm would be capable of resisting in vivo tests with the ATAH implanted for fifteen days in calves. In this study, a mock loop system simulating the human circulatory system was used. The test protocol was elaborated to reproduce extreme physiological conditions. The technique to produce the textured diaphragms made of polyurethane is shown. The textured surface is used as basis to fix a layer of calf-skin gelatin. The technique used to make the diaphragm guaranteed a totally textured surface without cracking. The diaphragm demonstrated enough resistance to be used at the 15 day in vivo experiments.
C1 Inst Dante Pazzanese Cardiol, Dept Bioengn, BR-04012180 Sao Paulo, Brazil.
   Univ Sao Paulo, Dept Bioengn, Sao Carlos, SP, Brazil.
RP Legendre, D (reprint author), Inst Dante Pazzanese Cardiol, Dept Bioengn, Av Dr Dante Pazzanese 500, BR-04012180 Sao Paulo, Brazil.
CR Andrade A, 1999, ARTIF ORGANS, V23, P876, DOI 10.1046/j.1525-1594.1999.06273.x
   Andrade A, 1996, ARTIF ORGANS, V20, P605, DOI 10.1111/j.1525-1594.1996.tb04489.x
   BLASS J, 1976, J AM LEATHER CHEM AS, P71
   GRAHAM T R, 1990, Artificial Organs, V14, P135
   IMAI Y, 1970, T AM SOC ART INT ORG, P16
   KAMBIC H, 1976, T AM SOC ART INT ORG, V22, P664
   KAMBIC H, 1978, T AM SOC ART INT ORG, V24, P426
   KIRALY R, 1979, ARTIF ORGANS, V3, P216
   KWANGETT CS, 1967, T AM SOC ART INT ORG, V13, P313
   NOSE Y, 1967, J THORAC CARDIOV SUR, V54, P697
   NOSE Y, 1980, N01HV429606
   NOSE YUKIHIKO, 1967, J BIOMED MAT RES, V1, P151, DOI 10.1002/jbm.820010114
   Ohashi Y, 1999, ARTIF ORGANS, V23, P884, DOI 10.1046/j.1525-1594.1999.t01-1-06308_2.x
   ORIME Y, 1994, ARTIF ORGANS, V18, P54, DOI 10.1111/j.1525-1594.1994.tb03299.x
NR 14
TC 8
Z9 8
U1 0
U2 2
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD MAY
PY 2003
VL 27
IS 5
BP 457
EP 460
DI 10.1046/j.1525-1594.2003.07238.x
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 674RY
UT WOS:000182650800013
PM 12752208
DA 2018-10-19
ER

PT J
AU Ha, BJ
   Lee, JY
AF Ha, BJ
   Lee, JY
TI The effect of chondroitin sulfate against CCl4-induced hepatotoxicity
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE chondroitin sulfate; carbone tetrachloride; malondialdehyde
ID LIPID-PEROXIDATION; LIVER-INJURY; RAT-LIVER; GLUTATHIONE; DISEASE;
   ANTIOXIDANTS
AB This study was conducted to develop a new biomaterial to be used for an antioxidative drug. In this study, the hepatoprotective effect of chondroitin sulfate (CS) (100 mg/kg and 200 mg/kg body weight) was investigated at the antioxidative enzyme levels of liver total homogenate and mitochondria fraction. And the carbone tetrachloride (CCl4)-induced rats were used as hepatotoxic models. The CCl4 induced rat has been widely used as a hepatotoxic model due to its practicality, convenience and cost effectiveness since the generation of free oxygen radicals by CCl4 injection was proposed as an important causative agent of hepatotoxicity. Malondialdehyde (MDA) levels were determined as well as the activities of superoxide dismutase (SOD), catalase (CAT), reduced-glutathione (GSH), oxidized-glutathione (GSSG) and glutathione peroxidase (GPx) in the liver. In addition, histopathology of liver tissue was investigated. Liver antioxidative enzyme activity was elevated while MDA concentration was decreased in all CS treated animals. The results demonstrated that CS protected oxidative stress in a dose dependent manner. Moreover, inflammation and cirrhosis in liver tissue of CS treated group were significantly decreased. It gave us an impression that CS might be a radical scavenger.
C1 Silla Univ, Dept New Mat Chem & Biotechnol, Sasang Gu 617736, Busan, South Korea.
   Inje Univ, Coll Med, Dept Biochem, Busanjin Gu 614735, Busan, South Korea.
RP Ha, BJ (reprint author), Silla Univ, Dept New Mat Chem & Biotechnol, SAN 1-1, Sasang Gu 617736, Busan, South Korea.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   BALDWIN DA, 1984, J BIOL CHEM, V259, P3391
   BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8
   BIRD RP, 1980, J TOXICOL ENV HEALTH, V6, P811, DOI 10.1080/15287398009529899
   BRATTIN W J, 1985, Journal of Free Radicals in Biology and Medicine, V1, P27, DOI 10.1016/0748-5514(85)90026-1
   Ellman GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI DOI 10.1016/0003-9861(59)90090-6.PMID:13650640
   GERMAIN GS, 1977, BIOCHEM BIOPH RES CO, V79, P119, DOI 10.1016/0006-291X(77)90068-7
   HALLIWELL B, 1992, J LAB CLIN MED, V119, P598
   HARDINGHAM T, 1990, SEMIN ARTHRITIS RHEU, V20, P12, DOI 10.1016/0049-0172(90)90044-G
   Jollow D J, 1980, Arch Toxicol Suppl, V3, P95
   KURATA M, 1993, COMP BIOCHEM PHYS B, V106, P477, DOI 10.1016/0305-0491(93)90121-K
   LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6
   LEEUWENBURGH C, 1995, ARCH BIOCHEM BIOPHYS, V316, P941, DOI 10.1006/abbi.1995.1125
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MEGO JL, 1985, BIOCHIM BIOPHYS ACTA, V841, P139, DOI 10.1016/0304-4165(85)90014-5
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   Polavarapu R, 1998, HEPATOLOGY, V27, P1317, DOI 10.1002/hep.510270518
   PROCTOR PH, 1986, ARCH DERMATOL, V122, P507
   PUGLIA CD, 1984, ENVIRON HEALTH PERSP, V57, P307, DOI 10.2307/3429932
   RACKER E, 1955, J BIOL CHEM, V217, P855
   SALMINEN A, 1984, ACTA PHYSIOL SCAND, V122, P565, DOI 10.1111/j.1748-1716.1984.tb07545.x
   SENO N, 1982, CARBOHYD RES, V103, P190
   STRIPP B, 1972, BIOCHEM PHARMACOL, V21, P745, DOI 10.1016/0006-2952(72)90069-X
   Sugimura Y, 1998, J NUTR SCI VITAMINOL, V44, P613
   SUZUKI S, 1960, J BIOL CHEM, V235, P3585
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
NR 27
TC 20
Z9 24
U1 0
U2 4
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD MAY
PY 2003
VL 26
IS 5
BP 622
EP 626
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 675PM
UT WOS:000182703800010
PM 12736501
DA 2018-10-19
ER

PT J
AU Grigolo, B
   Roseti, L
   Fiorini, M
   Piacentini, A
   De Franceschi, L
   Facchini, A
AF Grigolo, B
   Roseti, L
   Fiorini, M
   Piacentini, A
   De Franceschi, L
   Facchini, A
TI Cathepsin B as a soluble marker to monitor the phenotypic stability of
   engineered cartilage
SO BIOMATERIALS
LA English
DT Article
DE chondrocytes; cathepsin B; Hyaff (R)-11; real-time PCR
ID RABBIT ARTICULAR CHONDROCYTES; FEMORAL-HEAD CARTILAGE; EXPRESSION;
   CULTURE; OSTEOARTHRITIS; DEFECTS; DIFFERENTIATION; GELS; LOSE
AB The clinical need for improved human autologous chondrocyte transplantation has motivated the use of different biomaterials, which are aimed at fixing the cells in the defect area and permit their proliferation and differentiation. The maintenance of the original phenotype by isolated chondrocytes grown in vitro is an important requisite for their use in repairing damaged articular cartilage. The methods to verify the expression of cartilage-specific molecules usually involve destructive procedures to recover the cells from the scaffolds for tests. The aim of our study was to find a soluble marker able to attest the occurrence of a differentiation process by chondrocytes grown onto a biomaterial used for cell transplantation. We turned our attention to cathepsin B which is known to be abnormally synthesized in de-differentiated chondrocytes and scarcely produced in the differentiated ones. The production of cathepsin B by human articular chondrocytes expanded in vitro and then grown onto a hyaluronan-based polymer derivative (Hyaff(Jf)-11) three-dimensional scaffold was evaluated with a specific enzyme-immunoassay at different experimental times together with the expression of mRNA by real-time PCR. We showed that cathepsin B, which is abundantly produced by chondrocytes grown in a monolayer culture, decreases significantly after the cells are seeded onto the scaffold, giving further evidence of a re-differentiation process. This result suggests cathepsin B a practical soluble marker to evaluate the "good" quality of transplantable constructs. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Ist Ric Codivilla Putti, Ist Ortoped Rizzoli, Lab Immunol & Genet, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40138 Bologna, Italy.
RP Grigolo, B (reprint author), Ist Ric Codivilla Putti, Ist Ortoped Rizzoli, Lab Immunol & Genet, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   AULTHOUSE AL, 1989, IN VITRO CELL DEV B, V25, P659
   BAICI A, 1990, CELL TISSUE RES, V259, P567, DOI 10.1007/BF01740785
   BAICI A, 1988, ANN RHEUM DIS, V47, P684, DOI 10.1136/ard.47.8.684
   BAICI A, 1995, ANN RHEUM DIS, V54, P289, DOI 10.1136/ard.54.4.289
   BAICI A, 1995, ANN RHEUM DIS, V54, P281, DOI 10.1136/ard.54.4.281
   BAICI A, 1990, FEBS LETT, V277, P93, DOI 10.1016/0014-5793(90)80816-2
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Berardi S, 2001, ARTHRITIS RHEUM, V44, P1819, DOI 10.1002/1529-0131(200108)44:8<1819::AID-ART319>3.0.CO;2-4
   BLANCO FJ, 1995, J IMMUNOL, V154, P4018
   Blaschke V, 2000, J IMMUNOL METHODS, V246, P79, DOI 10.1016/S0022-1759(00)00304-5
   DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6
   GONG QM, 1993, DNA CELL BIOL, V12, P299, DOI 10.1089/dna.1993.12.299
   GRANDOLFO M, 1993, CALCIFIED TISSUE INT, V52, P42, DOI 10.1007/BF00675625
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P334, DOI 10.1006/bbrc.2001.4787
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   HOMMINGA GN, 1993, ACTA ORTHOP SCAND, V64, P441, DOI 10.3109/17453679308993663
   Kostoulas G, 1997, FEBS LETT, V412, P453, DOI 10.1016/S0014-5793(97)00825-9
   Lang A, 2000, J RHEUMATOL, V27, P1970
   MAYNE R, 1976, P NATL ACAD SCI USA, V73, P1674, DOI 10.1073/pnas.73.5.1674
   Mort JS, 1997, INT J BIOCHEM CELL B, V29, P715, DOI 10.1016/S1357-2725(96)00152-5
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
NR 28
TC 11
Z9 11
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2003
VL 24
IS 10
BP 1751
EP 1757
DI 10.1016/S0142-9612(02)00569-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 651BJ
UT WOS:000181300100009
PM 12593957
DA 2018-10-19
ER

PT J
AU Neut, D
   van de Belt, H
   van Horn, JR
   van der Mei, HC
   Busscher, HJ
AF Neut, D
   van de Belt, H
   van Horn, JR
   van der Mei, HC
   Busscher, HJ
TI Residual gentamicin-release from antibiotic-loaded
   polymethylmethacrylate beads after 5 years of implantation
SO BIOMATERIALS
LA English
DT Article
DE polymethylmethacryate; beads; gentamicin; biodegradable; antibiotic
   resistance
ID ELUTION CHARACTERISTICS; PMMA BEADS; OSTEOMYELITIS; INFECTION
AB In infected joint arthroplasty, high local levels of antibiotics are achieved through temporary implantation of non-biodegradable gentamicin-loaded polymethylmethacrylate beads. Despite their antibiotic release, these beads act as a biomaterial surface to which bacteria preferentially adhere, grow and potentially develop antibiotic resistance. In routine clinical practice, these beads are removed after 14 days, but for a variety of reasons, we were confronted with a patient in which these beads were left in situ for 5 years. Retrieval of gentamicin-loaded beads from this patient constituted an exceptional case to study the effects of long-term implantation on potentially colonizing microflora and gentamicin release. Gentamicin-release test revealed residual antibiotic release after being 5 years in situ and extensive microbiological sampling resulted in recovery of a gentamicin-resistant staphylococcal strain from the bead surface. This case emphasizes the importance of developing biodegradable antibiotic-loaded beads Lis an antibiotic delivery system. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen Hosp, Dept Orthoped Surg, NL-9713 GZ Groningen, Netherlands.
   Streekziekenhuis Coevorden Hardenberg, Dept Orthoped Surg, NL-7772 SE Hardenberg, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR Burd TA, 2001, J ORTHOP TRAUMA, V15, P424, DOI 10.1097/00005131-200108000-00007
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   KLEMM KW, 1993, CLIN ORTHOP RELAT R, P63
   NELSON CL, 1994, ORTHOPEDICS, V17, P415
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   von Eiff C, 1998, Z ORTHOP GRENZGEB, V136, P268, DOI 10.1055/s-2008-1054234
   WAHLIG H, 1979, ZBL CHIR, V104, P923
   WALENKAMP GHIM, 1986, CLIN ORTHOP RELAT R, P171
   Walenkamp GHIM, 1997, ACTA ORTHOP SCAND, V68, P497, DOI 10.3109/17453679708996270
   Wichelhaus TA, 2001, J ANTIMICROB CHEMOTH, V48, P117, DOI 10.1093/jac/48.1.117
NR 11
TC 111
Z9 115
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2003
VL 24
IS 10
BP 1829
EP 1831
DI 10.1016/S0142-9612(02)00614-2
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 651BJ
UT WOS:000181300100017
PM 12593965
DA 2018-10-19
ER

PT J
AU Suppes, GJ
   Goff, MJ
   Lopes, S
AF Suppes, GJ
   Goff, MJ
   Lopes, S
TI Latent heat characteristics of fatty acid derivatives pursuant phase
   change material applications
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE renewable; energy; storage; fats; phase change; material
ID THERMAL-ENERGY STORAGE; TRANSFORMATION
AB In their natural form, fats and vegetable oils melt at temperatures useful for thermal energy storage. Incremental improvement of their heat release characteristics could pave the way for commercial applications as phase change materials (PCM). These chemicals could provide a biomaterial alternative to a technology dominated by paraffin and salt products.
   Mixture heats of fusion and melting points were evaluated for single acid derivatives of stearic, palmitic, and oleic acids to develop a fundamental understanding of the solid liquid transition and to better understand how to convert natural compositions to useful PCM products. Many mixtures of monoacid derivatives of a single fatty acid formed single sharp solid-liquid phase transitions useful for PCM applications. These mixtures also qualitatively exhibited freezing point depression therein allowing the mixture composition to be used as a means to control the temperature of the phase transition. In mixtures of monoacid derivatives from different fatty acids, melting occurred over wider temperature ranges with eventual separation of the solid-liquid transition to at least two different events. This work demonstrates that it is possible to fully convert natural fatty acid mixtures into high performance phase change materials. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA.
RP Suppes, GJ (reprint author), Univ Missouri, Dept Chem Engn, W2028 Engn Bldg E, Columbia, MO 65211 USA.
CR ABHAT A, 1983, SOL ENERGY, V30, P313, DOI 10.1016/0038-092X(83)90186-X
   Banu D, 1998, J MATER CIVIL ENG, V10, P98, DOI 10.1061/(ASCE)0899-1561(1998)10:2(98)
   BLAUROCK AE, 1999, PHYSICAL PROPERTIES
   Bockisch M., 1993, FATS OILS HDB
   DAYTON, 1997, INT J GLOBAL ENERGY, V9, P183
   FELDMAN D, 1993, 28 INT EN CONV ENG C, V2
   HADJIEVA M, 1992, SOL ENERG MAT SOL C, V27, P181, DOI 10.1016/0927-0248(92)90119-A
   HAGEMANN JW, 1983, J AM OIL CHEM SOC, V60, P1123, DOI 10.1007/BF02671340
   HAGEMANN JW, 1988, CRYSTALLIZATION POLY, P30
   Hinrichs R. A, 2002, ENERGY ITS USE ENV
   HOLDER GA, 1965, J I PETROL, V51, P228
   Johnson R. W., 1989, FATTY ACIDS IND
   KISSOCK JH, 1998, 1998 INT SOL EN C AS
   LANE GA, 1991, SOLAR ENERGY MAT SOL, V27, P4
   MAROUGIU MJ, 1997, 32 INT EN CONV ENG C
   ROBBELEN G, 1988, OIL CROPS WORLD
   Sandler S. I., 1989, CHEM ENG THERMODYNAM
   SATO K, 1987, J AM OIL CHEM SOC, V64, P124, DOI 10.1007/BF02546266
   SATO K, 1999, CRYSTALLIZATIOIN SOL
   Solomons T. G., 1988, ORGANIC CHEM
   Suppes GJ, 2001, J AM OIL CHEM SOC, V78, P139, DOI 10.1007/s11746-001-0234-y
   SUPPES GJ, 2000, 2000012014 SAE
   SWERN D, 1982, BAILEYS IND OIL FAT, V2
   TIMMS RE, 1984, PROG LIPID RES, V23, P1, DOI 10.1016/0163-7827(84)90004-3
   VERNER C, 1997, THESIS BRIGHTON U
   WEAST RC, 1982, CRC HDB CHEM PHYSICS
NR 26
TC 79
Z9 81
U1 1
U2 36
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD MAY
PY 2003
VL 58
IS 9
BP 1751
EP 1763
DI 10.1016/S0009-2509(03)00006-X
PG 13
WC Engineering, Chemical
SC Engineering
GA 677BB
UT WOS:000182786100009
DA 2018-10-19
ER

PT J
AU Rosch, R
   Junge, K
   Schachtrupp, A
   Klinge, U
   Klosterhalfen, B
   Schumpelick, V
AF Rosch, R
   Junge, K
   Schachtrupp, A
   Klinge, U
   Klosterhalfen, B
   Schumpelick, V
TI Mesh implants in hernia repair - Inflammatory cell response in a rat
   model
SO EUROPEAN SURGICAL RESEARCH
LA English
DT Article
DE biomaterial; hernia; inflammation; mesh; macrophage; T-cell; mast cell;
   cellular proliferation; ED3; CD3; PCNA
ID POLYPROPYLENE MESH; ABDOMINAL-WALL; TISSUE REACTION;
   MONOCLONAL-ANTIBODIES; INCISIONAL HERNIAS; INGUINAL-HERNIA; MAST-CELLS;
   BIOMATERIALS; HERNIORRHAPHY; MACROPHAGE
AB Background: In the reinforcement of the abdominal wall with mesh implants, various complications including hernia recurrence, abdominal pain, seroma formation and infection are discussed to depend on the biocompatibility of the alloplastic prosthesis. Particularly macrophages, T-cells and mast cells have been shown to play a major role in the inflammatory response to biomaterials. To approach biocompatibility of surgical meshes we therefore examined the infiltrate of these cells as well as the proliferation rate in response to different clinically applied materials. Materials and Methods: Three mesh materials (polypropylene: PP, Prolene(R); polyethylene terephthalate: PET, Mersilene(R), and polypropylene/polyglactin: PP + PG, Vypro(R)) were compared after inlay implantation in a standardized rodent animal model. A suture-closed laparotomy served as control. After 7 and 90 days of implantation, histochemical analysis of the inflammatory response to all biomaterials was performed: macrophages (ED3), T-cells (CD3), proliferating cells (PCNA) and mast cells (Giemsa) were investigated. Results: In all groups a persisting T-cell response was observed. Colonization of the interface with macrophages showed a pronounced reduction in the PP + PG-mesh group. Infiltration of mast cells at the tissue graft interface showed a time-dependent decrease in the PET-and PP + PG-mesh groups, whereas in contrast, index of mast cells increased in the PP-mesh group. At both time points, indices of proliferation were highest in the PP-mesh group. Conclusion: The present data confirm the development of a biomaterial-dependent chronic inflammatory response to surgical meshes with macrophages as the predominant cell type. Further research on the recruitment of inflammatory cells and in particular on the role of mast cells and their granular products should be encouraged. Copyright (C) 2003 S. Karger AG, Basel.
C1 Univ Aachen, Dept Surg, Rhein Westfal TH Aachen, D-52074 Aachen, Germany.
   Univ Aachen, Inst Pathol, Rhein Westfal TH Aachen, D-52074 Aachen, Germany.
RP Rosch, R (reprint author), Univ Aachen, Dept Surg, Rhein Westfal TH Aachen, Pauwelsstr 30, D-52074 Aachen, Germany.
EM r.rosch@chir.rwth-aachen.de
CR AMID PK, 1994, LANGENBECK ARCH CHIR, V379, P168, DOI 10.1007/BF00680113
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anthony T, 2000, WORLD J SURG, V24, P95, DOI 10.1007/s002689910018
   Beets GL, 1996, BRIT J SURG, V83, P203, DOI 10.1046/j.1365-2168.1996.02223.x
   Beets GL, 1996, EUR J SURG, V162, P823
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   BELLON JM, 1994, EUR SURG RES, V26, P46, DOI 10.1159/000129317
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   CHRISTENSON L, 1991, J BIOMED MATER RES, V25, P1119, DOI 10.1002/jbm.820250906
   DABROWIECKI S, 1991, EUR SURG RES, V23, P240, DOI 10.1159/000129159
   DEGUZMAN LJ, 1995, ENDOSCOPY, V27, P459, DOI 10.1055/s-2007-1005743
   Durden J G, 1974, Am Surg, V40, P662
   GRAY MR, 1994, BRIT J SURG, V81, P1213, DOI 10.1002/bjs.1800810845
   Hagerty RD, 2000, J BIOMED MATER RES, V49, P489, DOI 10.1002/(SICI)1097-4636(20000315)49:4<489::AID-JBM7>3.0.CO;2-2
   JANEWAY C, 2001, IMMUNOBIOLOGY
   JONES DA, 1993, BIOPHYS J, V65, P1560, DOI 10.1016/S0006-3495(93)81195-0
   Kama NA, 1999, EUR J SURG, V165, P1080
   Klinge U, 1998, EUR J SURG, V164, P951
   Klinge U, 2002, J SURG RES, V103, P208, DOI 10.1006/jsre.2002.6358
   Klosterhalfen B, 2000, CHIRURG, V71, P43
   KUBES P, 1994, J IMMUNOL, V152, P3570
   KURKI P, 1988, J IMMUNOL METHODS, V109, P49, DOI 10.1016/0022-1759(88)90441-3
   LAM KH, 1995, J BIOMED MATER RES, V29, P929, DOI 10.1002/jbm.820290804
   Leber GE, 1998, ARCH SURG-CHICAGO, V133, P378, DOI 10.1001/archsurg.133.4.378
   LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   O'Dwyer P, 1999, LANCET, V354, P185
   Schumpelick V, 1996, CHIRURG, V67, P1028, DOI 10.1007/s001040050099
   Silich RC, 1996, SURG ENDOSC-ULTRAS, V10, P537, DOI 10.1007/BF00188403
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   WALDREP DJ, 1993, AM SURGEON, V59, P716
   Westerband A, 1997, J VASC SURG, V25, P64, DOI 10.1016/S0741-5214(97)70322-7
NR 33
TC 72
Z9 77
U1 0
U2 7
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-312X
EI 1421-9921
J9 EUR SURG RES
JI Eur. Surg. Res.
PD MAY-JUN
PY 2003
VL 35
IS 3
BP 161
EP 166
DI 10.1159/000070045
PG 6
WC Surgery
SC Surgery
GA 681CE
UT WOS:000183018700003
PM 12740536
DA 2018-10-19
ER

PT J
AU dos Santos, LA
   Carrodeguas, RG
   Boschi, AO
   de Arruda, ACF
AF dos Santos, LA
   Carrodeguas, RG
   Boschi, AO
   de Arruda, ACF
TI Fiber-enriched double-setting calcium phosphate bone cement
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone cement; calcium phosphate cement; bioceramics; composite;
   biomaterial
ID DRUG-DELIVERY SYSTEM; COMPOSITES; RELEASE
AB Calcium phosphate bone cements are useful in orthopedics and traumatology, their main advantages being their biocompatibility and bioactivity, which render bone tissue osteoconductive, providing in situ hardening and easy handling. However, their low mechanical strength, which, in the best of cases, is equal to the trabecular bone, and their very low toughness are disadvantages. Calcium phosphate cement compositions with mechanical properties more closely resembling those of human bone would broaden the range of applications, which is currently limited to sites subjected to low loads. This study investigated the influence of added polypropylene, nylon, and carbon fibers on the mechanical properties of double setting alpha-tricalcium phosphate-based cement, using calcium phosphate cement added to an in situ polymerizable acrylamide-based system recently developed by the authors. Although the addition of fibers was found to reduce the compression strength of the double-setting calcium phosphate cement because of increased porosity, it strongly increased the cement's toughness (J(IC)) and tensile strength. The composites developed in this work, therefore, have a potential application in shapes subjected to flexure. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Estadual Campinas, FEM, BR-13081970 Campinas, SP, Brazil.
   Univ Fed Sao Carlos, BR-13560 Sao Carlos, SP, Brazil.
   Univ La Habana, Ctr Biomat, Havana, Cuba.
RP dos Santos, LA (reprint author), Univ Estadual Campinas, FEM, Caixa Postal 6122, BR-13081970 Campinas, SP, Brazil.
RI BOSCHI, Anselmo/K-7091-2013; Garcia Carrodeguas, Raul/E-5087-2012
OI Garcia Carrodeguas, Raul/0000-0002-4379-4598
CR BANTHIA N, 1994, J MATER CIVIL ENG, V6, P88, DOI 10.1061/(ASCE)0899-1561(1994)6:1(88)
   Beaudoin J. J., 1990, HDB FIBER REINFORCED
   Driessens FCM, 1997, AN QUIM-INT, V93, pS38
   GRUNINGER SE, 1984, J DENT RES, P63
   Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R
   Kokubo T, 1997, AN QUIM, V93, pS49
   LI VC, 1987, CEMENT CONCRETE RES, V17, P441, DOI 10.1016/0008-8846(87)90008-1
   MINDESS S, 1977, CEMENT CONCRETE RES, V7, P731, DOI 10.1016/0008-8846(77)90057-6
   Monma H, 1984, GYPSUM LIME, V188, P11
   OTSUKA M, 1994, J PHARM SCI, V83, P1569, DOI 10.1002/jps.2600831110
   Park CK, 1998, J CERAM SOC JPN, V106, P268, DOI 10.2109/jcersj.106.268
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Santos L.A., 1999, BONE, V25, p99S
   SANTOS LA, 2001, P 45 BRAZ C CER
   SANTOS LA, 2000, Patent No. 00007609
   TOPOLESKI LDT, 1990, J BIOMED MATER RES, V24, P135, DOI 10.1002/jbm.820240202
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
NR 17
TC 24
Z9 24
U1 1
U2 12
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY 1
PY 2003
VL 65A
IS 2
BP 244
EP 250
DI 10.1002/jbm.a.10474
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 674FW
UT WOS:000182627600017
PM 12734819
DA 2018-10-19
ER

PT J
AU Sun, DH
   Trindade, MCD
   Nakashima, Y
   Maloney, WJ
   Goodman, SB
   Schurman, DJ
   Smith, RL
AF Sun, DH
   Trindade, MCD
   Nakashima, Y
   Maloney, WJ
   Goodman, SB
   Schurman, DJ
   Smith, RL
TI Human serum opsonization of orthopedic biomaterial particles:
   Protein-binding and monocyte/macrophage activation in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE opsonization; particles; cytokines; macrophages; total joint
   arthroplasty; human
ID IN-VITRO; HIP-ARTHROPLASTY; BONE-RESORPTION; MACROPHAGES; PHAGOCYTOSIS;
   WEAR; INTERLEUKIN-6; ENDOTOXIN; RECEPTOR; RELEASE
AB Wear particles generated after total joint arthroplasty activate monocyte/macrophages and incite formation of a granulomatous periprosthetic tissue associated with bone loss and implant loosening. This study tested the hypothesis that selective opsonization of orthopedic implant biomaterial wear particles by human serum proteins influences monocyte/macrophage activation. Serum protein binding to metallic, polymeric, and ceramic particles was determined by one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Individual proteins bound to particles were subsequently identified using two-dimensional SDS-PAGE, microsequencing techniques, and SWISS-PROT analysis. Effects of selective protein opsonization on particle-induced monocyte/macrophage activation were assessed by quantification of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha release. Results from one-dimensional gel analyses revealed distinct serum protein-binding patterns specific for each material tested. Two-dimensional gel analysis together with amino acid sequencing of the prominent protein species confirmed the presence of albumin and alpha-l-antitrypsin bound to all particles tested. In contrast to the metallic particles, apolipoprotein was a major species associated with polymeric particles. Opsonization of PMMA particles with purified preparations of each of the identified proteins showed that albumin significantly enhanced particle-induced monocyte/macrophage activation. These data confirm orthopedic biomaterial specific binding of human serum proteins and demonstrate that albumin exacerbates particle-induced monocyte/macrophage activation. Alterations in the chemical and surface properties of orthopedic biomaterials to modulate protein interactions may improve implant longevity. (C) 2003 Wiley Periodicals, Inc.
C1 Stanford Univ, Sch Med, Orthopaed Res Lab, Stanford, CA 94305 USA.
RP Smith, RL (reprint author), Stanford Univ, Sch Med, Orthopaed Res Lab, Stanford, CA 94305 USA.
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   Blaine TA, 1996, J BONE JOINT SURG AM, V78A, P1181, DOI 10.2106/00004623-199608000-00008
   Blaine TA, 1997, J BONE JOINT SURG AM, V79A, P1519, DOI 10.2106/00004623-199710000-00009
   BRIEN WW, 1992, CLIN ORTHOP RELAT R, P66
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   DUNBAR BS, 1987, 2 DIMENSIONAL ELECTR, P249
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Gonzalez O, 1996, J BIOMED MATER RES, V30, P463, DOI 10.1002/(SICI)1097-4636(199604)30:4<463::AID-JBM4>3.3.CO;2-I
   Goodman SB, 1996, J BIOMED MATER RES, V31, P421, DOI 10.1002/(SICI)1097-4636(199607)31:3<421::AID-JBM17>3.0.CO;2-L
   GOODMAN SB, 1989, CLIN ORTHOP RELAT R, P182
   Gordon SB, 2000, INFECT IMMUN, V68, P2286, DOI 10.1128/IAI.68.4.2286-2293.2000
   Hallab NJ, 2000, J BIOMED MATER RES, V49, P353, DOI 10.1002/(SICI)1097-4636(20000305)49:3<353::AID-JBM8>3.0.CO;2-T
   Hitchins VM, 1999, J BIOMED MATER RES, V46, P434
   HOROWITZ SM, 1993, J BONE JOINT SURG AM, V75A, P802, DOI 10.2106/00004623-199306000-00002
   HOROWITZ SM, 1995, CALCIFIED TISSUE INT, V57, P301, DOI 10.1007/BF00298886
   HOWIE DW, 1988, J BONE JOINT SURG AM, V70A, P257, DOI 10.2106/00004623-198870020-00015
   Imai S, 1998, J BONE JOINT SURG BR, V80B, P701, DOI 10.1302/0301-620X.80B4.7952
   Jacobs J J, 1992, Instr Course Lect, V41, P119
   JACOBS JJ, 1996, CLIN ORTHOP S, V329, P256
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007
   Junker VL, 1999, BIOINFORMATICS, V15, P1066
   KEMP AS, 1986, IMMUNOLOGY, V59, P69
   KIM KJ, 1993, CLIN ORTHOP RELAT R, P142
   KOBZIK L, 1993, J IMMUNOL, V151, P2753
   KOZZIN SC, 1986, J ARTHROPLASTY, V1, P249
   Kusner DJ, 1999, J IMMUNOL, V162, P2266
   Kwon Soon Yong, 2000, Journal of Orthopaedic Research, V18, P202
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1448, DOI 10.2106/00004623-199509000-00022
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   Maloney WJ, 1998, J BIOMED MATER RES, V41, P371, DOI 10.1002/(SICI)1097-4636(19980905)41:3<371::AID-JBM5>3.3.CO;2-A
   Maloney WJ, 1996, CLIN ORTHOP RELAT R, P268
   MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035
   Mevorach D, 2000, ANN NY ACAD SCI, V926, P226
   Mulenga A, 2000, BBA-MOL BASIS DIS, V1501, P219, DOI 10.1016/S0925-4439(00)00026-0
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   Nakashima Y, 1999, J BONE JOINT SURG BR, V81B, P155, DOI 10.1302/0301-620X.81B1.8884
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   PAROD RJ, 1986, J IMMUNOL, V136, P2041
   RAE T, 1975, J BONE JOINT SURG BR, V57, P444
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Sabokbar A, 1995, J ARTHROPLASTY, V10, P810, DOI 10.1016/S0883-5403(05)80080-4
   Sabokbar A, 1998, ARCH ORTHOP TRAUM SU, V117, P136, DOI 10.1007/s004020050213
   Schagat TL, 1999, INFECT IMMUN, V67, P4693
   SCHMALZRIED TP, 1992, J BONE JOINT SURG AM, V74A, P849, DOI 10.2106/00004623-199274060-00006
   SHANBHAG AS, 1995, J ORTHOPAED RES, V13, P792, DOI 10.1002/jor.1100130520
   Stringer B, 1996, AM J RESP CELL MOL, V14, P155, DOI 10.1165/ajrcmb.14.2.8630265
   TAKATA K, 1988, J BIOL CHEM, V263, P14819
   TAKGI M, 1995, J BONE JOINT SURG AM, V77, P16
   Trindade MCD, 1999, J ORTHOP RES, V17, P797, DOI 10.1002/jor.1100170602
   Trindade MCD, 1999, J BIOMED MATER RES, V47, P1
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202
   WITT JD, 1991, J BONE JOINT SURG BR, V73, P559
   Wooley PH, 1999, J BONE JOINT SURG AM, V81A, P616, DOI 10.2106/00004623-199905000-00003
NR 58
TC 35
Z9 35
U1 0
U2 8
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY 1
PY 2003
VL 65A
IS 2
BP 290
EP 298
DI 10.1002/jbm.a.10477
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 674FW
UT WOS:000182627600022
PM 12734824
DA 2018-10-19
ER

PT J
AU Beiko, DT
   Knudsen, BE
   Denstedt, JD
AF Beiko, DT
   Knudsen, BE
   Denstedt, JD
TI Reviews in endourology - Advances in ureteral stent design
SO JOURNAL OF ENDOUROLOGY
LA English
DT Review
ID OXALOBACTER-FORMIGENES; REDUCES ENCRUSTATION; PORCINE MODEL; SPIRAL
   STENT; BIOCOMPATIBILITY; EXPRESSION; RETRIEVAL; UROLOGY; FLOW; TAIL
AB Background and Purpose: Ureteral stents are widely used in patients with urologic disorders. This review critically evaluates the recent literature, providing an update on advances in the development and design of stents.
   Methods: A thorough MEDLINE and PubMed literature search on ureteral stents was performed, and all pertinent articles were reviewed in detail. This review was formulated on the basis of these articles, encompassing both basic science and clinical aspects of advances in ureteral stent design.
   Results: The advances in development and design have been directed primarily toward decreasing stent-related morbidity such as discomfort, bladder irritability, infection, encrustation, and the need for an additional cystoscopic procedure to remove the stent. In recent years, there have been many significant advances in the design of ureteral stents, including tapered distal ends, and construction, such as magnetic, biodegradable, and tissue-engineered materials.
   Conclusions: There are many different bulk materials and coatings available for the manufacturing of ureteral stents, many of which are new. However, the ideal biomaterial has yet to be discovered. With ongoing research in this area, further advances in ureteral stent design will continue to improve outcomes for patients who require stents. Future advances are likely to include drug-coated stents, drug-eluting stents, and localized stenting techniques such as endoluminal gel paving.
C1 Univ Western Ontario, Dept Urol, London, ON, Canada.
RP Denstedt, JD (reprint author), St Josephs Hlth Ctr, 268 Grosvenor St, London, ON N6A 4V2, Canada.
RI Knudsen, Bodo/E-3411-2011
CR Amiel GE, 2001, J UROLOGY, V165, P2091, DOI 10.1016/S0022-5347(05)66300-8
   Antimisiaris SG, 2000, J ENDOUROL, V14, P743, DOI 10.1089/end.2000.14.743
   Auge BK, 2002, J UROLOGY, V168, P808, DOI 10.1016/S0022-5347(05)64748-9
   Brewer AV, 1999, J ENDOUROL, V13, P269, DOI 10.1089/end.1999.13.269
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Dunn MD, 2000, J ENDOUROL, V14, P195, DOI 10.1089/end.2000.14.195
   FINNEY RP, 1978, J UROLOGY, V120, P678, DOI 10.1016/S0022-5347(17)57326-7
   HEPPERLEN TK, 1978, TRENDS CLIN UROL, V1, P405
   Hiatt BL, 2002, CATHETER CARDIO INTE, V55, P409, DOI 10.1002/ccd.10161
   KAY A, 2002, J ENDOUROL S, V16, P8
   Ko GY, 2002, RADIOLOGY, V223, P83, DOI 10.1148/radiol.2231010734
   Kulkarni RP, 1999, BJU INT, V83, P755
   Laaksovirta S, 2002, J ENDOUROL, V16, P311, DOI 10.1089/089277902760102811
   Laaksovirta S, 2002, J UROLOGY, V167, P1527, DOI 10.1016/S0022-5347(05)65357-8
   Lam J S, 2001, Curr Urol Rep, V2, P277, DOI 10.1007/s11934-001-0064-2
   Liatsikos EN, 2002, UROLOGY, V59, P15, DOI 10.1016/S0090-4295(01)01475-3
   LINGEMAN JE, IN PRESS J UROL
   LUNG HY, 1994, J BACTERIOL, V176, P2468
   MACALUSO JN, 1989, J UROLOGY, V142, P701, DOI 10.1016/S0022-5347(17)38858-4
   Mardis Hal K., 2001, Journal of Urology, V165, P362
   MARDIS HK, 1988, UROL CLIN N AM, V15, P471
   MARDIS HK, 1993, J ENDOUROL, V7, P105, DOI 10.1089/end.1993.7.105
   MARX M, 1988, J UROLOGY, V139, P180, DOI 10.1016/S0022-5347(17)42349-4
   Multanen M, 2002, UROL RES, V30, P227, DOI 10.1007/s00240-002-0252-7
   MYKULAK DJ, 1994, J UROLOGY, V152, P976, DOI 10.1016/S0022-5347(17)32634-4
   Olweny EO, 2000, UROLOGY, V56, P857, DOI 10.1016/S0090-4295(00)00734-2
   Olweny EO, 2002, J UROLOGY, V167, P2198, DOI 10.1016/S0022-5347(05)65128-2
   Riedl CR, 2002, INT J ANTIMICROB AG, V19, P507, DOI 10.1016/S0924-8579(02)00097-3
   Sidhu H, 1997, J BACTERIOL, V179, P3378, DOI 10.1128/jb.179.10.3378-3381.1997
   Slepian M J, 1996, Semin Interv Cardiol, V1, P103
   Stickler DJ, 2002, INT J ANTIMICROB AG, V19, P499, DOI 10.1016/S0924-8579(02)00091-2
   Stoller ML, 2000, BJU INT, V85, P628, DOI 10.1046/j.1464-410x.2000.00489.x
   Taylor WN, 2002, J UROLOGY, V168, P2020, DOI 10.1097/01.ju.0000033964.15384.e2
   TSCHADA RK, 1994, J ENDOUROL, V8, P119, DOI 10.1089/end.1994.8.119
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   WATTERSON JD, IN PRESS J ENDOUROL
   WATTERSON JD, 2002, AUA UPDATE SERIES, V21, P122
   Zupkas P, 2000, J ENDOUROL, V14, P483, DOI 10.1089/end.2000.14.483
NR 38
TC 46
Z9 49
U1 0
U2 9
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 0892-7790
J9 J ENDOUROL
JI J. Endourol.
PD MAY
PY 2003
VL 17
IS 4
BP 195
EP 199
DI 10.1089/089277903765444294
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 684TQ
UT WOS:000183223000001
PM 12816579
DA 2018-10-19
ER

PT J
AU Zhukovskii, YG
AF Zhukovskii, YG
TI On establishment of individuality of the cholinesterase enzyme in the
   studied preparation
SO JOURNAL OF EVOLUTIONARY BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Article
ID OMMASTREPHES-BARTRAMI; SQUID
AB Theoretical analvsis is carried out and a reliable kinetic method for establishment of individuality of cholinesterases in studied preparation is proposed. For reliable conclusion about the presence of single cholinesterase or a mixture of cholinesterases in the biosample, it is necessary to determine values of the experimental kinetic constant of irreversible inhibition by several (three or more) inhibitors, using for evaluation of the catalytic activity of the biomaterial not less than three different substrates consecutively, for example, acetyl-beta-methylcholine (substrate selective to typical acetylcholinesterase), butyrylcholine (substrate selective to typical butyrylcholinesterase), and acetylcholine (substrate hydrolyzed easily by cholinesterases of different types).
C1 Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 196140, Russia.
RP Zhukovskii, YG (reprint author), Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 196140, Russia.
CR Augustinsson K.-B., 1948, ACTA PHYSIOL SCA S52, V15, P1
   BRESTKIN A P, 1983, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V19, P138
   BRESTKIN AP, 1973, BIOCHEMISTRY-USSR+, V38, P467
   BRESTKIN AP, 1974, BIOCHEMISTRY-USSR+, V39, P13
   BRESTKIN AP, 1978, KHIMIYA FIZIOLOGICHE, P3
   BRIK IL, 1977, SRAVNITELNAYA FARMAK, P143
   DOWDALL MJ, 1973, J NEUROCHEM, V20, P921, DOI 10.1111/j.1471-4159.1973.tb00063.x
   EARL CJ, 1952, BRIT J PHARM CHEMOTH, V7, P261, DOI 10.1111/j.1476-5381.1952.tb01321.x
   GRIGOREVA GM, 1979, COMP BIOCHEM PHYS C, V64, P199, DOI 10.1016/0306-4492(79)90049-2
   GRIGOREVA GM, 1976, ELEDONE MOSCHATA SRV, P3
   GRIGOREVA GM, 1981, 6 KONF BIOKHIMIKOV, P103
   GRIGOREVA GM, 1969, FERMENTY EVOLYUTSII, P177
   Grigoryeva G. M., 1977, SRAVNITEL NAYA FARMA, P137
   MYERS DK, 1953, BIOCHEM J, V55, P67, DOI 10.1042/bj0550067
   SHEVTSOVA SP, 1979, OKEANOLOGIYA+, V19, P481
   SHEVTSOVA SP, 1977, OKEANOLOGIYA+, V17, P1102
   TILYABAEV Z, 1979, Biokhimiya, V44, P2083
   TILYABAEV Z, 1978, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V14, P405
   VOLKOVA RM, 1981, 6 KONF BIOKHIMIKOV P, P546
   VOLONT LA, 1981, 6 KONF BIOKH PRIB RE, P542
NR 20
TC 2
Z9 2
U1 0
U2 1
PU CONSULTANTS BUREAU
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-0930
J9 J EVOL BIOCHEM PHYS+
JI J. Evol. Biochem. Physiol.
PD MAY-JUN
PY 2003
VL 39
IS 3
BP 281
EP 290
DI 10.1023/A:1026187506987
PG 10
WC Biochemistry & Molecular Biology; Evolutionary Biology; Physiology
SC Biochemistry & Molecular Biology; Evolutionary Biology; Physiology
GA 730ZA
UT WOS:000185859000003
DA 2018-10-19
ER

PT J
AU Wikesjo, UME
   Lim, WH
   Thomson, RC
   Cook, AD
   Wozney, JM
   Hardwick, WR
AF Wikesjo, UME
   Lim, WH
   Thomson, RC
   Cook, AD
   Wozney, JM
   Hardwick, WR
TI Periodontal repair in dogs: Evaluation of a bioabsorbable
   space-providing macro-porous membrane with recombinant human bone
   morphogenetic protein-2
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE alveolar ridge augmentation; animal studies; bone regeneration;
   membranes, barrier, membranes, bioabsorbable; periodontal attachment;
   wound healing
ID GUIDED TISSUE REGENERATION; FENESTRATION DEFECTS; RIDGE AUGMENTATION;
   BARRIER MEMBRANES; INTRABONY DEFECTS; DELIVERY SYSTEMS; ALVEOLAR BONE;
   IN-VIVO; RHBMP-2; OSSEOINTEGRATION
AB Background: Recombinant human bone morphogenetic protein-2 (rhBMP-2) technologies have been shown to significantly support alveolar bone formation. Biomaterial limitations, however, have restricted the biologic potential for onlay indications. The objective of this study was to evaluate regeneration of alveolar bone and periodontal attachment, and biomaterials reaction following surgical implantation of a space-providing, bioabsorbable, macroporous, polyglycolic acid-trimethylene carbonate (PGA-TMC) membrane combined with a rhBMP-2 construct in a discriminating onlay defect model.
   Methods: Routine supraalveolar periodontal defects were created at the mandibular premolar teeth in 9 beagle dogs. Contralateral jaw quadrants in subsequent animals were randomly assigned to receive the dome-shaped PGA-TMC (100 to 120 mum pores) membrane with rhBMP-2 (0.2 mg/mL) in a bioresorbable hyaluronan (Hy) carrier or the PGA-TMC membrane with Hy alone (control). The gingival flaps were advanced to submerge the membranes and teeth and sutured. Animals were euthanized at 8 and 24 weeks postsurgery for histologic observations.
   Results: Jaw quadrants receiving the PGA-TMC membrane alone experienced exposures at various time points throughout the study. Jaw quadrants receiving the PGA-TMC/rhBMP-2 combination remained intact, although one site experienced a late minor exposure. Newly formed alveolar bone approached and became incorporated into the macroporous PGA-TMC membrane in sites receiving rhBMP-2. The PGA-TMC biomaterial was occasionally associated with a limited inflammatory reaction. Residual PGA-TMC could not be observed at 24 weeks postsurgery. Residual Hy could not be observed at any time interval. Regeneration of alveolar bone height (means +/- SD) was significantly increased in sites receiving the PGA-TMC/rhBMP 2 combination compared to control (3.8 +/- 1.3 versus 0.7 +/- 0.5 mm at 8 weeks and 4.6 +/- 0.8 versus 2.1 +/- 0.4 mm at 24 weeks; P<0.05). Limited cementum regeneration was observed for PGA-TMC/rhBMP-2 and PGA-TMC control sites. Ankylosis compromised regeneration in sites receiving PGA-TMC/rhBMP-2.
   Conclusions: The bioabsorbable, space-providing, macroporous PGA-TMC membrane appears to be a compatible biomaterial for bone augmentation procedures. rhBMP-2 significantly enhances alveolar bone augmentation and soft tissue healing when combined with the PGA-TMC membrane.
C1 Temple Univ, Sch Dent, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA 19122 USA.
   Temple Univ, Sch Dent, Dept Periodontol, Philadelphia, PA 19122 USA.
   WL Gore & Assoc Inc, Flagstaff, AZ USA.
   Wyeth Res, Cambridge, MA USA.
RP Wikesjo, UME (reprint author), Temple Univ, Sch Dent, Lab Appl Periodontal & Craniofacial Regenerat, Philadelphia, PA 19122 USA.
RI Wikesjo, Ulf/A-4159-2009
OI Wikesjo, Ulf/0000-0003-1607-0583
CR Barboza EP, 2000, J PERIODONTOL, V71, P488, DOI 10.1902/jop.2000.71.3.488
   Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   Giannobile WV, 1998, J PERIODONTOL, V69, P129, DOI 10.1902/jop.1998.69.2.129
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   HARDWICK R, 1995, J PERIODONTOL, V66, P495, DOI 10.1902/jop.1995.66.6.495
   Hardwick R, 1994, GUIDED BONE REGENERA, P101
   Hunt DR, 2001, J PERIODONTOL, V72, P651, DOI 10.1902/jop.2001.72.5.651
   Ishibashi K, 2002, SUPERLATTICE MICROST, V31, P141, DOI 10.1006/spmi.2002.1035
   Karaki R, 1984, Nihon Shishubyo Gakkai Kaishi, V26, P516
   King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801
   King GN, 1998, J PERIODONTOL, V69, P561, DOI 10.1902/jop.1998.69.5.561
   King GN, 1999, J PERIODONTOL, V70, P1125, DOI 10.1902/jop.1999.70.10.1125
   King GN, 1998, J PERIODONTAL RES, V33, P226, DOI 10.1111/j.1600-0765.1998.tb02194.x
   Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103
   LUNA LG, 1992, HISTOLOGIC METHODS C, P113
   Ripamonti U, 1996, ARCH ORAL BIOL, V41, P121, DOI 10.1016/0003-9969(95)00110-7
   SCANTLEBURY TV, 1993, J PERIODONTOL, V64, P1129, DOI 10.1902/jop.1993.64.11s.1129
   Schenk R, 1984, METHODS CALCIFIED TI, P1
   SCHENK RK, 1994, GUIDED BONE REGENERA, P49
   Selvig KA, 2002, J PERIODONTOL, V73, P1020, DOI 10.1902/jop.2002.73.9.1020
   SELVIG KA, 1990, J PERIODONTOL, V61, P515, DOI 10.1902/jop.1990.61.8.515
   SELVIG KA, 1992, J PERIODONTOL, V63, P974, DOI 10.1902/jop.1992.63.12.974
   Sigurdsson TJ, 1996, INT J PERIODONT REST, V16, P525
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P511, DOI 10.1902/jop.1995.66.6.511
   Sigurdsson TJ, 1997, CLIN ORAL IMPLAN RES, V8, P367, DOI 10.1034/j.1600-0501.1997.080503.x
   Sigurdsson TJ, 2001, INT J PERIODONT REST, V21, P461
   SIGURDSSON TJ, 1994, J PERIODONTOL, V65, P350, DOI 10.1902/jop.1994.65.4.350
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Tatakis DN, 1999, PERIODONTOL 2000, V19, P59, DOI 10.1111/j.1600-0757.1999.tb00147.x
   Tatakis DN, 1999, J PERIODONTOL, V70, P542, DOI 10.1902/jop.1999.70.5.542
   Tatakis DN, 2002, J PERIODONTAL RES, V37, P93, DOI 10.1034/j.1600-0765.2002.00021.x
   Trombelli L, 1999, J CLIN PERIODONTOL, V26, P381, DOI 10.1034/j.1600-051X.1999.260608.x
   Trombelli L, 1997, J CLIN PERIODONTOL, V24, P366, DOI 10.1111/j.1600-051X.1997.tb00199.x
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   Wikesjo UME, 2001, J BONE JOINT SURG AM, V83A, pS136
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
   Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x
   WIKESJO UME, 2002, IN PRESS CLIN IMPLAN
   WIKESJO UME, 2003, IN PRESS J CLIN PERI
   Zellin G, 1997, J BIOMED MATER RES, V35, P181
   Zellin G, 1996, BIOMATERIALS, V17, P695, DOI 10.1016/0142-9612(96)86739-1
NR 42
TC 65
Z9 65
U1 1
U2 5
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAY
PY 2003
VL 74
IS 5
BP 635
EP 647
DI 10.1902/jop.2003.74.5.635
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 754KG
UT WOS:000187315000011
PM 29539121
DA 2018-10-19
ER

PT J
AU Sommer, AP
   Franke, RP
AF Sommer, AP
   Franke, RP
TI Biomimicry patterning with nanosphere suspensions
SO NANO LETTERS
LA English
DT Article
ID THUNDERCLOUDS; LIGHT
AB Experiments designed to mimic cell receptor structures on biomaterial surfaces showed that slow evaporation of water-based suspensions containing polystyrene nanospheres created translucent nanostructured films enclosed by highly regular ring shaped patterns. Our finding represents a novel method to functionalize biomaterial surfaces by structurizing both the micro- and nanoscale topography in one single process, answering practically the complete scale of biological demands required for a better integration of biomaterials into the targeted site of the body.
C1 Univ Ulm, Cent Inst Biomed Engn, Dept Biomat, ENSOMA Lab, D-89081 Ulm, Germany.
RP Sommer, AP (reprint author), Univ Ulm, Cent Inst Biomed Engn, Dept Biomat, ENSOMA Lab, D-89081 Ulm, Germany.
CR Cachile M, 2002, LANGMUIR, V18, P7985, DOI 10.1021/la020231e
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Lezec HJ, 2002, SCIENCE, V297, P820, DOI 10.1126/science.1071895
   Sommer AP, 2002, LANGMUIR, V18, P5040, DOI 10.1021/la025619o
   Sommer AP, 2002, J PROTEOME RES, V1, P475, DOI 10.1021/pr0255396
   Sommer AP, 2002, J PROTEOME RES, V1, P111, DOI 10.1021/pr025501t
   Sommer AP, 2001, ATMOS RES, V58, P129, DOI 10.1016/S0169-8095(01)00086-2
   Williams E, 2000, J APPL METEOROL, V39, P2223, DOI 10.1175/1520-0450(2001)040<2223:GLVCBC>2.0.CO;2
NR 8
TC 36
Z9 36
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD MAY
PY 2003
VL 3
IS 5
BP 573
EP 575
DI 10.1021/nl0258269
PG 3
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 681MN
UT WOS:000183040100001
DA 2018-10-19
ER

PT J
AU Kurotobi, K
   Suzuki, Y
   Nakajima, H
   Suzuki, H
   Iwaki, M
AF Kurotobi, K
   Suzuki, Y
   Nakajima, H
   Suzuki, H
   Iwaki, M
TI Platelet adhesion and plasma protein adsorption control of collagen
   surfaces by He+ ion implantation
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Ion Beam Modification of Materials
CY SEP 01-06, 2002
CL KOBE, JAPAN
DE biomaterial; collagen; ion implantation; plasma protein; artificial
   graft; antithrombogenicity
ID DIAMETER ARTIFICIAL GRAFTS; FIBRINOGEN; DOMAINS
AB He+ ion implanted collagen-coated tubes with a fluence of 1 x 10(14) ions/cm(2) were exhibited antithrombogenicity. To investigate the mechanisms of antithrombogenicity of these samples, plasma protein adsorption assay and platelet adhesion experiments were performed. The adsorption of fibrinogen (Fg) and von Willebrand factor (vWf) was minimum on the He+ ion implanted collagen with a fluence of 1 x 10(14) ions/cm(2). Platelet adhesion (using platelet rich plasma) was inhibited on the He+ ion implanted collagen with a fluence of 1 x 10(14) ions/cm(2) and was accelerated on the untreated collagen and ion implanted collagen with fluences of 1 x 10(13), 1 x 10(15) and 1 x 10(16) ions/cm(2). Platelet activation with washed platelets was observed on untreated collagen and He+ ion implanted collagen with a fluence of 1 x 10(14) ions/cm(2) and was inhibited with fluences of 1 x 10(13), 1 x 10(15) and 1 x 10(16) ions/cm(2). Generally, platelets can react with a specific ligand inside the collagen (GFOGER sequence). The results of platelets adhesion experiments using washed platelets indicated that there were no ligands such as GFOGER on the He+ ion implanted collagen over a fluence of 1 x 10(13) ions/cm(2). On the 1 x 10(14) ions/cm(2) implanted collagen, no platelet activation was observed due to the influence of plasma proteins. From the above, it is concluded that the decrease of adsorbed Fg and vWf caused the antithrombogenicity of He+ ion implanted collagen with a fluence of 1 x 10(14) ions/cm(2) and that plasma protein adsorption took an important role repairing the graft surface. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 Inst Phys & Chem Res, Div Surface Characterizat, Wako, Saitama 3510198, Japan.
   Teikyo Univ, Sch Med, Tokyo 1738605, Japan.
   Tokyo Metropolitan Inst Med Sci, Pharmaceut R&D Ctr, Tokyo 1138613, Japan.
RP Kurotobi, K (reprint author), Inst Phys & Chem Res, Div Surface Characterizat, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
CR KATAGIRI Y, 1990, THROMB HAEMOSTASIS, V63, P122
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Kurotobi K, 2001, NUCL INSTRUM METH B, V175, P791, DOI 10.1016/S0168-583X(00)00526-7
   Kurotobi K, 2000, COLLOID SURFACE B, V19, P227, DOI 10.1016/S0927-7765(00)00160-0
   LAMBRECHT LK, 1986, THROMB RES, V41, P99, DOI 10.1016/0049-3848(86)90283-5
   LINDON JN, 1986, BLOOD, V68, P355
   Suzuki Y, 1997, NUCL INSTRUM METH B, V127, P1019, DOI 10.1016/S0168-583X(97)00050-5
NR 7
TC 3
Z9 3
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAY
PY 2003
VL 206
BP 532
EP 537
DI 10.1016/S0168-583X(03)00782-1
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 692ZQ
UT WOS:000183690500116
DA 2018-10-19
ER

PT J
AU Yang, P
   Kwok, SCH
   Chu, PK
   Leng, YX
   Chen, JY
   Wang, J
   Huang, N
AF Yang, P
   Kwok, SCH
   Chu, PK
   Leng, YX
   Chen, JY
   Wang, J
   Huang, N
TI Haemocompatibility of hydrogenated amorphous carbon (a-C : H) films
   synthesized by plasma immersion ion implantation-deposition
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Ion Beam Modification of Materials
CY SEP 01-06, 2002
CL KOBE, JAPAN
DE hydrogenated amorphous carbon (a-C:H); plasma immersion; ion
   implantation-deposition (PIII-D); blood compatibility
ID DIAMOND-LIKE CARBON; DLC FILMS; BIOMATERIALS; MICROWAVE; TITANIUM
AB Diamond-like-carbon has attracted much attention recently as a potential biomaterial in blood contacting biomedical devices. However, previous reports in this area have not adequately addressed the biocompatibility and acceptability of the materials in blood contacting applications. In this study, hydrogenated amorphous carbon (a-C:H) films were fabricated on silicon wafers (100) using plasma immersion ion implantation-deposition. A series of a-C:H films with different structures and chemical bonds were fabricated under different substrate voltages. The results indicate that film graphitization is promoted at higher substrate bias. The film deposited at a lower substrate bias of -75 V possesses better blood compatibility than the films at higher bias and stainless steel. Our results suggest two possible paths to improve the blood compatibility, suppression of the endogenic clotting system and reduction of platelet activation. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Dept Mat Engn, Chengdu 610031, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 83 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
RI Chu, Paul/B-5923-2013; Leng, Yongxiang/G-5488-2010
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Fedosenko G, 2001, DIAM RELAT MATER, V10, P920, DOI 10.1016/S0925-9635(00)00507-0
   Gu JW, 2002, MAT SCI ENG C-BIO S, V20, P199, DOI 10.1016/S0928-4931(02)00033-4
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Lai KH, 2001, DIAM RELAT MATER, V10, P1862, DOI 10.1016/S0925-9635(01)00460-5
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   Littmark U., 1985, STOPPING RANGE IONS, V1
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   Silinskas M, 2002, DIAM RELAT MATER, V11, P1026, DOI 10.1016/S0925-9635(01)00734-8
   Tian XB, 2001, J VAC SCI TECHNOL A, V19, P1008, DOI 10.1116/1.1365136
   Tian XB, 2000, REV SCI INSTRUM, V71, P2839, DOI 10.1063/1.1150700
   Yu SJ, 2001, THIN SOLID FILMS, V390, P98, DOI 10.1016/S0040-6090(01)00945-2
NR 15
TC 18
Z9 20
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD MAY
PY 2003
VL 206
BP 721
EP 725
DI 10.1016/S0168-583X(03)00871-1
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 692ZQ
UT WOS:000183690500156
DA 2018-10-19
ER

PT J
AU Van Meerbeek, B
   De Munck, J
   Yoshida, Y
   Inoue, S
   Vargas, M
   Vijay, P
   Van Landuyt, K
   Lambrechts, P
   Vanherle, G
AF Van Meerbeek, B
   De Munck, J
   Yoshida, Y
   Inoue, S
   Vargas, M
   Vijay, P
   Van Landuyt, K
   Lambrechts, P
   Vanherle, G
TI Buonocore Memorial Lecture - Adhesion to enamel and dentin: Current
   status and future challenges
SO OPERATIVE DENTISTRY
LA English
DT Review
ID TENSILE BOND STRENGTH; SELF-ETCHING PRIMER; CLINICAL-EVALUATION;
   GLASS-IONOMER; WATER STORAGE; SURFACE-AREA; MARGINAL ADAPTATION; RESIN
   COMPOSITES; ONE-BOTTLE; IN-VIVO
AB Bonding to tooth tissue can be achieved through an "etch&rinse," "self-etch" or "glass-ionomer" approach. In this paper, the basic bonding mechanism to enamel and dentin of these three approaches is demonstrated by means of ultra-morphological and chemical characterization of tooth-biomaterial interfacial interactions. Furthermore, bond-strength testing and measurement of marginal-sealing effectiveness (the two most commonly employed methodologies to determine "bonding effectiveness" in the laboratory) are evaluated upon their value and relevance in predicting clinical performance. A new dynamic methodology to test biomaterial-tooth bonds in a fatigue mode is introduced with a recently developed micro-rotary fatigue-testing device. Eventually, today's adhesives will be critically weighted upon their performance in diverse laboratory studies and clinical trials. Special attention has been given to the benefits/drawbacks of an etch&rinse versus a self-etch approach and the long-term performance of these adhesives. Correlating data gathered in the laboratory with clinical results clearly showed that laboratory research CAN predict clinical effectiveness. Although there is a tendency to simplify bonding procedures, the data presented confirm that conventional three-step etch&rinse adhesives still perform most favorably and are most reliable in the long-term. Nevertheless, a self-etch approach may have the best future perspective. Clinically, when adhesives no longer require an "etch&rinse" step, the application time, and probably more importantly, the technique-sensitivity are substantially reduced. Especially "mild," two-step self-etch adhesives that bond through a combined micromechanical and chemical interaction with tooth tissue closely approach conventional three-step systems in bonding performance.
C1 Catholic Univ Louvain, Leuven BIOMAT Res Cluster, Dept Conservat Dent, Sch Dent Oral Pathol & Maxillofacial Surg, B-3000 Louvain, Belgium.
   Okayama Univ, Grad Sch Med & Dent, Dept Biomat, Okayama, Japan.
   Hokkaido Univ, Dent Hosp, Div Gen Dent, Sapporo, Hokkaido 060, Japan.
   Univ Iowa, Dept Operat Dent, Iowa City, IA 52242 USA.
RP Van Meerbeek, B (reprint author), Catholic Univ Louvain, Leuven BIOMAT Res Cluster, Dept Conservat Dent, Sch Dent Oral Pathol & Maxillofacial Surg, Kapucijnenvoer 7, B-3000 Louvain, Belgium.
EM bart.vanmeerbeek@med.kuleuven.ac.be
RI Inoue, Satoshi/A-5522-2012; Van Landuyt, Kirsten/K-5850-2015; YOSHIDA,
   Yasuhiro/B-2472-2011
OI Van Landuyt, Kirsten/0000-0002-4932-3148; 
CR Alani AH, 1997, OPER DENT, V22, P173
   AQUILINO SA, 1991, J DENT RES, V70, P208, DOI 10.1177/00220345910700031001
   Armstrong SR, 2001, DENT MATER, V17, P268, DOI 10.1016/S0109-5641(00)00081-6
   Blunck U, 1999, J Adhes Dent, V1, P143
   Blunck U, 2000, J DENT RES, V79, P149
   BLUNCK U, 2002, J DENT RES, V81
   BOGHOSIAN A, 2002, J DENT RES, pA52
   Bouillaguet S, 2000, J Adhes Dent, V2, P201
   Bouschlicher MR, 1997, AM J DENT, V10, P279
   Brackett WW, 2002, OPER DENT, V27, P218
   Buonocore MG., 1955, J DENT RES, V34, P849, DOI DOI 10.1177/00220345550340060801
   Castelnuovo J, 1996, AM J DENT, V9, P245
   Ceballos L, 2001, DENT MATER, V17, P340, DOI 10.1016/S0109-5641(00)00092-0
   De Munck J, 2003, J DENT RES, V82, P136, DOI 10.1177/154405910308200212
   DEGRANGE H, 1997, MINIMALLY INVASIVE D
   Del-Nero M O, 2000, J Adhes Dent, V2, P117
   DEMUNCK J, 2003, IN PRESS AM J DENT
   DEMUNCK J, 2003, IN PRESS J DENT RES, V82
   DEMUNCK J, 2002, EUR FEST OR SCI CARD
   Denehy G, 1998, Dent Clin North Am, V42, P719
   DERKSON GD, 1986, J PROSTHET DENT, V56, P435, DOI 10.1016/0022-3913(86)90384-7
   DESTOOP V, 2002, THESIS U CATHOLIQUE
   Dewji HR, 1998, EUR J ORAL SCI, V106, P594, DOI 10.1046/j.0909-8836.1998.eos106110.x
   Dorfer CE, 2000, EUR J ORAL SCI, V108, P346, DOI 10.1034/j.1600-0722.2000.108004346.x
   Drummond JL, 1996, J BIOMED MATER RES, V32, P533, DOI 10.1002/(SICI)1097-4636(199612)32:4<533::AID-JBM6>3.3.CO;2-5
   Ferrari M, 2002, J DENT RES, V81, pA139
   FISSORE B, 1991, J PROSTHET DENT, V65, P80, DOI 10.1016/0022-3913(91)90054-Z
   Folwaczny M, 2001, AM J DENT, V14, P153
   Frankenberger R, 2000, OPER DENT, V25, P324
   Frankenberger R, 1999, Clin Oral Investig, V3, P11, DOI 10.1007/s007840050072
   Frankenberger R, 2000, OPER DENT, V25, P40
   FUKUDA R, 2003, IN PRESS BIOMATERIAL
   GIVAN DA, 1995, J PROSTHET DENT, V73, P377
   GLADYS S, 1995, J DENT, V23, P329, DOI 10.1016/0300-5712(95)98768-X
   GWINNETT AJ, 1995, AM J DENT, V8, P109
   Hashimoto M, 2002, J BIOMED MATER RES, V63, P306, DOI 10.1002/jbm.10208
   Hashimoto M, 2000, J DENT RES, V79, P1385, DOI 10.1177/00220345000790060601
   Imazato S, 1997, J DENT RES, V76, P768, DOI 10.1177/00220345970760030901
   Inoue S, 2001, J Adhes Dent, V3, P237
   Inoue S, 2001, DENT MATER, V17, P445, DOI 10.1016/S0109-5641(01)00003-3
   INOUE S, 2003, IN PRESS AM J DENT
   INOUE S, 2000, ADV ADHESIVE DENT, P131
   Kidd E A, 1976, J Dent, V4, P199, DOI 10.1016/0300-5712(76)90048-8
   KREJCI I, 1993, J DENT RES, V72, P490, DOI 10.1177/00220345930720020401
   Kwong SM, 2002, DENT MATER, V18, P359, DOI 10.1016/S0109-5641(01)00051-3
   Latta MA, 2000, J DENT RES, V79, P272
   MARTIN N, 2002, J DENT RES, pA52
   Munoz C.A., 2001, J DENT RES, V80, P65
   Nakajima M, 1995, J DENT RES, V74, P1679, DOI 10.1177/00220345950740100901
   Pagliarini A, 1996, Quintessence Int, V27, P265
   Pashley D H, 1999, J Adhes Dent, V1, P299
   Pashley DH, 2001, DENT MATER, V17, P430, DOI 10.1016/S0109-5641(00)00104-4
   Paul SJ, 1999, OPER DENT, V24, P181
   PEUMANS M, 2003, IN PRESS J DENT RES, V82
   Phrukkanon S, 1998, DENT MATER, V14, P212, DOI 10.1016/S0109-5641(98)00034-7
   Phrukkanon S, 1998, DENT MATER, V14, P120, DOI 10.1016/S0109-5641(98)00018-9
   Pilo R, 1999, J PROSTHET DENT, V82, P209, DOI 10.1016/S0022-3913(99)70158-7
   Pioch T, 2001, AM J DENT, V14, P252
   Pioch Thomas, 2002, J Adhes Dent, V4, P23
   Ripps A, 2000, J DENT RES, V79, P273
   Roeters J J, 2000, J Adhes Dent, V2, P235
   ROULET JF, 1994, J DENT, V22, pS9, DOI 10.1016/0300-5712(94)90164-3
   ROULET JF, 1989, SCANNING MICROSCOPY, V3, P147
   RUSE ND, 1995, J BIOMED MATER RES, V29, P411, DOI 10.1002/jbm.820290316
   SANO H, 1994, DENT MATER, V10, P236, DOI 10.1016/0109-5641(94)90067-1
   SANO H, 1994, OPER DENT, V19, P59
   Sano H, 1999, J DENT RES, V78, P906, DOI 10.1177/00220345990780041101
   SANO H, 1995, OPER DENT, V20, P18
   Schranz DB, 1998, DIABETES METAB REV, V14, P3, DOI 10.1002/(SICI)1099-0895(199803)14:1<3::AID-DMR206>3.0.CO;2-T
   Schulz KJ, 1997, IEEE NETWORK, V11, P10, DOI 10.1109/65.580907
   SHIMADA Y, 2000, ADV ADHESIVE DENT P, P91
   Shono Y, 1999, J Adhes Dent, V1, P211
   Sunnegardh K, 2000, J DENT RES, V79, P272
   Swift EJ, 2001, J AM DENT ASSOC, V132, P1117, DOI 10.14219/jada.archive.2001.0337
   Tay F R, 2000, J Adhes Dent, V2, P9
   Tay F R, 2001, J Adhes Dent, V3, P153
   Tay FR, 2002, J DENT RES, V81, P472, DOI 10.1177/154405910208100708
   Tay FR, 2002, J DENT, V30, P371, DOI 10.1016/S0300-5712(02)00064-7
   Tay FR, 1996, J DENT RES, V75, P1034, DOI 10.1177/00220345960750040601
   Tyas MJ, 2000, INT DENT J, V50, P1, DOI 10.1111/j.1875-595X.2000.tb00540.x
   Unlu N, 2002, J DENT RES, V81, pB236
   van Dijken JWV, 2000, DENT MATER, V16, P285, DOI 10.1016/S0109-5641(00)00019-1
   Van Meerbeek B, 1998, J DENT, V26, P1, DOI 10.1016/S0300-5712(96)00070-X
   Van Meerbeek B, 1998, J DENT RES, V77, P911
   Van Meerbeek B, 1998, J DENT RES, V77, P50, DOI 10.1177/00220345980770010501
   Van Meerbeek S, 2000, J DENT RES, V79, P249
   VANDIJKEN JW, 2000, 4 JOINT M CED NOF IA
   VANDIJKEN JW, 2001, S HELD CED IADR M RO
   VANDIJKEN JWV, 2002, EUR FEST OR SCI CARD
   VANMEERBEEK B, 1994, J DENT RES, V73, P1690, DOI 10.1177/00220345940730110401
   VanMeerbeek B, 1996, J DENT RES, V75, P879, DOI 10.1177/00220345960750030401
   VANMEERBEEK B, 2001, OPERATIVE DENT S, V6, P119
   VANMEERBEEK B, 2003, J DENT RES, V82
   VANMEERBEEK B, 2001, J DENT RES, V80, P739
   VANNOORT R, 1989, J DENT, V17, P61, DOI 10.1016/0300-5712(89)90131-0
   Versluis A, 1998, J DENT RES, V77, P1435, DOI 10.1177/00220345980770060801
   Wilson NHF, 2001, ADVANCES IN OPERATIVE DENTISTRY, VOL 2: CHALLENGES OF THE FUTURE, P105
   WISKOTT HWA, 1994, DENT MATER, V10, P215
   Yip HK, 2001, DENT MATER, V17, P456, DOI 10.1016/S0109-5641(01)00007-0
   Yoshida Y, 2000, J DENT RES, V79, P709, DOI 10.1177/00220345000790020301
   Yoshida Y, 2001, J DENT RES, V80, P1565, DOI 10.1177/00220345010800061701
   Yoshida Y, 1999, J BIOMED MATER RES, V47, P85, DOI 10.1002/(SICI)1097-4636(199910)47:1<85::AID-JBM12>3.0.CO;2-H
   YOSHIDA Y, 2002, UNPUB
   YOSHIDA Y, 2003, J DENT RES, V82
   Yoshioka M, 2002, J BIOMED MATER RES, V59, P56, DOI 10.1002/jbm.1216
   YOSHIYAMA M, 2000, ADV ADHESIVE DENT P, P177
NR 106
TC 1011
Z9 1056
U1 5
U2 87
PU OPERATIVE DENTISTRY INC
PI INDIANAPOLIS
PA INDIANA UNIV SCHOOL DENTISTRY, ROOM S411, 1121 WEST MICHIGAN ST,
   INDIANAPOLIS, IN 46202-5186 USA
SN 0361-7734
EI 1559-2863
J9 OPER DENT
JI Oper. Dent.
PD MAY-JUN
PY 2003
VL 28
IS 3
BP 215
EP 235
PG 21
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 672ZK
UT WOS:000182553800002
PM 12760693
DA 2018-10-19
ER

PT J
AU Yaremchuk, MJ
AF Yaremchuk, MJ
TI Facial skeletal reconstruction using porous polyethylene implants
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID HIGH-DENSITY POLYETHYLENE; ORBITAL FLOOR IMPLANT; FRACTURE REPAIR; LATE
   COMPLICATION; TISSUE-RESPONSE; CHIN IMPLANTS; BONE; AUGMENTATION;
   PROPLAST; BIOMATERIALS
AB A retrospective review of clinical outcomes was performed to determine the clinical utility and morbidity associated with the use of porous polyethylene facial implants. Three hundred seventy implants were placed in 162 consecutive patients, in 178 operations performed in 11 years. The number of patients, the number of implants used, and the average follow-up period were categorized according to the cause of the deformity. The resultant distribution was as follows: acquired (tumor-related), 17 patients, 39 implants, and 30 months; congenital, eight patients, 31 implants, and 92 months; aesthetic, 39 patients, 97 implants, and 24 months; secondary posttraumatic, 48 patients, 139 implants, and 37 months; and acute trauma (internal orbit reconstruction), 50 patients, 64 implants, and 9 months. The distribution of implants according to location was as follows: frontal, 21; temporal, 30; internal orbit, 145; infraorbital rim, 28; malar, 58; paranasal, 29; nasal, 13; mandible, 24; and chin, 22. The combined average follow-up period per patient was 27 months (range, immediate postoperative period to 11 years). All implants were placed in the subperiosteal plane, and the majority were fixed with titanium screws. Antibiotics were administered perioperatively. No implants were extruded or migrated, formed clinically apparent capsules, or caused symptoms attributable to bioincompatibility. The overall reoperation rate was 10 percent (n = 16), which included operations to remove implants because of acute infections (2 percent, n = 3) or a late infection (1 percent, n = 1), to remove implants causing displeasing contours (2 percent, n = 3), and to improve contours (6 percent, n = 9). Porous polyethylene implants have biomaterial properties favorable for facial skeletal augmentation. Screw application of the implants to the skeleton allows precise predictable contouring, thus limiting the need for revisional surgical procedures.
C1 Massachusetts Gen Hosp, Dept Surg, Div Plast Surg, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
RP Yaremchuk, MJ (reprint author), Massachusetts Gen Hosp, Dept Surg, Div Plast Surg, 15 Parkman St,Suite 453, Boston, MA 02114 USA.
CR ADAMS JR, 1995, PLAST RECONSTR SURG, V95, P382, DOI 10.1097/00006534-199502000-00021
   ALPAR JJ, 1977, ANN OPHTHALMOL, V9, P1173
   ANDERSON MF, 1967, J ORAL SURG, V25, P182
   BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154
   BERGHAUS A, 1984, ARCH OTO-RHINO-LARYN, V240, P115
   BIKHAZI HB, 1990, PLASTIC RECONSTRUCTI, P271
   BROWN AE, 1993, BRIT J ORAL MAX SURG, V31, P154, DOI 10.1016/0266-4356(93)90114-C
   Choi JC, 1999, OPHTHALMIC PLAST REC, V15, P56, DOI 10.1097/00002341-199901000-00012
   COHEN SR, 1992, PLAST RECONSTR SURG, V89, P1148, DOI 10.1097/00006534-199206000-00024
   COHEN SR, 1991, PLAST RECONSTR SURG, V88, P62, DOI 10.1097/00006534-199107000-00010
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   COULDWELL WT, 1994, J NEUROSURG, V81, P483, DOI 10.3171/jns.1994.81.3.0483
   Davis P K, 1971, Br J Plast Surg, V24, P405, DOI 10.1016/S0007-1226(71)80099-1
   DAVIS RM, 1986, ANN OPHTHALMOL, V18, P223
   Dougherty W R, 1994, J Craniofac Surg, V5, P26, DOI 10.1097/00001665-199402000-00007
   FRIEDLAND JA, 1976, PLAST RECONSTR SURG, V57, P144, DOI 10.1097/00006534-197602000-00002
   Frodel JL, 1998, ARCH OTOLARYNGOL, V124, P1219, DOI 10.1001/archotol.124.11.1219
   Hoffman S, 1981, Ann Plast Surg, V7, P484, DOI 10.1097/00000637-198112000-00010
   HOMSY C A, 1970, Journal of Biomedical Materials Research, V4, P341, DOI 10.1002/jbm.820040306
   Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396
   JORDAN DR, 1992, OPHTHALMOLOGY, V99, P1600
   KLAWITTER JJ, 1976, J BIOMED MATER RES, V10, P311, DOI 10.1002/jbm.820100212
   KOHN R, 1976, AM J OPHTHALMOL, V82, P934, DOI 10.1016/0002-9394(76)90074-X
   Lacey M, 1993, J Craniofac Surg, V4, P74, DOI 10.1097/00001665-199304000-00004
   LIPSHUTZ H, 1966, PLAST RECONSTR SURG, V37, P249, DOI 10.1097/00006534-196603000-00010
   Loftfield K, 1987, Ophthalmic Plast Reconstr Surg, V3, P187, DOI 10.1097/00002341-198703030-00010
   MAAS CS, 1990, ARCH OTOLARYNGOL, V116, P551
   MACKAY IS, 1983, J LARYNGOL OTOL, V97, P43, DOI 10.1017/S0022215100093786
   MARKS MW, 1994, PLAST RECONSTR SURG, V93, P856, DOI 10.1097/00006534-199404000-00032
   Matarasso A, 1996, PLAST RECONSTR SURG, V98, P1007, DOI 10.1097/00006534-199611000-00012
   MAURIELLO JA, 1987, OPHTHALMOLOGY, V94, P248
   MAURIELLO JA, 1990, OPHTHALMIC PLAST REC, V6, P218, DOI 10.1097/00002341-199009000-00013
   MAURIELLO JA, 1984, OPHTHALMOLOGY, V91, P102
   Milward T M, 1972, Br J Plast Surg, V25, P276, DOI 10.1016/S0007-1226(72)80062-6
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   Ng SGJ, 2001, EYE, V15, P578
   Niechajev I, 1999, AESTHET PLAST SURG, V23, P395, DOI 10.1007/s002669900308
   PEAK J, 1992, J ORAL MAXIL SURG, V50, P1234, DOI 10.1016/0278-2391(92)90162-S
   RIDLEY MT, 1978, J ORAL SURG, V36, P616
   ROBINSON M, 1972, ARCHIV OTOLARYNGOL, V95, P30
   Romo T, 1998, AESTHET PLAST SURG, V22, P211, DOI 10.1007/s002669900193
   Rubin JP, 1997, PLAST RECONSTR SURG, V100, P1336, DOI 10.1097/00006534-199710000-00043
   RUBIN LR, 1983, BIOMATERIALS PLASTIC, P477
   RUBIN PAD, 1994, OPHTHALMOLOGY, V101, P1697
   SPECTOR M, 1975, J BIOMED MATER RES, V9, P537, DOI 10.1002/jbm.820090514
   SPECTOR M, 1979, J BIOMED MATER RES, V13, P677, DOI 10.1002/jbm.820130502
   SUTULA FC, 1991, OPHTHALMIC PLAST REC, V7, P267, DOI 10.1097/00002341-199112000-00006
   TERINO EO, 2000, ART ALLOPLASTIC FACI, P79
   Turegun M, 1998, AESTHET PLAST SURG, V22, P38, DOI 10.1007/s002669900163
   WELLISZ T, 1993, J LONG-TERM EFF MED, V3, P223
   WELLISZ T, 1995, PLAST RECONSTR SURG, V96, P957, DOI 10.1097/00006534-199509001-00029
   WELLISZ T, 1993, ANN PLAS SURG, V30, P531, DOI 10.1097/00000637-199306000-00011
   WHEAR NM, 1993, BRIT J ORAL MAX SURG, V31, P292, DOI 10.1016/0266-4356(93)90062-2
   Wolfe S A, 1979, Ann Plast Surg, V2, P448, DOI 10.1097/00000637-197905000-00016
   WOLFE SA, 1981, PLAST RECONSTR SURG, V68, P429, DOI 10.1097/00006534-198109000-00037
   Yaremchuk MJ, 1998, PLAST RECONSTR SURG, V102, P1676, DOI 10.1097/00006534-199810000-00055
   Yaremchuk MJ, 2000, PLAST RECONSTR SURG, V106, P697, DOI 10.1097/00006534-200009030-00030
   Yaremchuk MJ, 2001, PLAST RECONSTR SURG, V107, P1585, DOI 10.1097/00006534-200105000-00047
NR 58
TC 120
Z9 125
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD MAY
PY 2003
VL 111
IS 6
BP 1818
EP 1827
DI 10.1097/01.PRS.0000056866.80665.7A
PG 10
WC Surgery
SC Surgery
GA 674AM
UT WOS:000182614200005
PM 12711941
DA 2018-10-19
ER

PT J
AU Pelissier, P
   Villars, F
   Mathoulin-Pelissier, S
   Bareille, R
   Lafage-Proust, MH
   Vilamitjana-Amedee, J
AF Pelissier, P
   Villars, F
   Mathoulin-Pelissier, S
   Bareille, R
   Lafage-Proust, MH
   Vilamitjana-Amedee, J
TI Influences of vascularization and osteogenic cells on heterotopic bone
   formation within a madreporic ceramic in rats
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT 25th Annual Meeting of the Society-for-Biomaterials
CY APR 28-MAY 02, 1999
CL PROVIDENCE, RI
SP Soc Biomat
ID CALCIUM-PHOSPHATE CERAMICS; MARROW-CELLS; CORALLINE HYDROXYAPATITE;
   ENDOTHELIAL-CELLS; MORPHOGENETIC PROTEIN; POROUS HYDROXYAPATITE; FLAP
   PREFABRICATION; GRAFTS; TISSUE; OSTEOBLASTS
AB Research in biomaterials for bone reconstruction has led to elaborate osteogenic composites that combine porous ceramics with bone marrow stromal cells. The aim of this study was to evaluate the influence of direct vascularization of such composites on osteogenesis and the ability to produce a vascularized bone substitute transplant in an ectopic muscular site. Sixty-four coralline biomaterials were implanted in 32 Fisher rats under four conditions: (1) alone (reference group M, n = 16), (2) coated with bone marrow stromal cells (group MC, n = 16), (3) combined with a vascular pedicle (group W, n = 16), or (4) coated with bone marrow stromal cells and combined with a vascular pedicle (MCV group, n = 16). The number of vessels in the pores (vessel-pore ratio) of the implants and the proportion of pores showing bone ingrowth (bone-pore ratio) were measured at 2, 4, 6, and 8 weeks on four implants of each group. Compared with the reference group, angiogenesis was higher when the biomaterial was combined with a vascular pedicle or was coated with osteoprogenitor cells. The association of both vascular pedicle and osteoprogenitor cells increased vascularization by 60 percent (p = 0.003) and osteogenesis by 62 percent (p < 0.001). A combination of both vascular pedicle and bone marrow osteoprogenitor cells in coralline implants enhances neovascularization and osteogenesis after implantation in ectopic intramuscular sites to a greater extent than either does alone.
C1 Hop Pellegrin Tondu, Serv Chirurg Plast, F-33076 Bordeaux, France.
   Univ Bordeaux 2, F-33076 Bordeaux, France.
   Inst Bergonie, Dept Biostat, Bordeaux, France.
   Fac Med Jacques Lisfranc, Lab Biol & Biochim Tissu Osseux, St Etienne, France.
RP Pelissier, P (reprint author), Hop Pellegrin Tondu, Serv Chirurg Plast, F-33076 Bordeaux, France.
EM philippe.pelissier@chu.bordeaux.fr
RI VILAMITJANA AMEDEE, Joelle/F-3369-2013
CR ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   ALPER G, 1989, AM J MED SCI, V298, P371, DOI 10.1097/00000441-198912000-00003
   Bancroft JD, 1990, THEORY PRACTICE HIST
   Baudet J, 1995, Ann Chir Plast Esthet, V40, P597
   BERNARD SL, 1991, PLAST RECONSTR SURG, V87, P96, DOI 10.1097/00006534-199101000-00015
   BINDERMA.I, 1974, J CELL BIOL, V61, P427, DOI 10.1083/jcb.61.2.427
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   COLLINOSDOBY P, 1994, J CELL BIOCHEM, V55, P304, DOI 10.1002/jcb.240550306
   CONNOLLY J, 1989, J BONE JOINT SURG AM, V71A, P684, DOI 10.2106/00004623-198971050-00007
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   DICKERSON RC, 1963, J BONE JOINT SURG AM, V45, P356, DOI 10.2106/00004623-196345020-00015
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   FAUCHEUX C, 1994, J MATER SCI-MATER M, V5, P635, DOI 10.1007/BF00120345
   FRAYSSINET P, 1993, REV RHUM, V60, P342
   GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, V225, P7
   GOSHIMA J, 1991, BIOMATERIALS, V12, P253, DOI 10.1016/0142-9612(91)90209-S
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, V269, P274
   GRENGA TE, 1989, PLAST RECONSTR SURG, V84, P245, DOI 10.1097/00006534-198908000-00009
   HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258
   HIRASE Y, 1989, BRIT J PLAST SURG, V42, P216, DOI 10.1016/0007-1226(89)90207-5
   HOLLINGER JO, 1980, CLIN ORTHOP RELAT R, V207, P290
   Hori Y, 1979, J Hand Surg Am, V4, P23
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JONES AR, 1995, J ORTHOP RES, V13, P553, DOI 10.1002/jor.1100130410
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Lin CC, 1996, BIOMATERIALS, V17, P1133, DOI 10.1016/0142-9612(96)85916-3
   MIZUMOTO S, 1992, J RECONSTR MICROSURG, V8, P325, DOI 10.1055/s-2007-1006716
   MIZUMOTO S, 1993, J RECONSTR MICROSURG, V9, P441, DOI 10.1055/s-2007-1006754
   MOORE JB, 1984, PLAST RECONSTR SURG, V73, P382, DOI 10.1097/00006534-198403000-00007
   NADE S, 1983, CLIN ORTHOP RELAT R, V181, P255
   NETTELBLAD H, 1985, PLAST RECONSTR SURG, V76, P851, DOI 10.1097/00006534-198512000-00008
   OBRIEN BM, 1990, WORLD J SURG, V14, P786
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   OKUMURA M, 1991, BIOMATERIALS, V12, P411, DOI 10.1016/0142-9612(91)90010-8
   ONO I, 1992, PLAST RECONSTR SURG, V90, P870, DOI 10.1097/00006534-199211000-00023
   ONO I, 1995, J CRANIOFAC SURG, V6, P238, DOI 10.1097/00001665-199505000-00011
   Poirier P, 1996, Ann Chir Plast Esthet, V41, P185
   PRIBAZ JJ, 1994, BRIT J PLAST SURG, V47, P250, DOI 10.1016/0007-1226(94)90007-8
   Tark KC, 1996, J RECONSTR MICROSURG, V12, P325, DOI 10.1055/s-2007-1006495
   TRUETA J, 1963, J BONE JOINT SURG BR, V45, P402
   Vogelin E, 2000, TISSUE ENG, V6, P449, DOI 10.1089/107632700418155
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   WEILAND AJ, 1984, PLAST RECONSTR SURG, V74, P368, DOI 10.1097/00006534-198409000-00006
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 48
TC 50
Z9 63
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD MAY
PY 2003
VL 111
IS 6
BP 1932
EP 1941
DI 10.1097/01.PRS.0000055044.14093.EA
PG 10
WC Surgery
SC Surgery
GA 674AM
UT WOS:000182614200019
PM 12711955
DA 2018-10-19
ER

PT J
AU Asami, K
   Saito, K
   Ohtsu, N
   Nagata, S
   Hanawa, T
AF Asami, K
   Saito, K
   Ohtsu, N
   Nagata, S
   Hanawa, T
TI Titanium-implanted CaTiO3 films and their changes in Hanks' solution
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE CaTiO3 film; Ti implantation; XPS; biomaterial; hydroxyapatite
ID RAY PHOTOELECTRON-SPECTROSCOPY; ALLOYS; INTERFACE; CHROMIUM; SURFACES;
   COATINGS; OXIDES; IRON; XPS
AB Titanium-implanted CaTiO3 film was prepared and then characterized by x-ray photoelectron spectroscopy (XPS) and Rutherford backscattering spectrometry (RBS) before and after immersion in Hanks' solution for 7 days. An as-prepared specimen contained a small amount of Ar implanted during sputtering, although the pressure was as low as 10(-4) Torr. Even though Ar convolution increased with an increase in the relative Ti ion dose, most of the convoluted Ar was not from the Ar gas used for Ti ion production but rather was from the Ar gas used for sputtering the CaTiO3. During Ti implantation, the CaTiO3 films were ion-etched by Ti ions. The composition of the CaTiO3 film was not changed to any great degree by the Ti implantation, however its properties changed considerably. After immersion in Hanks' solution, the thickness of the specimen not implanted with Ti decreased the most whereas the [Ca]/[P] ratio, which was nearly unity before exposure, decreased significantly, becoming 0.23 on the Ti-implanted specimen prepared at 200 W and 0.13 on the Ti-implanted specimen prepared at 50 W. It was also observed by XPS that the ratio [Ca]/[P] was similar to1.9 for all Ti-implanted specimens after immersion in Hanks' solution for 7 days. judging from the binding energies of Ca 2p(3/2) and P 2p electrons and the [Ca]/[P] ratio, it was suggested that a hydroxyapatite-like substance had formed on the surfaces of the Ti-implanted specimens after immersion in Hanks' solution. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050047, Japan.
RP Asami, K (reprint author), Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RI Ohtsu, Naofumi/L-6021-2018; Nagata, Shinji/A-1796-2015
OI Ohtsu, Naofumi/0000-0001-7935-3949; 
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ASAMI K, 1984, CORROS SCI, V24, P83, DOI 10.1016/0010-938X(84)90039-8
   ASAMI K, 1990, CORROS SCI, V31, P727, DOI 10.1016/0010-938X(90)90188-B
   ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   ASAMI K, 1985, ANN U FERRARA V, V8, P769
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   HANAWA T, 1995, MATER T JIM, V36, P438, DOI 10.2320/matertrans1989.36.438
   HANAWA T, 1993, J ELECTRON SPECTROSC, V63, P347, DOI 10.1016/0368-2048(93)80032-H
   HANSSON HA, 1983, J PROSTHET DENT, V50, P108, DOI 10.1016/0022-3913(83)90175-0
   KANGASNIEMI IMO, 1994, J BIOMED MATER RES, V28, P563, DOI 10.1002/jbm.820280506
   LINDER L, 1983, ACTA ORTHOP SCAND, V54, P45, DOI 10.3109/17453678308992868
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
NR 15
TC 24
Z9 24
U1 0
U2 11
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD MAY
PY 2003
VL 35
IS 5
BP 483
EP 488
DI 10.1002/sia.1554
PG 6
WC Chemistry, Physical
SC Chemistry
GA 679FH
UT WOS:000182909700011
DA 2018-10-19
ER

PT J
AU Cadieux, P
   Watterson, JD
   Denstedt, J
   Harbottle, RR
   Puskas, J
   Howard, J
   Gan, BS
   Reid, G
AF Cadieux, P
   Watterson, JD
   Denstedt, J
   Harbottle, RR
   Puskas, J
   Howard, J
   Gan, BS
   Reid, G
TI Potential application of polyisobutylene-polystyrene and a Lactobacillus
   protein to reduce the risk of device-associated urinary tract infections
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE biomaterials; urinary tract; bacterial adhesion; Lactobacillus proteins
ID BACTERIAL ADHERENCE; FERMENTUM RC-14; BINDING PROTEIN; NETWORKS;
   ADHESION; ACID
AB Urinary tract infections (UTI) associated with prostheses continue to cause significant morbidity despite the development and implementation of new biomaterials and device coatings. Ureteral stents, placed to improve drainage of the kidney can become a nidus for infection and potentially serious kidney damage, through attachment of pathogens and biofilm formation. The present study investigated two approaches to reducing the risk of ureteral stent infection. The first involved comparing the resistance to bacterial attachment of medical grade silicone rubber, the current gold standard biomaterial for urinary tract devices, to that of polyisobutylene-poly styrene block copolymer (PIB-PS), a polymer with proven biomaterial potential but as yet untested within the urinary tract. The second approach studied the capacity of a recombinant protein (p29) originally isolated from Lactobacillus fermentum RC-14 to inhibit bacterial attachment when used as a device coating. The protein coat was successfully identified by atomic force microscopy (AFM), gel electrophoresis and surface enhanced laser desorption/ionization (SELDI) protein chip analysis and shown to be present for at least 96 h. The coating and the PIB-PS surface alone were found to significantly reduce the attachment of two common uropathogenic species. Escherichia coli 67 and Enterococcus faecalis 1131 in vitro in the presence of phosphate buffered saline alone. However, the effect was negated following additional urine coating of the sections prior to challenge, likely due to p29 desorption and the development of a urinary conditioning film. These findings highlight the complexity of translating in vitro data to the in vivo setting and the critical role urinary constituents play in the development of urinary tract device-associated infections. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 St Josephs Hlth Care, Lawson Hlth Res Inst, Macromol Engn Res Ctr, London, ON N6A 4V2, Canada.
   St Josephs Hlth Care, Div Urol, London, ON N6A 4V2, Canada.
   St Josephs Hlth Care, Div Surg, London, ON N6A 4V2, Canada.
   Univ Western Ontario, Macromol Engn Res Ctr, London, ON, Canada.
   Univ Western Ontario, Dept Chem & Biochem Engn, London, ON, Canada.
   Univ Western Ontario, Dept Chem, London, ON, Canada.
   Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.
   Univ Western Ontario, Dept Biochem, London, ON, Canada.
   Univ Western Ontario, Dept Pharmacol & Toxicol, London, ON, Canada.
   Univ Western Ontario, Dept Med Biophys, London, ON, Canada.
RP Reid, G (reprint author), St Josephs Hlth Care, Lawson Hlth Res Inst, Macromol Engn Res Ctr, H414,268 Grosvenor St, London, ON N6A 4V2, Canada.
CR ANTONY P, 2001, UNPUB EUR POLYM J
   Burrows LL, 1999, WORLD J UROL, V17, P402, DOI 10.1007/s003450050166
   CHEN D, 1989, J BIOMED MATER RES, V23, P1327, DOI 10.1002/jbm.820231109
   Gan BS, 2002, J INFECT DIS, V185, P1369, DOI 10.1086/340126
   GARDINER G, 2001, INT DAIRY J, V12, P191
   Gardiner GE, 2002, CLIN DIAGN LAB IMMUN, V9, P92, DOI 10.1128/CDLI.9.1.92-96.2002
   HAWTHORN L, 1990, J BIOMED MATER RES, V24, P1325, DOI 10.1002/jbm.820241005
   Heinemann C, 2000, FEMS MICROBIOL LETT, V190, P177, DOI 10.1016/S0378-1097(00)00331-1
   KASZAS G, 1992, POLYM MAT SCI ENG, V67, P325
   KENNEDY JP, 1993, J BIOMAT SCI-POLYM E, V4, P445
   Koivusalo A, 1996, SCAND J GASTROENTERO, V31, P398, DOI 10.3109/00365529609006417
   MINGCHAO S, 2001, J BIOMED MATER RES, V57, P336
   Petas A, 1998, BIOMATERIALS, V19, P677, DOI 10.1016/S0142-9612(97)00171-3
   PINCHUK L, 2001, 6 WORLD BIOM C T, P1452
   Puskas JE, 2001, MACROMOL MATER ENG, V286, P565, DOI 10.1002/1439-2054(20011001)286:10<565::AID-MAME565>3.0.CO;2-E
   Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1
   Reid G, 2001, FEMS IMMUNOL MED MIC, V30, P49, DOI 10.1016/S0928-8244(00)00233-9
   REID G, 1998, MED IMPORTANCE NORMA, P405
   Roos S, 1996, FEMS MICROBIOL LETT, V144, P33, DOI 10.1016/0378-1097(96)00334-5
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   Sherman MA, 1999, J BIOMAT SCI-POLYM E, V10, P259, DOI 10.1163/156856299X00333
   Thibon P, 2000, J HOSP INFECT, V45, P117, DOI 10.1053/jhin.1999.0715
   TRAUTNER BW, 2002, J UROLOGY, V67, P375
   Turner MS, 1997, J BACTERIOL, V179, P3310, DOI 10.1128/jb.179.10.3310-3316.1997
   Uddin MS, 2001, J MICROENCAPSUL, V18, P199
   Velraeds MMC, 1996, COLLOID SURFACE B, V8, P51, DOI 10.1016/S0927-7765(96)01297-0
NR 26
TC 15
Z9 15
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 25
PY 2003
VL 28
IS 2-3
BP 95
EP 105
AR PII S0927-7765(02)00147-9
DI 10.1016/S0927-7765(02)00147-9
PG 11
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 665DF
UT WOS:000182103800002
DA 2018-10-19
ER

PT J
AU Itala, A
   Valimaki, VV
   Kiviranta, R
   Ylanen, HO
   Hupa, M
   Vuorio, E
   Aro, HT
AF Itala, A
   Valimaki, VV
   Kiviranta, R
   Ylanen, HO
   Hupa, M
   Vuorio, E
   Aro, HT
TI Molecular biologic comparison of new bone formation and resorption on
   microrough and smooth bioactive glass microspheres
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioactive glass; microrough surface; gene expression; osteogenesis; rat
   model
ID MESSENGER-RNA; TITANIUM IMPLANTS; MOUSE DEVELOPMENT; TRABECULAR BONE;
   MINIATURE PIGS; CATHEPSIN-K; IN-VITRO; EXPRESSION; SURFACE; OSTEONECTIN
AB In a recent in vitro study, chemical microroughening of a bioactive glass surface was shown to enhance attachment of MG-63 osteoblastic cells to glass. The current study was designed to delineate the effects of microroughening on the gene expression patterns of bone markers during osteogenesis and new bone remodeling on bioactive glass surface in vivo. With the use of a rat model of paired comparison, a portion of the medullary canal in the proximal tibia was evacuated through cortical windows and filled with microroughened or smooth bioactive glass microspheres. The primary bone-healing response and subsequent remodeling were analyzed at 1, 2, and 8 weeks, respectively, by radiography, pQCT, histomorphometry, BEI-SEM, and molecular biologic analyses. The expression of various genes for bone matrix components (type I collagen, osteocalcin, osteopontin, osteonectin) and proteolytic enzymes (cathepsin K, MMP-9) were determined by Northern analysis of the respective mRNAs. Paired comparison showed significant differences in the mRNAs levels for specific bone matrix components at 2 weeks: osteopontin was significantly higher (p = .01) and osteonectin significantly lower (p = .05) in bones filled with microroughened microspheres than in those filled with smooth microspheres. Bones filled with microrough microspheres also showed significantly increased ratios of cathepsin K and MMP-9 (both markers of osteoclastic resorption) to type I collagen (p = .02 and p = .02, respectively) at 2 weeks and a significantly increased expression of MMP-9 at 8 weeks (p = .05). The pQCT, histomorphometric, and BEI-SEM analyses revealed no significant differences in the pattern of bone-healing response. Based on these results, microroughening of a bioactive glass surface could trigger temporal changes in the expression of specific genes especially by promoting the resorption part of new bone-remodeling processes. Future studies are needed to evaluate if the observed changes of gene expression are directly related to the microrough surface of any biomaterial or are biomaterial specific. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Turku, Dept Surg, FIN-20520 Turku, Finland.
   Univ Turku, Dept Med Biochem & Mol Biol, SF-20500 Turku, Finland.
   Abo Akad Univ, Proc Chem Grp Combust & Mat Chem, Turku, Finland.
RP Aro, HT (reprint author), Univ Turku, Dept Surg, Kiinanmyllynkatu 4-8, FIN-20520 Turku, Finland.
OI Aro, Hannu/0000-0003-3118-9144
CR BOLANDER ME, 1988, P NATL ACAD SCI USA, V85, P2919, DOI 10.1073/pnas.85.9.2919
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Itala A, 2001, J BIOMED MATER RES, V56, P282, DOI 10.1002/1097-4636(200108)56:2<282::AID-JBM1096>3.0.CO;2-5
   ITALA A, IN PRESS J BIOMED MA
   Kiviranta R, 2001, J BONE MINER RES, V16, P1444, DOI 10.1359/jbmr.2001.16.8.1444
   Laczka-Osyczka A, 1998, J BIOMED MATER RES, V42, P433, DOI 10.1002/(SICI)1097-4636(19981205)42:3<433::AID-JBM13>3.0.CO;2-H
   Matsuoka H, 1999, J BIOMED MATER RES, V47, P176, DOI 10.1002/(SICI)1097-4636(199911)47:2<176::AID-JBM7>3.0.CO;2-Z
   METSARANTA M, 1991, BIOCHIM BIOPHYS ACTA, V1089, P241, DOI 10.1016/0167-4781(91)90014-D
   OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819
   PITKANEN V, 1995, J AEROSOL SCI, V26, P831
   Rantakokko J, 1996, FEBS LETT, V393, P307, DOI 10.1016/0014-5793(96)00907-6
   Rantakokko J, 1999, J BONE MINER RES, V14, P1934, DOI 10.1359/jbmr.1999.14.11.1934
   REPONEN P, 1994, ANN NY ACAD SCI, V732, P472, DOI 10.1111/j.1749-6632.1994.tb24789.x
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Sela J, 2000, CRIT REV ORAL BIOL M, V11, P423, DOI 10.1177/10454411000110040301
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4
   Uusitalo H, 2001, BONE, V28, P423, DOI 10.1016/S8756-3282(01)00406-9
   Virolainen P, 1997, J BIOMED MATER RES, V35, P9, DOI 10.1002/(SICI)1097-4636(199704)35:1<9::AID-JBM2>3.3.CO;2-H
   Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1
   Wen XJ, 1996, BIO-MED MATER ENG, V6, P173
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   YOUNG MF, 1990, CONNECT TISSUE RES, V24, P17, DOI 10.3109/03008209009152419
NR 31
TC 16
Z9 16
U1 0
U2 2
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR 15
PY 2003
VL 65B
IS 1
BP 163
EP 170
DI 10.1002/jbm.b.10529
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671EV
UT WOS:000182453100005
PM 12632386
DA 2018-10-19
ER

PT J
AU Carnagey, J
   Hern-Anderson, D
   Ranieri, J
   Schmidt, CE
AF Carnagey, J
   Hern-Anderson, D
   Ranieri, J
   Schmidt, CE
TI Rapid endothelialization of PhotoFix natural biomaterial vascular grafts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE small-diameter vascular graft; endothelial cell layer;
   flow-conditioning; PhotoFix
ID CORONARY-ARTERY BYPASS; DYE-MEDIATED PHOTOOXIDATION; PERICARDIAL TISSUE;
   IN-VITRO; SHEAR-STRESS; CELLS; SURFACES; TRANSPLANTATION; PROSTHESES;
   ATTACHMENT
AB To date, no off-the-shelf graft has performed better than the autologous vessel in applications requiring small-bore (< 6-mm diameter) vascular grafts. Much research has been devoted to seeding endothelial cells on synthetic grafts to improve their long-term clinical performance. One key challenge is the ability to retain the endothelium on the graft lumen for extended times. The goal of this research was to develop a process to seed endothelial cells inside a vascular graft and to quickly condition the cells so as to minimize their damage or removal under physiological flow. In addition, the use of PhotoFix(R) natural biomaterial grafts as an improved substrate for human umbilical vein endothelial cells has been evaluated. A motorized system that provides uniform cell seeding of a small-diameter graft (4-mm inner diameter, 10-cm length) by automated radial rotation has been developed. The same system is subsequently adapted for gradual increases in flow rates to strengthen the endothelium, which ultimately was exposed to a final flow rate of 300 ml/min. This process is accomplished without graft transfer, decreasing risks of contamination and physical damage. Cell coverage and cell morphology were evaluated with the use of fluorescence microscopy and scanning-electron microscopy to determine the effectiveness of the How conditioning process. It was found that endothelial cells exhibit roughly 20-50% improved adhesion to PhotoFix vessels compared to fibrin-treated polytetrafluoroethylene (PTFE) synthetic grafts. Flow conditioning for 6 h enhanced in vitro cell retention by 24% and 40% on PhotoFix and PTFE grafts, respectively. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Sulzer Biol, Austin, TX 78752 USA.
RP Schmidt, CE (reprint author), Univ Texas, Dept Chem & Biomed Engn, 26th & Speedway,MC C0400, Austin, TX 78712 USA.
RI Schmidt, Christine/P-1613-2016
CR ANDERSON JS, 1987, SURGERY, V101, P577
   BALLERMANN BJ, 1995, BLOOD PURIFICAT, V13, P125, DOI 10.1159/000170195
   Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Bonatti J, 1998, THORAC CARDIOV SURG, V46, P59, DOI 10.1055/s-2007-1010190
   Bordenave L, 1999, ENDOTHELIUM-J ENDOTH, V6, P267, DOI 10.3109/10623329909078494
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   CLAGETT GP, 1984, CIRCULATION, V69, P632, DOI 10.1161/01.CIR.69.3.632
   Consigny PM, 2000, J LONG-TERM EFF MED, V10, P79
   Conte MS, 1998, FASEB J, V12, P43
   Cooper GJ, 1996, EUR J CARDIO-THORAC, V10, P129, DOI 10.1016/S1010-7940(96)80135-7
   Dunn PF, 1996, CIRCULATION, V93, P1439, DOI 10.1161/01.CIR.93.7.1439
   EDELMAN RR, 1993, JMRI-J MAGN RESON IM, V3, P699, DOI 10.1002/jmri.1880030503
   Grist TM, 1997, CARDIOLOGY, V88, P80, DOI 10.1159/000177314
   HAEGERSTRAND A, 1993, SCAND J THORAC CARD, V27, P21, DOI 10.3109/14017439309099089
   HERRING M, 1994, J VASC SURG, V20, P650, DOI 10.1016/0741-5214(94)90291-7
   JARRELL BE, 1991, J BIOMECH ENG-T ASME, V113, P120, DOI 10.1115/1.2891225
   KAEHLER J, 1989, J VASC SURG, V9, P434
   KEMPCZINSKI RF, 1985, J VASC SURG, V2, P424, DOI 10.1067/mva.1985.avs0020424
   KESLER KA, 1986, J VASC SURG, V3, P58
   KLEIN K, 2001, UNPUB COMMUNICATION
   L'Heureux N, 1998, FASEB J, V12, P47
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   Leseche G, 1995, ANN VASC SURG, V9, pS15, DOI 10.1016/S0890-5096(06)60447-0
   Li J M, 1993, Cardiovasc Surg, V1, P362
   MAZZUCOTELLI JP, 1993, ARTIF ORGANS, V17, P787
   Meinhart J, 1997, ASAIO J, V43, pM515
   Moazami N, 1998, ASAIO J, V44, P89, DOI 10.1097/00002480-199801000-00017
   MOORE MA, 1994, J BIOMED MATER RES, V28, P611, DOI 10.1002/jbm.820280511
   Moore MA, 1997, J HEART VALVE DIS, V6, P521
   Moore MA, 1997, J HEART VALVE DIS, V6, P307
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   OTT MJ, 1995, SURGERY, V117, P334, DOI 10.1016/S0039-6060(05)80210-7
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Sipehia R, 1996, ARTIF CELL BLOOD SUB, V24, P51, DOI 10.3109/10731199609117431
   Vohra R K, 1990, Eur J Vasc Surg, V4, P33, DOI 10.1016/S0950-821X(05)80036-2
   Wang ZG, 2000, INT ANGIOL, V19, P259
   WILSON JM, 1989, SCIENCE, V244, P1344, DOI 10.1126/science.2734614
   WILSON JM, 1995, TEX HEART I J, V22, P145
   ZILLA P, 1993, J CARDIAC SURG, V8, P32, DOI 10.1111/j.1540-8191.1993.tb00574.x
   ZILLA P, 1987, J VASC SURG, V6, P535, DOI 10.1067/mva.1987.avs0060535
   ZILLA P, 1989, SURGERY, V105, P515
NR 41
TC 15
Z9 17
U1 0
U2 2
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR 15
PY 2003
VL 65B
IS 1
BP 171
EP 179
DI 10.1002/jbm.b.10558
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671EV
UT WOS:000182453100006
PM 12632387
DA 2018-10-19
ER

PT J
AU Lakshmi, S
   Jayakrishnan, A
AF Lakshmi, S
   Jayakrishnan, A
TI Properties and performance of sulfide-substituted plasticized poly(vinyl
   chloride) as a biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE poly(vinyl chloride); plasticizer migration; di-(2-ethylhexyl)
   phthalate; surface modification; blood compatibility
ID POLYVINYL-CHLORIDE; BLOOD BAGS; MIGRATION; PHTHALATE; ESTERS;
   DI(2-ETHYLHEXYL)PHTHALATE; HEMODIALYSIS; EXPOSURE; FILMS; LINES
AB Plasticized poly(vinyl chloride) (PVC) was surface modified by nucleophilic substitution of the chlorine atoms of PVC by sulfide ions in aqueous media in the presence of a phase-transfer catalyst (PTC) to make it migration resistant. The modified PVC was sterilized by steam autoclaving and gamma radiation and subjected to plasticizer extraction in an extraction medium such as hexane. Virtually no plasticizer migrated out of modified PVC into the medium even after prolonged incubation for 30 d. The properties of the modified surface were evaluated by contact angle measurements, scanning electron microscopy (SEM), cell-culture studies, hemolysis assay, and whole-blood clotting time measurements. The mechanical properties of modified sheets were evaluated by measurements of tensile strength and strain at break after subjecting the specimens to different modes of sterilization. The modified PVC surface showed enhanced wettabillity and was found to be non-hemolytic and non-cytotoxic. Whole-blood clotting profiles of unmodified and modified PVC were virtually the same. Modification imparted slight yellow color to the material. Surface modification resulted in an 8% decrease in the ultimate stress and 28% decrease in the strain at break values. The sulfide-substituted PVC was found to be blood compatible and would be useful in applications such as tubing for transfusion, dialysis etc., where migration resistance is important. (C) 2003 Wiley Periodicals, Inc.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Div Polymer Chem, Trivandrum 695012, Kerala, India.
RP Jayakrishnan, A (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Div Polymer Chem, Biomed Technol Wing,Satelmond Palace Campus, Trivandrum 695012, Kerala, India.
EM dr_jkrishnan@sify.com
OI Athipettah, Jayakrishnan/0000-0003-2738-6161
CR *ASTM, 1998, ANN BOOK ASTM STAND, P229
   BLASS CR, 1992, INT J ARTIF ORGANS, V15, P200
   Bradbury J, 1996, LANCET, V347, P1541, DOI 10.1016/S0140-6736(96)90681-9
   CASTLE L, 1988, FOOD ADDIT CONTAM, V5, P9
   COGHLAN P, 2001, CSIRO REPORT, P1
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195
   Dickerson RN, 1997, NUTRITION, V13, P1010, DOI 10.1016/0899-9007(97)90962-X
   DUVIS T, 1991, J APPL POLYM SCI, V42, P191, DOI 10.1002/app.1991.070420123
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6
   ISHIKAWA Y, 1983, VOX SANG, V45, P68, DOI 10.1111/j.1423-0410.1983.tb04125.x
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460
   Jayakrishnan A, 1996, POLYMER, V37, P5213, DOI 10.1016/0032-3861(96)00501-0
   Jayakrishnan K, 1998, NATURE, V396, P638
   KRISHNAN VK, 1991, BIOMATERIALS, V12, P489, DOI 10.1016/0142-9612(91)90147-3
   Lakshmi S, 1998, ARTIF ORGANS, V22, P222, DOI 10.1046/j.1525-1594.1998.06124.x
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278
   LEE JD, 1983, NEW CONCISE INORGANI, P231
   Levin G, 1989, U. S. Patent, Patent No. [4,806,393, 4806393]
   Levin G, 1993, U. S. Patent, Patent No. [5,209,931, 5209931]
   Liu XH, 1996, J BIOMATER APPL, V10, P330
   LJUNGGREN L, 1984, ARTIF ORGANS, V8, P99, DOI 10.1111/j.1525-1594.1984.tb04251.x
   Marin ML, 1998, B ENVIRON CONTAM TOX, V60, P68, DOI 10.1007/s001289900592
   Okawara M., 1980, ACS SYM SER, V121, P41
   OLEARY RK, 1968, J PHARM SCI, V57, P12, DOI 10.1002/jps.2600570102
   SMITH MD, 1995, J BIOMAT SCI-POLYM E, V7, P453
   STARKS CM, 1979, PHASE TRANSFER CATAL, P139
   Steiner I, 1998, FOOD ADDIT CONTAM, V15, P812
   THOMAS JA, 1984, CRC CR REV TOXICOL, V13, P283, DOI 10.3109/10408448409023761
   WOODWARD KN, 1990, HUM EXP TOXICOL, V9, P397, DOI 10.1177/096032719000900607
NR 29
TC 11
Z9 12
U1 2
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR 15
PY 2003
VL 65B
IS 1
BP 204
EP 210
DI 10.1002/jbm.b.10562
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671EV
UT WOS:000182453100010
PM 12632391
DA 2018-10-19
ER

PT J
AU Dalsin, JL
   Hu, BH
   Lee, BP
   Messersmith, PB
AF Dalsin, JL
   Hu, BH
   Lee, BP
   Messersmith, PB
TI Mussel adhesive protein mimetic polymers for the preparation of
   nonfouling surfaces
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID MYTILUS-EDULIS; L-DOPA; BIOADHESIVE; HYDROXYPROLINE; PEPTIDES; ACID;
   GLUE
AB A new biomimetic strategy for modification of biomaterial surfaces with poly(ethylene glycol) (PEG) was developed. The strategy exploits the adhesive characteristics of 3,4-dihydroxyphenylalanine (DOPA), an important component of mussel adhesive proteins, to anchor PEG onto surfaces, rendering the surfaces resistant to cell attachment. Linear monomethoxy-terminated PEGS were conjugated either to a single DOPA residue (mPEG-DOPA) or to the N-terminus of Ala-Lys-Pro-Ser-Tyr-Hyp-Hyp-Thr-DOPA-Lys (mPEG-MAPD), a decapeptide analogue of a protein found in Mytilus edulis adhesive plaques. Gold and titanium surfaces were modified by adsorption of mPEG-DOPA and mPEG-MAPD from solution, after which surface analysis by X-ray photoelectron spectroscopy and time-of-flight secondary ion mass spectroscopy confirmed the presence of immobilized PEG on the surface. The ability of modified surfaces to resist cell attachment was examined by culturing 3T3 fibroblasts on the surfaces for up to 14 days. Quantitative image analysis revealed that cell adhesion to mPEG-DOPA and mPEG-MAPD modified surfaces decreased by as much as 98% compared to control surfaces. Modified Ti surfaces exhibited low cell adhesion for up to 2 weeks in culture, indicating that the nonfouling properties of mPEG-DOPA and mPEG-MAPD treated surfaces persist for extended periods of time. This strategy paradoxically exploits the strong fouling characteristics of MAP analogues for antifouling purposes and may be broadly applied to medical implants and diagnostics, as well as numerous nonmedical applications in which the minimization of surface fouling is desired.
C1 Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   Northwestern Univ, Inst Bioengn & Nanosci Adv Med, Evanston, IL 60208 USA.
RP Messersmith, PB (reprint author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RI Messersmith, Phil/B-6695-2009; Messersmith, Phillip/F-3433-2013; Lee,
   Bruce/H-5233-2011
OI Messersmith, Phillip/0000-0002-1197-333X; Lee, Bruce/0000-0002-6529-0032
FU NIDCR NIH HHS [DE 14193]
CR Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004
   BERENBAUM MB, 1989, POLYM PREPR, V30, P350
   Golander C, 1992, POLYETHYLENE GLYCOL
   Harris J. M., 1997, POLYETHYLENE GLYCOL
   Hu BH, 2000, TETRAHEDRON LETT, V41, P5795, DOI 10.1016/S0040-4039(00)00957-6
   Huang K, 2002, BIOMACROMOLECULES, V3, P397, DOI 10.1021/bm015650p
   LAURSEN RA, 1992, STRUCTURE CELLULAR S, P55
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lu HB, 2000, LANGMUIR, V16, P1711, DOI 10.1021/la990221m
   Michel R, 2000, LANGMUIR, V16, P6503, DOI 10.1021/la991436z
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Ooka AA, 2000, BIOPOLYMERS, V57, P92
   Rodriguez R, 1996, J COLLOID INTERF SCI, V177, P122, DOI 10.1006/jcis.1996.0012
   Schedlich LJ, 1998, J BIOL CHEM, V273, P18347, DOI 10.1074/jbc.273.29.18347
   Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797
   SWERDLOFF MD, 1989, INT J PEPT PROT RES, V33, P318
   TAYLOR SW, 1994, J AM CHEM SOC, V116, P10803, DOI 10.1021/ja00102a063
   WAITE JH, 1980, BIOCHEM BIOPH RES CO, V96, P1554, DOI 10.1016/0006-291X(80)91351-0
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   WAITE JH, 1985, BIOCHEMISTRY-US, V24, P5010, DOI 10.1021/bi00340a008
   WAITE JH, 1987, CHEMTECH, V17, P692
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   WAITE JH, 1984, METHOD ENZYMOL, V107, P397
   Yamada K, 2000, BIOMACROMOLECULES, V1, P252, DOI 10.1021/bm0003009
   YAMAMOTO H, 1995, J COLLOID INTERF SCI, V176, P105, DOI 10.1006/jcis.1995.0013
   Yamamoto H, 1996, BIOTECHNOL GENET ENG, V13, P133, DOI 10.1080/02648725.1996.10647926
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
NR 28
TC 384
Z9 391
U1 18
U2 302
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD APR 9
PY 2003
VL 125
IS 14
BP 4253
EP 4258
DI 10.1021/ja0284963
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 663JY
UT WOS:000182003500052
PM 12670247
DA 2018-10-19
ER

PT J
AU Chappard, D
   Degasne, I
   Hure, G
   Legrand, E
   Audran, M
   Basle, MF
AF Chappard, D
   Degasne, I
   Hure, G
   Legrand, E
   Audran, M
   Basle, MF
TI Image analysis measurements of roughness by texture and fractal analysis
   correlate with contact profilometry
SO BIOMATERIALS
LA English
DT Article
DE titanium; contact profilometry; image analysis; fractal geometry;
   roughness
ID DIFFERENT OXIDE THICKNESSES; MODIFIED TITANIUM IMPLANTS; ELECTROPOLISHED
   IMPLANTS; BONE RESPONSE; DIMENSION; BIOMATERIAL; MORPHOLOGY; SURFACES;
   PATTERN
AB Surface properties of a biomaterial are important factors that govern in part its biocompatibility. Among them, surface roughness is now recognized as a very important factor for cell interactions. Surface roughness (Ra) is routinely measured by contact profilometry but other methods are presently usable. We compared two methods (contact profilometry and image analysis of scanning electron microscopic images SEM) on a series of 12 titanium test pieces. The texture analysis of SEM pictures was done by the heterogeneity and run-length methods. Fractal geometry was also used with the "skyscraper" and "blanket" methods providing respectively the D-SKY and D-BLANK fractal dimensions. The fractal dimension of the profilometric curve was also computed (D-MINK). Computer-simulated textures were used to evaluate the pertinence of the algorithms. A significant correlation was found between Ra and all the texture descriptors except heterogeneity. The correlation coefficient was dependent on the microscopic magnification. The fractal dimension of the curve was correlated with D-SKY and D-BLANK. Run-length, D-SKY and D-BLANK were highly correlated, independent of the magnification used, a finding related to the self-similarity of the images. Image texture analysis can be a useful alternative to profilometry with brittle or soft materials or with objects having a complex shape. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 CHU Angers, LHEA, F-49045 Angers, France.
   Fac Med, F-49045 Angers, France.
   CHU Angers, Serv Rhumatol, F-49033 Angers, France.
   Clin Implantol, Paris, France.
RP Chappard, D (reprint author), CHU Angers, LHEA, F-49045 Angers, France.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   BLACHER S, 1997, ACTA STEREOL, V16, P19
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   CALDWELL CB, 1990, PHYS MED BIOL, V35, P235, DOI 10.1088/0031-9155/35/2/004
   Chappard D, 2002, MATH BIOSCI INTERAC, P171
   Chappard D, 2001, BONE, V28, P72, DOI 10.1016/S8756-3282(00)00438-5
   CHERMANT JL, 1983, ACTA STEREOL, V14, P509
   CHU A, 1990, PATTERN RECOGN LETT, V11, P415, DOI 10.1016/0167-8655(90)90112-F
   Coster M, 1995, ACTA STEREOL, V14, P35
   Einstein AJ, 1997, ANAL QUANT CYTOL, V19, P361
   EXNER HE, 1985, J MICROSC-OXFORD, V138, P161, DOI 10.1111/j.1365-2818.1985.tb02610.x
   GERAETS WGM, 1993, BONE, V14, P859, DOI 10.1016/8756-3282(93)90315-2
   Haralick R. M., 1986, HDB PATTERN RECOGNIT, P247
   HURE G, 1996, INT J ORAL MAXILLOF, V11, P97
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Mandelbrot BB, 1982, FRACTAL GEOMETRY NAT
   Meiqiang W, 1995, ACTA STEREOL, V14, P45
   NOWICKI B, 1985, WEAR, V102, P160
   PELEG S, 1984, IEEE T PATTERN ANAL, V6, P518, DOI 10.1109/TPAMI.1984.4767557
   PENTLAND AP, 1984, IEEE T PATTERN ANAL, V6, P661, DOI 10.1109/TPAMI.1984.4767591
   PIMIENTA C, 1994, CELL MATER, V4, P379
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Russ J.C, 1994, FRACTAL SURFACES
   UNDERWOOD EE, 1987, ACTA STEREOL, V6, P855
   UNDERWOOD EE, 1983, ACTA STEREOL, P75
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1996, J BIOMED MATER RES, V30, P251, DOI 10.1002/(SICI)1097-4636(199602)30:2<251::AID-JBM16>3.0.CO;2-P
   WENNERBERG A, 1992, J BIOMED ENG, V14, P412, DOI 10.1016/0141-5425(92)90087-2
NR 31
TC 76
Z9 79
U1 0
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2003
VL 24
IS 8
BP 1399
EP 1407
AR PII S0142-9612(02)00524-0
DI 10.1016/S0142-9612(02)00524-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 638ZY
UT WOS:000180604200007
PM 12527281
DA 2018-10-19
ER

PT J
AU Moseley, R
   Walker, M
   Waddington, RJ
   Chen, WYJ
AF Moseley, R
   Walker, M
   Waddington, RJ
   Chen, WYJ
TI Comparison of the antioxidant properties of wound dressing
   materials-carboxymethylcellulose, hyaluronan benzyl ester and
   hyaluronan, towards polymorphonuclear leukocyte-derived reactive oxygen
   species
SO BIOMATERIALS
LA English
DT Article
DE reactive oxygen species; hyaluronan; 75% benzyl esterified hyaluronan;
   carboxymethylcellulose; antioxidants; chronic wounds
ID HUMAN DERMAL FIBROBLASTS; FREE-RADICAL DAMAGE; SODIUM HYALURONATE;
   SUPEROXIDE ANION; IN-VITRO; ACID; DERIVATIVES; DISEASE; SKIN;
   GLYCOSAMINOGLYCANS
AB In chronic wounds, factors are released which perpetuate inflammatory processes, including polymorphonuclear leukocyte (PMN)-derived reactive oxygen species (ROS), such as superoxide radical (O-2(.-)) and hydroxyl radical ((OH)-O-.) species. The glycosaminoglycan, hyaluronan, has established antioxidant properties towards ROS, although the antioxidant potential of wound dressing biomaterials, such as 75% benzyl esterified hyaluronan (BEHA) and carboxymethylcellulose (CMCH), are less characterised. This study compared the antioxidant properties of high and low molecular weight hyaluronan (HMWT HA and LMWT HA), BEHA and CMCH towards ROS, generated by stimulated PMN in vitro. The antioxidant capacities of each biomaterial were assessed by their inhibition of O-2(.-)-induced cytochrome C reduction, generated via PMN stimulation by phorbol myristyl acetate (PMA); and their inhibition of (OH)-O-.-induced 2-deoxy-D-ribose degradation, generated by PMA stimulated PMN in the presence of a ferric chloride-EDTA chelate.
   All biomaterials, except LMWT HA, possessed dose-dependent antioxidant properties against O-2(.-), BEHA having greatest antioxidant potential, followed by HMWT HA and CMCH. HMWT HA exhibited the highest dose-dependent antioxidant properties towards (OH)-O-., followed by BEHA and CMCH. LMWT HA demonstrated no antioxidant properties towards (OH)-O-.. These antioxidant activities, particularly towards (OH)-O-. may be beneficial in removing the initial source of ROS necessary for the secondary formation of (OH)-O-., implicated as a causal factor for the extensive metabolic alterations observed in chronic wounds. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Cardiff Univ, Dept Oral Surg Med & Pathol, Sch Dent, Cardiff CF4 4XN, S Glam, Wales.
   Cardiff Univ, Matrix Biol & Tissue Repair Res Unit, Dept Dent Hlth & Biol Sci, Sch Dent, Cardiff CF4 4XN, S Glam, Wales.
RP Moseley, R (reprint author), Cardiff Univ, Dept Oral Surg Med & Pathol, Sch Dent, Heath Pk, Cardiff CF4 4XN, S Glam, Wales.
EM moseleyr@cardiff.ac.uk
CR Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1
   ALASSAF S, 1995, RADIAT PHYS CHEM, V46, P207, DOI 10.1016/0969-806X(95)00015-P
   ARTOLA A, 1993, CORNEA, V12, P109, DOI 10.1097/00003226-199303000-00003
   AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X
   Band PA, 1998, WENN GR INT, V72, P33
   BAZZONI G, 1993, J LAB CLIN MED, V121, P268
   BELLAVITE P, 1988, FREE RADICAL BIO MED, V4, P225, DOI 10.1016/0891-5849(88)90044-5
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   CAPECCHI PL, 1993, INT J TISSUE REACT, V15, P71
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Cortivo R, 1996, SEMIN ARTHRITIS RHEU, V26, P492, DOI 10.1016/S0049-0172(96)80030-8
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   Dandona P, 1999, THROMB RES, V96, P437, DOI 10.1016/S0049-3848(99)00132-2
   Edmonds M., 2000, DIABETIC FOOT, V3, P29
   FOSCHI D, 1990, INT J TISSUE REACT, V12, P333
   Fukuda K, 1997, INFLAMM RES, V46, P114, DOI 10.1007/s000110050132
   Galassi G, 2000, BIOMATERIALS, V21, P2183, DOI 10.1016/S0142-9612(00)00147-2
   Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nutr.16.1.33
   HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6
   HALLIWELL B, 1992, J LAB CLIN MED, V119, P598
   HERRICK SE, 1992, AM J PATHOL, V141, P1085
   Hollander DA, 2000, WOUNDS, V12, P111
   Kawaguchi Y, 1997, FREE RADICAL BIO MED, V23, P162, DOI 10.1016/S0891-5849(96)00570-9
   KVAM BJ, 1995, EXP CELL RES, V218, P79, DOI 10.1006/excr.1995.1133
   LARSEN NE, 1992, J ORTHOPAED RES, V10, P23, DOI 10.1002/jor.1100100104
   Laurent T.C., 1998, WENNER GREN INT SERI, V72
   Manuskiatti W, 1996, INT J DERMATOL, V35, P539, DOI 10.1111/j.1365-4362.1996.tb03650.x
   Moseley R, 1997, BBA-MOL BASIS DIS, V1362, P221, DOI 10.1016/S0925-4439(97)00083-5
   Moseley R, 2002, BIOMATERIALS, V23, P2255, DOI 10.1016/S0142-9612(01)00360-X
   Nakata M, 1997, J BIOCHEM-TOKYO, V122, P188
   OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785
   Ortonne JP, 1996, J DERMATOL TREAT, V7, P75, DOI 10.3109/09546639609089533
   Osawa T, 1999, MECH AGEING DEV, V111, P133, DOI 10.1016/S0047-6374(99)00069-X
   OToole EA, 1996, DERMATOL SURG, V22, P525, DOI 10.1111/j.1524-4725.1996.tb00368.x
   PASINI FL, 1984, THROMB RES, V35, P527, DOI 10.1016/0049-3848(84)90284-6
   Peschen M, 2000, ACTA DERM-VENEREOL, V80, P162
   PRESTI D, 1994, CELL BIOCHEM FUNCT, V12, P281, DOI 10.1002/cbf.290120409
   Rasik AM, 2000, INT J EXP PATHOL, V81, P257, DOI 10.1046/j.1365-2613.2000.00158.x
   Sakurai K, 1997, GLYCOCONJUGATE J, V14, P723, DOI 10.1023/A:1018521501289
   Senel O, 1997, ANN PLAS SURG, V39, P516
   Shukla A, 1997, FREE RADICAL RES, V26, P93, DOI 10.3109/10715769709097788
   Steiling H, 1999, EXP CELL RES, V247, P484, DOI 10.1006/excr.1998.4366
   SUZUKI Y, 1993, AGENTS ACTIONS, V38, P32, DOI 10.1007/BF02027210
   Suzumura K, 1999, CHEM PHARM BULL, V47, P1477
   TANAKA H, 1993, ARCH DERMATOL RES, V285, P352, DOI 10.1007/BF00371836
   Taylor DM, 1998, APPL RADIAT ISOTOPES, V49, P677, DOI 10.1016/S0969-8043(97)00268-6
   VESSEY DA, 1992, J INVEST DERMATOL, V99, P859, DOI 10.1111/1523-1747.ep12614831
   Waddington RJ, 2000, ORAL DIS, V6, P138
   Waring MJ, 2001, BIOMATERIALS, V22, P903, DOI 10.1016/S0142-9612(00)00254-4
   WEIGEL PH, 1988, INT J TISSUE REACT, V10, P355
   Wenk J, 2001, J INVEST DERMATOL, V116, P833, DOI 10.1046/j.1523-1747.2001.01345.x
   WHITE MJ, 1990, CLIN PLAST SURG, V17, P473
   Williams C, 1999, Br J Nurs, V8, P676
NR 54
TC 44
Z9 47
U1 2
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2003
VL 24
IS 9
BP 1549
EP 1557
AR PII S0142-9612(02)00540-9
DI 10.1016/S0142-9612(02)00540-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645BY
UT WOS:000180957400003
PM 12559815
DA 2018-10-19
ER

PT J
AU Wettero, J
   Tengvall, P
   Bengtsson, T
AF Wettero, J
   Tengvall, P
   Bengtsson, T
TI Platelets stimulated by IgG-coated surfaces bind and activate
   neutrophils through a selectin-dependent pathway
SO BIOMATERIALS
LA English
DT Article
DE respiratory burst; aggregation; biomaterial; integrin; actin
ID HYDROPHOBIC GLASS SURFACES; LIGAND 1 PSGL-1; P-SELECTIN; GLYCOPROTEIN
   LIGAND-1; SUPEROXIDE ANION; WHOLE-BLOOD; IN-VIVO; TYROSINE
   PHOSPHORYLATION; RESPIRATORY BURST; HYDROGEN-PEROXIDE
AB Blood platelets bind rapidly to foreign surfaces and interact with adsorbed proteins and neutrophil granulocytes. We demonstrate by use of luminol-amplified chemiluminescence under stirred and non-stirred conditions that platelets at IgG-coated surfaces amplify the neutrophil extracellular release of reactive oxygen species (ROS). The neutrophil response involved tyrosine phosphorylation, but was only in part induced by neutrophil F-cgamma-receptor stimulation. The platelet mediated effects were contact-dependent since the respiratory burst was inhibited when the IgG-stimulated platelets were removed by filtration, but not when they were fixed in paraformaldehyde. Bodipyphallacidin-staining of filamentous actin (F-actin) revealed that an actin-dependent platelet adhesion supported the subsequent adhesion and spreading of neutrophils. The neutrophil ROS-response was lowered when the interaction between platelet P-selectin (CD62P) and neutrophil P-selectin glycoprotein ligand-1 (PSGL-1 or CD162) was inhibited. The blocking of L-selectin (CD62L) or blocking of the interaction between platelet glycoprotein (Gp) IIb/IIIa and neutrophil complement receptor 3 (CR3) showed no effect. We conclude that platelet activation on immobilized IgG trigger a contact-dependent "frustrated" phagocytosis by neutrophils, associated with a release of toxic ROS. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Linkoping Univ, Dept Phys & Measurement Technol, Div Appl Phys, SE-58183 Linkoping, Sweden.
   Linkoping Univ, Fac Hlth Sci, Dept Mol & Clin Med, Div Med Microbiol, SE-58185 Linkoping, Sweden.
RP Wettero, J (reprint author), Linkoping Univ, Dept Phys & Measurement Technol, Div Appl Phys, SE-58183 Linkoping, Sweden.
EM jonwe@ifm.liu.se
RI Wettero, Jonas/C-9578-2009
OI Wettero, Jonas/0000-0002-6916-5490
CR ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Babior BM, 1999, BLOOD, V93, P1464
   Barkalow FJ, 2000, BLOOD, V96, P3070
   Bengtsson T, 1999, SCAND J CLIN LAB INV, V59, P439, DOI 10.1080/00365519950185463
   BENGTSSON T, 1994, EUR J CELL BIOL, V63, P345
   BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
   Broberg M, 1998, COLLOID SURFACE B, V11, P123, DOI 10.1016/S0927-7765(98)00024-1
   Broberg M, 1998, COLLOID SURFACE B, V10, P251, DOI 10.1016/S0927-7765(98)00011-3
   Brown KK, 1998, AM J RESP CELL MOL, V18, P100, DOI 10.1165/ajrcmb.18.1.2314
   Caccese D, 2000, THROMB HAEMOSTASIS, V83, P485
   CANOSO RT, 1974, BLOOD, V43, P645
   CLARK RA, 1980, J IMMUNOL, V124, P399
   Diacovo TG, 1996, BLOOD, V88, P146
   Dore M, 1998, AM HEART J, V135, pS146, DOI 10.1016/S0002-8703(98)70242-X
   Elsbach P, 1999, INFLAMMATION BASIC P, P801
   Evangelista V, 1999, BLOOD, V93, P876
   FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8
   Forlow SB, 2000, BLOOD, V95, P1317
   Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Gemmell CH, 2001, J BIOMAT SCI-POLYM E, V12, P933, DOI 10.1163/156856201753113114
   Heijnen HFG, 1999, BLOOD, V94, P3791
   Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750
   Jy WC, 1995, BLOOD CELL MOL DIS, V21, P217, DOI 10.1006/bcmd.1995.0025
   Kalltorp M, 1999, J BIOMED MATER RES, V47, P251, DOI 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O
   Kaplan SS, 1996, J BIOMED MATER RES, V30, P67
   KOUFOS A, 1980, BLOOD, V55, P835
   LETO TL, 1999, INFLAMMATION BASIC P, P769
   LEVINE PH, 1976, J CLIN INVEST, V57, P955, DOI 10.1172/JCI108372
   Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342
   Liu L, 1997, CLIN EXP IMMUNOL, V109, P204, DOI 10.1046/j.1365-2249.1997.4311329.x
   Marcus AJ, 1999, INFLAMMATION BASIC P, P77
   Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877
   Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588
   MOORE KL, 1994, J BIOL CHEM, V269, P23318
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   Nomura S, 2000, CLIN APPL THROMB-HEM, V6, P213, DOI 10.1177/107602960000600406
   Norman KE, 2000, BLOOD, V96, P3585
   NYGREN H, 1995, J VAC SCI TECHNOL A, V13, P2613, DOI 10.1116/1.579459
   Peters MJ, 1999, BRIT J HAEMATOL, V106, P391, DOI 10.1046/j.1365-2141.1999.01553.x
   Piccardoni P, 2001, BLOOD, V98, P108, DOI 10.1182/blood.V98.1.108
   PICKER LJ, 1991, CELL, V66, P921, DOI 10.1016/0092-8674(91)90438-5
   PRATICO D, 1993, AM J PHYSIOL, V264, pH1582
   Pratico D, 1999, CIRCULATION, V99, P3118, DOI 10.1161/01.CIR.99.24.3118
   RUF A, 1995, BRIT J HAEMATOL, V90, P791, DOI 10.1111/j.1365-2141.1995.tb05197.x
   Sakamoto N, 1998, J LEUKOCYTE BIOL, V64, P631
   Seno T, 2001, THROMB RES, V103, P399, DOI 10.1016/S0049-3848(01)00341-3
   Sheikh S, 1997, BIOCHEM BIOPH RES CO, V238, P910, DOI 10.1006/bbrc.1997.7407
   Siedlecki CA, 1999, BIOMATERIALS, V20, P1521, DOI 10.1016/S0142-9612(99)00065-4
   Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193
   Snapp KR, 1998, J CELL BIOL, V142, P263, DOI 10.1083/jcb.142.1.263
   Soslau G, 2000, THROMB RES, V97, P15, DOI 10.1016/S0049-3848(99)00124-3
   Stief TW, 2000, THROMB RES, V97, P473, DOI 10.1016/S0049-3848(99)00211-X
   Stief TW, 2001, THROMB RES, V104, P361, DOI 10.1016/S0049-3848(01)00367-X
   Stief TW, 2001, CLIN APPL THROMB-HEM, V7, P219, DOI 10.1177/107602960100700307
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tengvall P, 1996, BIOMATERIALS, V17, P1001, DOI 10.1016/0142-9612(96)84675-8
   TSUJI T, 1994, J LEUKOCYTE BIOL, V56, P583
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Wettero J, 2001, J BIOMED MATER RES, V57, P550, DOI 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T
   Wettero J, 2000, J BIOMED MATER RES, V51, P742, DOI 10.1002/1097-4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
   WHITE LA, 1978, AM J HEMATOL, V4, P313, DOI 10.1002/ajh.2830040403
   WONG CS, 1991, P NATL ACAD SCI USA, V88, P2397, DOI 10.1073/pnas.88.6.2397
   Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769
   Zalavary S, 1996, J LEUKOCYTE BIOL, V60, P58
   ZHOU MJ, 1994, J CELL BIOL, V125, P1407, DOI 10.1083/jcb.125.6.1407
   Zielinski T, 2001, THROMB RES, V103, P149, DOI 10.1016/S0049-3848(01)00282-1
NR 69
TC 20
Z9 21
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2003
VL 24
IS 9
BP 1559
EP 1573
DI 10.1016/S0142-9612(02)00543-4
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645BY
UT WOS:000180957400004
PM 12559816
DA 2018-10-19
ER

PT J
AU Gingras, M
   Paradis, I
   Berthod, F
AF Gingras, M
   Paradis, I
   Berthod, F
TI Nerve regeneration in a collagen-chitosan tissue-engineered skin
   transplanted on nude mice
SO BIOMATERIALS
LA English
DT Article
DE nerve regeneration; biomaterial; tissue engineering; skin equivalent
ID VITRO RECONSTRUCTED SKIN; DERMAL SUBSTITUTE; ARTIFICIAL SKIN; SCAR
   TISSUE; IN-VIVO; GRAFTS; FIBROBLASTS; THICKNESS; WOUNDS; KERATINOCYTES
AB A reconstructed skin made of a collagen-chitosan sponge seeded with human fibroblasts and keratinocytes and grown in vitro for 31 days was developed for the treatment of deep and extensive burns. The aim of this study was to assess whether this tissue-engineered skin could promote nerve regeneration in vivo, since recovery of sensation is a major concern for burnt patients. The human reconstructed skin was transplanted on the back of nude mice and the growth of nerve fibres within it was assessed 40, 60, 90 and 120 days after graft. Nerve growth was monitored by confocal microscopy using immunohistochemical staining of PGP 9.5 and 150kD neurofilament, while Schwann cell migration was observed using protein S100 expression and laminin deposition. Nerve growth was first detected 60 days after transplantation and was more abundant 90 and 120 days after graft. Linear arrangements of Schwann cells were observed in the graft as early as 40 days after graft. Nerve growth was observed along these Schwann cell extensions 60 days after transplantation. We conclude that the three-dimensional architecture of the collagen-chitosan tissue-engineered skin sponge encourages nerve growth. This result provides new perspectives to increase nerve regeneration within the tissue-engineered skin by linkage of neurotrophic factors in the sponge before transplantation. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Laval, CHA, Hop St Sacrament, Lab Organogenese Expt, St Foy, PQ G1S 4L8, Canada.
RP Berthod, F (reprint author), Univ Laval, CHA, Hop St Sacrament, Lab Organogenese Expt, 1050 Chemin, St Foy, PQ G1S 4L8, Canada.
CR Altun V, 2001, BURNS, V27, P717, DOI 10.1016/S0305-4179(01)00026-2
   AUGER FA, 1995, IN VITRO CELL DEV-AN, V31, P432
   Bayramicli M, 2000, BRIT J PLAST SURG, V53, P130, DOI 10.1054/bjps.1999.3204
   Berthod F, 1996, J BIOMED MATER RES, V32, P87, DOI 10.1002/(SICI)1097-4636(199609)32:1<87::AID-JBM10>3.0.CO;2-F
   Berthod F, 1997, J INVEST DERMATOL, V108, P737, DOI 10.1111/1523-1747.ep12292122
   BERTHOD F, 1993, BIOMATERIALS, V14, P749, DOI 10.1016/0142-9612(93)90039-5
   Berthod F, 1997, BRIT J DERMATOL, V136, P809, DOI 10.1111/j.1365-2133.1997.tb03917.x
   Berthod F, 2001, MATRIX BIOL, V20, P463, DOI 10.1016/S0945-053X(01)00162-7
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   Berthod F, 1997, SKIN SUBSTITUTE PROD, P23
   BOYCE ST, 1995, ANN SURG, V222, P743, DOI 10.1097/00000658-199512000-00008
   Brunelli G. A., 1995, Annals Academy of Medicine Singapore, V24, P108
   Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593
   Compton CC, 1998, J INVEST DERMATOL, V110, P908, DOI 10.1046/j.1523-1747.1998.00200.x
   Eaglstein WH, 1999, DERMATOL SURG, V25, P195, DOI 10.1046/j.1524-4725.1999.08186.x
   ENGLISH KB, 1992, J INVEST DERMATOL, V99, P120, DOI 10.1111/1523-1747.ep12616765
   GERMAIN L, 1993, BURNS, V19, P99, DOI 10.1016/0305-4179(93)90028-7
   GU XH, 1995, BRIT J DERMATOL, V132, P376, DOI 10.1111/j.1365-2133.1995.tb08670.x
   Juma A, 2002, PLAST RECONSTR SURG, V109, P562, DOI 10.1097/00006534-200202000-00023
   KANGESU T, 1993, BRIT J PLAST SURG, V46, P401, DOI 10.1016/0007-1226(93)90046-E
   KISHIMOTO S, 1982, BURNS, V9, P121, DOI 10.1016/0305-4179(82)90060-2
   Kremer M, 2000, BRIT J PLAST SURG, V53, P459, DOI 10.1054/bjps.2000.3368
   Lamme EN, 1996, J HISTOCHEM CYTOCHEM, V44, P1311, DOI 10.1177/44.11.8918906
   Lamme EN, 1998, J INVEST DERMATOL, V111, P989, DOI 10.1046/j.1523-1747.1998.00459.x
   Lamme EN, 2000, J PATHOL, V190, P595, DOI 10.1002/(SICI)1096-9896(200004)190:5<595::AID-PATH572>3.0.CO;2-V
   Li H, 1997, J SURG RES, V73, P143, DOI 10.1006/jsre.1997.5229
   Lutz ME, 1998, ARCH DERMATOL, V134, P1271, DOI 10.1001/archderm.134.10.1271
   Malenfant A, 1998, Pain, V77, P241, DOI 10.1016/S0304-3959(98)00096-7
   Martini R, 2001, MUSCLE NERVE, V24, P456, DOI 10.1002/mus.1027
   Muhart M, 1999, ARCH DERMATOL, V135, P913, DOI 10.1001/archderm.135.8.913
   Parenteau N, 1996, BIOTECHNOL BIOENG, V52, P3, DOI 10.1002/(SICI)1097-0290(19961005)52:1<3::AID-BIT1>3.3.CO;2-D
   Rangappa N, 2000, J BIOMED MATER RES, V51, P625, DOI 10.1002/1097-4636(20000915)51:4<625::AID-JBM10>3.0.CO;2-U
   Regnier M, 1997, J INVEST DERMATOL, V109, P510, DOI 10.1111/1523-1747.ep12336627
   SCHLIEPHAKE H, 1994, J ORAL MAXIL SURG, V52, P1247, DOI 10.1016/0278-2391(94)90045-0
   SHAHABEDDIN L, 1990, Skin Pharmacology, V3, P107
   STELLA M, 1994, BURNS, V20, P491, DOI 10.1016/0305-4179(94)90003-5
   Sulaiman OAR, 2000, GLIA, V32, P234, DOI 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   TERENGHI G, 1995, HISTOL HISTOPATHOL, V10, P709
   TOMPKINS RG, 1989, CRIT CARE MED, V17, P734, DOI 10.1097/00003246-198908000-00003
   Tsiper MV, 2002, J CELL SCI, V115, P1005
   VALLE CAL, 1992, PLAST RECONSTR SURG, V89, P139
   Wallengren J, 1999, BRIT J DERMATOL, V140, P400
   Ward R S, 1989, J Burn Care Rehabil, V10, P536, DOI 10.1097/00004630-198911000-00015
   WARD R S, 1991, Journal of Burn Care and Rehabilitation, V12, P569, DOI 10.1097/00004630-199111000-00013
   Ward RS, 1998, J BURN CARE REHABIL, V19, P10, DOI 10.1097/00004630-199801000-00005
   WARIS T, 1983, PLAST RECONSTR SURG, V72, P439, DOI 10.1097/00006534-198310000-00001
   WARIS T, 1978, SCAND J PLAST RECONS, V12, P173, DOI 10.3109/02844317809012992
   Waymack P, 2000, BURNS, V26, P609, DOI 10.1016/S0305-4179(00)00017-6
   Williams WG, 1999, ANN PLAS SURG, V43, P397, DOI 10.1097/00000637-199910000-00010
   Xu W., 1996, Journal of Burn Care and Rehabilitation, V17, P7, DOI 10.1097/00004630-199601000-00005
NR 51
TC 108
Z9 117
U1 2
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2003
VL 24
IS 9
BP 1653
EP 1661
DI 10.1016/S0142-9612(02)00572-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 645BY
UT WOS:000180957400013
PM 12559825
DA 2018-10-19
ER

PT J
AU Guzzardella, GA
   Torricelli, P
   Giardino, NNAR
AF Guzzardella, GA
   Torricelli, P
   Giardino, NNAR
TI Osseointegration of endosseous ceramic implants after postoperative
   low-power laser stimulation: an in vivo comparative study
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial; bone implant; low-power laser; osseointegration
ID AS DIODE-LASER; BONE-GROWTH; YAG LASER; IRRADIATION; HYDROXYAPATITE;
   BIOSTIMULATION; RATS; TISSUE; REPAIR
AB Stimulation with low-power laser (LPL) can enhance bone repair as reported in experimental studies on bone defects and fracture healing. Little data exist concerning the use of LPL postoperative stimulation to improve osseointegration of endosseous implants in orthopaedic and dental surgery. An in vivo model was used for the present study to evaluate whether Ga-Al-As (780 nm) LPL stimulation can improve biomaterial osseoi nteg ration. After drilling holes, cylindrical implants of hydroxyapatite (HA) were placed into both distal femurs of 12 rabbits. From postoperative day 1 and for 5 consecutive days, the left femurs of all rabbits were submitted to LPL treatment (LPL group) with the following parameters: 300 J/cm(2), 1 W, 300 Hz, pulsating emission, 10 min. The right femurs were sham-treated (control group). Three and 6 weeks after implantation, histomorphometric and microhardness measurements were taken. A higher affinity index was observed at the HA-bone interface in the LPL group at 3 (P<0.0005) and 6 weeks (P<0.001); a significant difference in bone microhardness was seen in the LPL group vs. the control group (P<0.01). These results suggest that LPL postoperative treatment enhances the bone-implant interface.
C1 Ist Ricerca Codivilla Putti, Serv Chirurg Sperimentale, Ist Ortoped Rizzoli, Dept Expt Surg, I-40136 Bologna, BO, Italy.
   Univ Bologna, Chair Surg Pathophysiol, Bologna, Italy.
RP Guzzardella, GA (reprint author), Ist Ricerca Codivilla Putti, Serv Chirurg Sperimentale, Ist Ortoped Rizzoli, Dept Expt Surg, Via Barbiano 1-10, I-40136 Bologna, BO, Italy.
EM gaetanoantonio.guzzardella@ior.it
RI TORRICELLI, PAOLA/J-5298-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970
CR AMANO A, 1994, LASER SURG MED, V15, P290, DOI 10.1002/lsm.1900150309
   Asanami Soichiro, 1993, Laser Therapy, V5, P29
   Capello WN, 1998, CLIN ORTHOP RELAT R, P200, DOI 10.1097/00003086-199810000-00021
   DEW DK, 1993, ORTHOPEDICS, V16, P581
   Dorr LD, 1998, J ARTHROPLASTY, V13, P729, DOI 10.1016/S0883-5403(98)90023-7
   Dortbudak O, 2000, CLIN ORAL IMPLAN RES, V11, P540, DOI 10.1034/j.1600-0501.2000.011006540.x
   el-Montaser M, 1999, Implant Dent, V8, P79, DOI 10.1097/00008505-199901000-00010
   FINI M, 2002, J ORTHOPAED RES, V20, P765
   GLOWACKI J, 1991, BONE-BIOMATERIAL INTERFACE, P265
   Gouw-Soares S, 2001, J CLIN LASER MED SUR, V19, P193, DOI 10.1089/104454701316918961
   Guzzardella GA, 2001, ARTIF CELL BLOOD SUB, V29, P235, DOI 10.1081/BIO-100103047
   GUZZARDELLA GA, 2001, IN PRESS INT J ARTIF
   HALL RR, 1971, NATURE, V232, P131, DOI 10.1038/232131a0
   HONMURA A, 1992, LASER SURG MED, V12, P441, DOI 10.1002/lsm.1900120414
   Huja SS, 1998, J ORTHOPAED RES, V16, P54, DOI 10.1002/jor.1100160110
   Kawasaki K, 2000, LASER SURG MED, V26, P282, DOI 10.1002/(SICI)1096-9101(2000)26:3<282::AID-LSM6>3.3.CO;2-O
   KUSAKARI H, 1992, P 3 WORLD C INT SOC, P49
   Lee JJ, 2000, J ORAL MAXIL SURG, V58, P1372, DOI 10.1053/joms.2000.18269
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Lewandrowski KU, 1996, LASER SURG MED, V19, P40, DOI 10.1002/(SICI)1096-9101(1996)19:1<40::AID-LSM6>3.3.CO;2-3
   Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.0.CO;2-R
   Matsumoto H, 2000, CLIN ORAL IMPLAN RES, V11, P354, DOI 10.1034/j.1600-0501.2000.011004354.x
   Meffert R M, 1999, Adv Dent Res, V13, P170
   Morrone G, 1998, LASER MED SCI, V13, P293, DOI 10.1007/s101030050011
   Morrone G, 2000, ARTIF CELL BLOOD SUB, V28, P321, DOI 10.3109/10731190009119362
   Morrone G, 2000, ARTIF CELL BLOOD SUB, V28, P193, DOI 10.3109/10731190009118581
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   Ottani V, 2002, MICRON, V33, P121, DOI 10.1016/S0968-4328(01)00008-7
   Rokkum M, 1999, J ARTHROPLASTY, V14, P689, DOI 10.1016/S0883-5403(99)90224-3
   Romanos GE, 2000, J PERIODONTOL, V71, P810, DOI 10.1902/jop.2000.71.5.810
   Shigino T, 2000, INT J PROSTHODONT, V13, P365
   SOBALLE K, 1993, ACTA ORTHOP SCAND S, V64, P255
   TANG XM, 1986, LASER SURG MED, V6, P346, DOI 10.1002/lsm.1900060309
   Tanzer M, 2001, J ORTHOPAED RES, V19, P195, DOI 10.1016/S0736-0266(00)00034-6
   TORIYAMA M, 1995, J MATER SCI, V30, P3216, DOI 10.1007/BF01209240
   Torricelli P, 2001, BIOMED PHARMACOTHER, V55, P117, DOI 10.1016/S0753-3322(00)00025-1
   TRELLES MA, 1987, LASER SURG MED, V7, P36, DOI 10.1002/lsm.1900070107
   TUNER J, 1999, LOW LEVEL LASER THER, P167
   Ueda Y, 2001, J Oral Sci, V43, P55
   Yamamoto M, 2001, LASER MED SCI, V16, P213, DOI 10.1007/PL00011357
NR 40
TC 29
Z9 32
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD APR
PY 2003
VL 14
IS 2
BP 226
EP 232
DI 10.1034/j.1600-0501.2003.00872.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 669ZC
UT WOS:000182380900014
PM 12656884
DA 2018-10-19
ER

PT J
AU Sharma, SK
   Sehgal, N
   Kumar, A
AF Sharma, SK
   Sehgal, N
   Kumar, A
TI Biomolecules for development of biosensors and their applications
SO CURRENT APPLIED PHYSICS
LA English
DT Article; Proceedings Paper
CT India/Japan Workshop on New Advanced Materials in Molecular Electronics
CY DEC 10-11, 2001
CL NEW DELHI, INDIA
DE biomaterials; biomolecules; biosensors; enzymes; immunosensors
ID ENZYME SENSOR; AMPEROMETRIC DETERMINATION; FISH; ELECTRODE;
   HYPOXANTHINE; GLUCOSE; ACID
AB Biosensors are analytical devices incorporating biological materials such as enzymes, tissues, microorganisms, antibodies, cell receptors or biologically derived materials or a biomimic component intimately associated with or integrated within a physicochemical transducer or transducing microsystem which may be either optical, electrochemical, thermometric, piezoelectric or magnetic. The electronic signals produced are proportional to the concentration of specific analyte. A biomaterial may be any material, natural or man-made, that comprises whole or part of a living structure or biomedical device, which performs natural function. An essential component of molecular sensor is reagent layers. Creation of these layers require the immobilization of recognition elements for the detection method. The recognition elements are biomolecules. Laboratory methods of immobilization are numerous, but may not always appropriate for manufacture of biosensors. In the present article, we describe the use of various biomaterials for biosensors as well as their availability. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Inst Genom & Integrat Biol, Delhi 110007, India.
   Univ Delhi, Dept Zool, Delhi 110007, India.
RP Kumar, A (reprint author), Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.
EM ashokcbt@rediffmail.com
RI Sharma, Sandeep/F-7420-2010; Ganju, Shahji/F-3409-2012
OI Sharma, Sandeep/0000-0002-0039-7883; 
CR ANDERSON GP, 2000, ULTRASENSITIVE FIBER
   ARNOLD MA, 1987, BIOSENSORS FUNDAMENT, P31
   ASAKAWA S, 1959, NIPPON SUISAN GAKKIS, V24, P714
   BARKER SA, 1987, BIOSENSORS FUNDAMENT, P85
   BURT JR, 1968, J FOOD TECHNOL, V31, P165
   CASS AEG, 1984, ANAL CHEM, V56, P667, DOI 10.1021/ac00268a018
   CLARK LC, 1962, ANN NY ACAD SCI, V102, P29, DOI 10.1111/j.1749-6632.1962.tb13623.x
   Cooper MA, 2002, NAT REV DRUG DISCOV, V1, P515, DOI 10.1038/nrd838
   COULET RR, 1991, AMPEROMETRIC ENZYME, P758
   Dong Shaojun, 2002, J Biotechnol, V82, P303, DOI 10.1016/S1389-0352(01)00048-4
   EHIRA S, 1969, BULL JAP SOC SCI FISH, V35, P1080
   EHIRA S, 1966, NIPPON SUISAN GAKK, V32, P716
   FUJII Y, 1966, NIPPON SUISAN GAKK, V32, P410
   FUKUI S, 1982, ANNU REV MICROBIOL, V36, P145, DOI 10.1146/annurev.mi.36.100182.001045
   GOULD BJ, 1986, HDB ENZYME BIOTECHNO, P434
   GRIFFITHS D, 1993, TRENDS BIOTECHNOL, V11, P122, DOI 10.1016/0167-7799(93)90086-O
   GUILBAULT G, 1984, HDB IMMOBILIZED ENZY, P87
   GUILBAULT GG, 1988, ANAL CHIM ACTA, V206, P369, DOI 10.1016/S0003-2670(00)80859-4
   GUILBAULT GG, 1985, IMMOBILIZED CELLS EN, P56
   HIKUMA M, 1979, ANAL CHIM ACTA, V109, P33, DOI 10.1016/S0003-2670(01)84223-9
   HIKUMA M, 1979, BIOTECHNOL BIOENG, V21, P1845, DOI 10.1002/bit.260211011
   HIKUMA M, 1980, ENZYME MICROB TECH, V2, P234, DOI 10.1016/0141-0229(80)90053-8
   HIKUMA M, 1979, EUR J APPL MICROBIOL, V8, P289, DOI 10.1007/BF00508793
   IWAI H, 1986, CHEM PHARM BULL, V34, P3471
   JAHNS FD, 1976, FOOD TECHNOL-CHICAGO, V30, P27
   JANCHEN M, 1985, ANAL LETT PT B, V18, P1799
   JONES NR, 1965, J FOOD SCI, V30, P791, DOI 10.1111/j.1365-2621.1965.tb01842.x
   JONES NR, 1964, J SCI FOOD AGR, V15, P763, DOI 10.1002/jsfa.2740151105
   KARUBE I, 1979, EUR J APPL MICROBIOL, V7, P343, DOI 10.1007/BF00499848
   KARUBE I, 1980, ENZYME MICROB TECH, V2, P117, DOI 10.1016/0141-0229(80)90066-6
   KARUBE I, 1981, ANAL CHEM, V53, P1852, DOI 10.1021/ac00235a030
   KARUBE I, 1989, BIOSENSORS FUNDAMENT, P28
   KARUBE I, 1996, MICROBIAL BIOSENSORS, P165
   KAS JA, 2000, NATURAL POLYM
   KAWABATA T, 1952, NIPPON SUISAN GAKK, V18, P124
   KAWASHIMA T, 1980, NIPPON KAGAKU KAISHI, P1542, DOI 10.1246/nikkashi.1980.1542
   KOLOT FB, 1982, PROCESS BIOCHEM, V17, P12
   KOSHCHEYENKO KA, 1981, PRIKIL BIOCH MICROBI, V27, P477
   KOSHCHEYENKO KA, 1981, MICROBIOLOGIA, V11, P55
   KUAN SS, 1987, BIOSENSOR FUNDAMENTA, P44
   KULIS J, 1985, ZH ANAL KHIM, V40, P2077
   KULYS J, 1980, BIOTECHNOL BIOENG, V22, P221, DOI 10.1002/bit.260220116
   Kwon HJ, 2002, COMP BIOCHEM PHYS A, V132, P231, DOI 10.1016/S1095-6433(02)00058-2
   LEE EH, 1982, B JPN SOC SCI FISH, V48, P255
   LIGLER FS, 2000, LECT BIOSENSORS 0605
   LIGLER FS, 2000, IMMUNOLOGICALLY BASE
   LIGLER FS, 2000, FABRICATION CELL BAS
   LUONG JHT, 1988, TRENDS BIOTECHNOL, V6, P310, DOI 10.1016/0167-7799(88)90026-1
   MACHOLAN L, 1991, BIOINSTRUMENTATION B, P349
   MARTHEWS DR, 1987, LANCET, V1, P778
   MIKAYE M, 1955, NIPPON SUISAN GAKK, V21, P123
   NANJO M, 1974, ANAL CHEM, V46, P1769, DOI 10.1021/ac60348a058
   NIKOLELIS DP, 1984, ANAL CHIM ACTA, V161, P343, DOI 10.1016/S0003-2670(00)85804-3
   NUMATA K, 1981, NIPPON SHOKUHIN KOGY, V28, P542
   OTA F, 1954, NIPPON SUISAN GAKK, V19, P1150
   PICKUP J, 1993, TRENDS BIOTECHNOL, V11, P285, DOI 10.1016/0167-7799(93)90016-3
   PICKUP JC, 1989, APPL BIOSENSORS, P234
   REID C, 2000, BIOSENS BIOELEC 0605
   ROBINSON G, 1991, ADV BIOSENSORS, P229
   Saito T., 1961, Bulletin of the Japanese Society of Scientific Fisheries, V27, P461
   SAITO T., 1959, BULL JAPANESE SOC SCI FISH, V24, P749
   SCHELLER FW, 1987, BIOSENSOR FUNDAMENTA, P319
   *SIGM ALDR CO, 2001, SIGM BIOCH REAG LIF
   SUZUKI TANEKO, 1953, BULL JAPANESE SOC SCI FISH, V19, P102
   TAKASE A, 1953, NIPPON SUISAN GAKK, V19, P71
   TOKUNAGA T, 1977, Nippon Suisan Gakkaishi, V43, P219
   Turner A.P.F., 1987, BIOSENSORS FUNDAMENT, P13
   UCHIYAMA H, 1970, NIPPON SUISAN GAKK, V36, P977
   Velasco-Garcia MN, 2001, TRENDS BIOTECHNOL, V19, P433, DOI 10.1016/S0167-7799(01)01841-8
   WATANABE E, 1984, J FOOD SCI, V49, P114, DOI 10.1111/j.1365-2621.1984.tb13684.x
   WATANABE E, 1983, J FOOD SCI, V48, P496, DOI 10.1111/j.1365-2621.1983.tb10775.x
   WATANABE E, 1987, J FOOD SCI, V52, P592, DOI 10.1111/j.1365-2621.1987.tb06682.x
   WATANABE E, 1984, ENZYME MICROB TECH, V6, P207, DOI 10.1016/0141-0229(84)90105-4
   WATANABE E, 1984, APPL MICROBIOL BIOT, V19, P18
   YAMADA K, 1981, Nippon Suisan Gakkaishi, V47, P631
   YAMAMOTO M, 1953, NIPPON SUISAN GAKK, V19, P761
   YAMAMURA Y, 1936, NIPPON SUISAN GAKK, V5, P98
   YAMAMURA Y, 1933, NIPPON SUISAN GAKK, V2, P118
NR 78
TC 43
Z9 44
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
EI 1878-1675
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD APR
PY 2003
VL 3
IS 2-3
BP 307
EP 316
DI 10.1016/S1567-1739(02)00219-5
PG 10
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 667FH
UT WOS:000182220200033
DA 2018-10-19
ER

PT J
AU Fujita, H
   Iida, H
   Shimizu, K
   Kitaori, T
   Hiroshima, Y
   Nakamura, T
AF Fujita, H
   Iida, H
   Shimizu, K
   Kitaori, T
   Hiroshima, Y
   Nakamura, T
TI A novel femoral intramedullary plug with sliding mechanism
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE total hip arthroplasty; cement; intramedullary plug; pressurization; and
   biomaterial
ID BONE
AB A novel femoral intramedullary plug with a sliding mechanism has been developed and evaluated clinically. The new plug consists of a pair of specially designed components, each shaped like an obliquely cut cylinder. Postoperative plain radiographs of 30 arthroplasties using the plug were examined for cement leakage, plug migration, and radiolucent line formation between the cement and the femoral cortex. Plugging was complete in 22 cases. Leakage of the cement was seen in 4 cases, and migration of the plug was seen in the other 4 cases. Our study showed the efficacy of the plug in occluding the femoral canal completely in 14 of 22 cases. The plug appears to be promising for clinical applications, because it has good biocompatibility and can occlude the femoral canal tightly.
C1 Kyoto Univ, Dept Orthoped Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Natl Hosp, Dept Orthopaed Surg, Kyoto, Japan.
   Kansai Med Univ, Dept Orthopaed Surg, Osaka, Japan.
RP Fujita, H (reprint author), Kyoto Univ, Dept Orthoped Surg, Sakyo Ku, Kawahara Cho 54, Kyoto 6068507, Japan.
CR Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CHRISTIE J, 1995, J BONE JOINT SURG BR, V77B, P456
   DOJIER JK, 2000, J ARTHROPLASTY, V15, P488
   Fujita H, 2000, J BONE JOINT SURG BR, V82B, P614, DOI 10.1302/0301-620X.82B4.9739
   HARRIS WH, 1986, J BONE JOINT SURG AM, V68A, P1064, DOI 10.2106/00004623-198668070-00014
   Kawanabe K, 1998, J BONE JOINT SURG BR, V80B, P527, DOI 10.1302/0301-620X.80B3.8576
   KNIGHT WE, 1982, CLIN ORTHOP RELAT R, P167
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NEO M, 1994, J BIOMED MATER RES, V28, P365, DOI 10.1002/jbm.820280311
   SONG Y, 1994, CLIN ORTHOP RELAT R, P297
NR 11
TC 2
Z9 2
U1 0
U2 1
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD APR
PY 2003
VL 18
IS 3
BP 367
EP 370
DI 10.1054/arth.2003.50059
PG 4
WC Orthopedics
SC Orthopedics
GA 673XB
UT WOS:000182605100020
PM 12728432
DA 2018-10-19
ER

PT J
AU Niedhart, C
   Maus, U
   Redmann, E
   Schmidt-Rohlfing, B
   Niethard, FU
   Siebert, CH
AF Niedhart, C
   Maus, U
   Redmann, E
   Schmidt-Rohlfing, B
   Niethard, FU
   Siebert, CH
TI Stimulation of bone formation with an in situ setting tricalcium
   phosphate/rhBMP-2 composite in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE in situ setting cement; resorbable cement; recombinant human bone
   morphogenetic protein-2; osteoinduction; bone regeneration
ID MORPHOGENETIC PROTEIN-2; BIOMATERIAL CARRIERS; ECTOPIC MODEL; RHBMP-2;
   DEFECTS; MATRIX; PHARMACOKINETICS; RECONSTRUCTION; IMPLANTS; RABBIT
AB The aim of the study was to determine bone-regenerative effects of an in situ setting tricalcium phosphate (TCP) cement combined with rhBMP-2 and to compare it with autologous bone graft. A trepanation defect of 1.5 mm in the femur diaphysis of Sprague-Dawley rats was filled with an in situ setting TCP cement combined with 0, 0.25, 2.5, or 25 mug of rhBMP-2, an autologous bone graft, or left empty. The rats were euthanized after 1 and 3 weeks and examined by radiography, histology, histomorphometry, and bending tests. All TCP groups with or without BMP-2 showed a good bony ingrowth with a close bone-cement contact. Histomorphometric analysis showed no increase of new bone formation in the defect, but a dose-dependent increase in callus formation with a maximum at 25 mug of rhBMP-2. As shown with intravital fluorochrome staining, new bone formation started earlier using rhBMP-2. Bone strength, measured in a three-point bending test and expressed in percentage of the contralateral healthy femur, was 75% for TCP + 25 mug rhBMP-2, 44% for TCP + 2.5 mug rhBMP-2, and 34% for autologous bone graft. TCP particles were detectable in all groups after 3 weeks. Callus formation and bending strength of the TCP + 25 mug rhBMP-2 group was superior to autologous bone graft. So TCP/rhBMP-2 composites may prove to be an effective substitute for autologous bone grafts. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Aachen, Dept Orthoped Surg, D-52074 Aachen, Germany.
RP Niedhart, C (reprint author), Univ Aachen, Dept Orthoped Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
CR AGRAWAL CM, 1995, BIOMATERIALS, V16, P1255, DOI 10.1016/0142-9612(95)98133-Y
   ALAM MI, 2000, J BIOMED MATER RES, V54, P129
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.3.CO;2-T
   JOHNSON EE, 1988, CLIN ORTHOP RELAT R, P257
   JOHNSON EE, 1990, CLIN ORTHOP RELAT R, P234
   Kamegai Akihide, 1994, Bio-Medical Materials and Engineering, V4, P291
   KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004
   Koempel JA, 1998, J BIOMED MATER RES, V41, P359, DOI 10.1002/(SICI)1097-4636(19980905)41:3<359::AID-JBM3>3.0.CO;2-B
   LEE SC, 1994, J BIOMED MATER RES, V28, P1149, DOI 10.1002/jbm.820281005
   MARDEN LJ, 1994, J BIOMED MATER RES, V28, P1127, DOI 10.1002/jbm.820281003
   MEIKLE MC, 1994, BIOMATERIALS, V15, P513, DOI 10.1016/0142-9612(94)90017-5
   Mori M, 2000, J BIOMED MATER RES, V50, P191, DOI 10.1002/(SICI)1097-4636(200005)50:2<191::AID-JBM14>3.0.CO;2-0
   NIEDHARDT C, 1998, BIOCERAMICS ORTHOPAE, P46
   Niedhart C, 2001, J BIOMED MATER RES, V55, P530, DOI 10.1002/1097-4636(20010615)55:4<530::AID-JBM1046>3.0.CO;2-D
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   REDDI AH, 1981, COLLAGEN REL RES, V1, P209
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   Seto I, 2001, J ORAL MAXIL SURG, V59, P53, DOI 10.1053/joms.2001.19286
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1987, CLIN ORTHOP RELAT R, P295
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
NR 24
TC 42
Z9 47
U1 1
U2 7
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2003
VL 65A
IS 1
BP 17
EP 23
DI 10.1002/jbm.a.10362
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671FA
UT WOS:000182453600003
PM 12635149
DA 2018-10-19
ER

PT J
AU del Real, RP
   Ooms, E
   Wolke, JGC
   Vallet-Regi, M
   Jansen, JA
AF del Real, RP
   Ooms, E
   Wolke, JGC
   Vallet-Regi, M
   Jansen, JA
TI In vivo bone response to porous calcium phosphate cement
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium phosphate cement; macroporosity; animal study
ID HYDROXYAPATITE; SUBSTITUTE; IMPLANTS
AB We conducted an in vivo experiment to evaluate the resorption rate of a calcium phosphate cement (CPC) with macropores larger than 100 mum, using the CPC called Biocement D (Merck Biomaterial, Darmstadt, Germany), which after setting only shows pores smaller than 1 mum. The gas bubble method used during the setting process created macroporosity. Preset nonporous and porous cement implants were inserted into the trabecular bone of the tibial metaphysis of goats. The size of the preset implants was 6 mm. and the diameter of the drill hole was 6.3 mm., leaving a gap of 0.3 mm. between implant surface and drill wall. After 2 and 10 weeks, the animals were euthanized and cement implants with surrounding bone were retrieved for histologic evaluation. Light microscopy at 2 weeks revealed that the nonporous implants were surrounded by connective tissue. On the cement surface, we observed a monolayer of multinucleated cells. Ten weeks after implantation, the nonporous implants were still surrounded by connective tissue. However, a thin layer of bone now covered the implant surface. No sign of cement resorption was observed. In contrast, the porous cement evoked a completely different bone response. At 2 weeks, bone formation had already occurred inside the implant porosity. Bone formation even appeared to occur as a result of osteoinduction. Also, at their outer surface, the porous implants were completely surrounded by bone. At 2 weeks, about 31% of the initial cement was resorbed. After 10 weeks, 81% of the initial phosphate cement was resorbed and new bone was deposited. On the basis of these observations, we conclude that the creation of macropores can significantly improve the resorption rate of CPC. This increased degradation is associated with almost complete bone replacement. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
RI perez del real, rafael/C-2178-2013; Vallet-Regi, Maria/M-3378-2014;
   Jansen, John/H-8055-2014; Wolke, J.G.C./L-4768-2015
OI Vallet-Regi, Maria/0000-0002-6104-4889; 
CR BROWN WE, 1985, Patent No. 4518430
   Comuzzi L, 2002, CLIN ORAL IMPLAN RES, V13, P304, DOI 10.1034/j.1600-0501.2002.130311.x
   DELREAL RP, UNPUB NEW METHOD PRO
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Heymann D, 1999, HISTOL HISTOPATHOL, V14, P871, DOI 10.14670/HH-14.871
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210
   Khairoun I, 1997, J BIOMED MATER RES, V38, P356, DOI 10.1002/(SICI)1097-4636(199724)38:4<356::AID-JBM8>3.0.CO;2-N
   LeGeros R Z, 1988, Ann N Y Acad Sci, V523, P268, DOI 10.1111/j.1749-6632.1988.tb38519.x
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Sarkar MR, 2001, J BIOMED MATER RES, V58, P329, DOI 10.1002/1097-4636(2001)58:3<329::AID-JBM1025>3.3.CO;2-0
   SHIMAZAKI K, 1985, J ORTHOPAED RES, V3, P301, DOI 10.1002/jor.1100030306
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 15
TC 92
Z9 93
U1 0
U2 14
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2003
VL 65A
IS 1
BP 30
EP 36
DI 10.1002/jbm.a.10432
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671FA
UT WOS:000182453600005
PM 12635151
DA 2018-10-19
ER

PT J
AU Jhon, YI
   Kim, HG
   Jhon, MS
AF Jhon, YI
   Kim, HG
   Jhon, MS
TI The structure of water near platinum and its significance in
   water-adsorbent system: molecular dynamics study
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE water structure; adsorbent; biomaterial; biological effect;
   photocatalysis
ID SIMULATION; INTERFACE
AB Water structure around hydrophilic adsorbents is expected to differ from normal water structure. In some cases, a change of water structure seems to significantly affect phenomena involved in water-adsorbent systems. To investigate this, we have performed molecular dynamic simulations of three systems, water between (111) surfaces of Pt, water between (100) surfaces of Pt, and pure water at 298 K. For the analysis of water structure, we concentrated on the five-membered ring (R5) structure and six-membered ring (R6) structure, which are the most probable in nature. For both (111) and (100) of Pt, the ratio of hexameric ring/pentameric ring (R6/R5) in semibound regions was higher than that of bulk water, as expected. The function of adsorbent ceramics was explained in terms of the change of water structure when they are used as biomaterials, support materials, etc. The obscure mechanisms for the effects of medicine stones, antioxidants, etc., were also discussed from this point of view. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Korea Adv Inst Sci & Technol, Dept Chem, Yusong Gu, Taejon 305701, South Korea.
   Korea Adv Inst Sci & Technol, Dept Chem, Yusong Gu, Taejon 305701, South Korea.
   Korea Adv Inst Sci & Technol, Dept Chem, Yusong Gu, Taejon 305701, South Korea.
RP Jhon, MS (reprint author), Korea Adv Inst Sci & Technol, Dept Chem, Yusong Gu, 373-1 Kusong Dong, Taejon 305701, South Korea.
CR BELCH AC, 1987, J CHEM PHYS, V86, P5676, DOI 10.1063/1.452545
   Colic M, 1999, COLLOID SURFACE A, V154, P167, DOI 10.1016/S0927-7757(98)00894-2
   Cooney DO, 1995, ACTIVATED CHARCOAL M
   FINNEY JL, 1979, WATER COMPREHENSIVE, V6, P47
   FOSTER K, 1989, CHEM PHYS LETT, V162, P32, DOI 10.1016/0009-2614(89)85061-4
   Halliwell B, 2000, LANCET, V355, P1179, DOI 10.1016/S0140-6736(00)02075-4
   Hench Larry L., 1993, INTRO BIOCERAMICS
   JAEGER CD, 1979, J PHYS CHEM-US, V83, P3146, DOI 10.1021/j100487a017
   JHON MS, 1987, SPECULAT SCI TECHNOL, V10, P179
   JHON MS, 1987, INT J QUANT CHEM QUA, V14, P9
   KANG JY, 2000, J KOREAN SOC AGR CHE, V43, P266
   KANOVA GAT, 1978, SOVIET PLANT PHYSL, V25, P147
   KIM S, 1988, J COMPUT CHEM, V9, P125, DOI 10.1002/jcc.540090205
   KIM TK, 1994, J MOL LIQ, V59, P179, DOI 10.1016/0167-7322(94)00658-X
   KONG YS, 1987, INT J QUANTUM CHEM Q, V14, P189
   Marginean P, 1997, APPL CATAL A-GEN, V165, P241, DOI 10.1016/S0926-860X(97)00205-6
   MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025
   RAGHAVAN K, 1991, J CHEM PHYS, V94, P2110, DOI 10.1063/1.459934
   SEO BI, 1998, J E W MED, V23, P1
   Serpone N., 1989, PHOTOCATALYSIS FUNDA
   SONG MY, 1990, J MOL LIQ, V47, P35, DOI 10.1016/0167-7322(90)80065-R
   SPEEDY RJ, 1984, J PHYS CHEM-US, V88, P3364, DOI 10.1021/j150659a046
   SUZUKI S, 1982, CHITIN CHITOSAN, P210
   Yeh IC, 1998, J ELECTROANAL CHEM, V450, P313, DOI 10.1016/S0022-0728(97)00654-2
   YU JY, 1994, INT J QUANTUM CHEM, V51, P241, DOI 10.1002/qua.560510407
NR 25
TC 3
Z9 3
U1 2
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 1
PY 2003
VL 260
IS 1
BP 9
EP 18
DI 10.1016/S0021-9797(02)000250-3
PG 10
WC Chemistry, Physical
SC Chemistry
GA 667WT
UT WOS:000182258100002
PM 12742029
DA 2018-10-19
ER

PT J
AU Suga, K
   Saitoh, M
   Kokubo, S
   Fukushima, S
   Kaku, S
   Yasuda, S
   Miyata, K
AF Suga, K
   Saitoh, M
   Kokubo, S
   Fukushima, S
   Kaku, S
   Yasuda, S
   Miyata, K
TI Interleukin-11 acts synergistically with bone morphogenetic protein-2 to
   accelerate bone formation in a rat ectopic model
SO JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
LA English
DT Article
ID RECOMBINANT HUMAN INTERLEUKIN-11; BIOMATERIAL CARRIERS; CELLS;
   DIFFERENTIATION; PHARMACOKINETICS; FAMILY; MICE
AB We previously demonstrated that recombinant human interleukin-11 (rHuIL-11) induced osteoblast differentiation of C3H10T1/2 progenitor cells and also acted synergistically with recombinant human bone morphogenetic protein-2 (rHuBMP-2) in performing the same function. In this study, we investigated the effect of rHuIL-11 and rHuBMP-2 on bone formation in a rat ectopic model. When placed in rats, implants consisting of polymer-coated gelatin sponges containing various concentrations of rHuBMP-2 showed a dose-dependent increase in calcium content. This was confirmed by radiographic analysis of the implants. Although implants containing rHuIL-11 alone did not accumulate calcium, implants containing a combination of rHuBMP-2 and rHuIL-11 had significantly higher calcium levels than those containing rHuBMP-2 alone. This increase was rHuIL-11 dose dependent. The synergistic effect of 20 mug rHuIL-11 and 6 mg rHuBMP-2 on bone formation was estimated to be 1 week in advance of that of 6 mg rHuBMP-2 alone. Histologic examination revealed that the combination of rHuIL-11 and rHuBMP-2 caused spindle cells to accumulate around implants and induced cell infiltration into implants. Bone formation occurred faster in implants with the combination of rHuIL-11 and rHuBMP-2 compared with rHuBMP-2 alone. These results suggest that rHuIL-11 acts synergistically with rHuBMP-2 to more rapidly stimulate bone formation compared with rHuBMP-2 alone. This novel combined therapy may be of great clinical benefit in bone healing.
C1 Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Pharmacol Labs, Tsukuba, Ibaraki 3058585, Japan.
RP Suga, K (reprint author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Pharmacol Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.
CR CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27
   Du X, 1995, Curr Opin Hematol, V2, P182
   DU X, 1997, BLOOD, V11, P3897
   DU XX, 1994, BLOOD, V83, P2023
   GIRASOLE G, 1994, J CLIN INVEST, V93, P1516, DOI 10.1172/JCI117130
   Hill PA, 1998, ENDOCRINOLOGY, V139, P1564, DOI 10.1210/en.139.4.1564
   MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0
   MUSASHI M, 1991, P NATL ACAD SCI USA, V88, P765, DOI 10.1073/pnas.88.3.765
   MUSASHI M, 1991, BLOOD, V78, P1448
   Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479
   NEBEN TY, 1993, BLOOD, V81, P901
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   Schlerman FJ, 1996, STEM CELLS, V14, P517, DOI 10.1002/stem.140517
   Suga K, 2001, J INTERF CYTOK RES, V21, P695, DOI 10.1089/107999001753124435
   Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200
   TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   TORIUMI DM, 1991, ARCH OTOLARYNGOL, V117, P1101
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   Verhaeghe J, 1998, J INTERF CYTOK RES, V18, P49, DOI 10.1089/jir.1998.18.49
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212
   YIN TG, 1992, J EXP MED, V175, P211, DOI 10.1084/jem.175.1.211
   Yokota S, 2001, INT J PHARMACEUT, V223, P69, DOI 10.1016/S0378-5173(01)00728-1
NR 26
TC 13
Z9 14
U1 0
U2 0
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1079-9907
J9 J INTERF CYTOK RES
JI J. Interferon Cytokine Res.
PD APR
PY 2003
VL 23
IS 4
BP 203
EP 207
DI 10.1089/107999003765027401
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 674VD
UT WOS:000182656800004
PM 12856332
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Garcia-Honduvilla, N
   Lopez, R
   Corrales, C
   Jurado, F
   Bujan, J
AF Bellon, JM
   Garcia-Honduvilla, N
   Lopez, R
   Corrales, C
   Jurado, F
   Bujan, J
TI In vitro mesothelialization of prosthetic materials designed for the
   repair of abdominal wall defects
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID VASCULAR PROSTHESES; MIGRATION; HERNIA; MESH
AB The aim of this study was to evaluate the in vitro response of mesothelial cells (MC) in terms of their ability to cover different biomaterials. MC were harvested from human omentum. The MC from the first passage were seeded onto different biomaterials from 10 min to 24 h: PL-PU99 (polypropylene-polyurethane); DM (ePTFE); PL (polypropylene); and PL + Col (polypropylene-collagen). The prosthetic surface covered was examined by microscopy and quantified. PL-PU99: The MC were adhered to the biomaterial 10 min post-incubation. At 4 h, the 53.12 +/- 7.86% of the prosthesis were coated with polygonal cells. At 12 h, 96.32 +/- 11.32% of the biomaterial was coated. DM: between 30 min to 8 h, the MC cells form small, round colonies. At 12 h, polygonal and fusiform secretory cells were observed (68.94 +/- 5.78%). 93.54 +/- 11.49% of surface was coated after 24h. PL: only isolated cells were observed on the prosthesis. PL + Col: MC form a monolayer over prosthetic surface after 18 h (90.21 +/- 9.76). We conclude: (a) MC formed a stable monolayer over all the biomaterials tested with the exception of the PL due to its porosity. (b) The PL-PU99 showed the greatest potential for in vitro mesothelialization compared to the PL-Col and DM prostheses. (C) 2003 Kluwer Academic Publishers.
C1 Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Surg Res Lab, Alcala De Henares 28871, Madrid, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Surg Res Lab, Crta Madrid Barcelona,Km 33-6, Alcala De Henares 28871, Madrid, Spain.
EM juanm.bellon@uah.es
OI Garcia Honduvilla, Natalio/0000-0003-0904-6198; BELLON, JUAN
   M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476
CR Bellon JM, 2000, J MATER SCI-MATER M, V11, P25, DOI 10.1023/A:1008981517743
   Bellon JM, 1997, EUR J VASC ENDOVASC, V13, P142, DOI 10.1016/S1078-5884(97)80010-X
   Bellon JM, 1999, EUR J SURG, V165, P145
   BUJAN J, 1995, HISTOL HISTOPATHOL, V10, P803
   Chew DKW, 2000, SURGERY, V127, P352, DOI 10.1067/msy.2000.100886
   Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122
   HERNANDO A, 1994, EUR J VASCULAR SURG, V8, P531, DOI 10.1016/S0950-821X(05)80586-9
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   KERN PA, 1983, J CLIN INVEST, V71, P1822, DOI 10.1172/JCI110937
   Law NW, 1988, CLIN MATER, V3, P95
   Majeski J, 1998, SOUTH MED J, V91, P496, DOI 10.1097/00007611-199805000-00020
   Savioz D, 1997, EUR J SURG, V163, P631
   SCHNEIDER R, 1979, AM SURGEON, V45, P337
NR 13
TC 15
Z9 15
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2003
VL 14
IS 4
BP 359
EP 364
DI 10.1023/A:1022936016618
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 660DY
UT WOS:000181819600009
PM 15348460
DA 2018-10-19
ER

PT J
AU Lindfors, NC
   Aho, AJ
AF Lindfors, NC
   Aho, AJ
TI Granule size and composition of bioactive glasses affect osteoconduction
   in rabbit
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VIVO REACTIONS; BONE; BEHAVIOR; CERAMICS; REPAIR; TISSUE
AB Bioactive glass granules of three different compositions, regarding particularly Si- and Al-content (S53P4, S59.7P2.5, S52P3) and of two different granule sizes (200-250 mum and 630-800 mum) were implanted for 4 and 8 weeks in the distal part of rabbit femur. The effect of glass composition and granule size on bone formation was studied. The results were evaluated using histology, computerized histomorphometry, scanning electron microscopy and energy dispersive X-ray analysis, and used for mathematical description of bone formation.
   The results showed that both the composition of the glass and the granule size of the granules, have influence on bone growth from the surrounding tissue. Glass S53P4, which from previous observations is known to be an effective bioactive glass and widely used in the Biomaterial Project of Turku, Finland, showed bone bonding and increasing bone growth between the granules. Glass S59.7P2.5 which due to its high Si-content should be inert, showed bone bonding. At 4 weeks the bone growth was significantly more abundant in bone defects filled with large granules (630-800 mum) than in defects filled with small granules (200-250 mum). Glass S52P3 with an alumina content of 3 wt%, showed good bone conduction, possibly even bone bonding for granules of 630-800 mum size. Granules of 200-250 mum with a high alumina content at the surface of the reaction layer, showed hardly any bone contact at all.
   This data, therefore, gives new information concerning bone bonding and osteoconduction of bioactive glasses with a high silica or alumina content. (C) 2003 Kluwer Academic Publishers.
C1 Biomat Project Turku, Turku 20520, Finland.
   Univ Cent Hosp, Dept Surg, Turku 20520, Finland.
   Invalid Fdn, Orton Res Inst, Helsinki 00281, Finland.
RP Lindfors, NC (reprint author), Biomat Project Turku, Kiinanmyllykatu 4-8, Turku 20520, Finland.
EM Nina.C.Lindfors@hus.fi
CR AHLBACK J, 1995, LECT NOTES SWEDISH
   Andersson O. H., 1990, THESIS ABO AKAD U TU
   ANDERSSON OH, 1990, J MATER SCI-MATER M, V1, P219, DOI 10.1007/BF00701080
   ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808
   ANDERSSON OH, 1988, GLASTECH BER-GLASS, V61, P300
   ANDERSSON OH, 1991, BIOCERAMICS, V4, P127
   ANDERSSON OH, 1993, BIOCERAMICS, V6, P289
   BERGMAN SA, 1995, BIOCERAMICS, V8, P17
   GATTI AM, 1994, BIOMATERIALS, V15, P208, DOI 10.1016/0142-9612(94)90069-8
   GATTI AM, 1991, BIOMATERIALS, V12, P497, DOI 10.1016/0142-9612(91)90149-5
   GATTI AM, 1993, CELL MATER, V3, P283
   GATTI AM, 1995, MAT CLIN APPL, P409
   GATTI AM, 1990, BIOMATERIALS, V10, P245
   GROSS U, 1985, J BIOMED MATER RES, V19, P251, DOI 10.1002/jbm.820190308
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench L.L., 1973, J BIOMED MATER RES S, V4, P25
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HIMMELBLAU DM, 1970, PROCESS ANAL STAT ME, P1
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Lindfors NC, 2000, EUR SPINE J, V9, P30, DOI 10.1007/s005860050005
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   Oonishi H, 1995, BIOCERAMICS, V8, P137
   PELTOLA M, 2000, ACTA OTOLAR S, V53, P167
   TURUNEN T, 1995, J MATER SCI-MATER M, V6, P639, DOI 10.1007/BF00123444
NR 24
TC 6
Z9 6
U1 0
U2 1
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2003
VL 14
IS 4
BP 365
EP 372
DI 10.1023/A:1022988117526
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 660DY
UT WOS:000181819600010
PM 15348461
DA 2018-10-19
ER

PT J
AU Zhao, CS
   Liu, XD
   Rikimaru, S
   Nomizu, M
   Nishi, N
AF Zhao, CS
   Liu, XD
   Rikimaru, S
   Nomizu, M
   Nishi, N
TI Surface characterization of polysulfone membranes modified by DNA
   immobilization
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE polysulfone membrane; surface modification; DNA; contact angle; protein
   adsorption; biomaterial
ID ULTRAFILTRATION MEMBRANES; PROTEIN-ADSORPTION; BLOOD COMPATIBILITY;
   POLY(ETHYLENE GLYCOL); PHOSPHOLIPID POLYMER; PLATELET-ADHESION;
   IMPROVEMENT; COPOLYMERS; FTIR
AB Modification of a polysulfone (PSf) membrane was carried out by immobilizing single-strand DNA onto its surface. The immobilized DNA was found to be stable in water and in normal saline solution. The hydrophilicity increased when DNA was immobilized onto the membranes by UV-irradiation. The amount of protein adsorbed onto the surface of the membranes after DNA immobilization had decreased, but it was not obvious, due to the interaction between the DNA and protein. To study the effect of the surface properties on the amount of immobilized DNA and protein adsorption, PSf membranes with different surface properties were prepared. It was found that the PSf membranes exhibit significant differences depending on their surface properties and intrinsic properties due to different fabrication processes. The amount of immobilized DNA and protein adsorption were higher for the porous membranes prepared by immersing the polymer solution into a precipitation bath compared to the smooth membrane prepared by the solvent evaporation process. These results showed that insoluble DNA can be immobilized onto the surface of the PSf membrane, and the DNA-immobilized membrane prepared by UV-irradiation has the potential to be used in biomedical fields. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan.
   Sichuan Univ, Dept Polymer Mat Sci & Engn, Chengdu 610065, Peoples R China.
RP Nishi, N (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan.
RI XiangDong, Liu/M-9548-2015
OI XiangDong, Liu/0000-0001-5262-0031
CR Bummer PM, 1996, INT J PHARM, V132, P143, DOI 10.1016/0378-5173(95)04344-6
   Castro RP, 1996, J MEMBRANE SCI, V115, P179, DOI 10.1016/0376-7388(96)00019-1
   CENNI E, 1993, BIOMATERIALS, V14, P588, DOI 10.1016/0142-9612(93)90176-3
   de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3
   Freij-Larsson C, 2000, BIOMATERIALS, V21, P307, DOI 10.1016/S0142-9612(99)00195-7
   Haris PI, 1999, J MOL CATAL B-ENZYM, V7, P207, DOI 10.1016/S1381-1177(99)00030-2
   Hasegawa T, 2001, BIOMATERIALS, V22, P243, DOI 10.1016/S0142-9612(00)00180-0
   Ishihara K, 1999, BIOMATERIALS, V20, P1545, DOI 10.1016/S0142-9612(99)00052-6
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   Kaeselev B, 2001, J MEMBRANE SCI, V194, P245, DOI 10.1016/S0376-7388(01)00544-0
   KIMA YJ, 2000, BIOMATERIALS, V21, P121
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lewis AL, 2000, BIOMATERIALS, V21, P1847, DOI 10.1016/S0142-9612(00)00055-7
   LINA DT, 2001, BIOMATERIALS, V22, P1521
   Nakabayashi N, 1996, MACROMOL SYMP, V101, P405, DOI 10.1002/masy.19961010146
   NISHIMURA T, 1993, BIOMEDICAL APPL POLY, P191
   OHNO S, 1992, Patent No. 0559086
   Pall D. B., 1989, US 4,880,548, Patent No. 4880548
   Schmidt B, 1996, ARTIF ORGANS, V20, P375, DOI 10.1111/j.1525-1594.1996.tb04519.x
   Song YQ, 2000, J APPL POLYM SCI, V78, P979, DOI 10.1002/1097-4628(20001031)78:5<979::AID-APP60>3.0.CO;2-U
   TANAKA M, 2001, C SURF A, V203, P195
   Torrestiana-Sanchez B, 1999, J MEMBRANE SCI, V152, P19, DOI 10.1016/S0376-7388(98)00172-0
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   Ulbricht M, 1998, BIOMATERIALS, V19, P1229, DOI 10.1016/S0142-9612(98)00029-5
   Ulbricht M, 1996, J MEMBRANE SCI, V120, P239, DOI 10.1016/0376-7388(96)00148-2
   UNGCHHUN NS, 1997, Patent No. 5647985
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8
   Yamada M., 1999, NUCL ACIDS S SER, V42, P103
   YAMAGISHI H, 1995, J MEMBRANE SCI, V105, P237, DOI 10.1016/0376-7388(95)00063-I
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
   Zhao CS, 2001, ARTIF ORGANS, V25, P60
NR 33
TC 40
Z9 43
U1 2
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD APR 1
PY 2003
VL 214
IS 2
BP 179
EP 189
AR PII S0376-7388(02)00524-0
DI 10.1016/S0376-7388(02)00524-0
PG 11
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 663DY
UT WOS:000181992000002
DA 2018-10-19
ER

PT J
AU Gorman, SP
   Garvin, CP
   Quigley, F
   Jones, DS
AF Gorman, SP
   Garvin, CP
   Quigley, F
   Jones, DS
TI Design and validation of a dynamic flow model simulating encrustation of
   biomaterials in the urinary tract
SO JOURNAL OF PHARMACY AND PHARMACOLOGY
LA English
DT Article
ID CATHETERS; INVITRO; STENTS
AB A number of models exist for assessing encrustation on biomaterials employed as devices in the urinary tract. However, static urine models are suitable only for assessment of biomaterials residing in the bladder and the dynamic models available suffer from a number of disadvantages, notably their complexity and limitation to short-term assessment. The dynamic model described herein is a relatively simple design incorporating the ability to assess a large number of biomaterials in replicate fashion and over long periods of time. The biomaterials tested in the dynamic model conform to the urethral catheter and ureteral stent devices that experience urine flow within the urinary tract. The model was initially validated using Percuflex as a test biomaterial. The mass of calcium and magnesium, representing hydroxyapatite and struvite encrustation, respectively, on Percuflex was detected by atomic absorption spectrometry. No significant differences in encrustation levels were detected either between vessels or between biomaterial positions on any mandrel within the vessels, indicating the suitability of the dynamic model for reproducible determination of biomaterial encrustation. The dynamic model was then used to compare the encrustation of biomaterials commonly employed in urinary-tract devices, namely polyurethane, Percuflex and silicone. Calcium and magnesium levels on polyurethane and Percuflex were shown to be statistically similar, whereas silicone exhibited significantly reduced encrustation. When, subsequently, comparisons were made of biomaterial encrustation between the dynamic model and a static model, calcium and magnesium levels arising from the latter model were significantly higher on each of the biomaterials. However, the same rank order of encrustation resistance was observed for the biomaterials in both models, with silicone performing better than polyurethane or Percuflex. The prediction of in-vivo performance based on in-vitro models of encrustation is often difficult, although the model described provides a more accurate method for assessing the potential of novel and existing biomaterials for use in urinary medical devices requiring flow of urine.
C1 Queens Univ Belfast, Med Devices Grp, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
   Boston Sci Corp, Galway, Ireland.
RP Gorman, SP (reprint author), Queens Univ Belfast, Med Devices Grp, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
CR Cox A J, 1987, Eng Med, V16, P37
   COX AJ, 1988, BRIT J UROL, V61, P156, DOI 10.1111/j.1464-410X.1988.tb05067.x
   Desgrandchamps F, 1997, BRIT J UROL, V79, P24, DOI 10.1046/j.1464-410X.1997.02775.x
   GLEESON MJ, 1989, T AM SOC ART INT ORG, V35, P495
   Gorman SP, 1997, J BIOMATER APPL, V12, P136, DOI 10.1177/088532829701200204
   Gorman SP, 2003, MED IMPLICATIONS BIO, P136
   HEDELIN H, 1991, UROL RES, V19, P297, DOI 10.1007/BF00299063
   HOLMES SAV, 1992, BRIT J UROL, V69, P651, DOI 10.1111/j.1464-410X.1992.tb15640.x
   Jones D. S., 2002, PHARM STAT
   Jones DS, 1997, J MATER SCI-MATER M, V8, P713, DOI 10.1023/A:1018596109061
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   SARANGAPANI S, 1995, J BIOMED MATER RES, V29, P1185, DOI 10.1002/jbm.820291005
   SCHMITZ W, 1993, CELL MATER, V3, P1
   SINNOTT RK, 1998, COULSON RICHARDSONS, V6, P179
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
NR 16
TC 15
Z9 15
U1 1
U2 7
PU ROYAL PHARMACEUTICAL SOC GREAT BRITAIN
PI LONDON
PA 1 LAMBETH HIGH ST, LONDON SE1 7JN, ENGLAND
SN 0022-3573
J9 J PHARM PHARMACOL
JI J. Pharm. Pharmacol.
PD APR
PY 2003
VL 55
IS 4
BP 461
EP 468
DI 10.1211/002235702856
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 685UL
UT WOS:000183281600006
PM 12803767
DA 2018-10-19
ER

PT J
AU Wu, PK
   Ringeisen, BR
   Krizman, DB
   Frondoza, CG
   Brooks, M
   Bubb, DM
   Auyeung, RCY
   Pique, A
   Spargo, B
   McGill, RA
   Chrisey, DB
AF Wu, PK
   Ringeisen, BR
   Krizman, DB
   Frondoza, CG
   Brooks, M
   Bubb, DM
   Auyeung, RCY
   Pique, A
   Spargo, B
   McGill, RA
   Chrisey, DB
TI Laser transfer of biomaterials: Matrix-assisted pulsed laser evaporation
   (MAPLE) and MAPLE Direct Write
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID THIN-FILMS; BIODEGRADABLE POLYMERS; ELECTROCHEMICAL BIOSENSOR; SOFT
   LITHOGRAPHY; DEPOSITION; SURFACES; ABLATION; PROTEINS; GLUCOSE; DNA
AB Two techniques for transferring biomaterial using a pulsed laser beam were developed: matrix-assisted pulsed laser evaporation (MAPLE) and MAPLE direct write (MDW). MAPLE is a large-area vacuum based technique suitable for coatings, i.e., antibiofouling, and MDW is a localized deposition technique capable of fast prototyping of devices, i.e., protein or tissue arrays. Both techniques have demonstrated the capability of transferring large (mol wt >100 kDa) molecules in different forms, e.g., liquid and gel, and preserving their functions. They can deposit patterned films with spatial accuracy and resolution of tens of mum and layering on a variety of substrate materials and geometries. MDW can dispense volumes less than 100 pl, transfer solid tissues, fabricate a complete device, and is computed aided design/computer aided manufacturing compatible. They are noncontact techniques and can be integrated with other sterile processes. These attributes are substantiated by films and arrays of biomaterials, e.g., polymers, enzymes, proteins, eucaryotic cells, and tissue, and a dopamine sensor. These examples, the instrumentation, basic mechanisms, a comparison with other techniques, and future developments are discussed. (C) 2003 American Institute of Physics.
C1 USN, Res Lab, Washington, DC 20375 USA.
   NCI, Ctr Adv Technol, Gaithersburg, MD 20877 USA.
   Good Samaritan Hosp, Johns Hopkins Orthopaed, Baltimore, MD 21239 USA.
   So Oregon Univ, Dept Phys, Ashland, OR 97520 USA.
RP Wu, PK (reprint author), USN, Res Lab, 4555 Overlook Ave SW, Washington, DC 20375 USA.
CR ADAMS RN, 1976, ANAL CHEM, V48, P359
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   BHATTACHARYA D, 1991, J APPL PHYS, V70, P5433, DOI 10.1063/1.350201
   Borman S, 2000, CHEM ENG NEWS, V78, P31, DOI 10.1021/cen-v078n031.p031
   Brooks SA, 2000, ANAL CHEM, V72, P3253, DOI 10.1021/ac9914531
   Bubb DM, 2002, APPL PHYS A-MATER, V74, P123, DOI 10.1007/s003390101010
   Bubb DM, 2002, J APPL PHYS, V91, P9809, DOI 10.1063/1.1478136
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   Chen CY, 1997, ANN VASC SURG, V11, P74, DOI 10.1007/s100169900013
   CHUARD C, 1993, ANTIMICROB AGENTS CH, V37, P625, DOI 10.1128/AAC.37.4.625
   Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027
   DIAMOND D, 1996, CHEMOSENSORS ION MOL, P91
   Eggins B., 1996, BIOSENSORS INTRO
   Fitz-Gerald J. M., 2000, Integrated Ferroelectrics, V28, P13, DOI 10.1080/10584580008222217
   Freshney RI, 2000, CULTURE ANIMAL CELLS
   Geohegan D. B., 1994, PULSED LASER DEPOSIT, P115
   Gerritsen M, 2000, BIOMATERIALS, V21, P71, DOI 10.1016/S0142-9612(99)00136-2
   Graves DJ, 1998, ANAL CHEM, V70, P5085, DOI 10.1021/ac980456n
   Guschin D, 1997, ANAL BIOCHEM, V250, P203, DOI 10.1006/abio.1997.2209
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   Horvath L, 2001, PATHOLOGY, V33, P125, DOI 10.1080/003130201200338791
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P2543
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   KAR A, 1994, PHYS REV E, V49, P410, DOI 10.1103/PhysRevE.49.410
   Kelly R, 1997, NUCL INSTRUM METH B, V122, P374, DOI 10.1016/S0168-583X(96)00765-3
   Kelly R., 1994, PULSED LASER DEPOSIT, P55
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   Lewis AL, 2000, COLLOID SURFACE B, V18, P261, DOI 10.1016/S0927-7765(99)00152-6
   Lewis D. H., 1990, BIODEGRADABLE POLYM, P1
   Maissel L.I., 1970, HDB THIN FILM TECHNO
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   NEWMAN JD, 1992, ANAL CHIM ACTA, V262, P13, DOI 10.1016/0003-2670(92)80002-O
   PACHENCE JM, 2000, PRINCIPLES TISSUE EN, P263
   PALMER JK, 1963, PLANT PHYSIOL, V38, P508, DOI 10.1104/pp.38.5.508
   Pique A, 2000, P SOC PHOTO-OPT INS, V3933, P105, DOI 10.1117/12.387545
   PIQUE A, 2000, THIN SOLID FILMS, V355, P536
   PONCHON JL, 1979, ANAL CHEM, V51, P1483, DOI 10.1021/ac50045a030
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Rimm DL, 2001, CANCER J, V7, P24
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   RINGEISEN BR, 2001, MOD SIM MICR C CHARL
   Roda A, 2000, BIOTECHNIQUES, V28, P492, DOI 10.2144/00283st07
   SIDWELL JS, 1985, BIOTECHNOL LETT, V7, P419, DOI 10.1007/BF01166215
   Sirkar K, 2000, ANAL CHEM, V72, P2930, DOI 10.1021/ac991041k
   STAMFORD JA, 1996, ANAL CHEM A, V68, P359
   THOMSON RC, 2000, PRINCIPLES TISSUE EN, P251
   Tortora GJ, 1995, MICROBIOLOGY INTRO
   Vacanti C. A, 2000, PRINCIPLES TISSUE EN, V2nd, P671
   Vaidya R, 1998, BIOTECHNOL PROGR, V14, P371, DOI 10.1021/bp980039w
   WANG J, 1988, ANAL CHEM, V60, P1545, DOI 10.1021/ac00166a014
   Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Wong W.H., 1997, SYNTHETIC BIODEGRADA, P51
   Wu PK, 2001, THIN SOLID FILMS, V398, P607, DOI 10.1016/S0040-6090(01)01347-5
   Wu PK, 2001, J APPL PHYS, V90, P3623, DOI 10.1063/1.1398068
   WU PK, 2000, MAT RES SOC S P, V617
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913
   YOIGI O, 2001, ANAL CHEM, V73, P1892
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
   ZWAAL RFA, 1977, NATURE, V268, P358, DOI 10.1038/268358a0
NR 66
TC 105
Z9 106
U1 0
U2 19
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD APR
PY 2003
VL 74
IS 4
BP 2546
EP 2557
DI 10.1063/1.1544081
PG 12
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 660JA
UT WOS:000181829000043
DA 2018-10-19
ER

PT J
AU Palmer, EM
   Baum, LG
   van Seventer, GA
AF Palmer, EM
   Baum, LG
   van Seventer, GA
TI Small intestinal submucosa induces loss of mitochondrial integrity and
   caspase-dependent apoptosis in human T cells
SO TISSUE ENGINEERING
LA English
DT Article
ID INFLAMMATORY BOWEL-DISEASE; EXTRACELLULAR-MATRIX; CROHNS-DISEASE;
   GROWTH-FACTOR; FAS LIGAND; EXPRESSION; LECTIN; ACTIVATION; MODEL; DEATH
AB Porcine small intestinal submucosa (SIS) is a cell-free biomaterial used in humans for wound healing and as scaffold material for constructive remodeling of damaged or missing tissue. We have previously shown that SIS contains a factor that suppresses human helper T cell subset differentiation and expansion by inducing programmed cell death. Our aims here were to identify in detail the processes involved in SIS-induced T cell apoptosis and to perform the first characterization of the apoptosis-inducing factor present in SIS. In in vitro experiments, we utilized human T cell lines, Jurkat and CEM, to identify the processes involved in SIS-induced T cell apoptosis. Two types of sterile SIS material were used: hydrated sheets and rehydrated clinical-grade sheets. We found that SIS-mediated apoptosis as detected by induction of membrane annexin V staining involved the loss of mitochondrial membrane potential and was dependent on caspase activation. We eliminated transforming growth factor beta (TGF-beta), Fas ligand (FasL), and galectin family members as factors in SIS-mediated T cell apoptosis. We further established that processes required to prepare SIS for clinical use, freeze-drying, and gas sterilization destroyed the apoptosis-inducing factor. SIS contains a factor that induces loss of mitochondrial integrity and caspase-dependent apoptosis in human T cells. This factor is destroyed by freeze-drying and gas sterilization and is not TGF-beta, FasL, or a galectin family member. Normal T cell homeostasis in gut-associated tissues may be regulated in part by this unknown factor.
C1 Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA.
   Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA.
RP van Seventer, GA (reprint author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, 715 Albany St,Talbot 2E, Boston, MA 02118 USA.
EM gvsevent@bu.edu
CR ALLEN HJ, 1991, TUMOR BIOL, V12, P52, DOI 10.1159/000217688
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BRUHIN H, 1961, SCHWEIZ MED WSCHR, V91, P607
   BURGIO VL, 1995, GASTROENTEROLOGY, V109, P1029
   Camoglio L, 1998, INFLAMM BOWEL DIS, V4, P285, DOI 10.1002/ibd.3780040406
   Cerwenka A, 1999, MICROBES INFECT, V1, P1291, DOI 10.1016/S1286-4579(99)00255-5
   CHOY MY, 1990, GUT, V31, P1365, DOI 10.1136/gut.31.12.1365
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cohen GM, 1997, BIOCHEM J, V326, P1
   COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681
   Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R
   Fell JME, 1996, CLIN EXP IMMUNOL, V104, P280, DOI 10.1046/j.1365-2249.1996.999701.x
   Gitt MA, 1998, J BIOL CHEM, V273, P2954, DOI 10.1074/jbc.273.5.2954
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hodde JP, 2001, WOUNDS, V13, P195
   Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Muneta Y, 2001, J INTERF CYTOK RES, V21, P305, DOI 10.1089/107999001300177493
   Pace KE, 2000, J IMMUNOL, V165, P2331, DOI 10.4049/jimmunol.165.5.2331
   Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259
   Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354
   Sandrin MS, 1999, CURR OPIN IMMUNOL, V11, P527, DOI 10.1016/S0952-7915(99)00011-4
   Sillett HK, 2001, IMMUNOLOGY, V102, P310, DOI 10.1046/j.1365-2567.2001.01185.x
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WELLER M, 1994, EUR J IMMUNOL, V24, P1293, DOI 10.1002/eji.1830240608
NR 29
TC 11
Z9 13
U1 1
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD APR
PY 2003
VL 9
IS 2
BP 307
EP 314
DI 10.1089/107632703764664774
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 669DG
UT WOS:000182336200012
PM 12740093
DA 2018-10-19
ER

PT J
AU Karaiskou, A
   Zergioti, I
   Fotakis, C
   Kapsetaki, M
   Kafetzopoulos, D
AF Karaiskou, A
   Zergioti, I
   Fotakis, C
   Kapsetaki, M
   Kafetzopoulos, D
TI Microfabrication of biomaterials by the sub-ps laser-induced forward
   transfer process
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Conference on Physics and Chemistry of Advanced Laser Materials
   Processing
CY JUN 18-21, 2002
CL STRASBOURG, FRANCE
DE laser microprinting; DNA microarrays; laser-induced forward transfer
ID DNA MICROARRAYS; DEPOSITION; METAL; FILMS
AB The precise fabrication of micro-dimensioned patterns of biomaterials by the laser microprinting technique using a sub-ps UV laser is described. An ultrashort UV laser has been used to transfer the biomaterial, with low angular divergence, and deposit it onto the substrate with minimum spread and high spatial resolution. The laser-transferred features of 100mum x 100 mum size have been studied by means of scanning electron microscopy and scanning laser confocal fluorescence microscopy. The analysis of DNA and protein microarrays provides an excellent tool to expand our knowledge of genome functions. (C) 2003 Elsevier Science B.V. All rights reserved.
C1 FORTH, IESL, Iraklion 71110, Crete, Greece.
   Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.
RP Zergioti, I (reprint author), FORTH, IESL, POB 1527, Iraklion 71110, Crete, Greece.
RI Fotakis, Costas/G-8751-2011
CR BOHANDY J, 1986, J APPL PHYS, V60, P1538, DOI 10.1063/1.337287
   Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462
   CAHILL DJ, 2000, PROTEOMICS TRENDS GU, P49
   Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439
   ESROM H, 1995, APPL SURF SCI, V86, P202, DOI 10.1016/0169-4332(94)00385-8
   Fodor SPA, 1997, SCIENCE, V277, P393, DOI 10.1126/science.277.5324.393
   FOGARASSY E, 1989, J APPL PHYS, V66, P457, DOI 10.1063/1.344470
   HARE DE, 1995, J APPL PHYS, V77, P5950, DOI 10.1063/1.359177
   Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730
   Kodadek T, 2001, CHEM BIOL, V8, P105, DOI 10.1016/S1074-5521(00)90067-X
   PIMENOV SM, 1995, APPL SURF SCI, V86, P208, DOI 10.1016/0169-4332(94)00419-6
   PIQUE A, 2002, DIRECT WRITE TECHNOL, P93
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   TOTH Z, 1993, APPL SURF SCI, V69, P317, DOI 10.1016/0169-4332(93)90525-G
   van Hal NLW, 2000, J BIOTECHNOL, V78, P271, DOI 10.1016/S0168-1656(00)00204-2
   Wang J, 2000, NUCLEIC ACIDS RES, V28, P3011, DOI 10.1093/nar/28.16.3011
   WU PK, 2002, J BIOMATER, V23, P161
   Zergioti I, 1998, APPL PHYS A-MATER, V66, P579, DOI 10.1007/s003390050717
NR 19
TC 57
Z9 57
U1 3
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 15
PY 2003
VL 208
BP 245
EP 249
DI 10.1016/S0169-4332(02)01396-X
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 661BK
UT WOS:000181871200040
DA 2018-10-19
ER

PT J
AU Cui, ZD
   Man, HC
   Yang, XJ
AF Cui, ZD
   Man, HC
   Yang, XJ
TI Characterization of the laser gas nitrided surface of NiTi shape memory
   alloy
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Conference on Physics and Chemistry of Advanced Laser Materials
   Processing
CY JUN 18-21, 2002
CL STRASBOURG, FRANCE
DE NiTi; laser gas nitriding; titanium nitride; surface characterization;
   ion release
ID CORROSION PROPERTIES; TITANIUM; BEHAVIOR; XPS; TI; TI-6AL-4V; COATINGS
AB Owing to its unique properties such as shape memory effects, superelasticity and radiopacity, NiTi alloy is a valuable biomaterial for fabricating implants. The major concern of this alloy for biological applications is the high atomic percentage of nickel in the alloy and the deleterious effects to the body by the corrosion and/or wears products. In this study, a continuous wave Nd-YAG laser was used to conduct laser gas nitriding on the substrate of NiTi alloy. The results show that a continuous and crack-free thin TiN layer was produced in situ on the NiTi substrate. The characteristics of the nitrided surface layer were investigated using SEM, XRD, XPS and AAS. No nickel signal was detected on the top surface of the laser gas nitrided layer. As compared with the mechanical polished NiTi alloy, the nickel ion release rate out of the nitrided NiTi alloy decreased significantly in Hanks' solution at 37 degreesC, especially the initial release rate. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Hong Kong Polytech Univ, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.
   Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Man, HC (reprint author), Hong Kong Polytech Univ, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.
CR Belhomme C, 2001, J ELECTROANAL CHEM, V503, P69, DOI 10.1016/S0022-0728(01)00375-8
   BERTOTI I, 1995, APPL SURF SCI, V84, P357, DOI 10.1016/0169-4332(94)00545-1
   CHANG YH, 1995, J APPL PHYS A, V13, P2819
   Endo K, 1994, Dent Mater J, V13, P228
   FOLKES JA, 1994, SURF COAT TECH, V63, P65, DOI 10.1016/S0257-8972(05)80009-X
   Fukumoto S, 1999, MAT SCI ENG A-STRUCT, V263, P205, DOI 10.1016/S0921-5093(98)01166-6
   Galvanetto E, 2001, THIN SOLID FILMS, V384, P223, DOI 10.1016/S0040-6090(00)01871-X
   Garcia I, 1998, CORROS SCI, V40, P1411, DOI 10.1016/S0010-938X(98)00046-8
   Green SM, 1997, MAT SCI ENG A-STRUCT, V224, P21, DOI 10.1016/S0921-5093(96)10563-3
   Hu C, 1997, ACTA MATER, V45, P4311, DOI 10.1016/S1359-6454(97)00076-1
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   Man HC, 2001, SCRIPTA MATER, V45, P1447, DOI 10.1016/S1359-6462(01)01182-4
   Man HC, 2002, J LASER APPL, V14, P242, DOI 10.2351/1.1514236
   Meletis EI, 1999, SURF COAT TECH, V113, P201, DOI 10.1016/S0257-8972(98)00841-X
   MILOSEV I, 1994, SURF COAT TECH, V63, P173, DOI 10.1016/0257-8972(94)90095-7
   RODRIGUEZ D, 1998, P 11 C ESB 8 11 JUL, P49
   Santucci S, 1996, THIN SOLID FILMS, V290, P376, DOI 10.1016/S0040-6090(96)09126-2
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Villermaux F, 1997, APPL SURF SCI, V109, P62, DOI 10.1016/S0169-4332(96)00619-8
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   XIN H, 2000, J MATER SCI, V38, P3373
   Xue L, 1997, ADV PERFORM MATER, V4, P25, DOI 10.1023/A:1008668115226
NR 23
TC 54
Z9 59
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 15
PY 2003
VL 208
BP 388
EP 393
DI 10.1016/S0169-4332(02)01414-9
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 661BK
UT WOS:000181871200064
DA 2018-10-19
ER

PT J
AU Morra, M
   Cassinelli, C
   Pavesio, A
   Renier, D
AF Morra, M
   Cassinelli, C
   Pavesio, A
   Renier, D
TI Atomic force microscopy evaluation of aqueous interfaces of immobilized
   hyaluronan
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE hyaluronan; surface modification; surface analysis; atomic force
   microscope; biomaterials; cell adhesion
ID POLYSACCHARIDE-COATED SURFACES; ACID; POLYSTYRENE; MODEL; WATER
AB Hyaluronan (HA) was immobilized on aminated glass surfaces in three different ways: by simple ionic interaction and by covalent linking at low density and at full density. In agreement with previous reports, in vitro experiments show that the outcome of fibroblast adhesion tests is markedly affected by the details of the coupling procedure, suggesting that different interfacial forces are operating at the aqueous/HA interface in the three cases investigated. The interfacial properties of the HA-coated surfaces were probed by force-distance curves obtained with the atomic force microscope (AFM). This approach readily shows significant differences among the tested samples, which are directly related to the coupling strategy and to results of cell adhesion tests. In particular, the range of interaction between the tip and the surface is much lower when HA is covalently linked than when it is ionically coupled, suggesting a more compact surface structure in the former case. Increasing HA surface density minimizes the interaction force between the surface and the AFM tip, likely reflecting more complete shielding by the HA chains of the underlying substrate. In summary, these measurements clearly show the different nature of the aqueous interfaces tested, and underline the role of this analytical approach in the development and control of finely tuned biomaterial surfaces. (C) 2003 Elsevier Science (USA). All rights reserved.
C1 Nobil Bio Ric, Villafranca Dasti, Italy.
   Fidia Adv Biopolymers, Abano Terme, Pd, Italy.
RP Morra, M (reprint author), Nobil Bio Ric, Str S Rocco 32, Villafranca Dasti, Italy.
CR ABATANGELO G, 2000, REDEFINING HYALURONA
   BALAZS EA, 1973, BIOL FIBROBLAST
   BESSELING NAM, 1997, LANGMUIR, V13, P2109
   Braithwaite GJC, 1999, J COLLOID INTERF SCI, V213, P525, DOI 10.1006/jcis.1999.6134
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   BUTT HJ, 1995, BIOELECTROCH BIOENER, V38, P191, DOI 10.1016/0302-4598(95)01800-T
   BUTT HJ, 2001, WATER BIOMATERIALS S, P245
   Cappella B, 1997, NANOTECHNOLOGY, V8, P82, DOI 10.1088/0957-4484/8/2/006
   Cassinelli C, 2000, J BIOMAT SCI-POLYM E, V11, P961, DOI 10.1163/156856200744138
   Dupont-Gillain CC, 1999, J COLLOID INTERF SCI, V220, P163, DOI 10.1006/jcis.1999.6524
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   EVERED D, 1989, BIOL HYALURONAN
   Kurutz JW, 2001, LANGMUIR, V17, P7323, DOI 10.1021/la010645s
   Laurent TC, 1998, CHEM BIOL MED APPL H
   Lesley J, 2000, J BIOL CHEM, V275, P26967
   LISE M, 2000, REDEFINING HYALURONA, P339
   Mason M, 2000, BIOMATERIALS, V21, P31, DOI 10.1016/S0142-9612(99)00129-5
   Morra M, 1998, SURF INTERFACE ANAL, V26, P742, DOI 10.1002/(SICI)1096-9918(199809)26:10<742::AID-SIA417>3.0.CO;2-P
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   MORRA M, 2001, WATER BIOMATERIALS S, P377
   Pavesio A, 1997, Med Device Technol, V8, P20
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   PRESTWICH GD, 2000, REDEFINING HYALURONA, P181
   Verheye S, 2000, ARTERIOSCL THROM VAS, V20, P1168, DOI 10.1161/01.ATV.20.4.1168
   Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Yoon RH, 1997, J COLLOID INTERF SCI, V185, P363, DOI 10.1006/jcis.1996.4583
NR 30
TC 16
Z9 16
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAR 15
PY 2003
VL 259
IS 2
BP 236
EP 243
DI 10.1016/S0021-9797(02)00204-7
PG 8
WC Chemistry, Physical
SC Chemistry
GA 663RR
UT WOS:000182019800004
PM 16256502
DA 2018-10-19
ER

PT J
AU Shen, MC
   Wagner, MS
   Castner, DG
   Ratner, BD
   Horbett, TA
AF Shen, MC
   Wagner, MS
   Castner, DG
   Ratner, BD
   Horbett, TA
TI Multivariate surface analysis of plasma-deposited tetraglyme for
   reduction of protein adsorption and monocyte adhesion
SO LANGMUIR
LA English
DT Article
ID LEAST-SQUARES REGRESSION; GLYCOL DIMETHYL ETHER; FIBRINOGEN ADSORPTION;
   PLATELET-ADHESION; POLYSTYRENE; CHEMISTRY; FILMS; BIOCOMPATIBILITY;
   CALIBRATION; COPOLYMER
AB Adsorbed proteins on implanted biomedical devices mediate platelet and leukocyte adhesion. Radio frequency plasma deposited tetraglyme (CH3O(CH2CH2O)(4)CH3), which forms a PEO-like coating, has been shown to resist protein adsorption and monocyte adhesion in vitro. By using different plasma deposition powers (5-80 W), we produced a series of plasma-deposited tetraglyme surfaces that varied in surface chemistry as measured by electron spectroscopy for chemical analysis (ESCA) and time-of-flight secondary ion mass spectrometry (ToF-SIMS). Both fibrinogen and IgG adsorption were increased on surfaces made at high plasma power. Monocyte adhesion correlated linearly with the amount of adsorbed protein. To identify the surface chemical features that contributed to the nonfouling properties of plasma-deposited tetraglyme, multivariate analysis using partial least squares (PLS) regression was applied. A PLS calibration model based on deposited tetraglyme samples placed downstream in the plasma reactor successfully predicted fibrinogen adsorption to deposited tetraglyme samples placed midstream in the reactor. The model identified how each surface spectral variable from ESCA and ToF-SIMS contributed to protein adsorption. The fraction of carbon in ether carbon linkages as measured by ESCA and ToF-SIMS peaks at m/z 59 and 103 was higher on surfaces that exhibited ultralow fibrinogen adsorption (<10 ng/cm(2)). The fraction of hydrocarbon-like carbons as measured by ESCA and low-mass ToF-SIMS peaks such as m/z 29 and 31 was greater on surfaces exhibiting high fibrinogen adsorption (>200 ng/cm(2)). This study elucidated the surface chemical features of deposited tetraglyme that most affect its resistance to protein and cell uptake and provided guidelines for engineering improved nonfouling biomaterial surfaces.
C1 Univ Washington, Dept Chem Engn, UWEB, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Ratner, BD (reprint author), Univ Washington, Dept Chem Engn, UWEB, Box 351720, Seattle, WA 98195 USA.
CR ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   BEEBE KR, 1987, ANAL CHEM, V59, pA1007, DOI 10.1021/ac00144a725
   Beyer D, 1997, J BIOMED MATER RES, V36, P181, DOI 10.1002/(SICI)1097-4636(199708)36:2<181::AID-JBM6>3.0.CO;2-G
   Bryers James D., 1993, Current Opinion in Biotechnology, V4, P197, DOI 10.1016/0958-1669(93)90125-G
   CHILKOTI A, 1993, ANAL CHEM, V65, P1736, DOI 10.1021/ac00061a017
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   DEJONG S, 1993, CHEMOMETR INTELL LAB, V18, P251, DOI 10.1016/0169-7439(93)85002-X
   Favia P., 1996, PLASMAS POLYM, V1, P299
   Ferrari S, 2000, SURF INTERFACE ANAL, V29, P837, DOI 10.1002/1096-9918(200012)29:12<837::AID-SIA937>3.0.CO;2-O
   GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Horbett T. A., 1986, TECHNIQUES BIOCOMPAT, V2
   HORBETT TA, 1981, J BIOMED MATER RES, V15, P673, DOI 10.1002/jbm.820150506
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Johnston E. E., 1997, PLASMA PROCESSING PO
   Johnston EE, 1996, J ELECTRON SPECTROSC, V81, P303, DOI 10.1016/0368-2048(95)02666-5
   JOHNSTON EE, 1996, SURFACE MODIFICATION
   JOHNSTON EE, 1997, THESIS U WASHINGTON
   Kidane A, 1999, J BIOMAT SCI-POLYM E, V10, P1089, DOI 10.1163/156856299X00702
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LOPEZ GP, 1992, J BIOMED MATER RES, V26, P415, DOI 10.1002/jbm.820260402
   MARLETTA G, 1990, SURF INTERFACE ANAL, V16, P407, DOI 10.1002/sia.740160185
   NAGAOKA S, 1983, POLYM PREPR-ACS, V24, P67
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Vandeginste B. G. M., 1998, HDB CHEMOMETRICS Q B
   WISE BM, 1998, PLS TOOLBOX 2 0
   Yasuda H., 1985, PLASMA POLYM
NR 34
TC 117
Z9 117
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 4
PY 2003
VL 19
IS 5
BP 1692
EP 1699
DI 10.1021/la0259297
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 651FJ
UT WOS:000181309600033
DA 2018-10-19
ER

PT J
AU Miller, T
   Boettiger, D
AF Miller, T
   Boettiger, D
TI Control of intracellular signaling by modulation of fibronectin
   conformation at the cell-materials interface
SO LANGMUIR
LA English
DT Article
ID FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; BIOLOGICAL-ACTIVITY;
   EMBRYO FIBROBLASTS; PLASMA FIBRONECTIN; ACTIVATION STATE; MIGRATION;
   BINDING; ADSORPTION; INTEGRINS
AB Fibronectin adsorbs to a variety of surfaces. Adsorption on different biomaterial substrates can result in different conformations for the adsorbed fibronectin. The adsorption isotherms of fibronectin to either neutral polystyrene or negatively charged polystyrene are indistinguishable. Sulfonation was used to vary the level of negative charge on polystyrene surfaces, and adhesion strength of HT1080 cells to these surfaces following fibronectin coating was measured using a spinning disk device. Adhesion to the different fibronectin surfaces was alpha5beta1 integrin dependent, and charge variation had little effect on overall adhesion strength. Ligation of alpha5beta1 integrin to surface-bound fibronectin resulted in a fibronectin-density-dependent increase in phosphorylation of FAK Y397 when negatively charged substrates were used but resulted in no FAK phosphorylation when uncharged substrates were used. Similarly, cell spreading was dependent on the level of negative charge. Thus, the use of specific biomaterial substrates can separate the adhesion and signaling functions of alpha5beta1 integrin. Polylysine coating was used to analyze the effect of positive charge. On the polylysine substrate, there is an increase in the level of nonspecific adhesion following coating with fibronectin and/or bovine serum albumin (BSA). On BSA substrates, there was no stimulation of FAKY397 phosphorylation. Addition of fibronectin to the polylysine surfaces produced a weak stimulation of FAK Y397 phosphorylation indicating that the positively charged surface was also unfavorable for supporting alpha5beta1-mediated signals.
C1 Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
RP Boettiger, D (reprint author), Univ Penn, Dept Microbiol, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.
CR AOTA S, 1994, J BIOL CHEM, V269, P24756
   Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6
   CALALB MB, 1995, MOL CELL BIOL, V15, P954
   Cary LA, 1996, J CELL SCI, V109, P1787
   Cheresh DA, 2002, NAT MED, V8, P193, DOI 10.1038/nm0302-193
   COBB BS, 1994, MOL CELL BIOL, V14, P147, DOI 10.1128/MCB.14.1.147
   Datta A, 2001, MOL CELL BIOL, V21, P7295, DOI 10.1128/MCB.21.21.7295-7306.2001
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GUAN JL, 1991, CELL REGUL, V2, P951
   Hanks SK, 1997, BIOESSAYS, V19, P137, DOI 10.1002/bies.950190208
   Hauck CR, 2000, IMMUNOL RES, V21, P293, DOI 10.1385/IR:21:2-3:293
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hynes RO, 1990, FIBRONECTINS
   Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9
   KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392
   Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351
   Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999
   MARTIN GR, 1974, EXP CELL RES, V85, P319, DOI 10.1016/0014-4827(74)90133-5
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021
   Pitt W.G., 1987, PROTEINS INTERFACES, P324
   Rief M, 2000, ADV EXP MED BIOL, V481, P129
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   SHI Q, UNPUB
   Sieg DJ, 1999, J CELL SCI, V112, P2677
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   VARNER JA, 1995, MOL BIOL CELL, V6, P725
   Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716
NR 36
TC 31
Z9 31
U1 1
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 4
PY 2003
VL 19
IS 5
BP 1723
EP 1729
DI 10.1021/la0261500
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 651FJ
UT WOS:000181309600037
DA 2018-10-19
ER

PT J
AU Capadona, JR
   Collard, DM
   Garcia, AJ
AF Capadona, JR
   Collard, DM
   Garcia, AJ
TI Fibronectin adsorption and cell adhesion to mixed monolayers of
   tri(ethylene glycol)- and methyl-terminated alkanethiols
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; PLATELET-ADHESION;
   SURFACE-CHEMISTRY; GEOMETRIC CONTROL; GOLD; POLYSTYRENE; ATTACHMENT;
   FILMS; BIOCOMPATIBILITY
AB Surface chemistries that prevent protein adsorption and render surfaces nonadhesive have emerged as promising biomaterial modifications for minimizing host-implant inflammatory responses and providing a nonspecific background for the presentation of bioactive motifs to elicit directed cellular responses. Oligo(ethylene glycol) moieties (-(CH2CH2O)(n)-, abbreviated as EG.) have proven to be the most protein-resistant functionality and remain the standard for comparison. In the present study, we analyzed fibronectin (FN) adsorption and cell adhesion to CH3/EG(3) mixed self-assembled monolayers. In contrast to previous studies with ellipsometry and surface plasmon resonance spectroscopy, we demonstrate significant radiolabeled FN adsorption onto EG(3)-containing surfaces, including pure EG(3) Monolayers. These FN-coated surfaces supported FN density-dependent increases in fibroblast adhesion strength. However, while FN adsorbed irreversibly to CH3-terminated surfaces, adsorbed FN was removed from EG(3) monolayers and the corresponding cell adhesion eliminated by long-term (16 h) incubation in either protein-free or serum-containing solutions. Once the adsorbed FN was eluted, EG(3) monolayers remained nonadhesive, even in the presence of serum-containing media. These results provide new insights into the interactions between cells and synthetic, nonadhesive surfaces.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & BioSci, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,Room 2314 IBB, Atlanta, GA 30332 USA.
RI Capadona, Jeffrey/G-4772-2010
OI Capadona, Jeffrey/0000-0001-8030-6947
CR ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Baier R E, 1969, J Biomed Mater Res, V3, P191, DOI 10.1002/jbm.820030115
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BRASH JL, 1987, ACS SYM SER, V343, P490
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Deng L, 1996, J AM CHEM SOC, V118, P5136, DOI 10.1021/ja960461d
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   KESELOWSKY BG, IN PRESS J BIOMED MA
   Kidane A, 1999, J BIOMAT SCI-POLYM E, V10, P1089, DOI 10.1163/156856299X00702
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LEWANDOWSKA K, 1992, J BIOMED MATER RES, V26, P1343, DOI 10.1002/jbm.820261007
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   MARRA M, 2000, J BIOMAT SCI-POLYM E, V11, P547
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Mrksich M, 1997, EXP CELL RES, V235, P305, DOI 10.1006/excr.1997.3668
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   PETTIT DK, 1994, J BIOMED MATER RES, V28, P685, DOI 10.1002/jbm.820280605
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   SHARMA SK, 1980, J CHROMATOGR, V184, P471, DOI 10.1016/S0021-9673(00)93875-5
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Zhu B, 2001, J BIOMED MATER RES, V56, P406, DOI 10.1002/1097-4636(20010905)56:3<406::AID-JBM1110>3.0.CO;2-R
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 41
TC 65
Z9 68
U1 3
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 4
PY 2003
VL 19
IS 5
BP 1847
EP 1852
DI 10.1021/la026244
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 651FJ
UT WOS:000181309600053
DA 2018-10-19
ER

PT J
AU Wong, JY
   Velasco, A
   Rajagopalan, P
   Pham, Q
AF Wong, JY
   Velasco, A
   Rajagopalan, P
   Pham, Q
TI Directed movement of vascular smooth muscle cells on gradient-compliant
   hydrogels
SO LANGMUIR
LA English
DT Article
ID FIBROBLAST GROWTH-FACTOR; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION;
   FOCAL ADHESIONS; BALLOON INJURY; MIGRATION; INTEGRIN; RAT;
   CONTRACTILITY; PROLIFERATION
AB Current solutions in the treatment of cardiovascular disease include angioplasty and the insertion of stents, but a large number of these cases result in restenosis. Biomaterial coatings that control vascular smooth muscle cell migration are therefore desirable. In this study, we describe a novel method to create substrata with defined gradients in mechanical compliance using photopolymerization and patterning. Cell speed was found to be 53 +/- 2.6 mum/h on a substrate with a Young's modulus of 15 kPa compared to 40 +/- 3.1 mum/h for a 28 kPa substratum (P < 0.005). We demonstrate that vascular smooth muscle cells undergo direct migration on radial-gradient-compliant substrata from soft to stiff regions of the substrate and that cells accumulate in the stiff regions after 24 h. Our results show that the pattern of the compliance gradient is important and that substrate compliance may be a key design parameter for modulation of cell migration for vascular tissue engineering applications.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Wong, JY (reprint author), 44 Cummington St, Boston, MA 02215 USA.
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381
CR ADLER ID, 1993, MUTAT RES, V301, P249, DOI 10.1016/0165-7992(93)90065-4
   Anseth KS, 2002, MRS BULL, V27, P130, DOI 10.1557/mrs2002.49
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   CHOI ET, 1994, J VASC SURG, V19, P125, DOI 10.1016/S0741-5214(94)70127-X
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   Dunn G A, 1983, Agents Actions Suppl, V12, P14
   Fang KS, 1999, J CELL SCI, V112, P1967
   FLANAGAN L, 2001, BED SERIES, V50, P379
   Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963
   HARRIS A, 1973, EXP CELL RES, V77, P285, DOI 10.1016/0014-4827(73)90579-X
   LI Y, 1993, J APPL POLYM SCI, V50, P1107, DOI 10.1002/app.1993.070500619
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Nelson PR, 1996, J VASC SURG, V24, P25, DOI 10.1016/S0741-5214(96)70141-6
   Nielsen L. E., 1994, MECH PROPERTIES POLY
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Pickering JG, 1997, CIRC RES, V80, P627, DOI 10.1161/01.RES.80.5.627
   Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x
   Rajagopalan P, 2002, MATER RES SOC SYMP P, V711, P231
   RAJAGOPALAN P, UNPUB
   Rutherford C, 1997, ATHEROSCLEROSIS, V130, P45, DOI 10.1016/S0021-9150(96)06042-X
   Shimokado K, 1997, ANN NY ACAD SCI, V811, P130, DOI 10.1111/j.1749-6632.1997.tb51995.x
   Slepian MJ, 1998, CIRCULATION, V97, P1818, DOI 10.1161/01.CIR.97.18.1818
   SPERLING LH, 1986, INTRO PHYSICAL POLYM
   Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198
   West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188
   Zempo N, 1996, ARTERIOSCL THROM VAS, V16, P28, DOI 10.1161/01.ATV.16.1.28
NR 30
TC 304
Z9 309
U1 4
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAR 4
PY 2003
VL 19
IS 5
BP 1908
EP 1913
DI 10.1021/la026403p
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 651FJ
UT WOS:000181309600060
DA 2018-10-19
ER

PT J
AU Albertsson, AC
AF Albertsson, AC
TI Special issue - Microstructured Biomaterial Surfaces - Proceedings of
   Symposium R, E-MRS Spring Meeting 2002 - June 18-21, 2002, Strasbourg,
   France
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Editorial Material
C1 Royal Inst Technol, Dept Fibre & Polymer Technol, KTH, S-10044 Stockholm, Sweden.
RP Albertsson, AC (reprint author), Royal Inst Technol, Dept Fibre & Polymer Technol, KTH, Teknikrigen 56-58, S-10044 Stockholm, Sweden.
RI Albertsson, Ann-Christine/Q-6107-2016
OI Albertsson, Ann-Christine/0000-0001-8696-9143
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAR 3
PY 2003
VL 23
IS 3
SI SI
BP 313
EP 313
AR PII S0928-4931(02)00289-8
DI 10.1016/S0928-4931(02)00289-8
PG 1
WC Materials Science, Multidisciplinary
SC Materials Science
GA 643NT
UT WOS:000180867900001
DA 2018-10-19
ER

PT J
AU Hwang, KE
   Kim, CS
AF Hwang, KE
   Kim, CS
TI Interface characteristics changed by heat treatment of Ti materials with
   hydroxyapatite
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Spring Meeting of the European-Materials-Research-Society (E-MRS)
CY JUN 18-21, 2002
CL STRASBOURG, FRANCE
SP European Mat Res Soc
DE titanium; hydroxyapatite; surface modification; heat treatment; titanium
   phosphide
ID SIMULATED BODY-FLUID; TITANIUM; COATINGS; SURFACE
AB The titanium materials buried in hydroxyapatite (HA) powder and HA dip coated-Ti based materials were heated and the interface was investigated for microstructure and chemical composition using a combination of scanning electron microscopy (SEM), atomic force microscopy (AFM), and scanning Auger electron spectroscopy (SAES). The cylindrically shaped specimens were heated at 800, 850, and 900 degreesC for 1 h in protective argon atmosphere, which led to the formation of porous surfaces. The pore spaces increased with the grain growth caused by the elevated temperature. The phosphorus concentration diffused from the HA coating layer after heating at 800 degreesC and increased up to 7 at.%. The phosphorus concentration obtained from this heating process was 3 times higher than that formed by heat treatment of Ti materials buried in HA powder. Observations from the interfaces heated at 900 degreesC revealed a high concentration of oxygen and little concentrations of P and Ca. The composition and morphology in the interfaces of phosphide and oxide films show a variety of properties. This low-cost and simple surface modification technique of titanium materials may provide a biomaterial for hard tissue replacements. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Chonbuk Natl Univ, Div Elect & Informat Engn, Duckgin Gu, Jeonju 561756, Chonbuk, South Korea.
   Seoul Natl Univ, Intellectual Biointerface Engn Ctr, Seoul, South Korea.
   Chonbuk Natl Univ, Grad Sch, Dept Mechatron, Jeonju 561756, Chonbuk, South Korea.
RP Kim, CS (reprint author), Chonbuk Natl Univ, Div Elect & Informat Engn, Duckgin Gu, Jeonju 561756, Chonbuk, South Korea.
CR [Anonymous], 2001, ANN BOOK ASTM STAND
   Bianco PD, 1996, J BIOMED MATER RES, V31, P227
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   DUCHEYNE P, 1992, BIOMATERIALS, V13, P617, DOI 10.1016/0142-9612(92)90030-R
   Grant DM, 1996, J MATER SCI-MATER M, V7, P579, DOI 10.1007/BF00122181
   HEALY KE, 1993, J MATER SCI-MATER M, V4, P117, DOI 10.1007/BF00120380
   KIM CS, 1991, BIOMATERIALS, V12, P461, DOI 10.1016/0142-9612(91)90143-X
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   NORMAN C, 1989, J BIOMED MAT RES J A, V23, P13
   OKABE H, 1988, ANN NY ACAD SCI, V523, P19
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Textor M., 2001, TITANIUM MED, P172
   VOROS J, 2001, TITANIUM MED, P87
   WILLIAMS DF, 2001, TITANIUM MED, P13
NR 15
TC 6
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAR 3
PY 2003
VL 23
IS 3
SI SI
BP 401
EP 405
AR PII S0928-4931(02)00311-9
DI 10.1016/S0928-4931(02)00311-9
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 643NT
UT WOS:000180867900015
DA 2018-10-19
ER

PT J
AU Shin, K
   Kim, CS
AF Shin, K
   Kim, CS
TI Application of EQCN for quantitative analysis of alkanethiol adsorbed on
   modified Ti surfaces
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Spring Meeting of the European-Materials-Research-Society (E-MRS)
CY JUN 18-21, 2002
CL STRASBOURG, FRANCE
SP European Mat Res Soc
DE titanium; surface modification; EQCN; alkanethiol; adsorption
ID TITANIUM; COATINGS; CELL; GOLD
AB Self-assembled monolayers (SAMs) have become a basic modification technique for immobilization of peptides and specific proteins on a biomaterial surface. Little attempt has been made in investigating the relation between protein adsorption behavior and the surface chemistry of metallic implant materials. In this study, we examined the alkanethiol adsorption behavior on the modified titanium surfaces by using an electrochemical quartz crystal nanobalance (EQCN) developed in our laboratory. The resolution limit of the constructed EQCN was about 0.1 ng. Using the EQCN, we were able to precisely investigate the mass change ratio on the surfaces versus immersion time. We examined the formation of SAMs by alkanethiol on three working electrode surfaces (Au-coated Ti, pure Ti and TiO2). The mass changes on the Au/Ti and pure Ti surfaces were about 11.5 ng/cm(2) for 450 s reaction time and 7.7 ng/cm(2) for 400 s, respectively. The frequency variation on the TiO2 surface with less than +/- 1 Hz for 400 s reaction time indicated a negligible formation of SAMs. Results obtained from this study have shown that by altering titanium surface chemistry, titanium surface may be modified into a functional bioactive surface by introducing alkanethiol and can be used in the same way as Au substrate. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Chonbuk Natl Univ, Div Elect & Informat Engn, Jeonju 561756, Chonbuk, South Korea.
   Seoul Natl Univ, Intellectual Biointerface Engn Ctr, Seoul, South Korea.
   Chonbuk Natl Univ, Grad Sch, Dept Biomed Engn, Jeonju 561756, Chonbuk, South Korea.
RP Kim, CS (reprint author), Chonbuk Natl Univ, Div Elect & Informat Engn, 664-14,Duckgin Gu, Jeonju 561756, Chonbuk, South Korea.
CR AIZAWA M, 1994, CHEM SENS TECHNOL, P5
   Bianco PD, 1996, J BIOMED MATER RES, V31, P227
   BRUNEEL N, 1988, J BIOMED MATER RES, V22, P203, DOI 10.1002/jbm.820220305
   DUCHEYNE P, 1992, BIOMATERIALS, V13, P617, DOI 10.1016/0142-9612(92)90030-R
   Fraker A. C., 1983, ASTM STP, V786, P206
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   Kalltorp M, 1999, BIOMATERIALS, V20, P2123, DOI 10.1016/S0142-9612(99)00115-5
   KIM CS, 1991, BIOMATERIALS, V12, P461, DOI 10.1016/0142-9612(91)90143-X
   Lausmaa J., 2001, TITANIUM MED, P231
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   SHIN MS, 1997, THESIS CHONBUK NATL
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Textor M., 2001, TITANIUM MED, P172
   Ulman A, 1991, INTRO ULTRATHIN ORGA, P237
   Xia S. J., 1998, LANGMUIR, V14, P5507
   XIAO SJ, 2001, TITANIUM MED, P417
   Yoshinari M, 2001, BIOMATERIALS, V22, P709, DOI 10.1016/S0142-9612(00)00234-9
NR 17
TC 5
Z9 6
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAR 3
PY 2003
VL 23
IS 3
SI SI
BP 407
EP 411
DI 10.1016/S0928-4931(02)00312-0
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 643NT
UT WOS:000180867900016
DA 2018-10-19
ER

PT J
AU Bide, MJ
   Phaneuf, MD
   LoGerfo, FW
   Quist, WC
AF Bide, MJ
   Phaneuf, MD
   LoGerfo, FW
   Quist, WC
TI Use of textile technology for creating novel biomaterial surfaces.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 225th National Meeting of the American-Chemical-Society
CY MAR 23-27, 2003
CL NEW ORLEANS, LA
SP Amer Chem Soc
C1 Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
   Beth Israel Deaconess Med Ctr, Vasc Surg Res, Boston, MA USA.
EM mbide@uri.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR
PY 2003
VL 225
MA 81-CELL
BP U280
EP U280
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 761PU
UT WOS:000187917801222
DA 2018-10-19
ER

PT J
AU Coffer, JL
   Senter, RA
   Wang, ZY
   Nagesha, DK
AF Coffer, JL
   Senter, RA
   Wang, ZY
   Nagesha, DK
TI Structural and biomaterial properties of silicon nanowires.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 225th National Meeting of the American-Chemical-Society
CY MAR 23-27, 2003
CL NEW ORLEANS, LOUISIANA
SP Amer Chem Soc
C1 Texas Christian Univ, Dept Chem, Ft Worth, TX 76129 USA.
EM j.coffer@tcu.edu
RI Coffer, Jeffery/G-5686-2011
OI Coffer, Jeffery/0000-0003-0267-9646
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR
PY 2003
VL 225
MA 830-INOR
BP U153
EP U154
PN 2
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 761PW
UT WOS:000187918000824
DA 2018-10-19
ER

PT J
AU Emerson, RJ
   Camesano, TA
AF Emerson, RJ
   Camesano, TA
TI Characterization of bacterial and fungal adhesion in biomaterial systems
   using atomic force microscopy
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 225th National Meeting of the American-Chemical-Society
CY MAR 23-27, 2003
CL NEW ORLEANS, LA
SP Amer Chem Soc
C1 Worcester Polytech Inst, Dept Chem Engn, Worcester, MA 01609 USA.
EM rayjenks@wpi.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR
PY 2003
VL 225
MA 40
BP U802
EP U802
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 761PU
UT WOS:000187917803751
DA 2018-10-19
ER

PT J
AU Wang, YC
   Kao, SH
   Hsieh, HJ
AF Wang, YC
   Kao, SH
   Hsieh, HJ
TI A chemical surface modification of chitosan by glycoconjugates to
   enhance the cell-biomaterial interaction
SO BIOMACROMOLECULES
LA English
DT Article
ID MESSENGER-RNA EXPRESSION; WHEAT-GERM-AGGLUTININ; RT-PCR ANALYSIS;
   DRUG-DELIVERY SYSTEMS; POLYMERIC BIOMATERIALS; BIOLOGICAL RESPONSES;
   ADHESION; PROTEINS; BINDING; NEUTROPHILS
AB The use of wheat germ agglutinin (WGA), a lectin molecule, to modify chitosan and enhance the cell-biomaterial interaction was examined. The percentage of living fibroblast cells on the surfaces of tissue culture polystyrene (TCPS) control, WGA-modified chitosan, and unmodified chitosan films increased to 99%, 99%, and 85%, respectively, after seeding for 48 h. DNA staining revealed that a portion of fibroblasts cultivated on chitosan films were undergoing apoptosis. In contrast, fibroblasts growing on WGA-modified chitosan film surfaces did not show any indication of apoptosis. The number of fibroblast cells was the highest on the WGA-modified chitosan surfaces, followed by the TCPS and unmodified chitosan surfaces. This WGA-mediated enhancement on the fibroblast cell-biomaterial interaction was cell type dependent. Other types of cells may need different lectin molecules for enhanced interaction with biomaterials. Further, the evaluation of the heat shock protein (HSP) mRNA expression indicated that HSP 90 expression was increased in the fibroblast cells cultivated on chitosan films and decreased to basal levels on the WGA-modified chitosan films. Taken together, our data suggest that the use of WGA and other lectin molecules to enhance the cell-biomaterial interaction via oligosaccharide-mediated cell adhesion is a promising way to improve cell adhesion and proliferation, the two key issues in tissue engineering.
C1 Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
   Taipei Med Univ, Grad Inst Biomed Technol, Taipei 110, Taiwan.
RP Hsieh, HJ (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
RI Sanguansri, Luz/B-6630-2011
OI Sanguansri, Luz/0000-0003-1908-7604
CR Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238
   BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335
   Ciapetti G, 1996, BIOMATERIALS, V17, P1259, DOI 10.1016/0142-9612(96)88670-4
   Clark MA, 2000, ADV DRUG DELIVER REV, V43, P207, DOI 10.1016/S0169-409X(00)00070-3
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Dixit P, 2001, J BIOMED MATER RES, V56, P545, DOI 10.1002/1097-4636(20010915)56:4<545::AID-JBM1126>3.0.CO;2-V
   Ertl B, 2000, J DRUG TARGET, V8, P173, DOI 10.3109/10611860008996863
   Genta I, 1999, EXS, V87, P305
   Hardouin P, 2000, JOINT BONE SPINE, V67, P419
   Hebert E, 2000, BIOSCIENCE REP, V20, P213, DOI 10.1023/A:1026484722248
   Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200
   Kato S, 2000, J BIOMAT SCI-POLYM E, V11, P333, DOI 10.1163/156856200743733
   Kato S, 2000, BIOMATERIALS, V21, P521, DOI 10.1016/S0142-9612(99)00214-8
   Kato S, 1998, BIOMATERIALS, V19, P821, DOI 10.1016/S0142-9612(97)00240-8
   Kato S, 1997, J BIOMAT SCI-POLYM E, V8, P809, DOI 10.1163/156856297X00335
   KINOSHITA T, 1992, ANAL BIOCHEM, V206, P231, DOI 10.1016/0003-2697(92)90358-E
   Kuwahara H, 2000, BIOSCI BIOTECH BIOCH, V64, P1278, DOI 10.1271/bbb.64.1278
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Langer R, 2000, MOL THER, V1, P12, DOI 10.1006/mthe.1999.0003
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4
   LARSEN E, 1990, CELL, V63, P467, DOI 10.1016/0092-8674(90)90443-I
   Lehr CM, 2000, J CONTROL RELEASE, V65, P19, DOI 10.1016/S0168-3659(99)00228-X
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   MIVECHI NF, 1990, CANCER RES, V50, P2877
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Muzzarelli RAA, 1999, EXS, V87, P251
   NAGATA Y, 1974, J BIOL CHEM, V249, P3116
   Narita T, 2000, BIOMACROMOLECULES, V1, P162, DOI 10.1021/bm9900085
   Nizheradze KA, 2000, FOLIA HISTOCHEM CYTO, V38, P167
   Pearl LH, 2000, CURR OPIN STRUC BIOL, V10, P46, DOI 10.1016/S0959-440X(99)00047-0
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   REEKE GN, 1974, ANN NY ACAD SCI, V234, P369, DOI 10.1111/j.1749-6632.1974.tb53049.x
   Sabnis S, 2000, INT J BIOL MACROMOL, V27, P181, DOI 10.1016/S0141-8130(00)00118-5
   Sethi KK, 2002, WOUND REPAIR REGEN, V10, P397, DOI 10.1046/j.1524-475X.2002.10609.x
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Thomas C, 1990, BIOMATERIALS ARTIFIC, V18, P1
   THOMSON GJL, 1991, SURGERY, V109, P20
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241
   Whitley D, 1999, J VASC SURG, V29, P748, DOI 10.1016/S0741-5214(99)70329-0
NR 47
TC 43
Z9 45
U1 2
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR-APR
PY 2003
VL 4
IS 2
BP 224
EP 231
DI 10.1021/bm0256294
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 654KP
UT WOS:000181496300006
PM 12625716
DA 2018-10-19
ER

PT J
AU Zhang, SP
   Yang, J
   Liu, XY
   Chang, JH
   Cao, AM
AF Zhang, SP
   Yang, J
   Liu, XY
   Chang, JH
   Cao, AM
TI Synthesis and characterization of poly(butylene succinate-co-butylene
   malate): A new biodegradable copolyester bearing hydroxyl pendant groups
SO BIOMACROMOLECULES
LA English
DT Article
ID RING-OPENING POLYMERIZATION; ALIPHATIC POLYESTERS; POLY(TETRAMETHYLENE
   SUCCINATE); POLYCONDENSATION REACTION; FUNCTIONAL-GROUPS; MALIC-ACID;
   COPOLYMERS; MALOLACTONATE; DEGRADATION; KINETICS
AB A new biodegradable copolyester, poly(butylene succinate-co-butylene malate) P(BS-co-BM), has been preliminarily prepared with optically active centers and lateral hydroxyl functional groups via a four-step synthetic strategy. First, an optically active benzyl-protected dimethyl malate was synthesized from a starting material of (S)-dimethyl malate and purified with good yield. Then, copolyester poly(butylene succinate-co-benzyl-protected butylene malate), P(BS-co-BBM), was prepared through a skilled condensation copolymerization of the benzyl-protected dimethyl malate, dimethyl succinate, and 1,4-butanediol in the presence of titanium tetraisopropoxide as the catalyst. Finally, a Pd/C catalyzed hydrogenation was applied to eliminate the benzyl protection group in a mixed solution of THF and methanol; thus the target copolyester P(BS-co-BM) was attained. On the other hand, physical properties of the synthesized copolyesters were systematically characterized by means of nuclear magnetic resonance spectrometer, Fourier transformed infrared spectrometer, gel permeation chromatography, optical polarimeter, quantitative hydroxyl titration, and thermal analytical instruments. The experimental evidence demonstrated a successful construction of the product P(BS-co-BM) bearing lateral hydroxyl functional groups. It was also revealed that the lower BBM unit content was in the benzyl-protected optically active P(BS-co-BBM) copolyester, the higher melting point T-m, crystallinity, the broader molecular distribution, and the lower glass transition temperature T-g would be detected, and these results can be accounted for the presence of bulky lateral benzyl moieties. In contrast, the deprotected product P(BS-co-55 mol % BM) showed a higher T-m, crystallinity and lower T-g than its counterpart P(BS-co-55 mol % BBM). Interestingly, a thermal stability as high as that of the linear PBS was observed for P(BS-co-55 mol % BM) while a strong BBM unit content dependence of thermal stability was detected for the benzyl-protected copolyester P(BS-co-BBM)s. Therefore, these results may be beneficial for the new optically active P(BS-co-BM) bearing hydrophilic hydroxyl functional groups as a potential biomaterial.
C1 Chinese Acad Sci, Shanghai Inst Organ Chem, Polymer Mat Lab, Shanghai 200032, Peoples R China.
   NW Univ Xian, Dept Chem, Xian 710069, Peoples R China.
RP Cao, AM (reprint author), Chinese Acad Sci, Shanghai Inst Organ Chem, Polymer Mat Lab, 354 Fenglin St, Shanghai 200032, Peoples R China.
EM acao@pub.sioc.ac.cn
CR Aoi K, 2002, MACROMOL CHEM PHYSIC, V203, P1018, DOI 10.1002/1521-3935(20020401)203:7<1018::AID-MACP1018>3.0.CO;2-9
   BENVENUTI M, 1991, J POLYM SCI POL CHEM, V29, P793, DOI 10.1002/pola.1991.080290602
   Bizzarri R, 2002, MACROMOLECULES, V35, P1215, DOI 10.1021/ma0111257
   BRAUD C, 1992, POLYM BULL, V29, P177, DOI 10.1007/BF00558054
   Cao A, 2002, POLYM DEGRAD STABIL, V78, P107, DOI 10.1016/S0141-3910(02)00124-6
   Cao A, 2002, POLYMER, V43, P671, DOI 10.1016/S0032-3861(01)00658-9
   Deng XM, 2001, EUR POLYM J, V37, P211, DOI 10.1016/S0014-3057(00)00090-2
   Duda A, 2002, MACROMOLECULES, V35, P4266, DOI 10.1021/ma012207y
   Fujimaki T, 1998, POLYM DEGRAD STABIL, V59, P209, DOI 10.1016/S0141-3910(97)00220-6
   Fujimaki T, 1996, SEN-I GAKKAISHI, V52, pP320, DOI 10.2115/fiber.52.8_P320
   Gohy JF, 2002, MACROMOL RAPID COMM, V23, P555, DOI 10.1002/1521-3927(20020601)23:9<555::AID-MARC555>3.0.CO;2-K
   GROSS RA, 1988, MACROMOLECULES, V21, P2657, DOI 10.1021/ma00187a002
   GUERIN P, 1985, POLYM BULL, V14, P187, DOI 10.1007/BF00708479
   Hong K, 2002, EUR POLYM J, V38, P305, DOI 10.1016/S0014-3057(01)00110-0
   Ichikawa Y, 2000, POLYMER, V41, P4719, DOI 10.1016/S0032-3861(99)00659-X
   IHN KJ, 1995, MACROMOLECULES, V28, P2460, DOI 10.1021/ma00111a045
   Ishii M, 2001, BIOMACROMOLECULES, V2, P1267, DOI 10.1021/bm015576a
   *ISO, 1997, 2554 ISO
   Kawabe M, 2002, MACROMOL CHEM PHYSIC, V203, P24, DOI 10.1002/1521-3935(20020101)203:1<24::AID-MACP24>3.0.CO;2-5
   KECK GE, 1991, J ORG CHEM, V56, P417, DOI 10.1021/jo00001a076
   KIMURA Y, 1988, MACROMOLECULES, V21, P3338, DOI 10.1021/ma00189a037
   KIMURA Y, 1999, BASICS APPL BIODEGRA, P7
   Lee SH, 1999, POLYM INT, V48, P861, DOI 10.1002/(SICI)1097-0126(199909)48:9<861::AID-PI233>3.3.CO;2-0
   Lenz R., 1983, POLYM MED, P219
   Mecerreyes D, 1999, ADV POLYM SCI, V147, P1
   NICHLIN J, 1999, INSTANT NOTES MICROB, P10
   OUCHI T, 2002, POLYM PREPR, V43, P648
   Patil VJ, 1996, TETRAHEDRON LETT, V37, P1481, DOI 10.1016/0040-4039(96)00044-5
   Shirahama H, 2001, J APPL POLYM SCI, V80, P340, DOI 10.1002/1097-4628(20010418)80:3<340::AID-APP1105>3.0.CO;2-F
   Storey RF, 2002, MACROMOLECULES, V35, P1504, DOI 10.1021/ma010986c
   TAIKYAMA E, Patent No. 5310782
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   WIDER U, 1987, SYNTHESIS-STUTTGART, P568
   Won CY, 1998, POLYMER, V39, P6677, DOI 10.1016/S0032-3861(98)00032-9
   Ydens I, 2000, MACROMOLECULES, V33, P6713, DOI 10.1021/ma0002803
   ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728
NR 36
TC 54
Z9 64
U1 4
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR-APR
PY 2003
VL 4
IS 2
BP 437
EP 445
DI 10.1021/bm0201183
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 654KP
UT WOS:000181496300033
PM 12625743
DA 2018-10-19
ER

PT J
AU Wang, YC
   Lin, MC
   Wang, DM
   Hsieh, HJ
AF Wang, YC
   Lin, MC
   Wang, DM
   Hsieh, HJ
TI Fabrication of a novel porous PGA-chitosan hybrid matrix for tissue
   engineering
SO BIOMATERIALS
LA English
DT Article
DE chitosan; polyglycolide; porous matrix; tissue engineering
ID BIODEGRADABLE POLYMERIC SCAFFOLDS; DRUG-DELIVERY SYSTEMS; IN-VITRO
   DEGRADATION; SURFACE MODIFICATION; RGD PEPTIDES; CELLS; BIOMATERIALS;
   GROWTH; ACID; DNA
AB Polyglycolide (PGA) and chitosan mixture solution was prepared using solvents of low toxicity to create novel, porous, biocompatible, degradable, and modifiable hybrid matrices for biomedical applications. The porosity of these PGA-chitosan hybrid matrices (P/C matrices) was created by a thermally induced phase separation method. Two types of the P/C hybrid matrices containing 70wt% PGA (P/C-1 matrix) and 30wt% PGA (P/C-2 matrix) were fabricated. Chitosan matrix was also prepared for comparison. A 35-day in vitro degradation revealed that the weight losses for the P/C-1 and P/C-2 matrices were similar (similar to 61%), but the releases of glycolic acid from the P/C-1 and P/C-2 matrices were 95% and 60%, respectively. The P/C-1 matrix had higher porosity and higher mechanical strength than the P/C-2 and chitosan matrices. Fibroblast cells cultivated in these matrices proliferated well and the cell density was the highest in the P/C-1 matrix, followed by the chitosan and P/C-2 matrices, suggesting good biocompatibility for the P/C-1 matrix. We thereby concluded that the P/C-1 matrix, due to its high strength, porosity, biocompatibility and degradability, is a promising biomaterial. The presence of chitosan in the P/C matrices provides many amino groups for further modifications such as biomolecule conjugation and thus enhances the application potential of the P/C hybrid matrices in tissue engineering. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
RP Hsieh, HJ (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 106, Taiwan.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Andersen NH, 2002, J INORG BIOCHEM, V88, P316, DOI 10.1016/S0162-0134(01)00358-0
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Baures PW, 2000, BIOORGAN MED CHEM, V8, P1599, DOI 10.1016/S0968-0896(00)00090-0
   BENICEWICZ BC, 1991, J BIOACT COMPAT POL, V6, P64, DOI 10.1177/088391159100600106
   BOSTMAN OM, 1992, CLIN ORTHOP RELAT R, P263
   Bridges KG, 2001, J VIROL, V75, P4990, DOI 10.1128/JVI.75.11.4990-4998.2001
   Bures P, 2001, J CONTROL RELEASE, V72, P25, DOI 10.1016/S0168-3659(01)00259-0
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Ciapetti G, 1996, BIOMATERIALS, V17, P1259, DOI 10.1016/0142-9612(96)88670-4
   Epple M, 1998, J BIOMED MATER RES, V43, P83
   Furuki T, 2002, CARBOHYD RES, V337, P441, DOI 10.1016/S0008-6215(01)00332-9
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Genta I, 1999, EXS, V87, P305
   Gilding D., 1981, BIOCOMPATIBILITY CLI, V2, P209
   Giunchedi P, 1998, J CONTROL RELEASE, V56, P53, DOI 10.1016/S0168-3659(98)00068-6
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   IKEA Y, 1994, BIOMATERIALS, V15, P725
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li ZJ, 2001, J PHARM SCI, V90, P1523
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Muzzarelli RAA, 1999, EXS, V87, P251
   Myles JL, 2000, J BIOMAT SCI-POLYM E, V11, P69, DOI 10.1163/156856200743508
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nishikawa H, 2000, J ENDODONT, V26, P169, DOI 10.1097/00004770-200003000-00010
   Park A, 1998, J BIOMAT SCI-POLYM E, V9, P89, DOI 10.1163/156856298X00451
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Pohle W, 2001, ARCH BIOCHEM BIOPHYS, V396, P151, DOI 10.1006/abbi.2001.2593
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Risbud M, 2001, CELL TRANSPLANT, V10, P195
   Sabnis S, 2000, INT J BIOL MACROMOL, V27, P181, DOI 10.1016/S0141-8130(00)00118-5
   SAUCED S, 2000, INT J DEV NEUROSCI, V18, P705
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Takano K, 2001, BIOCHEMISTRY-US, V40, P4853, DOI 10.1021/bi002792f
   Taylor LS, 1998, J PHARM SCI, V87, P1615, DOI 10.1021/js9800174
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Ueno H, 2001, BIOMATERIALS, V22, P1667, DOI 10.1016/S0142-9612(00)00328-8
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
NR 44
TC 116
Z9 126
U1 4
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2003
VL 24
IS 6
BP 1047
EP 1057
AR PII S0142-9612(02)00434-9
DI 10.1016/S0142-9612(02)00434-9
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 636KE
UT WOS:000180454000019
PM 12504527
DA 2018-10-19
ER

PT J
AU Lee, YJ
   Park, SJ
   Lee, WK
   Ko, JS
   Kim, HM
AF Lee, YJ
   Park, SJ
   Lee, WK
   Ko, JS
   Kim, HM
TI MG63 osteoblastic cell adhesion to the hydrophobic surface precoated
   with recombinant osteopontin fragments
SO BIOMATERIALS
LA English
DT Article
DE recombinant osteopontin; hydrophobic surface; biomaterial; osteoblast;
   cell signaling
ID HEMA/EMA COPOLYMERS; HUMAN FIBROBLASTS; MATRIX PROTEINS; BONE-CELLS;
   FIBRONECTIN; WETTABILITY; INTEGRINS; STRENGTH; DIFFERENTIATION;
   PHOSPHORYLATION
AB The hydrophobicity of biomaterials has been recognized as a limitation to the adequate function of anchorage-dependent cells when hydrophobic biomaterials are used for tissue engineering. This is due to flawed solid-state signals from cell adhesion. In this study, a recombinant osteopontin (rOPN17-169) fragment containing the cell adhesion motifs was expressed in E coli and was precoated on the hydrophobic surface prior to osteoblastic MG63 cell culture. Precoating the hydrophobic surface with rOPN17-169 improved osteoblastic cell adhesion, which was blocked by soluble RGDS. The adhesion of MG63 cells to rOPN17-169 precoated surface-activated mitogen-activated protein kinases (MAPK) such as extracellular signal-receptor kinase 1/2, p38, and c-Jun N-terminal kinase (JNK). In addition, p38 MAPK was activated in response to a soluble factor of transforming growth factor-beta in the cells adhered to the hydrophobic surface via rOPN17-169. This suggests that rOPN17-169 precoated on the hydrophobic surface can allow osteoblastic cells to generate adhesion signals sufficient for cell adhesion, MAPK activation, and the cytokine activation of osteoblastic cells. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Seoul Natl Univ, Coll Dent, Dept Oral Anat, Lab Study Mol Biointerfaces,ChongRo Ku, Seoul 110749, South Korea.
   Seoul Natl Univ, Intellectual Biointerface Engn Ctr, Seoul 110749, South Korea.
RP Kim, HM (reprint author), Seoul Natl Univ, Coll Dent, Dept Oral Anat, Lab Study Mol Biointerfaces,ChongRo Ku, BK21HLS,28-22,YeonKun Dong, Seoul 110749, South Korea.
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   APLIN AE, 1999, CURR OPIN CELL BIOL
   Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200
   BRIGHTON CT, 1992, J ORTHOPAED RES, V10, P766, DOI 10.1002/jor.1100100604
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   Burmeister JS, 1999, J BIOMED MATER RES, V47, P577, DOI 10.1002/(SICI)1097-4636(19991215)47:4<577::AID-JBM15>3.0.CO;2-S
   BUTLER WT, 1995, INT J DEV BIOL, V39, P169
   Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133
   Kim HD, 1997, BIOMATERIALS, V18, P1175
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   Liu YK, 1997, J BIOCHEM-TOKYO, V121, P961
   McFarland CD, 1999, J BIOMED MATER RES, V44, P1
   Panetti TS, 2002, FRONT BIOSCI, V7, pD143, DOI 10.2741/panetti
   Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4
   Schwartz Z, 2001, BIOMATERIALS, V22, P731, DOI 10.1016/S0142-9612(00)00241-6
   Siggelkow H, 2002, J CELL BIOCHEM, V85, P279, DOI 10.1002/jcb.10122
   Sommerfeldt DW, 2001, BIOCHEM BIOPH RES CO, V285, P355, DOI 10.1006/bbrc.2001.5198
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   STEIN GS, 1990, FASEB J, V4, P3111
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Vermeer AWP, 2001, BBA-GEN SUBJECTS, V1526, P61, DOI 10.1016/S0304-4165(01)00101-5
   Yokasaki Y, 2000, TRENDS CARDIOVAS MED, V10, P155, DOI 10.1016/S1050-1738(00)00055-4
   Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328
   Zoungrana T, 1997, J COLLOID INTERF SCI, V190, P437, DOI 10.1006/jcis.1997.4895
NR 36
TC 37
Z9 37
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2003
VL 24
IS 6
BP 1059
EP 1066
AR PII S0142-9612(02)00439-8
DI 10.1016/S0142-9612(02)00439-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 636KE
UT WOS:000180454000020
PM 12504528
DA 2018-10-19
ER

PT J
AU Zaffe, D
   Bertoldi, C
   Consolo, U
AF Zaffe, D
   Bertoldi, C
   Consolo, U
TI Element release from titanium devices used in oral and maxillofacial
   surgery
SO BIOMATERIALS
LA English
DT Article
DE titanium; corrosion resistance; skeletal tissues; element analysis
ID HUMAN TISSUES; IN-VITRO; BONE; IMPLANTS; BEHAVIOR; OSSEOINTEGRATION;
   BIOMATERIAL; DISSOLUTION; CORROSION; ABSENCE
AB Optical microscopy, scanning electron microscopy and X-ray microanalysis (EDS system) were used on c.p. titanium devices (21 grids and 10 plates) removed from 28 patients without signs of inflammation 6-24 months after surgery. Plates, grids and surrounding tissue were investigated to evaluate the titanium release and accumulation. Titanium was only present in the interfacial bone, probably due to fretting, and in all fibrous tissue surrounding the devices. Titanium content followed a decreasing gradient extending from the device surface and was not detected at a distance greater than I mm. High titanium levels were found in blood cells in the connective tissue. In conclusion, titanium release from the devices stops only after bone is laid down on the titanium surfaces. Titanium release does not seem to interfere with the osteogenic process but perhaps may interact with it. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Modena & Reggio Emilia, Dipartimento Anat & Istol, Sez Anat Umana, Policlin Modena, I-41100 Modena, Italy.
   Univ Modena & Reggio Emilia, Sect Dent, Dept Neurosci Head Neck & Rehabil, I-41100 Modena, Italy.
RP Zaffe, D (reprint author), Univ Modena & Reggio Emilia, Dipartimento Anat & Istol, Sez Anat Umana, Policlin Modena, Via Pozzo 71, I-41100 Modena, Italy.
RI Zaffe, Davide/G-1181-2016; Consolo, Ugo/F-2704-2017
OI Zaffe, Davide/0000-0003-1241-385X; Consolo, Ugo/0000-0001-5557-3285;
   BERTOLDI, Carlo/0000-0001-9776-5138
CR BESSHO K, 1995, J BIOMED MATER RES, V29, P901, DOI 10.1002/jbm.820290716
   Bianco PD, 1996, J BIOMED MATER RES, V31, P227
   Bianco PD, 1996, BIOMATERIALS, V17, P1937, DOI 10.1016/0142-9612(96)00023-3
   BLACK J, 1990, J BONE JOINT SURG AM, V72A, P126, DOI 10.2106/00004623-199072010-00021
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Doran A, 1998, BIOMATERIALS, V19, P751, DOI 10.1016/S0142-9612(97)00209-3
   HECK DA, 1986, J BONE JOINT SURG AM, V68A, P118, DOI 10.2106/00004623-198668010-00015
   HEIMKE G, 1989, ADV MATER, V101, P345
   Hobo S, 1991, OSSEOINTEGRATION OCC
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   Jorgenson DS, 1997, PLAST RECONSTR SURG, V99, P976, DOI 10.1097/00006534-199704000-00006
   Jorgenson DS, 1999, BIOMATERIALS, V20, P675, DOI 10.1016/S0142-9612(98)00225-7
   Katou F, 1996, J CRANIO MAXILL SURG, V24, P155, DOI 10.1016/S1010-5182(96)80049-7
   Kazuhisa B., 1993, CLIN MAT, V14, P223
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kuphasuk C, 2001, J PROSTHET DENT, V85, P195, DOI 10.1067/mpr.2001.113029
   Lee TM, 1999, J MATER SCI-MATER M, V10, P541, DOI 10.1023/A:1008916314329
   Liu HC, 1999, ARTIF ORGANS, V23, P1099, DOI 10.1111/j.1525-1594.1999.06343.x
   Maiorano E, 1994, Boll Soc Ital Biol Sper, V70, P257
   Marotti G, 1996, Ital J Anat Embryol, V101, P25
   Matthew IR, 1998, J ORAL MAXIL SURG, V56, P45, DOI 10.1016/S0278-2391(98)90915-6
   MAURER AM, 1993, J ORTHOPAED RES, V11, P865, DOI 10.1002/jor.1100110613
   MOBERG LE, 1989, INT J ORAL MAX SURG, V18, P311, DOI 10.1016/S0901-5027(89)80102-X
   MORAN CA, 1991, HUM PATHOL, V22, P450, DOI 10.1016/0046-8177(91)90130-H
   MUNSTER D, 1987, ENCY MED CHIRURG STO, V1, P1
   ONODERA K, 1993, ORAL SURG ORAL MED O, V75, P495, DOI 10.1016/0030-4220(93)90177-6
   ROSENBERG A, 1993, INT J ORAL MAX SURG, V22, P185, DOI 10.1016/S0901-5027(05)80249-8
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   Soncini M, 2002, BIOMATERIALS, V23, P9, DOI 10.1016/S0142-9612(01)00073-4
   TAKATSUKA K, 1995, J BIOMED MATER RES, V29, P157, DOI 10.1002/jbm.820290204
   Tamai  K, 2001, Breast Cancer, V8, P90, DOI 10.1007/BF02967485
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Urabe M, 2000, J BIOMED MATER RES, V49, P17, DOI 10.1002/(SICI)1097-4636(200001)49:1<17::AID-JBM3>3.0.CO;2-G
   Wang JY, 1996, BIOMATERIALS, V17, P2233, DOI 10.1016/0142-9612(96)00072-5
   WEINGART D, 1994, INT J ORAL MAX SURG, V23, P450, DOI 10.1016/S0901-5027(05)80045-1
   ZAFFE D, IN PRESS J BIOMED MA
NR 39
TC 46
Z9 52
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2003
VL 24
IS 6
BP 1093
EP 1099
AR PII S0142-9612(02)00424-6
DI 10.1016/S0142-9612(02)00424-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 636KE
UT WOS:000180454000024
PM 12504532
DA 2018-10-19
ER

PT J
AU Sellborn, A
   Andersson, M
   Fant, C
   Gretzer, C
   Elwing, H
AF Sellborn, A
   Andersson, M
   Fant, C
   Gretzer, C
   Elwing, H
TI Methods for research on immune complement activation on modified sensor
   surfaces
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE quartz crystal microbalance (QCM-D); immune complement system; surface
   modifications
ID QUARTZ-CRYSTAL MICROBALANCE; PLASMON RESONANCE; WHOLE-BLOOD; INHIBITS
   COMPLEMENT; IN-VITRO; BIOMATERIAL; ELLIPSOMETRY; ADSORPTION; TITANIUM;
   BINDING
AB We have developed a methodological system consisting of a new surface sensitive quartz crystal microbalance with dissipation monitoring (QCM-D) sensor surfaces together with different surface modification methods for the investigation of surface associated complement activation in human sera. The QCM-D surface, 10 mm in diameter, was modified by spin-coating of poly(urethane urea) (PUUR) and polystyrene (PS). Some sensor surfaces were also sputtered with titanium (Ti) or modified by hydrophobic self-assembled monolayer (SAM) of an 18-carbon alkane thiol with a -CH3 end group. The amount of surface deposited complement protein was investigated by incubation of the modified sensor surfaces in human sera, followed by incubation with antibodies directed against complement factor 3c (C3c). The amounts of bound anti-C3c were then used as an arbitrary measure of surface induced complement activation. The order of complement activation of the different surfaces, as judged by three separate measurements per surface modification, was PUUR > PS = SAM > Ti. The Ti surface had a similar low degree of anti-C3c binding as the negative controls (heat inactivated sera). The novel QCM-D methodology was found to be very simple, accurate, sensitive and well suited as a screening method for complement activation and protein adsorption on different materials. We also compared the sensitivity of QCM-D method with surface plasmon resonance (SPR) for the quantification of protein adsorption and complement activation on gold sensor surfaces. The QCM-D method was equally sensitive as the SPR for the detection of protein adsorption from a solution independently if low flow rate (5 mul/ min) was used. A slight increase in sensitivity was found at higher flow rate (30 mul/min). However, we found it difficult to use the SPR method on the Ti, PS and PUUR surfaces due to decreased light penetration of the modified SPR sensor chip. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Gothenburg, Dept Cell & Mol Biol, Interface Biophys Lundberg lab, SE-40530 Gothenburg, Sweden.
   Univ Gothenburg, Sahlgrenska Acad, Inst Surg Sci, Dept Biomat, SE-40530 Gothenburg, Sweden.
RP Sellborn, A (reprint author), Univ Gothenburg, Dept Cell & Mol Biol, Interface Biophys Lundberg lab, Box 462, SE-40530 Gothenburg, Sweden.
CR Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   ANDERSSON M, UNPUB J BIOMATER SCI
   Babiker AA, 2002, AM J REPROD IMMUNOL, V47, P183, DOI 10.1034/j.1600-0897.2002.1o023.x
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   Elwing H, 1998, BIOMATERIALS, V19, P397, DOI 10.1016/S0142-9612(97)00112-9
   ELWING H, 1986, EUR J BIOCHEM, V156, P359, DOI 10.1111/j.1432-1033.1986.tb09591.x
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Kalltorp M, 1999, J BIOMED MATER RES, V44, P222
   Kalltorp M, 1999, J BIOMED MATER RES, V47, P251, DOI 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   LIEDBERG B, 1993, SENSOR ACTUAT B-CHEM, V11, P63, DOI 10.1016/0925-4005(93)85239-7
   LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7
   LIM F, 1993, BIOMATERIALS, V14, P537, DOI 10.1016/0142-9612(93)90243-U
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   Nilsson B, 1998, BLOOD, V92, P1661
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Rodahl M, 1996, ANAL CHEM, V68, P2219, DOI 10.1021/ac951203m
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   SAURBREY G, 1959, Z PHYS, V155, P206
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Vikinge TP, 2000, BIOSENS BIOELECTRON, V15, P605, DOI 10.1016/S0956-5663(00)00125-1
   Walivaara B, 1996, J BIOMAT SCI-POLYM E, V8, P41, DOI 10.1163/156856297X00560
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Yang YQ, 1996, J HEART VALVE DIS, V5, P532
NR 30
TC 25
Z9 25
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2003
VL 27
IS 4
BP 295
EP 301
AR PII S0927-7765(02)00066-8
DI 10.1016/S0927-7765(02)00066-8
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 649MW
UT WOS:000181213400003
DA 2018-10-19
ER

PT J
AU Mochizuki, M
   Kadoya, Y
   Wakabayashi, Y
   Kato, K
   Okazaki, I
   Yamada, M
   Sato, T
   Sakairi, N
   Nishi, N
   Nomizu, M
AF Mochizuki, M
   Kadoya, Y
   Wakabayashi, Y
   Kato, K
   Okazaki, I
   Yamada, M
   Sato, T
   Sakairi, N
   Nishi, N
   Nomizu, M
TI Laminin-1 peptide-conjugated chitosan membranes as a novel approach for
   cell engineering
SO FASEB JOURNAL
LA English
DT Article
DE basement membrane; cell attachment; integrin; proteoglycan; neurite
   outgrowth
ID ALPHA-1 CHAIN; SYNTHETIC PEPTIDES; G-DOMAIN; BRANCHING MORPHOGENESIS;
   SUBMANDIBULAR-GLAND; BINDING SEQUENCES; GLOBULAR DOMAIN; GAMMA-1 CHAIN;
   BETA-1 CHAIN; IDENTIFICATION
AB Laminin, a major component of the basement membrane, has diverse biological activities. Recently, we identified various biologically active sequences on laminin-1 by using a large set of synthetic peptides. Chitosan, a polysaccharide, is biodegradable and has been used as a biomaterial. Here, we conjugated several biologically active laminin peptides onto chitosan membranes and measured the cell attachment activity of peptide-conjugated chitosan membranes with various cell types. The active laminin peptide-conjugated chitosan membranes promoted cell attachment with cell type specificity. A99 (AGTFALRGDNPQG)-chitosan membrane promoted cell attachment with well-organized actin stress fibers. This adhesion was inhibited by EDTA but not by heparin. AG73 (RKRLQVQLSIRT)-chitosan membrane promoted cell attachment with filopodia formation, and this adhesion was inhibited by heparin but not by EDTA. These data suggest that the A99-chitosan membrane interacted with an integrin cellular receptor and that the AG73-chitosan membrane promoted proteoglycan-mediated cell attachment, as previously reported. Furthermore, both AG73-chitosan and A99-chitosan membranes effectively promoted neurite outgrowth with PC12 rat pheochromocytoma cells. We conclude that conjugation on a chitosan membrane is applicable for testing quantitatively the biological activity of synthetic peptides and that these constructs have a potential ability to serve as bioadhesive materials for tissue regeneration and engineering.
C1 Hokkaido Univ, Lab Biomat Chem, Div Biosci, Grad Sch Environm Earth Sci,Kita Ku, Sapporo, Hokkaido 0600810, Japan.
   Kitasato Univ, Sch Med, Dept Anat, Sagamihara, Kanagawa 2288555, Japan.
RP Nomizu, M (reprint author), Hokkaido Univ, Lab Biomat Chem, Div Biosci, Grad Sch Environm Earth Sci,Kita Ku, Kita 10 Nishi 5, Sapporo, Hokkaido 0600810, Japan.
EM nomizu@ees.hokudai.ac.jp
CR BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Engbring JA, 2002, CANCER RES, V62, P3549
   Fleischmajer R, 1998, J CELL SCI, V111, P1929
   Gallaher CM, 2000, J NUTR, V130, P2753
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Henriksen I, 1996, INT J PHARM, V145, P231, DOI 10.1016/S0378-5173(96)04776-X
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200
   Hosokawa Y, 1999, DEV GROWTH DIFFER, V41, P207
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107
   Kadoya Y, 1998, DEV DYNAM, V212, P394
   Kim WH, 1998, INT J CANCER, V77, P632, DOI 10.1002/(SICI)1097-0215(19980812)77:4<632::AID-IJC25>3.0.CO;2-6
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kuratomi Y, 1999, EXP CELL RES, V249, P386, DOI 10.1006/excr.1999.4497
   KURITA K, 1977, MAKROMOL CHEM, V178, P3197
   Malinda KM, 1999, FASEB J, V13, P53
   Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Ponce ML, 1999, CIRC RES, V84, P688, DOI 10.1161/01.RES.84.6.688
   Ponce ML, 2001, FASEB J, V15, P1389, DOI 10.1096/fj.00-0736com
   RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z
   Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Song SY, 1997, INT J CANCER, V71, P436, DOI 10.1002/(SICI)1097-0215(19970502)71:3<436::AID-IJC22>3.0.CO;2-C
   SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   TASHIRO K, 1991, J CELL PHYSIOL, V146, P451, DOI 10.1002/jcp.1041460316
   Weeks BS, 1998, EXP CELL RES, V243, P375, DOI 10.1006/excr.1998.4157
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
NR 36
TC 69
Z9 70
U1 0
U2 11
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD MAR
PY 2003
VL 17
IS 3
BP 875
EP +
DI 10.1096/fj.02-0564fje
PG 20
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 661LT
UT WOS:000181892600030
PM 12626440
DA 2018-10-19
ER

PT J
AU Gollwitzer, H
   Ibrahim, K
   Meyer, H
   Mittelmeier, W
   Busch, R
   Stemberger, A
AF Gollwitzer, H
   Ibrahim, K
   Meyer, H
   Mittelmeier, W
   Busch, R
   Stemberger, A
TI Antibacterial poly(D,L-lactic acid) coating of medical implants using a
   biodegradable drug delivery technology
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
DE polylactide; PDLLA; drug release; Staphylococcus; biomaterial
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; GROWTH-FACTORS; BACTERIA; VANCOMYCIN;
   INFECTIONS; ADHERENCE; ADHESION; SURFACES; RELEASE; DEGRADATION
AB Objectives: Biomaterial-associated bacterial infections present common and challenging complications with medical implants. The purpose of this study was to determine the antibacterial properties of a low molecular weight biodegradable poly(D,L-lactic acid) coating with integrated antibiotics gentamicin and teicoplanin.
   Methods: Coating of Kirschner-wires was carried out by a solvent casting technique under aseptic conditions with and without incorporated antibiotics. Release kinetics of gentamicin and teicoplanin were studied in phosphate-buffered saline. Initial bacterial adhesion of Staphylococcus epidermidis on coated and bare implants was determined by radiolabelling and counts of detached viable organisms.
   Results: The incorporated antibiotics showed a continuous release over a period of at least 96 h with an initial peak of release in the first 6 h. Attachment of non-viable microorganisms, detected by radiolabelled bacteria, was increased significantly by the polymer coatings (P < 0.05). In contrast, the number of viable bacteria was reduced by the pure polymer (P < 0.01) and further by the polymer-antibiotic combinations (P < 0.05).
   Conclusions: Poly(D,L-lactic acid) coating of implants could offer new perspectives in preventing biomaterial-associated infections. Combinations with other drugs to formulate custom-tailored implant surfaces are feasible.
C1 Tech Univ Munich, Inst Expt Onkol & Therapieforsch, D-81675 Munich, Germany.
   Tech Univ Munich, Klin & Poliklin Orthopadie & Sportorthopadie, D-81675 Munich, Germany.
   Tech Univ Munich, Inst Med Stat & Epidemiol, D-81675 Munich, Germany.
RP Gollwitzer, H (reprint author), Tech Univ Munich, Inst Expt Onkol & Therapieforsch, Ismaninger Str 22, D-81675 Munich, Germany.
EM h.gollwitzer@lrz.tu-muenchen.de
CR Ahlborg HG, 1999, ACTA ORTHOP SCAND, V70, P116, DOI 10.3109/17453679909011246
   Barnes LM, 1999, APPL ENVIRON MICROB, V65, P4543
   Bellon JM, 2001, BIOMATERIALS, V22, P2021, DOI 10.1016/S0142-9612(00)00390-2
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   CARBALLO J, 1991, MED MICROBIOL IMMUN, V180, P149
   CHRISTENSEN GD, 1995, METHOD ENZYMOL, V253, P477
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Cowsar DR, 1974, ADV EXPT MED BIOL, V47, P1
   CUTRIGHT DE, 1974, ORAL SURG ORAL MED O, V37, P142, DOI 10.1016/0030-4220(74)90171-6
   DAROUICHE RO, 1994, J INFECT DIS, V170, P720, DOI 10.1093/infdis/170.3.720
   Diez-Pena E, 2002, CHEM PHARM BULL, V50, P1201, DOI 10.1248/cpb.50.1201
   DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522
   FRANSON TR, 1984, J CLIN MICROBIOL, V20, P500
   Gallardo-Moreno AM, 2001, FEMS MICROBIOL LETT, V203, P75, DOI 10.1016/S0378-1097(01)00345-7
   Garberina MJ, 2001, CLIN ORTHOP RELAT R, P168
   GREEN SA, 1983, CLIN ORTHOP RELAT R, P109
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   Habash M, 1999, J CLIN PHARMACOL, V39, P887, DOI 10.1177/00912709922008506
   Hebert CK, 1996, CLIN ORTHOP RELAT R, P140
   Herrmann R, 1999, THROMB HAEMOSTASIS, V82, P51
   Kohn J, 1996, BIOMATERIALS SCI INT, P64
   KRAMER SJ, 1981, CLIN ORTHOP RELAT R, P154
   MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   PETERS G, 1989, INFECTIONS ASS INDWE, P61
   PITT CG, 1981, BIOMATERIALS, V2, P215
   QUIRYNEN M, 1994, J DENT, V22, pS13, DOI 10.1016/0300-5712(94)90165-1
   Schierholz JM, 2000, J ANTIMICROB CHEMOTH, V46, P45, DOI 10.1093/jac/46.1.45
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449
   Schmidmaier G, 2001, BONE, V28, P341, DOI 10.1016/S8756-3282(00)00456-7
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   VONEIFF C, 1998, HIP INT, V8, P1
   WILCOX MH, 1991, J ANTIMICROB CHEMOTH, V27, P577, DOI 10.1093/jac/27.5.577
   WILCOX MH, 1994, J ANTIMICROB CHEMOTH, V33, P431, DOI 10.1093/jac/33.3.431
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
NR 37
TC 124
Z9 130
U1 1
U2 34
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD MAR
PY 2003
VL 51
IS 3
BP 585
EP 591
DI 10.1093/jac/dkg105
PG 7
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA 658NU
UT WOS:000181727700013
PM 12615858
OA Bronze
DA 2018-10-19
ER

PT J
AU Wang, XH
   Zhu, Y
   Feng, QL
   Cui, FZ
   Ma, JB
AF Wang, XH
   Zhu, Y
   Feng, QL
   Cui, FZ
   Ma, JB
TI Responses of osteo- and fibroblast cells to phosphorylated chitin
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE phosphorylated chitin (P-chitin); cytocompatibility; fibroblasts;
   osteoblasts; cell culture
ID CALCIUM-PHOSPHATE CEMENTS; IN-VITRO; CHITOSAN; GROWTH; DERIVATIVES;
   CULTURE; SHAPE
AB The cell responses of rat osteoblasts and fibroblasts to water-soluble phosphorylated chitin (P-chitin) were examined in vitro. Cell morphology was observed at 1, 4 and 7 days, respectively. A wide range of measurements, including the percentages of viable cells, total intracellular protein content, and 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrasodium bromide (MTT) assay on osteoblasts and fibroblasts, as well as alkaline phosphatase activity assay on osteoblasts at the end of 7 days culture, were conducted. P-chitin had no cytotoxity on either cell lines. An increase of viability and protein content of both cell types was found in media containing 0.10 g/mL of P-chitin after 7 days culture. The positive effects were especially significant for osteoblasts. Water-soluble P-chitin could be a promising biomaterial for tissue engineering.
C1 Tsinghua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
   Nankai Univ, Inst Polymer Chem, State Key Lab Funct Polymer Mat Adsorpt & Separat, Tianjin 300071, Peoples R China.
RP Feng, QL (reprint author), Tsinghua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.
EM biomater@mail.tsinghua.edu.cn
CR ARCHER CW, 1982, CELL DIFFER DEV, V11, P245, DOI 10.1016/0045-6039(82)90072-0
   Boudeville P, 1999, J MATER SCI-MATER M, V10, P99, DOI 10.1023/A:1008921104080
   BRONWYN MK, 2000, DEV BRAIN RES, V120, P199
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   INUI H, 1995, BIOSCI BIOTECH BIOCH, V59, P2111, DOI 10.1271/bbb.59.2111
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   LIEBERHERR M, 1973, BIOCHIM BIOPHYS ACTA, V293, P160, DOI 10.1016/0005-2744(73)90387-2
   LOWRY OH, 1954, J BIOL CHEM, V207, P19
   Mazanet MM, 2000, J IMMUNOL, V164, P5383, DOI 10.4049/jimmunol.164.10.5383
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   NISHI N, 1986, INT J BIOL MACROMOL, V8, P311, DOI 10.1016/0141-8130(86)90046-2
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   SAKAGUCHI T, 1981, AGR BIOL CHEM TOKYO, V45, P2191, DOI 10.1080/00021369.1981.10864862
   SRINGA E, 1996, BONE, V16, P663
   Takagi S, 1998, BIOMATERIALS, V19, P1593, DOI 10.1016/S0142-9612(97)00119-1
   THOMAS JW, 2000, BIOMATERIALS, V21, P1803
   Wang XH, 2002, CHINESE J POLYM SCI, V20, P325
   Wang XH, 2002, BIOMATERIALS, V23, P4591, DOI 10.1016/S0142-9612(02)00205-3
   WANG XH, 1999, J FUNC POLYM, V2, P197
   Yokogawa Y, 1997, J MATER SCI-MATER M, V8, P407, DOI 10.1023/A:1018549404092
NR 22
TC 19
Z9 19
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2003
VL 18
IS 2
BP 135
EP 146
DI 10.1177/088391103033857
PG 12
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 694YL
UT WOS:000183802800004
DA 2018-10-19
ER

PT J
AU Lester, EA
   Babensee, JE
AF Lester, EA
   Babensee, JE
TI Proinflammatory phenotype of endothelial cells after coculture with
   biomaterial-treated blood cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 28th Annual Meeting of the Society-for-Biomaterials
CY APR 24-27, 2002
CL TAMPA, FLORIDA
SP Soc Biomat
DE blood; biomaterials; endothelial cells; mononuclear cells; platelets;
   microparticles
ID ADHESIVE PROTEIN EXPRESSION; IN-VITRO; WHOLE-BLOOD; POLYETHYLENE
   TEREPHTHALATE; LEUKOCYTE MICROPARTICLES; PROCOAGULANT ACTIVITIES;
   PLATELET ACTIVATION; CONTACT; MOLECULES; DACRON
AB An understanding of the endothelial cell/blood/biomaterial interactions is central to advancing the success of cardiovascular devices that continue to fail because of the lack of nonthrombogenic biomaterials. A simplified endothelial cell/blood cell/biomaterial static model was used to assess these interactions. Human whole blood or isolated blood cells (mononuclear cells, neutrophils, platelets) were pretreated with biomaterial beads with different surface chemistries: polystyrene (PS), PS beads grafted with 3-kDa polyethylene glycol (PEG) with either hydroxyl (PS-PEG-OH) or amine (PS-PEG-NH2) terminal groups at bead concentrations of 5.4 or 54 x 10(4) beads/mL. Leukocyte and platelet activation and microparticle formation was assessed using flow cytometry. Biomaterial-activated whole blood or isolated cells or mononuclear cell fractions were applied to human umbilical cord endothelial cells (HUVEC) for static coculture, and the resultant proinflammatory HUVEC phenotype was characterized. ICAM-1 and E-selectin expression on HUVEC was increased after 4-h static coculture with biomaterial-treated human whole blood or mononuclear cells but not neutrophils or platelets. VCAM-1 expression on HUVEC was similarly increased after 24-h static coculture but not after 4 h of coculture. Increased concentrations of cytokines, IL-6, IL-8, and MCP-1, were detected in the supernatant of cocultures of HUVEC with biomaterial-treated whole blood or mononuclear cells but not neutrophils or platelets, compared with the media control. After 24 h, cytokine release was significantly increased for both IL-8 and MCP-1 but not IL-6 above concentrations after 4 h of coculture. Neither the cell adhesion molecule (CAM) expression nor cytokine release induced by coculture with biomaterialtreated whole blood or isolated cells was dependent on either material surface chemistry or material surface area. The changes in HUVEC CAM expression and cytokine release induced by biomaterial-treated mononuclear cells can be attributed predominantly to adherent cells on beads and nonadherent bulk cells with moderate regulation by the soluble supernatant; however, mononuclear cell-derived microparticles induced no significant changes in CAM expression or cytokine release after static coculture with HUVEC. (C) 2003 Wiley Periodicals, Inc.
C1 Georgia Inst Technol, Walter H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30322 USA.
   Georgia Inst Technol, Dept Chem Engn, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Walter H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
CR Cenni E, 1996, BIOMATERIALS, V17, P2071, DOI 10.1016/0142-9612(96)00037-3
   CENNI E, 1995, BIOMATERIALS, V16, P1223, DOI 10.1016/0142-9612(95)98128-2
   Cenni E, 1997, BIOMATERIALS, V18, P489, DOI 10.1016/S0142-9612(96)00160-3
   FALCK P, 1995, BIOMATERIALS, V16, P61, DOI 10.1016/0142-9612(95)91097-I
   Gemmell CH, 1996, J BIOMED MATER RES, V32, P29, DOI 10.1002/(SICI)1097-4636(199609)32:1<29::AID-JBM4>3.0.CO;2-R
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P176, DOI 10.1002/(SICI)1097-4636(199711)37:2<176::AID-JBM5>3.3.CO;2-Z
   Gemmell CH, 1998, J BIOMED MATER RES, V42, P611, DOI 10.1002/(SICI)1097-4636(19981215)42:4<611::AID-JBM18>3.0.CO;2-D
   Gorbet MB, 1999, J BIOMED MATER RES, V44, P289, DOI 10.1002/(SICI)1097-4636(19990305)44:3<289::AID-JBM7>3.0.CO;2-O
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Granchi D, 1998, BIOMATERIALS, V19, P93, DOI 10.1016/S0142-9612(97)00161-0
   Guidollet J, 1999, J BIOMED MATER RES, V44, P156, DOI 10.1002/(SICI)1097-4636(199902)44:2<156::AID-JBM5>3.0.CO;2-H
   HERRING M, 1978, SURGERY, V84, P498
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   KO TM, 1993, BIOMATERIALS, V14, P657
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Macnair R, 1998, P I MECH ENG H, V212, P465, DOI 10.1243/0954411981534222
   Mesri C, 1998, J IMMUNOL, V161, P4382
   Mesri M, 1999, J BIOL CHEM, V274, P23111, DOI 10.1074/jbc.274.33.23111
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Remy M, 1999, BIOMATERIALS, V20, P241, DOI 10.1016/S0142-9612(98)00167-7
   SATTA N, 1994, J IMMUNOL, V153, P3245
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
NR 24
TC 7
Z9 8
U1 0
U2 5
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2003
VL 64A
IS 3
BP 397
EP 410
DI 10.1002/jbm.a.10378
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671EY
UT WOS:000182453400001
PM 12870471
DA 2018-10-19
ER

PT J
AU Vehof, JWM
   van den Dolder, J
   de Ruijter, JE
   Spauwen, PHM
   Jansen, JA
AF Vehof, JWM
   van den Dolder, J
   de Ruijter, JE
   Spauwen, PHM
   Jansen, JA
TI Bone formation in CaP-coated and noncoated titanium fiber mesh
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 28th Annual Meeting of the Society-for-Biomaterials
CY APR 24-27, 2002
CL TAMPA, FL
SP Soc Biomat
DE tissue engineering; calcium phosphate coating; porous titanium;
   osteogenesis; bone marrow; cell loading method; culture method
ID MESENCHYMAL STEM-CELLS; RAT ECTOPIC MODEL; MARROW-CELLS; IN-VIVO;
   MORPHOGENETIC PROTEIN-2; BIOMATERIAL CARRIERS; POROUS CERAMICS; AGED
   RATS; CULTURE; CALCIUM
AB The osteogenic activity of calcium phosphate (CaP)-coated and noncoated porous titanium (Ti) fiber mesh loaded with cultured syngeneic osteogenic cells after prolonged in situ culturing was compared in a syngeneic rat ectopic assay model. Rat bone marrow (RBM) cells were loaded onto the CaP-coated and noncoated Ti scaffolds using either a droplet or a suspension loading method. After loading, the RBM cells were cultured for 8 days in vitro. Thereafter, implants were subcutaneously placed in 39 syngeneic rats. The rats were euthanized and the implants retrieved at 2, 4, and 8 weeks postoperatively. Further, in the 8 week group fluorochrome bone markers were injected at 2, 4, and 6 weeks. Histological analysis demonstrated that only the CaP-coated meshes supported bone formation. The amount of newly formed bone varied between single and multiple spheres to filling a significant part of the mesh porosity. In the newly formed bone, osteocytes embedded in a mineralized matrix could be observed clearly. On the other hand, in the noncoated titanium implants, abundant deposition of calcium-containing material was seen. This deposit lacked a bonelike tissue organization. Further analysis revealed that the cell-loading method did not influence the final amount of bone formation. In CaP-coated implants the accumulation sequence of the fluorochrome markers showed that bone formation started on the mesh fibers. In conclusion, our results prove that the combination of a thin CaP coating, Ti-mesh, and RBM cells can indeed generate ectopic bone formation after prolonged in vitro culturing. No effect of the loading method was observed on the final amount of bone. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Nijmegen, Ctr Med, Coll Dent Sci, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Ctr Med, Coll Dent Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.kun.nl
RI Jansen, John/H-8055-2014
CR ARIJI H, 2000, JPN J ORAL BIOL, V42, P49
   BAKSH D, 2000, T 6 WORLD BIOM C KAM, P438
   Bergman RJ, 1996, J BONE MINER RES, V11, P568
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Caplan AI, 1997, PRINCIPLES TISSUE EN, P603
   CONNERTY HV, 1966, AM J CLIN PATHOL, V45, P290
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Dennis J E, 1993, J Oral Implantol, V19, P106
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   EGRISE D, 1992, BONE, V13, P355, DOI 10.1016/8756-3282(92)90451-2
   GOSHIMA J, 1991, BIOMATERIALS, V12, P253, DOI 10.1016/0142-9612(91)90209-S
   Granet C, 1998, MED BIOL ENG COMPUT, V36, P513, DOI 10.1007/BF02523224
   GUNDLE R, 1995, BONE, V16, P597, DOI 10.1016/8756-3282(95)00112-Q
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   Haynesworth SE, 1998, ADV DRUG DELIVER REV, V33, P3, DOI 10.1016/S0169-409X(98)00016-7
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Hulshoff JEG, 1996, J BIOMED MATER RES, V31, P329
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   JANSEN JA, 1992, BIOMATERIALS, V13, P959, DOI 10.1016/0142-9612(92)90121-4
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   KAHN A, 1995, CLIN ORTHOP RELAT R, P69
   KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6
   Kim KJ, 1997, J BIOMED MATER RES, V35, P279, DOI 10.1002/(SICI)1097-4636(19970605)35:3<279::AID-JBM2>3.3.CO;2-S
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Krzymanski G, 1996, TRANSPL P, V28, P3528
   LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LEIS HJ, 1994, CELL CALCIUM, V15, P447, DOI 10.1016/0143-4160(94)90109-0
   LIANG CT, 1992, BONE, V13, P435, DOI 10.1016/8756-3282(92)90087-D
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mendes SC, 1998, J MATER SCI-MATER M, V9, P855, DOI 10.1023/A:1008904413859
   Mizuno M, 1997, BONE, V20, P101, DOI 10.1016/S8756-3282(96)00349-3
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.3.CO;2-N
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   OHGUSHI H, 1990, ACTA ORTHOP SCAND, V61, P431, DOI 10.3109/17453679008993556
   OKUMURA M, 1991, BIOMATERIALS, V12, P411, DOI 10.1016/0142-9612(91)90010-8
   Okumura Motoaki, 1992, Bio-Medical Materials and Engineering, V2, P191
   QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   Takaoka T, 1996, BIOMATERIALS, V17, P1499, DOI 10.1016/0142-9612(96)89774-2
   TERBRUGGE PJ, 2000, UNPUB EFFECT CALCIUM
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
   VEHOF JWM, 2001, IN PRESS TISSUE ENG
   VEHOF JWM, 2000, IN PRESS PLAST RECON
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 55
TC 53
Z9 55
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2003
VL 64A
IS 3
BP 417
EP 426
DI 10.1002/jbm.a.10288
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671EY
UT WOS:000182453400003
PM 12579555
DA 2018-10-19
ER

PT J
AU Lu, HH
   El-Amin, SF
   Scott, KD
   Laurencin, CT
AF Lu, HH
   El-Amin, SF
   Scott, KD
   Laurencin, CT
TI Three-dimensional, bioactive, biodegradable, polymer-bioactive glass
   composite scaffolds with improved mechanical properties support collagen
   synthesis and mineralization of human osteoblast-like cells in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 28th Annual Meeting of the Society-for-Biomaterials
CY APR 24-27, 2002
CL TAMPA, FL
SP Soc Biomat
DE polymer; bioactive glass; composite; bone; tissue engineering;
   osteointegration; bioactivity; biodegradable
ID FIBER-MATRIX INTERFACE; INTERNAL-FIXATION; BONE-TISSUE; ORTHOPEDIC
   APPLICATIONS; RESORBABLE MATERIALS; FRACTURE FIXATION; HYDROXYAPATITE;
   POLY(L-LACTIDE); INVIVO; BIOMATERIALS
AB In the past decade, tissue engineering-based bone grafting has emerged as a viable alternative to biological and synthetic grafts. The biomaterial component is a critical determinant of the ultimate success of the tissue-engineered graft. Because no single existing material possesses all the necessary properties required in an ideal bone graft, our approach has been to develop a three dimensional (3-D), porous composite of polylactide-co-glycolide (PLAGA) and 45S5 bioactive glass (BG) that is biodegradable, bioactive, and suitable as a scaffold for bone tissue engineering (PLAGA-BG composite). The objectives of this study were to examine the mechanical properties of a PLAGA-BG matrix, to evaluate the response of human osteoblast-like cells to the PLAGA-BG composite, and to evaluate the ability of the composite to form a surface calcium phosphate layer in vitro. Structural and mechanical properties of PLAGA-BG were measured, and the formation of a surface calcium phosphate layer was evaluated by surface analysis methods. The growth and differentiation of human osteoblast-like cells on PLAGA-BG were also examined. A hypothesis was that the combination of PLAGA with BG would result in a biocompatible and bioactive composite, capable of supporting osteoblast adhesion, growth and differentiation, with mechanical properties superior to PLAGA alone. The addition of bioactive glass granules to the PLAGA matrix resulted in a structure with higher compressive modulus than PLAGA alone. Moreover, the PLAGA-BA composite was found to be a bioactive material, as it formed surface calcium phosphate deposits in a simulated body fluid (SBF), and in the presence of cells and serum proteins. The composite supported osteoblast-like morphology, stained positively for alkaline phosphatase, and supported higher levels of Type I collagen synthesis than tissue culture polystyrene controls. We have successfully developed a degradable, porous, polymer bioactive glass composite possessing improved mechanical properties and osteointegrative potential compared to degradable polymers of poly(lactic acid-glycolic acid) alone. Future work will focus on the optimization of the composite scaffold for bone tissue-engineering applications and the evaluation of the 3-D composite in an in vivo model. (C) 2003 Wiley Periodicals, Inc.
C1 Drexel Univ, Ctr Adv Biomat & Tissue Engn, Dept Chem Engn, Philadelphia, PA 19104 USA.
   MCP, Hahnemann Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
   Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.
RP Laurencin, CT (reprint author), Drexel Univ, Ctr Adv Biomat & Tissue Engn, Dept Chem Engn, Philadelphia, PA 19104 USA.
EM laurencin@drexel.edu
CR BORDEN MD, IN PRESS BIOMATERIAL
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   DUCHEYNE P, 1987, J BIOMED MATER RES-A, V21, P219
   El-Amin SF, 2002, J ORTHOPAED RES, V20, P20, DOI 10.1016/S0736-0266(01)00062-6
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   ELGHANNAM A, 1998, J BIOMED MATER RES, V40, P48
   Fini M, 1995, INT J ARTIF ORGANS, V18, P772
   GATTI AM, 1994, BIOMATERIALS, V15, P208, DOI 10.1016/0142-9612(94)90069-8
   HABAL MB, 1994, CLIN PLAST SURG, V21, P525
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   KOKUBO T, 1992, BONE BONDING BIOMATE, P31
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P70, DOI 10.1016/0142-9612(87)90034-2
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   Lin FH, 1999, ARTIF ORGANS, V23, P186, DOI 10.1046/j.1525-1594.1999.06164.x
   Lu HH, 2000, J BIOMED MATER RES, V51, P80, DOI 10.1002/(SICI)1097-4636(200007)51:1<80::AID-JBM11>3.0.CO;2-6
   LU HH, 2000, 6 WORLD BIOM C T, V2, P972
   Marcolongo M, 1998, J BIOMED MATER RES, V39, P161, DOI 10.1002/(SICI)1097-4636(199801)39:1<161::AID-JBM18>3.0.CO;2-I
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   MATSUSUE Y, 1992, J BIOMED MATER RES, V26, P1553, DOI 10.1002/jbm.820261203
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   NIEDERAUER GG, 1997, SOC BIOMATER P, V23, P162
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   QIU Q, 2000, 6 WORLD BIOM C T, V2, P938
   Qiu QQ, 2000, J BIOMED MATER RES, V52, P66, DOI 10.1002/1097-4636(200010)52:1<66::AID-JBM9>3.0.CO;2-2
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Slivka MA, 1997, J BIOMED MATER RES, V36, P469
   Slivka MA, 1997, J BIOMED MATER RES, V37, P353
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 37
TC 230
Z9 240
U1 3
U2 78
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2003
VL 64A
IS 3
BP 465
EP 474
DI 10.1002/jbm.a.10399
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671EY
UT WOS:000182453400008
PM 12579560
DA 2018-10-19
ER

PT J
AU Bonnema, H
   Popa, ER
   van Timmeren, MM
   van Wachem, PB
   de Leij, LFMH
   van Luyn, MJA
AF Bonnema, H
   Popa, ER
   van Timmeren, MM
   van Wachem, PB
   de Leij, LFMH
   van Luyn, MJA
TI Distribution patterns of the membrane glycoprotein CD44 during the
   foreign-body reaction to a degradable biomaterial in rats and mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 28th Annual Meeting of the Society-for-Biomaterials
CY APR 24-27, 2002
CL TAMPA, FLORIDA
SP Soc Biomat
DE CD44; foreign-body reaction; macrophage fusion; multinucleated giant
   cell; collagen implant
ID HYALURONAN RECEPTOR CD44; MACROPHAGE MULTINUCLEATION; VARIANT ISOFORMS;
   GIANT-CELLS; IN-VIVO; T-CELL; EXPRESSION; METASTASIS; BREAST; FUSION
AB Although biomaterials have been used in the clinical setting for a long time, little is known of the molecular mechanisms underlying the foreign-body reaction (FBR). A good understanding of these mechanisms is requisite for the controlled regulation of the FBR needed to prevent adverse tissue reactions and thus to improve the function of the biomaterial. Macrophages are essential in the inflammatory reaction in, as well as around, the implants, and they also are believed to initiate most of the adverse responses. Typically, during the FBR macrophages become activated and fuse into multinucleated giant cells (MnGCs). CD44, an integral membrane glycoprotein expressed on a broad spectrum of cell types, is involved in MnGC formation in vitro and in inflammation processes in general. In vivo it is not known whether CD44 is part of a specific protein machinery that enables macrophage fusion or whether it has additional functions in the FBR. In the present in vivo study, CD44 expression patterns were followed in rats and mice during the FBR to a degradable collagen type I biomaterial. We found that CD44 is upregulated on all migrating cells and on newly formed blood vessels at the onset of the FBR and that MnGCs, up to week 15 postimplantation, expressed CD44. Although no evidence was found that CD44 participates in macrophage fusion leading to multinucleation, it nevertheless may be an interesting target molecule for modulating the FBR in vivo, possibly by affecting cell activation, cell migration towards the biomaterial, vascularization, and MnGC formation. (C) 2003 Wiley Periodicals, Inc.
C1 Univ Groningen, Fac Med Sci, Dept Pathol & Lab Med, NL-9713 GZ Groningen, Netherlands.
RP van Luyn, MJA (reprint author), Univ Groningen, Fac Med Sci, Dept Pathol & Lab Med, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
CR Abbondanzo SL, 1999, MODERN PATHOL, V12, P706
   AMERONGEN M, IN PRESS NEOVASCULAR
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ARCH R, 1992, SCIENCE, V257, P682, DOI 10.1126/science.1496383
   Beljaars L, 1999, HEPATOLOGY, V29, P1486, DOI 10.1002/hep.510290526
   BIRCH M, 1991, CANCER RES, V51, P6660
   Borland G, 1998, IMMUNOLOGY, V93, P139
   BRIDGES AJ, 1993, ARCH INTERN MED, V153, P2638, DOI 10.1001/archinte.153.23.2638
   CAO L, 1995, IMMUNOBIOLOGY, V193, P1
   Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697
   DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672
   DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119
   DICKINSON HR, 1981, J BIOMED MATER RES, V15, P577, DOI 10.1002/jbm.820150412
   DIJKSTRA CD, 1993, PROG HISTOCHEM CYTOC, V27, P1
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Falzoni S, 2000, MOL BIOL CELL, V11, P3169, DOI 10.1091/mbc.11.9.3169
   Felszeghy S, 2001, ARCH ORAL BIOL, V46, P939, DOI 10.1016/S0003-9969(01)00053-X
   Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189
   Goodison S, 1998, HISTOPATHOLOGY, V32, P1
   Griffioen AW, 1997, BLOOD, V90, P1150
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   KENNEL SJ, 1993, J CELL SCI, V104, P373
   Khaldoyanidi S, 1997, BRIT J HAEMATOL, V96, P31, DOI 10.1111/j.1365-2141.1997.tb00001.x
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Kinoshita J, 1999, BREAST CANCER RES TR, V53, P177, DOI 10.1023/A:1006130601575
   Koopman G, 1998, BIOCHEM BIOPH RES CO, V245, P172, DOI 10.1006/bbrc.1998.8295
   KRAAL G, 1987, SCAND J IMMUNOL, V26, P653, DOI 10.1111/j.1365-3083.1987.tb02301.x
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   Mikecz K, 1999, ARTHRITIS RHEUM, V42, P659, DOI 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z
   Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3
   Pol BJM, 1996, J BIOMED MATER RES, V32, P307
   Pure E, 2001, TRENDS MOL MED, V7, P213, DOI 10.1016/S1471-4914(01)01963-3
   Saginario C, 1995, P NATL ACAD SCI USA, V92, P12210, DOI 10.1073/pnas.92.26.12210
   Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213
   Seiter S, 1996, CLIN CANCER RES, V2, P447
   Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837
   TEDER P, 1995, CANCER RES, V55, P3908
   VANLUYN MJA, 1994, J MATER SCI-MATER M, V5, P671, DOI 10.1007/BF00120354
   VANWACHEM PB, 1994, J MATER SCI-MATER M, V5, P628, DOI 10.1007/BF00120344
   Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x
   VIGNERY A, 1989, AM J PATHOL, V135, P565
   Yakushijin Y, 1998, BLOOD, V91, P4282
NR 42
TC 12
Z9 12
U1 0
U2 4
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 1
PY 2003
VL 64A
IS 3
BP 502
EP 508
DI 10.1002/jbm.a.10404
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 671EY
UT WOS:000182453400012
PM 12579564
DA 2018-10-19
ER

PT J
AU Simionescu, DT
   Lovekamp, JJ
   Vyavahare, NR
AF Simionescu, DT
   Lovekamp, JJ
   Vyavahare, NR
TI Glycosaminoglycan-degrading enzymes in porcine aortic heart valves:
   Implications for bioprosthetic heart valve degeneration
SO JOURNAL OF HEART VALVE DISEASE
LA English
DT Article
ID CALCIFICATION; HYALURONAN; COLLAGEN; BIOMATERIAL; PREVENTION
AB Background and aim of the study: Glutaraldehyde (GA)-fixed aortic valves used in heart valve replacement surgery have limited durability due to tissue degeneration and calcification. Despite their structural and functional importance, very little is known about the fate of glycosaminoglycans (GAGs) within the extracellular matrix of bioprosthetic heart valves. The study aim was to investigate the stability of GAGs in GA-fixed tissues and to identify enzymatic mechanisms that may be responsible for GAG degeneration.
   Methods: Porcine aortic valve cusps were fixed with GA and implanted subdermally in rats for 21 days. Fresh, fixed and explanted cusps were analyzed for GAG content by hexosamine determination, and GAG-degrading enzyme activity was evaluated using zymography. GAG classes in fresh cusps were also assessed by flurorophore-assisted carbohydrate electrophoresis. Fresh and GA-fixed cusps were also exposed in vitro to hyaluronidase and chondroitinase in order to test the susceptibility of cusp GAGs towards enzymatic degradation.
   Results: Native aortic cusps contained similar to3.5% GAGs by dry weight, consisting of hyaluronic acid, chondroitin sulfate and dermatan sulfate. Significantly lower GAG levels were found in aortic cusps after fixation with. GA, and even lower levels were found after subdermal implantation in rats. GAG levels in GA-fixed cusps were also significantly reduced by in-vitro incubation with hyaluronidase and chondroitinase. Novel GAG-degrading enzymes were detected in considerable levels in native cusps, in lower levels in GA-fixed cusps and significantly increased levels after subdermal implantation of GA-fixed cusps.
   Conclusion: The combined action of active GAG-degrading enzymes and the failure of GA to stabilize GAGs towards enzymatic digestion may contribute significantly to bioprosthetic heart valve degeneration and subsequent structural failure.
C1 Clemson Univ, Cardiovasc Implant Res Lab, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
RP Vyavahare, NR (reprint author), Clemson Univ, Cardiovasc Implant Res Lab, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
FU NHLBI NIH HHS [HL 61652]
CR BAIG MM, 1979, AM J PATHOL, V96, P771
   BAIG MM, 1978, CIRC RES, V42, P271, DOI 10.1161/01.RES.42.2.271
   BLIX G, 1948, ACTA CHEM SCAND, V2, P467, DOI 10.3891/acta.chem.scand.02-0467
   Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273
   CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033
   Grande-Allen KJ, 2001, J HEART VALVE DIS, V10, P325
   Hascall VC, 1981, CELL BIOL EXTRACELLU, P39
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   KANKE Y, 1971, BIOCHEM J, V124, P207, DOI 10.1042/bj1240207
   LAURENT TC, 1992, FASEB J, V6, P2397
   Lovekamp J, 2001, J BIOMED MATER RES, V56, P478, DOI 10.1002/1097-4636(20010915)56:4<478::AID-JBM1119>3.0.CO;2-C
   MAKO WJ, 1997, CIRCULATION, V155, P863
   Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5
   MIURA RO, 1995, ANAL BIOCHEM, V225, P333, DOI 10.1006/abio.1995.1163
   MORETTI A, 1963, BIOCHEM J, V87, P396, DOI 10.1042/bj0870396
   MORI Y, 1982, GLYCOSAMINOGLYCANS P, P187
   MURATA K, 1981, J MOL CELL CARDIOL, V13, P281, DOI 10.1016/0022-2828(81)90316-3
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   RAJA RH, 1984, ANAL BIOCHEM, V139, P168, DOI 10.1016/0003-2697(84)90402-0
   Schoen FJ, 1999, J HEART VALVE DIS, V8, P350
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SCOTT JE, 1985, BIOSCIENCE REP, V5, P71, DOI 10.1007/BF01117443
   Simionescu A, 1996, ASAIO J, V42, pM561, DOI 10.1097/00002480-199609000-00049
   SIMIONESCU D, 2003, J HEART VALVE DIS, V12, P225
   Stair-Nawy S, 1999, BIOCHEM BIOPH RES CO, V266, P268, DOI 10.1006/bbrc.1999.1802
   STRATES B, 1989, COLLAGEN 1989, V3, P274
   TALMAN EA, 1995, ANN THORAC SURG, V60, pS369, DOI 10.1016/0003-4975(95)00250-O
   TORII S, 1965, BIOCHIM BIOPHYS ACTA, V101, P285, DOI 10.1016/0926-6534(65)90007-2
   Vyavahare N, 1999, J BIOMED MATER RES, V46, P44
   Vyavahare N, 2000, AM J PATHOL, V157, P885, DOI 10.1016/S0002-9440(10)64602-0
   Vyavahare NR, 2000, J HEART VALVE DIS, V9, P561
   Vyavahare NR, 1998, J BIOMED MATER RES, V40, P577, DOI 10.1002/(SICI)1097-4636(19980615)40:4<577::AID-JBM9>3.3.CO;2-B
NR 32
TC 42
Z9 42
U1 0
U2 5
PU I C R PUBLISHERS
PI NORTHWOOD
PA CRISPIN HOUSE, 12/A SOUTH APPROACH, MOOR PARK, NORTHWOOD HA6 2ET,
   ENGLAND
SN 0966-8519
J9 J HEART VALVE DIS
JI J. Heart Valve Dis.
PD MAR
PY 2003
VL 12
IS 2
BP 217
EP 225
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 659AA
UT WOS:000181752900017
PM 12701795
DA 2018-10-19
ER

PT J
AU Kwon, OH
   Nho, YC
   Lee, YM
AF Kwon, OH
   Nho, YC
   Lee, YM
TI Radiation-induced copolymerization of 2-hydroxyethyl methacrylate and
   polyethylene glycol methacrylate, and its protein adsorption and
   bacterial attachment
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE radiation-induced copolymerization; 2-hydroxyethyl methacrylate;
   polyethylene glycol methacrylate; hydrogel; protein adsorption;
   bacterial attachment; biomaterial
ID BLOOD COMPATIBILITY
AB In an attempt to produce biomaterial that shows the low levels of adsorption of proteins and adhesion of bacteria, 2-hydroxyethyl methacrylate(HEMA) and polyethylene glycol methacrylate(PEG-MA) co-monomers with ethylene dimethacrylate(EDMA) crosslinker were co-polymerized by using a gamma-ray radiation technique. PEG-MA having a different molecular weight of polyethylene oxide was used for synthesizing copolymeric hydrogels for contact lenses. The degree of polymerization and water content of the hydrogels were examined. The protein adsorption on the hydrogel surfaces was investigated by electron spectroscopy for chemical analysis (ESCA). Bacterial attachments were evaluated by examining the adhesion on hydrogel surfaces by microscope and a viable cell counting method against Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aeruginosa). The amount of adsorption of protein and adhesion of bacteria on sample surface decreased significantly in the copolymer specimen of HEMA and PEG-MA, when comparing with the hydrogel of polyHEMA alone.
C1 Korea Atom Energy Res Inst, Radiat Applicat Div, Taejon 305600, South Korea.
   Hanyang Univ, Coll Engn, Dept Ind Chem, Seoul 133791, South Korea.
RP Nho, YC (reprint author), Korea Atom Energy Res Inst, Radiat Applicat Div, Taejon 305600, South Korea.
RI Lee, Young Moo/G-5920-2015
OI Lee, Young Moo/0000-0002-5047-3143
CR BERSCHT PC, 1995, J MATER SCI-MATER M, V6, P201, DOI 10.1007/BF00146856
   BRAATZ JA, 1991, Patent No. 5039458
   DEICHERT WG, 1990, Patent No. 4943150
   DRAKE NJ, 1984, Patent No. 4450262
   GATTI AM, 1994, J MATER SCI-MATER M, V5, P190, DOI 10.1007/BF00121087
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HOFFMAN AS, 1987, IAEATECDOC486, P25
   HOFFMAN AS, 1999, J RADIOANAL NUCL CHE, V240, P943
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   KIM CH, 1995, J KOREA IND ENG CHEM, V6, P267
   KIM CH, 1995, J KOREA IND ENG CHEM, V6, P464
   Kwon OH, 1999, J APPL POLYM SCI, V71, P631, DOI 10.1002/(SICI)1097-4628(19990124)71:4<631::AID-APP15>3.0.CO;2-G
   Lee CS, 1997, MET MATER-KOREA, V3, P51, DOI 10.1007/BF03026106
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lee SD, 1996, BIOMATERIALS, V17, P587, DOI 10.1016/0142-9612(96)88709-6
   LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381
   Merrill EW, 1983, AM SOC ARTIF INTERN, V6, P60
   Merritt K, 1998, J BIOMED MATER RES, V39, P415, DOI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9
   Park JS, 1998, J APPL POLYM SCI, V69, P2213, DOI 10.1002/(SICI)1097-4628(19980912)69:11<2213::AID-APP13>3.0.CO;2-#
NR 19
TC 6
Z9 8
U1 0
U2 4
PU KOREAN SOC INDUSTRIAL ENGINEERING CHEMISTRY
PI SEOUL
PA A-803 TWIN BLDG, 275-3, YANGJAE-DONG, SEOCHO-KU, SEOUL 137-130, SOUTH
   KOREA
SN 1226-086X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD MAR
PY 2003
VL 9
IS 2
BP 138
EP 145
PG 8
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 660ZM
UT WOS:000181866100005
DA 2018-10-19
ER

PT J
AU Daculsi, G
   Laboux, O
   Malard, O
   Weiss, P
AF Daculsi, G
   Laboux, O
   Malard, O
   Weiss, P
TI Current state of the art of biphasic calcium phosphate bioceramics
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE; IMPLANTS; CERAMICS; ELECTRON
AB We have developed 15 years ago, with the collaboration of Lynch, Nery, and LeGeros in the USA, a bioactive concept based on biphasic calcium phosphate (BCP) ceramics. The concept is determined by an optimum balance of the more stable phase of HA and more soluble TCP. The material is soluble and gradually dissolves in the body, seeding new bone formation as it releases calcium and phosphate ions into the biological medium.
   The bioactive concept based on the dissolution/transformation processes of HA and TCP has been applied to both Bulk, Coating and Injectable Biomaterials. The events at the calcium phosphate (CaP) biomaterial/bone interface represent a dynamic process, including physicochemical processes, crystal/proteins interactions, cells and tissue colonization, bone remodeling, finally contributing to the unique strength of such interfaces. An important literature and numerous techniques have been used for the evaluation of the fundamental physico chemical and biological performance of BCP concept. This type of artificial bone used from a long time in preclinical and in clinical trial, revealed the efficiency for bone filling, performance for bone reconstruction and efficacy for bone ingrowth at the expense of the micro macroporous BCP bioceramics. (C) 2003 Kluwer Academic Publishers.
C1 Fac Chirurg Dent, Ctr Rech Mat Interet Biol, INSERM E 99 03, F-44042 Nantes 01, France.
RP Daculsi, G (reprint author), Fac Chirurg Dent, Ctr Rech Mat Interet Biol, INSERM E 99 03, 1 Pl Alexis Ricordeau, F-44042 Nantes 01, France.
RI Weiss, Pierre/P-1372-2014; LABOUX, OLIVIER/A-8270-2015; Daculsi,
   Guy/P-1320-2014; Malard, Olivier/A-4742-2012
OI Weiss, Pierre/0000-0002-6159-8590; Daculsi, Guy/0000-0003-1030-3446; 
CR Albee FH, 1920, ANN SURG, V71, P32
   BHASKAR SN, 1971, ORAL SURG ORAL MED O, V32, P336, DOI 10.1016/0030-4220(71)90238-6
   BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DACULSI G, 1989, CALCIFIED TISSUE INT, V45, P95, DOI 10.1007/BF02561408
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Daculsi G, 1999, BONE, V25, P59
   DACULSI G, 1994, Patent No. 9401414
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P100
   DUCHEYNE P, 1993, INTRO BIOCERAMICS, P281
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   LeGeros R. Z., 1995, ENCY HDB BIOMATERI A, V2, P1429
   LEGEROS RZ, 1990, HDB BIOACTIVE CERAMI, P2
   MALARD O, 2002, IN PRESS P EMBEC 02
   Millot F., 1999, Cells and Materials, V9, P21
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 26
TC 294
Z9 303
U1 1
U2 31
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2003
VL 14
IS 3
BP 195
EP 200
DI 10.1023/A:1022842404495
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 658YQ
UT WOS:000181749000001
PM 15348464
DA 2018-10-19
ER

PT J
AU Legeros, RZ
   Lin, S
   Rohanizadeh, R
   Mijares, D
   Legeros, JP
AF Legeros, RZ
   Lin, S
   Rohanizadeh, R
   Mijares, D
   Legeros, JP
TI Biphasic calcium phosphate bioceramics: preparation, properties and
   applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PERIODONTAL OSSEOUS DEFECTS; IN-VITRO; OSTEOCLASTIC RESORPTION; APATITE
   PRECIPITATION; SYNTHESIS PARAMETERS; BONE SUBSTITUTE; HA/BETA-TCP;
   STEM-CELLS; CERAMICS; HYDROXYAPATITE
AB Biphasic calcium phosphate (BCP) bioceramics belong to a group of bone substitute biomaterials that consist of an intimate mixture of hydroxyapatite (HA), Ca-10(PO4)(6)(OH)(2), and beta-tricalcium phosphate (beta-TCP), Ca-3(PO4)(2), of varying HA/beta-TCP ratios. BCP is obtained when a synthetic or biologic calcium-deficient apatite is sintered at temperatures at and above 700degreesC. Calcium deficiency depends on the method of preparation (precipitation, hydrolysis or mechanical mixture) including reaction pH and temperature. The HA/beta-TCP ratio is determined by the calcium deficiency of the unsintered apatite (the higher the deficiency, the lower the ratio) and the sintering temperature.
   Properties of BCP bioceramics relating to their medical applications include: macroporosity, microporosity, compressive strength, bioreactivity (associated with formation of carbonate hydroxyapatite on ceramic surfaces in vitro and in vivo), dissolution, and osteoconductivity. Due to the preferential dissolution of the beta-TCP component, the bioreactivity is inversely proportional to the HA/beta-TCP ratio. Hence, the bioreactivity of BCP bioceramics can be controled by manipulating the composition (HA/beta-TCP ratio) and/or the crystallinity of the BCP.
   Currently, BCP bioceramics is recommended for use as an alternative or additive to autogeneous bone for orthopedic and dental applications. It is available in the form of particulates, blocks, customized designs for specific applications and as an injectible biomaterial in a polymer carrier. BCP ceramic can be used also as grit-blasting abrasive for grit-blasting to modify implant substrate surfaces. Exploratory studies demonstrate the potential uses of BCP ceramic as scaffold for tissue engineering, drug delivery system and carrier of growth factors. (C) 2003 Kluwer Academic Publishers.
C1 NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
RP Legeros, RZ (reprint author), NYU, Coll Dent, Dept Biomat & Biomimet, 345 E 24th St, New York, NY 10010 USA.
RI Rohanizadeh, Ramin/J-5719-2016
OI Rohanizadeh, Ramin/0000-0002-7967-5515
CR ALAM MI, 2000, J BIOMED MATER RES, V54, P129
   Albee FH, 1920, ANN SURG, V71, P32
   Aoki H, 1975, CERAMICS, V10, P469
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   Benahmed M, 1996, BIOMATERIALS, V17, P2173, DOI 10.1016/0142-9612(96)00046-4
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247
   Chang YL, 2000, J BIOMED MATER RES, V52, P270, DOI 10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   DACULSI G, 1990, SCANNING MICROSCOPY, V4, P309
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DACULSI G, 1994, Patent No. 9401414
   DACULSI G, 2001, 14 EUR C BIOM LOND U
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DENISSEN H, 1979, THESIS VRIJE U AMSTE
   DRIESSEN AA, 1982, BIOMATERIALS, V3, P113
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   ELLINGER RF, 1986, INT J PERIODONT REST, V3, P223
   FAN D, 1995, J DENT RES, V74, P525
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Gautier H, 1998, J BIOMED MATER RES, V40, P606, DOI 10.1002/(SICI)1097-4636(19980615)40:4<606::AID-JBM12>3.0.CO;2-D
   GOUIN F, 1995, REV CHIR ORTHOP, V81, P59
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, V256, P256
   HENCH LL, 1993, AM CERAM SOC BULL, V72, P93
   HEUGHEBAERT M, 1988, J BIOMED MATER RES-A, V22, P257, DOI 10.1002/jbm.820221406
   Hubbard W, 1974, THESIS MARQUETTE U M
   Ishikawa I, 1995, INT J PERIODONT REST, V15, P204
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LeGeros R. Z., 1991, MONOGRAPH ORAL SCI, V15
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   LEGEROS RZ, 1994, AM SOC TEST MATER, V1196, P43, DOI 10.1520/STP25182S
   LEGEROS RZ, 1989, SCANNING MICROSCOPY, V3, P129
   LEGEROS RZ, 1991, BONE-BIOMATERIAL INTERFACE, P76
   LEGEROS RZ, 1983, SCAN ELECTRON MICROS, P407
   LEGEROS RZ, 1986, J DENT RES, V65, P292
   LeGeros RZ, 1996, ADV DENT RES, V10, P252
   LEGEROS RZ, 1990, CRC HDB BIOACTIVE CE, P17
   LeGeros RZ, 1971, ADV XRAY ANALYSIS, V14, P57
   LEGEROS RZ, 1988, 3 WORLD BIOM C
   LEGEROS RZ, IN PRESS CLIN ORTHOP
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   NERY EB, 1990, J PERIODONTOL, V61, P737, DOI 10.1902/jop.1990.61.12.737
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   Ransford AO, 1998, J BONE JOINT SURG BR, V80B, P13, DOI 10.1302/0301-620X.80B1.7276
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP, P432
   RAVAGNA R, 1999, J LONGTERM EFFECTS M, V9, P403
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.3.CO;2-Y
   Rohanizadeh R, 1999, CALCIFIED TISSUE INT, V64, P430, DOI 10.1007/PL00005825
   SALGADO T, 1998, BIOCERAMICS, V11, P683
   SCHMITT M, 2000, THESIS U NANTES NANT
   Soares EJC, 1998, BIOCERAMICS, P633
   SOUEIDAN A, 1995, CELL MATER, V5, P31
   SUZUKI K, 1998, BIOCERAMICS, V11, P629
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   TRECANT M, 1994, CLIN MATER, V15, P233, DOI 10.1016/0267-6605(94)90051-5
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Weiss P, 1997, J MATER SCI-MATER M, V8, P621, DOI 10.1023/A:1018519419539
   WENG HT, 1991, DENT JPN, V28, P155
   WYKROTA LL, 1998, BIOCERAMICS, V11, P641
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
NR 76
TC 473
Z9 495
U1 12
U2 208
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2003
VL 14
IS 3
BP 201
EP 209
DI 10.1023/A:1022872421333
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 658YQ
UT WOS:000181749000002
PM 15348465
DA 2018-10-19
ER

PT J
AU Otto, M
   Wahn, B
   Kirkpatrick, CJ
AF Otto, M
   Wahn, B
   Kirkpatrick, CJ
TI Modification of human polymorphonuclear neutrophilic cell (PMN)-adhesion
   on biomaterial surfaces by protein preadsorption under static and flow
   conditions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PLATELET-ADHESION; GRADIENT SURFACES; IMPLANT MATERIALS; LEUKOCYTES;
   ACTIVATION; SHEAR; THROMBOSIS; ADSORPTION; CHEMISTRY; RHEOLOGY
AB Biomaterials induce a specific reaction after implantation in the human body. This reaction depends on the chemical and physico-chemical properties of the material as well as on the site and type of implantation. We have used a dynamic model, the parallel-plate flow-chamber, to examine the interactions of different biomaterials with polymorphonuclear neutrophilic cell (PMN) and how these interactions are influenced by protein preadsorption. Our results clearly show that for hydrophobic materials, glass and PE, which induce a prominent adhesion of PMN, the mixture of albumin and fibrinogen induces the best inhibitory effect. On hydrophilic biomaterial surfaces, untreated TCPS and PC-coated TCPS, reveal only a minor influence of adsorbed proteins on PMN adhesion because of a primary low adhesive surface for PMN and proteins as well. Human citrated plasma leads only to a slight inhibition of PMN adhesion. On the hydrophobic materials, glass and PE, bovine serum albumin (BSA) had the best anti-adhesive potential with respect to PMN. The coating using phosphorylcholine is an excellent surface modification to prevent PMN-adhesion and protein adsorption. The results of our experiments suggest that investigations under static and flow conditions are also needed to determine the influence of protein adsorption on other relevant blood cell populations, for example, platelets and monocytes. (C) 2003 Kluwer Academic Publishers.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RP Otto, M (reprint author), Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
EM otto@patho-trier.de
CR [Anonymous], 1997, 109931 ISO
   [Anonymous], 1992, 109934 ISO
   Bos JC, 1997, NEPHROL DIAL TRANSPL, V12, P1387, DOI 10.1093/ndt/12.7.1387
   Cadroy Y, 2000, J IMMUNOL, V164, P3822, DOI 10.4049/jimmunol.164.7.3822
   CAMPBELL EJ, 1994, ASAIO J, V40, P853
   DEKKER A, 1990, MODERN ASPECTS PROTE
   Eddy RJ, 2000, J CELL SCI, V113, P1287
   GALLIK S, 1989, BIORHEOLOGY, V26, P823
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   INTERNATIONAL ORGANIZATION FOR STANDARDIZATION-ISO, 1992, 109933 ISO
   ISO 10993-5, 1999, 109935 ISO
   KATZ DA, 1994, SURGERY, V116, P454
   Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Lee JH, 1998, J BIOMED MATER RES, V40, P180, DOI 10.1002/(SICI)1097-4636(199805)40:2<180::AID-JBM2>3.0.CO;2-H
   LoPresti R, 2000, HAEMOSTASIS, V30, P168
   Montdargent B, 2000, INFECT CONT HOSP EP, V21, P404, DOI 10.1086/501782
   Moore MA, 2001, J BIOMED MATER RES, V55, P257, DOI 10.1002/1097-4636(20010605)55:3<257::AID-JBM1013>3.0.CO;2-H
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   Nose Y, 1998, ARTIF ORGANS, V22, P1003, DOI 10.1046/j.1525-1594.1998.00746.x
   Nussler AK, 1999, LANGENBECK ARCH SURG, V384, P222, DOI 10.1007/s004230050196
   Otto M, 1997, J MATER SCI-MATER M, V8, P119, DOI 10.1023/A:1018515001850
   OTTO M, 2001, IN PRESS PATHOBIOLOG
   OTTO M, 1996, 5 WORLD BIONM C C P, V1, P705
   Polanowska-Grabowska R, 1999, THROMB HAEMOSTASIS, V81, P118
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   SPARGO BJ, 1994, BIOMATERIALS, V15, P853, DOI 10.1016/0142-9612(94)90042-6
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   THOMPSON HL, 1992, CLIN EXP IMMUNOL, V90, P280
   VANDAMME HS, 1990, MODERN ASPECTS PROTE
   WAKABAYASHI Y, 1995, BBA-GEN SUBJECTS, V1243, P521, DOI 10.1016/0304-4165(94)00186-2
   Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067
NR 32
TC 13
Z9 13
U1 0
U2 7
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2003
VL 14
IS 3
BP 263
EP 270
DI 10.1023/A:1022840909038
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 658YQ
UT WOS:000181749000010
PM 15348473
DA 2018-10-19
ER

PT J
AU Di Carmine, M
   Toto, P
   Feliciani, C
   Scarano, A
   Tulli, A
   Strocchi, R
   Piattelli, A
AF Di Carmine, M
   Toto, P
   Feliciani, C
   Scarano, A
   Tulli, A
   Strocchi, R
   Piattelli, A
TI Spreading of epithelial cells on machined and sandblasted titanium
   surfaces: An in vitro study
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE cells; epithelial/growth and development; dental implants; keratinocytes
ID BIOLOGICAL PROPERTIES; PROTEIN ADSORPTION; SOLUBLE LAMININ-5; DENTAL
   IMPLANTS; ORAL IMPLANTS; ATTACHMENT; ROUGHNESS; ORIENTATION;
   FIBRONECTIN; BIOMATERIAL
AB Background: The purpose of this investigation was to determine the influence of the surface structure of dental implants on epithelial cell spreading and growth in vitro. Cell morphology on machined and sandblasted titanium surfaces was investigated.
   Methods: A total of 10 machined and 10 sandblasted discs and 10 glass coverslips were used for the present study. Samples were analyzed using scanning electron microscopy (SEM) and the cell spreading area was determined using a video image analysis system.
   Results: After 24 hours incubation, keratinocytes grown on sandblasted titanium samples displayed numerous, long, and branched or dendritic filopodia closely adapted to the surface roughness. Filopodia varied from 3 to 12 mum in length and 0.1 to 0.3 mum in width. Cells cultured on a machined surface did not present such cytoplasmic extensions and displayed a round morphology. Keratinocytes seeded on glass coverslips were flat and edged by filopodia (maximum length 7 to 8 mum) on the spreading site of the cluster. Though cell morphology is comparable with that observed on sandblasted specimens, cytoplasmic extensions suggestive of strong adhesion and spreading attitude were less pronounced.
   Conclusion: These results indicate that sandblasted surfaces are the optimal substrata for epithelial cell adhesion and spreading.
C1 Univ G DAnnunzio, Sch Dent, Chieti, Italy.
   Univ G DAnnunzio, Sch Med, Dept Dermatol, Chieti, Italy.
RP Piattelli, A (reprint author), Via F Sciucchi 63, I-66100 Chieti, Italy.
EM apiattelli@unich.it
RI Scarano, Antonio/F-6961-2017
OI Scarano, Antonio/0000-0003-1374-6146; feliciani,
   claudio/0000-0003-0883-3210
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   Are A, 2001, CELL MOTIL CYTOSKEL, V48, P24, DOI 10.1002/1097-0169(200101)48:1<24::AID-CM3>3.0.CO;2-9
   Baier R E, 1986, J Oral Implantol, V12, P389
   Baier R. E., 1970, ADHESION BIOL SYSTEM, P15
   Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325
   Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985
   Branemark PI, 1985, TISSUE INTEGRATED PR, p[11, 253]
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BRUNETTE D M, 1986, Critical Reviews in Biocompatibility, V1, P323
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   Cochran David, 1994, Int J Oral Maxillofac Implants, V9, P289
   Cordioli G, 2000, INT J ORAL MAX IMPL, V15, P668
   Dean J W 3rd, 1995, Int J Oral Maxillofac Implants, V10, P721
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R
   ENENSTEIN J, 1988, J INVEST DERMATOL, V91, P34, DOI 10.1111/1523-1747.ep12463285
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   GORELIK JV, 1995, CELL BIOL INT, V19, P59, DOI 10.1006/cbir.1995.1008
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   Heydenrijk K, 2002, INT J ORAL MAX IMPL, V17, P829
   HORMIA M, 1991, J PERIODONTAL RES, V26, P491, DOI 10.1111/j.1600-0765.1991.tb01800.x
   Kasemo B, 1988, Int J Oral Maxillofac Implants, V3, P247
   Kasten FH, 1990, INT J PERIODONT REST, V10, P69
   Kawahara H, 1998, INT J ORAL MAX IMPL, V13, P457
   Lagneau C, 1998, BIOMATERIALS, V19, P1109, DOI 10.1016/S0142-9612(98)00041-6
   Lowell S, 2001, MECH DEVELOP, V107, P133, DOI 10.1016/S0925-4773(01)00459-2
   MALMSTROM HS, 1990, J PERIODONTOL, V61, P300, DOI 10.1902/jop.1990.61.5.300
   McAlarney M E, 1993, N Y State Dent J, V59, P45
   MERRITT K, 1984, BIOMATERIALS, V5, P47, DOI 10.1016/0142-9612(84)90066-8
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   Natiella J R, 1974, Oral Sci Rev, V5, P85
   OHARA PT, 1979, EXP CELL RES, V121, P235, DOI 10.1016/0014-4827(79)90002-8
   Park JC, 1998, INT J ORAL MAX IMPL, V13, P826
   Piattelli A, 1999, INT J ORAL MAX IMPL, V14, P233
   Piattelli A, 1998, INT J ORAL MAX IMPL, V13, P805
   Pins GD, 2000, FASEB J, V14, P593
   Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147
   Raisanen L, 2000, J BIOMED MATER RES, V49, P79
   SCHLUGER S, 1990, PERIODONTAL DIS, P207
   Silva R., 1990, British Corrosion Journal, V25, P136
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Toto P, 2000, J IMMUNOL, V164, P522, DOI 10.4049/jimmunol.164.1.522
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   WEISS L, 1978, INT DENT J, V28, P7
   Wieland M, 2002, J BIOMED MATER RES, V60, P434, DOI 10.1002/jbm.10059
NR 50
TC 18
Z9 18
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD MAR
PY 2003
VL 74
IS 3
BP 289
EP 295
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 754KC
UT WOS:000187314600002
PM 12710747
DA 2018-10-19
ER

PT J
AU Bahar, H
   Yaffe, A
   Binderman, I
AF Bahar, H
   Yaffe, A
   Binderman, I
TI The influence of nacre surface and its modification on bone apposition:
   A bone development model on rats
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE animal studies; bone; deminerallized; bone marrow; bone regeneration;
   bone substitutes; nacre/therapeutic use
ID OSTEOBLASTS MAINTAINED INVITRO; GRAFT SUBSTITUTES; CALCIUM-CARBONATE;
   CELLS; PHASE
AB Background: Bone graft substitutes are currently used individually or in various combinations in reconstructing bone defects. Nacre, marine mineralized structure, was recently proposed as a very biocompatible and osteoinductive material for use in periodontal and implant surgery. Our aim was to investigate the interaction between natural nacre and fresh bone marrow, during bone development, in an ectopic site of DA rats. Surface modifications of nacre were tested.
   Methods: Demineralized bone matrix (DBM) cylinders (demineralized cortex of diaphysis) prepared from rat femurs were filled with fresh marrow, which was removed from other 2-month old DA rat femurs. Natural nacre particle or nacre which was treated with HCl, phosphate buffer saline (PBS), and Ca(OH)(2) to modify its surface was placed into the DBM cylinders. The cylinders were implanted subcutaneously at the thoracic region of growing DA rats. After 4 weeks the cylinders were surgically removed, fixed in buffered formalin, and x-rayed. Scans of the microradiographs and histological evaluation of the DBM cylinders including bone developed at the interface of nacre and its surface modifications were compared to marrow controls.
   Results: The results show that natural nacre is a poor conductive biomaterial in a bone developmental environment. Nacre surface treated with Ca(OH)(2) and PBS was found to be most biocompatible. In this group, new bone was apposed directly on the nacre surface and the total amount of bone was highest in comparison to other treatment groups.
   Conclusions: This study does not support previous observations that nacre is osseoinductive. Our model system seems to be very sensitive and capable of testing interaction between surface modifications of biomaterials and fresh marrow in the process of new bone development.
C1 Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel.
   Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Prosthodont, Jerusalem, Israel.
RP Binderman, I (reprint author), Tel Aviv Univ, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel.
CR Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   CONNOLLY J, 1989, J BONE JOINT SURG AM, V71A, P684, DOI 10.2106/00004623-198971050-00007
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   Goldberg VM, 2000, CLIN ORTHOP RELAT R, P68
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HANEIN D, 1994, SCIENCE, V263, P1413, DOI 10.1126/science.8128221
   IRVING JT, 1981, CLIN ORTHOP RELAT R, P249
   Lamghari M, 1999, BONE, V25, p91S, DOI 10.1016/S8756-3282(99)00141-6
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   LOPEZ E, 1995, INT S BIOM MON 1993, P49
   NIMNI ME, 1988, CLIN ORTHOP RELAT R, P255
   OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705
   OHGUSHI H, 1991, BIOCERAMICS, V14, P213
   Perry CR, 1999, CLIN ORTHOP RELAT R, P71
   Sarikaya M., 1992, Results and Problems in Cell Differentiation, V19, P1
   SAUTIER JM, 1992, BIOMATERIALS, V13, P400, DOI 10.1016/0142-9612(92)90046-Q
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Tavassoli M, 1984, Kroc Found Ser, V18, P31
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   VASILIEV JM, 1981, DEV CELL BIOL SERIES, V8, P19
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   Yaffe A, 1997, J PERIODONTOL, V68, P884, DOI 10.1902/jop.1997.68.9.884
NR 25
TC 13
Z9 13
U1 0
U2 1
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAR
PY 2003
VL 74
IS 3
BP 366
EP 371
DI 10.1902/jop.2003.74.3.366
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 754KC
UT WOS:000187314600012
PM 12710757
DA 2018-10-19
ER

PT J
AU Peterkova, P
   Lapcik, L
AF Peterkova, P
   Lapcik, L
TI Attachment of collagen type I to polypropylene
SO JOURNAL OF POLYMER MATERIALS
LA English
DT Article
DE Atelocollagen I; polypropylene; RF plasma; adhesive joint; contact
   angle; peel strength
AB Air RF-plasma treatment followed by collagen type I attachment was applied for polypropylene surface modification. A new biomaterial suitable for cell attachment and growth was prepared. Treated polypropylene surfaces were characterized by EPR, sessile drop contact angles, FT IR and SEM methods. Three modes of collagen chemical modification were used for coating preparation: non-modified, periodate oxidized and glutaraldehyde crosslinked gel. Collagen was deposited on two types of the substrate surfaces: air RF-plasma treated one, and ammonia post-treated air RF-plasma preparation. Peeling strengths of the interfacial joints polypropylene/collagen were determined. They were ranging between 40 to 50 N/m.
C1 Tomas Bata Univ Zlin, Fac Technol, Inst Phys & Mat Engn, CZ-76272 Zlin, Czech Republic.
   Tech Univ Brno, CZ-60190 Brno, Czech Republic.
RP Lapcik, L (reprint author), Tomas Bata Univ Zlin, Fac Technol, Inst Phys & Mat Engn, Nam TG Masaryka 275, CZ-76272 Zlin, Czech Republic.
RI Lapcik, Lubomir/E-3246-2012
OI Lapcik, Lubomir/0000-0002-9917-7310
CR DUTTA PK, 2002, JMS POLYM REV, V42, P1532
   Ho HO, 2001, J CONTROL RELEASE, V77, P97, DOI 10.1016/S0168-3659(01)00467-9
   KEOGH JR, 1998, Patent No. 5821343
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   LAPCIK L, 2001, Patent No. 20011975
   LIDE DR, 1999, CRC HDB CHEM PHYSICS, P9
   Mason M, 2000, BIOMATERIALS, V21, P31, DOI 10.1016/S0142-9612(99)00129-5
   NOVAK I, 1987, FINE MECH OPTICS, V4, P109
   Peterkova P, 2000, CHEM LISTY, V94, P371
   Peterkova P, 2000, COLLOID POLYM SCI, V278, P1014, DOI 10.1007/s003960000366
   Ranby B., 1975, PHOTODEGRADATION PHO
   Schneider RP, 1996, J COLLOID INTERF SCI, V182, P204, DOI 10.1006/jcis.1996.0452
   SCHONHORN H, 1981, NATO C SERIES, V6, P91
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
NR 14
TC 5
Z9 5
U1 0
U2 3
PU OXFORD & IBH PUBL CO PVT LTD
PI NEW DELHI
PA 66 JANPATH, NEW DELHI 110 001, INDIA
SN 0970-0838
J9 J POLYM MATER
JI J. Polym. Mater.
PD MAR
PY 2003
VL 20
IS 1
BP 67
EP 74
PG 8
WC Polymer Science
SC Polymer Science
GA 708HU
UT WOS:000184561800009
DA 2018-10-19
ER

PT J
AU Cioffi, MOH
   Voorwald, HJC
   Mota, RP
AF Cioffi, MOH
   Voorwald, HJC
   Mota, RP
TI Surface energy increase of oxygen-plasma-treated PET
SO MATERIALS CHARACTERIZATION
LA English
DT Article; Proceedings Paper
CT 1st Meeting of the Brazilian-Society-for-Materials-Research
CY JUL 07-10, 2002
CL RIO DE JANEIRO, BRAZIL
SP Brazilian Soc Materials Res
DE plasma treatment; PET/PMMA; composite; contact angle; tensile strength
ID INTERFACIAL ADHESION; TENSILE-STRENGTH; COMPOSITES; FIBERS; PART;
   FRACTURE; POLYMER
AB Prosthetic composite is a widely used biomaterial that satisfies the criteria for application as an organic implant without adverse reactions. Polyethylene therephthalate (PET) fiber-reinforced composites have been used because of the excellent cell adhesion, biodegradability and biocompatibility. The chemical inertness and low surface energy of PET in general are associated with inadequate bonds for polymer reinforcements. It is recognized that the high strength of composites, which results from the interaction between the constituents, is directly related to the interfacial condition or to the interphase. A radio frequency plasma reactor using oxygen was used to treat PET fibers for 5, 20, 30 and 100 s. The treatment conditions were 13.56 MHz, 50 W, 40 Pa and 3.33 x 10(-7) m(3)/s. A Rame-Hart goniometer was used to measure the contact angle and surface energy variation of fibers treated for different times. The experimental results showed contact angle values from 47degrees to 13degrees and surface energies from 6.4 x 10(-6) to 8.3 x 10(-6) J for the range of 5 to 100 s, respectively. These results were confirmed by the average ultimate tensile strength of the PET fiber/polymethylmethacrylate (PMMA) matrix composite tested in tensile mode and by scanning electron microscopy. (C) 2003 Elsevier Inc. All rights reserved.
C1 Univ Estadual Paulista, DMT, BR-12516410 Guaratingueta, SP, Brazil.
   Univ Estadual Paulista, DFQ, BR-12516410 Guaratingueta, SP, Brazil.
RP Cioffi, MOH (reprint author), Univ Estadual Paulista, DMT, Av Ariberto Pereira Cunha,333 Cep, BR-12516410 Guaratingueta, SP, Brazil.
RI Voorwald, Herman/H-2917-2012; Cioffi, Maria Odila/H-2411-2012
OI Voorwald, Herman/0000-0001-7060-8757; Cioffi, Maria
   Odila/0000-0002-4155-4769
CR *ASM INT, 1992, ASM HDB FRACT, V12, P116
   Beyerlein IJ, 1997, ENG FRACT MECH, V57, P241, DOI 10.1016/S0013-7944(97)00012-X
   BLACKMAN BRK, 1994, COMPOSITES, V25, P332, DOI 10.1016/S0010-4361(94)80003-0
   CHAPMAN B, 1980, GLOW DISCHARGE PROCE, P177
   Cioffi MOH, 2002, J MATER ENG PERFORM, V11, P659, DOI 10.1361/105994902770343665
   CIOFFI MOH, 2001, THESIS STATE U SAO P
   CIOFFI MOH, 1999, J MECH BEHAV MAT, V11, P329
   Decker EL, 1999, COLLOID SURFACE A, V156, P177, DOI 10.1016/S0927-7757(99)00069-2
   FERRANTE D, 1998, J MATER SCI, V33, P1
   GAO SL, 1993, J APPL POLYM SCI, V47, P2065, DOI 10.1002/app.1993.070471116
   GOULD SAC, 1998, J APPL POLYM SCI, P1237
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hu X, 1999, BIOMATERIALS, V20, P907, DOI 10.1016/S0142-9612(98)00232-4
   Iwamoto M, 1999, ENG FRACT MECH, V64, P721, DOI 10.1016/S0013-7944(99)00096-X
   JANG BZ, 1992, COMPOS SCI TECHNOL, V44, P333, DOI 10.1016/0266-3538(92)90070-J
   Marmur A, 1996, COLLOID SURFACE A, V116, P55, DOI 10.1016/0927-7757(96)03585-6
   PITT WG, 1993, J APPL POLYM SCI, V48, P845, DOI 10.1002/app.1993.070480509
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Weidner S, 1998, J POLYM SCI POL CHEM, V36, P1639
   Zhao FM, 2000, COMPOS PART A-APPL S, V31, P1215, DOI 10.1016/S1359-835X(00)00086-5
NR 20
TC 45
Z9 45
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
J9 MATER CHARACT
JI Mater. Charact.
PD MAR
PY 2003
VL 50
IS 2-3
BP 209
EP 215
DI 10.1016/S1044-5803(03)00094-9
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 737UJ
UT WOS:000186249900020
DA 2018-10-19
ER

PT J
AU Sommer, AP
   Franke, RP
AF Sommer, AP
   Franke, RP
TI Nanospheres promote the storage of perfluorocarbons in water: Could
   nanoscale aerosols reduce ozone killer concentrations in stratospheric
   clouds?
SO NANO LETTERS
LA English
DT Article
ID AIR-POLLUTION; THUNDERCLOUDS
AB In previous experiments designed to mimic cell-receptor structures on biomaterial surfaces, we demonstrated that the evaporation of water-based suspensions containing polystyrene nanospheres created translucent nanostructured films enclosed by highly regular ring-shaped patterns. Here we show that similar nanospheres promote partial miscibility between liquids regarded as completely immiscible-water and perfluorocarbons. The result could indicate that solid nanoscopic aerosols from urban and industrial sources may ultimately be instrumental in reducing the concentration of ozone killers in the stratosphere.
C1 Univ Ulm, Cent Inst Biomed Engn, Dept Biomat, ENSOMA Lab, D-89081 Ulm, Germany.
RP Sommer, AP (reprint author), Univ Ulm, Cent Inst Biomed Engn, Dept Biomat, ENSOMA Lab, D-89081 Ulm, Germany.
CR Bowden N, 1997, SCIENCE, V276, P233, DOI 10.1126/science.276.5310.233
   Breen TL, 1999, SCIENCE, V284, P948, DOI 10.1126/science.284.5416.948
   Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a
   Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868
   Kerr RA, 2002, SCIENCE, V297, P1623, DOI 10.1126/science.297.5587.1623
   Lelieveld J, 2002, SCIENCE, V298, P794, DOI 10.1126/science.1075457
   Reilly J, 1999, NATURE, V401, P549, DOI 10.1038/44069
   Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793
   Sommer AP, 2003, NANO LETT, V3, P19, DOI 10.1021/nl025839m
   Sommer AP, 2002, LANGMUIR, V18, P5040, DOI 10.1021/la025619o
   Sommer AP, 2002, J PROTEOME RES, V1, P111, DOI 10.1021/pr025501t
   Sommer AP, 2001, ATMOS RES, V58, P129, DOI 10.1016/S0169-8095(01)00086-2
   SOMMER AP, IN PRESS NANO LETT
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Wuebbles DJ, 1997, SCIENCE, V278, P1090, DOI 10.1126/science.278.5340.1090
NR 15
TC 10
Z9 10
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
J9 NANO LETT
JI Nano Lett.
PD MAR
PY 2003
VL 3
IS 3
BP 321
EP 324
DI 10.1021/nl025940r
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 656AN
UT WOS:000181586600010
DA 2018-10-19
ER

PT J
AU Balazs, DJ
   Triandafillu, K
   Chevolot, Y
   Aronsson, BO
   Harms, H
   Descouts, P
   Mathieu, HJ
AF Balazs, DJ
   Triandafillu, K
   Chevolot, Y
   Aronsson, BO
   Harms, H
   Descouts, P
   Mathieu, HJ
TI Surface modification of PVC endotracheal tubes by oxygen glow discharge
   to reduce bacterial adhesion
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE surface modification; poly(vinyl chloride); bacterial adhesion; oxygen
   plasma; x-ray photoelectron spectroscopy
ID BIOMATERIAL SURFACES; INFECTION; POLYMERS; ARGON
AB A d.c. oxygen glow discharge was used to modify medical-grade poly(vinyl chloride) (PVC) to study how surface chemistry and hydrophilicity influence Pseudomonas aeruginosa adhesion. The effects of plasma exposure time on the resulting surface, including chemical composition, wettability and roughness, were assessed using x-ray photoelectron spectroscopy, contact angle measurements and atomic force microscopy analysis. A significant alteration in the hydrophilicity of the native PVC surface was observed after oxygen glow discharge treatment. The water contact angle decreased from similar to80degrees to 8-20degrees, with a weak dependence of the exposure time used. The change in surface wettability resulted from the incorporation of oxygenated functional groups, including esters, ketones and acids, as indicated by XPS analysis. The amount of oxygen incorporation was shown to be essentially independent of plasma exposure time. However, prolonged plasma exposure resulted in increased surface roughness. Bacterial adhesion efficiency was evaluated for PVC modified by 120 s of plasma exposure, because this exposure time was determined to yield the maximum decrease in contact angle. Oxygen plasma treatment of native PVC was found to yield a 70% reduction in bacterial adhesion for the four strains of Pseudomonas aeruginosa tested. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Swiss Fed Inst Technol, EPFL, Dept Mat Sci, CH-1015 Lausanne, Switzerland.
   Swiss Fed Inst Technol, EPFL, Dept Environm Sci & Technol, CH-1015 Lausanne, Switzerland.
   Univ Geneva, Grp Appl Phys Biomed, CH-1211 Geneva, Switzerland.
RP Balazs, DJ (reprint author), Swiss Fed Inst Technol, EPFL, Dept Mat Sci, CH-1015 Lausanne, Switzerland.
EM dawn.balazs@epfl.ch
RI Harms, Hauke/I-4406-2012
OI Harms, Hauke/0000-0002-7316-7341; Chevolot, Yann/0000-0003-3479-3371
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   ASFARDJANI K, 1991, J APPL POLYM SCI, V43, P271, DOI 10.1002/app.1991.070430206
   BAGGERMAN JAG, 1994, J APPL PHYS, V75, P758, DOI 10.1063/1.356481
   Coullerez G., 1999, J SURF ANAL, V5, P235
   EGITTO FD, 1994, IBM J RES DEV, V38, P423, DOI 10.1147/rd.384.0423
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Gachter R, 1993, PLASTIC ADDITIVES HD
   Gerenser LJ, 2000, SURF INTERFACE ANAL, V29, P12, DOI 10.1002/(SICI)1096-9918(200001)29:1<12::AID-SIA687>3.3.CO;2-Z
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1991, HIGH PERFORMANCE BIO, P143
   HOGT AH, 1986, INFECT IMMUN, V51, P294
   Hudis M., 1974, Techniques and applications of plasma chemistry, P113
   LISTON EM, 1993, J ADHES SCI TECHNOL, V7, P1091, DOI 10.1163/156856193X00600
   Rad AY, 1998, J BIOMAT SCI-POLYM E, V9, P915
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   SHEU MS, 1993, J ADHES SCI TECHNOL, V7, P1065, DOI 10.1163/156856193X00583
   Sheu MS, 1995, ENCY HDB BIOMATERI A, V1, P865
   SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001
   Teixeira P, 1999, J ADHES SCI TECHNOL, V13, P1287, DOI 10.1163/156856199X00190
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   VANDOOREN AA, 1991, PHARM WEEKBLAD, V13, P109, DOI 10.1007/BF01981526
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639
NR 26
TC 75
Z9 77
U1 3
U2 21
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD MAR
PY 2003
VL 35
IS 3
BP 301
EP 309
DI 10.1002/sia.1533
PG 9
WC Chemistry, Physical
SC Chemistry
GA 658MR
UT WOS:000181725200011
DA 2018-10-19
ER

PT J
AU Wong, C
   Inman, E
   Spaethe, R
   Helgerson, S
AF Wong, C
   Inman, E
   Spaethe, R
   Helgerson, S
TI Fibrin-based biomaterials to deliver human growth factors
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE fibrin(ogen); fibrin sealant; growth factors; angiogenesis; wound
   healing
ID CLINICAL-APPLICATIONS; EXTRACELLULAR-MATRIX; FACTOR VEGF; RAT AORTA;
   FIBROBLAST; BINDING; ANGIOGENESIS; REGENERATION; FIBRONECTIN; DEPOSITION
AB Fibrin-based biomaterial preparations can be used as provisional growth matrices for cells important in tissue repair during wound healing in vivo. Their efficacy can be enhanced by including bioactive agents that promote specific cellular responses. This study examined the controlled delivery of the angiogenic growth factors bFGF, VEGF(165), and VEGF(121) using biomatrix preparations prepared from Fibrin Sealant product components. The growth factors were added prior to formation of the Fibrin Sealant clots, and the release kinetics of the proteins from the clots measured. The results indicated that the proteins were released from the clots more slowly in the order bFGF much less than VEGF(165) < VEGF(121). The biologic activity of the growth factors delivered from Fibrin Sealant clots was established by assaying growth stimulation of human microvascular endothelial cells (HMVEC) and angiogenesis in the chicken embryo chorioallantoic membrane (CAM) model of neovascularization. In the latter assay, clots containing bFGF, VEGF(165), orVEGF(121) all displayed angiogenic activity. However, delivery of either bFGF, VEGF(165), orVEGF(121) alone resulted in a significant percentage of clots becoming filled with blood, indicating that the newly developing vessels invading the clots were leaky and immature. In contrast, this hemorrhaging behavior did not occur with delivery of combinations, e.g., (VEGF(165) +VEGF(121)) or (VEGF(165) + bFGF), indicating that the vessels were more mature than those produced in response to single growth factors. Thus, delivering a combination of growth factors constituted an improvement over the delivery of individual growth factors for enhancing neovascularization.
C1 Baxter Healthcare Corp, BioSci R&D, BioSurg Grp, Duarte, CA 91010 USA.
RP Helgerson, S (reprint author), Baxter Healthcare Corp, BioSci R&D, BioSurg Grp, 1720 Flower Ave, Duarte, CA 91010 USA.
EM Sam_Helgerson@baxter.com
CR ALBES JM, 1994, ANN THORAC SURG, V57, P444, DOI 10.1016/0003-4975(94)91015-4
   Banks RE, 1998, BRIT J CANCER, V77, P956, DOI 10.1038/bjc.1998.158
   Campbell PG, 1999, J BIOL CHEM, V274, P30215, DOI 10.1074/jbc.274.42.30215
   Carmeliet P, 1997, AM J PHYSIOL-HEART C, V273, pH2091
   Chibber B A, 1974, Methods Enzymol, V34, P424
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   FERRARA N, 2001, AM J PHYSIOL-CELL PH, V280, P1358
   FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664
   Greisler HP, 1996, J CONTROL RELEASE, V39, P267, DOI 10.1016/0168-3659(95)00159-X
   HARRISON P, 1993, BLOOD REV, V7, P52, DOI 10.1016/0268-960X(93)90024-X
   HASIMOTO J, 1992, AM J SPORTS MED, V20, P537
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HOUCK K, 1992, J BIOL CHEM, V267, P23031
   Jackson MR, 1996, BLOOD COAGUL FIBRIN, V7, P737, DOI 10.1097/00001721-199611000-00001
   Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788
   Kim WJH, 2000, YONSEI MED J, V41, P692, DOI 10.3349/ymj.2000.41.6.692
   Lee RJ, 2000, CIRCULATION, V102, P898
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   LOBB RR, 1988, BIOCHEMISTRY-US, V27, P2572, DOI 10.1021/bi00407a045
   MACPHEE MJ, 1996, SURG ADHESIVES SEALA, P109
   MADRI JA, 1996, MOL CELLULAR BIOL WO, P355
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Nakanishi R, 1998, ANN SURG, V227, P446, DOI 10.1097/00000658-199803000-00018
   NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119
   PARK JE, 1993, MOL BIOL CELL, V4, P1317
   Parsons-Wingerter P, 2000, ARTERIOSCL THROM VAS, V20, P1250, DOI 10.1161/01.ATV.20.5.1250
   PIERCE GF, 1995, ANNU REV MED, V46, P467
   Quirinia A, 1998, SCAND J PLAST RECONS, V32, P9
   RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L
   Sahni A, 2000, BLOOD, V96, P3772
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Sahni A, 2000, THROMB HAEMOSTASIS, V83, P736
   SCHLAG G, 1986, FIBRIN SEALANT OPERA, P3
   Sierra D H, 1993, J Biomater Appl, V7, P309, DOI 10.1177/088532829300700402
   Thompson WD, 1996, NATO ADV SCI INST SE, V285, P161
   TISCHER E, 1991, J BIOL CHEM, V266, P11947
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   VILLASCHI S, 1993, AM J PATHOL, V143, P181
   VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292
   Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79
   WILTING J, 1993, CELL TISSUE RES, V274, P163, DOI 10.1007/BF00327997
NR 42
TC 157
Z9 169
U1 0
U2 9
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD MAR
PY 2003
VL 89
IS 3
BP 573
EP 582
PG 10
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 656KU
UT WOS:000181607600022
PM 12624643
DA 2018-10-19
ER

PT J
AU Rohlke, W
   Fuhrmann, R
   Franke, RP
   Mucke, A
   Voegele, J
   Rieger, B
AF Rohlke, W
   Fuhrmann, R
   Franke, RP
   Mucke, A
   Voegele, J
   Rieger, B
TI CO/alkene copolymers as a promising class of biocompatible materials, 2
   - Bone growth directed performance of bone marrow cell spreading
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomineralization; 1,4-polyketones; surface polarity; surfaces
AB The influence of polymers polarity of three different CO/alkene copolymers on the production of bone materials by human bone marrow cells was demonstrated. The effects were measured by a specific immunohistochemical glycoprotein (osteonectin, osteopontin) test. Von Kossa staining, as an integral indicator for the formation of hard tissue on the biomaterial surfaces, visualized the obtained findings. The results clearly demonstrated an increase in mineralization activities with decreasing polarity of the tested polymers.
C1 Univ Ulm, ZIBMT Dep, D-89069 Ulm, Germany.
RP Rieger, B (reprint author), Univ Ulm, ZIBMT Dep, D-89069 Ulm, Germany.
RI Rieger, Bernhard/C-1183-2010
OI Rieger, Bernhard/0000-0002-0023-884X
CR RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Reuter P, 2003, MACROMOL BIOSCI, V3, P123, DOI 10.1002/mabi.200390012
NR 2
TC 6
Z9 6
U1 0
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD FEB 28
PY 2003
VL 3
IS 2
BP 131
EP 135
DI 10.1002/mabi.200390013
PG 5
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 664DW
UT WOS:000182047300007
DA 2018-10-19
ER

PT J
AU Bezzi, G
   Celotti, G
   Landi, E
   La Torretta, TMG
   Sopyan, I
   Tampieri, A
AF Bezzi, G
   Celotti, G
   Landi, E
   La Torretta, TMG
   Sopyan, I
   Tampieri, A
TI A novel sol-gel technique for hydroxyapatite preparation
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE biomaterial; sol-gel process; hydroxyapatite
ID CALCIUM
AB The concept of biocompatible, osteoconductive material mimicking the structure of natural bone to be used as bone graft has generated a considerable interest in recent decades. This paper reports on a novel and simple sol-gel technique for fabricating pure hydroxyapatite powder. Compositional, microstructural, morphological and mechanical characterisations carried out on the powder as well as on dense and porous sintered bodies, are also reported. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 ENEA, CRNM, Faenza, Italy.
   CNR, ISTEC, Inst Sci & Technol Ceram, Faenza, Italy.
   BPPT Mat Technol Ctr, Jakarta, Indonesia.
RP Landi, E (reprint author), ENEA, CRNM, Via Ravegnana 186, Faenza, Italy.
OI SOPYAN, IIS/0000-0003-0740-7340; Landi, Elena/0000-0003-4495-129X
CR Aoki H, 1975, CERAMICS, V10, P469
   Asada M., 1987, Yogyo-Kyokai-Shi, V95, P703
   Guicciardi S, 2001, J MATER RES, V16, P163, DOI 10.1557/JMR.2001.0027
   HATTORI T, 1988, ADV CERAM MATER, V3, P426
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Jillavenkatesa A, 1998, J MATER SCI, V33, P4111, DOI 10.1023/A:1004436732282
   MISHRA RK, 1980, COLLOID SURFACE, V1, P105, DOI 10.1016/0166-6622(80)80040-0
   OSAKA A, 1991, J MATER SCI-MATER M, V2, P51, DOI 10.1007/BF00701687
   PRETTO M, IN PRESS J AM CERAM
   Rodriguez-Lorenzo LM, 2001, BIOMATERIALS, V22, P1847, DOI 10.1016/S0142-9612(00)00366-5
   Somasundaran P, 1984, ADSORPTION SURFACE C, P129
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   2000, Patent No. 000603
NR 14
TC 150
Z9 155
U1 2
U2 40
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD FEB 28
PY 2003
VL 78
IS 3
BP 816
EP 824
AR PII S0254-0584(02)00392-9
DI 10.1016/S0254-0584(02)00392-9
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 625XB
UT WOS:000179839900038
DA 2018-10-19
ER

PT J
AU Liu, CK
AF Liu, CK
TI Absorption of glycerol and its effects on the physical properties of a
   collagen material: Leather
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE adsorption; diffusion; stiffness; modeling
ID ACOUSTIC-EMISSION; ANIONIC SURFACTANTS; DESTABILIZATION; CALORIMETRY;
   SULFATES; HIDE
AB An aqueous solution of glycerol was applied to a polymeric biomaterial, leather, to evaluate its effects on the physical properties of leather, particularly stiffness. The initial strain energy, Young's modulus, and acoustic-emission methods were used to characterize the stiffness of the resultant leather treated with these glycerol solutions. The measurements revealed that the glycerol treatment significantly reduced the stiffness of the dried leather, indicating the strong lubrication function of glycerol for leather. Experiments were also conducted to investigate the mechanism of glycerol adsorption into the leather matrix. Fick's second law of diffusion was employed to systematically derive a mathematical model for the absorption rate. The effect of temperature on the absorption rate was also included in the model by incorporation of the Arrhenius equation into Fick's second law of diffusion. The resultant model fits the experimental data very well. It not only depicts the mechanism of absorption but also predicts the absorption rate as a function of key variables. (C) 2002 Wiley Periodicals, Inc.
C1 USDA, Agr Res Serv, Eastern Reg Res Ctr, Wyndmoor, PA 19038 USA.
RP Liu, CK (reprint author), USDA, Agr Res Serv, Eastern Reg Res Ctr, 600 E Mermaid Lane, Wyndmoor, PA 19038 USA.
CR Barrer RM, 1937, NATURE, V140, P106, DOI 10.1038/140106b0
   BOX GEP, 1951, J ROY STAT SOC B, V13, P1
   BOX GEP, 1957, ANN MATH STAT, V28, P195, DOI 10.1214/aoms/1177707047
   COCHRAN WG, 1957, EXPT DESIGNS, P343
   CRANK J, 1968, DIFFUSION POLYM, P16
   Diebschlag W., 1975, LEDER, V26, P7
   Guy R., 1972, BLMRA J, V15, P65
   HEIDEMANN E, 1993, FUNDAMENTALS LEATHER, P113
   KRONICK PL, 1989, J AM LEATHER CHEM AS, V84, P257
   Kronick PL, 1998, J POLYM SCI POL PHYS, V36, P805, DOI 10.1002/(SICI)1099-0488(19980415)36:5<805::AID-POLB8>3.0.CO;2-J
   Kronick PL, 1996, J AM LEATHER CHEM AS, V91, P246
   Liu CK, 1999, J AM LEATHER CHEM AS, V94, P8
   Liu CK, 2000, J AM LEATHER CHEM AS, V95, P170
   Liu CK, 1997, J AM LEATHER CHEM AS, V92, P157
   Liu CK, 2002, J MATER SCI, V37, P3827, DOI 10.1023/A:1019678716389
   Liu CK, 2001, J AM LEATHER CHEM AS, V96, P367
   Liu CK, 2002, J AM LEATHER CHEM AS, V97, P284
   Liu CK, 2001, J AM LEATHER CHEM AS, V96, P243
   Liu CK, 2002, J AM LEATHER CHEM AS, V97, P329
   LIU CK, 1993, Patent No. 5217485
   Marmer WN, 2001, J AM LEATHER CHEM AS, V96, P88
   MONTGOMERY DC, 1978, DESIGN ANAL EXPT, P334
   MORTON WE, 1978, PHYSICAL PROPERTIES, P272
   *NEW ENGL TANN CLU, 1994, LEATH FACTS, P19
   PAUL DR, 1985, ACS SYM SER, V285, P257
   THORSTENSEN TC, 1985, PRACTICAL LEATHER TE, P190
NR 26
TC 7
Z9 7
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 22
PY 2003
VL 87
IS 8
BP 1221
EP 1231
DI 10.1002/app.11516
PG 11
WC Polymer Science
SC Polymer Science
GA 627YU
UT WOS:000179965100007
DA 2018-10-19
ER

PT J
AU Assad, M
   Jarzem, P
   Leroux, MA
   Coillard, C
   Chernyshov, AV
   Charette, S
   Rivard, CH
AF Assad, M
   Jarzem, P
   Leroux, MA
   Coillard, C
   Chernyshov, AV
   Charette, S
   Rivard, CH
TI Porous titanium-nickel for intervertebral fusion in a sheep model: Part
   1. Histomorphometric and radiological analysis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE porous; titanium-nickel; nitinol; osseointegration; bone ingrowth;
   intervertebral; spine fusion
ID LUMBAR INTERBODY FUSION; BONE APPOSITION; THREADED CAGE; ANIMAL-MODEL;
   IMPLANT; SPINE; ARTHRODESIS; INGROWTH; REGENERATION; MULTICENTER
AB Porous titanium-nickel (PTN) implants represent an alternative to traditional intervertebral fusion cages. Indeed, PTN materials possess interconnecting pores with cell capillarity properties that may promote bone ingrowth and intervertebral fusion without the need for bone grafting. In this study, a PTN intervertebral fusion device was compared to a conventional TiAlV cage packed with autologous bone in a sheep model. The two devices were implanted at two noncontiguous intervertebral lumbar sites for 3, 6, and 12 months. PTN osseointegration showed a time-dependent trend increasing from 21.4% to 37.6% (3-12 months), whereas TiAlV cages remained at the same level of bone ingrowth (22.7%-25.4%; 3-12 months). Furthermore, PTN bone apposition (10.9%-24.2%; 3-12 months) was significantly higher than that of TiAlV implants (1.1%-5.1%; 3-12 months; p < 0.001, ANOVA). Radiological fusion scores increased with postsurgery time regardless of material type, but were consistently superior for PTN (12.5-18.5; 3-12 months) than for TiAlV cages (2.0-15.0; 3-12 months; p < 0.001, ANOVA). Implant materials were not significantly different according to the radiological interbody index based on preoperative disc height: Interbody index began at 132.6% (PTN) and 123.5% (TiAlV) immediately after surgery, then declined to 80.8% (PTN) and 91.0% (TiAlV) after 12 months. Nevertheless, ungrafted PTN constituted an excellent substrate for osteogenic cell integration and represents a new osteoconductive biomaterial with improved fusion characteristics in comparison to conventional TiAlV cages. (C) 2003 Wiley Periodicals, Inc.
C1 Biorthex Inc, R&D Dept, Montreal, PQ H4N 3H5, Canada.
   St Cabrini Hosp, Dept Orthopaed Surg, Montreal, PQ H1T 1P7, Canada.
   St Justine Hosp, Paediat Res Ctr, Montreal, PQ H3T 1C5, Canada.
RP Assad, M (reprint author), Biorthex Inc, R&D Dept, 9001 Acadie Blvd,Suite 802, Montreal, PQ H4N 3H5, Canada.
OI Assad, Michel/0000-0001-8734-0267
CR Assad M, 2002, BIO-MED MATER ENG, V12, P225
   Ayers R A, 2000, SHAPE MEMORY IMPLANT, P73
   Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   BAGBY GW, 1988, ORTHOPEDICS, V11, P931
   Baramki HG, 2000, SPINE, V25, P1053, DOI 10.1097/00007632-200005010-00003
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1996, SPINE, V21, P2689, DOI 10.1097/00007632-199611150-00020
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   BRANTIGAN JW, 1994, SPINE, V19, P1436, DOI 10.1097/00007632-199407000-00002
   Brantigan JW, 2000, SPINE, V25, P1437, DOI 10.1097/00007632-200006010-00017
   Brodke DS, 1997, SPINE, V22, P26, DOI 10.1097/00007632-199701010-00005
   CAMERON HU, 1982, CLIN ORTHOP RELAT R, P188
   COOK SD, 1988, CLIN ORTHOP RELAT R, P90
   COOK SD, 1991, J ARTHROPLASTY S, V6, P37
   COTTERILL PC, 1986, J ORTHOPAED RES, V4, P298, DOI 10.1002/jor.1100040306
   CUNNINGHAM BW, 2000, T 46 ANN M ORTH RES, P357
   Feiertag MA, 1996, SPINE, V21, P27, DOI 10.1097/00007632-199601010-00006
   Hadjipavlou AG, 2000, SPINE, V25, P10, DOI 10.1097/00007632-200001010-00004
   HERKOWITZ HN, 1994, SPINE, V19, P1444, DOI 10.1097/00007632-199407000-00003
   JASTY M, 1993, J BIOMED MATER RES, V27, P639, DOI 10.1002/jbm.820270511
   Jensen L N, 1991, Biotech Histochem, V1, P82
   Kanagaraja S, 2001, BIOMATERIALS, V22, P1809, DOI 10.1016/S0142-9612(00)00362-8
   Kapanen A, 2001, BIOMATERIALS, V22, P2475, DOI 10.1016/S0142-9612(00)00435-X
   Kuslich SD, 1998, SPINE, V23, P1267, DOI 10.1097/00007632-199806010-00019
   KUSLICH SD, 1996, P 11 ANN M N AM SPIN, P123
   KUSLICH SD, 1994, P 9 ANN M N AM SPIN, P28
   Liu YL, 2000, J MATER SCI-MATER M, V11, P711, DOI 10.1023/A:1008971611885
   Lund T, 1998, J BONE JOINT SURG BR, V80B, P351, DOI 10.1302/0301-620X.80B2.7693
   Maniatopoulos C, 1986, Int J Oral Maxillofac Implants, V1, P31
   McAfee PC, 1999, SPINE, V24, P2147, DOI 10.1097/00007632-199910150-00015
   Meraw SJ, 1999, J PERIODONTOL, V70, P1228, DOI 10.1902/jop.1999.70.10.1228
   Meraw SJ, 1999, J PERIODONTOL, V70, P151, DOI 10.1902/jop.1999.70.2.151
   Meraw SJ, 2000, J PERIODONTOL, V71, P8, DOI 10.1902/jop.2000.71.1.8
   NILLES JL, 1973, J BIOMED MATER RES, V7, P63, DOI 10.1002/jbm.820070306
   Ray CD, 1997, SPINE, V22, P681, DOI 10.1097/00007632-199703150-00021
   Regan JJ, 1999, SPINE, V24, P402, DOI 10.1097/00007632-199902150-00023
   RICCI JL, 1997, T 23 ANN M SOC BIOM, P481
   Riley LH, 1997, SPINE, V22, P1407, DOI 10.1097/00007632-199706150-00021
   ROSENQVIST R, 1986, J BONE JOINT SURG AM, V68A, P538, DOI 10.2106/00004623-198668040-00009
   Sandhu HS, 1996, SPINE, V21, P1201, DOI 10.1097/00007632-199605150-00013
   SANDHU HS, 1997, T AM AC ORTH SURG AN
   Silberstei B.M., 2000, SHAPE MEMORY IMPLANT, P147
   SILBERSTEIN B, 1997, P 2 INT C SHAP MEM S, P617
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   Spector M, 1987, J Arthroplasty, V2, P163, DOI 10.1016/S0883-5403(87)80024-4
   STAROKHA A, 1995, P 1 INT C SHAP MEM S, P509
   Steffen T, 2000, CLIN ORTHOP RELAT R, P28
   Steffen T, 2000, EUR SPINE J, V9, pS89, DOI 10.1007/PL00010027
   Svehla M, 2000, J BIOMED MATER RES, V51, P15, DOI 10.1002/(SICI)1097-4636(200007)51:1<15::AID-JBM3>3.0.CO;2-9
   Takeuchi T, 1999, SPINE, V24, P1414, DOI 10.1097/00007632-199907150-00005
   TOGAWA D, 2001, T 27 ANN M SOC BIOM, P301
   Tropiano P, 1999, Chirurgie, V124, P58, DOI 10.1016/S0001-4001(99)80043-9
   VANDIJK M, 2000, T 46 ANN M ORTH RES, P350
   WETZEL FT, 1991, SPINE, V16, P839, DOI 10.1097/00007632-199107000-00027
   Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009
   Zdeblick TA, 1998, SPINE, V23, P758, DOI 10.1097/00007632-199804010-00002
NR 59
TC 74
Z9 75
U1 0
U2 6
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2003
VL 64B
IS 2
BP 107
EP 120
DI 10.1002/jbm.b.10530
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 670TG
UT WOS:000182424600007
PM 12516085
DA 2018-10-19
ER

PT J
AU Assad, M
   Chernyshov, AV
   Jarzem, P
   Leroux, MA
   Coillard, C
   Charette, S
   Rivard, CH
AF Assad, M
   Chernyshov, AV
   Jarzem, P
   Leroux, MA
   Coillard, C
   Charette, S
   Rivard, CH
TI Porous titanium-nickel for intervertebral fusion in a sheep model: Part
   2. Surface analysis and nickel release assessment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE porous; titanium; nickel; nitinol; intervertebral; spinal fusion;
   surface analysis; ion release
ID SHAPE-MEMORY ALLOYS; ORTHODONTIC APPLIANCES; CORROSION BEHAVIOR;
   NITINOL; IMPLANT; BIODEGRADATION; GENOTOXICITY; APPOSITION; FRACTURES;
   INGROWTH
AB Porous titanium-nickel (PTN) devices represent an alternative to traditional cage implants. PTN materials possess an interconnecting network of pores with capillarity properties that may promote bone ingrowth, long-term fixation, and intervertebral fusion without the need for bone grafting. However, their considerable surface area and nickel content may elicit concerns over sensitization potential. Therefore, PTN surface corrosion and nickel release resistance must be carefully studied. To evaluate this possibility, a PTN interbody fusion device (IFD) was compared to a conventional nonporous cage made of TiAlV, a well-known biocompatible biomaterial, in a sheep model. PTN and TiAlV IFDs were inserted at two non-contiguous lumbar sites for 3, 6, and 12 months postsurgery. Their surface was then evaluated by scanning electron microscopy (SEM) combined with backscattered electron analysis (BSE). No evidence of surface corrosion was observed either pre- or postimplantation, regardless of device type. Dosage of nickel ions was also performed with the use of inductively coupled plasma-mass spectrometry (ICP-MS). Blood nickel levels were observed to be within acceptable levels at all postinstrumentation times. Nickel content in PTN-adjacent tissue, as well as in detoxification and remote organs, was equivalent both in PTN-treated and control sheep. Therefore, porous titanium-nickel demonstrated resistance to both in vivo surface corrosion and nickel ion release and compared very well with a conventional titanium implant in the course of a 12-month sheep study. (C) 2003 Wiley Periodicals, Inc.
C1 Biorthex Inc, R&D Dept, Montreal, PQ H4N 3H5, Canada.
   St Cabrini Hosp, Dept Orthopaed Surg, Montreal, PQ H1T 1P7, Canada.
   St Justine Hosp, Paediat Res Ctr, Montreal, PQ H3T 1C5, Canada.
RP Assad, M (reprint author), Biorthex Inc, R&D Dept, 9001 Acadie Blvd,Suite 802, Montreal, PQ H4N 3H5, Canada.
EM massad@biorthex.com
OI Assad, Michel/0000-0001-8734-0267
CR ANDERSEN KE, 1983, CONTACT DERMATITIS, V9, P140, DOI 10.1111/j.1600-0536.1983.tb04321.x
   ANDREASEN GF, 1973, AM J ORTHOD DENTOFAC, V63, P462, DOI 10.1016/0002-9416(73)90159-0
   ANDREASEN GF, 1971, J AM DENT ASSOC, V82, P1373, DOI 10.14219/jada.archive.1971.0209
   Assad M, 2003, J BIOMED MATER RES B, V64B, P107, DOI 10.1002/jbm.b.10530
   Assad M, 2002, BIO-MED MATER ENG, V12, P339
   Assad M, 2002, BIO-MED MATER ENG, V12, P225
   Ayers R A, 2000, SHAPE MEMORY IMPLANT, P73
   Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   BARBER FA, 1993, ARTHROSCOPY, V9, P647, DOI 10.1016/S0749-8063(05)80500-6
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   CASTLEMAN LS, 1976, J BIOMED MATER RES, V10, P695, DOI 10.1002/jbm.820100505
   CIVJAN S, 1975, J DENT RES, V54, P89, DOI 10.1177/00220345750540014301
   CRAGG AH, 1993, RADIOLOGY, V189, P775, DOI 10.1148/radiology.189.3.8234703
   CUSCHIERI A, 1991, SURG ENDOSC-ULTRAS, V5, P179, DOI 10.1007/BF02653258
   DAI KR, 1993, INJURY, V24, P651, DOI 10.1016/0020-1383(93)90313-U
   DRUGACZ J, 1995, J ORAL MAXIL SURG, V53, P665, DOI 10.1016/0278-2391(95)90166-3
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   ENDO K, 2000, SHAPE MEMORY IMPLANT, P177
   Filip P, 2001, BIOMATERIALS, V22, P2131, DOI 10.1016/S0142-9612(00)00404-X
   FLYVHOLM MA, 1984, Z LEBENSM UNTERS FOR, V179, P427, DOI 10.1007/BF01043419
   FUKUYO S, 1990, ENG ASPECTS SHAPE ME, P470
   Gil FJ, 1999, J BIOMED MATER RES, V48, P682, DOI 10.1002/(SICI)1097-4636(1999)48:5<682::AID-JBM12>3.0.CO;2-M
   GRANDJEAN P, 1992, SCAND J CLIN LAB INV, V52, P321, DOI 10.3109/00365519209088366
   GUNTHER VE, 1999, Patent No. 5986169
   Gunther VE, 2000, DELAY LAW NEW CLASS
   HAUSINGER RP, 1994, BIOCH ELEMENTS, V2
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Kasano Fujihiko, 1997, Auris Nasus Larynx, V24, P137, DOI 10.1016/S0385-8146(96)00026-0
   Kuo P P, 1989, Orthopedics, V12, P111
   LATAL D, 1994, UROL RES, V22, P295, DOI 10.1007/BF00297198
   MATSUMOTO K, 1993, J JPN ORTHOP ASSOC, V67, P267
   Menne T, 1996, ANN CLIN LAB SCI, V26, P133
   Moffa J P, 1984, CDA J, V12, P45
   NIELSEN GD, 1984, IARC SCI PUBL, P333
   PELTONEN L, 1979, CONTACT DERMATITIS, V5, P27, DOI 10.1111/j.1600-0536.1979.tb05531.x
   RANDIN JP, 1988, J BIOMED MATER RES, V22, P649, DOI 10.1002/jbm.820220706
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   RYHANEN J, 1999, THESIS U OULU OULU F
   RYHANEN J, 2000, P 2 INT S ADV BIOM M, P83
   SANDERS JO, 1993, SPINE, V18, P1640, DOI 10.1097/00007632-199309000-00012
   SCHMERLING MA, 1976, J BIOMED MATER RES, V10, P879, DOI 10.1002/jbm.820100607
   Silberstei B.M., 2000, SHAPE MEMORY IMPLANT, P147
   SILBERSTEIN B, 1997, P 2 INT C SHAP MEM S, P617
   SIMON M, 1977, RADIOLOGY, V125, P89, DOI 10.1148/125.1.89
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   STAROKHA A, 1995, P 1 INT C SHAP MEM S, P509
   SUNDERMAN FW, 1993, SCAND J WORK ENV HEA, V19, P75
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   Trepanier C, 2000, SHAPE MEMORY IMPLANT, V3, P35, DOI DOI 10.1007/978-3-642-59768-8_3
   VANHUMBEECK J, 1992, MATER RES SOC S P, V246, P377
   Villermaux F, 1996, BIO-MED MATER ENG, V6, P241
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   WOLFORD LM, 1995, P SMST 94 1 INT C SH, P477
NR 55
TC 44
Z9 48
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2003
VL 64B
IS 2
BP 121
EP 129
DI 10.1002/jbm.b.10531
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 670TG
UT WOS:000182424600008
PM 12516086
DA 2018-10-19
ER

PT J
AU Salem, AK
   Rose, FRAJ
   Oreffo, ROC
   Yang, XB
   Davies, MC
   Mitchell, JR
   Roberts, CJ
   Stolnik-Trenkic, S
   Tendler, SJB
   Williams, PM
   Shakesheff, KM
AF Salem, AK
   Rose, FRAJ
   Oreffo, ROC
   Yang, XB
   Davies, MC
   Mitchell, JR
   Roberts, CJ
   Stolnik-Trenkic, S
   Tendler, SJB
   Williams, PM
   Shakesheff, KM
TI Porous polymer and cell composites that self-assemble in situ
SO ADVANCED MATERIALS
LA English
DT Article
ID STEM-CELLS; SCAFFOLDS; CHONDROCYTES; CARTILAGE; DELIVERY
AB A cell-laden 3D network is formed upon the addition of avidin to biotinylated polymer particles in the presence of a suspension of cells (see Figure). Applications in tissue engineering and drug delivery are demonstrated; a shape-retaining biomaterial is formed within minutes of injecting the components into a cavity. The molecular interaction mechanism of self-assembly differentiates this polymer/cell composite from other injectable systems.
C1 Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
   Univ Southampton, Southampton Gen Hosp, Univ Orthopaed, Southampton SO16 6YD, Hants, England.
   Univ Nottingham, Sch Biol Sci, Nottingham NG7 2RD, England.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RI Salem, Aliasger/J-3674-2012; Williams, Philip/C-6947-2009; Roberts,
   Clive/C-6970-2009; Oreffo, Richard/A-4615-2011; Shakesheff,
   Kevin/O-6371-2018
OI Salem, Aliasger/0000-0002-1923-6633; Williams,
   Philip/0000-0002-1822-2133; Roberts, Clive/0000-0001-9443-3445; Oreffo,
   Richard/0000-0001-5995-6726; Shakesheff, Kevin/0000-0003-3236-2439;
   Davies, Martyn/0000-0001-7695-0596; Rose, Felicity/0000-0001-6640-8840;
   Stolnik, Snjezana Snow/0000-0002-2345-5062
CR Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Burg KJL, 2000, J BIOMED MATER RES, V51, P642, DOI 10.1002/1097-4636(20000915)51:4<642::AID-JBM12>3.0.CO;2-L
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   CIMA LG, 1991, BIOTECHNOL BIOENG, V38, P145, DOI 10.1002/bit.260380207
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3
   McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Ramiya VK, 2000, NAT MED, V6, P278
   Roach HI, 1998, J BONE MINER RES, V13, P950, DOI 10.1359/jbmr.1998.13.6.950
NR 15
TC 71
Z9 73
U1 3
U2 35
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD FEB 5
PY 2003
VL 15
IS 3
BP 210
EP +
DI 10.1002/adma.200390047
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 648FM
UT WOS:000181139200005
DA 2018-10-19
ER

PT J
AU Puolakkainen, P
   Bradshaw, AD
   Kyriakides, TR
   Reed, M
   Brekken, R
   Wight, T
   Bornstein, P
   Ratner, B
   Sage, EH
AF Puolakkainen, P
   Bradshaw, AD
   Kyriakides, TR
   Reed, M
   Brekken, R
   Wight, T
   Bornstein, P
   Ratner, B
   Sage, EH
TI Compromised production of extracellular matrix in mice lacking secreted
   protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign
   body reaction to implanted biomaterials
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID MATRICELLULAR PROTEIN; ENDOTHELIAL-CELLS; BREAST IMPLANTS; WOUND REPAIR;
   I COLLAGEN; EXPRESSION; TISSUE; OSTEONECTIN; DEFICIENT; INJURY
AB SPARC (secreted protein, acidic and rich in cysteine), a matricellular glycoprotein, modulates the interaction of cells with the extracellular matrix (ECM). Recently, accelerated cutaneous wound closure and altered deposition of collagen were reported in SPARC-null mice. Herein we asked whether SPARC might influence the foreign body reaction to biomaterial implants. Polydimethylsiloxane (silicone rubber) disks and cellulose Millipore filters were implanted into wild-type and SPARC-null mice. In wild-type animals, significant levels of SPARC were observed in the cells and the ECM comprising the capsules around the implants. After 4 weeks, SPARC-null mice exhibited a significant decrease in the thickness of the foreign body capsule, as compared to that observed in wildtype mice. A significant reduction in capsular vascular density was also associated with the silicone implants in the SPARC-null animals. Electron microscopy revealed that collagen fibers in the capsules produced by SPARC-null mice were smaller and more uniform in size than those in wild-type animals. Furthermore, staining with picrosirius-red showed that the collagen fibers were less mature in SPARC-null than in wild-type mice. The altered ECM resulting in decreased capsular thickness, indicative of an altered foreign body reaction in SPARC-null mice, implicates SPARC as an important modulator of the encapsulation of implanted biomaterials.
C1 Hope Heart Inst, Dept Vasc Biol, Seattle, WA 98104 USA.
   Univ Helsinki, Cent Hosp, Dept Surg, Helsinki, Finland.
   Univ Washington, Dept Med, Seattle, WA USA.
   Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Seattle, WA USA.
RP Sage, EH (reprint author), Hope Heart Inst, Dept Vasc Biol, 1124 Columbia St,7th Floor, Seattle, WA 98104 USA.
FU NIGMS NIH HHS [R01 GM040711, GM 40711]; NCRR NIH HHS [RR01296]; NHLBI
   NIH HHS [HL 59475]
CR Basu A, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-15
   Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7
   Bradshaw AD, 2002, J HISTOCHEM CYTOCHEM, V50, P1
   Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939
   BRADSHAW AD, 2000, PRINCIPLES TISSUE EN, P119
   BRADSHAW AD, 2002, WOUND REPAIR REGEN, V9, P522
   Brekken RA, 2000, MATRIX BIOL, V19, P569, DOI 10.1016/S0945-053X(00)00105-0
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   Delany AM, 2000, J CLIN INVEST, V105, P915, DOI 10.1172/JCI7039
   Francki A, 1999, J BIOL CHEM, V274, P32145, DOI 10.1074/jbc.274.45.32145
   Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   IruelaArispe ML, 1996, DEV DYNAM, V207, P171, DOI 10.1002/(SICI)1097-0177(199610)207:2<171::AID-AJA5>3.0.CO;2-E
   KARP RD, 1973, J NATL CANCER I, V51, P1275, DOI 10.1093/jnci/51.4.1275
   KASUGAI S, 1991, J CELL PHYSIOL, V147, P111, DOI 10.1002/jcp.1041470115
   Kiviluoto T, 2001, AM J PHYSIOL-GASTR L, V281, pG1151
   Kyriakides TR, 1999, J INVEST DERMATOL, V113, P782, DOI 10.1046/j.1523-1747.1999.00755.x
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674
   Park AJ, 1998, PLAST RECONSTR SURG, V101, P261, DOI 10.1097/00006534-199802000-00001
   Puolakkainen P, 1999, DIGEST DIS SCI, V44, P1554, DOI 10.1023/A:1026602708263
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Reed MJ, 1996, MECH AGEING DEV, V89, P21, DOI 10.1016/0047-6374(96)01737-X
   REED MJ, 1993, J HISTOCHEM CYTOCHEM, V41, P1467, DOI 10.1177/41.10.8245406
   REED MJ, 1995, AM J PATHOL, V147, P1068
   SAGE H, 1989, J MOL CELL CARDIOL, V21, P13, DOI 10.1016/0022-2828(89)90833-X
   SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400
   SALTZMANWM, 2000, CELL INTERACTIONS PO, P221
   STENNER DD, 1986, P NATL ACAD SCI USA, V83, P6892, DOI 10.1073/pnas.83.18.6892
   Vernon RB, 1996, J CELL BIOCHEM, V60, P185, DOI 10.1002/(SICI)1097-4644(19960201)60:2<185::AID-JCB3>3.0.CO;2-T
   Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122
   VUORIO T, 1991, J RHEUMATOL, V18, P247
   Weinzweig J, 1998, PLAST RECONSTR SURG, V101, P1836, DOI 10.1097/00006534-199806000-00009
   Wight TN, 1997, AM J PATHOL, V151, P963
   Yan Q, 2002, J CELL SCI, V115, P2747
NR 35
TC 45
Z9 45
U1 0
U2 2
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3993 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD FEB
PY 2003
VL 162
IS 2
BP 627
EP 635
DI 10.1016/S0002-9440(10)63856-4
PG 9
WC Pathology
SC Pathology
GA 638NL
UT WOS:000180577100027
PM 12547720
OA Green Published
DA 2018-10-19
ER

PT J
AU Altman, GH
   Diaz, F
   Jakuba, C
   Calabro, T
   Horan, RL
   Chen, JS
   Lu, H
   Richmond, J
   Kaplan, DL
AF Altman, GH
   Diaz, F
   Jakuba, C
   Calabro, T
   Horan, RL
   Chen, JS
   Lu, H
   Richmond, J
   Kaplan, DL
TI Silk-based biomaterials
SO BIOMATERIALS
LA English
DT Article
DE silk; sericin; fibroin; foreign body response; suture; tissue
   engineering; biomaterial; scaffold
ID GENETICALLY-ENGINEERED SILK; SPIDER SILK; SUTURE MATERIALS; BOMBYX-MORI;
   DRAGLINE SILK; MECHANICAL-PROPERTIES; NEPHILA-CLAVIPES; FIBROIN;
   PROTEINS; GENE
AB Silk from the silkworm, Bombyx mori, has been used as biomedical suture material for centuries. The unique mechanical properties of these fibers provided important clinical repair options for many applications. During the past 20 years, some biocompatibility problems have been reported for silkworm silk; however, contamination from residual sericin (glue-like proteins) was the likely cause. More recent studies with well-defined silkworm silk fibers and films suggest that the core silk fibroin fibers exhibit comparable biocompatibility in vitro and in vivo with other commonly used biomaterials such as polylactic acid and collagen. Furthermore, the unique mechanical properties of the silk fibers, the diversity of side chain chemistries for 'decoration' with growth and adhesion factors, and the ability to genetically tailor the protein provide additional rationale for the exploration of this family of fibrous proteins for biomaterial applications. For example, in designing scaffolds for tissue engineering these properties are particularly relevant and recent results with bone and ligament formation in vitro support the potential role for this biomaterial in future applications. To date, studies with silks to address biomaterial and matrix scaffold needs have focused on silkworm silk. With the diversity of silk-like fibrous proteins from spiders and insects, a range of native or bioengineered variants can be expected for application to a diverse set of clinical needs. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Tufts Univ, Ctr Bioengn, Dept Biol & Chem Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Ctr Bioengn, Dept Biol & Chem Engn, 4 Colby St, Medford, MA 02155 USA.
FU NIAMS NIH HHS [R01 AR46563-01]; NIDCR NIH HHS [R01 DE13405-01]
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   ALTMAN GH, 2001, FASEB J, V16, P270
   ALTMAN GH, 2001, FASEB J, V10, P1096
   Anderson James M., 1996, P165
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asakura T, 1997, BIOPOLYMERS, V41, P193, DOI 10.1002/(SICI)1097-0282(199702)41:2<193::AID-BIP6>3.0.CO;2-O
   BUCKNALL TE, 1983, EUR SURG RES, V15, P59, DOI 10.1159/000128334
   CAPPELLO J, 1990, TRENDS BIOTECHNOL, V8, P309, DOI 10.1016/0167-7799(90)90207-E
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   DAHLKE H, 1980, J BIOMED MATER RES, V14, P251, DOI 10.1002/jbm.820140307
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   Dunn MG, 1997, J APPL POLYM SCI, V63, P1423, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1423::AID-APP4>3.0.CO;2-O
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   *ETH INC, 2000, WOUND CLOS MAN SUT S, pCH2
   Foschi D, 2001, EUR SURG RES, V33, P16, DOI 10.1159/000049687
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   HOLLANDER DH, 1994, MED HYPOTHESES, V43, P155, DOI 10.1016/0306-9877(94)90142-2
   Hood EE, 1999, CURR OPIN BIOTECH, V10, P382, DOI 10.1016/S0958-1669(99)80069-X
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   JIN HJ, IN PRESS BIOMACROMOL
   KADLER KE, 1995, PROTEIN PROFILES EXT, V1
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   KAPLAN DL, 1992, MATER RES SOC S P, V255, P19
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Kourie JI, 2000, AM J PHYSIOL-CELL PH, V278, pC1063
   Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x
   Kurosaki S, 1999, Nihon Ika Daigaku Zasshi, V66, P41, DOI 10.1272/jnms.66.41
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MORROW FA, 1974, J UROLOGY, V112, P655, DOI 10.1016/S0022-5347(17)59821-3
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Moynihan BGA, 1920, BRIT J SURG, V8, P27, DOI 10.1002/bjs.1800082906
   NEBEL L, 1977, EUR SURG RES, V9, P224, DOI 10.1159/000127941
   PELEG H, 1986, J THORAC CARDIOVASC, V34, P384
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   POSTLETHWAIT RW, 1962, ARCH SURG-CHICAGO, V84, P698
   POSTLETHWAIT RW, 1970, ANN SURG, V171, P892, DOI 10.1097/00000658-197006010-00010
   Postlethwait RW, 1969, REPAIR REGENERATION, P263
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   SALTHOUSE TN, 1977, AM J OPHTHALMOL, V84, P224, DOI 10.1016/0002-9394(77)90856-X
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Setzen G, 1997, PLAST RECONSTR SURG, V100, P1788, DOI 10.1097/00006534-199712000-00023
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   Winkler S., 2000, REV MOL BIOTECHNOL, V74, P85
   Wong PC, 1996, THROMB RES, V83, P117, DOI 10.1016/0049-3848(96)00112-0
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
   Zarkoob S, 1998, POLYM PREPR, V39, P244
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 72
TC 1854
Z9 1971
U1 68
U2 1092
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2003
VL 24
IS 3
BP 401
EP 416
AR PII S0142-9612(02)00353-8
DI 10.1016/S0142-9612(02)00353-8
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 617VV
UT WOS:000179382300004
PM 12423595
DA 2018-10-19
ER

PT J
AU Timmer, MD
   Ambrose, CG
   Mikos, AG
AF Timmer, MD
   Ambrose, CG
   Mikos, AG
TI In vitro degradation of polymeric networks of poly(propylene fumarate)
   and the crosslinking macromer poly(propylene fumarate)-diacrylate
SO BIOMATERIALS
LA English
DT Article
DE poly(propylene fumarate); poly(propylene fumarate)-diacrylate;
   mechanical properties; in vitro degradation; orthopedic biomaterial
ID IN-VITRO; BONE-CEMENT; VIVO DEGRADATION; COMPOSITE; BIODEGRADATION;
   IMPLANTS; SCAFFOLD
AB Polymeric networks of poly(propylene fumarate) (PPF) crosslinked with poly(propylene fumarate)-diacrylate (PPF-DA) are currently being investigated as an injectable, biodegradable bone cement. This study examined the effect of crosslinking density, medium pH, and the incorporation of a beta-tricalcium phosphate (beta-TCP) filler on the in vitro degradation of PPF/PPF-DA. Cylindrical specimens were submerged in buffered saline at 37degreesC and the change in weight, geometry, and compressive mechanical properties were monitored over a 52-week period. All formulations showed an initial increase in modulus and yield strength over the first 12 weeks, achieving maxima of 1307 +/- 101 and 51 +/- 3 MPa, respectively, for the beta-TCP composite. PPF/PPF-DA networks with the lower crossfinking density demonstrated the greatest degradation with a 17% mass loss. Samples in the lower buffer pH 5.0 compared to physiological pH 7.4 did not show any differences in mass loss, but exhibited a faster decrease in the compressive strength over time. The beta-TCP composites maintained their mechanical properties at the level following their initial increase. These results show that the degradation of PPF/PPF-DA networks can be controlled by the crosslinking density, accelerated at a lower pH, and prolonged with the incorporation of the beta-TCP filler. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Rice Univ, Dept Bioengn, Inst Biosci & Bioengn, Houston, TX 77251 USA.
   Univ Texas, Hlth Sci Ctr, Dept Orthopaed Surg, Houston, TX 77030 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, Inst Biosci & Bioengn, POB 1892,MS-142, Houston, TX 77251 USA.
OI Ambrose, Catherine/0000-0002-3866-0683
FU NIDCR NIH HHS [R01 DE 13031]
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Bruining MJ, 2000, BIOMATERIALS, V21, P595, DOI 10.1016/S0142-9612(99)00223-9
   DANIELS AU, 1994, J APPL BIOMATER, V5, P51, DOI 10.1002/jab.770050108
   Eck Jason C, 2002, Am J Orthop (Belle Mead NJ), V31, P123
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Frazier DD, 1997, J BIOMED MATER RES, V35, P383, DOI 10.1002/(SICI)1097-4636(19970605)35:3<383::AID-JBM12>3.0.CO;2-G
   Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100
   GRESSER JD, 1995, J BIOMED MATER RES, V29, P1241, DOI 10.1002/jbm.820291011
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Jang JS, 2002, J NEUROSURG, V96, P131, DOI 10.3171/spi.2002.96.1.0131
   Kikuchi M, 2001, KEY ENG MATER, V192, P677
   Kim BS, 2000, BIOMATERIALS, V21, P259, DOI 10.1016/S0142-9612(99)00174-X
   LOONEY MA, 1986, J BIOMED MATER RES, V20, P555, DOI 10.1002/jbm.820200503
   McKoy BE, 2000, J BIOMED MATER RES, V53, P216, DOI 10.1002/(SICI)1097-4636(2000)53:3<216::AID-JBM5>3.3.CO;2-F
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Peter SJ, 1997, TISSUE ENG, V3, P207, DOI 10.1089/ten.1997.3.207
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   Suuronen R, 1998, J ORAL MAXIL SURG, V56, P604, DOI 10.1016/S0278-2391(98)90461-X
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Timmer MD, 2002, MACROMOLECULES, V35, P4373, DOI 10.1021/ma020028q
   TIMMER MD, UNPUB J BIOMED MAT R
   Tracy MA, 1999, BIOMATERIALS, V20, P1057, DOI 10.1016/S0142-9612(99)00002-2
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
NR 27
TC 87
Z9 92
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2003
VL 24
IS 4
BP 571
EP 577
AR PII S0142-9612(02)00368-X
DI 10.1016/S0142-9612(02)00368-X
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 620YK
UT WOS:000179561600005
PM 12437951
DA 2018-10-19
ER

PT J
AU Yang, YZ
   Ong, JL
   Tian, J
AF Yang, YZ
   Ong, JL
   Tian, J
TI Deposition of highly adhesive ZrO2 coating on Ti and CoCrMo implant
   materials using plasma spraying
SO BIOMATERIALS
LA English
DT Article
DE zirconia; coatings titanium; CoCrMo alloy; plasma spraying
ID IN-VITRO EVALUATION; MECHANICAL-PROPERTIES; STABILIZED ZIRCONIA; WEAR;
   HIP; CERAMICS; TITANIUM; PHASE; BIOMATERIAL; PARTICLES
AB ZrO2 (4%CeO2) and ZrO2 (3%Y2O3) coatings were deposited on titanium (Ti) and CoCrMo implants using plasma spraying and the adhesive, morphological and structural properties of the plasma-sprayed coatings were evaluated. Characterization of these coatings was performed using X-ray diffraction (XRD), scanning electron microscopy (SEM), surface roughness, hardness, and adhesive strength. XRD patterns showed that both the coatings appeared to be primitive tetragonal phase. SEM observations showed that both the ZrO2 coatings appeared to be rough, porous and melted. The cross-section surface morphology of the coatings, coating-substrate interfaces and substrates without acid etching was very dense and smooth. After acid etching, as compared to the dense ZrO, coating-CoCrMo substrate interfaces, the thin gaps appeared within the Zi-O-2, coating-Ti substrate interfaces. It is suggested that plasma spraying probably formed an amorphous Ti layer in the coating-Ti substrate interface that can be removed by acid etching. The average surface roughness of ZrO2 (3%Y2O3) and ZrO, (4%CeO2) coatings was correlated to the starting powder size and substrates. No significant difference between the hardness of all coatings and substrates was observed. The adhesive strengths of ZrO, (4%CeO2,) coating to Ti and CoCrMo substrates were higher than 68 Wa and significantly greater than that of ZrO, (3%Y2O3) coatings. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, San Antonio, TX 78229 USA.
   Tsinghua Univ, Beijing Fine Ceram Lab, Beijing 100084, Peoples R China.
   Univ Texas, Hlth Sci Ctr, Ctr Clin Bioengn, San Antonio, TX 78229 USA.
RP Yang, YZ (reprint author), Univ Texas, Hlth Sci Ctr, Dept Restorat Dent, Div Biomat, 7703 Floyd Curl Dr,MSC 7890, San Antonio, TX 78229 USA.
EM yangy3@uthscsa.edu
FU NIAMS NIH HHS [1R01 AR 46581]
CR Adolfsson E, 1999, BIOMATERIALS, V20, P1263, DOI 10.1016/S0142-9612(99)00018-6
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, P7
   BENABDALLAH A, 1991, WEAR, V142, P43
   Bender SA, 2000, BIOMATERIALS, V21, P299, DOI 10.1016/S0142-9612(99)00183-0
   BUNSHAH RF, 1982, DEPOSITION TECHNOLOG, P1
   CHEVALIER J, 1977, BIOCERAMICS, V10, P135
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   CLARKE IC, 1992, CLIN ORTHOP RELAT R, P19
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   GUPTA TK, 1978, J MATER SCI, V13, P1464, DOI 10.1007/BF00553200
   HARMAND M F, 1992, Clinical Materials, V11, P145
   Herman H, 1988, MRS BULL, V12, P60
   Hummer CD, 1995, J ARTHROPLASTY, V10, P848, DOI 10.1016/S0883-5403(05)80085-3
   *ISO TC, 1995, 150SC1 ISO TC
   Ito A., 1993, Clinical Materials, V12, P203, DOI 10.1016/0267-6605(93)90074-H
   KUMAR P, 1990, ADV BIOMAT, V9, P373
   Li J., 1993, Clinical Materials, V12, P197, DOI 10.1016/0267-6605(93)90073-G
   OKA M, 1992, BIOCERAMICS, V5, P373
   ONG JL, 1999, CRIT REV BIOMED ENG, V28, P667
   OONISHI H, 1996, BIOCERAMICS, V9, P503
   Palka V, 1998, BIOMATERIALS, V19, P1763, DOI 10.1016/S0142-9612(98)00087-8
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   REED JS, 1977, MATER RES BULL, V12, P949, DOI 10.1016/0025-5408(77)90017-4
   RICHTER HG, 1995, CERAM T, V48, P73
   RIETH PH, 1976, AM CERAM SOC BULL, V55, P717
   SALOMONI A, 1994, J MATER SCI-MATER M, V5, P651, DOI 10.1007/BF00120349
   SCOTT HG, 1975, J MATER SCI, V10, P1527, DOI 10.1007/BF01031853
   SHACHEFORD JF, 1999, MAT SCI FORUM, V29
   Standard O. C., 1998, Key Engineering Materials, V153-154, P251
   STREICHER RM, 1991, CERAMICS SUBSTITUTIV, P197
   Subbarao E.C., 1981, ADV CERAM, V3, P1
   THEUNISSEN GSAM, 1992, J MATER SCI, V27, P4429, DOI 10.1007/BF00541576
   TIAN JM, 2000, UNPUB RES REPORT IMP
   Willmann G, 1996, BIOMATERIALS, V17, P2157, DOI 10.1016/0142-9612(96)00042-7
   Yang YZ, 2000, J BIOMED MATER RES, V52, P333, DOI 10.1002/1097-4636(200011)52:2<333::AID-JBM12>3.3.CO;2-K
   Yang YZ, 2002, BIOMATERIALS, V23, P1383, DOI 10.1016/S0142-9612(01)00259-9
   Yang YZ, 2001, J BIOMED MATER RES, V55, P442, DOI 10.1002/1097-4636(20010605)55:3<442::AID-JBM1034>3.3.CO;2-9
   YANG YZ, IN PRESS J BIOMED MA
NR 41
TC 48
Z9 51
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2003
VL 24
IS 4
BP 619
EP 627
AR PII S0142-9612(02)00376-9
DI 10.1016/S0142-9612(02)00376-9
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 620YK
UT WOS:000179561600010
PM 12437956
DA 2018-10-19
ER

PT J
AU Chiarini, A
   Petrini, P
   Bozzini, S
   Dal Pra, I
   Armato, U
AF Chiarini, A
   Petrini, P
   Bozzini, S
   Dal Pra, I
   Armato, U
TI Silk fibroin/poly(carbonate)-urethane as a substrate for cell growth: in
   vitro interactions with human cells
SO BIOMATERIALS
LA English
DT Article
DE silk fibroin; poly(carbonate) urethanes; human fibroblasts;
   cytocompatibility; proinflammatory cytokines
ID HUMAN DERMAL FIBROBLASTS; TUMOR-NECROSIS-FACTOR; HUMAN-DIPLOID
   FIBROBLASTS; IN-VITRO; INTERLEUKIN-6 EXPRESSION; CULTURED FIBROBLASTS;
   COLLAGEN PRODUCTION; VASCULAR GRAFT; FACTOR-ALPHA; FIBROIN
AB Silk fibroin (SF)-based or -coated biomaterials are likely to be endowed with structural and surface properties that render them particularly apt for biomedical applications. In this work we investigated the behavior of four different strains of normal human adult fibroblasts that had been seeded onto membranes made tip of poly(carbonate) urethane (PCU), the surfaces of which had or had not been homogeneously coated with SF. Cell adhesion within 3 h to the SF-coated PCU films was 2.2-fold that to their uncoated homologues. After 30 days of incubation in vitro, 2.5-fold more cells had grown on the SF-coated specimens than on the uncoated ones. This enhanced cell adherence and hence growth on the SF-coated surfaces Was Coupled with higher cumulative rates Of D-glucose (but not L-glutamine) Uptake and of both lactate and interleukin-6 (IL-6) cumulative secretion. Conversely, human fibroblasts Cultured on either type of PCU scaffolds never secreted any ELISA-assayable amount of three main proinflammatory cytokines, namely interleukin-1beta (IL-1beta), tumor necrosis factor-alpha (TNF-alpha.), and transforming growth factor-beta1 (TGF-beta1). Finally, when the metabolic activities were compared on a per 10(5) cells basis, it became clear that the adhesion to SF favored an initially higher consumption of D-glucose, a late higher release of IL-6, and an at-first more intense, but declining, extracellular assembly of type I collagen fibers. Overall, these results show that SF-coated PCU membranes represent a novel type of biomaterial that favors the adhesion, the growth and performance of specific metabolic tasks by normal human adult fibroblasts without eliciting any concurrent secretion of some of the chief proinflammatory cytokines. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Dept Biomed & Surg Sci, Histol & Embryol Unit, Verona, Italy.
   Politecn Milan, Lab Biomat, Dept Bioengn, I-20133 Milan, Italy.
RP Chiarini, A (reprint author), Dept Biomed & Surg Sci, Histol & Embryol Unit, Verona, Italy.
EM anna.chiarini@univr.it
RI Petrini, Paola/A-3150-2013; Chiarini, Anna/F-4097-2011
OI Petrini, Paola/0000-0002-5081-5254; Chiarini, Anna/0000-0002-6974-7685
CR ARMATO U, 1986, CELL TISSUE RES, V245, P471
   BARHAM D, 1972, ANALYST, V97, P142, DOI 10.1039/an9729700142
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   Boxman ILA, 1996, ARCH DERMATOL RES, V288, P391, DOI 10.1007/BF02507108
   BRAUCHLE M, 1994, ONCOGENE, V9, P3199
   Brenneisen P, 1999, FEBS LETT, V449, P36, DOI 10.1016/S0014-5793(99)00402-0
   BUTLER DM, 1994, EUR CYTOKINE NETW, V5, P441
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   DUNCAN MR, 1991, J INVEST DERMATOL, V97, P686, DOI 10.1111/1523-1747.ep12483971
   Edwards A, 1998, J BIOMATER APPL, V13, P23, DOI 10.1177/088532829801300102
   Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933
   ELIAS JA, 1990, ANN NY ACAD SCI, V580, P233, DOI 10.1111/j.1749-6632.1990.tb17932.x
   FEHGALI CA, 1992, CLIN IMMUNOL IMMUNOP, V63, P182
   Gotoh Y, 1997, BIOMATERIALS, V18, P267, DOI 10.1016/S0142-9612(96)00137-8
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   HERGENROTHER RW, 1992, BIOMATERIALS, V13, P240
   HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kesenci K, 2001, J BIOMAT SCI-POLYM E, V12, P337, DOI 10.1163/156856201750180852
   Lee TY, 1999, ANN PLAS SURG, V43, P179
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   Liechty KW, 2000, CYTOKINE, V12, P671, DOI 10.1006/cyto.1999.0598
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   Maruyama Kohji, 1995, Journal of Dermatology (Tokyo), V22, P901
   MATEO RB, 1994, AM J PHYSIOL, V266, pR1840
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   MAUVIEL A, 1991, J INVEST DERMATOL, V96, P243, DOI 10.1111/1523-1747.ep12462185
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MOTTA A, 1999, 3 INT S FRONT BIOM P, P26
   Ninomiya JT, 2001, J ORTHOPAED RES, V19, P621, DOI 10.1016/S0736-0266(00)00061-9
   Norihiko M., 1995, J BIOMED MATER RES, V29, P1215
   Paquet P, 1996, INT ARCH ALLERGY IMM, V109, P308, DOI 10.1159/000237257
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Phaneuf MD, 1997, J BIOMATER APPL, V12, P100, DOI 10.1177/088532829701200202
   RAMPINO T, 1994, NEPHROL DIAL TRANSPL, V9, P1560
   REVILLARD JP, 2001, CYTOKINES CYTOKINE R
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Salacinski HJ, 2000, EUR J VASC ENDOVASC, V20, P342, DOI 10.1053/ejvs.2000.1185
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schmalz G, 1998, BIOMATERIALS, V19, P1689, DOI 10.1016/S0142-9612(98)00075-1
   Skutek M, 2001, KNEE SURG SPORT TR A, V9, P322
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Sun YY, 1997, J APPL POLYM SCI, V65, P959, DOI 10.1002/(SICI)1097-4628(19970801)65:5<959::AID-APP14>3.0.CO;2-N
   Takemura H, 1998, J RHEUMATOL, V25, P1534
   Tanzi MC, 2000, J BIOMATER APPL, V14, P325, DOI 10.1106/7TJU-H1YA-4NYT-XL84
   TAUBMAN MB, 1974, SCIENCE, V186, P1115, DOI 10.1126/science.186.4169.1115
   TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158
   UNEMORI EN, 1994, EXP CELL RES, V210, P166, DOI 10.1006/excr.1994.1025
   VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597
   WACLTI ER, 1992, J INVEST DERMATOL, V98, P805
   Xue H, 2000, J BURN CARE REHABIL, V21, P142, DOI 10.1097/00004630-200021020-00010
   Zhang Z, 2001, J BIOMED MATER RES, V57, P63, DOI 10.1002/1097-4636(200110)57:1<63::AID-JBM1142>3.0.CO;2-L
   ZHANG Z, 1994, BIOMATERIALS, V15, P1129, DOI 10.1016/0142-9612(94)90233-X
   Zhou LJ, 2000, BRIT J DERMATOL, V143, P506, DOI 10.1111/j.1365-2133.2000.03702.x
   ZIELKE HR, 1980, J CELL PHYSIOL, V104, P433, DOI 10.1002/jcp.1041040316
   ZIELKE HR, 1978, J CELL PHYSIOL, V95, P41
NR 61
TC 91
Z9 116
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2003
VL 24
IS 5
BP 789
EP 799
AR PII S0142-9612(02)00417-9
DI 10.1016/S0142-9612(02)00417-9
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637AH
UT WOS:000180489100010
PM 12485797
DA 2018-10-19
ER

PT J
AU Lim, SM
   Kim, G
   Gurau, M
   Cremer, PS
AF Lim, SM
   Kim, G
   Gurau, M
   Cremer, PS
TI Vibrational sum frequency spectroscopy on biomaterial interaction with
   surfaces
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the Biophysical-Society
CY MAR 01-05, 2003
CL SAN ANTONIO, TEXAS
SP Biophys Soc, Axon Instruments, ALA Sci Instruments
C1 Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 2003
VL 84
IS 2
SU S
BP 45A
EP 45A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 682ZW
UT WOS:000183123800216
DA 2018-10-19
ER

PT J
AU Chrisey, DB
   Pique, A
   McGill, RA
   Horwitz, JS
   Ringeisen, BR
   Bubb, DM
   Wu, PK
AF Chrisey, DB
   Pique, A
   McGill, RA
   Horwitz, JS
   Ringeisen, BR
   Bubb, DM
   Wu, PK
TI Laser deposition of polymer and biomaterial films
SO CHEMICAL REVIEWS
LA English
DT Review
ID FREE-ELECTRON LASERS; POLY(METHYL METHACRYLATE) FILMS; IMPLANTATION
   TECHNIQUES LIMIT; FLUOROPOLYMER THIN-FILMS; FLIGHT MASS-SPECTROMETRY;
   ABLATION DEPOSITION; ASSISTED DEPOSITION; MOLECULAR IMPLANTATION;
   EVAPORATION MAPLE; XECL LASER
C1 USN, Res Lab, Washington, DC 20375 USA.
   Seton Hall Univ, S Orange, NJ 07079 USA.
   So Oregon Univ, Ashland, OR 97520 USA.
RP Chrisey, DB (reprint author), USN, Res Lab, Washington, DC 20375 USA.
CR Agarwal G, 1998, MAT SCI ENG C-BIO S, V6, P13, DOI 10.1016/S0928-4931(97)00070-2
   Agarwal G, 1999, NANOTECHNOLOGY, V10, P336, DOI 10.1088/0957-4484/10/3/318
   Albert KJ, 2000, ANAL CHEM, V72, P1947, DOI 10.1021/ac991397w
   Allwood DA, 1999, CHEM PHYS LETT, V301, P91, DOI 10.1016/S0009-2614(98)01452-3
   ANDREW JE, 1983, APPL PHYS LETT, V43, P717, DOI 10.1063/1.94488
   Baudach S, 2000, APPL SURF SCI, V154, P555, DOI 10.1016/S0169-4332(99)00474-2
   BLANCHET GB, 1995, MACROMOLECULES, V28, P4603, DOI 10.1021/ma00117a034
   BLANCHET GB, 1993, APPL PHYS LETT, V62, P479, DOI 10.1063/1.108939
   BLANCHET GB, 1993, APPL PHYS LETT, V62, P1026, DOI 10.1063/1.108514
   BLANCHET GB, 1993, SCIENCE, V262, P719, DOI 10.1126/science.262.5134.719
   BLANCHET GB, 1994, ADV MATER, V6, P881, DOI 10.1002/adma.19940061120
   Borman S, 2000, CHEM ENG NEWS, V78, P31, DOI 10.1021/cen-v078n031.p031
   BRANNON JH, 1985, J APPL PHYS, V58, P2036, DOI 10.1063/1.336012
   BRANNON JH, 1985, J APPL PHYS, V2036, P58
   BRAU CA, 1988, SCIENCE, V239, P1115, DOI 10.1126/science.239.4844.1115
   Bubb DM, 2002, APPL PHYS A-MATER, V74, P123, DOI 10.1007/s003390101010
   Bubb DM, 2001, APPL PHYS A-MATER, V73, P121, DOI 10.1007/s003390100884
   Bubb DM, 2002, CHEM PHYS LETT, V352, P135, DOI 10.1016/S0009-2614(01)01423-3
   Bubb DM, 2002, J APPL PHYS, V91, P9809, DOI 10.1063/1.1478136
   Bubb DM, 2002, J APPL PHYS, V91, P2055, DOI 10.1063/1.1427138
   Bubb DM, 2001, J APPL PHYS, V89, P5739, DOI 10.1063/1.1362405
   Bubb DM, 2001, J VAC SCI TECHNOL A, V19, P2698, DOI 10.1116/1.1387052
   Bubb DM, 2001, APPL PHYS LETT, V79, P2847, DOI 10.1063/1.1406556
   CHAUDHARI GN, 1993, APPL PHYS A-MATER, V56, P353, DOI 10.1007/BF00324355
   CHAUDHARI GN, 1991, PHYS STATUS SOLIDI A, V128, pK57, DOI 10.1002/pssa.2211280141
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Chrisey DB, 2000, APPL SURF SCI, V154, P593, DOI 10.1016/S0169-4332(99)00465-1
   Colson WB, 2002, PHYS TODAY, V55, P35, DOI 10.1063/1.1457263
   Corbisier P, 1997, RES MICROBIOL, V148, P534, DOI 10.1016/S0923-2508(97)88360-X
   Das A, 1998, APPL SURF SCI, V135, P37, DOI 10.1016/S0169-4332(98)00305-5
   Edwards GS, 1996, IEEE J SEL TOP QUANT, V2, P810, DOI 10.1109/2944.577303
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   FEIT MD, 1998, APPL SURF SCI, V869, P127
   Fitz-Gerald JM, 2000, APPL PHYS LETT, V76, P1386, DOI 10.1063/1.126040
   Fitz-Gerald JM, 1999, J MATER RES, V14, P3281, DOI 10.1557/JMR.1999.0444
   Fukumura H, 1996, APPL SURF SCI, V96-8, P569, DOI 10.1016/0169-4332(95)00532-3
   FUKUMURA H, 1994, J AM CHEM SOC, V116, P10304, DOI 10.1021/ja00101a062
   Fukumura H, 1998, APPL SURF SCI, V127, P761, DOI 10.1016/S0169-4332(97)00737-X
   Fukumura H, 1997, J PHOTOCH PHOTOBIO A, V106, P3, DOI 10.1016/S1010-6030(97)00030-0
   Gery G, 1998, CHEM COMMUN, P811, DOI 10.1039/a708539g
   Gery G, 1997, J PHYS CHEM B, V101, P3698, DOI 10.1021/jp9637136
   GITAY M, 1991, APPL PHYS LETT, V58, P197, DOI 10.1063/1.104921
   Goto M, 2001, J APPL PHYS, V90, P4755, DOI 10.1063/1.1407315
   Goto M, 2000, APPL SURF SCI, V154, P701, DOI 10.1016/S0169-4332(99)00469-9
   Goto M, 1999, JPN J APPL PHYS 2, V38, pL87, DOI 10.1143/JJAP.38.L87
   Goto M, 1999, APPL PHYS A-MATER, V69, pS257, DOI 10.1007/s003390051395
   Graves DJ, 1998, ANAL CHEM, V70, P5085, DOI 10.1021/ac980456n
   Guschin D, 1997, ANAL BIOCHEM, V250, P203, DOI 10.1006/abio.1997.2209
   Haglund RF, 1994, LASER ABLATION PRINC
   HANSEN SG, 1988, APPL PHYS LETT, V52, P81, DOI 10.1063/1.99332
   HANSEN SG, 1988, J APPL PHYS, V64, P2122, DOI 10.1063/1.341722
   HARRIS JM, 1991, ACS SYM SER, V467, P418
   Henry CM, 2000, CHEM ENG NEWS, V78, P49, DOI 10.1021/cen-v078n028.p049
   Hobley J, 2000, MOL CRYST LIQ CRYST, V345, P623
   Hobley J, 1999, APPL PHYS A-MATER, V69, pS945, DOI 10.1007/s003390051564
   Ina E, 1998, APPL SURF SCI, V127, P574, DOI 10.1016/S0169-4332(97)00708-3
   Inayoshi M, 1996, J VAC SCI TECHNOL A, V14, P1981, DOI 10.1116/1.580071
   JIANG WB, 1995, J MATER RES, V10, P1038, DOI 10.1557/JMR.1995.1038
   KALE S, 1992, MATER LETT, V15, P260, DOI 10.1016/0167-577X(92)90081-T
   KANEKO Y, 1998, BIORELATED POLYM GEL, P29
   Karnakis DM, 1998, APPL SURF SCI, V127, P781, DOI 10.1016/S0169-4332(97)00742-3
   Katoh T, 1996, APPL PHYS LETT, V68, P865, DOI 10.1063/1.116526
   Kishimoto M, 2001, ADV MATER, V13, P1155, DOI 10.1002/1521-4095(200108)13:15<1155::AID-ADMA1155>3.0.CO;2-O
   Li ST, 1998, APPL SURF SCI, V125, P17, DOI 10.1016/S0169-4332(97)00398-X
   Luo Q, 1997, APPL SURF SCI, V108, P89, DOI 10.1016/S0169-4332(96)00545-4
   Mar MN, 1999, SENSOR ACTUAT B-CHEM, V54, P125, DOI 10.1016/S0925-4005(98)00330-X
   Matsumoto N, 1997, APPL PHYS LETT, V71, P2469, DOI 10.1063/1.120114
   McGill RA, 1998, IEEE T ULTRASON FERR, V45, P1370, DOI 10.1109/58.726464
   MIOTELLO A, 1995, APPL PHYS LETT, V3535, P67
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   Modi R, 2001, J MATER RES, V16, P3214, DOI 10.1557/JMR.2001.0443
   MONTAUDO G, 1995, RAPID COMMUN MASS SP, V9, P453, DOI 10.1002/rcm.1290090514
   NELSON RW, 1990, RAPID COMMUN MASS SP, V4, P348, DOI 10.1002/rcm.1290040911
   Nishio S, 1997, SYNTHETIC MET, V84, P367, DOI 10.1016/S0379-6779(97)80785-0
   Nishio S, 1996, J APPL PHYS, V79, P7198, DOI 10.1063/1.361522
   Nishio S, 1998, J PHOTOCH PHOTOBIO A, V116, P245, DOI 10.1016/S1010-6030(98)00311-6
   Nishio S, 1996, APPL SURF SCI, V106, P132, DOI 10.1016/S0169-4332(96)00384-4
   Nishio S, 1996, SYNTHETIC MET, V83, P67, DOI 10.1016/S0379-6779(97)80054-9
   Nishio S, 1998, APPL SURF SCI, V127, P589, DOI 10.1016/S0169-4332(97)00711-3
   NOHMI T, 1992, J AM CHEM SOC, V114, P3241, DOI 10.1021/ja00035a012
   Norton MG, 1996, APPL SURF SCI, V96-8, P617, DOI 10.1016/0169-4332(95)00555-2
   Odde DJ, 1999, TRENDS BIOTECHNOL, V17, P385, DOI 10.1016/S0167-7799(99)01355-4
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.0.CO;2-F
   OREAR JG, 1971, J PAINT TECHNOL, V43, P113
   Pancrazio JJ, 1999, ANN BIOMED ENG, V27, P697, DOI 10.1114/1.225
   Patel N, 1998, FASEB J, V12, P1447
   Phadke RS, 1998, MAT SCI ENG C-BIOMIM, V5, P237, DOI 10.1016/S0928-4931(97)00051-9
   Pique A, 1998, MATER RES SOC SYMP P, V526, P421, DOI 10.1557/PROC-526-421
   Pique A, 1999, APPL PHYS A-MATER, V69, pS279, DOI 10.1007/s003390051400
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   Pique A, 2000, J MATER RES, V15, P1872, DOI 10.1557/JMR.2000.0271
   Ptitsyn LR, 1997, APPL ENVIRON MICROB, V63, P4377
   Ringeisen BR, 2002, BIOTECHNOL PROGR, V18, P1126, DOI 10.1021/bp015516g
   Ringeisen BR, 2002, BIOMATERIALS, V23, P161, DOI 10.1016/S0142-9612(01)00091-6
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   RINGEISEN BR, GENERATION LIVING CE
   RUBENCHIK AM, 1998, APPL SURF SCI, V193, P127
   Salih AJ, 1996, APPL PHYS LETT, V69, P2231, DOI 10.1063/1.117137
   Salih AJ, 1998, J NON-CRYST SOLIDS, V227, P1240, DOI 10.1016/S0022-3093(98)00306-8
   Salih AJ, 1997, PHIL MAG LETT, V75, P169, DOI 10.1080/095008397179732
   Schwodiauer R, 1999, J POLYM SCI POL PHYS, V37, P2115, DOI 10.1002/(SICI)1099-0488(19990815)37:16<2115::AID-POLB14>3.0.CO;2-W
   Schwodiauer R, 1998, APPL PHYS LETT, V73, P2941, DOI 10.1063/1.122637
   SERAFETINIDES AA, 2001, APPL SURF SCI, V42, P180
   SMITH HM, 1965, APPL OPTICS, V4, P147, DOI 10.1364/AO.4.000147
   SRINIVASAN R, 1986, MACROMOLECULES, V19, P916, DOI 10.1021/ma00157a074
   SRINIVASAN R, 1989, CHEM REV, V89, P1303, DOI 10.1021/cr00096a003
   SRINIVASAN R, 1986, SCIENCE, V559, P234
   Stevens MA, 1999, SYNTHETIC MET, V101, P234, DOI 10.1016/S0379-6779(98)01293-4
   Suggs L.J., 1998, POLYM TISSUE ENG, P99
   Suzuki M, 1998, MAT SCI ENG A-STRUCT, V246, P36, DOI 10.1016/S0921-5093(97)00730-2
   Suzuki M, 2001, J PHOTOCH PHOTOBIO A, V145, P223, DOI 10.1016/S1010-6030(01)00586-X
   TALTON J, 2000, P RESP DRUG DELIVERY, V1, P67
   TEMKIN AY, 1999, LASER ENG, V239, P9
   TOULOUKIAN YS, 1973, THERMAL DIFFUSIVITY, P605
   Tsuboi Y, 1999, APPL PHYS LETT, V74, P3896, DOI 10.1063/1.124216
   Tsuboi Y, 1999, J APPL PHYS, V85, P4189, DOI 10.1063/1.370330
   Tsuboi Y, 2001, J APPL PHYS, V89, P7917, DOI 10.1063/1.1371266
   Tsuboi Y, 1998, CHEM LETT, P521, DOI 10.1246/cl.1998.521
   UENO Y, 1994, APPL PHYS LETT, V65, P1370, DOI 10.1063/1.112055
   Vansteenkiste SO, 2000, LANGMUIR, V16, P3330, DOI 10.1021/la981740c
   Vertes A., 1993, LASER IONIZATION MAS
   VONDERLINDE D, 2000, APPL SURF SCI, V1, P154
   Wu PK, 2001, THIN SOLID FILMS, V398, P607, DOI 10.1016/S0040-6090(01)01347-5
   WU PK, IN PRESS REV SCI INS
   WU PK, 2001, J APPL PHYS, V3623, P90
   WU PK, 2000, MATER RES SOC S P, P617
   YAU WW, 1979, MODERN SIZE EXCLUSIO
   Yershov G, 1996, P NATL ACAD SCI USA, V93, P4913, DOI 10.1073/pnas.93.10.4913
   Young D, 2002, APPL SURF SCI, V197, P181, DOI 10.1016/S0169-4332(02)00322-7
   YUDASAKA M, 1994, APPL PHYS LETT, V64, P3237, DOI 10.1063/1.111321
   Zeng XY, 1999, J MATER RES, V14, P232, DOI 10.1557/JMR.1999.0035
   Zeng XY, 1999, APPL SURF SCI, V140, P90, DOI 10.1016/S0169-4332(98)00478-4
   Zhang Y, 2001, J ELECTRON SPECTROSC, V119, P247, DOI 10.1016/S0368-2048(01)00300-0
   Zhang Y, 2000, J PHYS CHEM B, V104, P6212, DOI 10.1021/jp9934811
   ZNOTINS TA, 1987, LASER FOCUS WORLD, V23, P54
   1998, BIORELATED POLYM GEL
NR 136
TC 400
Z9 402
U1 6
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2665
EI 1520-6890
J9 CHEM REV
JI Chem. Rev.
PD FEB
PY 2003
VL 103
IS 2
BP 553
EP 576
DI 10.1021/cr010428w
PG 24
WC Chemistry, Multidisciplinary
SC Chemistry
GA 645QB
UT WOS:000180988900010
PM 12580642
DA 2018-10-19
ER

PT J
AU Tsukamoto, M
   Fujihara, T
   Abe, N
   Miyake, S
   Katto, M
   Nakayama, T
   Akedo, J
AF Tsukamoto, M
   Fujihara, T
   Abe, N
   Miyake, S
   Katto, M
   Nakayama, T
   Akedo, J
TI Hydroxyapatite coating on titanium plate with an ultrafine particle beam
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS
LA English
DT Article
DE hydoroxyapatite; biomaterial; coating technology; ultrafine particle
   beam; gas deposition method
ID DEPOSITION
AB A coating technology was developed to form hydroxyapatite (HAp) films on the surface of titanium (Ti) plates using an ultrafine particle (UFP) beam. The UFP beam was composed of HAp particles of submicron size. The dependence of the film's formation on the beam's incident angle was also investigated. A thick HAp film was produced at an incident angle of 0degrees, but the film did not display good adhesion to the Ti plate. At incident angles of 40degrees and 60degrees, the HAp films formed were fine, although not as thick as that formed at 0degrees. The adhesion strength between the HAp film and the Ti plate was found to be higher than 20 MPa in the films formed at both 40degrees and 60degrees.
C1 Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan.
   Kinki Univ, Osaka 5778502, Japan.
   Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058564, Japan.
RP Tsukamoto, M (reprint author), Osaka Univ, Joining & Welding Res Inst, 11-1 Mihogaoka, Osaka 5670047, Japan.
RI AKEDO, JUN/M-5992-2018
OI AKEDO, JUN/0000-0002-2956-9802
CR AKEDO J, 1998, SENSOR ACTUAT A-PHYS, V69, P107
   Choi JM, 2000, BIOMATERIALS, V21, P469, DOI 10.1016/S0142-9612(99)00186-6
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Dykhuizen RC, 1998, J THERM SPRAY TECHN, V7, P205, DOI 10.1361/105996398770350945
   ELLIES LG, 1992, BIOMATERIALS, V13, P313, DOI 10.1016/0142-9612(92)90055-S
   KASYU S, 1984, JPN J APPL PHYS, V23, pL910
   Lebedev M, 2000, J VAC SCI TECHNOL A, V18, P563, DOI 10.1116/1.582226
   ONG JL, 1994, BIOMATERIALS, V15, P337, DOI 10.1016/0142-9612(94)90245-3
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
NR 10
TC 20
Z9 20
U1 1
U2 4
PU INST PURE APPLIED PHYSICS
PI MINATO-KU TOKYO
PA DAINI TOYOKAIJI BLDG, 4-24-8 SHINBASHI, MINATO-KU TOKYO, 105-004, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 2
JI Jpn. J. Appl. Phys. Part 2 - Lett.
PD FEB 1
PY 2003
VL 42
IS 2A
BP L120
EP L122
DI 10.1143/JJAP.42.L120
PG 3
WC Physics, Applied
SC Physics
GA 648QC
UT WOS:000181161200012
DA 2018-10-19
ER

PT J
AU Sato, M
   Asazuma, T
   Ishihara, M
   Kikuchi, T
   Masuoka, K
   Ichimura, S
   Kikuchi, M
   Kurita, A
   Fujikawa, K
AF Sato, M
   Asazuma, T
   Ishihara, M
   Kikuchi, T
   Masuoka, K
   Ichimura, S
   Kikuchi, M
   Kurita, A
   Fujikawa, K
TI An atelocollagen honeycomb-shaped scaffold with a membrane seal
   (ACHMS-scaffold) for the culture of annulus fibrosus cells from an
   intervertebral disc
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tissue engineering; cultured cell; scaffold; intervertebral disc;
   annulus fibrosus; phenotype
ID EXTRACELLULAR-MATRIX; CARTILAGE FORMATION; NUCLEUS PULPOSUS; COLLAGEN;
   TISSUE; BIOMATERIAL; ALGINATE; PROTEOGLYCANS; BIOSYNTHESIS; DEGENERATION
AB The aim of this study was to investigate the possibility of using the atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) for the culture of annulus fibrosus (AF) cells in tissue engineering procedures of intervertebral disc repair. AF cells from the intervertebral discs of Japanese white rabbits were cultured for up to 3 weeks in the ACHMS-scaffold to allow a high density, three-dimensional culture. Although the DNA content in the scaffold increased at a lower rate than in the monolayer culture, scanning electron microscopy data showed that the scaffold was filled with the grown AF cells and produced extracellular matrix on day 21. The amount of type 11 collagen and its mRNA expression by the scaffold cultured cells were determined using Western blotting and Northern blotting analyses, respectively, and remained at a higher level than in the monolayer cultured cells. Furthermore, glycosaminoglycan (GAG) accumulation in the scaffold culture was at a higher level than in the monolayer culture. Western blot analysis for extracted proteoglycans from the scaffold culture also exhibited a much higher proteoglycan accumulation than the monolayer culture. These results indicate that the AF cells are able to grow and remain phenotypically stable in the scaffold. (C) 2002 Wiley Periodicals, Inc.
C1 Natl Def Med Coll, Dept Orthopaed Surg, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Inst Res, Tokorozawa, Saitama 3598513, Japan.
   Natl Def Med Coll, Dept Med Engn, Tokorozawa, Saitama 3598513, Japan.
RP Sato, M (reprint author), Natl Def Med Coll, Dept Orthopaed Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.
OI Sato, Masato/0000-0003-4049-7325
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   BURGESON RE, 1979, BIOCHEM BIOPH RES CO, V87, P1124, DOI 10.1016/S0006-291X(79)80024-8
   Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011
   ENGLERBLUM G, 1993, ANAL BIOCHEM, V210, P235, DOI 10.1006/abio.1993.1189
   EYRE DR, 1977, BIOCHIM BIOPHYS ACTA, V492, P29, DOI 10.1016/0005-2795(77)90211-2
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gan JC, 2000, J BIOMED MATER RES, V51, P596, DOI 10.1002/1097-4636(20000915)51:4<596::AID-JBM7>3.0.CO;2-O
   Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Itoh H, 2001, ARTIF ORGANS, V25, P213, DOI 10.1046/j.1525-1594.2001.025003213.x
   JOHNSTONE B, 1995, SPINE, V20, P674, DOI 10.1097/00007632-199503150-00008
   KATSUURA A, 1994, SPINE, V19, P2426, DOI 10.1097/00007632-199411000-00011
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KUMAGAI J, 1994, J ANAT, V185, P279
   Loty S, 1998, J BIOMED MATER RES, V42, P213, DOI 10.1002/(SICI)1097-4636(199811)42:2<213::AID-JBM6>3.0.CO;2-S
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Nishimura K, 1998, SPINE, V23, P1531, DOI 10.1097/00007632-199807150-00006
   OLSON EJ, 1991, SPINE, V16, P1081, DOI 10.1097/00007632-199109000-00013
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Poiraudeau S, 1999, SPINE, V24, P837, DOI 10.1097/00007632-199905010-00002
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   STEVEN LF, 1994, SPINE, V19, P1826
   TAKAGI M, 1991, J HISTOCHEM CYTOCHEM, V39, P41, DOI 10.1177/39.1.1898498
   Takaishi H, 1997, J ORTHOPAED RES, V15, P528, DOI 10.1002/jor.1100150408
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
NR 29
TC 33
Z9 34
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2003
VL 64A
IS 2
BP 249
EP 256
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 670RT
UT WOS:000182423200007
DA 2018-10-19
ER

PT J
AU Park, JH
   Bae, YH
AF Park, JH
   Bae, YH
TI Hydrogels based on poly(ethylene oxide) and poly(tetramethylene oxide)
   or poly(dimethyl siloxane). III. In vivo biocompatibility and
   biostability
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(ethylene oxide); poly(tetramethylene oxide); poly(dimethyl
   siloxane); hydrogel; biocompatibility; biostability
ID POLY(ETHERURETHANE UREA) ELASTOMERS; GIANT-CELL FORMATION; CROSS-LINKED
   POLYETHERS; SOFT SEGMENT CHEMISTRY; IN-VIVO; PROTEIN ADSORPTION;
   MACROPHAGE ADHESION; PLATELET-ADHESION; POLYURETHANE BIOSTABILITY;
   HYDROLYTIC DEGRADATION
AB To investigate the effects of polymer chemistry and topology (linear or graft copolymer) on in vivo biocompatibility and biostability based on cage implant system, various hydrogels, composed of short hydrophilic [polyethylene oxide (PEO)] and hydrophobic block, were prepared by polycondensation reaction. Poly(tetramethylene oxide) (PTMO) or poly(dimethyl siloxane) (PDMS) was chosen as a hydrophobic block because of their wide utilization as a biomaterial. By using the specimens retrieved from rats killed after 1, 2, 3, 5, and 7 weeks' implantation, cellular and material responses were assessed. Most hydrogels showed a comparable value of macrophage density to Pellethane(R), control polymer, whereas they did significantly lower foreign body giant cell (FBGC) density and coverage because of the presence of PEO. However, PEO block length and polymer topology did not affect macrophage adhesion and FBGC formation in our polymer composition. The hydrogel based on PDMS alone showed significantly lower macrophage density and FBGC density than Pellethane(R), indicating that PDMS plays a role in inhibiting cellular adhesion. The results obtained from get permeation chromatography curve and Fourier transform infrared spectra exhibited that all the polymers were susceptible to oxidative degradation in vivo. Although Pellethane(R) revealed surface degradation by 5 weeks in vivo, hydrogels showed rapid degradation in the bulk within 2 weeks because of the penetration of oxidative chemicals released from phagocytic cells into PEO domain of phase-separated hydrogels. The more significant degradation was observed in the hydrogels with longer PEO block and PTMO as a hydrophobic block instead of PDMS. It was evident that the minor degradation could be achieved by grafting PEO and adopting PDMS as a hydrophobic block in the hydrogel. (C) 2002 Wiley Periodicals, Inc.
C1 Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, Puk Gu, Kwangju 500712, South Korea.
RP Bae, YH (reprint author), Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, Puk Gu, 1 Oryong Dong, Kwangju 500712, South Korea.
RI Park, Jae Hyung/B-5967-2018; byun, jaehyun/G-5584-2014
CR ABRAMSON SL, 1990, J IMMUNOL, V144, P625
   Anderson James M., 1996, P165
   Anderson JM, 1998, POLYM INT, V46, P163, DOI 10.1002/(SICI)1097-0126(199807)46:3<163::AID-PI972>3.0.CO;2-9
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ARNOLD DW, 1995, J CHEM PHYS, V102, P6088, DOI 10.1063/1.469343
   Chan C.M., 1994, POLYM SURFACE MODIFI, P1
   Chen Z, 1999, J BIOMAT SCI-POLYM E, V10, P901
   Chinn JA, 1998, J BIOMED MATER RES, V39, P130, DOI 10.1002/(SICI)1097-4636(19980101)39:1<130::AID-JBM15>3.0.CO;2-J
   Fare S, 1999, J BIOMED MATER RES, V45, P62, DOI 10.1002/(SICI)1097-4636(199904)45:1<62::AID-JBM9>3.0.CO;2-F
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   Hsu S, 2000, POLYM DEGRAD STABIL, V67, P171, DOI 10.1016/S0141-3910(99)00110-X
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P819, DOI 10.1002/jbm.820280709
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KLANING UK, 1994, J PHYS CHEM-US, V98, P8946, DOI 10.1021/j100087a022
   Labow RS, 1996, BIOMATERIALS, V17, P2381, DOI 10.1016/S0142-9612(96)00088-9
   LABOW RS, 1995, BIOMATERIALS, V16, P51, DOI 10.1016/0142-9612(95)91096-H
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lee E, 1997, ECON IND DEMOCRACY, V18, P35, DOI 10.1177/0143831X97181002
   Lee HJ, 2000, COLLOID SURFACE B, V18, P355, DOI 10.1016/S0927-7765(99)00161-7
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   Martin DJ, 2000, BIOMATERIALS, V21, P1021, DOI 10.1016/S0142-9612(99)00271-9
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   Maurin N, 1997, J BIOMED MATER RES, V34, P73
   McCarthy SJ, 1997, BIOMATERIALS, V18, P1387, DOI 10.1016/S0142-9612(97)00083-5
   MEIJS GF, 1993, J BIOMED MATER RES, V27, P345, DOI 10.1002/jbm.820270308
   PAPADIMITRIOU J, 1975, AM J PATHOL, V78, P342
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   PARK JH, 2002, UNPUB PHYSICAL PROPE
   Pol BJM, 1996, J BIOMED MATER RES, V32, P321
   Pol BJM, 1996, J BIOMED MATER RES, V32, P307
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Satulovsky J, 2000, P NATL ACAD SCI USA, V97, P9037, DOI 10.1073/pnas.150236197
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   Schubert MA, 1997, J BIOMED MATER RES, V35, P319, DOI 10.1002/(SICI)1097-4636(19970605)35:3<319::AID-JBM6>3.0.CO;2-K
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   STOKES K, 1984, POLYURETHANES BIOMED, P243
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Tang YW, 1997, BIOMATERIALS, V18, P37, DOI 10.1016/S0142-9612(96)00101-9
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   VOGLER EA, 2001, WATER BIOMATERIALS S, pCH6
   Welle A, 1998, J COLLOID INTERF SCI, V197, P263, DOI 10.1006/jcis.1997.5238
   Wu LM, 2000, POLYM DEGRAD STABIL, V70, P65, DOI 10.1016/S0141-3910(00)00089-6
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
   WU Y, 1991, J BIOMED MATER RES, V25, P725, DOI 10.1002/jbm.820250604
   XI TF, 1994, J BIOMED MATER RES, V28, P483, DOI 10.1002/jbm.820280411
   ZHANG Z, 1994, BIOMATERIALS, V15, P1129, DOI 10.1016/0142-9612(94)90233-X
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 55
TC 24
Z9 24
U1 0
U2 15
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2003
VL 64A
IS 2
BP 309
EP 319
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 670RT
UT WOS:000182423200014
DA 2018-10-19
ER

PT J
AU Brodbeck, WG
   Voskerician, G
   Ziats, NP
   Nakayama, Y
   Matsuda, T
   Anderson, JM
AF Brodbeck, WG
   Voskerician, G
   Ziats, NP
   Nakayama, Y
   Matsuda, T
   Anderson, JM
TI In vivo leukocyte cytokine mRNA responses to biomaterials are dependent
   on surface chemistry
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatibility; cytokines; inflammation; leukocytes; wound healing
ID GIANT-CELL FORMATION; CAGE IMPLANT SYSTEM; IN-VIVO; MONOCYTES
   MACROPHAGES; EXPRESSION; BIOCOMPATIBILITY; INTERLEUKIN-4; INVITRO;
   FUSION; ADHESION
AB An in vivo mouse cage implant system was used to determine whether leukocyte cytokine mRNA responses to implanted biomaterials were dependent on surface chemistry. Surfaces displaying various chemistries (hydrophobic, hydrophilic, anionic, and cationic) were placed into stainless steel cages and implanted subcutaneously. Semiquantitative RT-PCR analyses revealed that hydrophilic surfaces showed a decreased expression of proinflammatory cytokines, IL-6 and IL-8, and pro-wound healing cytokines, IL-10 and TGF-beta by adherent cells, and mRNA levels of the proinflammatory cytokine, IL-1beta, and the pro-wound healing cytokine IL-13 were decreased in surrounding, exudate cells. Cytokine responses by adherent and exudate cells to hydrophobic, anionic and cationic surfaces were similar and indicative of a strong inflammatory response at the earliest time point followed by a wound healing response at later time points. However, no differences in the types or levels of exudate cells for any of the surfaces or the empty cage at each of the respective time points were observed, indicating their respective biocompatibility. These studies identify hydrophilic surface chemistries as having significant effects on leukocyte cytokine responses in vivo by decreasing the expression of inflammatory and wound healing cytokines by inflammatory cells adherent to the biomaterial as well as present in the surrounding exudate. (C) 2002 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Natl Cardiovasc Ctr, Dept Bioengn, Osaka, Japan.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
FU NIGMS NIH HHS [GM-20380]; NHLBI NIH HHS [HL-33849, HL-55714]
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   ANDERSON JM, 1996, BIOMATERIALS SCI, P451
   BERGSMA JE, 1995, J BIOMED MATER RES, V29, P173, DOI 10.1002/jbm.820290206
   BRIDBECK WG, 2001, T 27 ANN M SOC BIOM, P214
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Chang JR, 2000, VIROLOGY, V278, P346, DOI 10.1006/viro.2000.0646
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KREIPE H, 1988, AM J PATHOL, V130, P232
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   SPILEZEWSKI KL, 1988, BIOMATERIALS, V9, P253, DOI 10.1016/0142-9612(88)90093-2
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   Todt J, 2000, J IMMUNOL, V164, P4037, DOI 10.4049/jimmunol.164.8.4037
   WEINBERG JB, 1984, P NATL ACAD SCI USA, V81, P454
   Westphal JR, 2000, INT J CANCER, V86, P768, DOI 10.1002/(SICI)1097-0215(20000615)86:6<768::AID-IJC3>3.3.CO;2-5
   WU Y, 1991, J BIOMED MATER RES, V25, P1415, DOI 10.1002/jbm.820251109
   Zeyse D, 2000, ENDOCRINOLOGY, V141, P1521, DOI 10.1210/en.141.4.1521
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 28
TC 129
Z9 131
U1 2
U2 17
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2003
VL 64A
IS 2
BP 320
EP 329
DI 10.1002/jbm.a.10425
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 670RT
UT WOS:000182423200015
PM 12522819
DA 2018-10-19
ER

PT J
AU Karp, JM
   Shoichet, MS
   Davies, JE
AF Karp, JM
   Shoichet, MS
   Davies, JE
TI Bone formation on two-dimensional (DL-lactide-co-glycolide) (PLGA) films
   and three-dimensional PLGA tissue engineering scaffolds in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; scaffold; trabecular bone; cement line matrix;
   biomaterial interface
ID CEMENT LINE; MARROW; DEGRADATION; POLYMERS; IMPLANTS; INVITRO; CELLS
AB For some bone tissue engineering strategies, direct contact of newly synthesized bone with a scaffold is important for structural continuity and stability at the scaffold/bone interface. Thus, as the polymer degrades, the support function of the scaffold could be adopted by the developing bone structure. This study was designed to determine whether poly(DL-lactide-co-glycolide) with a comonomer ratio of 75:25 supports bone apposition in vitro. Osteogenic cells derived from rat bone marrow cells were cultured for 2 weeks on polymeric two-dimensional films and three-dimensional tissue engineering scaffolds. Bacteriological grade polystyrene and tissue culture polystyrene dishes served as negative and positive controls for interfacial bone deposition, respectively. The surfaces of the prepared substrates were characterized by X-ray photoelectron spectroscopy, dynamic water contact angle, scanning electron microscopy, and atomic force microscopy. After cell culture, the elaborated matrix was examined using scanning electron microscopy, transmission electron microscopy, and energy dispersive spectroscopy. The results show that poly(DL-lactide-co-glycolide) supports appositional bone growth on both two-dimensional films and three-dimensional scaffolds, including the formation of a mineralized cement line matrix. Furthermore, surface topographical features are not required for the adherence of the cement line matrix to the polymer. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
   Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
RP Davies, JE (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, 4 Taddle Creek Rd, Toronto, ON M5S 3G9, Canada.
EM davies@ecf.utoronto.ca
CR AGRAWAL CM, 1995, BIOMATERIALS, V16, P1255, DOI 10.1016/0142-9612(95)98133-Y
   Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BENICEWICZ BC, 1991, J BIOACT COMPAT POL, V6, P64, DOI 10.1177/088391159100600106
   BLACK CM, 1986, J INFECT DIS, V154, P952, DOI 10.1093/infdis/154.6.952
   BOSTMAN OM, 1991, J BONE JOINT SURG BR, V73, P679
   BURR DB, 1988, J BIOMECH, V21, P939, DOI 10.1016/0021-9290(88)90132-7
   Davies J.E., 2000, BONE ENG, P1
   DAVIES JE, 1991, CELL MATER, V1, P3
   DAVIES JE, 1996, ANAT REC, V245, P246
   Gibbons D. F., 1992, DEGRADATION PHENOMEN, P97
   Gopferich A, 1997, MACROMOLECULES, V30, P2598, DOI 10.1021/ma961627y
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   HOLY CE, 2000, BONE ENG, P496
   HOLY CE, 1997, BIOMATERIALS CARRIER, P272
   HOLY CE, 1998, THESIS U TORONTO
   Hosseini M. M., 1996, Cells and Materials, V6, P233
   HOSSEINI MM, 2000, BONE ENG, P295
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   KLEINSCHMIDT JC, 1993, PLAST RECONSTR SURG, V91, P581, DOI 10.1097/00006534-199304000-00002
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Peel SAF, 1995, THESIS U TORONTO
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   SCHAFFLER MB, 1987, ANAT REC, V217, P223, DOI 10.1002/ar.1092170302
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Vaananen HK, 1996, PRINCIPLES BONE BIOL, P103
   von Ebner V, 1875, SHER AKAD WISS WIEN, V72, P49
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
NR 30
TC 115
Z9 123
U1 0
U2 27
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2003
VL 64A
IS 2
BP 388
EP 396
DI 10.1002/jbm.a.10420
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 670RT
UT WOS:000182423200023
PM 12522827
DA 2018-10-19
ER

PT J
AU Ito, A
   Mase, A
   Takizawa, Y
   Shinkai, M
   Honda, H
   Hata, K
   Ueda, M
   Kobayashi, T
AF Ito, A
   Mase, A
   Takizawa, Y
   Shinkai, M
   Honda, H
   Hata, K
   Ueda, M
   Kobayashi, T
TI Transglutaminase-mediated gelatin matrices incorporating cell adhesion
   factors as a biomaterial for tissue engineering
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE tissue engineering; transglutaminase; gelatin; RGD peptide; cell
   adhesion factor
ID CROSS-LINKING; FIBROBLASTS; FABRICATION; FIBRONECTIN; HYDROGELS;
   SCAFFOLDS; PEPTIDES; SURFACE
AB The goal of this work was to develop a novel biomaterial to be used for either wound dressing or as a scaffold for tissue engineering. The biodegradable hydrogels were prepared through crosslinking of gelatin with transglutaminase (TGase) in an aqueous solution. We found that the concentrations of 5 wt% gelatin and 1 unit/ml TGase were optimum for the proliferation of NIH/3T3 fibroblasts. Then, we investigated whether the cell proliferation was enhanced by incorporation of cell adhesion factors into the gelatin hydrogels. Since vitronectin and fibronectin can bind with gelatin by the action of TGase, we added these cell adhesion proteins into the gelatin hydrogels. The hydrogels incorporating these cell adhesion proteins significantly enhanced cell proliferation compared with the gelatin hydrogels without these proteins (p<0.05). Two types of synthetic Arg-Gly-Asp (RGD) peptides, RGDLLQ and RGDLLG, were also added to the gelatin solution where RGDLLQ is a substrate of TGase by virtue of a glutamine (Q) residue with an epsilon-amino group and RGDLLG is not. These two RGD peptides enhanced cell proliferation, but RGDLLQ significantly enhanced the proliferation compared with RGDLLG (p<0.05). These results suggest that TGase-mediated incorporation of cell adhesion factors into gelatin matrices enhanced cell proliferation and this novel biomaterial is a potent tool for wound dressing or tissue engineering.
C1 Nagoya Univ, Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648603, Japan.
   Nagoya Univ, Sch Med, Regenerat Med Ctr, Nagoya, Aichi 4668550, Japan.
   Nagoya Univ, Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4668550, Japan.
RP Kobayashi, T (reprint author), Nagoya Univ, Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648603, Japan.
RI Ito, Akira/S-8099-2017
CR BOWNESS JM, 1988, BIOCHIM BIOPHYS ACTA, V967, P234
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   COULOMB B, 1989, J INVEST DERMATOL, V92, P122, DOI 10.1111/1523-1747.ep13071335
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   FOLK JE, 1975, ADV PROTEIN CHEM, V31, P1
   Fuchsbauer HL, 1996, BIOMATERIALS, V17, P1481, DOI 10.1016/0142-9612(96)89772-9
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hazel B, 1980, BIOCHIM BIOPHYS ACTA, V632, P589
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Inada R, 2000, AM J PATHOL, V157, P1875, DOI 10.1016/S0002-9440(10)64826-2
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   KESKIOJA J, 1976, CELL, V9, P29, DOI 10.1016/0092-8674(76)90049-0
   LANGER R, 1995, SCI AM, V273, P130
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SANE DC, 1988, BIOCHEM BIOPH RES CO, V157, P115, DOI 10.1016/S0006-291X(88)80020-2
   Schacht E., 1993, Polymer Gels and Networks, V1, P213, DOI 10.1016/0966-7822(93)90001-X
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   SELA M, 1960, BIOCHEM J, V75, P91, DOI 10.1042/bj0750091
   Sung HW, 1996, BIOMATERIALS, V17, P1405, DOI 10.1016/0142-9612(96)87282-6
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   TOMIHATA K, 1994, ACS S SERIES, V540
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   YAEGER PC, 1991, J CELL PHYSIOL, V149, P110, DOI 10.1002/jcp.1041490114
NR 27
TC 76
Z9 83
U1 4
U2 22
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD FEB
PY 2003
VL 95
IS 2
BP 196
EP 199
DI 10.1016/S1389-1723(03)80129-9
PG 4
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 665JE
UT WOS:000182115800016
PM 16233392
DA 2018-10-19
ER

PT J
AU Letic-Gavrilovic, A
   Piattelli, A
   Abe, K
AF Letic-Gavrilovic, A
   Piattelli, A
   Abe, K
TI Nerve growth factor beta(NGF beta) delivery via a
   collagen/hydroxyapatite (Col/HAp) composite and its effects on new bone
   growth
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MOUSE CALVARIAL OSTEOBLASTS; NEUROLOGICAL DISORDERS; IMMUNOREACTIVE
   NERVES; EXPRESSION; CELLS; DIFFERENTIATION; RECEPTORS; MARROW
AB In craniofacial surgery, bone is needed to augment misshapen areas and to fill gaps during repair of congenital anomalies and injuries resulting into bone deficiencies. Examples of conditions requiring bone tissue include missing alveolar bone in cleft palates, bony nasal pyramid defects following removal of fistulous tracts or cysts and defects following removal of sinus and mandibular tumors. Moreover, maxillofacial neurosensory deficiencies may be caused by various surgical procedures, such as tooth extraction, osteotomies, pre-prosthetic procedures, excision of tumors or cysts, surgery of TMJ, and surgical treatment of fractures and cleft lip/palate. Therefore, a tissue engineering approach to craniofacial surgery has a crucial importance: the use of various composites with osteoconductive ceramics, polymers, bioactive factors, cells, or a combination of them, offers the possibility of rapid tissue regeneration and integration with the host tissue. In this study, a composite consisting of two well-known biomaterials, collagen/hydroxyapatite (Col/HAp), was used as a drug delivery device for neurotrophin - nerve growth factor Beta (NGF Beta). This delivery device, enriched with neurogenic-osteogenic factor, was analyzed in vitro and in vivo. It was implanted into calvaria defects of 20 Wistar rats, weighing 200-250 g. Implants were left in place for different periods of time. Controls were as follows: (a) contralateral defect without any implant; and (b) contralateral defect implanted with composite without NGF factor. The rats were euthanized after 30 days, and the implant sites and explants were examined clinically, histologically, SEM and histomorphometrically. Our results evidenced stimulation of periosteal and endocortical woven and lamellar bone formation, with increases in bone mass and decreases in bone marrow. We found that NGF enhanced the remodeling activity in the intracortical region, and induced an increase in the intracortical cavity number and area by the end of the study. In vitro results were in line with in vivo ones. We believe that the composite proposed in this study has considerable advantages in tissue engineering and is very suitable as a biomaterial for the filling of irregular defects in maxillo-facial surgery. Two areas of clinical research will be impacted by this system. The first is pharmaceutical research on drug delivery and high-throughput screening of neurotrophic-osteogenic compounds. Transplantation research is the second area that will benefit from the system. (C) 2002 Kluwer Academic Publishers.
C1 Int Clin Neoorgans, Rome, Italy.
   Univ Chieti, Sch Dent, Chieti, Italy.
   Fukuoka Dent Coll, Dept Funct Biosci, Sect Biochem, Fukuoka, Japan.
RP Letic-Gavrilovic, A (reprint author), Via della Chiesetta 4, I-00030 San Cesareo, Roma, Italy.
CR Akal UK, 2000, INT J ORAL MAX SURG, V29, P331, DOI 10.1034/j.1399-0020.2000.290503.x
   Akopian A, 2000, PEPTIDES, V21, P559, DOI 10.1016/S0196-9781(00)00185-6
   Aloe L, 1997, ALLERGY, V52, P883, DOI 10.1111/j.1398-9995.1997.tb01247.x
   Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7
   Auffray I, 1996, BLOOD, V88, P1608
   Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3
   BJURHOLM A, 1988, J AUTONOM NERV SYST, V25, P119, DOI 10.1016/0165-1838(88)90016-1
   BJURHOLM A, 1998, PEPTIDES, V9, P165
   CALVO W, 1968, AM J ANAT, V123, P315, DOI 10.1002/aja.1001230206
   FREEHAFER HA, 1965, J BONE JOINT SURG, V47, P683
   GAGE FH, 1987, NEUROSCIENCE, V23, P795, DOI 10.1016/0306-4522(87)90159-X
   GILLESPIE JA, 1963, J BONE JT SURG, V36, P464
   HARDY AG, 1963, J BONE JOINT SURG BR, V45, P76
   HOHMANN EL, 1986, SCIENCE, V232, P871
   HUKKANEN M, 1993, NEUROSCIENCE, V54, P969, DOI 10.1016/0306-4522(93)90588-7
   Jee WSS, 1997, BONE, V21, P297, DOI 10.1016/S8756-3282(97)00147-6
   Kasperk C H, 1990, Growth Factors, V3, P147, DOI 10.3109/08977199009108277
   KONTITINEN YT, 1996, ACTA ORTHOP SCAND, V67, P639
   LENER UH, 1994, ORAL SURG ORAL MED O, V78, P481
   Letic-Gavrilovic A, 2000, Dent Mater J, V19, P99
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   Lind M, 1998, Acta Orthop Scand Suppl, V283, P2
   Lundberg P, 1999, REGUL PEPTIDES, V85, P47, DOI 10.1016/S0167-0115(99)00069-5
   Lundberg P, 2001, ENDOCRINOLOGY, V142, P339, DOI 10.1210/en.142.1.339
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   MAUROF HA, 1990, INT J ORAL MAXILLOF, V5, P148
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   PEHAN JM, 2000, BIOMATERIALS, V21, P2097
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   Tamargo R. J., 1992, NEUROSURG QUART, V2, P243
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   XUDONG C, 1999, BIOMATERIALS, V20, P329
   YADA M, 1994, BIOCHEM BIOPH RES CO, V205, P1187, DOI 10.1006/bbrc.1994.2791
NR 35
TC 54
Z9 63
U1 1
U2 11
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2003
VL 14
IS 2
BP 95
EP 102
DI 10.1023/A:1022099208535
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 635HE
UT WOS:000180392800001
PM 15348479
DA 2018-10-19
ER

PT J
AU Mano, JF
   Koniarova, D
   Reis, RL
AF Mano, JF
   Koniarova, D
   Reis, RL
TI Thermal properties of thermoplastic starch/synthetic polymer blends with
   potential biomedical applicability
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; THERMOGRAVIMETRIC ANALYSIS; STARCH BLENDS;
   PROCESSING CONDITIONS; MECHANICAL-PROPERTIES; BIODEGRADABLE BLENDS;
   DEGRADATION BEHAVIOR; CELLULOSE-ACETATE; GLASS-TRANSITION; COMPOSITES
AB Previous studies shown that thermoplastic blends of corn starch with some biodegradable synthetic polymers (poly(e-caprolactone), cellulose acetate, poly(lactic acid) and ethylene-vinyl alcohol copolymer) have good potential to be used in a series of biomedical applications. In this work the thermal behavior of these structurally complex materials is investigated by differential scanning calorimetry (DSC) and by thermogravimetric analysis (TGA). In addition, Fourier-transform infrared (FTIR) spectroscopy was used to investigate the chemical interactions between the different components. The endothermic gelatinization process (or water evaporation) observed by DSC in starch is also observed in the blends. Special attention was paid to the structural relaxation that can occur in the blends with poly(lactic acid) at body temperature that may change the physical properties of the material during its application as a biomaterial. At least three degradation mechanisms were identified in the blends by means of using TGA, being assigned to the mass loss due to the plasticizer leaching, and to the degradation of the starch and the synthetic polymer fractions. The non-isothermal kinetics of the decomposition processes was analyzed using two different integral methods. The analysis included the calculation of the activation energy of the correspondent reactions. (C) 2003 Kluwer Academic Publishers.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4710057 Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Mano,
   Joao/0000-0002-2342-3765; Harvanova, Denisa/0000-0002-3038-7520
CR Aggarwal P, 1997, THERMOCHIM ACTA, V291, P65, DOI 10.1016/S0040-6031(96)03103-6
   Alves NM, 2002, POLYMER, V43, P4111, DOI 10.1016/S0032-3861(02)00236-7
   BAGFEY EB, 1977, POLYM ENG SCI, V17, P311
   BROIDO A, 1969, J POLYM SCI A2, V7, P1761, DOI 10.1002/pol.1969.160071012
   Day M, 1998, J THERM ANAL CALORIM, V52, P261, DOI 10.1023/A:1010195105547
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   FANTA GF, 1978, STARKE, V30, P237, DOI 10.1002/star.19780300706
   FANTA GF, 1992, J APPL POLYM SCI, V44, P2037, DOI 10.1002/app.1992.070441119
   Gedde U. W., 1995, POLYM PHYS
   GEORGE ER, 1994, POLYM ENG SCI, V34, P17, DOI 10.1002/pen.760340107
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Griffin GJL, 1974, ACS ADV CHEM SER, V134, P159
   Hanna AA, 1998, ANGEW MAKROMOL CHEM, V260, P1
   HATAKEYAMA T, 1994, THERMAL ANALYSIS FUN
   HOROWITZ HH, 1963, ANAL CHEM, V35, P1465
   Huang SJ, 1993, BIODEGRADABLE POLYM, P97
   Jacobsen S, 1996, POLYM ENG SCI, V36, P2799, DOI 10.1002/pen.10680
   Khalil AH, 2000, FOOD CHEM, V68, P61, DOI 10.1016/S0308-8146(99)00156-9
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Kweon DK, 2000, J APPL POLYM SCI, V78, P986, DOI 10.1002/1097-4628(20001031)78:5<986::AID-APP70>3.0.CO;2-T
   LENK RS, 1981, POLYMER, V21, P371
   LEONOR IB, 2002, J MATER SCI-MATER M, V13, P1
   LEONOR IB, 2002, IN PRESS BIOMATERIAL
   Liao KR, 2002, EUR POLYM J, V38, P157, DOI 10.1016/S0014-3057(01)00166-5
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   MANO JF, 2002, NATO SCI SER POLYMER
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   OTEY FH, 1974, IND ENG CHEM PROD RD, V13, P90, DOI 10.1021/i360049a018
   Park JW, 2000, POLYM ENG SCI, V40, P2539, DOI 10.1002/pen.11384
   PATIL DR, 1994, STARCH-STARKE, V46, P142, DOI 10.1002/star.19940460405
   PEANASKY JS, 1991, J POLYM SCI POL PHYS, V29, P565, DOI 10.1002/polb.1991.090290506
   Qu X, 2000, POLYMER, V41, P4841, DOI 10.1016/S0032-3861(99)00704-1
   Raghavan D, 2001, POLYM DEGRAD STABIL, V72, P509, DOI 10.1016/S0141-3910(01)00054-4
   Rao RV, 2000, POLYM DEGRAD STABIL, V70, P11
   Reis R., 2001, ENCY MAT SCI TECHNOL, P8810
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Soliman AAA, 1997, THERMOCHIM ACTA, V296, P149, DOI 10.1016/S0040-6031(97)00040-3
   SOUSA FS, 2001, J THERM ANAL CALORIM, V64, P739
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   Swanson CL, 1993, J ENVIRON POLYM DEGR, V1, P155
   TIKUISIS T, 1993, POLYM ENG SCI, V33, P26, DOI 10.1002/pen.760330104
   Tokiwa Y, 1990, POLYM MATER SCI ENG, V63, P742
   Vaz CM, 2001, MATER RES INNOV, V4, P375, DOI 10.1007/s100190000112
   Vega D, 1996, POLYM BULL, V37, P229, DOI 10.1007/BF00294126
   Whistler R.L., 1984, STARCH CHEMISTRY TEC
   Yang ZH, 1996, POLYMER, V37, P2137, DOI 10.1016/0032-3861(96)85859-9
   ZHANG X, 2002, P 7 WORLD C BIODEGRA, P131
NR 50
TC 224
Z9 230
U1 7
U2 79
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2003
VL 14
IS 2
BP 127
EP 135
DI 10.1023/A:1022015712170
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 635HE
UT WOS:000180392800006
PM 15348484
DA 2018-10-19
ER

PT J
AU Kasai, Y
   Takegami, K
   Uchida, A
AF Kasai, Y
   Takegami, K
   Uchida, A
TI Mixture ratios of local bone to artificial bone in lumbar posterolateral
   fusion
SO JOURNAL OF SPINAL DISORDERS & TECHNIQUES
LA English
DT Article; Proceedings Paper
CT 35th Annual Meeting of the Scoliosis-Research-Society
CY OCT 18-21, 2000
CL CAIRNS, AUSTRALIA
SP Scoliosis Res Soc
DE lumbar spine; lumbar spinal canal stenosis; spinal fusion; biomaterial;
   bone graft substitute
ID SPINAL-FUSION; INTEROBSERVER
AB There have been no reports on the effects of the mixture ratio of local bone graft to artificial bone on the outcome of intervertebral bone fusion. The purpose of this study was to determine whether the mixture ratio of local bone removed from laminae and spinous processes to apatite- and wollastonite-containing glass ceramic (AWGC) granules affected fusion rates in spinal fusion. Posterolateral lumbar fusion at two levels without spinal instrumentation was performed in 35 patients who were diagnosed with lumbar spinal canal stenosis. The patients were randomly divided into three groups, each of which received a different mixture ratio of local bone to AWGC granules: 2:1, 1:1, and 1:2. The total mass of grafted bone was 20 g in all three groups. The fusion rate was approximately 80% in all three groups. Our results indicate that lumbar posterolateral fusion can be successfully achieved even when the mixture ratio of local bone graft to AWGC granules is 1:2.
C1 Mie Univ, Fac Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan.
RP Kasai, Y (reprint author), Mie Univ, Fac Med, Dept Orthopaed Surg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.
CR Brodsky AE, 1991, SPINE S, V16, P261
   Christensen FB, 2001, SPINE, V26, P538, DOI 10.1097/00007632-200103010-00018
   FERNYHOUGH JC, 1992, SPINE, V17, P1474, DOI 10.1097/00007632-199212000-00006
   Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003
   Hamill CL, 1997, J SPINAL DISORD, V10, P387
   HERKOWITZ HN, 1991, J BONE JOINT SURG AM, V73A, P802, DOI 10.2106/00004623-199173060-00002
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kawanabe K, 1998, J BONE JOINT SURG BR, V80B, P527, DOI 10.1302/0301-620X.80B3.8576
   KITSUGI T, 1989, J BONE JOINT SURG AM, V71A, P264, DOI 10.2106/00004623-198971020-00014
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   MARDJETKO SM, 1994, SPINE, V19, pS2256, DOI 10.1097/00007632-199410151-00002
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   ZDEBLICK TA, 1993, SPINE, V18, P983, DOI 10.1097/00007632-199306150-00006
NR 15
TC 15
Z9 16
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1536-0652
J9 J SPINAL DISORD TECH
JI J. Spinal Disord. Tech.
PD FEB
PY 2003
VL 16
IS 1
BP 31
EP 37
DI 10.1097/00024720-200302000-00006
PG 7
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 642ZP
UT WOS:000180837600005
PM 12571482
DA 2018-10-19
ER

PT J
AU Voytik-Harbin, SL
   Roeder, BA
   Sturgis, JE
   Kokini, K
   Robinson, JP
AF Voytik-Harbin, SL
   Roeder, BA
   Sturgis, JE
   Kokini, K
   Robinson, JP
TI Simultaneous mechanical loading and confocal reflection microscopy for
   three-dimensional microbiomechanical analysis of biomaterials and tissue
   constructs
SO MICROSCOPY AND MICROANALYSIS
LA English
DT Article
DE confocal reflection microscopy; extracellular matrix; biomaterials;
   mechanical properties; biomechanics; three-dimensional; microstructure;
   micromechanics
ID EXTRACELLULAR-MATRIX; MICROSTRUCTURAL MODEL; ARTICULAR-CARTILAGE;
   CHONDROCYTE DEFORMATION; STRAIN; BEHAVIOR; AGAROSE; STRESS; GELS
AB At present, mechanisms by which specific structural and mechanical properties of the three-dimensional extracellular matrix microenvironment influence cell behavior arc not known. Lack of such knowledge precludes formulation of engineered scaffolds or tissue Constructs that would deliver specific growth-inductive signals required for improved tissue restoration. This article describes a new mechanical loading-imaging technique that allows investigations of structural-mechanical properties of biomaterials as well as the structural-mechanical basis of cell-scaffold interactions at a microscopic level and in three dimensions. The technique is based upon the integration of a modified, miniature mechanical loading instrument with a confocal microscope. Confocal microscopy is conducted in a reflection and/or fluorescence mode for selective visualization of load-induced changes to the scaffold and any resident cells, while maintaining each specimen in a "live," fully hydrated state. This innovative technique offers several advantages over current biomechanics methodologies, including simultaneous visualization of scaffold and/or cell microstructure in three dimensions during mechanical loading; quantification of macroscopic mechanical parameters including true stress and strain; and the ability to perform multiple analyses on the same specimen. This technique was used to determine the structural-mechanical properties of three very different biological materials: a reconstituted Collagen matrix, a tissue-derived biomaterial, and a tissue construct representing cells and matrix.
C1 Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.
RP Voytik-Harbin, SL (reprint author), Purdue Univ, Dept Basic Med Sci, 1515 Hansen Hall, W Lafayette, IN 47907 USA.
EM voytik@ecn.purdue.edu
RI Robinson, Joseph/K-8492-2012
OI Robinson, Joseph/0000-0001-8383-3240; Roeder, Blayne/0000-0003-1998-4372
CR Agoram B, 2001, J BIOMECH ENG-T ASME, V123, P362, DOI 10.1115/1.1385843
   Bay BK, 1999, EXP MECH, V39, P217, DOI 10.1007/BF02323555
   BIGI A, 1981, J MATER SCI, V16, P2557, DOI 10.1007/BF01113596
   Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5
   Brightman AO, 2000, BIOPOLYMERS, V54, P222
   BROOM ND, 1977, J BIOMECH, V10, P707, DOI 10.1016/0021-9290(77)90086-0
   CHEN CS, 1995, BIOMATERIALS, V16, P777, DOI 10.1016/0142-9612(95)99640-8
   Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6
   CLARK RE, 1974, J THORAC CARDIOV SUR, V67, P792
   Cowin SC, 2000, J BIOMECH ENG-T ASME, V122, P553, DOI 10.1115/1.1324665
   Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G
   FARQUHAR T, 1990, J BIOMECH ENG-T ASME, V112, P414, DOI 10.1115/1.2891205
   Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966
   Fung YC, 1993, BIOMECHANICS MECH PR
   Galbraith CG, 1998, CURR OPIN CELL BIOL, V10, P566, DOI 10.1016/S0955-0674(98)80030-6
   GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315
   HSU S, 1994, BIORHEOLOGY, V31, P21
   Ingber D, 1998, J CELL BIOCHEM, P232, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<232::AID-JCB28>3.0.CO;2-O
   Knight MM, 1998, BBA-MOL CELL RES, V1405, P67, DOI 10.1016/S0167-4889(98)00102-5
   Lee DA, 2000, J BIOMECH, V33, P81, DOI 10.1016/S0021-9290(99)00160-8
   Misof K, 1997, BIOPHYS J, V72, P1376, DOI 10.1016/S0006-3495(97)78783-6
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   Ottani V, 2001, MICRON, V32, P251, DOI 10.1016/S0968-4328(00)00042-1
   Ozerdem B, 1995, J BIOMECH ENG-T ASME, V117, P397, DOI 10.1115/1.2794198
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   SCHWARTZ MH, 1994, J BIOMECH, V27, P865, DOI 10.1016/0021-9290(94)90259-3
   Soulhat J, 1999, J BIOMECH ENG-T ASME, V121, P340, DOI 10.1115/1.2798330
   VIIDIK A, 1972, Z ANAT ENTWICKLUNGS, V136, P204, DOI 10.1007/BF00519178
   Voytik-Harbin SL, 2001, METHOD CELL BIOL, V63, P583
   Wang YN, 2000, J BIOMECH, V33, P483, DOI 10.1016/S0021-9290(99)00194-3
   Wren TAL, 1998, J BIOMECH ENG-T ASME, V120, P55, DOI 10.1115/1.2834307
NR 31
TC 49
Z9 50
U1 0
U2 9
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1431-9276
J9 MICROSC MICROANAL
JI Microsc. microanal.
PD FEB
PY 2003
VL 9
IS 1
BP 74
EP 85
DI 10.1017/S1431927603030046
PG 12
WC Materials Science, Multidisciplinary; Microscopy
SC Materials Science; Microscopy
GA 641NZ
UT WOS:000180752300008
PM 12597789
DA 2018-10-19
ER

PT J
AU Schlobe, A
   Schnitzler, N
   Schweizer, K
   Rohde, D
AF Schlobe, A
   Schnitzler, N
   Schweizer, K
   Rohde, D
TI Granulocyte colony-stimulating factor for the treatment of
   biomaterial-associated staphylococcal infections in-vitro
SO UROLOGICAL RESEARCH
LA English
DT Article
DE rhG-CSF; biomaterial; Staphylococcus epidermidis; phagocytosis
ID FOREIGN-BODY INFECTION; MICE; EPIDERMIDIS; NEUTROPHILS; PHAGOCYTOSIS;
   NEUTROPENIA; RESISTANCE; MODEL; CSF
AB Staphylococcal infections are a common and severe complication after the implantation of a prosthesis. We developed an in-vitro model for biomaterial-associated infections and studied the effects of human recombinant granulocyte colony-stimulating factor (rhuG-CSF; filgrastime) on the eradication of bacteria from the surface of biomaterial. Latex beads (25 mum) were incubated with 10(7) colony forming units of either a slime producing (DSM 3269) or non-slime producing strain (ATCC 14990) of Staphylococcus epidermidis. Infected particles were consecutively confronted with effector cells, derived from heparinized whole blood samples taken from healthy volunteers, after stimulation with rhuG-CSF (5,000 IU/ml, 10,000 IU/ml). Control blood specimens were not stimulated or conditioned with normal saline. The results indicate that stimulation with rhuG-CSF induced an increased rate of phagocytosis and lead to a more rapid reduction of adhering bacteria from the surface of the beads. Therefore, the in-vitro data suggest that patients with prosthesis infection may profit from an additional treatment with rhuG-CSF.
C1 Univ Aachen, Dept Urol, D-52057 Aachen, Germany.
   Univ Aachen, Inst Microbiol & Immunol, D-52057 Aachen, Germany.
RP Rohde, D (reprint author), Univ Aachen, Dept Urol, Pauwelsstr 30, D-52057 Aachen, Germany.
CR Baldassarri L, 1997, INFECT IMMUN, V65, P1522
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   BONILLA MA, 1989, NEW ENGL J MED, V320, P1574, DOI 10.1056/NEJM198906153202402
   HAMOOD M, 1994, MYCOSES, V37, P93
   Henke PK, 1997, J SURG RES, V69, P372, DOI 10.1006/jsre.1997.5088
   KABALIN JN, 1988, J UROLOGY, V139, P953, DOI 10.1016/S0022-5347(17)42727-3
   Kaplan SS, 1999, INFECT IMMUN, V67, P1640
   MATSUMOTO M, 1991, MICROBIOL IMMUNOL, V35, P461, DOI 10.1111/j.1348-0421.1991.tb01576.x
   PAULSSON M, 1993, BIOMATERIALS, V14, P845, DOI 10.1016/0142-9612(93)90006-N
   PERTICARARI S, 1994, J IMMUNOL METHODS, V170, P117, DOI 10.1016/0022-1759(94)90251-8
   RIBER U, 1995, APMIS, V103, P439, DOI 10.1111/j.1699-0463.1995.tb01130.x
   ROILIDES E, 1991, J INFECT DIS, V163, P579, DOI 10.1093/infdis/163.3.579
   Rozalska B, 1996, MICROBIOL IMMUNOL, V40, P931, DOI 10.1111/j.1348-0421.1996.tb01162.x
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   SHIMONO N, 1994, CLIN DIAGN LAB IMMUN, V1, P556
   SHINOMIYA N, 1991, INFECT IMMUN, V59, P4740
   Van Wijngaerden E, 1999, J ANTIMICROB CHEMOTH, V44, P669, DOI 10.1093/jac/44.5.669
   WHITEOWEN C, 1993, CLIN EXP IMMUNOL, V92, P477
   YASUDA H, 1990, INFECT IMMUN, V58, P2502
NR 19
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0300-5623
J9 UROL RES
JI Urol. Res.
PD FEB
PY 2003
VL 30
IS 6
BP 394
EP 398
DI 10.1007/s00240-002-0289-7
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 654WY
UT WOS:000181521000009
PM 12599021
DA 2018-10-19
ER

PT J
AU Zhou, SB
   Liao, XY
   Li, XH
   Deng, XM
   Li, H
AF Zhou, SB
   Liao, XY
   Li, XH
   Deng, XM
   Li, H
TI Poly-D,L-lactide-co-poly(ethylene glycol) microspheres as potential
   vaccine delivery systems
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE microspheres; controlled release; polylactide-co-poly(ethylene glycol);
   biodegradable polymers; vaccine adjuvants; single-dose vaccines
ID SINGLE-STEP IMMUNIZATION; VIBRIO-CHOLERA ANTIGENS; ABA TRIBLOCK
   COPOLYMERS; HUMAN SERUM-ALBUMIN; POLY(ETHYLENE GLYCOL);
   CONTROLLED-RELEASE; BLOCK-COPOLYMERS; L-LACTIDE; ETHYLENE-GLYCOL;
   DL-LACTIDE
AB Adjuvants aimed at increasing the immunogenicity of recombinant antigens remain a focus in vaccine development. Worldwide, there is currently considerable care for the development of biodegradable microspheres as controlled release of vaccines, since the major disadvantage of several currently available vaccines is the need for repeated administration. Microspheres prepared from the biodegradable and biocompatible polymers, the polylactide (PLA) or polylactide-co-glycolide (PLGA), have been shown to be effective adjuvants for a number of antigens. This review mainly focuses on polylactide-co-poly(ethylene glycol) (PELA) microspheres adjuvant as vaccine delivery systems by summarizing our and other research groups' investigation on properties of the microspheres formulation encapsulating several kinds of antigens. The results indicate that compared with the commonly used PLA and PLGA, PELA showed several potentials in vaccine delivery systems, which may be due to the block copolymer have its capability to provide a biomaterial having a broad range of amphiphilic structure. PELA microspheres can control the rate of release of entrapped antigens and therefore, offer potential for the development of single-dose vaccines. The PELA microspheres have shown great potential as a next generation adjuvant to replace or complement existing aluminum salts for vaccine potential. The review mainly aims to promote the investigation of PELA microspheres adjuvant for antigens for worldwide researcher. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China.
   Natl Inst Control Pharmaceut & Biol Prod, Beijing 100050, Peoples R China.
RP Zhou, SB (reprint author), Chinese Acad Sci, Chengdu Inst Organ Chem, POB 415, Chengdu 610041, Peoples R China.
RI zhou, shaobing/B-3148-2010; Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR AGUADO MT, 1992, IMMUNOBIOLOGY, V184, P113, DOI 10.1016/S0171-2985(11)80470-5
   ALLISON AC, 1991, MOL IMMUNOL, V28, P279, DOI 10.1016/0161-5890(91)90074-T
   ALONSO MJ, 1994, VACCINE, V12, P299, DOI 10.1016/0264-410X(94)90092-2
   ALONSO MJ, 1993, PHARMACEUT RES, V10, P945, DOI 10.1023/A:1018942118148
   AMARPREET S, 1993, MACROMOLECULES, V26, P581
   BERGLUND F, 1968, ACTA PHYSIOL SCAND, V73, pA20, DOI 10.1111/j.1748-1716.1968.tb04132.x
   BITTLE JL, 1989, VACCINE BIOTECHNOL, V33, P313
   Chang AC, 1996, J PHARM SCI, V85, P129, DOI 10.1021/js950365v
   CHOI SW, 1993, J POLYM SCI A, V37, P2305
   COHN D, 1987, BIOMATERIALS CLIN AP, P503
   Deng XM, 1999, CHINESE J POLYM SCI, V17, P265
   Deng XM, 1999, J CONTROL RELEASE, V58, P123, DOI 10.1016/S0168-3659(98)00147-3
   DENG XM, 1990, J POLYM SCI POL LETT, V28, P411, DOI 10.1002/pol.1990.140281303
   Deng XM, 2001, J CONTROL RELEASE, V71, P165, DOI 10.1016/S0168-3659(01)00210-3
   DENG XM, 1995, J APPL POLYM SCI, V55, P1193, DOI 10.1002/app.1995.070550806
   DU YJ, 1995, MACROMOLECULES, V28, P2124, DOI 10.1021/ma00111a004
   ESPARZA I, 1992, VACCINE, V10, P714, DOI 10.1016/0264-410X(92)90094-Z
   HU DSG, 1994, J APPL POLYM SCI, V51, P473, DOI 10.1002/app.1994.070510310
   Huh KM, 1999, POLYMER, V40, P6147, DOI 10.1016/S0032-3861(98)00822-2
   JEDLINSKI Z, 1993, MAKROMOL CHEM, V194, P1681
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong BM, 1999, J POLYM SCI POL CHEM, V37, P751
   Jiang WL, 2001, PHARMACEUT RES, V18, P878, DOI 10.1023/A:1011009117586
   Kissel T, 2002, ADV DRUG DELIVER REV, V54, P99, DOI 10.1016/S0169-409X(01)00244-7
   KISSEL T, 1993, P INT S CONTR REL BI, P127
   KOHN J, 1986, J IMMUNOL METHODS, V95, P31, DOI 10.1016/0022-1759(86)90314-5
   KRICHELDORF HR, 1993, MAKROMOL CHEM, V194, P715
   KRICHELDORF HR, 1993, MAKROMOL CHEM-M SYMP, V73, P47, DOI 10.1002/masy.19930730107
   Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Lee HK, 1997, J CONTROL RELEASE, V44, P283, DOI 10.1016/S0168-3659(96)01534-9
   Lee YM, 1997, POLYMER, V38, P2415, DOI 10.1016/S0032-3861(96)00789-6
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   Li XH, 1999, INT J PHARM, V178, P245, DOI 10.1016/S0378-5173(98)00379-2
   Li XH, 2000, J CONTROL RELEASE, V68, P41, DOI 10.1016/S0168-3659(00)00235-2
   Li XH, 2001, PHARMACEUT RES, V18, P117, DOI 10.1023/A:1011043230573
   Li XH, 2002, J APPL POLYM SCI, V83, P850, DOI 10.1002/app.10081
   LI XH, 1999, ACTA POLYM SIN, V2, P156
   Li XW, 1997, J APPL POLYM SCI, V66, P583, DOI 10.1002/(SICI)1097-4628(19971017)66:3<583::AID-APP20>3.0.CO;2-V
   LI YX, 1993, J CONTROL RELEASE, V27, P247
   Liao X., UNPUB
   Lucke A, 2002, J CONTROL RELEASE, V80, P157, DOI 10.1016/S0168-3659(02)00020-2
   MARCOTTE N, 1990, J PHARM SCI, V79, P407, DOI 10.1002/jps.2600790509
   MEN Y, 1995, VACCINE, V13, P683
   Mohammadi-Rovshandeh J, 1998, J APPL POLYM SCI, V68, P1949, DOI 10.1002/(SICI)1097-4628(19980620)68:12<1949::AID-APP8>3.0.CO;2-L
   MOHAMMADIROVSHA.J, 1999, J APPL POLYM SCI, V8, P2004
   Nellore R V, 1992, J Parenter Sci Technol, V46, P176
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095
   OHAGAN D, 1998, ADV DRUG DELIV REV, V31, P225
   Perez C, 2001, J CONTROL RELEASE, V75, P211, DOI 10.1016/S0168-3659(01)00397-2
   PLOTKIN SL, 1988, SHORT HIST VACCINATI, P1
   RAGHUVANSHI RS, 1993, INT J PHARM, V93, pR1, DOI 10.1016/0378-5173(93)90188-L
   Sakurai K, 1999, J MACROMOL SCI PURE, V36, P1863, DOI 10.1081/MA-100101630
   SINGH M, 1995, PHARMACEUT RES, V12, P1796, DOI 10.1023/A:1016294512292
   Singh M, 1997, VACCINE, V15, P475, DOI 10.1016/S0264-410X(97)00225-9
   Singh M, 1997, INFECT IMMUN, V65, P1716
   STEVELS WM, 1995, CHEM PHYS, V11, P3687
   Suh HR, 1998, J BIOMED MATER RES, V42, P331, DOI 10.1002/(SICI)1097-4636(199811)42:2<331::AID-JBM19>3.0.CO;2-L
   TICE TR, 1908, DRUG DELIVERY ITS TH, pCH21
   Tobio M, 1998, PHARMACEUT RES, V15, P270, DOI 10.1023/A:1011922819926
   VILA A, UNPUB
   WARREN HS, 1986, ANNU REV IMMUNOL, V4, P369, DOI 10.1146/annurev.iy.04.040186.002101
   Wise D L, 1979, DRUG CARRIERS BIOL M, P237
   WU XR, 2000, LIFE SCI RES, V4, P167
   WU XR, 2000, CHIN J BIOLOG, V13, P89
   YAMAGUCHI K, 1993, J CONTROL RELEASE, V24, P81, DOI 10.1016/0168-3659(93)90169-6
   YOUNES H, 1987, J BIOMED MATER RES, V21, P1301, DOI 10.1002/jbm.820211103
   YOUNES H, 1988, BIOMATER ARTIF CELL, V16, P705, DOI 10.3109/10731198809117563
   Zhang Wenbin, 1999, Journal of West China University of Medical Sciences, V30, P31
   ZHANG XC, 1994, J POLYM SCI POL CHEM, V32, P2965, DOI 10.1002/pola.1994.080321519
   Zhao Z, 1996, J PHARM SCI-US, V85, P1261, DOI 10.1021/js9602812
   Zhou SB, 2001, J CONTROL RELEASE, V75, P27, DOI 10.1016/S0168-3659(01)00379-0
   ZHU KJ, 1990, J APPL POLYM SCI, V39, P1, DOI 10.1002/app.1990.070390101
   Zhu ZX, 1999, EUR POLYM J, V35, P1821, DOI 10.1016/S0014-3057(98)00265-1
   1992, PHYSICIANS DESK REFE, P1544
NR 76
TC 65
Z9 81
U1 2
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JAN 17
PY 2003
VL 86
IS 2-3
BP 195
EP 205
AR PII S0168-3659(02)00426-6
DI 10.1016/S0168-3659(02)00423-6
PG 11
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 641TA
UT WOS:000180761200001
PM 12526816
DA 2018-10-19
ER

PT J
AU Prince, JL
   Dickinson, RB
AF Prince, JL
   Dickinson, RB
TI Kinetics and forces of adhesion for a pair of capsular/unencapsulated
   staphylococcus mutant strains
SO LANGMUIR
LA English
DT Article
ID CELL-SURFACE; BACTERIA; ATTACHMENT; POLYMERS; GLASS
AB Staphylococcus is a major pathogen recognized as the most common cause of nosocomial infections, postoperative infections, and rejection of implants and other biomaterial-related devices. Capsules are a compact layer of polysaccharides extending from the cell wall of some bacteria. Capsulated bacteria are frequently associated with biofouling, serious invasive infections, and biofilm formation. The attachment kinetics of bacteria mutant strains Staphylococcus aureus Smith diffuse (SD) and Stophylococcus aureus Smith compact (SC) were measured under well-defined, laminar flow conditions using a parallel plate flow chamber. The attachment rate of capsule-free SC to a glass slide was approximately 2 orders of magnitude greater than that of encapsulated SD bacteria from which it was derived. Ancillary physicochemical characterization supports that this marked difference in adhesion is due to the absence of a capsule outside the cell wall of SC. Electrophoresis measurements showed no statistically significant difference in the cell surface charge of the two mutant strains. In addition, contact angle measurements showed little variation in hydrophobic character and suggested that both the encapsulated and capsule-deficient strains were hydrophilic. To further quantify the affect of extracellular capsule on the adhesion of the S. aureus mutants, optical tweezers in combination with evanescent wave light scattering was used to directly measure the interaction forces upon probing a single bacterium, toward a flat surface. The force-distance profile of SD suggests steric repulsion, while that of SC illustrates the overall attraction. Therefore, differences in deposition were most likely due to steric stabilization forces from the capsular polysaccharides. This study reports the premier direct measurement of biopolymer-induced interaction forces between a single, living bacterium and a surface under physiological conditions.
C1 Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.
   Univ Florida, Biomed Engn Program, Gainesville, FL 32611 USA.
RP Dickinson, RB (reprint author), Univ Florida, Dept Chem Engn, POB 116005, Gainesville, FL 32611 USA.
RI Dickinson, Richard/A-4435-2012
OI Dickinson, Richard/0000-0002-7415-2889
CR BENDINGER B, 1993, APPL ENVIRON MICROB, V59, P3973
   Busscher H J, 1997, Adv Dent Res, V11, P24
   Clapp AR, 1999, REV SCI INSTRUM, V70, P2627, DOI 10.1063/1.1149820
   Costerton J.W, 1985, BACTERIAL ADHESION M
   Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001
   Derjaguin B, 1941, ACTA PHYSICOCHIM URS, V14, P633, DOI DOI 10.1016/0079-6816(93)90013-L
   Dickinson R. B., 2000, ANTIMICROBIAL ANTIIN
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   Dogariu AC, 2000, LANGMUIR, V16, P2770, DOI 10.1021/1a994004
   FLETCHER M, 1988, J BACTERIOL, V170, P2027, DOI 10.1128/jb.170.5.2027-2030.1988
   FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812
   GORDON AS, 1984, APPL ENVIRON MICROB, V47, P495
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   HUNT GA, 1958, SCIENCE, V128, P1574, DOI 10.1126/science.128.3338.1574
   Lauffenburger D., 1993, RECEPTORS
   MADIGAN MT, 1997, BROCK BIOL MICROOGAN
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   MARSHALL PA, 1989, APPL ENVIRON MICROB, V55, P2827
   Poortinga AT, 2001, COLLOID SURFACE B, V20, P105, DOI 10.1016/S0927-7765(00)00182-X
   PRINCE JL, 1998, THESIS MICHIGAN STAT
   RIJNAARTS HHM, 1995, COLLOID SURFACE B, V4, P191, DOI 10.1016/0927-7765(94)01164-Z
   ROBBINS JB, 1978, IMMUNOCHEMISTRY, V15, P839, DOI 10.1016/0161-5890(78)90117-7
   RUTA AG, 1998, THESIS U FLORIDA
   SMITH IM, 1956, J EXP MED, V103, P499
   VANOSS CJ, 1975, ENGULFMENT CELL ADHE
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   VERWEY EJW, 1948, THEORY STABILITY LYO
   WARD JB, 1980, MICROBIAL ADHESION S
NR 29
TC 18
Z9 18
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JAN 7
PY 2003
VL 19
IS 1
BP 154
EP 159
DI 10.1021/1a026072g
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 634GW
UT WOS:000180332500022
DA 2018-10-19
ER

PT S
AU Jarfors, AEW
   Sim, C
   San, TE
AF Jarfors, AEW
   Sim, C
   San, TE
BE Lai, MO
   Lu, L
TI Influence of process parameters on reaction products during
   self-propagating high-temperature synthesis of porous NiTi
SO ADVANCED MATERIALS PROCESSING II
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Advanced Materials Processing
CY DEC 02-04, 2002
CL SINGAPORE, SINGAPORE
DE biomaterial; Ni; NiTi; phase selection; reaction synthesis; Ti
ID SHAPE-MEMORY ALLOY
AB NiTi is proposed to be a biomaterial suitable for bone replacements. Reactive synthesis, Self-Propagating High-Temperature Synthesis (SHS) of NiTi from Ni and Ti powder is a suitable method to produce porous structures to promote osseointegration. The influence of pressed density and ignition temperature on the reaction products formed is investigated. Porosity after pressing was 20%, 30% and 40% and ignition temperatures were 400degreesC, 500degreesC and 600degreesC. The reaction products found were NiTi, as well as Ti2Ni and Ni3Ti, in addition to residual Ni and Ti. The amount of NiTi formed increases with ignition temperature, with a maximum at an initial porosity of 30% and ignition temperature of 600degreesC. This coincides with the minimum amount of residual Ni and Ti. The reaction imbalance is caused by the formation of Ti2Ni at high pressed densities and by a preferential nucleation of Ni3Ti, both suggested to be dominated by the effective contact area between the Ni and Ti particles after pressing.
C1 Singapore Inst Mfg Technol, Proc Technol Div, Precis Met Forming Grp, Singapore 638075, Singapore.
RP Jarfors, AEW (reprint author), Singapore Inst Mfg Technol, Proc Technol Div, Precis Met Forming Grp, 71 Nanyang Dr, Singapore 638075, Singapore.
RI Jarfors, Anders/C-6679-2009
OI Thian, Eng San/0000-0001-6925-6811; Jarfors, Anders/0000-0002-0101-0062
CR CRAGG AH, 1993, RADIOLOGY, V189, P775, DOI 10.1148/radiology.189.3.8234703
   Green SM, 1997, POWDER METALL, V40, P43, DOI 10.1179/pom.1997.40.1.43
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   KAMBIC H, 1988, INT J ARTIF ORGANS, V11, P487
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   LI BY, 1997, MAT RES, V13, P43
   Li YH, 2001, J ALLOY COMPD, V325, P259, DOI 10.1016/S0925-8388(01)01382-2
   Munir Z. A., 1990, P 1 US JAP WORKSH CO, P123
   SIMON M, 1989, RADIOLOGY, V172, P99, DOI 10.1148/radiology.172.1.2662259
   ZHU M, 1991, ACTA METALL MATER, V39, P1481, DOI 10.1016/0956-7151(91)90233-Q
NR 10
TC 6
Z9 6
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-921-0
J9 MATER SCI FORUM
PY 2003
VL 437-4
BP 475
EP 478
DI 10.4028/www.scientific.net/MSF.437-438.475
PG 4
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Materials Science, Coatings & Films;
   Materials Science, Composites
SC Materials Science
GA BX62Y
UT WOS:000185937400116
DA 2018-10-19
ER

PT S
AU Rigo, ECS
   Santos, LA
   Carrodeguas, RG
   Boschi, AO
AF Rigo, ECS
   Santos, LA
   Carrodeguas, RG
   Boschi, AO
BE Salgado, L
   Filho, FA
TI Bonelike apatite coating on Ti6Al4V: Novel nucleation process using
   sodium silicate solution
SO ADVANCED POWDER TECHNOLOGY III
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 3rd International Latin-American Conference on Powder Technology
CY NOV 26-28, 2001
CL SANTA CATARINA, BRAZIL
SP Assoc Brazilian Ceram
DE biomimetic coating; bioceramics; hydroxyapatite; sodium silicate
AB Despite the well known biocompatibility and bioactivity of synthetic hydroxyapatite (HA), its use, as structural biomaterial has been limited because of intrinsic low mechanical properties. In order to avoid this problem, metallic implants are commonly coated with a thin HA layers. Among the various techniques used to produce coatings on metals, the biomimetic process has gained increasing attention in the last years. In this work, a metallic substrate (Ti6Al4V) was coated using a variation of the traditional biomimetic method. The HA coatings were characterised by diffused reflectance spectroscopy (DRIFT) and scanning electron microscopy (SEM).
C1 Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
   Univ Estadual Campinas, Fac Mech Engn, BR-13081970 Campinas, SP, Brazil.
   Univ Havana, Ctr Biomat, Havana, Cuba.
RP Rigo, ECS (reprint author), Univ Fed Sao Carlos, Dept Mat Engn, Rodovia Washington Luis Km 35, BR-13565905 Sao Carlos, SP, Brazil.
RI Garcia Carrodeguas, Raul/E-5087-2012; BOSCHI, Anselmo/K-7091-2013; Rigo,
   Eliana/H-4926-2012
OI Garcia Carrodeguas, Raul/0000-0002-4379-4598; Rigo,
   Eliana/0000-0003-3368-5707
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   DHERT WJA, 1992, PLASMA SPRAYED COATI, V4
   FISHER G, 1986, AM CERAM SOC BULL, V65, P283
   HENCH LL, 1991, CERAMIC GLASSES GLAS
   JARCHO M, 1992, Dental Clinics of North America, V36, P19
   KLEE WE, 1970, J INORG NUCL CHEM, V32, P1837, DOI 10.1016/0022-1902(70)80590-5
   Kokubo T, 1999, COMPOS PART A-APPL S, V30, P405, DOI 10.1016/S1359-835X(98)00127-4
   LACEFIELD WR, 1993, HYDROXYAPATITE COATI, V1, P223
   Stoch A, 2000, J MOL STRUCT, V555, P375, DOI 10.1016/S0022-2860(00)00623-2
NR 9
TC 4
Z9 4
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-912-1
J9 MATER SCI FORUM
PY 2003
VL 416-4
BP 658
EP 662
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW62F
UT WOS:000182605200108
DA 2018-10-19
ER

PT B
AU Ahmed, S
   Tsuchiya, T
AF Ahmed, S
   Tsuchiya, T
BE Yagasaki, K
   Miura, Y
   Hatori, M
   Nomura, Y
TI Different expression of gap junctional protein Connexin43 in two strains
   of mice after one-month implantation of poly-L-lactic acid
SO ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 13
LA English
DT Proceedings Paper
CT 15th Annual Meeting of the
   Japanese-Association-for-Animal-Cell-Technology
CY NOV 11-15, 2002
CL Fuchu, JAPAN
SP Japanese Assoc Anim Cell Technol
DE poly-L-lactic acid; GJIC; Connexin43
AB The implantation of a biomaterial often induces host inflammatory responses. Some adverse effects by the biomaterials, such as poly-L-lactic acid (PLLA) and polyurethanes (PUs) were reported in animal experiments. PLLA produced tumorigenicity in rats after long-term implantation. The purpose of this study was to determine the in vitro effect of PLAO3 (high-molecular weights of PLLA) and PU8 (PTMO/MD/BD) on the function of the normal human dermal fibroblasts (NHDF) and the in vivo effect of PLAO3 on the function of the cells originated from the subcutaneous tissue in the two female mouse strains, BALB/cJ and SJL/J. The results with Scrape-loading and dye transfer (SLDT) assay, Western Blot and RT-PCR analysis clearly demonstrated that gap-junctional intercellular communication (GJIC) and the expression of Cx43 were significantly suppressed in PLAO3-implanted group of BALB/cJ mice in compared to the control mice. While, no significant difference was found in GJIC and the expression of mRNA level but a little bit difference was observed in the Cx43 protein expression between the SJL/J implanted and the control mice. We considered that the PLAO3 suppressed irreversibly gap junctional protein connexin43 at the earlier stage after implantation and the suppression of connexin43 gene-expression might play a vital role in the inhibition of GJIC and thus promotes the tumorigenesis.
C1 Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan.
RP Ahmed, S (reprint author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, 1-18-1,Kamiyoga, Tokyo 1588501, Japan.
CR MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9
   NAKAMURA T, 1994, J BIOMED MATER RES, V28, P17, DOI 10.1002/jbm.820280104
   TROSKO JE, 1993, LIFE SCI, V53, P1, DOI 10.1016/0024-3205(93)90606-4
   XI TF, 1994, J BIOMED MATER RES, V28, P483, DOI 10.1002/jbm.820280411
NR 4
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-1970-X
PY 2003
BP 481
EP 485
PG 5
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Cell Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Cell Biology
GA BAJ50
UT WOS:000222558600083
DA 2018-10-19
ER

PT J
AU Vogel, V
   Baneyx, G
AF Vogel, V
   Baneyx, G
TI The tissue engineering puzzle: A molecular perspective
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE biomaterials; scaffolds; 3-D cell culture; fibronectin; mechanical
   force; integrin; cell signaling; angiogenesis; vascularization
ID RECEPTOR TYROSINE KINASES; FOCAL ADHESION KINASE; CELL-MATRIX ADHESIONS;
   GREEN FLUORESCENT PROTEIN; GROWTH-FACTOR RECEPTOR; STRESS FIBER
   FORMATION; EXTRACELLULAR-MATRIX; FIBRONECTIN MATRIX; IN-VITRO;
   SIGNAL-TRANSDUCTION
AB The inability of biomaterial scaffolds to functionally integrate into surrounding tissue is one of the major roadblocks to developing new biomaterials and tissue-engineering scaffolds. Despite considerable advances, current approaches to engineering cell-surface interactions fall short in mimicking the complexity of signals through which surrounding tissue regulates cell behavior. Cells adhere and interact with their extracellular environment via integrins, and their ability to activate associated downstream signaling pathways depends on the character of adhesion complexes formed between cells and their extracellular matrix. In particular, alpha(5)beta(1) and alpha(v)beta(3) integrins are central to regulating downstream events, including cell survival and cell-cycle progression. In contrast to previous findings that alpha(v)beta(3) integrins promote angiogenesis, recent evidence argues that alpha(v)beta(3) integrins may act as negative regulators of proangiogenic integrins such as alpha(5)beta(1). This suggests that fibronectin is critical for scaffold vascularization because it is the only mammalian adhesion protein that binds and activates alpha(5)beta(1) integrins. Cells are furthermore capable of stretching fibronectin matrices such that the protein partially unfolds, and recent computational simulations provide structural models of how mechanical stretching affects fibronectin function. We propose a model whereby excessive tension generated by cells in contact to biomaterials may in fact render fibronectin fibrils nonangiogenic and potentially inhibit vascularization. The model could explain why current biomaterials independent of their surface chemistries and textures fail to vascularize.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Ctr Nanotechnol, Seattle, WA 98195 USA.
RP Vogel, V (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RI Vogel, Viola/O-8025-2015
OI Vogel, Viola/0000-0003-2898-7671
FU NHLBI NIH HHS [IP50HL02360-01]; NIBIB NIH HHS [8R01EB0024909]
CR Alahari SK, 2002, INT REV CYTOL, V220, P145
   Alam H, 1998, SURGERY, V124, P87, DOI 10.1016/S0039-6060(98)70079-0
   Aplin AE, 2002, J CELL SCI, V115, P2781
   Arnaout MA, 2002, CURR OPIN CELL BIOL, V14, P641, DOI 10.1016/S095506740200371X
   Assoian RK, 1996, J CLIN INVEST, V98, P2436, DOI 10.1172/JCI119059
   Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799
   Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998
   Baneyx G, 1999, P NATL ACAD SCI USA, V96, P12518, DOI 10.1073/pnas.96.22.12518
   BEER JH, 1992, BLOOD, V79, P117
   Bhatia SN, 1998, J BIOMAT SCI-POLYM E, V9, P1137, DOI 10.1163/156856298X00695
   Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265
   Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889
   Bottaro DP, 2002, ANN NY ACAD SCI, V961, P143, DOI 10.1111/j.1749-6632.2002.tb03068.x
   BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751
   BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8
   Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6
   Burton K, 1999, MOL BIOL CELL, V10, P3745, DOI 10.1091/mbc.10.11.3745
   Carr PA, 1997, STRUCTURE, V5, P949, DOI 10.1016/S0969-2126(97)00248-7
   Chaikof EL, 2002, ANN NY ACAD SCI, V961, P96, DOI 10.1111/j.1749-6632.2002.tb03057.x
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen J, 1996, CELL ADHES COMMUN, V4, P237, DOI 10.3109/15419069609010769
   Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393
   Christopher RA, 1997, J CELL SCI, V110, P569
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Corbett SA, 1996, BLOOD, V88, P158
   Coussen F, 2002, J CELL SCI, V115, P2581
   Craig D, 2001, P NATL ACAD SCI USA, V98, P5590, DOI 10.1073/pnas.101582198
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Damsky Caroline H., 1992, Current Opinion in Cell Biology, V4, P772, DOI 10.1016/0955-0674(92)90100-Q
   Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137
   DiazGonzalez F, 1996, MOL BIOL CELL, V7, P1939
   Eaglstein W H, 1998, Adv Wound Care, V11, P1
   Eiselt P, 1998, BIOTECHNOL PROGR, V14, P134, DOI 10.1021/bp970135h
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   ERICKSON HP, 1983, J BIOL CHEM, V258, P4539
   FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   Fukai F, 2000, CELL MOL BIOL, V46, P145
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Galbraith CG, 1999, J CELL BIOL, V147, P1313, DOI 10.1083/jcb.147.6.1313
   Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gilmore AP, 1996, MOL BIOL CELL, V7, P1209
   Godbey WT, 2002, ANN NY ACAD SCI, V961, P10, DOI 10.1111/j.1749-6632.2002.tb03041.x
   Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x
   Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431
   HOCKING DC, 1994, J BIOL CHEM, V269, P19183
   Howe AK, 2002, CURR OPIN GENET DEV, V12, P30, DOI 10.1016/S0959-437X(01)00260-X
   Huang XZ, 2000, MOL CELL BIOL, V20, P755, DOI 10.1128/MCB.20.3.755-759.2000
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588
   Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918
   Hynes RO, 1990, FIBRONECTINS
   Ilic Dusko, 1995, Nature (London), V377, P539
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718
   Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Kang YH, 2002, TISSUE ENG, V8, P681, DOI 10.1089/107632702760240599
   Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352
   KHAN MY, 1990, BIOCHEM J, V270, P33, DOI 10.1042/bj2700033
   Koo LY, 2002, J CELL SCI, V115, P1423
   Krammer A, 1999, P NATL ACAD SCI USA, V96, P1351, DOI 10.1073/pnas.96.4.1351
   Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4
   Langenbach KJ, 1999, J BIOL CHEM, V274, P7032, DOI 10.1074/jbc.274.11.7032
   Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099
   LIN CQ, 1993, FASEB J, V7, P737
   LITVINOVICH SV, 1995, J MOL BIOL, V248, P611, DOI 10.1006/jmbi.1995.0246
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633
   MIYAMOTO S, 1995, SCIENCE, V267, P883, DOI 10.1126/science.7846531
   Mosher Deane F., 1992, Current Opinion in Cell Biology, V4, P810, DOI 10.1016/0955-0674(92)90104-K
   Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   NOWLIN DM, 1993, J BIOL CHEM, V268, P20352
   Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6
   Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153
   Ohashi T, 2002, J CELL SCI, V115, P1221
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Parenteau N, 1994, KERATINOCYTE METHODS, P45
   Parenteau NL, 2002, ANN NY ACAD SCI, V961, P27, DOI 10.1111/j.1749-6632.2002.tb03042.x
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   PLOPPER GE, 1995, MOL BIOL CELL, V6, P1349
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27
   RICARDBLUM S, 2000, INCONVENTIONAL COLLA
   Roy P, 2001, CELL TRANSPLANT, V10, P609
   SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066
   Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Schwartz MA, 2001, J CELL SCI, V114, P2553
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   Sechler JL, 1998, ANN NY ACAD SCI, V857, P143, DOI 10.1111/j.1749-6632.1998.tb10114.x
   Sechler JL, 1998, J BIOL CHEM, V273, P25533, DOI 10.1074/jbc.273.40.25533
   Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034
   Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Sieg DJ, 1999, J CELL SCI, V112, P2677
   Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x
   Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882
   STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883
   SUMAN KO, 1997, J BIOL CHEM, V272, P29380
   Taipale J, 1997, FASEB J, V11, P51
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1
   TILLES AW, 2002, HLTH CARE, V10, P177
   Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Vogel V, 2001, TRENDS BIOTECHNOL, V19, P416, DOI 10.1016/S0167-7799(01)01737-1
   Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Weiss TS, 2002, CELL PROLIFERAT, V35, P257, DOI 10.1046/j.1365-2184.2002.00248.x
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wu X, 1998, J CELL BIOL, V143, P241, DOI 10.1083/jcb.143.1.241
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zamir E, 2000, NAT CELL BIOL, V2, P191
   Zamir E, 1999, J CELL SCI, V112, P1655
   Zhang QH, 1997, MOL BIOL CELL, V8, P1415
   Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539
NR 135
TC 94
Z9 99
U1 0
U2 32
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1523-9829
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2003
VL 5
BP 441
EP 463
DI 10.1146/annurev.bioeng.5.040202.121615
PG 25
WC Engineering, Biomedical
SC Engineering
GA 742AV
UT WOS:000186493800015
PM 14527318
DA 2018-10-19
ER

PT J
AU Liu, LR
   Zhang, LH
   Ren, BZ
   Wang, FJ
   Zhang, QQ
AF Liu, LR
   Zhang, LH
   Ren, BZ
   Wang, FJ
   Zhang, QQ
TI Preparation and characterization of collagen-hydroxyapatite composite
   used for bone tissue engineering scaffold
SO ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY
LA English
DT Article
DE collagen-hydroxyapatite composite; bone tissue engineering;
   microstructure; histocompatibility
ID BIOMATERIAL; OSTEOBLAST; MATRICES
AB In this study, highly porous collagen-HA scaffolds were prepared by solid-liquid phase separation method. Microstructure of the composites was characterized by SEM, TEM and XRD. The results show that collagen-HA scaffolds are porous with three-dimension interconnected fiber microstructure, pore sizes are 50 - 150 mum, and HA particles are dispersed evenly among collagen fiber. Compared with pure collagen, the mechanical property of collagen-HA composite improves significantly. To gain further insight into cell growth throughout 3D scaffolds, the cell proliferation and attachment on the scaffold in vitro was investigated. The collagen-HA composite has good biocompatibility, and adding HA does not affect the histocompatibility of the scaffold materials. The porous collagen-HA composite is suitable as scaffold used for bone tissue engineering.
C1 Chinese Acad Med Sci, Inst Biomed Engn, Tianjin 300192, Peoples R China.
   Peking Union Med Coll, Tianjin 300192, Peoples R China.
RP Liu, LR (reprint author), Chinese Acad Med Sci, Inst Biomed Engn, POB 25 204, Tianjin 300192, Peoples R China.
RI Liu, Yifei/L-7828-2014; Zhang, QQ/G-3361-2010
OI Liu, Yifei/0000-0002-1087-9827; 
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Yang HY, 2001, J MATER SCI TECHNOL, V17, P495
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Zhang K, 2002, J BIOMED MATER RES, V61, P551, DOI 10.1002/jbm.10227
   Zhang LH, 2002, ARTIF CELL BLOOD SUB, V30, P319, DOI 10.1081/BIO-120006122
   Zhang QQ, 1999, ARTIF CELL BLOOD SUB, V27, P245, DOI 10.3109/10731199909117697
NR 15
TC 20
Z9 27
U1 2
U2 12
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1073-1199
J9 ARTIF CELL BLOOD SUB
JI Artif. Cells Blood Substit. Immobil. Biotechnol.
PY 2003
VL 31
IS 4
BP 435
EP 448
DI 10.1081/BIO-120025414
PG 14
WC Biotechnology & Applied Microbiology; Engineering, Biomedical; Materials
   Science, Biomaterials
SC Biotechnology & Applied Microbiology; Engineering; Materials Science
GA 747TE
UT WOS:000186820300005
PM 14672418
DA 2018-10-19
ER

PT J
AU Soman, N
   Banerjee, R
AF Soman, N
   Banerjee, R
TI Artificial vitreous replacements
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE vitreous; biomaterials; collagen and hyaluronic acid; silicone oil;
   polymer hydrogels
ID CROSS-LINKED POLY(1-VINYL-2-PYRROLIDINONE); FLUOROSILICONE COPOLYMER
   OIL; RETINAL-DETACHMENT SURGERY; PERFLUORO-N-OCTANE; SILICONE OIL;
   HYALURONIC-ACID; RABBIT EYES; SUBSTITUTES; COLLAGEN; RHEOLOGY
AB Vitreoretinal pathologies remain the significant leading cause of blindness, after cataract, throughout the world. Biomaterials as a whole, and vitreous substitutes in particular, have had a major role to play in vitreoretinal surgery. History has witnessed the advent of vitreous substitutes from collagen and hyaluronic acid to gases, silicone oils and perfluorocarbon liquids and now to polymer hydrogels. Such a long list only underscores the fact that we have been found wanting in our quest for an ideal vitreous substitute. This review focuses on the merits and demerits of various vitreous substitutes, which have been tried to date, clinical as well as experimental. The properties required of an ideal substitute and the performance of the vitreous substitutes with respect to these criteria have been described. Finally, the concluding note dwells on the future directions for biomaterial research in the posterior segment of the eye and undermines the role of tissue engineering in vitreoretinal regeneration.
C1 Indian Inst Technol, BJM Sch Biosci & Biotechnol, Biomed Engn Div, Bombay 400076, Mumbai, India.
RP Banerjee, R (reprint author), Indian Inst Technol, BJM Sch Biosci & Biotechnol, Biomed Engn Div, Bombay 400076, Mumbai, India.
CR Bishop P, 1996, GRAEF ARCH CLIN EXP, V234, P710, DOI 10.1007/BF00292358
   Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6
   BLINDER KJ, 1991, BRIT J OPHTHALMOL, V75, P240, DOI 10.1136/bjo.75.4.240
   Bos KJ, 2001, MICRON, V32, P301, DOI 10.1016/S0968-4328(00)00035-4
   BUCHSBAUM G, 1984, BIORHEOLOGY, V21, P285
   CHANG S, 1991, RETINA-J RET VIT DIS, V11, P367
   CHANG S, 1987, AM J OPHTHALMOL, V103, P29, DOI 10.1016/S0002-9394(14)74165-0
   CHATTERJEE B, 1997, HDB OPHTHALMOLOGY, P159
   Chirila TV, 1998, POLYM INT, V46, P183, DOI 10.1002/(SICI)1097-0126(199807)46:3<183::AID-PI941>3.3.CO;2-0
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   Colthurst MJ, 2000, BIOMATERIALS, V21, P649, DOI 10.1016/S0142-9612(99)00220-3
   CONSTABLE IJ, 1975, ARCH OPHTHALMOL-CHIC, V93, P416
   Dalton PD, 1995, POLYM GELS NETW, V3, P429, DOI 10.1016/0966-7822(94)00011-5
   DOI M, 1994, EXP EYE RES, V59, P737, DOI 10.1006/exer.1994.1160
   DOI M, 1995, EXP EYE RES, V61, P469, DOI 10.1016/S0014-4835(05)80142-3
   FERNANDEZVIGO J, 1990, RETINA-J RET VIT DIS, V10, P148, DOI 10.1097/00006982-199004000-00012
   Giordano GG, 1998, PROG POLYM SCI, V23, P509, DOI 10.1016/S0079-6700(97)00046-4
   GREMILLION CM, 1990, BRIT J OPHTHALMOL, V74, P643, DOI 10.1136/bjo.74.11.643
   Hara Yoshiaki, 1998, Nippon Ganka Gakkai Zasshi, V102, P247
   Hong Y, 1998, J BIOMED MATER RES, V39, P650, DOI 10.1002/(SICI)1097-4636(19980315)39:4<650::AID-JBM21>3.0.CO;2-9
   Hong Y, 1996, J BIOMED MATER RES, V30, P441, DOI 10.1002/(SICI)1097-4636(199604)30:4<441::AID-JBM2>3.0.CO;2-P
   Hong Y, 1996, J BIOMATER APPL, V11, P135, DOI 10.1177/088532829601100202
   JIANG YR, 1997, CHIN J OPHTHALMOL, V33, P39
   JONG C, 2000, B SOC BELGE OPHTALMO, V278, P71
   KOSTER R, 1986, DOC OPHTHALMOL, V64, P13, DOI 10.1007/BF00166680
   LEE B, 1992, BIORHEOLOGY, V29, P521
   LEE B, 1994, BIORHEOLOGY, V31, P339
   LEE B, 1994, BIORHEOLOGY, V31, P327
   Liang CP, 1999, RETINA-J RET VIT DIS, V19, P230, DOI 10.1097/00006982-199905000-00009
   MABERLEY AL, 1989, CAN J OPHTHALMOL, V24, P265
   Malson T, 1987, United States Patent n&DEG;, Patent No. [4 716 154, 4716154, USP4716154]
   Nakagawa M, 1997, OPHTHALMIC RES, V29, P409, DOI 10.1159/000268042
   NEMA H, 1998, TXB OPHTHALMOLOGY, P212
   Pastor JC, 1998, EUR J OPHTHALMOL, V8, P179
   PEYMAN GA, 1975, ARCH OPHTHALMOL-CHIC, V93, P514
   PRUETT RC, 1974, ARCH OPHTHALMOL-CHIC, V91, P29, DOI 10.1001/archopht.1974.03900060033008
   PRUETT RC, 1972, ARCH OPHTHALMOL-CHIC, V88, P540, DOI 10.1001/archopht.1972.01000030542015
   PUNNONEN E, 1989, ACTA OPHTHALMOL, V67, P30
   Ratiglia R, 1997, Eur J Ophthalmol, V7, P59
   SAATES N, 1996, RETINA, V16, P7
   Savinykh V I, 2000, Vestn Oftalmol, V116, P31
   SILVER FH, 1994, BIOMATERIALS MED DEV, P120
   Snell R., 1995, CLIN ANATOMY MED STU, P723
   TAKENOBU A, 1999, INTERNET J OPHTHALMO, V4, pS1
   VELIKAY M, 1995, GRAEF ARCH CLIN EXP, V233, P26, DOI 10.1007/BF00177782
   Vijayasekaran S, 1996, J BIOMAT SCI-POLYM E, V7, P685, DOI 10.1163/156856296X00453
NR 46
TC 72
Z9 73
U1 0
U2 19
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2003
VL 13
IS 1
BP 59
EP 74
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 657GP
UT WOS:000181658300006
PM 12652023
DA 2018-10-19
ER

PT J
AU Otsuka, M
   Marunaka, S
   Matsuda, Y
   Ito, A
   Naito, H
   Ichinose, N
   Kokubo, T
   Nakamura, T
   Higuchi, WI
AF Otsuka, M
   Marunaka, S
   Matsuda, Y
   Ito, A
   Naito, H
   Ichinose, N
   Kokubo, T
   Nakamura, T
   Higuchi, WI
TI Effect of particle size on zinc release from zinc containing tricalcium
   phosphate (ZnTCP) in Zn-deficient osteoporosis rats
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE biomaterial; zinc; drug delivery system; tricalcium phosphate; in vitro
   release; in vivo release; calcium level-responsive drug release
ID OVARIECTOMIZED RATS; CALCIUM LEVEL; DRUG-RELEASE; IN-VITRO; CEMENT
AB The effect of particle size on in vivo and in vitro Zn release of ZnTCP was investigated for the purpose of understanding Zn release behavior from a sustained-release device. The tricalcium phosphate powders (Ca2.7Zn0.3(PO4)(2)), with particle size of 7.5 and 553 mum (S-ZnTCP and L-ZnTCP), including a 10 mol% of Zn (6.17 w/w%), as new sustained-release preparations, were synthesized by heating, after then ground and sieved using 38 and 300 mum screens. The different powder samples were characterized by the X-ray powder diffractometry and scanning electron microscopy. The release rates from Zn-TCP powders (10 mg) were measured in 10 ml of simulated body fluid (SBF) containing 10 mg/100 ml Ca2+(SBF/H), SBF containing 5 mg/100 ml Ca2+ (SBF/L) or SBF without Ca2+ (SBF/-) at 37.0degreesC. The in vitro Zn release profiles for the smallest and the largest particles size of ZnTCP powders (L-ZnTCP and S-ZnTCP) at various Ca concentrations in SBF were significantly higher in SBF/- and SBF/L than in SBF/H. The Zn release rate from ZnTCP with different particle sizes were found to be inversely proportional to the concentration of calcium in SBF. After injection of a ZnTCP suspension containing 30 mg of S-ZnTCP powder on the backs of the rats, the plasma Zn level increased rapidly, reaching a concentration range of around 2 mug/ml. The area under the curve values of the plasma Zn concentration (Zn-AUC) over 6 days post injection of S-ZnTCP and L-ZnTCP were significantly higher than that of the control experiment. After the injection of S-ZnTCP and L-ZnTCP suspension, the plasma alkaline phosphatase activity (AIP) levels increased to more than 300 IU/l. In contrast, the AIP for the control decreased after 2 days. The area under the curve of the AIP (AIP-AUC) for 6 days of S-ZnTCP was significantly higher than that of other groups.
C1 Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Higashinada Ku, Kobe, Hyogo 658, Japan.
   Natl Inst Adv Interdisciplinary Res, Higashi Ku, Tsukuba, Ibaraki 3058562, Japan.
   Waseda Univ, Fac Sci & Technol, Shinjuku Ku, Tokyo 1698555, Japan.
   Kyoto Univ, Fac Med, Sakyo Ku, Kyoto, Japan.
   Kyoto Univ, Fac Engn, Div Mat Chem, Sakyo Ku, Kyoto, Japan.
   Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
RP Otsuka, M (reprint author), Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Higashinada Ku, Motoyama Kitamachi 4-19-1, Kobe, Hyogo 658, Japan.
RI Ito, Atsuo/M-6785-2018
OI Ito, Atsuo/0000-0003-3318-040X
CR BETTGER WJ, 1993, J NUTR BIOCHEM, V4, P194, DOI 10.1016/0955-2863(93)90052-X
   Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   CORLTZ BR, 1995, SCIENCE, V267, P1796
   ERIKSEN EF, 1990, BONE MINERAL RES, V7, P273
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   KIND PRN, 1954, J CLIN PATHOL, V7, P322, DOI 10.1136/jcp.7.4.322
   KISHI S, 1994, BIOCHEM PHARMACOL, V48, P1225, DOI 10.1016/0006-2952(94)90160-0
   KITANO M, 1971, NIPPON KAGAKU ZASSHI, V92, P168, DOI 10.1246/nikkashi1948.92.168
   KOKUBO T, 1991, J AM CERAM SOC, V74, P1739, DOI 10.1111/j.1151-2916.1991.tb07176.x
   MCLEAN F, 1968, FUNDAMENTALS PHYSL S, P119
   OKANO T, 1994, J BONE MINER MET, pS23
   Otsuka M, 1997, J CONTROL RELEASE, V43, P115, DOI 10.1016/S0168-3659(96)01493-9
   OTSUKA M, 1995, J PHARM SCI, V84, P733, DOI 10.1002/jps.2600840614
   Otsuka M, 1997, J PHARM PHARMACOL, V49, P1182, DOI 10.1111/j.2042-7158.1997.tb06067.x
   Otsuka M, 2000, J BIOMED MATER RES, V52, P819, DOI 10.1002/1097-4636(20001215)52:4<819::AID-JBM27>3.3.CO;2-F
   RELEA P, 1995, AGE AGEING, V24, P303, DOI 10.1093/ageing/24.4.303
   SUDA T, 1970, J NUTR, V100, P1049
   Szathmari Miklos, 1993, Orvosi Hetilap, V134, P911
   YAMAGUCHI M, 1993, JPN J PHARMACOL, V63, P203, DOI 10.1254/jjp.63.203
NR 21
TC 13
Z9 13
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2003
VL 13
IS 2
BP 103
EP 113
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 681YJ
UT WOS:000183062900001
PM 12775901
DA 2018-10-19
ER

PT J
AU Sanchez-Munoz, OL
   Nordstrom, EG
   Prerez-Hernandez, E
AF Sanchez-Munoz, OL
   Nordstrom, EG
   Prerez-Hernandez, E
TI Electrophoretic and thermodynamic properties for biomaterial particles
   with Bovine Serum Albumin adsorption
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE zeta potential; bioceramic; bioglass and association constant
AB The main purpose of our investigation is to achieve better insight into the electrophoretic and thermodynamic properties of protein-coated biomaterial particles. Many academic studies have been performed to understand the complex phenomena of microscopic biomaterial particles as a function of ionic strength, pH and temperature. By electrophoretic measurements of biomaterial particles, the surface structures of it can be analysed with a suitable model. Therefore, the zeta potential measurements are useful to know the effects of adsorbed BSA concentration upon the electrophoretic properties of bioceramics and bioglasses. Unexpectedly, the zeta potential of the BSA-coated biomaterials exhibits a local minimum as the concentrations of adsorbed BSA increases. Apparently, the structures of the attached BSA layer on the biomaterial particles play a significant role. In an attempt to elaborate the phenomenon observed, a model for proteins, which composes two BSA sublayers with different structures and properties, is proposed. Also, the association or equilibrium constant were determined and represented the isotherm curves in function of the zeta potential measurements.
C1 CUJAE, Dept Phys, FISDILAB,Biocolloids Biomat, Phys Disperse Syst Lab, CP-19390 Havana, Cuba.
   Abo Akad Univ, Proc Chem Grp, SF-20500 Turku, Finland.
   CIGB, Dept Carbohydrates, Chem Modificat Prot Lab, Havana, Cuba.
RP Sanchez-Munoz, OL (reprint author), CUJAE, Dept Phys, FISDILAB,Biocolloids Biomat, Phys Disperse Syst Lab, 127 S-N Marianao, CP-19390 Havana, Cuba.
CR Dukhin S. S., 1974, SURFACE COLLOID SCI, V7
   Hunter R. J, 1981, ZETA POTENTIAL COLLO
   Lyklema J, FUNDAMENTALS INTERFA, VII
   Nakamura R.M., 1992, IMMUNOCHEMICAL ASSAY
   Nordstrom EG, 2001, BIO-MED MATER ENG, V11, P221
   NORDSTROM EG, 1995, THESIS ABO AKAD U
   PEULA JM, 1994, SURFACE PROPERTIES B
   SANCHEZMUNOZ OL, 2002, J CAPILLARY ELECTROP, V11
   SANCHEZMUNOZ OL, 1998, MEMORIAS ELECT 3 TAL
   YLANEN H, 2000, BONE INGROWTH POROUS
NR 10
TC 4
Z9 4
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2003
VL 13
IS 2
BP 147
EP 158
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 681YJ
UT WOS:000183062900005
PM 12775905
DA 2018-10-19
ER

PT S
AU Ozawa, N
   Ideta, Y
   Shimizu, K
   Yao, T
AF Ozawa, N
   Ideta, Y
   Shimizu, K
   Yao, T
BE BenNissan, B
   Sher, D
   Walsh, W
TI Development of a bioactive alumina-based composite by electrophoretic
   deposition
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE electrophoretic deposition; alumina; wollastonite; composite; apatite;
   SBF
AB Alumina is excellent biomaterial and used in hip prostheses, dental implants and so on. Wollastonite particles were deposited in the pores of foamed alumina by electrophoretic deposition. Apatite was formed both inside the pores and on the surface of the composite of foamed alumina and wollastonite by soaking in a simulated body fluid. It is indicated that the deposited wollastonite particles induced the apatite formation. It is considered that novel alumina-based composite with both excellent mechanical properties and high bioactivity was developed.
C1 Kyoto Univ, Grad Sch Energy Sci, Kyoto, Japan.
RP Ozawa, N (reprint author), Kyoto Univ, Grad Sch Energy Sci, Kyoto, Japan.
CR KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   YAO T, 2001, Patent No. 200170183
NR 3
TC 6
Z9 6
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 67
EP 70
DI 10.4028/www.scientific.net/KEM.240-242.67
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600016
DA 2018-10-19
ER

PT S
AU Yokogawa, Y
   Varman, HK
   Sreenivasan, K
AF Yokogawa, Y
   Varman, HK
   Sreenivasan, K
BE BenNissan, B
   Sher, D
   Walsh, W
TI Biomimetic growth of calcium phosphate over ATP coupled PMMA films
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE biomaterial; calcium phosphate; biomimetic; phosphorylation; SBF
ID COTTON
AB Biomimetic growth of calcium phosphate phase was studied over phosphate group functionalised polymethy methaerylate (PMMA) films using Fourier Transform Infrared Spectroscopy (FTIR), Electron Spectroscopy (ESCA), Scanning Electron Microscopy (SEM) and Energy Dispersive X ray Analysis(EDS). PMMA films were prepared by dissolving PMMA pellets in chloroform and cast into thin sheets. The films were immersed in a methanol solution of sodium hydroxide before treating with 1.5% solution of adenosine triphosphate (ATP) at a pH of 5.2 for 24 hours. The films were then soaked in saturated lime solution for 4 days to initiate formation of calcium phosphate precursor phase over their surface. The above films immersed in simulated body fluid solution (1.5 x SBF) for more than 5 days led to the nucleation of apatitic calcium phosphate phase over the film surface.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
   ASIT Chubu Ctr, Biofunct Ceram Grp, Nagoya, Aichi, Japan.
RP Yokogawa, Y (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
CR BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   DALAS E, 1991, LANGMUIR, V7, P1822, DOI 10.1021/la00056a040
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P597, DOI 10.1007/BF00121284
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P409, DOI 10.1007/BF00120283
   NANCOLLAS GH, 1989, STUDIES CALCIUM PHOS
   Ohtsuki C, 2001, J MATER SCI-MATER M, V12, P895, DOI 10.1023/A:1012876108210
   Tanahashi M, 1996, J BIOMED MATER RES, V31, P243, DOI 10.1002/(SICI)1097-4636(199606)31:2<243::AID-JBM11>3.0.CO;2-M
   Varma HK, 1999, J MATER SCI-MATER M, V10, P395, DOI 10.1023/A:1008970913107
NR 8
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 75
EP 79
DI 10.4028/www.scientific.net/KEM.240-242.75
PG 5
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600018
DA 2018-10-19
ER

PT S
AU Saravanapavan, P
   Patel, MH
   Hench, LL
AF Saravanapavan, P
   Patel, MH
   Hench, LL
BE BenNissan, B
   Sher, D
   Walsh, W
TI Effect of composition and texture on controlled rate of release of an
   antibacterial agent from bioactive gel-glasses
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE antimicrobial; in-vitro bioactivity; silver-doped; gel-glass powders
AB Bioactive glasses are not only biocompatible they elicit a cellular response from the host tissue resulting in an interfacial bond to implants. However, the incidence of biomaterial-centred infections underlies the need to improve the properties of existing biomaterials. The broad-spectrum antimicrobial action of silver has been well exploited since ancient times. Combining the bioactive properties of glasses with that of the silver would prevent infections without the use of antibiotic drugs. In this paper the in vitro bioactivity of two bioactive gel-glass compositions (58S and S70C30) and their silver containing equivalents are reported. This study leads to the following conclusions: 1) The rate of formation of hydroxy apatite on the silver doped powders is slower than their un-doped counterparts. 2) The presence of silver does not compromise the in vitro bioactivity of the gel-glasses
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, Tissue Engn Ctr, London SW7 2BP, England.
RP Saravanapavan, P (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Mat, Tissue Engn Ctr, London SW7 2BP, England.
CR Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   Hidalgo E, 1998, SKIN PHARMACOL APPL, V11, P140, DOI 10.1159/000029820
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   SARAVANAPAVAN P, 2002, UNPUB J BIOMED MAT R
   Sepulveda P, 2002, J BIOMED MATER RES, V61, P301, DOI 10.1002/jbm.10207
   Stoor P, 1998, ACTA ODONTOL SCAND, V56, P161, DOI 10.1080/000163598422901
NR 6
TC 4
Z9 4
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 233
EP 236
DI 10.4028/www.scientific.net/KEM.240-242.233
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600049
DA 2018-10-19
ER

PT S
AU Mansur, HS
   Giovannini, JFBG
   Jansen, WC
   Avelar, MM
AF Mansur, HS
   Giovannini, JFBG
   Jansen, WC
   Avelar, MM
BE BenNissan, B
   Sher, D
   Walsh, W
TI Study of the manipulation energy on fluoride release by dental
   bioceramic
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE fluoride release; ionomer; dental bioceramic
ID GLASS
AB The beneficial effects of fluoride on the human dentition have prompted the inclusion of fluoride in many dental restorative materials. This work investigates Fluoride release of glass polyalkenoate (glass ionomers) for cementation on dental restoration. The samples were prepared in 3 different pieces of equipment (Capmix(R), Deltronix(R), Dentomat(R)), using three power setups, 4300, 3200 and 2400 cycles/min, for two different manipulation times of 10 and 15 s. Fluoride concentration [F-] of each group of samples was measured for different immersion intervals: 1 h, 4 h, 12 h, 24 h, 48 h, 3 days, 5 days, 7 days and 14 days. The fluoride concentration was measured using the direct potenciometry technique with ion-selective electrode for fluoride. The results indicated we have successfully used the ion-selective electrode technique for [F-] release study on dental biomaterial. It was not observed any major difference on the [F-] release kinetics pattern for all 3 manipulation power used on the glass ionomer preparation. Although, it was also noted a slightly higher initial [F-] release rate for the glass ionomer manipulated at 4300 cycles/min compared to the others.
C1 Univ Fed Minas Gerais, Dept Met & Mat, Belo Horizonte, MG, Brazil.
   Dev Ctr Nucl Technol, Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat, Belo Horizonte, MG, Brazil.
OI Mansur, Herman/0000-0002-3032-495X
CR Bala O, 1997, J Nihon Univ Sch Dent, V39, P123
   FORSS H, 1990, SCAND J DENT RES, V98, P173
   Forsten L, 1998, BIOMATERIALS, V19, P503, DOI 10.1016/S0142-9612(97)00130-0
   GEE D, 1993, BRIT DENT J, V174, P65, DOI 10.1038/sj.bdj.4808079
   Grobler SR, 1998, J DENT, V26, P259, DOI 10.1016/S0300-5712(97)00011-0
   HATIBOVICKOFMAN S, 1991, SWED DENT J, V15, P253
NR 6
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 353
EP 356
DI 10.4028/www.scientific.net/KEM.240-242.353
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600078
DA 2018-10-19
ER

PT S
AU Shinzato, S
   Nakamura, T
   Kokub, T
AF Shinzato, S
   Nakamura, T
   Kokub, T
BE BenNissan, B
   Sher, D
   Walsh, W
TI Alumina powder/PMMA composite cements: An evaluation of
   osteoconductivity
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE alumina; composite; crystal phase; osteoconductivity; polymethyl
   methacrylate (PMMA); animal studies; bone cement
ID BIOACTIVE BONE-CEMENT; BEAD FILLER CONTENT; MECHANICAL-PROPERTIES;
   BIOLOGICAL PROPERTIES
AB New composites consisting of high molecular weight polymethyl methacrylate (hPMMA) and delta- or alpha-alumina powder (designated deltaAPC and alphaAPC, respectively), which allow direct bone formation on their surfaces in vivo, have been developed. Especially, deltaAPC allowed much more bone formation on the surface. delta-Alumina powder was manufactured by fusing pulverized alumina powder and quenching it. It was composed mainly of delta-crystal phases of alumina. The purpose of the present study was to evaluate osteoconductivity of these composites. The hPMMA itself was used as a reference material. These three types of composites were packed into the intramedullary canals of rat tibiae to evaluate osteoconductivity, as determined by an affinity index. Rats were sacrificed at 4 and 8 weeks after surgery. The affinity index, equal to the length of bone in direct contact with the composite surface expressed as a percentage of the total length of the composite surface, was calculated for each composite at each interval. Histologically, new bone had formed along the surface of both delta APC and alphaAPC within 4 weeks. The affinity indices for both deltaAPC and alphaAPC increased significantly with time up to 8 weeks. At 8 weeks, the affinity index for delta APC was significantly higher than those for alphaAPC and hPMMA. This study revealed that the excellent osteoconductivity of deltaAPC was due to the alumina's delta-crystal phases and the high molecular weight of hPMMA. deltaAPC shows promise as a basis for developing a highly osteoconductive biomaterial.
C1 Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Rakuyo Hosp, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6060017, Japan.
   Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Sakyo Ku, Kyoto 6068501, Japan.
RP Shinzato, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kawahara Cho 54, Kyoto 6068507, Japan.
CR KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NAKAMURA T, 2000, T 6 WORLD BIOM C KAM, V3, P1098
   NAKAMURA T, 2000, BIOCERAMICS, V13, P661
   Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F
   Shinzato S, 2002, J BIOMED MATER RES, V59, P225, DOI 10.1002/jbm.1236
   Shinzato S, 2001, J BIOMED MATER RES, V56, P452, DOI 10.1002/1097-4636(20010905)56:3<452::AID-JBM1115>3.0.CO;2-1
   Shinzato S, 2001, J BIOMED MATER RES, V55, P277, DOI 10.1002/1097-4636(20010605)55:3<277::AID-JBM1015>3.0.CO;2-5
   Shinzato S, 1999, J BIOMED MATER RES, V46, P287, DOI 10.1002/(SICI)1097-4636(199908)46:2<287::AID-JBM19>3.0.CO;2-I
   Shinzato S, 2000, J BIOMED MATER RES, V53, P51
   Shinzato S, 2000, J BIOMED MATER RES, V51, P258, DOI 10.1002/(SICI)1097-4636(200008)51:2<258::AID-JBM15>3.0.CO;2-S
NR 12
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 365
EP 368
DI 10.4028/www.scientific.net/KEM.240-242.365
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600081
DA 2018-10-19
ER

PT S
AU Kim, SR
   Kim, YH
   Riu, DH
   Jung, SJ
   Lee, YJ
AF Kim, SR
   Kim, YH
   Riu, DH
   Jung, SJ
   Lee, YJ
BE BenNissan, B
   Sher, D
   Walsh, W
TI Synthesis and characterization of ti-substituted hydroxyapatite
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE hydroxyapatite; titanium; synthesis; substitution
AB A titanium-substituted hydroxyapatite has been prepared using titanium (IV) isopropoxide as a titanium source to obtain a biomaterial having an improved biocompatibility. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing titanium has formed without revealing the presence of extra phases related to titanium dioxide or other calcium phosphate species. Titanium content was up to 0.73% by weight. EDS investigation confirmed the presence of titanium in the framework of hydroxyapatite structure.
C1 Korea Inst Ceram Engn & Technol, Seoul, South Korea.
RP Kim, SR (reprint author), Korea Inst Ceram Engn & Technol, Seoul, South Korea.
CR Bertoni E, 1998, J INORG BIOCHEM, V72, P29, DOI 10.1016/S0162-0134(98)10058-2
   ELLIOTT JC, 1994, STRUCTURE CHEM APATI, P188
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Kim S. R., 2002, KEY ENG MATER, V85, P218
   LOPEZ JG, 2001, J RAMAN SPECTROSC, V32, P255
   Mayer I, 2000, J CRYST GROWTH, V219, P98, DOI 10.1016/S0022-0248(00)00608-4
   OKAZAKI M, 1995, BIOMATERIALS, V16, P703, DOI 10.1016/0142-9612(95)99698-L
   Skrtic D, 2002, J BIOMED MATER RES, V59, P597, DOI 10.1002/jbm.10017
NR 8
TC 2
Z9 2
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 501
EP 504
DI 10.4028/www.scientific.net/KEM.240-242.501
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600114
DA 2018-10-19
ER

PT S
AU Kizuki, T
   Ohgaki, M
   Nakamura, S
   Hashimoto, K
   Toda, Y
   Yamashita, K
AF Kizuki, T
   Ohgaki, M
   Nakamura, S
   Hashimoto, K
   Toda, Y
   Yamashita, K
BE BenNissan, B
   Sher, D
   Walsh, W
TI Synthesis of new biocompatible apatite-type rare-earth silicates
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE apatite-type; rare-earth; biocompatibility; cell behavior; tissue
   reaction; silicates; synthesis; in vitro
AB Series of apatite-type rare-earth silicates were synthesized by a solid state reaction at 1400degreesC as a new biomaterial. The synthesized apatite-type rare-earth silicates were analyzed by X-ray diffraction (XRD) and infrared spectroscopy (IR), and lattice parameters were calculated. Single phase of the apatite-type rare-earth silicates was obtained, and the lattice parameters became smaller with the increase of the rare-earth content or increasing of an atomic number of the substituted ions. The ceramic apatite-type rare-earth silicates were obtained by a sintering at 1400degreesC, and its biocompatibility was estimated by in vitro and in vivo tests. The ceramic apatite-type rare-earth silicates had a good cell proliferation, and no inflammation was observed in the vicinity of the implanted ceramic. It was suggested that the ceramic apatite-type rare-earth silicates could use as a biocompatible material.
C1 Tokyo Med & Dent Univ, Tokyo, Japan.
RP Kizuki, T (reprint author), Tokyo Med & Dent Univ, Tokyo, Japan.
CR ITO J, 1968, AM MINERAL, V53, P890
   Kizuki T, 2001, J CERAM SOC JPN, V109, P162, DOI 10.2109/jcersj.109.1266_162
   KIZUKI T, 1999, BIOCERAMICS, V12, P215
   Takeda H, 2000, J AM CERAM SOC, V83, P2884
NR 4
TC 0
Z9 1
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 559
EP 562
DI 10.4028/www.scientific.net/KEM.240-242.559
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600127
DA 2018-10-19
ER

PT S
AU Wei, M
   Vellinga, D
   Leavesley, D
   Evans, J
   Upton, Z
AF Wei, M
   Vellinga, D
   Leavesley, D
   Evans, J
   Upton, Z
BE BenNissan, B
   Sher, D
   Walsh, W
TI Cell attachment and proliferation on hydroxyapatite and ion substituted
   hydroxyapatites
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE Partially fluoride substituted hydroxyapatite; hydroxyapatite; cell
   attachment; cell proliferation
ID BONE
AB Hydroxyapatite (HA), partially fluoride substituted hydroxyapatite (fHA), and fluorapatite (FA) were synthesized in-house and characterised. Cell attachment and proliferation on polystyrene, titanium, HA, fHA and FA were investigated. It was found that fHA was a promising biomaterial. This material supports osteoblast cell attachment equivalent to that observed with polystyrene (plastic tissue culture well), titanium (a widely used metal implant material), HA and FA. However, it is significantly superior to these materials in inducing proliferation of the human osteoblast cell line. The cell proliferation rate on fHA is more than double the rate of the remaining materials, including HA, a widely used biomaterial. fHA may thus be a potential candidate biomaterial for biomedical applications.
C1 Univ Connecticut, Dept Met & Mat Engn, Storrs, CT 06269 USA.
   Queensland Univ Technol, Ctr Rehabil Sci & Engn, Brisbane, Qld 4001, Australia.
   Queensland Univ Technol, Sch Life Sci, Brisbane, Qld 4001, Australia.
RP Vellinga, D (reprint author), Univ Connecticut, Dept Met & Mat Engn, 97 N Eagleville Rd,Unit 3136, Storrs, CT 06269 USA.
RI Leavesley, David/C-9532-2009; Upton, Zee/I-9777-2012
OI Leavesley, David/0000-0002-1033-5459; 
CR BRAUN M, 1995, J MATER SCI-MATER M, V6, P150, DOI 10.1007/BF00120291
   Clemens JAM, 1997, J BIOMED MATER RES, V36, P55, DOI 10.1002/(SICI)1097-4636(199707)36:1<55::AID-JBM7>3.0.CO;2-K
   DHERT WJA, 1991, J BIOMED MATER RES, V25, P1183, DOI 10.1002/jbm.820251002
   Gross KA, 2002, J BIOMED MATER RES, V63, P106, DOI 10.1002/jbm.10090
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P139
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   TRAVERIACROS A, 1980, ACTA GEOL HISP, V15, P15
NR 9
TC 3
Z9 3
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 671
EP 674
DI 10.4028/www.scientific.net/KEM.240-242.671
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600154
DA 2018-10-19
ER

PT S
AU Zreiqat, H
   Howlett, CR
   Zannettino, A
   Evans, P
   Knabe, C
   Schulze-Tanzil, G
   Shakibae, GM
AF Zreiqat, H
   Howlett, CR
   Zannettino, A
   Evans, P
   Knabe, C
   Schulze-Tanzil, G
   Shakibae, GM
BE BenNissan, B
   Sher, D
   Walsh, W
TI Surface modification of bioceramics. affect osteoblastic cells response
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE magnesium ions; osteoblasts; adhesion; integrins; matrix proteins;
   bioceramic
ID BONE-DERIVED CELLS
AB Poor cell adhesion to orthopaedic and dental implants may result in implant failure. Cellular adhesion to biomaterial surfaces is primarily mediated by integrins, which act as signal transduction and adhesion proteins. Since integrin function depends on divalent cations, we investigated the effect of magnesium ions modified bioceramic substrata (Al2O3-Mg2+) on human bone-derived cell (HBDC) adhesion, integrin expression and activation of intracellular signalling molecules. Our findings demonstrated that adhesion, spreading and expression of extracellular matrix proteins was increased when HBDC were cultured on Al2O3-Mg2+ compared to the Mg2+-free Al2O3. Moreover, these cells grown on Al2O3-Mg2+ expressed significantly enhanced levels of beta1-, alpha5beta1- and alpha3beta1-integrins receptors. Tyrosine phosphorylation. of intracellular integrin-dependent signalling proteins and Shc isoforms (p46, p52, p66) were significantly enhanced when HBDC were grown on Al2O3-Mg2+ compared to Al2O3. We demonstrated that Mg2+-promoted cell adhesion depends on alpha5beta1- and beta1-integrins associated signal transduction pathways involving the key signalling protein. Since Mg2+-modified substrata enhanced osteoblastic proliferation and differentiation, their potency to enhance osteogenesis is hereby suggested. Mg2+ supplementation of bioceramic substrata may be a promising way to improve integration of implants in orthopaedic and dental surgery.
C1 Univ New S Wales, Sch Med Sci, Dept Pathol, Sydney, NSW 2052, Australia.
   Inst Med & Vet Sci, Hanson Ctr Canc Res, Adelaide, SA 5000, Australia.
   ANSTO, Sydney, NSW 2052, Australia.
   Univ Hosp Benjamin Franklin, Dept Expt Dent, Berlin, Germany.
   Free Univ Berlin, Benjamin Franklin Med Ctr, Inst Anat, D-1000 Berlin, Germany.
RP Zreiqat, H (reprint author), Univ New S Wales, Sch Med Sci, Dept Pathol, Sydney, NSW 2052, Australia.
CR Bilek MMM, 2000, J APPL PHYS, V87, P4198, DOI 10.1063/1.373052
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   DEDHAR S, 1987, J CELL BIOL, V105, P1175, DOI 10.1083/jcb.105.3.1175
   Howlett CR, 1999, J BIOMED MATER RES, V45, P345, DOI 10.1002/(SICI)1097-4636(19990615)45:4<345::AID-JBM9>3.0.CO;2-J
   HOWLETT CR, 2000, EFFECT BIOMATERIAL C
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 7
TC 3
Z9 3
U1 1
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 707
EP 710
DI 10.4028/www.scientific.net/KEM.240-242.707
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600163
DA 2018-10-19
ER

PT S
AU Pezzotti, G
AF Pezzotti, G
BE BenNissan, B
   Sher, D
   Walsh, W
TI Introducing a unique measurement for biomaterial nanomechanics
SO BIOCERAMICS 15
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Ceramics in Medicine
CY DEC 04-08, 2002
CL UNIV TECHNOL, SYDNEY, AUSTRALIA
SP Int Soc Ceram Med
HO UNIV TECHNOL
DE Raman microprobe piezo-spectroscopy; nanomechanics; hydroxyapatite;
   zirconia
ID POLYCRYSTALLINE CERAMICS; RAMAN-SPECTROSCOPY; ZIRCONIA; FRACTURE;
   STRESSES
AB Raman spectroscopy techniques can be routinely used for the quantitative assessments of structure and stresses in biomaterials. As a first step towards the development of an experimental field of biomaterials micro/nanomechanics into the Raman microprobe spectroscope, we show in this paper that reliable measurements of microscopic stress fields can be obtained in both biogenic and synthetic biomaterials, taking advantage of their intense Raman spectra. Experimental micro/ nanomechanics assessments may open a completely new perspective in the development of new biomaterials because, for the first time, one can directly visualize how stresses distribute within the microstructure. In addition, the quantitative knowledge of microscopic structure/stress relations may provide invaluable information in the attempt of unfolding unknown functionalities in biogenic materials.
C1 Kyoto Inst Technol, Ceram Phys Lab, Kyoto 6068585, Japan.
RP Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Kyoto 6068585, Japan.
CR ANASTASSAKIS E, 1981, J RAMAN SPECTROSC, V10, P64, DOI 10.1002/jrs.1250100112
   ANASTASSAKIS E, 1971, J PHYS CHEM SOLIDS, V32, P79
   BLAKESLEE KC, 1971, J AM CERAM SOC, V54, P559, DOI 10.1111/j.1151-2916.1971.tb12207.x
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   CARLONE C, 1992, PHYS REV B, V45, P2079, DOI 10.1103/PhysRevB.45.2079
   CERNANSKY M, 1999, DEFECT MICROSTRUCTUR, P613
   CLARKE DR, 1982, J AM CERAM SOC, V65, P284, DOI 10.1111/j.1151-2916.1982.tb10445.x
   Clarke IC, 2000, P I MECH ENG H, V214, P331, DOI 10.1243/0954411001535381
   De Wolf I, 1999, J RAMAN SPECTROSC, V30, P877
   HAERLE AG, 1991, J AM CERAM SOC, V74, P2897, DOI 10.1111/j.1151-2916.1991.tb06860.x
   Kontoyannis CG, 2000, APPL SPECTROSC, V54, P1605, DOI 10.1366/0003702001948853
   MA Q, 1994, J AM CERAM SOC, V77, P298, DOI 10.1111/j.1151-2916.1994.tb06996.x
   MA Q, 1993, J AM CERAM SOC, V76, P1433, DOI 10.1111/j.1151-2916.1993.tb03922.x
   Pezzotti G, 1999, COMPOS SCI TECHNOL, V59, P821, DOI 10.1016/S0266-3538(99)00013-5
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 15
TC 7
Z9 7
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-911-3
J9 KEY ENG MAT
PY 2003
VL 240-2
BP 893
EP 900
DI 10.4028/www.scientific.net/KEM.240-242.893
PG 8
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Coatings & Films; Materials Science, Composites
SC Materials Science
GA BW65Q
UT WOS:000182706600203
DA 2018-10-19
ER

PT S
AU Kim, YH
   Kim, SR
   Jung, SJ
   Lee, YJ
   Song, H
AF Kim, YH
   Kim, SR
   Jung, SJ
   Lee, YJ
   Song, H
BE Sundar, V
   Rusin, RP
   Rutiser, CA
TI Porous hydroxyapatite containing silicon derived from natural coral
SO BIOCERAMICS: MATERIALS AND APPLICATIONS IV
SE CERAMIC TRANSACTIONS
LA English
DT Proceedings Paper
CT Symposium on Bioceramics held at the 105th Annual Meeting of the
   American-Ceramic-Society
CY APR 27-30, 2003
CL NASHVILLE, TN
SP Amer Ceram Soc
ID SUBSTITUTED HYDROXYAPATITE
AB Ion-substituted hydroxyapatite may be used as a biological material in the form of porous body. A porous silicon-substituted hydroxyapatite has been prepared using natural coral as a calcium source to obtain a biomaterial having a good biocompatibility. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing silicon has formed without revealing the presence of extra phases related to silicon dioxide or other calcium phosphate species. Silicon content was 0.73% by weight. EDS investigation confirmed the presence of silicon in the framework of hydroxyapatite structure.
C1 Korea Inst Ceram Engn & Technol, Seoul, South Korea.
RP Kim, YH (reprint author), Korea Inst Ceram Engn & Technol, Seoul, South Korea.
CR Bertoni E, 1998, J INORG BIOCHEM, V72, P29, DOI 10.1016/S0162-0134(98)10058-2
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Hayakawa S, 1999, J AM CERAM SOC, V82, P2155
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Innes JK, 2003, KEY ENG MAT, V240-2, P43, DOI 10.4028/www.scientific.net/KEM.240-242.43
   Kim SR, 2002, KEY ENG MATER, V218-2, P85, DOI 10.4028/www.scientific.net/KEM.218-220.85
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   KOKUBO T., 1994, BIOCERAMICS, V7, P49
   OKAZAKI M, 1995, BIOMATERIALS, V16, P703, DOI 10.1016/0142-9612(95)99698-L
NR 10
TC 0
Z9 0
U1 0
U2 0
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 1042-1122
BN 1-57498-202-8
J9 CERAM TRANS
PY 2003
VL 147
BP 45
EP 52
PG 8
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials
SC Engineering; Materials Science
GA BY27K
UT WOS:000188655200005
DA 2018-10-19
ER

PT S
AU Jin, HJ
   Chen, JS
   Karageorgiou, V
   Altman, GH
   Kaplan, DL
AF Jin, HJ
   Chen, JS
   Karageorgiou, V
   Altman, GH
   Kaplan, DL
BE Simon, U
   Schmid, G
   Hong, S
   Stranick, SJ
   Arrivo, SM
TI Human bone marrow stem cell responses on electrospun Bombyx mori silk
   fibroin
SO BIOINSPIRED NANOSCALE HYBRID SYSTEMS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Bioinspired Nanoscale Hybrid Systems held at the 2002 MRS
   Fall Meeting
CY DEC 02-04, 2002
CL BOSTON, MA
SP Mat Res Soc, USAF, Off Sci Res, AlCove Surfaces, Henkel, Pfizer Global Res & Dev, NIST
ID SCAFFOLD
AB Electrospinning for the formation of nanoscale diameter fibers has been explored for high performance filters and biomaterial scaffolds for vascular grafts or wound dressings. Fibers with nanoscale diameters provide benefits due to high surface area. In this study we used electrospinning for protein-based biomaterials to fabricate scaffolds from aqueous regenerated silkworm silk, Bombyx mori,. Adhesion, spreading and proliferation of human bone marrow stem cells (hBMSCs) on electrospun silk was characterized. Scanning electron microscopy (SEM) and MTT analyses demonstrated that the electrospun silk matrices promoted hBMSC attachment and proliferation over 10 days in culture. The responses of the hBMSCs on the electrospun silk matrices, combined with the biocompatibile properties of the silk fibroin protein matrix, suggest potential for use of this biomaterial as scaffolds for tissue engineering.
C1 Tufts Univ, Bioengn Ctr, Dept Chem & Biol Engn, Medford, MA 02155 USA.
RP Jin, HJ (reprint author), Tufts Univ, Bioengn Ctr, Dept Chem & Biol Engn, 4 Colby St, Medford, MA 02155 USA.
OI Karageorgiou, Vassilis/0000-0002-0892-510X
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Boland E. D., 2001, POLYM MAT SCI ENG, V85, P51
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Stitzel JD, 2001, J BIOMATER APPL, V16, P22, DOI 10.1106/U2UU-M9QH-Y0BB-5GYL
NR 7
TC 1
Z9 1
U1 1
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-672-9
J9 MATER RES SOC SYMP P
PY 2003
VL 735
BP 129
EP 133
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BW86R
UT WOS:000183431000022
DA 2018-10-19
ER

PT J
AU Kolhe, P
   Kannan, RM
AF Kolhe, P
   Kannan, RM
TI Improvement in ductility of chitosan through blending and
   copolymerization with PEG: FTIR investigation of molecular interactions
SO BIOMACROMOLECULES
LA English
DT Article
ID INFRARED-SPECTROSCOPY; MECHANICAL-PROPERTIES; DEACETYLATION; MORPHOLOGY;
   BEHAVIOR; OXIDE); CHITIN; RATIOS; FILMS
AB Chitosan is an important biomaterial used widely in medical applications. One of the key concerns about its use is the fragile nature of chitosan films. By comparing the component molecular interactions using FTIR, this study attempts to understand how the ductility of chitosan can be improved by blending and copolymerizing with poly(ethylene glycol) (PEG). An improvement in ductility was obtained for all compositions of blend as manifested by a decrease in modulus and an increase in strain at break. For comparable PEG composition (-30%), the properties of the solution-cast blend were better than those of the grafted copolymer. Therefore, blending may be a more efficient way to improve ductility of chitosan. FTIR characterization of the materials revealed subtle decreases in molecular interactions upon annealing the partially miscible blend. These may not be apparent in DSC or X-ray diffraction, yet they play a key role in the mechanical behavior. It appears that in the case of the graft copolymer the improvement in the properties comes from suppression of the crystallinity of each component and not from component interactions. On the other hand, in the blend, the improvement appears to come predominantly from the "well-dispersed", "kinetically trapped" phase morphology and from the intermolecular interactions. Therefore, annealing the blend leads to decreased intermolecular interactions, phase coarsening, and deterioration in properties.
C1 Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA.
RP Kannan, RM (reprint author), Wayne State Univ, Dept Chem Engn & Mat Sci, 5050 Anthony Wayne Dr, Detroit, MI 48202 USA.
CR Alekseev VL, 2001, POLYM SCI SER B+, V43, P281
   Alexeev VL, 2000, POLYM ENG SCI, V40, P1211, DOI 10.1002/pen.11248
   Bentley MD, 1998, J PHARM SCI, V87, P1446, DOI 10.1021/js980064w
   Coleman MM, 1991, SPECIFIC INTERACTION
   Corrigan DO, 2002, INT J PHARM, V235, P193, DOI 10.1016/S0378-5173(01)00990-5
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   Dufresne A, 1999, POLYMER, V40, P1657, DOI 10.1016/S0032-3861(98)00335-8
   Harris JM, 1997, ACS S SERIES, V680
   Jiang WH, 1998, J POLYM SCI POL PHYS, V36, P1275, DOI 10.1002/(SICI)1099-0488(199806)36:8<1275::AID-POLB2>3.0.CO;2-R
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MOSS D, 1990, EUR J BIOCHEM, V187, P565, DOI 10.1111/j.1432-1033.1990.tb15338.x
   Mucha M, 1999, MACROMOL SYMP, V144, P391, DOI 10.1002/masy.19991440137
   Muzzarelli R., 1986, CHITIN NATURE TECHNO
   Painter PC, 1997, FUNDAMENTALS POLYM S
   Prashanth KVH, 2002, CARBOHYD POLYM, V50, P27
   RATHKE TD, 1993, J POLYM SCI POL CHEM, V31, P749, DOI 10.1002/pola.1993.080310320
   Ratto JA, 1996, J APPL POLYM SCI, V59, P1451, DOI 10.1002/(SICI)1097-4628(19960228)59:9<1451::AID-APP13>3.0.CO;2-1
   Sakurai K, 2000, POLYMER, V41, P7051, DOI 10.1016/S0032-3861(00)00067-7
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   Socrates G., 1994, INFRARED CHARACTERIS
   WANG W, 1997, ADV CHITIN SCI, V2, P561
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   ZHAO WW, 1995, J MACROMOL SCI PHYS, VB34, P231, DOI 10.1080/00222349508215531
   ZHONG J, UNPUB CRYSTALLINITY
NR 24
TC 179
Z9 184
U1 2
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN-FEB
PY 2003
VL 4
IS 1
BP 173
EP 180
DI 10.1021/bm025689+
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 635YW
UT WOS:000180428600026
PM 12523863
DA 2018-10-19
ER

PT J
AU Majd, ES
   Goldberg, M
   Stanislawski, L
AF Majd, ES
   Goldberg, M
   Stanislawski, L
TI In vitro effects of ascorbate and Trolox on the biocompatibility of
   dental restorative materials
SO BIOMATERIALS
LA English
DT Article
DE dental biomaterials; antioxidants; trolox; ascorbate; glutathione; iron;
   aluminum
ID GLASS-IONOMER CEMENTS; VITAMIN-C; OXIDATIVE DAMAGE; IN-VITRO; IRON;
   CYTOTOXICITY; ALUMINUM; ANTIOXIDANTS; RELEASE; GLUTATHIONE
AB Previous in vitro studies on the cytotoxicity of eight dental restorative materials including composites, compomers, resin-modified glass ionomer cements and glass ionomer cements have demonstrated a depletion of intracellular glutathione in gingival fibroblasts incubated with eluates of these materials and a protective effect of N-acetylcysteine. In the present study, we investigate the effects of two other antioxidants: ascorbate and Trolox. It was found that Trolox reduced the cytotoxicity induced by resin-based biomaterial eluates. In contrast, ascorbate increased in a dose-dependent manner the toxic effect of all eluates except for 2100 MP and Tetric flow (composites). The effect of D-mannitol was studied for GC FUJI II and was found to neutralize the additional toxic effect of ascorbate. Ascorbate increased the depletion of intracellular glutathione of these dental material eluates (between 17% and 24%, depending on the material). Quantification of metal ions in the dental material eluates showed the presence of significant amounts of aluminum and iron in GC FUJI II > photac fil > GC FUJI II LC > F2000. The mechanism of this increased cytotoxicity could be explained by the Fenton reaction resulting from the pro-oxidant effect of ascorbate in the presence of iron (transition metal ions) and/or aluminum. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Paris 05, Fac Chirurg Dentaire, Lab Biol & Physiopathol Cranio Faciales, F-92120 Montrouge, France.
RP Stanislawski, L (reprint author), Univ Paris 05, Fac Chirurg Dentaire, Lab Biol & Physiopathol Cranio Faciales, EA 2496,1 Rue Maurice Arnoux, F-92120 Montrouge, France.
CR AMANN S, 1997, INT J VITAM NUTR RES, V65, P356
   ANDERSSON OH, 1994, BIOMATERIALS, V15, P882, DOI 10.1016/0142-9612(94)90111-2
   BAPNA MS, 1994, J ORAL REHABIL, V21, P577, DOI 10.1111/j.1365-2842.1994.tb01172.x
   Bondy SC, 1996, MOL CHEM NEUROPATHOL, V27, P185, DOI 10.1007/BF02815093
   Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271
   Campbell A, 2001, BRAIN RES BULL, V55, P125, DOI 10.1016/S0361-9230(01)00455-5
   Chapple ILC, 1997, J CLIN PERIODONTOL, V24, P287, DOI 10.1111/j.1600-051X.1997.tb00760.x
   Chaudiere J, 1999, FOOD CHEM TOXICOL, V37, P949, DOI 10.1016/S0278-6915(99)00090-3
   Engelmann J., 2001, Journal of Dental Research, V80, P869
   FERNANDEZCHECA JC, 1990, ANAL BIOCHEM, V190, P212, DOI 10.1016/0003-2697(90)90183-A
   FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x
   FORSS H, 1993, J DENT RES, V72, P1257, DOI 10.1177/00220345930720081601
   FUJISAWA S, 1988, J DENT RES, V67, P1438, DOI 10.1177/00220345880670111501
   Gassen M, 1999, J NEURAL TRANSM-SUPP, P193
   Gerster H, 1999, INT J VITAM NUTR RES, V69, P67, DOI 10.1024/0300-9831.69.2.67
   Geurtsen W, 1998, J BIOMED MATER RES, V41, P474, DOI 10.1002/(SICI)1097-4636(19980905)41:3<474::AID-JBM18>3.0.CO;2-I
   Halliwell B, 1999, TRENDS BIOCHEM SCI, V24, P255, DOI 10.1016/S0968-0004(99)01418-8
   Halliwell B, 1996, FREE RADICAL RES, V25, P439, DOI 10.3109/10715769609149066
   HERBERT V, 1994, STEM CELLS, V12, P289, DOI 10.1002/stem.5530120305
   Hunag TH, 2001, J BIOMED MATER RES, V54, P390
   MEISTER A, 1992, BIOCHEM PHARMACOL, V44, P1905, DOI 10.1016/0006-2952(92)90091-V
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OSSENI RA, 1990, BIOL CLOCKS MECH APP, P111
   Rehman A, 1998, BIOCHEM BIOPH RES CO, V246, P293, DOI 10.1006/bbrc.1998.8592
   Sakagami H, 1997, ANTICANCER RES, V17, P3513
   Sakagami H, 1997, ANTICANCER RES, V17, P221
   SAPPEY C, 1995, AIDS RES HUM RETROV, V11, P1049, DOI 10.1089/aid.1995.11.1049
   Satoh K, 1997, ANTICANCER RES, V17, P2459
   Savarino L, 2000, J BIOMAT SCI-POLYM E, V11, P289, DOI 10.1163/156856200743706
   SMITH DC, 1990, J AM DENT ASSOC, V120, P20, DOI 10.14219/jada.archive.1990.0002
   Song JH, 1999, J NEUROSCI RES, V58, P328, DOI 10.1002/(SICI)1097-4547(19991015)58:2<328::AID-JNR13>3.3.CO;2-F
   Stanislawski L, 1999, J BIOMED MATER RES, V48, P277, DOI 10.1002/(SICI)1097-4636(1999)48:3<277::AID-JBM11>3.0.CO;2-T
   Stanislawski L, 2000, J BIOMED MATER RES, V51, P469, DOI 10.1002/1097-4636(20000905)51:3<469::AID-JBM22>3.0.CO;2-B
   WATAHA JC, 1994, J ORAL REHABIL, V21, P453, DOI 10.1111/j.1365-2842.1994.tb01159.x
   Xie CX, 1996, ARCH BIOCHEM BIOPHYS, V327, P222, DOI 10.1006/abbi.1996.0113
   Yang EY, 1999, BRAIN RES, V839, P221, DOI 10.1016/S0006-8993(99)01694-7
   Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5
NR 37
TC 25
Z9 27
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2003
VL 24
IS 1
BP 3
EP 9
AR PII S0142-9612(02)00221-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 615HW
UT WOS:000179240600001
PM 12417172
DA 2018-10-19
ER

PT J
AU Qiu, B
   Stefanos, S
   Ma, JL
   Lalloo, A
   Perry, BA
   Leibowitz, MJ
   Sinko, PJ
   Stein, S
AF Qiu, B
   Stefanos, S
   Ma, JL
   Lalloo, A
   Perry, BA
   Leibowitz, MJ
   Sinko, PJ
   Stein, S
TI A hydrogel prepared by in situ cross-linking of a thiol-containing
   poly(ethylene glycol)-based copolymer: a new biomaterial for protein
   drug delivery
SO BIOMATERIALS
LA English
DT Article
DE poly(ethylene glycol); thiol-containing copolymer; protein drug
   delivery; hydrogel; in situ cross-linking
ID RELEASE; SYSTEMS
AB A new poly(ethylene glycol)-based copolymer containing multiple thiol (-SH) groups was cross-linked in situ to form a polymer hydrogel under mild conditions. No organic solvent, elevated temperature, or harsh pH is required in the formulation or patient administration processes, making it particularly useful for delivery of fragile therapeutics, such as proteins. The in vitro release of fluorescein-labeled bovine serum albumin and the in vivo release of the model proteins, erythropoietin, RANTES and three PEG-conjugated RANTES derivatives showed sustained release for 2-4 weeks and demonstrated prolonged biological activity of the released proteins in animals. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.
   Rutgers State Univ, Coll Pharm, Piscataway, NJ 08854 USA.
   Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA.
   TheraPort BioSci Inc, E Brunswick, NJ 08816 USA.
   Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA.
   Canc Inst New Jersey, New Brunswick, NJ 08901 USA.
   Ctr Biomat, Piscataway, NJ 08854 USA.
RP Stein, S (reprint author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.
EM stein@cabm.rutgers.edu
OI Sinko, Patrick/0000-0003-0157-1895
CR BAILEY J, 1976, POLYETHYLENE GLYCOL
   Bartus RT, 1998, SCIENCE, V281, P1161, DOI 10.1126/science.281.5380.1161
   Breimer DD, 1998, ADV DRUG DELIVER REV, V33, P265, DOI 10.1016/S0169-409X(98)00034-9
   CORKHILL PH, 1989, BIOMATERIALS, V10, P3, DOI 10.1016/0142-9612(89)90002-1
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Harris J. M., 1997, POLYETHYLENE GLYCOL
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LEE HJ, 1995, PEPTIDE BASED DRUG D, P69
   MANNING MC, 1989, PHARM RES-DORDR, V6, P903, DOI 10.1023/A:1015929109894
   MOORE JS, 1990, MACROMOLECULES, V23, P65, DOI 10.1021/ma00203a013
   Morpurgo M, 1996, BIOCONJUGATE CHEM, V7, P363, DOI 10.1021/bc9600224
   Peppas N. A., 1986, HYDROGELS MED PHARM, V1
   Putney SD, 1998, CURR OPIN CHEM BIOL, V2, P548, DOI 10.1016/S1367-5931(98)80133-6
   Putney SD, 1998, NAT BIOTECHNOL, V16, P153, DOI 10.1038/nbt0298-153
   SANDERS LM, 1990, EUR J DRUG METAB PH, V15, P95, DOI 10.1007/BF03190192
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   WALLACE TJ, 1966, CHEM IND-LONDON, P1558
   Wang Wei, 1999, International Journal of Pharmaceutics (Amsterdam), V185, P129, DOI 10.1016/S0378-5173(99)00152-0
   WEST JL, 1995, BIOMATERIALS, V16, P1153, DOI 10.1016/0142-9612(95)93579-3
   YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432
NR 23
TC 89
Z9 89
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2003
VL 24
IS 1
BP 11
EP 18
AR PII S0142-9612(02)00227-2
DI 10.1016/S0142-9612(02)00227-2
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 615HW
UT WOS:000179240600002
PM 12417173
DA 2018-10-19
ER

PT J
AU Garcia-Alonso, MC
   Saldana, L
   Valles, G
   Gonzalez-Carrasco, JL
   Gonzalez-Cabrero, J
   Martinez, ME
   Gil-Garay, E
   Munuera, L
AF Garcia-Alonso, MC
   Saldana, L
   Valles, G
   Gonzalez-Carrasco, JL
   Gonzalez-Cabrero, J
   Martinez, ME
   Gil-Garay, E
   Munuera, L
TI In vitro corrosion behaviour and osteoblast response of thermally
   oxidised Ti6Al4V alloy
SO BIOMATERIALS
LA English
DT Article
DE corrosion behaviour; human osteoblastic cells; thermal oxidation
   treatment; Ti64V alloy; cell attachment
ID SURFACE MODIFICATION; IMPLANT MATERIALS; TITANIUM; SPECTROSCOPY;
   DISSOLUTION; RESISTANCE; OXIDATION; TI-6AL-4V; ADHESION; CELLS
AB In this work, the influence of thermal oxidation treatments of Ti6Al4V at 500 degreesC and 700 degreesC for 1 h on the in vitro corrosion behaviour and osteoblast response is studied. The potential of these treatments, aimed to improve the wear surface performance as biomaterial, relies in the formation of an outer "ceramic" layer of rutile. The corrosion behaviour was evaluated in simulated human fluids by electrochemical impedance spectroscopy and anodic polarisation tests. The effect of these thermal oxidation treatments on osteoblastic behaviour was studied in primary cultures of human osteoblastic cells. Results show that thermal oxidation treatments do not decrease the high in vitro corrosion resistance of the Ti6Al4V alloy. Osteoblast adhesion studies indicate that thermal oxidation treatments do not impair the material biocompatibility. Moreover, the thermal oxidation at 700 C enhances the in vitro osteoblastic cell attachment compared to the thermal oxidation at 500degreesC. (C) 2002 Published by Elsevier Science Ltd.
C1 CSIC, CENIM, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
   Hosp La Paz, Unidad Invest, Madrid 28046, Spain.
   Fdn Jimenez Diaz, Unidad Invest, Madrid 28040, Spain.
   Hosp La Paz, Dept Bioquim, Madrid 28046, Spain.
   Hosp La Paz, Dept Traumatol & Cirugia Ortoped, Madrid 28046, Spain.
RP Garcia-Alonso, MC (reprint author), CSIC, CENIM, Ctr Nacl Invest Met, Avda Gregorio Amo 8, E-28040 Madrid, Spain.
RI Saldana, Laura/N-2412-2014; Garcia-Alonso, Maria Cristina/K-3779-2014;
   Gonzalez Carrasco, Jose Luis/A-7971-2008
OI Saldana, Laura/0000-0003-3057-4649; Garcia-Alonso, Maria
   Cristina/0000-0003-0275-4626; Gonzalez-Carrasco, Jose
   Luis/0000-0003-2004-4505
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   ASK M, 1988, APPL SURF SCI, V35, P283
   AZIZKERRZO M, 2001, BIOMATERIALS, V22, P531
   Bloyce A, 1998, SURF COAT TECH, V107, P125, DOI 10.1016/S0257-8972(98)00580-5
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   Chen GF, 1998, BIO-MED MATER ENG, V8, P61
   Dong H., 1997, Surface Engineering, V13, P402
   DU HL, 1994, CORROS SCI, V36, P631, DOI 10.1016/0010-938X(94)90069-8
   LILLEY PA, 1992, 4 WORD BIOM C BERL A, P227
   Martinez ME, 1999, BONE, V24, P203, DOI 10.1016/S8756-3282(98)00181-1
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Oji MO, 1999, J MATER SCI-MATER M, V10, P869, DOI 10.1023/A:1008933318756
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   SHINA RK, 1994, CLIN ORTHOP RELAT R, V305, P258
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Taira Y, 1998, J DENT, V26, P69, DOI 10.1016/S0300-5712(96)00072-3
   WISBEY A, 1991, BIOMATERIALS, V12, P470, DOI 10.1016/0142-9612(91)90144-Y
NR 21
TC 124
Z9 129
U1 1
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2003
VL 24
IS 1
BP 19
EP 26
AR PII S0142-9612(02)00237-5
DI 10.1016/S0142-9612(02)00237-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 615HW
UT WOS:000179240600003
PM 12417174
DA 2018-10-19
ER

PT J
AU Dexter, SJ
   Camara, M
   Davies, M
   Shakesheff, KM
AF Dexter, SJ
   Camara, M
   Davies, M
   Shakesheff, KM
TI Development of a bioluminescent ATP assay to quantify mammalian and
   bacterial cell number from a mixed population
SO BIOMATERIALS
LA English
DT Article
DE bioluminescent ATP assay; bacterial adhesion; mammalian cell adhesion;
   biomaterial
ID ADENOSINE-TRIPHOSPHATE; STAPHYLOCOCCUS-AUREUS; EXTRACELLULAR-MATRIX;
   ADHESION; PROTEINS; BINDING; VIABILITY; INFECTION; ADHERENCE; BIOFILMS
AB Modification of biomaterial surfaces is one approach aimed at improving cellular interactions and the subsequent integration of medical devices into the body. However, by optimising surfaces to enhance mammalian cell adhesion there is the potential risk that adhesion of bacteria will also be increased. Bacterial colonisation of biomaterials can be problematic as infection often results in morbidity and the consequent removal of the failing device from the body.
   Currently, quantifying cellular adhesion from a mixed population of bacterial and mammalian cells can only be determined by slow and laborious methods such as microscopy. ATP is a key molecule in the metabolism of both mammalian and bacterial cells and can be used to quantify cell numbers. In this study, we have modified a bioluminescence-based ATP assay to enable the differential measurement of both mammalian and bacterial cell ATP levels within the same culture. Mixed populations of Staphylococcus epidermidis and 3T3 fibroblasts were assessed both in suspension and adhered to a surface. ATP levels from cultures in suspension were selectively extracted and measured from both cell types, revealing a linear trend that would enable the differentiation of cell numbers from a mixed population. The application of the assay to adhered mixed cultures also allowed differences in ATP levels from both cell types to be distinguished. The data presented reveals that this assay would be useful for the rapid screening of cellular adhesion to modified surfaces although, its use in detecting subtle differences in ATP levels may be limited due to natural interactions between the two cell types. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RP Shakesheff, KM (reprint author), Univ Nottingham, Sch Pharmaceut Sci, Nottingham NG7 2RD, England.
RI Shakesheff, Kevin/O-6371-2018
OI Shakesheff, Kevin/0000-0003-3236-2439; Camara,
   Miguel/0000-0003-4585-7385; Davies, Martyn/0000-0001-7695-0596
CR An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   Bradbury DA, 2000, J IMMUNOL METHODS, V240, P79, DOI 10.1016/S0022-1759(00)00178-2
   BRONZINO JD, 1995, BIOMEDICAL ENG HDB, P1583
   BROWN MRW, 1993, J APPL BACTERIOL, V74, pS87, DOI 10.1111/j.1365-2672.1993.tb04345.x
   CHAPPELLE EW, 1978, METHOD ENZYMOL, V57, P65
   CHRISTENSEN GD, 1995, METHOD ENZYMOL, V253, P477
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   DUNNE WM, 1991, APPL ENVIRON MICROB, V57, P863
   Gallez F, 2000, CELL BIOCHEM FUNCT, V18, P103, DOI 10.1002/(SICI)1099-0844(200006)18:2<103::AID-CBF860>3.0.CO;2-N
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HEALY KE, 1999, BIOARTIFICIAL ORGANS, V11, P24
   HUSSAIN M, 1991, J MED MICROBIOL, V34, P143, DOI 10.1099/00222615-34-3-143
   KANGAS L, 1984, MED BIOL, V62, P338
   Lammers A, 1999, FEMS MICROBIOL LETT, V180, P103, DOI 10.1016/S0378-1097(99)00470-X
   Ljungh A, 1996, FEMS IMMUNOL MED MIC, V16, P117, DOI 10.1016/S0928-8244(96)00073-9
   LUNDIN A, 1986, METHOD ENZYMOL, V133, P27
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PETTY RD, 1995, J BIOLUM CHEMILUM, V10, P29, DOI 10.1002/bio.1170100105
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x
   SQUATRITO RC, 1995, GYNECOL ONCOL, V58, P101, DOI 10.1006/gyno.1995.1190
   STANLEY PE, 1986, METHOD ENZYMOL, V133, P14
   STANLEY PE, 1989, J BIOLUM CHEMILUM, V4, P375, DOI 10.1002/bio.1170040151
   Stollenwerk M, 1998, ZBL BAKT-INT J MED M, V287, P7
   WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x
NR 28
TC 21
Z9 23
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2003
VL 24
IS 1
BP 27
EP 34
AR PII S0142-9612(02)00239-9
DI 10.1016/S0142-9612(02)00239-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 615HW
UT WOS:000179240600004
PM 12417175
DA 2018-10-19
ER

PT J
AU Chan, CK
   Chu, IM
AF Chan, CK
   Chu, IM
TI Crystalline and dynamic mechanical behaviors of synthesized poly(sebacic
   anhydride-co-ethylene glycol)
SO BIOMATERIALS
LA English
DT Article
DE poly(ethylene glycol); poly(sebacic anhydride); crystallinity; dynamic
   mechanical analysis
ID MULTIBLOCK COPOLYMERS; POLY(ETHYLENE GLYCOL); PHASE-BEHAVIOR;
   POLYANHYDRIDES; DEGRADATION; POLYMERS; NMR; MOBILITY; BLENDS
AB A novel biomaterial: poly(sebacic anhydride-co-ethylene glycol) was synthesized by introducing poly(ethylene glycol) (PEG) into a polyanhydride system. This copolymer was synthesized using sebacic acid and PEG via melt-condensation polymerization. The crystalline behavior of these synthesized products was studied, and compared to that of polymer blends of poly(sebacic anhydride) (PSA) and PEG. The crystallinity of PSA chain segments can be significantly enhanced by increasing chain mobility via the introduction of PEG. The crystallinity of the PSA component in copolymers was substantially greater than that of blends. However, the crystalline growth of the PEG segments was totally hindered by the presence of PSA chain segments, such that no crystal for PEG component was found in these copolymers. Besides, a dynamic mechanical analysis of these materials was also performed to provide additional information concerning visco-elastic behavior for other biomedical applications, where it was found that the viscous behavior in copolymers was more significant than in neat PSA and PEG. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 300, Taiwan.
RP Chu, IM (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 300, Taiwan.
CR Brus J, 2000, MACROMOLECULES, V33, P6448, DOI 10.1021/ma000533s
   Chan CK, 2002, BIOMATERIALS, V23, P2353, DOI 10.1016/S0142-9612(01)00370-2
   Chan CK, 2001, POLYMER, V42, P6823, DOI 10.1016/S0032-3861(01)00178-1
   Chen XH, 1997, MACROMOLECULES, V30, P4295, DOI 10.1021/ma970385e
   CHU PP, 1999, J POLYM SCI POL PHYS, V35, P1155
   DOMB AJ, 1987, J POLYM SCI POL CHEM, V25, P3373, DOI 10.1002/pola.1987.080251217
   FENG HQ, 1993, MAKROMOL CHEM, V194, P2257
   Gan ZH, 1996, J APPL POLYM SCI, V59, P961, DOI 10.1002/(SICI)1097-4628(19960207)59:6<961::AID-APP8>3.0.CO;2-N
   Georgi U, 1997, J SOL-GEL SCI TECHN, V8, P507, DOI 10.1007/BF02436890
   Hanes J, 1996, MACROMOLECULES, V29, P5279, DOI 10.1021/ma960393f
   HARTMANN M, 1989, MAKROMOL CHEM, V190, P2133
   HATAKEYAMA, 1994, THERMAL ANAL FUNDAME, P117
   Hollinger J.O., 1995, BIOMEDICAL APPL SYNT
   HU DSG, 1994, J APPL POLYM SCI, V51, P473, DOI 10.1002/app.1994.070510310
   Huh KM, 1999, POLYMER, V40, P6147, DOI 10.1016/S0032-3861(98)00822-2
   Jiang HL, 1999, POLYM INT, V48, P47, DOI 10.1002/(SICI)1097-0126(199901)48:1<47::AID-PI107>3.0.CO;2-X
   Kim KS, 1999, J APPL POLYM SCI, V72, P341, DOI 10.1002/(SICI)1097-4628(19990418)72:3<341::AID-APP4>3.0.CO;2-D
   LEONG KW, 1985, J BIOMED MATER RES, V19, P941, DOI 10.1002/jbm.820190806
   MATHIOWITZ E, 1988, J APPL POLYM SCI, V35, P755, DOI 10.1002/app.1988.070350316
   Penning JP, 1996, MACROMOLECULES, V29, P77, DOI 10.1021/ma950651t
   PEPPAS NA, 1993, ADV POLYM SCI, V107
   SCHMIDT-ROHR K, 1992, MACROMOLECULES, V25, P3273, DOI 10.1021/ma00038a037
   UHRICH KE, 1995, MACROMOLECULES, V28, P2184, DOI 10.1021/ma00111a012
   WU MP, 1994, J BIOMED MATER RES, V28, P387, DOI 10.1002/jbm.820280314
NR 24
TC 23
Z9 25
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2003
VL 24
IS 1
BP 47
EP 54
AR PII S0142-9612(02)00242-9
DI 10.1016/S0142-9612(02)00242-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 615HW
UT WOS:000179240600006
PM 12417177
DA 2018-10-19
ER

PT J
AU Marchion, DC
   Pfau, JC
   Weber, PA
   Grobe, AC
   Duran, CMG
   Cheung, DT
AF Marchion, DC
   Pfau, JC
   Weber, PA
   Grobe, AC
   Duran, CMG
   Cheung, DT
TI An in vitro model of pericardial tissue healing
SO BIOMATERIALS
LA English
DT Article
DE pericardium; in vitro model; contraction; proliferation; serum
ID TERM FOLLOW-UP; AUTOLOGOUS PERICARDIUM; GROWTH-FACTORS; CONTRACTION;
   SKIN; REPLACEMENT; CULTURE; SERUM; PATCH; DOGS
AB Introduction: A previous study in our laboratory showed that a flap of fresh autologous pericardium bisecting the aorta of sheep retracted and became fibrotic. Histologic analyses suggested that activated cells within the pericardium contributed to the retraction of the implant. Here we report the development of an in vitro model to investigate the effects of serum on cellular proliferation and cell-mediated tissue contraction.
   Methods: Sections of living and ethanol-treated sheep pericardium were incubated with 0.5%, 5%, 10%, 20%, and 50% serum in medium for up to 8 days and evaluated for cellular proliferation and tissue contraction. These serum-stimulated events were further evaluated in the presence of Mitomycin C, Cytochalasin B and D, Aphidicolin, AraC, and Cycloheximide.
   Results: Cellular proliferation and cell-mediated tissue contraction were induced by serum in a dose-dependent manner. Expression of PCNA was suppressed in the presence of Cytochalasin B, Cytochalasin D, Aphidicolin, and AraC. Tissue contraction was prevented by Cycloheximide. Mitomyein C inhibited both proliferation and tissue contraction. Ethanol-treated tissue, which was absent of living cells, did not respond to stimulation with serum.
   Conclusions: An in vitro model was developed to study the responses of cells within pericardial tissues to stimulation by serum. In this model, serum induced cellular proliferation and tissue contraction. Different chemical inhibitors independently modulated these serum-stimulated events. Pre-existing cells within pericardial tissues might respond to stimulus through differential pathways. This model may help to develop methods to make autologous pericardium a clinically useful biomaterial. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Int Heart Inst Montana Fdn, Missoula, MT 59802 USA.
RP Duran, CMG (reprint author), Int Heart Inst Montana Fdn, 554 W Braodway, Missoula, MT 59802 USA.
CR Borderie VM, 1999, GRAEF ARCH CLIN EXP, V237, P861, DOI 10.1007/s004170050324
   BORTOLOTTI U, 1984, THORAC CARDIOV SURG, V32, P15, DOI 10.1055/s-2007-1023337
   Cheung DT, 1999, J THORAC CARDIOV SUR, V118, P998, DOI 10.1016/S0022-5223(99)70093-0
   Duran CG, 1993, HEART SURG, P69
   FRATER WM, 1992, J HEART VALVE DIS, V1, P213
   Gabbiani G, 1998, CARDIOVASC RES, V38, P545, DOI 10.1016/S0008-6363(98)00065-0
   HAWE A, 1970, J THORAC CARDIOV SUR, V60, P131
   HJELMS E, 1981, J THORAC CARDIOV SUR, V81, P120
   Kratz G, 1998, MICROSC RES TECHNIQ, V42, P345, DOI 10.1002/(SICI)1097-0029(19980901)42:5<345::AID-JEMT5>3.0.CO;2-O
   Lee YR, 1996, ENDOCRINOLOGY, V137, P5278, DOI 10.1210/en.137.12.5278
   LYER VR, 1999, SCIENCE, V283, P83
   Miki H, 2000, AM J PHYSIOL-LUNG C, V278, pL13
   MOHRI H, 1970, J THORAC CARDIOV SUR, V59, P501
   MOULIN V, 1995, EUR J CELL BIOL, V68, P1
   Naimark W A, 1999, Biomed Sci Instrum, V35, P397
   PARENZAN L, 1978, J THORAC CARDIOV SUR, V76, P305
   PIEHLER JM, 1983, J THORAC CARDIOV SUR, V86, P350
   RENDINA EA, 1995, J THORAC CARDIOV SUR, V110, P867, DOI 10.1016/S0022-5223(95)70128-1
   Schlichter AJ, 1996, ANN THORAC SURG, V62, P155, DOI 10.1016/0003-4975(96)00263-9
   Skold CM, 1999, P ASSOC AM PHYSICIAN, V111, P249, DOI 10.1046/j.1525-1381.1999.99269.x
   Taylor PM, 2000, J HEART VALVE DIS, V9, P150
   TOMASEK JJ, 1992, ANAT REC, V232, P359, DOI 10.1002/ar.1092320305
NR 22
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2003
VL 24
IS 1
BP 89
EP 95
AR PII S0142-9612(02)00255-7
DI 10.1016/S0142-9612(02)00255-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 615HW
UT WOS:000179240600011
PM 12417182
DA 2018-10-19
ER

PT J
AU Varma, HK
   Sreenivasan, K
   Yokogawa, Y
   Hosumi, A
AF Varma, HK
   Sreenivasan, K
   Yokogawa, Y
   Hosumi, A
TI In vitro calcium phosphate growth over surface modified PMMA film
SO BIOMATERIALS
LA English
DT Article
DE biomaterial; calcium phosphate; biomimetic; functionalization
ID HYDROXYAPATITE; CEMENT; COTTON
AB In vitro nucleation of calcium phosphate phase was studied over functionalized polymethyl methacrylate (PMMA) films using Fourier transform infrared spectroscopy, electron spectroscopy, scanning electron microscopy and energy dispersive X-ray analysis. PMMA films were prepared by dissolving commercial grade pellets in chloroform and cast into thin sheets. The films were immersed in a methanol solution of sodium hydroxide before treating with 1.5% solution of adenosine triphosphate (ATP) at a pH of 5.2 for 24 h. ATP treated films were then soaked in saturated lime solution for 4 days to initiate formation of calcium phosphate precursor phase over their surface. The above films immersed in simulated body fluid solution (1.5 x SBF) for more than 5 days led to the nucleation of apatitic calcium phosphate phase all over the film surface. The ATP coupled film not subjected to lime treatment did not show calcium phosphate nucleation behaviour upon immersion in SBF solution. The Ca/P ratio of the calcium phosphate phase increase with increase in soaking time in SBF solution. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Trivandrum 695012, Kerala, India.
   Natl Inst Adv Ind Sci & Technol, Ceram Res Inst, Biofunct Ceram Res Grp, Nagoya, Aichi 4638560, Japan.
RP Varma, HK (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Trivandrum 695012, Kerala, India.
CR DALAS E, 1991, LANGMUIR, V7, P1822, DOI 10.1021/la00056a040
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   MOURSI, 2002, BIOMATERIALS, V23, P133
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P597, DOI 10.1007/BF00121284
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P409, DOI 10.1007/BF00120283
   Ohtsuki C, 2001, J MATER SCI-MATER M, V12, P895, DOI 10.1023/A:1012876108210
   Varma HK, 1999, J MATER SCI-MATER M, V10, P395, DOI 10.1023/A:1008970913107
NR 7
TC 32
Z9 34
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2003
VL 24
IS 2
BP 297
EP 303
AR PII S0142-9612(02)00318-6
DI 10.1016/S0142-9612(02)00318-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 619JC
UT WOS:000179472000013
PM 12419631
DA 2018-10-19
ER

PT J
AU Vacatello, M
   D'Auria, G
   Falcigno, L
   Oliva, R
   Bevilacqua, C
   Dettin, M
   Conconi, MT
   Gambaretto, R
   Di Bello, C
   Paolillo, L
AF Vacatello, M
   D'Auria, G
   Falcigno, L
   Oliva, R
   Bevilacqua, C
   Dettin, M
   Conconi, MT
   Gambaretto, R
   Di Bello, C
   Paolillo, L
TI Conformation and bioactive properties of novel osteoblast adhesive
   peptides for biomaterial design
SO BIOPOLYMERS
LA English
DT Meeting Abstract
CT 18th American Peptide Symposium
CY JUL 19-23, 2003
CL BOSTON, MASSACHUSETTS
C1 Univ Naples Federico II, Dept Chem, I-80126 Naples, Italy.
   Univ Padua, Dept Chem Proc Engn, Padua, Italy.
   Univ Padua, Dept Pharmaceut Sci, Padua, Italy.
RI Falcigno, Lucia/A-6720-2012; D'Auria, Gabriella/E-2076-2011
OI D'Auria, Gabriella/0000-0002-1340-8545
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
NR 2
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PY 2003
VL 71
IS 3
MA O70
BP 300
EP 300
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 696GG
UT WOS:000183878800111
DA 2018-10-19
ER

PT J
AU Vacatello, M
   D'Auria, G
   Falcigno, L
   Oliva, R
   Bevilacqua, C
   Dettin, M
   Conconi, MT
   Gambaretto, R
   Di Bello, C
   Paolillo, L
AF Vacatello, M
   D'Auria, G
   Falcigno, L
   Oliva, R
   Bevilacqua, C
   Dettin, M
   Conconi, MT
   Gambaretto, R
   Di Bello, C
   Paolillo, L
TI Conformation and bioactive properties of novel osteoblast-adhesive
   peptides for biomaterial design
SO BIOPOLYMERS
LA English
DT Meeting Abstract
CT 18th American Peptide Symposium
CY JUL 19-23, 2003
CL BOSTON, MASSACHUSETTS
C1 Univ Naples Federico II, Dept Chem, I-80126 Naples, Italy.
   Univ Padua, Dept Chem Proc Engn, Padua, Italy.
   Univ Padua, Dept Pharmaceut Sci, Padua, Italy.
RI Falcigno, Lucia/A-6720-2012
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
NR 2
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PY 2003
VL 71
IS 3
MA P465
BP 403
EP 403
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 696GG
UT WOS:000183878800587
DA 2018-10-19
ER

PT J
AU Babensee, JE
   Yoshida, M
   Stein, M
   Coulter, WH
AF Babensee, JE
   Yoshida, M
   Stein, M
   Coulter, WH
TI Role of biomaterial component of tissue-engineered constructs on immune
   responses
SO CELL TRANSPLANTATION
LA English
DT Meeting Abstract
CT 6th International Congress of the Cell-Transplant-Society
CY MAR 02-05, 2003
CL ATLANTA, GEORGIA
SP Cell Transplant Soc
C1 Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
NR 0
TC 2
Z9 2
U1 0
U2 3
PU COGNIZANT COMMUNICATION CORP
PI ELMSFORD
PA 3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA
SN 0963-6897
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2003
VL 12
IS 2
BP 159
EP 159
PG 1
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 680CM
UT WOS:000182958800045
DA 2018-10-19
ER

PT J
AU Rickert, D
   Moses, MA
   Lendlein, A
   Kelch, S
   Franke, RP
AF Rickert, D
   Moses, MA
   Lendlein, A
   Kelch, S
   Franke, RP
TI The importance of angiogenesis in the interaction between polymeric
   biomaterials and surrounding tissue
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
ID VESSEL; CELLS
AB The uncomplicated outcome of surgical interventions after biomedical application of biomaterials depends on successful wound healing. Wound healing is a highly complex process compossed of a number of overlapping phases, including inflammation, epithelialization, angiogenesis and matrix deposition. Inadequate angiogenesis limits the transport between the microvasculature and implanted biomaterials. The regulation of angiogenesis is based on numerous growth factors, proteolytic enzymes, extracellular matrix components, cell adhesion molecules, and vasoactive factors. Capillary endothelial cells were grown for different time periods (day 1, 3, 6, 9 and 12) on the surface of a recently developed biodegradable polymeric biomaterial. As control the cells were seeded on the gelatine coated polystyrene surface of commercially available cell cultures dishes. Endothelial cells became adherent and showed confluent cells layers during increasing time period on both surfaces. The total cell number of cells grown on the gelatine coated polystyrene surface was higher in comparison to the polymer surface. The chorioallantois membrane (CAM) assay was used as a sensitive assay to investigate the influence of angiogenesis in vivo. After 48 hours of exposure of the CAM to polymer samples no avascular zones, free of capillaries and/or thrombosis or hemorrhage were detectable. Considering the biofunctionality of our recently developed polymer in these experiments different surface modifications of the polymer are the topic of current investigation to support the biomaterial-microvasculature interactions in vivo.
C1 Univ Ulm, Dept Otolaryngol & Head & Neck Surg, D-89075 Ulm, Germany.
   GKSS Forschungszentrum GmbH, Inst Chem, D-14513 Teltow, Germany.
   Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, D-89069 Ulm, Germany.
   Harvard Univ, Sch Med, Childrens Hosp, Boston, MA USA.
RP Rickert, D (reprint author), Univ Ulm, Dept Otolaryngol & Head & Neck Surg, Prittwitzstr 43, D-89075 Ulm, Germany.
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   BRANEMARK P. I., 1965, BIBL ANAT, V7, P9
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Clark RA., 1995, MOL CELLULAR BIOL WO, P3
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   FOLKMAN J, 1979, P NATL ACAD SCI USA, V76, P5217, DOI 10.1073/pnas.76.10.5217
   FOLKMAN J, 1997, ANGIOGENESIS ANGIOGE, P1
   FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0
   JUNG F, 1992, J VASC RES, V29, P71, DOI 10.1159/000158935
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Klagsbrun M, 1999, CHEM BIOL, V6, P217
   L'Heureux N, 1998, FASEB J, V12, P47
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645
   Nehls V, 1998, HISTOCHEM CELL BIOL, V109, P319, DOI 10.1007/s004180050232
   NGUYEN M, 1994, MICROVASC RES, V47, P31, DOI 10.1006/mvre.1994.1003
   Nicosia RF, 1999, INT REV CYTOL, V185, P1
   SALTZMAN WM, 1997, PRINCIPLES TISSUE EN, P228
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
NR 19
TC 52
Z9 53
U1 0
U2 7
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2003
VL 28
IS 3
BP 175
EP 181
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 681YH
UT WOS:000183062800006
PM 12775899
DA 2018-10-19
ER

PT J
AU Binzen, E
   Rickert, D
   Kelch, S
   Fuhrmann, R
AF Binzen, E
   Rickert, D
   Kelch, S
   Fuhrmann, R
TI Angiogenesis around new AB-polymer networks after one week of
   implantation in mice
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
ID TISSUE; BIOMATERIALS
AB Biomaterial research is expected to forward new materials to be used as, e.g., implant materials or as scaffolds for tissue engineering. It is central for such a scaffold material to create the track on which those cells can inhabitate the scaffold needed to rebuild functional tissue substitutes. The tissue engineering concept expects a gradual gain in functionality of the newly created tissues while the scaffold materials are degraded and subsequently eliminated. Not only for the elimination of the degradation products the angiogenesis of new blood vessels is thought to play an important role. In the present study, a new biomaterial, a non-porous polymeric AB-network based on oligo (epsilon-hydroxycaproat) and oligobutylacrylat, was implanted in animals. Male NMRI mice were implanted subcutaneously for one week. Immediately after the explantation, the probes were examined histologically. Already one week after implantation, there was a strong tissue-integration of the polymer. Importantly, blood vessels occurred at the polymer surface. There were also clusters of cells around the vessels, which were phenotypically similar to fat cells. The mechanism of the early integration of the polymer is not clear. The relationship between the new periimplant vessels and the integration of the polymer has to be studied.
C1 Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, D-89069 Ulm, Germany.
   Univ Ulm, Dept Otolaryngol & Head & Neck Surg, D-89075 Ulm, Germany.
   GKSS Forschungszentrum GmbH, Inst Chem, D-14513 Teltow, Germany.
RP Binzen, E (reprint author), Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, Albert Einstein Allee 47, D-89069 Ulm, Germany.
EM eva.binzen@zibmt.uni-ulm.de
CR Black AF, 1998, FASEB J, V12, P1331
   BRANEMARK P. I., 1965, BIBL ANAT, V7, P9
   Bromer H., 1973, German patent, Patent No. [2,326,100, 2326100]
   CANFIELD AE, 2000, BONE ENG, V2, P143
   CHONEKA J, 1996, J BIOMED MATER RES, V31, P35
   CLOWES AW, 1986, AM J PATHOL, V123, P220
   ERTEL S, 1995, J BIOMED MATER RES, V29, P1137
   FLOREY HW, 1962, BRIT J EXP PATHOL, V43, P655
   GREISLER HP, 1986, J VASC SURG, V3, P747, DOI 10.1067/mva.1986.avs0030747
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   ILLIG L, 1961, PATHOLOGIE KLIN EINZ
   JARCHO M, 1977, J BIOENG, V1, P79
   JUNG F, 1992, J VASC RES, V29, P71, DOI 10.1159/000158935
   JUNG F, 1995, ARZNEIMITTEL-FORSCH, V45-2, P1138
   KOKUBO T, 1982, B I CHEM RES KYOTO U, V60, P206
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   MainilVarlet P, 1997, BIOMATERIALS, V18, P257, DOI 10.1016/S0142-9612(96)00126-3
   Niimi H, 2000, CLIN HEMORHEOL MICRO, V23, P293
   RADDER AM, 1995, BIOMATERIALS, V16, P507, DOI 10.1016/0142-9612(95)91122-F
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   YAN WQ, 1997, J BIOMED MATER RES, V37, P265
NR 23
TC 15
Z9 15
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2003
VL 28
IS 3
BP 183
EP 188
PG 6
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 681YH
UT WOS:000183062800007
PM 12775900
DA 2018-10-19
ER

PT J
AU Fang, N
   Chan, V
   Wan, KT
AF Fang, N
   Chan, V
   Wan, KT
TI The effect of electrostatics on the contact mechanics of adherent
   phospholipid vesicles
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE phosphate buffer saline; unilamellar vesicles; multilamellar vesicles
ID LIPID-BILAYERS; GIANT VESICLES; ADHESION; TRANSITION; INTERFERENCE;
   DEFORMATION; ELASTICITY; INTERFACES; MEMBRANES; FORCES
AB Adhesion of cells on biomaterial surface is resulted from the complex interplay of specific recognitions and colloidal interactions. Thus understanding the role of electrostatic interactions in bioadhesion may help to elucidate the physiochemical basis of cell signaling pathway on therapeutic devices. In this report, high-resolution reflection interference contrast microscopy, cross-polarized light microscopy and contact mechanics modeling are applied to probe the equilibrium adhesion of giant phospholipid vesicles on 3-amino-propyl-triethoxy-silane coated glass. Simultaneously, the effects of vesicle wall thickness, pH, osmotic stress and surface chemistry on the electrostatic interactions at the membrane-substrate interface are evaluated. The results show that both unilamellar vesicles (ULV) and multilamellar vesicles (MLV) strongly adhere on the cationic substrates at neutral pH. In the presence of electrostatic interactions, ULV is slightly deformed on the substrate as the dimension of its adhesive-cohesive zone is only 6-10% higher than the theoretical value of a rigid sphere with the same mid-plane diameter. The variances of contact angle and capillary length at different locations surrounding MLV are ten times higher than those of ULV. The adhesion energy of ULV with mid-plane diameter of 45 and 20 mum is determined as 3.8 x 10(-12) and 8.6 x 10(-12) J/m(2), respectively, from the truncated sphere model. Moreover, the increase of osmotic stress induces irregular pattern in ULV's adhesion disc and raises the adhesion energy by 10-fold. Finally, the reduction of pH further enhances the electrostatic attractions/repulsions between vesicle surface and cationic or anionic substrates and leads to an increase of adhesion strength. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Tissue Engn Lab, Singapore 639798, Singapore.
   Virginia Tech, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA.
RP Chan, V (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Tissue Engn Lab, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mvchan@ntu.edu.sg
RI Chan, Vincent/G-6197-2010
OI Chan, Vincent/0000-0003-2149-4479
CR ARMSTRONG PB, 1989, CRIT REV BIOCHEM MOL, V24, P119, DOI 10.3109/10409238909086396
   Bernard AL, 2000, LANGMUIR, V16, P6809, DOI 10.1021/la991341x
   Bruckner E, 2001, LANGMUIR, V17, P2308, DOI 10.1021/la000256i
   Bruinsma R, 2000, PHYS REV E, V61, P4253, DOI 10.1103/PhysRevE.61.4253
   BRUINSMA R, 1995, NATO ASI SER E, V322, P61
   Chan V, 1998, J COLLOID INTERF SCI, V203, P197, DOI 10.1006/jcis.1998.5495
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8
   FANG N, IN PRESS COLLOIDS B
   Fresta M, 2000, J COLLOID INTERF SCI, V226, P222, DOI 10.1006/jcis.2000.6816
   Guttenberg Z, 2000, LANGMUIR, V16, P8984, DOI [10.1021/la000279x, 10.1021/1a000279x]
   Guttenberg Z, 2001, EUROPHYS LETT, V54, P826, DOI 10.1209/epl/i2001-00328-9
   Hammer DA, 1996, ANNU REV MATER SCI, V26, P651
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hunter DG, 1998, BIOPHYS J, V74, P2996, DOI 10.1016/S0006-3495(98)78006-3
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   Iwanaga Y, 2001, EUR BIOPHYS J BIOPHY, V30, P17, DOI 10.1007/s002490000119
   Lasic D. D., 1997, LIPOSOME GENE DELIVE
   Lauffenburger DA, 1993, RECEPTORS MODELS BIN
   Liu KK, 2000, MED BIOL ENG COMPUT, V38, P690, DOI 10.1007/BF02344877
   Mishima K, 2001, CHEM PHYS LIPIDS, V110, P27, DOI 10.1016/S0009-3084(00)00225-5
   Moy VT, 1999, BIOPHYS J, V76, P1632, DOI 10.1016/S0006-3495(99)77322-4
   Nagase H, 1997, BBA-BIOMEMBRANES, V1328, P197, DOI 10.1016/S0005-2736(97)00088-6
   NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P8261, DOI 10.1021/bi00421a041
   Petsev DN, 1999, LANGMUIR, V15, P1096, DOI 10.1021/la981034b
   RADLER JO, 1995, PHYS REV E, V51, P4526, DOI 10.1103/PhysRevE.51.4526
   Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3
   Stuart JK, 1999, BIOPHYS J, V76, P500, DOI 10.1016/S0006-3495(99)77218-8
   Varga CM, 2000, BIOTECHNOL BIOENG, V70, P593, DOI 10.1002/1097-0290(20001220)70:6<593::AID-BIT1>3.0.CO;2-N
   Wan KT, 2001, J ADHESION, V75, P369, DOI 10.1080/00218460108029611
   Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189
NR 31
TC 1
Z9 1
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JAN
PY 2003
VL 27
IS 1
BP 83
EP 94
AR PII S0937-7765(02)00040-1
DI 10.1016/S0927-7765(02)00040-1
PG 12
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 627VB
UT WOS:000179955900010
DA 2018-10-19
ER

PT S
AU Huang, XH
   Liang, SF
   Ming, L
   Bing, SX
AF Huang, XH
   Liang, SF
   Ming, L
   Bing, SX
BE Zhang, L
   Guo, JK
   Tuan, WH
TI Effect of the BMP on the degradability of the porous calcium phosphate
   bioceramic in vivo
SO COMPOSITE MATERIALS III
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 3rd China Cross-Strait Conference on Composite Materials
CY MAY 07-12, 2003
CL WUHAN, PEOPLES R CHINA
SP Nat Sci Fdn China, Wuhan Univ Technol
DE calcium phosphate; BMP; degradation; osteogenesis effect
AB The biodegradability, osteogenesis effect of calcium phosphate porous ceramic(CP) and the bone morphogenetic protein(BMP)-calcium phosphate composite (BCP) as well as the microstructure of the boundary between the material above and bone were studied by the X-ray photography, SEM, and EPMA techniques. The statistic T examination was used to dispose the data of the rate of new bone forming after two kinds of materials CP and BCP had been embedded into body. The results show that the rate of new bone forming of BCP is obviously higher than that of CP. BMP evidently accelerates the formation of the new bone and the degradation of the calcium phosphate mineral. The porous structure also contributes to the mineral degradation and the new bone formation. The new bone which grows into the pores of the ceramics forms a kind of interpenetrating network structure, and it strengthens the mechanical properties of embedded part and compensates the attenuation of mechanical properties resulted from the degradation. Therefore, it is evident that a kind of biomaterial can be prepared, which can completely degrade in a suitable pore structure and by the osteogenesis abduction mechanism.
C1 Wuhan Univ Technol, Inst Mat Sci & Engn, Wuhan 430070, Peoples R China.
   Hubei Coll Tradit Chinese Med, Wuhan 430061, Peoples R China.
RP Huang, XH (reprint author), Wuhan Univ Technol, Inst Mat Sci & Engn, Wuhan 430070, Peoples R China.
CR ARITA H, 1995, J MATER SCI LETT, V6, P9
   DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309
   DACULSI G, 1998, J SUBMICROSER CYTOL, V20, P379
   Helm G.A., 2001, NEUROSURG FOCUS, V10, P1
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HUANG TS, 1995, ENVIRON GEOCHEM HLTH, V17, P1, DOI 10.1007/BF00188624
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   MCINNTYRE JP, 1991, CERAMIC B, V70, P1250
   Truumees E, 1999, U PENN ORTHOP J, V12, P77
   YAYLAGLU MB, 1999, BIOMATERIALS, V20, P7119
NR 10
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-926-1
J9 KEY ENG MAT
PY 2003
VL 249
BP 441
EP 445
DI 10.4028/www.scientific.net/KEM.249.441
PG 5
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Materials Science
GA BX62X
UT WOS:000185937300095
DA 2018-10-19
ER

PT S
AU Schmidt, C
   Rivers, T
   Hudson, T
   Collier, J
AF Schmidt, C
   Rivers, T
   Hudson, T
   Collier, J
BE Rubinson, JF
   Mark, HB
TI Modification of electroactive biomaterials for neural engineering
   applications
SO CONDUCTING POLYMERS AND POLYMER ELECTROLYTES: FROM BIOLOGY TO
   PHOTOVOLTAICS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on Electrified Polymer/Solution Interfaces held at the 219th
   National Meeting of the American-Chemical-Society
CY MAR 26-30, 2000
CL SAN FRANCISCO, CALIFORNIA
SP Amer Chem Soc
ID ENDOTHELIAL-CELL PROLIFERATION; HYALURONIC-ACID; NERVE REGENERATION;
   IN-VITRO; POLYPYRROLE; ANGIOGENESIS; POLY(STYRENESULFONATE);
   OLIGOSACCHARIDES; BINDING; ANIONS
AB New tissue engineering technologies will rely increasingly more on interactive biomaterials that can both physically support tissue growth and stimulate specific cell functions. In our research, we have focused on a biomaterial with electrical properties (i.e., the electrically conducting polymer, polypyrrole) that has been shown to improve the regeneration of several tissues including nerve. We have modified polypyrrole for tissue engineering applications by either incorporating biological molecules that can specifically trigger desired cellular responses (e.g., the formation of new blood vessels), or by adding unique linkage sites within the polypyrrole backbone to control its degradation and mechanical integrity. To this end, we are synthesizing two distinct materials: (1) composites of polypyrrole and the polysaccharide hyaluronan which stimulates angiogenesis as it degrades; and (2) conducting pyrrole oligomers of three units in length connected using degradable ester linkages. These materials are promising candidates for tissue engineering applications, such as nerve repair, that may benefit ftom electrical stimulation and/or enhanced vascularization.
C1 Univ Texas, Biomed Engn Program, Austin, TX 78712 USA.
RP Schmidt, C (reprint author), Univ Texas, Biomed Engn Program, Austin, TX 78712 USA.
CR BOYLE A, 1990, J ELECTROANAL CHEM, V279, P179, DOI 10.1016/0022-0728(90)85175-5
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   COUVES LD, 1989, SYNTHETIC MET, V28, pC761
   Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J
   DIAZ AF, 1978, HDB CONDUCTING POLYM
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Hobson MI, 1997, BRIT J PLAST SURG, V50, P125, DOI 10.1016/S0007-1226(97)91325-4
   KNUDSON CB, 1993, FASEB J, V7, P1233
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LAURENT TC, 1992, FASEB J, V6, P2397
   Lokeshwar VB, 1996, J BIOL CHEM, V271, P23853, DOI 10.1074/jbc.271.39.23853
   MERRILL BA, 1990, J ORG CHEM, V55, P2904, DOI 10.1021/jo00296a062
   MILLER LL, 1987, MACROMOLECULES, V20, P1594, DOI 10.1021/ma00173a027
   MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004
   MILLESI H, 1991, OPERATIVE NERVE REPA, P525
   NAGY JI, 1995, J NEUROSCI, V15, P241
   PODHAJSKY RJ, 1994, BRAIN RES, V662, P88, DOI 10.1016/0006-8993(94)90799-4
   PREZYNA LA, 1991, MACROMOLECULES, V24, P5283, DOI 10.1021/ma00019a010
   Rahmanian M, 1997, EXP CELL RES, V237, P223, DOI 10.1006/excr.1997.3792
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4
   Van der Pauw L.J., 1958, Philips Research Reports, V13, P1
   VORK FTA, 1990, ELECTROCHIM ACTA, V35, P567, DOI 10.1016/0013-4686(90)87045-4
   WALLACE DM, 1993, J ORG CHEM, V58, P7245, DOI 10.1021/jo00077a056
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
NR 25
TC 2
Z9 2
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3770-0
J9 ACS SYM SER
PY 2003
VL 832
BP 154
EP 165
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA BW17H
UT WOS:000181072700012
DA 2018-10-19
ER

PT S
AU Uskokovic, V
   Ignjatovic, N
   Petranovic, N
AF Uskokovic, V
   Ignjatovic, N
   Petranovic, N
BE Uskokovic, DP
   Battiston, GA
   Milonjic, SK
   Rakovic, DI
TI Synthesis and characterization of hydroxyapatite-collagen biocomposite
   materials
SO CONTEMPORARY STUDIES IN ADVANCED MATERIALS AND PROCESSES: YUCOMAT IV
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th Yugoslav-Materials-Research-Society Conference
CY SEP 10-14, 2001
CL HERCEG NOVI, YUGOSLAVIA
SP Fed Republic Yugoslavia, Minist Dev, Sci & Environm, Republic Serbia, Minist Sci Technol
DE consolidation; FT-IR Spectroscopy; hydroxyapatite-collagen composite;
   microstructure; thermal analysis
ID L-LACTIDE; BIOMATERIALS; COMPOSITE
AB Hydroxyapatite-collagen composite is a prosperous biomaterial in reconstructive surgery for the reparation of defects in human hard tissue. Within this. research, three-dimensional blocks of HAp/colkagen composite biomaterial were synthesized by homogenizing a HAp/collagen mixture and its subsequent cold and hot (T=60degreesC) pressing (P=49 MPa). The changes in the system were registered by, thermal analysis (DSC & TGA), FT-IR spectroscopy, and scanning electron microscopy.(SEM). Identification and the kinetic analysis of phase transitions were made. FT-IR spectrum of the biocomposite shows that neither cold nor hot pressing had significant influence on the individual components of the composite. SEM of the fracture surfaces showed that more intimate contact between the phases took place during the hot consolidation. The obtained results suggest destruction of the native but not of the primary structure of collagen molecules. Such a slight modification of collagen molecules can possibly lead to the elimination of antigenicity effects after implantation. of this kind of biomaterial into a human body.
C1 Fac Phys Chem, Belgrade, Yugoslavia.
   SASA, Inst Tech Sci, Belgrade, Yugoslavia.
RP Uskokovic, V (reprint author), Fac Phys Chem, Belgrade, Yugoslavia.
RI Ignjatovic, Nenad/C-4489-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X
CR CONSTANZ BR, 1995, Patent No. 5455231
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   GAGNIEU C, 1998, Patent No. 5763579
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2000, ADV ENG MATER, V2, P511, DOI 10.1002/1527-2648(200008)2:8<511::AID-ADEM511>3.0.CO;2-B
   MCINTYRE JP, 1991, AM CERAM SOC BULL, V70, P1499
   NISHIHARA K, 1999, Patent No. 5990381
   PISSIOTIS E, 1990, J ENDODONT, V16, P486
   Rhee SH, 1998, J AM CERAM SOC, V81, P3029
   RHEE SH, 2000, J AM CERAM SOC, V83, P2455
   SICENIKOV IA, 1978, MEDICINA MOSKVA, P10
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
NR 14
TC 9
Z9 9
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-904-0
J9 MATER SCI FORUM
PY 2003
VL 413
BP 269
EP 274
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW04X
UT WOS:000180730700047
DA 2018-10-19
ER

PT J
AU Blackwood, DJ
AF Blackwood, DJ
TI Biomaterials: Past successes and future problems
SO CORROSION REVIEWS
LA English
DT Article
DE biomedical applications; surgical implants; dental amalgams
ID SHAPE-MEMORY ALLOYS; CORROSION BEHAVIOR; SURGICAL IMPLANTS; POROUS
   TITANIUM; PITTING CORROSION; STAINLESS-STEELS; DENTAL AMALGAM;
   CASE-HISTORIES; RESISTANCE; NICKEL
AB The practice of using metals and alloys to repair or replace human body parts is now well established. This paper will briefly review the successes and, in reality, the remarkably few failures of the traditional materials mainly titanium alloys, cobalt-chrome alloys, amalgams and stainless steels. The paper will then concentrate on the problems likely to be encountered before new advanced, but not necessarily corrosion resistant, materials can be successfully used for in-vivo purposes. Two of the most important parameters in determining the suitability of a material for biomedical applications are its biocompatibility and corrosion resistance. With regard to these two parameters pure titanium appears to be almost the perfect biomaterial. Unfortunately, many surgical and-dental applications require materials with specific mechanical properties, such as high strength or ductility, which pure titanium is unable to provide. Hence materials such as the Ti6Al4V alloy and 316L stainless steels are used despite their poorer corrosion resistance, occasionally with undesirable consequences. Furthermore, there is a desire to make use of a number of advanced materials, such as: memory-shaped alloys, porous materials and composites, low precious metal amalgams and rare earth magnets. Unfortunately, nearly all of these materials have inadequate corrosion resistances to be used directly in-vivo without some form of protection. However, it is obvious that most of the traditional techniques for reducing corrosion rates, such as controlling the environment and cathodic protection, cannot be applied to biomaterials, even coatings are of only limited use since many orthopaedic and dental devices are subjected to wearing and abrasion processes. As a result it has traditionally been considered that the only successful method of reducing corrosion within the human body is to fabricate the implants from a corrosion resistant alloy. However, although this approach may eventually be successful in some areas, for example it may be possible to. use alloying additions to design a highly corrosion resistant memory-shape alloy; it is highly unlikely that such an approach will be successful with respect to rare earth magnets. One challenge therefore appears to be to design biocompatible coatings that can resist both the chemical and mechanical environments, which are often poorly defined for both orthopaedic and dental applications, without degrading the very property that is required in the advance material. Potential examples of these applications are hydroxyapatite (HA) coatings on porous titanium, titanium or titanium nitride films on Ni-Ti memory-shaped alloys and very high chromium ferritic stainless steel claddings, on rare earth magnets.
C1 Natl Univ Singapore, Dept Mat Sci, Singapore 119260, Singapore.
RP Blackwood, DJ (reprint author), Natl Univ Singapore, Dept Mat Sci, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
RI Blackwood, Daniel/F-4289-2011
OI Blackwood, Daniel/0000-0002-4897-3536
CR BANOCZY J, 1979, ORAL SURG ORAL MED O, V48, P319, DOI 10.1016/0030-4220(79)90031-8
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   Bechtol C. O., 1975, ORTHOP REV, V4, P23
   Becker BS, 1995, POWDER METALL, V38, P305, DOI 10.1179/pom.1995.38.4.305
   Blackwood DJ, 2002, CORROS SCI, V44, P395, DOI 10.1016/S0010-938X(01)00080-4
   Blackwood DJ, 2000, CORROS SCI, V42, P481, DOI 10.1016/S0010-938X(99)00103-1
   BLACKWOOD DJ, 1988, ELECTROCHIM ACTA, V33, P1143, DOI 10.1016/0013-4686(88)80206-8
   Blackwood DJ, 2001, J MAGN MAGN MATER, V223, P103, DOI 10.1016/S0304-8853(00)00716-2
   BLACKWOOD DJ, 2002, P 15 INT CORR C GRAN
   BRANSDEN AS, 1990, J MOD OPTIC, V37, P813, DOI 10.1080/09500349014550871
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P355, DOI 10.1002/jbm.820210308
   Bundy K. J., 1985, ASTM STP, V859, P73
   Cahoon J R, 1968, J Biomed Mater Res, V2, P1, DOI 10.1002/jbm.820020102
   CHEW BR, 2002, THESIS NATL U SINGAP
   Ciolac S, 2000, REV CHIM-BUCHAREST, V51, P36
   Clerc CO, 1997, J BIOMED MATER RES, V38, P229, DOI 10.1002/(SICI)1097-4636(199723)38:3<229::AID-JBM7>3.0.CO;2-R
   CURTIS RV, 1992, DENT MATER, V8, P240
   Disegi JA, 1999, AM SOC TEST MATER, V1361, P49, DOI 10.1520/STP12373S
   Disegi JA, 1997, SO BIOMM ENGN CONF P, P129, DOI 10.1109/SBEC.1997.583231
   EDWARDS BJ, 1985, ATSM STP, V859, P11
   Eley BM, 1997, BRIT DENT J, V182, P247, DOI 10.1038/sj.bdj.4809360
   Endo K., 1998, ZAIRYO TO KANKYO, V47, P570
   Fontana M. G., 1987, CORROSION ENG
   Frangini S, 2001, MATER CORROS, V52, P372, DOI 10.1002/1521-4176(200105)52:5<372::AID-MACO372>3.0.CO;2-O
   FUSAYAMA T, 1963, J DENT RES, V42, P1183, DOI 10.1177/00220345630420051301
   GALANTE J, 1972, CLIN ORTHOP RELAT R, P237
   Gil FX, 1996, J MATER SCI-MATER M, V7, P403, DOI 10.1007/BF00122008
   GREEN ND, 1985, ATSM STP, V859, P5
   Hayashi K, 1999, BIOMATERIALS, V20, P111, DOI 10.1016/S0142-9612(98)00011-8
   HEINTZ C, 2001, CHIR FORUM EXP KLIN, P483
   HILLE GH, 1966, J MATER, V1, P373
   Hubler R, 1999, SURF COAT TECH, V116, P1111, DOI 10.1016/S0257-8972(99)00221-2
   Hughes A. N., 1978, Engineering in Medicine, V7, P135
   JACKSONBURROWS H, 1975, J BONE JT SURG     B, V57, P148
   Jedwab J, 1974, Acta Orthop Belg, V40, P877
   Jones D. A., 1996, PRINCIPLES PREVENTIO
   JOSKA L, 2002, P 15 INT CORR C GRAN
   JOYSTONBECHAL S, 1994, DENTAL UPDATE, P366
   Kenny ED, 1999, SURFACE ENG, V15, P415, DOI 10.1179/026708499101516812
   Kondo S, 2000, JPN J APPL PHYS 1, V39, P6216, DOI 10.1143/JJAP.39.6216
   LECLERC MF, 1994, CORROSION, V1, P2
   Lemons JE, 1998, SURF COAT TECH, V104, P135
   Liang P. G., 1973, ORTHOP CLIN N AM, V4, P249
   LUCAS LC, 1982, J BIOMED MATER RES, V16, P799, DOI 10.1002/jbm.820160606
   Lund J.W.G., 1982, Progress phycol. Res., V1, P1
   Makjanic J, 1998, NEUROSCI LETT, V240, P123, DOI 10.1016/S0304-3940(97)00940-3
   Mantovani D, 2000, JOM-J MIN MET MAT S, V52, P36, DOI 10.1007/s11837-000-0082-4
   MEARS DC, 1975, J BIOMED MATER RES, V9, P133, DOI 10.1002/jbm.820090417
   Montague A, 1996, J BIOMED MATER RES, V32, P519, DOI 10.1002/(SICI)1097-4636(199612)32:4<519::AID-JBM4>3.0.CO;2-U
   Morita M, 1998, J JPN SOC TRIBOLOGIS, V43, P429
   MORITA M, 1988, J BIOMED MATER RES, V22, P529, DOI 10.1002/jbm.820220608
   Mueller H J, 1970, J Biomed Mater Res, V4, P29, DOI 10.1002/jbm.820040105
   Newton T, 2002, CHEM BRIT, V38, P24
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   NORMAND B, 1996, P 9 NAT THERM SPRAY, P73
   Pan J, 2000, J ELECTROCHEM SOC, V147, P1021, DOI 10.1149/1.1393307
   PEI XM, 2001, THESIS NATL U SINGAP
   PIKELNY A, 2002, 201 EL SOC M PHIL
   Probster L, 1992, INT J ORAL MAXILLOF, V7, P390
   RIEU J, 1995, P 8 INT C SURF MOD T, P43
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   ROSTOKER W, 1974, J BIOMED MATER RES, V8, P407, DOI 10.1002/jbm.820080609
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   SARKAR NK, 1987, J ORAL REHABIL, V14, P27, DOI 10.1111/j.1365-2842.1987.tb00690.x
   SCALES JT, 1959, J BONE JOINT SURG BR, V41, P810
   SEAH KHW, 1995, CORROS SCI, V37, P1333, DOI 10.1016/0010-938X(95)00033-G
   Sella C., 1987, ADV BIOMATER, V7, P119
   Sheehan J.P, 1985, ASTM STP, V859, P57
   Shenhar A, 2000, SURF COAT TECH, V126, P210, DOI 10.1016/S0257-8972(00)00524-7
   Sloter L. E., 1985, ASTM STP, V859, P93
   Solar RJ, 1979, ASTM STP, P259
   SPECTOR M, 1978, J BIOMED MATER RES, V12, P665, DOI 10.1002/jbm.820120508
   Starosvetsky D, 2001, J MATER SCI-MATER M, V12, P145, DOI 10.1023/A:1008922111376
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   STEWART J, 1992, CORROS SCI, V33, P457, DOI 10.1016/0010-938X(92)90074-D
   SYRETT BC, 1978, CORROSION, V34, P138, DOI 10.5006/0010-9312-34.4.138
   SYRETT BC, 1978, ASTM STP, V684, P229
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   THOMSEN P, 1991, BONE BIOMATERIAL INT, P153
   Thong PSP, 1997, NUCL INSTRUM METH B, V130, P460, DOI 10.1016/S0168-583X(97)00239-5
   TRAISNEL M, 1990, Clinical Materials, V5, P309, DOI 10.1016/0267-6605(90)90030-Y
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   Villermaux F, 1997, MATER RES SOC SYMP P, V459, P477
   VONFRAUNHOFER JA, 1994, CORROISION, V1, P2
   VONKNOCH M, 2002, IN PRESS J ARTHROPLA
   Walker G.D., 1974, J BIOMED MAT RES S, V5, P11
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   YU J, 1993, CORROS SCI, V35, P587, DOI 10.1016/0010-938X(93)90193-K
   ZITTER H, 1991, WERKST KORROS, V42, P455
   ZITTER H, 1981, WERKST KORROS, V32, P324
NR 90
TC 39
Z9 41
U1 1
U2 30
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-6005
EI 2191-0316
J9 CORROS REV
JI Corros. Rev.
PY 2003
VL 21
IS 2-3
BP 97
EP 124
PG 28
WC Electrochemistry; Metallurgy & Metallurgical Engineering; Materials
   Science, Coatings & Films
SC Electrochemistry; Metallurgy & Metallurgical Engineering; Materials
   Science
GA 690ZT
UT WOS:000183580900003
DA 2018-10-19
ER

PT B
AU Madaree, A
   Siolo, E
   Morris, WMM
   McGarr, P
   Simango, S
   Daya, M
AF Madaree, A
   Siolo, E
   Morris, WMM
   McGarr, P
   Simango, S
   Daya, M
BE Salyer, KE
TI Use of porous of polyethylene (Medpor (R)) biomaterial in cranial and
   facial reconstruction
SO CRANIOFACIAL SURGERY 10
LA English
DT Proceedings Paper
CT 10th International Congress of the
   International-Society-of-Craniofacial-Surgery
CY SEP 21-24, 2003
CL Monterey, CA
C1 Univ Natal, Dept Plast & Reconstruct Surg, Nelson R Mandela Sch Med, ZA-4001 Durban, South Africa.
RP Madaree, A (reprint author), Univ Natal, Dept Plast & Reconstruct Surg, Nelson R Mandela Sch Med, ZA-4001 Durban, South Africa.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND PUBLISHING CO
PI BOLOGNA
PA VIA RUBBIANI 6/2, 40124 BOLOGNA, ITALY
BN 88-7587-097-7
PY 2003
BP 435
EP 436
PG 2
WC Surgery
SC Surgery
GA BBR71
UT WOS:000227470500086
DA 2018-10-19
ER

PT J
AU Satturwar, PM
   Fulzele, SV
   Joshi, SB
   Dorle, AK
AF Satturwar, PM
   Fulzele, SV
   Joshi, SB
   Dorle, AK
TI Evaluation of the film-forming property of hydrogenated rosin
SO DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
LA English
DT Article
DE hydrogenated rosin; dibutyl sebacate; mechanical properties; coating
ID MECHANICAL-PROPERTIES; COATING SYSTEMS; PLASTICIZERS; PERMEABILITY;
   DERIVATIVES; PELLETS; POLYMER
AB The film-forming and coating properties of a new biomaterial, hydrogenated rosin (HR), is investigated in the present communication. Films produced by casting method are studied for mechanical, (tensile strength, elongation, and Young's modulus), water vapor transmission, and moisture absorption characteristics. Type of plasticizer and its concentration were observed to play an important role in modifying the film characteristics. Dibutyl sebacate (DBS), a hydrophobic plasticizer, was found to be suitable for development of flexible and smooth films. Film formulations plasticized with DBS were investigated for coating the drug layered nonpareil seeds where plasticization facilitated development of smooth and uniformly coated pellets. The increase in coat buildup, however, did not sustain the drug release significantly. The studies conclude that HR films promise utility as moisture-protective hydrophobic, film-coating materials.
C1 Nagpur Univ, Dept Pharmaceut Sci, Nagpur 440010, Maharashtra, India.
RP Fulzele, SV (reprint author), Nagpur Univ, Dept Pharmaceut Sci, Campus Amravati Rd, Nagpur 440010, Maharashtra, India.
CR BENITA S, 1986, INT J PHARM, V33, P71, DOI 10.1016/0378-5173(86)90040-2
   Felton LA, 1997, INT J PHARM, V154, P167, DOI 10.1016/S0378-5173(97)00133-6
   Felton LA, 2002, DRUG DEV IND PHARM, V28, P225, DOI 10.1081/DDC-120002839
   LEHTOLA VM, 1995, DRUG DEV IND PHARM, V21, P675, DOI 10.3109/03639049509048134
   Li SP, 2002, DRUG DEV IND PHARM, V28, P389, DOI 10.1081/DDC-120003000
   LIM LY, 1994, DRUG DEV IND PHARM, V20, P1007, DOI 10.3109/03639049409038347
   LIN SY, 1991, PHARMACEUT RES, V8, P1137, DOI 10.1023/A:1015850301214
   Lopez CR, 1996, DRUG DEV IND PHARM, V22, P1201
   Mandaogade PM, 2002, REACT FUNCT POLYM, V50, P233, DOI 10.1016/S1381-5148(01)00117-1
   Nunthanid J, 2001, DRUG DEV IND PHARM, V27, P143, DOI 10.1081/DDC-100000481
   OKOR RS, 1988, PHARMACEUT RES, V5, P604, DOI 10.1023/A:1015902332068
   PATEL M, 1964, J PHARM SCI, V53, P286, DOI 10.1002/jps.2600530308
   Pathak Y V, 1985, J Microencapsul, V2, P137, DOI 10.3109/02652048509031557
   Pathak Y V, 1990, Drug Des Deliv, V6, P223
   PATHAK YV, 1985, INT J PHARM, V24, P351, DOI 10.1016/0378-5173(85)90033-X
   Ramani CC, 1996, INT J PHARM, V137, P11, DOI 10.1016/0378-5173(95)04268-7
   Sahu NH, 1999, J BIOACT COMPAT POL, V14, P344, DOI 10.1177/088391159901400405
   SARISUTA N, 1994, J CONTROL RELEASE, V31, P215, DOI 10.1016/0168-3659(94)90002-7
   Satturwar PM, 2002, DRUG DEV IND PHARM, V28, P383
   SPROCKEL OL, 1990, J PHARM PHARMACOL, V42, P152, DOI 10.1111/j.2042-7158.1990.tb05375.x
   Umprayn K, 1999, DRUG DEV IND PHARM, V25, P477, DOI 10.1081/DDC-100102198
   UTSUMI I, 1961, J PHARM SCI, V50, P592, DOI 10.1002/jps.2600500714
NR 22
TC 7
Z9 7
U1 0
U2 5
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 0363-9045
J9 DRUG DEV IND PHARM
JI Drug Dev. Ind. Pharm.
PY 2003
VL 29
IS 8
BP 877
EP 884
DI 10.1081/DDC-120024183
PG 8
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 728XD
UT WOS:000185740900006
PM 14570308
DA 2018-10-19
ER

PT J
AU Nikolovski, J
   Kim, BS
   Mooney, DJ
AF Nikolovski, J
   Kim, BS
   Mooney, DJ
TI Cyclic strain inhibits switching of smooth muscle cells to an
   osteoblast-like phenotype
SO FASEB JOURNAL
LA English
DT Article
DE tissue engineering; mechanical strain; calcification; osteopontin;
   matrix gla protein
ID HUMAN ATHEROSCLEROTIC PLAQUES; ALKALINE-PHOSPHATASE ACTIVITY;
   MESSENGER-RNA EXPRESSION; GROWN IN-VITRO; DISTRACTION OSTEOGENESIS;
   EXTRACELLULAR-MATRIX; VASCULAR CELLS; OSTEOPONTIN; TISSUE; CALCIFICATION
AB Ectopic calcification is commonly associated with cardiovascular disease, injury, aging, and biomaterial implantation. We hypothesized that the normal mechanical environment of smooth muscle cells (SMCs) inhibits a phenotypic switch to a pattern of gene expression more typical for bone and inducive for calcification. This hypothesis was tested using a 3-D engineered smooth muscle tissue model subjected to cyclic mechanical strain. This simplified model maintained a 3-D tissue architecture while eliminating systemic effects as can be seen with in vivo models. All engineered tissues were found to express bone-associated genes (osteopontin, matrix gla protein, alkaline phosphatase, and the transcription factor CBFA-1). Strikingly, however, expression of these genes was down-regulated in tissues exposed to cyclic strain at all time points ranging from 5 to 150 days. Furthermore, long-term strain played a protective role in regard to calcification, as unstrained tissues exhibited increased calcium deposition with respect to strained tissues. The results of this study suggest that without an appropriate mechanical environment, SMCs in 3-D culture undergo a phenotypic conversion to an osteoblast-like pattern of gene expression. This finding has significant implications for the mechanisms underlying a variety of cardiovascular diseases and indicates the broad utility of engineered tissue models in basic biology studies.
C1 Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Chem Engn, 2300 Hayward Ave,3074 HH Dow, Ann Arbor, MI 48109 USA.
EM mooneyd@umich.edu
RI Kim, Byung-Soo/O-2352-2013
CR BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391
   Bostrom KI, 2000, Z KARDIOL, V89, P69
   CARON JM, 1985, J CELL BIOL, V101, P1763, DOI 10.1083/jcb.101.5.1763
   Crosby AH, 1996, MAMM GENOME, V7, P149, DOI 10.1007/s003359900037
   Cunningham JJ, 2002, BIOTECHNIQUES, V32, P876, DOI 10.2144/02324rr05
   Cunningham JJ, 2002, ANN BIOMED ENG, V30, P927, DOI 10.1114/1.1500408
   DEMER LL, 1995, CIRCULATION, V92, P2029, DOI 10.1161/01.CIR.92.8.2029
   Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   GADEAU AP, 1993, ARTERIOSCLER THROMB, V13, P120, DOI 10.1161/01.ATV.13.1.120
   Giachelli C M, 2001, Z Kardiol, V90 Suppl 3, P31
   GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   HAO H, 1995, ARTERIOSCL THROM VAS, V15, P1474, DOI 10.1161/01.ATV.15.9.1474
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Iizuka K, 2001, BIOCHEM BIOPH RES CO, V283, P493, DOI 10.1006/bbrc.2001.4796
   Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   L'Heureux N, 2001, FASEB J, V15, P515, DOI 10.1096/fj.00-0283com
   Lee DA, 1998, J ORTHOP RES, V16, P726, DOI 10.1002/jor.1100160615
   Lehoux S, 1998, HYPERTENSION, V32, P338, DOI 10.1161/01.HYP.32.2.338
   Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6
   MANOLAGAS SC, 1981, J BIOL CHEM, V256, P7115
   Meyer U, 1999, J CRANIO MAXILL SURG, V27, P222, DOI 10.1016/S1010-5182(99)80033-X
   Meyer U, 2001, BRIT J ORAL MAX SURG, V39, P22, DOI 10.1045/bjom.2000.0549
   Mills I, 1997, J CELL PHYSIOL, V170, P228, DOI 10.1002/(SICI)1097-4652(199703)170:3<228::AID-JCP2>3.0.CO;2-Q
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Parhami F, 2001, Z Kardiol, V90 Suppl 3, P27
   Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje
   Proudfoot D, 1998, ARTERIOSCL THROM VAS, V18, P379, DOI 10.1161/01.ATV.18.3.379
   Putnam AJ, 1998, J CELL SCI, V111, P3379
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   Sato R, 1998, POSITIVITY, V2, P1, DOI 10.1023/A:1009728507209
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246
   SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   STEIN GS, 1990, FASEB J, V4, P3111
   Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070
   Stock UA, 2001, J CELL BIOCHEM, V81, P220, DOI 10.1002/1097-4644(20010501)81:2<220::AID-JCB1037>3.0.CO;2-O
   Wada T, 1999, CIRC RES, V84, P166, DOI 10.1161/01.RES.84.2.166
   WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205
   Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731
   Yamamoto M, 1997, HISTOCHEM CELL BIOL, V107, P279, DOI 10.1007/s004180050113
NR 49
TC 49
Z9 51
U1 0
U2 4
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD JAN
PY 2003
VL 17
IS 1
BP 455
EP +
DI 10.1096/fj.02-0459fje
PG 21
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 653TT
UT WOS:000181453700017
PM 12514116
DA 2018-10-19
ER

PT B
AU Wang, B
   Chen, RJ
   Zhang, T
   Jiang, XP
AF Wang, B
   Chen, RJ
   Zhang, T
   Jiang, XP
BE Yuan, YS
   Shah, SP
   Lu, HL
TI The application of polymer concrete in the airfield rapid repair
SO ICACS 2003: INTERNATIONAL CONFERENCE ON ADVANCES IN CONCRETE AND
   STRUCTURES, VOL 1 AND 2
SE RILEM PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Advances in Concrete and Structures (ICACS
   2003)
CY SEP 17-19, 2003
CL Xuzhou, PEOPLES R CHINA
SP China Univ Mining & Technol, NW Univ, Ctr Adv Cement-Based Mat, Tsinghua Univ, Tongji Univ, Amer Concrete Inst Int, Natl Nat Sci Fdn China, China Civil Engn Soc, RILEM, Int Union Lab & Experts Mat Systs & Construct
DE polymer concrete; S101; ZXR; AS coagulation material
AB Polymer concrete is a new kind of material that is combined with non-biomaterial and biomaterial. In this article we mainly discuss three new kinds of material, S101 super-strong and rapid congealed preparation, the ZXR ameliorative cement sand slurry and super quick concreting AS coagulation material, as well as their application in the airfield rapid repair.
CR LENG PY, 1995, DESIGN AIRFIELD PAVE
   SUN HS, 2000, RAPID RUNWAY REPAIR
   TAN MQ, 2001, APPLYING STUDY HIGH
NR 3
TC 0
Z9 0
U1 1
U2 1
PU R I L E M PUBLICATIONS
PI BAGNEUX
PA 157 RUE DES BLAINS, 92220 BAGNEUX, FRANCE
BN 2-912143-41-1
J9 RILEM PROC
PY 2003
VL 32
BP 691
EP 695
PG 5
WC Engineering, Civil; Materials Science, Characterization & Testing;
   Materials Science, Composites
SC Engineering; Materials Science
GA BBV81
UT WOS:000228044500083
DA 2018-10-19
ER

PT J
AU Freytag, CC
   Thies, FL
   Konig, W
   Welte, T
AF Freytag, CC
   Thies, FL
   Konig, W
   Welte, T
TI Prolonged application of closed in-line suction catheters increases
   microbial colonization of the lower respiratory tract and bacterial
   growth on catheter surface
SO INFECTION
LA English
DT Article
ID CENTRAL VENOUS CATHETER; TRACHEAL TUBE BIOFILM; MECHANICAL VENTILATION;
   RISK-FACTORS; PNEUMONIA; SYSTEM; CONTAMINATION; BACTEREMIA; INFECTION;
   MORTALITY
AB Background: Microorganisms become attracted to polymer surfaces for a number of reasons including positive charge of biomaterial or concentration of nutrients on the biomaterial surface. Many bacteria additionally possess specific receptors for the interaction with extracellular host protein components that adhere on the biomaterial surface. Several authors suggest that application of closed in-Line polypropylene suction catheters (CISC) in intubated patients for more than 24 h is safe and can reduce the costs associated with mechanical ventilation. Therefore, we evaluated the possible role of prolonged application of CISC to cause enhanced colonization of both the biomaterial and the tower respiratory tract.
   Patients and Methods: The prospective, randomized study included 23 mechanically ventilated patients. The CISC tips, adjacent segments and tracheobronchial aspirates of each patient were examined for microbial growth.
   Results: Application for 72 h significantly enhanced the microbial growth on the CISC tips and on the adjacent catheter segment. Usage for 3 days led to a significant increase in colonization in the lower respiratory tract.
   Conclusion: Normal saline instillation in conjunction with endotracheal suctioning may lead to a dispersion of microorganisms into the Lower respiratory tract. More effective self-cleaning mechanisms are necessary to decontaminate the CISC surface after suctioning.
C1 Univ Magdeburg, Inst Med Microbiol, D-39120 Magdeburg, Germany.
   Univ Magdeburg, Div Pulm & Crit Care, D-39120 Magdeburg, Germany.
RP Freytag, CC (reprint author), Univ Magdeburg, Inst Med Microbiol, Leipzigerstr 44, D-39120 Magdeburg, Germany.
CR Adams D H, 1997, Intensive Crit Care Nurs, V13, P72, DOI 10.1016/S0964-3397(97)80135-8
   Angle J S, 1994, Microb Releases, V2, P247
   Blackwood B, 1998, J HOSP INFECT, V39, P315, DOI 10.1016/S0195-6701(98)90297-3
   Bonten MJM, 1996, AM J RESP CRIT CARE, V154, P1339, DOI 10.1164/ajrccm.154.5.8912745
   BRUNBUISSON C, 1987, ARCH INTERN MED, V147, P873, DOI 10.1001/archinte.147.5.873
   CARLON GC, 1987, CRIT CARE MED, V15, P522, DOI 10.1097/00003246-198705000-00015
   COBLEY M, 1991, ANAESTHESIA, V46, P957, DOI 10.1111/j.1365-2044.1991.tb09858.x
   CRAVEN DE, 1986, AM REV RESPIR DIS, V133, P792
   Crimlisk J T, 1994, Dimens Crit Care Nurs, V13, P292, DOI 10.1097/00003465-199411000-00003
   DEPEW CL, 1993, DIMENS CRIT CARE NUR, V13, P73
   DEPPE SA, 1990, CRIT CARE MED, V18, P1389, DOI 10.1097/00003246-199012000-00016
   Dhillon SS, 2000, CHEST, V117, P1515, DOI 10.1378/chest.117.5.1515
   FREYTAG C, 1999, AM J RESP CRIT CARE, V159, P609
   Ghiran I, 2000, J EXP MED, V192, P1797, DOI 10.1084/jem.192.12.1797
   GUTIERREZ J, 1992, DIAGN MICR INFEC DIS, V15, P575, DOI 10.1016/0732-8893(90)90033-R
   INGLIS TJJ, 1989, J CLIN MICROBIOL, V27, P2014
   INGLIS TJJ, 1995, CHEST, V108, P1049, DOI 10.1378/chest.108.4.1049
   INGLIS TJJ, 1989, BRIT J HOSP MED, V42, P141
   JOHNSON KL, 1994, CRIT CARE MED, V22, P658, DOI 10.1097/00003246-199404000-00023
   Kollef MH, 1997, AM J RESP CRIT CARE, V156, P466, DOI 10.1164/ajrccm.156.2.9612083
   Livingston DH, 2000, AM J SURG, V179, P12
   MAKI DG, 1977, NEW ENGL J MED, V296, P1305, DOI 10.1056/NEJM197706092962301
   MAYHALL CG, 1988, INFECT CONT HOSP EP, V9, P125
   PENNER J, 1993, CHEMOTHERAPY, V39, P336, DOI 10.1159/000239146
   PRENTICE D, 1994, CRIT CARE MED, V22, P92
   RITZ R, 1986, RESPIR CARE, V31, P1087
   SOTTILE FD, 1986, CRIT CARE MED, V14, P265, DOI 10.1097/00003246-198604000-00001
   STAMME C, 1999, AM J PHYSIOL, V276, P540
   van Nieuwenhoven C, 1999, HOSP MED, V60, P558, DOI 10.12968/hosp.1999.60.8.1174
   WEBB CH, 1995, J HOSP INFECT, V31, P219, DOI 10.1016/0195-6701(95)90069-1
NR 30
TC 31
Z9 32
U1 0
U2 1
PU MMV MEDIEN & MEDIZIN VERLAGSGESELLSCHAFT MBH
PI MUNICH
PA NEUMARKTER STR 18, D-81673 MUNICH, GERMANY
SN 0300-8126
J9 INFECTION
JI Infection
PD JAN
PY 2003
VL 31
IS 1
BP 31
EP 37
DI 10.1007/s15010-002-3066-1
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA 645MC
UT WOS:000180980400007
PM 12590330
DA 2018-10-19
ER

PT J
AU Jastrzebska, M
   Wrzalik, R
   Kocot, A
   Zalewska-Rejdak, J
   Cwalina, B
AF Jastrzebska, M
   Wrzalik, R
   Kocot, A
   Zalewska-Rejdak, J
   Cwalina, B
TI Raman spectroscopic study of glutaraldehyde-stabilized collagen and
   pericardium tissue
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE Raman spectroscopy; glutaraldehyde; collagen; cross-linking
ID CROSS-LINKING; HYDRATION FORCES; DRUG-DELIVERY; CROSSLINKING; MECHANISM;
   PROTEINS; WATER; SKIN; BIOPROSTHESES; BIOMATERIAL
AB For the first time, Raman spectroscopy has been employed to investigate formation of cross-links in collagen and porcine pericardium tissue upon glutaraldehyde (GA) treatment. GA treatment causes a very high fluorescence background, which overlaps Raman bands. It has been found that short fixation time, i.e. 2 h, reduces background radiation significantly, providing new possibilities for studying changes in molecular structure of collagen upon GA modification. The observed changes in position and intensity of Raman bands allowed us to recognize different types of GA-collagen interactions. Strong spectral evidence has been found for the peptide contribution to the formation of the GA-collagen cross-links and for the formation of secondary amines via Schiff base intermediates, and pyridinium-type cross-links. The results also revealed that different hydration levels and a more complex structure of intact tissue in comparison to collagen preparation strongly influence the formation of a GA cross-linking network, e.g. ether-type bond is preferred to form in a less hydrated collagen preparation. Our results have shown that GA treatment causes an increase in water content of pericardium tissue and collagen.
C1 Med Univ Silesia, Fac Pharm, Dept Biophys, PL-41200 Sosnowiec, Poland.
   Silesian Univ, Inst Phys, PL-40007 Katowice, Poland.
RP Jastrzebska, M (reprint author), Med Univ Silesia, Fac Pharm, Dept Biophys, Ostrogorska 30, PL-41200 Sosnowiec, Poland.
CR BARAGA JJ, 1992, P NATL ACAD SCI USA, V89, P3473, DOI 10.1073/pnas.89.8.3473
   BELLAMY LJ, 1975, INFRARED SPECTRA COM
   Brodsky-Doyle B, 1975, BIOPOLYMERS, V14, P937
   Buschman HP, 2001, CARDIOVASC PATHOL, V10, P69, DOI 10.1016/S1054-8807(01)00064-3
   CHACHQUES JC, 1988, ANN NY ACAD SCI, V529, P184
   Charulatha V, 1997, J BIOMED MATER RES, V36, P478
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P187, DOI 10.3109/03008208209034418
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   Edwards HGM, 2002, VIB SPECTROSC, V28, P3, DOI 10.1016/S0924-2031(01)00141-2
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211
   Gniadecka M, 1998, J INVEST DERMATOL, V111, P1129, DOI 10.1046/j.1523-1747.1998.00430.x
   GRIGERA JR, 1979, BIOPOLYMERS, V18, P47, DOI 10.1002/bip.1979.360180106
   Hanlon E.B., 2000, PHYS MED BIOL, V45, P1
   HARDY PM, 1979, J CHEM SOC PERK T 1, P2282, DOI 10.1039/p19790002282
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Jahn A, 2002, SPECTROCHIM ACTA A, V58, P2271, DOI 10.1016/S1386-1425(01)00697-7
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kucharz E. J., 1992, COLLAGENS BIOCH PATH
   Kupper L, 2001, J MOL STRUCT, V565, P497, DOI 10.1016/S0022-2860(00)00935-2
   LAZAREV YA, 1992, BIOPOLYMERS, V32, P189, DOI 10.1002/bip.360320209
   Leikin S, 1997, P NATL ACAD SCI USA, V94, P11312, DOI 10.1073/pnas.94.21.11312
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   Menter JM, 2001, PHOTODERMATOL PHOTO, V17, P114, DOI 10.1034/j.1600-0781.2001.170302.x
   MORISON RT, 1997, ORGANIC CHEM
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   SINGH BR, 2000, INFRARED ANAL PEPTID
   Sionkowska A, 2000, POLYM DEGRAD STABIL, V68, P147, DOI 10.1016/S0141-3910(99)00176-7
   STANGEL JX, 1997, J DENT RES, V76, P596
   Suh H, 1999, YONSEI MED J, V40, P159, DOI 10.3349/ymj.1999.40.2.159
   Tait JK, 1995, SPECTROCHIM ACTA A, V51, P2101, DOI 10.1016/0584-8539(95)01456-5
   TWARDOWSKI J, 1994, RAMAN IR SPECTROSCOP
   Walrafen GE, 2000, CHEM PHYS, V258, P427, DOI 10.1016/S0301-0104(00)00072-0
   WOODROOF EA, 1977, T TISS VALV, V2, P1
NR 40
TC 41
Z9 41
U1 3
U2 27
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 2
BP 185
EP 197
DI 10.1163/156856203321142605
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 664JV
UT WOS:000182058700005
PM 12661667
DA 2018-10-19
ER

PT J
AU Patel, JD
   Ebert, M
   Stokes, K
   Ward, R
   Anderson, JM
AF Patel, JD
   Ebert, M
   Stokes, K
   Ward, R
   Anderson, JM
TI Inhibition of bacterial and leukocyte adhesion under shear stress
   conditions by material surface chemistry
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE bacterial adhesion; leukocyte adhesion; biomaterials; shear stress;
   infection
ID STAPHYLOCOCCUS-EPIDERMIDIS ADHESION; POLYETHYLENE OXIDE; BIOMATERIAL
   INTERACTIONS; IN-VITRO; POLYMERS; FIBRINOGEN; APOPTOSIS; PROTEINS; VIVO
AB Biomaterial-centered infections, initiated by bacterial adhesion, persist due to a compromised host immune response. Altering implant materials with surface modifying endgroups (SMEs) may enhance their biocompatibility by reducing bacterial and inflammatory cell adhesion. A rotating disc model, which generates shear stress within physiological ranges, was used to characterize adhesion of leukocytes and Staphylococcus epidermidis on polycarbonate-urethanes and polyetherurethanes modified with SMEs (polyethylene oxide, fluorocarbon and dimethylsiloxane) under dynamic flow conditions. Bacterial adhesion in the absence of serum was found to be mediated by shear stress and surface chemistry, with reduced adhesion exhibited on materials modified with polydimethylsiloxane and polyethylene oxide SMEs. In contrast, bacterial adhesion was enhanced on materials modified with fluorocarbon SMEs. In the presence of serum, bacterial adhesion was primarily neither material nor shear dependent. However, bacterial adhesion in serum was significantly reduced to <10% compared to adhesion in serum-free media. Leukocyte adhesion in serum exhibited a shear dependency with increased adhesion occurring in regions exposed to lower shear-stress levels of <7 dyne/cm(2). Additionally, polydimethylsiloxane and polyethylene oxide SMEs reduced leukocyte adhesion on polyether-urethanes. In conclusion, these results suggest that surface chemistry and shear stress can mediate bacterial and cellular adhesion. Furthermore, materials modified with polyethylene oxide SMEs are capable of inhibiting bacterial adhesion, consequently minimizing the probability of biomaterial-centered infections.
C1 Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Medtronic Inc, Minneapolis, MN 55432 USA.
   Polymer Technol Grp, Berkeley, CA 94710 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd,room 306, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [HL 43700]
CR ABSOLOM DR, 1988, CAN J MICROBIOL, V34, P287, DOI 10.1139/m88-054
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BRASH JL, 1991, BLOOD COMPATIBLE MAT
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Chen Z, 2002, J BIOMED MATER RES, V62, P254, DOI 10.1002/jbm.10075
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   DESAI NP, 1992, BIOMATERIALS, V13, P417, DOI 10.1016/0142-9612(92)90160-P
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRAY ED, 1984, LANCET, V1, P365
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Haslam J., 1972, IDENTIFICATION ANAL
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HIGASHI JM, 1999, HDB BIOMATERIALS EVA
   HOGT AH, 1983, J GEN MICROBIOL, V129, P2959
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   KLEINSTREUER C, 1997, ENG FLUID DYNAMICS
   Levich V. G., 1962, PHYSICOCHEMICAL HYDR
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   Lim F, 1991, ASAIO Trans, V37, pM146
   MCCREA KR, 2002, SOC BIOMATERIALS POL
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Sapatnekar S, 1997, J BIOMED MATER RES, V35, P409, DOI 10.1002/(SICI)1097-4636(19970615)35:4<409::AID-JBM1>3.0.CO;2-L
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Shive MS, 2002, J BIOMED MATER RES, V60, P148, DOI 10.1002/jbm.10035
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   Szleifer I, 1997, CURR OPIN SOLID ST M, V2, P337, DOI 10.1016/S1359-0286(97)80125-8
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   VACHEETHASANEE K, 2000, HDB BACTERIAL ADHESI
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WARD RS, 1996, 5 WORLD BIOM C TOR C
   WARD RS, 1987, Patent No. 4675361
   WARD RS, 1996, Patent No. 5589563
   WARD RS, 2002, POL MED BIOL AM CHEM
   WHITE KA, 1996, SURFACE MODIFICATION
   Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299
NR 44
TC 26
Z9 26
U1 0
U2 6
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 3
BP 279
EP 295
DI 10.1163/156856203763572725
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 673LA
UT WOS:000182581400007
PM 12713100
DA 2018-10-19
ER

PT J
AU Zhu, A
   Zhang, M
   Shen, R
AF Zhu, A
   Zhang, M
   Shen, R
TI Covalent immobilization of O-butyrylchitosan with a photosensitive
   hetero-bifunctional crosslinking reagent on biopolymer substrate surface
   and bloodcompatibility characterization
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE O-butyrylchitosan; hetero-bifunctional crosslinking reagent;
   immobilization; bloodcompatibility
ID POLYMORPHONUCLEAR CELLS; BLOOD COMPATIBILITY; VASCULAR GRAFTS; CHITOSAN;
   PLATELETS; POLYMERS
AB O-Butyrylchitosan (OCS) was covalently immobilized onto a substrate (suture and PTFE) surface using the photosensitive hetero-bifunctional crosslinking reagent 4-azidobenzoic acid, which was previously bonded to OCS by the reaction between an acid group of the crosslinking reagent and a free amino group of OCS. The immobilization was accomplished by irradiating the modified OCS coated on the substrate surface with ultraviolet light to photolyze azide groups, thus the crosslinking OCS was immobilized on the substrate surface. The result indicated that OCS molecules immobilized on the substrate, and significantly reduced the fibrinogen adsorption and the deposition and spreading of platelets, demonstrating superior bloodcompatibility. Therefore, OCS could be developed into bloodcompatible biomaterial that used to modify the biomedical devices, such as PTFE and Dacron vascular prostheses surface.
C1 Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225009, Peoples R China.
   Nanjing Univ, Dept Polymer Sci & Engn, Nanjing 210093, Peoples R China.
   Nanjing Univ, Coll Med, Nanjing 210093, Peoples R China.
RP Zhu, A (reprint author), Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225009, Peoples R China.
EM zapyz@yahoo.com
CR ALDENHOFF YBJ, 1995, J BIOMED MATER RES, V29, P917, DOI 10.1002/jbm.820290803
   BAIER RE, 1987, ANN NY ACAD SCI, V516, P68, DOI 10.1111/j.1749-6632.1987.tb33031.x
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   DRURY JK, 1987, ANN VASC SURG, V5, P542
   FLORIAN A, 1976, ARCH SURG-CHICAGO, V111, P267
   GRANT S, 1988, POLYM COMMUN, V29, P342
   HAYASHI A, 1992, MACROMOLECULES, V25, P5094, DOI 10.1021/ma00045a041
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, V207, P290
   JOIST JH, 1987, T AM SOC ART INT ORG, V33, P341
   Kito H, 1996, J BIOMED MATER RES, V30, P321
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   MALETTE EG, 1993, ANN THORAC SURG, V35, P55
   MUSTARD JF, 1975, THROMB DIATH HAEMOST, V33, P444, DOI 10.1055/s-0038-1647838
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P925, DOI 10.1016/0142-9612(93)90134-N
   NOISHIKI Y, 1987, VASCULAR SURG, V21, P401, DOI 10.1177/153857448702100605
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   ROALD HE, 1994, BLOOD COAGUL FIBRIN, V5, P355
   SHARMA CP, 1991, BLOOD COMPATIBLE MAT, P25
   Tseng DY, 1998, J BIOMED MATER RES, V42, P188, DOI 10.1002/(SICI)1097-4636(199811)42:2<188::AID-JBM4>3.0.CO;2-L
   USAMI Y, 1994, J VET MED SCI, V56, P761, DOI 10.1292/jvms.56.761
   Usami Y, 1997, CARBOHYD POLYM, V32, P115, DOI 10.1016/S0144-8617(96)00153-1
   VROMAN L, 1988, B NEW YORK ACAD MED, V64, P352
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
NR 25
TC 8
Z9 8
U1 1
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 5
BP 411
EP 421
DI 10.1163/156856203766652039
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 691CU
UT WOS:000183587900002
PM 12807144
DA 2018-10-19
ER

PT J
AU Finer, Y
   Santerre, JP
AF Finer, Y
   Santerre, JP
TI Biodegradation of a dental composite by esterases: dependence on enzyme
   concentration and specificity
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biodegradation; biomaterial hydrolysis; esterases; dental resins;
   monomers
ID CHOLESTEROL ESTERASE; PERMANENT TEETH; ACTIVE-SITE; RESIN; HYDROLYSIS;
   DEGRADATION; POLYMERS; MONOMERS; PRODUCTS; SALIVA
AB Studies have shown that inflammatory (cholesterol esterase, CE) and salivary (pseudo-cholinesterase, PCE) enzymes can cause the breakdown of bisphenol-A diglycidyl dimethacrylate (bisGMA) and triethylene glycol dimethacrylate (TEGDMA) components from composite resins. Based on the above consideration, it was desired to show how CE- and PCE-catalyzed hydrolysis of resin components was dependent on the enzymes' concentration and to determine their distinct specificities (if any) towards resin components. Photopolymerized model composite resin samples (60% weight fraction silanated barium glass filler) based on bisGMA and TEGDMA monomers (55/45 weight ratio of the matrix, respectively) were incubated with PBS and either 0.01, 0.05, 0.1 or 1 unit/ml of CE or PCE for 16 days (pH 7.0, 37degreesC). Incubation solutions were analyzed by high-performance liquid chromatography (HPLC), UV spectroscopy and mass spectrometry. The composite samples were characterized by scanning electron microscopy (SEM). Degradation rates of bisGMA and TEGDMA monomers were assessed. The results showed that CE had a greater specificity towards cleaving bisGMA while PCE showed a greater specificity towards TEGDMA. A strong enzyme concentration dependence was observed which suggests that the level of degradation products generated for a material will depend on the esterase make-up of an individual's saliva in combination with the specific formulation of monomer components used.
C1 Univ Toronto, Fac Dent, Biomat Discipline, Toronto, ON M5G 1G6, Canada.
   Univ Toronto, Fac Dent, Prosthodont Discipline, Toronto, ON M5G 1G6, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Biomat Discipline, 124 Edward St, Toronto, ON M5G 1G6, Canada.
CR Feaster SR, 1996, BIOCHEMISTRY-US, V35, P16723, DOI 10.1021/bi961677v
   FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x
   FINER Y, 2003, UNPUB J DENT RES
   FREUND M, 1990, SCAND J DENT RES, V98, P351
   Hansel C, 1998, J DENT RES, V77, P60, DOI 10.1177/00220345980770010601
   Jaffer F, 2002, BIOMATERIALS, V23, P1707, DOI 10.1016/S0142-9612(01)00298-8
   KODA T, 1990, DENT MATER, V6, P13, DOI 10.1016/0109-5641(90)90037-F
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Mjor IA, 1999, ACTA ODONTOL SCAND, V57, P257, DOI 10.1080/000163599428661
   Mjor IA, 2000, ACTA ODONTOL SCAND, V58, P97
   MUNKSGAARD EC, 1990, SCAND J DENT RES, V98, P261
   Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888
   RUYTER IE, 1985, POSTERIOR COMPOSITE, P109
   Santerre JP, 1999, J DENT RES, V78, P1459, DOI 10.1177/00220345990780081201
   Santerre JP, 2001, CRIT REV ORAL BIOL M, V12, P136, DOI 10.1177/10454411010120020401
   Shajii L, 1999, BIOMATERIALS, V20, P1897, DOI 10.1016/S0142-9612(99)00087-3
   SUTTON LD, 1990, BIOCHIM BIOPHYS ACTA, V1041, P79, DOI 10.1016/0167-4838(90)90125-Y
   SUTTON LD, 1991, BIOCHEMISTRY-US, V30, P5888, DOI 10.1021/bi00238a012
   TANAKA K, 1991, J ORAL REHABIL, V18, P353, DOI 10.1111/j.1365-2842.1991.tb00067.x
   Wahl MJ, 2001, QUINTESSENCE INT, V32, P696
   Yourtee DM, 2001, J BIOMED MATER RES, V57, P522, DOI 10.1002/1097-4636(20011215)57:4<522::AID-JBM1198>3.0.CO;2-9
NR 21
TC 36
Z9 37
U1 1
U2 15
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 8
BP 837
EP 849
DI 10.1163/156856203768366558
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 734BZ
UT WOS:000186036500006
PM 14533861
DA 2018-10-19
ER

PT J
AU Ma, L
   Gao, CY
   Mao, ZW
   Shen, JC
   Hu, XQ
   Han, CM
AF Ma, L
   Gao, CY
   Mao, ZW
   Shen, JC
   Hu, XQ
   Han, CM
TI Thermal dehydration treatment and glutaraldehyde cross-linking to
   increase the biostability of collagen-chitosan porous scaffolds used as
   dermal equivalent
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE collagen; chitosan; DHT; glutaraldehyde; dermis; tissue engineering
ID DEEP BURN COVERAGE; MECHANICAL-PROPERTIES; ARTIFICIAL SKIN; TISSUE;
   CHITIN; BIOMATERIAL; THICKNESS; DESIGN; DOGS
AB A biodegradable scaffold for skin-tissue engineering was designed using collagen and chitosan, which are common materials for biomedical application. The scaffolds containing different amounts of chitosan were prepared by mixing the collagen and chitosan solutions followed by removal of the solvent using a freeze-drying method. The cross-linking treatment of these scaffolds was performed using the dehydrothermal treatment (DHT) method or glutaraldehyde (GA) to increase their biostability. The effect of the chitosan concentration and the cross-linking methods on the morphology of these scaffolds was studied by SEM. The water retention and the biodegradability in vitro of various collagen-chitosan scaffolds were investigated. Finally the biocompatibility of the collagen-chitosan (10 wt% chitosan) scaffold treated with different cross-linking methods was evaluated using a in vivo animal test. A mild inflammatory reaction could be detected in the early stages, and GA treatment can decrease the inflammatory reaction in a long-term implantation. After implantation for four weeks, all kinds of scaffolds, especially the GA-treated scaffolds (Col-GA) were filled with a large number of fibroblasts and were vascularized to a certain extent. These results suggest that the GA-treated scaffold has an increased biostability and excellent biocompatibility. It can be a potential candidate for skin-tissue engineering.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
   Zhejiang Univ, Affiliated Hosp 2, Fac Burn, Hangzhou 310027, Peoples R China.
RP Gao, CY (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RI mao, zhengwei/I-5785-2012
OI Gao, Changyou/0000-0001-5084-7208
CR Augustin C, 1997, SKIN PHARMACOL, V10, P63
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417
   DAMOUR O, 1994, CLIN MATER, V15, P273, DOI 10.1016/0267-6605(94)90057-4
   Eppley BL, 2001, PLAST RECONSTR SURG, V107, P757, DOI 10.1097/00006534-200103000-00016
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Kojima K, 1998, CARBOHYD POLYM, V37, P109, DOI 10.1016/S0144-8617(98)00055-1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Ma HY, 2001, CHINESE J CATAL+, V22, P3
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   OKAMOTO Y, 1993, J VET MED SCI, V55, P743, DOI 10.1292/jvms.55.743
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Radhika M, 1999, COMP BIOCHEM PHYS C, V124, P131, DOI 10.1016/S0742-8413(99)00042-0
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   SU CH, 1997, BIOMATERIALS, V18, P567
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   Thomson R. C., 1997, ADV BIOPOLYM, V122, P245
   TSUBOI R, 1995, J DERMATOL SCI, V10, P82
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   WEADOCK K, 1984, BIOMAT MED EV ARTIF, V11, P293
   WIDMER MS, 1980, FRONTIERS TISSUE ENG, P107
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   Yannas IV., 1995, BIOMEDICAL ENG HDB, P1619
NR 29
TC 45
Z9 57
U1 1
U2 19
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 8
BP 861
EP 874
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 734BZ
UT WOS:000186036500008
PM 14533863
DA 2018-10-19
ER

PT J
AU Poncin-Epaillard, F
   Legeay, G
AF Poncin-Epaillard, F
   Legeay, G
TI Surface engineering of biomaterials with plasma techniques
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE biomaterial; polymer; plasma; biofilm; adhesion; surface modification;
   sterilisation
ID HUMAN ENDOTHELIAL-CELLS; POST POLYMERIZATION TECHNIQUE; INDUCED
   GRAFT-POLYMERIZATION; GLUCOSE-OXIDASE MEMBRANE; GLOW-DISCHARGE; PRESSURE
   PLASMA; ACRYLIC-ACID; IN-VITRO; FIBRINOGEN ADSORPTION; POLY(ETHYLENE
   OXIDE)
AB In this study, 3 types of plasma techniques, i.e. plasma modification, plasma deposition and plasma followed by grafting reaction, are used for the fabrication of tools, medical devices and biomaterials. Depending on purpose, bioadhesion of cells and biomolecules is either looked for or avoided. Since the mechanisms of bioadhesion depend on the characteristics of the surface (hydrophilic or hydrophobic), modifying the surface by a treatment will alter the bioadhesion. These treatments are developed for the anti-fouling process, the sterilisation and the improvement of the formation of biofilms. They have also proved useful for the synthesis of biomimicking devices.
C1 Univ Maine, Lab Polymeres Colloides & Interfaces, CNRS, UMR 6120, F-72085 Le Mans, France.
   CTTM, F-72000 Le Mans, France.
RP Poncin-Epaillard, F (reprint author), Univ Maine, Lab Polymeres Colloides & Interfaces, CNRS, UMR 6120, Ave O Messiaen, F-72085 Le Mans, France.
CR Allen Matthew, 1994, Clinical Materials, V17, P1, DOI 10.1016/0267-6605(94)90041-8
   Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   BREUERS W, 1991, J MATER SCI-MATER M, V2, P121
   CARTER AJ, 2001, P TRANSSCCARD THER
   Chen H, 1999, J APPL POLYM SCI, V72, P1699, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1699::AID-APP6>3.0.CO;2-9
   Chevallier P, 2001, J PHYS CHEM B, V105, P12490, DOI 10.1021/jp011607k
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   d'Agostino R., 1990, PLASMA DEPOSITION TR
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Elftonson JE, 1996, J ADHES SCI TECHNOL, V10, P761, DOI 10.1163/156856196X00643
   ELOY R, 1993, J CATARACT REFR SURG, V19, P364, DOI 10.1016/S0886-3350(13)80307-0
   Favia P., 2000, PLASMAS POLYM, DOI [10.1023/A:1009517408368, DOI 10.1023/A:1009517408368]
   GEBHARDT R, 1995, P 12 ISPC MINN MN, P155
   GIROUX TA, 1990, J COLLOID INTERF SCI, V139, P351, DOI 10.1016/0021-9797(90)90109-2
   GOLANDER CG, 1992, J BIOMAT SCI-POLYM E, V4, P25
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   HETTLICH HJ, 1991, BIOMATERIALS, V12, P521, DOI 10.1016/0142-9612(91)90153-2
   Hill D, 1998, DESIGN ENG BIOMATERI, P480
   Hirotsu T, 2002, POLYM ENG SCI, V42, P299, DOI 10.1002/pen.10949
   HOFFMAN A S, 1991, Clinical Materials, V8, P3, DOI 10.1016/0267-6605(91)90003-X
   HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419
   HSIUE GH, 1989, J APPL POLYM SCI, V38, P1591, DOI 10.1002/app.1989.070380903
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   Hury S, 1998, LETT APPL MICROBIOL, V26, P417
   IKADA Y, 1983, POLYM PREPR, V24, P135
   KAKU S, 1993, ANAL CHIM ACTA, V272, P213, DOI 10.1016/0003-2670(93)80571-2
   Kang IK, 2001, J BIOMAT SCI-POLYM E, V12, P1091, DOI 10.1163/15685620152691878
   Kessler L, 1997, J BIOMED MATER RES, V34, P235, DOI 10.1002/(SICI)1097-4636(199702)34:2<235::AID-JBM13>3.0.CO;2-H
   KESSLER L, 2003, IN PRESS BIOMATERIAL, V24
   KIAEI D, 1992, RADIAT PHYS CHEM, V39, P463
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   KITADE T, 1987, CHEM PHARM BULL, V35, P4410
   Klee D, 1999, ADV POLYM SCI, V149, P1
   KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908
   Koulik P, 1999, PLASMA CHEM PLASMA P, V19, P311, DOI 10.1023/A:1021604027855
   LAI JY, 1989, J APPL POLYM SCI, V37, P1465, DOI 10.1002/app.1989.070370603
   LAI JY, 1991, J APPL POLYM SCI, V43, P1431, DOI 10.1002/app.1991.070430804
   Laroussi M, 1996, IEEE T PLASMA SCI, V24, P1188, DOI 10.1109/27.533129
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   LEGEAY G, 2002, Patent No. 2820057
   LEGEAY G, 2001, Patent No. 0103977
   LEGEAY G, 2001, P CIP 2001 ANT, P10
   LEGEAY G, 2002, Patent No. 0200347
   LEGEAY G, 2001, Patent No. 1133972
   LEGEAY G, 2000, SCI TECH APPL S, V294, P423
   Lens JP, 1998, POLYMER, V39, P3437, DOI 10.1016/S0032-3861(97)10091-X
   Lerouge S, 2000, J BIOMED MATER RES, V51, P128, DOI 10.1002/(SICI)1097-4636(200007)51:1<128::AID-JBM17>3.3.CO;2-R
   LETHI T, 2001, Patent No. 1070508
   LI DJ, 1995, J ADHES SCI TECHNOL, V9, P1249
   Lin JC, 1996, J COLLOID INTERF SCI, V182, P315, DOI 10.1006/jcis.1996.0470
   LOPEZ GP, 1993, MACROMOLECULES, V26, P3247, DOI 10.1021/ma00065a001
   MAN N K, 1990, Artificial Organs, V14, P44
   Mason M, 2000, BIOMATERIALS, V21, P31, DOI 10.1016/S0142-9612(99)00129-5
   Medard N, 2002, LANGMUIR, V18, P2246, DOI 10.1021/la011481i
   MO TM, 1993, J COLLOID INTERF SCI, V156, P207
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   Murugesan G, 2000, J BIOMED MATER RES, V49, P396, DOI 10.1002/(SICI)1097-4636(20000305)49:3<396::AID-JBM13>3.0.CO;2-H
   MUTLU M, 1991, J MATER CHEM, V1, P447, DOI 10.1039/jm9910100447
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   OHL A, 1999, SURF COAT TECH, V119, P820
   Poncin-Epaillard F, 1998, MACROMOL CHEM PHYSIC, V199, P1613, DOI 10.1002/macp.1998.021990820
   Poncin-Epaillard F, 2000, MACROMOL CHEM PHYSIC, V201, P212, DOI 10.1002/(SICI)1521-3935(20000201)201:2<212::AID-MACP212>3.0.CO;2-5
   Poncin-Epaillard F, 2001, J POLYM SCI POL CHEM, V39, P3052, DOI 10.1002/pola.1286
   PONCINEPAILLARD F, 1994, J APPL POLYM SCI, V53, P1291, DOI 10.1002/app.1994.070531003
   Poon M, 1996, J CLIN INVEST, V98, P2277, DOI 10.1172/JCI119038
   Purevdorj D, 2001, ACTA BIOTECHNOL, V21, P333, DOI 10.1002/1521-3846(200111)21:4<333::AID-ABIO333>3.0.CO;2-6
   Ramires PA, 2000, J BIOMED MATER RES, V51, P535, DOI 10.1002/1097-4636(20000905)51:3<535::AID-JBM31>3.0.CO;2-P
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   SHEU MS, 1992, J ADHES SCI TECHNOL, V6, P905
   Simon F, 1996, MACROMOL SYMP, V103, P243, DOI 10.1002/masy.19961030122
   Sodhi RNS, 2001, J ELECTRON SPECTROSC, V121, P249, DOI 10.1016/S0368-2048(01)00338-3
   Sugiyama K, 2000, MACROMOL MATER ENG, V282, P5, DOI 10.1002/1439-2054(20001001)282:1<5::AID-MAME5>3.0.CO;2-H
   Sugiyama K, 1998, MACROMOL CHEM PHYSIC, V199, P1201, DOI 10.1002/(SICI)1521-3935(19980601)199:6<1201::AID-MACP1201>3.3.CO;2-Y
   Suzer S, 1997, APPL SPECTROSC, V51, P1741, DOI 10.1366/0003702971939451
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   THE TC, 1996, BIOMATERIALS, V17, P1273
   WANG CC, 1993, J APPL POLYM SCI, V50, P1141, DOI 10.1002/app.1993.070500704
   WANG CC, 1993, J POLYM SCI POL CHEM, V31, P2601, DOI 10.1002/pola.1993.080311021
   Wang P, 2002, J ADHES SCI TECHNOL, V16, P111, DOI 10.1163/156856102317293650
   Werner C, 1999, COLLOID SURFACE A, V159, P519, DOI 10.1016/S0927-7757(99)00290-3
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
   YOSHIMURA K, 1991, MICROCHEM J, V43, P133, DOI 10.1016/0026-265X(91)90008-D
   ZHOU XP, 2002, SURF COAT TECH, V149, P119
NR 85
TC 90
Z9 93
U1 2
U2 61
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 10
BP 1005
EP 1028
DI 10.1163/156856203769231538
PG 24
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 753BA
UT WOS:000187210500001
PM 14661876
DA 2018-10-19
ER

PT J
AU Kim, YJ
   Shin, JW
   Park, KD
   Lee, JW
   Yui, N
   Park, SA
   Jee, KS
   Kim, JK
AF Kim, YJ
   Shin, JW
   Park, KD
   Lee, JW
   Yui, N
   Park, SA
   Jee, KS
   Kim, JK
TI A study of compatibility between cells and biopolymeric surfaces through
   quantitative measurements of adhesive forces
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE finite element method (FEM); cell adhesive force; polymer surface;
   micropipette
ID FIBROBLASTS; FIBRONECTIN; ATTACHMENT; BINDING
AB The mechanism of cell adhesion to biomaterials or components of the extracellular matrix is an important topic in the field of tissue engineering and related biotechnological processes,. Many factors affect cell adhesion, and many biochemical and biological studies have attempted to identify their roles in the adhesion mechanism. Systematic studies of this nature require quantification of the adhesive force of a cell to identify the effect of a specific factor. However, most studies of cell adhesive force have used qualitative approaches. We propose a new technique for quantifying the force by which cells adhere to various biomaterial surfaces, which utilizes the relationship between the deflection of a cantilever beam and the required force. A micropipette was used as the cantilever beam. This technique was used to measure the attachment forces of chondrocytes seeded on three different biodegradable polymers commonly used in tissue engineering and medicine: poly epsilon-carprolactone (PCL), poly(L-lactide) (PLLA) and poly(lactic-co-glycolic acid) (PGLA, L/G = 75:25). The bond between the cells and the three polymers was evaluated using the quantified adhesive forces. The adhesive forces were also measured 8, 12, 24 h and 5 days after seeding the chondrocytes on the polymer surfaces. Results of statistical analysis showed that the cells attached to the PLLA had the strongest average attachment force for up to 24 h after seeding (P < 0.05).
C1 Inje Univ, Dept Biomed Engn, Kimhae, Kyongnam, South Korea.
   Ajou Univ, Dept Mol Sci & Technol, Suwon 442749, Kyonggi, South Korea.
   Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul 120749, South Korea.
   Japan Adv Inst Sci & Technol, Sch Mat Sci, Tatsunokuchi, Ishikawa 9231292, Japan.
RP Shin, JW (reprint author), Inje Univ, Dept Biomed Engn, 607 Obang Dong, Kimhae, Kyongnam, South Korea.
EM sjw@bme.inje.ac.kr
CR Athanasiou KA, 1999, BIOMATERIALS, V20, P2405, DOI 10.1016/S0142-9612(99)00168-4
   Craig Jr R R, 2001, MECH MAT
   Crandall SH, 1978, INTRO MECH SOLIDS
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Jones WR, 1999, J BIOMECH, V32, P119, DOI 10.1016/S0021-9290(98)00166-3
   Kennedy S, 2000, J IMMUNOL METHODS, V244, P153, DOI 10.1016/S0022-1759(00)00266-0
   Lam A, 2001, ENZYME MICROB TECH, V29, P28, DOI 10.1016/S0141-0229(01)00329-5
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   Ming F, 1998, ENZYME MICROB TECH, V22, P94, DOI 10.1016/S0141-0229(97)00136-1
   Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0
   Reed MJ, 2001, MECH AGEING DEV, V122, P1203, DOI 10.1016/S0047-6374(01)00260-3
   Santini MT, 2000, CRIT REV ONCOL HEMAT, V36, P75, DOI 10.1016/S1040-8428(00)00078-0
   Stanford CM, 1999, J BIOMED MATER RES, V47, P345, DOI 10.1002/(SICI)1097-4636(19991205)47:3<345::AID-JBM8>3.0.CO;2-N
   SUNG KLP, 1994, J BIOMECH ENG-T ASME, V116, P237, DOI 10.1115/1.2895725
   Svetlicic V, 2000, BIOELECTROCHEMISTRY, V53, P79
   Turner CE, 2000, NAT CELL BIOL, V2, P231
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   YAMAGIWA K, 1998, RRD BIOTECH BIOENG 1, V1, P19
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
NR 20
TC 15
Z9 15
U1 0
U2 2
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 12
BP 1311
EP 1321
DI 10.1163/156856203322599662
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 770XU
UT WOS:000188757300001
PM 14870936
DA 2018-10-19
ER

PT J
AU Yuan, J
   Zhang, J
   Zhou, J
   Yuan, YL
   Shen, J
   Lin, SC
AF Yuan, J
   Zhang, J
   Zhou, J
   Yuan, YL
   Shen, J
   Lin, SC
TI Platelet adhesion onto segmented polyurethane surfaces modified by
   carboxybetaine
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE polyurethane; carboxybetaine; surface modification; platelet adhesion;
   nonthrombogenic biomaterials
ID BLOOD COMPATIBILITY; IMPROVE HEMOCOMPATIBILITY; CHEMICAL-MODIFICATION;
   POLY(ETHER URETHANE); VINYL MONOMER; COPOLYMERS; FILM; SULFOBETAINE;
   POLYMERS
AB Polyurethanes are widely used as blood-contacting biomaterials due to their good biocompatibility and mechanical properties. Nevertheless, their blood compatibility is still not adequate for more demanding applications. Surface modification is an effective way to improve the hemocompatibility for biomaterials. The purpose of present study was to synthesize a novel nonthrombogenic biomaterial by modifying the surface of polyurethane with Zwitterions of carboxybetaine monomer. The films of polyurethane were grafted with two kinds of carboxybetaine by a three-step procedure. In the first step, the film surfaces were treated with hexamethylene diisocyanate (HDI) in toluene at 50degreesC in the presence of di-n-butyl tin dilaurate (DBTDL) as a catalyst. The extent of the reaction was measured by ATR-FT-IR spectra; a maximum number of free NCO group was obtained after a reaction time of 90 min. In the second step, the hydroxyl group of N,N-dimethylethylethanolamine (DMEA) or 4-dimethylamino-1-butanol (DMBA) was allowed to react in toluene with isocyanate groups bound on surface. In the third step, carboxybetaines were formed in the surface through the ring-opening reaction between tertiary amine of DMEA or DMBA and beta-propiolactone (PL). It was characterized by ATR-FT-IR and XPS that the grafted surfaces were composed of carboxybetaine. The results of the contact angle measurements showed that they were strongly hydrophilic. Platelet adhesion tests showed that films grafted carboxybetaine have good blood compatibility, as featured by the low platelet adhesion.
C1 Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Res Ctr Surface & Interface Chem & Engn Technol, Nanjing 210093, Peoples R China.
EM Sicong_lin@yahoo.com
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Chen Z, 2000, J APPL POLYM SCI, V76, P382, DOI 10.1002/(SICI)1097-4628(20000418)76:3<382::AID-APP13>3.0.CO;2-A
   CHRISTINA FL, 1993, J APPL POLYM SCI, V50, P345
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Ishihara K, 1997, TRENDS POLYM SCI, V5, P401
   Iwasaki Y, 1998, J BIOMAT SCI-POLYM E, V9, P801, DOI 10.1163/156856298X00163
   Kim JH, 2002, BIOMATERIALS, V23, P2015, DOI 10.1016/S0142-9612(01)00330-1
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Liaw DJ, 2000, POLYMER, V41, P6123, DOI 10.1016/S0032-3861(99)00824-1
   Lin JC, 2001, J MATER SCI-MATER M, V12, P827, DOI 10.1023/A:1017937304964
   Lin SC, 1998, POLYM B, V1, P1
   Nakaya T, 1999, PROG POLYM SCI, V24, P143, DOI 10.1016/S0079-6700(98)00015-X
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   RATER BD, 1978, J APPL POLYM SCI, V22, P643
   Wang DA, 2001, BIOMATERIALS, V22, P1549, DOI 10.1016/S0142-9612(00)00311-2
   Yuan J, 2003, CHINESE J POLYM SCI, V21, P419
   Yuan J, 2003, CHEM J CHINESE U, V24, P916
   Yuan J, 2003, COLLOID SURFACE B, V30, P147, DOI 10.1016/S0927-7765(03)00082-1
   YUAN J, 2003, IN PRESS POLYM INT
   [袁江 Yuan Jiang], 2003, [应用化学, Chinese Journal of Applied Chemistry], V20, P269
   Yuan YL, 2003, COLLOID SURFACE B, V29, P247, DOI 10.1016/S0927-7765(02)00210-2
   Yuan YL, 2002, J BIOMAT SCI-POLYM E, V13, P1081, DOI 10.1163/156856202320813800
   YUAN YL, 2003, IN PRESS POLYM INT
   Zhang J, 2003, COLLOID SURFACE B, V30, P249, DOI 10.1016/S0927-7765(03)00069-9
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   Zhang J, 2003, EUR POLYM J, V39, P847, DOI 10.1016/S0014-3057(02)00286-0
   ZHANG J, 2003, BIOMATERIALS, V4, P4223
   Zhou J, 2002, CHEM J CHINESE U, V23, P2393
NR 34
TC 13
Z9 15
U1 2
U2 16
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2003
VL 14
IS 12
BP 1339
EP 1349
DI 10.1163/156856203322599680
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 770XU
UT WOS:000188757300003
PM 14870938
DA 2018-10-19
ER

PT J
AU Poshusta, AK
   Burdick, JA
   Mortisen, DJ
   Padera, RF
   Ruehlman, D
   Yaszemski, MJ
   Anseth, KS
AF Poshusta, AK
   Burdick, JA
   Mortisen, DJ
   Padera, RF
   Ruehlman, D
   Yaszemski, MJ
   Anseth, KS
TI Histocompatibility of photocrosslinked polyanhydrides: A novel in situ
   forming orthopaedic biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyanhydrides; orthopaedic biomaterial; photopolymerization;
   biocompaibility; surface eroding
ID DEGRADATION PRODUCTS; BONE; COMPOSITE; POLYMERS; NETWORKS
AB Cell-polymer interactions in subcutaneous and bony tissue were examined for a novel class of in situ forming and surface eroding polyanhydride networks. Specifically, photopolymerized disks of several polyanhydride compositions were implanted subcutaneously in rats, and the tissue was analyzed for an inflammatory response. The compositions elicited varied histological responses, ranging from highly active cell layers to moderate fibrous capsules, depending on the degrading polymer composition. Furthermore, one composition was photopolymerized in a model orthopaedic defect in the proximal tibia. The feasibility of photopolymerizing the methacrylated monomers in situ and the adherence of the photocrosslinked polyanhydride to the medullary canal were examined. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
   Univ Colorado, Dept Chem Engn, Boulder, CO 80309 USA.
   Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
   Mayo Clin, Dept Orthopaed Surg, Rochester, MN 55901 USA.
RP Anseth, KS (reprint author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
FU NIAMS NIH HHS [AR44375]
CR Bernheim KA, 1999, J INVEST MED, V47, p42A
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   BOSTMAN OM, 1992, CLIN ORTHOP RELAT R, P263
   BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6
   Burkoth AK, 2000, BIOMATERIALS, V21, P2395, DOI 10.1016/S0142-9612(00)00107-1
   Burkoth AK, 2000, J BIOMED MATER RES, V51, P352
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   Conix A, 1966, MACROMOL SYNTHESES, V2, P95
   DOMB AJ, 1993, ADV POLYM SCI, V107, P93
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   James K, 1999, BIOMATERIALS, V20, P2203, DOI 10.1016/S0142-9612(99)00151-9
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   ROKKANEN P, 1986, ACTA ORTHOP SCAND, V57, P237
   SMITH A, 1999, ANIMALS MODELS ORTHO
   SVALDIMUGGLI D, 1998, MACROMOLECULES, V31, P4120
   SVALDIMUGGLI D, 1998, J BIOMED MATER RES, V46, P271
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   TELFORD IR, 1995, INTRO FUNCTIONAL HIS
   URICH EK, 1995, MACROMOLECULES, V28, P2184
NR 20
TC 37
Z9 41
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN 1
PY 2003
VL 64A
IS 1
BP 62
EP 69
DI 10.1002/jbm.a.10274
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 670RQ
UT WOS:000182423000007
PM 12483697
DA 2018-10-19
ER

PT J
AU Torricelli, P
   Fini, M
   Giavaresi, G
   Botter, R
   Beruto, D
   Giardino, R
AF Torricelli, P
   Fini, M
   Giavaresi, G
   Botter, R
   Beruto, D
   Giardino, R
TI Biomimetic PMMA-based bone substitutes: A comparative in vitro
   evaluation of the effects of pulsed electromagnetic field exposure
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE pulsed electromagnetic field; osteoblasts; biomaterials; bone
   substitutes
ID IN-VITRO; CORALLINE HYDROXYAPATITE; STIMULATION; GROWTH; PHOSPHATE;
   INGROWTH; IMPLANT; FUSION; REPAIR; GRAFT
AB Pulsed electromagnetic fields (PEMFs) are known to be effective in the stimulation of cultured osteo-blasts and in vivo healing of delayed and nonunion fractures. In the present in vitro study the effects of PEMFs on osteoblastic cell cultures (MG63 human osteoblast-like cells) grown in the presence of poly-methylmethacrylate (PMMA) and of a biomimetic bone substitute made of a PMMA matrix added with alfa-tricalcium phosphate (PMMA+alpha-TCP) were evaluated, to assess the biological response at the cell-biomaterial interaction. Cultures were stimulated with PEMFs (75 Hz, 2.3 mT, 1.3-ms pulse duration) 12 h/day for 3 days and evaluations (MTT, ALP, OC, PICP, TGFbeta-1, IL-6) were performed at 3 and 6 days. PMMA had a negative effect on osteoblasts, whereas PMMA+alpha-TCP enhanced production of ALP, PICP, OC and TGFbeta-1, and reduced IL-6 levels. Cells responded positively to PEMF stimulation even when cultured with a poorly biocompatible material, such as PMMA. This effect was more evident in the presence of PMMA+alpha-TCP (further improvement in proliferation and synthetic activity) both at 3 and at 6 days. The properties of PMMA+alpha-TCP look promising, and the present results support the use of PEMFs to improve tissue response to biomaterials implanted as bone substitutes. (C) 2002 Wiley Periodicals, Inc.
C1 IOR, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Bologna, Italy.
   Univ Genoa, Dipartimento Edilzia Urbanist & Ingn, Genoa, Italy.
   Univ Bologna, Cattedra Fisiopatol Chirurg, I-40126 Bologna, Italy.
RP Torricelli, P (reprint author), IOR, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Bologna, Italy.
OI Giavaresi, Gianluca/0000-0001-7843-5969; Fini,
   Milena/0000-0002-3732-3570
CR Andreani J. F., 1993, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V94, P21
   BASSETT CAL, 1991, CALCIFIED TISSUE INT, V49, P216, DOI 10.1007/BF02556121
   Beruto DT, 2002, BIOMATERIALS, V23, P2509, DOI 10.1016/S0142-9612(01)00385-4
   Beruto DT, 2000, J BIOMED MATER RES, V49, P498, DOI 10.1002/(SICI)1097-4636(20000315)49:4<498::AID-JBM8>3.3.CO;2-T
   Bigi A, 2002, BIOMATERIALS, V23, P1849, DOI 10.1016/S0142-9612(01)00311-8
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312
   Bozic KJ, 1999, SPINE, V24, P2127, DOI 10.1097/00007632-199910150-00012
   CANE V, 1993, J ORTHOPAED RES, V11, P664, DOI 10.1002/jor.1100110508
   De Mattei M, 1999, BIOELECTROMAGNETICS, V20, P177, DOI 10.1002/(SICI)1521-186X(1999)20:3<177::AID-BEM4>3.0.CO;2-#
   DEBASTIANI B, 1991, Patent No. 5004501
   Dickman CA, 2001, SPINE, V26, P1409, DOI 10.1097/00007632-200107010-00002
   Elliott JC, 1994, STRUCTURE CHEM APATI, V18, P1
   FINI M, 2002, IN PRESS BIOMATERIAL
   FINI M, 2002, IN PRESS J ORTHOP RE
   Fredericks DC, 2000, J ORTHOP TRAUMA, V14, P93, DOI 10.1097/00005131-200002000-00004
   FREEMAN MAR, 1992, CLIN ORTHOP RELAT R, P19
   GERLING JA, 1985, AM J ORTHOD DENTOFAC, V87, P211, DOI 10.1016/0002-9416(85)90042-9
   Grace KLR, 1998, ORTHOPEDICS, V21, P297
   Guerkov HH, 2001, CLIN ORTHOP RELAT R, P265
   Hofmann AA, 1997, ACTA ORTHOP SCAND, V68, P161, DOI 10.3109/17453679709004000
   Hollinger JO, 1999, TISSUE ENGINEERING, P17
   Ijiri K, 1996, ANTICANCER RES, V16, P2853
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Landry PS, 1997, CLIN ORTHOP RELAT R, P262
   LIN FH, 1995, MED ENG PHYS, V17, P20, DOI 10.1016/1350-4533(95)90373-J
   Lind M, 1998, Acta Orthop Scand Suppl, V283, P2
   Lohmann CH, 2000, J ORTHOP RES, V18, P637, DOI 10.1002/jor.1100180417
   MCKANE WR, 1994, J BONE MINER RES, V9, P1313
   Miki T, 2000, J CRANIO MAXILL SURG, V28, P294, DOI 10.1054/jems.2000.0161
   Nzihou A, 1998, POWDER TECHNOL, V99, P60, DOI 10.1016/S0032-5910(98)00091-6
   Ottani V, 2002, MICRON, V33, P121, DOI 10.1016/S0968-4328(01)00008-7
   *PF CNR, PROJ MSTA 2 BIOM
   SALAZAR V, 1997, BIOELECTROMAGNETICS, V18, P541
   SKJODT H, 1992, CYTOKINES BONE METAB, P14
   Sommerville SMM, 2000, AUST NZ J SURG, V70, P480, DOI 10.1046/j.1440-1622.2000.01888.x
   TABRAH F, 1990, J BONE MINER RES, V5, P437, DOI 10.1002/jbmr.5650050504
   Tagil M, 2000, Acta Orthop Scand Suppl, V290, P1
   Torricelli P, 1998, ELECTRO MAGNETOBIOL, V17, P335, DOI 10.3109/15368379809030733
   Torricelli P, 2000, ELECTRO MAGNETOBIOL, V19, P359, DOI 10.1081/JBC-100102128
   Wang JS, 1996, CLIN ORTHOP RELAT R, P252
   Zambonin G, 2000, J BONE JOINT SURG BR, V82B, P457, DOI 10.1302/0301-620X.82B3.9310
   Zambonin G, 1998, CALCIFIED TISSUE INT, V62, P362, DOI 10.1007/s002239900445
NR 43
TC 13
Z9 21
U1 0
U2 14
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN 1
PY 2003
VL 64A
IS 1
BP 182
EP 188
DI 10.1002/jbm.a.10372
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 670RQ
UT WOS:000182423000022
PM 12483712
DA 2018-10-19
ER

PT J
AU Knowles, JC
AF Knowles, JC
TI Phosphate based glasses for biomedical applications
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID CONTROLLED-RELEASE GLASS; POLYHYDROXYBUTYRATE COMPOSITE; DEGRADABLE
   COMPOSITES; OXYNITRIDE GLASSES; SOLUBLE GLASSES; BONE; FLUORIDE;
   METAPHOSPHATE; POLYMER; SYSTEM
AB Biomaterials and tissue engineering are rapidly expanding fields for research and also commercial exploitation. A greater understanding of the interaction of materials with cells has allowed implant materials to be designed with the aim of promoting a specific biological response. Phosphate-based glasses are a unique group of materials that offer great potential for hard and soft tissue engineering. The move from passive inert implant materials to active degradable materials indicates that phosphate glasses may have a role in tissue engineering. Whilst significant work has been carried out to elucidate the structure of these materials, there is a paucity of data to correlate this information with the physical properties such as dissolution rate. This paper details some of the basic properties of these materials and how these may be exploited in the design of a biomaterial. Also a review of some of the current and potential clinical uses for these materials is included.
C1 UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
RP Knowles, JC (reprint author), UCL, Eastman Dent Inst, Div Biomat & Tissue Engn, 256 Grays Inn Rd, London WC1X 8LD, England.
RI Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446
CR ABDULHALIM I, 1994, OPT QUANT ELECTRON, V26, P997, DOI 10.1007/BF00304999
   Abrahams I, 1997, J CHEM SOC DALTON, P1483, DOI 10.1039/a701029j
   AHMED I, 2003, BIOMATERIALS, DOI DOI 10.1016/S0142-9612(03)00547-7
   ALLEN WM, 1984, VET REC, V115, P55, DOI 10.1136/vr.115.3.55
   ALLEN WM, 1978, VET SCI COMMUN, V2, P73, DOI 10.1007/BF02291434
   ALLEN WM, 1982, VET PHARM TOXICOL, P183
   ALLEN WM, 1984, TEMA, V5, P1
   ALLEN WM, 1985, VET REC, V116, P174
   Babin V, 2003, PHYS STATUS SOLIDI A, V196, P484, DOI 10.1002/pssa.200306449
   Batyaev IM, 2003, TECH PHYS LETT+, V29, P327, DOI 10.1134/1.1573305
   BROW RK, 1990, J NON-CRYST SOLIDS, V116, P39, DOI 10.1016/0022-3093(90)91043-Q
   Cartmell SH, 1998, J MATER SCI-MATER M, V9, P1, DOI 10.1023/A:1008830025416
   CHEN WS, 1991, BIOMATERIALS, V12, P561, DOI 10.1016/0142-9612(91)90051-B
   Click CA, 2003, J NON-CRYST SOLIDS, V319, P95, DOI 10.1016/S0022-3093(02)01962-2
   Clifford A, 2001, J MATER SCI, V36, P3955, DOI 10.1023/A:1017974306184
   Cole JM, 2001, J PHYS-CONDENS MAT, V13, P4105, DOI 10.1088/0953-8984/13/18/318
   Cole JM, 2001, J PHYS-CONDENS MAT, V13, P6659, DOI 10.1088/0953-8984/13/31/307
   CURZON MEJ, 1988, CARIES RES, V22, P99
   Das SS, 2003, J POWER SOURCES, V114, P346, DOI 10.1016/S0378-7753(02)00604-3
   Delahaye F, 1998, J NON-CRYST SOLIDS, V242, P25, DOI 10.1016/S0022-3093(98)00784-4
   Fernandez M, 2002, J MATER SCI-MATER M, V13, P1251, DOI 10.1023/A:1021135314619
   Franks K, 2000, J MATER SCI-MATER M, V11, P609, DOI 10.1023/A:1008949527695
   FRANKS K, 2000, THESIS U LONDON
   Gilchrist T, 1998, BRIT J PLAST SURG, V51, P231, DOI 10.1054/bjps.1997.0243
   GILCHRIST T, 1991, BIOMATERIALS, V12, P76, DOI 10.1016/0142-9612(91)90136-X
   Gough JE, 2002, J BIOMED MATER RES, V59, P481, DOI 10.1002/jbm.10020
   Hoppe U, 1996, J NON-CRYST SOLIDS, V195, P138, DOI 10.1016/0022-3093(95)00524-2
   Hudgens JJ, 1998, J NON-CRYST SOLIDS, V223, P21, DOI 10.1016/S0022-3093(97)00347-5
   Hwang BC, 1999, ELECTRON LETT, V35, P1007, DOI 10.1049/el:19990668
   KIRKPATRICK RJ, 1995, SOLID STATE NUCL MAG, V5, P9, DOI 10.1016/0926-2040(95)00042-O
   Knowles J. C., 1994, BIOCERAMICS, V7, P85
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   KNOWLES JC, 1994, J INTEL MAT SYST STR, V5, P122, DOI 10.1177/1045389X9400500115
   Knowles JC, 2001, BIOMATERIALS, V22, P3091, DOI 10.1016/S0142-9612(01)00057-6
   KNOWLES JC, 1993, J MATER SCI-MATER M, V4, P102, DOI 10.1007/BF00120377
   Latia A, 2003, J OPTOELECTRON ADV M, V5, P185
   Lenihan DV, 1998, J HAND SURG-BRIT EUR, V23B, P588, DOI 10.1016/S0266-7681(98)80007-7
   LOEHMAN RE, 1980, J NON-CRYST SOLIDS, V42, P433, DOI 10.1016/0022-3093(80)90042-3
   LU YL, 1995, J MATER SCI, V30, P5705, DOI 10.1007/BF00356709
   Luklinska ZB, 1997, J MATER SCI-MATER M, V8, P379, DOI 10.1023/A:1018589018205
   MARTIN SW, 1991, EUR J SOL STATE INOR, V28, P163
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mountjoy G, 2001, J NON-CRYST SOLIDS, V279, P20, DOI 10.1016/S0022-3093(00)00406-3
   Mulligan AM, 2003, BIOMATERIALS, V24, P1797, DOI 10.1016/S0142-9612(02)00577-X
   MULLIGAN AM, 2003, IN PRESS J BIOMED MA
   Ni J, 2002, MAT SCI ENG C-BIO S, V20, P101, DOI 10.1016/S0928-4931(02)00019-X
   Ravikumar RVSSN, 2003, SOLID STATE COMMUN, V126, P251, DOI 10.1016/s0038-1098(03)00132-7
   REIDMEYER MR, 1995, J NON-CRYST SOLIDS, V181, P201, DOI 10.1016/S0022-3093(94)00511-7
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Salih V, 2000, J MATER SCI-MATER M, V11, P615, DOI 10.1023/A:1008901612674
   Savitski VG, 2003, APPL PHYS B-LASERS O, V76, P253, DOI 10.1007/s00340-002-1070-x
   SCHRIMPF C, 1983, J NON-CRYST SOLIDS, V56, P153, DOI 10.1016/0022-3093(83)90461-1
   Shelby JE, 1997, INTRO GLASS SCI TECH
   Shih PY, 2003, MATER CHEM PHYS, V80, P299, DOI 10.1016/S0254-0584(02)00516-3
   SWENSON J, 2003, PHYS REV LETT, V90
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   TOUMBA KJ, 1993, CARIES RES, V27, P43, DOI 10.1159/000261601
   Toumba KJ, 1997, J DENT RES, V76, P1041
   Toumba KJ, 1997, J DENT RES, V76, P964
   WILLIAMS DF, 1999, WILLIAMS DICT BIOMAT
   Ylinen P, 2002, INT J ORAL MAX SURG, V31, P405, DOI 10.1054/ijom.2002.0252
   Zachariasen WH, 1932, J AM CHEM SOC, V54, P3841, DOI 10.1021/ja01349a006
NR 62
TC 220
Z9 222
U1 3
U2 57
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2003
VL 13
IS 10
BP 2395
EP 2401
DI 10.1039/b307119g
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 724PT
UT WOS:000185496500001
DA 2018-10-19
ER

PT J
AU Desai, SD
   Emanuel, AL
   Sinha, VK
AF Desai, SD
   Emanuel, AL
   Sinha, VK
TI Biomaterial based polyurethane adhesive for bonding rubber and wood
   joints
SO JOURNAL OF POLYMER RESEARCH-TAIWAN
LA English
DT Article
DE biomaterial based polyol; lap shear strength; peel strength; PU
   adhesive; wood and rubber joints
ID RENEWABLE RESOURCES; POLYTETRAHYDROFURAN DIOLS; GLUCOSIDES; POLYMERS;
   POLYOLS
AB An intermediate compound for synthesizing polyester polyol was prepared from glycosylation of potato starch by reacting it with ethylene glycol in presence of sulphuric acid. Glycol glycoside thus prepared was characterized by HPLC and FTIR. This polyhydroxy compound was replaced in varying amounts with trimethylolpropane for polyester polyol synthesis. Sebacic acid was used as dicarboxylic acid along with castor oil for polyester polyol formulation. Polyols were reacted with toluene 2,4-diisocyanate adduct for polyurethane formation. Polyester polyol and polyurethane were characterized by FTIR. Polyurethane was utilized for bonding wood as well as rubber joints. Bond strength was measured by means of lap shear strength and peel strength for wood and rubber joints, respectively. Chemical resistance of polyurethane adhesive was also evaluated.
C1 VP&RPTP Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
RP Sinha, VK (reprint author), VP&RPTP Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
CR Athawale VD, 2001, EURO COAT J, P18
   COCKS LV, 1976, LAB HDB OIL FAT ANAL
   DESAI DH, 1973, THESIS SARDAR PATEL
   DONNELLY MJ, 1995, POLYM INT, V37, P1, DOI 10.1002/pi.1995.210370101
   DONNELLY MJ, 1995, POLYM INT, V37, P297, DOI 10.1002/pi.1995.210370409
   DONNELLY MJ, 1993, POLYM INT, V32, P197, DOI 10.1002/pi.4990320214
   HUI YH, 1996, BAILEYS IND OIL FAT, P224
   John N., 1998, J APPL POLYM SCI, V168, P1185
   LEE SC, 1995, J APPL POLYM SCI, V55, P1271, DOI 10.1002/app.1995.070550813
   LEITHEISER RH, 1966, IND ENG CHEM PROD RD, V5, P276, DOI 10.1021/i360019a016
   MULLER E, 1963, HOUBEN WEYL, V14, P2
   NEWMANN W, 1962, ANGEW CHEM, V74, P801
   OERTEL G, 1985, POLYURETHANE HDB, P57
   OERTEL G, 1985, POLYURETHANE HDB, P54
   OTTEY FH, 1969, I EC PRODUCT RES DEV, V8, P267
   OTTEY FH, 1965, I EC PRODUCT RES DEV, V4, P228
   SANCHEZADSUAR MS, 2001, INT ADHESION ADHESIV, V17, P155
   SCHMELZER HG, 1987, POLYURETHANES WORLD, P614
   SINGH P, 1991, J POLYM MATER, V8, P275
   Vallat MF, 2000, J APPL POLYM SCI, V76, P665, DOI 10.1002/(SICI)1097-4628(20000502)76:5<665::AID-APP8>3.0.CO;2-A
   Vick CB, 1998, FOREST PROD J, V48, P71
NR 21
TC 22
Z9 23
U1 1
U2 17
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
J9 J POLYM RES-TAIWAN
JI J. Polym. Res.-Taiwan
PY 2003
VL 10
IS 4
BP 275
EP 281
DI 10.1023/B:JPOL.0000004630.77120.bb
PG 7
WC Polymer Science
SC Polymer Science
GA 757QB
UT WOS:000187572000008
DA 2018-10-19
ER

PT J
AU Landi, E
   Celotti, G
   Logroscino, G
   Tampieri, A
AF Landi, E
   Celotti, G
   Logroscino, G
   Tampieri, A
TI Carbonated hydroxyapatite as bone substitute
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article; Proceedings Paper
CT International Workshop on Interfaces: Ceramic and metal Interfaces:
   Control at the Atomic Level
CY JUN 23-27, 2002
CL OVIEDO, SPAIN
DE biomaterial; carbonated hydroxyapatite; porous ceramic; bone tissue
   mimicking
ID BEHAVIOR
AB B-carbonateapatite (CHA) powder was synthesized starting from calcium nitrate tetrahydrate, diammonium hydrogen phosphate and sodium hydrogen carbonate. The powder was fully characterized in terms of phase purity, stoichiometry, morphology, specific surface area and particle size distribution. The thermal stability of the powder in air and CO2 atmosphere also was evaluated by thermal analysis. Electroacoustic analysis of the water based suspension of the CHA powder was used to determine the stability of the slurry. Porous bodies of CHA were prepared by impregnation of cellulose sponges with a proper Slurry of the powder and optimizing the subsequent sintering. The fired samples were characterized in terms of phase purity and carbonate content, microstructure and pore size distribution. The compressive strength also was evaluated, resulting in 6.0 +/- 0.5 MPa. First results of in vivo tests on New Zealand White rabbits showed good biocompatibility and osteointegration of the CHA implant, with higher osteoconductive properties and earlier bioresorption, compared to HA samples, used as control. (C) 2003 Published by Elsevier Ltd.
C1 Inst Sci & Technol Ceram, ISTEC, CNR, I-48018 Faenza, Italy.
   Univ Cattolica Sacro Cuore, Clin Ortoped, I-00185 Rome, Italy.
RP Landi, E (reprint author), Inst Sci & Technol Ceram, ISTEC, CNR, Via Granarolo 64, I-48018 Faenza, Italy.
OI LOGROSCINO, GIANDOMENICO/0000-0003-1301-5343; Landi,
   Elena/0000-0003-4495-129X
CR BURNELL JM, 1980, CALCIFIED TISSUE INT, V31, P13, DOI 10.1007/BF02407162
   DRIESSENS FCM, 1983, BIOCERAMICS CALCIUM
   Guicciardi S, 2001, J MATER RES, V16, P163, DOI 10.1557/JMR.2001.0027
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   LEGEROS RZ, 1991, MONOGRAPHS ORAL SCI, P82
   PRETTO M, IN PRESS J AM CERAM
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   REY C, 1989, CALCIFIED TISSUE INT, V45, P157, DOI 10.1007/BF02556059
   REY C, 1991, CALCIFIED TISSUE INT, V49, P251, DOI 10.1007/BF02556214
   REY C, 1998, CALCIUM PHOSPHATES B, P217
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Wang CK, 1998, MATER CHEM PHYS, V53, P138, DOI 10.1016/S0254-0584(97)02074-9
   ZYMAN Z, 1993, BIOMATERIALS, V14, P1140, DOI 10.1016/0142-9612(93)90158-X
NR 14
TC 272
Z9 289
U1 2
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. European Ceram. Soc.
PY 2003
VL 23
IS 15
BP 2931
EP 2937
DI 10.1016/S0955-2219(03)00304-2
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA 722NF
UT WOS:000185381600025
DA 2018-10-19
ER

PT J
AU Shi, J
   Le Maguer, M
AF Shi, J
   Le Maguer, M
TI Mass transfer in cellular material at solid-liquid contacting interface
SO LEBENSMITTEL-WISSENSCHAFT UND-TECHNOLOGIE-FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article
DE cellular tissue; interface; multicomponent transfer; ternary system;
   binary section; solid-liquid contacting
AB The effective mass transfer (water and solute) and volume shrinkage were measured during solid-liquid contacting process for red beet material tissue under a wide range of process parameters. The mass transfer process of each component in the solid-liquid system is affected not only by operating parameters, but also by the matrix properties of cellular material. The main driving force for the mass transfer phenomena of water out of red beet tissue and sucrose taken into red beet tissue from sucrose solution is attributed to the concentration gradient be-tween external and internal red beet material, and the interaction among water, sucrose fluxes and tissue matrix. The coupled mass transfer fluxes across the interface in an isothermal solid-liquid system were analysed by means of a film model as a function of the concentration gradients, based on the generalized multicomponent mass transfer theories. The relation between individual flux and the independent driving force is nonlinear. The mass transfer model and parameters proposed in the present study is applicable to the unit operation such as osmotic treatment of cellular porous biomaterial. Crown Copyright (C) 2003 Published by Elsevier Science Ltd. on behalf of Swiss Society of Food Science and Technology. All rights reserved.
C1 Agr & Agri Food Canada, Food Res Ctr, Guelph, ON N1G 5C9, Canada.
   Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada.
RP Shi, J (reprint author), Agr & Agri Food Canada, Food Res Ctr, Guelph, ON N1G 5C9, Canada.
CR AOAC, 1995, OFF METH
   BIRD RB, 1960, TRANSPORT PHENOMENA
   BOLIN HR, 1983, J FOOD SCI, V48, P202, DOI 10.1111/j.1365-2621.1983.tb14823.x
   CHANDRASEKARAN SK, 1972, AICHE J, V18, P513, DOI 10.1002/aic.690180309
   Cussler E. L., 1984, DIFFUSION MASS TRANS
   DAINTY J, 1976, TRANSPORT PLANTS A, V2, P279
   DELVALLE FR, 1967, J FOOD SCI, V32, P218
   FITO P, 1997, FOOD ENG 2000
   Hawkes J., 1978, Journal of Food Processing and Preservation, V2, P265, DOI 10.1111/j.1745-4549.1978.tb00562.x
   Isse MG, 1992, P 4 WORLD C CHEM ENG, P728
   KING CJ, 1970, FREEZE DRYING FOODS
   KRISHNA R, 1986, HDB HEAT MASS TRANSF
   LEMAGUER M, 1988, MASS TRANSFER OSMOTI
   LENART A, 1984, J FOOD TECHNOL, V19, P65, DOI 10.1108/02651330210419733
   LEVIN RL, 1979, J MEMBRANE BIOL, V46, P91, DOI 10.1007/BF01961376
   NILSSON SB, 1958, PHYSIOL PLANTARUM, V11, P818, DOI 10.1111/j.1399-3054.1958.tb08275.x
   Nobel PS, 1983, BIOPHYSICAL PLANT PH
   RAOULTWACK A, 1991, DRYING TECHNOLOGY, V9, P598
   TOOR HL, 1964, AICHE J, V10, P448, DOI 10.1002/aic.690100408
   TOUPIN C J, 1989, Journal of Food Engineering, V10, P13, DOI 10.1016/0260-8774(89)90018-6
   Yao ZM, 1996, J FOOD ENG, V29, P349, DOI 10.1016/0260-8774(95)00045-3
NR 21
TC 5
Z9 5
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0023-6438
J9 LEBENSM-WISS TECHNOL
JI Lebensm.-Wiss. Technol.-Food Sci. Technol.
PY 2003
VL 36
IS 1
BP 3
EP 11
DI 10.1016/S0023-6438(02)00219-0
PG 9
WC Food Science & Technology
SC Food Science & Technology
GA 656PP
UT WOS:000181616400001
DA 2018-10-19
ER

PT S
AU Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Hosokawa, H
   Mabuchi, M
AF Wen, CE
   Yamada, Y
   Shimojima, K
   Chino, Y
   Hosokawa, H
   Mabuchi, M
BE Kojima, Y
   Aizawa, T
   Higashi, K
   Kamado, S
TI Porous bioresorbable magnesium as bone substitute
SO MAGNESIUM ALLOYS 2003, PTS 1 AND 2
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on Platform Science and Technology for
   Advanced Magnesium Alloys
CY JAN 26-30, 2003
CL OSAKA, JAPAN
SP Minist Educ, Sci, Culture, Sports & Technol Japan, USAF Off Sci Res, Asian Off Aerosp Res & Dev
DE magnesium; porous materials; porosity; pore size; mechanical property
ID SCAFFOLDS; HYDROXYAPATITE; OSTEOGENESIS; MORPHOLOGY; FOAMS
AB Recently magnesium has been recognized as a very promising biomaterial for bone substitutes because of its excellent properties of biocompatibility, biodegradability and bioresorbability. In the present study, magnesium foams were fabricated by using a powder metallurgical process. Scanning electron microscopy equipped with energy dispersive X-ray spectrometer (EDS) and compressive tester were used to characterize the porous magnesium. Results show that the Young's modulus and the peak stress of the porous magnesium increase with decreasing porosity and pore size. This study suggests that the mechanical properties of the porous magnesium with the low porosity of 35 % and/or with the small pore size of about 70 mum are close to those of human cancellous bones.
C1 Natl Inst Adv Ind Sci & Technol, Inst Struct & Engn Mat, Moriyama Ku, Nagoya, Aichi 4638560, Japan.
RP Wen, CE (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Struct & Engn Mat, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.
OI Wen, Cuie/0000-0001-8008-3536
CR Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   AVEDESIAN MM, 1999, ASM SPECIALTY HDB MA, P10
   Chanda K.C., 1995, J TIME SER ANAL, V16, P1, DOI DOI 10.1111/J.1467-9892.1995.TB00220.X
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   Evans F G, 1969, Artif Limbs, V13, P37
   Franchi M, 1991, Bull Group Int Rech Sci Stomatol Odontol, V34, P123
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Gogolewski S, 2000, INJURY, V31, pS28
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kuwahara H, 2000, MATER SCI FORUM, V350-3, P349, DOI 10.4028/www.scientific.net/MSF.350-351.349
   Lawless M.W., 2000, J MUSCULOSKELET RES, V4, P129
   Miyoshi T, 2000, ADV ENG MATER, V2, P179, DOI 10.1002/(SICI)1527-2648(200004)2:4<179::AID-ADEM179>3.0.CO;2-G
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Nieh TG, 1998, SCRIPTA MATER, V38, P1487, DOI 10.1016/S1359-6462(98)00090-6
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Vuola J, 1998, BIOMATERIALS, V19, P223, DOI 10.1016/S0142-9612(97)00211-1
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Wiesmann HP, 1997, J BONE MINER RES, V12, P380, DOI 10.1359/jbmr.1997.12.3.380
   Yamada Y, 2000, MATER T JIM, V41, P1136, DOI 10.2320/matertrans1989.41.1136
NR 21
TC 26
Z9 29
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-914-8
J9 MATER SCI FORUM
PY 2003
VL 419-4
BP 1001
EP 1006
DI 10.4028/www.scientific.net/MSF.419-422.1001
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Coatings & Films; Materials Science,
   Composites
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BW62G
UT WOS:000182606100155
DA 2018-10-19
ER

PT J
AU Rodriguez-Lugo, V
   Angeles-Chavez, C
   Hernandez, M
AF Rodriguez-Lugo, V
   Angeles-Chavez, C
   Hernandez, M
TI Synthesis of hydroxylapatite from sand dollar and beta-tricalcium
   phosphate by solid-state method
SO MATERIALS AND MANUFACTURING PROCESSES
LA English
DT Article
DE hydroxylapatite; sand dollar; beta-tricalcium phosphate; synthesis;
   solid state; biomaterials; structure
ID HYDROXYAPATITE; HYDROLYSIS; WHISKERS; MONETITE; CRYSTALS; NA+
AB Synthesis of porous hydroxylapatite from the sand dollar (Mellita eduardobarrosoi sp. nov.) and beta-tricalcium phosphate (beta-TCP) by solid-state reaction was performed. Reaction conditions were explored at different molar ratios of the precursors and at different temperatures. X-ray diffraction was used to determine the crystalline structure of the sample at molar ratio of 1.25 TCP:1 sand dollar at 1473 K. The morphology of the product obtained under these conditions is a porous structure, which is a requirement for better clinical application of the hydroxylapatite as a biomaterial. Chemical analysis carried out by energy-dispersive spectroscopy on the product presented a molar ratio of Ca/P closer to the stoichiometric molar ratio of the pure hydroxylapatite. This crystalline structure was analyzed by transmission electron microscopy, and large single hydroxylapatite crystals were observed. Electron diffraction patterns in different directions are discussed.
C1 Benemerita Univ Autonoma Puebla, Inst Fis, Puebla 72540, Mexico.
   Program Invest & Desarrollo Ductos, Inst Mexicano Petr, Mexico City, DF, Mexico.
RP Rodriguez-Lugo, V (reprint author), Benemerita Univ Autonoma Puebla, Inst Fis, 29 Oriente 601-1 Col Ladrillera Benetiz, Puebla 72540, Mexico.
OI Rodriguez Lugo, Ventura/0000-0001-8767-032X
CR Ascencio JA, 2002, COMP MATER SCI, V25, P413, DOI 10.1016/S0927-0256(02)00243-4
   DEMAEYER EAP, 1993, INORG CHEM, V32, P5709, DOI 10.1021/ic00077a011
   DEMAEYER EAP, 1994, INORG CHEM, V33, P5999, DOI 10.1021/ic00104a006
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Ito A, 1996, J CRYST GROWTH, V163, P311, DOI 10.1016/0022-0248(95)00955-8
   Rodriguez-Lugo V, 2003, MATER MANUF PROCESS, V18, P67, DOI 10.1081/AMP-120017589
   RODRIGUEZLUGO V, 2001, MATER TECHNOL, V16, P90
   RODRIGUEZLUGO V, 1999, 5 INT EL MICR C MAT
   Rosa AL, 2002, J MATER SCI-MATER M, V13, P1071, DOI 10.1023/A:1020305008042
   Suchanek WL, 1998, J AM CERAM SOC, V81, P765
   SUGIMOTO TG, 2000, METAL PHOSPHATE APAT, V92, P362
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
   YOSHIMURA M, 1998, HYDROTHERMAL PROCESS
   YUBAO L, 1994, J MATER SCI-MATER M, V5, P263, DOI 10.1007/BF00122395
NR 14
TC 9
Z9 9
U1 1
U2 7
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1042-6914
J9 MATER MANUF PROCESS
JI Mater. Manuf. Process.
PY 2003
VL 18
IS 6
BP 903
EP 913
DI 10.1081/AMP-120025078
PG 11
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 740NZ
UT WOS:000186409600005
DA 2018-10-19
ER

PT S
AU Reddi, AH
AF Reddi, AH
BE Thomas, JL
   Kiick, KL
   Gower, LA
TI Bio-inspired morphogens and biomimetic bioniaterials for regenerative
   medicine
SO MATERIALS INSPIRED BY BIOLOGY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Materials Inspired by Biology held at the the MRS Spring
   Meeting
CY APR 21-25, 2003
CL SAN FRANCISCO, CA
SP AF Res Lab, ML, Avanti Polar Lipids Inc, Boston Sci Corp, DuPont Cent Res & Dev, Natl Sci Fdn, Div Mat Res, Natl Inst Hlth Natl Inst Biomed Imaging & Bioengn, Natl Inst Hlth Natl Inst Dent & Craniofacial Res
ID HUMAN OSTEOGENIC PROTEIN-1; FACTOR-BETA SUPERFAMILY;
   EXTRACELLULAR-MATRIX; BONE DIFFERENTIATION; CARTILAGE; TRANSFORMATION;
   IMPLANTS; INVIVO
AB Regenerative medicine is the science of design and manufacture of parts for functional restoration of damaged tissues due to cancer, disease and,trauma. Morphogenesis is the developmental cascade of pattern formation, body plan establishment and differentiation of tissues culminating in adult form. Regeneration in general, recapitulates in parts, embryonic morphogenesis. Thus, the principles of morphogenesis can be applied to tissue engineering for regenerative medicine and surgery. The three-key ingredients for tissue engineering and regenerative medicine are inductive morphogens, responding stem cells, and extracellular matrix materials. Therefore bioactive morphogens can be integrated into materials for functional restoration by tissue engineering. A morphogen is a morphogenetic protein signal that acts on responding stem cells. Bone morphogenesis is induced by bone morphogenetic proteins (BMPs). BMPs play a role in pattern formation, cell differentiation, maintenance and regeneration of tissues. BMPs are pleiotropic and act on chemotaxis, mitosis and differentiation of progenitor stem cells. There are nearly twenty BMPs in the human genome. BMPs have actions beyond bone in development of teeth, heart, kidney, eye, skin, and brain. Thus, BMPs may be called body morphogenctic proteins. Stem cells are primordial cells with unlimited replicative potential and can be programmed by morphogens such as BMPs. Extracellular matrix is the native scaffolding material that can be used to deliver morphogens such as BMPs for tissue engineering of bone. Biomimetic materials are typically synthetic, polymeric structures that mimic extracellular matrix scaffolding by presenting the cellular binding sites found within collagens, fibronectin, proteoglycans and glycoproteins. Materials that mimic extracellular matrix scaffolding such as BMPs bind to collagens I&IV, heparan sulfate and heparin. BMPs bound to collagen acts as a composite biomaterial to initiate bone formation and the shape can be molded by an appropriate template. In addition to including BMPs in a carrier matrix, the geometry of the carrier matrix is critical for optimal tissue engineering. For example: collagen particles smaller than 44 mum are feeble in bone induction compared to the coarse (420 mum) particles. Gene therapy approaches using genes for morphogenesis such as BMPs allows a sustained, prolonged secretion of gene products. Thus, morphogens integrated into biomaterials may be useful in regenerative medicine.
C1 Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA.
RP Reddi, AH (reprint author), Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Ctr Tissue Regenerat & Repair, Sacramento, CA 95817 USA.
CR Bostrom M, 1996, CLIN ORTHOP RELAT R, P272
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   CHANG SC, 1994, J BIOL CHEM, V269, P28227
   Cochran DL, 1999, J PERIODONTOL, V70, P139, DOI 10.1902/jop.1999.70.2.139
   COOK SD, 1994, SPINE, V19, P1655, DOI 10.1097/00007632-199408000-00002
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Hollinger J, 1996, J CONTROL RELEASE, V39, P287, DOI 10.1016/0168-3659(95)00183-2
   Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2
   KHOURI RK, 1991, JAMA-J AM MED ASSOC, V266, P1953, DOI 10.1001/jama.266.14.1953
   LACROIX P, 1945, NATURE, V156, P576, DOI 10.1038/156576a0
   LUYTEN FP, 1989, J BIOL CHEM, V264, P13377
   Reddi A. Hari, 1994, Current Opinion in Genetics and Development, V4, P737, DOI 10.1016/0959-437X(94)90141-O
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   REDDI AH, 1981, COLLAGEN REL RES, V1, P209
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   Ripamonti U, 1996, GROWTH FACTORS, V13, P273, DOI 10.3109/08977199609003228
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   SAMPATH TK, 1983, P NATL ACAD SCI-BIOL, V80, P6591, DOI 10.1073/pnas.80.21.6591
   Senn N, 1889, AM J MED SCI, V98, P219
   STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WEISS RE, 1980, P NATL ACAD SCI-BIOL, V77, P2074, DOI 10.1073/pnas.77.4.2074
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681
   Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6
NR 31
TC 0
Z9 0
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-711-3
J9 MATER RES SOC SYMP P
PY 2003
VL 774
BP 3
EP 10
PG 8
WC Biotechnology & Applied Microbiology; Materials Science,
   Multidisciplinary; Materials Science, Biomaterials; Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA BX72Z
UT WOS:000186233100001
DA 2018-10-19
ER

PT S
AU Lee, Y
   Singh, A
AF Lee, Y
   Singh, A
BE Thomas, JL
   Kiick, KL
   Gower, LA
TI Poly-beta-cyclodextrins: Multifunctional polymer support for the
   hydrolysis and removal of methyl parathion
SO MATERIALS INSPIRED BY BIOLOGY
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Materials Inspired by Biology held at the the MRS Spring
   Meeting
CY APR 21-25, 2003
CL SAN FRANCISCO, CA
SP AF Res Lab, ML, Avanti Polar Lipids Inc, Boston Sci Corp, DuPont Cent Res & Dev, Natl Sci Fdn, Div Mat Res, Natl Inst Hlth Natl Inst Biomed Imaging & Bioengn, Natl Inst Hlth Natl Inst Dent & Craniofacial Res
AB Microparticles (32-53 mum) of cross-linked poly-beta-Cyclodextrin (PCD) having a bifunctional hexyl spacer were prepared. PCD served as an insoluble robust matrix, which is chemically inert in acidic and basic media while preserving accessibility of pesticide methyl parathion (MPT) and its hydrolysis product p-nitrophenol (p-NP) to cyclodextrin cavities. The multi-utility of PCD was demonstrated as a stable biomaterial for adsorption of MPT and p-NP through inclusion phenomena and as a single unit system suitable for casting alternate enzyme/polyelectrolyte multilayers.
C1 USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA.
RP Lee, Y (reprint author), USN, Res Lab, Ctr Biomol Sci & Engn, 4555 Overlook Ave, Washington, DC 20375 USA.
CR BERTRAND GL, 1989, J PHYS CHEM-US, V93, P6863, DOI 10.1021/j100355a057
   Caruso F, 2000, LANGMUIR, V16, P9595, DOI 10.1021/la000942h
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Lee YW, 2003, LANGMUIR, V19, P1330, DOI 10.1021/la0263065
   Li DK, 1999, CYCLOTRONS AND THEIR APPLICATIONS 1998, P31
   Lvov Y, 2001, ANAL CHEM, V73, P4212, DOI 10.1021/ac010118d
   Santos JP, 2001, LANGMUIR, V17, P5361, DOI 10.1021/la0102556
   Sukhorukov GB, 1998, POLYM ADVAN TECHNOL, V9, P759, DOI 10.1002/(SICI)1099-1581(1998100)9:10/11<759::AID-PAT846>3.0.CO;2-Q
   Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c
NR 9
TC 0
Z9 0
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-711-3
J9 MATER RES SOC SYMP P
PY 2003
VL 774
BP 99
EP 104
PG 6
WC Biotechnology & Applied Microbiology; Materials Science,
   Multidisciplinary; Materials Science, Biomaterials; Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA BX72Z
UT WOS:000186233100013
DA 2018-10-19
ER

PT B
AU Niinomi, M
   Akahori, T
   Ishimizu, K
AF Niinomi, M
   Akahori, T
   Ishimizu, K
BE Liaw, PK
   Buchanan, RA
   Klarstrom, DL
   Wei, RP
   Harlow, DG
   Tortorelli, PF
TI Fatigue and fretting fatigue of biomaterial, TI-29NB-13TA-4.6ZR, in air
   and simulated body environment
SO MATERIALS LIFETIME SCIENCE & ENGINEERING
LA English
DT Proceedings Paper
CT Symposium on Materials Lifetime Science and Engineering held at the 2003
   TMS Annual Meeting
CY MAR 02-06, 2003
CL SAN DIEGO, CA
SP Minerals, Met & Mat Soc, Struct Mat Div
ID BIOMEDICAL APPLICATIONS; TITANIUM-ALLOYS
AB Low rigidity titanium alloy, Ti-29Nb-13Ta-4.6Zr, for biomedical applications has been newly developed. Fatigue and fretting fatigue characteristics of Ti-29Nb-13Ta-4.6Zr, which are important factors for biomedical applications, were examined in air and simulated body environment, that is, Ringer's solution in this study. Fatigue strength of Ti-29Nb-13Ta-4.6Zr increases with conducting aging treatment after solution treatment. Fretting fatigue damage is lowered with decreasing modulus of elasticity in this study. Fatigue strength of Ti-29Nb-13Ta4.6Zr is not degraded in Ringer's solution. Fretting fatigue strength of Ti-29Nb-13Ta-4.6Zr is a little greater than that in air in low cycle fretting fatigue region, but a little smaller than that in air in high cycle fretting fatigue life region.
C1 Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
CR Akahori T, 2002, J JPN I MET, V66, P715, DOI 10.2320/jinstmet1952.66.7_715
   Akahori T., 2001, P PRICM, P209
   *ASTM, 2001, F206601 ASTM, P1605
   *ASTM, 3 ASTM
   DAVIDSON JA, 1987, P IMPL MAN MAT TECHN
   Kawahara H., 1963, J JPN SOC DENT APPAR, V4, P65
   KUDO S, 1990, J CERAMICS SOC JAPAN, V98, P635
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kuroda D, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P99
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   NIINOMI M, 2001, P PRICM, V4, P201
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
NR 13
TC 3
Z9 3
U1 0
U2 3
PU MINERALS, METALS & MATERIALS SOC
PI WARRENDALE
PA 184 THORN HILL RD, WARRENDALE, PA 15086-7514 USA
BN 0-87339-544-1
PY 2003
BP 223
EP 230
PG 8
WC Engineering, Mechanical; Metallurgy & Metallurgical Engineering
SC Engineering; Metallurgy & Metallurgical Engineering
GA BW63U
UT WOS:000182663100021
DA 2018-10-19
ER

PT S
AU Tsou, CY
   Chen, SJ
   Chen, YC
   Hsiu, FM
   Chien, FC
   Lin, GY
   Su, YD
   Ku, WC
   Chiu, SK
   Tzeng, CM
AF Tsou, CY
   Chen, SJ
   Chen, YC
   Hsiu, FM
   Chien, FC
   Lin, GY
   Su, YD
   Ku, WC
   Chiu, SK
   Tzeng, CM
BE Nicolau, DV
   Raghavachari, R
TI Surface plasmon resonance phase-shift interferometry: Real-time
   microarray biomolecular interaction analysis
SO MICROARRAYS AND COMBINATORIAL TECHNOLOGIES FOR BIOMEDICAL APPLICATIONS:
   DESIGN, FABRICATION, AND ANALYSIS
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Microarrays and Combinatorial Technologies for Biomedical
   Applications
CY JAN 26-28, 2003
CL SAN JOSE, CA
SP SPIE
DE SPR imaging system; biomolecular interaction analysis; microarray; DNA
   hybridization; phase-shifting interferometry
ID IMAGING MEASUREMENTS; HYBRIDIZATION; ADSORPTION; DNA
AB A novel surface plasmon resonance (SPR) imaging system based on modified Mach-Zehnder phase-shifting interferometry (PSI) measures the spatial phase variation of a resonantly reflected light in biomolecular interaction. In this technique, the SPR DNA microarray can diagnose the target DNA without additional labeling in real-time biomolecular interaction analysis (BIA). Owing to the feasible and swift measurements, the SPR microarray with this SPR imaging system can be extensively applied to the nonspecific adsorption of protein, the membrane-protein interaction, receptor-ligand interaction, DNA hybridization. The detection limitation of the SPR PSI imaging system is improved to about 1 pg/mm(2) surface coverage of biomaterial for each individual spot over that of the conventional SPR imaging system that observe the intensity variation of a resonantly reflected light. The SPR PSI imaging system and its SPR microarray can provide the capability to analyze DNA hybridization or protein interaction in real-time, with high resolution, and at high-throughout screening rates.
C1 Natl Cent Univ, Dept Mech Engn, Chungli 320, Taiwan.
RP Tsou, CY (reprint author), Natl Cent Univ, Dept Mech Engn, Chungli 320, Taiwan.
OI Chiu, David/0000-0002-9927-7346
CR Bier FF, 1997, SENSOR ACTUAT B-CHEM, V38, P78, DOI 10.1016/S0925-4005(97)80174-8
   GHIGLIA DC, 1987, J OPT SOC AM A, V4, P267, DOI 10.1364/JOSAA.4.000267
   HARIHARAN P, 1987, APPL OPTICS, V26, P2504, DOI 10.1364/AO.26.002504
   Hsiu FM, 2002, P SOC PHOTO-OPT INS, V4819, P167, DOI 10.1117/12.450922
   Jordan CE, 1997, ANAL CHEM, V69, P1449, DOI 10.1021/ac961012z
   KABASHIN AV, 1998, OPT COMMUN, V50, P5
   Kim SH, 2000, DYES PIGMENTS, V46, P55, DOI 10.1016/S0143-7208(00)00029-2
   LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7
   Nelson BP, 2001, ANAL CHEM, V73, P1, DOI 10.1021/ac0010431
   Nikitin PI, 2000, SENSOR ACTUAT A-PHYS, V85, P189, DOI 10.1016/S0924-4247(00)00386-1
   Notcovich AG, 2000, APPL PHYS LETT, V76, P1665, DOI 10.1063/1.126129
   O'Brien MJ, 2001, BIOSENS BIOELECTRON, V16, P97, DOI 10.1016/S0956-5663(00)00137-8
   Raether H., 1988, SURFACE PLASMONS SMO
   Salamon Z, 1999, TRENDS BIOCHEM SCI, V24, P213, DOI 10.1016/S0968-0004(99)01394-8
   Steiner G, 1999, J MOL STRUCT, V509, P265, DOI 10.1016/S0022-2860(99)00226-4
NR 15
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-4766-8
J9 P SOC PHOTO-OPT INS
PY 2003
VL 4966
BP 18
EP 25
DI 10.1117/12.478354
PG 8
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA BX38G
UT WOS:000185091500003
DA 2018-10-19
ER

PT S
AU Tulloch, AJD
   Bizios, R
   Siegel, RW
AF Tulloch, AJD
   Bizios, R
   Siegel, RW
BE Berndt, CC
   Fischer, TE
   Ovidko, I
   Skandan, G
   Tsakalakos, T
TI Nanophase alumina/poly(L-lactic acid) composite scaffolds for biomedical
   applications
SO NANOMATERIALS FOR STRUCTURAL APPLICATIONS
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanomaterials for Structural Applications held at the 2002
   MRS Fall Meeting
CY DEC 02-06, 2002
CL BOSTON, MA
SP Mat Res Soc
ID ENHANCED OSTEOBLAST ADHESION; CERAMICS; ALUMINA
AB Three-dimensional composites of nanophase alumina and poly(L-lactic acid) with an interconnected porous network and an overall porosity in excess of 90% are cytocompatible. Osteoblast proliferation on the nanophase ceramic/polymer composites is a function of time of cell culture and of nanoceramic loading in the biomaterial substrates.
C1 Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA.
RP Tulloch, AJD (reprint author), Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA.
CR *ASTM, 162100 ASTM
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   LAM KH, 1994, J MATER SCI-MATER M, V5, P181, DOI 10.1007/BF00121086
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   MCMANUS AJ, 2001, THESIS RENSSELAER PO
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1222
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 13
TC 2
Z9 2
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-677-X
J9 MATER RES SOC SYMP P
PY 2003
VL 740
BP 161
EP 166
PG 6
WC Engineering, Mechanical; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering; Materials Science,
   Characterization & Testing; Materials Science, Composites
SC Engineering; Materials Science; Metallurgy & Metallurgical Engineering
GA BW62S
UT WOS:000182613300024
DA 2018-10-19
ER

PT B
AU Mikhalovsky, SV
   Santin, M
   Mikhalovska, LI
   Lloyd, AW
   Denyer, SP
AF Mikhalovsky, SV
   Santin, M
   Mikhalovska, LI
   Lloyd, AW
   Denyer, SP
BE Gogotsi, YG
   Uvarova, IV
TI Current trends in biomaterial coatings
SO NANOSTRUCTURED MATERIALS AND COATINGS FOR BIOMEDICAL AND SENSOR
   APPLICATIONS
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Nanostructured Materials and Coatings
   for Biomedical and Sensor Applications
CY AUG 04-08, 2002
CL KIEV, UKRAINE
SP NATO
ID IN-VITRO; SURFACES; IMPLANTS; ADHESION
C1 Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Mikhalovsky, SV (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Cockcroft Bldg,Lewed Rd, Brighton BN2 4GJ, E Sussex, England.
CR ARCIOLA CR, 1993, J APPL BIOMATER, V4, P249, DOI 10.1002/jab.770040306
   GURLAND HJ, 1994, NEPHROL DIAL TRANSPL, V9, P4
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   LAZARENKO ON, 1999, BASIC RES CARDIOL, V94, P379
   Lloyd AW, 1999, J MATER SCI-MATER M, V10, P621, DOI 10.1023/A:1008935707910
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SCHRADER ME, 1982, J COLLOID INTERF SCI, V88, P296, DOI 10.1016/0021-9797(82)90176-X
   Serruys PW, 2000, CIRCULATION, V102, P2930
   STEFLIK DE, 1992, J BIOMED MATER RES, V26, P529, DOI 10.1002/jbm.820260409
   TEER DG, 2001, WEAR, V250, P1068
   ZISMAN WA, 1963, ADV CHEM SER, V43, P1
NR 15
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-1320-5
J9 NATO SCI SER II MATH
PY 2003
VL 102
BP 15
EP 26
PG 12
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Coatings & Films
SC Materials Science
GA BX13V
UT WOS:000184410200002
DA 2018-10-19
ER

PT B
AU Ivanchenko, LA
   Pinchuk, ND
   Sulyma, VS
AF Ivanchenko, LA
   Pinchuk, ND
   Sulyma, VS
BE Gogotsi, YG
   Uvarova, IV
TI The researches of properties of biomaterials based on biological
   hydroxyapatite in synthetic and natural physiological mediums
SO NANOSTRUCTURED MATERIALS AND COATINGS FOR BIOMEDICAL AND SENSOR
   APPLICATIONS
SE NATO SCIENCE SERIES, SERIES II: MATHEMATICS, PHYSICS AND CHEMISTRY
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Nanostructured Materials and Coatings
   for Biomedical and Sensor Applications
CY AUG 04-08, 2002
CL KIEV, UKRAINE
SP NATO
AB Biomaterial "Osteoapatit keramichesky" (OK) based on biological hydroxyapatite (BHAp) under the trademark "Osteoapatit" were studied. A silicate-borate-sodium glass amount in the OK samples composition reached 85 % (mass.). The degree of biochemical activity was appreciated on a loss of sample mass in blood plasma and normal saline solution. An influence of biomaterial on activity of humane bone marrow osteogenics cells-precursors was investigated. The experimental researches of interaction "in vivo" between biomaterials and bone tissue were conducted in 35 adult mongrel dogs. A new bone formation and rebuilding of OK granules after implantation in bone defect have been studied.
C1 Natl Acad Sci Ukraine, Inst Problems Mat Sci, UA-03142 Kiev, Ukraine.
RP Ivanchenko, LA (reprint author), Natl Acad Sci Ukraine, Inst Problems Mat Sci, 3 Krzhyzhanovsky Str, UA-03142 Kiev, Ukraine.
CR IVANCHENKO IA, 1997, MAT C OST EP KLIN II, P45
   IVANCHENKO LA, 1999, POWDER MET MET CERAM, V38, P418
   Pinchuk N. D., 2000, PROBLEMY OSTEOLOGYI, V3, P37
   PODRUSHNYAK EP, 2000, ORTOPEDIJA TRAVMATOL, P129
   Podrushnyak Ye. P., 2000, PROBLEMY OSTEOLOGYI, V3, P89
   PODRUSHNYAK YP, 1998, PROBLEMY OSTEOLOGYI, V1, P102
   SULYMA VS, 2002, GALICKIY LIKARSKIY V, V9, P87
NR 7
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
BN 1-4020-1320-5
J9 NATO SCI SER II MATH
PY 2003
VL 102
BP 77
EP 82
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Coatings & Films
SC Materials Science
GA BX13V
UT WOS:000184410200008
DA 2018-10-19
ER

PT B
AU Nakamura, S
   Ueshima, M
   Kobayashi, T
   Yamashita, K
AF Nakamura, S
   Ueshima, M
   Kobayashi, T
   Yamashita, K
BE Laudon, M
   Romanowicz, B
TI Nanoscale activated field on ceramic electret in pseudobiological
   environment
SO NANOTECH 2003, VOL 3
LA English
DT Proceedings Paper
CT Nanotechnology Conference and Trade Show (Nanotech 2003)
CY FEB 23-27, 2003
CL San Francisco, CA
SP Def Adv Res Projects Agcy, Ardesta, LLC, Swiss Nanotechnol Initiat, Belgian Nanotechnol Initiat, Oppenheimer wolff & Donnelly LLP, Accelrys Inc, Ciphergen Biosyst Inc, Motorola Inc, ANSYS Inc, COMSOL, Thomson, Derwent, M&W Zander US Operat Inc, Small Times Media
DE hydroxyapatite; simulated body fluid; surface charge; electret;
   electrical polarization
ID HYDROXYAPATITE; POLARIZATION
AB A pseudo-biological environment using simulated body fluid (SBF) has been widely accepted as an osteobonding estimation of biomaterial surfaces. We have been demonstrated by SBF tests that the negative surface charges induced by an electrical polarization increased the overgrowth conductivity on the hydroxyapatite (HA) ceramic surface but that the positive charge diminished the overgrowth ability. Almost of the particles were deposited on each of the negatively charged ceramic substrate grain. The grain boundaries of the substrate clearly appeared as linear lacks of deposition. Therefore, the similar to10 nanometer-scale morphological modification was attributed to the electrostatic force generated by the HA electret. The idea of the nano-scale activated field concerning the in vitro overgrowth should be extensible into the in vivo calcification reactions of the electrically polarized HA ceramics implanted in bone tissues.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan.
RP Nakamura, S (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
CR KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Nakamura S, 2002, J BIOMED MATER RES, V61, P593, DOI 10.1002/jbm.10224
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   NAKAMURA S, 2000, PHOSPHORUS RES B, V11, P1
   Ueshima M, 2002, ADV MATER, V14, P591, DOI 10.1002/1521-4095(20020418)14:8<591::AID-ADMA591>3.0.CO;2-7
   YAMASHITA K, 1995, J AM CERAM SOC, V78, P1191, DOI 10.1111/j.1151-2916.1995.tb08468.x
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
NR 7
TC 0
Z9 0
U1 1
U2 1
PU COMPUTATIONAL PUBLICATIONS
PI CAMBRIDGE
PA PUBISHING OFFICE, 308 ONE KENDALL SQ BLDG 600, CAMBRIDGE, MA 02139 USA
BN 0-9728422-2-5
PY 2003
BP 372
EP 375
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA BAN98
UT WOS:000223047000100
DA 2018-10-19
ER

PT S
AU Wang, WW
   Knopf, GK
   Bassi, AS
AF Wang, WW
   Knopf, GK
   Bassi, AS
BE Knopf, GK
TI Photonic transistor based on bacteriorhodopsin films
SO OPTOMECHATRONIC SYSTEMS IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 4th Optomechatronic Systems Conference
CY OCT 28-29, 2003
CL PROVIDENCE, RI
SP SPIE
DE photonic transistor; bacteriorhodopsin; suppression-modulated
   transmission; photo-electro response
ID OPTICAL LOGIC GATES; MEMORIES; PROTEIN
AB Light activated optical circuits have several key advantages over conventional electronics because they are free from electrical current losses, resistive heat dissipation, and friction forces that greatly diminish system performance and efficiency. The effects of current leakage and power loss are also crucial design constraints in developing microelectromechanical (MEMS) technology. An essential device for creating viable micro-optical circuitry is a robust photonic transistor that can act as a small signal switch and amplifier. The proposed photonic transistor is based on the complementary suppression-modulated light transmission properties of thin bacteriorhodopsin (bR) films. The light transmission properties exhibited by the thin film are controlled using the variable wavelength and intensity of the impinging light sources. The light transmission properties of the bR film are illustrated using a mathematical model for the two-state photoreaction system. The two-state model represents the longest lifetime in the bR photocycle, largest change in absorption maxima, and high photochemical stability. The optical response is proportional to changes in the light transmission properties of the biomaterial, and therefore represents a viable material for creating optoelectronic devices.
C1 Univ Western Ontario, Fac Engn, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada.
RP Bassi, AS (reprint author), Univ Western Ontario, Fac Engn, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada.
CR Birge RR, 1999, J PHYS CHEM B, V103, P10746, DOI 10.1021/jp991883n
   BIRGE RR, 1992, IEEE COMPUTER    NOV, P56
   DOWNIE JD, 1995, APPL OPTICS, V34, P5210, DOI 10.1364/AO.34.005210
   GROSS RB, 1992, P SOC PHOTO-OPT INS, V1662, P186, DOI 10.1117/12.58502
   Gu LQ, 1996, OPT COMMUN, V131, P25, DOI 10.1016/0030-4018(96)00200-3
   Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x
   Rao DVGLN, 1996, OPT COMMUN, V127, P193, DOI 10.1016/0030-4018(96)00180-0
   RAYFIELD G, 1994, MOL BIOMOLECULAR ELE, P561
   SONG QW, 1993, OPT LETT, V18, P1373, DOI 10.1364/OL.18.001373
   THOMA R, 1991, J OPT SOC AM A, V14, P3285
   TIMUCIN DA, 1997, OPT LETT, V16, P651
   Zhang TH, 2000, OPT ENG, V39, P527, DOI 10.1117/1.602400
NR 12
TC 0
Z9 0
U1 1
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5152-5
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5264
BP 194
EP 205
DI 10.1117/12.515208
PG 12
WC Computer Science, Artificial Intelligence; Instruments &
   Instrumentation; Optics
SC Computer Science; Instruments & Instrumentation; Optics
GA BX99P
UT WOS:000187162300023
DA 2018-10-19
ER

PT J
AU Gourlay, T
   Samartzis, I
   Taylor, KM
AF Gourlay, T
   Samartzis, I
   Taylor, KM
TI The effect of haemodilution on blood-biomaterial contact-mediated CD11b
   expression on neutrophils: ex vivo studies
SO PERFUSION-UK
LA English
DT Article
ID PLASTICIZED POLYVINYL-CHLORIDE; CARDIOPULMONARY BYPASS CIRCUIT; RAT
   RECIRCULATION MODEL; INFLAMMATORY RESPONSE; SURGERY
AB Modern cardiopulmonary bypass (CPB) systems are getting smaller, both in terms of the exposed surface area of biomaterials and the priming volume. In a series of studies utilizing a rat recirculation model, we demonstrated that the magnitude of the inflammatory response seen under these conditions is proportional to the surface area of exposed material, a finding that supports the use of miniature systems in terms of moderating the inflammatory response. However, the second impact of miniature perfusion systems, the reduced priming volume with concomitant reduction in haemodilution, was not investigated with reference to inflammation. The present study was designed to determine whether this change in CPB haematocrit profile has any effect on the inflammatory response. In common with previous studies by this group, we employed the expression of the integrin CD11b on neutrophils as a marker of neutrophil activation, and hence the inflammatory response, in a rat recirculation biomaterial testing model, containing di-(2-ethyl-hexyl)phthalate plasticized polyvinyl chloride of the type commonly employed in CPB circuits.
   The results demonstrated that neutrophil activation is influenced by haemodilution. We studied five groups of animals, each with different mean induced haematocrit: Group 1 (41.3 +/- 1.27%); Group 2 (30.93 +/- 2.85%); Group 3 (24.83 +/- 1.36%); Group 4 (20.60 +/- 3.47%); Group 5 (20.48 +/- 1.31%). Groups 1 and 5 animals were controls, neither of which underwent the period of recirculation. Rather, these controls were employed to isolate the noncontact effect of haemodilution on CD11b expression. We found that there were differences in per cent change in CD11b expression from start to end of the recirculation period between Group 1 (109.54+/- 49.53%), Group 2 (189.1 +/- 18.68%), Group 3 (224.28 +/- 43.97), Group 4 (368.97 +/- 24.28%) and Group 5 (127 +/- 57.8%). There were intergroup statistically significant differences (p < 0.05).
   These results confirm that there is a relationship between haematocrit level and biomaterial contact-mediated activation of neutrophils. Furthermore, these studies confirm that haemodilution alone has no effect on neutrophil activation. One possible explanation for this outcome is that with higher levels of haemodilution, neutrophils have a greater opportunity to contact surface 'receptor' sites on the biomaterial, resulting in more neutrophil activation. Whatever the mechanism, these data tend to support the modern trend towards lower circuit surface area and higher haematocrit.
C1 Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI, Dept Cardiac Surg, London W12 ONN, England.
RP Gourlay, T (reprint author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med,NHLI, Dept Cardiac Surg, 2nd Floor,B Block,DuCane Rd, London W12 ONN, England.
CR Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2
   Berryessa R, 2000, PERFUSION-UK, V15, P63, DOI 10.1177/026765910001500109
   Darling E, 2000, PERFUSION-UK, V15, P3, DOI 10.1177/026765910001500102
   Edmunds LH, 2002, PERFUSION-UK, V17, P243, DOI 10.1191/0267659102pf585oa
   Eising GP, 2003, ANN THORAC SURG, V75, P23, DOI 10.1016/S0003-4975(02)04099-7
   Fromes Y, 2002, EUR J CARDIO-THORAC, V22, P527, DOI 10.1016/S1010-7940(02)00372-X
   Gourlay T, 2001, PERFUSION-UK, V16, P381, DOI 10.1177/026765910101600508
   Gourlay T, 2003, ARTIF ORGANS, V27, P256, DOI 10.1046/j.1525-1594.2003.07107.x
   Gourlay T, 2002, ARTIF ORGANS, V26, P5, DOI 10.1046/j.1525-1594.2002.06730.x
   Gourlay T, 2001, ARTIF ORGANS, V25, P475, DOI 10.1046/j.1525-1594.2001.025006475.x
   Hayashi Y, 2001, EUR J CARDIO-THORAC, V20, P621, DOI 10.1016/S1010-7940(01)00833-8
   Hilt Tim, 2002, Crit Care Nurs Clin North Am, V14, P7, DOI 10.1016/S0899-5885(03)00033-9
   McCusker K, 2001, PERFUSION-UK, V16, P447, DOI 10.1177/026765910101600603
   Mueller XM, 2002, EUR J CARDIO-THORAC, V21, P840, DOI 10.1016/S1010-7940(02)00086-6
   Nollert G, 2001, THORAC CARDIOV SURG, V49, P226, DOI 10.1055/s-2001-16115
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x
NR 16
TC 13
Z9 13
U1 0
U2 0
PU ARNOLD, HODDER HEADLINE PLC
PI LONDON
PA 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PY 2003
VL 18
IS 2
BP 87
EP 93
DI 10.1191/0267659103pf648oa
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 694MW
UT WOS:000183779200005
PM 12868786
DA 2018-10-19
ER

PT J
AU Gourlay, T
   Connolly, P
AF Gourlay, T
   Connolly, P
TI Does cardiopulmonary bypass still represent a good investment? The
   biomaterials perspective
SO PERFUSION-UK
LA English
DT Article; Proceedings Paper
CT Hammersmith Hospital Perfusion Workshop
CY 2002
CL HOMMERSMITH, ENGLAND
ID PLASTICIZED POLYVINYL-CHLORIDE; RAT RECIRCULATION MODEL; INFLAMMATORY
   RESPONSE; CYTOKINE RELEASE; BIOSENSORS; CIRCUIT; SURGERY; COMPLEMENT;
   PHTHALATE; EXPRESSION
AB Cardiopulmonary (CPB) bypass is 50 years old this year, and has undergone considerable change in that time, particularly with regard to developing technology. However, in recent years the routine application of CPB, as the treatment of choice for patients undergoing reparative heart surgery, has been challenged by new, evolving techniques, particularly Off-Pump Coronary Artery Bypass (OPCAB) and stenting. This paper considers whether CPB still represents a sound investment prospect, with particular emphasis on the biomaterial developments currently taking place. Whilst we accept that routine application of CPB is shrinking under pressure from less invasive techniques, we suggest that this may represent an opportunity to deliver a more highly evolved perfusion to the core of very sick and complex patients who may not be suitable candidates for OPCAB or stenting. These patients will benefit from the application of new technologies currently under development, such as smaller perfusion circuits, improved biomaterial surfaces, smart membranes, and biosensor technology, all aimed at making clinical perfusion a safer and more predictable procedure for the patient. All things considered, we feel that CPB, although shrinking in absolute size, still represents a good investment.
C1 Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI, Dept Cardiothorac Surg, London W12 0NN, England.
   Univ Strathclyde, Bioengn Unit, Glasgow, Lanark, Scotland.
RP Gourlay, T (reprint author), Univ London Imperial Coll Sci Technol & Med, Fac Med, NHLI, Dept Cardiothorac Surg, 2nd Floor,B Block,Hammersmith Hosp Campus,DuCane, London W12 0NN, England.
CR Abel PU, 2002, BIOSENS BIOELECTRON, V17, P1059, DOI 10.1016/S0956-5663(02)00099-4
   Baufreton C, 2002, PERFUSION-UK, V17, P407, DOI 10.1191/0267659102pf615oa
   Butler J, 2002, ANN THORAC SURG, V74, P139, DOI 10.1016/S0003-4975(02)03594-4
   CHENOWETH DE, 1981, NEW ENGL J MED, V304, P497, DOI 10.1056/NEJM198102263040901
   CONNOLLY P, 2002, P IEEE EMBS C MOL CE, P57
   Cormack JE, 2000, PERFUSION-UK, V15, P129, DOI 10.1177/026765910001500207
   COURTNEY JM, 1993, IMMOBILISED MACROMOL, P175
   Defraigne JO, 2000, ANN THORAC SURG, V69, P1084, DOI 10.1016/S0003-4975(00)01093-6
   Draper CJ, 2002, TRANSFUSION, V42, P830, DOI 10.1046/j.1537-2995.2002.00138.x
   Earls AO, 2003, J CHROMATOGR A, V983, P237, DOI 10.1016/S0021-9673(02)01736-3
   EDMUNDS LH, 2002, CARDIOPULMONARY BYPA
   Eising GP, 2003, ANN THORAC SURG, V75, P23, DOI 10.1016/S0003-4975(02)04099-7
   Ereth MH, 2001, J CARDIOTHOR VASC AN, V15, P545, DOI 10.1053/jcan.2001.26525
   FERMANN GJ, 2002, J EMERGENCY MED, V22, P303
   Flom-Halvorsen HI, 2002, PERFUSION-UK, V17, P339, DOI 10.1191/0267659102pf594oa
   Fromes Y, 2002, EUR J CARDIO-THORAC, V22, P527, DOI 10.1016/S1010-7940(02)00372-X
   GIBBON J H Jr, 1954, Minn Med, V37, P171
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   Gourlay T, 2001, PERFUSION-UK, V16, P381, DOI 10.1177/026765910101600508
   Gourlay T, 2003, ARTIF ORGANS, V27, P256, DOI 10.1046/j.1525-1594.2003.07107.x
   Gourlay T, 2002, ARTIF ORGANS, V26, P5, DOI 10.1046/j.1525-1594.2002.06730.x
   Gourlay T, 2001, ARTIF ORGANS, V25, P475, DOI 10.1046/j.1525-1594.2001.025006475.x
   GU YJ, 1993, ANN THORAC SURG, V55, P912
   KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
   KLINKMANN H, 1986, CONTRIB NEPHROL, V26, pS9
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658
   McCusker K, 2001, PERFUSION-UK, V16, P447, DOI 10.1177/026765910101600603
   Merino V, 1999, J CONTROL RELEASE, V61, P65, DOI 10.1016/S0168-3659(99)00102-9
   Mettang T, 1999, ADV PERIT D, V15, P229
   MONGERO LB, 2003, HEART SURG FORUM, V6, P112
   Mueller XM, 2002, EUR J CARDIO-THORAC, V21, P840, DOI 10.1016/S1010-7940(02)00086-6
   Olsson C, 2000, SCAND CARDIOVASC J, V34, P33
   Tamada JA, 1999, JAMA-J AM MED ASSOC, V282, P1839, DOI 10.1001/jama.282.19.1839
   Traynor Kate, 2002, Am J Health Syst Pharm, V59, P1706
   Vo-Dinh T, 2000, FRESEN J ANAL CHEM, V366, P540, DOI 10.1007/s002160051549
   Wang J, 1999, J PHARMACEUT BIOMED, V19, P47, DOI 10.1016/S0731-7085(98)00056-9
   Wang J, 2001, ELECTROANAL, V13, P983, DOI 10.1002/1521-4109(200108)13:12<983::AID-ELAN983>3.0.CO;2-#
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x
NR 38
TC 7
Z9 7
U1 0
U2 1
PU ARNOLD, HODDER HEADLINE PLC
PI LONDON
PA 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND
SN 0267-6591
J9 PERFUSION-UK
JI Perfusion-UK
PY 2003
VL 18
IS 4
BP 225
EP 231
DI 10.1191/0267659103pf667oa
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 731QN
UT WOS:000185898100004
PM 14575411
DA 2018-10-19
ER

PT J
AU Satoh, S
   Yamada, M
   Nomizu, M
   Nishi, N
AF Satoh, S
   Yamada, M
   Nomizu, M
   Nishi, N
TI Accumulation-exclusion combined system for the DNA-binding harmful
   chemicals with insolubilized DNA
SO POLYMER JOURNAL
LA English
DT Article
DE DNA; UV-irradiation cross-linking; water-insolubilization;
   intercalation; functional material; endocrine disruptor
ID UV-IRRADIATION; AFFINITY; COMPLEX; SEPARATION; ADSORPTION; CELLULOSE
AB DNA is not only the most important genetic material but a highly functional biomaterial. The unique structure of the double-stranded DNA causes its highly specific functions, such as intercalation, groove-binding and other molecular recognitions. Previously, we reported the preparation of insolubilized DNA by UV-irradiation. The UV-irradiated DNA showed the potential utility as an accumulation device for harmful DNA-binding chemicals such as the dioxin-derivative. In this study, we investigated the exclusion process of accumulated chemicals from the insolubilized DNA, and extended this approach to the construction of an accumulation-exclusion combined system for DNA-binding harmful chemicals. Such a system would allow us to systematically concentrate very small amount of DNA-binding chemicals from large amounts of water. It might provide a suitable method to omit the complicated pre-treatment processes which are popular in the analysis for the highly diluted chemicals in the water system such as some environmental hormones. Two different procedures were performed to exclude ethidium bromide (EtBr) from UV-irradiated DNA containing EtBr. The first one is the treatment with a cationic polymer which would induce DNA-condensation and, as a result, exclude EtBr. Another one is the extraction of EtBr with organic solvent. The extraction process with an organic solvent attained a high exclusion efficiency for EtBr. The UV-irradiated DNA which accumulated the EtBr, could be easily recovered by washing with some organic solvents and maintain the efficiency to accumulate the DNA-binding chemicals.
C1 Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Bio Mat Chem,Kita Ku, Sapporo, Hokkaido 0600810, Japan.
RP Nishi, N (reprint author), Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosci, Lab Bio Mat Chem,Kita Ku, Kita 10,Nishi 5, Sapporo, Hokkaido 0600810, Japan.
EM nishin@ees.hokudai.ac.jp
CR BOLTON ET, 1962, P NATL ACAD SCI USA, V48, P1390, DOI 10.1073/pnas.48.8.1390
   Burgener M, 2000, BIOCONJUGATE CHEM, V11, P749, DOI 10.1021/bc0000029
   COAREC JP, 2002, BIOSENS BIOELECTRON, V17, P405
   Dufourcq J, 1998, FEBS LETT, V421, P7, DOI 10.1016/S0014-5793(97)01522-6
   FODER SPA, 1993, NATURE, V364, P555
   Geall AJ, 1999, FEBS LETT, V459, P337, DOI 10.1016/S0014-5793(99)01262-4
   GILHAM PT, 1962, J AM CHEM SOC, V84, P1311, DOI 10.1021/ja00866a055
   Iwata K, 1996, INT J BIOL MACROMOL, V18, P149, DOI 10.1016/0141-8130(95)01073-4
   Izumrudov VA, 1999, MACROMOL CHEM PHYS, V200, P2533, DOI 10.1002/(SICI)1521-3935(19991101)200:11<2533::AID-MACP2533>3.0.CO;2-R
   KAWAGUCHI H, 1989, NUCLEIC ACIDS RES, V17, P6229, DOI 10.1093/nar/17.15.6229
   Kitamura H, 1997, INT J BIOL MACROMOL, V20, P75, DOI 10.1016/S0141-8130(97)01146-X
   LITMAN RM, 1968, J BIOL CHEM, V243, P6222
   MILLER EC, 1987, CANCER, V47, P2275
   Palecek E, 2002, ANAL CHIM ACTA, V469, P73, DOI 10.1016/S0003-2670(01)01605-1
   RICKWOOD D, 1972, BIOCHIM BIOPHYS ACTA, V269, P47, DOI 10.1016/0005-2787(72)90072-X
   Saenger W., 1987, PRINCIPLES NUCL ACID
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   Umeno D, 1998, ANAL CHIM ACTA, V365, P101, DOI 10.1016/S0003-2670(98)00094-4
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M, 2001, BIOMATERIALS, V22, P3121, DOI 10.1016/S0142-9612(01)00061-8
NR 22
TC 5
Z9 5
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0032-3896
J9 POLYM J
JI Polym. J.
PY 2003
VL 35
IS 11
BP 872
EP 878
DI 10.1295/polymj.35.872
PG 7
WC Polymer Science
SC Polymer Science
GA 759JN
UT WOS:000187734700006
OA Bronze
DA 2018-10-19
ER

PT B
AU Wu, PF
   Rao, DVGLN
AF Wu, PF
   Rao, DVGLN
BE Kalinowski, HJ
   Romero, MA
   Barbin, SE
TI Medical image processing with optical Fourier techniques
SO PROCEEDINGS OF THE INTERNATIONAL 2003 SBMO/IEEE MTT-S INTERNATIONAL
   MICROWAVE AND OPTOELECTRONICS CONFERENCE - IMOC 2003, VOLS I AND II
LA English
DT Proceedings Paper
CT 10th International Microwave and Optoelectronics Conference (IMOC)
CY SEP 20-23, 2003
CL Iguazu Falls, BRAZIL
SP SMBO, UFPR, IEEE, MTTS, Ctr Fed Educ Tecnol Parana
DE Fourier transform; medical image processing; photo-induced anisotropy;
   nonlinear optical films
ID AZO-DYE; NONLINEARITY; POLYMERS; FILMS
AB Medical image processing is demonstrated by using Fourier techniques. Two optical Fourier systems are designed: the first one is a real-time optical processor with spatial filters and the second one is a self-adaptive optical processor with nonlinear optical films of the biomaterial Bacteriorhodopsin. Medical images including mammograms and Pap smears are investigated by using our optical systems. The desired components which are not clearly visible to the naked eye in original images clearly show up in the processed images. The image processing facilitates detection of microcalcifications buried in dense tissue in the case of mammograms, and abnormal cells in Pap smears. The results will be helpful for early diagnosis of breast and cervical cancers. It is possible to develop low cost rugged portable battery operated systems for rapid screening of mammograms and Pap smears.
C1 Univ Massachusetts, Dept Phys, Boston, MA 02125 USA.
RP Wu, PF (reprint author), Univ Massachusetts, Dept Phys, Boston, MA 02125 USA.
CR Berg RH, 1996, NATURE, V383, P505, DOI 10.1038/383505a0
   BORING CC, 1991, CA-CANCER J CLIN, V41, P19, DOI 10.3322/canjclin.41.1.19
   CHENG I, 1995, MED ELECT, V155, P50
   DOWNIE JD, 1995, APPL OPTICS, V34, P5210, DOI 10.1364/AO.34.005210
   Egami C, 1997, APPL PHYS B-LASERS O, V64, P471, DOI 10.1007/s003400050201
   HUIGNARD JP, 1978, APPL OPTICS, V17, P2671, DOI 10.1364/AO.17.002671
   Joseph J, 1996, OPT LETT, V21, P1499, DOI 10.1364/OL.21.001499
   Kumar J, 1998, APPL PHYS LETT, V72, P2096, DOI 10.1063/1.121287
   Ozaktas HM, 1996, APPL OPTICS, V35, P1212, DOI 10.1364/AO.35.001212
   Panchangam A, 2001, MED PHYS, V28, P22, DOI 10.1118/1.1328079
   Rangel-Rojo R, 1998, APPL PHYS LETT, V72, P1021, DOI 10.1063/1.120977
   SANDALPHON B, 1994, OPT LETT, V19, P68
   TOMOV IV, 1991, J OPT SOC AM B, V8, P1477, DOI 10.1364/JOSAB.8.001477
   VOLODIN B, 1994, P SOC PHOTO-OPT INS, V2144, P72, DOI 10.1117/12.177217
   WU YZ, 1992, MED PHYS, V19, P555, DOI 10.1118/1.596845
NR 15
TC 2
Z9 2
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-7824-5
PY 2003
BP 689
EP 694
PG 6
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BY56F
UT WOS:000189409000124
DA 2018-10-19
ER

PT S
AU Gupta, B
   Anjum, N
AF Gupta, Bhuvanesh
   Anjum, Nishat
BE Kausch, H
TI Plasma and Radiation-Induced Graft Modification of Polymers for
   Biomedical Applications
SO RADIATION EFFECTS ON POLYMERS FOR BIOLOGICAL USE
SE Advances in Polymer Science
LA English
DT Review
DE Polymer; Biomaterial; Radiation; Plasma; Graft Polymerization;
   Modification
ID LOW-TEMPERATURE PLASMA; SURFACE-MODIFICATION; ACRYLIC-ACID; BLOOD
   COMPATIBILITY; 2-HYDROXYETHYL METHACRYLATE; SILICONE-RUBBER;
   POLY(ETHYLENE-TEREPHTHALATE) FILMS; ULTRAFILTRATION MEMBRANES; COLLAGEN
   IMMOBILIZATION; TREATED POLYETHYLENE
AB Polymers have generated considerable interest in a number of innovative domains for biomedical applications. There is a great need to develop and design polymers for better acceptability to the biosystem that includes the blood and tissue compatibility and a perfect cell-material interaction. The modification of existing polymers by careful designing of the macromolecular architecture is one of the most attractive ways to develop such biomaterials. Plasma and high-energy radiation, such as gamma radiation and electron beam lead to enough activation of polymers so that specific monomer may be grafted. The extent of modification, i.e., the degree of grafting may be easily controlled by the careful variation of the radiation exposure and reaction conditions. The graft modification may be carried out almost on all polymers with the creation of a desired functional chemistry both on the surface and in the bulk matrix. such biomaterials are being used for implants, sutures, tissue engineering, and as structured surface materials. The most recent innovation in the development of biomaterials has been in the area of tissue engineering where human cells are seeded on top of a polymer support and are harvested as tissue. The grafting method is extremely attractive as the modified biomaterial is obtained in the purest form possible. The grafting is applicable to almost all polymer-monomer combinations with enormous possibilities of physico-chemical and biological characteristics.
C1 [Gupta, Bhuvanesh; Anjum, Nishat] Indian Inst Technol, Dept Text Technol, New Delhi 110016, India.
RP Gupta, B (reprint author), Indian Inst Technol, Dept Text Technol, New Delhi 110016, India.
EM bgupta@textile.iitd.ernet.in
CR ABSOLOM DR, 1988, J BIOMED MATER RES, V22, P215, DOI 10.1002/jbm.820220306
   ALEXANDER JW, 1967, ANN SURG, V165, P192, DOI 10.1097/00000658-196702000-00005
   BAE J, 1999, KAN, V20, P529
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   BUCKENSKA J, 1996, J APPL POLYM SCI, V61, P567
   BURES P, 2001, PEPPA NA J, V72, P25
   BURG KJL, 2001, INT FIBER J, V16, P38
   Chapiro A., 1962, RAD CHEM POLYM SYSTE
   Chen H, 1999, J APPL POLYM SCI, V72, P1699, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1699::AID-APP6>3.0.CO;2-9
   COHN D, 1987, J APPL POLYM SCI, V31, P1
   DESAI NP, 1991, J BIOMED MATER RES, V25, P829, DOI 10.1002/jbm.820250704
   Eckert AW, 2000, BIOMATERIALS, V21, P441
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gupta B, 2000, J APPL POLYM SCI, V77, P1401, DOI 10.1002/1097-4628(20000808)77:6<1401::AID-APP28>3.0.CO;2-T
   Gupta B, 2000, J APPL POLYM SCI, V77, P1331, DOI 10.1002/1097-4628(20000808)77:6<1331::AID-APP18>3.0.CO;2-M
   Gupta B, 2002, J APPL POLYM SCI, V86, P1118, DOI 10.1002/app.11129
   Gupta B, 2001, J APPL POLYM SCI, V81, P2993, DOI 10.1002/app.1749
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Gupta B, 2000, J APPL POLYM SCI, V78, P1083, DOI 10.1002/1097-4628(20001031)78:5<1083::AID-APP170>3.0.CO;2-5
   GUPTA B, 2000, POLYM PREPRINTS, V4, P1040
   GUPTA B, 1994, POLYM ADVAN TECHNOL, V5, P493
   GUPTA BD, 1990, J MACROMOL SCI CHEM, VA27, P831, DOI 10.1080/10601329008544808
   HAN DK, 1991, J BIOMED MATER RES, V25, P561, DOI 10.1002/jbm.820250502
   HAYAT U, 1992, BIOMATERIALS, V13, P801, DOI 10.1016/0142-9612(92)90022-G
   HELMUS MN, 1984, J BIOMED MATER RES, V18, P165, DOI 10.1002/jbm.820180207
   HILBORN J, Patent No. 9824562
   HOFFMAN AS, 1972, KRAFT AM ART, V18, P10
   HSIUE GH, 1993, J POLYM SCI POL CHEM, V31, P3327, DOI 10.1002/pola.1993.080311321
   HSIUE GH, 1993, J BIOMAT SCI-POLYM E, V5, P205
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Jen M.Y., 1998, J MEMBRANE SCI, V138, P19
   Kabanov VY, 1997, NUCL INSTRUM METH B, V131, P291, DOI 10.1016/S0168-583X(97)00393-5
   KAMATH KR, 1994, J APPL BIOMATER, V5, P163, DOI 10.1002/jab.770050210
   KANG I, 1997, LEE YM, V18, P1099
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   Kato K, 2000, J ADHES SCI TECHNOL, V14, P635, DOI 10.1163/156856100742807
   KIAEI D, 1995, RADIAT PHYS CHEM, V46, P191, DOI 10.1016/0969-806X(95)00012-M
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KIM EJ, 1998, PARKY, V19, P239
   KIM H, 2001, NAKAMURE, V22, P2489
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   KISHIDA A, 1991, BIOMATERIALS, V12, P786, DOI 10.1016/0142-9612(91)90031-5
   KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Kwon OH, 1999, J APPL POLYM SCI, V71, P631, DOI 10.1002/(SICI)1097-4628(19990124)71:4<631::AID-APP15>3.0.CO;2-G
   LANGER R, 1993, VACANTI TISSUE ENG S, V260, P920
   LEE HB, 1972, AM CHEM SOC POLYM PR, V13, P729
   LEE JH, 1991, BIOMATERIALS, V12, P443
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   LEE SD, 1994, J APPL POLYM SCI, V54, P1279, DOI 10.1002/app.1994.070540909
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   Oehr C, 1999, SURF COAT TECH, V116, P25, DOI 10.1016/S0257-8972(99)00201-7
   Park JS, 1998, J APPL POLYM SCI, V69, P2213, DOI 10.1002/(SICI)1097-4628(19980912)69:11<2213::AID-APP13>3.0.CO;2-#
   RATNER BD, 1974, J APPL POLYM SCI, V18, P3183, DOI 10.1002/app.1974.070181101
   RATNER BD, 1978, J BIOENG, V2, P313
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   REVAGADE N, 2001, THESIS IIT DELHI IND
   RICHEY T, 2000, MAT Y, V21, P1057
   SANO S, 1993, BIOMATERIALS, V20, P529
   Sharma C P, 1987, J Biomater Appl, V2, P205, DOI 10.1177/088532828700200202
   SINGH DK, 1994, J APPL POLYM SCI, V53, P1115, DOI 10.1002/app.1994.070530814
   SINGH H, 1989, ANGEW MAKROMOL CHEM, V172, P87, DOI 10.1002/apmc.1989.051720108
   SUN YH, 1986, J BIOACT COMP POLYM, V1, P317
   SUZUKI M, 1986, MACROMOLECULES, V19, P1808
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   TOMITA N, 1994, J APPL BIOMATER, V5, P175, DOI 10.1002/jab.770050211
   TYAGI PK, 1993, J MACROMOL SCI PURE, VA30, P303, DOI 10.1080/10601329308009408
   UCHIDA E, 1990, J APPL POLYM SCI, V41, P677, DOI 10.1002/app.1990.070410317
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Ulbricht M, 1996, J MEMBRANE SCI, V111, P193, DOI 10.1016/0376-7388(95)00207-3
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   UYAMA Y, 1990, J APPL POLYM SCI, V39, P489, DOI 10.1002/app.1990.070390301
   VANKAMPEN CL, 1979, J BIOMED MATER RES, V13, P517, DOI 10.1002/jbm.820130402
   VANWACHEM PB, 1985, J MAT, V6, P403
   WARD TL, 1982, POLYM PHOTOCHEM, V2, P109, DOI 10.1016/0144-2880(82)90034-3
   Wise DL, 1995, ENCY HDB BIOMATERIAL
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   YEH YS, 1988, J BIOMED MATER RES, V22, P795, DOI 10.1002/jbm.820220904
   ZHANG F, 2001, BIO, V56, P324
NR 84
TC 36
Z9 38
U1 5
U2 36
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 978-3-540-44020-8
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2003
VL 162
BP 35
EP 61
PG 27
WC Polymer Science
SC Polymer Science
GA BSC11
UT WOS:000284100800003
DA 2018-10-19
ER

PT J
AU Yan, YN
   Wu, RD
   Zhang, RJ
   Xiong, Z
   Lin, F
AF Yan, YN
   Wu, RD
   Zhang, RJ
   Xiong, Z
   Lin, F
TI Biomaterial forming research using RP technology
SO RAPID PROTOTYPING JOURNAL
LA English
DT Article
DE rapid prototyping; biotechnology; manufacturing
ID SCAFFOLDS; BONE
AB This paper introduces a new subject called biomanufacturing. Bio-manufacturing combines life science with manufacturing science, and uses manufacturing method to form materials with bio-activity and biodegradability into scaffolds. In this paper, we discuss the hierarchy of bio-manufacturing: the lower grade uses undegradable bio-material to form permanent organ replacement such as auricular cartilage and the higher grade uses biodegradable bio-materials to repair organ damage or organ replacement which degrades after embedded in the human body. They all adopt jetting/extrusion deposition process (fused deposition modelling or 3D printer), the distinct different point being the temperature of the forming chamber. The samples of bones and auricular cartilage produced by those processes had been practiced on dogs and rabbits, repaired their damage.
C1 Tsing Hua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.
RP Yan, YN (reprint author), Tsing Hua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.
CR Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   NAM YS, 1999, J BIOMED MATER RES, V4, P8
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   WANG L, 2001, MATERIAL GUIDE, V15, P49
   XING X, 2000, APPL BEAUTY PLASTIC, V11, P281
   XIONG Z, 2001, CHINA MECH ENG, V12, P515
NR 8
TC 22
Z9 24
U1 0
U2 12
PU EMERALD
PI BRADFORD
PA 60/62 TOLLER LANE, BRADFORD BD8 9BY, W YORKSHIRE, ENGLAND
SN 1355-2546
J9 RAPID PROTOTYPING J
JI Rapid Prototyping J.
PY 2003
VL 9
IS 3
BP 142
EP 149
DI 10.1108/13552540310477445
PG 8
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 694FL
UT WOS:000183763200004
DA 2018-10-19
ER

PT S
AU Krishnan, RV
   Bhaumik, SK
AF Krishnan, RV
   Bhaumik, SK
BE Mohan, S
   Dattaguru, B
   Gopalakrishnan, S
TI Shape memory alloys: Properties and engineering applications
SO SMART MATERIALS, STRUCTURES, AND SYSTEM, PTS 1 AND 2
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Smart Materials, Structures and Systems
CY DEC 12-14, 2002
CL BANGALORE, INDIA
SP Inst Smart Struct & Syst, Indian Inst Sci, SPIE
DE shape memory alloys; properties; applications
ID FATIGUE BEHAVIOR; MARTENSITIC TRANSFORMATIONS; COMPOSITES
AB Shape memory alloys (SMAs) are a promising class of advanced materials with interesting properties, which make them suitable for a variety of engineering applications. The uses of SMAs in engineering applications have extended year by year. SMAs are being used in a number of industrial applications such as aerospace, automotive, biomaterial, chemical-sensor, construction, electronics, metal forming, storage and retrieval of information, optics etc. This paper highlights some of these engineering applications of SMAs. This also includes the recent research on the possible use of SMAs in smart structures. The important properties of SMAs that provide the impetus for using these materials in innovative applications are (i) shape memory effect, (ii) pseudoelasticity and (iii) high damping capacity. For a better appreciation, some of the basic principles and properties related to the unique behaviour of this class of materials are also discussed.
C1 Natl Aeronaut Lab, Div Mat Sci, Bangalore 560017, Karnataka, India.
RP Krishnan, RV (reprint author), Natl Aeronaut Lab, Div Mat Sci, Bangalore 560017, Karnataka, India.
CR ANDREASEN GF, 1978, AM J ORTHOD DENTOFAC, V73, P141
   BEAUCHAMP CH, 1992, P SOC PHOTO-OPT INS, V1777, P189
   Buehler W., 1965, US Patent, Patent No. [3,174,851, 3174851]
   BUEHLER WJ, 1963, J APPL PHYS, V34, P1475, DOI 10.1063/1.1729603
   CHANG LC, 1951, T AM I MIN MET ENG, V191, P47
   DELAEY L, 1974, J MATER SCI, V9, P1521, DOI 10.1007/BF00552939
   DOLEE M, 2001, INT J MECH SCI, V43, P2657
   DUERIG TW, 1990, MATER SCI FORUM, V56, P679
   Duerig TW, 1990, ENG ASPECTS SHAPE ME, P115
   Ford DS, 1996, ACTA MATER, V44, P2295, DOI 10.1016/1359-6454(95)00343-6
   Greninger AB, 1938, T AM I MIN MET ENG, V128, P337
   Hodgson D. E., 1990, METALS HDB, V2, P897
   MCNICHOLS JL, 1981, J APPL PHYS, V52, P7442, DOI 10.1063/1.328738
   MELTON KN, 1979, MATER SCI ENG, V40, P81, DOI 10.1016/0025-5416(79)90010-7
   OHKATA I, 1998, SHAPE MEMORY MAT, P240
   OTSUKA K, 1977, SCRIPTA METALL MATER, V11, P757, DOI 10.1016/0036-9748(77)90071-0
   Otsuka K., 1998, SHAPE MEMORY MAT, P27
   Porter GA, 2000, JOM-J MIN MET MAT S, V52, P52, DOI 10.1007/s11837-000-0084-2
   Saburi T, 1998, SHAPE MEMORY MAT, P49
   SABURI T, 1980, ACTA METALL, V28, P28
   SCHROEDER TA, 1977, SCRIPTA METALL MATER, V11, P225, DOI 10.1016/0036-9748(77)90058-8
   Sittner P, 2000, JOM-J MIN MET MAT S, V52, P15, DOI 10.1007/s11837-000-0077-1
   Srinivasan A. V., 2001, SMART STRUCTURES ANA
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
   VANHUMBEECK J, 1991, ENDEAVOUR, V15, P148, DOI 10.1016/0160-9327(91)90119-V
   VANHUMBEECK J, 1998, SHAPE MEMORY ALLOYS
   VANHUMBEECK J, 1991, J PHYS C SOLID STATE, V4, P189
   VANHUMBEECK J, 1992, MATER RES SOC S P, V246, P377
   WARAM T, 1990, ENG ASPECTS SHAPE ME, P234
   Wayman CM, 1990, ENG ASPECTS SHAPE ME, P3
   Wilkes KE, 2000, JOM-J MIN MET MAT S, V52, P45, DOI 10.1007/s11837-000-0083-3
   Zhao C, 2001, ADV MATER PROCESS, P33
NR 32
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 0-8194-4868-0
J9 PROC SPIE
PY 2003
VL 5062
BP 879
EP 890
DI 10.1117/12.514735
PN 1&2
PG 12
WC Engineering, Electrical & Electronic; Engineering, Mechanical; Materials
   Science, Multidisciplinary
SC Engineering; Materials Science
GA BX98A
UT WOS:000187118400116
DA 2018-10-19
ER

PT J
AU Notingher, I
   Jones, JR
   Verrier, S
   Bisson, I
   Embanga, P
   Edwards, P
   Polak, JM
   Hench, LL
AF Notingher, I
   Jones, JR
   Verrier, S
   Bisson, I
   Embanga, P
   Edwards, P
   Polak, JM
   Hench, LL
TI Application of FTIR and Raman spectroscopy to characterisation of
   bioactive materials and living cells
SO SPECTROSCOPY-AN INTERNATIONAL JOURNAL
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Biomedical Spectroscopy
CY JUL 07-10, 2002
CL CARDIFF, WALES
ID IN-VITRO; HYDROXYAPATITE FORMATION; EXCIMER LASER; GEL; TISSUE;
   SPECTROMICROSCOPY; BIOMATERIALS; CHROMOSOMES; RADIATION; GLASSES
AB Both Fourier Transform Infrared (FTIR) and Raman spectroscopy have been applied to the in vitro characterisation of biomaterials, mainly surface reactions leading to the formation of a biologically active hydroxycarbonate apatite (HCA) layer on the sample surface when immersed in simulated body fluids (SBF). The HCA layer indicates the degree of bioactivity of the sample, because it leads to a strong bond between the biomaterial and living tissue. Reflection measurements using FTIR allow quick, non-destructive detection of the HCA layer for solid and powder samples. Due to the low Raman scattering efficiency and low absorption of water in the visible-near infrared region, Raman micro-spectroscopy was successfully used for the in situ characterisation of 20 and 40 mum diameter 45S5 Bioglass(R) fibres. The in situ capabilities of the Raman micro-spectrometer have also been extended to the characterisation of living cells attached on bioinert silica and bioactive 45S5 Bioglass(R) and 58S substrates. Using a high power 785 nm laser, living cells in physiological conditions can be real-time sampled over long periods of time without inducing cell damage and with good signal strength. Cell death can be monitored because it proved to induce strong changes in the Raman signature in the spectral regions 1000-1150 cm(-1) and 1550-1650 cm(-1).
C1 Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   Univ London Imperial Coll Sci Technol & Med, Tissue Engn Ctr, London SW10 9NH, England.
RI Jones, Julian/B-1007-2012
OI Jones, Julian/0000-0002-2647-8024
CR BLAKESLEE KC, 1971, J AM CERAM SOC, V54, P559, DOI 10.1111/j.1151-2916.1971.tb12207.x
   Blazewicz M, 2001, J MOL STRUCT, V563, P147, DOI 10.1016/S0022-2860(00)00956-X
   Boydston-White S, 1999, BIOSPECTROSCOPY, V5, P219, DOI 10.1002/(SICI)1520-6343(1999)5:4<219::AID-BSPY2>3.0.CO;2-O
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Carter EA, 2001, INFRARED RAMAN SPECT, P421
   Clark A.E., 1979, MAGAZINES IND, P1
   FELD MS, 1991, AM HEART J, V122, P1803, DOI 10.1016/0002-8703(91)90326-D
   GREENSPAN DC, 1994, P M C BIOC, P28
   GREVE J, 1993, ADV SPECTROSC, V20, P231
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench LL, 1998, J SOL-GEL SCI TECHN, V13, P245, DOI 10.1023/A:1008643303888
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HENCHA LL, 1993, INTRO BIOCERAMICS
   HILL RG, 1996, J MATER SCI LETT, V15, P112
   Holman HN, 2000, BIOPOLYMERS, V57, P329
   Holman HYN, 2000, ENVIRON SCI TECHNOL, V34, P2513, DOI 10.1021/es991430w
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   LASH P, 2002, VIB SPECTROSC, V848, P1
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Mahadevan-Jansen A, 1996, J Biomed Opt, V1, P31, DOI 10.1117/12.227815
   Nakamoto K., 1997, INFRARED RAMAN SPECT
   NAUMANN D, 2001, INFRARED RAMAN SPECT, P323
   Notingher I, 2002, SPECTROSC-INT J, V16, P43, DOI 10.1155/2002/408381
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   OVERMAN SA, 1998, BIOSPECTROSCOPY, V4, P47
   Peltola T, 2001, J BIOMED MATER RES, V54, P579, DOI 10.1002/1097-4636(20010315)54:4<579::AID-JBM150>3.3.CO;2-H
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   PEREIRA MM, 1994, J MATER SYNTH PROCES, V2, P189
   PUPPELS GJ, 1991, EXP CELL RES, V195, P361, DOI 10.1016/0014-4827(91)90385-8
   PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7
   PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0
   RASMUSSEN RE, 1989, PHOTOCHEM PHOTOBIOL, V49, P413, DOI 10.1111/j.1751-1097.1989.tb09188.x
   REHMAN I, 1993, BIOCERAMICS, V6, P123
   REHMAN I, 1994, BIOCERAMICS, V7, P79
   REVELL PA, 1986, PATHOLOGY BONE
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   SEPULVEDA P, 2000, P 13 C BIOC, P629
   Wallace KE, 1999, J MATER SCI-MATER M, V10, P697, DOI 10.1023/A:1008910718446
   WARREN LD, 1989, J BIOMED MATER RES-A, V23, P201
   WILSON J, 1990, P 3 C BIOC, P283
   Wolthuis R, 1999, FLUORESCENT LUMINESC, P433
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
NR 51
TC 32
Z9 33
U1 0
U2 29
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0712-4813
J9 SPECTROSC-INT J
JI Spectr.-Int. J.
PY 2003
VL 17
IS 2-3
BP 275
EP 288
DI 10.1155/2003/893584
PG 14
WC Biochemical Research Methods; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 665MB
UT WOS:000182123800015
OA Bronze, Other Gold
DA 2018-10-19
ER

PT J
AU Shuhaiber, JH
   Shuhaiber, HH
AF Shuhaiber, JH
   Shuhaiber, HH
TI Plantaris tendon graft for atrioventricular valve repair - A novel
   hypothetical technique
SO TEXAS HEART INSTITUTE JOURNAL
LA English
DT Article
DE bioprosthesis; chordae tendineae; heart valve prosthesis; methods;
   mitral valve/surgery; tendons/anatomy & histology; transplantation;
   autologous; tricuspid valve/surgery
ID REGURGITATION
AB Heart valve repair is a biomaterial-dependent procedure, yet autogenous tissue for valvular reconstruction has to date been obtained mostly from the pericardium and fascia lata. Most clinical studies recommend valve repair as an alternative to replacement. We now put forward a hypothesis, extrapolated from hand surgery, for use of the plantaris tendon in heart valve repair. This proposal, if implemented, would increase the supply of autogenous donor tissue for valve repair thereby enhancing the surgeon's armamentarium. The report describes a novel technique that in our judgment warrants future clinical development.
C1 Univ Illinois, Dept Surg, Chicago, IL 60612 USA.
   St Georges Med Sch, St Georges, Grenada.
RP Shuhaiber, JH (reprint author), Univ Illinois, Dept Surg, 840 Southwood St,CSB Suite 518-E, Chicago, IL 60612 USA.
CR BRAN MR, 1996, J BIOMOL SCREEN, V1, P43
   CARABELLO BA, 1992, ANN THORAC SURG, V53, P191, DOI 10.1016/0003-4975(92)91319-5
   CUTTS A, 1991, J ANAT, V176, P133
   DELOCHE A, 1990, J THORAC CARDIOV SUR, V99, P990
   ENRIQUEZSARANO M, 1995, CIRCULATION, V91, P1022, DOI 10.1161/01.CIR.91.4.1022
   FRATER RWM, 1983, ANN THORAC SURG, V35, P14, DOI 10.1016/S0003-4975(10)61426-9
   GELBERMAN RH, 1985, J HAND SURG-AM, V10A, P776, DOI 10.1016/S0363-5023(85)80151-9
   GRAY H, 2003, ANATOMY HUMAN BODY
   IONESCU MI, 1970, BRIT J SURG, V57, P437, DOI 10.1002/bjs.1800570609
   KER RF, 1981, J EXP BIOL, V93, P283
   KOBAYASHI Y, 1996, CIRCULATION, V94, P29
   MCCARTHY JG, 1990, PLASTIC SURG, V1, P535
   SIMPSON SL, 1991, J HAND SURG-AM, V16A, P708
NR 13
TC 13
Z9 15
U1 0
U2 0
PU TEXAS HEART INST
PI HOUSTON
PA PO BOX 20345, HOUSTON, TX 77225-0345 USA
SN 0730-2347
J9 TEX HEART I J
JI Tex. Heart Inst. J.
PY 2003
VL 30
IS 1
BP 42
EP 44
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 652ZA
UT WOS:000181409700009
PM 12638670
DA 2018-10-19
ER

PT S
AU Nebe, B
   Luthen, F
   Baumann, A
   Beck, U
   Diener, A
   Neumann, HG
   Rychly, J
AF Nebe, B
   Luthen, F
   Baumann, A
   Beck, U
   Diener, A
   Neumann, HG
   Rychly, J
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Effects of titanium surface topography on the cell-extracellular matrix
   interaction in osteoblasts
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE titanium surface topography; V2A stainless steel; integrin adhesions;
   vinculin; actin cytoskeleton; fibronectin; human osteoblasts
ID INTEGRINS; ADHESION
AB Mechanisms of cell adhesion and extracellular matrix formation are primary processes in the interaction with the biomaterial. We investigated whether the surface topography of titanium influences the cell-extracellular matrix interaction of human osteoblasts in comparison with V2A stainless steel. Corundum blasted titanium as the roughest surface inhibited the formation of fibrillar adhesions of beta1, led to clustered vinculin contacts, and to their impaired motility, and affected the organization and the alignment of the actin cytoskeleton as well as of secreted fibronectin. These effects of surface topography of pure titanium on human osteoblasts were comparable with the influence of stainless steel although the R-a value is distinctly (43 times) lower. We conclude that cell-extracellular matrix interactions were controlled by the surface topography of titanium which has the same influence comparable to chemical components of V2A stainless steel. We suggest that local differences in cell signaling maintain the cell physiology.
C1 Univ Rostock, Dept Internal Med, D-18057 Rostock, Germany.
   Univ Rostock, Dept Elect Engn & Informat Technol, D-18051 Rostock, Germany.
RP Nebe, B (reprint author), Univ Rostock, Dept Internal Med, Ernst Heydemann Str 6, D-18057 Rostock, Germany.
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lauffenburger DA, 2001, NAT CELL BIOL, V3, P110
   Nebe B, 2001, BIOMATERIALS, V22, P2425, DOI 10.1016/S0142-9612(00)00430-0
   Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603
   Rychly J, 1998, CELL BIOL INT, V22, P7, DOI 10.1006/cbir.1997.0210
   SCHWARTZ MA, 1994, MOL BIOL CELL, V5, P389
NR 12
TC 4
Z9 4
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3023
EP 3029
DI 10.4028/www.scientific.net/MSF.426-432.3023
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400486
DA 2018-10-19
ER

PT S
AU Iost, A
   Najjar, D
   Anselme, K
   Bigerelle, M
AF Iost, A
   Najjar, D
   Anselme, K
   Bigerelle, M
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Relationships between the surface morphology and a physical response in
   the biomaterial field
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE biomaterial; roughness; cell adhesion; statistics; Bootstrap
ID ADHESION; CELLS
AB Because of the various industrial and scientific interests, a proliferation of roughness parameters, possibly running into hundreds, has been developed to describe the different kinds of surface morphology with regard to specific functions, properties or applications. In spite of this of roughness parameters, there is still no complete comprehensive account for the relevance of all these parameters. Hence, the selection of a roughness parameter for describing and/or modelling a surface morphology is very often subjective.
   Thanks to a methodology based on the Computer-Based Bootstrap Method (CBBM), the experimental results of this study exhibit the major influence of the order parameter as far as the relationships between the surface morphology of Ti6Al4V substrates and the in vitro cell adhesion of human osteoblasts are concerned. The lower is the value of this roughness parameter that characterises the surface texture, the better is the cell adhesion. Moreover, the cell adhesion seems to be rather affected by the surface morphology than by the surface chemistry in the experimental conditions of our work.
C1 ENSAM, Equipe Surfaces & Interfaces, UMR CNRS 8517, Lab Met Phys & Genie Mat, F-59046 Lille, France.
   Univ Littoral & Cote Opale, Lab Rech Biomat & Biotechnol, LR2B, F-62608 Berck Sur Mer, France.
RP Iost, A (reprint author), ENSAM, Equipe Surfaces & Interfaces, UMR CNRS 8517, Lab Met Phys & Genie Mat, 8 Blvd Louis XIV, F-59046 Lille, France.
RI IOST, alain/D-8909-2011
OI IOST, alain/0000-0003-2185-4673; Anselme, Karine/0000-0002-6669-205X;
   Maxence, Bigerelle/0000-0002-4144-245X
CR Bigerelle M, 2002, BIOMOL ENG, V19, P79, DOI 10.1016/S1389-0344(02)00048-5
   BIGERELLE M, IN PRESS J MAT SCI
   DEGLIANNI DD, 2001, BIOMATERIALS, V22, P1241
   EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552
   EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390
   EFRON B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   NAJJAR D, IN PRESS WEAR
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Scotchford CA, 2003, BIOMATERIALS, V24, P1147, DOI 10.1016/S0142-9612(02)00488-X
   ter Brugge PJ, 2002, BIOMATERIALS, V23, P3269, DOI 10.1016/S0142-9612(02)00085-6
   Tibshirani R. J, 1993, INTRO BOOTSTRAP
NR 12
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3031
EP 3036
DI 10.4028/www.scientific.net/MSF.426-432.3031
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400487
DA 2018-10-19
ER

PT S
AU Stamm, C
   Freier, T
   Backhaus-Pohl, C
   Trenkmann, N
   Drechsel, A
   Schmitz, KP
   Steinhoff, G
   Haubold, A
AF Stamm, C
   Freier, T
   Backhaus-Pohl, C
   Trenkmann, N
   Drechsel, A
   Schmitz, KP
   Steinhoff, G
   Haubold, A
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Biomaterial/polymer composite for heart valve engineering:
   Biocompatibility testing
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE heart; bioengineering; polymer; surgery; tissue engineering; heart valve
ID TISSUE
AB In cardiovascular medicine, there is an urgent need for improved heart valve prostheses, since traditional designs are either subject to rapid degeneration (tissue valves) or have a high risk of blood clot formation (mechanical prostheses). As part of an innovative heart valve design, we have manufactured biomaterial/polymer composite materials based on decellularized vascular matrix scaffolds that are coated with biodegradable polymers. The goal is to improve the mechanical strength of the decellularized matrix so that is able to withstand hemodynamic forces. The polymer is then subject to slow degradation, while the matrix scaffold is repopulated with the recipients own cells. Here, we describe a series of experiments that assess the biocompatibility of such composite materials, which is prerequisite for successful in vivo application.
C1 Univ Rostock, Dept Cardiac Surg, D-18057 Rostock, Germany.
   Univ Rostock, Inst Biomed Engn, D-18055 Rostock, Germany.
RP Stamm, C (reprint author), Univ Rostock, Dept Cardiac Surg, Schillingallee 35, D-18057 Rostock, Germany.
RI Stamm, Christof/J-5719-2014
CR Hoerstrup SP, 2000, CIRCULATION, V102, P44
   SHINOKA T, 1995, ANN THORAC SURG, V60, P513
   Sodian R, 2000, CIRCULATION, V102, P22
   Steinhoff G, 2000, CIRCULATION, V102, P50
NR 4
TC 1
Z9 1
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3049
EP 3054
DI 10.4028/www.scientific.net/MSF.426-432.3049
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400490
DA 2018-10-19
ER

PT S
AU Khosravi, A
   Stamm, C
   Philipp, M
   Freier, T
   Schmitz, KP
   Haubold, A
   Steinhoff, G
AF Khosravi, A
   Stamm, C
   Philipp, M
   Freier, T
   Schmitz, KP
   Haubold, A
   Steinhoff, G
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Pulsatile flow testing of a biomaterial/polymer composite heart valve
   obtained through tissue engineering
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE heart valve; bioengineering; polymer; tissue engineering; pulse
   duplicator
ID GROWN IN-VITRO; REPLACEMENT
AB To improve biocompatibility and durability of valve prostheses, "tissue engineering" is being investigated to develop an ideal replacement heart valve. Our approach is to extract all cells from porcine heart valves leaving behind only a collagenous matrix. The remaining collagen framework is reinforced using slowly resorbable, biodegradable polymers poly(4-hydroxybutyrate) and poly(3/4-hydroxybutyrate). To determine if the bioresorbable polymer/collagen composite possesses the mechanical properties necessary for a replacement heart valve, pulsatile flow studies were carried out in a pulse-duplicator. Instrumentation allows simultaneously measurement of flow rate and pressure drop across the valve, while leaflet motion is assessed by high-resolution video morphometry (500 frames/sec). Matrices at various stages in the tissue engineering process were tested. Strictly decellularized valves performed like normal valves with minimal leakage. The mechanical properties of the polymer/collagen composite valves varied markedly, depending on the type of polymer as well as the polymer concentration in the coating suspension. Further development is necessary to achieve an effective polymer/collagen coupling for dynamic usage.
C1 Univ Rostock, Dept Cardiac Surg, D-18057 Rostock, Germany.
   Univ Rostock, Inst Biomed Engn, D-18055 Rostock, Germany.
RP Khosravi, A (reprint author), Univ Rostock, Dept Cardiac Surg, Schillingallee 35, D-18057 Rostock, Germany.
RI Stamm, Christof/J-5719-2014
CR ANDERSON JM, 1995, J BIOMED MAT RES, V29
   BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Love JW, 1997, PRINCIPLES TISSUE EN, P365
   Mayer J E Jr, 1995, Semin Thorac Cardiovasc Surg, V7, P130
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4
   SKALAK R, 1988, TISS ENG GRANL LAK T, P26
   Sodian R, 2000, CIRCULATION, V102, P22
   Steinhoff G, 2000, CIRCULATION, V102, P50
   WAIN EH, 1980, INT J ARTIF ORGANS, V3, P169
NR 15
TC 2
Z9 2
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3067
EP 3072
DI 10.4028/www.scientific.net/MSF.426-432.3067
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400493
DA 2018-10-19
ER

PT S
AU Asaoka, K
   Kon, M
AF Asaoka, K
   Kon, M
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Sintered porous titanium and titanium alloys as advanced biomaterials
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE titanium; sintering; surface modification; calcium phosphate;
   hydroxyapatite; biomimetic coating
ID IMPLANTS; SURFACE
AB Titanium (Ti) and Ti alloys such as Ti-6Al-4V are used for dental and medical implant materials. These alloys have excellent mechanical properties, but inferior to calcium phosphate such as hydroxyapatite (HAp) in biocompatibility. To improve the biocompatibility, surface modification of the calcium phosphate by chemical, physical or electro-chemical treatments were applied and employed in clinical devices. Porous titanium can extremely improve activity of the modification by the HAp. Sintered porous titanium compacts, which have continuous pores, were fabricated by spark plasma sintering (SPS). Three different grain size of Ti powders (250, 150 and 45 mum under) and titanium alloy powders (Ti-6Al-4V; 150 mum under) were employed to arrange the sintered specimens. The powders of pure Ti and Ti alloy were sintered by SPS in the carbon dies to the shape, respectively. To evaluate the degree of sintering by SPS process, the sintered specimens were annealed at 1000degreesC for 24 hours in an evacuated furnace. Compressive stress-strain curve of the annealed specimens were measured, and compared with that of the specimens by SPS. The sintered compacts were immersed in simulated body fluid and evaluate the biocompatibility. Calcium and phosphate ions were precipitated as HAp crystals on the sintered particles. Because HAp is a main component of bone structure, functional proteins are expected to impregnate with the precipitated HAp crystals. It was concluded that the developed titanium compact is an advanced biomaterial both with excellent mechanical properties and good biocompatibility.
C1 Univ Tokushima, Sch Dent, Dept Dent Engn, Tokushima 7708504, Japan.
RP Asaoka, K (reprint author), Univ Tokushima, Sch Dent, Dept Dent Engn, 3 Kuramoto Cho, Tokushima 7708504, Japan.
CR Asaoka K, 2001, PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS AND PROCESSING, VOLS I AND II, P245
   ASAOKA K, 1985, J BIOMED MATER RES, V19, P699, DOI 10.1002/jbm.820190609
   ASAOKA K, 2002, T 28 ANN M SOC BIOM, P630
   *ASM, 1981, ASM MET HDB
   BRONZINO JD, 2000, BIOL ENG HDB
   FENG B, J MAT SCI MAT MED, V13, P457
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Hamada K, 2002, BIOMATERIALS, V23, P2265, DOI 10.1016/S0142-9612(01)00361-1
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   Li W, 2003, BIOMATERIALS, V24, P937, DOI 10.1016/S0142-9612(02)00428-3
   Park JB, 1979, BIOMATERIALS INTRO
NR 11
TC 9
Z9 9
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3079
EP 3084
DI 10.4028/www.scientific.net/MSF.426-432.3079
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400495
DA 2018-10-19
ER

PT S
AU Kempen, DHR
   Kim, CW
   Lu, L
   Dhert, WJA
   Currier, BL
   Yaszemski, MJ
AF Kempen, DHR
   Kim, CW
   Lu, L
   Dhert, WJA
   Currier, BL
   Yaszemski, MJ
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Controlled release from poly(lactic-co-glycolic acid) microspheres
   embedded in an injectable, biodegradable scaffold for bone tissue
   engineering
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE poly(lactic-co-glycolic acid); poly(propylene fumarate); microspheres;
   controlled release; injectable biomaterial; bone; tissue engineering
ID POLY(PROPYLENE FUMARATE); DEGRADATION; COMPOSITE
AB For the repair of bone defects, the ideal biomaterial has good mechanical properties, can be fabricated easily into a desired shape, supports cell attachment, contains factors to induce bone formation, and is biodegradable to permit natural bone formation and remodeling. The synthetic polymer poly(propylene fumarate) (PPF) satisfies these criteria. This study presents a new approach to fabricate porous PPF scaffolds with incorporated microspheres for the release of bioactive molecules. Using a double emulsion-solvent extraction technique, the model drug Texas red dextran was encapsulated into poly(lactic-co-glycolic acid) microspheres. Porous scaffolds were fabricated by injecting PPF in a low viscosity state with 100 or 250 mg microspheres into a Teflon coated mold using a disposable syringe with needle. A foaming technique was used to create porosity. The average porosity of the scaffolds was 65.5 ( +/-3.5) % and 62.8 ( +/-7.8) % for the 100 mg and 250 mg microsphere loading respectively. Scanning electron microscopy (SEM) and confocal microscopy showed interconnectivity of the pores and presence of microspheres within the scaffold. For all formulations, the compressive modulus values of the scaffold-microsphere composites were between 2.4-15.3 MPa initially and between 14.9-62.8 MPa after 28 days of degradation in phosphate buffered saline. Scaffold and microspheres exhibited a sustained release of the model drug for at least 28 days. Compared to microspheres alone, the scaffold-microsphere composite had a lower burst release during the initial phase of release. This study shows a promising system for delivery of bioactive molecules from an injectable, biodegradable scaffold-microsphere composite.
C1 Mayo Clin, Tissue Engn & Polymer Biomat Lab, Dept Orthoped Surg, Rochester, MN 55905 USA.
   Univ Calif San Diego, Dept Orthoped Surg, La Jolla, CA 92093 USA.
   Vet Adm Med Ctr, La Jolla, CA 90034 USA.
   Univ Utrecht, Med Ctr, Dept Orthoped, Utrecht, Netherlands.
RP Kempen, DHR (reprint author), Mayo Clin, Tissue Engn & Polymer Biomat Lab, Dept Orthoped Surg, Rochester, MN 55905 USA.
CR ASLAM MA, 2002, T 28 ANN M SOC BIOM
   Cleland JL, 1996, PHARMACEUT RES, V13, P1464, DOI 10.1023/A:1016063109373
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   JO S, 2000, IN PRESS POLYMER
   LU L, 2000, J BONE JOINT S A 2 S, V83, P82
   Morita T, 2000, J CONTROL RELEASE, V69, P435, DOI 10.1016/S0168-3659(00)00326-6
   Oldham JB, 2000, J BIOMECH ENG-T ASME, V122, P289, DOI 10.1115/1.429662
   PAYNE RG, 2001, THESIS RICE U HOUSTO
   Peter SJ, 1997, TISSUE ENG, V3, P207, DOI 10.1089/ten.1997.3.207
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Peter SJ, 1999, J BIOMAT SCI-POLYM E, V10, P363, DOI 10.1163/156856299X00423
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   VERHOF JWM, 2002, J BIOMED MATER RES, V60, P241
NR 13
TC 8
Z9 8
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3151
EP 3156
DI 10.4028/www.scientific.net/MSF.426-432.3151
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400507
DA 2018-10-19
ER

PT S
AU Kasuga, T
   Nogami, M
   Niinomi, M
AF Kasuga, T
   Nogami, M
   Niinomi, M
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Novel machinable calcium phosphate glass-ceramics for biomedical use
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE calcium phosphate; glass; glass-ceramic; sintering; biomaterial;
   machinability; bioactivity; apatite formation; coating; titanium alloy
ID INVERT GLASSES; TITANIUM-ALLOYS; CRYSTALLIZATION; CRYSTAL
AB SiO2-free calcium phosphate glass-ceramics with easy machinability were prepared by heat-treatment of a 60CaO-3OP(2)O(5)-3TiO(2)-7Na(2)O (in mol%) glass. The glass-ceramics containing beta-Ca2P2O7 and beta-Ca-3(PO4)(2) crystals were found to show good machinability, as confirmed by a drilling test using a conventional carbide tool. SEM observation of the glass-ceramic showed that beta-Ca2P2O7 crystals having a layered morphology are interlocking one another; plate-like crystals of several tens nanometers in thickness are piled up. The easy machinability of the glass-ceramics was suggested to result from the cleavage of beta-Ca2P2O7 crystals precipitated in the glass. The glass-ceramics formed bonelike apatite crystals on the surface in simulated body fluid. The glass-ceramics were also found to be strongly joined with a new B-type titanium alloy, Ti-29Nb-13Ta-4.6Zr, by heating in air.
C1 Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan.
   Toyohashi Univ Technol, Toyohashi, Aichi 4118580, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan.
RI Niinomi, Mitsuo/B-5965-2011
CR CORBRIDGE DEC, 1957, ACTA CRYSTALLOGR, V10, P85, DOI 10.1107/S0365110X57000201
   GROSSMAN DG, 1972, J AM CERAM SOC, V55, P446, DOI 10.1111/j.1151-2916.1972.tb11337.x
   HARTMANN P, 1994, J NON-CRYST SOLIDS, V176, P157, DOI 10.1016/0022-3093(94)90073-6
   HOLAND W, 1983, GLASS TECHNOL, V24, P318
   HOLAND W, 1985, J BIOMED MATER RES, V19, P303, DOI 10.1002/jbm.820190311
   Kasuga T, 2001, J AM CERAM SOC, V84, P450
   Kasuga T, 2001, J MATER SCI LETT, V20, P1249, DOI 10.1023/A:1010939326541
   Kasuga T, 2001, J MATER RES, V16, P876, DOI 10.1557/JMR.2001.0107
   Kasuga T, 1998, J MATER RES, V13, P3357, DOI 10.1557/JMR.1998.0455
   Kasuga T, 2001, BIOMATERIALS, V22, P577, DOI 10.1016/S0142-9612(00)00216-7
   Kasuga T, 1999, BIOMATERIALS, V20, P1415, DOI 10.1016/S0142-9612(99)00047-2
   Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5
   KASUGA T, 2003, IN PRESS J AM CERAM, V86
   KASUGA T, 2002, BIOMATER, V24, P283
   Kasuga T, 2001, PHOSPHORUS RES B, V12, P39
   Klein C, 1993, INTRO BIOCERAMICS, V1, P199
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MARTIN SW, 1991, EUR J SOL STATE INOR, V28, P163
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Park JB, 1992, BIOMATERIALS INTRO
   Rawson H., 1960, INORGANIC GLASS FORM, P155
   WEBB NC, 1966, ACTA CRYSTALLOGR, V21, P942, DOI 10.1107/S0365110X66004225
NR 23
TC 2
Z9 2
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3183
EP 3188
DI 10.4028/www.scientific.net/MSF.426-432.3183
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400512
DA 2018-10-19
ER

PT S
AU Sen Gupta, A
   Lopina, ST
AF Sen Gupta, A
   Lopina, ST
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Development of novel "pseudo"polypeptidic biodegradable polymers based
   on natural amino acid L-tyrosine for biomaterial application
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE biomaterial; biodegradable; "pseudo"poly(amino acid)
ID GLUTAMIC-ACID; RELEASE
AB Synthetic biodegradable polymers, using natural metabolites as monomers, have been established as an effective class of biomaterials. The biodegradation of such polymers into the corresponding naturally metabolizable monomers and their derivatives renders the polymers biocompatible. Amino acid "monomers" seem a logical choice for the development of such biomaterials. Despite their biocompatibility, use of poly(amino acids) is limited by practical difficulties like insolubility in common organic solvents, thermolability, unpredictable water intake and swelling behavior, etc., which have been traced back to the highly crystalline structure and hydrogen bonding induced by the sequence of amide(peptide) bonds in the polymer backbone. Hence introduction of non-amide bonds alternating with the amide(peptide) link in the poly(amino acid) backbone is being investigated as one of the ways to circumvent such properties. The resulting polymer would be called a "pseudo"poly(amino acid). The non-peptide link is expected to impart properties that are potentially favorable for biomaterial applications. In this paper development of such "pseudo"poly(amino acids) starting from natural amino acid L-tyrosine, is described. The process involves the synthesis of a model diphenolic compound containing a peptide link, from L-tyrosine. This compound is further polymerized through the phenolic terminals using conventional tools of polymer chemistry to produce non-peptidic polymeric linkages. The resulting polymers, namely, a polycarbonate and a polyphosphate are characterized for their physicochemical properties. Based upon preliminary investigation of these properties, potential biomaterial applications of such polymers are discussed.
C1 Univ Akron, Dept Chem Engn, Akron, OH 44325 USA.
RP Sen Gupta, A (reprint author), Univ Akron, Dept Chem Engn, Akron, OH 44325 USA.
CR ANDERSON JM, 1985, BIOCOMPATIBILITY TIS, P67
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   Hooper KA, 1995, J BIOACT COMPAT POL, V10, P327, DOI 10.1177/088391159501000404
   James K, 1996, TRENDS POLYM SCI, V4, P394
   KEMNITZER J, 1997, HDB BIODEGRADABLE PO, P251
   KOHN J, 1984, POLYM MAT SCI ENG, V51, P119
   MARTIN E C, 1971, Journal of Biomedical Materials Research, V5, P53, DOI 10.1002/jbm.820050105
   MIYAMAE T, Patent No. 3371069
   NATHAN A, 1996, PROTEIN ENG DESIGN, P265
   SIDMAN KR, 1980, J MEMBRANE SCI, V7, P277, DOI 10.1016/S0376-7388(00)80473-1
   SIDMAN KR, 1983, BIOPOLYMERS, V22, P547, DOI 10.1002/bip.360220167
   SPIRA M, 1969, Journal of Biomedical Materials Research, V3, P213, DOI 10.1002/jbm.820030203
NR 12
TC 2
Z9 2
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3261
EP 3266
DI 10.4028/www.scientific.net/MSF.426-432.3261
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400525
DA 2018-10-19
ER

PT S
AU Chou, CW
   Hsu, SH
AF Chou, CW
   Hsu, SH
BE Chandra, T
   Torralba, JM
   Sakai, T
TI Preparation and characterization of chitosan/alginate sponge immobilized
   onto polyurethane-g-acrylic acid modified film surface as a wound
   dressing
SO THERMEC'2003, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 07-11, 2003
CL UNIV CARLOS III MADRID, MADRID, SPAIN
SP Minerals, Met & Mat Soc
HO UNIV CARLOS III MADRID
DE wound dressing; grafting; acrylic acid (AA); polyurethane (PU);
   gamma-ray irradiation
ID HEALING ACCELERATOR; BIOMATERIAL; CHITOSAN; CHITIN
AB The grafting of acrylic acid (AA) onto polyurethane (PU) films was induced by gamma-ray irradiation without degassing to obtain the PU-g-AA modified PU films. The chitosan/alginate (CA) gel was further grafted onto the PU-g-AA modified PU films by using 1-ethyl-3- (3-dimethyamino propyl) carbodiimide (EDC). The PU-g-AA modified PU films were characterized by FTIR spectroscopy. The effect of acrylic acid and CA gel grafting on the properties was investigated. The results show that the PU films exhibited were sufficiently strength and that the acrylic acid was grafted onto PU films by gamma-ray irradiation. The hydrophility of PU films significantly increased after graft polymerization with gamma-ray irradiation.
C1 Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan.
RP Chou, CW (reprint author), Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan.
OI Hsu, Shan-hui/0000-0003-3399-055X
CR CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   FUKASAWA M, 1992, SURG TODAY, V22, P333, DOI 10.1007/BF00308742
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Purna S K, 2000, Burns, V26, P54
   Radhakrishnan VV, 1991, BIOMEDICINE, V2, P3
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P83
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
NR 10
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-919-9
J9 MATER SCI FORUM
PY 2003
VL 426-4
BP 3273
EP 3277
DI 10.4028/www.scientific.net/MSF.426-432.3273
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BW92N
UT WOS:000183626400527
DA 2018-10-19
ER

PT J
AU Mendes, SC
   Bezemer, J
   Claase, MB
   Grijpma, DW
   Bellia, G
   Degli-Innocenti, F
   Reis, RL
   De Groot, K
   Van Blitterswijk, CA
   De Bruijn, JD
AF Mendes, SC
   Bezemer, J
   Claase, MB
   Grijpma, DW
   Bellia, G
   Degli-Innocenti, F
   Reis, RL
   De Groot, K
   Van Blitterswijk, CA
   De Bruijn, JD
TI Evaluation of two biodegradable polymeric systems as substrates for bone
   tissue engineering
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT International Conference on Materials for Advanced Technologies
   (ICMAT2001)
CY JUL 01-06, 2001
CL SINGAPORE, SINGAPORE
SP Mat Res Soc, Int Union Mat Res Soc
ID MARROW STROMAL FIBROBLASTS; IN-VIVO; POROUS HYDROXYAPATITE; CULTURED
   BONE; CELLS; CERAMICS; SCAFFOLDS; TRANSPLANTATION; OSTEOGENESIS;
   BIOMATERIAL
AB The aim of this study was to evaluate two biodegradable polymeric systems as scaffolds for bone tissue engineering. Rat bone marrow cells were seeded and cultured for 1 week on two biodegradable porous polymeric systems, one composed of poly(ethylene glycol)-terephthalate/poly(butylene terephthalate) (PEGT/PBT) and the other composed of cornstarch blended with poly(epsilon-caprolactone) (SPCL). Porous hydroxyapatite granules were used as controls. The ability of cells to proliferate and form extracellular matrix on these scaffolds was assessed by a DNA quantification assay and by scanning electron microscopy examination; their osteogenic differentiation was screened by the expression of alkaline phosphatase. In addition, the in vivo osteogenic potential of the engineered constructs was evaluated through ectopic implantation in a nude mouse model. Results revealed that cells were able to proliferate, differentiate, and form extracellular matrix on all materials tested. Moreover, all constructs induced abundant formation of bone and bone marrow after 4 weeks of implantation. The extent of osteogenesis (similar to30% of void volume) was similar in all types of implants. However, the amount of bone marrow and the degree of bone contact were higher on HA scaffolds, indicating that the polymers still need to be modulated for higher osteoconductive capacity. Nevertheless, the findings suggest that both PEGT/PBT and SPCL systems are excellent candidates to be used as scaffolds for a cell therapy approach in the treatment of bone defects.
C1 IsoTis NV, NL-3720 MB Bilthoven, Netherlands.
   Univ Twente, BMTI, NL-7500 AE Enschede, Netherlands.
   Univ Twente, Dept Polymer Chem & Biomat, NL-7500 AE Enschede, Netherlands.
   Novamont, Novara, Italy.
   Univ Minho, Dept Polymer Engn, Guimaraes, Portugal.
RP De Bruijn, JD (reprint author), IsoTis NV, POB 98, NL-3720 MB Bilthoven, Netherlands.
RI Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Degli
   Innocenti, Francesco/0000-0001-5572-0935
CR Anselme K, 1999, BONE, V25, p51S, DOI 10.1016/S8756-3282(99)00133-7
   AUBIN JE, 1996, PRINCIPLES BONE BIOL, P39
   BAKKER D, 1990, J BIOMED MATER RES, V24, P277, DOI 10.1002/jbm.820240302
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Bruder SP, 1997, BONE, V21, P225, DOI 10.1016/S8756-3282(97)00127-0
   Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   Calvert JW, 2000, J BIOMED MATER RES, V52, P279, DOI 10.1002/1097-4636(200011)52:2<279::AID-JBM6>3.0.CO;2-8
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   DEBOER HH, 1988, CLIN ORTHOP RELAT R, P292
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Ishaug Riley S L, 1997, J BIOMED MATER RES, V36, P1
   Ishaug Riley SL, 1998, BIOMATERIALS, V19, P1405
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Langer R, 1997, PHARMACEUT RES, V14, P840, DOI 10.1023/A:1012131329148
   Laurencin C. T., 1999, CURR OPIN ORTHOP, V10, P445, DOI DOI 10.1097/00001433-199912000-00005
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Mendes SC, 1998, J MATER SCI-MATER M, V9, P855, DOI 10.1023/A:1008904413859
   MENDES SC, 2000, 6 WORLD BIOM C KAM H
   MENDES SC, 2000, BONE ENG, P505
   Ng Kee Woei, 2001, Tissue Engineering, V7, P441, DOI 10.1089/10763270152436490
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OHGUSHI H, 1990, ACTA ORTHOP SCAND, V61, P431, DOI 10.3109/17453679008993556
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   RADDER AM, 1994, J BIOMED MATER RES, V28, P141, DOI 10.1002/jbm.820280202
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   Weng YL, 2001, J ORAL MAXIL SURG, V59, P185, DOI 10.1053/joms.2001.20491
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
   Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P49
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
NR 40
TC 41
Z9 41
U1 0
U2 6
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PY 2003
VL 9
SU 1
BP S91
EP S101
DI 10.1089/10763270360697003
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 715ZN
UT WOS:000185004500008
PM 14511473
DA 2018-10-19
ER

PT S
AU Lauto, A
   Stewart, RB
   Felsen, D
   Foster, J
   Poole-Warren, L
   Poppas, DP
AF Lauto, A
   Stewart, RB
   Felsen, D
   Foster, J
   Poole-Warren, L
   Poppas, DP
BE Longo, L
   Hofstetter, AG
   Pascu, ML
   Waidelich, WRA
TI Low temperature solder for laser tissue welding
SO WINDOW ON THE LASER MEDICINE WORLD
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on A Window on the Laser Medicine World
CY OCT 28-31, 2002
CL FLORENCE, ITALY
SP IALMS, ILM, President Italian Repub, MURST, European Community, Florence Med Assoc, Florence Univ, Regione Toscana, Ente Cassa Risparmio Firenze, ISLMS, SPIE Romania Chapter, OSA, EOS, RSLMB, Natl Inst Laser Plasma Radiat Phys, ESLAS, Forum Venoso Latino Amer, WALT
DE solder strength; temperature control; biomaterial
ID PROTEIN SOLDER; IN-VIVO; NERVE REPAIR; RECONSTRUCTION; CLOSURE; MODEL
AB In this study, a two layer (TL) solid solder was developed-with a fixed thickness to minimize the difference in temperature across the solder (DeltaT) and to weld at low temperature. Solder strips comprising two layers (65% albumin, 35% waters were welded onto rectangular sections of dog small intestine by a diode laser (lambda=808 nm). The laser delivered a power of 170+/-10 mW through an optical fiber (spot sizesimilar to1 mm) for 100 seconds. A solder layer incorporated also a dye (carbon black, 0.25%) to absorb the laser radiation. A thermocouple and an infrared thermometer system recorded the temperatures at the tissue interface and at the external solder surface, during welding. The repaired tissue was tested for tensile strength by a calibrated tensiometer.
   The TL strips were able to minimize DeltaT (12+/-4 degreesC) and control the temperature at tissue-interface. The strips fused on tissue at 55less than or equal toTless than or equal to62 degreesC had higher tensile strength than the strips soldered at 51less than or equal toTless than or equal to55 degreesC (19.1+/-6.6 versus 13.1+/-6.4 gmf). The solid solder could efficiently weld at 60 degreesC as it became insoluble and formed stable bonds with tissue. Fluid albumin solders, by contrast, requires temperatures greater than or equal to70 degreesC for tissue repair, which cause more irreversible thermal damage.
C1 Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
RP Lauto, A (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
CR Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   Cilesiz I, 1997, LASER SURG MED, V21, P269, DOI 10.1002/(SICI)1096-9101(1997)21:3<269::AID-LSM7>3.0.CO;2-O
   Fung LC, 1999, LASER SURG MED, V25, P285, DOI 10.1002/(SICI)1096-9101(1999)25:4<285::AID-LSM3>3.0.CO;2-S
   Kirsch AJ, 1997, UROLOGY, V50, P263, DOI 10.1016/S0090-4295(97)00278-1
   KIRSCH AJ, 1995, UROLOGY, V46, P261, DOI 10.1016/S0090-4295(99)80206-4
   Lauto A, 1998, MICROSURG, V18, P60, DOI 10.1002/(SICI)1098-2752(1998)18:1<60::AID-MICR13>3.0.CO;2-Q
   Lauto A, 1997, LASER SURG MED, V21, P134, DOI 10.1002/(SICI)1096-9101(1997)21:2<134::AID-LSM4>3.0.CO;2-R
   Lauto A, 1999, LASER SURG MED, V25, P250, DOI 10.1002/(SICI)1096-9101(1999)25:3<250::AID-LSM9>3.3.CO;2-M
   McNally KM, 2000, LASER SURG MED, V27, P147, DOI 10.1002/1096-9101(2000)27:2<147::AID-LSM6>3.0.CO;2-P
   OZ MC, 1990, J VASC SURG, V11, P718, DOI 10.1067/mva.1990.18591
   Poppas DP, 1996, LASER SURG MED, V18, P335, DOI 10.1002/(SICI)1096-9101(1996)18:4<335::AID-LSM2>3.0.CO;2-T
   POPPAS DP, 1988, J UROLOGY, V139, P415, DOI 10.1016/S0022-5347(17)42446-3
   POPPAS DP, 1992, J UROLOGY, V148, P220, DOI 10.1016/S0022-5347(17)36557-6
   SCHOBER R, 1986, SCIENCE, V232, P1421, DOI 10.1126/science.3715454
   SHENFELD O, 1994, LASER SURG MED, V14, P323, DOI 10.1002/lsm.1900140405
   Stewart RB, 1996, LASER SURG MED, V19, P9, DOI 10.1002/(SICI)1096-9101(1996)19:1<9::AID-LSM2>3.0.CO;2-W
NR 16
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5188-6
J9 P SOC PHOTO-OPT INS
PY 2003
VL 5287
BP 83
EP 90
DI 10.1117/12.544880
PG 8
WC Medicine, Research & Experimental; Optics; Physics, Applied
SC Research & Experimental Medicine; Optics; Physics
GA BY26K
UT WOS:000188516000012
DA 2018-10-19
ER

PT J
AU Guerret, S
   Govignon, E
   Hartmann, DJ
   Ronfard, V
AF Guerret, S
   Govignon, E
   Hartmann, DJ
   Ronfard, V
TI Long-term remodeling of a bilayered living human skin equivalent
   (Apligraf (R)) grafted onto nude mice: immunolocalization of human cells
   and characterization of extracellular matrix
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID HUMAN EPIDERMAL-KERATINOCYTES; ATHYMIC MICE; VENOUS ULCERS; CULTURED
   SKIN; BURN WOUNDS; IN-VITRO; FIBROBLASTS; TISSUE; COLLAGEN; MOUSE
AB Type I collagen is a clinically approved biomaterial largely used in tissue engineering. It acts as a regenerative template in which the implanted collagen is progressively degraded and replaced by new cell-synthesized tissue. Apligraf(R), a bioengineered living skin, is composed of a bovine collagen lattice containing living human fibroblasts overlaid with a fully differentiated epithelium made of human keratinocytes. To investigate its progressive remodeling, athymic mice were grafted and the cellular and the extracellular matrix components were studied from 0 to 365 days after grafting. Biopsies were analyzed using immunohistochemistry with species-specific antibodies and electron microscopy techniques. We observed that this bioengineered tissue provided living and bioactive cells to the wound site up to 1 year after grafting. The graft was rapidly incorporated within the host tissue and the bovine collagen present in the graft was progressively replaced by human and mouse collagens. A normal healing process was observed, i.e., type III collagen appeared transiently with type I collagen, the major collagen isoform present at later stages. New molecules, such as elastin, were produced by the living human cells contained within the graft. This animal model combined with species-specific immunohistochemistry tools is thus very useful for studying long-term tissue remodeling of bioengineered living tissues.
C1 Univ Lyon 1, Biomat Lab, Fac Pharm, F-69373 Lyon 08, France.
   Novotec, Lyon, France.
   Organogenesis Inc, Canton, MS USA.
RP Hartmann, DJ (reprint author), Univ Lyon 1, Biomat Lab, Fac Pharm, EA 3090,8 Ave Rockefeller, F-69373 Lyon 08, France.
CR BAILEY AJ, 1975, BIOCHEM BIOPH RES CO, V66, P1160, DOI 10.1016/0006-291X(75)90480-5
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   BELL E, 1981, PLAST RECONSTR SURG, V67, P386, DOI 10.1097/00006534-198103000-00024
   Boyce S T, 1995, Ostomy Wound Manage, V41, P26
   Boyce ST, 2002, AM J SURG, V183, P445, DOI 10.1016/S0002-9610(02)00813-9
   BOYCE ST, 1992, CANCER LETT, V62, P141, DOI 10.1016/0304-3835(92)90184-W
   Boyce ST, 1995, OSTOMY WOUND MANAG, V41, P32
   Boyce ST, 1995, OSTOMY WOUND MANAG, V41, P30
   CONWAY K, 1992, CANCER RES, V52, P6487
   Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018
   CUONO C, 1986, LANCET, V1, P1123
   DEMARCHEZ M, 1987, DEV BIOL, V121, P119, DOI 10.1016/0012-1606(87)90145-X
   DEMARCHEZ M, 1987, TRANSPLANTATION, V43, P896, DOI 10.1097/00007890-198743060-00025
   DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090
   Duplan-Perrat F, 2000, J INVEST DERMATOL, V114, P365, DOI 10.1046/j.1523-1747.2000.00885.x
   EAGLSTEIN WH, 1995, DERMATOL SURG, V21, P839, DOI 10.1111/j.1524-4725.1995.tb00709.x
   EPSTEIN EH, 1978, J BIOL CHEM, V253, P1336
   Falabella AF, 1999, ARCH DERMATOL, V135, P1219, DOI 10.1001/archderm.135.10.1219
   Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   HANSBROUGH JF, 1992, SURGERY, V111, P438
   Hansbrough John F., 1994, Journal of Burn Care and Rehabilitation, V15, P346, DOI 10.1097/00004630-199407000-00010
   Harding KG, 2002, BRIT MED J, V324, P160, DOI 10.1136/bmj.324.7330.160
   HEIMBACH D, 1988, ANN SURG, V208, P313, DOI 10.1097/00000658-198809000-00008
   Herrick SE, 1996, J INVEST DERMATOL, V106, P187, DOI 10.1111/1523-1747.ep12329920
   HIGOUNENC I, 1994, SKIN PHARMACOL, V7, P167
   INOKUCHI S, 1995, CELL TISSUE RES, V281, P223, DOI 10.1007/s004410050419
   JOHNSON EW, 1992, IN VITRO CELL DEV-AN, V28A, P429
   KETCHUM LD, 1974, PLAST RECONSTR SURG, V53, P140, DOI 10.1097/00006534-197402000-00004
   Kolodka TM, 1998, P NATL ACAD SCI USA, V95, P4356, DOI 10.1073/pnas.95.8.4356
   Kuroyanagi Y, 2001, ARTIF ORGANS, V25, P180, DOI 10.1046/j.1525-1594.2001.025003180.x
   LIGHT ND, 1985, METHODS SKIN RES, P559
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Medalie DA, 1996, J INVEST DERMATOL, V107, P121, DOI 10.1111/1523-1747.ep12298363
   Parenteau N, 1994, KERATINOCYTE METHODS, P45
   PARENTEAU NL, 1992, CYTOTECHNOLOGY, V9, P163, DOI 10.1007/BF02521744
   PARENTEAU NL, 1991, J CELL BIOCHEM, V45, P245, DOI 10.1002/jcb.240450304
   PARENTEAU NL, 1997, CHRONIC WOUND CARE C, P389
   PHILLIPS TJ, 1989, J AM ACAD DERMATOL, V21, P191, DOI 10.1016/S0190-9622(89)70160-2
   PIERCE GF, 1994, AM J PATHOL, V145, P1399
   Pilcher BK, 1999, ANN NY ACAD SCI, V878, P12, DOI 10.1111/j.1749-6632.1999.tb07671.x
   PLENAT F, 1992, TRANSPLANTATION, V53, P1002, DOI 10.1097/00007890-199205000-00008
   Purdue Gary F., 1997, Journal of Burn Care and Rehabilitation, V18, P52, DOI 10.1097/00004630-199701000-00009
   Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009
   Rossio-Pasquier P, 1999, ARCH DERMATOL RES, V291, P591, DOI 10.1007/s004030050460
   Sabolinski ML, 1996, BIOMATERIALS, V17, P311, DOI 10.1016/0142-9612(96)85569-4
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   STOTTS NA, 1909, CHRONIC WOUND CARE, P64
   Supp DM, 2000, WOUND REPAIR REGEN, V8, P26, DOI 10.1046/j.1524-475x.2000.00026.x
   Supp Dorothy M., 2002, Journal of Burn Care & Rehabilitation, V23, P10, DOI 10.1097/00004630-200201000-00004
   TENG P, 1993, WOUNDS, V5, P133
   Uitto J, 1989, Clin Geriatr Med, V5, P127
   Uitto J, 1989, J INVEST DERMATOL, V92, p61S
   Waymack P, 2000, BURNS, V26, P609, DOI 10.1016/S0305-4179(00)00017-6
   WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23
   White SJ, 1998, HUM GENE THER, V9, P1187, DOI 10.1089/hum.1998.9.8-1187
NR 56
TC 38
Z9 38
U1 0
U2 3
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 1067-1927
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD JAN-FEB
PY 2003
VL 11
IS 1
BP 35
EP 45
DI 10.1046/j.1524-475X.2003.11107.x
PG 11
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA 642JV
UT WOS:000180801100006
PM 12581425
DA 2018-10-19
ER

PT J
AU Moberg, L
   Johansson, H
   Lukinius, A
   Berne, C
   Foss, A
   Kallen, R
   Ostraat, O
   Salmela, K
   Tibell, A
   Tufveson, G
   Elgue, G
   Ekdahl, KN
   Korsgren, O
   Nilsson, B
AF Moberg, L
   Johansson, H
   Lukinius, A
   Berne, C
   Foss, A
   Kallen, R
   Ostraat, O
   Salmela, K
   Tibell, A
   Tufveson, G
   Elgue, G
   Ekdahl, KN
   Korsgren, O
   Nilsson, B
TI Production of tissue factor by pancreatic islet cells as a trigger of
   detrimental thrombotic reactions in clinical islet transplantation
SO LANCET
LA English
DT Article
ID COMPLEMENT ACTIVATION; ENDOCRINE PANCREAS; HUMAN BLOOD; COAGULATION;
   BIOMATERIAL; EXPRESSION; INHIBITION; RECEPTOR; MODEL; RNA
AB Background Intraportal transplantation of pancreatic islets offers improved glycaemic control and insulin independence in type 1 diabetes mellitus, but intraportal thrombosis remains a possible complication. The thrombotic reaction may explain why graft loss occurs and islets from more than one donor are needed, since contact between human islets and ABO-compatible blood in vitro triggers a thrombotic reaction that damages the islets. We investigated the possible mechanism and treatment of such thrombotic reactions.
   Methods Coagulation activation and islet damage were monitored in four patients undergoing clinical islet transplantation according to a modified Edmonton protocol. Expression of tissue factor (TF) in the islet preparations was investigated by immunohistochemistry, immunoprecipitation, electron microscopy, and RT-PCR. To assess TF activity in purified islets, human islets were mixed with non-anticoagulated ABO-compatible blood in tubing loops coated with heparin.
   Findings Coagulation activation and subsequent release of insulin were found consistently after clinical islet transplantation, even in the absence of signs of intraportal thrombosis. The endocrine, but not the exocrine, cells of the pancreas were found to synthesise and secrete active TF. The clotting reaction triggered by pancreatic islets in vitro could be abrogated by blocking the active site of TF with specific antibodies or site-inactivated factor Vlla, a candidate drug for inhibition of TF activity in vivo.
   Interpretation Blockade of TF represents a new therapeutic approach that might increase the success of islet transplantation in patients with type 1 diabetes, in terms of both the risk of intraportal thrombosis and the need for islets from more than one donor.
C1 Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, Div Pathol, S-75185 Uppsala, Sweden.
   Univ Uppsala Hosp, Dept Med Sci, Div Med, S-75185 Uppsala, Sweden.
   Univ Uppsala Hosp, Dept Surg Sci, Div Transplantat Surg, S-75185 Uppsala, Sweden.
   Dept Transplantat Surg, Oslo, Norway.
   Malmo Univ Hosp, Dept Nephrol & Transplantat, Malmo, Sweden.
   Skejby Hosp, Dept Urol, Aarhus, Denmark.
   Univ Helsinki, Surg Hosp, Div Transplantat, Helsinki, Finland.
   Dept Transplantat Surg, Stockholm, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Rudbeck Lab, Div Clin Immunol, Dept Radiol Oncol & Clin Immunol, S-75185 Uppsala, Sweden.
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012
OI Nilsson, Bo/0000-0003-0057-2730; 
CR Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1
   Colman RW, 1996, BLOOD, V87, P2089
   DRAKE TA, 1989, AM J PATHOL, V134, P1087
   Ekdahl KN, 1997, ARTHRITIS RHEUM, V40, P2178, DOI 10.1002/art.1780401212
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Froberg MK, 1997, HUM PATHOL, V28, P1295, DOI 10.1016/S0046-8177(97)90204-5
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9
   Lakey JRT, 1999, CELL TRANSPLANT, V8, P285, DOI 10.1177/096368979900800309
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   LUKINIUS A, 1992, DEV BIOL, V153, P376, DOI 10.1016/0012-1606(92)90122-W
   Lukinius A, 2001, DIABETES, V50, P962, DOI 10.2337/diabetes.50.5.962
   Luther T, 1996, AM J PATHOL, V149, P101
   Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x
   Morrissey JH, 2001, THROMB HAEMOSTASIS, V86, P66
   Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779
   PARKER RC, 1957, NY ACAD SCI, V5, P303
   Pazzagli M, 1999, CLIN APPL THROMB-HEM, V5, P228, DOI 10.1177/107602969900500404
   Peppelenbosch MP, 2001, TRENDS CARDIOVAS MED, V11, P335, DOI 10.1016/S1050-1738(01)00137-2
   POTGENS AJG, 1994, THROMB HAEMOSTASIS, V71, P208
   RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   SHAPIRO AMJ, 1995, TRANSPLANTATION, V59, P1060, DOI 10.1097/00007890-199504150-00027
   VANSUYLICHEM PTR, 1995, CELL TRANSPLANT, V4, P609, DOI 10.1016/0963-6897(95)00026-7
   WILDGOOSE P, 1990, BIOCHEMISTRY-US, V29, P3413, DOI 10.1021/bi00465a039
   ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451
NR 30
TC 356
Z9 360
U1 0
U2 15
PU LANCET LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0140-6736
J9 LANCET
JI Lancet
PD DEC 21
PY 2002
VL 360
IS 9350
BP 2039
EP 2045
DI 10.1016/S0140-6736(02)12020-4
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 628CH
UT WOS:000179974200013
PM 12504401
DA 2018-10-19
ER

PT J
AU Tang, LP
   Jiang, WW
   Welty, SE
AF Tang, LP
   Jiang, WW
   Welty, SE
TI The participation of P- and E-selectins on biomaterial-mediated tissue
   responses
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article; Proceedings Paper
CT 27th Annual Meeting of the Society-for-Biomaterials
CY APR 24-29, 2001
CL ST PAUL, MINNESOTA
SP Soc Biomat
DE biomaterial; selectin; fibrosis; inflammation; phagocytes
ID INTERCELLULAR-ADHESION MOLECULE-1; NECROSIS-FACTOR-ALPHA; ACUTE
   INFLAMMATORY RESPONSES; ROLLING IN-VIVO; ENDOTHELIAL SELECTINS;
   DEFICIENT MICE; LEUKOCYTE RECRUITMENT; CELL-ADHESION; MAST-CELLS; MODEL
AB Biomaterial-mediated inflammatory responses often compromise the functions of implantable devices. The mechanism(s) involved in the inflammatory responses, which can be arbitrarily divided into phagocyte transmigration, chemotaxis, and adhesion to implant surfaces, are not totally understood. Because adhesion molecules have been shown to involved in phagocyte transmigration, this study was designed to investigate the participation of endothelial adhesion molecules in the pathogenesis of biomaterial-mediated inflammatory responses and fibrotic tissue formation. Using transgenic adhesion molecule knockout mice, we found that (1) deficiency of P-selectin reduced polymorphonuclear neutrophils (PMN) but not macrophages/ monocytes (M(D) transmigration and adhesion. (2) Furthermore, absence of both P- and E-selectin (P/E-deficient) dramatically diminished both PMN and M(D recruitment to the peritoneal cavity and accumulation on implanted biomaterials. (3) Finally, the impairment of inflammatory responses in P/E-deficient mice significantly reduced the extent of subsequent biomaterial-mediated fibrotic responses. We conclude that P- and E-selectins are important for both biomaterial-mediated inflammatory and fibrotic reactions. Our results also indicate that the reduction of phagocyte accumulation might be responsible to the decrease of fibrotic tissue formation surrounding material implants. Better understanding of such sequence of events may:help the rational design of biomaterials with desired tissue reactivity. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Texas, Biomed Engn Program, Arlington, TX 76019 USA.
   Ohio State Univ, Dept Pediat, Childrens Res Inst, Columbus, OH 43205 USA.
RP Tang, LP (reprint author), Univ Texas, Biomed Engn Program, POB 19138, Arlington, TX 76019 USA.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Barton PA, 1996, J LAB CLIN MED, V128, P181, DOI 10.1016/S0022-2143(96)90010-4
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329
   Cadic-Amadeuf C M, 1992, ASAIO J, V38, pM386, DOI 10.1097/00002480-199207000-00061
   CARLOS TM, 1994, BLOOD, V84, P2068
   Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   CHRISTENSON L, 1991, J BIOMED MATER RES, V25, P1119, DOI 10.1002/jbm.820250906
   COLEMAN SE, 1986, J BIOMED MATER RES, V20, P301, DOI 10.1002/jbm.820200304
   DESAI NP, 1992, BIOMATERIALS, V13, P505, DOI 10.1016/0142-9612(92)90101-S
   DOMANSKIS EJ, 1976, PLAST RECONSTR SURG, V58, P689, DOI 10.1097/00006534-197612000-00006
   ENTMAN ML, 1994, CARDIOVASC RES, V28, P1301, DOI 10.1093/cvr/28.9.1301
   Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6
   FREYRIA AM, 1991, BIOMATERIALS, V12, P111, DOI 10.1016/0142-9612(91)90187-F
   FURIE MB, 1987, J CELL SCI, V88, P161
   FURIE MB, 1989, J IMMUNOL, V143, P3309
   GORDON M, 1982, J BONE JOINT SURG AM, V64, P574, DOI 10.2106/00004623-198264040-00013
   GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198
   Harari OA, 1999, J IMMUNOL, V163, P6860
   HARLAN JM, 1985, BLOOD, V66, P167
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   HOGQUIST KA, 1991, J IMMUNOL, V147, P2181
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JEFFREY JJ, 1981, COLLAGEN REL RES, V1, P257
   Jung U, 1999, J IMMUNOL, V162, P6755
   Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498
   KOSSOVSKY N, 1991, J BIOMED MATER RES, V25, P1287, DOI 10.1002/jbm.820251009
   KUKIELKA GL, 1993, J CLIN INVEST, V92, P1504, DOI 10.1172/JCI116729
   Kunkel EJ, 1996, CIRC RES, V79, P1196, DOI 10.1161/01.RES.79.6.1196
   Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57
   LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8
   LEY K, 1995, J EXP MED, V181, P669, DOI 10.1084/jem.181.2.669
   MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J
   McCafferty DM, 2000, EUR J IMMUNOL, V30, P2362, DOI 10.1002/1521-4141(2000)30:8<2362::AID-IMMU2362>3.0.CO;2-F
   MCEVER RP, 1991, THROMB HAEMOSTASIS, V65, P223
   MULLIGAN MS, 1992, J CLIN INVEST, V90, P1600, DOI 10.1172/JCI116029
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   Norman KE, 2000, BLOOD, V96, P3585
   Ohno N, 1997, INFLAMMATION, V21, P313, DOI 10.1023/A:1027349900279
   PICHA GJ, 1990, PLAST RECONSTR SURG, V85, P903, DOI 10.1097/00006534-199006000-00011
   Ramos CL, 1997, BLOOD, V89, P3009
   Reiner E., 1989, ENZYMES HYDROLYSING
   Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452
   RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957
   Shreeniwas R, 1996, CHEST, V110, P1143, DOI 10.1378/chest.110.5.1143
   SMAHEL J, 1979, BRIT J PLAST SURG, V32, P35, DOI 10.1016/0007-1226(79)90058-4
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Tang T, 1996, J CLIN INVEST, V97, P2485, DOI 10.1172/JCI118695
   TIPPING PG, 1994, KIDNEY INT, V46, P79, DOI 10.1038/ki.1994.246
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
   VANOEVEREN W, 1994, CELL MATER, V4, P187
   Vestweber D, 1999, PHYSIOL REV, V79, P181
   WARD R, 1989, BIOMATERIALS, V10, P425, DOI 10.1016/0142-9612(89)90135-X
   WELLER A, 1992, J BIOL CHEM, V267, P15176
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   YAMAZAKI T, 1993, AM J PATHOL, V143, P410
   YATES SG, 1973, SURG GYNECOL OBSTET, V136, P12
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 63
TC 16
Z9 17
U1 1
U2 35
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2002
VL 62
IS 4
BP 471
EP 477
DI 10.1002/jbm.10271
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 600CZ
UT WOS:000178374200001
PM 12378692
DA 2018-10-19
ER

PT J
AU Rupp, F
   Axmann, D
   Ziegler, C
   Geis-Gerstorfer, J
AF Rupp, F
   Axmann, D
   Ziegler, C
   Geis-Gerstorfer, J
TI Adsorption/desorption phenomena on pure and Teflon((R)) AF-coated
   titania surfaces studied by dynamic contact angle analysis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE titanium implant; protein adsorption; Teflon((R)); AF; interfacial
   reaction; wetting tension hysteresis
ID BOVINE SERUM-ALBUMIN; INTRAOCULAR LENSES; IN-VITRO; ADSORPTION; WATER;
   MECHANISM; PROTEINS; POWDER
AB As a result of inflammatory processes, plaque formation on dental titanium implants often leads to clinically pathogenic situations. This special biofilm formation on (bio)materials in contact with saliva is initiated by ionic and protein interactions. In this interfacial process, albumin becomes a main constituent of dental pellicle. Interfacial reactions change the surface characteristics. They determine the following steps of macromolecular adsorption and bacterial adhesion. This work focuses on the dynamic contact angle analysis (DCA), which is a tool for online measurements of dynamic changes of wettability without disturbing the interface during detection. Repeatability of the DCA method has been assessed according to the Bland and Altman method. The kinetics and equilibrium data of shifts in the wetting tension hysteresis indicate ionic influences at the titanium/bovine serum albumin (BSA) interface: the Ca-mediated increase of the BSA adsorption on titanium and the adsorption maximum at the isoelectric point (IEP) of BSA. Ti was surface modified by Teflon(R) AF polymeric coatings. The result of the assessment gives reason to consider Teflong AF as a reference material for DCA repeatability studies. This surface modification caused drastic changes in the dynamic interfacial reactions. Shifts in the wetting tensions during DCA adsorption-desorption experiments clearly demonstrated the partially irreversible adsorption of BSA on Teflon(R) AF. In contrast, reversible adsorption behavior was detected on pure Ti surfaces. These findings strengthen the hypothesis that the analysis of dynamic changes in wetting tension and wetting tension hysteresis is a sensitive analytical method for the detection of dynamic interfacial changes at biomaterial/biosystem interfaces during the initial steps of biofilm formation. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Tubingen, Dept Prosthet Dent Med Mat & Technol, D-72076 Tubingen, Germany.
   Univ Kaiserslautern, Dept Phys, D-67663 Kaiserslautern, Germany.
RP Rupp, F (reprint author), Univ Tubingen, Dept Prosthet Dent Med Mat & Technol, Osianderstr 2-8, D-72076 Tubingen, Germany.
RI Rupp, Frank/G-4725-2012
OI Ziegler, Christiane/0000-0002-7963-3729
CR Altman DG, 1991, PRACTICAL STAT MED R
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   BLAND JM, 1986, LANCET, V1, P307
   BOEHM HP, 1971, DISCUSS FARADAY SOC, P264
   COLLIS JJ, 1992, BIOMATERIALS, V13, P548, DOI 10.1016/0142-9612(92)90107-Y
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Fukuzaki S, 1996, J FERMENT BIOENG, V81, P163, DOI 10.1016/0922-338X(96)87596-9
   Geckeler KE, 1997, ADV MATER, V9, P513, DOI 10.1002/adma.19970090614
   GOODE R, 1993, COMMERCIAL AND CONSUMER LAW, P3
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   JOHNSON RE, 1964, J PHYS CHEM-US, V68, P1744, DOI 10.1021/j100789a012
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Legeais JM, 1998, J CATARACT REFR SURG, V24, P371, DOI 10.1016/S0886-3350(98)80326-X
   Legeais JM, 1997, J FR OPHTALMOL, V20, P527
   Matsumoto Yutaka, 1998, Membrane, V23, P87
   Miyama M, 1997, LANGMUIR, V13, P5494, DOI 10.1021/la960870n
   Morra M, 1997, J BIOMED MATER RES, V37, P198, DOI 10.1002/(SICI)1097-4636(199711)37:2<198::AID-JBM8>3.0.CO;2-M
   Nakae H, 1998, ACTA MATER, V46, P2313, DOI 10.1016/S1359-6454(97)00387-X
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   Serro A. P. V. A., 1997, COLL SURFACES B, V10, P95
   STEINBERG D, 1995, BIOMATERIALS, V16, P1339, DOI 10.1016/0142-9612(95)91050-9
   UEDA T, 1995, J BIOMED MATER RES, V29, P381, DOI 10.1002/jbm.820290313
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Volger EA, 1993, WETTABILITY, P184
   Wassell DTH, 1996, BIOMATERIALS, V17, P859, DOI 10.1016/0142-9612(96)83280-7
   Werner L, 1999, J BIOMED MATER RES, V48, P814, DOI 10.1002/(SICI)1097-4636(1999)48:6<814::AID-JBM8>3.0.CO;2-C
   Werner L, 1999, J BIOMED MATER RES, V46, P347
   Werner LP, 1997, J CATARACT REFR SURG, V23, P1013, DOI 10.1016/S0886-3350(97)80073-9
   Wolansky G, 1999, COLLOID SURFACE A, V156, P381, DOI 10.1016/S0927-7757(99)00098-9
   Xie X, 1999, J ADHES SCI TECHNOL, V13, P1119, DOI 10.1163/156856199X00820
NR 32
TC 39
Z9 39
U1 0
U2 22
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2002
VL 62
IS 4
BP 567
EP 578
DI 10.1002/jbm.10198
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 600CZ
UT WOS:000178374200012
PM 12221705
DA 2018-10-19
ER

PT J
AU Kim, JH
   Kim, SH
   Kim, HK
   Akaike, T
   Kim, SC
AF Kim, JH
   Kim, SH
   Kim, HK
   Akaike, T
   Kim, SC
TI Adhesion and growth of endothelial cell on amphiphilic PU/PS IPN
   surface: Effect of amphiphilic balance and immobilized collagen
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE endothelial cell; IPN; surface energy; collagen; biocompatibility
ID SUBSTRATUM-BOUND FIBRONECTIN; PROTEIN ADSORPTION; POLYMER SURFACES;
   EXTRACELLULAR-MATRIX; POLYSTYRENE SURFACE; BIOLOGICAL-ACTIVITY; COATED
   POLYSTYRENE; PLATELET-ADHESION; CONTACT ANGLES; BIOCOMPATIBILITY
AB Since natural blood vessels are lined with an endothelial cell (EC) monolayer, it is proposed that synthetic biomaterial surfaces be covered or seeded with endothelial cells for ideal nonthrombogenicity under normal conditions. The effects of the surface energy of hydrophilic-hydrophobic IPN on EC adhesion and growth were investigated. The human umbilical vein endothelial cells (HUVECs) were cultured on polyurethane (PU)/polystyrene (PS) IPN prepared by changing only the amphiphilic balance and controlling the microphase separated surface structure. The collagens were immobilized on the IPN surfaces for enhanced adhesion of HUVECs, and the morphology of the collagens immobilized highly depended on the surface energy of the IPNs. The stranded rope structure of the collagen molecules in the solution state was maintained only on the surface of the IPN with intermediate hydrophilicity. The adhesion and the proliferation of ECs on the nontreated IPN surfaces increased by increasing the hydrophobicity of the IPNs, and they were optimized on the collagen-treated IPN surface having an intermediate hydrophilicity. Finally, platelet adhesion was significantly reduced on the EC-hybridized surface of the IPNs. (C) 2002 Wiley Periodicals, Inc.
C1 Korea Adv Inst Sci & Technol, Ctr Adv Funct Polymers, Taejon 305701, South Korea.
   Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Tokyo 152, Japan.
RP Kim, SC (reprint author), Korea Adv Inst Sci & Technol, Ctr Adv Funct Polymers, Taejon 305701, South Korea.
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   AKAIKE T, 1989, MULTIPHASE BIOMEDICA, P73
   Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   Bacakova L, 2000, BIOMATERIALS, V21, P1173, DOI 10.1016/S0142-9612(00)00009-0
   Bos GW, 1999, J BIOMED MATER RES, V47, P279, DOI 10.1002/(SICI)1097-4636(19991205)47:3<279::AID-JBM1>3.0.CO;2-W
   Burmeister JS, 1999, J BIOMED MATER RES, V47, P577, DOI 10.1002/(SICI)1097-4636(19991215)47:4<577::AID-JBM15>3.0.CO;2-S
   Cenni E, 2000, J BIOMED MATER RES, V50, P483, DOI 10.1002/(SICI)1097-4636(20000615)50:4<483::AID-JBM3>3.3.CO;2-9
   DAVID DJ, 1969, ANAL CHEM POLYURETHA
   FAJARDO LF, 1989, AM J CLIN PATHOL, V92, P241, DOI 10.1093/ajcp/92.2.241
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   HORBETT TA, 1988, J BIOMED MATER RES, V22, P383, DOI 10.1002/jbm.820220503
   Imbert E, 1998, BIOMATERIALS, V19, P2285, DOI 10.1016/S0142-9612(98)00137-9
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9
   Johnson G, 2000, J BIOMED MATER RES, V51, P612, DOI 10.1002/1097-4636(20000915)51:4<612::AID-JBM9>3.3.CO;2-Q
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   Kaibara M, 2000, COLLOID SURFACE B, V19, P209, DOI 10.1016/S0927-7765(00)00158-2
   KATAOKA K, 1993, J BIOMED MATER RES, V27, P1519
   Kim S., 1997, IPNS WORLD SCI ENG
   KLEMPNER D, 1994, ADV INTERPENETRATING, V4
   Klempner D., 1994, ADV CHEM SERIES, V239
   Kothari S, 1995, J MATER SCI-MATER M, V6, P695, DOI 10.1007/BF00134303
   KottkeMarchant K, 1996, J BIOMED MATER RES, V30, P209
   KOVEKER GB, 1991, SURGERY, V109, P313
   KUSAKABE M, 1995, RADIAT PHYS CHEM, V46, P263, DOI 10.1016/0969-806X(95)00022-P
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lee PC, 1996, J BIOMED MATER RES, V32, P645, DOI 10.1002/(SICI)1097-4636(199612)32:4<645::AID-JBM18>3.0.CO;2-C
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   MCAUSLAN BR, 1987, J BIOMED MATER RES, V21, P921, DOI 10.1002/jbm.820210708
   Moulin AM, 1999, LANGMUIR, V15, P8776, DOI 10.1021/la990416u
   Murugesan G, 2000, J BIOMED MATER RES, V49, P396, DOI 10.1002/(SICI)1097-4636(20000305)49:3<396::AID-JBM13>3.0.CO;2-H
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OKANO T, 1986, J BIOMED MATER RES, V20, P1035, DOI 10.1002/jbm.820200716
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OKANO T, 1986, J BIOMED MATER RES, V20, P917
   Olabisi O., 1979, POLYM POLYM MISCIBIL
   Palacio L, 1999, J MEMBRANE SCI, V152, P189, DOI 10.1016/S0376-7388(98)00203-8
   Paul DR, 1978, POLYM BLENDS
   PERRIN DD, 1980, PURIFICATION LAB CHE
   PETTIT DK, 1992, J BIOMED MATER RES, V26, P1259, DOI 10.1002/jbm.820261002
   Ramires PA, 2000, J BIOMED MATER RES, V51, P535, DOI 10.1002/1097-4636(20000905)51:3<535::AID-JBM31>3.0.CO;2-P
   RATNER BD, 1975, J BIOMED MATER RES, V9, P407, DOI 10.1002/jbm.820090505
   Ruoslahti E, 1996, TUMOR BIOL, V17, P117, DOI 10.1159/000217975
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   Sperling L.H., 1981, INTERPENETRATING POL
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   Utracki L., 1989, POLYM ALLOYS BLENDS
   Wertz CF, 1999, LANGMUIR, V15, P8884, DOI 10.1021/la990089q
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
NR 57
TC 28
Z9 28
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 15
PY 2002
VL 62
IS 4
BP 613
EP 621
DI 10.1002/jbm.10340
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 600CZ
UT WOS:000178374200017
PM 12221710
DA 2018-10-19
ER

PT J
AU Burmaster, S
   Smith, R
   Eick, D
   Kostoryz, EL
   Yourtee, D
AF Burmaster, S
   Smith, R
   Eick, D
   Kostoryz, EL
   Yourtee, D
TI In-vitro stability, metabolism, and transport of dental monomers made
   from bisphenol A and bisphenol F
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE bioavailability; dental polymers; enzymatic stability; mass
   spectrometry; monomers
ID CELL-LINE CACO-2; PERFORMANCE LIQUID-CHROMATOGRAPHY; CYTOSOLIC EPOXIDE
   HYDROLASE; HUMAN-SERUM-CHOLINESTERASE; SHEAR BOND STRENGTHS; COMPOSITE
   RESINS; HUMAN-LIVER; MOUSE SKIN; RAT-LIVER; EPITHELIAL TRANSPORT
AB The stability and bioavailability of the biomaterial monomers, bisglycidyl methacrylate (BISGMA), bisphenol F diglycidyl ether (BFDGE), and bisphenol A dimethacrylate (BPADM) were investigated using in-vitro techniques. A reverse-phase high-pressure liquid chromatographic/mass spectrometric (HPLC/MS) system was developed to quantitate each monomer and its primary metabolite. Each monomer (10x10(-6) M) was incubated at 37degreesC under various conditions. Aliquots (n-3) were removed at various time intervals and quantitated form a standard curve. The in vitro transport of each parent monomer and its tetrahydroxy metabolite was measured in a Caco-2 system. BISGMA and BPADM, was unstable. Plasma esterase of the rat rapidly hyrolyzed the ester compounds, but human esterase did not have a hydrolytic effect of BISGMA or BPADM. BFDGE disappeared in both rat and human plasma, but no tetrahydroxy metabolite was observed. All three parent compounds were unstable in human- and rat-hepatic fractions producing either tetrahydroxy metabolites, however, were relatively stable under identical conditions, but BPA disappeared when incubated in hepatic-microsomal fractions. While BPADM metabolism produced BPA, and estrogen disrupter, BISGMA and BFDGE did not appear to produce BPA. These results suggest that the potential toxicity of leached dental monomers is more likely to be a result of the metabolite rather than the parent monomer. From Caco-2 transport studies, BFDGE and its tetrahydroxy metabolite both crossed the Caco-2 membrane at a low rate of transport of 2 h (approximately 3 and 5.2% respectively). The BISGMA metabolite crossed at approximately 8%, indicative of a moderate rate of transport, and BPA crossed at approximately 10% in 1 h (high rate of transport). The transport of BPADM and BISGMA was unstable to be determined due to nonspecific absorption to the acrylic vertical transport well. The transport of BFDGE tetrahydroxy metabolite is of particular interest as BFDGE is likely to be chemically hydrolyzed in stomach acid. It is well known that epoxies react with acids resulting in ring opening so it is not surprising that BFDGE decomposes a pH 1. As a result, it is necessary to identify the decomposition (hydrolysis) products and test their bioavailability.
C1 Univ Missouri, Sch Pharm, Kansas City, MO 64108 USA.
   Univ Missouri, Sch Dent, Kansas City, MO 64108 USA.
RP Yourtee, D (reprint author), Univ Missouri, Sch Pharm, Kansas City, MO 64108 USA.
EM yourteed@umkc.edu
CR ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117
   ANDERBERG EK, 1993, J PHARM SCI, V82, P392, DOI 10.1002/jps.2600820412
   Arenholt-Bindslev D, 1998, J DENT RES, V77, P692
   ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U
   ARTURSSON P, 1990, J PHARM SCI, V79, P476, DOI 10.1002/jps.2600790604
   ASHBY J, 1988, MUTAT RES, V204, P17, DOI 10.1016/0165-1218(88)90114-0
   ATKINSON A, 1995, ENVIRON MOL MUTAGEN, V26, P60, DOI 10.1002/em.2850260109
   ATKINSON A, 1993, TOXICOLOGIST, V32, P111
   Barnes D M, 1991, Quintessence Int, V22, P143
   BAUER RS, 1983, EPOXY RESIN CHEM, V2
   BEETHAM JK, 1995, DNA CELL BIOL, V14, P61, DOI 10.1089/dna.1995.14.61
   BEETHAM JK, 1993, ARCH BIOCHEM BIOPHYS, V305, P197, DOI 10.1006/abbi.1993.1411
   BENTLEY P, 1989, CARCINOGENESIS, V10, P321, DOI 10.1093/carcin/10.2.321
   BITMAN J, 1970, J AGR FOOD CHEM, V18, P1108, DOI 10.1021/jf60172a019
   BJELOGRLIC NM, 1994, CARCINOGENESIS, V15, P771, DOI 10.1093/carcin/15.4.771
   BOWEN R L, 1956, J Dent Res, V35, P360, DOI 10.1177/00220345560350030501
   Bowen R.L., 1962, USPatent, Patent No. [US3066112A, 3066112, 3, 066, 112]
   BOWEN RL, 1963, J AM DENT ASSOC, V66, P57, DOI 10.14219/jada.archive.1963.0010
   BRAYDEN DJ, 1997, PHARM NEWS, V4, P11
   BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439
   Buonocore MG., 1955, J DENT RES, V34, P849, DOI DOI 10.1177/00220345550340060801
   CAIN K, 1983, BIOCHEM J, V215, P91, DOI 10.1042/bj2150091
   Carrillo JA, 1998, THER DRUG MONIT, V20, P319, DOI 10.1097/00007691-199806000-00013
   CLIMIE IJG, 1981, XENOBIOTICA, V11, P401, DOI 10.3109/00498258109045851
   CLIMIE IJG, 1981, XENOBIOTICA, V11, P391, DOI 10.3109/00498258109045850
   COGURN JN, 1991, PHARMACEUT RES, V8, P210
   Colerangle JB, 1997, J STEROID BIOCHEM, V60, P153, DOI 10.1016/S0960-0760(96)00130-6
   COLLINGTON GK, 1992, BIOCHEM PHARMACOL, V44, P417, DOI 10.1016/0006-2952(92)90431-H
   Cooley R L, 1991, Quintessence Int, V22, P979
   CRAIG RG, 1981, DENT CLIN N AM, V25, P219
   deGee AJ, 1996, BIOMATERIALS, V17, P1327, DOI 10.1016/0142-9612(96)88679-0
   DICKINSON RG, 1991, J PHARM SCI, V80, P952, DOI 10.1002/jps.2600801010
   ECOBICHON DJ, 1972, RES COMMUN CHEM PATH, V3, P629
   FERRACANE JL, 1994, J ORAL REHABIL, V21, P441, DOI 10.1111/j.1365-2842.1994.tb01158.x
   FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221
   FREUND M, 1990, SCAND J DENT RES, V98, P351
   FU JY, 1989, BIOCHIM BIOPHYS ACTA, V1006, P121
   FUNG YK, 1999, J DENT RES, V78, P270
   Gaido KW, 1997, TOXICOL APPL PHARM, V143, P205, DOI 10.1006/taap.1996.8069
   Gasser R, 1996, EXP TOXICOL PATHOL, V48, P467
   GRASSET E, 1984, AM J PHYSIOL, V247, pC260
   GREGO B, 1983, J CHROMATOGR, V255, P67, DOI 10.1016/S0021-9673(01)88274-1
   GUENGERICH FP, 1982, REV BIOCHEM TOXICOL, V4, P5
   Haeggstrom J Z, 1994, Adv Prostaglandin Thromboxane Leukot Res, V22, P3
   Hamid A, 1997, DENT MATER, V13, P98, DOI 10.1016/S0109-5641(97)80018-8
   Hanioka N, 1998, ARCH TOXICOL, V72, P387, DOI 10.1007/s002040050518
   HANKS CT, 1991, J DENT RES, V70, P1450, DOI 10.1177/00220345910700111201
   HEYMANN E, 1982, METABOLIC BASIS DETO, P229
   HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736
   HIDALGO IJ, 1989, BIOCHEM BIOPH RES CO, V160, P317, DOI 10.1016/0006-291X(89)91658-6
   HILGERS AR, 1990, PHARMACEUT RES, V7, P902, DOI 10.1023/A:1015937605100
   HOJRING N, 1977, BIOCHIM BIOPHYS ACTA, V481, P500, DOI 10.1016/0005-2744(77)90283-2
   INOUE K, 1982, J ORAL REHABIL, V9, P493, DOI 10.1111/j.1365-2842.1982.tb01039.x
   KEITH LH, 1997, ENV ENDOCRINE DISRUP, P261
   KLAASSEN CD, 1996, CASARETT DOULLS TOXI, P214
   KNAAK JB, 1966, TOXICOL APPL PHARM, V8, P175, DOI 10.1016/S0041-008X(66)80001-7
   KRISHMAN AV, 1998, ENDOCRINOLOGY, V132, P2279
   KRISHNAN AV, 1993, ENDOCRINOLOGY, V132, P2279, DOI 10.1210/en.132.6.2279
   Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863
   LEINFELDER KF, 1995, J AM DENT ASSOC, V126, P663, DOI 10.14219/jada.archive.1995.0247
   Leung BWH, 1997, J DENT RES, V76, P2460
   LOCKRIDGE O, 1990, PHARMACOL THERAPEUT, V47, P35, DOI 10.1016/0163-7258(90)90044-3
   LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549
   LOMBARDO D, 1980, BIOCHIM BIOPHYS ACTA, V611, P136, DOI 10.1016/0005-2744(80)90049-2
   MAY CA, 1973, EPOXY RESINS
   MENTLEIN R, 1980, ARCH BIOCHEM BIOPHYS, V200, P547, DOI 10.1016/0003-9861(80)90386-0
   MUNKSGAARD EC, 1984, J DENT RES, V63, P1087, DOI 10.1177/00220345840630081701
   NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307
   Nathanson D, 1997, J AM DENT ASSOC, V128, P1517, DOI 10.14219/jada.archive.1997.0091
   NG KY, 1993, LIFE SCI, V53, P1121, DOI 10.1016/0024-3205(93)90548-H
   NORMAN RD, 1990, J PROSTHET DENT, V64, P523, DOI 10.1016/0022-3913(90)90121-R
   OERTEL J, 1983, BLUT, V46, P101, DOI 10.1007/BF00320666
   Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888
   ORAY B, 1983, J CHROMATOGR, V270, P253, DOI 10.1016/S0021-9673(01)96371-X
   Oude Elferink Ronald P. J., 1993, Biochemical Journal, V290, P759
   PACEASCIAK CR, 1989, J BIOL CHEM, V264, P9310
   PANNATIER A, 1981, INT J PHARMACEUT, V8, P167, DOI 10.1016/0378-5173(81)90094-6
   PETERS WHM, 1992, CANCER RES, V52, P1886
   PINTO M, 1983, BIOL CELL, V47, P323
   Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3
   Rappaport SM, 1996, CANCER RES, V56, P5410
   RATHBUN MA, 1991, J BIOMED MATER RES, V25, P443
   REES JS, 1989, DENT MATER, V5, P41, DOI 10.1016/0109-5641(89)90092-4
   RUYTER IE, 1978, ACTA ODONTOL SCAND, V36, P75, DOI 10.3109/00016357809027569
   Santerre JP, 1999, J DENT RES, V78, P1459, DOI 10.1177/00220345990780081201
   SAYER JM, 1985, J BIOL CHEM, V260, P1630
   Schmalz G, 1998, J DENT RES, V77, P823
   SEVANIAN A, 1986, J BIOL CHEM, V261, P54
   SKODA RC, 1988, J BIOL CHEM, V263, P1549
   Smith RE, 2001, J LIQ CHROMATOGR R T, V24, P531, DOI 10.1081/JLC-100103391
   Snyder RW, 2000, TOXICOL APPL PHARM, V168, P225, DOI 10.1006/taap.2000.9051
   SPENNEY JG, 1979, DRUG METAB DISPOS, V7, P215
   Steinmetz R, 1998, ENDOCRINOLOGY, V139, P2741, DOI 10.1210/en.139.6.2741
   SUZUKI T, 1988, DENT MATER, V4, P379, DOI 10.1016/S0109-5641(88)80053-8
   SVENSMAR.O, 1965, ACTA PHYSIOL SCAND, VS 64, P1
   Swift E J Jr, 1991, J Esthet Dent, V3, P91, DOI 10.1111/j.1708-8240.1991.tb00974.x
   TANG AS, 1993, PHARMACEUT RES, V10, P1620, DOI 10.1023/A:1018976804403
   TAO L, 1988, DENT MATER, V4, P208, DOI 10.1016/S0109-5641(88)80066-6
   TRIOLO PT, 1992, DENT MATER, V8, P370, DOI 10.1016/0109-5641(92)90022-5
   VANKERCKHOVEN H, 1981, J DENT RES, V60, P1957, DOI 10.1177/00220345810600120601
   Vielnascher E, 1996, PHARMAZIE, V51, P586
   Vom Saal FS, 1998, TOXICOL IND HEALTH, V14, P239, DOI 10.1177/074823379801400115
   WILLIAMS FM, 1989, J PHARM PHARMACOL, V41, P407, DOI 10.1111/j.2042-7158.1989.tb06487.x
   WILLIAMS FM, 1985, CLIN PHARMACOKINET, V10, P392, DOI 10.2165/00003088-198510050-00002
   WOOD AW, 1986, CANCER RES, V46, P2760
   YOKATA H, 1999, BIOCHEM J, V340, P405
   ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V316, P443, DOI 10.1006/abbi.1995.1059
   ZELDIN DC, 1993, J BIOL CHEM, V268, P6402
   1952, Patent No. 2558139
NR 109
TC 3
Z9 3
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC 12
PY 2002
VL 2
IS 8
BP 365
EP 379
DI 10.1002/1616-5195(200211)2:8<365::AID-MABI365>3.0.CO;2-L
PG 15
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 641VC
UT WOS:000180766900002
DA 2018-10-19
ER

PT J
AU Malpass, CA
   Millsap, KW
   Sidhu, H
   Gower, LB
AF Malpass, CA
   Millsap, KW
   Sidhu, H
   Gower, LB
TI Immobilization of an oxalate-degrading enzyme on silicone elastomer
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE urological biomaterials; encrustation; plasma; oxalate; enzyme
   immobilization
ID CROSS-LINKED POLYDIMETHYLSILOXANE; INDUCED GRAFT-COPOLYMERIZATION;
   SURFACE MODIFICATION; PLASMA TREATMENT; ACRYLIC-ACID; OXIDASE;
   POLYMERIZATION; RUBBER; BIOMATERIALS; ENCRUSTATION
AB Urinary biomaterials are compromised by device-related urinary tract infections, bacterial biofilm formation, and biomineral encrustation. In the absence of urinary infection, calcium oxallate is the prevalent encrustation mineral formed. Considering this, a novel approach was taken in the study reported here, in that an oxalate-degrading enzyme, oxalate oxidase (OXO), was immobilized on the surface of silicone elastomer (PDMS), a common urological biomaterial. It was hypothesized that the enzymatic action of OXO could lower urinary oxalate levels near the device surface, thereby preventing calcium oxalate crystal formation. The PDMS surface was functionalized with the use of radio-frequency plasma discharge (RFPD) in the presence of water vapor, then coated with 3-aminopropyltriethoxysilane (AMEO). The resulting aminated surface was covalently coupled with OXO via glutaraldehyde bioconjugation. The ability of the OXO-coated PDMS to prevent calcium oxalate encrustation was evaluated with the use of a modified Robbins device (MRD) encrustation model. RFPD performed on PDMS resulted in an increase in the hydrophilicity of treated surfaces, as measured by contact angle. X-ray photoelectron spectroscopy studies showed increases in elemental oxygen, after water-vapor plasma, and in nitrogen after AMEO derivatization. The immobilized enzyme was shown to retain 47.5% of its specific enzymatic activity as compared to free enzyme. In vitro experiments for 6 days, with the use of a MRD, showed 53% less encrustation deposits on discs coated with OXO than control discs. The results from the current study suggest that PDMS-immobilized oxalate-degrading enzymes are active against calcium oxalate encrustation. (C) 2002 Wiley Periodicals. Inc.
C1 Ixion Biotechnol Inc, Alachua, FL 32615 USA.
   Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
RP Sidhu, H (reprint author), Ixion Biotechnol Inc, 13709 Progress Blvd, Alachua, FL 32615 USA.
RI Gower, Laurie/A-5947-2008
OI Gower, Laurie/0000-0003-2927-5406
CR Chandran P, 2001, J BIOTECHNOL, V85, P1, DOI 10.1016/S0168-1656(00)00321-7
   Delamarche E, 2001, ADV MATER, V13, P1164
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Elves AWS, 1997, BRIT J UROL, V80, P1, DOI 10.1046/j.1464-410X.1997.00208.x
   Emoto K, 1999, LANGMUIR, V15, P5212, DOI 10.1021/la980918s
   Fateh-Alavi K, 2001, POLYM DEGRAD STABIL, V74, P49, DOI 10.1016/S0141-3910(01)00098-2
   GABOURY SR, 1992, J APPL POLYM SCI, V44, P401, DOI 10.1002/app.1992.070440304
   GABOURY SR, 1993, ADV CHEM SER, V236, P777
   Grases F, 2001, NEPHRON, V88, P320, DOI 10.1159/000046015
   Hillborg H, 2000, POLYMER, V41, P6851, DOI 10.1016/S0032-3861(00)00039-2
   HOWARD IH, 1991, THESIS U FLORIDA GAI, P76
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Kim J, 1999, IEEE T DIELECT EL IN, V6, P695, DOI 10.1109/94.798126
   Kim J, 2000, J COLLOID INTERF SCI, V226, P231, DOI 10.1006/jcis.2000.6817
   Langefeld S, 1999, INT J ARTIF ORGANS, V22, P235
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   LEE SD, 1994, J APPL POLYM SCI, V54, P1279, DOI 10.1002/app.1994.070540909
   Lee SD, 1996, J POLYM SCI POL CHEM, V34, P141, DOI 10.1002/(SICI)1099-0518(19960115)34:1<141::AID-POLA15>3.0.CO;2-L
   Mason M, 2000, BIOMATERIALS, V21, P31, DOI 10.1016/S0142-9612(99)00129-5
   Milardovic S, 2000, ELECTROANAL, V12, P1051, DOI 10.1002/1521-4109(200009)12:13<1051::AID-ELAN1051>3.0.CO;2-Z
   MUTLU M, 1991, J MATER CHEM, V1, P447, DOI 10.1039/jm9910100447
   Oswald PR, 1998, ENZYME MICROB TECH, V23, P14, DOI 10.1016/S0141-0229(98)00005-2
   OWEN MJ, 1994, J ADHES SCI TECHNOL, V8, P1063, DOI 10.1163/156856194X00942
   RAU KR, 2000, THESIS U FLORIDA GAI, P216
   REDDY SM, 1994, ANALYST, V119, P949, DOI 10.1039/an9941900949
   Requena L, 1999, BIOCHEM J, V343, P185, DOI 10.1042/0264-6021:3430185
   Sodhi RNS, 2001, J ELECTRON SPECTROSC, V121, P249, DOI 10.1016/S0368-2048(01)00338-3
   Sonntag J, 1997, BIOL NEONATE, V71, P277
   Thakur M, 2000, J BIOCHEM BIOPH METH, V44, P77, DOI 10.1016/S0165-022X(00)00071-3
   Tissot E, 2001, EUR J CLIN MICROBIOL, V20, P260, DOI 10.1007/s100960100480
   URBAN MW, 1990, J APPL POLYM SCI, V39, P265, DOI 10.1002/app.1990.070390206
   WERNESS PG, 1985, J UROLOGY, V134, P1242, DOI 10.1016/S0022-5347(17)47703-2
   WILLIAMS HE, 1989, J UROLOGY, V141, P742, DOI 10.1016/S0022-5347(17)40999-2
   Wollin TA, 1998, J ENDOUROL, V12, P101, DOI 10.1089/end.1998.12.101
NR 34
TC 30
Z9 31
U1 1
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2002
VL 63
IS 6
BP 822
EP 829
DI 10.1002/jbm.10410
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 617QQ
UT WOS:000179372700021
PM 12418030
DA 2018-10-19
ER

PT J
AU Wan, WK
   Campbell, G
   Zhang, ZF
   Hui, AJ
   Boughner, DR
AF Wan, WK
   Campbell, G
   Zhang, ZF
   Hui, AJ
   Boughner, DR
TI Optimizing the tensile properties of polyvinyl alcohol hydrogel for the
   construction of a bioprosthetic heart valve stent
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE polyvinyl alcohol hydrogel; freeze-thaw; bioprosthetic heart valve;
   stent; tensile; stress relaxation
ID BOVINE PERICARDIUM; AORTIC-VALVE; FIXATION; FAILURE; GELS; LOAD
AB Although bioprosthetic heart valves offer the benefits of a natural opening and closing, better hemodynamics, and avoidance of life-long anticoagulant therapy, they nevertheless tend to fail in 10-15 years from tears and calcification. Several authors, including the present ones, have identified the rigid stent as a factor contributing to these failures. The ultimate solution is an artificial heart valve that has mechanical properties that allow it to move in conformity with the aortic root during the cardiac cycle, has superior hemodynamics, is nonthrombogenic, will last more than 20 years, and mitigates the need for anticoagulants. We have identified a polymer, polyvinyl alcohol (PVA) hydrogel, that has mechanical properties similar to soft tissue. The purpose of this research is to match the tensile properties of PVA to the porcine aortic root and to fabricate a stent prototype for a bioprosthetic heart valve with the use of the PVA hydrogel. Specimens of 15% w/w PVA were prepared by processing through 1-6 cycles of freezing (-20 degreesC) at 0.2 degreesC/min freeze rate and thawing (+20degreesC) at different thawing rates (0.2 degreesC/min and 1 degreesC/min), for different holding times (1 and 6 h) at -20 degreesC. Subsequently tensile tests and stress-relaxation tests were conducted on the specimens. The different holding times at -20 degreesC demonstrated no difference in the result. The slower thawing rate improved the tensile properties but did not produce significant changes on the stress-relaxation properties. The nonlinear stress-strain curve for the PVA after the fourth freeze-thaw cycle matched the porcine aortic root within the physiological pressure range. The stress-relaxation curve for PVA also approximated the shape of the aortic root. The complex geometry of an artificial heart valve stent was successfully injection molded. These results, in combination with other preliminary findings for biocompatibility and fatigue behavior, suggest that PVA hydrogel is a promising biomaterial for implants, catheters, and artificial skin. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
   Univ Western Ontario, Dept Mech & Mat Engn, London, ON N6A 5B9, Canada.
   Univ Western Ontario, Dept Med Biophys, London, ON N6A 5B9, Canada.
   Univ Western Ontario, Dept Cardiol, London, ON N6A 5B9, Canada.
   John P Robarts Res Inst, London, ON N6A 5K8, Canada.
   CNR, IMTI, London, ON, Canada.
RP Wan, WK (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RI Boughner, Derek/G-3282-2011
CR BORTOKOTTI U, 1989, SURG HEART VALVE DIS, P289
   Boughner DR, 2000, J HEART VALVE DIS, V9, P752
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   BREWER RJ, 1977, J THORAC CARDIOV SUR, V74, P645
   BURTON TA, 1992, J THORAC CARDIOVASC, V103, P238
   DRURY PJ, 1981, THORAC CARDIOV SURG, V29, P105, DOI 10.1055/s-2007-1023453
   Hansen Bjarne, 1995, Annals of Thoracic Surgery, V60, P384
   HILBERT SL, 1987, J THORAC CARDIOV SUR, V94, P419
   JONATHAN AJ, 1999, J HEART VALVE DIS, V18, P331
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   LEE JM, 1985, CIRC RES, V55, P475
   Leeson-Dietrich J, 1995, J Heart Valve Dis, V4, P88
   LOCKIE KJ, 1993, ANN THORAC SURG, V56, P125, DOI 10.1016/0003-4975(93)90415-E
   NISTAL F, 1986, AM J CARDIOL, V57, P161, DOI 10.1016/0002-9149(86)90972-0
   NOSEWORTHY R, UNPUB IN VITRO BIOCO
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P305, DOI 10.1016/0168-3659(91)90007-Z
   PEPPAS NA, 1996, ACADEMIC, P62
   POHLNER PG, 1979, J THORAC CARDIOV SUR, V77, P287
   RATNER BD, 1985, ACS SYM SER, V31, P14
   ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681
   Roe B. B., 1966, CIRCULATION, V33, P124
   SCHOEN FJ, 1983, AM J CARDIOL, V51, P957, DOI 10.1016/S0002-9149(83)80173-8
   SHEREBRIN MH, 1989, CAN J PHYSIOL PHARM, V67, P871, DOI 10.1139/y89-136
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   SWANSON WM, 1974, CIRC RES, V35, P871, DOI 10.1161/01.RES.35.6.871
   THUBRIKAR M, 1979, J THORAC CARDIOV SUR, V77, P863
   THUBRIKAR M, 1980, AM HEART J, V99, P217, DOI 10.1016/0002-8703(80)90768-1
   TROWBRIDGE EA, 1985, J MATER SCI, V20, P114, DOI 10.1007/BF00555905
   VESELY I, 1990, IEEE T BIO-MED ENG, V37, P925, DOI 10.1109/10.102804
   Vesely I, 1994, ASAIO J, V40, P199
   WATASE M, 1983, CRYO-LETT, V4, P197
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
   ZHANG ZF, 1999, 25 C P CMBES CAN MED, P108
   ZHANG ZF, UNPUB CYCLIC LOADING
   ZHANG ZF, IN PRESS J MAT SCI M
NR 35
TC 108
Z9 113
U1 5
U2 82
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2002
VL 63
IS 6
BP 854
EP 861
DI 10.1002/jbm.10333
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 617QQ
UT WOS:000179372700025
PM 12418034
DA 2018-10-19
ER

PT J
AU Giliberti, DC
   Anderson, KA
   Dee, KC
AF Giliberti, DC
   Anderson, KA
   Dee, KC
TI A jet impingement investigation of osteoblastic cell adhesion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone marrow stromal cells; cell adhesion; integrins; jet impingement;
   peptide-modified surfaces
ID MARROW STROMAL CELLS; CHEMICALLY-MODIFIED SURFACES; BONE-DERIVED CELLS;
   CYTOSKELETAL ORGANIZATION; IN-VITRO; BETA-GLYCEROPHOSPHATE;
   EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; MEDIATED ADHESION; BIOACTIVE
   GLASS
AB When designing dental and orthopedic implants, it is important to consider phenomena occurring at the microscopic level, particularly at the bone-implant interface. The presence of hard tissue at this interface is essential to implant viability. The integrity of this tissue-biomaterial interface is dependent on appropriate osteoblast functions (adhesion, matrix deposition, etc.) in the immediate area. Researchers have modified various materials with cell-adhesive peptides with the ultimate goal of controlling osteoblast functions. This study used microjet impingement to compare the strength of adhesion of osteoblastic cells (at varying populations) and fibroblasts to peptide-modified substrates m the presence and absence of fetal bovine serum. In the presence of the serum, there was no significant difference in cellular adhesion strength between substrates. In the absence of serum, all cells tested adhered more strongly to underlying substrates, and the strength of cellular adhesion was greater on modified surfaces than on plain glass surfaces. In the absence of serum, second-passage osteoblastic cells generally adhered to substrates more strongly than first-passage osteoblastic cells; fibroblasts adhered similarly to second-passage osteoblastic cells. Fundamental studies such as the present increase the understanding of cell adhesion to various substrates-knowledge that may be ultimately useful in creating an optimal bone-implant interface. 2002 (C) Wiley Periodicals, Inc.
C1 Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
RP Dee, KC (reprint author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
OI Dee, Kay C/0000-0002-9069-4880
CR *AM AC ORTH SURG, 2001, ARTHR TOT JOINT REPL
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BENAYAHU D, 1995, J CELL BIOCHEM, V59, P151, DOI 10.1002/jcb.240590204
   BUNDY KJ, 1994, J MATER SCI-MATER M, V5, P500, DOI 10.1007/BF00058991
   Cargill RS, 1999, BIOMATERIALS, V20, P2417, DOI 10.1016/S0142-9612(99)00169-6
   Castoldi M, 1997, CELL BIOL INT, V21, P7, DOI 10.1006/cbir.1996.0110
   CHAUDHARY LR, 1994, CALCIFIED TISSUE INT, V55, P16, DOI 10.1007/BF00310163
   Cheng SL, 1998, J CELL BIOCHEM, V71, P449, DOI 10.1002/(SICI)1097-4644(19981201)71:3<449::AID-JCB13>3.0.CO;2-D
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   DAVIES JE, 1991, CELL MATER, V1, P3
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DESHPANDE MD, 1982, J FLUID MECH, V114, P213, DOI 10.1017/S0022112082000111
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Garratt AN, 1995, ACTA ANAT, V154, P34
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Humphries MJ, 1999, BIOCHEM SOC SYMP, V65, P63
   Humphries MJ, 1998, TRENDS CELL BIOL, V8, P78, DOI 10.1016/S0962-8924(98)80016-0
   Humphries MJ, 2000, TRENDS PHARMACOL SCI, V21, P29, DOI 10.1016/S0165-6147(99)01410-8
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kim CH, 1999, J ENDOCRINOL, V162, P371, DOI 10.1677/joe.0.1620371
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306
   Lehenkari PP, 1999, BIOCHEM BIOPH RES CO, V259, P645, DOI 10.1006/bbrc.1999.0827
   Longhurst CM, 1998, CELL MOL LIFE SCI, V54, P514, DOI 10.1007/s000180050180
   MASSIA SP, 1992, J BIOL CHEM, V267, P10133
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   Okamoto K, 1998, J DENT RES, V77, P481, DOI 10.1177/00220345980770030701
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Pistone M, 1996, CELL BIOL INT, V20, P471, DOI 10.1006/cbir.1996.0062
   PUBLICOVER SJ, 1994, CALCIFIED TISSUE INT, V54, P125, DOI 10.1007/BF00296063
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0
   RATNER BD, 1996, BIOMATERIALS SCI INT, P484
   RATNER BD, 1987, PROGR BIOMEDICAL ENG, V6, P334
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 1997, ANN BIOMED ENG, V25, P190, DOI 10.1007/BF02738550
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   SATOMURA K, 1991, BONE MINER, V14, P41, DOI 10.1016/0169-6009(91)90101-5
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   SCUTT A, 1995, J BONE MINER RES, V10, P474
   Siggelkow H, 1998, EXP CLIN ENDOCR DIAB, V106, P217, DOI 10.1055/s-0029-1211979
   Stanford CM, 1999, J BIOMED MATER RES, V47, P345, DOI 10.1002/(SICI)1097-4636(19991205)47:3<345::AID-JBM8>3.0.CO;2-N
   SUNG KLP, 1994, J BIOMECH ENG-T ASME, V116, P237, DOI 10.1115/1.2895725
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   TRUSKEY GA, 1993, BIOMATERIALS, V14, P243, DOI 10.1016/0142-9612(93)90114-H
   VAISHNAV RN, 1983, J BIOMECH ENG-T ASME, V105, P77, DOI 10.1115/1.3138389
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   WESOLOWSKI G, 1995, EXP CELL RES, V219, P679, DOI 10.1006/excr.1995.1279
   YAMAGATA M, 1993, J CELL SCI, V106, P55
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   Zisman W. A., 1964, CONTACT ANGLE WETTAB, P1, DOI DOI 10.1021/BA-1964-0043.CH001
NR 70
TC 13
Z9 13
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD DEC 5
PY 2002
VL 62
IS 3
BP 422
EP 429
DI 10.1002/jbm.10343
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 593VE
UT WOS:000178014000013
PM 12209928
DA 2018-10-19
ER

PT J
AU Jones, DS
   Djokic, J
   McCoy, CP
   Gorman, SP
AF Jones, DS
   Djokic, J
   McCoy, CP
   Gorman, SP
TI Poly(epsilon-caprolactone) and
   poly(epsilon-caprolactone)-polyvinylpyrrolidone-iodine blends as
   ureteral biomaterials: characterisation of mechanical and surface
   properties, degradation and resistance to encrustation in vitro
SO BIOMATERIALS
LA English
DT Article
DE poly(epsilon-caprolactone); povidone-iodine; encrustation; mechanical
   properties; contact angle; ureteral stents; degradation
ID INTERPENETRATING POLYMER NETWORKS; URINARY-TRACT; SOLVENT EVAPORATION;
   STENT BIOMATERIAL; RELEASE; POLYESTERS; HYDROGEL; SYSTEMS; DEVICES
AB This study describes the physicochemical properties and in vitro resistance to encrustation of solvent cast films composed of either poly(epsilon-caprolactone) (PCL), prepared using different ratios of high (50,000) to low (4000) (molecular weight) m.wt., or blends of PCL and the polymeric antimicrobial complex, poly(vinylpyrrolidone)-iodine (PVP-I). The incorporation of PVP-I offered antimicrobial activity to the biomaterials. Films were characterised in terms of mechanical (tensile analysis, dynamic mechanical thermal analysis) and surface properties (dynamic contact angle analysis, scanning electron microscopy), whereas degradation (at 37degreesC in PBS at pH 7.4) was determined gravimetrically. The resistance of the films to encrustation was evaluated using an in vitro encrustation model. Reductions in the ratio of high:low-m.wt. PCL significantly reduced the ultimate tensile strength, % elongation at break and the advancing contact angle of the films. These effects were attributed to alterations in the amorphous content and the more hydrophilic nature of the films. Conversely, there were no alterations in Young's modulus, the viscoelastic properties and glass-transition temperature. Incorporation of PVP-I did not affect the mechanical or rheological properties of the films, indicative of a limited interaction between the two polymers in the solid state. Manipulation of the high:low m.wt. ratio of PCL significantly altered the degradation of the films, most notably following longer immersion periods, and resistance to encrustation. Accordingly, maximum degradation and resistance to encrustation was observed with the biomaterial composed of 40:60 high:low m.wt. ratios of PCL; however, the mechanical properties of this system were considered inappropriate for clinical application. Films composed of either 50:50 or 60:40 ratio of high:low m.wt. PCL offered an appropriate compromise between physicochemical properties and resistance to encrustation. This study has highlighted the important usefulness of degradable polymer systems as ureteral biomaterials. (C) 2002 Published by Elsevier Science Ltd.
C1 Queens Univ Belfast, Sch Pharm, Med Devices Unit, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Sch Pharm, Med Devices Unit, Ctr Med Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
OI McCoy, Colin/0000-0002-6468-2018
CR AKAY M, 1988, POLYMER, V29, P37, DOI 10.1016/0032-3861(88)90197-8
   AKAY M, 1993, POLYMER, V34, P1865, DOI 10.1016/0032-3861(93)90428-D
   Callister W. D., 1997, MAT SCI ENG INTRO, P465
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   GENT AN, 1972, J POLYM SCI A2, V10, P571, DOI 10.1002/pol.1972.160100314
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   GORMAN SP, 1987, J CLIN PHARM THER, V12, P393, DOI 10.1111/j.1365-2710.1987.tb00552.x
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   Grosvenor MP, 1996, INT J PHARM, V135, P103, DOI 10.1016/0378-5173(95)04404-3
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   Jones DS, 2000, PLAST RUBBER COMPOS, V29, P371, DOI 10.1179/146580100101541175
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 1997, J MATER SCI-MATER M, V8, P713, DOI 10.1023/A:1018596109061
   KEMPPAINEN E, 1993, UROL RES, V21, P235, DOI 10.1007/BF00590042
   Lemoine D, 1996, BIOMATERIALS, V17, P2191, DOI 10.1016/0142-9612(96)00049-X
   MARDIS HK, 1988, UROL CLIN N AM, V15, P471
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Medlicott NJ, 1996, INT J PHARM, V143, P25, DOI 10.1016/S0378-5173(96)04675-3
   MEDLICOTT NJ, 1992, INT J PHARM, V84, P85, DOI 10.1016/0378-5173(92)90218-Q
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   PITT CG, 1979, J PHARM SCI, V68, P1534, DOI 10.1002/jps.2600681219
   PITT CG, 1980, CONTROLLED RELEASE B, P19
   Talja M, 1997, J ENDOUROL, V11, P391, DOI 10.1089/end.1997.11.391
   Tunney MM, 1997, INT J PHARMACEUT, V151, P121, DOI 10.1016/S0378-5173(97)04902-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1999, METHOD ENZYMOL, V310, P558
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
   Wironen J, 1997, J LONG-TERM EFF MED, V7, P1
NR 29
TC 70
Z9 75
U1 5
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2002
VL 23
IS 23
BP 4449
EP 4458
AR PII S0142-9612(02)00158-8
DI 10.1016/S0142-9612(02)00158-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 595PA
UT WOS:000178116900002
PM 12322963
DA 2018-10-19
ER

PT J
AU Tunney, MM
   Gorman, SP
AF Tunney, MM
   Gorman, SP
TI Evaluation of a poly(vinyl pyrollidone)-coated biomaterial for
   urological use
SO BIOMATERIALS
LA English
DT Article
DE urinary tract; encrustation; bacterial adherence; hydrogel; poly(vinyl
   pyrollidone); polyurethane
ID URETERAL STENT BIOMATERIAL; URINARY-TRACT BIOMATERIALS; BACTERIAL
   ADHESION; URETHRAL CATHETERS; ENCRUSTATION; ADHERENCE; POLYMERS;
   POLYURETHANE; HYDROGEL; SURFACES
AB The associated problems of bacterial biofilm formation and encrustation that may cause obstruction or blockage of urethral catheters and ureteral stents often hinders the effective use of biomaterials within the urinary tract. In this in vitro study, we have investigated the surface properties of a hydrophilic polyvinyl pyrollidone) (PVP)-coating applied to polyurethane and determined its suitability for use as a urinary tract biomaterial by comparing its lubricity and ability to resist bacterial adherence and encrustation with that of uncoated polyurethane and silicone. The PVP-coated polyurethane was significantly more hydrophilic and more lubricious than either uncoated polyurethane or silicone. Adherence of a hydrophilic Escherichia coli isolate to PVP-coated polyurethane and uncoated polyurethane was similar but significantly less than adherence to silicone. Adherence of a hydrophobic Enterococcus faecalis isolate to PVP-coated polyurethane and silicone was similar but was significantly less than adherence to uncoated polyurethane. Struvite encrustation was similar on the PVP-coated polyurethane and silicone but significantly less than on uncoated polyurethane. Furthermore, hydroxyapatite encrustation was significantly less on the PVP-coated polyurethane than on either uncoated polyurethane or silicone. The results suggest that the PVP-coating could be useful in preventing complications caused by bacterial biofilm formation and the deposition of encrustation on biomaterials implanted in the urinary tract and, therefore, warrants further evaluation. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
RP Gorman, SP (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Grp, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
CR AXELSSON H, 1977, SCAND J UROL NEPHROL, V11, P283, DOI 10.3109/00365597709179966
   BASSETT J, 1978, VOGELS TXB QUANTITAT, P837
   Bonner MC, 1997, INT J PHARM, V151, P201, DOI 10.1016/S0378-5173(97)04903-X
   BOULANGEPETERMANN L, 1993, J ADHES SCI TECHNOL, V7, P221, DOI 10.1163/156856193X00673
   BRIDGETT MJ, 1993, BIOMATERIALS, V14, P184, DOI 10.1016/0142-9612(93)90021-S
   BRUCE AW, 1974, CAN MED ASSOC J, V111, P238
   Choong SKS, 2000, BJU INT, V86, P414, DOI 10.1046/j.1464-410X.2000.00861.x
   CORMIO L, 1995, J UROLOGY, V153, P494, DOI 10.1097/00005392-199502000-00069
   Cormio L, 1995, Scand J Urol Nephrol Suppl, V171, P1
   COX AJ, 1990, BRIT J UROL, V65, P55, DOI 10.1111/j.1464-410X.1990.tb14662.x
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   COX AJ, 1988, BRIT J UROL, V61, P156, DOI 10.1111/j.1464-410X.1988.tb05067.x
   DENYER SP, 1990, J CLIN MICROBIOL, V28, P1813
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   Gorman SP, 1997, J BIOMATER APPL, V12, P136, DOI 10.1177/088532829701200204
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   GORMAN SP, 1993, J MED MICROBIOL, V38, P411, DOI 10.1099/00222615-38-6-411
   GORMAN SP, 1991, P 10 PHARM TECH C, V2, P649
   Gorman SP, 1991, MECH ACTION CHEM BIO, P271
   HOLMES SAV, 1992, BRIT J UROL, V69, P651, DOI 10.1111/j.1464-410X.1992.tb15640.x
   JANSEN B, 1993, GASTROINTEST ENDOSC, V39, P670, DOI 10.1016/S0016-5107(93)70220-5
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   KRASOVSKAYA SM, 1991, BIOMATERIALS, V12, P817, DOI 10.1016/0142-9612(91)90067-K
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   KUNIN CM, 1987, J UROLOGY, V138, P899, DOI 10.1016/S0022-5347(17)43412-4
   Marmieri G, 1996, J BIOMED MATER RES, V33, P29, DOI 10.1002/(SICI)1097-4636(199621)33:1<29::AID-JBM5>3.3.CO;2-M
   MILLER JM, 1975, J UROLOGY, V113, P530, DOI 10.1016/S0022-5347(17)59518-X
   OHKAWA M, 1990, J UROLOGY, V143, P717, DOI 10.1016/S0022-5347(17)40071-1
   RAMSAY JWA, 1986, BRIT J UROL, V58, P70, DOI 10.1111/j.1464-410X.1986.tb05431.x
   STICKLER DJ, 1993, CELL MATER, V3, P315
   THOMPSON JE, 1993, EUR J VASCULAR SURG, V7, P2, DOI 10.1016/S0950-821X(05)80944-2
   Tunney M. M., 1996, European Journal of Pharmaceutical Sciences, V4, pS177, DOI 10.1016/S0928-0987(97)86539-6
   Tunney M. M., 1997, Journal of Pharmacy and Pharmacology, V49, P86
   Tunney Michael, 1996, Journal of Urology, V155, p473A
   Tunney MM, 1997, INT J PHARMACEUT, V151, P121, DOI 10.1016/S0378-5173(97)04902-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1997, J BIOMED MATER RES, V38, P87, DOI 10.1002/(SICI)1097-4636(199722)38:2<87::AID-JBM2>3.0.CO;2-C
   TUNNEY MM, 1995, BIOMATERIALS, V17, P1025
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
   VANPELT AWJ, 1985, APPL ENVIRON MICROB, V49, P1270
NR 40
TC 67
Z9 70
U1 5
U2 57
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2002
VL 23
IS 23
BP 4601
EP 4608
AR PII S0142-9612(02)00206-5
DI 10.1016/S0142-9612(02)00206-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 595PA
UT WOS:000178116900020
PM 12322981
DA 2018-10-19
ER

PT J
AU Chen, XG
   Wang, Z
   Liu, WS
   Park, HJ
AF Chen, XG
   Wang, Z
   Liu, WS
   Park, HJ
TI The effect of carboxymethyl-chitosan on proliferation and collagen
   secretion of normal and keloid skin fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE CM-chitosan; fibroblast; keloid; proliferation; collagen; biomaterial
ID PROCOLLAGEN MESSENGER-RNAS; FUNGAL MYCELIA; CHITIN; CULTURE;
   BIOSYNTHESIS; METABOLISM; EXPRESSION; TISSUE; WATER
AB In this study, different molecular weight CM-chitosans were prepared and the effects on the growth and collagen secretion of normal skin fibroblasts and keloid fibroblasts were investigated in vitro. CM-chitosan promoted the proliferation of the normal skin fibroblast significantly but inhibited the proliferation of keloid fibroblast. The higher CM-chitosan concentration had a higher initial effect and the lower CM-chitosan concentration had a longer affecting time to the normal skin fibroblast. The lower molecular weight CM-chitosan had significant twofold activities. The CM-chitosan could reduce the ratio of type I/III collagen in keloid fibroblast by inhibiting the secretion of collagen type 1; and had no effect on the secretion of types I and III collagen in the normal skin fibroblast. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Korea Univ, Grad Sch Biotechnol, Sungbuk Ku, Seoul 136701, South Korea.
   Ocean Univ Qingdao, Life Sci Coll, Qingdao 266003, Peoples R China.
RP Park, HJ (reprint author), Korea Univ, Grad Sch Biotechnol, Sungbuk Ku, 1-5 Ka Anam Dong, Seoul 136701, South Korea.
RI Park, Hyun Jin/F-4735-2013; Park, Hyun Jin/I-4942-2015
CR ABERGEL RP, 1985, J INVEST DERMATOL, V84, P384, DOI 10.1111/1523-1747.ep12265471
   ALAKOKKO L, 1987, J INVEST DERMATOL, V89, P238, DOI 10.1111/1523-1747.ep12471056
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   CHEN XG, 1999, J OCEAN U QINGDAO, V2, P221
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   CHUNG LY, 1994, J BIOMED MATER RES, V28, P463, DOI 10.1002/jbm.820280409
   Ehrlich H P, 1998, Adv Wound Care, V11, P326
   HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9
   Hirano S, 1999, POLYM INT, V48, P732, DOI 10.1002/(SICI)1097-0126(199908)48:8<732::AID-PI211>3.3.CO;2-L
   Hjerde RJN, 1997, CARBOHYD POLYM, V34, P131, DOI 10.1016/S0144-8617(97)00113-6
   Huang Y, 1998, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V12, P332
   Kubota N, 2000, CARBOHYD RES, V324, P268, DOI 10.1016/S0008-6215(99)00263-3
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Nirodi CS, 2000, WOUND REPAIR REGEN, V8, P371, DOI 10.1111/j.1524-475X.2000.00371.x
   NISHIMURA SI, 1986, CARBOHYD RES, V146, P251, DOI 10.1016/0008-6215(86)85044-3
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   Shimojoh M, 1998, CARBOHYD POLYM, V35, P223, DOI 10.1016/S0144-8617(97)00244-0
   Su CH, 1999, BIOMATERIALS, V20, P61, DOI 10.1016/S0142-9612(98)00139-2
   TOKURA S, 1983, POLYM J, V15, P485, DOI 10.1295/polymj.15.485
   TOMOE K, 1998, J BIOMED MATER RES, V39, P486
   UITTO J, 1985, P NATL ACAD SCI USA, V82, P5935, DOI 10.1073/pnas.82.17.5935
   UITTO J, 1980, BIOCHIM BIOPHYS ACTA, V624, P545, DOI 10.1016/0005-2795(80)90095-1
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   YAMADA H, 1995, J DERMATOL SCI, V9, P45, DOI 10.1016/0923-1811(94)00355-I
NR 28
TC 135
Z9 167
U1 5
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2002
VL 23
IS 23
BP 4609
EP 4614
AR PII S0142-9612(02)00207-7
DI 10.1016/S0142-9612(02)00207-7
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 595PA
UT WOS:000178116900021
PM 12322982
DA 2018-10-19
ER

PT J
AU Zhu, AP
   Zhang, M
   Wu, J
   Shen, J
AF Zhu, AP
   Zhang, M
   Wu, J
   Shen, J
TI Covalent immobilization of chitosan/heparin complex with a
   photosensitive hetero-bifunctional crosslinking reagent on PLA surface
SO BIOMATERIALS
LA English
DT Article
DE PLA; chitosan; heparin; hetero-bifunctional crosslinking reagent;
   photosensitivity
ID CARDIOPULMONARY BYPASS; HEMOCOMPATIBILITY; GRAFTS; ACID)
AB Chitosan (CS) was covalently immobilized onto polylactic acid (PLA) film surface using the photosensitive hetero-bifunctional crosslinking reagent, 4-azidobenzoic acid, which was previously bonded to chitosan by reaction between an acid group of the crosslinking reagent and a free amino group of chitosan. The immobilization was accomplished by irradiating with ultraviolet light, the modified chitosan being coated on the film surface to photolyze azide groups, thus crosslinking chitosan and PLA together. The hydroxyl and amino groups of chitosan may provide the opportunity for them being further derived by chemically immobilizing a variety of functional groups. These modifications could be carried out to tailor PLA biomaterial to meet the specific needs of different biomedical applications. For example, chitosan molecules immobilized on the PLA could be modified by heparin (Hp) solution to form a polyelectrolyte complex on the PLA surface. Platelet adhesion assay showed that PLA surface modified by chitosan/heparin complex could inhibit platelet adhesion and activation. Cell culture assay indicated that PLA surface with CS/Hp complex showed enhanced cell adhesion. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Nanjing Univ, Dept Polymer Sci & Engn, Nanjing 210093, Peoples R China.
   Nanjing Univ, Coll Med, Nanjing 210093, Peoples R China.
RP Shen, J (reprint author), Nanjing Univ, Dept Polymer Sci & Engn, Nanjing 210093, Peoples R China.
CR CECILIA FLC, 1999, BIOCHIM BIOPHYS ACTA, V1472, P479
   Chuang WY, 1999, BIOMATERIALS, V20, P1479, DOI 10.1016/S0142-9612(99)00054-X
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Drury J K, 1987, Ann Vasc Surg, V1, P542, DOI 10.1016/S0890-5096(06)61437-4
   FOSTER A, 1998, P NOBCCHE, V25, P127
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   GILDING DK, 1981, BIOCOMPATIBILITY CLI, P209
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   HAYASHI A, 1992, MACROMOLECULES, V25, P5094, DOI 10.1021/ma00045a041
   Hill GE, 1998, J CARDIOTHOR VASC AN, V12, P21
   Kito H, 1996, J BIOMED MATER RES, V30, P321
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LI SM, 1990, J MATER SCI-MATER M, V1, P123, DOI 10.1007/BF00700871
   Lo H, 1995, Tissue Eng, V1, P15, DOI 10.1089/ten.1995.1.15
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   NOISHIKI Y, 1987, VASCULAR SURG, V21, P401, DOI 10.1177/153857448702100605
   POPOWICZ P, 1985, BIOMED BIOCHIM ACTA, V44, P1329
   SAHIL AP, 2000, ADV DRUG DELIV REV, V42, P139
   Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
NR 21
TC 132
Z9 137
U1 0
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2002
VL 23
IS 23
BP 4657
EP 4665
AR PII S0142-9612(02)00215-6
DI 10.1016/S0142-9612(02)00215-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 595PA
UT WOS:000178116900026
PM 12322987
DA 2018-10-19
ER

PT J
AU Janssen, MI
   van Leeuwen, MBM
   Scholtmeijer, K
   van Kooten, TG
   Dijkhuizen, L
   Wosten, HAB
AF Janssen, MI
   van Leeuwen, MBM
   Scholtmeijer, K
   van Kooten, TG
   Dijkhuizen, L
   Wosten, HAB
TI Coating with genetic engineered hydrophobin promotes growth of
   fibroblasts on a hydrophobic solid
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; RGD peptide; surface modification; self-assembly;
   hydrophobin
ID CELL-BIOMATERIAL INTERACTION; SCHIZOPHYLLUM-COMMUNE; AGARICUS-BISPORUS;
   RGD-PEPTIDES; ENDOTHELIAL-CELLS; FRUITING BODIES; SERUM-PROTEINS;
   SURFACE; ATTACHMENT; ADHESION
AB Class I Hydrophobins self-assemble at hydrophilic-hydrophobic interfaces into a highly insoluble amphipathic film. Upon self-assembly of these fungal proteins hydrophobic solids turn hydrophilic, while hydrophilic materials can be made hydrophobic. Hydrophobins thus change the nature of a surface. This property makes them interesting candidates to improve physio- and physico-chemical properties of implant surfaces. We here show that growth of fibroblasts on Teflon can be improved by coating the solid with genetically engineered SC3 hydrophobin. Either deleting a stretch of 25 amino acids at the N-terminus of the mature hydrophobin (TrSC3) or fusing the RGD peptide to this end (RGD-SC3) improved growth of fibroblasts on the solid surface. In addition, we have shown that assembled SC3 and TrSC3 are not toxic when added to the medium of a cell culture of fibroblasts in amounts up to 125 mug ml(-1). (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Utrecht, NL-3584 CH Utrecht, Netherlands.
   Groningen Biotechnol & Biomol Sci Inst, NL-9751 NN Haren, Netherlands.
   Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   BioMaDe, NL-9747 AG Groningen, Netherlands.
RP Wosten, HAB (reprint author), Univ Utrecht, Padualaan 8, NL-3584 CH Utrecht, Netherlands.
RI Dijkhuizen, Lubbert/E-9454-2014
OI Dijkhuizen, Lubbert/0000-0003-2312-7162
CR Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   CARPENTER CE, 1992, MOL PLANT MICROBE IN, V4, P55
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Cole G. T., 1991, The fungal spore and disease initiation in plants and animals., P403
   de Vocht ML, 1998, BIOPHYS J, V74, P2059, DOI 10.1016/S0006-3495(98)77912-3
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kantlehner M, 1999, ANGEW CHEM INT EDIT, V38, P560, DOI 10.1002/(SICI)1521-3773(19990215)38:4<560::AID-ANIE560>3.0.CO;2-F
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lugones LG, 1998, MICROBIOL-UK, V144, P2345, DOI 10.1099/00221287-144-8-2345
   Lugones LG, 1999, MYCOL RES, V103, P635, DOI 10.1017/S0953756298007552
   Lugones LG, 1996, MICROBIOL-UK, V142, P1321, DOI 10.1099/13500872-142-5-1321
   LUGONES LG, 1999, THESIS U GRONINGEN N
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   OLLBRICH KC, 1996, BIOMATERIALS, V17, P759
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1982, J BIOL CHEM, V257, P9593
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ruardy T. G., 1997, Cells and Materials, V7, P123
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   RUSSO PS, 1982, CAN J BOT, V60, P1414, DOI 10.1139/b82-180
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Scholtmeijer K, 2002, APPL ENVIRON MICROB, V68, P1367, DOI 10.1128/AEM.68.3.1367-1373.2002
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   van Wetter MA, 2000, MOL MICROBIOL, V36, P201, DOI 10.1046/j.1365-2958.2000.01848.x
   VANDERMEI HC, 1991, MICROBIAL CELL SURFA, P261
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   vanWetter MA, 1996, FEMS MICROBIOL LETT, V140, P265, DOI 10.1016/0378-1097(96)00192-9
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wessels JGH, 1997, ADV MICROB PHYSIOL, V38, P1
   WOSTEN HAB, 1994, J BACTERIOL, V176, P7085
   WOSTEN HAB, 1995, COLLOID SURFACE B, V5, P189, DOI 10.1016/0927-7765(94)01151-T
   WOSTEN HAB, 1993, PLANT CELL, V5, P1567
   WOSTEN HAB, 1994, EMBO J, V13, P5848, DOI 10.1002/j.1460-2075.1994.tb06929.x
   Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625
   Wosten HAB, 2000, BIOCHIM BIOPHYS ACTA, V85524, P1, DOI DOI 10.1016/S0304-4157(00)00002-2)
   Wosten Han A. B., 1997, Mycoscience, V38, P363, DOI 10.1007/BF02464099
NR 39
TC 60
Z9 61
U1 2
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2002
VL 23
IS 24
BP 4847
EP 4854
AR PII S0142-9612(02)00240-5
DI 10.1016/S0142-9612(02)00240-5
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 600WN
UT WOS:000178414900019
PM 12361625
DA 2018-10-19
ER

PT J
AU Koob, TJ
AF Koob, TJ
TI Biomimetic approaches to tendon repair
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-MOLECULAR AND INTEGRATIVE
   PHYSIOLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Society-for-Integrative-and-Comparative-Biology
CY JAN   04, 2002
CL ANAHEIM, CALIFORNIA
SP Soc Integrat & Comparat Biol
DE tendon; biomimetics; tissue engineering; nor-dihydroguaiaretic acid;
   collagen; egg capsule; quinone tanning; catechol; biomaterial
ID RABBIT FLEXOR TENDON; FIBROBLASTS IN-VITRO; GROWTH-FACTOR-I; POLYMERIZED
   COLLAGEN-FIBERS; DIGITORUM PROFUNDUS TENDON; CONTROLLED PASSIVE MOTION;
   ERINACEA EGG CAPSULE; RAT TAIL TENDON; CELL-PROLIFERATION; CROSS-LINKING
AB The linear organization of collagen fibers in tendons results in optimal stiffness and strength at low strains under tensile load. However, this organization makes repairing ruptured or lacerated tendons extremely difficult. Current suturing techniques to join split ends of tendons, while providing sufficient mechanical strength to prevent gapping, are inadequate to carry normal loads. Immobilization protocols necessary to restore tendon congruity result in scar formation at the repair site and peripheral adhesions that limit excursion. These problems are reviewed to emphasize the need for novel approaches to tendon repair, one of which is the development of biontimetic tendons. The objective of the empirical work described here was to produce biologically-based, biocompatible tendon replacements with appropriate mechanical properties to enable immediate mobilization following surgical repair., Nor-dihydroguaiaretic acid (NDGA), a di-catechol from creosote bush, caused a dose dependent increase in the material properties of reconstituted collagen fibers, achieving a 100-fold increase in strength and stiffness over untreated fibers. The maximum tensile strength of the optimized NDGA treated fibers averaged 90 MPa; the elastic modulus of these fibers averaged 580 MPa. These properties were independent of strain rates ranging from 0.60 to 600 mm/min. Fatigue tests established that neither strength nor stiffness were affected after 80 k cycles at 5% strain. Treated fibers were not cytotoxic to tendon fibroblasts. Fibroblasts attached and proliferated on NDGA treated collagen normally. NDGA fibers did not elicit a foreign body response nor did they stimulate an immune reaction during six weeks in vivo. The fibers survived 6 weeks with little evidence of fragmentation or degradation. The polymerization scheme described here produces a fiber-reinforced NDGA polymer with mechanical properties approaching an elastic solid. The strength, stiffness and fatigue properties of the NDGA treated fibers are comparable to those of tendon. These fibers are biocompatible with tendon fibroblasts and elicit little rejection or antigenic response in vivo. These results indicate that NDGA polymerization may provide a viable approach for producing collagenous materials that can be used to bridge gaps in ruptured or lacerated tendons. The tendon-like properties of the NDGA fiber would allow early mobilization after surgical repair. We predict that timely loading of parted tendons joined by this novel biomaterial will enhance mechanically driven production of neotendon by the colonizing fibroblasts and result in superior repair and rapid return to normal properties. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Shriners Hosp Children, Ctr Res Skeletal Dev & Pediat Orthopaed, Skeletal Biol Sect, Tampa, FL 33612 USA.
RP Koob, TJ (reprint author), Shriners Hosp Children, Ctr Res Skeletal Dev & Pediat Orthopaed, Skeletal Biol Sect, 12502 N Pine Dr, Tampa, FL 33612 USA.
CR ABRAHAMSSON SO, 1991, J ORTHOPAED RES, V9, P495, DOI 10.1002/jor.1100090405
   Abrahamsson SO, 1996, J ORTHOPAED RES, V14, P370, DOI 10.1002/jor.1100140305
   ABRAHAMSSON SO, 1989, SCAND J PLAST RECONS, V23, P191, DOI 10.3109/02844318909075117
   ABRAHAMSSON SO, 1991, J ORTHOPAED RES, V9, P503, DOI 10.1002/jor.1100090406
   ABRAHAMSSON SO, 1995, J ORTHOPAED RES, V13, P58, DOI 10.1002/jor.1100130110
   ABRAHAMSSON SO, 1994, J HAND SURG-AM, V19A, P259, DOI 10.1016/0363-5023(94)90016-7
   AMIEL D, 1991, MATRIX, V11, P184, DOI 10.1016/S0934-8832(11)80157-5
   AMIEL D, 1995, J ORTHOPAED RES, V13, P459, DOI 10.1002/jor.1100130321
   AMIEL D, 1989, J HAND SURG-AM, V14A, P837, DOI 10.1016/S0363-5023(89)80085-1
   AOKI M, 1994, J HAND SURG-AM, V19A, P984, DOI 10.1016/0363-5023(94)90102-3
   AOKI M, 1995, J HAND SURG-BRIT EUR, V20B, P310, DOI 10.1016/S0266-7681(05)80084-1
   AOKI M, 1995, CLIN ORTHOP RELAT R, P205
   ARK JW, 1994, J HAND SURG-AM, V19A, P249, DOI 10.1016/0363-5023(94)90015-9
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BANES AJ, 1988, J ORTHOP RES, V6, P83, DOI 10.1002/jor.1100060111
   Banes AJ, 1995, J BIOMECH, V28, P1505, DOI 10.1016/0021-9290(95)00098-4
   BANES AJ, 1988, J ORTHOP RES, V6, P73, DOI 10.1002/jor.1100060110
   Banes AJ, 1999, OSTEOARTHR CARTILAGE, V7, P141, DOI 10.1053/joca.1998.0169
   Banes AJ, 1999, CLIN ORTHOP RELAT R, pS356
   BECKER H, 1978, HAND, V10, P37, DOI 10.1016/S0072-968X(78)80023-0
   BECKER H, 1981, J HAND SURG-AM, V6, P616, DOI 10.1016/S0363-5023(81)80146-3
   BRUNELLI G, 1983, HAND, V15, P352
   BUCHANAN CI, 2002, COMP BIOCH PHYSL
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Butler DL, 1999, CLIN ORTHOP RELAT R, pS324
   CANTY EG, 2002, COMP BIOCH PHYSL
   Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.3.CO;2-4
   Chan BP, 1997, CLIN ORTHOP RELAT R, P239
   Chang J, 1998, J HAND SURG-AM, V23A, P1052, DOI 10.1016/S0363-5023(98)80015-4
   Chang J, 1997, PLAST RECONSTR SURG, V100, P937, DOI 10.1097/00006534-199709001-00016
   CHOW JA, 1988, J BONE JOINT SURG BR, V70, P591
   CULLEN KW, 1989, J HAND SURG-BRIT EUR, V14B, P392, DOI 10.1016/0266-7681(89)90153-8
   DOCKERY G L, 1986, Journal of Foot Surgery, V25, P469
   DUFFY FJ, 1995, J HAND SURG-AM, V20A, P645, DOI 10.1016/S0363-5023(05)80284-9
   ELLIOT D, 1994, J HAND SURG-BRIT EUR, V19B, P607, DOI 10.1016/0266-7681(94)90126-0
   Fenwick SA, 2002, ARTHRITIS RES, V4, P252, DOI 10.1186/ar416
   Gelberman R, 1988, INJURY REPAIR MUSCUL, P5
   GELBERMAN R H, 1984, Journal of Orthopaedic Research, V2, P39, DOI 10.1002/jor.1100020107
   GELBERMAN RH, 1992, J HAND SURG-AM, V17A, P551, DOI 10.1016/0363-5023(92)90370-5
   GELBERMAN RH, 1981, HAND, V13, P120, DOI 10.1016/S0072-968X(81)80051-4
   GELBERMAN RH, 1990, J HAND SURG-AM, V15A, P69, DOI 10.1016/S0363-5023(09)91108-X
   GELBERMAN RH, 1986, J HAND SURG-AM, V11A, P106, DOI 10.1016/S0363-5023(86)80115-0
   GELBERMAN RH, 1982, J HAND SURG-AM, V7, P170, DOI 10.1016/S0363-5023(82)80083-X
   GELBERMAN RH, 1985, J HAND SURG-AM, V10A, P776, DOI 10.1016/S0363-5023(85)80151-9
   GELBERMAN RH, 1983, J BONE JOINT SURG AM, V65, P70, DOI 10.2106/00004623-198365010-00010
   GILLARD GC, 1979, CONNECT TISSUE RES, V7, P37, DOI 10.3109/03008207909152351
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   Hannafin JA, 1995, J ORTHOP RES, V13, P907, DOI 10.1002/jor.1100130615
   Harwood FL, 1999, WOUND REPAIR REGEN, V7, P381, DOI 10.1046/j.1524-475X.1999.00381.x
   HITCHCOCK TF, 1987, J HAND SURG-AM, V12A, P590, DOI 10.1016/S0363-5023(87)80213-7
   HUNTER JM, 1988, J HAND SURG-AM, V13A, P849, DOI 10.1016/0363-5023(88)90259-6
   IANNACE S, 1995, BIOMATERIALS, V16, P675, DOI 10.1016/0142-9612(95)99693-G
   KAIN CC, 1988, CLIN ORTHOP RELAT R, P295
   Kakar S, 1998, J HAND SURG-BRIT EUR, V23B, P627, DOI 10.1016/S0266-7681(98)80017-X
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   KER RF, 2002, COMP BIOCH PHYSL
   KETCHUM LD, 1977, PLAST RECONSTR SURG, V59, P708, DOI 10.1097/00006534-197705000-00014
   Khan U, 1996, J HAND SURG-BRIT EUR, V21B, P813, DOI 10.1016/S0266-7681(96)80199-9
   Khan U, 1998, J HAND SURG-AM, V23A, P266, DOI 10.1016/S0363-5023(98)80125-1
   Klein MB, 2002, J HAND SURG-AM, V27A, P615, DOI 10.1053/jhsu.2002.34004
   Klein MB, 2001, J HAND SURG-AM, V26A, P847, DOI 10.1053/jhsu.2001.26185
   Komanduri M, 1996, J HAND SURG-AM, V21A, P605, DOI 10.1016/S0363-5023(96)80011-6
   KOOB TJ, 1987, BIOCHEM J, V246, P589, DOI 10.1042/bj2460589
   KOOB TJ, 1992, ARCH BIOCHEM BIOPHYS, V298, P303, DOI 10.1016/0003-9861(92)90127-I
   KOOB TJ, 1990, J MAR BIOL ASSOC UK, V70, P395, DOI 10.1017/S0025315400035499
   Koob TJ, 2001, J BIOMED MATER RES, V56, P31, DOI 10.1002/1097-4636(200107)56:1<31::AID-JBM1065>3.0.CO;2-N
   Koob TJ, 2001, J BIOMED MATER RES, V56, P40, DOI 10.1002/1097-4636(200107)56:1<40::AID-JBM1066>3.3.CO;2-9
   Koob TJ, 2002, BIOMATERIALS, V23, P203, DOI 10.1016/S0142-9612(01)00096-5
   KOOB TJ, 1993, ENVIRON BIOL FISH, V38, P151, DOI 10.1007/BF00842911
   KOOB TJ, 1988, BIOL BULL-US, V175, P202, DOI 10.2307/1541560
   Kubota H, 1996, J HAND SURG-BRIT EUR, V21B, P474, DOI 10.1016/S0266-7681(96)80049-0
   LEE H, 1990, J HAND SURG-AM, V15A, P953, DOI 10.1016/0363-5023(90)90022-J
   Lou J, 2000, CLIN ORTHOP RELAT R, pS252
   Lou JR, 2001, J ORTHOPAED RES, V19, P1199, DOI 10.1016/S0736-0266(01)00042-0
   LUNDBORG G, 1980, HAND, V12, P3, DOI 10.1016/S0072-968X(80)80023-4
   Malaviya P, 2000, J ORTHOP RES, V18, P116, DOI 10.1002/jor.1100180117
   MANSKE PR, 1984, J BONE JOINT SURG AM, V66A, P385, DOI 10.2106/00004623-198466030-00011
   MANSKE PR, 1984, J HAND SURG-BRIT EUR, V9B, P117, DOI 10.1016/S0266-7681(84)80005-4
   MANSKE PR, 1984, CLIN ORTHOP RELAT R, P297
   MASS DP, 1993, CLIN ORTHOP RELAT R, P301
   MCMASTER WC, 1986, B HOSP JOINT DIS ORT, V46, P174
   McNeilly CM, 1996, J ANAT, V189, P593
   MENDES DG, 1986, J BIOMED MATER RES, V20, P699, DOI 10.1002/jbm.820200604
   MESSINA A, 1992, J HAND SURG-AM, V17A, P137, DOI 10.1016/0363-5023(92)90129-D
   MILTHORPE BK, 1994, BIOMATERIALS, V15, P745, DOI 10.1016/0142-9612(94)90027-2
   Murphy DJ, 1997, AM J VET RES, V58, P103
   Pennisi E, 2002, SCIENCE, V295, P1011, DOI 10.1126/science.295.5557.1011
   Ralphs JR, 2002, MATRIX BIOL, V21, P67, DOI 10.1016/S0945-053X(01)00179-2
   RANK F, 1980, SCAND J PLAST RECONS, V14, P179, DOI 10.3109/02844318009106706
   RIEDERERHENDERSON MA, 1983, IN VITRO CELL DEV B, V19, P127
   ROBERTSON GA, 1992, J HAND SURG-BRIT EUR, V17B, P92, DOI 10.1016/0266-7681(92)90020-3
   ROE SC, 1990, ARTIF ORGANS, V14, P443, DOI 10.1111/j.1525-1594.1990.tb03001.x
   ROGERS GT, 1995, BIOMATERIALS, V16, P803, DOI 10.1016/0142-9612(95)99643-Z
   RUSSELL JE, 1990, J ORTHOPAED RES, V8, P13, DOI 10.1002/jor.1100080103
   SALTI NI, 1993, J SURG RES, V55, P411, DOI 10.1006/jsre.1993.1161
   SAVAGE R, 1989, J HAND SURG-BRIT EUR, V14B, P396, DOI 10.1016/0266-7681(89)90154-X
   SAVAGE R, 1985, J HAND SURG-BRIT EUR, V10B, P135, DOI 10.1016/0266-7681(85)90001-4
   SCHWARZ R, 1976, EXP CELL RES, V102, P63, DOI 10.1016/0014-4827(76)90299-8
   SEILER JG, 1995, J HAND SURG-AM, V20A, P492, DOI 10.1016/S0363-5023(05)80115-7
   SEILER JG, 1993, J BONE JOINT SURG AM, V75A, P1004, DOI 10.2106/00004623-199307000-00006
   SILFVERSKIOLD KL, 1994, J HAND SURG-AM, V19A, P53, DOI 10.1016/0363-5023(94)90224-0
   SILFVERSKIOLD KL, 1993, J HAND SURG-AM, V18A, P58, DOI 10.1016/0363-5023(93)90246-Y
   SLACK C, 1986, CELL TISSUE RES, V245, P359
   SLACK C, 1984, CONNECT TISSUE RES, V12, P229, DOI 10.3109/03008208409013685
   SMALL JO, 1989, J HAND SURG-BRIT EUR, V14B, P383, DOI 10.1016/0266-7681(89)90152-6
   SMITH DJ, 1986, J HAND SURG-AM, V11A, P97, DOI 10.1016/S0363-5023(86)80114-9
   SMITH RKW, 2002, COMP BIOCH PHYSL
   SOO C, 1993, J DERMATOL SURG ONC, V19, P431, DOI 10.1111/j.1524-4725.1993.tb00370.x
   STRICKLAND JW, 1980, J HAND SURG-AM, V5, P537, DOI 10.1016/S0363-5023(80)80101-8
   Strickland JW, 2000, J HAND SURG-AM, V25A, P214
   Sung HW, 2000, BIOMATERIALS, V21, P1353, DOI 10.1016/S0142-9612(00)00017-X
   SZABO RM, 1990, J HAND SURG-AM, V15A, P480, DOI 10.1016/0363-5023(90)90066-Z
   TANAKA H, 1995, J HAND SURG-AM, V20A, P467, DOI 10.1016/S0363-5023(05)80109-1
   THOMAS SC, 1986, CLIN ORTHOP RELAT R, P281
   VATER CA, 1979, J BIOL CHEM, V254, P3045
   Wiig M, 1996, J HAND SURG-AM, V21A, P599, DOI 10.1016/S0363-5023(96)80010-4
   WOO SL, 1999, CLIN ORTHOP S, V367, pS312
   WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P51, DOI 10.1115/1.3138246
   Yamamoto E, 2002, J BIOMECH ENG-T ASME, V124, P85, DOI 10.1115/1.1427924
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
NR 123
TC 47
Z9 50
U1 1
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1095-6433
J9 COMP BIOCHEM PHYS A
JI Comp. Biochem. Physiol. A-Mol. Integr. Physiol.
PD DEC
PY 2002
VL 133
IS 4
BP 1171
EP 1192
AR PII S1095-6433(02)00247-7
DI 10.1016/S1095-6433(02)00247-7
PG 22
WC Biochemistry & Molecular Biology; Physiology; Zoology
SC Biochemistry & Molecular Biology; Physiology; Zoology
GA 627ZK
UT WOS:000179966900020
PM 12485699
DA 2018-10-19
ER

PT J
AU Tamura, Y
   Yokoyama, A
   Watari, F
   Kawasaki, T
AF Tamura, Y
   Yokoyama, A
   Watari, F
   Kawasaki, T
TI Surface properties and biocompatibility of nitrided titanium for
   abrasion resistant implant materials
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE titanium nitride; implant; biomaterial
ID SCANNING ANALYTICAL MICROSCOPY; GRADED DENTAL IMPLANT; FREE-ENERGY;
   BACTERIAL ADHESION; INVIVO; TISSUE
AB Corrosion, other related properties and biocompatibility of surface nitrided titanium were investigated to examine its possible use as an abrasion resistant implant material. The nitrided layer about 2mum thick composed of TiN and Ti2N was formed on titanium by a gas nitriding method. The dissolved amount of titanium ion in SBF was as low as the detection limit of ICP, and that in the 1% lactic acid showed no significant difference from titanium. The tissue reaction of the cylindrical implant in soft tissue of rats showed no inflammation, and fine particles of 1mum induced phagocytosis, which was similar to titanium. The implantation in the femor showed the new bone formed in direct contact with implants. All the results suggested that the wettability, corrosion resistance, S.mutans adhesion and biocompatibility were nearly equivalent to those of titanium. The surface of nitrided titanium was promising, with biocompatibility comparable with titanium, as an implant material such as for an abutment part of a dental implant, which requires high abrasion resistance.
C1 Hokkaido Univ, Grad Sch Dent Med,Dept Oral Funct Sci, Div Removable Prosthodont & Stomatognathostat Reh, Kita Ku, Sapporo, Hokkaido 0608586, Japan.
   Hokkaido Univ, Grad Sch Dent Med,Dept Oral Hlth Sci, Div Dent Mat & Engn, Kita Ku, Sapporo, Hokkaido 0608586, Japan.
RP Tamura, Y (reprint author), Hokkaido Univ, Grad Sch Dent Med,Dept Oral Funct Sci, Div Removable Prosthodont & Stomatognathostat Reh, Kita Ku, Kita 13,Nishi 7, Sapporo, Hokkaido 0608586, Japan.
RI Yokoyama, Atsuro/F-6418-2012
CR BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1016/0378-1097(87)90062-0
   DANJYO T, 1993, DENT J IWATE U, V18, P89
   DOYLE RJ, 1982, FEMS MICROBIOL LETT, V15, P1
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   FREEMAN MAR, 1992, CLIN ORTHOP RELAT R, P19
   GALANTE JO, 1991, J ORTHOPAED RES, V9, P760, DOI 10.1002/jor.1100090516
   Gottlander M, 1992, Int J Oral Maxillofac Implants, V7, P485
   ITO A, 1991, J JPN SOC BIOMATER, V19, P236
   JOANNE LM, 1987, PHASE DIAGRAMS BINAR, P176
   KAWAMURA H, 1996, J JAP SOC BIOMATER, V14, P254
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   Kumazawa R, 2002, BIOMATERIALS, V23, P3757, DOI 10.1016/S0142-9612(02)00115-1
   KUMAZAWA R, 2001, J JPN SOC DENT MAT D, V20, P356
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   MATSUNO H, 1999, J JPN SOC DENT MAT D, V18, P447
   Miyao R, 2001, J DENT MAT, V20, P344
   Nukata Kazuto, 1995, Shika Igaku, V58, P31
   OGUCHI H, 1994, BIOCERAM, V7, P215
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   TAKAMURA A, 1960, T JPN I MET, V24, P565
   TAMURA Y, 2002, IN PRESS MAT T
   Uo M, 2001, BIOMATERIALS, V22, P1787, DOI 10.1016/S0142-9612(00)00349-5
   Uo M, 1999, BIOMATERIALS, V20, P747, DOI 10.1016/S0142-9612(98)00224-5
   Uo M, 2001, BIOMATERIALS, V22, P677, DOI 10.1016/S0142-9612(00)00230-1
   URAYAMA A, 1998, SHIKOKU DENT RES, V11, P1
   VANDIJK J, 1987, J CLIN PERIODONTOL, V14, P300
   Watari F, 2001, CERAM TRANS, V114, P73
   Watari F, 1998, J JPN I MET, V62, P1095, DOI 10.2320/jinstmet1952.62.11_1095
   Watari F, 1997, COMPOS PART B-ENG, V28, P5, DOI 10.1016/S1359-8368(96)00021-2
   WATARI F, 1995, P 3 INT S STRUCT FUN, P703
   Watari F., 1991, J JPN SOC DENT MAT D, V10, P266
   WATARI F, 2000, J JAP SOC POWDER POW, V47, P1226
   WATARI F, 1993, J JPN SOC DENT MAT D, V12, P84
   YOSHINARI M, 1984, J JAPANESE SOC DENT, V3, P71
NR 35
TC 46
Z9 48
U1 1
U2 9
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KAMAGOME TS BDG, KOMAGONE, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD DEC
PY 2002
VL 21
IS 4
BP 355
EP 372
DI 10.4012/dmj.21.355
PG 18
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 648GT
UT WOS:000181142600008
PM 12608425
OA Bronze
DA 2018-10-19
ER

PT J
AU Dupont, L
   Guillon, E
   Bouanda, J
   Dumonceau, J
   Aplincourt, M
AF Dupont, L
   Guillon, E
   Bouanda, J
   Dumonceau, J
   Aplincourt, M
TI EXAFS and XANES studies of retention of copper and lead by a
   lignocellulosic biomaterial
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID X-RAY-ABSORPTION; SURFACE COMPLEXATION MODEL; METAL-IONS;
   FINE-STRUCTURE; WHEAT BRAN; SPECTROSCOPY; REMOVAL; BINDING; ACID;
   DISTORTION
AB Lignocellulosic substrate (LS), which is a low cost biomaterial, has a strong complexing ability and can be used in the treatment of wastewaters as biosorbent to remove heavy metals. The speciation of copper and lead to this biomaterial has been studied by X-ray absorption spectroscopy. The copper(II) has a 6-coordinate structure with four oxygen atoms in the equatorial plane at 1.95 Angstrom and two in axial position at 2.35 Angstrom. In the case of lead a particularly low coordination number of about 3 has been obtained. The combination of extended X-ray absorption fine structure (EXAFS) and X-ray absorption near edge structure (XANES) suggested that Cu and Pb are bound to the surface of LS through carboxylic moieties.
C1 Univ Reims, GRECI, F-51687 Reims 2, France.
RP Guillon, E (reprint author), Univ Reims, GRECI, BP 1039, F-51687 Reims 2, France.
CR Alcacio TE, 2001, GEOCHIM COSMOCHIM AC, V65, P1355, DOI 10.1016/S0016-7037(01)00546-4
   Bargar JR, 1997, GEOCHIM COSMOCHIM AC, V61, P2617, DOI 10.1016/S0016-7037(97)00124-5
   BIANCONI A, 1982, PHYS REV B, V26, P6502, DOI 10.1103/PhysRevB.26.6502
   Blair R. A., 1980, PHYS REV B, V22, P2767
   Bouanda J, 2002, ANAL BIOANAL CHEM, V373, P174, DOI 10.1007/s00216-002-1305-z
   Bull DC, 2000, J WOOD SCI, V46, P248, DOI 10.1007/BF00776457
   CHAN WH, 1992, ANAL LETT, V25, P305, DOI 10.1080/00032719208018528
   COSTA ETH, 1995, SEPAR SCI TECHNOL, V30, P2593, DOI 10.1080/01496399508021405
   Davies G, 1997, J CHEM SOC DALTON, P4047, DOI 10.1039/a703145i
   DAVILA JS, 1992, WATER SCI TECHNOL, V26, P2309
   DEVASCONCELOS LAT, 1992, EUR WATER POLLUT CON, V2, P13
   Duverneuil P., 1997, RECUPERATION METAUX
   Gaballah I, 1998, J GEOCHEM EXPLOR, V62, P241, DOI 10.1016/S0375-6742(97)00068-X
   GARCIA J, 1989, CHEM PHYS, V132, P295, DOI 10.1016/0301-0104(89)80095-3
   GAUTHIER A, 2002, IN PRESS J ANAL APPL
   Guillon E, 2001, J COLLOID INTERF SCI, V239, P39, DOI 10.1006/jcis.2001.7535
   HAHN JE, 1982, CHEM PHYS LETT, V88, P595, DOI 10.1016/0009-2614(82)85016-1
   JOYNER RW, 1980, CHEM PHYS LETT, V72, P162, DOI 10.1016/0009-2614(80)80264-8
   KAU LS, 1987, J AM CHEM SOC, V109, P3
   Konigsberger D. C., 1988, XRAY ABSORPTION PRIN
   Korshin GV, 1998, ENVIRON SCI TECHNOL, V32, P2699, DOI 10.1021/es980016d
   KOSUGI N, 1984, CHEM PHYS, V91, P249, DOI 10.1016/0301-0104(84)80058-0
   LENGELER B, 1980, PHYS REV B, V21, P4507, DOI 10.1103/PhysRevB.21.4507
   LYTLE FW, 1989, PHYSICA B, V158, P701
   Manceau A, 1996, ENVIRON SCI TECHNOL, V30, P1540, DOI 10.1021/es9505154
   MCBRIDE MB, 1978, SOIL SCI, V126, P200, DOI 10.1097/00010694-197810000-00002
   Merdy P, 2002, ENVIRON SCI TECHNOL, V36, P1728, DOI 10.1021/es010197a
   Merdy P, 2002, ANAL CHIM ACTA, V459, P133, DOI 10.1016/S0003-2670(02)00078-8
   MERDY P, 2001, J COLLOID INTERF SCI, V245, P24
   Michalowicz A, 1997, J PHYS IV, V7, P235, DOI 10.1051/jp4/1997178
   PALLADINO L, 1993, J CHEM PHYS, V98, P2720, DOI 10.1063/1.464153
   Ravat C, 2000, WATER RES, V34, P1327, DOI 10.1016/S0043-1354(99)00255-9
   Ravat C, 2000, J COLLOID INTERF SCI, V225, P329, DOI 10.1006/jcis.2000.6782
   Sarret G, 2001, ENVIRON SCI TECHNOL, V35, P2854, DOI 10.1021/es000219d
   Sarret G, 1998, ENVIRON SCI TECHNOL, V32, P3325, DOI 10.1021/es970718n
   SENESI N, 1990, ANAL CHIM ACTA, V232, P51, DOI 10.1016/S0003-2670(00)81225-8
   SHUKLA SR, 1991, DYES PIGMENTS, V17, P101, DOI 10.1016/0143-7208(91)87024-H
   Surville-Barland C, 1998, INORG CHIM ACTA, V278, P159, DOI 10.1016/S0020-1693(98)00016-4
   SVOBODA L, 1994, COLLECT CZECH CHEM C, V59, P1319, DOI 10.1135/cccc19941319
   TEO BK, 1986, INORGANIC CHEM CONCE, P9
   TROGER L, 1992, PHYS REV B, V46, P3283, DOI 10.1103/PhysRevB.46.3283
   Xia K, 1997, J COLLOID INTERF SCI, V185, P252, DOI 10.1006/jcis.1996.4590
NR 42
TC 34
Z9 37
U1 3
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD DEC 1
PY 2002
VL 36
IS 23
BP 5062
EP 5066
DI 10.1021/es025764o
PG 5
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 623CE
UT WOS:000179685000022
PM 12523421
DA 2018-10-19
ER

PT J
AU Lloyd, SN
   Cross, W
AF Lloyd, SN
   Cross, W
TI The current use of biomaterials in urology
SO EUROPEAN UROLOGY SUPPLEMENTS
LA English
DT Article; Proceedings Paper
CT 17th Congress of the EAU
CY FEB 23, 2002
CL BIRMINGHAM, ENGLAND
SP EAU
DE implants; prostheses; reconstruction; injectables; grafts; Peyronie's
   disease; natural polymers; acellular collagen grafts
AB There are many applications for biomaterials in urology, including: implants for sphincters, testicular and penile prostheses, vaginal wall reconstruction, injectables for stress incontinence, restoration of function or structure, e.g. bladder augmentation or use of grafts in Peyronie's disease. A biomaterial can be used alone (e.g. as a graft) or as a component of a medical device (e.g. a heart valve). Although the distinction between a biomaterial and a medical device is often blurred, it may carry medico-legal implications. There are currently five types of biomaterials in use: polymers, composites, metals and alloys, ceramics (often used in combination with metals) and biological materials. Polymers have the advantage of being tailorable and cheap, and are used in catheters and sutures. Biologicals are used for complex function replacement in soft tissue augmentation and vascular grafts. Biomaterials used in surgical repair may be further categorised as synthetic or natural, and absorbable or non-absorbable. A recent development has been the use of natural biomaterials to promote new tissue growth in areas of disease or defective tissue. One advantage of natural over synthetic products is that revascularisation of the tissue allows the graft to be left in place in the presence of infection while antibiotics are administered. Natural biomaterials include: cadaveric allografts, autografts of autologous tissue (e.g. rectus fascia), and acellular collagen grafts such as those derived from porcine dermis (Pelvicol(TM) Implant). (C) 2002 Published by Elsevier Science B.V.
C1 St James Univ Hosp, Pyrah Dept Urol, Leeds LS9 7TF, W Yorkshire, England.
RP Lloyd, SN (reprint author), St James Univ Hosp, Pyrah Dept Urol, Leeds LS9 7TF, W Yorkshire, England.
EM stuartlloyd@leedsth.nhs.uk
CR Fenner DE, 2000, CLIN OBSTET GYNECOL, V43, P650, DOI 10.1097/00003081-200009000-00024
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   *NIH, 1982, NIH CONS STAT, V4, P1
   *SCI TECHN POL I, 2000, RAND, V194, P1
NR 4
TC 9
Z9 10
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-9056
EI 1878-1500
J9 EUR UROL SUPPL
JI Eur. Urol. Suppl.
PD DEC
PY 2002
VL 1
IS 10
BP 2
EP 6
AR PII S1569-9056(02)00146-X
DI 10.1016/S1569-9056(02)00146-X
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 632GA
UT WOS:000180214500002
DA 2018-10-19
ER

PT J
AU De Ridder, D
AF De Ridder, D
TI The use of biomaterials in reconstructive urology
SO EUROPEAN UROLOGY SUPPLEMENTS
LA English
DT Article; Proceedings Paper
CT 17th Congress of the EAU
CY FEB   23, 2002
CL BIRMINGHAM, ENGLAND
SP EAU
DE reconstructive surgery; modified Raz procedure; Pelvicol (TM) implant;
   cystocoele; rectocoele; uterine prolapse; enterocoele; vault prolapse
ID SACROSPINOUS LIGAMENT SUSPENSION; VAGINAL VAULT PROLAPSE; PELVIC SUPPORT
   DEFECTS; SACRAL COLPOPEXY; MESH EROSION; REPAIR; GRAFT
AB Objectives: Implant materials are used for a variety of reconstructive surgeries in urology including cystocoele, rectocoele, uterine prolapse, enterocoele and vault prolapse. We review the use of natural and synthetic implant materials in reconstructive urology and examine how these new biomaterials may behave in the management of those patients with surgical complications. We describe our experience with a new collagen biomaterial (Pelvicol(TM) Implant) in reconstructive urology and present a new technique for the surgical repair of cystocoele using a modified Raz surgical procedure for cystocoele grade III repair.
   Methods: Patients underwent either a Raz classical repair using polyglactin mesh (n = 30) or a modified Raz technique using Pelvicol(TM) Implant as a plug of overlay material (n = 28).
   Results: Preliminary results are presented with a mean follow-up of 9.3 months. There were no recurrences in the Pelvicol(TM) Implant group compared with three recurrences in the control group. Furthermore, there were no erosions or infections in the Pelvicol(TM) Implant group. The modified Raz technique prolonged the operation time by only 10 minutes.
   Conclusions: In vaginal reconstruction surgery, the ultimate goal is not only to mend damaged tissue, but also to replace or regenerate the tissue by sustaining it on some form of matrix. The second generation of biomaterials currently being evaluated provide great potential to achieve this objective. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Hosp, Pelv Floor Unit, Louvain, Belgium.
RP De Ridder, D (reprint author), Univ Hosp, Pelv Floor Unit, Louvain, Belgium.
RI De Ridder, Dirk/G-2481-2010
OI De Ridder, Dirk/0000-0001-6914-0077
CR CUMBERLAND V H, 1952, Med J Aust, V1, P143
   Farrell SA, 2001, OBSTET GYNECOL, V98, P794, DOI 10.1016/S0029-7844(01)01533-2
   Fenner DE, 2000, CLIN OBSTET GYNECOL, V43, P650, DOI 10.1097/00003081-200009000-00024
   Fitzgerald MP, 1999, BJU INT, V84, P785
   Hardimann PJ, 1996, AM J OBSTET GYNECOL, V175, P612
   Julian TM, 1996, AM J OBSTET GYNECOL, V175, P1472, DOI 10.1016/S0002-9378(96)70092-3
   Kohli N, 1998, OBSTET GYNECOL, V92, P999, DOI 10.1016/S0029-7844(98)00330-5
   LANSMAN HH, 1984, OBSTET GYNECOL, V63, P577
   MALONEY JC, 1990, J REPROD MED, V35, P6
   Paraiso MFR, 1996, AM J OBSTET GYNECOL, V175, P1423, DOI 10.1016/S0002-9378(96)70085-6
   PELOSI MA, 1980, OBSTET GYNECOL, V55, P385, DOI 10.1097/00006250-198003000-00025
   Safir MH, 1999, J UROLOGY, V161, P587, DOI 10.1016/S0022-5347(01)61958-X
   Sand PK, 2001, AM J OBSTET GYNECOL, V184, P1357, DOI 10.1067/mob.2001.115118
   SCALES J T, 1953, Proc R Soc Med, V46, P647
   SHULL BL, 1992, AM J OBSTET GYNECOL, V166, P1764, DOI 10.1016/0002-9378(92)91567-T
   Timmons MC, 1997, J PELVIC SURG, V3, P75
   VANLINDERT ACM, 1993, EUR J OBSTET GYN R B, V50, P133, DOI 10.1016/0028-2243(93)90177-E
   Visco AG, 2001, AM J OBSTET GYNECOL, V184, P297, DOI 10.1067/mob.2001.109654
   Weber AM, 2001, AM J OBSTET GYNECOL, V185, P1299, DOI 10.1067/mob.2001.119081
NR 19
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-9056
J9 EUR UROL SUPPL
JI Eur. Urol. Suppl.
PD DEC
PY 2002
VL 1
IS 10
BP 7
EP 11
AR PII S1569-9056(02)00147-1
DI 10.1016/S1569-9056(02)00147-1
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 632GA
UT WOS:000180214500003
DA 2018-10-19
ER

PT J
AU Grise, P
AF Grise, P
TI The future of biomaterials in urology
SO EUROPEAN UROLOGY SUPPLEMENTS
LA English
DT Article; Proceedings Paper
CT 17th Congress of the EAU
CY FEB   23, 2002
CL BIRMINGHAM, ENGLAND
SP EAU
DE tissue engineering; stents; catheters; urinary tubular replacement;
   slings; artificial bladder; penile tissue
ID URINARY-BLADDER; IN-VIVO; REPLACEMENT; RECONSTITUTION; IMPLANTATION;
   MUSCLE; CELLS
AB The fields of application of implant biomaterials will continue to widen, expanding from the use of catheters and slings in the genito-urinary tract to the production of morphological and organ tissues. The focus of research has changed in recent years from the macroscopic to the microscopic view, with attention shifting from mechanical macrodevices such as prostheses, catheters, and slings to the cell unit, with increasing attention being given to in vitro cell cultures. Novel techniques such as gene therapy and tissue engineering have only recently been introduced to the field of urology, and prospective biocompatibility studies are needed to establish appropriate standards of consistency. The development of new biomaterials will require a poly-disciplinary approach involving engineers, biologists and physicians, and will increasingly rely on specialised centres of biocompatibility research, and close cooperation between basic biosciences and clinical practice. The synthetic biomaterials of the future will have virtually unlimited mechanical properties, allowing them to be applied to more specific uses. There will be a move towards materials with a minimal risk of infection, erosion, mineral deposition, particle migration and adverse reactions, yet having long-term durability. However, it is unlikely that any synthetic material can ever be as durable as a natural or a nature-like biomaterial in the long-term. (C) 2002 Published by Elsevier Science B.V.
C1 Hosp Rouen, Serv Urol, Rouen, France.
RP Grise, P (reprint author), Hosp Rouen, Serv Urol, Rouen, France.
CR ABBOU C, 1977, T AM SOC ART INT ORG, V23, P371
   Amiel GE, 1999, UROL CLIN N AM, V26, P235, DOI 10.1016/S0094-0143(99)80019-6
   ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   Atala A, 1998, UROL CLIN N AM, V25, P39, DOI 10.1016/S0094-0143(05)70431-6
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   BARRETT DM, 1992, MAYO CLIN PROC, V67, P215, DOI 10.1016/S0025-6196(12)60095-0
   BOGASH M, 1960, Surg Forum, V10, P900
   Choong S, 2000, BJU INT, V86, P935, DOI 10.1046/j.1464-410x.2000.00949.x
   CILENTO BG, 1996, J UROLOGY, P155
   Desgrandchamps F, 2000, J ENDOUROL, V14, P63, DOI 10.1089/end.2000.14.63
   Fauza DO, 1998, J PEDIATR SURG, V33, P7, DOI 10.1016/S0022-3468(98)90350-5
   Gurpinar T, 1996, WORLD J UROL, V14, P47, DOI 10.1007/BF01836344
   Jabbour ME, 2001, J ENDOUROL, V15, P611, DOI 10.1089/089277901750426391
   KLINE J, 1978, T AM SOC ART INT ORG, V24, P254
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Pariente JL, 2000, BIOMATERIALS, V21, P835, DOI 10.1016/S0142-9612(99)00253-7
   Park HJ, 1999, J UROLOGY, V162, P1106, DOI 10.1016/S0022-5347(01)68084-4
   Reddy PP, 2000, J UROLOGY, V164, P936, DOI 10.1016/S0022-5347(05)67221-7
   Reid G, 1999, J ENDOUROL, V13, P1, DOI 10.1089/end.1999.13.1
   Rohrmann D, 1996, J UROLOGY, V156, P2094, DOI 10.1016/S0022-5347(01)65442-9
   Woods JD, 1997, SEMIN NEPHROL, V17, P381
   Yokoyama T, 2000, WORLD J UROL, V18, P56, DOI 10.1007/s003450050010
   Yoo JJ, 1998, J UROLOGY, V160
   YOO JJ, 1995, J UROLOGY, P153
NR 24
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-9056
J9 EUR UROL SUPPL
JI Eur. Urol. Suppl.
PD DEC
PY 2002
VL 1
IS 10
BP 17
EP 20
AR PII S1569-9056(02)00149-5
DI 10.1016/S1569-9056(02)00149-5
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 632GA
UT WOS:000180214500005
DA 2018-10-19
ER

PT J
AU Bemelmans, B
AF Bemelmans, B
TI Stress incontinence: New developments in the post-TVT world
SO EUROPEAN UROLOGY SUPPLEMENTS
LA English
DT Article; Proceedings Paper
CT 16th European Urological Winter Forum of the EAU
CY MAR   25, 2002
CL DAVOS, SWITZERLAND
SP EAU
DE tension-free surgical correction; TVT; stress incontinence; biomaterial
   sling
AB The past few years have seen considerable progress in the understanding and management of stress incontinence. Tension-free surgical correction (tension-free vaginal tape, TVT) represents a significant advance, allowing surgery to be undertaken during day care admission, under local anaesthesia, and using a technique that is fast, simple and standardised worldwide. More than 100,000 TVT procedures have been undertaken in Europe, resulting in a high success rate of around 85%. However, TVT is not recommended for patients with Type III stress incontinence (ISD), and is not generally recommended in complicated or repeat procedures. Moreover, a number of serious TVT-related complications are emerging, which have so far been underreported in the literature, including erosions, vascular lesions, intestinal perforations and even deaths. The question also remains as to what should be done with the 15% of patients who remain incontinent after TVT surgery. Not all slings are the same. A tight sling compresses the urethra, while a tension-free sling or tape only provides support to the urethra. This concept of compression versus support is a new one. The key advantage of a biomaterial over TVT is that the sling procedure can be carried out in either a loose TVT-like fashion or in a classical tight fashion. This paper discusses recent developments in our understanding of the pathogenesis of stress incontinence, and provides an overview of new and emerging surgical techniques in the post-TVT era. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Nijmegen, Ctr Med, Unit Funct Urol, Nijmegen, Netherlands.
RP Bemelmans, B (reprint author), Univ Nijmegen, Ctr Med, Unit Funct Urol, Nijmegen, Netherlands.
CR BEMELMANS B, EAU PAPER
   ENHORNING GE, 1976, UROL INT, V31, P3, DOI 10.1159/000280024
   Petros P E, 1990, Acta Obstet Gynecol Scand Suppl, V153, P7
NR 3
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1569-9056
J9 EUR UROL SUPPL
JI Eur. Urol. Suppl.
PD DEC
PY 2002
VL 1
IS 10
BP 38
EP 40
AR PII S1569-9056(02)00154-9
DI 10.1016/S1569-9056(02)00154-9
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 632GA
UT WOS:000180214500010
DA 2018-10-19
ER

PT J
AU Heublein, B
   Evagorou, EG
   Rohde, R
   Ohse, S
   Meliss, RR
   Barlach, S
   Haverich, A
AF Heublein, B
   Evagorou, EG
   Rohde, R
   Ohse, S
   Meliss, RR
   Barlach, S
   Haverich, A
TI Polymerized degradable hyaluronan - a platform for stent coating with
   inherent inhibitory effects on neointimal formation in a porcine
   coronary model
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE hyaluronic acid; cross-linking; stent covering/coating; neointimal
   hyperplasia; porcine model; restenosis; interactive biomaterial
ID SMOOTH-MUSCLE CELLS; RECEPTOR RHAMM; ARTERY INJURY; RESTENOSIS; ACID;
   EXPRESSION; IMPLANTATION; MIGRATION; DELIVERY; HUMANS
AB Biodegradable hyaluronan (hyaluronic acid, HA) made insoluble by self-cross-linking in the presence of N-(3-dimethylaminopropyl)-N'-ethyl carbodiimide (EDC) has been used to cover stents. The maximum polymer-mass on a 16-mm stainless steel stent is approximately 2 mg. During manual crimping and simulated application, the loss of polymerized HA is negligible. The insoluble HA coating has an advantageous inherent antiproliferative effect regarding neointimal formation after local vessel wall injury (overstretch model) and leads to a reduced inflammatory response compared to uncoated stainless-steel stents, used as control, in undiseased pig coronary arteries, over a follow-up period of four weeks. Thus, cross-linked HA stent coating warrants further research as an interactive degradable biomaterial with an inherent inhibitory effect on neointimal formation as a possible biomatrix for local drug delivery to reduce restenosis rate. (Int J Artif Organs 2002; 25: 1166-73).
C1 Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs, D-30659 Hannover, Germany.
RP Heublein, B (reprint author), Hannover Med Sch, Leibniz Res Labs Biotechnol & Artificial Organs, Podbielskistr 380, D-30659 Hannover, Germany.
CR Alt E, 2000, CIRCULATION, V101, P1453, DOI 10.1161/01.CIR.101.12.1453
   BURNS JW, 1991, Patent No. 5017229
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44
   Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6
   Heldman AW, 2001, CIRCULATION, V103, P2289
   Heublein B, 1998, J INVASIVE CARDIOL, V10, P255
   JAM M, 1996, J CLIN INVEST, V97, P596
   KIMURA T, 2001, CIRCULATION, V104, P928
   Lamb RF, 1997, MOL CELL BIOL, V17, P963, DOI 10.1128/MCB.17.2.963
   Mohapatra S, 1996, J EXP MED, V183, P1663, DOI 10.1084/jem.183.4.1663
   Oertli B, 1998, J IMMUNOL, V161, P3431
   Papakonstantinou E, 1998, GLYCOBIOLOGY, V8, P821, DOI 10.1093/glycob/8.8.821
   SAMUEL SK, 1993, J CELL BIOL, V123, P749, DOI 10.1083/jcb.123.3.749
   Savani RC, 1995, INT J TISSUE REACT, V17, P141
   SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764
   SCHWARTZ RS, 1994, ARTERIOSCLER THROMB, V14, P395, DOI 10.1161/01.ATV.14.3.395
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4
   SMEDSROD B, 1991, ADV DRUG DELIVER REV, V7, P265, DOI 10.1016/0169-409X(91)90006-X
   SOUZA JE, 2001, CIRCULATION, V104, P2007
   Suzuki T, 2001, CIRCULATION, V104, P1188, DOI 10.1161/hc3601.093987
   Tamai H, 2000, CIRCULATION, V102, P399
   Teirstein PS, 2001, CIRCULATION, V104, P1996, DOI 10.1161/circ.104.17.1996
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Travis JA, 2001, CIRC RES, V88, P77, DOI 10.1161/01.RES.88.1.77
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Whelan DM, 2000, HEART, V83, P338, DOI 10.1136/heart.83.3.338
   Yamawaki T, 1998, J AM COLL CARDIOL, V32, P780, DOI 10.1016/S0735-1097(98)00312-X
   ZHONG SP, 1994, BIOMATERIALS, V15, P359, DOI 10.1016/0142-9612(94)90248-8
NR 29
TC 21
Z9 21
U1 0
U2 4
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD DEC
PY 2002
VL 25
IS 12
BP 1166
EP 1173
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 635HG
UT WOS:000180393000008
PM 12518961
DA 2018-10-19
ER

PT J
AU Hart, J
   Silcock, D
   Gunnigle, S
   Cullen, B
   Light, ND
   Watt, PW
AF Hart, J
   Silcock, D
   Gunnigle, S
   Cullen, B
   Light, ND
   Watt, PW
TI The role of oxidised regenerated cellulose/collagen in wound repair:
   effects in vitro on fibroblast biology and in vivo in a model of
   compromised healing
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE fibroblast migration/proliferation; delayed wound healing; biomaterial;
   diabetes
ID GENETICALLY DIABETIC MOUSE; COLLAGEN-LIKE POLYPEPTIDES; CHRONIC LEG
   ULCERS; GROWTH-FACTOR; ALPHA-1-PROTEINASE INHIBITOR; MATRIX
   METALLOPROTEINASE; DERMAL FIBROBLASTS; VENOUS ULCERS; I COLLAGEN;
   EXPRESSION
AB Irrespective of underlying chronic wound pathology, delayed wound healing is normally characterised by impaired new tissue formation at the site of injury. It is thought that this impairment reflects both a reduced capacity to synthesize new tissue and the antagonistic activities of high levels of proteinases within the chronic wound environment. Historically, wound dressings have largely been passive devices that offer the wound interim barrier function and establish a moist healing. environment. A new generation of devices, designed to interact with the wound and promote new tissue formation, is currently being developed and tested. This study considers one such device, oxidised regenerated cellulose (ORC)/collagen, in terms of its ability to promote fibroblast migration and proliferation in vitro and to accelerate wound repair in the diabetic mouse, a model of delayed wound healing. ORC/collagen was found to promote both human dermal fibroblasts proliferation and cell migration. In vivo studies considered the closure and histological characteristics of diabetic wounds treated with ORC/collagen compared to those of wounds given standard treatment on both diabetic and non-diabetic mice. ORC/collagen was found to significantly accelerate diabetic wound closure and result in a measurable improvement in the histological appearance of wound tissues. As the diabetic mouse is a recognised model of impaired healing, which may share some characteristics of human chronic wounds, the results of this in vivo study, taken together with those relating the positive effects of ORC/collagen in vitro, may predict the beneficial use of this device in the clinical setting. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Johnson & Johnson Wound Management, R&D Dept, Div ETHICON, Gargrave BD23 3RX, N Yorkshire, England.
   Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Wound Repair Programme, Leeds LS9 7TF, W Yorkshire, England.
RP Cullen, B (reprint author), Johnson & Johnson Wound Management, R&D Dept, Div ETHICON, Gargrave BD23 3RX, N Yorkshire, England.
CR Abd-El-Aleem SA, 2000, J PATHOL, V191, P434, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH654>3.0.CO;2-S
   ALBINI A, 1985, EUR J CELL BIOL, V36, P104
   Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x
   Barone EJ, 1998, PLAST RECONSTR SURG, V102, P1023, DOI 10.1097/00006534-199809040-00015
   Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188
   Bitar MS, 1996, J SURG RES, V61, P113, DOI 10.1006/jsre.1996.0090
   BORREGAARD N, 1987, AGENTS ACTIONS, V22, P255, DOI 10.1007/BF02009054
   Brown A, 1984, SCANNING ELECTRON MI, V2, P747
   Brown DL, 1997, SURGERY, V121, P372, DOI 10.1016/S0039-6060(97)90306-8
   BROWN RL, 1994, J SURG RES, V56, P562, DOI 10.1006/jsre.1994.1090
   BULLEN EC, 1995, J INVEST DERMATOL, V104, P236, DOI 10.1111/1523-1747.ep12612786
   CAWSTON TE, 1989, BRIT J RHEUMATOL, V28, P386
   CULLEN B, 2002, IN PRESS INT J BIOCH
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V198, P331
   DORING G, 1995, J IMMUNOL, V154, P4842
   DOXEY DL, 1995, LIFE SCI, V57, P1111, DOI 10.1016/0024-3205(95)02056-O
   FAHEY TJ, 1991, J SURG RES, V50, P308, DOI 10.1016/0022-4804(91)90196-S
   FALANGA V, 1992, J DERMATOL SURG ONC, V18, P604, DOI 10.1111/j.1524-4725.1992.tb03514.x
   GREENHALGH DG, 1990, AM J PATHOL, V136, P1235
   Grinnell F, 1996, J INVEST DERMATOL, V106, P335, DOI 10.1111/1523-1747.ep12342990
   GRINNELL F, 1992, J INVEST DERMATOL, V98, P410, DOI 10.1111/1523-1747.ep12499839
   Hamacher J, 1998, EUR RESPIR J, V11, P112, DOI 10.1183/09031936.98.11010112
   Harris I R, 1995, Exp Dermatol, V4, P342, DOI 10.1111/j.1600-0625.1995.tb00058.x
   HART J, 2000, WOUND MANAGEMENT THE, P153
   Hasan A, 1997, J DERMATOL SCI, V16, P59, DOI 10.1016/S0923-1811(97)00622-1
   HENNESSEY PJ, 1990, J PEDIATR SURG, V25, P893, DOI 10.1016/0022-3468(90)90198-I
   Herrick S, 1997, LAB INVEST, V77, P281
   Herrick SE, 1996, J INVEST DERMATOL, V106, P187, DOI 10.1111/1523-1747.ep12329920
   Jacob AK, 1997, SURGERY, V122, P243, DOI 10.1016/S0039-6060(97)90015-5
   Kitazawa M, 1999, BBA-GEN SUBJECTS, V1473, P400, DOI 10.1016/S0304-4165(99)00203-2
   Kuntz RM, 1997, BIOPHYS J, V72, P1472, DOI 10.1016/S0006-3495(97)78793-9
   LASKIN DL, 1994, AM J RESP CELL MOL, V10, P58, DOI 10.1165/ajrcmb.10.1.8292381
   LASKIN DL, 1986, J LEUKOCYTE BIOL, V39, P255
   Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x
   Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271
   MALONE JD, 1991, MATRIX, V11, P289
   Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x
   MATUSZEWSKA B, 1994, PHARM RES-DORDR, V11, P65, DOI 10.1023/A:1018993610801
   Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495
   Okumura M, 1996, ARZNEIMITTEL-FORSCH, V46, P547
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Palolahti M, 1993, Exp Dermatol, V2, P29, DOI 10.1111/j.1600-0625.1993.tb00196.x
   PIERCE AM, 1984, J ORAL PATHOL MED, V13, P661, DOI 10.1111/j.1600-0714.1984.tb01468.x
   PIERCE GF, 1995, J CLIN INVEST, V96, P1336, DOI 10.1172/JCI118169
   PORTEU F, 1991, J BIOL CHEM, V266, P18846
   POSTLETHWAITE AE, 1976, J EXP MED, V143, P1299, DOI 10.1084/jem.143.6.1299
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   RAO CN, 1995, J INVEST DERMATOL, V105, P572, DOI 10.1111/1523-1747.ep12323503
   Rogers Alan A., 1995, Wound Repair and Regeneration, V3, P273, DOI 10.1046/j.1524-475X.1995.30307.x
   Saarialho-Kere UK, 1998, ARCH DERMATOL RES, V290, pS47, DOI 10.1007/PL00007453
   SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880
   SCHMID P, 1993, J PATHOL, V171, P191, DOI 10.1002/path.1711710307
   Schultz GS, 1998, WOUNDS, V10, p1F
   SEFTON MV, 1998, CUTAN MED SURG, V3, P18
   STACEY MC, 1993, BRIT J SURG, V80, P596, DOI 10.1002/bjs.1800800515
   Stilwell R. L., 1997, HDB BIODEGRADABLE PO, P291
   Stocum David L., 1998, Wound Repair and Regeneration, V6, P276, DOI 10.1046/j.1524-475X.1998.60404.x
   Stringer SE, 1997, INT J BIOCHEM CELL B, V29, P709, DOI 10.1016/S1357-2725(96)00170-7
   SYMONS J, 1998, FREE RADICALS IRON C
   Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x
   Waddington RJ, 2000, ORAL DIS, V6, P138
   Weckroth M, 1996, J INVEST DERMATOL, V106, P1119, DOI 10.1111/1523-1747.ep12340167
   WERNER S, 1994, J INVEST DERMATOL, V103, P469, DOI 10.1111/1523-1747.ep12395564
   Wlaschek M, 1997, BRIT J DERMATOL, V137, P646, DOI 10.1111/j.1365-2133.1997.tb03804.x
   WYSOCKI AB, 1993, J INVEST DERMATOL, V101, P64, DOI 10.1111/1523-1747.ep12359590
   Yager Dorne R., 1997, Wound Repair and Regeneration, V5, P23, DOI 10.1046/j.1524-475X.1997.50108.x
   Yager DR, 1996, J INVEST DERMATOL, V107, P743, DOI 10.1111/1523-1747.ep12365637
NR 67
TC 62
Z9 64
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD DEC
PY 2002
VL 34
IS 12
BP 1557
EP 1570
AR PII S1357-2725(02)00062-6
DI 10.1016/S1357-2725(02)00062-6
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 612VN
UT WOS:000179096300008
PM 12379278
DA 2018-10-19
ER

PT J
AU Kodjikian, L
   Burillon, C
   Chanloy, C
   Bostvironnois, V
   Pellon, G
   Mari, E
   Freney, J
   Roger, T
AF Kodjikian, L
   Burillon, C
   Chanloy, C
   Bostvironnois, V
   Pellon, G
   Mari, E
   Freney, J
   Roger, T
TI In vivo study of bacterial adhesion to five types of intraocular lenses
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology
CY MAY, 2002
CL FT LAUDERDALE, FLORIDA
SP Assoc Res Vis & Ophthalmol
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; PSEUDOMONAS-AERUGINOSA; ADHERENCE;
   HEPARIN; BIOFILM; EPIDERMIDIS; ANTIBIOTICS; RESISTANCE
AB PURPOSE. To determine in vivo behavior of the ability of the Staphylococcus epidermidis strain (American Type Culture Collection [ATCC] 14990) to attach to 120 intraocular lenses (IOLs) made of five different biomaterials: fluorine polymethylmethacrylate (PMMA), heparinized PMMA, silicone, hydrophobic acrylic, and hydrogel. The pig was chosen as an animal model of endophthalmitis, after a bibliographical analysis and a personal study of its aqueous humor composition.
   METHODS. Crystalline lenses from 90 domestic pigs were removed aseptically and replaced with previously infected IOLs' The animals were killed 24 hours, 72 hours, and 1 week after implantation of the IOLs. The extent of bacterial binding was then measured by counting. Results were compared with a two-factor analysis of variance (ANOVA 2), confirmed by the Kruskal-Wallis nonparametric test.
   RESULTS. The extent of bacterial binding (expressed as bound bacteria per area unit) was found to range in increasing order from hydrogel, to fluorine PMMA, to hydrophobic acrylic, to heparinized PMMA, to silicone polymer. Comparison of pairs of materials showed statistically significant differences, except between hydrogel and fluorine PMMA.
   CONCLUSIONS. To the authors' knowledge, no study has been published so far concerning the in vivo evolution of populations of bacteria adhering to different intraocular materials. Bacterial adhesion to the implant surface must therefore depend on the hydrophobicity or hydrophilicity of the biomaterial. Adhesion is also affected by the nature,of the surrounding medium. Because of its complexity, the latter appears to be very difficult to model, thus making in vivo studies. essential.
C1 Hop Edouard Herriot, Dept Ophthalmol, F-69003 Lyon, France.
   Vet Dept, Marcy Letoile, France.
   Univ Lyon, Dept Microbiol, Lyon, France.
   Univ Lyon, Dept Biochem, Lyon, France.
RP Kodjikian, L (reprint author), Hop Edouard Herriot, Dept Ophthalmol, EA 3090,5 Pl Arsonval, F-69003 Lyon, France.
RI burillon, carole/C-5989-2014
OI burillon, carole/0000-0002-1850-9038
CR ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1347, DOI 10.1128/AAC.36.7.1347
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   BAYSTON R, 1972, DEV MED CHILD NEUROL, V14, P25
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Burillon C, 2002, DRUG DEV IND PHARM, V28, P95, DOI 10.1081/DDC-120001490
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   CUSUMANO A, 1994, ARCH OPHTHALMOL-CHIC, V112, P1015, DOI 10.1001/archopht.1994.01090200017002
   CUSUMANO A, 1991, OPHTHALMOLOGY, V98, P1703
   DILLY PN, 1989, J CATARACT REFR SURG, V15, P317, DOI 10.1016/S0886-3350(89)80092-6
   ECOFFET M, 1985, ENCYCL MED CHIR, P12
   ELOY R, 1993, J CATARACT REFR SURG, V19, P364, DOI 10.1016/S0886-3350(13)80307-0
   EVANS RC, 1987, ANTIMICROB AGENTS CH, V31, P889, DOI 10.1128/AAC.31.6.889
   GARCIASAENZ MC, 2000, J CATARACT REFR SURG, V11, P1673
   JANSEN B, 1991, J HOSP INFECT, V19, P83, DOI 10.1016/0195-6701(91)90100-M
   Magnusson KE, 1982, SCAND J INFECT DIS S, V33, P32
   Ng EWM, 1996, J CATARACT REFR SURG, V22, P1331, DOI 10.1016/S0886-3350(96)80093-9
   NICHOLS WW, 1989, J GEN MICROBIOL, V135, P1291
   NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   PAULSSON M, 1994, J BIOMED MATER RES, V28, P311, DOI 10.1002/jbm.820280305
   PORTOLES M, 1993, J CATARACT REFR SURG, V19, P755, DOI 10.1016/S0886-3350(13)80345-8
   PROSSER BL, 1987, ANTIMICROB AGENTS CH, V31, P1502, DOI 10.1128/AAC.31.10.1502
   ROSTAND KS, 1997, INFECT IMMUN, V112, P1015
   Rutter P. R., 1980, MICROBIAL ADHESION S, P79
   SALVANETBOUCCARA A, 1992, J FR OPHTALMOL, V15, P669
   Scherrer B, 1984, BIOSTATISTIQUES
   SHETH NK, 1985, LANCET, V2, P1266
   Thouvenin D, 1996, J CATARACT REFR SURG, V22, P1226, DOI 10.1016/S0886-3350(96)80072-1
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
NR 29
TC 37
Z9 38
U1 1
U2 9
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0146-0404
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD DEC
PY 2002
VL 43
IS 12
BP 3717
EP 3721
PG 5
WC Ophthalmology
SC Ophthalmology
GA 620LE
UT WOS:000179534200020
PM 12454042
DA 2018-10-19
ER

PT J
AU Araujo, MG
   Sonohara, M
   Hayacibara, R
   Cardaropoli, G
   Lindhe, J
AF Araujo, MG
   Sonohara, M
   Hayacibara, R
   Cardaropoli, G
   Lindhe, J
TI Lateral ridge augmentation by the use of grafts comprised of autologous
   bone or a biomaterial. An experiment in the dog
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE bone grafts; bone substitute; dogs; onlay graft; ridge augmentation
ID IMPLANTS; MAXILLA; REGENERATION; BIO-OSS(R); MEMBRANES
AB Objective: The present investigation was performed to determine if a block of Bio-Ossa(R) used as an onlay graft can be used as a scaffold for new bone formation.
   Material and methods: Five mongrel dogs were used. The mandibular premolars were extracted. On both sides of the mandible, the buccal bone plate was resected and defects, about 25 mm long, 8 mm high and 5 mm wide, were produced After 3 months of healing, a second surgical procedure was performed. In the left side, a block of Bio-Oss(R) was adjusted to the buccal bone wall. The graft had the shape of a cylinder and was retained with a miniscrew and covered with a collagen membrane. In the contra-lateral side of the mandible, a block biopsy was first obtained from the ascending ramus. This bone graft had the shape of a cylinder that was 8 mm in diameter and 3 mm thick. The graft was transferred to the experimental site, adjusted to the buccal wall, retained with a miniscrew, and covered with a membrane. The flaps were repositioned and closed with sutures to ensure a complete coverage of the experimental sites. After 6 months of healing, the dogs were sacrificed and the experimental sites dissected. The biopsies were processed for ground sectioning. The sections were stained in toluidine blue, examined in the microscope, and a number of histo- and morphometric assessments made.
   Results: The study demonstrated that cortical bone used as an onlay graft in the lateral aspect of the alveolar ridge, during a 6-month period of healing integrated with the host bone but underwent marked peripheral resorption. Thus, close to 30% of the height and 50% of the length of the graft was replaced with connective tissue. It was further observed that while the dimensions of a graft which contained a scaffold of cancellous bovine bone mineral remained unchanged, only moderate amounts of new bone formed at the base of this graft.
   Conclusion: Grafts of autologous cortical bone, placed on the surface of a one-wall defect, may undergo marked resorption during healing. A similar graft of Bio-Oss(R) may retain its dimension, and limited amounts of new bone will form within the biomaterial.
C1 Univ Gothenburg, Fac Odontol, Dept Periodontol, SE-40530 Gothenburg, Sweden.
   Univ Estadual Maringa, Dept Dent, Maringa, Parana, Brazil.
RP Araujo, MG (reprint author), Univ Gothenburg, Fac Odontol, Dept Periodontol, Box 450, SE-40530 Gothenburg, Sweden.
CR Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Buser D, 1999, PERIODONTOL 2000, V19, P151, DOI 10.1111/j.1600-0757.1999.tb00153.x
   Carmagnola D, 2002, J CLIN PERIODONTOL, V29, P377, DOI 10.1034/j.1600-051X.2002.290501.x
   CARMAGNOLA D, 2001, THESIS GOTEBORG U
   CARMAGNOLA D, 2002, IN PRESS CLIN ORAL I
   Davis W H, 1975, J Maxillofac Surg, V3, P103, DOI 10.1016/S0301-0503(75)80026-9
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donath K., 1988, PRAPARATOR, V34, P197
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Hammerle CHF, 1997, CLIN ORAL IMPLAN RES, V8, P198, DOI 10.1034/j.1600-0501.1997.080306.x
   KAHNBERG KE, 1989, INT J ORAL MAXILLOF, V4, P297
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   LOZANO AJ, 1976, PLAST RECONSTR SURG, V58, P302, DOI 10.1097/00006534-197609000-00007
   Mayfield LJA, 2001, CLIN ORAL IMPLAN RES, V12, P508
   Nystrom E, 1993, Int J Oral Maxillofac Implants, V8, P45
   NYSTROM E, 1995, INT J ORAL MAX SURG, V24, P20, DOI 10.1016/S0901-5027(05)80851-3
   NYSTROM E, 1995, THESIS U UMEA
   Ozaki W, 1998, PLAST RECONSTR SURG, V102, P291, DOI 10.1097/00006534-199808000-00001
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P75, DOI 10.1034/j.1600-0501.1997.080201.x
   Scipioni A, 1997, CLIN ORAL IMPLAN RES, V8, P39, DOI 10.1111/j.1600-0501.1997.tb00006.x
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Slotte C, 1999, CLIN ORAL IMPLAN RES, V10, P468, DOI 10.1034/j.1600-0501.1999.100605.x
   Stavropoulos A, 2001, Clin Implant Dent Relat Res, V3, P156, DOI 10.1111/j.1708-8208.2001.tb00136.x
   STOELINGA PJW, 1978, J ORAL SURG, V36, P30
   STOELINGA PJW, 1983, J MAXILLOFAC SURG, V11, P107, DOI 10.1016/S0301-0503(83)80026-5
   URIST MR, 1968, CLIN ORTHOP RELAT R, P59
   von Arx T, 2001, INT J ORAL MAX IMPL, V16, P343
   von Arx T, 2001, CLIN ORAL IMPLAN RES, V12, P260, DOI 10.1034/j.1600-0501.2001.012003260.x
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   Widmark G, 1997, INT J ORAL MAX SURG, V26, P106, DOI 10.1016/S0901-5027(05)80827-6
   Zitzmann NU, 1998, ORAL SURG ORAL MED O, V85, P8, DOI 10.1016/S1079-2104(98)90391-2
NR 33
TC 120
Z9 125
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD DEC
PY 2002
VL 29
IS 12
BP 1122
EP 1131
DI 10.1034/j.1600-051X.2002.291213.x
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 630QK
UT WOS:000180119500013
PM 12492915
DA 2018-10-19
ER

PT J
AU Santos, FA
   Zenobio, EG
   Spolidoro, LC
   Marcantonio, E
AF Santos, FA
   Zenobio, EG
   Spolidoro, LC
   Marcantonio, E
TI Biomaterial implants in dental socket. Histologic analysis in dogs
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Meeting Abstract
CT 18th Annual Meeting of the International-Association-for-Dental-Research
CY SEP 02-05, 2001
CL SAO PAULO, BRAZIL
SP Int Assoc Dent Res
C1 FOAr, Dept Diagnost & Cirurugia, Araraquara, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD DEC
PY 2002
VL 81
SI B
BP B145
EP B145
PG 1
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 632HM
UT WOS:000180217901034
DA 2018-10-19
ER

PT J
AU Yuan, HP
   Van den Doel, M
   Li, SH
   Van Blitterswijk, CA
   De Groot, K
   De Bruijn, JD
AF Yuan, HP
   Van den Doel, M
   Li, SH
   Van Blitterswijk, CA
   De Groot, K
   De Bruijn, JD
TI A comparison of the osteoinductive potential of two calcium phosphate
   ceramics implanted intramuscularly in goats
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN; OSTEOGENESIS; DOGS; HYDROXYAPATITE;
   RESPONSES; INDUCTION; TISSUE; KINDS
AB The osteoinductive potential, or bone induction potency, of two calcium phosphate ceramics was evaluated after intramuscular implantation in goats. The ceramics were comprised of hydroxyapatite (HA) and biphasic calcium phosphate (BCP), the later of which contained a 85/15 mixture of hydroxyapatite and tricalcium phosphate (TCP). Both ceramics had a similar macroporosity of around 55% and a pore distribution between 100 and 800 mum. Besides the difference in chemistry, BCP was also microporous and hence had a different surface microstructure. After implantation in the back muscles of four goats for 12 weeks, all 8 BCP samples (7 x 7 x 7 mm(3)) showed the presence of bone formation in the macropores (1 +/- 1%), while no bone was found in any of the HA samples. The used BCP can therefore be characterized as an osteoinductive material. Having the ability to induce bone formation in soft tissues, the BCP presented herein may be a useful biomaterial for bone repair when combined with cultured osteogenic cells, growth factors or both. (C) 2002 Kluwer Academic Publishers.
C1 IsoTis NV, NL-3723 MB Bilthoven, Netherlands.
   Univ Twente, NL-7500 AE Enschede, Netherlands.
   Leiden Univ, Biomat Res Grp, NL-2300 RA Leiden, Netherlands.
RP Yuan, HP (reprint author), IsoTis NV, Prof Bronkhorstlaan 10, NL-3723 MB Bilthoven, Netherlands.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR DAMIEN CJ, 1992, J APPL BIOMATER, V2, P187
   De Bruijin J. D., 2000, BONE ENG, P421
   de Bruijn J.D., 1999, T 25 ANN M SOC BIOM, P235
   GOSIMA J, 1991, CLIN ORTHOP RELAT R, V262, P298
   HOLLINGER JO, 1996, CLIN ORTHOP, V324
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   TOTH JM, 1993, BIOCERAMICS, V6, P9
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   Vargervik K., 1992, BONE GRAFTS BONE SUB, P112
   WINTER GD, 1969, NATURE, V223, P88, DOI 10.1038/223088a0
   Yang ZJ, 1997, J MATER SCI-MATER M, V8, P697, DOI 10.1023/A:1018540024082
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   YUAN H, 2002, T 28 ANN M SOC BIOM, P239
   YUAN H, 2002, T 2002 ESB C BARC SP
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 25
TC 159
Z9 168
U1 0
U2 14
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2002
VL 13
IS 12
BP 1271
EP 1275
DI 10.1023/A:1021191432366
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 616PF
UT WOS:000179311600027
PM 15348676
DA 2018-10-19
ER

PT J
AU Matsuura, H
   Inoue, T
   Konno, H
   Sasaki, M
   Ogasawara, K
   Ogawa, A
AF Matsuura, H
   Inoue, T
   Konno, H
   Sasaki, M
   Ogasawara, K
   Ogawa, A
TI Quantification of susceptibility artifacts produced on high-field
   magnetic resonance images by various biomaterials used for neurosurgical
   implants - Technical note
SO JOURNAL OF NEUROSURGERY
LA English
DT Article
DE neurosurgical implant; magnetic resonance imaging; susceptibility
   artifact
ID IMAGING PARAMETERS; ANEURYSM CLIPS; MR; TITANIUM; VISUALIZATION;
   COMPATIBILITY; ANGIOGRAPHY; SPINE
AB Although various biomaterials such as ceramics or titanium alloy are widely used in neurosurgery, the susceptibility artifacts that appear around these materials cause problems when a magnetic resonance (MR) imager is used to assess lesions after surgery. The purpose of the present study was to quantify the susceptibility artifacts produced by various biomaterials used for neurosurgical implants.
   Using a 3-tesla MR imaging unit, we obtained MR images of various biomaterials, including six types of ceramics, a cobalt-based alloy (Elgiloy), pure titanium, a titanium alloy, and stainless steel. All implants shared a uniform size and shape. In each image, a linear region of interest was defined across the center of the biomaterial in the transverse direction, and the diameter of the susceptibility artifact was calculated.
   The ceramics produced a considerably smaller artifact diameter than those produced by other biomaterials. Among the types of ceramics, zirconia was found to produce the smallest artifact diameter. Among the remaining biomaterials, the diameters of the artifacts decreased in order from that associated with stainless steel to those associated with cobalt-based alloys, pure titanium, and titanium alloy. Little difference was observed between the artifact diameters associated with pure titanium and titanium alloy.
   Ceramics are the most suitable biomaterials for minimizing artifacts in high-field MR imaging.
C1 Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 0208505, Japan.
   Iwate Med Univ, Dept Radiol, Morioka, Iwate 0208505, Japan.
RP Inoue, T (reprint author), Iwate Med Univ, Dept Neurosurg, Uchimaru 19-1, Morioka, Iwate 0208505, Japan.
CR BATZDORF U, 1991, SPINE, V16, P123, DOI 10.1097/00007632-199102000-00004
   BYDDER GM, 1982, AM J ROENTGENOL, V139, P215, DOI 10.2214/ajr.139.2.215
   CHRISTOFFERSSON JO, 1991, ACTA RADIOL, V32, P426, DOI 10.1177/028418519103200519
   CROOKS LE, 1982, RADIOLOGY, V144, P843, DOI 10.1148/radiology.144.4.7111736
   CROOKS LE, 1983, RADIOLOGY, V146, P123, DOI 10.1148/radiology.146.1.6849032
   FARAHANI K, 1990, COMPUT MED IMAG GRAP, V14, P409, DOI 10.1016/0895-6111(90)90040-I
   Frahm C, 1996, CARDIOVASC INTER RAD, V19, P335
   Fujisawa A., 1996, BIOCERAMICS, V9, P495
   Grieve JP, 1999, NEURORADIOLOGY, V41, P680, DOI 10.1007/s002340050824
   KOBAYASHI S, 1981, SURG NEUROL, V15, P196, DOI 10.1016/0090-3019(81)90142-7
   KOYAMA T, 1986, SURG NEUROL, V25, P71, DOI 10.1016/0090-3019(86)90118-7
   KUMAR P, 1991, J BIOMED MATER RES, V25, P813, DOI 10.1002/jbm.820250703
   Nitatori T, 1999, Radiat Med, V17, P329
   Petersilge CA, 1996, AM J ROENTGENOL, V166, P1213, DOI 10.2214/ajr.166.5.8615272
   Port JD, 2000, J COMPUT ASSIST TOMO, V24, P958, DOI 10.1097/00004728-200011000-00024
   ROSS JS, 1990, AM J NEURORADIOL, V11, P449
   Shellock FG, 1998, RADIOLOGY, V206, P838, DOI 10.1148/radiology.206.3.9494511
   Shellock FG, 1996, JMRI-J MAGN RESON IM, V6, P954, DOI 10.1002/jmri.1880060620
   TOMINAGA T, 1995, NEUROSURGERY, V36, P951, DOI 10.1227/00006123-199505000-00010
   Wichmann W, 1997, AM J NEURORADIOL, V18, P939
   YAMASHIMA T, 1988, ACTA NEUROCHIR, V90, P157, DOI 10.1007/BF01560572
NR 21
TC 37
Z9 38
U1 0
U2 10
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI CHARLOTTESVILLE
PA UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA
SN 0022-3085
J9 J NEUROSURG
JI J. Neurosurg.
PD DEC
PY 2002
VL 97
IS 6
BP 1472
EP 1475
DI 10.3171/jns.2002.97.6.1472
PG 4
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 626YG
UT WOS:000179901000033
PM 12507151
DA 2018-10-19
ER

PT J
AU Ozawa, T
   Mickle, DAG
   Weisel, RD
   Koyama, N
   Wong, H
   Ozawa, S
   Li, RK
AF Ozawa, T
   Mickle, DAG
   Weisel, RD
   Koyama, N
   Wong, H
   Ozawa, S
   Li, RK
TI Histologic changes of nonbiodegradable and biodegradable biomaterials
   used to repair right ventricular heart defects in rats
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID OUTFLOW TRACT; PULMONARY-ARTERY; CARDIAC GRAFT; TISSUE; CONDUITS;
   RECONSTRUCTION; REPLACEMENT; VALVE; CELLS; MODEL
AB Objectives: Nonbiodegradable synthetic materials have been widely used to repair cardiac defects. Material-related failures, however, such as lack of growth, thrombosis, and infection, do occur. Because a biodegradable scaffold can be replaced by the patient's own cells and will be treated as a foreign body for a limited period, we compared four biodegradable materials (gelatin, polyglycolic acid, (PGA), and copolymer made of epsilon-caprolactone and L-lactic acid reinforced with a poly-L-lactide knitted [KN-PCLA] or woven fabric [WV-PCLA]) with a nonbiodegradable polytetrafluoroethylene (PTFE) material. An animal heart model was tested that simulates the in vivo clinical condition to which a synthetic material would be used.
   Methods: The five patches were used to repair transmural defects surgically created in the right ventricular outflow tracts of adult rat hearts (n = 5, each patch group). The PTFE patch group served as a control group. At 8 weeks after implantation, the biomaterials were excised. Patch size, patch thickness, infiltrated cell number, extracellular matrix composition, and patch degradation were evaluated.
   Results: The PTFE patch itself did not change in size except for increasing in thickness because of fibroblast and collagen coverage of both its surfaces. Host cells did not migrate into the PTFE biomaterial. In contrast, cells migrated into the biodegrading gelatin, PGA, and KN-PCLA and WV-PCLA scaffolds. Cellular ingrowth per unit patch area was highest in the KN-PCLA patch. The KN-PCLA patch increased modestly in size and thinness. The WV-PCNA patch did not change in size or thickness. Fibroblasts and collagen were the dominant cellular infiltrate and extracellular matrix formed in the biodegrading scaffolds. The in vivo rates of biomaterial degradation, thinning, and expansion were material specific. All the subendocardial patch surfaces were covered with endothelial cells. No thrombi were seen.
   Conclusions: The unique, spongy matrix structure of the PCLA patch favored cell colonization relative to the other patches. The strong, durable outer Poly-L-lactide fabric layers in these patches offered physical, biocompatible, and bioresorbable advantages relative to the other biodegradable materials studied. Host cells migrated into all the biomaterials. The cells secreted matrix and formed tissue, which was endothelialized on the endocardial surface. The biomaterial degradation rates and the tissue formation rates were material related. The PCLA grafts hold promise to become a suitable patch for surgical repair.
C1 Toronto Gen Hosp, Toronto Gen Res Inst, Dept Surg, Div Cardiovasc Surg, Toronto, ON M5G 2C4, Canada.
   Univ Toronto, Toronto, ON, Canada.
RP Li, RK (reprint author), Toronto Gen Hosp, Toronto Gen Res Inst, Dept Surg, Div Cardiovasc Surg, CCRW 1-815,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.
OI Li, Ren-Ke/0000-0002-2584-060X
CR Carver SE, 1999, BIOTECHNOL BIOENG, V65, P274
   Danielson G K, 1995, Semin Thorac Cardiovasc Surg, V7, P162
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   HAVERICH A, 1984, ANN THORAC SURG, V37, P404, DOI 10.1016/S0003-4975(10)60766-7
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Homann M, 2000, EUR J CARDIO-THORAC, V17, P624, DOI 10.1016/S1010-7940(00)00414-0
   Izutani H, 2000, ASAIO J, V46, P553, DOI 10.1097/00002480-200009000-00008
   Kang SW, 2000, MOL CELLS, V10, P193, DOI 10.1007/s100590050011
   Kim BS, 1998, J BIOMED MATER RES, V41, P322, DOI 10.1002/(SICI)1097-4636(199808)41:2<322::AID-JBM18>3.0.CO;2-M
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   MALM T, 1994, EUR SURG RES, V26, P298, DOI 10.1159/000129349
   Mayer JE, 1997, CURR OPIN CARDIOL, V12, P528, DOI 10.1097/00001573-199711000-00005
   Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3
   Shi Q, 1997, J VASC SURG, V25, P736, DOI 10.1016/S0741-5214(97)70303-3
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Shinoka T, 1996, CIRCULATION, V94, P164
   SHINOKA T, 1995, ANN THORAC SURG, V60, P513
   Stark J, 1998, J THORAC CARDIOV SUR, V115, P506, DOI 10.1016/S0022-5223(98)70312-5
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Uemura H, 2000, EUR J CARDIO-THORAC, V17, P543, DOI 10.1016/S1010-7940(00)00410-3
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   YOUNG B, 2000, WHEATERS FUNCTIONAL, P65
   Yu T J, 1994, J Invest Surg, V7, P195, DOI 10.3109/08941939409018286
NR 26
TC 52
Z9 56
U1 1
U2 9
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD DEC
PY 2002
VL 124
IS 6
BP 1157
EP 1164
DI 10.1067/mtc.2002.127449
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 623MC
UT WOS:000179706200016
PM 12447182
OA Bronze
DA 2018-10-19
ER

PT J
AU Li, SJ
   Hao, YL
   Yang, R
   Cui, YY
   Niinomi, M
AF Li, SJ
   Hao, YL
   Yang, R
   Cui, YY
   Niinomi, M
TI Effect of Nb on microstructural characteristics of Ti-Nb-Ta-Zr alloy for
   biomedical applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium-niobium-tantalum-zirconium alloy; biomaterial; microstructure;
   phase transformation
ID OMEGA PHASE TRANSFORMATION; TITANIUM-ALLOYS; CAST-IRON; STRENGTH;
   MODULUS; BETA
AB The effects of several commonly used heat treatment schemes on the microstructures of two Ti-Nb-Ta-Zr alloys aimed at biomedical applications were studied in this work using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The specimens were water quenched from 790degreesC and then aged at temperatures between 300degreesC and 600degreesC. The experimental results showed that alpha and omega phase precipitated from the metastable beta matrix in Ti-29Nb-13Ta-4.6Zr alloy during isothermal ageing. But for Ti-39Nb-13Ta-4.6Zr, the precipitation reaction was more sluggish than that in Ti-29Nb-13Ta-4.6Zr because of high amount of beta stabilizing elements in the former alloy. As a result the a phase was unable to precipitate during short time ageing treatment. After longer time (12 days) ageing treatment at 500degreesC or 400degreesC, recognizable a precipitates were observed in the aged samples. It is concluded that Ti-29Nb-13Ta-4.6Zr can be heat treated to obtain different microstructures and is better than Ti-39Nb-13Ta-4.6Zr in terms of age hardenability.
C1 Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Li, SJ (reprint author), Chinese Acad Sci, Inst Met Res, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
RI Niinomi, Mitsuo/B-5965-2011
CR Boccaccini AR, 1997, Z METALLKD, V88, P23
   Burgers WG, 1934, PHYSICA, V1, P561, DOI 10.1016/S0031-8914(34)80244-3
   CHO K, 1988, METALL TRANS A, V19, P2027, DOI 10.1007/BF02645206
   COLLINGS EW, 1984, PHYSICAL METALLURGY
   DEFONTAI.D, 1970, ACTA METALL MATER, V18, P275, DOI 10.1016/0001-6160(70)90035-0
   DEFONTAINE D, 1971, ACTA METALL MATER, V19, P1153, DOI 10.1016/0001-6160(71)90047-2
   FAN Z, 1993, MATER SCI TECH SER, V9, P863, DOI 10.1179/mst.1993.9.10.863
   FAN Z, 1993, MATER SCI TECH SER, V9, P1094, DOI 10.1179/mst.1993.9.12.1094
   FAN ZY, 1993, SCRIPTA METALL MATER, V29, P1427, DOI 10.1016/0956-716X(93)90331-L
   HAO YL, UNPUB METALL MAT T A
   HAO YL, IN PRESS METALL MA A
   Kaufman L, 1970, COMPUTER CALCULATION
   KOUL MK, 1970, ACTA METALL MATER, V18, P579, DOI 10.1016/0001-6160(70)90087-8
   LEDBETTER H, 1992, Z METALLKD, V83, P195
   LI QY, 1984, HDB NONFERROUS MAT P, P48
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mishra A. K., 1996, ASTM STP, V1272, P96
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   MOFFAT DL, 1988, METALL TRANS A, V19, P1687, DOI 10.1007/BF02645136
   NARAYANAN GH, 1970, METALL TRANS, V1, P2281, DOI 10.1007/BF02643446
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   ROBARE EW, 1997, ADV SCI TECHNOLOGY T, P283
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   SILCOCK JM, 1956, I METALS MONOGR REP, V18, P93
   SLANINA P, 1985, ACTA PHARMACOL TOX, V56, P331
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Song Y, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P273
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   VANDERVOET GB, 1991, ALUMINUM NEUROTOXICI, P135
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   ZWICKER R, 1980, TITANIUM 80 SCI TECH, P505
NR 31
TC 30
Z9 33
U1 0
U2 16
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 2964
EP 2969
DI 10.2320/matertrans.43.2964
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300006
OA Bronze
DA 2018-10-19
ER

PT J
AU Takahashi, E
   Sakurai, T
   Watanabe, S
   Masahashi, N
   Hanada, S
AF Takahashi, E
   Sakurai, T
   Watanabe, S
   Masahashi, N
   Hanada, S
TI Effect of heat treatment and sn content on superelasticity in
   biocompatible TiNbSn alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium; niobium; tin; martensitic transformation; superelasticity;
   biomaterial; heat treatment; Sn content
AB Martensitic transformation and tensile properties of 4 to 5 mol%Sn-doped Ti-16 mol%Nb alloys consisting of biocompatible elements were investigated to provide superelasticity for biomedical applications as a function of heat treatment and Sri content. Martensitic transformation (bee to orthorhombic structure) is accelerated at such quenching conditions that the bcc parent phase is slightly decomposed. Martensitic transformation temperature decreases rapidly with increasing Sri content. In-situ optical microscopic observation on cooling and heating indicates that the martensite is thermoelastic, corresponding to small temperature hysteresis between the martensitic and the reverse transformations, which is determined by differential scanning calorimetry. By controlling the heat treatment condition and Sn content, large superelastic strain is obtained at room temperature.
C1 Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Takahashi, E (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RI Masahashi, Naoya/A-8131-2011
CR Baker C., 1971, Metal Science Journal, V5, P92
   CHAN CM, 1990, SURF INTERFACE ANAL, V15, P349, DOI 10.1002/sia.740150602
   Duerig TW, 2002, MRS BULL, V27, P101, DOI 10.1557/mrs2002.44
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   IARC (International Agency for Research on Cancer), 1990, IARC MON EV CARC RIS, V49, P257
   KAWASHIMA A, IN PRESS P 15 INT CO
   KOLLEROV MY, P TIT 95 SCI TECHN, P2571
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   Niinomi M., 1998, MAT JAPAN, V37, P843
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Ohmori Y, 2001, MAT SCI ENG A-STRUCT, V312, P182, DOI 10.1016/S0921-5093(00)01891-8
   OKAZAKI Y, 1998, J JPN I MET, V37, P838
   SASANO H, 1988, P 6 WORLD C TIT, P1667
   Shimizu K., 1987, SHAPE MEMORY ALLOYS, P1
   STENEMANN SG, 1996, SURFACE PERFORMANCE, P33
NR 15
TC 199
Z9 207
U1 3
U2 40
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 2978
EP 2983
DI 10.2320/matertrans.43.2978
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300008
OA Bronze
DA 2018-10-19
ER

PT J
AU Koganemaru, M
   Okazaki, Y
   Nishimura, E
   Nishida, S
   Nakano, K
   Yanagida, Y
   Tamasaki, H
AF Koganemaru, M
   Okazaki, Y
   Nishimura, E
   Nishida, S
   Nakano, K
   Yanagida, Y
   Tamasaki, H
TI Tensile property, corrosion resistance and cytocompatibility of tungsten
   short fiber reinforced Ti-6Al-4V alloy
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE mechanical property; corrosion resistance; cytocompatibility; titanium
   alloy; tungsten short fiber; metal matrix composite (MMC); hot isostatic
   pressing (HIP)
ID TITANIUM-ALLOYS; STRENGTH; IMPLANTS; TI; AL
AB Tungsten short fiber reinforced Ti-6Al-4V alloy has been investigated in terms of its tensile properties, corrosion resistance and cytocompatibility. This composite material was fabricated by a hot isostatic pressing process. The room temperature tensile strength and the 0.2% proof stress were very high, approximately 1300 MPa and 1200 MPa, respectively. These strengths are excellent compared to those of the existing biomaterial of titanium-base. The cytocompatibility of this composite material was evaluated using the anodic polarization test and the cytocompatibility test to clarify the possibility of its application as a structural biomaterial. Anodic polarization tests in Eagle's minimum essential medium and in I mass% lactic acid were carried out to investigate the corrosion resistance of the composite material in vivo. The current density at the entrance to the passive region of the composite material tended to increase more than that of Ti-6Al-4V alloy. However, the passive region was retained at a potential of about 2 V, which is sufficiently high compared to the potential in vivo. In addition, the cytocompatibility was evaluated by investigating the relative growth ratio of fibroblast L929 cells after four days incubation on the test material. The relative growth ratio is obtained as follows: number of cells on the test material/number of cells on the reference material (control). The relative growth ratio of the composite material in making Ti-6Al-4V alloy into a control was 0.9032. According to the result of ICP-MS analysis, the concentration of tungsten in the medium after four days of incubation on the composite material was high compared to that of titanium, aluminum and vanadium.
C1 Fukuoka Ind Technol Ctr, Mech & Elect Res Inst, Kitakyushu, Fukuoka 8070831, Japan.
   AIST, Inst Mech Syst Engn, Tsukuba, Ibaraki 3058564, Japan.
   Natl Inst Technol & Evaluat, Independent Adm Inst, Tsukuba, Ibaraki 3050044, Japan.
   Saga Univ, Fac Sci & Engn, Dept Mech Engn, Saga 8400852, Japan.
   Takada Corp, Technol Res & Dev Dept, Kitakyushu, Fukuoka 8080143, Japan.
   Kuroki Kogyosho Co Ltd, Res Lab, Kitakyushu, Fukuoka 8060012, Japan.
   Nippon Steel Bolten Co Ltd, Tech Div, Yukuhashi 8240038, Japan.
RP Koganemaru, M (reprint author), Fukuoka Ind Technol Ctr, Mech & Elect Res Inst, Kitakyushu, Fukuoka 8070831, Japan.
RI Okazaki, Yoshimitsu/M-8964-2018
OI Okazaki, Yoshimitsu/0000-0003-0354-564X
CR HAYASHI T, 1988, COMPOSITE MAT ENG, P3
   Higo Y, 1993, P 3 JPN INT SAMPE S, P1621
   Kuroda D, 2000, TETSU TO HAGANE, V86, P602, DOI 10.2355/tetsutohagane1955.86.9_602
   Nishida S, 2000, KEY ENG MAT, V183-1, P1243, DOI 10.4028/www.scientific.net/KEM.183-187.1243
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1996, J JPN I MET, V60, P890, DOI 10.2320/jinstmet1952.60.9_890
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   OKAZAKI Y, 1998, J JPN I MET, V37, P838
   Okazaki Y., 1997, MAT JAPAN, V36, P1092
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
NR 11
TC 0
Z9 0
U1 1
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 2995
EP 2999
DI 10.2320/matertrans.43.2995
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300011
OA Bronze
DA 2018-10-19
ER

PT J
AU Tamura, Y
   Yokoyama, A
   Watari, F
   Uo, M
   Kawasaki, T
AF Tamura, Y
   Yokoyama, A
   Watari, F
   Uo, M
   Kawasaki, T
TI Mechanical properties of surface nitrided titanium for abrasion
   resistant implant materials
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; implant; titanium; surface reforming; titanium nitride;
   abrasion resistance; hardness
AB In order to verify its application for abrasion-resistant implant materials such as abutment in dental implants and artificial joints, mechanical properties of surface nitrided titanium were evaluated by three different tests, the Vickers hardness test. Martens scratch test and ultrasonic scaler abrasion test. The Vickers hardness of a nitrided layer of 2 mum in the thickness was 1300, about ten times higher than that of pure titanium. The Martens scratch test showed high bonding strength for the nitrided layer with matrix titanium. The abrasion test using an ultrasonic scaler showed very small scratch depth and width, demonstrating extremely high abrasion resistance. The results show that a surface-nitrided titanium has sufficient abrasion resistance if it is used under clinical conditions.
C1 Hokkaido Univ, Grad Sch Dent Med, Dept Oral Funct Sci, Sapporo, Hokkaido 0608586, Japan.
   Hokkaido Univ, Grad Sch Dent Med, Dept Oral Hlth Sci, Sapporo, Hokkaido 0608586, Japan.
RP Tamura, Y (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Oral Funct Sci, Sapporo, Hokkaido 0608586, Japan.
RI Yokoyama, Atsuro/F-6418-2012
CR DANJYO T, 1993, DENT J IWATE U, V18, P89
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   ITO A, 1991, J JPN SOC BIOMATER, V19, P236
   Kumazawa R, 2002, BIOMATERIALS, V23, P3757, DOI 10.1016/S0142-9612(02)00115-1
   KUMAZAWA R, 2001, J JPN SOC DENT MAT D, V20, P356
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   MATSUNO H, 1999, J JPN SOC DENT MAT D, V8, P447
   MICHI K, 1991, ASS DENT SCI, V10, P171
   Nukata Kazuto, 1995, Shika Igaku, V58, P31
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   TAKAMURA A, 1960, T JPN I MET, V24, P565
   TAMURA Y, 2002, IN PRESS DENT MAT J
   Watari F, 1997, COMPOS PART B-ENG, V28, P5, DOI 10.1016/S1359-8368(96)00021-2
NR 13
TC 22
Z9 22
U1 0
U2 1
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 3043
EP 3051
DI 10.2320/matertrans.43.3043
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300021
OA Bronze
DA 2018-10-19
ER

PT J
AU Kuroda, D
   Hanawa, T
   Hiromoto, S
   Katada, Y
   Asami, K
AF Kuroda, D
   Hanawa, T
   Hiromoto, S
   Katada, Y
   Asami, K
TI Characterization of the surface oxide film of nickel-free austenitic
   stainless steel located in simulated body environments
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE nickel-free stainless steel; simulated body environment; surface
   composition; biomaterial
ID PHYSIOLOGICAL SOLUTION; HIGH-NITROGEN; TITANIUM; XPS; ADSORPTION;
   CHROMIUM; ALLOYS; IRON
AB The surface oxide film on the nickel-free austenitic stainless steel located in various environments was characterized to estimate the reconstruction of the film in the human body. The specimens were polished, autoclaved, immersed in Hanks' solution, immersed in Eagle's minimum essential medium containing fetal bovine serum, and incubated with cultured cells. X-ray photoelectron spectroscopy was performed to determine the composition of the surface oxide film and substrate and thickness of the film. The depth profiles of elements in the surface region were also characterized using Auger electron spectroscopy in combination with argon-ion-sputtering. The surface oxide film on the nickel-free austenitic stainless steel, Fe-24.0Cr-1.1Mo-5.1N (at%), polished mechanically in deionized water consists of oxidic species of iron, chromium, and molybdenum, thickness of the surface oxide was about 4 nm and contained a large amount of OH-. Large amount of carbon, nitrogen, oxygen, and sulfur originating from amino acids and proteins were detected after immersion in the MEM + FBS and incubation with L929. Sulfur existed as sulfite or sulfide. Nitrogen as alloy component was enriched in the substrate just under the film. Calcium phosphate was formed on the film after immersion in the Hanks and MEM + FBS and incubation with L929.
C1 Natl Inst Mat Sci, Biomat Ctr, Tsukuba, Ibaraki 3050047, Japan.
   Natl Inst Mat Sci, Steel Ctr, Tsukuba, Ibaraki 3050047, Japan.
   Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Kuroda, D (reprint author), Natl Inst Mat Sci, Biomat Ctr, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011
CR ASAMI K, 1976, J ELECTRON SPECTROSC, V9, P469, DOI 10.1016/0368-2048(76)80065-5
   ASAMI K, 1977, CORROS SCI, V17, P559, DOI 10.1016/S0010-938X(77)80002-4
   ASAMI K, 1977, CORROS SCI, V17, P713, DOI 10.1016/0010-938X(77)90067-1
   Asami K., 1985, P 6 EUR S CORR BEH A, P769
   CHANG LW, 1996, TOXICOLOGY METALS, P827
   Frauchiger L, 1999, APPL SURF SCI, V143, P67, DOI 10.1016/S0169-4332(98)00932-5
   GEBEAU RC, 2001, ADV MAT P, P46
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   HASHIMOTO K, 1978, BOSHOKU GIJUTSU, V27, P279
   HASHIMOTO K, 1977, BOSHOKU GIJUTSU, V26, P445
   HEALY KE, 1992, BIOMATERIALS, V13, P553, DOI 10.1016/0142-9612(92)90108-Z
   *IARC WORK GROUP E, 1999, IARC MON EV CARC RIS, V74, P241
   KATADA Y, 2001, J MAT PROCESS TECH, V117
   KATADA Y, 2000, CUR ADV MAT P, V13, P116
   Kelly E. J., 1982, MOD ASPECT ELECTROC, P319
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   KURODA D, 2002, IN PRESS P 17 EUR SO
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   ONG JL, 1995, J MATER SCI-MATER M, V6, P113, DOI 10.1007/BF00120418
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SEKINE T, 1989, JITSUYOU OHJE DENSHI, P222
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   TERAMOTO K, 1978, BOSHOKU GIJUTSU, V27, P57
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Wagner C., 1979, HDB XRAY PHOTOELECTR, P54
   YAMAMOTO A, 2001, J BIOMED MATER RES, V59, P176
   YANO E, 1994, TOXICOLOGY TODAY, P119
   YOSHIOKA H, 1991, CORROS SCI, V32, P313, DOI 10.1016/0010-938X(91)90076-2
NR 31
TC 11
Z9 12
U1 2
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 3093
EP 3099
DI 10.2320/matertrans.43.3093
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300029
OA Bronze
DA 2018-10-19
ER

PT J
AU Kuroda, D
   Hiromoto, S
   Hanawa, T
   Katada, Y
AF Kuroda, D
   Hiromoto, S
   Hanawa, T
   Katada, Y
TI Corrosion behavior of nickel-free high nitrogen austenitic stainless
   steel in simulated biological environments
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE nickel-free high nitrogen austenitic stainless steel; biological
   environment; polarization behavior; biomaterial
ID PASSIVATION; MOLYBDENUM
AB The corrosion resistance of the nickel-free high nitrogen austenitic stainless steel without manganese, Fe-23Cr-2Mo-1.5N (mass%) (HNS) as biomaterials, was evaluated by the polarization test in various electrolytes: 0.9%NaCl solution (saline), phosphate buffered saline (PBS(-)), Hanks' solution (Hanks) and Eagle's minimum essential medium (E-MEM). Conventional austenitic stainless steel, 316L, was also polarized for comparison. The both alloys were spontaneously passivated in all electrolytes. The HNS didn't show pitting corrosion in the polarization range in all electrolytes although the 316L showed pitting corrosion. Passive current densities of the HNS in all electrolytes were lower than those of 316L. Therefore, the HNS shows higher passivity and resistance to pitting corrosion than 316L. The passive current density in Hanks of HNS was lower than that in saline, indicating that the protectiveness of surface oxide film increased with the existence of inorganic ions such as phosphate and calcium ions. On the other hand, the passive current density in E-MEM was higher than that in Hanks, but was lower than that in saline. Consequently, the HNS must show high corrosion resistance in vivo and be a promising biomaterials.
C1 Natl Inst Mat Sci, Biomat Ctr, Tsukuba, Ibaraki 3050047, Japan.
   Natl Inst Mat Sci, Steel Res Ctr, Tsukuba, Ibaraki 3050047, Japan.
RP Kuroda, D (reprint author), Natl Inst Mat Sci, Biomat Ctr, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011
CR CHANG LW, 1996, TOXICOLOGY METALS, P827
   Endo K., 1998, ZAIRYO TO KANKYO, V47, P570
   Gebeau RC, 2001, ADV MATER PROCESS, V159, P46
   *IARC WORK GROUP E, 1999, IARC MON EV CARC RIS, V74, P241
   KATADA Y, 2001, J MAT PROCESS TECH, V117
   KATADA Y, 2000, CUR ADV MAT P, V13, P116
   Koster R, 2000, LANCET, V356, P1895, DOI 10.1016/S0140-6736(00)03262-1
   KURODA D, UNPUB MAT T
   LECKIE HP, 1966, J ELECTROCHEM SOC, V113, P1262, DOI 10.1149/1.2423801
   LU YC, 1983, J ELECTROCHEM SOC, V130, P1774, DOI 10.1149/1.2120091
   Menzel J, 1996, ISIJ INT, V36, P893, DOI 10.2355/isijinternational.36.893
   NEWMAN RC, 1987, CORROS SCI, V27, P827, DOI 10.1016/0010-938X(87)90040-0
   Olefjord I, 1996, CORROS SCI, V38, P1203, DOI 10.1016/0010-938X(96)00018-2
   OLSSON COA, 1995, CORROS SCI, V37, P467, DOI 10.1016/0010-938X(94)00148-Y
   PALIT GC, 1993, CORROSION, V49, P977, DOI 10.5006/1.3316025
   PESSALL N, 1974, CORROSION, V30, P381, DOI 10.5006/0010-9312-30.11.381
   POURBAIX M, 1974, ATLAS ELECTROCHEMICA, P540
   SAGARA M, 2000, CUR ADV MAT P, V14, P694
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   VANINI AS, 1994, CORROS SCI, V36, P1825
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   YAMAMOTO A, 2001, J BIOMED MATER RES, V59, P176
   YANO E, 1994, TOXICOLOGY TODAY, P119
NR 23
TC 36
Z9 38
U1 1
U2 6
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 3100
EP 3104
DI 10.2320/matertrans.43.3100
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300030
OA Bronze
DA 2018-10-19
ER

PT J
AU Hiromoto, S
   Tsai, AP
   Sumita, M
   Hanawa, T
AF Hiromoto, S
   Tsai, AP
   Sumita, M
   Hanawa, T
TI Polarization behavior of bulk Zr-base amorphous alloy immersed in cell
   culture medium
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE amorphous powder consolidated zirconium-base alloy; cell culture medium;
   proteins; amino acids; immersion term; polarization; biomaterial
ID CORROSION BEHAVIOR; ADSORPTION; SURFACES; METAL; PROTEINS; OXYGEN
AB Effects of amino acids and proteins on polarization behavior of Zr-base amorphous alloy were examined using Hanks' solution, minimum essential medium (MEM), and cell culture medium (MEM+FBS) consisting with MEM and fetal bovine serum (FBS), respectively. Amorphous powder consolidated Zr55Al10Ni10Cu15 alloy was cathodically and anodically polarized at the beginning of (after 1.8 ks) immersion and after a long-term (605 ks) immersion in each solution. Parameters on the anodic polarization curve; open-circuit potential (E-open), polarization resistance (R-p), and pitting potential (E-pit), were obtained for the examination of corrosion resistance. In the presence of amino acids and proteins, R-p and E-pit increased, indicating that resistance to both general and pitting corrosion was raised with those biomolecules. Thus, the adsorbed biomolecules probably work as a diffusion barrier to molecules and ions such as dissolved oxygen and phosphate and chloride ions. During immersion, the surface oxide film grew, leading to the increase in E-open, average E-pit, and R-p although the parameters showed wide variance of deviation probably caused by the defects in alloy structure. The lowest values of E-pit after the long-term immersion were not lower than those at the beginning of immersion, indicating that the sensitivity of defects to chloride ion was not enhanced during immersion. However, the pitting corrosion resistance decreased during immersion because the potential difference between E-open and E-pit decreased.
C1 Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RP Hiromoto, S (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RI HIROMOTO, Sachiko/H-2686-2011; BAI, JIE/D-7448-2016
CR BRUNEEL N, 1988, J BIOMED MATER RES, V22, P203, DOI 10.1002/jbm.820220305
   CLARK GCF, 1982, J BIOMED MATER RES, V16, P125, DOI 10.1002/jbm.820160205
   do Serro APVA, 1999, J BIOMED MATER RES, V46, P376, DOI 10.1002/(SICI)1097-4636(19990905)46:3<376::AID-JBM10>3.3.CO;2-K
   Hiromoto S, 2002, MATER TRANS, V43, P261, DOI 10.2320/matertrans.43.261
   Hiromoto S, 2002, CORROS SCI, V44, P955, DOI 10.1016/S0010-938X(01)00110-X
   Hiromoto S, 2000, CORROS SCI, V42, P2167, DOI 10.1016/S0010-938X(00)00043-3
   Hiromoto S, 2001, MATER TRANS, V42, P656, DOI 10.2320/matertrans.42.656
   HIROMOTO S, 2002, FUNCTION MAT, V22, P46
   HIROMOTO S, 2001, 1 JAP SWISS JOINT WO
   INOUE A, 1994, BULK AMORPHOUS ALLOY, P27
   IVARSSON B, 1986, CRIT REV BIOCOMPAT, V2, P1
   IVARSSON BA, 1985, COLLOID SURFACE, V13, P169
   KAWAMURA Y, 1988, MATER SCI ENG, V98, P449, DOI 10.1016/0025-5416(88)90204-2
   KAWAMURA Y, 1998, MAT JAPAN, V37, P133
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Milosev I, 2000, J BIOMED MATER RES, V52, P404, DOI 10.1002/1097-4636(200011)52:2<404::AID-JBM22>3.0.CO;2-Z
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   STONER GE, 1970, J PHYS CHEM, V74, P1088
   UENO K, 1964, CHELETMETRIC TITRATI, P31
NR 19
TC 7
Z9 8
U1 0
U2 9
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD DEC
PY 2002
VL 43
IS 12
BP 3112
EP 3117
DI 10.2320/matertrans.43.3112
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 640GX
UT WOS:000180681300032
OA Bronze
DA 2018-10-19
ER

PT J
AU Xue, JM
   Wang, YG
   Du, GH
   Yan, S
   Zhao, WJ
AF Xue, JM
   Wang, YG
   Du, GH
   Yan, S
   Zhao, WJ
TI Study on the desorption yield for natural botanic sample induced by
   energetic heavy ions
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article
DE desorption; sputtering; irradiation damage; biomaterial
ID LARGE ORGANIC-MOLECULES; DISTRIBUTIONS; IRRADIATION; IMPULSES; FILMS;
   MODEL; BEAM; ACID; SUM
AB The dependence of desorption yield for the natural botanic sample bombarded with heavy ion on the electronic stopping power (S,) and dose has been measured by weighing sample mass before and after irradiation. Primary ions including 50 keV N(+), 1.5 MeV F(+), 3.0 MeV F(2+), 4.0 MeV F(2+) and 3.0 MeV Si(2+) were used in the experiment. Three megaelectron volts of F(2+) with doses ranging from 4 x 10(15) to 4 x 10(16) ions/cm(2) were used in order to investigate the influence of ion dose. A mass spectrum from the sample bombarded with 3 MeV Si(2+) was also taken for a better understanding of the desorption process. Results show that the natural botanic sample is very easily to be desorpted. The yield of MeV heavy ions can be as high as thousands CH(2)O/ion, and significantly depends on both the S(e) and dose. The measured yields increase quickly with S(e), but drop down with increasing ion dose. These results fit roughly with the prediction of the pressure pulse model. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Peking Univ, Sch Phys, Inst Heavy Ion Phys, Beijing 100871, Peoples R China.
RP Xue, JM (reprint author), Peking Univ, Sch Phys, Inst Heavy Ion Phys, Beijing 100871, Peoples R China.
EM jmxue@pku.edu.cn
RI xue, jianming/D-2772-2014
OI xue, jianming/0000-0002-0213-9239
CR BRANDL D, 1991, PHYS REV B, V43, P525
   Cui FZ, 2000, NUCL INSTRUM METH B, V169, P48, DOI 10.1016/S0168-583X(00)00015-X
   deJong MP, 1997, J APPL PHYS, V82, P1058, DOI 10.1063/1.365871
   Delcorte A, 1996, NUCL INSTRUM METH B, V117, P235, DOI 10.1016/0168-583X(96)00306-0
   DU GH, IN PRESS ACTA BIOPHY
   ENS W, 1989, PHYS REV B, V39, P763, DOI 10.1103/PhysRevB.39.763
   Eriksson J, 1996, PHYS REV B, V54, P15025, DOI 10.1103/PhysRevB.54.15025
   ERIKSSON J, 1995, NUCL INSTRUM METH B, V101, P142, DOI 10.1016/0168-583X(95)00291-X
   FENYO D, 1993, PHYS REV B, V47, P8263, DOI 10.1103/PhysRevB.47.8263
   HEDIN A, 1985, PHYS REV B, V31, P1780, DOI 10.1103/PhysRevB.31.1780
   Huang WD, 1998, NUCL INSTRUM METH B, V140, P373, DOI 10.1016/S0168-583X(98)00006-8
   Imanishi N, 1999, AIP CONF PROC, V475, P396
   JAMES DM, 1988, PLANT ANOTOMY, P428
   JOHNSON RE, 1989, PHYS REV B, V40, P49, DOI 10.1103/PhysRevB.40.49
   JOHNSON RE, 1987, INT J MASS SPECTROM, V78, P357, DOI 10.1016/0168-1176(87)87060-X
   KOPNICZKY J, 1995, RADIAT MEAS, V25, P47, DOI 10.1016/1350-4487(95)00029-E
   Papaleo RM, 1996, PHYS REV B, V54, P3173, DOI 10.1103/PhysRevB.54.3173
   REIMANN CT, 1993, VIDENSK SELSK MAT FY, V43, P351
   SIGMUND P, 1981, SPUTTERING PARTICLE, V1
   STANDING KG, 1991, METHODES MECH PRODUC
   VENKATESAN T, 1983, POLYM ENG SCI, V23, P931, DOI 10.1002/pen.760231703
   VOIT H, 1989, J PHYS PARSIS C, V2, P237
   YU ZL, 1993, NUCL INSTRUM METH B, V80-1, P1328
   YU ZL, 1993, CNIC00746
NR 24
TC 2
Z9 2
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD DEC
PY 2002
VL 198
IS 3-4
BP 113
EP 118
AR PII S0168-583X(02)01384-8
DI 10.1016/S0168-583X(02)01384-8
PG 6
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 624RR
UT WOS:000179775200001
DA 2018-10-19
ER

PT J
AU Miyamoto, K
   Chinzei, H
   Komai, T
AF Miyamoto, K
   Chinzei, H
   Komai, T
TI Acyl-gelatins for cell-hybrid biomaterials: Preparation of gelatins with
   high melting point and affinity for hydrophobic surfaces
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
AB In the development of cell-hybrid biomaterials, the functional activity of cells depends on the selective binding of cells to artificial ligands on the biomaterials. The extracellular matrix (ECM) is the most important ligand for cell activity. ECM is known to contain collagen, one of whose constituents is gelatin. Although natural gelatin has good cell attachment properties, the melting point of gelatin hydrogel is lower than body temperature. Thus, non-chemically cross-linked gelatin hydrogel is not a biomaterial that is used for prostheses. In the present study, we report the preparation of acyl-gelatin hydrogels with high melting point (>37degreesC) and high affinity for hydrophobic surfaces for easy handling for transportation and adhesion activities on the hydrophobic surfaces. In addition, the doubling time of endothelial cells on the coated cell culture plate was faster than that of natural gelatin owing to the higher adhesion activity of acyl-gelatin. The results clearly demonstrated that the acyl-gelatin acted as an interface that enabled cell adhesion to artificial materials surfaces.
C1 Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 5148507, Japan.
CR Edelman JM, 1995, PRINCIPLES CELL ADHE, P163
   FLEISCHMAJER R, 1990, ANN NY ACAD SCI, P580
   Forns P, 2000, BIOPOLYMERS, V54, P531, DOI 10.1002/1097-0282(200012)54:7<531::AID-BIP60>3.0.CO;2-X
   Gross J, 1974, Harvey Lect, V68, P351
   Harrison MA, 1971, BRIT POLYM J, V3, P154
   HERRING M, 1984, SURGERY, V96, P745
   IAFFE EA, 1984, BIOL ENDOTHELIAL CEL
   KOUGE K, 1987, B CHEM SOC JPN, V60, P2409, DOI 10.1246/bcsj.60.2409
   MATSUMOTO H, 1973, SURGERY, V74, P519
   Miyazaki M, 2000, J Renin Angiotensin Aldosterone Syst, V1, P23, DOI 10.3317/jraas.2000.004
   Pakalns T, 1999, BIOMATERIALS, V20, P2265, DOI 10.1016/S0142-9612(99)00157-X
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
NR 12
TC 1
Z9 1
U1 1
U2 4
PU BENTHAM SCIENCE PUBL LTD
PI HILVERSUM
PA PO BOX 1673, 1200 BR HILVERSUM, NETHERLANDS
SN 0929-8665
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PD DEC
PY 2002
VL 9
IS 6
BP 521
EP 528
DI 10.2174/0929866023408436
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 633WM
UT WOS:000180307600007
PM 12553860
DA 2018-10-19
ER

PT J
AU Beatty, MW
   Ojha, AK
   Cook, JL
   Alberts, LR
   Mahanna, GK
   Iwasaki, LR
   Nickel, JC
AF Beatty, MW
   Ojha, AK
   Cook, JL
   Alberts, LR
   Mahanna, GK
   Iwasaki, LR
   Nickel, JC
TI Small intestinal submucosa versus salt-extracted polyglycolic
   acid-poly-L-lactic acid: A comparison of neocartilage formed in two
   scaffold materials
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT 3rd SIS 2000 Symposium
CY NOV 29-30, 2000
CL ORLANDO, FLORIDA
SP SIS
ID TISSUE ENGINEERED CARTILAGE; ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES;
   BIPHASIC INDENTATION; REGENERATION; CHONDROCYTES; BIOMATERIAL; GROWTH;
   HEAD; DOGS
AB This study sought to compare differences in neocartilage produced over time from two types of resorbable scaffold materials. One material was entirely synthetic and contained a polyglycolic acid-poly-L-lactic acid matrix (PGA-PLLA). The second scaffold material was bioactive and consisted of a four-layered construct of porcine small intestinal submucosa (SIS). Disk-shaped scaffolds were seeded with canine chondrocytes and implanted into athymic mice for periods of 5, 8, 12, and 24 weeks. Constructs were examined microscopically, assayed for hydroxyproline (HP) and glycosaminoglycan (GAG) content, and collagen typed (I or II) at each time period. Creep indentation tests determined aggregate and shear modulus, permeability, and thickness. Results indicated that SIS maintained its thickness through the first 12 weeks, and then doubled by week 24. The 24-week tissue appeared chondroid-like and possessed high GAG content. Tissues derived from PGA-PLLA scaffolds were lower in HP content than SIS-derived tissues, but type II collagen was demonstrated only in PGA-PLLA-derived tissues at 24 weeks. Mechanical properties were not significantly different for any tissue over time (p > 0.05), but aggregate and shear modulus mean values were consistently higher for PGA-PLLA-derived tissues at nearly every time interval. This, coupled with the presence of collagen types I and II, suggested a more congruent solid phase may be forming within the extracellular matrix of tissues derived from PGA-PLLA scaffolds. Future study is necessary to compare these materials under simulated loading conditions.
C1 Univ Nebraska, Med Ctr, Coll Dent, Dept Adult Restorat Dent,Sect Biomat, Lincoln, NE 68583 USA.
   Univ Nebraska, Med Ctr, Coll Med, Dept Otolaryngol Head & Neck Surg, Omaha, NE USA.
   Univ Nebraska, Med Ctr, Coll Dent, Dept Oral Biol, Lincoln, NE 68583 USA.
   Univ Missouri, Comparat Orthoped Lab, Columbia, MO USA.
   Univ Nebraska, Med Ctr, Coll Med, Dept Orthoped, Omaha, NE USA.
   Univ Nebraska, Med Ctr, Coll Dent, Dept Growth & Dev, Lincoln, NE 68583 USA.
RP Beatty, MW (reprint author), Univ Nebraska, Med Ctr, Coll Dent, Dept Adult Restorat Dent,Sect Biomat, 40th & Holdrege, Lincoln, NE 68583 USA.
OI Beatty, Mark/0000-0001-5836-1026; Cook, James/0000-0002-0862-995X
CR ALBERTS LR, 2001, T ORTHOP RES SOC, V46, P421
   ASTM, 2000, ASTM ANN BOOK STAND, V15.03
   ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Cook JL, 2001, TISSUE ENG, V7, P321, DOI 10.1089/10763270152044189
   Cook JL, 1999, AM J SPORT MED, V27, P658, DOI 10.1177/03635465990270051901
   DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FERRAND BK, 1993, J BIOMED MATER RES, V27, P1235, DOI 10.1002/jbm.820271004
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Gastel JA, 2001, ARTHROSCOPY, V17, P151, DOI 10.1053/jars.2001.20959
   GUNTHER M, 1994, ARTHRITIS RHEUM, V37, P395, DOI 10.1002/art.1780370314
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   MA PX, 1995, J BIOMED MATER RES, V29, P1587, DOI 10.1002/jbm.820291215
   MAK AF, 1987, J BIOMECH, V20, P703, DOI 10.1016/0021-9290(87)90036-4
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MOW VC, 1980, SIAM REV, V22, P275, DOI 10.1137/1022056
   MOW VC, 1989, J BIOMECH, V22, P853, DOI 10.1016/0021-9290(89)90069-9
   Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Sokal RR, 1981, BIOMETRY PRINCIPLES
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WIDMER MS, 1998, FRONTIERS TISSUE ENG, P107
NR 25
TC 20
Z9 26
U1 1
U2 5
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD DEC
PY 2002
VL 8
IS 6
BP 955
EP 968
DI 10.1089/107632702320934056
PG 14
WC Cell & Tissue Engineering
SC Cell Biology
GA 621EW
UT WOS:000179576400006
PM 12542941
DA 2018-10-19
ER

PT J
AU Shi, W
   Kamiya, A
   Zhu, J
   Watazu, A
AF Shi, W
   Kamiya, A
   Zhu, J
   Watazu, A
TI Properties of titanium biomaterial fabricated by sinter-bonding of
   titanium/hydroxyapatite composite surface-coated layer to pure bulk
   titanium
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE titanium matrix composite; hydroxyapatite; tensile strength; hot-press;
   biomaterial
AB A new titanium biomaterial was fabricated by hot press sinter-bonding of titanium/hydroxyapatite composite surface-coated layer to pure bulk titanium. The distribution of the hydroxyapatite particles in the composite surface-coated layer was mainly influenced by the hydroxyapatite volume fraction (V-ha) of the composite surface-coated layer. When the V-ha was less than 15% it was uniform. At the temperature of 1023 K, no interfacial reaction layer was observed at the interface between the hydroxyapatite and titanium matrices in the composite surface-coated layer. The tensile strength of the new titanium biomaterial was influenced both by the ratio of thickness of the composite surface-coated layer to the total thickness of the titanium biomaterial and the Three tensile damage phenomena associated with microstructure of the titanium biomaterial were observed after tensile test. (1) Cracks with small crevice appeared in the composite surface-coated layer and the tensile strength was almost equal to that of pure titanium. (2) Cracks with large crevice appeared in the composite surface-coated layer and the tensile strength was lower than that of pure titanium. (3) No crack appeared in the composite surface-coated layer and the tensile strength was much lower than that of pure titanium. The results of bone conductivity test showed that hydroxyapatite had an ability to improve the bonding between the titanium biomaterial and bone. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Natl Inst Adv Ind Sci & Technol, Inst Struct & Engn Mat, Highly Durable Mat Grp, Moriyama Ku, Nagoya, Aichi 4638560, Japan.
RP Shi, W (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Struct & Engn Mat, Highly Durable Mat Grp, Moriyama Ku, 2266 Anagohora Shimoshidami, Nagoya, Aichi 4638560, Japan.
CR AKAMATSU N, 1998, JPN I METALS, V37, P822
   CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   HUAXIA JI, 1992, J MATER SCI-MATER M, V3, P283
   *JAP SOC MECH ENG, 1994, BIOM, P100
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Kuroda D, 2000, TETSU TO HAGANE, V86, P602, DOI 10.2355/tetsutohagane1955.86.9_602
   LIN JHC, 1994, J MATER SCI-MATER M, V5, P279
   Ning CQ, 2000, J MATER SCI LETT, V19, P1243, DOI 10.1023/A:1006725529837
   OKAZAKI Y, 1998, J JPN I MET, V37, P838
   REIS RL, 1994, J MATER SCI-MATER M, V5, P457, DOI 10.1007/BF00058983
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
NR 11
TC 22
Z9 23
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD NOV 25
PY 2002
VL 337
IS 1-2
BP 104
EP 109
AR PII S0921-5093(02)00003-5
DI 10.1016/S0921-5093(02)00003-5
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 611FH
UT WOS:000179005400015
DA 2018-10-19
ER

PT J
AU Sharma, S
   Popat, KC
   Desai, TA
AF Sharma, S
   Popat, KC
   Desai, TA
TI Controlling nonspecific protein interactions in silicon biomicrosystems
   with nanostructured poly(ethylene glycol) films
SO LANGMUIR
LA English
DT Article
ID SURFACES; BIOCOMPATIBILITY; ADSORPTION; MEMBRANES; DENSITY; TISSUE
AB Protein interaction with surfaces is one of the most important criteria for the selection of implantable biomaterials as it can mediate further cellular interaction and therefore influence biocompatibility of the surfaces. An ideal biomaterial would adsorb no protein, which is practically impossible to achieve. Here we have demonstrated that control of protein adsorption can be achieved by modifying silicon surfaces with a biocompatible polymer like poly(ethylene glycol) (PEG). Two different methods to modify the silicon surface were used. Two model proteins, namely, fibrinogen and bovine serum albumin, were used to study the adsorption on PEG-modified surfaces. The adsorbed protein was characterized using fluorescence microscopy, atomic force microscopy, and X-ray photoelectron spectroscopy.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
RP Desai, TA (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
EM tdesai@bu.edu
OI Popat, Ketul C./0000-0002-2417-7789
CR Chow AY, 1999, OPHTHALMIC RES, V31, P246, DOI 10.1159/000055541
   Desai TA, 2000, BIOSENS BIOELECTRON, V15, P453, DOI 10.1016/S0956-5663(00)00088-9
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   DESAI TA, 1999, J BIOMED MICRODEVICE, V1, P131
   EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Leoni L, 2002, BIOMED MICRODEVICES, V4, P131, DOI 10.1023/A:1014639332543
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   MALMSTEN M, 1995, PROTEINS INTERFACES, V2, P228
   POPAT K, 2002, J ASS LAB AUTO, V7, P66
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106
   Sharma S, 2002, ENG MED BIOL SOC ANN, P41, DOI 10.1109/MMB.2002.1002261
   SHARMA S, 2002, ACS SYM SER, P326
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Stenberg M., 1983, Journal de Physique Colloque, V44, P83, DOI 10.1051/jphyscol:19831017
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 18
TC 75
Z9 78
U1 3
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 12
PY 2002
VL 18
IS 23
BP 8728
EP 8731
DI 10.1021/la026097f
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 612QN
UT WOS:000179087100003
DA 2018-10-19
ER

PT J
AU Wu, PF
   Rao, DVGLN
   Kimball, BR
   Nakashima, M
   DeCristofano, BS
AF Wu, PF
   Rao, DVGLN
   Kimball, BR
   Nakashima, M
   DeCristofano, BS
TI Enhancement of photoinduced anisotropy and all-optical switching in
   Bacteriorhodopsin films
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID WAVE-GUIDE STRUCTURES; BIREFRINGENCE; STORAGE
AB Large enhancement of photoanisotropic effects is demonstrated in thin films of the biomaterial Bacteriorhodopsin by using two exciting beams of orthogonal polarization. The mechanism of the enhancement originates from optimization of direction-selected photoisomerization of the biomaterial controlled by the polarized exciting beams. The technique is applied for achieving an all-optical switch with the additional feature of output sign control. (C) 2002 American Institute of Physics.
C1 Univ Massachusetts, Dept Phys, Boston, MA 02125 USA.
   USA, Soldier Syst Ctr, Mat Sci Team, Natick, MA 01760 USA.
RP Wu, PF (reprint author), Univ Massachusetts, Dept Phys, Boston, MA 02125 USA.
RI Rao, Devulapalli/L-8863-2015
CR Bauer S, 1996, J APPL PHYS, V80, P5531, DOI 10.1063/1.363604
   Bhattacharya P, 2002, OPT LETT, V27, P839, DOI 10.1364/OL.27.000839
   Clays K, 2000, OPT LETT, V25, P1391, DOI 10.1364/OL.25.001391
   Dovgalenko GE, 1996, APPL PHYS LETT, V68, P287, DOI 10.1063/1.116061
   IKEDA T, 1995, SCIENCE, V268, P1873, DOI 10.1126/science.268.5219.1873
   IMAM H, 1995, OPT LETT, V20, P225, DOI 10.1364/OL.20.000225
   Inoue H, 1998, APPL PHYS LETT, V73, P10, DOI 10.1063/1.122952
   Kawatsuki N, 1999, APPL PHYS LETT, V74, P935, DOI 10.1063/1.123414
   Keuren E.V., 1999, APPL PHYS LETT, V75, P3312
   Kidowaki M, 2000, APPL PHYS LETT, V76, P1377, DOI 10.1063/1.126037
   KNOBLOCH H, 1994, J APPL PHYS, V76, P8212, DOI 10.1063/1.357883
   KNOBLOCH H, 1995, J APPL PHYS, V77, P481, DOI 10.1063/1.359028
   Korchemskaya EY, 1999, J BIOL PHYS, V24, P201, DOI 10.1023/A:1005135209028
   Oh MC, 2000, APPL PHYS LETT, V76, P3525, DOI 10.1063/1.126695
   Okada-Shudo Y, 2001, P SOC PHOTO-OPT INS, V4461, P138, DOI 10.1117/12.449824
   Peretti J, 1999, APPL PHYS LETT, V74, P1657, DOI 10.1063/1.123645
   RAO DVG, 1998, PHOTONIC POLYM SYSTE, P633
   Sanio M, 1999, OPT LETT, V24, P379, DOI 10.1364/OL.24.000379
   Song QW, 1998, P SOC PHOTO-OPT INS, V3470, P226, DOI 10.1117/12.326865
NR 19
TC 38
Z9 41
U1 0
U2 3
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0003-6951
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD NOV 11
PY 2002
VL 81
IS 20
BP 3888
EP 3890
DI 10.1063/1.1521581
PG 3
WC Physics, Applied
SC Physics
GA 611XB
UT WOS:000179042200062
DA 2018-10-19
ER

PT J
AU Bowden, MG
   Visai, L
   Longshaw, CM
   Holland, KT
   Speziale, P
   Hook, M
AF Bowden, MG
   Visai, L
   Longshaw, CM
   Holland, KT
   Speziale, P
   Hook, M
TI Is the GehD lipase from Staphylococcus epidermidis a collagen binding
   adhesin?
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; CAPSULAR POLYSACCHARIDE ADHESIN;
   AUREUS STRAINS; MOLECULAR CHARACTERIZATION; STREPTOCOCCUS-PNEUMONIAE;
   LIPOLYTIC-ACTIVITY; MATRIX MOLECULES; ALPHA-ENOLASE; PROTEIN; SURFACE
AB The opportunistic human pathogen Staphylococcus epidermidis is the major cause of nosocomial biomaterial infections. S. epidermidis has the ability to attach to indwelling materials coated with extracellular matrix proteins such as fibrinogen, fibronectin, vitronectin, and collagen. To identify the proteins necessary for S. epidermidis attachment to collagen, we screened an expression library using digoxigenin-labeled collagen as well as two monoclonal antibodies generated against the Staphylococcus aureus collagen-adhesin, Cna, as probes. These monoclonal antibodies recognize collagen binding epitopes on the surface of S. aureus and S. epidermidis cells. Using this approach, we identified GehD, the extracellular lipase originally found in S. epidermidis 9, as a collagen-binding protein. Despite the monoclonal antibody cross-reactivity, the GehD amino acid sequence and predicted structure are radically different from those of Cna. The mature GehD circular dichroism spectra differs from that of Cna but strongly resembles that of a mammalian cell-surface collagen binding receptor, known as the a, integrin I domain, suggesting that they have similar secondary structures. The GehD protein is translated as a preproenzyme, secreted, and post-translationally processed into mature lipase. GehD does not have the conserved LPXTG C-terminal motif present in cell wall-anchored proteins, but it can be detected in lysostaphin cell wall extracts. A recombinant version of mature GehD binds to collagens type 1, II, and IV adsorbed onto microtiter plates in a dose-dependent saturable manner. Recombinant, mature GehD protein and anti-GehD antibodies can inhibit the attachment of S. epidermidis to immobilized collagen. These results provide evidence that GehD may be a bi-functional molecule, acting not only as a lipase but also as a cell surface-associated collagen adhesin.
C1 Texas A&M Univ, Inst Biosci & Technol, Syst Hlth Sci Ctr, Houston, TX 77030 USA.
   Univ Pavia, Dept Biochem, I-27100 Pavia, Italy.
   Univ Leeds, Div Microbiol, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
RP Hook, M (reprint author), Texas A&M Univ, Inst Biosci & Technol, Syst Hlth Sci Ctr, 2121 W Holcombe Blvd, Houston, TX 77030 USA.
RI Longshaw, Christopher/H-2871-2013
OI Longshaw, Christopher/0000-0002-5586-7256
FU NIAMS NIH HHS [AR44415]; NIAID NIH HHS [AI 10629]
CR Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x
   Courtney HS, 1996, INFECT IMMUN, V64, P2415
   Davis SL, 2001, J BIOL CHEM, V276, P27799, DOI 10.1074/jbc.M103873200
   de Silva GDI, 2001, CLIN INFECT DIS, V33, P1520, DOI 10.1086/323338
   Fagan PK, 2001, INFECT IMMUN, V69, P4851, DOI 10.1128/IAI.69.8.4851-4857.2001
   Fontan PA, 2000, J INFECT DIS, V182, P1712, DOI 10.1086/317604
   Garrett DO, 1999, INFECT CONT HOSP EP, V20, P167, DOI 10.1086/501605
   Gotz F, 1998, CHEM PHYS LIPIDS, V93, P15, DOI 10.1016/S0009-3084(98)00025-5
   GRIBBON EM, 1993, J GEN MICROBIOL, V139, P1745, DOI 10.1099/00221287-139-8-1745
   HEDSTROM SA, 1983, ACTA PATH MICRO IM B, V91, P169
   HEDSTROM SA, 1975, ACTA PATH MICRO IM B, V83, P285
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LIEBL W, 1986, MOL GEN GENET, V204, P166, DOI 10.1007/BF00330205
   Longshaw CM, 2000, MICROBIOL-UK, V146, P1419, DOI 10.1099/00221287-146-6-1419
   Lowe AM, 1998, MOL MICROBIOL, V27, P967, DOI 10.1046/j.1365-2958.1998.00741.x
   Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398
   MULLER E, 1993, INFECT IMMUN, V61, P551
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   Pancholi V, 1997, J EXP MED, V186, P1633, DOI 10.1084/jem.186.10.1633
   PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694
   REINSCHEID DJ, 2001, J BACTERIOL, V183, P1712
   Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906
   ROLLOF J, 1987, ACTA PATH MICRO IM B, V95, P109
   Rosenstein R, 2000, BIOCHIMIE, V82, P1005, DOI 10.1016/S0300-9084(00)01180-9
   Simons JWFA, 1998, CHEM PHYS LIPIDS, V93, P27, DOI 10.1016/S0009-3084(98)00026-7
   SYMERSKY J, 1997, NAT STRUCT BIOL, V10, P833
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Visai L, 2000, J BIOL CHEM, V275, P39837, DOI 10.1074/jbc.M005297200
   Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200
   YU J, 1994, BIOMATERIALS, V15, P805, DOI 10.1016/0142-9612(94)90035-3
NR 35
TC 59
Z9 63
U1 1
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 8
PY 2002
VL 277
IS 45
BP 43017
EP 43023
DI 10.1074/jbc.M207921200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 612MZ
UT WOS:000179081200078
PM 12218064
OA Bronze
DA 2018-10-19
ER

PT J
AU Reddy, VG
   El Oakley, R
   Ge, G
   Leng, LY
   Tian, LT
AF Reddy, VG
   El Oakley, R
   Ge, G
   Leng, LY
   Tian, LT
TI Cell based gene therapy using autologus biomaterial coated stents
   augments vascular gene transfer
SO CIRCULATION
LA English
DT Meeting Abstract
CT American-Heart-Association Abstracts From Scientific Sessions
CY NOV 17-20, 2002
CL CHICAGO, IL
SP Amer Heart Assoc
C1 Natl Heart Ctr, Singapore 117548, Singapore.
   Natl Univ Singapore, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD NOV 5
PY 2002
VL 106
IS 19
SU S
MA 2223
BP 447
EP 447
PG 1
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 613QJ
UT WOS:000179142702261
DA 2018-10-19
ER

PT J
AU Xia, HY
   Rayson, GD
AF Xia, HY
   Rayson, GD
TI Cd-113-NMR spectrometry of Cd2+ binding sites on algae and higher plant
   tissues
SO ADVANCES IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE Cd-113-NMR; algae; plant tissues
ID METAL-ION-BINDING; DATURA-INNOXIA BIOMATERIAL; MEDICAGO-SATIVA ALFALFA;
   CHEMICAL MODIFICATION; EU(III) LUMINESCENCE; BIOMASS; NMR; SPECTROSCOPY;
   PH; DEPENDENCE
AB The binding of Cd2+ to various biologically generated materials has been investigated using. Cd-113-NMR. These biogenic materials included several strains of algae (Chlorella pyrenoidosa, Bryopsis spp., Cladophora spp., and Entiomorpha spp.), the fragments of cultured Datura innoxia cells, organic peat, sphagnum peat, freeze dried roots and stems of cattail plants (Typha latifolia), freeze dried leaves, roots and stems of mature and young tumble weed (Salsola spp.), and pecan shells. A soluble component of each of these materials (with the exception of the C pyrenoidosa, the sphagnum peat, and the immobilized D. innoxia materials) was observed to coordinate with the Cd2+ ions in solution. The metal bound to the solid biomaterials was determined to involve carboxylate functionalities associated with each biomass. Chemical moieties containing nitrogen, sulfur and phosphorous were eliminated as significant sources of cadmium metal ion binding under the solution conditions investigated. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.
RP Rayson, GD (reprint author), New Mexico State Univ, Dept Chem & Biochem, Box 30001,MSC 3C, Las Cruces, NM 88003 USA.
CR Armitage I. M., 1983, NMR NEWLY ACCESSIBLE, V2, P337
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   DARNALL D W, 1986, P1
   Drake LR, 1996, ENVIRON SCI TECHNOL, V30, P110, DOI 10.1021/es950131d
   Drake LR, 1997, APPL SPECTROSC, V51, P1476, DOI 10.1366/0003702971939253
   Ellis P. D., 1983, Multinuclear Approach to NMR Spectroscopy. Proceedings of the NATO Advanced Study Institute, P457
   Gardea-Torresdey J.L, 1999, ADV ENVIRON RES, V3, P83
   Gardea-Torresdey JL, 2000, ENVIRON SCI TECHNOL, V34, P4392, DOI 10.1021/es991325m
   GARDEATORRESDEY JL, 1990, ENVIRON SCI TECHNOL, V24, P1372, DOI 10.1021/es00079a011
   GREENE B, 1986, ENVIRON SCI TECHNOL, V20, P627, DOI 10.1021/es00148a014
   HARTMANN SR, 1962, PHYS REV, V128, P2042, DOI 10.1103/PhysRev.128.2042
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1993, ENVIRON SCI TECHNOL, V27, P2466, DOI 10.1021/es00048a024
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1994, ENVIRON SCI TECHNOL, V28, P586, DOI 10.1021/es00053a009
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   Lin S, 1998, ENVIRON SCI TECHNOL, V32, P1488, DOI 10.1021/es970843z
   LUJAN JR, 1994, SOLVENT EXTR ION EXC, V12, P803, DOI 10.1080/07366299408918239
   MAJIDI V, 1990, ENVIRON SCI TECHNOL, V24, P1309, DOI 10.1021/es00079a002
   MONCRIEF RM, 1995, SEPAR SCI TECHNOL, V30, P2421, DOI 10.1080/01496399508013120
   Stark PC, 2000, ADV ENVIRON RES, V4, P113, DOI 10.1016/S1093-0191(00)00012-5
   SUMMERS MF, 1988, COORDIN CHEM REV, V86, P43, DOI 10.1016/0010-8545(88)85012-4
   Tiemann KJ, 2000, ENVIRON SCI TECHNOL, V34, P693, DOI 10.1021/es9909071
   WATKINS JW, 1987, INORG CHEM, V26, P1147, DOI 10.1021/ic00254a033
   Xia HY, 2000, ADV ENVIRON RES, V4, P69
   Xia HY, 1998, ENVIRON SCI TECHNOL, V32, P2688, DOI 10.1021/es980171s
   ZHANG WX, 1993, APPL SPECTROSC, V47, P2151, DOI 10.1366/0003702934066406
NR 27
TC 17
Z9 17
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1093-0191
J9 ADV ENVIRON RES
JI Adv. Environ. Res.
PD NOV
PY 2002
VL 7
IS 1
BP 157
EP 167
AR PII S1093-0191(01)00121-6
DI 10.1016/S1093-0191(01)00121-6
PG 11
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 608WF
UT WOS:000178870000013
DA 2018-10-19
ER

PT J
AU Kopp, R
   Mottaghy, K
   Kirschfink, M
AF Kopp, R
   Mottaghy, K
   Kirschfink, M
TI Mechanism of complement activation during extracorporeal
   blood-biomaterial interaction: Effects of heparin coated and uncoated
   surfaces
SO ASAIO JOURNAL
LA English
DT Article
ID POLYANION BINDING-SITE; CARDIOPULMONARY BYPASS; IMMOBILIZED HEPARIN;
   ALTERNATIVE PATHWAY; CARDIAC-SURGERY; FACTOR-H; IN-VIVO; CIRCUITS;
   CIRCULATION; ADHESION
AB In vitro studies with miniaturized rotating circuits and heparinized human blood, as well as long-term extracorporeal membrane oxygenation with either heparin coated (HBS) or uncoated surfaces connected to adult sheep, were performed comparing the impact on complement activation in blood and on surfaces. Analysis of surface bound complement proteins revealed significantly reduced binding of activated C3 and C5b-9 to HBS in vitro, compared with uncoated surfaces, which was probably due to more HBS bound complement inhibitors (C1-Inhibitor, factor H) being present. This was reflected by significantly reduced activation of the alternative pathway (C3bBbP) and terminal complex (SC5b-9) by HBS but slightly increased levels of classic pathway complex (C1rs-C1-inhibitor). These results were confirmed during in vivo study by analysis of hemolytic complement function, activation specific C3 derived split products, and surface bound complement proteins. Increased binding of complement regulators to HBS appears to effectively reduce complement activation by biomaterials, leading to improved long-term biocompatibility.
C1 Univ Hosp Aachen, Dept Physiol, ECC Lab, Inst Physiol, D-52074 Aachen, Germany.
   Univ Heidelberg, Inst Immunol, D-6900 Heidelberg, Germany.
RP Kopp, R (reprint author), Univ Hosp Aachen, Dept Physiol, ECC Lab, Inst Physiol, Pauwelsstr 30, D-52074 Aachen, Germany.
CR ANTONSEN S, 1987, SCAND J THORAC CARD, V21, P47, DOI 10.3109/14017438709116918
   Baksaas ST, 1999, PERFUSION-UK, V14, P119, DOI 10.1177/026765919901400205
   Baufreton C, 1998, PERFUSION-UK, V13, P419, DOI 10.1177/026765919801300605
   Blezer R, 1997, J BIOMED MATER RES, V37, P108, DOI 10.1002/(SICI)1097-4636(199710)37:1<108::AID-JBM13>3.0.CO;2-C
   Caldwell EEO, 1999, ARCH BIOCHEM BIOPHYS, V361, P215, DOI 10.1006/abbi.1998.0996
   CAT R, 1993, EUR J PEDIATR, V152, P205, DOI 10.1007/BF01956145
   Edmunds L H Jr, 1995, Adv Card Surg, V6, P131
   Garred P, 1997, ARTIF ORGANS, V21, P293
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   HARKER LA, 1986, NEW ENGL J MED, V314, P1446, DOI 10.1056/NEJM198605293142209
   Hecker JF, 1983, SHEEP EXPT ANIMAL
   JANATOVA J, 1991, COMPLEMENT INFLAMMAT, V8, P61, DOI 10.1159/000463181
   JOINER KA, 1983, AM J CLIN PATHOL, V79, P65
   Keldenich S, 2000, ASAIO J, V46, P134, DOI 10.1097/00002480-200001000-00030
   KIRSCHFINK M, 1993, CIRC SHOCK, V40, P221
   Kotnik V, 1997, IMMUNOPHARMACOLOGY, V38, P215, DOI 10.1016/S0162-3109(97)00074-X
   MACNAUGHTON PD, 1992, CRIT CARE MED, V20, P1289, DOI 10.1097/00003246-199209000-00016
   Mahoney CB, 1999, EUR J CARDIO-THORAC, V16, P206, DOI 10.1016/S1010-7940(99)00157-8
   Mayer M M, 1984, Complement, V1, P2
   MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982
   MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008
   MOLLNES TE, 1995, ARTIF ORGANS, V19, P909, DOI 10.1111/j.1525-1594.1995.tb02450.x
   Mottaghy K, 1989, ASAIO Trans, V35, P635, DOI 10.1097/00002480-198907000-00152
   OVRUM E, 1995, J THORAC CARDIOV SUR, V110, P1623, DOI 10.1016/S0022-5223(95)70023-4
   Ovrum E, 1996, ANN THORAC SURG, V62, P1128, DOI 10.1016/0003-4975(96)00490-0
   Ranucci M, 1996, ANN THORAC SURG, V61, P76, DOI 10.1016/0003-4975(95)00820-9
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   Sanchez J, 1997, J BIOMED MATER RES, V37, P37, DOI 10.1002/(SICI)1097-4636(199710)37:1<37::AID-JBM5>3.3.CO;2-O
   Sanchez J, 1999, THROMB RES, V93, P27, DOI 10.1016/S0049-3848(98)00148-0
   Suen WS, 1998, ANGIOLOGY, V49, P789, DOI 10.1177/000331979804900902
   Svenmarker S, 1997, EUR J CARDIO-THORAC, V11, P957, DOI 10.1016/S1010-7940(96)01132-3
   Taggart DP, 1997, EUR J CARDIO-THORAC, V11, P645, DOI 10.1016/S1010-7940(96)01103-7
   Toft P, 1998, EUR J ANAESTH, V15, P345, DOI 10.1097/00003643-199805000-00018
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   WEILER JM, 1992, J IMMUNOL, V148, P3210
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Wildevuur CRH, 1997, EUR J CARDIO-THORAC, V11, P616, DOI 10.1016/S1010-7940(96)01122-0
NR 38
TC 28
Z9 29
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1058-2916
J9 ASAIO J
JI Asaio J.
PD NOV-DEC
PY 2002
VL 48
IS 6
BP 598
EP 605
DI 10.1097/01.MAT.0000033639.23941.7E
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 615QV
UT WOS:000179258800005
PM 12455769
DA 2018-10-19
ER

PT J
AU Jin, HJ
   Fridrikh, SV
   Rutledge, GC
   Kaplan, DL
AF Jin, HJ
   Fridrikh, SV
   Rutledge, GC
   Kaplan, DL
TI Electrospinning Bombyx mori silk with poly(ethylene oxide)
SO BIOMACROMOLECULES
LA English
DT Article
ID ELECTRICALLY FORCED JETS; POLYMER THIN-FILMS; BENDING INSTABILITY;
   FIBERS; NANOFIBERS; MICROSCOPY; BIOMATERIALS; FIBROIN; SPUN
AB Electrospinning for the formation of nanoscale diameter fibers has been explored for high-performance filters and biomaterial scaffolds for vascular grafts or wound dressings. Fibers with nanoscale diameters provide benefits due to high surface area. In the present study we explore electrospinning for protein-based biomaterials to fabricate scaffolds and membranes, from regenerated silkworm silk, Bombyx mori, solutions. To improve processability of the protein solution, poly(ethylene oxide) (PEO) with molecular weight of 900 000 was blended with the silk fibroin. A variety of compositions of the silk/PEO aqueous blends were successfully electrospun. The morphology of the fibers was characterized using high-resolution scanning electron microscopy. Fiber diameters were uniform and less than 800 nm. The composition was estimated by. X-ray photoelectron spectroscopy to characterize silk/PEO surface content. Aqueous-based electrospining of silk and silk/PEO blends provides potentially useful options for the fabrication of biomaterial scaffolds based on this unique fibrous protein.
C1 Tufts Univ, Ctr Bioengn, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Ctr Bioengn, Dept Chem & Biol Engn, 4 Colby St, Medford, MA 02155 USA.
FU NIDCR NIH HHS [R01 DE13405-01]
CR Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   ANDERSON JP, 1994, MATER RES SOC SYMP P, V330, P171
   Asakura T., 1994, ENCY AGR SCI, V4, P1
   BAUMGARTEN PK, 1971, J COLLOID INTERF SCI, V36, P71, DOI 10.1016/0021-9797(71)90241-4
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Boland E. D., 2001, POLYM MAT SCI ENG, V85, P51
   Buchko CJ, 2001, BIOMATERIALS, V22, P1289, DOI 10.1016/S0142-9612(00)00281-7
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   BUNNING TJ, 1993, ACS SYM SER, V544, P351
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Hohman MM, 2001, PHYS FLUIDS, V13, P2221, DOI 10.1063/1.1384013
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang L, 2001, SCANNING, V23, P372
   HUDSON SM, 1997, PROTEIN BASED MAT, P313
   Inoue SI, 2000, J POLYM SCI POL PHYS, V38, P1436, DOI 10.1002/(SICI)1099-0488(20000601)38:11<1436::AID-POLB30>3.0.CO;2-8
   Jaeger R, 1996, MACROMOLECULES, V29, P7634, DOI 10.1021/ma9610673
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   KIM SW, 1996, BIOMATERIALS SCI INT, P297
   Kobayashi M., 2001, POLYM PREPR, V42, P294
   MARTIN DC, 1997, PROTEIN BASED MAT, P339
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Shin YM, 2001, APPL PHYS LETT, V78, P1149, DOI 10.1063/1.1345798
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stitzel JD, 2001, J BIOMATER APPL, V16, P22, DOI 10.1106/U2UU-M9QH-Y0BB-5GYL
   Trabbic KA, 1998, MACROMOLECULES, V31, P462, DOI 10.1021/ma9708860
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Vandermiers C, 1998, POLYMER, V39, P5627, DOI 10.1016/S0032-3861(98)00028-7
   Willcox PJ, 1996, MACROMOLECULES, V29, P5106, DOI 10.1021/ma960588n
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Zarkoob S, 1998, POLYM PREPR, V39, P244
NR 39
TC 501
Z9 520
U1 16
U2 240
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV-DEC
PY 2002
VL 3
IS 6
BP 1233
EP 1239
DI 10.1021/bm025581u
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 615GB
UT WOS:000179236500013
PM 12425660
DA 2018-10-19
ER

PT J
AU Arciola, CR
   Campoccia, D
   Gamberini, S
   Cervellati, M
   Donati, E
   Montanaro, L
AF Arciola, CR
   Campoccia, D
   Gamberini, S
   Cervellati, M
   Donati, E
   Montanaro, L
TI Detection of slime production by means of an optimised Congo red agar
   plate test based on a colourimetric scale in Staphylococcus epidermidis
   clinical isolates genotyped for ica locus
SO BIOMATERIALS
LA English
DT Article
DE biomaterial-associated infections; Staphylococcus epidermidis; slime;
   ica genes; polymerase chain reaction (PCR); microtiter plate method;
   Congo red agar
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   STRAINS; EXPRESSION; INFECTIONS; AUREUS
AB This investigation was conduced on a collection of 113 S. epidermidis strains isolated front biomaterial-associated infections. All strains were examined both for the presence of icaA and icaD genes responsible for slime synthesis by a PCR method and for the in vitro slime production ability by the Congo red agar (CRA) plate test. In the present study, the original CRA test was optimised adopting a six-colour reference scale for a fine classification of colonies colours. The six-colour tones of the scale were Lis follows: very black (vb), black (b), almost black (ab), which were considered as positive results, and bordeaux (brd), red (r), and very red (vr), interpreted as negative. 57.5% of all the strains were found to be icaA icaD-positive Lis well as slime-forming onto CRA, exhibiting the following colonies colours: vb (35.4%) b (15.9%): ab (6.2%). The percentage of icaA icaD-negative strains was 42.5% and all of them were negative onto CRA: brd (19.5%), r (14.2%), vr (8.8%). The comparison of colour classification with the information on ica genes confirmed the validity of the scale adopted, providing Support to the criteria used for a correct interpretation of the colonies colour during the execution of the CRA test. Overall these results indicate a fine consistency between these two experimental methods and a good reliability of CRA plate test, especially when this is supported by a colourmetric scale. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Rizzoli Orthoped Inst, Res Lab Biocompatibil Implant Mat, I-40136 Bologna, Italy.
   Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthoped Inst, Res Lab Biocompatibil Implant Mat, Via Barbiano 1-10, I-40136 Bologna, Italy.
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
CR Ammendolia MG, 1999, J CLIN MICROBIOL, V37, P3235
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Arciola CR, 2001, J CLIN MICROBIOL, V39, P2151, DOI 10.1128/JCM.39.6.2151-2156.2001
   Arciola CR, 1998, J BIOMED MATER RES, V42, P1
   Arciola CR, 2001, DIAGN MOL PATHOL, V10, P130, DOI 10.1097/00019606-200106000-00010
   ARCIOLA CR, 1993, BIOMATERIALS, V14, P1161, DOI 10.1016/0142-9612(93)90161-T
   ARCIOLA CR, 1994, J CATARACT REFR SURG, V20, P158, DOI 10.1016/S0886-3350(13)80157-5
   CRISTHENSEN GD, 1982, INFECT IMMUN, P2870
   Foster T. J., 1994, P31
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   KLOOS WE, 1975, J CLIN MICROBIOL, V1, P82
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   Mack K. D., 2000, HDB BACTERIAL ADHESI, P307
   Montanaro L., 2000, HDB BACTERIAL ADHESI, P331
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 17
TC 96
Z9 105
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2002
VL 23
IS 21
BP 4233
EP 4239
AR PII S0142-9612(02)00171-0
DI 10.1016/S0142-9612(02)00171-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 584DK
UT WOS:000177451800008
PM 12194526
DA 2018-10-19
ER

PT J
AU Anderson, BC
   Mallapragada, SK
AF Anderson, BC
   Mallapragada, SK
TI Synthesis and characterization of injectable, water-soluble copolymers
   of tertiary amine methacrylates and poly(ethylene glycol) containing
   methacrylates
SO BIOMATERIALS
LA English
DT Article
DE cationic polymers; water-soluble; PH sensitive; PEGylated
ID GENE-TRANSFER AGENTS; 2-(DIMETHYLAMINO)ETHYL METHACRYLATE; OXYANIONIC
   POLYMERIZATION; INITIATED POLYMERIZATION; POLYELECTROLYTES;
   MACROMONOMERS; DELIVERY
AB Several homopolymers and copolymers of 2-(diethylamino)ethyl methacrylate (DEAEM) and poly(ethylene glycol) methyl ether methacrylate (PEGMEM) were synthesized using anionic polymerization initiated by potassium t-butoxide. The polymers were characterized by average molecular weight, polydispersity and monomeric unit composition. A very narrow molecular weight distribution was achieved with a well-controlled composition. The glass transition temperatures and compositions of the copolymers followed a Gordon-Taylor relationship. The water solubility and biocompatibility of the copolymers was compared to their parent homopolymers to determine if the addition of a poly(ethylene glycol) group was sufficient to solubilize the polymers in aqueous buffer solutions and to increase the biocompatibility of the polymers. These water-soluble, injectable cationic copolymers have potential applications in gene delivery as well as other biomaterial applications. Published by Elsevier Science Ltd.
C1 Iowa State Univ, Dept Chem Engn, Ames, IA 50011 USA.
   US DOE, Ames Lab, Ames, IA 50011 USA.
RP Mallapragada, SK (reprint author), Iowa State Univ, Dept Chem Engn, 2114 Sweeney Hall, Ames, IA 50011 USA.
RI Mallapragada, Surya/F-9375-2012
CR ANDERSON BC, 2001, MAT RES SOC S P, V662
   Asayama S, 1997, BIOCONJUGATE CHEM, V8, P833, DOI 10.1021/bc970097n
   Banez MVD, 2001, POLYMER, V42, P29
   CHEN W, 1992, CHEM ENG SCI, V47, P1039, DOI 10.1016/0009-2509(92)80230-A
   Fischer D, 1997, P INT S CONTROL REL, V24, P647
   FISCHER D, 1999, P INT S CONTROL RELE, V26, P104
   ISHIHARA K, 1984, POLYM J, V16, P625, DOI 10.1295/polymj.16.625
   Lascelles SF, 1999, MACROMOLECULES, V32, P2462, DOI 10.1021/ma981967e
   MILBURN P, 1990, ENZYME MICROB TECH, V12, P527, DOI 10.1016/0141-0229(90)90070-7
   MORTIMER DA, 1991, POLYM INT, V25, P29, DOI 10.1002/pi.4990250107
   Nagasaki Y, 1997, MACROMOL RAPID COMM, V18, P827, DOI 10.1002/marc.1997.030180911
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Rungsardthong U, 2001, J CONTROL RELEASE, V73, P359, DOI 10.1016/S0168-3659(01)00295-4
   Schneider HA, 1997, J RES NATL INST STAN, V102, P229, DOI 10.6028/jres.102.018
   SCHWARTE LM, 1998, ACS SYM SER, V709, P56
   Shen YQ, 2001, MACROMOLECULES, V34, P144, DOI 10.1021/ma001176o
   Vamvakaki M, 1999, MACROMOLECULES, V32, P2088, DOI 10.1021/ma981779o
   van de Wetering P, 1998, J CONTROL RELEASE, V53, P145, DOI 10.1016/S0168-3659(97)00248-4
   van de Wetering P, 2000, J CONTROL RELEASE, V64, P193, DOI 10.1016/S0168-3659(99)00130-3
   van de Wetering P, 1999, BIOCONJUGATE CHEM, V10, P589, DOI 10.1021/bc980148w
NR 20
TC 20
Z9 20
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2002
VL 23
IS 22
BP 4345
EP 4352
AR PII S0142-9612(02)00173-4
DI 10.1016/S0142-9612(02)00173-4
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 587WR
UT WOS:000177667400006
PM 12219824
DA 2018-10-19
ER

PT J
AU German, JB
   Dillard, CJ
   Ward, RE
AF German, JB
   Dillard, CJ
   Ward, RE
TI Bioactive components in milk
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Article
ID DIACYLGLYCEROL ACYLTRANSFERASE; ENDOCRINE TRAITS; NEONATAL CALVES;
   COLOSTRUM; IDENTIFICATION; PURIFICATION; EXPRESSION; SUBSTANCES;
   CLONING; FAMILY
AB Milk is the only biomaterial that evolved under the Darwinian selective pressure to nourish growing mammals. The purpose of this article is to review the scientific research that is using new techniques of integrating biological sequence, structure and function, to understand the innovative biology underlying the products of that evolutionary pressure. As it emerges that milk is actively communicating between the maternal mammary epithelia and the infant's gastrointestinal system, actively directing and educating the immune, metabolic and microflora systems within the infant, enhancing nutrient absorption and delivery, and conferring multiple means of protection, nutritionists are gaining a host of new molecular targets towards which to build scientific strategies for future foods and clinical applications. As new components and functions are being discovered in milk by using traditional methods and modern genomic tools, the complexities of demonstrating in vivo, and particularly in humans, the functional mechanisms behind milk's newly observed physiological benefits are becoming the next challenge of this rapidly growing field. (C) 2002 Lippincott Williams Wilkins.
C1 Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.
   Nestle Res Ctr, Lausanne, Switzerland.
RP German, JB (reprint author), Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA.
RI Ward, Robert/E-1250-2011
OI Ward, Robert/0000-0002-6981-4040
CR ABBE MR, 2000, J PEDIAT GASTOENTERO, V31, P270
   Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018
   Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200
   Clare DA, 2000, J DAIRY SCI, V83, P1187, DOI 10.3168/jds.S0022-0302(00)74983-6
   Colker CM, 2002, NUTRITION, V18, P388, DOI 10.1016/S0899-9007(01)00800-0
   Donnet-Hughes A, 2000, IMMUNOL CELL BIOL, V78, P74, DOI 10.1046/j.1440-1711.2000.00882.x
   Duffar T, 2000, J OPTOELECTRON ADV M, V2, P432
   Fiorotto ML, 2000, PEDIATR RES, V48, P511, DOI 10.1203/00006450-200010000-00015
   Gopal PK, 2000, BRIT J NUTR, V84, pS69
   Groziak SM, 2000, BRIT J NUTR, V84, pS119
   Hamosh M, 2001, PEDIATR CLIN N AM, V48, P69, DOI 10.1016/S0031-3955(05)70286-8
   Itoh H, 2002, HORM METAB RES, V34, P16, DOI 10.1055/s-2002-19961
   Karhumaa P, 2001, P NATL ACAD SCI USA, V98, P11604, DOI 10.1073/pnas.121172598
   Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540
   Kuhne S, 2000, J ANIM SCI, V78, P609
   Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200
   Liepke C, 2001, J CHROMATOGR B, V752, P369, DOI 10.1016/S0378-4347(00)00516-8
   Magi B, 2002, PEDIATR RES, V51, P619, DOI 10.1203/01.PDR.0000013670.85499.2C
   Matar C, 2001, J DAIRY RES, V68, P601, DOI 10.1017/S0022029901005143
   Molkentin J, 2000, BRIT J NUTR, V84, pS47
   Newburg DS, 2001, ADV EXP MED BIOL, V501, P3
   Oddy W H, 2001, Breastfeed Rev, V9, P11
   Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081
   Peterson JA, 2001, ADV EXP MED BIOL, V501, P179
   Pfeuffer M, 2000, BRIT J NUTR, V84, pS155
   Rauprich ABE, 2000, BIOL NEONATE, V78, P53, DOI 10.1159/000014247
   Rutherfurd KJ, 2000, BRIT J NUTR, V84, pS99
   Satake M, 2002, BIOSCI BIOTECH BIOCH, V66, P378, DOI 10.1271/bbb.66.378
   Schlimme E, 2000, BRIT J NUTR, V84, pS59
   Schmelz EM, 2000, J NUTR, V130, P522
   Scholz-Ahrens KE, 2000, BRIT J NUTR, V84, pS147
   Shah NP, 2000, BRIT J NUTR, V84, pS3
   Sternhagen LG, 2001, ADV EXP MED BIOL, V501, P115
   Van Den Driessche M, 2002, ACTA GASTRO-ENT BELG, V65, P45
   Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799
   Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212
NR 36
TC 74
Z9 74
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1363-1950
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD NOV
PY 2002
VL 5
IS 6
BP 653
EP 658
DI 10.1097/01.mco.0000038808.16540.7f
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 619BA
UT WOS:000179452300007
PM 12394640
DA 2018-10-19
ER

PT J
AU Shive, MS
   Brodbeck, WG
   Anderson, JM
AF Shive, MS
   Brodbeck, WG
   Anderson, JM
TI Activation of caspase 3 during shear stress-induced neutrophil apoptosis
   on biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE neutrophils; caspases; apoptosis; shear stress; polyurethanes
ID ADHESION; CASCADE; INHIBITORS
AB Within the complex environment of an implanted cardiovascular device comprised of dynamic flow and foreign materials, phagocytic neutrophils may be ineffective in combating infection due to cellular responses to shear stress. This may be explained, in part, by our recent reports of apoptosis of biomaterial-adherent leukocytes induced through exposure to shear stress. Here we utilize a rotating disk system to generate physiologically relevant shear stress levels (0-18 dynes / cm(2)) at the surface of a polyetherurethane urea (PEUU) and investigate neutrophil intracellular pathways involved in shear-induced apoptosis. In situ detection of activated caspases, the enzymatic mediators of the apoptosis cascade, showed qualitatively that these proteases participate in shear-induced apoptosis and are activated in a shear-dependent manner. The involvement of caspase 3 was confirmed through immunoprecipitation and immunoblotting of extracted neutrophil proteins. Comparative studies with neutrophils adherent under static conditions demonstrated time-dependent activation of caspases in TNF-alpha/cycloheximide-induced apoptosis, for which caspase-3 also was implicated. These findings are the first steps toward elucidation of the mechanisms behind the inappropriate induction of apoptosis by adhesion to biomaterials, which may contribute to the development and persistence of device-related infections. (C) 2002 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
CR Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269
   Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594
   Gao LY, 1999, INFECT IMMUN, V67, P4886
   Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2
   Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587
   Huppertz B, 1999, ANAT EMBRYOL, V200, P1, DOI 10.1007/s004290050254
   Lin K, 2000, P NATL ACAD SCI USA, V97, P9385, DOI 10.1073/pnas.170282597
   LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0
   Rainger GE, 1999, AM J PHYSIOL-HEART C, V276, pH858, DOI 10.1152/ajpheart.1999.276.3.H858
   Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619
   Schotte P, 1999, FEBS LETT, V442, P117, DOI 10.1016/S0014-5793(98)01640-8
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   SHIVE MS, 2001, J BIOMED MATER RES, V60, P148
   Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1
   Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281
   STICKLER DJ, 1995, CELL MATER, V5, P167
   STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   Watson RWG, 1999, FEBS LETT, V453, P67, DOI 10.1016/S0014-5793(99)00688-2
   Yamashita K, 1999, BLOOD, V93, P674
   YEOITA H, 1998, CIRCULATION, V87, P276
NR 22
TC 11
Z9 13
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 2002
VL 62
IS 2
BP 163
EP 168
DI 10.1002/jbm.10225
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 589JH
UT WOS:000177754800002
PM 12209935
DA 2018-10-19
ER

PT J
AU Zreiqat, H
   Howlett, CR
   Zannettino, A
   Evans, P
   Schulze-Tanzil, G
   Knabe, C
   Shakibaei, M
AF Zreiqat, H
   Howlett, CR
   Zannettino, A
   Evans, P
   Schulze-Tanzil, G
   Knabe, C
   Shakibaei, M
TI Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to
   commonly used orthopaedic implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE magnesium ions; osteoblasts; adhesion; integrins; matrix proteins;
   orthopaedic implants
ID BONE-DERIVED CELLS; MEDIATED SIGNAL-TRANSDUCTION; DIVALENT-CATIONS;
   INTEGRIN RECEPTORS; JOINT CARTILAGE; IN-VITRO; FIBRONECTIN RECEPTOR;
   HUMAN CHONDROCYTES; BETA(1) INTEGRINS; CYCLE PROGRESSION
AB Poor cell adhesion to orthopaedic and dental implants may result in implant failure. Cellular adhesion to biomaterial surfaces primarily is mediated by integrins, which act as signal transduction and adhesion proteins. Because integrin function depends on divalent cations, we investigated the effect of magnesium ions modified bioceramic substrata (Al2O3-Mg2+) on human bone-derived cell (HBDC) adhesion, integrin expression, and activation of intracellular signalling molecules. Immunohistochemistry, flow cytometry, cell adhesion, cell adhesion blocking, and Western blotting assays were used. Our findings demonstrated that adhesion of HBDC to Al2O3-Mg2+ was increased compared to on the Mg2+-free Al2O3. Furthermore, HBDC adhesion decreased significantly when the fibronectin receptor alpha5beta1-and beta1-integrins were blocked by functional blocking antibodies. HBDC grown on the Mg2+-modified bioceramic expressed significantly enhanced levels of beta1-, alpha5beta1-, and alpha3beta1-integrins receptors compared to those grown on the native unmodified Al2O3. Tyrosine phosphorylation of intracellular integrin-dependent signalling proteins as well as the expression of key signalling protein Shc isoforms (p46, p52, p66), focal adhesion kinase, and extracellular matrix protein collagen type I were significantly enhanced when HBDC were grown on Al2O3-Mg2+ compared to the native Al2O3. We conclude that cell adhesion to biomaterial surfaces is probably mediated by alpha5beta1- and beta1-integrin. Cation-promoted cell adhesion depends on 5beta1- and beta1-integrins associated signal transduction pathways involving the key signalling protein Shc and results also in enhanced gene expression of extracellular matrix proteins. Therefore, Mg2+ supplementation of bioceramic substrata may be a promising way to improve integration of implants in orthopaedic and dental surgery. (C) 2002 Wiley Periodicals, Inc.
C1 Univ New S Wales, Sch Pathol, Sydney, NSW 2052, Australia.
   Hanson Ctr Canc Res, Inst Med & Vet Sci, Adelaide, SA, Australia.
   Free Univ Berlin, Hosp Benjamin Franklin, Dept Expt Dent, D-1000 Berlin, Germany.
   Free Univ Berlin, Inst Anat, Benjamin Franklin Med Ctr, D-1000 Berlin, Germany.
RP Zreiqat, H (reprint author), Univ New S Wales, Sch Pathol, Sydney, NSW 2052, Australia.
CR AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290
   ALBELDA SM, 1990, FASEB J, V4, P2868
   ANAST CS, 1972, SCIENCE, V177, P606, DOI 10.1126/science.177.4049.606
   BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570
   Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670
   Bilek MMM, 2000, J APPL PHYS, V87, P4198, DOI 10.1063/1.373052
   BROWN IG, 1986, REV SCI INSTRUM, V57, P1069, DOI 10.1063/1.1138660
   Cowles EA, 2000, J BIOMED MATER RES, V52, P725, DOI 10.1002/1097-4636(20001215)52:4<725::AID-JBM18>3.3.CO;2-F
   Damsky CH, 1999, BONE, V25, P95, DOI 10.1016/S8756-3282(99)00106-4
   DEDHAR S, 1987, J CELL BIOL, V105, P1175, DOI 10.1083/jcb.105.3.1175
   Forster C, 1996, ARCH TOXICOL, V70, P261, DOI 10.1007/s002040050272
   GAILIT J, 1988, J BIOL CHEM, V263, P12927
   GEORGE EL, 1993, DEVELOPMENT, V119, P1079
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   GRONTHOS S, 1994, BLOOD, V84, P4164
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   HILDEBRAND JD, 1995, MOL BIOL CELL, V6, P637
   Howlett CR, 1999, J BIOMED MATER RES, V45, P345, DOI 10.1002/(SICI)1097-4636(19990615)45:4<345::AID-JBM9>3.0.CO;2-J
   HOWLETT CR, 2000, BONE ENG, P240
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Ilic Dusko, 1995, Nature (London), V377, P539
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Lansdown ABG, 1996, LANCET, V347, P706, DOI 10.1016/S0140-6736(96)90072-0
   LOESER RF, 1994, EXP CELL RES, V211, P17, DOI 10.1006/excr.1994.1053
   Longhurst CM, 1998, CELL MOL LIFE SCI, V54, P514, DOI 10.1007/s000180050180
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981
   OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Ruoslahti E, 1997, KIDNEY INT, V51, P1413, DOI 10.1038/ki.1997.193
   RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803
   SAITO T, 1994, J ORTHOP RES, V12, P384, DOI 10.1002/jor.1100120311
   SCHLAEPFER DD, 1994, NATURE, V372, P786
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Shakibaei M, 1999, CELL TISSUE RES, V296, P565, DOI 10.1007/s004410051318
   Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615
   Shakibaei M, 2001, ARCH TOXICOL, V75, P97, DOI 10.1007/s002040000203
   Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   STAHLMANN R, 1995, ANTIMICROB AGENTS CH, V39, P2013, DOI 10.1128/AAC.39.9.2013
   Stahlmann R, 2000, ARCH TOXICOL, V73, P573, DOI 10.1007/s002040050010
   Tahiliani PD, 1997, J BIOL CHEM, V272, P7892, DOI 10.1074/jbc.272.12.7892
   Takamatsu Y, 1998, CELL ADHES COMMUN, V5, P349, DOI 10.3109/15419069809010781
   van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6
   Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6
   Whittard JD, 2001, EXP CELL RES, V263, P65, DOI 10.1006/excr.2000.5099
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
   Zreiqat H, 1999, J BIOMED MATER RES, V44, P389, DOI 10.1002/(SICI)1097-4636(19990315)44:4<389::AID-JBM4>3.0.CO;2-O
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 53
TC 420
Z9 445
U1 6
U2 106
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 2002
VL 62
IS 2
BP 175
EP 184
DI 10.1002/jbm.10270
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 589JH
UT WOS:000177754800004
PM 12209937
DA 2018-10-19
ER

PT J
AU Cai, KY
   Yao, KD
   Hou, X
   Wang, YQ
   Hou, YJ
   Yang, ZM
   Li, XQ
   Xie, HQ
AF Cai, KY
   Yao, KD
   Hou, X
   Wang, YQ
   Hou, YJ
   Yang, ZM
   Li, XQ
   Xie, HQ
TI Improvement of the functions of osteoblasts seeded on modified
   poly(D,L-lactic acid) with poly(aspartic acid)
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE poly(aspartic acid); poly(D,L-lactic acid); osteoblast; cell affinity;
   surface modification; interaction
ID IMMOBILIZED ADHESIVE PEPTIDES; L-ASPARTIC ACID; SURFACE-ROUGHNESS;
   CELLS; DIFFERENTIATION; PROLIFERATION; BIOMATERIALS; RESPONSES;
   POLYMERS; TITANIUM
AB One of the challenges in the field of tissue engineering is the development of biomaterial / cell interactions. For the purposes of the present study, two molecular weights of poly(aspartic acid) (PASP) were used to modify poly(D,L-lactic acid) (PDLLA) films in order to enhance their cell affinity. The properties of the PDLLA-modified surfaces and the controls were investigated by water contact angle measurement and electron spectroscopy for chemical analysis (ESCA). These data reflect the change in the biocompatibility of modified PDLLA surfaces. Then rat osteoblasts were seeded onto these modified surfaces and on controls to examine their effects on cell adhesion and proliferation. Cell morphologies on these surfaces were studied by scanning electron microscopy (SEM), and cell viability was evaluated with a MTT assay. In addition, differentiated cell function was assessed by measuring alkaline phosphatase (ALP) activity. The results suggest that PASP-modified surfaces may enhance the interactions between osteoblasts and PDLLA films. (C) 2002 Wiley Periodicals, Inc.
C1 Tianjin Univ, Res Inst Polymer Mat, Tianjin 300072, Peoples R China.
   Tianjin Univ, State Key Lab C, Chem Technol Sch Chem Engn, Tianjin 300072, Peoples R China.
   W China Univ Med Sci, Univ Hosp 1, Chengdu 610041, Peoples R China.
RP Yao, KD (reprint author), Tianjin Univ, Res Inst Polymer Mat, Tianjin 300072, Peoples R China.
RI 蔡, 开勇/G-1233-2011; Cai, Kaiyong/B-3061-2012
CR BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BRYNAERT JM, 1999, BIOMATERIALS, V20, P1773
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Dee KC, 1999, BIOMATERIALS, V20, P221, DOI 10.1016/S0142-9612(98)00161-6
   Dewez JL, 1996, J BIOMED MATER RES, V30, P373
   Elisseeff J, 1997, MACROMOLECULES, V30, P2182, DOI 10.1021/ma961411w
   Hrkach JS, 1995, MATER RES SOC SYMP P, V394, P77, DOI 10.1557/PROC-394-77
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   John G, 1999, MACROMOLECULES, V32, P1853, DOI 10.1021/ma981729j
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KISHORE BK, 1990, J PHARMACOL EXP THER, V255, P875
   KWON GS, 1993, PHARMACEUT RES, V10, P970, DOI 10.1023/A:1018998203127
   Leopold CS, 1995, J PHARMACOKINET BIOP, V23, P397, DOI 10.1007/BF02353640
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nakato T, 1999, J MACROMOL SCI PURE, VA36, P949, DOI 10.1081/MA-100101574
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Olbrich KC, 1996, BIOMATERIALS, V17, P759, DOI 10.1016/0142-9612(96)81412-8
   Otto TE, 1996, J BIOMED MATER RES, V32, P513, DOI 10.1002/(SICI)1097-4636(199612)32:4<513::AID-JBM3>3.0.CO;2-U
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   Quirk RA, 2000, MACROMOLECULES, V33, P258, DOI 10.1021/ma9916133
   Rouhi AM, 1999, CHEM ENG NEWS, V77, P51, DOI 10.1021/cen-v077n003.p051
   SOO KB, 1998, TRENDS BIOTECHNOL, V16, P224
   Todd JH, 1997, TOXICOL LETT, V90, P217, DOI 10.1016/S0378-4274(96)03858-1
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   WHITTEM T, 1992, J PHARMACOL EXP THER, V262, P834
NR 29
TC 40
Z9 45
U1 0
U2 16
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD NOV
PY 2002
VL 62
IS 2
BP 283
EP 291
DI 10.1002/jbm.10067
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 589JH
UT WOS:000177754800016
PM 12209949
DA 2018-10-19
ER

PT J
AU Fitzpatrick, F
   Humphreys, H
   Smyth, E
   Kennedy, CA
   O'Gara, JP
AF Fitzpatrick, F
   Humphreys, H
   Smyth, E
   Kennedy, CA
   O'Gara, JP
TI Environmental regulation of biofilm formation in intensive care unit
   isolates of Staphylococcus epidermidis
SO JOURNAL OF HOSPITAL INFECTION
LA English
DT Article
DE Biofilm formation; ica operon; environmental regulation; clinical
   isolates
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; CATHETER-ASSOCIATED INFECTION;
   TRANSPOSON MUTANTS; PRIMARY ATTACHMENT; PHASE VARIATION; RAT MODEL;
   STRAINS; AUREUS; PATHOGENESIS; ADHERENCE
AB Staphylococcus epidermidis is a common cause of prosthetic device-related infection in the intensive care unit (ICU). The environmentally regulated ica operon encodes a polysaccharide adhesin which is a key virulence determinant in the development of S. epidermidis biofilms. To evaluate the capacity of ICU S. epidermidis isolates to form biofilm, we measured biofilm production by 18 isolates associated with device-related infection and 20 contaminating isolates that were not associated with clinically diagnosed infection. Biofilm assays were performed in brain-heart infusion (BHI) medium and in BFI supplemented with salt, ethanol or subinhibitory tetracycline, all of which have the potential to promote biofilm formation. Polymerase chain reaction (PCR) was used to screen for the presence of the ica genes. A significant proportion of S. epidermidis strains associated with device-related infections (89%) were found to contain the ica locus compared with 50% of contaminating isolates (P = 0.01). However only four of 26 (15.3%) of all ica-positive isolates were biofilm-positive when grown in BHI medium, indicating that no significant association existed between the presence of the ica locus and biofilm-forming capacity, under standard growth conditions. In contrast the number of ica-positive isolates that were biofilm-positive under stress-inducing growth conditions or in the presence of subinhibitory tetracycline increased significantly to 73% (P=0.02). These findings suggest that the presence of the ica locus alone is not sufficient for biofilm formation and that regulation, of biofilm formation under altered growth conditions, which may exist in the in vivo environment, also plays a possible role in the pathogenesis of biomaterial-related S. epidermidis infections. (C) 2002 The Hospital Infection Society.
C1 Royal Coll Surgeons Ireland, Dept Microbiol, RCSI Educ & Res Ctr, Dublin 9, Ireland.
   Beaumont Hosp, Dept Microbiol, Dublin 9, Ireland.
RP O'Gara, JP (reprint author), Royal Coll Surgeons Ireland, Dept Microbiol, RCSI Educ & Res Ctr, Smurfit Bldg, Dublin 9, Ireland.
RI fitzpatrick, fidelma/P-5483-2018; Humphreys, Hilary/C-9918-2012;
   fitzpatrick, fidelma/K-8601-2018
OI fitzpatrick, fidelma/0000-0002-3204-5962; fitzpatrick,
   fidelma/0000-0002-3204-5962; O'Gara, James/0000-0003-3866-7161
CR ARCHER GL, 1995, PRINCIPLES PRACTICE, P1777
   CHRISTENSEN GD, 1982, ANN INTERN MED, V96, P1, DOI 10.7326/0003-4819-96-1-1
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   de Silva GDI, 2002, J CLIN MICROBIOL, V40, P382, DOI [10.1128/JCM.40.02.382-388.2002, 10.1128/JCM.40.2.382-388.2002]
   Fowler VG, 2001, MED MICROBIOL IMMUN, V189, P127, DOI 10.1007/s430-001-8018-5
   Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877
   Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660
   Gelosia A, 2001, CLIN MICROBIOL INFEC, V7, P193, DOI 10.1046/j.1469-0691.2001.00214.x
   GENTRY LO, 1997, STAPHYLOCOCCI HUMAN, P455
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gosden PE, 1998, J ANTIMICROB CHEMOTH, V42, P161, DOI 10.1093/jac/42.2.161
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Heilmann C, 1998, ZBL BAKT-INT J MED M, V287, P69
   Ing MB, 1997, STAPHYLOCOCCI HUMAN, P331
   Jones SM, 2001, LANCET, V357, P40, DOI 10.1016/S0140-6736(00)03572-8
   Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   MACK D, 1994, INFECT IMMUN, V62, P3244
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9
   Martineau F, 1996, J CLIN MICROBIOL, V34, P2888
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   McKenney D, 1998, INFECT IMMUN, V66, P4711
   MEMPEL M, 1994, ANTIMICROB AGENTS CH, V38, P1251, DOI 10.1128/AAC.38.6.1251
   MEMPEL M, 1995, MED MICROBIOL IMMUN, V184, P109
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   ROOS KL, 1997, STAPHYLOCOCCI HUMAN, P413
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 38
TC 39
Z9 42
U1 0
U2 6
PU W B SAUNDERS CO LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0195-6701
J9 J HOSP INFECT
JI J. Hosp. Infect.
PD NOV
PY 2002
VL 52
IS 3
BP 212
EP 218
DI 10.1053/jhin.2002.1309
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 614DG
UT WOS:000179172600010
PM 12419274
DA 2018-10-19
ER

PT J
AU Junge, K
   Klinge, U
   Klosterhalfen, B
   Mertens, PR
   Rosch, R
   Schachtrupp, A
   Ulmer, F
   Schumpelick, V
AF Junge, K
   Klinge, U
   Klosterhalfen, B
   Mertens, PR
   Rosch, R
   Schachtrupp, A
   Ulmer, F
   Schumpelick, V
TI Influence of mesh materials on collagen deposition in a rat model
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Article
DE b-FGF; biomaterial; collagen; mesh; wound healing
ID INGUINAL-HERNIAS; GENE-EXPRESSION; III COLLAGEN; SKIN; TRANSVERSALIS;
   FIBROBLASTS; PHYSIOLOGY; FASCIA; WOUNDS; REPAIR
AB Alterations of the extracellular matrix (ECM) with its major component collagen are increasingly discussed as possible risk factors implicated in the development of abdominal-wall herniation. Because of the widespread use of alloplastic meshes for the surgical repair of hernias, an animal study was performed to analyze the influence of various mesh materials on the quantity and quality of collagen deposition. In 60 male Sprague-Dawley rats an abdominal replacement was performed using three different kinds of mesh materials: polyester (PE), a pure polypropylene (PP), and a composite mesh made of polypropylene and polyglactin (PG). A simple fascia suture repair served as control. The count of fibroblasts, the collagen/protein ratio, the type I/III collagen ratio, and the ex-pression of basic fibroblast growth factor (b-FGF) at the interface were analyzed after 7, 21, and 90 days. The ratio of collagen to overall protein (mug/mg) showed significant differences comparing different mesh materials (sham controls 38.44 +/- 16.33 mug/mg, PE 68.5 +/- 23.8 mug/mg, PP 101.6 +/- 32.3 mug/mg, PG 49.6 +/- 11.6 mug/mg at day 90). The ratio of Collagen type I/III increased over time in all groups. However, 90 days after mesh implantation the ratio was always significantly lowered compared to the controls. No significant difference was found comparing different mesh materials. The alteration of the scar composition is closely connected to an increased b-FGF expression. b-FGF and count of fibroblasts highly correlated (r = .95) and showed significant elevated levels compared to simple suture repair. The results of our study strongly support the notion that wound healing is affected by mesh implantation. The quality of the ECM deposition as determined by collagen type I/III ratio is impaired in general, whereas the quantity of ECM deposition is markedly influenced by the kind of mesh material.
C1 Rhein Westfal TH Aachen, Dept Surg, D-52057 Aachen, Germany.
   Rhein Westfal TH Aachen, Inst Pathol, Aachen, Germany.
   Rhein Westfal TH Aachen, Dept Internal Med, Aachen, Germany.
RP Junge, K (reprint author), Rhein Westfal TH Aachen, Dept Surg, Pauwelsstr 30, D-52057 Aachen, Germany.
EM karsten.junge@post.rwth-aachen.de
CR BAILEY AJ, 1975, BIOCHIM BIOPHYS ACTA, V405, P412, DOI 10.1016/0005-2795(75)90106-3
   Bellon JM, 2001, ANN SURG, V233, P287, DOI 10.1097/00000658-200102000-00020
   Bellon JM, 1997, EUR J CLIN INVEST, V27, P510, DOI 10.1046/j.1365-2362.1997.1400686.x
   Birk DE, 1997, EUR J CELL BIOL, V72, P352
   COHEN IK, 1976, J BIOMED MATER RES, V10, P965, DOI 10.1002/jbm.820100613
   Condon RE, 1994, SEMIN LAPAROSC SURG, V1, P75
   COOPER DM, 1994, ANN SURG, V219, P688, DOI 10.1097/00000658-199406000-00012
   Dale PD, 1996, P ROY SOC B-BIOL SCI, V263, P653, DOI 10.1098/rspb.1996.0098
   Debus ES, 2000, ZBL CHIR, V125, P49
   EPSTEIN EH, 1974, J BIOL CHEM, V249, P3225
   FRIEDMAN DW, 1993, J SURG RES, V55, P214, DOI 10.1006/jsre.1993.1132
   FRIEDMAN DW, 1993, ANN SURG, V218, P754, DOI 10.1097/00000658-199312000-00009
   Greca F H, 2001, Hernia, V5, P59
   HENKEL W, 1982, EUR J BIOCHEM, V122, P205, DOI 10.1111/j.1432-1033.1982.tb05868.x
   JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267
   Khouw IMSL, 1999, BIOMATERIALS, V20, P1815, DOI 10.1016/S0142-9612(99)00077-0
   Klinge U, 2000, EUR SURG RES, V32, P43, DOI 10.1159/000008740
   Klinge U, 1996, LANGENBECK ARCH CHIR, V381, P323
   Klinge U, 1998, EUR J SURG, V164, P951
   Klinge U, 1999, EUR SURG RES, V31, P480, DOI 10.1159/000008728
   LAPIERE C M, 1977, Connective Tissue Research, V5, P21
   LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480
   MADDEN JW, 1968, SURGERY, V64, P288
   MCCOY BJ, 1984, PLAST RECONSTR SURG, V73, P924, DOI 10.1097/00006534-198406000-00012
   Pans A, 2001, J SURG RES, V95, P107, DOI 10.1006/jsre.2000.6024
   Schaffer M, 1999, CHIRURG, V70, P897, DOI 10.1007/s001040050740
   Schumpelick V, 1996, CHIRURG, V67, P1028, DOI 10.1007/s001040050099
   Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6
   Takeshita T, 2000, ALCOHOL CLIN EXP RES, V24, P1
NR 29
TC 49
Z9 51
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0894-1939
EI 1521-0553
J9 J INVEST SURG
JI J. Invest. Surg.
PD NOV-DEC
PY 2002
VL 15
IS 6
BP 319
EP 328
DI 10.1080/08941930290086137
PG 10
WC Surgery
SC Surgery
GA 632LL
UT WOS:000180224700005
PM 12542866
DA 2018-10-19
ER

PT J
AU Wang, ML
   Nesti, LJ
   Tuli, R
   Lazatin, J
   Danielson, KG
   Sharkey, PF
   Tuan, RS
AF Wang, ML
   Nesti, LJ
   Tuli, R
   Lazatin, J
   Danielson, KG
   Sharkey, PF
   Tuan, RS
TI Titanium particles suppress expression of osteoblastic phenotype in
   human mesenchymal stem cells
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE mesenchymal stem cell; differentiation; wear particles; titanium;
   zirconia
ID BONE SIALOPROTEIN; MARROW; DIFFERENTIATION; DEBRIS; RESORPTION;
   SEQUENCE; ADHESION; DOMAIN; MOUSE; CDNA
AB Long-term stability of arthroplasty prosthesis depends on the integration between osseous tissue and the implant biomaterial. Integrity of the osseous tissue requires the contribution of mesenchymal stem cells and their continuous differentiation into an osteoblastic phenotype. This study aims to investigate the hypothesis that exposure to wear debris particles derived from orthopaedic biomaterials affects the osteoblastic differentiation of human mesenchymal stem cells (hMSC). Upon in vitro culture in the presence of osteogenic supplements (OS), we observe that cultures of hMSCs isolated from femoral head bone marrow are capable of osteogenic differentiation, expressing alkaline phosphatase, osteocalcin, and bone sialoprotein (BSP), in addition to producing collagen type I and BSP accompanied by extracellular matrix mineralization. Exposure of OS-treated hMSCs to submicron commercially pure titanium (cpTi) particles suppresses BSP gene expression, reduces collagen type I and BSP production, decreases cellular proliferation and viability, and inhibits matrix mineralization. In comparison, exposure to zirconium oxide (ZrO2) particles of similar size did not alter osteoblastic gene expression and resulted in only a moderate decrease in cellular proliferation and mineralization. Confocal imaging of cpTi-treated hMSC cultures revealed patchy groups of cells displaying disorganized cytoskeletal architecture and low levels of extracellular BSP. These in vitro findings suggest that chronic exposure of marrow cells to titanium wear debris in vivo may contribute to decreased bone formation at the bone/implant interface by reducing the population of viable hMSCs and compromising their differentiation into functional osteoblasts. Understanding the nature of hMSC bioreactivity to orthopaedic wear debris should provide additional insights into mechanisms underlying aseptic loosening. Published by Elsevier Science Ltd. on behalf of Orthopaedic Research Society.
C1 NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Bethesda, MD 20892 USA.
   Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.
RP Tuan, RS (reprint author), NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Bldg 50,Room 1503,50 South Dr, Bethesda, MD 20892 USA.
FU NIAMS NIH HHS [AR45181, AR44501]; NIDCR NIH HHS [DE12864]
CR ARCARI P, 1984, NUCLEIC ACIDS RES, V12, P9179, DOI 10.1093/nar/12.23.9179
   BENZ EW, 1977, EXP CELL RES, V108, P157, DOI 10.1016/0014-4827(77)90339-1
   BRIEN WW, 1992, CLIN ORTHOP RELAT R, P66
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Caterson EJ, 2001, J BIOMED MATER RES, V57, P394, DOI 10.1002/1097-4636(20011205)57:3<394::AID-JBM1182>3.0.CO;2-9
   CELESTE AJ, 1986, EMBO J, V5, P1885, DOI 10.1002/j.1460-2075.1986.tb04440.x
   CHARNLEY J, 1975, CLIN ORTHOP RELAT R, P105
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Engh CA, 1997, J BONE JOINT SURG AM, V79A, P1721, DOI 10.2106/00004623-199711000-00014
   Fisher L W, 1989, Connect Tissue Res, V21, P43, DOI 10.3109/03008208909049994
   Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61
   FISHER LW, 1989, J BIOL CHEM, V264, P4571
   Flores ME, 1996, EXP CELL RES, V227, P40, DOI 10.1006/excr.1996.0247
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   GLANT TT, 1994, J ORTHOPAED RES, V12, P720, DOI 10.1002/jor.1100120515
   HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Lohmann CH, 2000, BIOMATERIALS, V21, P551, DOI 10.1016/S0142-9612(99)00211-2
   Lomri A, 1999, CALCIFIED TISSUE INT, V64, P394, DOI 10.1007/PL00005821
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   MINTZ KP, 1993, J BONE MINER RES, V8, P985
   Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078
   Pioletti DP, 1999, J BIOMED MATER RES, V46, P399, DOI 10.1002/(SICI)1097-4636(19990905)46:3<399::AID-JBM13>3.3.CO;2-2
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rickard DJ, 1996, J BONE MINER RES, V11, P312
   SALVATI EA, 1993, CLIN ORTHOP RELAT R, P160
   Schmalzried TP, 1999, J BONE JOINT SURG AM, V81A, P115, DOI 10.2106/00004623-199901000-00016
   Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9
   SPOTILA LD, 1994, J BONE MINER RES, V9, P923
   Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210
   Yao JL, 1997, J BONE JOINT SURG AM, V79A, P107, DOI 10.2106/00004623-199701000-00011
NR 32
TC 81
Z9 87
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0736-0266
J9 J ORTHOPAED RES
JI J. Orthop. Res.
PD NOV
PY 2002
VL 20
IS 6
BP 1175
EP 1184
AR PII S0736-0266(02)00076-1
DI 10.1016/S0736-0266(02)00076-1
PG 10
WC Orthopedics
SC Orthopedics
GA 618CP
UT WOS:000179400800007
PM 12472226
DA 2018-10-19
ER

PT J
AU Aldini, NN
   Fini, M
   Giavaresi, G
   Giardino, R
   Greggi, T
   Parisini, P
AF Aldini, NN
   Fini, M
   Giavaresi, G
   Giardino, R
   Greggi, T
   Parisini, P
TI Pedicular fixation in the osteoporotic spine: a pilot in vivo study on
   long-term ovariectomized sheep
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE pedicular fixation; osteoporosis; osteopenic sheep; hydroxyapatite;
   osteointegration
ID BONE-MINERAL DENSITY; PEDICLE SCREW FIXATION; IN-VIVO; INSERTIONAL
   TORQUE; INTERNAL-FIXATION; STAINLESS-STEEL; IMPLANTS; HYDROXYAPATITE;
   TITANIUM; MODEL
AB Spinal instrumentation success is greatly affected by the presence of osteoporosis. To date, however, no data exist on in vivo investigations on biomaterial and surgical techniques in the osteoporotic spine. In the present study 24 uncoated and 24 HA-coated screws were implanted in the U, L4 and L5 pedicles of eight sheep (four ovariectomized, OVX Group; four sham-operated, Control Group). At four months, uncoated screws showed a significant decrease of about -22% in the extraction torque of the OVX Group as compared to the Control Group (p < 0.005). The extraction torque of HA-coated screws significantly (p < 0.0005) improved in both groups when compared to that of uncoated screws and showed increases ranging from 133% to 157%. Pedicle trabecular bone of OVX sheep showed a significant decrease in BV/TV (-30%; p < 0.05) and Tb.Th (-33%; p < 0.01). The affinity index (AI) results revealed significant (p < 0.0005) differences between uncoated and HA-coated screws for both groups: values were lower for uncoated than HA-coated screws by about -35%. A significant difference was also found for the AI data of uncoated screws between the OVX and Control Groups (-13%, p < 0.005). The current findings have demonstrated that long-term ovariectomized sheep can be used to study in vivo osteointegration in the osteoporotic spine. The HA coating has proven to improve bone purchase and bone-screw interface strength in healthy and osteopenic animals. (C) 2002 Published by Elsevier Science Ltd. on behalf of Orthopaedic Research Society.
C1 Res Inst Codivilla Putti, Dept Expt Surg, Rizzoli Orthopaed Inst, I-403136 Bologna, Italy.
   Rizzoli Orthopaed Inst, Dept Spinal Surg, I-40136 Bologna, Italy.
RP Giardino, R (reprint author), Res Inst Codivilla Putti, Dept Expt Surg, Rizzoli Orthopaed Inst, Via Barbiano 1110, I-403136 Bologna, Italy.
RI Fini, Milena/J-4808-2016
OI Fini, Milena/0000-0002-3732-3570; Giavaresi,
   Gianluca/0000-0001-7843-5969
CR Antonacci MD, 1997, SPINE, V22, P2393, DOI 10.1097/00007632-199710150-00014
   BARRIOS C, 1993, J ORTHOP TRAUMA, V7, P438, DOI 10.1097/00005131-199310000-00006
   Bellino FL, 2000, MENOPAUSE, V7, P14, DOI 10.1097/00042192-200007010-00004
   Blomqvist JE, 1996, INT J ORAL MAX SURG, V25, P63, DOI 10.1016/S0901-5027(96)80015-4
   Boos N, 1997, Eur Spine J, V6, P2, DOI 10.1007/BF01676569
   Brayda-Bruno M, 2001, INT J ARTIF ORGANS, V24, P41
   COE JD, 1990, SPINE, V15, P902, DOI 10.1097/00007632-199009000-00012
   COHEN LD, 1990, ORTHOP CLIN N AM, V21, P143
   COOK SD, 1995, J ARTHROPLASTY, V10, P351, DOI 10.1016/S0883-5403(05)80184-6
   DAFTARI TK, 1994, J SPINAL DISORD, V7, P139, DOI 10.1097/00002517-199407020-00007
   Deguchi M, 1998, J SPINAL DISORD, V11, P459
   DELFINO HL, 2001, EUR SPINE J, V10, P325
   Ding M, 2000, Acta Orthop Scand Suppl, V292, P1
   Fini M, 2000, INT J ARTIF ORGANS, V23, P275
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fini M, 2001, J BONE JOINT SURG BR, V83B, P139, DOI 10.1302/0301-620X.83B1.10162
   Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002
   Giavaresi G, 2001, J APPL ANIM RES, V20, P221, DOI 10.1080/09712119.2001.9706756
   Giavaresi G, 2001, INT J ARTIF ORGANS, V24, P814
   HALVORSON TL, 1994, SPINE, V19, P2415, DOI 10.1097/00007632-199411000-00008
   Hara T, 1999, J BONE JOINT SURG BR, V81B, P705, DOI 10.1302/0301-620X.81B4.9138
   Hasegawa K, 1997, SPINE, V22, P958, DOI 10.1097/00007632-199705010-00004
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   Hilibrand AS, 1996, SPINE, V21, P445, DOI 10.1097/00007632-199602150-00008
   Hu SS, 1997, SPINE, V22, p43S, DOI 10.1097/00007632-199712151-00008
   Jilka RL, 1998, BONE, V23, P75, DOI 10.1016/S8756-3282(98)00077-5
   Kanayama M, 1999, SPINE, V24, P1058, DOI 10.1097/00007632-199906010-00003
   Khosla Sundeep, 1995, P183
   Kotani Y, 1996, SPINE, V21, P278, DOI 10.1097/00007632-199602010-00005
   Kwok AWL, 1996, SPINE, V21, P2429, DOI 10.1097/00007632-199611010-00004
   Lill CA, 2000, J ORTHOP TRAUMA, V14, P559, DOI 10.1097/00005131-200011000-00007
   Livingstone Smith A, 1999, ANIMAL MODELS ORTHOP, P59
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   McKoy BE, 2001, J ORTHOPAED RES, V19, P545, DOI 10.1016/S0736-0266(00)00052-8
   Mori H, 1997, J ORAL MAXIL SURG, V55, P351, DOI 10.1016/S0278-2391(97)90124-5
   Moroni A, 2001, J BONE JOINT SURG AM, V83A, P717, DOI 10.2106/00004623-200105000-00010
   Moroni A, 1996, J ORTHOP TRAUMA, V10, P236, DOI 10.1097/00005131-199605000-00003
   NEWMAN E, 1995, BONE, V16, P277
   OKUYAMA K, 1993, SPINE, V18, P2240, DOI 10.1097/00007632-199311000-00016
   Okuyama K, 2000, SPINE, V25, P858, DOI 10.1097/00007632-200004010-00015
   Pan JL, 2000, J ORAL MAXIL SURG, V58, P877, DOI 10.1053/joms.2000.8212
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Rocca M, 2000, INT J ARTIF ORGANS, V23, P824
   Rocca M, 2001, INT J ARTIF ORGANS, V24, P649
   ROCCA M, 2001, BIOMATERIALS, V23, P1017
   Sanden B, 2000, EUR SPINE J, V9, P534, DOI 10.1007/s005860000180
   Sanden B, 2001, EUR SPINE J, V10, P334, DOI 10.1007/s005860100291
   Simmons CA, 2001, J ORTHOPAED RES, V19, P187, DOI 10.1016/S0736-0266(00)90006-8
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   SOSHI S, 1991, SPINE, V16, P1335, DOI 10.1097/00007632-199111000-00015
   STAUBER MH, 1994, SPINE, V19, P57, DOI 10.1097/00007632-199401000-00012
   STEA S, 1995, J BIOMED MATER RES, V29, P695, DOI 10.1002/jbm.820290604
   SUN C, 1999, CHIN MED J, V115, P456
   Thorndike E. A., 1998, FRONT BIOSCI, V3, P17
   Vaccaro AR, 1995, SPINE, V20, pS157
   Wilke HJ, 1997, ANAT REC, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P
   Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009
   WITTENBERG RH, 1991, SPINE, V16, P647, DOI 10.1097/00007632-199106000-00009
   Yamazaki M, 1999, ORAL SURG ORAL MED O, V87, P411, DOI 10.1016/S1079-2104(99)70239-8
   ZDEBLICK TA, 1993, SPINE, V18, P1673, DOI 10.1097/00007632-199309000-00016
NR 60
TC 42
Z9 51
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0736-0266
J9 J ORTHOPAED RES
JI J. Orthop. Res.
PD NOV
PY 2002
VL 20
IS 6
BP 1217
EP 1224
AR PII S0736-0266(02)00069-4
PG 8
WC Orthopedics
SC Orthopedics
GA 618CP
UT WOS:000179400800013
PM 12472232
DA 2018-10-19
ER

PT J
AU Brunius, CF
   Edlund, U
   Albertsson, AC
AF Brunius, CF
   Edlund, U
   Albertsson, AC
TI Synthesis and in vitro degradation of poly(N-vinyl-2-pyrrolidone)-based
   graft copolymers for biomedical applications
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE poly(vinyl pyrrolidone) (PVP); biomaterial; graft copolymer; dextran;
   degradation
ID EXPANDERS; OLIGOMERS; NMR
AB This work is devoted to the design of a novel family of hydrosoluble biomaterials: poly(N-vinyl-2-pyrrolidone) (PVP)-based graft copolymers. A synthesis route has been elaborated in which omega-functionalized PVP is prepared via chain-transfer radical polymerization, end-group modified, and subsequently grafted onto a polyhydroxylated backbone, typically dextran or poly(vinyl alcohol). The resulting graft copolymer biomaterials are designed for use in various biomedical applications, particularly as materials with a stronger potential for plasma expansion than already existing products have. The graft copolymers are potentially degradable because the PVP grafts are connected to the polyol backbone via a hydrolytically labile carbonate or ester linkage. The degradation of the graft copolymers was performed in vitro over a period of 6 weeks. (C) 2002 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 40: 3652-3661, 2002.
C1 Royal Inst Technol, Dept Polymer Technol, S-10044 Stockholm, Sweden.
RP Albertsson, AC (reprint author), Royal Inst Technol, Dept Polymer Technol, S-10044 Stockholm, Sweden.
RI Albertsson, Ann-Christine/Q-6107-2016
OI Albertsson, Ann-Christine/0000-0001-8696-9143; Brunius,
   Carl/0000-0003-3957-870X; /0000-0002-1631-1781
CR BARABAS E, 1989, ENCY POLYM SCI ENG, V17, P198
   BARON JF, 1998, VOLUME REPLACEMENT
   Boldt J, 2000, INTENS CARE MED, V26, P1181, DOI 10.1007/s001340000625
   Brunius CF, 2001, MACROMOL RAPID COMM, V22, P1474, DOI 10.1002/1521-3927(20011201)22:18<1474::AID-MARC1474>3.0.CO;2-7
   Dutta K, 1999, J POLYM SCI POL CHEM, V37, P3922, DOI 10.1002/(SICI)1099-0518(19991101)37:21<3922::AID-POLA7>3.0.CO;2-J
   KAMINSKI MV, 1992, CRIT CARE CLIN, V8, P311
   Kanekiyo M, 1998, J MOL STRUCT, V447, P49, DOI 10.1016/S0022-2860(98)00300-7
   KLOTZ U, 1987, CLIN PHARMACOKINET, V12, P123, DOI 10.2165/00003088-198712020-00003
   Marten F. L., 1985, ENCY POLYM SCI TECHN, V17, P167
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   Molyneux P., 1984, WATER SOLUBLE SYNTHE, VII
   RANUCCI E, 1995, MACROMOL CHEM PHYS, V196, P763, DOI 10.1002/macp.1995.021960307
   Ranucci E, 2000, MACROMOL CHEM PHYSIC, V201, P1219, DOI 10.1002/1521-3935(20000801)201:12<1219::AID-MACP1219>3.0.CO;2-G
   RANUCCI E, 1996, POLYM MAT ENCY, V3, P2053
   Roberts JS, 1998, DRUGS, V55, P621, DOI 10.2165/00003495-199855050-00002
   Robyt J. F, 1986, ENCY POLYM SCI ENG, P752
   Treib J, 1999, INTENS CARE MED, V25, P258, DOI 10.1007/s001340050833
   Warren BB, 1997, ANESTH ANALG, V84, P206, DOI 10.1097/00000539-199701000-00037
NR 18
TC 26
Z9 26
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD NOV 1
PY 2002
VL 40
IS 21
BP 3652
EP 3661
DI 10.1002/pola.10468
PG 10
WC Polymer Science
SC Polymer Science
GA 603EQ
UT WOS:000178546200011
DA 2018-10-19
ER

PT J
AU Iurlaro, M
   Sanders, JE
   Zhu, WH
   Scatena, M
   Mitchell, SB
   Nicosia, RF
AF Iurlaro, M
   Sanders, JE
   Zhu, WH
   Scatena, M
   Mitchell, SB
   Nicosia, RF
TI Use of vascular explants for ex vivo neovascularization of biomaterials
SO MICROVASCULAR RESEARCH
LA English
DT Article
ID RAT AORTA; GROWTH-FACTOR; IN-VITRO; ANGIOGENESIS; CELLS; COLLAGEN;
   INVITRO; TISSUE; MATRIX; SERUM
AB Biomaterial polymers have been proposed as scaffolds for cell assembly in vascular bioengineering. We describe here a new method for the neovascularization of polyurethane meshes from explants of rat aorta. Aortic rings embedded in collagen-permeated polyurethane meshes and cultured in medium supplemented with fetal bovine serum and vascular endothelial growth factor generated florid microvascular outgrowths that efficiently vascularized the available spaces between polyurethane fibers. The neovessels could be identified in the live cultures by phase-contrast microscopy, and in formalin-fixed preparations by the ABC peroxidase procedure, using the endothelial-specific Grifforlia isolectin B4. The aortic outgrowths were successfully labeled with the intravital fluorescent dyes Calcein AM or SPDiOC(18), which are notoxic and can be used for tracking studies. This study shows that artificial biomaterial meshes can be colonized ex vivo with histotypic microvascular networks, and provides the proof of concept for the future development of stably vascularized devices for in vivo implantation. (C) 2002 Elsevier Science (USA).
C1 Vet Adm Puget Sound Hlth Care Syst, Div Pathol & Lab Med, Seattle, WA 98108 USA.
   Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   Univ Bari, Dept Biomed Sci & Human Oncol, Bari, Italy.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Nicosia, RF (reprint author), Vet Adm Puget Sound Hlth Care Syst, Div Pathol & Lab Med, S-113-Lab,1660 S Columbian Way, Seattle, WA 98108 USA.
FU NICHD NIH HHS [R01 HD038554-01, R01 HD038554]; NHLBI NIH HHS [HL 52585]
CR Alessandri G, 2001, LAB INVEST, V81, P875, DOI 10.1038/labinvest.3780296
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Black AF, 1998, FASEB J, V12, P1331
   CHEN L, 1992, J BIOL CHEM, V267, P12380
   Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Gerritsen M, 1998, J INVEST SURG, V11, P163, DOI 10.3109/08941939809098031
   JOHNSON TE, 1992, J CELL PHYSIOL, V150, P17, DOI 10.1002/jcp.1041500104
   KIDD KR, 2001, J BIOMED MATER RES, V59, P366
   Mangiarua E. I., 2001, Archives of Physiology and Biochemistry, V109, P404, DOI 10.1076/apab.109.5.404.11827
   Marquez-Curtis LA, 2001, BRIT J HAEMATOL, V115, P595, DOI 10.1046/j.1365-2141.2001.03160.x
   NICOSIA RF, 1990, LAB INVEST, V63, P115
   Nicosia RF, 1997, AM J PATHOL, V151, P1379
   NICOSIA RF, 1995, LAB INVEST, V73, P658
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65
   VILLASCHI S, 1993, AM J PATHOL, V143, P181
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
NR 18
TC 6
Z9 7
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0026-2862
J9 MICROVASC RES
JI Microvasc. Res.
PD NOV
PY 2002
VL 64
IS 3
BP 398
EP 404
DI 10.1006/mvre.2002.2448
PG 7
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 618FZ
UT WOS:000179409200005
PM 12453434
DA 2018-10-19
ER

PT J
AU Rychly, J
   Diener, A
   Luthen, F
   Neumann, H
   Becker, P
   Beck, U
   Nebe, B
AF Rychly, J
   Diener, A
   Luthen, F
   Neumann, H
   Becker, P
   Beck, U
   Nebe, B
TI The dynamic behaviour of cellular adhesions is controlled by the
   topography of biomaterial surfaces
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the American-Society-for-Cell-Biology
CY DEC 14-18, 2002
CL SAN FRANCISCO, CALIFORNIA
SP Amer Soc Cell Biol
C1 Univ Rostock, D-2500 Rostock 1, Germany.
   DOT GmbH, Rostock, Germany.
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2002
VL 13
MA 350
BP 62A
EP 63A
PG 2
WC Cell Biology
SC Cell Biology
GA 621BR
UT WOS:000179569100350
DA 2018-10-19
ER

PT J
AU Grigolo, B
   Roseti, L
   Neri, S
   Gobbi, P
   Jensen, P
   Major, EO
   Facchini, A
AF Grigolo, B
   Roseti, L
   Neri, S
   Gobbi, P
   Jensen, P
   Major, EO
   Facchini, A
TI Human articular chondrocytes immortalized by HPV-16 E6 and E7 genes:
   Maintenance of differentiated phenotype under defined culture conditions
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE human chondrocytes; immortalization; HPV-16 E6-E7; collagen II
ID HUMAN-PAPILLOMAVIRUS TYPE-16; EXPRESSION; CELL; CARTILAGE;
   KERATINOCYTES; COLLAGEN; INVITRO; TRANSFORMATION; FIBROBLASTS;
   PROLIFERATION
AB Objective: To establish an immortalized normal human articular chondrocyte line which could be useful for a better understanding of cell molecular mechanisms relevant for the development of new therapeutic approaches in rheumatic diseases.
   Design: Chondrocytes from human adult articular healthy cartilage were transfected in primary culture with a plasmid containing two human papilloma virus type 16 (HPV-16) early function genes: E6 and E7, using the highly efficient cationic liposome-mediated (lipofection) procedure. The transfection was verified by reverse transcriptase-polymerase chain reaction analysis of E7 mRNA and by immunofluorence localization of the E7 protein in the cell cytoplasm. The established chondrocyte cell line was examined in monolayer and in two culture conditions that were described to re-induce differentiated characteristics: culturing in a serum-free defined medium supplemented with an insulin-containing serum substitute and seeding on a hyaluronan-based non-woven structured biomaterial. The expression of markers characteristic of cartilage was shown in the mRNA by reverse transcriptase-polymerase chain reaction. Immunohistological staining and Western blotting analysis were performed to evaluate type II collagen synthesis. Proteoglycans deposition was detected by Alcian Blue staining. A Field Emission In Lens Scanning Microscopy was used to look at the morphology of the immortalized cells at very high magnification.
   Results: Normal human articular chondrocytes were efficiently transfected leading to the establishment of an immortalized cell line as confirmed by HPV-16 E7 mRNA and protein detection. These cells were able to re-express type II collagen both at mRNA and protein levels under the two defined cultured conditions we used, still maintaining type I collagen expression. Collagen IX mRNA was present only in early primary culture while collagen type X and aggrecan transcripts were always detected. Alcian Blue staining showed a proteoglycan-rich matrix production. The ultrastructural analysis of the immortalized cells revealed that their morphology strictly resembled that of normal chondrocytes.
   Conclusions:The cell line that we obtained may be a useful tool for increasing our knowledge of the genetic and biochemical events involved in the processes of cartilage growth and differentiation. Moreover, it appears to be a suitable model for pharmacological and toxicological studies related to rheumatic diseases relevant to humans. (C) 2002 OsteoArthritis Research Society. Published by Elsevier Science Ltd. All rights reserved.
C1 IOR, Lab Immunol & Genet, Ist Ricerca Codivilla Putti, I-40136 Bologna, Italy.
   Univ Bologna, Dipartimento Sci Anat Umane & Fisiopatol Apparto, I-40126 Bologna, Italy.
   NIH, NINDS, Lab Mol Med & Neurosci, Bethesda, MD USA.
   Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40139 Bologna, Italy.
RP Facchini, A (reprint author), IOR, Lab Immunol & Genet, Ist Ricerca Codivilla Putti, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM labimge@alma.unibo.it
RI Grigolo, Brunella/J-5417-2016; Gobbi, Pietro/J-2566-2012
OI Grigolo, Brunella/0000-0002-3990-6745; Gobbi, Pietro/0000-0003-4705-0833
CR ADOLPHE M, 1984, EXP CELL RES, V155, P527, DOI 10.1016/0014-4827(84)90212-X
   ARCHER CW, 1990, J CELL SCI, V97, P361
   AULTHOUSE AL, 1989, IN VITRO CELL DEV B, V25, P659
   BENOIT B, 1995, IN VITRO CELL DEV-AN, V31, P174
   BENYA PD, 1982, CELL, V30, P373
   Biswas C, 1997, J CLIN MICROBIOL, V35, P1560
   BOHME K, 1992, J CELL BIOL, V116, P1035, DOI 10.1083/jcb.116.4.1035
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   BUCKWALTER JA, 1990, BRIS MYER Z, P19
   CAPASSO O, 1982, EXP CELL RES, V142, P197, DOI 10.1016/0014-4827(82)90423-2
   DURST M, 1987, ONCOGENE, V1, P251
   EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595
   Goomer RS, 2001, OSTEOARTHR CARTILAGE, V9, P248, DOI 10.1053/joca.2000.0382
   GREEN WT, 1971, CLIN ORTHOP RELAT R, P248
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Harms W, 2001, EXP CELL RES, V268, P252, DOI 10.1006/excr.2001.5274
   HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x
   HERING TM, 1994, ARCH BIOCHEM BIOPHYS, V314, P90, DOI 10.1006/abbi.1994.1415
   HORTON WE, 1988, EXP CELL RES, V178, P457, DOI 10.1016/0014-4827(88)90414-4
   Ke LD, 1999, ORAL ONCOL, V35, P415, DOI 10.1016/S1368-8375(99)00015-9
   KOLETTAS E, 1995, J CELL SCI, V108, P1991
   KUETTNER KE, 1998, RHEUMATOLOGY
   Loeuillet C, 2001, CELL GROWTH DIFFER, V12, P233
   MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289
   MUNGER K, 1989, J VIROL, V63, P4417
   Narayanan BA, 1998, LIFE SCI, V63, P565, DOI 10.1016/S0024-3205(98)00307-5
   Oyajobi BO, 1998, J BONE MINER RES, V13, P432, DOI 10.1359/jbmr.1998.13.3.432
   PEREZREYES N, 1992, P NATL ACAD SCI USA, V89, P1224, DOI 10.1073/pnas.89.4.1224
   PIRISI L, 1987, J VIROL, V61, P1061
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   RAMDI H, 1993, EXP CELL RES, V207, P449, DOI 10.1006/excr.1993.1214
   Robbins JR, 2000, ARTHRITIS RHEUM, V43, P2189, DOI 10.1002/1529-0131(200010)43:10<2189::AID-ANR6>3.0.CO;2-S
   Rucklidge GJ, 1996, BIOCHEM BIOPH RES CO, V224, P297, DOI 10.1006/bbrc.1996.1024
   Saldanha V, 2000, BIOMATERIALS, V21, P2427, DOI 10.1016/S0142-9612(00)00110-1
   Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148
   Schreiber RE, 1999, ANN NY ACAD SCI, V875, P398, DOI 10.1111/j.1749-6632.1999.tb08522.x
   SCHWARTZ R, 1979, SKELETAL RES EXPT AP, P61
   Steimberg N, 1999, EXP CELL RES, V249, P248, DOI 10.1006/excr.1999.4478
   SWEET MBE, 1987, S AFR J SCI, V83, P153
   TAUB M, 1990, TOXICOL IN VITRO, V4, P213, DOI 10.1016/0887-2333(90)90025-O
   VIALLET J, 1994, EXP CELL RES, V212, P36, DOI 10.1006/excr.1994.1115
   WATANABE S, 1989, J VIROL, V63, P965
   WATT FM, 1988, J CELL SCI, V89, P373
NR 45
TC 33
Z9 35
U1 0
U2 2
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD NOV
PY 2002
VL 10
IS 11
BP 879
EP 889
DI 10.1053/joca.2002.0836
PG 11
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 620QH
UT WOS:000179543700009
PM 12435333
OA Bronze
DA 2018-10-19
ER

PT J
AU Hariadi, R
   Langford, SC
   Dickinson, JT
AF Hariadi, R
   Langford, SC
   Dickinson, JT
TI Controlling nanometer-scale crystal growth on a model biomaterial with a
   scanning force microscope
SO LANGMUIR
LA English
DT Article
ID AQUEOUS-SOLUTION; ATOMIC-SCALE; BRUSHITE; HYDROXYAPATITE; SURFACES;
   CALCITE; WEAR
AB We investigate the consequences of exposing an inorganic single-crystal surface to mechanical stimulation with an atomic force microscope tip in the presence of a supersaturated solution. We show that on the {010} cleavage surfaces of brushite (CaHPO(4).2H(2)O) layer-by-layer growth at step edges can be induced and controlled with the tip. The growth rates are highly sensitive to the crystallographic orientation of the steps. Experimental evidence is presented that supports a mechanism involving tip-enhanced mass transport of ions to nucleation sites.
C1 Washington State Univ, Dept Phys, Pullman, WA 99164 USA.
RP Dickinson, JT (reprint author), Washington State Univ, Dept Phys, Pullman, WA 99164 USA.
EM jtd@wsu.edu
CR Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   CHERNOV AA, 1984, MODERN CRYSTALLOGR 3, V36
   CURRY NA, 1971, J CHEM SOC A, P3725, DOI 10.1039/j19710003725
   Drever J.I, 1997, GEOCHEMISTRY NATURAL
   DREXLER KE, 1992, NANOSYSTEMS MOL MACH
   EHRLICH G, 1966, J CHEM PHYS, V44, P1039, DOI 10.1063/1.1726787
   Hariadi R., UNPUB
   HILLNER PE, 1992, ULTRAMICROSCOPY, V42, P1387, DOI 10.1016/0304-3991(92)90454-R
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   LeGeros R. Z., 1972, Journal of Crystal Growth, V13-14, P476, DOI 10.1016/0022-0248(72)90284-9
   Liang Y, 1996, SURF SCI, V351, P172, DOI 10.1016/0039-6028(95)01298-2
   Meyer E, 1997, NATO ADV SCI I E-APP, V330, P193
   OHNESORGE F, 1993, SCIENCE, V260, P1451, DOI 10.1126/science.260.5113.1451
   OHTA M, 1979, J CRYST GROWTH, V47, P135, DOI 10.1016/0022-0248(79)90171-4
   Park NS, 1996, J APPL PHYS, V80, P2680, DOI 10.1063/1.363185
   RUAN JA, 1994, J APPL PHYS, V76, P5022, DOI 10.1063/1.357214
   SATIO Y, 1998, STAT PHYSICS CRYSTAL
   SCHWOEBEL RL, 1966, J APPL PHYS, V37, P3682, DOI 10.1063/1.1707904
   Scudiero L, 1999, TRIBOL LETT, V6, P41, DOI 10.1023/A:1019134901387
   SIPERKO LM, 1992, APPL PHYS LETT, V61, P2610, DOI 10.1063/1.108146
   Toroczkai Z, 1999, PHYS TODAY, V52, P24, DOI 10.1063/1.882897
   Walters DA, 1996, REV SCI INSTRUM, V67, P3583, DOI 10.1063/1.1147177
   Wyckoff R. W. G., 1965, CRYSTAL STRUCTURES, VIII
NR 23
TC 8
Z9 8
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 15
PY 2002
VL 18
IS 21
BP 7773
EP 7776
DI 10.1021/la025984f
PG 4
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 603YW
UT WOS:000178589700004
DA 2018-10-19
ER

PT J
AU Lin, S
   Drake, LR
   Rayson, GD
AF Lin, S
   Drake, LR
   Rayson, GD
TI Affinity distributions of lead ion binding to an immobilized biomaterial
   derived from cultured cells of Datura innoxia
SO ADVANCES IN ENVIRONMENTAL RESEARCH
LA English
DT Article
DE metal ion binding; binding affinities; biomaterials; Datura innoxia;
   frontal affinity chromatography
ID METAL HUMATE INTERACTIONS; HUMIC SUBSTANCES; PROTON BINDING; EU(III)
   LUMINESCENCE; COMPETITIVE-BINDING; PROBE SPECTROSCOPY; ADSORPTION
   MODELS; CATION BINDING; FULVIC-ACID; SITES
AB Datura innoxia biomass has been targeted as a potential sorbent for heavy metal remediation. Of interest in our laboratory are the binding mechanisms responsible for metal uptake. In this study, the binding behavior of Pb(II) to immobilized Datura innoxia biomaterial was investigated under different chemical conditions, such as ionic strength, the presence of calcium, and pH. Regularized regression analysis was employed to derive the corresponding affinity distributions. Two classes of binding sites were determined, having mean affinity of approximately 200 and 10(5) M-1, depending on solution conditions. Variations in apparent affinity distributions with ionic strength and pH suggest the low-affinity sites involve sulfonates and carboxylates in an ion exchange process. The high-affinity sites are proposed to result from the coordination of carboxylates to Pb2+ ions. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA.
RP Rayson, GD (reprint author), New Mexico State Univ, Dept Chem & Biochem, Box 30001,MSC 3C, Las Cruces, NM 88003 USA.
CR BARTSCHAT BM, 1992, ENVIRON SCI TECHNOL, V26, P284, DOI 10.1021/es00026a007
   BENEDETTI MF, 1995, ENVIRON SCI TECHNOL, V29, P446, DOI 10.1021/es00002a022
   BUFFLE J, 1990, GEOCHIM COSMOCHIM AC, V54, P1535, DOI 10.1016/0016-7037(90)90389-3
   CERNIK M, 1995, ENVIRON SCI TECHNOL, V29, P413, DOI 10.1021/es00002a018
   CRIST RH, 1994, ENVIRON SCI TECHNOL, V28, P1859, DOI 10.1021/es00060a016
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   DARNALL DW, 1986, ENVIRON SCI TECHNOL, V20, P206, DOI 10.1021/es00144a018
   Davis A, 1997, ENVIRON SCI TECHNOL, V31, P37, DOI 10.1021/es950960z
   DEWIT JCM, 1993, ENVIRON SCI TECHNOL, V27, P2005, DOI 10.1021/es00047a004
   DEWIT JCM, 1993, ENVIRON SCI TECHNOL, V27, P2015, DOI 10.1021/es00047a005
   DOBBS JC, 1989, ANAL CHEM, V61, P1519, DOI 10.1021/ac00189a012
   Drake LR, 1996, ENVIRON SCI TECHNOL, V30, P110, DOI 10.1021/es950131d
   Drake LR, 1996, ANAL CHEM, V68, pA22, DOI 10.1021/ac9618029
   Drake LR, 1997, APPL SPECTROSC, V51, P1476, DOI 10.1366/0003702971939253
   DZOMBAK DA, 1986, ENVIRON SCI TECHNOL, V20, P669, DOI 10.1021/es00149a004
   EPHRAIM J, 1986, ENVIRON SCI TECHNOL, V20, P367, DOI 10.1021/es00146a008
   FERGUSON J, 1974, CHEM GEOL, V13, P163, DOI 10.1016/0009-2541(74)90018-7
   FISH W, 1986, ENVIRON SCI TECHNOL, V20, P676, DOI 10.1021/es00149a005
   GALUN M, 1984, WATER AIR SOIL POLL, V21, P411, DOI 10.1007/BF00163640
   GREENBERG SB, 1986, CLIN NUCL MED, V11, P627, DOI 10.1097/00003072-198609000-00006
   HOUSE WA, 1978, J COLLOID INTERF SCI, V67, P166, DOI 10.1016/0021-9797(78)90223-0
   Huang JWW, 1997, ENVIRON SCI TECHNOL, V31, P800, DOI 10.1021/es9604828
   KE HY, 1992, APPL SPECTROSC, V47, P44
   KE HYD, 1992, APPL SPECTROSC, V46, P1168, DOI 10.1366/0003702924124178
   KE HYD, 1992, APPL SPECTROSC, V46, P1376, DOI 10.1366/0003702924123782
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P782, DOI 10.1021/es00028a018
   KE HYD, 1992, APPL SPECTROSC, V46, P479, DOI 10.1366/0003702924125258
   KE HYD, 1994, ENVIRON SCI TECHNOL, V28, P586, DOI 10.1021/es00053a009
   KE HYD, 1992, ENVIRON SCI TECHNOL, V26, P1202, DOI 10.1021/es50002a609
   KOOPAL LK, 1994, J COLLOID INTERF SCI, V166, P51, DOI 10.1006/jcis.1994.1270
   LEENHEER JA, 1995, ENVIRON SCI TECHNOL, V29, P393, DOI 10.1021/es00002a015
   Lin S, 1996, ANAL CHEM, V68, P4087, DOI 10.1021/ac960569b
   MILNE CJ, 1995, GEOCHIM COSMOCHIM AC, V59, P1101, DOI 10.1016/0016-7037(95)00027-W
   MONCRIEF RM, 1995, SEPAR SCI TECHNOL, V30, P2421, DOI 10.1080/01496399508013120
   NAKAJIMA A, 1990, BIOMASS, V21, P55, DOI 10.1016/0144-4565(90)90047-N
   NEDERLOF MM, 1993, ENVIRON SCI TECHNOL, V27, P846, DOI 10.1021/es00042a006
   NEDERLOF MM, 1990, J COLLOID INTERF SCI, V135, P410, DOI 10.1016/0021-9797(90)90011-C
   NEDERLOF MM, 1992, ENVIRON SCI TECHNOL, V26, P763, DOI 10.1021/es00028a015
   Plette ACC, 1996, ENVIRON SCI TECHNOL, V30, P1902, DOI 10.1021/es950568l
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   STARK PC, 1994, BIOSORPTION INORGANI
   TIPPING E, 1992, GEOCHIM COSMOCHIM AC, V56, P3627, DOI 10.1016/0016-7037(92)90158-F
   TIPPING E, 1993, ENVIRON SCI TECHNOL, V27, P520, DOI 10.1021/es00040a011
   VOS CHW, 1985, J COLLOID INTERF SCI, V105, P183, DOI 10.1016/0021-9797(85)90360-1
   WANG HK, 1984, ENVIRON SCI TECHNOL, V18, P106, DOI 10.1021/es00120a011
   Xia HY, 2000, ADV ENVIRON RES, V4, P69
NR 46
TC 6
Z9 7
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1093-0191
J9 ADV ENVIRON RES
JI Adv. Environ. Res.
PD OCT
PY 2002
VL 6
IS 4
BP 523
EP 532
AR PII S1093-0191(01)00078-8
DI 10.1016/S1093-0191(01)00078-8
PG 10
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA 601MZ
UT WOS:000178451500011
DA 2018-10-19
ER

PT J
AU Itoh, S
   Kikuchi, M
   Koyama, Y
   Takakuda, K
   Shinomiya, K
   Tanaka, J
AF Itoh, S
   Kikuchi, M
   Koyama, Y
   Takakuda, K
   Shinomiya, K
   Tanaka, J
TI Development of an artificial vertebral body using a novel biomaterial,
   hydroxyapatite/collagen composite
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite/collagen (HAp Col) composite; artificial vertebra system;
   anterior fusion of the cervical spine; recombinant human bone
   morphogenetic protein-2 (rhBMP-2); poly-L-lactide (PLLA) plate
ID ANTERIOR CERVICAL DISCECTOMY; INTERBODY FUSION; ILIAC BONE; DISKECTOMY;
   RHBMP-2; SPINE; MODEL
AB Hydroxyapatite:collagen (HAp/Col) composites having a bone-like nanostructure were synthesized and shaped into implants. This study was designed to develop,in artificial vertebra system using this novel implant for anterior fusion of the cervical spine. Anterior fusion was carried out on 6 beagle dogs with the implants adsorbing rhBMP-2 (400 mug/ml), and 9 dogs with the implants without rhBMP-2. In 3 dogs of the rhBMP-treated group. as well as 6 dogs of the non-rhBMP-treated group. the implant was fixed with a poly-L-lactide plate and 2 titanium screws. Implants were taken out after 13 weeks front each 3 dogs in the rhBMP(-):plate(-), rhBMP(-):plate(+) and rhBMP(-):plate(+) groups. Also, the implants were removed from each 3 dogs in the rhBMP(-):plate(+) and rhBMP(+):plate(+) groups after 24 weeks. Histological and radiographical analysis Suggested that since the larger part of the composite material was absorbed within 13 weeks. reduction of the intervertebral distance was caused, and that enhancement of callus formation and bone bridging by rhBMP-treatment, was effective to prevent collapse of the implant. even though an effect of anterior plate-fixation was not obvious. The HAp/Col implant adsorbing rhBMP-2 may be a suitable replacement for the existing ceramics in anterior interbody fusion of the cervical spine. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138519, Japan.
   NIMS, Ctr Biomat, Regenerat Mat Res Grp, Tsukuba, Ibaraki 3050044, Japan.
   Tokyo Med & Dent Univ, Dept Biomech Engn, Bunkyo Ku, Tokyo 1138519, Japan.
RP Itoh, S (reprint author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.
EM itoso.gene@cmn.tmd.ac.jp
RI Kikuchi, Masanori/B-5993-2008
OI Kikuchi, Masanori/0000-0002-9451-8147
CR CLOWARD RB, 1958, J NEUROSURG, V15, P602, DOI 10.3171/jns.1958.15.6.0602
   COOK SD, 1986, SPINE, V11, P305, DOI 10.1097/00007632-198605000-00002
   Hecht BP, 1999, SPINE, V24, P629, DOI 10.1097/00007632-199904010-00004
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   ITOH S, IN PRESS J BIOMED MA
   KELLER EE, 1987, J ORAL MAXIL SURG, V45, P11, DOI 10.1016/0278-2391(87)90079-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   LAURIE SWS, 1984, PLAST RECONSTR SURG, V73, P933, DOI 10.1097/00006534-198406000-00014
   LOWERY GL, 1992, CERV SPIN RES SOC AN
   LOWERY GL, 1995, N AM SPIN SOC ANN M
   McAfee PC, 1999, J BONE JOINT SURG AM, V81A, P859, DOI 10.2106/00004623-199906000-00014
   ROBINSON RA, 1962, J BONE JOINT SURG AM, V44, P1569, DOI 10.2106/00004623-196244080-00007
   SHIMA T, 1979, J NEUROSURG, V51, P533, DOI 10.3171/jns.1979.51.4.0533
   SHINOMIYA K, 2001, TISSUE ENG THERAP US, V5, P165
   Thalgott JS, 1999, SPINE, V24, P1295, DOI 10.1097/00007632-199907010-00005
   VILLANUEVA AR, 1974, STAIN TECHNOL, V49, P1, DOI 10.3109/10520297409116928
   ZDEBLICK TA, 1994, SPINE, V19, P2348, DOI 10.1097/00007632-199410150-00017
   ZDEBLICK TA, 1993, SPINE, V18, P1974, DOI 10.1097/00007632-199310001-00009
   ZDEBLICK TA, 1992, SPINE, V17, pS418, DOI 10.1097/00007632-199210001-00013
NR 19
TC 108
Z9 116
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2002
VL 23
IS 19
BP 3919
EP 3926
AR PII S0142-9612(02)00126-6
DI 10.1016/S0142-9612(02)00126-6
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 577ZV
UT WOS:000177093700001
PM 12162324
DA 2018-10-19
ER

PT J
AU Labow, RS
   Meek, E
   Matheson, LA
   Santerre, JP
AF Labow, RS
   Meek, E
   Matheson, LA
   Santerre, JP
TI Human macrophage-mediated biodegradation of polyurethanes: assessment of
   candidate enzyme activities
SO BIOMATERIALS
LA English
DT Article
DE biodegradation; cholesterol esterase; carboxylesterase; monocyte-derived
   macrophages; polyurethanes
ID MONOCYTE-DERIVED MACROPHAGES; CHOLESTEROL ESTERASE;
   POLYCARBONATE-POLYURETHANES; POLY(URETHANE)S; HYDROLYSIS; DEPENDENCE;
   POLYETHER; URETHANES; SYSTEMS
AB A predominant cell type associated with explanted failed devices is the monocyte-derived macrophage (MDM). However, there is still very little known about the specific cellular enzyme activities involved in interactions with these devices. The current study investigates the nature of candidate enzymes that may be involved in the degradation of polymeric biomaterials through the use of specific enzyme inhibitor agents. When MDM were incubated with a polycarbonate-based polyurethane (PCNU) synthesized with C-14-labeled hexane diisocyanate (HDI), polycarbonate diol and butanediol (BD) (referred to as C-14-HD1431). the radiolabel release (RR) measured was inhibited by phenylmethylsulfonyl fluoride, diethyl-p-nitrophenyl phosphate (serine protease/esterase inhibitors), and sodium fluoride (NaF) (a carboxyl esterase (CXE) inhibitor). Sodium taurocholate (NaT) (a cholesterol esterase (CE) stimulator) had little effect on RR. The two candidate enzymes proposed were CE and CXE, bused on the fact that both were identified by immunoblotting in the releasate of MDM following 48 It incubation with C-14-HD1431. The effect of the above reagents on the RR caused by purified CE and CXE, was measured and compared to changes in their activity with p-nitrophenylbutyrate (PNB). The effect of NaF on MDM was similar to that of purified CXE (inhibitory on both RR and lysate esterase activity), suggesting the involvement of CXE. However, NaT inhibited the PNB activity of purified CXE, but had no effect on MDM-mediated RR or PNB activity, implicating another esterase in the biomaterial degradation. Since NaT stimulated CE-mediated RR and PNB activity, it may also be involved in MDM-niecliated biodegradation of PCNUs. The results of these Studies point to both esterases as being candidates. However. the current methods were unable to determine the relative contribution of each one to the observed biodegradation. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Ottawa, Inst Heart, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
   Univ Ottawa, Inst Heart, Dept Surg, Ottawa, ON, Canada.
   Univ Toronto, Fac Dent, Toronto, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Inst Heart, Dept Biochem Microbiol & Immunol, 40 Ruskin St, Ottawa, ON, Canada.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Feaster SR, 1996, BIOCHEMISTRY-US, V35, P16723, DOI 10.1021/bi961677v
   GOLDBERG TL, 1995, HUM NATURE-INT BIOS, V6, P79, DOI 10.1007/BF02734137
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 1996, BIOMATERIALS, V17, P2381, DOI 10.1016/S0142-9612(96)00088-9
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   MATHESON LA, IN PRESS J BIOMED MA
   Moore ANJ, 1996, BIOTECHNOL TECH, V10, P523
   QUINN DM, 1985, BIOCHIM BIOPHYS ACTA, V834, P267, DOI 10.1016/0005-2760(85)90165-1
   SABOORI AM, 1990, J BIOL CHEM, V265, P19792
   Santerre JP, 1999, J DENT RES, V78, P1459, DOI 10.1177/00220345990780081201
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   VAHOUNY GV, 1964, BIOCHEM BIOPH RES CO, V15, P224, DOI 10.1016/0006-291X(64)90150-0
   WANG FGB, 1997, J BIOMED MATER RES, V35, P207
NR 21
TC 63
Z9 63
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2002
VL 23
IS 19
BP 3969
EP 3975
AR PII S0142-9612(02)00137-0
DI 10.1016/S0142-9612(02)00137-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 577ZV
UT WOS:000177093700006
PM 12162329
DA 2018-10-19
ER

PT J
AU Park, JH
   Cho, YW
   Kwon, IC
   Jeong, SY
   Bae, YH
AF Park, JH
   Cho, YW
   Kwon, IC
   Jeong, SY
   Bae, YH
TI Assessment of PEO/PTMO multiblock copolymer/segmented polyurethane
   blends as coating materials for urinary catheters: in vitro bacterial
   adhesion and encrustation behavior
SO BIOMATERIALS
LA English
DT Article
DE poly(ethylene oxide); multiblock copolymer; polyurethane; bacterial
   adhesion; encrustation; urinary catheter
ID URETERAL STENT BIOMATERIAL; PROTEUS-MIRABILIS BIOFILMS; URETHRAL
   CATHETERS; TRACT INFECTIONS; LATEX CATHETERS; BIOCOMPATIBILITY;
   HYDROGELS; MODEL; COPOLYMERS; MORTALITY
AB The effective long-term use of indwelling urinary catheters has often been hindered by catheter-associated infection and encrustation, In this study, the Suitability of poly(ethylene oxide) (PEO)-based multiblock copolymer/segmented Polyurethane (SPU) blends as coating materials for the commercial urinary catheters was assessed by measuring swellability, bacterial adhesion, and encrustation behavior. When exposed to PBS (pH 7.4), the blends absorbed a significant amount of water, which was proportional to the copolymer content. It was demonstrated from bacterial adhesion tests that compared to bare SPU. the blend surfaces could significantly reduce the adhesion of E. coli P. mirabilis, and S. epidermidis, the number of adherent bacteria correlated with the amount of copolymer additive, indicating that the swellability of the blends affected bacterial adhesion. Of the bacteria studied, the greatest effect of the copolymer additive was observed in S. epidermidis adhesion. in which there was an 85% decrease compared to bare SPU with a small amount of copolymer additive as low as 5% based on a dried blend. By using an artificial bladder model, allowing the catheter to be blocked by encrustation, it was revealed that the blend surfaces Could effectively resist encrustation. The duration of patency as extended up to 20 +/- 3.1 h on the blend Surface containing 10% of the copolymer additive, whereas the silicone-coated catheter, a control, required the least time for blockage, 7.8 +/- 3.1 h. The superior characteristics of the blends compared to other surfaces might be attributed to their PEO-rich Surfaces. produced by the migration of PEO phase in the copolymer chain of the blends in an aqueous environment. and provide promising potential as a coating material on the urinary catheter for long-term catheterization. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, Kwangju 500712, South Korea.
   Korea Inst Sci & Technol, Biomed Res Ctr, Seoul 136791, South Korea.
RP Bae, YH (reprint author), Kwangju Inst Sci & Technol, Dept Mat Sci & Engn, Ctr Biomat & Biotechnol, 1 Oryong Dong,Puk Gu, Kwangju 500712, South Korea.
RI byun, jaehyun/G-5584-2014; Park, Jae Hyung/B-5967-2018
OI jeong, seo young/0000-0002-3035-0867
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bae YH, 2000, J CONTROL RELEASE, V64, P3, DOI 10.1016/S0168-3659(99)00126-1
   BRONSEMA DA, 1993, J UROLOGY, V150, P414, DOI 10.1016/S0022-5347(17)35497-6
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   COOK AD, 1993, J BIOMED MATER RES, V27, P119, DOI 10.1002/jbm.820270115
   CORMIO L, 1995, J UROLOGY, V153, P494, DOI 10.1097/00005392-199502000-00069
   COX AJ, 1990, BRIT J UROL, V65, P55, DOI 10.1111/j.1464-410X.1990.tb14662.x
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   COX AJ, 1989, J UROLOGY, V142, P1347, DOI 10.1016/S0022-5347(17)39095-X
   COX AJ, 1988, BRIT J UROL, V61, P156, DOI 10.1111/j.1464-410X.1988.tb05067.x
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Desgrandchamps F, 1997, BRIT J UROL, V79, P24, DOI 10.1046/j.1464-410X.1997.02775.x
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Gabriel MM, 1996, CURR MICROBIOL, V33, P1, DOI 10.1007/s002849900064
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   HAWTHORN L, 1990, J BIOMED MATER RES, V24, P1325, DOI 10.1002/jbm.820241005
   HEDELIN H, 1984, BRIT J UROL, V56, P250, DOI 10.1111/j.1464-410X.1984.tb05382.x
   Iza M, 1998, J CONTROL RELEASE, V52, P41, DOI 10.1016/S0168-3659(97)00191-0
   Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P552
   KANEKO Y, 1995, MACROMOLECULES, V28, P7717, DOI 10.1021/ma00127a018
   Karadag E, 1996, BIOMATERIALS, V17, P67, DOI 10.1016/0142-9612(96)80757-5
   Kost J, 1986, HYDROGELS MED PHARM, V3, P95
   MAKI DG, 1981, AM J MED, V70, P719, DOI 10.1016/0002-9343(81)90603-3
   Morris NS, 1998, J HOSP INFECT, V39, P227, DOI 10.1016/S0195-6701(98)90262-6
   NACEY JN, 1991, BRIT J UROL, V67, P314, DOI 10.1111/j.1464-410X.1991.tb15143.x
   NICKEL JC, 1987, UROLOGY, V29, P501, DOI 10.1016/0090-4295(87)90037-9
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Park JH, 2002, BIOMATERIALS, V23, P1797, DOI 10.1016/S0142-9612(01)00306-4
   PARK JH, IN PRESS J BIOMATER
   PLATT R, 1982, NEW ENGL J MED, V307, P637, DOI 10.1056/NEJM198209093071101
   Rahman MM, 1999, J BIOL CHEM, V274, P22993, DOI 10.1074/jbc.274.33.22993
   ROBERTS JA, 1990, J UROLOGY, V144, P264, DOI 10.1016/S0022-5347(17)39428-4
   SARANGAPANI S, 1995, J BIOMED MATER RES, V29, P1185, DOI 10.1002/jbm.820291005
   Stamm WE, 1991, AM J MED S3B, V91, P65
   Stickler D, 1999, EUR J CLIN MICROBIOL, V18, P206, DOI 10.1007/s100960050260
   Stickler D, 1998, EUR J CLIN MICROBIOL, V17, P649, DOI 10.1007/BF01708349
   STICKLER D, 1993, UROL RES, V21, P407, DOI 10.1007/BF00300077
   Stickler DJ, 1996, BRIT J UROL, V78, P579, DOI 10.1046/j.1464-410X.1996.16915.x
   TALJA M, 1990, BRIT J UROL, V66, P652, DOI 10.1111/j.1464-410X.1990.tb07203.x
   Tambyah PA, 1999, MAYO CLIN PROC, V74, P131, DOI 10.4065/74.2.131
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639
NR 44
TC 36
Z9 37
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2002
VL 23
IS 19
BP 3991
EP 4000
AR PII S0142-9612(02)00144-8
DI 10.1016/S0142-9612(02)00144-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 577ZV
UT WOS:000177093700009
PM 12162332
DA 2018-10-19
ER

PT J
AU Davis, DH
   Giannoulis, CS
   Johnson, RW
   Desai, TA
AF Davis, DH
   Giannoulis, CS
   Johnson, RW
   Desai, TA
TI Immobilization of RGD to < 111 > silicon surfaces for enhanced cell
   adhesion and proliferation
SO BIOMATERIALS
LA English
DT Article
DE RGD peptide; surface rnodification; silicon; cell adhesion; cell
   proliferation; biocompatibility
ID AFFINITY LIGANDS; ATTACHMENT; PEPTIDE; PROTEINS
AB The ability of biomaterial surfaces to regulate cell behavior requires control over surface chemistry and microstructure. One of the greatest challenges with silicon-based biomedical microdevices such as those recently developed for neural stimulation, implantable encapsulation, biosensors. and drug delivery, is to improve biocompatibility and tissue integration. This may be achieved by modifying the exposed silicon surface with bioactive peptides. In this study. Arg-Gly Asp (RGD) peptide conjugated surfaces were prepared and characterized, The effect of these Surfaces on fibroblast adhesion and proliferation was examined over 4 days. Silicon surfaces coupled with a synthetic RGD peptide, as characterized with X-ray photoelectron spectroscopy and atomic force microscopy, display enhanced cell proliferation and bioactivity. Results demonstrate an almost three-fold greater cell attachment/proliferation on RGD immobilized surfaces compared to unmodified (control) silicon surfaces. Modulating the biological response of inorganic materials such as silicon will allow Lis to design more appropriate interfaces for implantable diagnostic and therapeutic silicon-based microdevices. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Abbott Labs, Abbott Pk, IL 60064 USA.
   Univ Illinois, Coll Engn, Dept Bioengn MC 063, Chicago, IL 60607 USA.
RP Desai, TA (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
RI Zhou, Feng/E-9510-2011
CR Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   CUATRECASAS P, 1971, ANNU REV BIOCHEM, V40, P259, DOI 10.1146/annurev.bi.40.070171.001355
   Desai TA, 2000, BIOMOL ENG, V17, P23, DOI 10.1016/S1389-0344(00)00063-0
   FALB RD, 1971, FED PROC, V30, P1688
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HOFFMAN A S, 1992, Clinical Materials, V11, P61, DOI 10.1016/0267-6605(92)90030-W
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   LEE T, 1994, PSYCHOL CRIME LAW, V1, P11, DOI 10.1080/10683169408411932
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   MANDENIUS CF, 1984, ANAL BIOCHEM, V137, P106, DOI 10.1016/0003-2697(84)90354-3
   MAOZ R, 1988, J CHIM PHYS PCB, V85, P1059, DOI 10.1051/jcp/1988851059
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   NILSSON K, 1981, BIOCHEM BIOPH RES CO, V102, P449, DOI 10.1016/0006-291X(81)91541-2
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RASMUSSEN JR, 1977, J AM CHEM SOC, V99, P4736, DOI 10.1021/ja00456a035
   Ratner BD, 1997, SURFACE MODIFICATION OF POLYMERIC BIOMATERIALS, P1
   Ratner BD, 1996, BIOMATERIALS SCI INT, P105
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   WEIGEL PH, 1979, J BIOL CHEM, V254, P830
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 23
TC 80
Z9 87
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2002
VL 23
IS 19
BP 4019
EP 4027
AR PII S0142-9612(02)00152-7
DI 10.1016/S0142-9612(02)00152-7
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 577ZV
UT WOS:000177093700012
PM 12162335
DA 2018-10-19
ER

PT J
AU Deng, Y
   Zhao, K
   Zhang, XF
   Hu, P
   Chen, GQ
AF Deng, Y
   Zhao, K
   Zhang, XF
   Hu, P
   Chen, GQ
TI Study on the three-dimensional proliferation of rabbit articular
   cartilage-derived chondrocytes on polyhydroxyalkanoate scaffolds
SO BIOMATERIALS
LA English
DT Article
DE polyhydroxyalkanoates; PHB; biomaterial; tissue engineering;
   chondrocytes
ID BIODEGRADABLE POLYMER BLENDS; TISSUE REGENERATION; BIOREACTOR SYSTEM;
   ACID; POLY(3-HYDROXYBUTYRATE); BIOMATERIALS; IMPLANTS; SURGERY; PATCH;
   BIOCOMPATIBILITY
AB Polymer scaffold systems consisting of poly(hydroxybutyrate-co-hydroxyhexanoate) (PHBHHx)/polyhydroxybutyrate (PHB) (PHBHHx/PHB) were investigated for possible application as a matrix for the three-dimensional growth of chondrocyte culture. Blend polymers of PHBHHx/PHB were fabricated into three-dimensional porous scaffolds by the salt-leaching method. Chondrocytes isolated from rabbit articular cartilage (RAC) were seeded on the scaffolds and incubated over 28 days, with change of the culture medium every 4 days. PHB scaffold was taken as a control. Methylthiazol tetrazolium (MTT) (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltertra-zolium bromide) assay was used to quantitatively examine the proliferation of chondrocytes. Results showed that chondrocytes proliferated better on the PHBHHx/PHB scaffolds than on PHB one. The maximal cell densities were all observed after 7 days of incubation. As for the blend polymers, cells grew better on scaffolds consisting of PHBHHx/PHB in ratios of 2:1 and 1:2 than they did on PHBHHx/PHB of 1:1. Scanning electron microscopy (SEM) also showed that large quantities of chondrocytes grew initially on the surface of the scaffold. After 7 days, they further grew into the open pores of the blend polymer scaffolds. Morphologically, cells found on the surface of the scaffold exhibited a flat appearance and slowly form confluent cell multilayers starting from 14 to 28 days of the growth. In contrast, cells showed rounded morphology, formed aggregates and islets inside the scaffolds. In addition, chondrocytes proliferated on the scaffold and preserved their phenotype for up to 28 days. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Tsing Hua Univ, Dept Biol Sci & Biotechnol, Microbiol Lab, Beijing 100084, Peoples R China.
   Tsing Hua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.
RP Chen, GQ (reprint author), Tsing Hua Univ, Dept Biol Sci & Biotechnol, Microbiol Lab, Beijing 100084, Peoples R China.
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Akhtar S., 1990, THESIS U BATH
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Chu CR, 1997, CLIN ORTHOP RELAT R, P220
   deGroot JH, 1997, BIOMATERIALS, V18, P613, DOI 10.1016/S0142-9612(96)00169-X
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   DUNKELMAN NS, 1995, BIOTECHNOL BIOENG, V46, P299, DOI 10.1002/bit.260460402
   DUVERNOY O, 1995, THORAC CARDIOV SURG, V43, P271, DOI 10.1055/s-2007-1013226
   FINE EG, 1994, P 20 ANN M SOC BIOM, P279
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Kim S S, 1999, Semin Pediatr Surg, V8, P119
   Lauret M, 1996, ETHNIC RACIAL STUD, V19, P935
   Liang HJ, 1999, LIFE SCI, V65, P1163, DOI 10.1016/S0024-3205(99)00350-1
   MALM T, 1994, EUR SURG RES, V26, P298, DOI 10.1159/000129349
   Nebe B, 2001, BIOMATERIALS, V22, P2425, DOI 10.1016/S0142-9612(00)00430-0
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   NEHRER S, 1997, J BIOMED MATER RES, V38, P288
   Nkere UU, 1998, THORAC CARDIOV SURG, V46, P77, DOI 10.1055/s-2007-1010194
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Rivard CH, 1996, ANN CHIR, V50, P651
   ROBINSON D, 1990, CALCIFIED TISSUE INT, V46, P246, DOI 10.1007/BF02555003
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Scandola M, 1997, MACROMOLECULES, V30, P2568, DOI 10.1021/ma961431y
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   SOLURSH M, 1991, J CELL BIOCHEM, V45, P258, DOI 10.1002/jcb.240450306
   Springer ING, 2001, BIOMATERIALS, V22, P2569, DOI 10.1016/S0142-9612(01)00148-X
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   Zhang LL, 1997, J APPL POLYM SCI, V65, P1849, DOI 10.1002/(SICI)1097-4628(19970906)65:10<1849::AID-APP1>3.0.CO;2-F
   Zhang LL, 1997, POLYMER, V38, P6001, DOI 10.1016/S0032-3861(97)00158-4
   Zhang LL, 1997, POLYM INT, V44, P104
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 41
TC 156
Z9 168
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2002
VL 23
IS 20
BP 4049
EP 4056
AR PII S0142-9612(02)00136-9
DI 10.1016/S0142-9612(02)00136-9
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 580KK
UT WOS:000177233600002
PM 12182306
DA 2018-10-19
ER

PT J
AU Hollister, SJ
   Maddox, RD
   Taboas, JM
AF Hollister, SJ
   Maddox, RD
   Taboas, JM
TI Optimal design and fabrication of scaffolds to mimic tissue properties
   and satisfy biological constraints
SO BIOMATERIALS
LA English
DT Article
DE biomaterial scaffolds; optimal design; homogenization; tissue
   engineering; solid free-form fabrication
ID MECHANICAL-PROPERTIES; POLYMERS
AB Bone tissue engineering scaffolds must shape regenerating tissue, provide temporary mechanical support and enhance tissue regeneration. These requirements result in conflicting design goals. For example, increased temporary mechanical function requires a dense scaffold while enhanced cell/gene delivery requires a porous scaffold. This paper demonstrates an image-based homogenization optimization approach that can design scaffold microstructure, scaffold material and regenerate tissue microstructure to meet conflicting design requirements. In addition, constraints to ensure adequate cell/gene delivery can be introduced using a minimum porosity threshold. Homogenization theory was used to compute relationships between scaffold microstructure and effective stiffness. The functional relationships were used in the MATLAB optimization toolbox to compute optimal pore dimensions and scaffold material such that the scaffold and regenerate tissue effective stiffness matched that of native bone stiffness. The scaffold design was converted into STL format for solid free-form fabrication. Scaffolds were designed that matched mandibular condyle trabecular bone properties. Results showed excellent agreement between native bone properties and designed scaffold properties (all R-2 > 0.89). Finally, example scaffolds were built from hydroxyapatite using a SFF casting technique. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Biomed Engn, Rm 3314 GG Brown Bldg,2520 Hayward St, Ann Arbor, MI 48109 USA.
FU NIDCR NIH HHS [DE13608, DE13416]
CR BAJPAI PK, 1995, BIOMEDICAL ENG HDB, P552
   Bruder S. P., 1998, T 44 ANN M ORTH RES, P147
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GULDBERG RE, 1995, ADV BIOENG, V31, P157
   Hollister SJ, 2000, INT J ORAL MAX SURG, V29, P67, DOI 10.1034/j.1399-0020.2000.290115.x
   HOLLISTER SJ, 1994, BIOTECHNOL BIOENG, V43, P586, DOI 10.1002/bit.260430708
   Hollister SJ, 2001, BONE MECH HDB, V36, P1
   HORI RY, 1982, J BIOMED MATER RES, V16, P911, DOI 10.1002/jbm.820160615
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   SIGMUND O, 1994, INT J SOLIDS STRUCT, V31, P2313, DOI 10.1016/0020-7683(94)90154-6
   Teng S, 1996, J DENT RES, V75, P1842, DOI 10.1177/00220345960750110501
NR 15
TC 433
Z9 452
U1 3
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2002
VL 23
IS 20
BP 4095
EP 4103
AR PII S0142-9612(02)00148-5
DI 10.1016/S0142-9612(02)00148-5
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 580KK
UT WOS:000177233600007
PM 12182311
DA 2018-10-19
ER

PT J
AU Altman, GH
   Horan, RL
   Lu, HH
   Moreau, J
   Martin I
   Richmond, JC
   Kaplan, DL
AF Altman, GH
   Horan, RL
   Lu, HH
   Moreau, J
   Martin, I
   Richmond, JC
   Kaplan, DL
TI Silk matrix for tissue engineered anterior cruciate ligaments
SO BIOMATERIALS
LA English
DT Article
DE silk; fibroin; ligament; bone marrow stromal cells; stem cells; tissue
   engineering
ID PATELLAR TENDON AUTOGRAFT; PHYSICAL CROSS-LINKING; SUTURE MATERIALS;
   CURRENT TRENDS; LONG-TERM; RECONSTRUCTION; PROSTHESIS; FIBROIN;
   COMPOSITE; FIBERS
AB A silk-fiber matrix was studied as a suitable material for tissue engineering anterior cruciate ligaments (ACL). The matrix was successfully designed to match the complex and demanding mechanical requirements of a native human ACL, including adequate fatigue performance. This protein matrix supported the attachment, expansion and differentiation of adult human progenitor bone marrow stromal cells based on scanning electron microscopy, DNA quantitation and the expression of collagen types I and III and tenascin-C markers. The results support the conclusion that properly prepared silkworm fiber matrices, aside from providing unique benefits in terms of mechanical properties as well as biocompatibility and slow degradability, can provide suitable biomaterial matrices for the support of adult stem cell differentiation toward ligament lineages. These results point toward this matrix as a new option for ACL repair to overcome current limitations with synthetic and other degradable materials. (C) 2002 Published by Elsevier Science Ltd.
C1 Tufts Univ, Dept Chem & Biol Engn, Ctr Bioengn, Medford, MA 02155 USA.
   Univ Basel Hosp, Div Res, Dept Surg, CH-4031 Basel, Switzerland.
   Tufts Univ New England Med Ctr, Dept Orthopaed, Boston, MA 02111 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, Ctr Bioengn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
CR Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   AMIEL D, 1984, Journal of Orthopaedic Research, V1, P257
   ARNOCZKY SP, 1993, CRUCIATE LIGAMENT CU
   Asakura T, 1997, BIOPOLYMERS, V41, P193, DOI 10.1002/(SICI)1097-0282(199702)41:2<193::AID-BIP6>3.0.CO;2-O
   Bosch U, 1998, AM J SPORT MED, V26, P103, DOI 10.1177/03635465980260010201
   BUCKNALL TE, 1983, EUR SURG RES, V15, P59, DOI 10.1159/000128334
   CHEN EH, 1980, J BIOMED MATER RES, V14, P567, DOI 10.1002/jbm.820140504
   Corry IS, 1999, AM J SPORT MED, V27, P444, DOI 10.1177/03635465990270040701
   Costello G.A., 1997, THEORY WIRE ROPE
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Dunn MG, 1997, J APPL POLYM SCI, V63, P1423, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1423::AID-APP4>3.0.CO;2-O
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   Fu FH, 2000, AM J SPORT MED, V28, P124, DOI 10.1177/03635465000280010801
   Fu FH, 1999, AM J SPORT MED, V27, P821, DOI 10.1177/03635465990270062501
   GREENWALD D, 1994, J SURG RES, V56, P372, DOI 10.1006/jsre.1994.1058
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Kurosaki S, 1999, Nihon Ika Daigaku Zasshi, V66, P41, DOI 10.1272/jnms.66.41
   LAM KH, 1995, J APPL BIOMATER, V6, P191, DOI 10.1002/jab.770060308
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LOPEZVAZQUEZ E, 1991, J BONE JOINT SURG AM, V73A, P1294, DOI 10.2106/00004623-199173090-00003
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   McCarthy Donal M., 1993, P343
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   NOYES FR, 1984, J BONE JOINT SURG AM, V66A, P344, DOI 10.2106/00004623-198466030-00005
   OCONNOR J, 1990, KNEE LIGAMENTS STRUC, P163
   Otto D, 1998, AM J SPORT MED, V26, P181, DOI 10.1177/03635465980260020601
   POSTLETHWAIT RW, 1970, ANN SURG, V171, P892, DOI 10.1097/00000658-197006010-00010
   RICHMOND JC, 1992, AM J SPORT MED, V20, P24, DOI 10.1177/036354659202000107
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   SALTHOUSE TN, 1977, AM J OPHTHALMOL, V84, P224, DOI 10.1016/0002-9394(77)90856-X
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SHINO K, 1995, AM J SPORT MED, V23, P203, DOI 10.1177/036354659502300213
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Tsuda E, 2001, AM J SPORT MED, V29, P450, DOI 10.1177/03635465010290041201
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   WOO SLY, 1991, AM J SPORT MED, V19, P217, DOI 10.1177/036354659101900303
   WOO SLY, 1990, KNEE LIGAMENTS STRUC, P279
NR 41
TC 580
Z9 629
U1 12
U2 190
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2002
VL 23
IS 20
BP 4131
EP 4141
AR PII S0142-9612(02)00156-4
DI 10.1016/S0142-9612(02)00156-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 580KK
UT WOS:000177233600011
PM 12182315
DA 2018-10-19
ER

PT J
AU Voinova, MV
   Jonson, M
   Kasemo, B
AF Voinova, MV
   Jonson, M
   Kasemo, B
TI 'Missing mass' effect in biosensor's QCM applications
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE acoustical biosensors; quartz crystal microbalance; supported membranes;
   viscoelasticity
ID QUARTZ-CRYSTAL MICROBALANCE; RESONATOR; FILMS; SURFACE; LIQUID
AB Nowadays, liquid applications of quartz crystal microbalance (QCM) opened a way for in situ studies of proteins, vesicles and cells adsorbed from the solution onto the QCM surface. The sensitivity of QCM to the viscoelasticity of the adsorbed biomaterial can be a reason of the experimentally observed deviation from a linear dependence of QCM resonant frequency on mass deposition (the so-called Sauerbrey relation) and can limit its application for biosensoring. Presented here rigorous theoretical analysis explains the deviation from ideal mass response of soft overlayers in the contact with liquid. The fundamental result of the theory is the analog of Sauerbrey relation for layered viscous/viscoelastic medium which can be exploited for the correct physical interpretation of QCM experimental data in biofluids, in particular for measurements of the 'true' surface mass of adsorbed biomolecular films. We predict a new physical effect 'missing mass' of the sample in liquid phase measurements and compare the results given by our theory with QCM measurements on supported membranes. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.
   Univ Gothenburg, S-41296 Gothenburg, Sweden.
RP Voinova, MV (reprint author), Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.
RI Jonson, Mats/D-6545-2011
CR BANDLEY HL, 1997, FARADAY DISCUSS, V107, P214
   BUTTRY DA, 1991, ELECTROCHEMICAL INTE, V92
   Di Natale C, 2000, SENSOR ACTUAT B-CHEM, V64, P15, DOI 10.1016/S0925-4005(99)00477-3
   Doi M, 1998, THEORY POLYM DYNAMIC
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693
   Hengerer A, 1999, BIOSENS BIOELECTRON, V14, P139, DOI 10.1016/S0956-5663(98)00111-0
   HOOK F, 1999, 1999 JOINT M EFTF IE, P966
   JOHANNSMANN D, 1992, PHYS REV B, V46, P7808, DOI 10.1103/PhysRevB.46.7808
   KANAZAWA KK, 1985, ANAL CHIM ACTA, V175, P99
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   KOSSLINGER C, 1995, SENSOR ACTUAT B-CHEM, V24, P107, DOI 10.1016/0925-4005(95)85023-6
   LANDAU LD, 1997, COURSE THEORETICAL P, V6
   Lekkerkerker HNW, 1997, PHYSICA A, V244, P227, DOI 10.1016/S0378-4371(97)00302-6
   LUCKLUM R, 1997, FARADAY DISCUSS, V107, P112
   Nwankwo E, 1998, SENSOR ACTUAT A-PHYS, V64, P119, DOI 10.1016/S0924-4247(98)80004-6
   Panizza P, 1996, LANGMUIR, V12, P248, DOI 10.1021/la9504016
   Petrov A. G., 1999, LYOTROPIC STATE MATT
   REED CE, 1990, J APPL PHYS, V68, P1993, DOI 10.1063/1.346548
   Rodahl M, 1996, SENSOR ACTUAT A-PHYS, V54, P448, DOI 10.1016/S0924-4247(97)80002-7
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Sakti SP, 1999, SENSOR ACTUAT A-PHYS, V76, P98, DOI 10.1016/S0924-4247(98)00358-6
   SAKTI SP, 2000, EUROSENSORS, V14, P475
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   SPERLING LH, 1986, INTRO PHYSICAL POLYM
   Stockbridge C. D., 1966, VAC MICROBALANCE TEC, V5, P147
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Voinova MV, 1997, J PHYS-CONDENS MAT, V9, P7799, DOI 10.1088/0953-8984/9/37/011
NR 29
TC 224
Z9 230
U1 8
U2 135
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD OCT
PY 2002
VL 17
IS 10
BP 835
EP 841
AR PII S0956-5663(02)00050-7
DI 10.1016/S0956-5663(02)00050-7
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 598GH
UT WOS:000178267200001
PM 12243901
DA 2018-10-19
ER

PT J
AU Marberry, KM
   Kazmier, P
   Simpson, WA
   Christensen, GD
   Phaup, JG
   Hendricks, KJ
   Anglen, JO
   Gainor, BJ
AF Marberry, KM
   Kazmier, P
   Simpson, WA
   Christensen, GD
   Phaup, JG
   Hendricks, KJ
   Anglen, JO
   Gainor, BJ
TI Surfactant wound irrigation for the treatment of staphylococcal clinical
   isolates
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article; Proceedings Paper
CT 11th Annual Scientific Meeting of the Musculoskeletal-Infection-Society
CY AUG 02-04, 2001
CL ASPEN-SNOWMASS, COLORADO
ID VIRULENCE
AB Deep wound infection involving an implanted biomaterial is a devastating complication in orthopaedic surgery. Two-thirds of such infections are monomicrobial and the most commonly isolated bacteria in human osteomyelitis and orthopaedic device infection are Staphylococcus aureus and Staphylococcus epidermidis. The purpose of the current study was to examine the effectiveness of the previously reported sequential surfactant irrigation protocol against human-isolated clinical strains of Staphylococcus aureus and Staphylococcus epidermidis in the rat model of orthopaedic implant contamination. The infectivity rate of human-isolated clinical strains of Staphylococcus aureus in a contaminated complex orthopaedic wound was reduced effectively by a sequential surfactant irrigation protocol. Also, in this model, the infectivity of Staphylococcus epidermidis was reduced by normal saline irrigation alone when compared with no irrigation. Therefore, the sequential surfactant irrigation protocol may represent an effective method of wound irrigation in monomicrobial Staphylococcus aureus orthopaedic implant contamination, and normal saline irrigation may suffice in cases of monomicrobial Staphylococcus epidermidis contamination. Additional studies are necessary to determine the clinical use of surfactant irrigation.
C1 Univ Missouri, Dept Orthopaed Surg, Columbia, MO 65212 USA.
   Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65201 USA.
RP Gainor, BJ (reprint author), Univ Missouri, Dept Orthopaed Surg, 1 Hosp Dr MC213, Columbia, MO 65212 USA.
CR ADLAM C, 1970, J MED MICROBIOL, V3, P147, DOI 10.1099/00222615-3-1-147
   Anglen J, 1996, J ORTHOPAED RES, V14, P251, DOI 10.1002/jor.1100140213
   ANGLEN JO, 1994, J ORTHOP TRAUMA, V8, P390, DOI 10.1097/00005131-199410000-00004
   BEINING PR, 1963, J BACTERIOL, V85, P732
   Buckwalter JA, 2000, J BONE JOINT SURG AM, V82A, P1782, DOI 10.2106/00004623-200012000-00012
   Christian A, 1994, NAT MUS, V124, P45
   Conroy BP, 1999, J ORTHOP TRAUMA, V13, P332, DOI 10.1097/00005131-199906000-00002
   GARVIN KL, 1995, J BONE JOINT SURG AM, V77, P1576, DOI 10.2106/00004623-199510000-00015
   Gristina A G, 1990, Instr Course Lect, V39, P471
   GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GUSTILO RB, 1990, J BONE JOINT SURG AM, V72A, P299, DOI 10.2106/00004623-199072020-00023
   Hamood AN, 1996, J SURG RES, V61, P425, DOI 10.1006/jsre.1996.0140
   Marshall K.C., 1985, BACTERIAL ADHESION M, P133
   MERRITT K, 1987, J ORTHOPAED RES, V5, P239
   Moussa FW, 1996, CLIN ORTHOP RELAT R, P255, DOI 10.1097/00003086-199608000-00032
   SCHUTZER SF, 1988, J BONE JOINT SURG AM, V70A, P724, DOI 10.2106/00004623-198870050-00013
   Tarbox BB, 1998, CLIN ORTHOP RELAT R, P255
   VANDEVELDE H, 1894, CELLULE, V10, P401
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   WATSON DL, 1982, RES VET SCI, V32, P311
NR 21
TC 10
Z9 10
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD OCT
PY 2002
IS 403
BP 73
EP 79
DI 10.1097/01.blo.0000030068.92399.d2
PG 7
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 604EX
UT WOS:000178604500012
PM 12360010
DA 2018-10-19
ER

PT J
AU Ai, H
   Mills, DK
   Jonathan, AS
   Jones, SA
AF Ai, H
   Mills, DK
   Jonathan, AS
   Jones, SA
TI Gelatin-glutaraldehyde cross-linking on silicone rubber to increase
   endothelial cell adhesion and growth
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Article
DE hydrophilic; hydrophobic; contact angle; viscosity; attachment
ID INDUCED GRAFT-COPOLYMERIZATION; FOREIGN-BODY REACTION; VITRO
   SHEAR-STRESS; IN-VITRO; LINKED GELATIN; SURFACE MODIFICATION; ARTIFICIAL
   CORNEA; VASCULAR GRAFTS; PROTEIN; MEMBRANE
AB Silicone is a biomaterial that is widely used in many areas because of its high optical clarity, its durability, and the ease with which it can be cast. However, these advantages are counterbalanced by strong hydrophobicity. Gelatin cross-linking has been used as a hydrophilic coating on many biomaterials but not on silicone rubber. In this study, two gelatin glutaraldehyde (GA) cross-linking methods were used to coat a hydrophilic membrane on silicone rubber. In method 1, gelatin and GA were mixed in three different proportions (64:1, 128:1, and 256:1) before coating. In method II, a newly formed 5% gelatin membrane was cross-linked with a 2.5% GA solution. All coatings were hydrophilic, as determined from the measurement of contact angle for a drop of water on the surface. Bovine coronary arterial endothelial cells were shown to grow well on the surface modified by method II at 72 h. In method I, the cells grew well for gelatin-CA proportions of 64:1 and 128:1 at 72 It. No cell attachment on untreated silicone rubber was observed by the third (I of seeding. The results indicated that both methods of gelatin-GA cross-linking provided a hydrophilic surface on silicone for endothelial cell adhesion and growth in vitro.
C1 Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71272 USA.
   Louisiana Tech Univ, Sch Biol Sci, Ruston, LA 71272 USA.
   Louisiana State Univ, Hlth Sci Ctr, Dept Cellular & Mol Physiol, Shreveport, LA 71130 USA.
RP Mills, DK (reprint author), Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71272 USA.
CR ACTON C, 1989, AUST DENT J, V34, P228, DOI 10.1111/j.1834-7819.1989.tb00675.x
   Adams WP, 1998, PLAST RECONSTR SURG, V101, P64, DOI 10.1097/00006534-199801000-00011
   Boateng S, 2002, ADV MATER, V14, P461, DOI 10.1002/1521-4095(20020318)14:6<461::AID-ADMA461>3.0.CO;2-S
   Bontempo AR, 1997, CURR EYE RES, V16, P776, DOI 10.1076/ceyr.16.8.776.8985
   CARMEN R, 1972, J BIOMED MATER RES, V6, P327, DOI 10.1002/jbm.820060504
   Chun JS, 1996, J BIOL CHEM, V271, P13008, DOI 10.1074/jbc.271.22.13008
   Crawford JR, 1998, MOL BIOL CELL, V9, P3429, DOI 10.1091/mbc.9.12.3429
   Dardik A, 1999, J VASC SURG, V29, P157, DOI 10.1016/S0741-5214(99)70357-5
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   DiTizio V, 2000, J BIOMED MATER RES, V51, P96, DOI 10.1002/(SICI)1097-4636(200007)51:1<96::AID-JBM13>3.0.CO;2-S
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   HAID M, 1988, J SURG ONCOL, V37, P136, DOI 10.1002/jso.2930370215
   HARTMAN LC, 1988, J BIOMED MATER RES, V22, P475, DOI 10.1002/jbm.820220604
   Hsiue GH, 1998, J BIOMED MATER RES, V42, P134, DOI 10.1002/(SICI)1097-4636(199810)42:1<134::AID-JBM17>3.0.CO;2-L
   Hsiue GH, 1996, ARTIF ORGANS, V20, P1196
   HSIUE GH, 1994, BIOMATERIALS, V15, P163
   HSIUE GH, 1993, J BIOMAT SCI-POLYM E, V5, P205
   Lee SD, 1996, BIOMATERIALS, V17, P587, DOI 10.1016/0142-9612(96)88709-6
   Lin FH, 1998, BIOMATERIALS, V19, P905, DOI 10.1016/S0142-9612(97)00202-0
   Lumsden AB, 1996, J VASC SURG, V24, P825, DOI 10.1016/S0741-5214(96)70019-8
   Maissa C, 1998, OPTOMETRY VISION SCI, V75, P697
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   MCDEVITT JJ, 1972, SURG GYNECOL OBSTETR, V135, P99
   MIGONNEY V, 1995, J BIOMAT SCI-POLYM E, V7, P265
   MOSS AH, 1990, AM J KIDNEY DIS, V16, P211, DOI 10.1016/S0272-6386(12)81020-1
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   OTT MJ, 1995, SURGERY, V117, P334, DOI 10.1016/S0039-6060(05)80210-7
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Sparks C H, 1966, Ann Thorac Surg, V2, P585
   STIMPSON C, 1989, BIOMATER ARTIF CELL, V17, P31, DOI 10.3109/10731198909118267
   Volcker N, 2001, J MATER SCI-MATER M, V12, P111, DOI 10.1023/A:1008938525489
   WINER DL, 1974, PLAST RECONSTR SURG, V53, P174
NR 35
TC 16
Z9 16
U1 2
U2 14
PU SOC IN VITRO BIOLOGY
PI LARGO
PA 9315 LARGO DR WEST, STE 25, LARGO, MD 20774 USA
SN 1071-2690
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD OCT
PY 2002
VL 38
IS 9
BP 487
EP 492
PG 6
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 672AY
UT WOS:000182499600001
PM 12703975
DA 2018-10-19
ER

PT J
AU Linti, C
   Zipfel, A
   Schenk, M
   Dauner, M
   Doser, M
   Viebahn, R
   Becker, HD
   Planck, H
AF Linti, C
   Zipfel, A
   Schenk, M
   Dauner, M
   Doser, M
   Viebahn, R
   Becker, HD
   Planck, H
TI Cultivation of porcine hepatocytes in polyurethane nonwovens as part of
   a biohybrid liver support system
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE biohybrid liver; nonwoven; biomaterial; hepatocytes; ammonia; MEGX;
   metabolism
ID EFFICACY; FAILURE
AB Many patients suffering from end-stage liver disease cannot be transplanted within reasonable time due to the shortage of donor organs. Bioartificial liver support systems may contribute to the liver regeneration or bridging the time until a liver graft for transplantation becomes available. Nonwovens with integrated oxygenation capacity have been developed and manufactured by melt blow technology using thermoplastic polyurethane. Capillary membranes for oxygenation were integrated into the nonwoven during the processing. The polyurethane nonwoven structures with adapted pore size and high pore volume allow high cell densities in the hepatocyte culture.
   The three-dimensional cell culture was housed by a flow bioreactor system and was integrated in a closed loop circulation with monitoring possibilities for pressure, pH, temperature, ammonia, and oxygen. Hepatocytes were isolated from rats or pigs by collagenase perfusion and infused into the medium-perfused circulation. Cells showed high viability and hepatocyte specific cytochrome P450-dependent metabolic function in culture (MEGX test).
C1 Inst Technol & Proc Engn, Dept Biomed Engn, D-37770 Denkendorf, Germany.
   Univ Tubingen, Dept Gen Surg, D-72074 Tubingen, Germany.
RP Linti, C (reprint author), Inst Technol & Proc Engn, Dept Biomed Engn, Koerschtaistr 26, D-37770 Denkendorf, Germany.
CR DEMEESTER J, 1999, LIVER DONATION WAITI, P39
   Flendrig LM, 1997, J HEPATOL, V26, P1379, DOI 10.1016/S0168-8278(97)80475-8
   GERLACH J, 1994, ZBL CHIR, V119, P334
   Gomez-Lechon MJ, 2000, J MATER SCI-MATER M, V11, P37, DOI 10.1023/A:1008985618651
   Hay PD, 2001, ARTIF ORGANS, V25, P119, DOI 10.1046/j.1525-1594.2001.025002119.x
   Naruse K, 1998, ARTIF ORGANS, V22, P1031, DOI 10.1046/j.1525-1594.1998.06104.x
   Pahernik SA, 2001, CELLS TISSUES ORGANS, V168, P170, DOI 10.1159/000047832
   Riordan SM, 1998, INT J ARTIF ORGANS, V21, P312
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SIES H, 1997, EUR J BIOCHEM, V72, P301
NR 10
TC 16
Z9 17
U1 0
U2 1
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD OCT
PY 2002
VL 25
IS 10
BP 994
EP 1000
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 614HZ
UT WOS:000179183700014
PM 12456041
DA 2018-10-19
ER

PT J
AU Sott, AH
   Rosson, JW
AF Sott, AH
   Rosson, JW
TI The influence of biomaterial on patterns of failure after cemented total
   hip replacement
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Article
AB We examined aseptic loosening and osteolysis in 77 revised McKee-Arden total hip arthroplasties (THAs) using polyethylene cups and identical femoral stems made from either cobalt chrome alloy or titanium alloy. Time to failure was significantly shorter in the titanium group. Loosening and peri-prosthetic osteolysis occurred with significantly higher frequency in the titanium group compared to the cobalt chrome group.
C1 Royal Surrey Cty Hosp, Dept Traumat & Orthopaed Surg, Surrey GU2 5XX, England.
RP Sott, AH (reprint author), 14 Darnley Pk, Surrey KT13 8EY, England.
CR BAL BS, 1988, J ANTHROPLASTY, V13, P492
   Bankston A B, 1993, J Arthroplasty, V8, P315
   BISCHOFF UW, 1994, J BONE JOINT SURG BR, V76B, P713
   BRIEN WW, 1992, CLIN ORTHOP RELAT R, P66
   DELEE JG, 1976, CLIN ORTHOP RELAT R, V121, P21
   ENGH CA, 1990, CLIN ORTHOP RELAT R, P107
   Gruen TA, 1979, CLIN ORTHOP RELAT R, V141, P17, DOI DOI 10.1097/00003086-197906000-00002
   ISAAC GH, 1990, J BONE JOINT SURG BR, V72, P149
   JOHNSTON RC, 1990, J BONE JOINT SURG AM, V72A, P161, DOI 10.2106/00004623-199072020-00002
   Maurer TB, 2001, INT ORTHOP, V25, P77, DOI 10.1007/s002640000219
   Meding JB, 1997, CLIN ORTHOP RELAT R, P184
NR 11
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0341-2695
J9 INT ORTHOP
JI Int. Orthop.
PD OCT
PY 2002
VL 26
IS 5
BP 287
EP 290
DI 10.1007/s00264-002-0367-z
PG 4
WC Orthopedics
SC Orthopedics
GA 614JC
UT WOS:000179184000008
PM 12378355
OA Green Published
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Herrero, EJ
   Rocha, A
   Martin-Maestro, M
   Castillo-Olivares, JL
   Millan, I
   Sanmartin, AC
   Cordon, A
AF Paez, JMG
   Herrero, EJ
   Rocha, A
   Martin-Maestro, M
   Castillo-Olivares, JL
   Millan, I
   Sanmartin, AC
   Cordon, A
TI The telescoping suture - Part 1: Does this technique improve the
   mechanical behavior of a biomaterial? Calf pericardium
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
ID TISSUE SELECTION SITES; BOVINE PERICARDIUM; HEART-VALVE; BIOPROSTHETIC
   VALVES; FIBER ARCHITECTURE; REOPERATION; PROSTHESES; ELASTICITY;
   PATHOLOGY; STRENGTH
AB The authors study the mechanical behavior of calf pericardium employed in the construction of cardiac valve leaflets when subjected to telescoping suture, followed by tensile stress until rupture.
   One hundred twenty pericardial. tissue samples were employed, 60 cut from root-to-apex and another 60 cut in transverse direction. Each of these two groups consisted of 12 control samples that were left unsutured and four sets of 12 samples each that were rejoined by telescoping suture using silk, Prolene, nylon or Gore-Tex., and subjected to tensile stress. At the rupture of the sutured tissues, the tensile stress of the suture materials ranged between 57.54 MPa for the series sewn lengthwise with Gore-tex and 114.08 MPa for the series sewn crosswise with silk. At these levels of stress, the deformation of the suture thread was much less marked than that of the calf pericardium, and internal stresses were produced that were difficult for the biomaterial to absorb.
   There was a loss of real load in all the sutured series when the observed resistance to rupture, expressed in kilograms, was compared with the estimated value. This loss of resistance did not invalidate the telescoping suture technique since the resistance to rupture was still much greater than that associated with suturing the two edges of the cut pericardium together. This report confirms the deleterious role of the shear force generated in the pericardium by the suture.
C1 Clin Puerto Hierro, Serv Cirugia Expt, Madrid, Spain.
   Clin Puerto Hierro, Serv Bioestadist, Madrid, Spain.
   Escuela Tecn Super Ingn Ind, Dept Mecan Estructural & Resistencia Mat, Madrid, Spain.
EM josempaez@telefonica.net
CR BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901
   Bortolotti U, 1994, J Heart Valve Dis, V3, P81
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   Bustamante John, 1996, Archivos del Instituto de Cardiologia de Mexico, V66, P229
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Carrera San Martin A., 1993, Biomaterials, V14, P76, DOI 10.1016/0142-9612(93)90079-H
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   Duncan AC, 1997, J THORAC CARDIOV SUR, V113, P302, DOI 10.1016/S0022-5223(97)70327-1
   EDWARDS TJ, 1995, ANN THORAC SURG, V60, pS211, DOI 10.1016/0003-4975(95)00220-F
   GLOWER DD, 1994, J THORAC CARDIOV SUR, V107, P381
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   KUNZELMAN KS, 1993, J LONG-TERM EFF MED, V3, P161
   Levy R J, 1994, J Heart Valve Dis, V3, P101
   Paez JMG, 2000, J BIOMATER APPL, V15, P47
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 1996, J BIOMED MATER RES, V30, P47
   Paez JMG, 1996, BIOMATERIALS, V17, P1677, DOI 10.1016/0142-9612(96)87647-2
   PAEZ JMG, 1994, BIOMATERIALS, V15, P981, DOI 10.1016/0142-9612(94)90078-7
   PAEZ JMG, 1994, BIOMATERIALS, V5, P172
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   San Martin AC, 1998, J MATER SCI-MATER M, V9, P77
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
NR 29
TC 0
Z9 0
U1 0
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 2002
VL 17
IS 2
BP 85
EP 103
DI 10.1106/088532802027863
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637UF
UT WOS:000180531600001
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Herrero, EJ
   Rocha, A
   Martin-Maestro, M
   Castillo-Olivares, JL
   Millan, I
   Sanmartin, AC
   Cordon, A
AF Paez, JMG
   Herrero, EJ
   Rocha, A
   Martin-Maestro, M
   Castillo-Olivares, JL
   Millan, I
   Sanmartin, AC
   Cordon, A
TI The telescoping a novel method suture - Part II: A novel method to
   improve the mechanical behavior of a new biomaterial: Ostrich
   pericardium
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
ID TISSUE SELECTION SITES; CARDIAC BIOPROSTHESES; BOVINE PERICARDIUM; FIBER
   ARCHITECTURE; HEART-VALVES; CONSTRUCTION; REOPERATION; DURABILITY;
   PROSTHESES; ELASTICITY
AB Ostrich pericardium, sutured using a telescoping or overlapping technique, was studied to determine its mechanical behavior. From each of 12 pericardial sacs, four contiguous strips were cut longitudinally, from root to apex, and another four contiguous strips were cut in transverse direction. One of the strips in each set of four was used as an unsutured control and the remaining three were sutured by overlapping 0.5 cm of the tissue and sewing with Gore-tex, Prolene or Pronova. These 96 samples were then subjected to tensile testing along their major axes until rupture. The tensile stresses recorded in the suture materials at the moment tears appeared in the pericardium ranged between 55.99 MPa and 70.23 MPa for Gore-tex in samples cut in the two directions. Shear stress became ostensible at 56 Wit, with clearly evident tears. However, microfracture of the collagen fibers must be produced at much lower stress levels. The comparison of the resistance in kilograms (machine-imposed), without taking into account the sections in which the load was applied, demonstrated only a slight loss of load when the telescoping suture was employed in ostrich pericardium samples. Ostrich pericardium may continue to be an alternative biological material for the construction of heart valve leaflets.
C1 Clin Puerta Hierro, Serv Cirugia Expt, Madrid, Spain.
   Clin Puerta Hierro, Serv Bioestadist, Madrid, Spain.
   Escuela Tecn Super Ingn Ind, Dept mecan Estructural & Resistencia Mat, Madrid, Spain.
EM josempaez@telefonica.net
CR BERNAL JM, 1995, ANN THORAC SURG, V60, pS248, DOI 10.1016/0003-4975(95)00218-A
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   BURR LH, 1995, ANN THORAC SURG, V60, pS264, DOI 10.1016/0003-4975(95)00300-A
   Bustamante John, 1996, Archivos del Instituto de Cardiologia de Mexico, V66, P229
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   GLOWER DD, 1994, J THORAC CARDIOV SUR, V107, P381
   GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   KUNZELMAN KS, 1993, J LONG-TERM EFF MED, V3, P161
   Paez JMG, 2000, J BIOMATER APPL, V15, P47
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 1996, J BIOMED MATER RES, V30, P47
   Paez JMG, 2001, J MATER SCI-MATER M, V12, P425, DOI 10.1023/A:1011201104225
   Paez JMG, 2001, BIOMATERIALS, V22, P2731
   PAEZ JMG, 1994, BIOMATERIALS, V15, P981, DOI 10.1016/0142-9612(94)90078-7
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   San Martin AC, 1998, J MATER SCI-MATER M, V9, P77
   Smith DB, 1997, J HEART VALVE DIS, V6, P424
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
NR 26
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 2002
VL 17
IS 2
BP 105
EP 123
DI 10.1106/088532802027864
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 637UF
UT WOS:000180531600002
DA 2018-10-19
ER

PT J
AU Lewis, G
AF Lewis, G
TI Key issues involved with the use of miniature specimens in the
   characterization of the mechanical behavior of polymeric biomaterials -
   A review
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Review
DE miniature test specimens; small punch test; small shear punch test;
   ultra-high-molecular-weight polyethylene; acrylic bone cement
ID ACRYLIC BONE-CEMENT; MOLECULAR-WEIGHT POLYETHYLENE; APPARENT
   FRACTURE-TOUGHNESS; CROSS-COMPARISON EXERCISE; CLINICAL-PERFORMANCE;
   TESTING TECHNIQUE; PUNCH TESTS; DEFORMATION; UHMWPE; COMPONENTS
AB This article is arranged in three parts. In the first, a brief history of the use of miniature specimens for characterizing the mechanical behavior of materials in general is given. In the second part, several trends in literature reports of small punch and small shear punch tests of ultra-high-molecular-weight polyethylene and acrylic bone cement specimens are examined critically. In this exercise, special attention is paid to one test metric; namely, the work to failure [which is the area under the punch load (P) versus punch displacement (A) plot up to the failure point]. In the third part of the article, seven key issues in this field are discussed. In each case, the gaps in the current knowledge base are pointed out. Among those issues are determination of sensitivity of test results to test variables, development of methods for converting P-Delta results to bulk material properties, and constitutive modeling of the mechanical behavior of a polymeric biomaterial, under both small punch and small shear punch loading. (C) 2002 Wiley Periodicals, Inc.
C1 Memphis State Univ, Dept Mech Engn, Memphis, TN 38152 USA.
RP Lewis, G (reprint author), Memphis State Univ, Dept Mech Engn, Memphis, TN 38152 USA.
EM glewis@memphis.edu
CR Arnold JC, 1998, POLYM TEST, V17, P597, DOI 10.1016/S0142-9418(98)00003-8
   Bargmann LS, 1999, CLIN ORTHOP RELAT R, P49
   BAYOUMI MR, 1983, INT J FRACTURE, V23, P71, DOI 10.1007/BF00020159
   Brookfield DJ, 1999, J STRAIN ANAL ENG, V34, P423, DOI 10.1243/0309324991513867
   CHARLEBOIS SJ, 1999, HTESIS U MEMPHIS MEM
   Cheon JS, 1996, J TEST EVAL, V24, P255
   Collier JP, 1996, J ARTHROPLASTY, V11, P377, DOI 10.1016/S0883-5403(96)80026-X
   Corwin W., 1998, ASTM STP, V1329
   CORWIN WR, 1986, ASTM STP, V888
   Currier BH, 1997, CLIN ORTHOP RELAT R, P111
   Currier BH, 2000, J BIOMED MATER RES, V53, P143, DOI 10.1002/(SICI)1097-4636(2000)53:2<143::AID-JBM3>3.0.CO;2-5
   EDIDIN A, 2000, T 46 ANN M ORTH RES, P563
   EDIDIN A, 2001, T 47 ANN M ORTH RES, P1064
   Edidin A. A., 2000, T 46 ORTH RES SOC OR, P1
   Edidin AA, 2000, BIOMATERIALS, V21, P1451, DOI 10.1016/S0142-9612(00)00021-1
   Edidin AA, 2000, J ARTHROPLASTY, V15, P321, DOI 10.1016/S0883-5403(00)90647-8
   Edidin AA, 1999, J ARTHROPLASTY, V14, P616, DOI 10.1016/S0883-5403(99)90086-4
   EDIDIN AA, 2001, T 27 ANN M SOC BIOM, P398
   EDIDIN AA, 2001, T 27 ANN M SOC BIOM, P591
   ELY S, 2000, T 46 ANN M ORTH RES, P558
   FITZ W, 2001, T 47 ANN M ORTH RES, P1035
   Fong RWL, 1998, AM SOC TEST MATER, V1329, P602, DOI 10.1520/STP38015S
   Foulds JR, 1998, AM SOC TEST MATER, V1329, P557, DOI 10.1520/STP38012S
   FOULDS JR, 1995, J TEST EVAL, V23, P3
   Fritsch EW, 1996, J BIOMED MATER RES, V31, P451, DOI 10.1002/(SICI)1097-4636(199608)31:4<451::AID-JBM3>3.0.CO;2-K
   Geary W, 1998, AM SOC TEST MATER, V1329, P588, DOI 10.1520/STP38014S
   Giddings VL, 2001, BIOMATERIALS, V22, P1875, DOI 10.1016/S0142-9612(00)00372-0
   Hamilton ML, 1998, AM SOC TEST MATER, V1329, P614, DOI 10.1520/STP38016S
   HAMILTON ML, 1996, ASTM STP, V1270, P1057
   Jaske CE, 2000, J ENG MATER-T ASME, V122, P327, DOI 10.1115/1.482814
   KAMEDA J, 1994, MAT SCI ENG A-STRUCT, V183, P121, DOI 10.1016/0921-5093(94)90896-6
   KASIVISWANATHAN KV, 1998, ASTM STP, V1329, P32
   KOHSE G, 1986, J NUCL MATER, V141, P513, DOI 10.1016/S0022-3115(86)80092-7
   Kurtz SM, 1998, BIOMATERIALS, V19, P1989, DOI 10.1016/S0142-9612(98)00112-4
   Kurtz SM, 1999, BIOMATERIALS, V20, P1449, DOI 10.1016/S0142-9612(99)00038-1
   Kurtz SM, 1997, BIOMATERIALS, V18, P1659, DOI 10.1016/S0142-9612(97)00124-5
   Kurtz SM, 1999, J BIOMED MATER RES, V48, P75, DOI 10.1002/(SICI)1097-4636(1999)48:1<75::AID-JBM13>3.0.CO;2-H
   KURTZ SM, 2001, T 27 ANN M SOC BIOM, P311
   KURTZ SM, 2001, T 27 ANN M SOC BIOM, P42
   Kurtz SS, 2000, BIOMATERIALS, V21, P283, DOI 10.1016/S0142-9612(99)00178-7
   Lee WK, 1998, AM SOC TEST MATER, V1329, P539, DOI 10.1520/STP38011S
   Lewis G, 1998, BIOMATERIALS, V19, P961, DOI 10.1016/S0142-9612(97)00193-2
   Lewis G, 2000, BIO-MED MATER ENG, V10, P1
   Lewis G, 1998, BIO-MED MATER ENG, V8, P285
   LEWIS G, 2000, SMALL PUNCH TESTING
   LUCAS G. E., 1986, ASTM STP, V888, P112
   LUCAS GE, 1986, J NUCL MATER, V141, P532, DOI 10.1016/S0022-3115(86)80096-4
   LUCAS GE, 1990, METALL TRANS A, V21, P1105, DOI 10.1007/BF02698242
   LUCAS GE, 1984, J NUCL MATER, V122, P429, DOI 10.1016/0022-3115(84)90635-4
   MAO X, 1991, J MATER SCI, P2436
   MAO X, 1967, SCRIPT METAL MAT, V25, P2481
   MAO XY, 1987, J NUCL MATER, V150, P42, DOI 10.1016/0022-3115(87)90092-4
   NORMAN TL, 1995, J BIOMED MATER RES, V29, P495, DOI 10.1002/jbm.820290409
   OKADA A, 1985, J NUCL MATER, V133, P321, DOI 10.1016/0022-3115(85)90160-6
   RIMNAC C, 2001, T 4M ANN M ORTH RES, P1023
   Rosinski ST, 1998, AM SOC TEST MATER, V1329, P3, DOI 10.1520/STP37979S
   Sharpe WN, 1998, AM SOC TEST MATER, V1329, P497, DOI 10.1520/STP38008S
   SUTULA LC, 1995, CLIN ORTHOP RELAT R, P28
   TOLCZKO MB, 1996, ASTM STP, V1270, P902
   TOPOLESKI LDT, 1995, J BIOMED MATER RES, V29, P299, DOI 10.1002/jbm.820290304
   VALO M, 1998, ASTM STP, V1329, P190
   Vila MM, 1999, J BIOMED MATER RES, V48, P128, DOI 10.1002/(SICI)1097-4636(1999)48:2<128::AID-JBM6>3.0.CO;2-1
   VILLARRAGA ML, 2001, T 27 ANN M SOC BIOM, P478
   White SE, 1996, CLIN ORTHOP RELAT R, P164
   YAMAMOTO K, 2000, T 46 ANN M ORTH RES, P561
NR 65
TC 9
Z9 9
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2002
VL 63
IS 5
BP 455
EP 466
DI 10.1002/jbm.10300
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 596HT
UT WOS:000178159600001
PM 12209888
DA 2018-10-19
ER

PT J
AU Itoh, S
   Kikuchi, M
   Takakuda, K
   Nagaoka, K
   Koyama, Y
   Tanaka, J
   Shinomiya, K
AF Itoh, S
   Kikuchi, M
   Takakuda, K
   Nagaoka, K
   Koyama, Y
   Tanaka, J
   Shinomiya, K
TI Implantation study of a novel hydroxyapatite/collagen (HAp/Col)
   composite into weight-bearing sites of dogs
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE hydroxyapatite/type I collagen (HAp/Col) composite; implant; recombinant
   human bone morphogenetic protein (rhBMP); carrier; bone remodeling unit
ID COLLAGEN COMPOSITE; BONE; RELEASE; PHASES
AB A hydroxyapatite/type I collagen (HAp/Col) composite, aligning hydroxyapatite nanocrystals along collagen molecules, has been prepared. The biocompatibility, osteoconductive activity, and efficacy as a carrier of rhBMP-2 of this novel biomaterial implanted in the weight-bearing site have been examined. The HAp/Col implants (15 mm in diameter and 20 mm in length) with a surface cross-linked layer containing rhBMP-2 (0 or 400 mug/ml) were implanted into bone defects of tibiae in three beagle dogs and fixed according to the Ilizarov method. As a control, bone defects of 20 nun in two beagle dogs did not receive implants, and the dogs were allowed to walk using an Ilizarov extraskeletal fixator. The specimens were removed from one dog in each group after 12 weeks. Also, the Ilizarov fixators in the rhBMP-treated dogs were removed after 12 weeks, after which full weight bearing started. The specimens were further taken out after 18 and 24 weeks in the rhBMP-treated and non-rhBMP-treated dogs, and after 24 weeks in the control group. The change of bone mineral density, as well as radiological and histological findings, suggest that the implants are able to induce bone remodeling units and are a superior carrier of rhBMP-2 due to the stimulation of early callus and new bone formation. (C) 2002 Wiley Periodicals, Inc.
C1 Tokyo Med & Dent Univ, Dept Orthopaed Surg & Biomech Engn, Tokyo 1138519, Japan.
   Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 3050044, Japan.
   Nihon Univ, Anim Med Ctr, Dept Surg, Kanagawa 2528510, Japan.
RP Shinomiya, K (reprint author), Tokyo Med & Dent Univ, Dept Orthopaed Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.
EM shinomiya.orth@tmd.ac.jp
RI Kikuchi, Masanori/B-5993-2008
OI Kikuchi, Masanori/0000-0002-9451-8147
CR AOKI H, 1994, MED APPL HYDROXYAPAT, P1
   Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   Borsato KS, 1997, J BIOMECH, V30, P955, DOI 10.1016/S0021-9290(97)00044-4
   COOK SD, 1986, SPINE, V11, P305, DOI 10.1097/00007632-198605000-00002
   Cornell C N, 1991, J Orthop Trauma, V5, P1
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Galbavy S, 1995, Bratisl Lek Listy, V96, P368
   HIROTA K, 1993, PRESSURE SINTERING B, P35
   Isaksson S, 1992, Swed Dent J Suppl, V84, P1
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   KOCIALKOWSKI A, 1990, INJURY, V21, P142, DOI 10.1016/0020-1383(90)90082-6
   MAMMONE JF, 1993, J BIOMECH, V26, P439, DOI 10.1016/0021-9290(93)90007-2
   MAROUF H A, 1990, International Journal of Oral and Maxillofacial Implants, V5, P148
   Martins VCA, 1998, ARTIF ORGANS, V22, P215, DOI 10.1046/j.1525-1594.1998.06004.x
   Martins VCA, 2000, ARTIF ORGANS, V24, P224, DOI 10.1046/j.1525-1594.2000.06517.x
   MEHLISCH DR, 1990, ORAL SURG ORAL MED O, V70, P685, DOI 10.1016/0030-4220(90)90001-9
   Miyamoto Y, 1998, BIOMATERIALS, V19, P707, DOI 10.1016/S0142-9612(97)00186-5
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   SUH H, 1995, ASAIO J, V41, pM652, DOI 10.1097/00002480-199507000-00091
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   VILLANUEVA AR, 1974, STAIN TECHNOL, V49, P1, DOI 10.3109/10520297409116928
   WALSH WR, 1994, BIOMATERIALS, V15, P137, DOI 10.1016/0142-9612(94)90263-1
   WALSH WR, 2000, CLIN ORTHOP RELAT R, V375, P258
   ZDEBLICK TA, 1994, SPINE, V19, P2348, DOI 10.1097/00007632-199410150-00017
   Zhang QQ, 1996, ARTIF CELL BLOOD SUB, V24, P693, DOI 10.3109/10731199609118892
NR 28
TC 51
Z9 52
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2002
VL 63
IS 5
BP 507
EP 515
DI 10.1002/jbm.10305
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 596HT
UT WOS:000178159600007
PM 12209894
DA 2018-10-19
ER

PT J
AU Lavos-Valereto, C
   Costa, I
   Wolynec, S
AF Lavos-Valereto, C
   Costa, I
   Wolynec, S
TI The electrochemical behavior of Ti-6Al-7Nb alloy with and without
   plasma-sprayed hydroxyapatite coating in Hank's solution
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE titanium alloy; hydroxyapatite; corrosion; biomaterial; dental implant
ID CALCIUM-PHOSPHATE; TITANIUM; DISSOLUTION; IMPLANTS
AB The electrochemical behavior of Ti-6AI-7Nb alloy with and without plasma-sprayed hydroxyapatite (HA) coating was investigated in Hank's balanced salt solution at 37 degreesC. This behavior was evaluated by analyzing both corrosion potential variation with time curves and potentiodynamic polarization curves. The polarization curves were determined both in aerated and deaerated solutions. It was found that the corrosion potential of uncoated sample is always more noble than that of coated one. In aerated solutions the polarization curve of a coating-free alloy presents a typical passive/transpassive behavior, which is absent in the HA-coated alloy and in deaerated solution for both coated and uncoated conditions. In the latter polarization curves, the current density continuously increases with the increase of the potential. The corrosion rate determined from polarization curves is higher for HA-coated alloys, but it still can be considered negligible (less than 1 muA/cm(2)). (C) 2002 Wiley Periodicals, Inc.
C1 Univ Sao Paulo, Dept Met & Mat Engn, Polytech Sch, BR-05508900 Sao Paulo, Brazil.
   CNEN, IPEN, Ctr Mat Sci & Technol, Sao Paulo, Brazil.
RP Lavos-Valereto, C (reprint author), Univ Sao Paulo, Dept Met & Mat Engn, Polytech Sch, Av Prof Mello Moraes 2463, BR-05508900 Sao Paulo, Brazil.
RI Costa, Isolda/E-8506-2012
OI Costa, Isolda/0000-0002-4987-3334
CR Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   CONSIDINE DM, 1976, VANNOSTRANDS SCI ENC
   DUCHEYNE P, 1990, BIOMATERIALS, V11, P244, DOI 10.1016/0142-9612(90)90005-B
   ELBASIOUNY MS, 1982, CORROSION, V38, P237, DOI 10.5006/1.3577344
   Eliades T, 1997, INT J ORAL MAX IMPL, V12, P621
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Lavos-Valereto IC, 2001, J BIOMED MATER RES, V58, P727, DOI 10.1002/jbm.1072
   Lavos-Valereto IC, 2001, J MATER SCI-MATER M, V12, P273, DOI 10.1023/A:1008975418453
   LAVOSVALERETO IC, 1998, THESIS U SAO PAULO U, P129
   Leadley SR, 1997, BIOMATERIALS, V18, P311, DOI 10.1016/S0142-9612(96)00134-2
   Park E, 1998, J MATER SCI-MATER M, V9, P643, DOI 10.1023/A:1008931508465
   Sergo V, 1997, BIOMATERIALS, V18, P477, DOI 10.1016/S0142-9612(96)00147-0
   Sousa SR, 1996, BIOMATERIALS, V17, P397, DOI 10.1016/0142-9612(96)89655-4
   Sridhar TM, 1997, J MATER SCI LETT, V16, P1964, DOI 10.1023/A:1018511406374
   WEST JM, 1970, ELECTRODEPOSITION CO, P87
NR 15
TC 32
Z9 32
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2002
VL 63
IS 5
BP 664
EP 670
DI 10.1002/jbm.10351
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 596HT
UT WOS:000178159600027
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Carrera, A
   Herrero, EJ
   Millan, I
   Rocha, A
   Cordon, A
   Tellez, G
   Maestro, M
   Calero, P
   Castillo-Olivares, JL
AF Paez, JMG
   Carrera, A
   Herrero, EJ
   Millan, I
   Rocha, A
   Cordon, A
   Tellez, G
   Maestro, M
   Calero, P
   Castillo-Olivares, JL
TI Mechanical behavior of chemically treated ostrich pericardium subjected
   to uniaxial tensile testing: influence of the suture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterials; ostrich pericardium; tensile strength; sutures; mechanical
   behavior
ID TISSUE SELECTION SITES; BOVINE PERICARDIUM; FIBER ARCHITECTURE;
   HEART-VALVES; BIOPROSTHESIS; DURABILITY; PATHOLOGY; AGE
AB The mechanical behavior of sutured ostrich pericardium was studied by uniaxial tensile testing. One hundred forty-four tissue specimens were assessed: 96 sutured samples (48 in which a centrally located suture was placed at an angle of 90 degrees with respect to the longitudinal axis, whereas in the remaining 48, a centrally located suture was placed at a 45degrees angle to the longitudinal axis, in sets of 12 samples each, sewn with sutures made of Gore-Tex, nylon, Prolene, or silk), and 48 unsutured controls. Each group of 24 samples sewn at one angle or the other with the different suture materials was assayed together with a corresponding control group of 12 unsutured samples. The mean tensile strengths in the unsutured controls ranged between 30.16 MPa and 43.42 MPa, whereas those of the sutured sets ranged from 14.68 MPa to 21,91 MPa, The latter presented a statistically significant loss of resistance (p < 0.01) when compared with the unsutured tissue samples. The angle of the suture with respect to the longitudinal axis influenced the degree of shear stress produced by the suture, as well as the behavior of the different suture materials used. The set of samples sewn with Prolene appeared to be that most sensitive to changes in the angle of the suture, whereas tissue sewn at a 45degrees angle with Gore-Tex presented lower shear stress values in comparison with samples in which the other three materials were used. A method of tissue selection based on morphological and mechanical criteria was used to ensure the homogeneity of the results in such a way that the coefficients of determination (R-2) for the stress/strain curve fitting equation ranged between 0.888 and 0.995. This excellent fit made it possible, applying regression analysis, to predict the mechanical behavior of a specimen by determining that of a contiguous tissue sample. Thus, it should be possible, at least theoretically, to characterize the behavior of a specific region or zone of the biomaterial. In conclusion, ostrich pericardium exhibits strong resistance to rupture, even when sutured. The selection method used ensures the homogeneity of the samples and, thus, of the results. The angle of the suture with respect to the longitudinal axis, where the load is centered, determines the shear stress produced by the suture and the mechanical behavior of each suture material. (C) 2002 Wiley Periodicals, Inc.
C1 Clin Puerta De Hierro, Serv Cirugia Expt, Madrid, Spain.
   Serv Biostadist, Madrid, Spain.
   Clin Puerta De Hierro, Serv Cirugia Cardiovasc, Madrid, Spain.
   Escuela Tecn Super Ingn Ind, Dept Mecan Estructural & Resisten Mat, Madrid, Spain.
RP Paez, JMG (reprint author), Clin Puerta De Hierro, Serv Cirugia Expt, Madrid, Spain.
EM ejorge@hpth.insalud.es
CR BERNAL JM, 1995, ANN THORAC SURG, V60, pS248, DOI 10.1016/0003-4975(95)00218-A
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   BURR LH, 1995, ANN THORAC SURG, V60, pS264, DOI 10.1016/0003-4975(95)00300-A
   Bustamante John, 1996, Archivos del Instituto de Cardiologia de Mexico, V66, P229
   CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635
   Carrera San Martin A., 1993, Biomaterials, V14, P76, DOI 10.1016/0142-9612(93)90079-H
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   EDWARDS TJ, 1995, ANN THORAC SURG, V60, pS211, DOI 10.1016/0003-4975(95)00220-F
   GLOWER DD, 1995, J THORAC CARDIOV SUR, V109, P877, DOI 10.1016/S0022-5223(95)70311-X
   Gratzer PF, 1996, J BIOMED MATER RES, V31, P533, DOI 10.1002/(SICI)1097-4636(199608)31:4<533::AID-JBM14>3.0.CO;2-H
   GRUNKEMEIER GL, 1994, J THORAC CARDIOV SUR, V108, P709
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kent PD, 1998, CARDIOVASC PATHOL, V7, P9, DOI 10.1016/S1054-8807(97)00040-9
   KUNZELMAN KS, 1993, J LONG-TERM EFF MED, V3, P161
   Levy R J, 1994, J Heart Valve Dis, V3, P101
   Munro AI, 1995, ANN THORAC SURG, V59, pS470
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 1996, J BIOMED MATER RES, V30, P47
   Paez JMG, 1996, BIOMATERIALS, V17, P1677, DOI 10.1016/0142-9612(96)87647-2
   PAEZ JMG, 1994, BIOMATERIALS, V5, P172
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   San Martin AC, 1998, J MATER SCI-MATER M, V9, P77
   Smith DB, 1997, J HEART VALVE DIS, V6, P424
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P105
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
NR 30
TC 5
Z9 5
U1 1
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2002
VL 62
IS 1
BP 73
EP 81
DI 10.1002/jbm.10266
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 579VW
UT WOS:000177199300008
DA 2018-10-19
ER

PT J
AU Kusy, RP
   Ambrose, WW
   LaVanier, LA
   Newman, JG
   Whitley, JQ
AF Kusy, RP
   Ambrose, WW
   LaVanier, LA
   Newman, JG
   Whitley, JQ
TI Analyses of rampant corrosion in stainless-steel retainers of
   orthodontic patients
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE AES; corrosion; ESCA; stainless steel; orthodontics
ID LOCALIZED CORROSION; ARTIFICIAL SALIVA; TITANIUM IMPLANTS;
   SURFACE-ANALYSIS; NICKEL-TITANIUM; APPLIANCES; CHROMIUM; RESISTANCE;
   BEHAVIOR; INVITRO
AB Retainers were collected from private, university, and dental labs. After viewing these corroded and control appliances using scanning electron microscopy, corroded maxillary and mandibular retainers were selected along with a control stainless-steel retainer for m-depth chemical analysis. Using electron spectroscopy for chemical analysis, monochromated Al x-rays were rastered over areas 1.5 X 0.3 mm. After survey spectra were acquired, high-resolution multiplex scans were obtained and binding energy shifts were noted. Using Auger electron spectroscopy, a spot size of approximately 30 nm was analyzed. Photos, survey scans, and depth profiles were acquired using a 3.5kV Ar+ ion beam that was calibrated using a SiO2 standard. Via electron spectroscopy for chemical analysis, the brown stains contained Fe and Cr decomposition products in which three carbon species were present. Proteinaceous N was found as amines or amides. No Ni was present because it had solubilized. The Cr:Fe ratio indicated severe Cr depletion in the stained regions (0.2) versus the control regions (1.3). The stained regions appeared mottled, having both dark and light areas. Via AES, the dark versus light areas of the stained regions indicated that there vas an absence versus a presence of both Cr and Ni. In the dark areas corrosion penetrated 700 nm; in the light areas the depth equaled 30 nm. By comparison, the passivated layer of the control retainer was 10-nm thick. After sputtering away the affected areas, all specimens had similar spectra as the control regions. The bacterial environment created the mottled appearance and induced electrochemical potential differences so that, upon reducing the passivated layer, an otherwise corrosion-resistant alloy became susceptibie to rampant corrosion. An integrated biological-biomaterial model is presented for the classic case of an orthodontic acrylic-based stainless steel retainer subject to crevice corrosion. (C) 2002 Wiley Periodicals, Inc.
C1 Univ N Carolina, Dept Orthodont, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Dent Res Ctr, Chapel Hill, NC 27599 USA.
   Phys Elect, Evans PHI, Eden Prairie, MN 55344 USA.
RP Kusy, RP (reprint author), Univ N Carolina, Dept Orthodont, Bldg 210-H,Room 313, Chapel Hill, NC 27599 USA.
CR AMEEN AP, 1993, CLIN ORAL IMPLAN RES, V4, P144, DOI 10.1034/j.1600-0501.1993.040305.x
   BARRETT RD, 1993, AM J ORTHOD DENTOFAC, V103, P8, DOI 10.1016/0889-5406(93)70098-9
   Beddoes J, 1999, J MATER SCI-MATER M, V10, P389, DOI 10.1023/A:1008918929036
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   BOYER HE, 1975, METALS HDB, V10, P347
   BRANTLEY WA, 2001, ORTHODONTIC MAT SCI, P61
   BRIANT CL, 1982, METALL TRANS A, V13, P745, DOI 10.1007/BF02642387
   Brockhurst P J, 1989, Aust Orthod J, V11, P96
   BRUNDLE CR, 1992, ENCY MAT CHARACTERIZ, P315
   Cortada M, 1997, BIO-MED MATER ENG, V7, P213
   DAVISON RM, 1987, METALS HDB, V13, P547
   DOWLING NJE, 1990, CORROSION, V90, P532
   DOWLING NJE, 1991, CORROSION HDB, P341
   Eliades T, 2000, EUR J ORTHODONT, V22, P317, DOI 10.1093/ejo/22.3.317
   FRANKLIN MJ, 1991, CURR OPIN BIOTECH, V2, P450, DOI 10.1016/S0958-1669(05)80155-7
   Fritz JD, 2001, ADV MATER PROCESS, V159, P36
   Gebeau RC, 2001, ADV MATER PROCESS, V159, P46
   GRIMSDOTTIR MR, 1992, AM J ORTHOD DENTOFAC, V101, P525, DOI 10.1016/0889-5406(92)70127-V
   GWINNETT AJ, 1982, AM J ORTHOD, V82, P441
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   HARVEY P. D., 1982, ENG PROPERTIES STEEL, P273
   Ibars Jose R., 1992, Microbiologia (Madrid), V8, P63
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Kerber SJ, 2000, ADV MATER PROCESS, V158, P33
   KEROSUO H, 1995, ANGLE ORTHOD, V65, P111
   Kerosuo H, 1997, AM J ORTHOD DENTOFAC, V111, P595, DOI 10.1016/S0889-5406(97)70310-X
   Kerosuo H, 1997, CONTACT DERMATITIS, V36, P112, DOI 10.1111/j.1600-0536.1997.tb00431.x
   Kilpadi DV, 1998, J BIOMED MATER RES, V40, P646, DOI 10.1002/(SICI)1097-4636(19980615)40:4<646::AID-JBM17>3.3.CO;2-L
   Kim H, 1999, ANGLE ORTHOD, V69, P39
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   KULIGOWSKI J, 1992, ARCH ENVIRON CON TOX, V23, P211, DOI 10.1007/BF00212277
   Kusy RP, 2000, J BIOMED MATER RES, V52, P797, DOI 10.1002/1097-4636(20001215)52:4<797::AID-JBM25>3.3.CO;2-0
   Kusy RP, 2000, CLIN ORTHOD RES, V3, P230
   LakatosVarsanyi M, 1997, INT J ORAL MAX IMPL, V12, P387
   LESLIE B, 1999, ADV MAT P, V155, P58
   Lindsten R, 1997, J Orofac Orthop, V58, P100
   LINNERT GE, 1967, JOINING STAINLESS ST, P1
   LITTLE B, 1991, INT MATER REV, V36, P253, DOI 10.1179/imr.1991.36.1.253
   LITTLE B, 1990, MICROBIAL CORROSION, P635
   LUKANICH J, 1998, CHEM ONLINE NEWS TEA
   LULA RA, 1986, STAINLESS STEEL, P105
   MAIJER R, 1982, AM J ORTHOD DENTOFAC, V81, P43, DOI 10.1016/0002-9416(82)90287-1
   MASON JF, 1968, SELECTION STAINLESS, P67
   MCCLYMONDS NL, 1968, FORMING STAINLESS ST, P27
   MonteroOcampo C, 1996, J BIOMED MATER RES, V32, P583, DOI 10.1002/(SICI)1097-4636(199612)32:4<583::AID-JBM11>3.0.CO;2-F
   MORRIS LA, 1968, SELECTION STAINLESS, P32
   MUELLER HJ, 1982, AM J ORTHOD DENTOFAC, V81, P140, DOI 10.1016/0002-9416(82)90038-0
   MUELLER HJ, 1983, J AM DENT ASSOC, V106, P43, DOI 10.14219/jada.archive.1983.0003
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nishida T, 1997, J Nihon Univ Sch Dent, V39, P38
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   PARK HY, 1983, AM J ORTHOD DENTOFAC, V84, P156, DOI 10.1016/0002-9416(83)90180-X
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   ROSSIWALL B, 1974, QUINTESSENCE INT, V5, P435
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   SARKAR NK, 1983, J ORAL REHABIL, V10, P121, DOI 10.1111/j.1365-2842.1983.tb00106.x
   SPELLER FN, 1951, CORROSION CAUSES PRE, P206
   Srivastava RB, 1998, PURE APPL CHEM, V70, P627, DOI 10.1351/pac199870030627
   STOECKER JG, 1987, METALS HDB, V13, P314
   SUTOW EJ, 1980, J BIOMED MATER RES, V14, P587, DOI 10.1002/jbm.820140505
   TOMS AP, 1988, EUR J ORTHODONT, V10, P87
   UHLIG HH, 1971, CORROSION CORROSION, P96
   VAUGHAN D, 1989, ENERGY DISPERSIVE XR, P6
   von Fraunhofer J A, 1997, Semin Orthod, V3, P198, DOI 10.1016/S1073-8746(97)80070-9
   WALCH M, 1983, P NACE CORR 83
   WHITE DC, 1988, BIOPR ENG S 1988 CHI, P89
   Williams D, 1996, BIOMATERIALS SCI INT, P260
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P181, DOI 10.1016/0142-9612(88)90119-6
   Wilson M, 1997, BIOMATERIALS, V18, P53, DOI 10.1016/S0142-9612(96)00084-1
   Yang S S, 1998, J Microbiol Immunol Infect, V31, P151
   YANG SS, 1996, CHINESE J MICROBIOL, V29, P185
   1995, ADV MAT P, V147, P36
   1998, ADV MAT P, V154, P63
NR 73
TC 4
Z9 4
U1 0
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD OCT
PY 2002
VL 62
IS 1
BP 106
EP 118
DI 10.1002/jbm.10226
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 579VW
UT WOS:000177199300012
PM 12124792
DA 2018-10-19
ER

PT J
AU Yang, JM
   Lin, HT
   Lai, WC
AF Yang, JM
   Lin, HT
   Lai, WC
TI Properties of modified hydroxyl-terminated polybutadiene based
   polyurethane membrane
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE hydroxyl-terminated polybutadiene; polyurethane; epoxidation; heparin;
   surface energy; protein adsorption
ID SBS-G-VP; DMAEMA COPOLYMER MEMBRANE; BIOMATERIAL USAGE; HEPARIN;
   RADIATION; EPOXIDATION
AB One hydroxyl-terminated polybutadiene (HTPB) based polyurethane (PU) solution was prepared by reacting equal equivalent of 4,4-methylene diphenyl diisocyanate (MDI) and HTPB with 1,4-butanediol (BDO) as chain extender. The PU was then cast into membrane. The kinetic of epoxidation of HTPB-based PU membrane by an in situ generated peracid method was studied by infrared spectroscopy. The epoxidized PU membrane was named as EPU. The other HTPB-based PU with different molar ratios of dimethyol propionic acid (DPA) and 1,4-BDO as chain extender were synthesized by solution polymerization. The present PU was then cast into a membrane and named as PUDPA. 1-Ethyl-3-(3-dimethyamino propyl) carbodiimide (EDAC) was used in the linking reaction to graft heparin to PUDPA to get heparin containing PUDPA membrane and named as PUDPA-Hep. The membranes were subsequently characterized by the Fourier transform infrared spectroscopy and electron spectroscopy for chemical analysis (ESCA). The properties of PU such as density and gas permeation test were measured. Wettability and protein adsorption on the membranes were also evaluated from the water content, contact angle, and protein adsorptions of fibrinogen and albumin on the PU membrane. The diffusion coefficient of water in the membrane was determined in accordance with the Fickian diffusion mechanism. By using Kaelble's equation and the contact angle data, the surface energy of PU membrane was determined. The protein adsorption of fibrinogen and albumin on PU membranes was evaluated. It was found that oxirane content in the EPU membrane increased with epoxidation time. The surface energy of EPU and PUDPA membranes increased with the increasing of oxirane content and DPA content on the EPU and PUDPA membrane, respectively, whereas the contact angle decreased inversely. The surface tension of wet EPU and PUDPA membrane was higher than that of dry EPU and PUDPA membrane, respectively. The adsorption of albumin and fibrinogen decreased with increasing the degree of epoxidation and the DPA content, respectively. After heparin treatment, the contact angel and protein absorption on PUDPA-Hep were lower than those on PUDPA. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 333, Taiwan.
CR Abusafieh A, 1997, J APPL POLYM SCI, V63, P75, DOI 10.1002/(SICI)1097-4628(19970103)63:1<75::AID-APP8>3.0.CO;2-P
   ADAMSON AW, 1990, PHYSICAL CHEM SURFAC
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   EBERT CD, 1982, THROMB RES, V26, P43, DOI 10.1016/0049-3848(82)90149-9
   GOOSEN MFA, 1980, THROMB RES, V20, P543, DOI 10.1016/0049-3848(80)90142-5
   HSIUE GH, 1990, J POLYM SCI POL CHEM, V28, P3761, DOI 10.1002/pola.1990.080281319
   ITO Y, 1987, BIOMATERIALS APPL, V2, P235
   KAELBLE DH, 1977, POLYMER, V18, P475, DOI 10.1016/0032-3861(77)90164-1
   KIIM SW, 1985, CRC CRIT R BIOCOMP, V1, P229
   LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474
   MINOURA N, 1993, BIOMEDICAL APPL POLY, P118
   PARK KD, 1992, J BIOMED MATER RES, V26, P739, DOI 10.1002/jbm.820260605
   PLATE NA, 1986, ADV POLYM SCI, V79, P96
   Ratner BD, 1996, BIOMATERIALS SCI, P133
   TAKAHARA A, 1990, Artificial Organs, V14, P87
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 2001, J MEMBRANE SCI, V187, P159, DOI 10.1016/S0376-7388(01)00340-4
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yang JM, 2001, J MEMBRANE SCI, V183, P37, DOI 10.1016/S0376-7388(00)00550-0
NR 24
TC 43
Z9 47
U1 7
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD OCT 1
PY 2002
VL 208
IS 1-2
BP 105
EP 117
AR PII S0376-7388(02)00180-1
DI 10.1016/S0376-7388(02)00180-1
PG 13
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 597MZ
UT WOS:000178226500011
DA 2018-10-19
ER

PT J
AU Barboza, EP
   de Souza, RO
   Caula, AL
   Neto, LG
   Caula, FD
   Duarte, MEL
AF Barboza, EP
   de Souza, RO
   Caula, AL
   Neto, LG
   Caula, FD
   Duarte, MEL
TI Bone regeneration of localized chronic alveolar defects utilizing cell
   binding peptide associated with anorganic bovine-derived bone mineral: A
   clinical and histological study
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE guided bone regeneration; cell binding peptide; alveolar ridge
   augmentation; animal studies; membranes; bioabsorbable
ID PERIODONTAL OSSEOUS DEFECTS; RIDGE AUGMENTATION; HYDROXYAPATITE; MATRIX;
   COMBINATION; MEMBRANES; COLLAGEN; PRESERVATION; IMPLANTS; DOGS
AB Background: Osteoinduction to treat osseous defects has been attempted by several means. Some clinical studies have demonstrated that a synthetic cell binding peptide (P-15) with anorganic bovine derived bone matrix (ABM) has the ability to enhance bone regeneration. These studies suggest that more histological data are necessary to better understand this process. We have developed a Class III chronic alveolar defect animal model to investigate space-maintaining regenerative materials. The objective of this study was to clinically and histologically evaluate the use of P-15/ABM with or without a bioabsorbable membrane (M) to regenerate localized chronic alveolar ridge defects in dogs.
   Methods: Six adult, male mongrel dogs were used in this study. Bilateral, Class 111, alveolar defects were surgically produced following extraction of the mandibular second premolar teeth and local reduction of the alveolar ridge. After an 8-week healing interval, mucoperiosteal flaps were elevated. P-15/ABM with or without bioabsorbable membranes were implanted into contralateral defects in 10 sites. Two sites received no biomaterial (controls). Mucoperiosteal flaps were advanced over the P-15/ABM or P-15/ABM/M constructs and sutured. Pre- and postaugmentation clinical evaluation was done utilizing periodontal probes and calipers. The animals were sacrificed 12 weeks postaugmentation and block specimens processed for histologic evaluation.
   Results: Clinical results showed no significant statistical augmentation on the control group (0.0 +/- 0.6 mm). In all experimental sites utilizing P-15/ABM or P-15/ABM/M, relevant ridge augmentation was observed (3.6 +/- 2.0 mm and 2.9 +/- 1.9 mm, respectively). Histologically, all experimental sites showed active bone formation with plump osteoblast and osteoid matrix deposition in the treated area. Bone ingrowth filled the area of the defects treated with P-15/ABM/M. Few P-15/ABM particles were seen in the cellular fibrous tissue surrounding the new formed bone trabeculae.
   Conclusions: P-15/ABM with or without membranes can produce a significant clinical ridge augmentation. Bone formation was histologically observed in all test areas. The association of a membrane with P15/ABM seemed to enhance the process of bone formation.
C1 Univ Fed Fluminense, Rio De Janeiro, Brazil.
   Brazilian Inst Periodontol, Rio De Janeiro, Brazil.
   Brazilian Air Force Cent Hosp, Rio De Janeiro, Brazil.
   Rio de Janeiro Fire Dept, Dept Periodontol, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Histol & Embryol, Rio De Janeiro, Brazil.
RP Barboza, EP (reprint author), Av Pres Wilson,165,Sala 810,Ctr, BR-20030020 Rio De Janeiro, Brazil.
CR Abrams L, 1980, Compend Contin Educ Gen Dent, V1, P205
   Anjos Beatriz Dos, 1998, Journal of Periodontology, V69, P454
   Artzi Z, 1998, J PERIODONTOL, V69, P1062, DOI 10.1902/jop.1998.69.9.1062
   Barboza E P, 1999, Implant Dent, V8, P167, DOI 10.1097/00008505-199908020-00010
   Barboza EP, 1999, INT J PERIODONT REST, V19, P601
   Barboza EP, 2001, J PERIODONTOL, V72, P538, DOI 10.1902/jop.2001.72.4.538
   BARBOZA EP, 1993, THESIS BOSTON U BOST
   Becker W, 1990, Int J Periodontics Restorative Dent, V10, P376
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155
   Brunel G, 2001, J PERIODONTOL, V72, P257, DOI 10.1902/jop.2001.72.2.257
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Buser D, 1993, Int J Periodontics Restorative Dent, V13, P29
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x
   Buser D, 1994, GUIDED BONE REGENERA, P31
   CALLAN DP, 1993, J PERIODONTOL, V64, P575, DOI 10.1902/jop.1993.64.6.575
   Caplanis N, 1997, INT J ORAL MAX IMPL, V12, P634
   Cho KS, 1998, CLIN ORAL IMPLAN RES, V9, P419, DOI 10.1034/j.1600-0501.1996.090607.x
   Denissen H, 1997, J PERIODONTAL RES, V32, P40, DOI 10.1111/j.1600-0765.1997.tb01380.x
   Gross J S, 1997, Compend Contin Educ Dent, V18, P1013
   Gross JS, 1997, COMPEND CONTIN ED DE, V18, P1020
   Gross JS, 1997, COMPEND CONTIN ED DE, V18, P1024
   HAGELBRADWAY S, 1989, J ORAL PATHOL MED, V18, P344, DOI 10.1111/j.1600-0714.1989.tb01564.x
   Krauser J T, 2000, Implant Dent, V9, P298, DOI 10.1097/00008505-200009040-00004
   Lekovic V, 1998, J PERIODONTOL, V69, P1044, DOI 10.1902/jop.1998.69.9.1044
   LYNCH SE, 1989, J CLIN PERIODONTOL, V16, P545, DOI 10.1111/j.1600-051X.1989.tb02334.x
   Mellonig J T, 1993, Int J Periodontics Restorative Dent, V13, P108
   Misch C E, 1991, Int J Oral Implantol, V8, P13
   Nevins M, 1992, Int J Periodontics Restorative Dent, V12, P96
   Nevins M, 1996, Int J Periodontics Restorative Dent, V16, P8
   NYMAN S, 1991, J CLIN PERIODONTOL, V18, P494, DOI 10.1111/j.1600-051X.1991.tb02322.x
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   SEIBERT J, 1990, J PERIODONTOL, V61, P157, DOI 10.1902/jop.1990.61.3.157
   Seyedin S M, 1989, Oral Surg Oral Med Oral Pathol, V68, P527, DOI 10.1016/0030-4220(89)90232-6
   Sigurdsson TJ, 2001, INT J PERIODONT REST, V21, P461
   Smiler D G, 2001, Implant Dent, V10, P139
   Smukler H, 1995, Int J Oral Maxillofac Implants, V10, P537
   Wozney J M, 1990, J Cell Sci Suppl, V13, P149
   YOUGER EM, 1989, J ORTHOP TRAUMA, V3, P192
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Yukna RA, 2000, J PERIODONTOL, V71, P1671, DOI 10.1902/jop.2000.71.11.1671
NR 41
TC 24
Z9 26
U1 0
U2 6
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD OCT
PY 2002
VL 73
IS 10
BP 1153
EP 1159
DI 10.1902/jop.2002.73.10.1153
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 608AN
UT WOS:000178823100009
PM 12416773
DA 2018-10-19
ER

PT J
AU Biresaw, G
   Carriere, CJ
AF Biresaw, G
   Carriere, CJ
TI Interfacial tension of poly(lactic acid)/polystyrene blends
SO JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS
LA English
DT Article
DE biodegradable polyesters; biopolymers; compatibility; imbedded fiber
   retraction (IFR); interfacial tension; poly(lactic acid); polymer
   blends; polystyrene; solubility parameter; surface energy
ID SOLUBILITY PARAMETERS; POLYMER BLENDS; TEMPERATURE; ACID); DEPENDENCE;
   FIBERS
AB Poly(lactic acid) (PLA) is a biodegradable synthetic polyester with unique properties that make it an excellent candidate for biomaterial blends. It provides improved moisture resistance to blends with biopolymers and biodegradability/biocompatibility to blends with synthetic polymers, without impairing the useful properties of blend components. The successful development of materials from blends of PLA requires an understanding of the factors affecting the interfacial properties of such blends. In this work, the effect of temperature on the interfacial tension of PLA/ polystyrene (PS) blends was measured at 170-200 degreesC with the imbedded fiber retraction (IFR) method. IFR allows for the direct measurement of the interfacial tension of blends with high molecular weight/high viscosity components. In the temperature range studied, the interfacial tension of PLA/PS was independent of temperature and had a value of 5.4 +/- 1.3 dyn/cm. The interfacial tension was also calculated from the surface energies of PLA and PS with geometric mean (GM), harmonic mean (HM), and Antonoffs equations and from solubility parameters with the procedure of Luciani et al. IFR measured values were similar to those predicted by the procedure of Luciani et al. and Antonoffs equations, which gave 4.4 and 3.0 +/- 1.4 dyn/cm, respectively. The GM and HM methods predicted much lower values of 1.1 +/- 0.5 and 1.7 +/- 1.1 dyn/cm, respectively. (C) 2002 Wiley Periodicals, Inc.
C1 USDA ARS, Natl Ctr Agr Utilizat Res, Cereal Prod & Food Res Unit, Peoria, IL 61604 USA.
RP Biresaw, G (reprint author), USDA ARS, Natl Ctr Agr Utilizat Res, Cereal Prod & Food Res Unit, 1815 N Univ St, Peoria, IL 61604 USA.
CR ANASTASIADIS SH, 1988, MACROMOLECULES, V21, P2980, DOI 10.1021/ma00188a015
   Antonoff G, 1942, J PHYS CHEM-US, V46, P497, DOI 10.1021/j150418a009
   Antonov G.N., 1907, J CHIM PHYS PCB, V5, P364
   BAO YT, 1988, J POLYM SCI POL LETT, V26, P41, DOI 10.1002/pol.1988.140260106
   Bird RB, 1987, DYNAMICS POLYM LIQUI, V1, P169
   Biresaw G, 2001, J POLYM SCI POL PHYS, V39, P920, DOI 10.1002/polb.1067
   Carriere CJ, 2000, RHEOL ACTA, V39, P476, DOI 10.1007/s003970000105
   CARRIERE CJ, 1989, J RHEOL, V33, P681, DOI 10.1122/1.550033
   Chandy T, 2001, DRUG DELIV, V8, P77
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   COHEN A, 1989, RHEOL ACTA, V28, P223, DOI 10.1007/BF01332854
   Du Y., 1996, PHYS PROPERTIES POLY, P227
   Gajria AM, 1996, POLYMER, V37, P437, DOI 10.1016/0032-3861(96)82913-2
   Grulke EA, 1989, POLYM HDB, pVII/519
   HANSEN CM, 2000, HANSEN SOLUBILITY PA, P186
   Hartmann MH, 1998, BIOPOLYMERS RENEWABL, P367
   HELFAND E, 1971, J POLYM SCI POL LETT, V9, P741, DOI 10.1002/pol.1971.110091006
   HELFAND E, 1978, MACROMOLECULES, V11, P960, DOI 10.1021/ma60065a023
   HELFAND E, 1975, J CHEM PHYS, V62, P1327, DOI 10.1063/1.430632
   HOY KL, 1970, J PAINT TECHNOL, V42, P76
   Hoy KL, 1989, J COATED FABRICS, V19, P53
   JONES NL, 2000, ASTM SPEC TECH PUBL, V1396, P69
   KAMMER HW, 1977, Z PHYS CHEM-LEIPZIG, V258, P1149
   Kaplan DL, 1998, BIOPOLYMERS RENEWABL, P1, DOI DOI 10.1007/978-3-662-03680-8_
   Krevelen DV, 1990, PROPERTIES POLYM, P189
   Lawton J. W., 1997, CEREALS NOVEL USES P, P43
   Luciani A, 1996, POLYM NETWORK BLEND, V6, P41
   Mohanty AK, 2000, MACROMOL MATER ENG, V276, P1, DOI 10.1002/(SICI)1439-2054(20000301)276:1<1::AID-MAME1>3.0.CO;2-W
   NOOLANDI J, 1982, MACROMOLECULES, V15, P482, DOI 10.1021/ma00230a054
   Owen M. J., 1996, PHYSICAL PROPERTIES, P669
   Pham HT, 1997, POLYM ENG SCI, V37, P636, DOI 10.1002/pen.11706
   RINGARDLEFEBVRE C, 1994, LANGMUIR, V10, P2376, DOI 10.1021/la00019a057
   Rocha G., 1992, POLYM PREPR, V33, P454
   ROE RJ, 1975, J CHEM PHYS, V62, P490, DOI 10.1063/1.430502
   SIEMANN U, 1992, EUR POLYM J, V28, P293, DOI 10.1016/0014-3057(92)90192-5
   SMALL PA, 1953, J APPL CHEM, V3, P71
   SOHN JE, 1989, J APPL POLYM SCI, V37, P2627, DOI 10.1002/app.1989.070370914
   TSAI FJ, 1999, Patent No. 5910545
   VANOENE H, 1972, J COLLOID INTERF SCI, V40, P448, DOI 10.1016/0021-9797(72)90355-4
   Wang L, 2000, POLYM ENG SCI, V40, P499, DOI 10.1002/pen.11182
   WU S, 1989, POLYM HDB, V6, P411
   Wu S., 1982, POLYM INTERFACE ADHE, P67
NR 42
TC 61
Z9 62
U1 3
U2 27
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-6266
J9 J POLYM SCI POL PHYS
JI J. Polym. Sci. Pt. B-Polym. Phys.
PD OCT 1
PY 2002
VL 40
IS 19
BP 2248
EP 2258
DI 10.1002/polb.10290
PG 11
WC Polymer Science
SC Polymer Science
GA 593JX
UT WOS:000177989000011
DA 2018-10-19
ER

PT J
AU Kropp, BP
   Cheng, EY
   Pope, JC
   Brock, JW
   Koyle, MA
   Furness, PD
   Weigel, ND
   Keck, RW
   Kropp, KA
AF Kropp, BP
   Cheng, EY
   Pope, JC
   Brock, JW
   Koyle, MA
   Furness, PD
   Weigel, ND
   Keck, RW
   Kropp, KA
TI Use of small intestinal submucosa for corporal body grafting in cases of
   severe penile curvature
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Section-on-Urology-American-Academy-of-Pediatrics
CY OCT 20-22, 2001
CL SAN FRANCISCO, CALIFORNIA
SP Amer Acad Pediatrics, Sec Urology
DE hypospadias; tissue engineering; transplants; penis
ID DERMAL GRAFTS; CHORDEE; HYPOSPADIAS; MANAGEMENT; REPAIR
AB Purpose: Small intestinal submucosa is a unique biomaterial that has been found to promote tissue specific regeneration in the urinary tract. We present our experimental and clinical experience with small intestinal submucosa (SurgiSis, Cook Biotech, Spencer, Indiana) for pediatric corporal body reconstruction.
   Material and Methods: A total of 20 Fischer rats underwent implantation of a 7 X 3 mm. small intestinal submucosa graft following excision of an ellipse of tunica albuginea and 14 control animals underwent tunical excision with reimplantation of this autologous segment. The animals were euthanized, and the penis was sectioned and histologically studied at intervals of 1, 2, 4, 6, 16 and 24 weeks. In 15 pediatric patients small intestinal submucosa was used for corporal body grafting. The grafting procedure was performed along the ventral (hypospadias cases) or dorsal (epispadias cases) surface of the corporal bodies. The tunica albuginea was incised full thickness at the point of maximal curvature down to the cavernosal tissue and the defect was filled with a single layer of small intestinal submucosa.
   Results: Measurements of the animal small intestinal submucosa grafts did not reveal significant graft contraction through 6 months. There was no graft expansion or ballooning after pharmacological induction of an artificial erection. Histologically, marked inflammation at 1 week precipitously decreased to a normal appearing tunica albuginea at 3 and 6 months. In all clinical cases small intestinal submucosa was found to be technically easy to handle. Mean followup is 14 months (range 5 to 26). All patients have a straight phallus as documented by observation of spontaneous erections or artificial erection at the time of stage 2 hypospadias repair. No complications occurred.
   Conclusions: Small intestinal submucosa demonstrates tissue specific regeneration properties in the rat and human tunica albuginea. It is an off-the-shelf material that is safe, technically easy to use and readily available.
C1 Childrens Hosp, Oklahoma City, OK USA.
   Vanderbilt Univ, Childrens Hosp, Nashville, TN USA.
   Univ Denver, Childrens Hosp, Denver, CO USA.
   Med Coll Ohio, Toledo, OH 43699 USA.
RP Kropp, BP (reprint author), Univ Oklahoma, Hlth Sci Ctr, Dept Urol, 920 Stanton L Young Blvd,WP 3150, Oklahoma City, OK 73014 USA.
CR AIKEN SW, 1994, VET COMP ORTHOPAED, V7, P124
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Baskin LS, 1998, BRIT J UROL, V81, P895
   Baskin LS, 1998, J UROLOGY, V160, P1108, DOI 10.1016/S0022-5347(01)62711-3
   Bologna RA, 1999, UROLOGY, V53, P608, DOI 10.1016/S0090-4295(98)00656-6
   BRIGHTMAN AO, 1996, 1 SIS S ORL FLOR
   Caesar RE, 2000, J UROLOGY, V164, P1691, DOI 10.1016/S0022-5347(05)67084-X
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   DUCKETT JWJ, 1985, J UROLOGY, V134, P313
   HORTON CE, 1993, J UROLOGY, V150, P452, DOI 10.1016/S0022-5347(17)35508-8
   HORTON CE, 1973, PLAST RECONSTR SURG, V52, P503, DOI 10.1097/00006534-197311000-00004
   Knoll LD, 2001, UROLOGY, V57, P753, DOI 10.1016/S0090-4295(00)01079-7
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Lindgren BW, 1998, J UROLOGY, V160, P1128, DOI 10.1016/S0022-5347(01)62715-0
   PERLMUTTER AD, 1985, J UROLOGY, V134, P311, DOI 10.1016/S0022-5347(17)47141-2
   Pope JC, 1996, UROLOGY, V48, P124, DOI 10.1016/S0090-4295(96)00097-0
   Vandersteen DR, 1998, J UROLOGY, V160, P1131, DOI 10.1016/S0022-5347(01)62716-2
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 22
TC 37
Z9 38
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 2002
VL 168
IS 4
BP 1742
EP 1745
DI 10.1097/01.ju.0000028154.79247.ca
PN 2
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 596VW
UT WOS:000178188000039
PM 12352349
DA 2018-10-19
ER

PT J
AU De Filippo, RE
   Yoo, JJ
   Atala, A
AF De Filippo, RE
   Yoo, JJ
   Atala, A
TI Urethral replacement using cell seeded tubularized collagen matrices
SO JOURNAL OF UROLOGY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Section-on-Urology-American-Academy-of-Pediatrics
CY OCT 20-22, 2001
CL SAN FRANCISCO, CALIFORNIA
SP Amer Acad Pediatrics, Sec Urology
DE hypospadias, urethral stricture; tissue engineering; muscles, urothelium
ID SKIN-GRAFT URETHROPLASTY; BUCCAL MUCOSAL GRAFTS; RECONSTRUCTION; REPAIR;
   EXPERIENCE; FLAPS
AB Purpose: Acellular collagen matrices derived from bladder submucosa have been used successfully as an off-the-shelf biomaterial for urethral replacement, experimentally and clinically in an onlay fashion. We investigated whether collagen matrices, either alone or with autologous cells, could be used for tubularized urethral replacement.
   Materials and Methods: Acellular collagen matrices were processed and tubularized. Ten rabbits underwent an open bladder biopsy with subsequent cell expansion. Autologous bladder cells were grown and seeded onto the pre-configured tubular matrices. A 1 cm. long urethral segment was excised in 24 male rabbits. Urethroplasty was performed with the tubularized collagen matrices seeded with cells in 12 animals and without cells in 12. Serial urethrography was performed preoperatively and at 1, 2, 3 and 6 months postoperatively. Retrieved urethras were analyzed grossly, histologically, immunocytochemically and with Western blots. Contractility and the presence of neurotransmitter receptors were confirmed with organ bath studies.
   Results: Serial urethrography confirmed the maintenance of a wide urethral caliber without any signs of strictures in animals implanted with the cell seeded matrices. The urethral segments replaced with the collagen scaffolds without cells demonstrated strictures and graft collapse at all time points. The implanted cell seeded matrices had a normal urethral architecture by 1 month, consisting of a transitional cell layer surrounded by muscle cell fiber bundles with increasing cellular organization with time. Epithelial and smooth muscle phenotypes were confirmed immunocytochemically and with Western blot analyses using pancytokeratins AE1/AE3 and smooth muscle specific a-actin antibodies. Formation of a transitional cell layer was confirmed in the matrices implanted without cells but only scant unorganized muscle fiber bundles were present, mostly at the anastomotic sites. Organ bath studies demonstrated the capacity for contractility along with cholinergic and adrenergic specific receptors in the tissue engineered scaffolds compared to controls.
   Conclusions: These results show that collagen matrices seeded with cells form normal urethral tissue can be used for tubularized replacement, whereas tubularized collagen matrices alone without cells lead to poor tissue formation and strictures. The collagen matrices seeded with cells may offer a useful alternative in the future for patients requiring a tubularized urethral segment replacement.
C1 Childrens Hosp, Dept Urol, Lab Tissue Engn & Cellular Therapeut, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA USA.
RP Atala, A (reprint author), Childrens Hosp, Dept Urol, Lab Tissue Engn & Cellular Therapeut, 300 Longwood Ave,Enders 450, Boston, MA 02115 USA.
RI Sano, Michael/E-1715-2011
OI Atala, Anthony/0000-0001-8186-2160
CR Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Barbagli G, 1996, J UROLOGY, V155, P123, DOI 10.1016/S0022-5347(01)66566-2
   BAZEED MA, 1983, UROLOGY, V21, P53, DOI 10.1016/0090-4295(83)90123-1
   Caldamone AA, 1998, UROLOGY, V51, P15, DOI 10.1016/S0090-4295(98)00088-0
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen F, 2000, WORLD J UROL, V18, P67, DOI 10.1007/s003450050012
   CILENTO B, 1996, J UROL S, V155, pA371
   COURT B, 1973, J UROL NEPHROL, V79, P643
   Court B, 1971, J UROLOGIE NEPHROLOG, V77, P562
   Da Silva E A, 2000, Actas Urol Esp, V24, P235
   Ehrlich RM, 1996, J UROLOGY, V155, P131, DOI 10.1016/S0022-5347(01)66568-6
   Gaschignard N, 1999, PROG UROL, V9, P112
   GEARHART JP, 1993, J UROLOGY, V150, P627, DOI 10.1016/S0022-5347(17)35566-0
   HAKKY SI, 1977, BRIT J UROL, V49, P167, DOI 10.1111/j.1464-410X.1977.tb04093.x
   Iselin CE, 1999, J UROLOGY, V161, P815, DOI 10.1016/S0022-5347(01)61779-8
   Kassaby El A., 2000, Journal of Urology, V163, P70
   KINKEAD TM, 1994, J UROLOGY, V151, P1056, DOI 10.1016/S0022-5347(17)35179-0
   Koshima I, 1999, PLAST RECONSTR SURG, V103, P964, DOI 10.1097/00006534-199903000-00030
   Kropfl D, 1998, EUR UROL, V34, P216, DOI 10.1159/000019716
   OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220
   PALLESCHI JR, 1978, INVEST UROL, V15, P408
   Pansadoro V, 1999, J UROLOGY, V161, P1501, DOI 10.1016/S0022-5347(05)68938-0
   Riccabona M, 1999, Tech Urol, V5, P133
   Szulczewski D H, 1999, Mund Kiefer Gesichtschir, V3, P34, DOI 10.1007/s100060050090
   VINCENT MP, 1988, CLIN PLAST SURG, V15, P411
   VYAS PR, 1987, J UROLOGY, V137, P471, DOI 10.1016/S0022-5347(17)44071-7
   Yerkes EB, 1999, J UROLOGY, V162, P1442, DOI 10.1016/S0022-5347(05)68335-8
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 28
TC 146
Z9 152
U1 0
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 2002
VL 168
IS 4
BP 1789
EP 1792
DI 10.1097/01.ju.0000027662.69103.72
PN 2
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 596VW
UT WOS:000178188000059
PM 12352360
DA 2018-10-19
ER

PT J
AU Ito, A
   Kawamura, H
   Otsuka, M
   Ikeuchi, M
   Ohgushi, H
   Ishikawa, K
   Onuma, K
   Kanzaki, N
   Sogo, Y
   Ichinose, N
AF Ito, A
   Kawamura, H
   Otsuka, M
   Ikeuchi, M
   Ohgushi, H
   Ishikawa, K
   Onuma, K
   Kanzaki, N
   Sogo, Y
   Ichinose, N
TI Zinc-releasing calcium phosphate for stimulating bone formation
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Asian Bioceramics Symposium 2001 (ABC2001)
CY SEP   27, 2001
CL TOKYO INST TECH, TOKYO, JAPAN
SP Ceramic Soc Japan
HO TOKYO INST TECH
DE zinc-containing tricalcium phosphate; cell proliferation; bone
   formation; crystal growth; calcium phosphate cement
ID TISSUE-CULTURE; IN-VITRO; MAGNESIUM; CELLS
AB Zinc-containing tricalcium phosphate (ZnTCP) is biocompatible and bioactive, and functions as an effective zinc carrier. ZnTCP contains a maximum of 12 mol% of zinc. ZnTCP ceramics and composite ceramics of ZnTCP and hydroxyapatite (ZnTCP/HAP) with a (Ca+Zn)/P molar ratio of 1.60 were prepared by sintering at 1100 degreesC. ZnTCP/HAP continued to release zinc for more than 50 days in 0.9 wt.% sodium chloride solution. ZnTCP/HAP with a zinc content of 1.2 wt.% significantly increased osteoblastic MC3T3-E1 cell proliferation and alkaline phosphatase activity of rat stromal cells in vitro. ZnTCP/HAP with a zinc content of 0.316 wt.% increased bone formation by 51% (n = 6; p = 0.0509) 4 weeks after implantation in rabbit compared to the control without zinc. A zinc concentration within a noncytotoxic level of a solution does not completely block the crystal growth of apatite in the solution. When ZnTCP is added to calcium phosphate cement, the ZnTCP showed neither inhibitory nor promoting effect on the setting ability of the cement. All these findings suggest that the zinc-containing tricalcium phosphate is a biomaterial that has a pharmaceutical effect of promoting bone formation. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Natl Inst Adv Ind Sci & Technol, Tissue Engn Res Ctr, Tsukuba, Ibaraki 3058562, Japan.
   Ryugasaki Saiseikai Hosp, Dept Orthopaed, Ryugasaki, Ibaraki 3010854, Japan.
   Kobe Pharmaceut Univ, Kobe, Hyogo 6588558, Japan.
   Kyushu Univ, Grad Sch Dent Sci, Dept Biomat, Higashi Ku, Fukuoka 8128585, Japan.
   Waseda Univ, Sch Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan.
RP Ito, A (reprint author), Natl Inst Adv Ind Sci & Technol, Tissue Engn Res Ctr, Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.
RI Ito, Atsuo/M-6785-2018; Sogo, Yu/L-8045-2018
OI Ito, Atsuo/0000-0003-3318-040X; Sogo, Yu/0000-0003-1228-4648
CR BETTGER WJ, 1993, J NUTR BIOCHEM, V4, P194, DOI 10.1016/0955-2863(93)90052-X
   DELVES HT, 1985, CLIN ENDOCRINOL META, V14, P725, DOI 10.1016/S0300-595X(85)80014-1
   FUIERER TA, 1994, LANGMUIR, V10, P4721, DOI 10.1021/la00024a054
   Hamilton EI, 1973, SCIENCE TOTAL ENVIRO, V1, P341, DOI DOI 10.1016/0048-9697(73)90024-7
   IKEUCHI M, 1999, BIOCERAMICS, V12, P207
   Ishikawa K, 2002, BIOMATERIALS, V23, P423, DOI 10.1016/S0142-9612(01)00121-1
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Kanzaki N, 2000, J PHYS CHEM B, V104, P4189, DOI 10.1021/jp9939726
   KANZAKI N, 2000, J PHYS CHEM B, V105, P1991
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   KREIDLER ER, 1967, INORG CHEM, V6, P524, DOI 10.1021/ic50049a021
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   Otsuka M, 2000, J BIOMED MATER RES, V52, P819, DOI 10.1002/1097-4636(20001215)52:4<819::AID-JBM27>3.3.CO;2-F
   SCHROEDER LW, 1977, J SOLID STATE CHEM, V22, P253, DOI 10.1016/0022-4596(77)90002-0
   Underwood EJ, 1977, TRACE ELEMENTS HUMAN, P196
   World Health Organization, 1973, WHO TECH REP SER, V532, P9
   YAMAGUCHI M, 1986, BIOCHEM PHARMACOL, V35, P773, DOI 10.1016/0006-2952(86)90245-5
   YAMAGUCHI M, 1988, BIOCHEM PHARMACOL, V37, P4075, DOI 10.1016/0006-2952(88)90098-6
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
NR 20
TC 175
Z9 180
U1 3
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD OCT 1
PY 2002
VL 22
IS 1
SI SI
BP 21
EP 25
AR PII S0928-4931(02)00108-X
DI 10.1016/S0928-4931(02)00108-X
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 596GM
UT WOS:000178156300005
DA 2018-10-19
ER

PT J
AU Volloch, V
   Kaplan, D
AF Volloch, V
   Kaplan, D
TI Matrix-mediated cellular rejuvenation
SO MATRIX BIOLOGY
LA English
DT Article
DE matrix; cellular aging; tissue engineering; stem cells; cloning
ID EXTENDED LIFE-SPAN; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER;
   SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; POSTPONED SENESCENCE; CONIDIAL
   LONGEVITY; NEUROSPORA-CRASSA; PROTEIN OXIDATION; MOTOR-NEURONS
AB Biomaterial surface morphology and chemistry influence cell responses mediated via signaling cascades that regulate a wide range of metabolic processes. These responses may range from changes in surface adhesion and remodeling of the extracellular matrix to activation of cytokine, cytoskeletal and other biochemical pathways regulating or modulating cellular morphology and function. The present study has focused on collagen Type I, a key extracellular matrix protein, and its potential impact on the process of cellular aging. This study was undertaken for several reasons. First, several investigators reported that growth of cells on a collagen matrix markedly enhanced the resistance of cells to stresses. Second, a large body of accumulated data strongly indicated a relationship between the potential to respond to stresses and cellular aging with the former strongly influencing the rate of the latter. Finally, it has been recently demonstrated that in aged cells one of the key aging-related processes previously considered irreversible, attenuation of the expression of a major stress response protein, Hsp70, can be reversed. This fact together with a probable regulatory role of the stress response potential in cellular aging suggested a possibility that the cellular aging process as a whole can be altered. Indeed, in the present study, growth on a denatured collagen matrices reversed in aged cells not only the attenuation of Hsp70 expression but also other aging-related processes, such as beta-galactosidase expression, increase in protein oxidation and changes in cell morphology. Moreover, it appeared to reduce the rate of aging in young cells. Understanding the nature of collagen matrix-mediated cellular rejuvenation might suggest approaches for interfering with organismic aging. Some immediate applications include cell rejuvenation for purposes of cloning and reduction of the rate of aging during expansion of stem cells for purposes of tissue engineering. (C) 2002 Elsevier Science B.V./International Society of Matrix Biology. All rights reserved.
C1 Tufts Univ, Ctr Bioengn, Medford, MA 02155 USA.
RP Volloch, V (reprint author), Tufts Univ, Ctr Bioengn, 4 Colby St,Room 125, Medford, MA 02155 USA.
CR Aoshiba K, 1997, AM J PHYSIOL-LUNG C, V272, pL28
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Cao L, 1999, MATRIX BIOL, V18, P343, DOI 10.1016/S0945-053X(99)00027-X
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   DMELLO NP, 1994, J BIOL CHEM, V269, P15451
   DUBON S, 1996, DEV GENET, V18, P144
   DUDAS SP, 1995, J GERONTOL A-BIOL, V50, pB117, DOI 10.1093/gerona/50A.3.B117
   FLEMING JE, 1992, MUTAT RES, V275, P267, DOI 10.1016/0921-8734(92)90031-J
   FRIEDMAN DB, 1988, GENETICS, V118, P75
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   GOLDSTEIN S, 1978, GENETICS AGING
   Hayflick L., 1977, HDB BIOL AGING
   Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997
   Howell SJ, 1998, EXP CELL RES, V241, P230, DOI 10.1006/excr.1998.4051
   HOYT DG, 1995, AM J PHYSIOL-LUNG C, V269, pL171
   Johnson TE, 1996, J GERONTOL A-BIOL, V51, pB392, DOI 10.1093/gerona/51A.6.B392
   Kale SP, 1996, DEV GENET, V18, P154, DOI 10.1002/(SICI)1520-6408(1996)18:2<154::AID-DVG8>3.0.CO;2-8
   KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   LARSEN PL, 1995, GENETICS, V139, P1567
   Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943
   Lithgow GJ, 1996, SCIENCE, V273, P80, DOI 10.1126/science.273.5271.80
   LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540
   LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270
   Lithgow GJ, 1998, NUTRITION, V14, P522
   Lithgow GJ, 1996, BIOESSAYS, V18, P809, DOI 10.1002/bies.950181007
   LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x
   MARTIN GM, 1978, GENETIC EFFECTS AGIN
   MAUNEY J, UNPUB MATRIX MEDIATE
   Mooney A, 1999, AM J PATHOL, V155, P599, DOI 10.1016/S0002-9440(10)65155-3
   MUNKRES KD, 1984, MECH AGEING DEV, V24, P83, DOI 10.1016/0047-6374(84)90177-5
   MUNKRES KD, 1984, MECH AGEING DEV, V25, P47, DOI 10.1016/0047-6374(84)90129-5
   Murakami S, 1996, GENETICS, V143, P1207
   OLIVER C, 1987, J BIOL CHEM, V262, P5484
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x
   SERVICE PM, 1985, PHYSIOL ZOOL, V58, P380, DOI 10.1086/physzool.58.4.30156013
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STANULISPRAEGER BM, 1987, MECH AGEING DEV, V38, P1, DOI 10.1016/0047-6374(87)90109-6
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   SUN JY, 1994, J BIOL CHEM, V269, P18638
   Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237
   VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605
   Volloch V, 1998, CELL STRESS CHAPERON, V3, P265, DOI 10.1379/1466-1268(1998)003<0265:RTIACR>2.3.CO;2
   Volloch V, 1999, EXP CELL RES, V253, P483, DOI 10.1006/excr.1999.4682
   Walker GA, 1998, ANN NY ACAD SCI, V851, P444, DOI 10.1111/j.1749-6632.1998.tb09022.x
NR 54
TC 26
Z9 29
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0945-053X
J9 MATRIX BIOL
JI Matrix Biol.
PD OCT
PY 2002
VL 21
IS 6
BP 533
EP 543
AR PII S0945-053X(02)00038-0
DI 10.1016/S0945-053X(02)00038-0
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 609NM
UT WOS:000178911900008
PM 12392764
DA 2018-10-19
ER

PT J
AU Ulanski, P
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Pietrzak, M
   Stasica, P
   Rosiak, JM
AF Ulanski, P
   Janik, I
   Kadlubowski, S
   Kozicki, M
   Kujawa, P
   Pietrzak, M
   Stasica, P
   Rosiak, JM
TI Polymeric biomaterials synthesized by radiation techniques - Current
   studies at IARC, Poland
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article; Proceedings Paper
CT 6th International Symposium on Polymers for Advanced Technologies
CY SEP 02-06, 2001
CL ELAT, ISRAEL
SP ACS, EPF, Israel Chem & Polymer & Plast Soc, Japan Chem & Polymer Soc
DE biomaterial; hydrogel; implant; drug delivery; ionizing radiation
ID INDUCED CROSS-LINKING; AQUEOUS-SOLUTION; POLY(VINYL METHYL-ETHER);
   PULSE-RADIOLYSIS; IRRADIATION; HYDROGELS; CHITOSAN; ALCOHOL); NANOGELS;
   PRODUCT
AB For over 15 years the Institute of Applied Radiation Chemistry in Lodz, Poland, has been involved in studies on new polymeric biomaterials. Some of the technologies developed employ radiation techniques for the synthesis Of crosslinked products (mainly hydrogels), for surface modification and for sterilization. An example of a mature technology of this kind is hydrogel wound dressings, now being produced on a large scale and available on the market in many Central European countries. Another advanced project is a hydrogel system for healing endometrium cancer by precise, local drug delivery. Preliminary clinical tests with over 70 patients have been completed with very good results.
   Current research projects, besides further development of the above mentioned systems, include: a hydrogel-based system for local, controlled drug delivery, polymer materials for encapsulation of living cells and for the construction of hybrid artificial organs, a new approach to the synthesis of polymeric material for intervertebral disc implant, temperature-sensitive membranes and supports for cell cultures; hydrogel phantoms for low-dose, three-dimensional radiation dosimetry; degradation-resistant nanogels and microgels for biomedical purposes (e.g. synovial fluid substitute); hydrogel-based dietary products and adjustment of the molecular weight of biopolymers by ultrasound and ionizing radiation. Copyright (C) 2003 John Wiley Sons, Ltd.
C1 Tech Univ Lodz, Inst Appl Radiat Chem, PL-93590 Lodz, Poland.
RP Ulanski, P (reprint author), Tech Univ Lodz, Inst Appl Radiat Chem, Wroblewskiego 15, PL-93590 Lodz, Poland.
EM ulanskip@mitr.p.lodz.pl
RI Ulanski, Piotr/S-9103-2018; Sanguansri, Luz/B-6630-2011; Kujawa,
   Piotr/D-5142-2013; Kozicki, Marek/M-2744-2018
OI Ulanski, Piotr/0000-0002-4310-3574; Sanguansri, Luz/0000-0003-1908-7604;
   Kozicki, Marek/0000-0002-8396-4344; Kadlubowski,
   Slawomir/0000-0003-0648-5208
CR Charlesby A, 1960, ATOMIC RAD POLYM
   Darwis D, 2002, RADIAT PHYS CHEM, V63, P539, DOI 10.1016/S0969-806X(01)00636-3
   DeRossi D, 1991, POLYM GELS FUNDAMENT
   Funke W, 1998, ADV POLYM SCI, V136, P139
   Gebelein C. G., 1994, BIOTECHNOLOGY BIOACT
   Goosen M. F. A., 1997, APPL CHITIN CHITOSAN
   GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002
   HIRASA O, 1986, KOBUNSHI, V35, P1100
   Janik I, 2000, J CHEM SOC PERK T 2, P2041, DOI 10.1039/b004777p
   KOLODZIEJCZYK M, 2001, 9 BRG WORKSH 62 ICB
   Kozicki M, 2002, RADIAT PHYS CHEM, V65, P133, DOI 10.1016/S0969-806X(02)00209-8
   Kozicki M, 1999, ENG BIOMATER, V2, P11
   KUJAWA P, 1997, 6 INT WORKSH BIOENC
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   MAEDA H, 1994, J POLYM SCI POL PHYS, V32, P91, DOI 10.1002/polb.1994.090320112
   MARYANSKI MJ, 1993, MAGN RESON IMAGING, V11, P253, DOI 10.1016/0730-725X(93)90030-H
   MUZZARELLI RAA, 1977, CHITIN
   Park JB, 1992, BIOMATERIALS INTRO
   Peppas N. A., 1986, HYDROGELS MED PHARM, V2
   RAY CD, Patent No. 5824093
   ROSIAK J, 1992, J RADIOAN NUCL CH AR, V159, P87, DOI 10.1007/BF02041021
   ROSIAK J, 1990, RADIAT PHYS CHEM, V36, P747
   Rosiak J. M., 1989, US patent, Patent No. [US4871490, 4871490]
   ROSIAK JM, 1994, J CONTROL RELEASE, V31, P9, DOI 10.1016/0168-3659(94)90246-1
   Rosiak JM, 1999, RADIAT PHYS CHEM, V55, P139, DOI 10.1016/S0969-806X(98)00319-3
   ROSIAK JM, 1988, RADIAT PHYS CHEM, V52, P307
   ROSIAK JM, 1991, ACS S SERIES, V475, P271
   ROSIAK JM, 1996, MED SCI MONIT, V2, P78
   Sabharwal S, 1999, RADIAT PHYS CHEM, V54, P643, DOI 10.1016/S0969-806X(98)00299-0
   Schnabel W., 1981, POLYM DEGRADATION PR
   SHALABY WS, 1994, BIOMEDICAL POLYM
   SILVER F, 1989, BIOCOMPATIBILITY INT, V1
   Spohr R., 1998, New Astronomy Reviews, V42, P189, DOI 10.1016/S1387-6473(98)00004-9
   Stasica P, 2000, ENG BIOMATER, V3, P9
   Ulanski P, 1996, J CHEM SOC PERK T 2, P13, DOI 10.1039/p29960000013
   Ulanski P, 1999, NUCL INSTRUM METH B, V151, P356, DOI 10.1016/S0168-583X(99)00085-3
   Ulanski P, 1998, RADIAT PHYS CHEM, V52, P289, DOI 10.1016/S0969-806X(98)00155-8
   Ulanski P, 2000, J CHEM SOC PERK T 2, P2022, DOI 10.1039/b003952g
   ULANSKI P, 1994, MACROMOL CHEM PHYSIC, V195, P1443, DOI 10.1002/macp.1994.021950427
   Ulanski P, 2002, RADIAT PHYS CHEM, V63, P533, DOI 10.1016/S0969-806X(01)00549-7
   ULANSKI P, 1994, CHITIN WORLD, P572
   ULANSKI P, 2000, ADV CHITIN SCI, V4, P429
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Wang BL, 1997, LANGMUIR, V13, P6108, DOI 10.1021/la970599p
NR 44
TC 19
Z9 19
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD OCT-DEC
PY 2002
VL 13
IS 10-12
BP 951
EP 959
DI 10.1002/pat.249
PG 9
WC Polymer Science
SC Polymer Science
GA 640GA
UT WOS:000180679000032
DA 2018-10-19
ER

PT J
AU Griesser, HJ
   Hartley, PG
   McArthur, SL
   McLean, KM
   Meagher, L
   Thissen, H
AF Griesser, HJ
   Hartley, PG
   McArthur, SL
   McLean, KM
   Meagher, L
   Thissen, H
TI Interfacial properties and protein resistance of nano-scale
   polysaccharide coatings
SO SMART MATERIALS & STRUCTURES
LA English
DT Article
ID SURFACES; BIOFILMS; MATRIX
AB For many applications, it is essential to be able to control the interface between devices and the biological environment by nanoscale control of the composition of the surface chemistry and the surface topography. Application of molecular thickness coatings of biologically active macromolecules provides predictable interfacial control over interactions with biological media. The covalent surface immobilization of polysaccharides, proteins and synthetic oligopeptides can be achieved via nanometres thick, interfacial bonding layers deposited by gas plasma methods, and the multi-step coating schemes are verified by XPS analyses. Interactions between biomolecular coatings and biological fluids are studied by MALDI mass spectrometry and ELISA assays. Using a colloid-modified AFM tip, quantitative measurement of interfacial forces is achieved. Comparison with theoretical predictions allows elucidation of the key interfacial forces that operate between surfaces and approaching bio-macromolecules. In this way, it is possible to unravel the fundamental information required for the guided design and optimization of biologically active nanoscale coatings that confer predictable properties to synthetic carriers used for the fabrication of bio-diagnostics and biomedical devices. By studying the relationships between interfacial forces and the adsorption of proteins, we have established the key properties that make specific polysaccharide coatings resistant to the adsorption of proteins, which is applicable to biomaterial, biosensor and biochip research.
C1 CSIRO Mol Sci, Clayton, Vic 3169, Australia.
RI McLean, Keith/H-1568-2011; Meagher, Laurence/G-1412-2012; Hartley,
   Patrick/C-1862-2015; Thissen, Helmut/D-3835-2011; McArthur,
   Sally/B-6848-2008; Griesser, Hans/E-5628-2011
OI Meagher, Laurence/0000-0002-2055-6159; Hartley,
   Patrick/0000-0002-2692-2682; McArthur, Sally/0000-0002-4914-6989;
   Griesser, Hans/0000-0003-1072-7863
CR BRYERS JD, 1994, COLLOID SURFACE B, V2, P9, DOI 10.1016/0927-7765(94)80013-8
   CHATELIER R, 1994, Patent No. 9406485
   CHATELIER RC, 1995, LANGMUIR, V11, P4122, DOI 10.1021/la00010a078
   CHATELIER RC, 1993, Patent No. 9302420
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   CREPON B, 1987, BIOMATERIALS, V8, P248, DOI 10.1016/0142-9612(87)90111-6
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   FLEER GJ, 1993, POLYM INTERFACES
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hartley P. G., 2000, Plasmas and Polymers, V5, P47, DOI 10.1023/A:1009508426115
   HORBETT TA, 1995, AM CHEM SOC S SERIES, V602
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   KINGSHOTT P, 1999, THESIS U NEW S WALES
   LOFAS S, 1990, J CHEM SOC CHEM COMM, P1526, DOI 10.1039/c39900001526
   Malmsten M, 1998, BIOPOLYMERS INTERFAC
   MARCHANT RE, 1994, J BIOMAT SCI-POLYM E, V6, P549, DOI 10.1163/156856294X00509
   MCARTHUR SL, 2000, THESIS U NEW S WALES
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
NR 20
TC 28
Z9 29
U1 2
U2 19
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0964-1726
J9 SMART MATER STRUCT
JI Smart Mater. Struct.
PD OCT
PY 2002
VL 11
IS 5
BP 652
EP 661
AR PII S0964-1726(02)52618-5
DI 10.1088/0964-1726/11/5/305
PG 10
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA 612LH
UT WOS:000179076600006
DA 2018-10-19
ER

PT J
AU Spijker, HT
   Busscher, HJ
   van Oeveren, W
AF Spijker, HT
   Busscher, HJ
   van Oeveren, W
TI Influence of abciximab on the adhesion of platelets on a shielded plasma
   gradient prepared on polyethylene
SO THROMBOSIS RESEARCH
LA English
DT Article
DE biomaterial; wettability gradient; platelets; GpIIb-IIIa; adhesion
ID PROTEIN ADSORPTION; IN-VITRO; ACTIVATION; BINDING; SURFACE; RECEPTORS
AB Introduction: Thrombotic effects of biomaterial implants are mediated merely through activation of the platelet glycoprotein IIb-Illa (GpIIb-IIIa) receptor. Consequently, platelet GpIIb-IIIa receptor inhibitors are successfully used during stent implantation procedures to prevent thrombosis. However, currently a new generation of stems contains surface coating, which changes the surface to more hydrophobic or hydrophilic. This change markedly affects the interaction of platelets and may influence the efficiency of GpIIb-IIla inhibitors. Materials and methods: To study the influence of the wettability of biomaterials on the effectiveness of abciximab, 5-cm polyethylene gradients with contact angles of 100 to 40 were made by means of glow discharge. Fresh whole blood with or without abciximab was recirculated over this gradient. Results: Inhibition of platelet adhesion by abciximab was maximal, but not complete, on the hydrophobic and moderate hydrophobic part of the gradient. with contact angles of 55degrees to 90degrees. Percentage inhibition by abciximab was maximal around 60degrees. Conclusions: Intermediate hydrophobicity of currently applied stent materials, such as stainless steel, seems optimal in combination with abciximab. However, on hydrophobic and particularly on hydrophilic materials, abciximab is less effective. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van Oeveren, W (reprint author), Univ Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM w.van.oeveren@med.rug.nl
CR Antoniucci D, 2000, AM J CARDIOL, V85, P821, DOI 10.1016/S0002-9149(99)00874-7
   Coller BS, 1999, THROMB HAEMOSTASIS, V82, P326
   COLLER BS, 1986, J LAB CLIN MED, V107, P384
   Gawaz M, 1996, CIRCULATION, V94, P279, DOI 10.1161/01.CIR.94.3.279
   Gemmell CH, 1998, J BIOMED MATER RES, V42, P611, DOI 10.1002/(SICI)1097-4636(19981215)42:4<611::AID-JBM18>3.0.CO;2-D
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Harmand MF, 1999, BIOMATERIALS, V20, P1561, DOI 10.1016/S0142-9612(99)00051-4
   KIAEI D, 1995, J BIOMED MATER RES, V29, P729, DOI 10.1002/jbm.820290609
   KIM BK, 1974, TRANSFUSION, V14, P130, DOI 10.1111/j.1537-2995.1974.tb04504.x
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Marciniak SJ, 2001, THROMB HAEMOSTASIS, V85, P539
   Mintz GS, 2000, CURR INTERV CARDIOL, V2, P316
   Montorsi P, 2000, BRIT J RADIOL, V73, P76, DOI 10.1259/bjr.73.865.10721325
   MUSIAL J, 1985, J LAB CLIN MED, V105, P514
   RUARDY TG, 1997, SURF SCI REP, V27, P1
   SEEGER JM, 1995, J VASC SURG, V22, P327, DOI 10.1016/S0741-5214(95)70148-6
   Spijker H. T., 1997, Cells and Materials, V7, P201
   Spijker HT, 1999, COLLOID SURFACE B, V15, P89, DOI 10.1016/S0927-7765(99)00056-9
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Suzuki H, 1996, PROG HISTOCHEM CYTOC, V30, P1
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Toes GJ, 1999, BIOMATERIALS, V20, P1951, DOI 10.1016/S0142-9612(99)00100-3
NR 22
TC 4
Z9 4
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD OCT 1
PY 2002
VL 108
IS 1
BP 57
EP 62
DI 10.1016/S0049-3848(02)00357-2
PG 6
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 660BN
UT WOS:000181814200010
PM 12586133
DA 2018-10-19
ER

PT J
AU Palmer, EM
   Beilfuss, BA
   Nagai, T
   Semnani, RT
   Badylak, SF
   van Seventer, GA
AF Palmer, EM
   Beilfuss, BA
   Nagai, T
   Semnani, RT
   Badylak, SF
   van Seventer, GA
TI Human helper T cell activation and differentiation is suppressed by
   porcine small intestinal submucosa
SO TISSUE ENGINEERING
LA English
DT Article
ID INTERCELLULAR-ADHESION MOLECULE-1; EXTRACELLULAR-MATRIX; HUMAN NAIVE;
   DOG-MODEL; INFLAMMATION; RESPONSES; INHIBIT
AB A cell-free biomaterial derived from porcine small intestinal submucosa (SIS) has been used successfully in many models as a xenogeneic scaffolding material without generating immune-mediated inflammatory reactions. We investigated whether this absence of inflammation is due to the presence of porcine transforming growth factor beta (TGF-beta) activity found in SIS that may have immunosuppressive properties on helper T (Th) cell subset activation and differentiation. We used in vitro models for the generation of human Th1 and Th2 cells to investigate the influence of SIS. We found that SIS partially suppressed Th1 cell expansion and secretion of interleukin 12 (IL-12) and interferon gamma (IFN-gamma) in a TGF-beta-dependent manner, but Th1 cell expansion and IFN-gamma secretion could be fully overcome by addition of recombinant IL-12. The suppression by SIS of Th cell activation also involved the induction of Th cell apoptosis. In addition, SIS completely abolished the generation of Th2 cells in vitro, but this effect of SIS was not reversed by neutralizing TGF-beta antibodies. Our results indicate the presence in SIS of factors that can suppress Th cell activation through both the inhibition of IL-12 secretion and the induction of Th cell apoptosis. We established further that these factors include TGF-beta and at least one other factor.
C1 Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA.
   Univ Chicago, Dept Pathol, Chicago, IL 60637 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
RP Palmer, EM (reprint author), Boston Univ, Sch Publ Hlth, Dept Environm Hlth, 715 Albany St,Talbot 2E, Boston, MA 02118 USA.
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Aoki K, 2001, NAT IMMUNOL, V2, P333, DOI 10.1038/86336
   BADYLAK S, CLIN ORTHOP S, V333, P199
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Blumberg RS, 1999, CURR OPIN IMMUNOL, V11, P648, DOI 10.1016/S0952-7915(99)00032-1
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   Cunliffe RN, 2000, GUT, V47, P16, DOI 10.1136/gut.47.1.16
   Fuss IJ, 1999, GASTROENTEROLOGY, V117, P1078, DOI 10.1016/S0016-5085(99)70392-6
   HILES MC, 1995, J BIOMED MATER RES, V29, P883, DOI 10.1002/jbm.820290714
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   King C, 1998, IMMUNITY, V8, P601, DOI 10.1016/S1074-7613(00)80565-8
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Liu FT, 2000, CLIN IMMUNOL, V97, P79, DOI 10.1006/clim.2000.4912
   McPherson TB, 2000, TISSUE ENG, V6, P233, DOI 10.1089/10763270050044416
   McRae BL, 1998, J IMMUNOL, V160, P4298
   McRae BL, 2000, BLOOD, V96, P210
   Palmer EM, 2001, J IMMUNOL, V167, P749, DOI 10.4049/jimmunol.167.2.749
   PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Schonherr E, 2000, Dev Immunol, V7, P89, DOI 10.1155/2000/31748
   SEMNANI RT, 1994, J EXP MED, V180, P2125, DOI 10.1084/jem.180.6.2125
   Takeuchi M, 1998, J IMMUNOL, V160, P1589
   TRINCHIERI G., 1998, ADV IMMUNOL, V70, P243
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 25
TC 50
Z9 60
U1 1
U2 3
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD OCT
PY 2002
VL 8
IS 5
BP 893
EP 900
DI 10.1089/10763270260424259
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 610AH
UT WOS:000178938200017
PM 12459068
DA 2018-10-19
ER

PT J
AU Ozawa, T
   Mickle, DAG
   Weisel, RD
   Koyama, N
   Ozawa, S
   Li, RK
AF Ozawa, T
   Mickle, DAG
   Weisel, RD
   Koyama, N
   Ozawa, S
   Li, RK
TI Optimal biomaterial for creation of autologous cardiac grafts
SO CIRCULATION
LA English
DT Article
DE congenital cardiac defect; myocardium; tissue engineering; smooth muscle
   cells; biomaterials
ID MUSCLE CELL TRANSPLANTATION; IMPROVES HEART FUNCTION;
   MYOCARDIAL-INFARCTION; TISSUE; STENTS; ARTERY
AB Background-The optimal cardiac graft for the repair of congenital heart defects will be composed of autologous cells and will grow with the child. The biodegradable material should permit rapid cellular growth and delayed degradation with minimal inflammation. We compared a new material, epsilon-caprolactone-co-L-lactide sponge reinforced with knitted poly-L-lactide fabric (PCLA), to gelatin (GEL) and polyglycolic acid (PEA), which are previously evaluated materials.
   Methods-Syngenic rat aortic smooth muscle cells (SMCs, 2X10(6)) were seeded onto GEL, PEA, and PCLA patches and cultured (n=11 per group). The DNA content in each patch was measured at 1, 2, and 3 weeks after seeding. Histological examination was performed 2 weeks after seeding. Cell-seeded patches were employed to replace a surgically created defect in the right ventricular outflow tract (RVOT) of rats (n=5 per group). Histology was studied at 8 weeks following implantation.
   Results-In vitro studies showed that the DNA content increased significantly (P<0.05) in all patches between 1 and 3 weeks after seeding. Histology and staining SMCs for anti-a-smooth muscle actin (alphaSMA) revealed better growth of cells in the interstices of the grafts with GEL and PCLA than the PGA graft. In vivo studies demonstrated that seeded SMCs survived at least 8 weeks after the patch implantation in all groups. PCLA scaffolds were replaced by more cells with larger alphaSMA-positive areas and by more extracellular matrix with larger elastin-positive areas than with GEL and PEA. The patch did not thin and expanded significantly. The GEL and PGA patches thinned and expanded. All grafts had complete endothelialization on the endocardial surface.
   Conclusions-SMC-seeded biodegradable materials can be employed to repair the RVOT. The novel PCLA patches permitted better cellular penetration in vitro and did not thin or dilate in vivo and did not produce an inflammatory response. The cell-seeded PCLA patch may permit the construction of an autologous patch to repair congenital heart defects.
C1 Univ Toronto, Toronto Gen Hosp, Dept Surg, Div Cardiovasc Surg,Toronto Gen Res Inst, Toronto, ON M5G 2C4, Canada.
RP Li, RK (reprint author), Univ Toronto, Toronto Gen Hosp, Dept Surg, Div Cardiovasc Surg,Toronto Gen Res Inst, CCRW 1-815,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Kim BS, 1998, J BIOMED MATER RES, V41, P322, DOI 10.1002/(SICI)1097-4636(199808)41:2<322::AID-JBM18>3.0.CO;2-M
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Kirklin J, 1993, CARDIAC SURG, P964
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P368, DOI 10.1016/S0022-5223(00)70193-0
   Li RK, 1999, CIRCULATION, V100, P63
   Li RK, 1999, J MOL CELL CARDIOL, V31, P513, DOI 10.1006/jmcc.1998.0882
   Li RK, 1996, ANN THORAC SURG, V62, P654
   Li RK, 2000, J THORAC CARDIOV SUR, V119, P62, DOI 10.1016/S0022-5223(00)70218-2
   Mayer JE, 1997, CURR OPIN CARDIOL, V12, P528, DOI 10.1097/00001573-199711000-00005
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Oechslin EN, 1999, J THORAC CARDIOV SUR, V118, P245, DOI 10.1016/S0022-5223(99)70214-X
   Rajasubramanian G, 1994, ASAIO J, V40, pM584, DOI 10.1097/00002480-199407000-00066
   Sakai T, 2001, J THORAC CARDIOV SUR, V121, P932, DOI 10.1067/mtc.2001.113600
   SCOTT SM, 1994, J VASC SURG, V19, P585, DOI 10.1016/S0741-5214(94)70030-3
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   SHINOKA T, 1995, ANN THORAC SURG, V60, P5513
   Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Tamai H, 2000, CIRCULATION, V102, P399
   THOMSON RC, 2000, PRINCIPLES TISSUE EN, P251
   Uemura H, 2000, EUR J CARDIO-THORAC, V17, P543, DOI 10.1016/S1010-7940(00)00410-3
   VANDERHEIJDEN FHWM, 1994, J VASC SURG, V20, P607, DOI 10.1016/0741-5214(94)90285-2
   VanMeter CH, 1996, ANN THORAC SURG, V62, P660
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   Yoo KJ, 2000, ANN THORAC SURG, V70, P859, DOI 10.1016/S0003-4975(00)01630-1
   YOUNG B, 2000, WHEATERS FUNCTIONAL, P65
NR 31
TC 40
Z9 45
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-7322
J9 CIRCULATION
JI Circulation
PD SEP 24
PY 2002
VL 106
IS 13
SU S
BP I176
EP I182
DI 10.1161/01.cir.0000032901.55215.cc
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 599DM
UT WOS:000178318900031
PM 12354729
DA 2018-10-19
ER

PT J
AU Alsberg, E
   Anderson, KW
   Albeiruti, A
   Rowley, JA
   Mooney, DJ
AF Alsberg, E
   Anderson, KW
   Albeiruti, A
   Rowley, JA
   Mooney, DJ
TI Engineering growing tissues
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE bone; cartilage; alginate; adhesion ligands; endochondral ossification
ID SYNTHETIC BIODEGRADABLE POLYMERS; FUNCTIONAL-DIFFERENTIATION;
   BASEMENT-MEMBRANE; CARTILAGE MATRIX; CELL-SHAPE; CHONDROCYTES; CULTURES;
   GROWTH; INVITRO; BONE
AB Regenerating or engineering new tissues and organs may one day allow routine replacement of lost or failing tissues and organs. However, these engineered tissues must not only grow to fill a defect and integrate with the host tissue, but often they must also grow in concert with the changing needs of the body over time. We hypothesized that tissues capable of growing with time could be engineered by supplying growth stimulus signals to cells from the biomaterial used for cell transplantation. In this study, chondrocytes and osteoblasts were cotransplanted on hydrogels modified with an RGD-containing peptide sequence to promote cell multiplication. New bone tissue was formed that grew in mass and cellularity by endochondral ossification in a manner similar to normal long-bone growth. Transplanted cells organized into structures that morphologically and functionally resembled growth plates. These engineered tissues could find utility in treating diseases and injuries of the growth plate, testing the effect of experimental drugs on growth-plate function and development, and investigating the biology of long-bone growth. Furthermore, this concept of promoting the growth of engineered tissues could find great utility in engineering numerous tissue types by way of the transplantation of a small number of precursor cells.
C1 Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
OI Alsberg, Eben/0000-0002-3487-4625
FU NIDCD NIH HHS [T32 DC005356, T32-DC05356]; NIDCR NIH HHS [T32 DE007057,
   R01-DE13033, R01 DE013033, T32-DE07057]; NIGMS NIH HHS [GM08353, T32
   GM008353]
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   ARMSTRONG PB, 1989, CRIT REV BIOCHEM MOL, V24, P119, DOI 10.3109/10409238909086396
   BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223
   Beers M. H., 1999, MERCK MANUAL DIAGNOS
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BRIGHTON CT, 1978, CLIN ORTHOP RELAT R, P22
   DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x
   FARQUHARSON C, 1995, IN VITRO CELL DEV-AN, V31, P288
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   GIBSON GJ, 1982, J CELL BIOL, V93, P767, DOI 10.1083/jcb.93.3.767
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783
   HORTON W, 1986, DEV BIOL, V115, P392, DOI 10.1016/0012-1606(86)90258-7
   Iannotti JP, 1994, ORTHOPAEDIC BASIC SC, P185
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Isogai N, 1999, J BONE JOINT SURG AM, V81A, P306, DOI 10.2106/00004623-199903000-00002
   IYODA K, 1993, CLIN ORTHOP RELAT R, P287
   JEE WSS, 1987, HISTOLOGY CELL TISSU, P212
   JIKKO A, 1993, DEV BIOL, V156, P372, DOI 10.1006/dbio.1993.1084
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kim SS, 1999, J SURG RES, V87, P6, DOI 10.1006/jsre.1999.5743
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743
   LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MANFRINI M, 1988, Microsurgery, V9, P242, DOI 10.1002/micr.1920090406
   Martin I, 2000, BIORHEOLOGY, V37, P141
   Mundlos S, 1997, FASEB J, V11, P125
   NAKAHARA H, 1992, CLIN ORTHOP RELAT R, P291
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   PAIGE KT, 1995, PLAST RECONSTR SURG, V96, P1390, DOI 10.1097/00006534-199511000-00024
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SHANNON JM, 1987, BIOCHIM BIOPHYS ACTA, V931, P143, DOI 10.1016/0167-4889(87)90200-X
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Tzanakakis ES, 2001, CELL MOTIL CYTOSKEL, V48, P175, DOI 10.1002/1097-0169(200103)48:3<175::AID-CM1007>3.0.CO;2-2
NR 44
TC 278
Z9 290
U1 6
U2 45
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 17
PY 2002
VL 99
IS 19
BP 12025
EP 12030
DI 10.1073/pnas.192291499
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 596VK
UT WOS:000178187000009
PM 12218178
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Zayats, M
   Raitman, OA
   Chegel, VI
   Kharitonov, AB
   Willner, I
AF Zayats, M
   Raitman, OA
   Chegel, VI
   Kharitonov, AB
   Willner, I
TI Probing antigen-antibody binding processes by impedance measurements on
   ion-sensitive field-effect transistor devices and complementary surface
   plasmon resonance analyses: Development of cholera toxin sensors
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID QUARTZ-CRYSTAL MICROBALANCE; IMMUNOSENSOR ELECTRODES; COLORIMETRIC
   DETECTION; AMPEROMETRIC DETECTION; ELECTROMAGNETIC-WAVES; SELECTIVE
   ELECTRODES; MONOLAYER INTERFACES; PROTEIN-DETECTION; THIN-FILMS;
   SPECTROSCOPY
AB Impedance measurements on ISFET devices are employed to develop new immunosensors. The analysis of the transconductance curves recorded at variable frequencies, upon the formation of antigen-antibody complexes on the ISFET devices, allows determination of the biomaterial film thicknesses. Complementary surface plasmon resonance measurements of analogous biosensor systems, using Au-coated glass slides as support, reveal similar film thicknesses of the biomaterials and comparable detection limits. A dinitrophenyl antigen layer is immobilized on the ISFET gate as a sensing interface for the anti-dinitrophenyl antibody (anti-DNP-Ab). The anti-DNP-Ab is analyzed with a sensitivity that corresponds to 0.1 mug mL(-1). The assembly of the biotinylated anti-anti-DNP-Ab and avidin layers on the base anti-DNP-Ab layer is characterized by impedance measurements. The development of an ISFET-based sensor for the cholera toxin is described. The anti-cholera toxin antibody is immobilized on the ISFET device. The association of the cholera toxin (CT) to the antibody is monitored by the impedance measurements. The detection limit for analyzing CT is 1.0 x 10(-11) M.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
RI Raitman, Oleg/S-3960-2016
CR Abad JM, 1998, ANAL CHIM ACTA, V368, P183, DOI 10.1016/S0003-2670(98)00205-0
   AIZAWA M, 1987, ELECTROCHEMICAL SENS, P269
   ALFONTA L, 2001, BIOSENS BIOELECTRON, V16, P645
   Antonisse MMG, 2000, ANAL CHEM, V72, P343, DOI 10.1021/ac990721k
   ARMSTRONG RD, 1990, ELECTROCHIM ACTA, V35, P1, DOI 10.1016/0013-4686(90)85028-L
   Badia A, 1999, SENSOR ACTUAT B-CHEM, V54, P145, DOI 10.1016/S0925-4005(98)00333-5
   Bardea A, 2000, ELECTROANAL, V12, P1097, DOI 10.1002/1521-4109(200010)12:14<1097::AID-ELAN1097>3.3.CO;2-O
   BARYAKHTAR IV, 1995, SURF SCI, V323, P142, DOI 10.1016/0039-6028(94)00642-3
   Beketov GV, 1998, SENSOR ACTUAT B-CHEM, V48, P432, DOI 10.1016/S0925-4005(98)00081-1
   BERGVELD P, 1989, SENSOR ACTUATOR, V18, P309, DOI 10.1016/0250-6874(89)87038-6
   Bergveld P., 1988, COMPREHENSIVE ANAL C, VXXIII
   Berney H, 1999, SENSOR ACTUAT B-CHEM, V57, P238, DOI 10.1016/S0925-4005(99)00085-4
   Blonder R, 1997, BIOSENS BIOELECTRON, V12, P627, DOI 10.1016/S0956-5663(97)00022-5
   Blonder R, 1996, ANAL CHEM, V68, P3151, DOI 10.1021/ac960290v
   BRECHT A, 1992, SENSOR ACTUAT B-CHEM, V6, P96, DOI 10.1016/0925-4005(92)80038-Y
   BRESLER HS, 1992, ACS SYM SER, V511, P89
   CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021
   CHOVELON JM, 1991, SENSOR ACTUAT B-CHEM, V3, P43, DOI 10.1016/0925-4005(91)85006-5
   COLLAPICCHIONI C, 1991, SENSOR ACTUAT B-CHEM, V4, P245
   Eijkel JCT, 1997, BIOSENS BIOELECTRON, V12, P991, DOI 10.1016/S0956-5663(97)00054-7
   GOPEL W, 1995, BIOSENS BIOELECTRON, V10, P35, DOI 10.1016/0956-5663(95)96793-X
   HADAS E, 1992, J IMMUNOASSAY, V13, P231, DOI 10.1080/15321819208021229
   HO WO, 1995, BIOSENS BIOELECTRON, V10, P683, DOI 10.1016/0956-5663(95)96959-3
   Ivnitski D, 1996, BIOSENS BIOELECTRON, V11, P409, DOI 10.1016/0956-5663(96)82736-9
   JAWETZ E, 1982, REV MED MICROBIOL, P227
   Jimenez C, 1997, ANAL CHIM ACTA, V351, P169, DOI 10.1016/S0003-2670(97)00332-2
   JINGHONG H, 1996, Z SENS ACTUATORS B, V35, P422
   Katz E, 1996, J ELECTROANAL CHEM, V418, P67, DOI 10.1016/S0022-0728(96)04855-3
   Kharitonov AB, 2000, SENSOR ACTUAT B-CHEM, V70, P222, DOI 10.1016/S0925-4005(00)00573-6
   Kharitonov AB, 2001, SENSOR ACTUAT B-CHEM, V76, P203, DOI 10.1016/S0925-4005(01)00640-2
   Kharitonov AB, 2001, J PHYS CHEM B, V105, P4205, DOI 10.1021/jp0045383
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   Koch S, 1999, BIOSENS BIOELECTRON, V14, P413, DOI 10.1016/S0956-5663(99)00008-1
   Koncki R, 1998, SENSOR ACTUAT B-CHEM, V47, P246, DOI 10.1016/S0925-4005(98)00031-8
   Kruchinin AA, 1996, SENSOR ACTUAT B-CHEM, V30, P77, DOI 10.1016/0925-4005(95)01752-H
   LANG G, 1996, FRESEN J ANAL CHEM, V68, P857
   Lugtenberg RJW, 1998, J ELECTROANAL CHEM, V452, P69, DOI 10.1016/S0022-0728(98)00080-1
   MAMMEN M, 1995, ANAL CHEM, V67, P3526, DOI 10.1021/ac00115a023
   Mirsky VM, 1997, BIOSENS BIOELECTRON, V12, P977, DOI 10.1016/S0956-5663(97)00053-5
   OTTENBACHER D, 1992, SENSOR ACTUAT B-CHEM, V6, P192, DOI 10.1016/0925-4005(92)80054-2
   Pan JJ, 1997, LANGMUIR, V13, P1365, DOI 10.1021/la9602675
   Patolsky F, 1998, J PHYS CHEM B, V102, P10359, DOI 10.1021/jp983700n
   Pavey KD, 1999, J PHARMACEUT BIOMED, V20, P241, DOI 10.1016/S0731-7085(99)00026-6
   Philips JR, 1999, IMMUNOL CELL BIOL, V77, P121, DOI 10.1046/j.1440-1711.1999.00801.x
   Puig-Lleixa C, 1999, ANAL CHIM ACTA, V389, P179, DOI 10.1016/S0003-2670(99)00157-9
   Rishpon J, 1996, ANN NY ACAD SCI, V799, P508, DOI 10.1111/j.1749-6632.1996.tb33247.x
   Sekiguchi T, 2000, SENSOR ACTUAT B-CHEM, V67, P265, DOI 10.1016/S0925-4005(00)00522-0
   Shirshov YM, 1995, P SOC PHOTO-OPT INS, V2648, P118, DOI 10.1117/12.226151
   Simonian AL, 2001, ANAL CHIM ACTA, V442, P15, DOI 10.1016/S0003-2670(01)01131-X
   Soldatkin AP, 2000, ANAL CHIM ACTA, V403, P25, DOI 10.1016/S0003-2670(99)00660-1
   STOYTCHEVA M, 1995, ELECTROANAL, V7, P660, DOI 10.1002/elan.1140070712
   STRIEBEL C, 1994, BIOSENS BIOELECTRON, V9, P139, DOI 10.1016/0956-5663(94)80105-3
   SULEIMAN AA, 1994, ANALYST, V119, P2279, DOI 10.1039/an9941902279
   TERRETTAZ S, 1993, LANGMUIR, V9, P1361, DOI 10.1021/la00029a033
   Volotovsky V, 1998, ANAL CHIM ACTA, V359, P143, DOI 10.1016/S0003-2670(97)00653-3
   Wijayawardhana CA, 1999, ANAL CHIM ACTA, V399, P3, DOI 10.1016/S0003-2670(99)00570-X
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   Willner I, 1999, BIOTECHNOL PROGR, V15, P991, DOI 10.1021/bp990115a
   Willner I, 2001, TRENDS BIOTECHNOL, V19, P222, DOI 10.1016/S0167-7799(01)01634-1
   Willner I, 1999, SENSORS UPDATE, V5, P45
   Zayats M, 2001, ANALYST, V126, P652, DOI 10.1039/b102363m
   Zayats M, 2000, BIOSENS BIOELECTRON, V15, P671, DOI 10.1016/S0956-5663(00)00120-2
NR 62
TC 72
Z9 72
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD SEP 15
PY 2002
VL 74
IS 18
BP 4763
EP 4773
DI 10.1021/ac020312f
PG 11
WC Chemistry, Analytical
SC Chemistry
GA 594TX
UT WOS:000178068000023
PM 12349981
DA 2018-10-19
ER

PT J
AU Matheson, LA
   Labow, RS
   Santerre, JP
AF Matheson, LA
   Labow, RS
   Santerre, JP
TI Biodegradation of polycarbonate-based polyurethanes by the human
   monocyte-derived macrophage and U937 cell systems
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article; Proceedings Paper
CT 28th Annual Meeting of the Society-for-Biomaterials
CY APR 24-27, 2002
CL TAMPA, FLORIDA
SP Soc Biomat
DE biodegradation; polyurethane; monocyte-derived macrophage; U937 cells;
   hydrolytic activities
ID CHOLESTEROL ESTERASE; DIFFERENTIATION; POLY(URETHANE)S; POLYETHER;
   URETHANES
AB The prominent cell type found on implanted medical devices during the chronic inflammatory response is the monocyte-derived macrophage (MDM). Using an activated in vitro cell system, it was possible to show that MDMs possess esterolytic activities that may contribute to the degradation of polyurethanes. In the present study, the U937 cell line was paralleled to the MDM cell system in order to validate the use of a cell line that could expedite studies on biomaterial biocompatibility and biostability. Using 12-o-tetradecanoylphorbol 13-acetate (PMA), the optimum differentiation time for the U937 cells was 72 h based on biodegradation, dearadative potential, and S-34-methionine uptake. After activation of the cells by resuspending from tissue culture polystyrene plates and reseeding onto a C-14-labeled polycarbonate-based polyurethane (PCNU), both U937 cells and the MDMs elicited comparable radiolabel release (measure of polymer breakdown) and esterase activity (measure of degradative potential) at 48 h, There was no difference in the effect on radiolabel release and esterase activity elicited by both cell types with inhibitors of protein synthesis, esterase activity, and phospholipase A(2). This established that both cell types likely used similar hydrolytic activities and signaling pathways to cause degradation of the PCNU. Immunoblotting demonstrated that both cell systems secreted monocyte-specific esterase and cholesterol esterase enzymes previously shown to degrade PCNUs. The U937 cell system is more convenient and reproducible than MDMs for pursuing possible biological pathways elucidating the mechanism of polyurethane biodegradation. Once established with U937s, the pathways can then be validated with the more physiologically relevant human MDM cell system. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Ottawa, Inst Heart, Ottawa, ON, Canada.
   Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
   Univ Ottawa, Dept Surg, Ottawa, ON, Canada.
   Univ Toronto, Fac Dent, Depb Biol & Diagnost Sci, Toronto, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON, Canada.
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   APPEL M, 1993, BIOL CELL, V74, P235
   BOYUM A, 1960, J CLIN LAB INVEST, V21, P77
   BOZDECH MJ, 1981, J EXP MED, V153, P182, DOI 10.1084/jem.153.1.182
   BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044
   HASS R, 1989, EUR J CELL BIOL, V48, P282
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   LABOW RS, IN PRESS BIOMATERIAL
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   Moore ANJ, 1996, BIOTECHNOL TECH, V10, P523
   NEWCOMBE DS, 1992, LANCET, V339, P539, DOI 10.1016/0140-6736(92)90349-8
   PAPADIMITRIOU JM, 1989, ULTRASTRUCT PATHOL, V13, P343, DOI 10.3109/01913128909048488
   PRUZANSKI W, 1991, INFLAMMATION, V15, P127, DOI 10.1007/BF00917507
   ROSENTHAL MD, 1992, BIOCHIM BIOPHYS ACTA, V1126, P319, DOI 10.1016/0005-2760(92)90247-S
   SABOORI AM, 1990, J BIOL CHEM, V265, P19792
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Uphoff CC, 2000, LEUKEMIA LYMPHOMA, V39, P257, DOI 10.3109/10428190009065825
   WYATT TA, 1993, AM J PHYSIOL, V265, P201
NR 28
TC 52
Z9 53
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 2002
VL 61
IS 4
BP 505
EP +
DI 10.1002/jbm.10286
PG 156
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 568PT
UT WOS:000176551800001
PM 12125674
DA 2018-10-19
ER

PT J
AU Marsh, LH
   Coke, M
   Dettmar, PW
   Ewen, RJ
   Havler, M
   Nevell, TG
   Smart, JD
   Smith, JR
   Timmins, B
   Tsibouklis, J
   Alexander, C
AF Marsh, LH
   Coke, M
   Dettmar, PW
   Ewen, RJ
   Havler, M
   Nevell, TG
   Smart, JD
   Smith, JR
   Timmins, B
   Tsibouklis, J
   Alexander, C
TI Adsorbed poly(ethyleneoxide)-poly(propyleneoxide) copolymers on
   synthetic surfaces: Spectroscopy and microscopy of polymer structures
   and effects on adhesion of skin-borne bacteria
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biocompatible polymers; bacterial adsorption; biofouling; surface
   analysis; poly(ethyleneoxide)-copoly(propyleneoxide); copolymers
ID SELF-ASSEMBLED MONOLAYERS; PEO TRIBLOCK COPOLYMERS; PROTEIN ADSORPTION;
   BIOMATERIAL SURFACES; POLYSTYRENE SURFACES; PLASMON RESONANCE;
   CONTACT-ANGLE; POLYETHYLENE; MECHANISMS; RESIST
AB Poly(ethyleneoxide)-copoly(propyleneoxide) (PEO-PPO) polymer coatings were evaluated for their resistance to the attachment of the marker organism Serratia marcescens and the skin-borne bacteria Staphylococcus epidemidis. The copolymers were adsorbed onto poly(styrene) films-chosen as simplified physicochemical models of skin surfaces-and their surface characteristics probed by contact angle goniometry, attenuated total reflectance-Fourier transform infrared (ATR-FTIR), atomic force microscopy (AFM), and X-ray photoelectron spectroscopy (XPS). These functional surfaces were then presented to microbial cultures, bacterial attachment was assessed by fluorescence microscopy and AFM, and the structures of the polymer films examined again spectroscopically, Surface characterization data suggest that the adsorbed copolymer was partially retained at the surface and resisted bacterial attachment for 24 h. Quantitative evaluation of cell attachment was carried out by scintillation counting of C-14-labeled microorganisms in conjunction with plate counts. The results show that a densely packed layer of PEO-PPO copolymer can reduce attachment of skin commensals by an order of magnitude, even when the coating is applied by a simple adsorptive process. The work supports the hypothesis that adhesion of microorganisms to biological substrates can be reduced if a pretreatment with an appropriate copolymer can be effected in vivo. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
   Reckitt Benckiser Healthcare UK Ltd, Kingston Upon Hull HU8 7DS, N Humberside, England.
   Univ W England, Fac Sci Appl, Bristol BS16 1QY, Avon, England.
RP Alexander, C (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, White Swan Rd, Portsmouth PO1 2DT, Hants, England.
RI Smith, James/D-2350-2011; Alexander, Cameron/N-7729-2014; Smith,
   James/F-1108-2014
OI Smith, James/0000-0001-8805-3788; Alexander,
   Cameron/0000-0001-8337-1875; Smith, James/0000-0001-8805-3788;
   Tsibouklis, John/0000-0001-5300-357X
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   BERGSTROM K, 1992, J BIOMED MATER RES, V26, P779, DOI 10.1002/jbm.820260607
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Brady RF, 1997, CHEM IND-LONDON, P219
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   CHARKOUDIAN JC, 1988, J SOC COSMET CHEM, V39, P225
   EDWARDS DP, 1995, THESIS U PORTSMOUTH
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   Geesin JC, 1996, J BIOMED MATER RES, V33, P1
   Good RJ, 1997, J ADHESION, V63, P5, DOI 10.1080/00218469708015210
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Holland NB, 1998, NATURE, V392, P799
   HOLMBERG K, 1993, J ADHES SCI TECHNOL, V7, P503, DOI 10.1163/156856193X00826
   Hudome SM, 2001, CURR OPIN INFECT DIS, V14, P303, DOI 10.1097/00001432-200106000-00010
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   LEE JH, 1988, POLYM SURFACE DYNAMI, P119
   Mavon A, 1997, COLLOID SURFACE B, V8, P147, DOI 10.1016/S0927-7765(96)01317-3
   MERRILL EW, 1993, J BIOMAT SCI-POLYM E, V5, P1
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   MORTON LHG, 1994, INT BIODETER BIODEGR, V34, P203, DOI 10.1016/0964-8305(94)90083-3
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   Ostuni E, 1999, COLLOID SURFACE B, V15, P3, DOI 10.1016/S0927-7765(99)00004-1
   OTSUKA H, 2000, CURR OPIN COLLOID IN, V6, P3
   PERRIN DD, 1980, PURIFICATION LAB CHE
   PHILLIPS TJ, 1993, J DERMATOL SURG ONC, V19, P794, DOI 10.1111/j.1524-4725.1993.tb00426.x
   Razatos A, 1998, P NATL ACAD SCI USA, V95, P11059, DOI 10.1073/pnas.95.19.11059
   Rijnaarts HHM, 1999, COLLOID SURFACE B, V14, P179, DOI 10.1016/S0927-7765(99)00035-1
   Sanderson NM, 1996, PESTIC SCI, V46, P255, DOI 10.1002/(SICI)1096-9063(199603)46:3<255::AID-PS345>3.0.CO;2-Y
   SCHOTT H, 1971, J PHARM SCI, V60, P1893, DOI 10.1002/jps.2600601233
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   WAGNER CD, 1981, SURF INTERFACE ANAL, V3, P211, DOI 10.1002/sia.740030506
   Wickson BM, 1999, COLLOID SURFACE A, V156, P201, DOI 10.1016/S0927-7757(99)00071-0
NR 43
TC 35
Z9 35
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 15
PY 2002
VL 61
IS 4
BP 641
EP 652
DI 10.1002/jbm.10174
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 568PT
UT WOS:000176551800016
PM 12115455
DA 2018-10-19
ER

PT J
AU Ma, ZW
   Gao, CY
   Juan, J
   Ji, J
   Gong, YH
   Shen, JC
AF Ma, ZW
   Gao, CY
   Juan, J
   Ji, J
   Gong, YH
   Shen, JC
TI Surface modification of poly-L-lactide by photografting of hydrophilic
   polymers towards improving its hydrophilicity
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE graft copolymers; modification surfaces; biocompatibility
ID HUMAN-ENDOTHELIAL CELLS; BLOCK-COPOLYMERS; ADHESION; POLYURETHANE;
   POLYETHYLENE; WETTABILITY; ACRYLAMIDE; ADSORPTION; CARTILAGE; MONOMERS
AB Poly-L-lactide (PLLA) has been used to prepare scaffolds to guide tissue regeneration in tissue engineering research. However, one of the limitations to the use of PLLA as an ideal biomaterial is its high hydrophobicity. To improve the hydrophilicity of PLLA, hydrophilic polymers were grafted onto PLLA membrane surfaces through the combination of photooxidization in hydrogen peroxide and subsequent ultraviolet (UV)-induced grafting copolymerization in the monomer solution. Three kinds of modified PLLA membranes (i.e., PLLA-g-polyhydroxyethyl methacrylate, PLLA-g-polyacrylamide, and PLLA-g-polymethacrylic acid) were obtained, resulting in the more wettable PLLA membranes. The occurrence of the grafting polymerization was confirmed by attenuated total reflectance infrared spectroscopy (ATR-IR) and X-ray photoelectron spectroscopy (XPS) analysis. Surface morphology of the modified PLLA membranes was studied by scan electronic microscopy (SEM). (C) 2002 Wiley Periodicals, Inc.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
   Zhejiang Univ, State Key Lab Silicon Mat Sci, Hangzhou 310027, Peoples R China.
RP Gao, CY (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
OI Gao, Changyou/0000-0001-5084-7208
CR AJAYAGHOSH A, 1992, J APPL POLYM SCI, V45, P1617, DOI 10.1002/app.1992.070450912
   BAMFORD CH, 1994, POLYMER, V35, P2844, DOI 10.1016/0032-3861(94)90316-6
   Bottino FA, 1998, MACROMOLECULES, V31, P7814, DOI 10.1021/ma9700183
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   CLARK P, 1992, J CELL SCI, V103, P287
   Fang YE, 1996, J APPL POLYM SCI, V62, P2209, DOI 10.1002/(SICI)1097-4628(19961226)62:13<2209::AID-APP4>3.0.CO;2-N
   FENG XD, 1985, MAKROMOL CHEM, V186, P1533
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   GERENSER LJ, 1985, POLYMER, V26, P1162, DOI 10.1016/0032-3861(85)90245-9
   Guan JJ, 2000, J APPL POLYM SCI, V77, P2505, DOI 10.1002/1097-4628(20000912)77:11<2505::AID-APP20>3.3.CO;2-L
   Guan JJ, 2000, J BIOMAT SCI-POLYM E, V11, P523, DOI 10.1163/156856200743841
   HAMILTON LM, 1994, J APPL POLYM SCI, V52, P413, DOI 10.1002/app.1994.070520306
   Kokatnur V. R., 1941, J AM CHEM SOC, V63, P1432
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lens JP, 1997, J BIOMAT SCI-POLYM E, V8, P963, DOI 10.1163/156856297X00128
   MATSUDA K, 1990, BIOMATERIALS, V11, P351, DOI 10.1016/0142-9612(90)90113-5
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MISHRA MK, 1982, J APPL POLYM SCI, V27, P1845, DOI 10.1002/app.1982.070270541
   NAKAJIMA K, 1990, POLYM J, V22, P985, DOI 10.1295/polymj.22.985
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Yuan XY, 1998, J APPL POLYM SCI, V69, P1907, DOI 10.1002/(SICI)1097-4628(19980906)69:10<1907::AID-APP3>3.3.CO;2-0
NR 24
TC 58
Z9 63
U1 1
U2 24
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 6
PY 2002
VL 85
IS 10
BP 2163
EP 2171
DI 10.1002/app.10803
PG 9
WC Polymer Science
SC Polymer Science
GA 564XA
UT WOS:000176337800014
DA 2018-10-19
ER

PT J
AU Tong, WD
   Eppell, SJ
AF Tong, WD
   Eppell, SJ
TI Control of surface mineralization using collagen fibrils
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE mineralization; collagen; osteoblast; orthopedic biomaterial; atomic
   force microscopy
ID ATOMIC-FORCE MICROSCOPY; NEUTRON-DIFFRACTION; PATTERN-FORMATION;
   CARBOXYL GROUPS; GROWTH; BONE; CRYSTAL; HYDROXYAPATITE; IMMOBILIZATION;
   INSTABILITIES
AB Surface structure in the form of roughness and organized patterning can affect osteoblastic adhesion and proliferation. This study investigates the effect of reconstituted collagen fibrils on the deposition pattern of a homogeneous inorganic mineral (sodium chloride). The patterns were monitored from nanometer to millimeter scales using atomic force and light microscopies. Initially, mineral deposits formed blocks following the contour of the collagen fibrils. At later times, dendritic structures formed. This demonstrates that collagen fibrils can affect the surface deposition pattern of saline minerals. It is also shown that collagen fibril diameter and the stoichiometry of the inorganic and organic phases effect the surface distribution of minerals. (C) 2002 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Nanoscale Orthoped Biomat Lab, Cleveland, OH 44106 USA.
RP Eppell, SJ (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Nanoscale Orthoped Biomat Lab, 10900 Euclid Ave, Cleveland, OH 44106 USA.
OI Eppell, Steven/0000-0002-0302-1910
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   BASELT DR, 1993, BIOPHYS J, V65, P2644, DOI 10.1016/S0006-3495(93)81329-8
   BENJACOB E, 1983, PHYS REV LETT, V51, P1930, DOI 10.1103/PhysRevLett.51.1930
   BONAR LC, 1985, J MOL BIOL, V181, P265, DOI 10.1016/0022-2836(85)90090-7
   BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   DEYME M, 1986, J BIOMED MATER RES, V20, P951, DOI 10.1002/jbm.820200710
   Eanes E. D., 1992, CALCIFICATION BIOL S, P1
   GALE M, 1995, BIOPHYS J, V68, P2124, DOI 10.1016/S0006-3495(95)80393-0
   GELMAN RA, 1979, J BIOL CHEM, V254, P180
   GLIMCHER MJ, 1998, METABOLIC BONE DIS C, P23
   GRATZ AJ, 1993, GEOCHIM COSMOCHIM AC, V57, P491, DOI 10.1016/0016-7037(93)90449-7
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HENCH LL, 2000, 6 WORLD BIOM C KAM H
   HILLNER PE, 1992, ULTRAMICROSCOPY, V42, P1387, DOI 10.1016/0304-3991(92)90454-R
   HODGE AJ, 1967, TREATISE COLLAGEN, V1, P185
   HOLMES DF, 1986, INT J BIOL MACROMOL, V8, P161, DOI 10.1016/0141-8130(86)90020-6
   KESSLER DA, 1988, ADV PHYS, V37, P255, DOI 10.1080/00018738800101379
   KESSLER DA, 1984, PHYS REV A, V30, P2820, DOI 10.1103/PhysRevA.30.2820
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kubinek R, 1998, Sb Lek, V99, P557
   LANGER JS, 1980, REV MOD PHYS, V52, P1, DOI 10.1103/RevModPhys.52.1
   LEE DD, 1991, J MOL BIOL, V217, P487, DOI 10.1016/0022-2836(91)90752-R
   LIU F, 1990, PHYS REV A, V42, P5052, DOI 10.1103/PhysRevA.42.5052
   LOWENSTAM HA, 1989, BIOMINERALISATION, P135
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MASSAS R, 1993, J DENT RES, V72, P1005, DOI 10.1177/00220345930720060201
   Matsumura K, 2000, J BIOMED MATER RES, V50, P512, DOI 10.1002/(SICI)1097-4636(20000615)50:4<512::AID-JBM6>3.3.CO;2-7
   MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119
   MERGENHAGEN SE, 1960, BIOCHIM BIOPHYS ACTA, V43, P563, DOI 10.1016/0006-3002(60)90488-1
   MULLERKRUMBHAAR H, 1981, ACTA METALL MATER, V29, P145, DOI 10.1016/0001-6160(81)90095-X
   ONUMA K, 1995, J CRYST GROWTH, V154, P118, DOI 10.1016/0022-0248(95)00201-4
   Park JB, 1992, BIOMATERIALS INTRO
   REVENKO I, 1994, BIOL CELL, V80, P67, DOI 10.1016/0248-4900(94)90019-1
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Sato K, 2000, J BIOMED MATER RES, V50, P16, DOI 10.1002/(SICI)1097-4636(200004)50:1<16::AID-JBM3>3.0.CO;2-G
   Sato K, 2001, J COLLOID INTERF SCI, V240, P133, DOI 10.1006/jcis.2001.7617
   SAWADA Y, 1986, PHYS REV LETT, V56, P1260, DOI 10.1103/PhysRevLett.56.1260
   TABATA Y, 1986, BIOMATERIALS, V7, P234, DOI 10.1016/0142-9612(86)90110-9
   WHITE SW, 1977, NATURE, V266, P421, DOI 10.1038/266421a0
NR 42
TC 14
Z9 14
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2002
VL 61
IS 3
BP 346
EP 353
DI 10.1002/jbm.10165
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 564ZJ
UT WOS:000176343200002
PM 12115459
DA 2018-10-19
ER

PT J
AU Vehof, JWM
   Takita, H
   Kuboki, Y
   Spauwen, PHM
   Jansen, JA
AF Vehof, JWM
   Takita, H
   Kuboki, Y
   Spauwen, PHM
   Jansen, JA
TI Histological characterization of the early stages of bone morphogenetic
   protein-induced osteogenesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone morphogenetic protein; bone engineering; scaffold; ectopic;
   osteogenesis
ID BMP-INDUCED OSTEOGENESIS; COATED TITANIUM-MESH; RAT ECTOPIC MODEL;
   ENDOCHONDRAL OSSIFICATION; CELL-DIFFERENTIATION; BIOMATERIAL CARRIERS;
   CALCIUM-PHOSPHATE; HYDROXYAPATITE; PHARMACOKINETICS; PURIFICATION
AB On the basis of currently available knowledge, we hypothesize that the initial bone formation, as induced by bone morphogenetic protein (BMP), is influenced by the chemical composition and three-dimensional spatial configuration of the used carrier material. Therefore, in the current study, the osteoinductive properties of porous titanium (Ti) fiber mesh with a calcium phosphate (Ca-P) coating (Ti-CaP), insoluble bone matrix (IBM), fibrous glass membrane (FGM), and porous particles of hydroxy apatite (PPHAP) loaded with rhBMP-2 were compared in a rat ectopic assay model at short implantation periods. Twelve Ti-CaP, 12 IBM, 12 FGM, and 12 PPHAP implants, loaded with rhBMP-P2, were subcutaneously placed in 16 Wistar King rats. The rats were sacrificed at 3, 5, 7, and 9 days post-operative, and the implants were retrieved. Histological analysis demonstrated that IBM and Ti-CaP had induced ectopic cartilage and bone formation by 5 and 7 days, respectively. However, in PPHAP, bone formation and cartilage formation were seen together at 7 days. At 9 days, in Ti-CaP, IBM, and PPHAP, cartilage was seen together with trabecular bone. At 9 days, in FGM, only cartilage was observed. Quantitative rating of the tissue response, using a scoring system, demonstrated that the observed differences were statistically significant (Wilcoxon rank sum test, p < 0.05). We conclude that IBM, CaP-coated Ti mesh, FGM, and PPHAP provided with rhBMP-2 can indeed induce ectopic bone formation with a cartilaginous phase in a rat model it short implantation periods. Considering the different chemical composition and three-dimensional spatial configuration of the carrier materials used, these findings even suggest that endochondral ossification is present in rhBMP-2-induced osteogenesis, even though the amount of cartilage may differ. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Nijmegen, Med Ctr, Dept Biomat, Coll Dent Sci, NL-6500 HB Nijmegen, Netherlands.
   Hokkaido Univ, Sch Dent, Dept Biochem, Sapporo, Hokkaido 060, Japan.
   Univ Nijmegen, Med Ctr, Dept Plast & Reconstruct Surg, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Dept Biomat, Coll Dent Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Jansen, John/H-8055-2014; Takita, Hiroko/G-1367-2012
CR BASSET CAL, 1962, NATURE, V190, P460
   Brekke J H, 1996, Tissue Eng, V2, P97, DOI 10.1089/ten.1996.2.97
   CAPLAN AI, 1990, CLIN ORTHOP RELAT R, P257
   Caplan AI, 1987, BONE MINERAL RES, P117
   Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   HALL BK, 1969, LIFE SCI, V8, P533
   IIDA S, 1994, JPN J ORAL BIOL, V36, P249
   Itoh H, 1994, Dent Mater J, V13, P25
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   JANSEN JA, 1994, J BIOMED MATER RES, V28, P1047, DOI 10.1002/jbm.820280909
   JANSEN JA, 1997, P 1 SMITH NEPH INT S
   Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.3.CO;2-T
   Kuboki Y, 1995, CONNECT TISSUE RES, V32, P219, DOI 10.3109/03008209509013726
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   KUBOKI Y, 1992, OSTEOGENESIS INDUCED, P127
   KUBOKI Y, 1998, J DENT RES, V77, P1262
   KUBOKI Y, 1997, P 2 INT C BMP SACR C
   LUYTEN FP, 1989, J BIOL CHEM, V264, P13377
   Mahmood J, 2001, J BIOCHEM-TOKYO, V129, P163, DOI 10.1093/oxfordjournals.jbchem.a002828
   Missana L, 1994, JPN J ORAL BIOL, V36, P9
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   MONMA H, 1987, J MATER SCI, V22, P4247, DOI 10.1007/BF01132015
   Mori S, 1998, BONE, V22, P99, DOI 10.1016/S8756-3282(97)00248-2
   Paquay YCGJ, 1997, BIOMATERIALS, V18, P161, DOI 10.1016/S0142-9612(96)00090-7
   REDDI AH, 1981, COLLAGEN REL RES, V1, P209
   REDDI AH, 1980, ENDOCRINOLOGY, V107, P1291, DOI 10.1210/endo-107-5-1291
   SASANO Y, 1993, ANAT REC, V236, P373, DOI 10.1002/ar.1092360211
   Sasano Y, 1997, ANAT RECORD, V247, P472, DOI 10.1002/(SICI)1097-0185(199704)247:4<472::AID-AR5>3.0.CO;2-T
   TAKAOKA K, 1994, BONE GRAFTS, DERIVATIVES AND SUBSTITUTES, P377
   TRUETA J, 1963, J BONE JOINT SURG BR, V45, P402
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vehof JWM, 2001, PLAST RECONSTR SURG, V108, P434, DOI 10.1097/00006534-200108000-00024
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 39
TC 26
Z9 30
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2002
VL 61
IS 3
BP 440
EP 449
DI 10.1002/jbm.10216
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 564ZJ
UT WOS:000176343200012
PM 12115469
DA 2018-10-19
ER

PT J
AU Meseguer-Olmo, L
   Ros-Nicolas, MJ
   Clavel-Sainz, M
   Vicente-Ortega, V
   Alcaraz-Banos, M
   Lax-Perez, A
   Arcos, D
   Ragel, CV
   Vallet-Regi, M
AF Meseguer-Olmo, L
   Ros-Nicolas, MJ
   Clavel-Sainz, M
   Vicente-Ortega, V
   Alcaraz-Banos, M
   Lax-Perez, A
   Arcos, D
   Ragel, CV
   Vallet-Regi, M
TI Biocompatibility and in vivo gentamicin release from bioactive sol-gel
   glass implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE in vivo gentamicin release; sol-gel glasses; bioactive glasses; in vivo
   bioactivity; SiO2-CaO-P2O5 system
ID DRUG-DELIVERY SYSTEM; COMPOSITES
AB Biomaterial pieces, with suitable osteogenic properties for use in the treatment of bone defects and the capability to avoid bone infections, have been synthesized. These materials are composed exclusively of gentamicin sulfate and bioactive SiO2-CaO-P2O5 sol-gel glass (previously synthesized.). Implant processing was achieved by uniaxial and isostatic pressure of the components mixture. After implanting the pieces into rabbit femur, we studied (i) the antibiotic release, determining the concentration in proximal and distal bone, liver, kidney, and lung as a function of time; and (ii) the bone growth resulting from the glass reactivity in the biologic environment. The results indicate that the implants are good carriers for local gentamicin release in the osseous tissue, exhibiting excellent biocompatibility and bone integration. Moreover, these implants are able to promote bone growth during their resorption process. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Complutense, Dept Quim Inorgan & Bioinorgan, Fac Farm, E-28040 Madrid, Spain.
   Univ Murcia, Fac Med, Lab Cirugia Ortoped Expt, E-30001 Murcia, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense, Dept Quim Inorgan & Bioinorgan, Fac Farm, E-28040 Madrid, Spain.
RI Arcos, Daniel/L-6167-2014; Vallet-Regi, Maria/M-3378-2014
OI Arcos, Daniel/0000-0002-5367-7272; Vallet-Regi,
   Maria/0000-0002-6104-4889; Meseguer-Olmo, Luis/0000-0003-3858-8148
CR Arcos D, 2001, BIOMATERIALS, V22, P701, DOI 10.1016/S0142-9612(00)00233-7
   Balas F, 2001, J MATER RES, V16, P1345, DOI 10.1557/JMR.2001.0187
   BARZA M, 1978, CLIN PHARMACOKINET, V3, P202, DOI 10.2165/00003088-197803030-00002
   BUCHHOLZ HW, 1970, CHIRURG, V41, P511
   del Real RP, 2000, J BIOMED MATER RES, V52, P1
   Ducheyne P, 1998, MRS BULL, V23, P43
   Hench L.L., 1998, HDB BIOMATERIAL PROP, P355, DOI 10.1007/978-1-4615-5801-9_22
   NOONE P, 1974, BRIT MED J, V1, P477, DOI 10.1136/bmj.1.5906.477
   NORDSTROEM L, 1973, Acta Pathologica et Microbiologica Scandinavica Supplementum, V241, P58
   OTSUKA M, 1995, J BIOMED MATER RES, V29, P33, DOI 10.1002/jbm.820290106
   Ragel CV, 2000, J BIOMED MATER RES, V51, P424, DOI 10.1002/1097-4636(20000905)51:3<424::AID-JBM17>3.0.CO;2-E
   TORHOLM C, 1983, CLIN ORTHOP RELAT R, P99
   Vallet-Regi M, 2000, J BIOMED MATER RES, V51, P23, DOI 10.1002/(SICI)1097-4636(200007)51:1<23::AID-JBM4>3.0.CO;2-B
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   vanWachem PB, 1997, J BIOMED MATER RES, V35, P217, DOI 10.1002/(SICI)1097-4636(199705)35:2<217::AID-JBM10>3.0.CO;2-E
   VECSEI V, 1981, CLIN ORTHOP RELAT R, P201
   Zaske D, 1986, TXB CLIN APPL THERAP, P285
NR 17
TC 52
Z9 53
U1 2
U2 12
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD SEP 5
PY 2002
VL 61
IS 3
BP 458
EP 465
DI 10.1002/jbm.10188
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 564ZJ
UT WOS:000176343200014
PM 12115471
DA 2018-10-19
ER

PT J
AU Cheng, NX
   Wang, YL
   Wang, JH
   Zhang, XM
   Zhong, H
AF Cheng, NX
   Wang, YL
   Wang, JH
   Zhang, XM
   Zhong, H
TI Complications of breast augmentation with injected hydrophilic
   polyacrylamide gel
SO AESTHETIC PLASTIC SURGERY
LA English
DT Article
DE breast augmentation; injection biomaterial; complication
AB Since 1997, the hydrophilic polyacrylamide gel (PAAG), an injectable alloplastic biomaterial, imported from the Ukraine has been used for augmentation mammaplasty in China. There were twelve patients with various complications visiting our hospitals after breast augmentation with injected hydrophilic polyacrylamide gel by other clinics, even though such procedures are not performed in our clinical practices. The complications included four cases of PAAG-induced multiple induration and lumps, and one with lactation, three cases of hematoma, two cases of inflammation (infection), and persistent mastodymia, unsatisfactory contour results and abnormal skin sensations in each case. All patients have been treated by removing the injected gel and giving antibiotics. Other procedures included replacement by silicon breast prostheses, mammotomy, and segmental mastectomy. We suggest that the injectable hydrophilic polyacrylamide gel be contraindications for breast augmentation in any young female who is not married, or without a child, with a tendency to hemorrhage, and with little mammary tissue. Some considerations to prevent and manage these complications are discussed.
C1 Guangzhou First Municipal Peoples Hosp, Dept Plast Surg, Guangzhou Med Coll, Guangzhou 510180, Peoples R China.
RP Cheng, NX (reprint author), Guangzhou First Municipal Peoples Hosp, Dept Plast Surg, Guangzhou Med Coll, 602 Renmin N Rd, Guangzhou 510180, Peoples R China.
CR BIRCOLL M, 1987, ANN PLAST SURG, V18, P27
   Chao MJ, 2000, J PRACT AESTH PLAST, V11, P16
   CHEN TH, 1995, BRIT J PLAST SURG, V48, P71, DOI 10.1016/0007-1226(95)90099-3
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001
   FANG ZL, 1998, CHIN J MED AESTH COS, V4, P158
   Filatov A V, 1998, Stomatologiia (Mosk), V77, P45
   HANFU L, 1995, AESTHET PLAST SURG, V19, P427
   LEWIS CM, 1980, PLAST RECONSTR SURG, V66, P134, DOI 10.1097/00006534-198007000-00026
   LEWIS CM, 1993, AESTH PLAST SURG, V17, P107
   Niechajev I, 2000, PLAST RECONSTR SURG, V105, P1173, DOI 10.1097/00006534-200003000-00055
   OKUBO M, 1992, AESTHET PLAST SURG, V16, P181, DOI 10.1007/BF00450611
   ORTIZMONASTERIO F, 1972, PLAST RECONSTR SURG, V50, P42, DOI 10.1097/00006534-197207000-00007
   ZHANG YR, 2000, CHIN J MED AESTH CIS, V6, P53
NR 13
TC 83
Z9 92
U1 0
U2 12
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0364-216X
J9 AESTHET PLAST SURG
JI Aesthet. Plast. Surg.
PD SEP-OCT
PY 2002
VL 26
IS 5
BP 375
EP 382
DI 10.1007/s00266-002-2052
PG 8
WC Surgery
SC Surgery
GA 610YT
UT WOS:000178990200011
PM 12432479
DA 2018-10-19
ER

PT J
AU Yang, HH
   Zhu, QZ
   Qu, HY
   Chen, XL
   Ding, MT
   Xu, JG
AF Yang, HH
   Zhu, QZ
   Qu, HY
   Chen, XL
   Ding, MT
   Xu, JG
TI Flow injection fluorescence immunoassay for gentamicin using
   sol-gel-derived mesoporous biomaterial
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE flow injection immunoassay; sol-gel material; gentamicin
ID IMMUNOAFFINITY CHROMATOGRAPHY; CAPILLARY ELECTROPHORESIS; POLARIZATION
   IMMUNOASSAY; BIOSENSOR; GLASS; ANTIBODIES; ENZYME; PHASE; SERUM
AB Sol-gel-derived mesoporous biomaterials were used for the first time in the flow-injection fluorescence immunoassay system. Anti-gentamicin antibody was immobilized in a mesoporous sol-gel material using tetramethoxysilane as a precursor and poly(ethylene glycol) as a template. The sol-gel glass was used to develop an immumoaffinity column for the flow-injection immunoassay of gentamicin. Little unspecific adsorption of gentamicin on the sol-gel and no antibody leaching under harsh elution conditions were found. The immunoassay is based on the competition between gentamicin and fluorescein isothiocyanate-labeled gentamicin for a limited number of encapsulated antibody binding sites. NaOH solution of 5 x 10(-3) mol/L is used for the regeneration of encapsulated antibody binding sites after each measurement, which allows the immunoreactor to be used for up to 20 times without any loss of reactivity. Sample preconcentration is not needed and a single assay can be performed within 10 min. The calibration for gentamicin has a working range of 250-5000 ng/mL with a detection limit of 200 ng/mL, which is close to that of the fluorescence immunoassay and fluorescence polarization immunoassay using the same reactants. Comparison of the results from this method with that obtained from HPLC showed an excellent correlation. (C) 2002 Elsevier Science (USA). All rights reserved.
C1 Xiamen Univ, Dept Chem, Key Lab Analyt Sci MOE, Xiamen 361005, Peoples R China.
   Xiamen Univ, Dept Mat Sci, Xiamen 361005, Peoples R China.
RP Xu, JG (reprint author), Xiamen Univ, Dept Chem, Key Lab Analyt Sci MOE, Xiamen 361005, Peoples R China.
RI Chen, XL/G-3951-2010
CR Bronshtein A, 2000, CHEM MATER, V12, P2050, DOI 10.1021/cm990780e
   Cichna M, 1997, ANAL CHIM ACTA, V339, P241, DOI 10.1016/S0003-2670(96)00503-X
   DUAN CM, 1994, ANAL CHEM, V66, P1369, DOI 10.1021/ac00081a003
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   GLEZER V, 1993, J AM CHEM SOC, V115, P2533, DOI 10.1021/ja00059a072
   HARA T, 1994, ANAL CHEM, V66, P351, DOI 10.1021/ac00075a007
   Hartnett AM, 1999, ANAL CHEM, V71, P1215, DOI 10.1021/ac981083t
   HUET D, 1993, ANAL CHIM ACTA, V272, P205, DOI 10.1016/0003-2670(93)80570-B
   Jain TK, 1998, J AM CHEM SOC, V120, P11092, DOI 10.1021/ja973849x
   JOLLEY ME, 1981, CLIN CHEM, V27, P1190
   JOLLEY ME, 1981, CLIN CHEM, V27, P1575
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lee WY, 2000, ANAL CHIM ACTA, V404, P195, DOI 10.1016/S0003-2670(99)00699-6
   Liu ZJ, 2000, ANAL CHEM, V72, P4707, DOI 10.1021/ac990490h
   Lu B, 1997, ANAL CHIM ACTA, V340, P175, DOI 10.1016/S0003-2670(96)00453-9
   Maupas H, 1997, J ELECTROANAL CHEM, V421, P165, DOI 10.1016/S0022-0728(96)04837-1
   Pulido-Tofino P, 2001, ANAL CHIM ACTA, V429, P337, DOI 10.1016/S0003-2670(00)01282-4
   RUZICKA J, 1975, ANAL CHIM ACTA, V78, P145, DOI 10.1016/S0003-2670(01)84761-9
   SCHULTZ NM, 1993, ANAL CHEM, V65, P3161, DOI 10.1021/ac00069a035
   Spitzer B, 2000, J CHROMATOGR A, V880, P113, DOI 10.1016/S0021-9673(99)01311-4
   Sun JH, 2000, CHEM J CHINESE U, V21, P95
   Tao L, 1996, ANAL CHEM, V68, P3899, DOI 10.1021/ac960560+
   Wang BQ, 1999, ANAL CHEM, V71, P1935, DOI 10.1021/ac980940q
   Wang J, 1998, ANAL CHEM, V70, P1171, DOI 10.1021/ac971093e
   Wang J, 1998, J AM CHEM SOC, V120, P5852, DOI 10.1021/ja9742747
   WANG R, 1993, ANAL CHEM, V65, P2671, DOI 10.1021/ac00067a020
   Zuehlke J., 1995, Fresenius' Journal of Analytical Chemistry, V352, P654
NR 28
TC 53
Z9 55
U1 0
U2 10
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD SEP 1
PY 2002
VL 308
IS 1
BP 71
EP 76
AR PII S0003-2697(02)00222-1
DI 10.1016/S0003-2697(02)00222-1
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 602PX
UT WOS:000178514600009
PM 12234465
DA 2018-10-19
ER

PT J
AU Chen, TM
   Wang, HJ
AF Chen, TM
   Wang, HJ
TI Cranioplasty using allogeneic perforated demineralized bone matrix with
   autogenous bone paste
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
ID INDUCED OSTEOGENESIS; BIOLOGICAL PRINCIPLE; SKULL DEFECTS;
   RECONSTRUCTION; SURGERY; GRAFTS; REPAIR
AB The efficacy of allogeneic perforated demineralized bone matrix with autogenous bone paste in the treatment of full-thickness cranial defects was evaluated in 10 consecutive patients between June 1998 and December 1998. The skull defects resulted from trauma in 9 patients and removal of a cranial tumor in 1 patient. The size of the skull defects ranged from 8 x 6 cm to 11 x 12.5 cm. Follow-up averaged 33 months for all patients. Postimplantation evaluations included serial photographs, repeated physical examination, and three-dimensional computed tomography for all patients. Visual inspection of the implanted biomaterial 6 months later was possible in I patient. The contour of the reconstructed skull was acceptable aesthetically without any secondary depression noted during the follow-up period. Three-dimensional computed tomographic scans taken 2 years after implantation indicated that the allogeneic perforated demineralized bone matrix provided a matrix for new bone formation with remarkable osteoinductive potential for new bone formation. The autogenous bone paste was able to caulk the demineralized bone matrix and fill the contour irregularities and gaps of the reconstructed cranium. The results from this clinical study indicated that allogeneic perforated demineralized bone matrix with autogenous bone paste is a promising alternative to an autogenous bone graft and or alloplastic material for cranioplasty.
C1 Tri Serv Gen Hosp, Natl Def Med Ctr, Div Plast Surg, Dept Surg, Taipei, Taiwan.
   Armed Forces Tao Yuan Gen Hosp, Tao Yuan, Taiwan.
RP Chen, TM (reprint author), POB 30-457, Taipei, Taiwan.
CR BAKAMJIAN VY, 1977, PLAST RECONSTR SURG, V60, P784, DOI 10.1097/00006534-197711000-00023
   EDWARDS MSB, 1987, NEUROSURGERY, V20, P273, DOI 10.1227/00006123-198702000-00013
   GENDLER E, 1986, J BIOMED MATER RES, V20, P687, DOI 10.1002/jbm.820200603
   GLOWACKI J, 1981, LANCET, V1, P959
   HABAL MB, 1978, PLAST RECONSTR SURG, V61, P394, DOI 10.1097/00006534-197803000-00014
   JACKSON IT, 1983, ANN PLAS SURG, V11, P527, DOI 10.1097/00000637-198312000-00014
   MANSON PN, 1986, PLAST RECONSTR SURG, V77, P888, DOI 10.1097/00006534-198606000-00003
   MELLONIG JT, 1992, J PERIODONTOL, V63, P979, DOI 10.1902/jop.1992.63.12.979
   Moss SD, 1995, PEDIATR NEUROSURG, V23, P199
   MULLIKEN JB, 1981, ANN SURG, V194, P366, DOI 10.1097/00000658-198109000-00015
   MULLIKEN JB, 1984, J SURG RES, V37, P487, DOI 10.1016/0022-4804(84)90218-X
   MULLIKEN JB, 1980, PLAST RECONSTR SURG, V65, P553, DOI 10.1097/00006534-198005000-00001
   NICKELL WB, 1972, ARCH SURG-CHICAGO, V105, P431
   OBroin ES, 1997, CLEFT PALATE-CRAN J, V34, P354, DOI 10.1597/1545-1569(1997)034<0353:TMABDC>2.3.CO;2
   OUSTERHOUT DK, 1985, ANN PLAS SURG, V15, P367, DOI 10.1097/00000637-198511000-00001
   PROLO DJ, 1979, NEUROSURGERY, V4, P18, DOI 10.1227/00006123-197901000-00005
   Salyer K E, 1992, J Craniofac Surg, V3, P55, DOI 10.1097/00001665-199209000-00002
   Salyer KE, 1997, PLAST RECONSTR SURG, V99, P1721, DOI 10.1097/00006534-199705000-00038
   Shehadi S I, 1970, Br J Plast Surg, V23, P227, DOI 10.1016/S0007-1226(70)80046-7
   TORIUMI DM, 1990, ARCH OTOLARYNGOL, V116, P676
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   WOLFE SA, 1982, CLIN PLAST SURG, V9, P539
NR 22
TC 34
Z9 35
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD SEP
PY 2002
VL 49
IS 3
BP 272
EP 277
DI 10.1097/01.SAP.0000015488.91165.B8
PG 6
WC Surgery
SC Surgery
GA 592DN
UT WOS:000177921600007
PM 12351975
DA 2018-10-19
ER

PT J
AU Betre, H
   Setton, LA
   Meyer, DE
   Chilkoti, A
AF Betre, H
   Setton, LA
   Meyer, DE
   Chilkoti, A
TI Characterization of a genetically engineered elastin-like polypeptide
   for cartilaginous tissue repair
SO BIOMACROMOLECULES
LA English
DT Article
ID INVERSE TEMPERATURE TRANSITION; EXTRACELLULAR-MATRIX;
   ARTICULAR-CARTILAGE; MECHANICAL-BEHAVIOR; ENDOTHELIAL-CELLS; IN-VITRO;
   CHONDROCYTES; CULTURE; PURIFICATION; COLLAGEN
AB Elastin-like polypeptides (ELPs) are artificial polypeptides with unique properties that make them attractive as a biomaterial for tissue-engineered cartilage repair. ELPs are composed of a pentapeptide repeat, Val-Pro-Gly-Xaa-Gly (Xaa is any amino acid except Pro), that undergo an inverse temperature phase transition. They are soluble in aqueous solution below their transition temperature (T-t) but aggregate when the solution temperature is raised above their T-t. This study investigates the theological behavior of an un-cross-linked ELP, below and above its T-t and also examines the ability of ELP to promote chondrogenesis in vitro. A thermally responsive ELP with a T-t of 35 degreesC was synthesized using recombinant DNA techniques. The complex shear modulus of the ELP increased by 3 orders of magnitude as it underwent its inverse temperature phase transition, forming a coacervate. or gel-like, ELP phase. Values for the complex shear moduli of the un-cross-linked ELP coacervate are comparable to those reported previously for collagen, hyaluronan, and cross-linked synthetic hydrogels. Cell culture studies show that chondrocytes cultured in ELP coacervate maintain a rounded morphology and their chondrocytic phenotype, characterized by the synthesis of a significant amount of extracellular matrix composed of sulfated glycosaminoglycans and collagen. These results suggest that ELPs demonstrate great potential for use as in situ forming scaffolds for cartilaginous tissue repair.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
RP Chilkoti, A (reprint author), Duke Univ, Dept Biomed Engn, Box 90281, Durham, NC 27708 USA.
OI Meyer, Dan/0000-0002-1574-1704
CR Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Ausubel F.M., 1995, CURRENT PROTOCOLS MO
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BOYD LM, 2001, ANN BIOMED ENG, V29
   Brun P, 1999, J MATER SCI-MATER M, V10, P683, DOI 10.1023/A:1008960413362
   BUCKWALTER JA, 1993, J BONE JOINT SURG AM, V75A, P1533, DOI 10.2106/00004623-199310000-00015
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   HAUSELMANN H, 1992, MATRIX, V22, P116
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Iatridis JC, 1997, J ORTHOP RES, V15, P318, DOI 10.1002/jor.1100150224
   KAMADA H, 2001, T ORTHOP RES SOC, V26, P616
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   LONG MM, 1989, J CELL PHYSIOL, V140, P512, DOI 10.1002/jcp.1041400316
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Meyer DE, 2001, CANCER RES, V61, P1548
   NETTLES D, 2001, T ORTHOP RES SOC, V26, P202
   NICOL A, 1992, J BIOMED MATER RES, V26, P393, DOI 10.1002/jbm.820260309
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Ragan PM, 2000, ARCH BIOCHEM BIOPHYS, V383, P256, DOI 10.1006/abbi.2000.2060
   SANDBERG LB, 1985, PATHOL BIOL, V33, P266
   Schreiber RE, 1999, ANN NY ACAD SCI, V875, P398, DOI 10.1111/j.1749-6632.1999.tb08522.x
   SETTON LA, 1995, J ORTHOPAED RES, V13, P473, DOI 10.1002/jor.1100130402
   Silverman RP, 1999, PLAST RECONSTR SURG, V103, P1809, DOI 10.1097/00006534-199906000-00001
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   SOLURSH M, 1982, DEV BIOL, V94, P259, DOI 10.1016/0012-1606(82)90090-2
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   URRY DW, 1992, ABSTR PAP AM CHEM S, V203, P202
   URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411
   URRY DW, 1992, SYNTHESES CHARACTERI, V1
   VunjakNovakovic G, 1996, AICHE J, V42, P850, DOI 10.1002/aic.690420323
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   ZHU W, 1996, J BIOMECH ENG, V29
   ZHU WB, 1994, J BIOMECH, V27, P571, DOI 10.1016/0021-9290(94)90066-3
NR 50
TC 172
Z9 178
U1 1
U2 58
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP-OCT
PY 2002
VL 3
IS 5
BP 910
EP 916
DI 10.1021/bm0255037
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 592XX
UT WOS:000177963100006
PM 12217035
DA 2018-10-19
ER

PT J
AU Cornelius, RM
   Archambault, J
   Brash, JL
AF Cornelius, RM
   Archambault, J
   Brash, JL
TI Identification of apolipoprotein A-I as a major adsorbate on biomaterial
   surfaces after blood or plasma contact
SO BIOMATERIALS
LA English
DT Article
DE apolipoprotein A-I; high-density lipoprotein; adsorption; blood-material
   interactions
ID PROTEIN ADSORPTION; MICROCAPSULES; POLYETHYLENE; MEMBRANES; LIPOSOMES;
   GLASS
AB Apolipoprotein A-I is the major protein component of HDL. It is reported in this communication that apo A-I is a significant component of the protein layer adsorbed from blood or plasma to a variety of biomaterial surfaces, including hydrophobic and hydrophilic polymers, liposomes, a heparinized surface, and a polysulfone hemodialyzer membrane. Evidence in support of this conclusion front SDS-PAGE and immunoblots of proteins eluted from the surfaces after blood or plasma contact is presented. Whether the presence of apo A-I on these surfaces results from the uptake of the free protein or HDL particles remains to be determined. It appears that apolipoprotein A-I and/or HDL deposition may be an important effect in blood-biomaterial interactions generally, and one that has been largely overlooked. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main W St, Hamilton, ON L8S 4L7, Canada.
CR Archambault J. G., 1998, T SOC BIOMATER, V21, P251
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   Bambauer R, 1997, Ther Apher, V1, P49, DOI 10.1111/j.1744-9987.1997.tb00013.x
   BRASH JL, 1986, J BIOMED MATER RES, V20, P1263, DOI 10.1002/jbm.820200904
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   CHANG PL, 2000, T 6 WORLD BIOM, P1278
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   Cornelius RM, 1999, BIOMATERIALS, V20, P341, DOI 10.1016/S0142-9612(98)00174-4
   Gurr M. I., 1991, LIPID BIOCH
   MCINTYRE N, 1991, LIPIDS LIPOPROTEINS
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   ODAKA M, 1987, BIOMAT ARTIF CELLS A, V15, P13
   Patsch W, 1996, METHOD ENZYMOL, V263, P3
   Peirone M, 1998, J BIOMED MATER RES, V42, P587, DOI 10.1002/(SICI)1097-4636(19981215)42:4<587::AID-JBM15>3.0.CO;2-X
   Price ME, 2001, BBA-BIOMEMBRANES, V1512, P191, DOI 10.1016/S0005-2736(01)00330-3
   ROSSENEU M, 1992, STRUCTURE FUNCTION A
   Soltys PJ, 2000, BIOMATERIALS, V21, P37, DOI 10.1016/S0142-9612(99)00130-1
   STANISLAWSKI L, 1995, J BIOMED MATER RES, V29, P315, DOI 10.1002/jbm.820290306
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   VANDAMME HS, 1991, J BIOMAT SCI-POLYM E, V3, P69, DOI 10.1163/156856292X00088
   Yamazaki A, 1999, BBA-BIOMEMBRANES, V1421, P103, DOI 10.1016/S0005-2736(99)00117-0
NR 21
TC 27
Z9 28
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2002
VL 23
IS 17
BP 3583
EP 3587
AR PII S0142-9612(02)00083-2
DI 10.1016/S0142-9612(02)00083-2
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 568BM
UT WOS:000176522600006
PM 12109682
DA 2018-10-19
ER

PT J
AU Wong, JY
   Weng, ZP
   Moll, S
   Kim, S
   Brown, CT
AF Wong, JY
   Weng, ZP
   Moll, S
   Kim, S
   Brown, CT
TI Identification and validation of a novel cell-recognition site (KNEED)
   on the 8th type III domain of fibronectin
SO BIOMATERIALS
LA English
DT Article
DE fibronectin; cell adhesion; cell spreading; adhesion peptides
ID INTEGRINS; ADHESION; RGD; FEATURES
AB Interactions between cell-surface integrins and extracellular matrix proteins underlie a versatile recognition system providing cells with anchorage, traction for migration or matrix remodeling, as well as signals for polarity, differentiation and growth. Short peptide sequences of fibronectin (FN), most notably RGD found on a loop in the 10th type III domain, are effective in promoting cell adhesion when immobilized to a biomaterial scaffold. Additional sequences (e.g. PHSRN) have been shown to act synergistically to enhance cell adhesion and other cellular processes. Using bioinformatics, we identified a candidate cell-binding peptide sequence, KNEED, located on the loop region of the 8th domain of FN that from in vitro studies appears to participate in cell attachment and spreading. Computational analysis revealed that KNEED exhibits both high solvent accessibility and sequence conservation values across FN sequences from seven species. We demonstrate the importance of the KNEED sequence using a solution-phase competitive inhibition assay utilizing soluble peptides. Results indicate that the presence of soluble KNEED peptides inhibits the attachment and spreading of 3T3 balb/c fibroblasts on FN-coated surfaces in a concentration-dependent manner. As more sequence and crystallographic data become available, computational approaches may aid in the identification of new targets for applications where biorecognition plays a key role. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Wong, JY (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
RI Wong, Joyce/F-3732-2011
OI Wong, Joyce/0000-0002-3526-6381
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4
   COTRAIT M, 1992, J COMPUT AID MOL DES, V6, P113, DOI 10.1007/BF00129423
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KIMIZUKA F, 1991, J BIOCHEM-TOKYO, V110, P284, DOI 10.1093/oxfordjournals.jbchem.a123572
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Leahy DJ, 1997, ANNU REV CELL DEV BI, V13, P363, DOI 10.1146/annurev.cellbio.13.1.363
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   RAJAGOPALAN P, IN PRESS MAT RES SOC
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   STREETER HB, 1987, J CELL BIOL, V105, P507, DOI 10.1083/jcb.105.1.507
NR 18
TC 21
Z9 22
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2002
VL 23
IS 18
BP 3865
EP 3870
AR PII S0142-9612(02)00127-8
DI 10.1016/S0142-9612(02)00127-8
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 579EM
UT WOS:000177165700010
PM 12164191
DA 2018-10-19
ER

PT J
AU Hansson, KM
   Tengvall, P
   Lundstrom, I
   Ranby, M
   Lindahl, TL
AF Hansson, KM
   Tengvall, P
   Lundstrom, I
   Ranby, M
   Lindahl, TL
TI Surface plasmon resonance and free oscillation rheometry in combination:
   a useful approach for studies on haemostasis and interactions between
   whole blood and artificial surfaces
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE surface plasmon resonance; free oscillation rheometry; whole blood
   coagulation; fibrinolysis
ID PROTEIN ADSORPTION; GLYCOPROTEIN IIB/IIIA; PLATELET BINDING;
   COAGULATION; GOLD; SENSOR; SENSITIVITY; EXPOSURE; BLOCKADE; THROMBIN
AB In haemostatic and biomaterial research biological processes at surfaces and in the bulk phase of the surface-contacting medium are important. The present work demonstrates the usefulness of the combination of surface plasmon resonance (SPR), sensitive to changes in refractive index at surfaces, and free oscillation rheometry (FOR), sensitive to rheological properties of the bulk, for simultaneous real-time measurements on coagulation and fibrinolysis of blood plasma and coagulation of whole blood. SFLLRN stimulated coagulation of native whole blood presented a higher SPR signal with different appearance than plasma coagulation, while the FOR signals corresponding to plasma and whole blood coagulation were similar. This indicated that the SPR technique was more sensitive to cell-surface interactions than to Fibrin formation in whole blood during coagulation, while the FOR technique were equally sensitive to coagulation in whole blood and plasma. Spontaneous coagulation of native whole blood in contact with methyl- and hydroxyl-terminated self-assembled monolayers (SAM) on gold and gold surfaces regenerated after coagulation were also studied. The regenerated gold surfaces displayed the shortest coagulation times, although the contact-activation of blood coagulation for these surfaces was low. The methylated and hydroxylated surfaces were comparable in terms of coagulation activation, while the hydroxylated surfaces presented FOR signals that indicated detaching of the coagulum from the surface. The combination of SPR and FOR is well suited for studies of cell- and protein-surface interactions and simultaneous bulk processes. Possible applications are investigations of blood cell defects in patients and monitoring of native whole blood interactions with artificial surfaces. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Linkoping Univ Hosp, Dept Biomed & Surg, Div Clin Chem, SE-58185 Linkoping, Sweden.
   Linkoping Univ, Forum Scientum Grad Sch, SE-58183 Linkoping, Sweden.
   Linkoping Univ, Dept Phys & Measurement Technol, Div Appl Phys, SE-58183 Linkoping, Sweden.
RP Hansson, KM (reprint author), Linkoping Univ Hosp, Dept Biomed & Surg, Div Clin Chem, SE-58185 Linkoping, Sweden.
CR BOHLIN L, 1998, Patent No. 9854475
   BOHLIN L, 1994, Patent No. 9408222
   Broberg M, 1998, COLLOID SURFACE B, V11, P67, DOI 10.1016/S0927-7765(98)00026-5
   CARR ME, 1995, THROMB HAEMOSTASIS, V73, P499
   DAVIES J, 1994, NANOBIOLOGY, V3, P5
   Eriksson C, 1997, J BIOMED MATER RES, V37, P130, DOI 10.1002/(SICI)1097-4636(199710)37:1<130::AID-JBM16>3.0.CO;2-K
   GAUTAM SK, 1995, BIO-MED MATER ENG, V5, P141
   GEMMELL CH, 1995, J LAB CLIN MED, V125, P276
   Hansson KM, 1999, BIOSENS BIOELECTRON, V14, P671, DOI 10.1016/S0956-5663(99)00050-0
   HUI KY, 1992, BIOCHEM BIOPH RES CO, V184, P790, DOI 10.1016/0006-291X(92)90659-9
   Johansen K, 2000, REV SCI INSTRUM, V71, P3530, DOI 10.1063/1.1287631
   JORGENSON RC, 1993, SENSOR ACTUAT B-CHEM, V12, P213, DOI 10.1016/0925-4005(93)80021-3
   JORGENSON RC, 1994, SENSOR ACTUAT A-PHYS, V43, P44, DOI 10.1016/0924-4247(93)00661-M
   KAIBARA M, 1985, BIORHEOLOGY, V22, P197
   KAIBARA M, 1989, PROGR NEW DIRECTIONS, P63
   Kanagaraja S, 1996, BIOMATERIALS, V17, P2225, DOI 10.1016/0142-9612(95)00311-8
   KINLOUGHRATHBONE RL, 1993, THROMB HAEMOSTASIS, V70, P1019
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   LESTELIUS M, 1995, J COLLOID INTERF SCI, V171, P533, DOI 10.1006/jcis.1995.1217
   LESTELIUS M, 1994, J BIOMED MATER RES, V28, P871, DOI 10.1002/jbm.820280806
   LIEDBERG B, 1995, BIOSENS BIOELECTRON, V10, pR1, DOI 10.1016/0956-5663(95)96965-2
   Nelson RW, 1997, ANAL CHEM, V69, P4363, DOI 10.1021/ac970538w
   QUICK AJ, 1935, AM J MED SCI, P190
   Ramstrom S, 1999, THROMB HAEMOSTASIS, P292
   RAMSTROM S, 2001, THROMB HAEMOST S JUL
   Ranby M, 1999, BLOOD COAGUL FIBRIN, V10, P173, DOI 10.1097/00001721-199906000-00003
   Ranby M, 1999, CLIN CHEM, V45, P1176
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SODERSTROM J, 2001, THROMB HAEMOST S JUL
   Tam SH, 1998, CIRCULATION, V98, P1085, DOI 10.1161/01.CIR.98.11.1085
   TENGVALL P, 1992, BIOMATERIALS, V13, P367, DOI 10.1016/0142-9612(92)90042-M
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Vikinge TP, 2000, J BIOMED OPT, V5, P51, DOI 10.1117/1.429968
NR 33
TC 23
Z9 23
U1 0
U2 10
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD SEP
PY 2002
VL 17
IS 9
BP 747
EP 759
AR PII S00956-5663(02)00048-9
DI 10.1016/S0956-5663(02)00048-9
PG 13
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 592CQ
UT WOS:000177919500005
PM 12191923
DA 2018-10-19
ER

PT J
AU Carter, DH
   Scully, AJ
   Heaton, DA
   Young, MPJ
   Aaron, JE
AF Carter, DH
   Scully, AJ
   Heaton, DA
   Young, MPJ
   Aaron, JE
TI Effect of deproteination on bone mineral morphology: Implications for
   biomaterials and aging
SO BONE
LA English
DT Article
DE bone salt; anorganic dehydrated bone; hard tissue cryopreservation and
   image enhancement; filamentous mineral and calcified needles and plates;
   bioimplant material; skeletal aging
ID COMPACT-BONE; ENAMEL MATRIX; RAT; CALCIUM; ULTRASTRUCTURE;
   PHOSPHOPROTEIN; DENTIN; CELLS; IMMUNOLOCALIZATION; HYDROXYAPATITE
AB Bone mineral morphology is altered by processing and this is rarely considered when preparing bone as a bioimplant material. To examine the degree of transformation, a commercial, coarsely particulate bone mineral biomaterial produced by prolonged deproteination, defatting, dehydration, and heating (donor material) was compared with similar particles of human bone (recipient material) prepared optimally by low-temperature milling. The two powders were freeze-substituted and embedded without thawing in Lowicryl K4M before sectioning for transmission electron microscopy (TEM) (other aliquots were processed by traditional TEM methods). To maximize resolution, electron micrographs were image-enhanced by digitization and printed as negatives using a Polaroid Sprint Scan 45. In addition to their morphology, the particles were examined for antigenicity (specific by reference to fluorescein isothiocyanate [FITC]-conjugated fibronectin, and nonspecific by reference to general FITC-conjugated immunoglobulins). Results showed that the optimally prepared human bone fragments stained discretely for fibronectin with negligible background autofluorescence. In contrast, the bioimplant fragments stained extensively with this and any other FITC-conjugated antibody and, unlike fresh bone, it also autofluoresced a uniform yellow. This difference was also expressed structurally and, although the bioimplant mineral consisted of rhomboidal plates up to 200 nm across and 10 nm thick, the optimally prepared bone mineral was composed of numerous clusters of 5-nm-wide sinuous calcified filaments of variable density and indeterminate length (which became straight needles 50 nm long and 5 run thick following traditional chemical TEM fixation/staining). It was concluded that the inorganic phase of bone is both morphologically and immunologically transmutable and that, in biomaterials, the transformation is apparently so great that a broad indigenous antigenicity is unmasked, increasing the likelihood of resorption or rejection. This marked change may also provide preliminary insight into a more modest natural aging phenomenon with the localized lateral fusion of calcified filaments into less flexible, more immunologically reactive fenestrated plates. (C) 2002 by Elsevier Science Inc. All rights reserved.
C1 Univ Manchester, Unit Oral Pathol, Turner Dent Sch, Manchester M15 6FH, Lancs, England.
   Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England.
RP Carter, DH (reprint author), Univ Manchester, Unit Oral Pathol, Turner Dent Sch, Higher Cambridge St, Manchester M15 6FH, Lancs, England.
CR Aaron J. E., 1978, Vitamin D, P201
   AARON JE, 1972, ISRAEL J MED SCI, V8, P625
   Aaron JE, 1999, HISTOCHEM J, V31, P455, DOI 10.1023/A:1003707909842
   AARON JE, 1973, CALC TISS RES, V12, P259, DOI 10.1007/BF02013740
   Albeck S, 1996, CONNECT TISSUE RES, V35, P365, DOI 10.3109/03008209609029213
   APPLETON J, 1970, CALC TISS RES, V5, P270, DOI 10.1007/BF02017555
   Arnold S, 1997, CELL TISSUE RES, V288, P185, DOI 10.1007/s004410050805
   Arnold S, 2001, J MICROSC-OXFORD, V202, P488, DOI 10.1046/j.1365-2818.2001.00831.x
   BARCKHAUS RH, 1978, CELL TISSUE RES, V186, P541
   Baskin TI, 1996, J MICROSC-OXFORD, V182, P149, DOI 10.1046/j.1365-2818.1996.135417.x
   Bonucci E, 1995, Connect Tissue Res, V33, P157, DOI 10.3109/03008209509016996
   Boyan BD, 2000, BONE, V27, P341, DOI 10.1016/S8756-3282(00)00347-1
   BOYDE A, 1978, CALC TISS RES, V26, P47, DOI 10.1007/BF02013233
   Boyde A, 1980, METAB BONE DIS REL S, V2, P69
   CARTER DH, 1994, HISTOCHEM J, V26, P103, DOI 10.1007/BF00157958
   CARTER DH, 1991, J HISTOCHEM CYTOCHEM, V39, P599, DOI 10.1177/39.5.1707904
   CARTER DH, 1992, ANAT EMBRYOL, V186, P229
   Carter DH, 1998, HISTOCHEM J, V30, P677, DOI 10.1023/A:1003490506980
   Carter DH, 1997, HISTOCHEM J, V29, P783, DOI 10.1023/A:1026425404169
   Carter DH, 2000, HISTOCHEM J, V32, P253, DOI 10.1023/A:1004059219242
   DAVIES JE, 1991, CELL MATER, V1, P3
   DEBERNARD B, 1986, J CELL BIOL, V103, P1615, DOI 10.1083/jcb.103.4.1615
   EANES ED, 1965, T NEW YORK ACAD SCI, V28, P233, DOI 10.1111/j.2164-0947.1965.tb02877.x
   Filmon R, 2002, BONE, V30, P152, DOI 10.1016/S8756-3282(01)00634-2
   Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130
   GAY CV, 1977, CALC TISS RES, V23, P215, DOI 10.1007/BF02012788
   GLIMCHER MJ, 1990, METABOLIC BONE DIS C, P42
   GORSKI JP, 1995, ANN NY ACAD SCI, V760, P12, DOI 10.1111/j.1749-6632.1995.tb44616.x
   GUIZZARDI S, 1995, BIOMATERIALS, V16, P931, DOI 10.1016/0142-9612(95)93118-W
   HARVEY DMR, 1982, J MICROSC-OXFORD, V127, P209, DOI 10.1111/j.1365-2818.1982.tb00414.x
   HAYAT M, 1989, BIOL APPL
   HOBLING HJ, 1995, CONNECT TISSUE RES, V33, P171
   HOHLING HJ, 1989, HDB MICROSCOPIC ANAT, V5, P475
   KANDORI K, 1995, COLLOID SURFACE B, V5, P81, DOI 10.1016/0927-7765(95)98210-E
   LESTER KS, 1890, J ULTRASTRUCT RES, V72, P141
   MARK MP, 1987, J HISTOCHEM CYTOCHEM, V35, P707, DOI 10.1177/35.7.3295029
   MARSH PD, 1995, J IND MICROBIOL, V15, P169, DOI 10.1007/BF01569822
   MCKEE MD, 1990, ANAT REC, V228, P77, DOI 10.1002/ar.1092280112
   Meleti Z, 2000, BONE, V27, P359, DOI 10.1016/S8756-3282(00)00346-X
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   Misra RP, 2000, CELL MOL LIFE SCI, V57, P421, DOI 10.1007/PL00000704
   Morgan A.J., 1979, SCANNING ELECT MICRO, V11, P635
   NYLEN MU, 1972, CALC TISS RES, V9, P95, DOI 10.1007/BF02061948
   Ong JL, 1998, J BIOMED MATER RES, V39, P176, DOI 10.1002/(SICI)1097-4636(199802)39:2<176::AID-JBM2>3.0.CO;2-M
   Oyajobi BO, 1998, J BONE MINER RES, V13, P432, DOI 10.1359/jbmr.1998.13.3.432
   Pautard F.G.E., 1975, Colloques int Cent natn Res scient, VNo. 230, P93
   PAUTARD FGE, 1976, PROGR BIOL CRYSTAL G, V4, P89
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Plate U, 1998, CONNECT TISSUE RES, V38, P149, DOI 10.3109/03008209809017032
   Plate U, 1996, J MICROSC-OXFORD, V183, P102, DOI 10.1046/j.1365-2818.1996.67430.x
   POSNER AS, 1987, BONE MINERAL RES, V5, P65
   RASPANTI M, 1994, BIOMATERIALS, V15, P433, DOI 10.1016/0142-9612(94)90222-4
   Robinson C, 1998, EUR J ORAL SCI, V106, P282, DOI 10.1111/j.1600-0722.1998.tb02188.x
   ROMBERG RW, 1986, BIOCHEMISTRY-US, V25, P1176, DOI 10.1021/bi00353a035
   Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3
   SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2
   SCHRAER H, 1977, CALC TISS RES, V23, P185, DOI 10.1007/BF02012785
   SHAHTAHERI MS, 1998, THESIS U LEEDS LEEDS
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Stratmann U, 1997, ANAT EMBRYOL, V195, P289, DOI 10.1007/s004290050048
   TERMINE JD, 1973, CALC TISS RES, V13, P73, DOI 10.1007/BF02013723
   Young M P, 2001, Implant Dent, V10, P149
NR 62
TC 12
Z9 12
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD SEP
PY 2002
VL 31
IS 3
BP 389
EP 395
AR PII S8756-3282(02)00840-2
DI 10.1016/S8756-3282(02)00840-2
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 597DF
UT WOS:000178206300006
PM 12231411
DA 2018-10-19
ER

PT J
AU Zoulgami, M
   Lucas-Girot, A
   Michaud, V
   Briard, P
   Gaude, J
   Oudadesse, H
AF Zoulgami, M
   Lucas-Girot, A
   Michaud, V
   Briard, P
   Gaude, J
   Oudadesse, H
TI Synthesis and physico-chemical characterization of a
   polysialate-hydroxyapatite composite for potential biomedical
   application
SO EUROPEAN PHYSICAL JOURNAL-APPLIED PHYSICS
LA English
DT Article
ID CALCIUM-PHOSPHATE; SILICATE
AB New composite materials based on aluminosilicate materials were developed to be used in orthopaedic or maxillo-facial surgery. They are called geopolymers or polysialate-siloxo (PSS) and were studied alone or mixed with hydroxyapatite (HAP). The properties of these materials were investigated for potential use in biological or surgery applications. In this work, the chemistry involved in materials preparation was described. Samples were characterized by some physico-chemical methods like X-ray diffraction (XRD), infrared spectrometry (IR) and electron dispersion X-ray spectrometry (EDX). Results indicate that the mixing hydroxyapatite-geopolymer (PSS) leads to a neutral porous composite material with interesting physico-chemical properties. A preliminary evaluation of its cytotoxicity reveals an harmlessness towards fibroblasts. These properties allow to envisage this association as a potential biomaterial.
C1 LCSIM, Grp Cristallochim & Biomat, UMR 6511, F-35042 Rennes, France.
RP Zoulgami, M (reprint author), LCSIM, Grp Cristallochim & Biomat, UMR 6511, Bat 10B,Campus Beaulieu,263 Ave Gen Leclerc,CS 74, F-35042 Rennes, France.
OI Michaud, veronique/0000-0001-5699-740X
CR DAVIDOVITS J, 1991, J THERM ANAL, V37, P1633, DOI 10.1007/BF01912193
   de Aza PN, 2000, J MICROSC-OXFORD, V197, P60
   Deany I L, 1996, Crit Rev Oral Biol Med, V7, P134
   Ehlers E. G., 1972, INTERPRETATION GEOLO
   Elliott JC, 1994, STUDIES INORGANIC CH, V18
   HENCH LL, 1986, CIBA F SYMP, V121, P231
   Kawasaki A, 1996, J DENT, V24, P429, DOI 10.1016/0300-5712(95)00101-8
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   MacDonald SA, 2000, J NON-CRYST SOLIDS, V275, P72, DOI 10.1016/S0022-3093(00)00121-6
   MARQUET V, 1997, POROUS MAT TISSUE EN, V250
   Martens M., 1984, NATURAL LIVING BIOMA, P89
   Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PARKES JB, 1992, BIOMATERIALS INTRO
   Shevtsova N. N., 1981, MOSCOW U CHEM BULL, V36, P117
   VANJAARSWELD JGS, 1996, MINER ENG, V10, P659
   Zoulgami M, 2001, BIOMATERIALS, V22, P1933, DOI 10.1016/S0142-9612(00)00384-7
NR 17
TC 11
Z9 11
U1 1
U2 11
PU E D P SCIENCES
PI LES ULIS CEDEXA
PA 7, AVE DU HOGGAR, PARC D ACTIVITES COURTABOEUF, BP 112, F-91944 LES ULIS
   CEDEXA, FRANCE
SN 1286-0042
J9 EUR PHYS J-APPL PHYS
JI Eur. Phys. J.-Appl. Phys
PD SEP
PY 2002
VL 19
IS 3
BP 173
EP 179
DI 10.1051/epjap:2002063
PG 7
WC Physics, Applied
SC Physics
GA 598ZA
UT WOS:000178306400003
DA 2018-10-19
ER

PT J
AU Filmon, R
   Grizon, E
   Cincu, C
   Basle, MF
   Audran, M
   Chappard, D
AF Filmon, R
   Grizon, E
   Cincu, C
   Basle, MF
   Audran, M
   Chappard, D
TI Preparation of a polymer biomaterial (poly (2-hydroxyethyl
   methacrylate)) with an inter-connected macroporosity. An X-ray
   microtomographic and histomorphometric study.
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT 24th Annual Meeting of the
   American-Society-for-Bone-and-Mineral-Research
CY SEP 20-24, 2002
CL SAN ANTONIO, TEXAS
SP American-Soc-Bone-Mineral-Res
C1 Univ Polytehnika Bucharest, Bucharest, Romania.
   LHEA GEROM, Angers, France.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU AMER SOC BONE & MINERAL RES
PI WASHINGTON
PA 2025 M ST, N W, STE 800, WASHINGTON, DC 20036-3309 USA
SN 0884-0431
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD SEP
PY 2002
VL 17
SU 1
MA SU52
BP S305
EP S305
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 592TK
UT WOS:000177952800765
DA 2018-10-19
ER

PT J
AU Pollack, GH
AF Pollack, GH
TI The cell as a biomaterial
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ACTIN FILAMENT; MUSCLE-CONTRACTION; SKELETAL-MUSCLE; F-ACTIN; FORCE
   GENERATION; MOLECULAR MOTORS; HEAVY-MEROMYOSIN; LENGTH CHANGES; MYOSIN;
   WATER
AB For materials scientists, the cell is evidently a biomaterial - rich with polymers, surface forces, solvent-solute interactions, liquid-crystalline structures, etc. Yet, the language of the materials scientist is as foreign to the biological world as French is to Chinese. Little of the materials scientists' perspective has been brought to bear on the question of biological function. This review aims to begin bridging the gap between the two disciplines-to show that a materials-oriented approach has power to bring fresh insights into an otherwise impenetrably complex maze. In this approach the cell is treated as a polymer gel. If the cell is a gel, then a logical approach to the understanding of cell function is through an understanding of gel function. Great strides have been made recently in understanding the principles of polymer-gel dynamics. It has become clear that a central mechanism is the phase-transition - a major structural change prompted by a subtle change of environment. Phase-transitions are capable of doing work and such work could be responsible for much of the work of the cell. Here, we pursue this approach. We set up a polymer-gel-based foundation for cell behavior, and explore the extent to which this foundation explains how the cell achieves its everyday tasks. (C) 2002 Kluwer Academic Publishers.
C1 Univ Washington, Dept Bioengn 357962, Seattle, WA 98195 USA.
RP Pollack, GH (reprint author), Univ Washington, Dept Bioengn 357962, Seattle, WA 98195 USA.
CR Alberts B, 1994, MOL BIOL CELL
   ASAKURA S, 1963, J MOL BIOL, V7, P55, DOI 10.1016/S0022-2836(63)80018-2
   Berry H, 2000, BBA-GEN SUBJECTS, V1524, P110, DOI 10.1016/S0304-4165(00)00144-6
   Block SM, 1996, CELL, V87, P151, DOI 10.1016/S0092-8674(00)81332-X
   Blyakhman FA, 1999, J MUSCLE RES CELL M, V20, P529, DOI 10.1023/A:1005590401721
   CAMERON IL, 1988, PHYSIOL CHEM PHYS M, V20, P221
   CASADEMONT J, 1988, J NEUROPATH EXP NEUR, V47, P618, DOI 10.1097/00005072-198811000-00005
   CLARKE MSF, 1995, CIRC RES, V76, P927, DOI 10.1161/01.RES.76.6.927
   COLLINS EW, 1971, AM J PHYSIOL, V221, P1130
   Cooke R, 1997, PHYSIOL REV, V77, P671
   DEBEER EL, 1998, CELL MOTIL CYTOSKEL, V38, P341
   DOSREMEDIOS CG, 1995, BBA-BIOENERGETICS, V1228, P99, DOI 10.1016/0005-2728(94)00169-6
   FERNANDEZ JM, 1991, BIOPHYS J, V59, P1022, DOI 10.1016/S0006-3495(91)82317-7
   FREYWYSSLING A, 1953, SUBMICROSCOPIC MORPH
   GRANZIER HLM, 1987, J MUSCLE RES CELL M, V8, P242, DOI 10.1007/BF01574592
   HATANO S, 1967, BIOCHIM BIOPHYS ACTA, V140, P109, DOI 10.1016/0005-2795(67)90385-6
   Hatori K, 1998, BIOPHYS CHEM, V75, P81, DOI 10.1016/S0301-4622(98)00184-7
   Hatori K, 1996, BIOPHYS CHEM, V60, P149, DOI 10.1016/0301-4622(96)00008-7
   Hochachka PW, 1999, P NATL ACAD SCI USA, V96, P12233, DOI 10.1073/pnas.96.22.12233
   Hoffman AS, 1991, POLYM GELS, V268, P82
   HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186
   HORN RG, 1981, J CHEM PHYS, V75, P1400, DOI 10.1063/1.442146
   Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247
   HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8
   HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0
   Huxley HE, 1996, ANNU REV PHYSIOL, V58, P1, DOI 10.1146/annurev.ph.58.030196.000245
   IRVING M, 1995, NATURE, V375, P688, DOI 10.1038/375688a0
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   ISRAELACHVILI JN, 1988, SCIENCE, V241, P795, DOI 10.1126/science.241.4867.795
   IWAZUMI, 1970, THESIS U PENNSYLVANI
   JACOBS WP, 1994, SCI AM, P100
   JACOBSON RC, 1983, J MUSCLE RES CELL M, V4, P529, DOI 10.1007/BF00712113
   Janmey P A, 2001, Results Probl Cell Differ, V32, P181
   Jarvis SP, 2000, J PHYS CHEM B, V104, P6091, DOI 10.1021/jp001616d
   Jones DS, 1999, INT J PHARM, V179, P167, DOI 10.1016/S0378-5173(98)00337-8
   KAS J, 1994, NATURE, V368, P226, DOI 10.1038/368226a0
   Katayama E, 1998, J MOL BIOL, V278, P349, DOI 10.1006/jmbi.1998.1715
   Kellermayer MSZ, 1996, BBA-BIOENERGETICS, V1277, P107, DOI 10.1016/S0005-2728(96)00089-8
   Kitamura K, 1999, NATURE, V397, P129
   KLENCHIN VA, 1991, BIOPHYS J, V60, P804, DOI 10.1016/S0006-3495(91)82115-4
   KRAUSE TL, 1994, J NEUROSCI, V14, P6638
   LING GN, 1965, ANN NY ACAD SCI, V125, P401, DOI 10.1111/j.1749-6632.1965.tb45406.x
   LING GN, 1976, SCIENCE, V191, P293, DOI 10.1126/science.1082166
   LING GN, 1992, REVOLUTION PHYSL LIV
   MANIOTIS A, 1991, CELL, V67, P495, DOI 10.1016/0092-8674(91)90524-3
   MCINTOSH JR, 1973, J CELL BIOL, V56, P324, DOI 10.1083/jcb.56.2.324
   McNeil PL, 1997, J CELL BIOL, V137, P1, DOI 10.1083/jcb.137.1.1
   MCNEIL PL, 1990, J CELL SCI, V67, P495
   MIKI M, 1994, BIOCHEMISTRY-US, V33, P10171, DOI 10.1021/bi00199a045
   OOSAWA F, 1972, COLD SPRING HARB SYM, V37, P277
   Oplatka A, 1997, CRIT REV BIOCHEM MOL, V32, P307, DOI 10.3109/10409239709082575
   OPLATKA A, 1996, CHEMTRACTS BIOCH MOL, V6, P18
   OSADA Y, 1993, PROG POLYM SCI, V18, P187, DOI 10.1016/0079-6700(93)90025-8
   PASHLEY RM, 1979, J COLLOID INTERF SCI, V71, P491, DOI 10.1016/0021-9797(79)90323-0
   POLLACK GH, 1983, PHYSIOL REV, V63, P1049
   Pollack GH, 1996, BIOPHYS CHEM, V59, P315, DOI 10.1016/0301-4622(95)00141-7
   POLLACK GH, 2001, CELLS GELS ENGINES L
   POLLACK GH, 1990, MUSCLE MOL UNCOVERIN
   PRAUSNITZ MR, 1994, BIOPHYS J, V66, P1522, DOI 10.1016/S0006-3495(94)80943-9
   Prochniewicz E, 1996, J MOL BIOL, V260, P756, DOI 10.1006/jmbi.1996.0435
   Rand RP, 2000, CELL MOL LIFE SCI, V57, P1018, DOI 10.1007/PL00000742
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Schutt CE, 1998, ACTA PHYSIOL SCAND, V163, P307, DOI 10.1046/j.1365-201X.1998.t01-1-00393.x
   SCHUTT CE, 1993, FEBS LETT, V325, P59, DOI 10.1016/0014-5793(93)81413-T
   SCHWISTER K, 1985, BIOCHIM BIOPHYS ACTA, V816, P332, DOI 10.1016/0005-2736(85)90501-2
   SERPERSU EH, 1985, BIOCHIM BIOPHYS ACTA, V812, P779, DOI 10.1016/0005-2736(85)90272-X
   SOSA H, 1994, BIOPHYS J, V67, P283, DOI 10.1016/S0006-3495(94)80479-5
   SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0
   TANAKA T, 1992, NATO ASI SERIES H, V64
   TAYLOR SR, 1975, BIOCHEM SOC T, V7, P759
   THOMAS DD, 1987, ANNU REV PHYSIOL, V49, P641
   Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0
   TUNG LH, COMMUNICATION
   VERDUGO P, 1992, NATO ASI SERIES H, V64
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   WIGGINS PM, 1990, MICROBIOL REV, V54, P432
   YAKOVENKO O, IN PRESS AM J PHYSL
   Yanagida T, 2000, PHILOS T ROY SOC B, V355, P441, DOI 10.1098/rstb.2000.0585
   YANAGIDA T, 1984, NATURE, V307, P58, DOI 10.1038/307058a0
   YANAGIDA T, 1978, J MOL BIOL, V126, P507, DOI 10.1016/0022-2836(78)90056-6
   YAWO H, 1985, J NEUROSCI, V5, P1626
   BIOPHYS J, V58, P13
NR 82
TC 9
Z9 10
U1 0
U2 4
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2002
VL 13
IS 9
BP 811
EP 821
DI 10.1023/A:1016547409660
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 578DJ
UT WOS:000177101900001
PM 15348544
DA 2018-10-19
ER

PT J
AU Paruchuru, SP
   Wang, XD
   Agrawal, CM
AF Paruchuru, Satya Prasad
   Wang, Xiaodu
   Agrawal, C. M.
TI FINITE ELEMENT SIMULATION OF ELASTIC COMPLIANCE TECHNIQUE FOR
   FORMULATING A TEST METHOD TO DETERMINE THE FRACTURE TOUGHNESS OF BONE
SO JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Fracture toughness; stress intensity factor; energy release rate;
   elastic compliance; compact sandwich specimen; finite element analysis
AB Compact Sandwich Specimen (CSS) is the best specimen to test the fracture toughness of bone from small laboratory animals. There exists a direct method to calculate the stress intensity factor (K) of bone using CSS. However, energy release rate (G) is the fundamental measure of fracture toughness of a material. The direct relation between K, G, Young's Modulus (E), and Poisson's ratio (nu), de fined for homogeneous materials may not apply to bone, which has a non-homogeneous microstucture. Therefore, a direct test method is required to calculate G of bone using CSS.
   Elastic compliance technique is used to measure G of a material. This paper presents an experimentally tested and reliable procedure to simulate the elastic compliance technique by finite element analysis. The procedure may eventually be used in formulating the direct test method to calculate G of bone and bone-biomaterial interface, using CSS.
C1 [Paruchuru, Satya Prasad] VR Siddhartha Engn Coll, Dept Mech Engn, Kanuru 520007, Vijayawada, India.
   [Wang, Xiaodu] Univ Texas San Antonio, Coll Engn, San Antonio, TX 78249 USA.
   [Agrawal, C. M.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Clin Bioengn, San Antonio, TX 78229 USA.
RP Paruchuru, SP (reprint author), VR Siddhartha Engn Coll, Dept Mech Engn, Kanuru 520007, Vijayawada, India.
EM paruchuru1@yahoo.co.in; xwang@utsa.edu; agrawal@uthscsa.edu
OI Paruchuru, Satya Prasad/0000-0001-7608-6304
FU Center for Enhancement of Biology-Biomaterial Interface, UTHSCSA, San
   Antonio, USA
FX Center for Enhancement of Biology-Biomaterial Interface, UTHSCSA, San
   Antonio, USA has funded this work.
CR American Society of Mechanical Engineering, 1965, AM SOC MECH ENG PUBL
   Anderson T. L., 1991, FRACTURE MECH FUNDAM
   [Anonymous], E39990 ASTM, P506
   BEHIRI JC, 1989, J BIOMECH, V22, P863, DOI 10.1016/0021-9290(89)90070-5
   BONFIELD W, 1987, J BIOMECH, V20, P1071, DOI 10.1016/0021-9290(87)90025-X
   CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1
   FLECK NA, 1991, INT J SOLIDS STRUCT, V27, P1683, DOI 10.1016/0020-7683(91)90069-R
   Fondrk N., 1988, J BIOMECH, V21, P623
   Grestle W. H., 1990, ASTM STP, V1074, P509
   Irwin G. R., 1956, SAGAMORE RES C P, V2, P289
   LAKES RS, 1990, J BIOMECH, V23, P967, DOI 10.1016/0021-9290(90)90311-P
   SUO ZG, 1989, MAT SCI ENG A-STRUCT, V107, P135, DOI 10.1016/0921-5093(89)90382-1
   Wang X., 1994, J APPL MAT
NR 13
TC 3
Z9 3
U1 1
U2 3
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-5194
J9 J MECH MED BIOL
JI J. Mech. Med. Biol.
PD SEP-DEC
PY 2002
VL 2
IS 3-4
BP 473
EP 486
DI 10.1142/S0219519402000526
PG 14
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA V26SD
UT WOS:000208564400018
DA 2018-10-19
ER

PT J
AU Louis-Ugbo, J
   Kim, HS
   Boden, SD
   Mayr, MT
   Li, RC
   Seeherman, H
   D'Augusta, D
   Blake, C
   Jiao, AP
   Peckham, S
AF Louis-Ugbo, J
   Kim, HS
   Boden, SD
   Mayr, MT
   Li, RC
   Seeherman, H
   D'Augusta, D
   Blake, C
   Jiao, AP
   Peckham, S
TI Retention of I-125-labeled recombinant human bone morphogenetic
   protein-2 by biphasic calcium phosphate or a composite sponge in a
   rabbit posterolateral spine arthrodesis model
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
ID OSTEOINDUCTIVE GROWTH-FACTOR; ABSORBABLE COLLAGEN SPONGES; RAT ECTOPIC
   MODEL; BIOMATERIAL CARRIERS; FUSION MODEL; RHBMP-2; PHARMACOKINETICS;
   AUGMENTATION; REGENERATION; GRAFT
AB The purpose of this study was to characterize the retention kinetics of recombinant human bone morphogenetic protein-2 (rhBMP-2) applied to two calcium-based delivery matrices. Biphasic calcium phosphate (BCP) and a composite containing BCP in an absorbable collagen sponge (BCP/ACS) were evaluated using a spinal fusion model in rabbits. rhBMP-2 labeled with radioactive iodine (I-125) was used as a tracer to assess in vivo retention of rhBMP-2 in the presence of these materials (nine animals per material studied). Over a 36 day study period, animals were assessed for the following: percent administered dose retained at the implant site as measured by scintigraphic imaging (counting) with a gamma camera (all animals), radiography of the implant site (all animals), radioactivity in blood and plasma (all animals), and radioactivity in the urine and feces (three animals for each material). Radioactivity data were corrected for the decay of I-125 and the attenuation between the implant in vivo and the gamma camera.
   Differences observed between the two materials for the area under the retention vs. time profile (AUC; 988%(*)day for BCP vs. 1070%(*)day for BCP/ACS, p = 0.57) and the mean residence time (MRT; 10.2 days for BCP vs. 7.6 days for BCP/ACS, p = 0.06) were not statistically significant. Initial retention/incorporation of rhBMP-2 was slightly higher for rhBMP-2/BCP/ACS than for rhBMP-2/BCP (96.8% vs. 86.0%, p < 0.05). Animals receiving rhBMP-2/BCP showed a longer terminal retention half-life (t(1/2)) than did those receiving rhBMP-2/BCP/ACS (7.5 vs. 4.5 days, p < 0.05). The urinary radioactivity recovery data supported the data obtained by scintigraphy. Over the 36 day collection period, essentially complete recovery of radioactivity (dose) in urine was observed for rhBMP-2/BCP and rhBMP-2/BCP/ACS and the majority of the radioactivity (approximately 95%) was soluble in trichloroacetic acid, suggesting extensive catabolism of rhBMP-2 before renal excretion. Fecal recovery of radioactivity was low, approximately 2-3%.
   In conclusion, rhBMP-2 was retained at the implant site when delivered with either BCP or BCP/ACS based on mean residence time and area under the retention curve vs. time profile. Use of these matrices resulted in detectable rhBMP-2 levels at the surgical site for over a week in contrast to data reported with several other matrices that lasted less time. Systemic catabolism and elimination of the rhBMP-2 was extensive and systemic presence of the protein was negligible. (C) 2002 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.
C1 Emory Univ, Sch Med, Dept Orthopaed Surg, Atlanta, GA 30322 USA.
   Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA.
   Genet Inst Inc, Andover, MA 01810 USA.
   Medron Sofamor Danek, Memphis, TN 38132 USA.
RP Boden, SD (reprint author), 2165 N Decatur Rd, Decatur, GA 30033 USA.
CR Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1995, SPINE, V20, P2626, DOI 10.1097/00007632-199512150-00003
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Fischgrund JS, 1997, J SPINAL DISORD, V10, P467
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303
   Murata M, 1999, INT J ORAL MAX SURG, V28, P232, DOI 10.1034/j.1399-0020.1999.283280316.x
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 1999, ANN NY ACAD SCI, V875, P369, DOI 10.1111/j.1749-6632.1999.tb08519.x
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   WILTSE LL, 1968, J BONE JOINT SURG AM, VA 50, P919, DOI 10.2106/00004623-196850050-00004
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   ZERWEKH JE, 1992, J ORTHOPAED RES, V10, P562, DOI 10.1002/jor.1100100411
NR 21
TC 41
Z9 42
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0736-0266
J9 J ORTHOPAED RES
JI J. Orthop. Res.
PD SEP
PY 2002
VL 20
IS 5
BP 1050
EP 1059
AR PII S0736-0266(02)00011-6
DI 10.1016/S0736-0266(02)00011-6
PG 10
WC Orthopedics
SC Orthopedics
GA 600GZ
UT WOS:000178383400024
PM 12382973
DA 2018-10-19
ER

PT J
AU Kumar, RR
   Maruno, S
AF Kumar, RR
   Maruno, S
TI Functionally graded coatings of HA-G-Ti composites and their in vivo
   studies
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE hydroxyapatite; biomaterial; composite; implant; functionally graded
   material; coating; bone bonding
ID GRADIENT COMPOSITE; HYDROXYAPATITE; TITANIUM; PRECIPITATION; BONE
AB Hydroxyapatite (HA) was synthesized by the wet chemical method using phosphoric acid (H;PO,) and calcium hydroxide Ca(OH)(2) aqueous solutions. The prepared HA powders were fired at various temperatures ranging from 200 to 1200 C for 2 h to obtain different degrees of crystallinity. The HA powders having different crystallinities were mixed with glass (G) in different weight percentages to form HA-G ceramics. The properties of the HA-G ceramics and the reaction of glass with HA were investigated by X-ray diffraction (XRD), differential scanning calorimetry (DSC) and Fourier transform infra-red spectrometry (FTIR). HA fired at higher temperature showed higher crystallinity and lower solubility. HA slightly reacted with glass and formed a small amount boron containing apatite. HA-G ceramic powders were coated on pure titanium substrate to obtain functionally graded layers of HA-G ceramics. The hydroxyapatite-glass-titanium (HA-G-Ti) composites consisting of HA fired at 400, 800 and 1200 C were implanted in the femur bone of dog to examine the in vivo behavior of the implant. The pull-out strength between the HA-G-Ti composite and the bone demonstrated that the composite using HA fired at 1200 degreesC showed the highest pull-out test value of 20.6 MPa and good biocompatibility. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
   Nagoya Inst Technol, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Kumar, RR (reprint author), Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
CR BAN S, 1994, J BIOMED MATER RES, V28, P65, DOI 10.1002/jbm.820280109
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   FUJISHIRO Y, 1995, J MATER SCI-MATER M, V6, P172, DOI 10.1007/BF00120295
   Ishikawa Tomoji, 1993, Clinical Materials, V14, P277, DOI 10.1016/0267-6605(93)90014-X
   ITO A, 1995, PHOSPHORUS LETT, V24, P24
   ITO A, 1988, J CERAM SOC JPN, V96, P302
   JARCHO M, 1976, J MATER SCI, V11, P2027, DOI 10.1007/BF02403350
   Maruno S., 1999, Materials Science Forum, V308-311, P344
   MARUNO S, 1991, BIOMATERIALS, V12, P225, DOI 10.1016/0142-9612(91)90204-N
   MARUNO S, 1992, NIPPON SERAM KYO GAK, V100, P362
   MARUNO S, 1993, P IMMM93, P305
   MARUNO S, 1992, BIOCERAMICS, V5, P165
   OGINO M, 1980, J NON-CRYST SOLIDS, V38-9, P673, DOI 10.1016/0022-3093(80)90514-1
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   WU JM, 1988, J MATER SCI, V23, P3771, DOI 10.1007/BF00540526
NR 16
TC 24
Z9 26
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD SEP 1
PY 2002
VL 334
IS 1-2
BP 156
EP 162
AR PII S0921-5093(01)01792-0
DI 10.1016/S0921-5093(01)01792-0
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 580LL
UT WOS:000177236000023
DA 2018-10-19
ER

PT J
AU Ponsonnet, L
   Comte, V
   Othmane, A
   Lagneau, C
   Charbonnier, M
   Lissac, M
   Jaffrezic, N
AF Ponsonnet, L
   Comte, V
   Othmane, A
   Lagneau, C
   Charbonnier, M
   Lissac, M
   Jaffrezic, N
TI Effect of surface topography and chemistry on adhesion, orientation and
   growth of fibroblasts on nickel-titanium substrates
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 3rd Maghreb/Europe Meeting on Materials and Their Applications for
   Devices and Physical, Chemical and Biological Sensors
CY OCT 29-30, 2001
CL HAMMAMET, TUNISIA
DE NiTi; cell adhesion; cell proliferation; surface roughness; surface
   composition; human fibroblasts
ID HUMAN GINGIVAL FIBROBLASTS; SHAPE-MEMORY METAL; CELL BEHAVIOR; IN-VITRO;
   BIOCOMPATIBILITY; ALLOY; INVITRO; PROLIFERATION; ATTACHMENT; ROUGHNESS
AB Nickel-titanium alloy (NiTi) is a metallic biomaterial known for its mechanical and shape memory properties. These properties suggest that it could be used for medical purposes such as surgical implants. To evaluate the effects of the chemical composition and microtexture of the metal surface on the cellular behaviour, the adhesion, orientation and proliferation of human gingival fibroblasts were studied with substrates having different surface roughnesses. To separate the effects of material roughness and composition on the fibroblast response, we have chosen to compare substrates of different surface roughnesses but of the same chemical composition (NiTi). Moreover, substrates of different surface compositions (Ti6Al4V, cp-Ti, 316L stainless steel) but of similar smooth surface topography were also tested. The texture, chemical state and composition of the surfaces were determined using a surface-tracing instrument for roughness characterisation and X-ray photoelectron spectroscopy (XPS) for chemical analysis. The effect of gamma-sterilisation on the chemical composition was studied. Human gingival fibroblasts attached, spread and proliferated on all titanium-based surfaces. On samples exhibiting the highest roughness, the cells were oriented in a parallel order along the grooves caused by mechanical polishing, whereas on smooth surfaces, they appeared to grow with no specific orientation. We observed low cell proliferation on the NiTi surfaces of the highest roughness. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Ecole Cent Lyon, Lab Ingn & Fonctionnalisat Surfaces IFoS, F-69131 Ecully, France.
   Univ Lyon 1, Lab Etud Interfaces & Biofilms Odontol, F-69372 Lyon, France.
   Fac Med Monastir, Biophys Lab, Monastir 5000, Tunisia.
   Univ Lyon 1, Lab Sci & Ingn Surfaces, F-69622 Villeurbanne, France.
RP Ponsonnet, L (reprint author), Ecole Cent Lyon, Lab Ingn & Fonctionnalisat Surfaces IFoS, BP 163, F-69131 Ecully, France.
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   ASSAD M, 1994, ANN CHIR, V48, P731
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   BLACKSHAW SE, 1988, J PHYSIOL-LONDON, V396, P121, DOI 10.1113/jphysiol.1988.sp016954
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BRUNETTE DM, 1986, EXP CELL RES, V11, P164
   CASTLEMAN LS, 1981, BIOCOMPATIBILITY CLI, P129
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1987, DEVELOPMENT, V99, P439
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Duerig TW, 1996, BIO-MED MATER ENG, V6, P255
   DUNN G, 1982, CELL BEHAV, P421
   DUNN GA, 1986, J CELL SCI, V83, P313
   DUNN GA, 1976, EXP CELL RES, V1, P101
   Endo K, 1994, Dent Mater J, V13, P228
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   HORMIA M, 1991, J PERIODONTAL RES, V26, P491, DOI 10.1111/j.1600-0765.1991.tb01800.x
   INOUE T, 1987, J BIOMED MATER RES, V21, P107, DOI 10.1002/jbm.820210114
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   LOWENBERG BF, 1987, J DENT RES, V66, P1000, DOI 10.1177/00220345870660050101
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   McKinney R V Jr, 1988, J Dent Educ, V52, P696
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   OHARA PT, 1979, EXP CELL RES, V121, P315
   OSHIDA Y, 1992, Bio-Medical Materials and Engineering, V2, P51
   PUTTERS JLM, 1992, EUR SURG RES, V24, P378, DOI 10.1159/000129231
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 2000, MINIM INVASIV THER, V9, P99, DOI 10.3109/13645700009063056
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   TRIGWELL S, 1997, SHAPE MEMORY SUPEREL, P383
   Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5
   WEAVER DJ, 1997, BIOMATERIALS, V18, P1115
NR 37
TC 95
Z9 99
U1 3
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP 1
PY 2002
VL 21
IS 1-2
SI SI
BP 157
EP 165
AR PII S0928-4931(02)00097-8
DI 10.1016/S0928-4931(02)00097-8
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 592YD
UT WOS:000177963700024
DA 2018-10-19
ER

PT J
AU Hiller, J
   Mendelsohn, JD
   Rubner, MF
AF Hiller, J
   Mendelsohn, JD
   Rubner, MF
TI Reversibly erasable nanoporous anti-reflection coatings from
   polyelectrolyte multilayers
SO NATURE MATERIALS
LA English
DT Article
ID POLYMER THIN-FILMS; SURFACES; GLASS
AB For nearly two centuries, researchers have sought novel methods to increase light transmission in optical systems, as well as to eliminate unwanted reflections and glare. Antireflection coatings and surfaces have enabled the increasing performance demands of optical components fabricated from glass-based optical materials. With the current trend of technology moving towards optically transparent polymeric media and coatings, the need for antireflection technology and environmentally benign processing methods for polymeric materials independent of shape or size has become quite apparent. We describe an economical, aqueous-based process controlled at the molecular level that simultaneously coats all surfaces of almost any material. Systematically designed nanoporous polymer films are used, which are suitable for optical applications operating at both visible and near-infrared wavelengths. These high-efficiency anti-reflection coatings are created from phase-separated polyelectrolyte multilayer films that undergo a reversible pH-induced swelling transition. Furthermore, such films, easily patterned by an inkjet printing technique, possess potential for pH-responsive biomaterial and membrane applications.
C1 MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
RP Rubner, MF (reprint author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
CR Calvert P, 2001, CHEM MATER, V13, P3299, DOI 10.1021/cm0101632
   CLAPHAM PB, 1973, NATURE, V244, P281, DOI 10.1038/244281a0
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DOUGLAS T, 1998, NATURE, V393, P6681
   FERREIRA M, 1994, THIN SOLID FILMS, V244, P806, DOI 10.1016/0040-6090(94)90575-4
   Fery A, 2001, LANGMUIR, V17, P3779, DOI 10.1021/la102612
   FRAUNHOFER J, 1888, VERSUCHE URSACHEN AN, P33
   Harris JJ, 1999, J AM CHEM SOC, V121, P1978, DOI 10.1021/ja9833467
   Hattori H, 2001, ADV MATER, V13, P51, DOI 10.1002/1521-4095(200101)13:1<51::AID-ADMA51>3.3.CO;2-6
   Ibn-Elhaj M, 2001, NATURE, V410, P796, DOI 10.1038/35071039
   Macleod H. A., 1969, THIN FILM OPTICAL FI
   Mark J. E., 1999, POLYM DATA HDB
   Mendelsohn JD, 2000, LANGMUIR, V16, P5017, DOI 10.1021/la000075g
   MINOT MJ, 1976, J OPT SOC AM, V66, P515, DOI 10.1364/JOSA.66.000515
   MONACO SF, 1961, J OPT SOC AM, V51, P280, DOI 10.1364/JOSA.51.000280
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6
   Uhlmann DR, 1997, J NON-CRYST SOLIDS, V218, P113, DOI 10.1016/S0022-3093(97)00162-2
   Walheim S, 1999, SCIENCE, V283, P520, DOI 10.1126/science.283.5401.520
   Wang TC, 2001, LANGMUIR, V17, P6610, DOI 10.1021/la010755z
   Yang SY, 2002, J AM CHEM SOC, V124, P2100, DOI 10.1021/ja017681y
   YOLDAS BE, 1980, APPL OPTICS, V19, P1425, DOI 10.1364/AO.19.001425
   Zhang H., 2002, HDB POLYELECTROLYTES, V1, P183
NR 24
TC 661
Z9 668
U1 24
U2 299
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD SEP
PY 2002
VL 1
IS 1
BP 59
EP 63
DI 10.1038/nmat719
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 654LM
UT WOS:000181498400026
PM 12618851
DA 2018-10-19
ER

PT J
AU Gamba, PG
   Conconi, MT
   Lo Piccolo, R
   Zara, G
   Spinazzi, R
   Parnigotto, PP
AF Gamba, PG
   Conconi, MT
   Lo Piccolo, R
   Zara, G
   Spinazzi, R
   Parnigotto, PP
TI Experimental abdominal wall defect repaired with acellular matrix
SO PEDIATRIC SURGERY INTERNATIONAL
LA English
DT Article
DE acellular matrix; abdominal-wall defect; diaphragmatic prosthesis
ID CULTURED URETHRAL EPITHELIUM; AUTOLOGOUS GRAFT; DERMAL MATRIX; MUSCLE;
   REGENERATION; GROWTH; RABBIT; HYPOSPADIAS; UROTHELIUM; MYOBLASTS
AB In the surgical repair of congenital abdominal-wall defects (AWD), the ready availability of a nonimmunogenic and non-prosthetic biomaterial that could guide the regeneration of normal tissue is a fascinating possibility. Biomaterials are already in use, but in our experience, an acellular matrix (ACM) can stimulate exact regeneration of the absent tissue. We explored the possibility of using an ACM to repair a muscular AWD in an animal model. Male New Zealand white rabbits (3-4 kg, n = 18) were anesthetized and the abdominal wall was shaved and scrubbed; a vertical incision was made in the left lower quadrant and a large patch of external-oblique muscle was resected (3 x 3 cm). The animals underwent reconstruction with homologous diaphragm acellular matrix (HDAM) grafts that were previously prepared using a detergent enzymatic method. The patches were evaluated histologically at 9 (n = 6), 40 (n = 6), and 90 (n = 6) days post-surgery in each group; moreover, 90 days post-surgery an electromyogram (EMG) (n = 6) of the implanted matrix was recorded. Histologic analysis demonstrated that the HDAM supported fibroblast migration, deposition of newly-formed collagen, and neovascularization. No signs of necrosis, or evidence of skeletal-muscle-cell ingrowth were detected. The EMG revealed minimum muscular electrophysiologic activity, probably due to muscle underlying the patch. The HDAM we employed was thus not able to produce reconstruction of the skeletal muscle, and was progressively remodeled into fibrous tissue. Since the ultimate reason for failure of muscle regeneration is a lack of myogenesis, future studies will use ACMs preconditioned by various regulators of myoblast proliferation and differentiation.
C1 Univ Padua, Dept Pharmaceut Sci, Padua, Italy.
   Univ Padua, Dept Neurol, Padua, Italy.
   Univ Padua, Dept Pediat Surg, Padua, Italy.
RP Gamba, PG (reprint author), Univ Padua, Azienda Ospedurg, Div Chirurg Pediat, Via Giustiniani 3, I-35121 Padua, Italy.
RI gamba, piergiorgio/J-1935-2018
OI gamba, piergiorgio/0000-0003-2068-342X
CR Arnaud E, 1999, Ann Chir Plast Esthet, V44, P357
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   BURGE SM, 1990, CRYOBIOLOGY, V27, P153, DOI 10.1016/0011-2240(90)90007-Q
   CHANG KS, 1994, PEDIATR SURG INT, V9, P307, DOI 10.1007/BF01685989
   Cooney DR., 1998, PEDIAT SURG, P1045
   Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6
   De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869
   DeBord JR, 1998, SURG CLIN N AM, V78, P973, DOI 10.1016/S0039-6109(05)70365-0
   FAIRBANKS JL, 1992, J UROLOGY, V148, P663, DOI 10.1016/S0022-5347(17)36686-7
   GAL LR, 1998, BIOCHIM BIOPHYS ACTA, V1402, P39
   Greenawalt KE, 2000, J SURG RES, V94, P92, DOI 10.1006/jsre.2000.6020
   Italiano G, 1997, UROL RES, V25, P137, DOI 10.1007/BF01037930
   LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001
   Lorenz C, 1996, PEDIATR SURG INT, V11, P456, DOI 10.1007/BF00180082
   Meadows KA, 2000, J CELL PHYSIOL, V183, P330, DOI 10.1002/(SICI)1097-4652(200006)183:3<330::AID-JCP5>3.0.CO;2-N
   MEDDINGS RN, 1993, J PEDIATR SURG, V28, P660, DOI 10.1016/0022-3468(93)90025-G
   MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8
   Parnigotto PP, 2000, UROL RES, V28, P46, DOI 10.1007/s002400050009
   Parnigotto PP, 2000, J PEDIATR SURG, V35, P1304, DOI 10.1053/jpsu.2000.9309
   ROMAGNOLI G, 1993, J UROLOGY, V150, P1204, DOI 10.1016/S0022-5347(17)35728-2
   ROMAGNOLI G, 1990, NEW ENGL J MED, V323, P527, DOI 10.1056/NEJM199008233230806
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Semsarian C, 1999, BIOCHEM J, V339, P443, DOI 10.1042/0264-6021:3390443
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Takami Y, 1996, BURNS, V22, P182, DOI 10.1016/0305-4179(95)00123-9
   van Wachem PB, 1999, BIOMATERIALS, V20, P419, DOI 10.1016/S0142-9612(98)00185-9
   WILSON GJ, 1990, T AM SOC ART INT ORG, V36, P340
   Wilson Gregory J., 1995, Annals of Thoracic Surgery, V60, P353
NR 28
TC 48
Z9 49
U1 0
U2 8
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0179-0358
J9 PEDIATR SURG INT
JI Pediatr. Surg. Int.
PD SEP
PY 2002
VL 18
IS 5-6
BP 327
EP 331
DI 10.1007/s00383-002-0849-5
PG 5
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 619ZM
UT WOS:000179508000009
PM 12415348
DA 2018-10-19
ER

PT J
AU Saxena, AK
   Hulskamp, G
   Schleef, J
   Schaarschmidt, K
   Harms, E
   Willital, GH
AF Saxena, AK
   Hulskamp, G
   Schleef, J
   Schaarschmidt, K
   Harms, E
   Willital, GH
TI Gastroschisis: a 15-year, single-center experience
SO PEDIATRIC SURGERY INTERNATIONAL
LA English
DT Article
DE gastroschisis; surgery; SDD implant; complications
ID INTESTINAL ATRESIA; GROWTH-RETARDATION; WALL DEFECTS; OMPHALOCELE;
   MANAGEMENT
AB 70 cases of gastroschisis (GS) were surgically treated at the Pediatric Surgical University Clinic, Winster, from 1984 through 1998. The defect occurred more frequently in males (44) than females (26). The average birth weight was 2,383 g and mean gestational age 36.8 weeks. 9 infants (12.9%) were delivered vaginally and the rest (87.1%) by cesarean section; 34 of the 61 (55.7%) cesarean sections were done solely for prenatal ultrasonic identification of the abdominal-wall defect. 10 infants (14.3%) underwent primary closure; in 19 (27.1%) primary closure of the skin was possible, however, a single solvent-dried dura (SDD) graft was required for fascial enlargement. The remaining 41 infants (58.6%) had extensive defects and required two grafts for optimal closure. 22 patients (31.4%) had associated anomalies, the most common being bowel atresias and undescended testis. 14 (20%) required secondary laparotomies because of bowel-associated complications and 1 (1.4%) for a urinary-bladder perforation. 11 patients (15.7%) had non-bowel-associated complications. The average postoperative trachea intubation time was 3.9 days and the average hospital stay was 75.6 days. The overall mortality was 2.8%. No major complications associated with SDD implants were encountered; only 4 patients (5.7%) had minor complications such as local inflamation and infection and were managed conservatively. The present data support the employment of SDD implants as acceptable biomaterial for the repair of large GS defects.
C1 Univ Munster, Pediat Surg Clin, D-48129 Munster, Germany.
RP Saxena, AK (reprint author), Univ Munster, Pediat Surg Clin, Albert Schweitzer Str 33, D-48129 Munster, Germany.
CR Adra AM, 1996, AM J OBSTET GYNECOL, V174, P540, DOI 10.1016/S0002-9378(96)70424-6
   AMOURY RA, 1977, SURGERY, V82, P373
   BERNSTEIN P, 1940, ARCH PEDIATR, V57, P505
   Brun M, 1996, PEDIATR RADIOL, V26, P723, DOI 10.1007/BF01383389
   CALZOLARI E, 1995, AM J MED GENET, V58, P187, DOI 10.1002/ajmg.1320580218
   CHUN K, 1993, J PEDIATR SURG, V28, P838, DOI 10.1016/0022-3468(93)90339-M
   Cusick E, 1997, Pediatr Surg Int, V12, P34
   DEBEUGNY P, 1990, CHIR PEDIATR, V31, P18
   Dykes E H, 1996, Semin Pediatr Surg, V5, P90
   FRIES MH, 1993, J ULTRAS MED, V12, P583
   GORNALL P, 1989, J PEDIATR SURG, V24, P522, DOI 10.1016/S0022-3468(89)80497-X
   Langer J C, 1996, Semin Pediatr Surg, V5, P124
   Lee SC, 1997, J PEDIATR SURG, V32, P66, DOI 10.1016/S0022-3468(97)90096-8
   MOLENAAR JC, 1993, WORLD J SURG, V17, P337, DOI 10.1007/BF01658701
   MORROW RJ, 1993, PRENATAL DIAG, V13, P111, DOI 10.1002/pd.1970130205
   Nichols C R, 1997, J Matern Fetal Med, V6, P225
   NOVOTNY DA, 1993, J PEDIATR SURG, V28, P650, DOI 10.1016/0022-3468(93)90022-D
   Ramsden WH, 1997, PEDIATR RADIOL, V27, P166, DOI 10.1007/s002470050092
   Raynor BD, 1997, J ULTRAS MED, V16, P13
   SALLER DN, 1994, OBSTET GYNECOL, V84, P852
   SANTULLI TV, 1961, ANN SURG, V154, P939
   SCHUSTER SR, 1967, SURG GYNECOL OBSTETR, V125, P837
   Srinathan SK, 1997, J SURG RES, V68, P1, DOI 10.1006/jsre.1996.4986
   STRINGEL G, 1993, J PEDIATR SURG, V28, P635
   Torfs CP, 1996, TERATOLOGY, V54, P84, DOI 10.1002/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4
   VANHOORN WA, 1985, Z KINDERCHIR, V40, P368
   WELLER U, 1993, MONATSSCHR KINDERH, V141, P665
   YANG P, 1992, AM J MED GENET, V44, P668, DOI 10.1002/ajmg.1320440528
NR 28
TC 23
Z9 25
U1 0
U2 0
PU SPRINGER-VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010 USA
SN 0179-0358
J9 PEDIATR SURG INT
JI Pediatr. Surg. Int.
PD SEP
PY 2002
VL 18
IS 5-6
BP 420
EP 424
DI 10.1007/s00383-002-0799-y
PG 5
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 619ZM
UT WOS:000179508000031
PM 12415370
DA 2018-10-19
ER

PT J
AU Emerson, RJ
   Camesano, TA
AF Emerson, RJ
   Camesano, TA
TI Characterization of bacterial and fungal adhesion in biomaterial systems
   using atomic force microscopy.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Worcester Polytech Inst, Dept Chem Engn, Worcester, MA 01609 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 18
PY 2002
VL 224
MA 009-COLL
BP U397
EP U397
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 583RL
UT WOS:000177422201957
DA 2018-10-19
ER

PT J
AU Gouzy, MF
   Sperling, C
   Streller, U
   Salchert, K
   Bohme, F
   Voit, B
   Werner, C
AF Gouzy, MF
   Sperling, C
   Streller, U
   Salchert, K
   Bohme, F
   Voit, B
   Werner, C
TI Immobilization of small synthetic thrombin inhibitors at the surface of
   a polymeric biomaterial.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Inst Polymer Res Dresden, Polymer React & Blends, D-01069 Dresden, Germany.
   Inst Polymer Res Dresden, Biocompatible Mat, D-01069 Dresden, Germany.
   Inst Polymer Res Dresden, Polymer Struct, D-01069 Dresden, Germany.
RI Umlauf, Ursula/D-3356-2014; Werner, Carsten/F-8127-2010; Voit,
   Brigitte/D-4755-2009
OI Werner, Carsten/0000-0003-0189-3448; Voit, Brigitte/0000-0002-4531-691X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 18
PY 2002
VL 224
MA 711-POLY
BP U477
EP U477
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 583RM
UT WOS:000177422302586
DA 2018-10-19
ER

PT J
AU Sousa, KA
   Phaneuf, MD
   Bide, MJ
   Aggarwal, P
   Alhilali, LM
   LoGerfo, FW
   Quist, WC
AF Sousa, KA
   Phaneuf, MD
   Bide, MJ
   Aggarwal, P
   Alhilali, LM
   LoGerfo, FW
   Quist, WC
TI Development of an infection-resistant anionic dacron biomaterial using
   textile dyeing technology.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
   Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 18
PY 2002
VL 224
MA 177-CHED
BP U307
EP U307
PN 1
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 583RL
UT WOS:000177422201495
DA 2018-10-19
ER

PT J
AU Brodbeck, WG
   Patel, J
   Voskerician, G
   Christenson, E
   Shive, MS
   Nakayama, Y
   Matsuda, T
   Ziats, NP
   Anderson, JM
AF Brodbeck, WG
   Patel, J
   Voskerician, G
   Christenson, E
   Shive, MS
   Nakayama, Y
   Matsuda, T
   Ziats, NP
   Anderson, JM
TI Biomaterial adherent macrophage apoptosis is increased by hydrophilic
   and anionic substrates in vivo
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID SURFACE-CHEMISTRY; CELL APOPTOSIS; BIOCOMPATIBILITY; POLYURETHANES;
   BIOSTABILITY; EXPRESSION; ADHESION; DEATH
AB An in vivo rat cage implant system was used to identify potential surface chemistries that prevent failure of implanted biomedical devices and prostheses by limiting monocyte adhesion and macrophage fusion into foreign-body giant cells while inducing adherent-macrophage apoptosis. Hydrophobic, hydrophilic, anionic, and cationic surfaces were used for implantation. Analysis of the exudate surrounding the materials revealed no differences between surfaces in the types or levels of cells present. Conversely, the proportion of adherent cells undergoing apoptosis was increased significantly on anionic and hydrophilic surfaces (46 +/- 3.7 and 57 +/- 5.0%, respectively) when compared with the polyethylene terephthalate base surface. Additionally, hydrophilic and anionic substrates provided decreased rates of monocyte/macrophage adhesion and fusion. These studies demonstrate that biomaterial-adherent cells undergo material-dependent apoptosis in vivo, rendering potentially harmful macrophages nonfunctional while the surrounding environment of the implant remains unaffected.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44139 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44139 USA.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 8128482, Japan.
   Natl Cardiovasc Ctr, Dept Bioengn, Osaka 5620025, Japan.
RP Brodbeck, WG (reprint author), Case Western Reserve Univ, Sch Med, Inst Pathol, Room 306, Cleveland, OH 44106 USA.
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
FU NIGMS NIH HHS [F32 GM020380, GM-20380]; NHLBI NIH HHS [HL-33849,
   HL-55714, R01 HL055714]
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   BRODBECK WG, 2001, J LAB CLIN MED, V139, P90
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Fabre T, 1999, J BIOMED MATER RES, V44, P429, DOI 10.1002/(SICI)1097-4636(19990315)44:4<429::AID-JBM9>3.0.CO;2-C
   Honma T, 1996, VIRCHOWS ARCH, V428, P165
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Labow RS, 1997, J BIOMAT SCI-POLYM E, V8, P779, DOI 10.1163/156856297X00317
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   SHIVE MS, 2001, J BIOMED MATER RES, V60, P148
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 21
TC 139
Z9 144
U1 0
U2 15
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 6
PY 2002
VL 99
IS 16
BP 10287
EP 10292
DI 10.1073/pnas.162124199
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 582HC
UT WOS:000177343200015
PM 12122211
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Jurado, F
   Garcia-Honduvilla, N
   Lopez, R
   Carrera-San Martin, A
   Bujan, J
AF Bellon, JM
   Jurado, F
   Garcia-Honduvilla, N
   Lopez, R
   Carrera-San Martin, A
   Bujan, J
TI The structure of a biomaterial rather than its chemical composition
   modulates the repair process at the peritoneal level
SO AMERICAN JOURNAL OF SURGERY
LA English
DT Article
DE peritoneal interface; laminar prosthesis; reticular prosthesis; behavior
ID ABDOMINAL-WALL DEFECTS; VENTRAL HERNIA; MESH; PROSTHESIS; IMPLANTATION;
   MIGRATION
AB Background: This study was designed to establish whether the spatial structure of a prosthesis conditions its behavior at the peritoneal level.
   Methods: Abdominal defects comprising all,the wall (except skin) were created in rabbits and repaired with a laminar (DM) or reticular (CV-4) ePTFE-prosthesis. Fourteen days postimplant, specimens were obtained for scanning electron and light microscopy. Peritoneal adhesions, resistance to traction, and neoperitoneum thickness were quantified.
   Results: Adhesions to CV-4 were firm and integrated within surrounding tissue; only scarce adhesion formation was observed for DM. Adhesion area was significantly greater (P<0.01) in the CV-4 than in DM (7.00&PLUSMN;2.6; 0.15&PLUSMN;0.08 cm(2)). The neoperitoneum was organized for DM and disorganized for CV-4. This layer was significantly thicker (P<0.05) in DM than CV-4 (455+/-3.4; 70+/-3.1 mum). The CV-4 showed a greater resistance to traction than the DM (26.75+/-3.71; 14.11+/-3.71 N; P<0.05).
   Conclusions: The structure of a biomaterial, rather than its chemical composition, modulates behavior at the peritoneal interface. (C) 2002 Excerpta Medica, Inc. All rights reserved.
C1 Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Surg Res Lab, Alcala De Henares 28871, Madrid, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Fac Med, Dept Morphol Sci & Surg, Surg Res Lab, Crta Madrid Barcelona,Km 33-6, Alcala De Henares 28871, Madrid, Spain.
OI Garcia Honduvilla, Natalio/0000-0003-0904-6198; BELLON, JUAN
   M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476
CR AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Bellon JM, 2000, J MATER SCI-MATER M, V11, P25, DOI 10.1023/A:1008981517743
   Bellon JM, 1996, BIOMATERIALS, V17, P1369, DOI 10.1016/0142-9612(96)87276-0
   Bellon JM, 1997, J BIOMED MATER RES, V38, P197
   Bellon JM, 1999, EUR J SURG, V165, P145
   BUJAN J, 2001, EUR SURG RES, V33, P180
   CHEW DK, 2000, SURGERY, V125, pS109
   Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122
   DEGUZMAN LJ, 1995, ENDOSCOPY, V27, P459, DOI 10.1055/s-2007-1005743
   KAUFMAN Z, 1981, DIS COLON RECTUM, V24, P543, DOI 10.1007/BF02604320
   LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Majeski J, 1998, SOUTH MED J, V91, P496, DOI 10.1097/00007611-199805000-00020
   Mauger D. T., 2001, SURG RES, P1201
NR 15
TC 44
Z9 44
U1 3
U2 3
PU EXCERPTA MEDICA INC
PI NEW YORK
PA 650 AVENUE OF THE AMERICAS, NEW YORK, NY 10011 USA
SN 0002-9610
J9 AM J SURG
JI Am. J. Surg.
PD AUG
PY 2002
VL 184
IS 2
BP 154
EP 159
AR PII S0002-9610(02)00907-8
DI 10.1016/S0002-9610(02)00907-8
PG 6
WC Surgery
SC Surgery
GA 585BL
UT WOS:000177503200013
PM 12169360
DA 2018-10-19
ER

PT J
AU Waar, K
   van der Mei, HC
   Harmsen, HJM
   Degener, JE
   Busscher, HJ
AF Waar, K
   van der Mei, HC
   Harmsen, HJM
   Degener, JE
   Busscher, HJ
TI Adhesion to bile drain materials and physicochemical surface properties
   of Enterococcus faecalis strains grown in the presence of bile
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID IMAGE-ANALYSIS; FLOW CHAMBER; AGGREGATION; INFECTIONS; PROTEIN; ESP
AB The aim of this study is to determine whether growth in the presence of bile influences the surface properties and adhesion to hydrophobic bile drain materials of Enterococcus faecalis strains expressing aggregation substance (Agg) or enterococcal surface protein (Esp), two surface proteins that are associated with infections. After growth in the presence of bile, the strains were generally more hydrophobic by water contact angles and the zeta potentials were more negative than when the strains were grown in the absence of bile. Nitrogen was found in lower surface concentrations upon growth in the presence of bile, whereas higher surface concentrations of oxygen were measured by X-ray photoelectron spectroscopy. Moreover, an up to twofold-higher number of bacteria adhered after growth in bile for E. faecalis not expressing Agg or Esp and E. faecalis with Esp on its surface. E.faecalis expressing Agg did not adhere in higher numbers after growth in bile, possibly because they mainly adhere through positive cooperativity and less through direct interactions with a substratum surface. Since adhesion of bacteria is the first step in biomaterial-centered infection, it can be concluded that growth in bile increases the virulence of E. faecalis.
C1 Univ Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands.
   Univ Groningen, Dept Biomed Engn, NL-9713 GZ Groningen, Netherlands.
RP Waar, K (reprint author), Univ Groningen, Dept Med Microbiol, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands.
CR Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Doyle RJ, 2000, MICROBES INFECT, V2, P391, DOI 10.1016/S1286-4579(00)00328-2
   Flahaut S, 1996, APPL ENVIRON MICROB, V62, P2416
   IKE Y, 1983, P NATL ACAD SCI-BIOL, V80, P5369, DOI 10.1073/pnas.80.17.5369
   JACOB AE, 1974, J BACTERIOL, V117, P360
   JETT BD, 1994, CLIN MICROBIOL REV, V7, P462
   Millsap KW, 1999, J COLLOID INTERF SCI, V212, P495, DOI 10.1006/jcis.1998.6054
   MUSCHOLL A, 1993, EUR J BIOCHEM, V214, P333, DOI 10.1111/j.1432-1033.1993.tb17928.x
   Muscholl-Silberhorn A, 1999, MOL MICROBIOL, V34, P620, DOI 10.1046/j.1365-2958.1999.01631.x
   NOORDMANS J, 1993, J COLLOID INTERF SCI, V156, P394, DOI 10.1006/jcis.1993.1128
   ROUXHET PG, 1991, MICROBIAL CELL SURFA, P173
   Shankar V, 1999, INFECT IMMUN, V67, P193
   Toledo-Arana A, 2001, APPL ENVIRON MICROB, V67, P4538, DOI 10.1128/AEM.67.10.4538-4545.2001
   VANDERMEI HC, 2000, SURF SCI REP, V329, P1
   WAAR K, 2001, J INFECT DIS, V185, P1121
   WAAR KH, 2000, MICROBIOLOGY, V148, P1863
   WELLS CL, 1995, CRIT CARE MED, V23, P301, DOI 10.1097/00003246-199502000-00016
   Yu JL, 1996, SCAND J GASTROENTERO, V31, P625, DOI 10.3109/00365529609009140
NR 21
TC 18
Z9 18
U1 1
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD AUG
PY 2002
VL 68
IS 8
BP 3855
EP 3858
DI 10.1128/AEM.68.8.3855-3858.2002
PG 4
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 580WV
UT WOS:000177260500024
PM 12147481
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Bisson, I
   Kosinski, M
   Ruault, S
   Gupta, B
   Hilborn, J
   Wurm, F
   Frey, P
AF Bisson, I
   Kosinski, M
   Ruault, S
   Gupta, B
   Hilborn, J
   Wurm, F
   Frey, P
TI Acrylic acid grafting and collagen immobilization on poly(ethylene
   terephthalate) surfaces for adherence and growth of human bladder smooth
   muscle cells
SO BIOMATERIALS
LA English
DT Article
DE poly(ethylene terephthalate); plasma graft polymerization; acrylic acid
   grafting; collagen immobilization; adherence and growth of human smooth
   muscle cells; tissue engineering
ID POLY(ETHYLENE-TEREPHTHALATE) FILMS; HUMAN UROTHELIUM; TISSUE;
   POLYMERIZATION; CULTURE; RECONSTITUTION; BIOMATERIAL; SURGERY; WALL
AB In tissue engineering, degradable or non-degradable polymer matrices can act as cell-carrier-scaffolds. Cell adhesion and growth on these scaffolds can he promoted by immobilizing extracellular matrix proteins. Therefore, in this study, polymer poly(ethylene terephthalate) (PET) films were surface modified by graft polymerization of acrylic acid, to subsequently allow collagen (types I and III) immobilization and human smooth muscle cell expansion. The surfaces of PET were activated by plasma, followed by acrylic acid graft polymerization, resulting in covalently bound brushes, containing an average of either 0.22 +/- 0.1 or 5.93 +/- 0.87 mug/cm(2) of poly(acrylic acid) (PAA). Subsequent electrostatic adsorption of collagen gave a Surface concentration of 4.96 and 17.2 mug/cm(2),, respectively. as determined using radiolabelled I-125 collagen. Both PET films grafted with 0.22 mug/cm(2) of PAA with or without adsorbed collagen were apt for smooth muscle cell adhesion and proliferation. However, films grafted with 5.93 mug/cm(2) were not. PAA-grafted PET films, onto which serum proteins of the Culture medium adsorbed spontaneously, proved to be better matrices than films oil which collagen has been immobilized. It, therefore, can be speculated that other serum proteins are more important than collagen for the human smooth muscle cell adhesion and growth Oil surface-modified polymer matrices. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 CHU Vaudois, Dept Pediat Surg, Lab Expt Pediat Urol, CH-1011 Lausanne, Switzerland.
   Univ Lausanne, Inst Appl Radiophys, Lausanne, Switzerland.
   Univ Uppsala, Angstrom Lab, Uppsala, Sweden.
   Ecole Polytech Fed Lausanne, Lab Cellular Biotechnol, Lausanne, Switzerland.
RP Frey, P (reprint author), CHU Vaudois, Dept Pediat Surg, Lab Expt Pediat Urol, CH-1011 Lausanne, Switzerland.
RI wurm, florian/D-7224-2013
OI Hilborn, Jons/0000-0001-6947-9601
CR Atala A, 1998, UROL CLIN N AM, V25, P39, DOI 10.1016/S0094-0143(05)70431-6
   Atala A, 1999, UROL CLIN N AM, V26, P157, DOI 10.1016/S0094-0143(99)80013-5
   ATALA A, 1997, SYNTHETIC BIODEGRADA, P149
   ATALA A, 1999, DIAL PED UROL, V22, P7
   BASKIN LS, 1993, J UROLOGY, V149, P190, DOI 10.1016/S0022-5347(17)36037-8
   Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5
   Falke G, 2000, WORLD J UROL, V18, P36, DOI 10.1007/s003450050007
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gupta B, 2001, J APPL POLYM SCI, V81, P2993, DOI 10.1002/app.1749
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS147
   HUTTON KAR, 1993, J UROLOGY, V150, P721, DOI 10.1016/S0022-5347(17)35597-0
   Ito Y, 1997, BIOMATERIALS, V18, P197, DOI 10.1016/S0142-9612(96)00119-6
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   KISMAN OK, 1991, J UROLOGY, V146, P1113, DOI 10.1016/S0022-5347(17)38017-5
   KLEE LW, 1990, J UROLOGY, V144, P1283, DOI 10.1016/S0022-5347(17)39720-3
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   REZNIKOFF CA, 1983, IN VITRO CELL DEV B, V19, P326
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0
   Sugasi S, 2000, J UROLOGY, V164, P951, DOI 10.1016/S0022-5347(05)67224-2
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Wilson CB, 1996, WORLD J UROL, V14, pS30
NR 26
TC 126
Z9 133
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2002
VL 23
IS 15
BP 3149
EP 3158
AR PII S0142-9612(02)00061-3
DI 10.1016/S0142-9612(02)00061-3
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563RF
UT WOS:000176268800010
PM 12102186
DA 2018-10-19
ER

PT J
AU Knabe, C
   Klar, F
   Fitzner, R
   Radlanski, RJ
   Gross, U
AF Knabe, C
   Klar, F
   Fitzner, R
   Radlanski, RJ
   Gross, U
TI In vitro investigation of titanium and hydroxyapatite dental implant
   surfaces using a rat bone marrow stromal cell culture system
SO BIOMATERIALS
LA English
DT Article
DE titanium; plasma-sprayed coatings; osteoblasts; cell-biomaterial
   interactions; dental implant
ID OSTEOBLAST-LIKE CELLS; SCREW-SHAPED IMPLANTS; PLASMA-SPRAYED COATINGS;
   PROTEIN-KINASE-A; IN-VITRO; HISTOMORPHOMETRIC EVALUATION;
   OSSEOINTEGRATED IMPLANTS; PHOSPHOLIPASE A(2); INTERFACE INVITRO;
   MINIATURE PIGS
AB In this study, rat bone marrow cells (RBM) were used to evaluate different titanium and hydroxyapatite dental implant surfaces. The implant surfaces investigated were a titanium surface having a porous titanium plasma-sprayed coating (sample code Ti-TPS), a titanium surface with a deep profile structure (sample code Ti-DPS), an uncoated tit,11141111 substrate with a machined surface (sample code Ti-ma) and a machined titanium substrate with a Porous hydroxyapatite plasma-sprayed coating (sample code Ti-HA). RBM cells were Cultured on the disc-shaped test substrates for 14 days. The culture medium was changed daily and examined for calcium and phosphate concentrations. After 14 days specimens were examined by light microscopy, scanning electron microscopy, energy dispersive X-ray analysis and morphometry of the cell-covered Substrate Surface. All test substrates facilitated RBM growth of extracellular matrix formation. Ti-DPS and Ti-TPS to the highest degree, followed by Ti-ma and Ti-HA. Ti-DPS and Ti-TPS displayed the highest cell density and thus seem to be well suited for the endosseous portion of dental implants. RBM cells cultured oil Ti-HA showed a delayed growth pattern. This may be related to its high phosphate ion release. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Free Univ Berlin, Univ Hosp Benjamin Franklin, Dept Expt Dent, D-14197 Berlin, Germany.
   Friadent Inc, D-68229 Mannheim, Germany.
   Free Univ Berlin, Univ Hosp Benjamin Franklin, Inst Clin Chem & Biochem, D-12200 Berlin, Germany.
   Free Univ Berlin, Univ Hosp Benjamin Franklin, Inst Pathol, D-12200 Berlin, Germany.
RP Knabe, C (reprint author), Free Univ Berlin, Univ Hosp Benjamin Franklin, Dept Expt Dent, Assmannshauser Str 4-6, D-14197 Berlin, Germany.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALBREKTSSON T, 1988, J PERIODONTOL, V59, P287, DOI 10.1902/jop.1988.59.5.287
   Anselme K, 1997, J BIOMED MATER RES, V34, P247, DOI 10.1002/(SICI)1097-4636(199702)34:2<247::AID-JBM14>3.0.CO;2-F
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Carr AB, 1997, INT J ORAL MAX IMPL, V12, P598
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CLAES L, 1976, ARCH ORTHOP TRAUM SU, V85, P155, DOI 10.1007/BF00415453
   Cochran DL, 1999, J PERIODONTOL, V70, P1523, DOI 10.1902/jop.1999.70.12.1523
   Cooper LF, 1999, INT J ORAL MAX IMPL, V14, P37
   CUNE MS, 1994, J PROSTHET DENT, V72, P144, DOI 10.1016/0022-3913(94)90072-8
   Davies JE, 1996, ANAT REC, V245, P426
   DAVIES JE, 1990, J BIOMED MATER RES, V24, P1289, DOI 10.1002/jbm.820241003
   DEBRUIJN JD, 1992, J BIOMED MATER RES, V26, P1365, DOI 10.1002/jbm.820261008
   DeSantis D, 1996, J MATER SCI-MATER M, V7, P21, DOI 10.1007/BF00121185
   ERICSSON I, 1994, CLIN ORAL IMPLAN RES, V5, P202, DOI 10.1034/j.1600-0501.1994.050402.x
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   Gondolph-Zink B, 1998, ORTHOPADE, V27, P96
   GOTTFREDSON K, 1992, CLIN ORAL IMPLAN RES, V3, P77
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Grossner-Schreiber B, 1991, Dtsch Zahnarztl Z, V46, P691
   Han CH, 1998, CLIN ORAL IMPLAN RES, V9, P1, DOI 10.1034/j.1600-0501.1998.090101.x
   Hendrich C, 1996, BIOMED TECH, V41, P278, DOI 10.1515/bmte.1996.41.10.278
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   Hutton J E, 1995, Int J Oral Maxillofac Implants, V10, P33
   *INT STAND BIOL EV, 1994, 10993 ISO INT STAND
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   Jemt T, 1992, Int J Oral Maxillofac Implants, V7, P162
   Kettner R, 1997, Mund Kiefer Gesichtschir, V1, P335
   KIEFER H, 1986, BIOL BIOMECHANICAL P, P471
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   Lazzara RJ, 1999, INT J PERIODONT REST, V19, P117
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Lohmann CH, 1999, J BIOMED MATER RES, V47, P139, DOI 10.1002/(SICI)1097-4636(199911)47:2<139::AID-JBM4>3.0.CO;2-2
   LOWENBERG B, 1991, CELL MATER, V1, P177
   LOWENBERG BF, 1996, T 5 WORLD BIOM C, P668
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Matsuo M, 1999, J PERIODONTOL, V70, P1330, DOI 10.1902/jop.1999.70.11.1330
   MICHAELS C M, 1989, Journal of Dental Research, V68, P276
   Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x
   Nakashima Y, 1997, J BIOMED MATER RES, V35, P287
   Noth U, 1999, BIOMED TECH, V44, P6, DOI 10.1515/bmte.1999.44.1-2.6
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   Ong J L, 1997, Implant Dent, V6, P19, DOI 10.1097/00008505-199700610-00004
   Ong J L, 1996, Implant Dent, V5, P83, DOI 10.1097/00008505-199600520-00002
   Ozawa S, 1996, BIOMATERIALS, V17, P23, DOI 10.1016/0142-9612(96)80751-4
   PULCO DA, 1991, J BIOMED MATER RES, V25, P711
   Qu J, 1996, Oral Dis, V2, P102
   Schroeder A, 1976, SSO Schweiz Monatsschr Zahnheilkd, V86, P713
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   Smedberg J I, 1993, Clin Oral Implants Res, V4, P39, DOI 10.1034/j.1600-0501.1993.040106.x
   Svehla M, 2000, J BIOMED MATER RES, V51, P15, DOI 10.1002/(SICI)1097-4636(200007)51:1<15::AID-JBM3>3.0.CO;2-9
   TODESCAN R, 1996, T 5 WORLD BIOM C, P721
   TRANQUILLI PL, 1994, J MATER SCI-MATER M, V5, P345, DOI 10.1007/BF00058960
   Trentz OA, 1997, UNFALLCHIRURG, V100, P39, DOI 10.1007/s001130050093
   Vercaigne S, 1998, CLIN ORAL IMPLAN RES, V9, P261, DOI 10.1034/j.1600-0501.1998.090407.x
   Vogel J, 1996, J MATER SCI-MATER M, V7, P495, DOI 10.1007/BF00705431
   Weiner E, 1996, FUTURIST, V30, P25
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wennerberg A, 1997, INT J ORAL MAX IMPL, V12, P486
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
   Zreiqat H, 1996, J BIOMED MATER RES, V33, P217, DOI 10.1002/(SICI)1097-4636(199624)33:4<217::AID-JBM2>3.0.CO;2-S
NR 70
TC 43
Z9 43
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2002
VL 23
IS 15
BP 3235
EP 3245
AR PII S0142-9612(02)00078-9
DI 10.1016/S0142-9612(02)00078-9
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563RF
UT WOS:000176268800019
PM 12102195
DA 2018-10-19
ER

PT J
AU Verne, E
   Bosetti, M
   Brovarone, CV
   Moisescu, C
   Lupo, F
   Spriano, S
   Cannas, M
AF Verne, E
   Bosetti, M
   Brovarone, CV
   Moisescu, C
   Lupo, F
   Spriano, S
   Cannas, M
TI Fluoroapatite glass-ceramic coatings on alumina: structural, mechanical
   and biological characterisation
SO BIOMATERIALS
LA English
DT Article
DE glass-ceramic; coatings; osteoblast-like cells; biocompatibility
ID BIOACTIVE GLASS; ZIRCONIA; CARBON; AL2O3
AB The aim of this work was to realise bioactive coatings on full density alpha-alumina substrates. An SiO(2)-CaO-based glass (SC) and an SiO(2)-Al(2)O(3)-P(2)O(5)-K(2)O-CaO-F(-)-based glass-ceramic (SAF) Were used for this purpose. Specifically, SAF is a fluoroapatite containing glass-ceramic and previous studies have shown that it is a highly bioactive biomaterial. Furthermore, these fluoroapatite crystals possess a needle-shaped morphology which mimics that of hydroxylapatite found in human hard tissues. particularly in teeth.
   SAF is a very viscous glass-ceramic and for this reason an intermediate, less viscous, SC layer was interposed in direct contact with alumina aiming, to obtain a good coating adhesion.
   Moreover, this intermediate layer strongly lowers the Al(3+) diffusion and thus minimises both compositional changes in the SAF outer layer and the risk of detrimental modifications of the nature of the crystalline phases.
   A complete characterisation of the coated samples was performed by means of X-ray diffraction, optical and scanning microscopy. Coating adhesion on alumina was tested by comparative shear tests while biocompatibility,vas investigated on alumina. bulk SAF and oil the realised coatings. For this purpose, cytotoxicity, adhesion and proliferation of human osteoblast-like cells were cultured onto the three materials. Results showed that the interposition of the SC layer was Successful ill allowing I good softening and spreading of the SAF outer layer and in avoiding the crystallisation undesired crystalline phases maintaining the good bioactive properties of the bulk one. In vitro results on the coatings showed osteoblast-like cell behaviour similar to bulk fluoroapatite glass-ceramic and better respect to alumina substrates, being a promising index of bone material integration and of its in vivo possible applications. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Politecn Torino, Dept Mat Sci & Chem Engn, I-10129 Turin, Italy.
   Univ Piemonte Orientale, Dept Med Sci, Novara, Italy.
   Univ Jena, Otto Schott Inst, D-6900 Jena, Germany.
RP Verne, E (reprint author), Politecn Torino, Dept Mat Sci & Chem Engn, C So Duca Abruzzi 24, I-10129 Turin, Italy.
EM verne@athena.polito.it
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Bosetti,
   Michela/0000-0002-3682-8702; Verne, Enrica/0000-0002-8649-4739; Spriano,
   Silvia/0000-0002-7367-9777
CR Bosetti M, 2001, BIOMATERIALS, V22, P987, DOI 10.1016/S0142-9612(00)00264-7
   Bosetti M, 1998, J BIOMED MATER RES, V40, P307, DOI 10.1002/(SICI)1097-4636(199805)40:2<307::AID-JBM16>3.0.CO;2-I
   Brovarone CV, 2001, J EUR CERAM SOC, V21, P2855
   BUSHBY RS, 1993, MATER SCI TECH SER, V9, P417, DOI 10.1179/mst.1993.9.5.417
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   Ehlers EM, 2001, ANN ANAT, V183, P13, DOI 10.1016/S0940-9602(01)80007-8
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Ferraris M, 1998, J NUCL MATER, V258, P1546, DOI 10.1016/S0022-3115(98)00176-7
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   Isola C, 1998, J EUR CERAM SOC, V18, P1017, DOI 10.1016/S0955-2219(97)00203-3
   Jiang GW, 1998, J BIOMED MATER RES, V43, P77, DOI 10.1002/(SICI)1097-4636(199821)43:1<77::AID-JBM9>3.0.CO;2-J
   KEPNER RL, 1994, MICROBIOL REV, V58, P603
   KIMIHIRO Y, 1998, J BIOMED MATER RES, V43, P46
   Lin J, 1995, MATER SCI TECH SER, V11, P1035, DOI 10.1179/mst.1995.11.10.1035
   Moisescu C, 1999, J NON-CRYST SOLIDS, V248, P169, DOI 10.1016/S0022-3093(99)00239-2
   Moisescu C, 1999, J NON-CRYST SOLIDS, V248, P176, DOI 10.1016/S0022-3093(99)00240-9
   NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811
   Payne JM, 1996, J PERIODONTOL, V67, P236, DOI 10.1902/jop.1996.67.3.236
   Verne E, 2000, J EUR CERAM SOC, V20, P473, DOI 10.1016/S0955-2219(99)00181-8
   Verne E, 1997, BIOCERAMICS, VOL 10, P199, DOI 10.1016/B978-008042692-1/50047-9
   Verne E, 2000, ACTA MATER, V48, P4667, DOI 10.1016/S1359-6454(00)00255-X
   VERNE E, 1999, BIOCERAMICS, P491
NR 23
TC 26
Z9 28
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2002
VL 23
IS 16
BP 3395
EP 3403
AR PII S0142-9612(02)00040-6
DI 10.1016/S0142-9612(02)00040-6
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563RG
UT WOS:000176268900011
PM 12099282
DA 2018-10-19
ER

PT J
AU Steffens, GCM
   Nothdurft, L
   Buse, G
   Thissen, H
   Hocker, H
   Klee, D
AF Steffens, GCM
   Nothdurft, L
   Buse, G
   Thissen, H
   Hocker, H
   Klee, D
TI High density binding of proteins and peptides to poly(D,L-lactide)
   grafted with polyacrylic acid
SO BIOMATERIALS
LA English
DT Article
DE poly(D,L-lactide); protein immobilisation; polyacrylic acid; graft
   polymerisation
ID COVALENT
AB The use of graft polymers for the functionalisation of biomaterial surfaces is already widespread. We investigated the adsorptive and covalent binding of a variety of proteins and peptides to poly((D),L-lactide) grafted with polyacrylic acid. Covalent attachincrit was achieved through coupling of amino groups of the protein/peptide to the carboxyl groups of the graft polymer by using a water-soluble carbodiimide and N-hydroxysuccinimide. Binding densities were determined by automated amino acid analysis after acid hydrolysis of both the poly((D),L-lactide) and the adsorbed and covalently bound proteins. Experiments in the absence and presence of the coupling reagents allow to discriminate between adsorptive and covalent binding. Although the adsorptive binding is quite substantial in absolute terms, the amount of adsorbed protein is relatively low as compared to the total amount of bound protein.
   Total binding densities of 20-30/mug/cm(2) can easily be achieved. Depending on the concentration and on the properties of the proteins and peptides, between 5% and 80% of the totally bound protein may be physically adsorbed.
   Densities expressed in molecules/10nm(2) vary from 0.5 molecule fibronectin to 2000 laminin-peptide molecules: their binding densities clearly correlate with their respective molecular masses. Obviously, the binding densities are governed by their individual three-dimensional space requirements rather than the density of the available carboxyl groups.
   From the number of carboxyl groups/nm(2) (18,000-30,000 COOH/10 nm(2)) the average length of the acrylic acid graft polymer molecules was estimated. Based on the assumption that about 10 copolymer chains can be accommodated on 10 nm(2), the average length of the polymer chains, which corresponds to the thickness of the graft phase, is estimated to be 0.5-1 mum.
   The organisation of the proteins and peptides within the polyacrylic acid phase was further investigated by experiments in which a protein (BSA) and a peptide (Val-Lys) were allowed to react in either a singular a consecutive or a simultaneous way XPS and IR-ATR surface characterisation experiments a three-dimensional picture of the arrangement of the immobilised proteins and peptides within the graft polymer phase emerges. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Klinikum RWTH, Dept Biochem, Inst Biochem, D-52057 Aachen, Germany.
   Rhein Westfal TH Aachen, Inst Textile Chem & Macromol Chem, D-52062 Aachen, Germany.
RP Steffens, GCM (reprint author), Univ Klinikum RWTH, Dept Biochem, Inst Biochem, Pauwelstr 30, D-52057 Aachen, Germany.
RI Thissen, Helmut/D-3835-2011
CR Atala A, 1997, SYNTHETIC BIODEGRADA
   Hoffman A.S., 1996, BIOMATERIALS SCI INT, P124
   NOBBS CL, 1966, NATURE, V209, P339, DOI 10.1038/209339a0
   Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   THISSEN H, 1999, THESIS AACHEN U TECH
   THISSEN H, 1998, BIODEGRADIERBARE IMP, P59
   THISSEN H, 1996, POLYM MED SURG
   Ulbricht M, 1998, BIOMATERIALS, V19, P1229, DOI 10.1016/S0142-9612(98)00029-5
   Valuev IL, 1998, BIOMATERIALS, V19, P41, DOI 10.1016/S0142-9612(97)00147-6
   Volcker N, 2001, J MATER SCI-MATER M, V12, P111, DOI 10.1023/A:1008938525489
   WELINDER KG, 1976, FEBS LETT, V72, P19, DOI 10.1016/0014-5793(76)80804-6
NR 12
TC 85
Z9 87
U1 0
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2002
VL 23
IS 16
BP 3523
EP 3531
AR PII S0142-9612(02)00091-1
DI 10.1016/S0142-9612(02)00091-1
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 563RG
UT WOS:000176268900027
PM 12099298
DA 2018-10-19
ER

PT J
AU Kirkpatrick, CJ
   Krump-Konvalinkova, V
   Unger, RE
   Bittinger, F
   Otto, M
   Peters, K
AF Kirkpatrick, CJ
   Krump-Konvalinkova, V
   Unger, RE
   Bittinger, F
   Otto, M
   Peters, K
TI Tissue response and biomaterial integration: the efficacy of in vitro
   methods
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT E-MRS 2001 Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
DE biomaterials; in vitro methods; endothelial cells; inflammation;
   angiogenesis; tissue engineering
ID MICROVASCULAR ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; HEAVY-METAL
   IONS; VASCULAR ENDOTHELIUM; EXTRACELLULAR-MATRIX; SHEAR-STRESS;
   EXPRESSION; MECHANISMS; APOPTOSIS; DELIVERY
AB Implantation involves tissue trauma, which evokes an inflammatory response, coupled to a wound healing reaction, involving angiogenesis, fibroblast activation and matrix remodelling. Until now the type and extent of such reactions to give optimal integration of various biomaterials are practically unknown. Three principal fields of research can yield useful data to understand these phenomena better: studies on explanted biomaterials, animal models and relevant in vitro techniques. This paper will present examples of the latter field and the application of endothelial cell (EC) culture systems to study the effects of important tissue (e.g. pro-inflammatory cytokines, chemokines) and material (e.g. metal ions, particulate debris) factors on the regulation of the inflammatory and angiogenic response. A central feature is the use of microvascular endothelial cells (MEC), which can be used in both 2-and 3-dimensional (3-D) assays. We have also used genetic manipulation to develop a permanent MEC line from the human lung (HPMEC-ST1), which is being tested for its suitability to study cell-biomaterial interactions. In addition, suitable in vitro techniques are being developed in order to investigate drug delivery systems (DDS). Of particular interest is the targeting of the central nervous system, our approach being to establish a human model of the blood-brain barrier (BBB). A mainstay of our scientific philosophy is that such in vitro methods can make an important contribution to understanding biological reactions at the tissue-biomaterial interface and thus further a causal approach to tissue engineering (TE) and drug delivery applications. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
RP Kirkpatrick, CJ (reprint author), Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany.
RI Peters, Kirsten/S-3484-2016
CR BLUMENTHAL NC, 1994, J APPL BIOMATER, V5, P191, DOI 10.1002/jab.770050303
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   Dard M, 2000, Clin Oral Investig, V4, P126, DOI 10.1007/s007840050128
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   Dimmeler S, 2000, CIRC RES, V87, P434
   ELAGLI K, 1995, BIOMATERIALS, V16, P1345, DOI 10.1016/0142-9612(95)91051-Y
   Folkman J, 1996, EUR J CANCER, V32A, P2534, DOI 10.1016/S0959-8049(96)00423-6
   Gariepy J, 2001, TRENDS BIOTECHNOL, V19, P21, DOI 10.1016/S0167-7799(00)01520-1
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Guida E, 1998, CELL PHYSIOL BIOCHEM, V8, P75, DOI 10.1159/000016272
   Haynes DR, 2000, J BIOMED MATER RES, V49, P167, DOI 10.1002/(SICI)1097-4636(200002)49:2<167::AID-JBM3>3.0.CO;2-9
   Haynes DR, 1997, J BONE JOINT SURG BR, V79B, P988, DOI 10.1302/0301-620X.79B6.7832
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Kao WYJ, 2000, BIOMATERIALS, V21, P2295, DOI 10.1016/S0142-9612(00)00156-3
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   Kirkpatrick CJ, 1997, INT J MICROCIRC, V17, P231, DOI 10.1159/000179235
   Lehmann I, 2000, J VASC RES, V37, P408, DOI 10.1159/000025757
   Lewis JC, 1995, EXP MOL PATHOL, V62, P207, DOI 10.1006/exmp.1995.1023
   Liu JP, 1999, FASEB J, V13, P2091
   MALEK AM, 1993, J CLIN INVEST, V92, P2013, DOI 10.1172/JCI116796
   MALONEY WJ, 1995, J BONE JOINT SURG AM, V77, P1301, DOI 10.2106/00004623-199509000-00002
   MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648
   Nakashima Y, 1998, J BONE JOINT SURG BR, V80B, P694, DOI 10.1302/0301-620X.80B4.8374
   NEREM RM, 1993, J BIOMECH ENG-T ASME, V115, P510, DOI 10.1115/1.2895532
   O'Donnell J, 2000, J VASC RES, V37, P540, DOI 10.1159/000054087
   Ono M, 1999, CANCER CHEMOTH PHARM, V43, pS69, DOI 10.1007/s002800051101
   Otto M, 1997, J MATER SCI-MATER M, V8, P119, DOI 10.1023/A:1018515001850
   Peters K, 2001, J MATER SCI-MATER M, V12, P955, DOI 10.1023/A:1012852814570
   RAGHOW R, 1994, FASEB J, V8, P823
   Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x
   SCHNITTLER HJ, 1993, AM J PHYSIOL, V265, P289
   Schwartz JJ, 2000, CURR OPIN MOL THER, V2, P162
   SHAHGALDI BF, 1995, J BONE JOINT SURG BR, V77B, P962
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Slavin J, 1996, J PATHOL, V178, P5
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   van Kooten TG, 2001, J BIOMED MATER RES, V54, P385
   van Kooten TG, 2000, J BIOMED MATER RES, V52, P199, DOI 10.1002/1097-4636(200010)52:1<199::AID-JBM26>3.0.CO;2-Z
   VERNON RB, 1995, AM J PATHOL, V147, P873
   Wagner M, 1999, AM J PHYSIOL-LUNG C, V277, pL1026, DOI 10.1152/ajplung.1999.277.5.L1026
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
   Walczak J, 1998, BIOMATERIALS, V19, P229, DOI 10.1016/S0142-9612(97)00208-1
NR 44
TC 62
Z9 65
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD AUG
PY 2002
VL 19
IS 2-6
SI SI
BP 211
EP 217
AR PII S1389-0344(02)00019-9
DI 10.1016/S1389-0344(02)00019-9
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 598GD
UT WOS:000178266800028
PM 12202185
DA 2018-10-19
ER

PT J
AU Knepper-Nicolai, B
   Reinstorf, A
   Hofinger, I
   Flade, K
   Wenz, R
   Pompe, W
AF Knepper-Nicolai, B
   Reinstorf, A
   Hofinger, I
   Flade, K
   Wenz, R
   Pompe, W
TI Influence of osteocalcin and collagen I on the mechanical and biological
   properties of Biocement D
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT E-MRS 2001 Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
DE hydroxyapatite-collagen composite; osteocalcin; interface control;
   osteoblast
ID CALCIUM-PHOSPHATE; BONE CEMENTS; PROTEINS; MATRIX; COMPLEX
AB lit order to generate a calcium-phosphate bone cement as a transient replacement for bone defects, we modified Biocement D (Merck Biomaterial GmbH) containing mineralised collagen [1] with osteocalcin, the most abundant non-collageneous protein of bone. Osteocalcin was added to the cement paste during setting in order to control the crystallisation kinetics of hydroxyapatite (HAP) as well as to stimulate the interaction of osteoblasts and osteoclasts with the bone replacement material. Analysts by SEM and AFM shows, that the addition of osteocalcin causes a nanosize microstructure of the calcium cement, which can be explained by inhibited growth of HAP crystals. The fracture strength of the material decreased by incorporation of osteocalcin, pointing onto a higher defect concentration of the crystalline structure. The impact of osteocalcin onto the interaction of bone cells with HAP-Collagen I-cements was studied in a cell culture system using the human osteosarcoma cell line SAOS-2. Results suggest, that osteocalcin might possibly improve the initial adherence of osteoblast-like cells, whereas proliferation of the cells is not effected. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Tech Univ Dresden, Inst Werkstoffwissensch, D-01069 Dresden, Germany.
   Merck Biomat GMBH, D-64271 Darmstadt, Germany.
RP Pompe, W (reprint author), Tech Univ Dresden, Inst Werkstoffwissensch, Hallwachsstr 3, D-01069 Dresden, Germany.
CR BILEZIKIAN JP, 1996, PRINCIPLES BONE BIOL, P183
   Bradt JH, 1999, CHEM MATER, V11, P2694, DOI 10.1021/cm991002p
   BURTH R, 2000, 1100 WORLD BIOM C KA
   CHENU C, 1994, J CELL BIOL, V127, P1149, DOI 10.1083/jcb.127.4.1149
   DRIESSENS FCM, 1994, J MATER SCI-MATER M, V5, P164, DOI 10.1007/BF00053338
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z
   GELINSKY M, 2000, CELLS TISSUES ORGANS, V166, P58
   GOLDNER H, 1991, LEHRBUCH HOHERE FEST, V1, P99
   HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990
   HAUSCHKA PV, 1989, ANAT REC, V224, P180, DOI 10.1002/ar.1092240208
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   JANSEN JA, 1995, J MATER SCI-MATER M, V6, P653, DOI 10.1007/BF00123447
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   Prigodich RV, 1997, ARCH BIOCHEM BIOPHYS, V345, P339, DOI 10.1006/abbi.1997.0254
   RITTER NM, 1992, J BONE MINER RES, V7, P877
NR 16
TC 43
Z9 47
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD AUG
PY 2002
VL 19
IS 2-6
SI SI
BP 227
EP 231
AR PII S1389-0344(02)00036-9
DI 10.1016/S1389-0344(02)00036-9
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 598GD
UT WOS:000178266800030
PM 12202187
DA 2018-10-19
ER

PT J
AU Eisenbarth, E
   Linez, P
   Biehl, V
   Velten, D
   Breme, J
   Hildebrand, HF
AF Eisenbarth, E
   Linez, P
   Biehl, V
   Velten, D
   Breme, J
   Hildebrand, HF
TI Cell orientation and cytoskeleton organisation on ground titanium
   surfaces
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT E-MRS 2001 Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
DE cell orientation; surface topography; cell adhesion
ID ADHESION
AB A stable connection between the biomaterial surface and the surrounding tissue is one of the most important prerequisites for the long-term success of implants. Therefore, a strong adhesion of the cells on the biomaterial surface is required. Beside the surface composition the surface topography influences the properties of the adherent cells. The quality of the connection between the cell and the biomaterial is-among other factors-determined by the dimensions of the surface topography. Osteoblasts and fibroblast-like cells in contact with a ground biomaterial surface spread in the direction of the surface structures. These aligned cells provide a more favourable adhesion behaviour than a spherically shaped cell. To determine the influence of the surface structure on the cell alignment and cytoskeleton organisation or arrangement, substrate discs of cp-titanium were ground, producing different roughness of the substrates. The oriented cells had a higher density of focal contacts when they were in contact with the edges of the grooves and showed a better organisation of the cytoskeleton and stronger actin fibres. These changes of the aligned cells depend on the peak to valley height of the surface structures. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Fac Med H Warembourg, Dept Biophys, Lab Biomat Res, F-59045 Lille, France.
   Univ Saarland, Lehrstuhl Met Werkstoffe, D-66041 Saarbrucken, Germany.
RP Hildebrand, HF (reprint author), Fac Med H Warembourg, Dept Biophys, Lab Biomat Res, 1 Pl Verdun, F-59045 Lille, France.
CR CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   Goodman SL, 1996, BIOMATERIALS, V17, P2087, DOI 10.1016/0142-9612(96)00016-6
   REES DA, 1977, NATURE, V267, P124, DOI 10.1038/267124a0
   Richards R. G., 1996, Injury, V27, pSC38
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
NR 6
TC 67
Z9 71
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD AUG
PY 2002
VL 19
IS 2-6
SI SI
BP 233
EP 237
AR PII S1389-0344(02)00028-X
DI 10.1016/S1389-0344(02)00028-X
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 598GD
UT WOS:000178266800031
PM 12202188
DA 2018-10-19
ER

PT J
AU Manso, M
   Ogueta, S
   Perez-Rigueiro, J
   Garcia, JP
   Martinez-Duart, JM
AF Manso, M
   Ogueta, S
   Perez-Rigueiro, J
   Garcia, JP
   Martinez-Duart, JM
TI Testing biomaterials by the in-situ evaluation of cell response
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT E-MRS 2001 Spring Meeting
CY JUN 05-08, 2001
CL STRASBOURG, FRANCE
DE biomaterials; biocompatibility; in-vitro testing; immune reaction; cells
ID MESENCHYMAL STEM-CELLS; ADHESION; TIN
AB In this work, we describe a technique for the in-situ observation of cells adhered on opaque biomaterial surfaces. The visualisation of the morphology of cells adhered onto a surface allows to derive nuclear apoptotic signs or even the existence of organisation between groups of these cells. The technique is based on the use of an auto-immune reaction combined with a fluorescent agent that allows a direct inspection of the cell behaviour. The versatility of the technique is demonstrated by presenting several examples with different cultured cells (human chondrosarcome cells (CSRCs) and pluripotential mesenchymal stem cells (MSCs) from bone marrow) seeded over two different Ti-based surfaces (TiO2 and TiN, respectively). These in-vitro observations are compared with the behaviour of the same cells on bare TiAlV alloy. From our results it is concluded that both TiO2 and TiN surfaces show enhanced biological responses. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Autonoma Madrid, Dept Fis Aplicada C 12, E-28049 Madrid, Spain.
   Univ Autonoma Madrid, Dept Biol Mol C 10, E-28049 Madrid, Spain.
   Univ Politecn Madrid, ETSI Caminos Canales & Puertos, Dept Ciencia Mat, E-28040 Madrid, Spain.
RP Manso, M (reprint author), Univ Autonoma Madrid, Dept Fis Aplicada C 12, E-28049 Madrid, Spain.
RI Manso Silvan, Miguel/B-4947-2010
OI Manso Silvan, Miguel/0000-0002-5063-1607
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   LI P, 1993, BIOCERAMICS, V6, P41
   OGUETA S, 2000, J ENDOCRINOL, V165, P329
   Tjia JS, 1999, BIOMATERIALS, V20, P2223, DOI 10.1016/S0142-9612(99)00153-2
NR 10
TC 15
Z9 17
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD AUG
PY 2002
VL 19
IS 2-6
SI SI
BP 239
EP 242
AR PII S1389-0344(02)00030-8
DI 10.1016/S1389-0344(02)00030-8
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 598GD
UT WOS:000178266800032
PM 12202189
DA 2018-10-19
ER

PT J
AU Wefer, J
   Schlote, N
   Sekido, N
   Sievert, KD
   Wefer, AE
   Nunes, L
   Bakircioglu, ME
   Dahiya, R
   Tanagho, EA
AF Wefer, J
   Schlote, N
   Sekido, N
   Sievert, KD
   Wefer, AE
   Nunes, L
   Bakircioglu, ME
   Dahiya, R
   Tanagho, EA
TI Tunica albuginea acellular matrix graft for penile reconstruction in the
   rabbit: a model for treating Peyronie's disease
SO BJU INTERNATIONAL
LA English
DT Article
DE penile induration; surgery; plastic; graft survival
ID VENOUS PATCH GRAFT; FUNCTIONAL-EVALUATION; OUTCOME ANALYSIS;
   REGENERATION; REPLACEMENT; MANAGEMENT; PLICATION; CURVATURE; TISSUE
AB Objective To evaluate the use of an acellular matrix graft of the tunica albuginea for functional penile reconstruction in severe cases of Peyronie's disease.
   Materials and methods In 18 rabbits, an acellular matrix graft of the tunica albuginea was used to cover a 4x8 mm tunical defect, and six animals each were killed 1, 3 and 6 months later; four unoperated animals served as histological controls. Before death an erection was induced by papaverine, with the quality classified on a scale of 0-5, and cavernosography performed. After death the penis was prepared for histological study, and the cell number, collagen and elastic fibre content evaluated in the regenerated matrix, and in control specimens and four unimplanted matrices.
   Results Of 18 experimental animals, 11 had normal erections before death, four had slight penile deviation and three developed no erection. Failure was caused by severe postoperative haematoma, resulting in scar tissue. There was no graft rejection. Histologically there was no difference between natural and regenerated tunica. The collagen content and cell number were not significantly different in regenerated and control samples. There were significantly fewer elastic fibres in the unimplanted grafts and the 1-month group, but in later samples this difference was no longer evident.
   Conclusion The homologous acellular matrix graft of the tunica albuginea warrants further evaluation as an alternative treatment in Peyronie's disease, despite some postoperative failures. The advantage of this orthotopic biomaterial is its rapid integration, with no rejection.
C1 Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA.
   Univ Calif San Francisco, Sch Med, Dept Radiol, San Francisco, CA 94143 USA.
RP Tanagho, EA (reprint author), Univ Calif San Francisco, Sch Med, Dept Urol, Box 0738, San Francisco, CA 94143 USA.
FU NINDS NIH HHS [R01 NS 18029]
CR AMIN M, 1980, J UROLOGY, V124, P815, DOI 10.1016/S0022-5347(17)55681-5
   *ARM FORC I PATH, 1968, MAN HIST STAIN METH, P79
   BAZEED MA, 1983, UROLOGY, V21, P501, DOI 10.1016/0090-4295(83)90050-X
   Brannigan RE, 1998, J UROLOGY, V159, P1064, DOI 10.1016/S0022-5347(01)63836-9
   Burnett AL, 1997, PLAST RECONSTR SURG, V99, P1061, DOI 10.1097/00006534-199704000-00021
   Dahms SE, 1997, UROLOGY, V50, P818, DOI 10.1016/S0090-4295(97)00391-9
   El-Sakka AI, 1998, J UROLOGY, V160, P2050, DOI 10.1016/S0022-5347(01)62240-7
   FAERBER GJ, 1993, J UROLOGY, V149, P1319, DOI 10.1016/S0022-5347(17)36381-4
   HELAL MA, 1995, UROLOGY, V46, P390, DOI 10.1016/S0090-4295(99)80225-8
   Jensen J S, 1992, Ugeskr Laeger, V154, P1104
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   KELAMI A, 1977, EUR UROL, V3, P191
   KISHEV SV, 1983, UROLOGE A, V22, P297
   Kondas J., 1998, International Urology and Nephrology, V30, P321, DOI 10.1007/BF02550318
   Lang TA, 1997, REPORT STAT MED, P65
   Licht MR, 1997, J UROLOGY, V158, P460, DOI 10.1016/S0022-5347(01)64502-6
   LOWE DH, 1982, UROLOGY, V19, P609, DOI 10.1016/0090-4295(82)90010-3
   Lue TF, 1998, J UROLOGY, V160, P2047, DOI 10.1016/S0022-5347(01)62239-0
   Lue TF, 1999, J UROLOGY, V161, P1141, DOI 10.1016/S0022-5347(01)61613-6
   MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8
   MORIEL EZ, 1994, UROLOGY, V43, P697, DOI 10.1016/0090-4295(94)90187-2
   Piechota HJ, 1998, BRIT J UROL, V81, P548
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Pryor JP, 1998, INT J IMPOT RES, V10, P129, DOI 10.1038/sj.ijir.3900331
   RALPH DJ, 1995, J UROLOGY, V154, P1362, DOI 10.1016/S0022-5347(01)66862-9
   Sievert KD, 2001, J UROLOGY, V165, P2096, DOI 10.1016/S0022-5347(05)66301-X
   WALDHAUSER M, 1988, J UROLOGY, V140, P525, DOI 10.1016/S0022-5347(17)41709-5
   Wefer J, 2001, J UROLOGY, V165, P1755, DOI 10.1016/S0022-5347(05)66408-7
NR 28
TC 19
Z9 21
U1 0
U2 0
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1464-4096
J9 BJU INT
JI BJU Int.
PD AUG
PY 2002
VL 90
IS 3
BP 326
EP 331
DI 10.1046/j.1464-410X.2002.02808.x
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 574YM
UT WOS:000176918300022
PM 12133073
OA Bronze
DA 2018-10-19
ER

PT J
AU Khor, E
AF Khor, E
TI Chitin: a biomaterial in waiting
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
ID IN-VITRO; CHITOSAN; PROLIFERATION; EXPRESSION; BEHAVIOR; MEMBRANE;
   SPONGE; FILMS; BEADS
C1 Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.
RP Khor, E (reprint author), Natl Univ Singapore, Dept Chem, 3 Sci Dr, Singapore 117543, Singapore.
CR Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chellat F, 2000, J BIOMED MATER RES, V53, P592, DOI 10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO;2-P
   Chellat F, 2000, J BIOMED MATER RES, V51, P107, DOI 10.1002/(SICI)1097-4636(200007)51:1<107::AID-JBM14>3.0.CO;2-F
   CHEMITE A, 2000, BIOMATERIALS, V21, P2155
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Dillon GP, 2000, J BIOMED MATER RES, V51, P510, DOI 10.1002/1097-4636(20000905)51:3<510::AID-JBM28>3.0.CO;2-G
   Gupta KC, 2000, BIOMATERIALS, V21, P1115, DOI 10.1016/S0142-9612(99)00263-X
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Jarry C, 2001, J BIOMED MATER RES, V58, P127, DOI 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
   Kato Y, 2000, BIOMATERIALS, V21, P1579, DOI 10.1016/S0142-9612(00)00044-2
   KHOR E, 2001, CHITIN FULFILLING BI, pCH9
   KHOR E, 2001, CHITIN FULFILLING BI, pCH3
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Ozmeric N, 2000, J BIOMED MATER RES, V51, P500, DOI 10.1002/1097-4636(20000905)51:3<500::AID-JBM26>3.0.CO;2-P
   Park SB, 2001, BIOMATERIALS, V22, P323, DOI 10.1016/S0142-9612(00)00187-3
   Park YJ, 2000, BIOMATERIALS, V21, P153
   Qu X, 2000, J BIOMED MATER RES, V52, P492, DOI 10.1002/1097-4636(20001205)52:3<492::AID-JBM7>3.0.CO;2-9
   Risbud MV, 2001, J BIOMED MATER RES, V57, P300, DOI 10.1002/1097-4636(200111)57:2<300::AID-JBM1171>3.0.CO;2-Q
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4
   van der Lubben IM, 2001, BIOMATERIALS, V22, P687, DOI 10.1016/S0142-9612(00)00231-3
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.3.CO;2-6
   Yan XL, 2001, J BIOMED MATER RES, V58, P358, DOI 10.1002/jbm.1029
   Yusof NLBM, 2001, J BIOMED MATER RES, V54, P59, DOI 10.1002/1097-4636(200101)54:1<59::AID-JBM7>3.0.CO;2-U
   Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 31
TC 88
Z9 89
U1 1
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD AUG
PY 2002
VL 6
IS 4
BP 313
EP 317
AR PII S1359-0286(02)00002-5
DI 10.1016/S1359-0286(02)00002-5
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 634AN
UT WOS:000180318000005
DA 2018-10-19
ER

PT J
AU Kenefick, NJ
   Vaizey, CJ
   Malouf, AJ
   Norton, CS
   Marshall, M
   Kamm, MA
AF Kenefick, NJ
   Vaizey, CJ
   Malouf, AJ
   Norton, CS
   Marshall, M
   Kamm, MA
TI RETRACTED: Injectable silicone biomaterial for faecal incontinence due
   to internal anal sphincter dysfunction (Retracted Article. See vol 55,
   pg 1824, 2006)
SO GUT
LA English
DT Article; Retracted Publication
ID AUTOLOGOUS FAT; INJECTION; MICROIMPLANTS; PRESSURE
AB Background: A weak or disrupted internal anal sphincter can cause passive faecal incontinence. Conservative measures may help some patients but there is no simple surgical solution for those who fail conservative treatment. A successful technique using trans-sphincteric injection of a bulking agent to augment the internal anal sphincter was developed in a previous pilot study.
   Aim: To determine the clinical results and underlying physiological effects of biomaterial injection.
   Patients: Six patients (four males, median age 53 years (range 36-65)) with faecal incontinence to solid or liquid stool related to poor internal anal sphincter function, of varied aetiology, were recruited.
   Methods: Silicone based biomaterial injections were performed, under local anaesthesia, with antibiotic cover. Three injections were placed circumferentially, trans-sphincterically, entering away from the anal margin and injecting at or just above the dentate line. Anorectal physiological studies, endoanal ultrasound, a bowel symptom diary, a validated incontinence score, and quality of life questionnaires were completed before treatment and on completion of follow up.
   Results: At a median follow up of 18 months (range 15-19), five of six patients had marked symptom. improvement. Faecal incontinence scores improved from a median of 14/24 (range 11-20) before to 8/24 (6-15) after injection. Short form-36 quality of life physical and social function scores improved from a median of 26/100 (5-33) to 79/100 (25-100) and from 10/100 (5-37) to 100/100 (50100), respectively. There was a corresponding physiological increase in maximum anal resting and squeeze pressures. Ultrasound showed the Bioplastique to be retained in the correct position in the improved patients without migration. There were no complications.
   Conclusion: Trans-sphincteric injection of silicone biomaterial can provide a marked improvement in faecal incontinence related to a weak or disrupted internal anal sphincter. This is associated with improved sphincter function and quality of life.
C1 St Marks Hosp, London EC1V 2PS, England.
RP Kamm, MA (reprint author), St Marks Hosp, Watford Rd, Harrow HA1 3UJ, Middx, England.
EM kamm@ic.ac.uk
CR Baeten GMI, 2000, DIS COLON RECTUM, V43, P743, DOI 10.1007/BF02238008
   BEISANG AA, 1992, AESTHET PLAST SURG, V16, P83, DOI 10.1007/BF00455154
   Bernardi C, 1998, PLAST RECONSTR SURG, V102, P1626, DOI 10.1097/00006534-199810000-00046
   BURNETT SJD, 1991, INT J COLORECTAL DIS, V6, P2, DOI 10.1007/BF00703951
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   ENGEL AF, 1994, GUT, V35, P857, DOI 10.1136/gut.35.6.857
   ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P693, DOI 10.1097/00006534-199104000-00014
   FRENCKNER B, 1975, GUT, V16, P482, DOI 10.1136/gut.16.6.482
   GARCIAAGUILAR J, 1999, DIS COLON RECTUM, V42, P687
   GIBBONS CP, 1986, INT J COLORECTAL DIS, V1, P231, DOI 10.1007/BF01648344
   Harriss DR, 1996, BRIT J UROL, V78, P722, DOI 10.1046/j.1464-410X.1996.17510.x
   JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437
   Kumar D, 1998, BRIT J SURG, V85, P978
   LAW PJ, 1989, GASTROINTEST RADIOL, V14, P349, DOI 10.1007/BF01889235
   Lehur PA, 1998, INT J COLORECTAL DIS, V13, P88, DOI 10.1007/s003840050141
   Leroi AM, 1997, INT J COLORECTAL DIS, V12, P243, DOI 10.1007/s003840050098
   LESTAR B, 1992, INT J COLORECTAL DIS, V7, P159, DOI 10.1007/BF00360358
   LESTAR B, 1989, INT J COLORECTAL DIS, V4, P118, DOI 10.1007/BF01646870
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   Malouf AJ, 2000, ANN SURG, V232, P143, DOI 10.1097/00000658-200007000-00020
   Morgan R, 1997, BRIT J SURG, V84, P226, DOI 10.1002/bjs.1800840225
   SAINIO P, 1985, ACTA CHIR SCAND, V151, P695
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
NR 26
TC 52
Z9 55
U1 3
U2 12
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD AUG
PY 2002
VL 51
IS 2
BP 225
EP 228
DI 10.1136/gut.51.2.225
PG 4
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 577XK
UT WOS:000177088100019
PM 12117884
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Katz, SL
AF Katz, SL
TI Design of heterothermic muscle in fish
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Review
DE fish; swimming; biomechanics; evolution; heterothermy; muscle
ID TUNA SWIMMING PERFORMANCE; LARGE WATER TUNNEL; RED MUSCLE; POWER OUTPUT;
   CONTRACTILE PROPERTIES; SCOMBRID FISHES; MYOXOCEPHALUS-SCORPIUS;
   MECHANICAL-PROPERTIES; STENOTOMUS CHRYSOPS; AEROBIC CAPACITY
AB Among the tremendous diversity of fish, there are a small number that are considered elite in their swimming performance. These include representatives from the tunas, billfish and sharks. In addition to being elite swimmers, these fish share numerous specialized anatomical features including the structure of their swimming muscles and some form of regional endothermy, termed heterothermy. These heterothermies fall into two classes: those that maintain elevated temperatures in swimming muscles and those that have muscle-derived tissues specialized for delivering warm blood to the brain. Because these versions of heterothermy are manifest in fish whose swimming performance is considered elite, it has been parsimonious to hypothesize that heterothermy is part of an integrated high-performance design. Recognizing that the design of skeletal muscle is hierarchical, the design of heterothermic muscle in fish will be examined within a hierarchical framework. This paper will examine, in order, the specific anatomical specializations, the performance of muscle as a biomaterial and then as a dynamic mechanical structure or device - in each case looking at the extent to which heterothermy is part of an integrated high-performance design or is perhaps just a happy accident. This examination will reveal how difficult it is to make a case for the central importance of heterothermy in the design of these swimming muscle systems.
C1 NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.
RP Katz, SL (reprint author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, 2725 Montlake Blvd E, Seattle, WA 98112 USA.
CR ALEXANDE.RM, 1969, J MAR BIOL ASSOC UK, V49, P263, DOI 10.1017/S0025315400035906
   ALTRINGHAM JD, 1990, J EXP BIOL, V148, P395
   Altringham JD, 1997, J EXP BIOL, V200, P2617
   ALTRINGHAM JD, 1993, J EXP BIOL, V182, P191
   ALTRINGHAM JD, 2001, FISH PHYSIOL, V19, P314
   BEDDOW TA, 1995, J EXP BIOL, V198, P193
   Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6
   BIEWENER AA, 1988, J EXP BIOL, V137, P191
   Biewener AA, 1999, J EXP BIOL, V202, P3387
   BLOCK BA, 1993, SCIENCE, V260, P210, DOI 10.1126/science.8469974
   BLOCK BA, 1991, AM ZOOL, V31, P726
   BONE Q, 1966, J MAR BIOL ASSOC UK, V46, P321, DOI 10.1017/S0025315400027168
   Bone Q., 1995, BIOL FISHES
   Bone Q, 1978, FISH PHYSIOL, P361
   Breen EC, 1996, J APPL PHYSIOL, V81, P355
   BRETT JR, 1973, J FISH RES BOARD CAN, V30, P379, DOI 10.1139/f73-068
   BRILL RW, 1979, J FISH BIOL, V15, P679, DOI 10.1111/j.1095-8649.1979.tb03677.x
   BRILL RW, 2000, HOT WATER TEMPERATUR
   CAREY FG, 1973, SCI AM, V228, P36, DOI 10.1038/scientificamerican0273-36
   CAREY FG, 1966, P NATL ACAD SCI USA, V56, P1464, DOI 10.1073/pnas.56.5.1464
   CAREY FG, 1982, COPEIA, P254
   CAREY FG, 1969, COMP BIOCHEM PHYSIOL, V28, P199, DOI 10.1016/0010-406X(69)91335-8
   CAREY FG, 1982, SCIENCE, V216, P1327, DOI 10.1126/science.7079766
   Coughlin DJ, 1996, J EXP BIOL, V199, P459
   Coughlin DJ, 1996, AM ZOOL, V36, P666
   Coughlin DJ, 1996, J EXP BIOL, V199, P2703
   D'Aout K, 1999, J EXP BIOL, V202, P1511
   DEWAR H, 1994, J EXP BIOL, V192, P33
   DEWAR H, 1994, J EXP BIOL, V192, P13
   Ellerby DJ, 2000, J EXP BIOL, V203, P2001
   Fierstine H., 1968, MEM STH CALIF ACAD S, V6, P1
   FUDGE DS, 1996, GUELPH ICHTHYOL REV, V4, P1
   Gillis GB, 1998, J EXP BIOL, V201, P3245
   GOODING RM, 1981, FISH B-NOAA, V79, P31
   Graham J.B., 1983, P248
   GRAHAM JB, 1989, EXP BIOL, V48, P89
   GRAHAM JB, 1975, FISH B-NOAA, V73, P219
   Graham JB, 2000, ZOOL J LINN SOC-LOND, V129, P419, DOI 10.1006/zjls.1998.0211
   GRAHAM JB, 1983, CAN J ZOOL, V61, P2087, DOI 10.1139/z83-274
   Hammond L, 1998, J EXP BIOL, V201, P1659
   HAYES JP, 1995, EVOLUTION, V49, P836, DOI 10.1111/j.1558-5646.1995.tb02320.x
   HEBRANK MR, 1986, BIOL BULL, V171, P236, DOI 10.2307/1541920
   HEBRANK MR, 1980, BIOL BULL, V158, P58, DOI 10.2307/1540758
   HESS F, 1984, J EXP BIOL, V109, P229
   JAYNE BC, 1995, J EXP BIOL, V198, P585
   JAYNE BC, 1995, J EXP BIOL, V198, P805
   JOHNSON TP, 1991, J EXP BIOL, V157, P409
   JOHNSON TP, 1991, J COMP PHYSIOL B, V161, P27, DOI 10.1007/BF00258743
   JOHNSON TP, 1994, AM J PHYSIOL, V267, pR481
   JOHNSRUDE CL, 1985, J EXP BIOL, V119, P71
   Johnston I.A., 1983, P36
   JOHNSTON IA, 1993, J EXP BIOL, V185, P251
   JOHNSTON IA, 1974, CAN J ZOOL, V52, P871, DOI 10.1139/z74-118
   JOSEPHSON RK, 1985, J EXP BIOL, V114, P493
   KAFUKU T, 1950, GYORUIGAKI ZASSHI, V1, P89
   Katz B, 1939, J PHYSIOL-LONDON, V96, P45, DOI 10.1113/jphysiol.1939.sp003756
   Katz S. L., 2000, SKELETAL MUSCLE MECH, P475
   Katz SL, 1999, J EXP BIOL, V202, P529
   Katz SL, 2001, NATURE, V410, P770, DOI 10.1038/35071170
   Katz SL, 1998, J THEOR BIOL, V193, P243, DOI 10.1006/jtbi.1998.0696
   KATZ SL, 1997, P 10 INT S UNM UNT S, P135
   Kishinouye K., 1923, Journal of the College of Agriculture Tokyo, V8, P293
   Knower T, 1999, J EXP BIOL, V202, P2127
   Korsmeyer KE, 1996, COMP BIOCHEM PHYS A, V113, P17, DOI 10.1016/0300-9629(95)02061-6
   Korsmeyer KE, 1997, J EXP BIOL, V200, P1975
   Lai NC, 1997, COPEIA, P424, DOI 10.2307/1447765
   LANGFELD KS, 1989, J EXP BIOL, V144, P437
   Long JH, 1996, J EXP BIOL, V199, P2139
   LUCAS MC, 1993, J EXP BIOL, V175, P325
   MOTTA PJ, 1977, COPEIA, P454, DOI 10.2307/1443263
   MULLER UK, 1991, J MAR BIOL ASSOC UK, V71, P738
   NURSALL J. R., 1956, PROC ZOOL SOC LONDON, V126, P127
   OHMENS JH, 1993, J BIOMECH, V26, P665
   RAYNER MD, 1967, NATURE, V214, P392, DOI 10.1038/214392a0
   Richardson RS, 1999, AM J PHYSIOL-HEART C, V277, pH2247, DOI 10.1152/ajpheart.1999.277.6.H2247
   ROME LC, 1993, SCIENCE, V261, P340, DOI 10.1126/science.8332898
   ROME LC, 1992, J EXP BIOL, V163, P281
   ROME LC, 1992, J EXP BIOL, V163, P259
   ROME LC, 1992, J EXP BIOL, V171, P261
   Rome LC, 1984, AM J PHYSIOL, V247, P272
   Rome LC, 1999, J EXP BIOL, V202, P333
   Shadwick RE, 1998, AM ZOOL, V38, P755
   Shadwick RE, 1999, J EXP BIOL, V202, P2139
   STEVENS ED, 1988, J MUSCLE RES CELL M, V9, P329, DOI 10.1007/BF01773876
   STEVENS ED, 1978, FISH PHYSIOL, V7, P316
   TAIGEN TL, 1983, AM NAT, V121, P94, DOI 10.1086/284041
   van Leeuwen J.L., 1992, Advances in Comparative and Environmental Physiology, V11, P191
   Videler J. J., 1993, FISH SWIMMING
   Wagner PD, 2000, ACTA PHYSIOL SCAND, V168, P609, DOI 10.1046/j.1365-201x.2000.00712.x
   Wainwright S.A., 1983, P68
   WARDLE CS, 1993, J FISH BIOL, V42, P347
   WARDLE CS, 1995, J EXP BIOL, V198, P1629
   Webb PW, 1975, B FISH RES BOARD CAN, V190, P1
   WESTNEAT MW, 1993, J MORPHOL, V217, P183, DOI 10.1002/jmor.1052170207
   Willemse J. J., 1966, P K NED AKAD C BIOL, V69, P58
   Young WC, 1989, ROARKS FORMULAS STRE
NR 96
TC 29
Z9 29
U1 2
U2 34
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
J9 J EXP BIOL
JI J. Exp. Biol.
PD AUG
PY 2002
VL 205
IS 15
BP 2251
EP 2266
PG 16
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 586XU
UT WOS:000177612100013
PM 12110659
DA 2018-10-19
ER

PT J
AU Gottenbos, B
   Busscher, HJ
   van der Mei, HC
AF Gottenbos, B
   Busscher, HJ
   van der Mei, HC
TI Pathogenesis and prevention of biomaterial centered infections
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID FOREIGN-BODY INFECTION; BACTERIAL ADHESION; TOTAL HIP; VOICE PROSTHESES;
   IN-VIVO; SURFACES; BIOCOMPATIBILITY; TRANSLOCATION; COLONIZATION;
   POLYMERS
AB One of the major drawbacks in the use of biomedical materials is the occurrence of biomaterials centered infections. After implantation, the host interacts with a biomaterial by forming a conditioning film on its surface and an immune reaction towards the foreign material. When microorganisms can reach the biomaterials surface they can adhere to it. Adhesion of microorganisms to an implant is mediated by their physico-chemical surface properties and the properties of the biomaterials surface itself. Subsequent surface growth of the microorganisms will lead to a mature biofilm and infection, which is difficult to eradicate by antibiotics. The purpose of this review is to give an overview of the mechanisms involved in biomaterials centered infection and the possible methods to prevent these infections. (C) 2002 Kluwer Academic Publishers.
C1 Univ Groningen, Fac Med Sci, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Fac Med Sci, Dept Cell Biol & Histol, NL-9713 AV Groningen, Netherlands.
RP Busscher, HJ (reprint author), Univ Groningen, Fac Med Sci, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
CR AHLBERG A, 1978, CLIN ORTHOP RELAT R, P69
   AKIYAMA H, 1979, J UROLOGY, V121, P40, DOI 10.1016/S0022-5347(17)56652-5
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   ANDERSON JM, 1988, ASAIO T, V34, P1401
   Asaria RHY, 1999, RETINA-J RET VIT DIS, V19, P447, DOI 10.1097/00006982-199909000-00014
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   BENGTSON S, 1987, ACTA ORTHOP SCAND, V58, P529, DOI 10.3109/17453678709146393
   BERG RD, 1975, INFECT IMMUN, V11, P320
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1016/0378-1097(87)90062-0
   CARLSSON AS, 1978, J BONE JOINT SURG AM, V60, P1059, DOI 10.2106/00004623-197860080-00007
   CHARNLEY J, 1972, CLIN ORTHOP RELAT R, P167
   CHRISTENSEN GD, 1989, INFECT ASS INDWELLIN, P27
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Denstedt JD, 1998, J ENDOUROL, V12, P493, DOI 10.1089/end.1998.12.493
   Dougherty S H, 1982, Curr Probl Surg, V19, P217
   Duchmann R, 1996, EUR J IMMUNOL, V26, P934, DOI 10.1002/eji.1830260432
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   ELKENAWY R, 1998, J CONTROLED RELEASE, V50, P145
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   FITZGERALD RH, 1985, AM J MED, V78, P225, DOI 10.1016/0002-9343(85)90389-4
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   FOO MC, 1972, INFECT IMMUN, V6, P525
   GEESEY GG, 1990, ANNU REV MICROBIOL, V44, P579
   Gilbert P, 1997, Adv Dent Res, V11, P160
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GUO W, 1993, SCAND J GASTROENTERO, V28, P393, DOI 10.3109/00365529309098238
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   HUNTER G, 1977, J BONE JOINT SURG BR, V59, P293
   JACKSON JH, 1988, HEMATOL ONCOL CLIN N, V2, P317
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   LIDWELL OM, 1982, BRIT MED J, V285, P10, DOI 10.1136/bmj.285.6334.10
   MAHIEU HF, 1986, ARCH OTOLARYNGOL, V112, P321
   MANILOFF G, 1987, CLIN ORTHOP RELAT R, P194
   MAYER KH, 1982, PROG CARDIOVASC DIS, V25, P43, DOI 10.1016/0033-0620(82)90003-2
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   MORA EM, 1991, ARCH SURG-CHICAGO, V126, P157
   NICKEL JC, 1994, J ANTIMICROB CHEMOTH, V33, P31, DOI 10.1093/jac/33.suppl_A.31
   POELSTRA KA, 2000, J BIOMED MATER RES, V50, P224
   Printzen G, 1996, INJURY, V27, P9
   Rediske AM, 1999, ANTIMICROB AGENTS CH, V43, P1211, DOI 10.1128/AAC.43.5.1211
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Spijker HT, 1999, COLLOID SURFACE B, V15, P89, DOI 10.1016/S0927-7765(99)00056-9
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   van de Belt H, 1999, NAT MED, V5, P358, DOI 10.1038/7330
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   Van Oss C. J., 1991, BIOFOULING, V4, P25
   VandenHoogen FJA, 1996, ACTA OTO-LARYNGOL, V116, P119, DOI 10.3109/00016489609137724
   VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   vanWachem PB, 1997, J BIOMED MATER RES, V35, P217, DOI 10.1002/(SICI)1097-4636(199705)35:2<217::AID-JBM10>3.0.CO;2-E
   WELLS CL, 1987, ARCH SURG-CHICAGO, V122, P48
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 58
TC 81
Z9 86
U1 2
U2 22
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2002
VL 13
IS 8
BP 717
EP 722
DI 10.1023/A:1016175502756
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 572EN
UT WOS:000176760600001
PM 15348557
DA 2018-10-19
ER

PT J
AU Kumar, TRS
   Krishnan, LK
AF Kumar, TRS
   Krishnan, LK
TI Fibrin-mediated endothelial cell adhesion to vascular biomaterials
   resists shear stress due to flow
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOPROSTHETIC HEART-VALVE; GRAFTS; ATTACHMENT; SUBSTRATE; GLUE
AB In vitro endothelial cell (EC) seeding onto biomaterials for blood-contacting applications can improve the blood compatibility of materials. Adhesive proteins adsorbed from serum that is supplemented with the culture medium intercede the initial cell adhesion and subsequent spreading on material surface during culture. Nevertheless, physical and chemical properties of vascular biomaterial surface fluctuate widely between materials resulting in dissimilarity in protein adsorption characteristics. Thus, a variation is expected in cell adhesion, growth and the ability of cell to resist shear stress when tissue engineering on to vascular biomaterials is attempted. This study was carried out with an objective to determine the significance of a matrix coating on cell adhesion and shear stress resistance when cells are cultured on materials such as polytetrafluoroethylene (PTFE, Teflon) and polyethyleneterephthalate (Dacron), ultra high molecular weight polyethylene (UHMWPE) and titanium (Ti), that are used for prosthetic devices. The study illustrates the distinction of EC attachment and proliferation between uncoated and matrix-coated surfaces. The cell attachment and proliferation on uncoated UHMWPE and titanium surfaces were not significantly different from matrix-coated surfaces. However, shear stress resistance of the cells grown on composite coated surfaces appeared superior compared to the cells grown on uncoated surface. On uncoated vascular graft materials, the cell adhesion was not supported by serum alone and proliferation was scanty as compared to matrix-coated surface. Therefore, coating of implant devices with a composite of adhesive proteins and growth factors can improve EC attachment and resistance of the cells to the forces of flow. (C) 2002 Kluwer Academic Publishers.
C1 Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thrombosis Res Unit, Trivandrum 695012, Kerala, India.
RP Krishnan, LK (reprint author), Rajiv Gandhi Ctr Biotechnol, Div Canc Biol, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BENGTSSON L, 1993, EUR J CARDIO-THORAC, V7, P393, DOI 10.1016/1010-7940(93)90001-R
   Bengtsson L A, 1993, J Heart Valve Dis, V2, P352
   Bhat VD, 1998, J BIOMED MATER RES, V40, P57, DOI 10.1002/(SICI)1097-4636(199804)40:1<57::AID-JBM7>3.3.CO;2-6
   GRABENWOGER M, 1992, J CARDIAC SURG, V7, P79, DOI 10.1111/j.1540-8191.1992.tb00778.x
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   MAZZUCOTELLI JP, 1991, INT J ARTIF ORGANS, V14, P482
   MCINTIRE LV, 1992, BLOOD CONTACT NATURA, V516, P513
   Meinhart J, 1997, ASAIO J, V43, P515
   PRATT KJ, 1988, J VASC SURG, V7, P591, DOI 10.1067/mva.1988.avs0070591
   SANTHOSHKUMAR TR, IN PRESS BIOMATERIAL
   SHINOKA T, 1995, ANN THORAC SURG, V60, P513
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   WILLIAMS SK, 1985, J SURG RES, V38, P618, DOI 10.1016/0022-4804(85)90084-8
   ZILLA P, 1989, SURGERY, V105, P515
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 18
TC 13
Z9 13
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2002
VL 13
IS 8
BP 751
EP 755
DI 10.1023/A:1016162706391
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 572EN
UT WOS:000176760600005
PM 15348561
DA 2018-10-19
ER

PT J
AU Michanetzis, GPA
   Missirlis, YF
   Rhodes, NP
   Williams, DF
   Eloy, R
   Lemm, W
AF Michanetzis, GPA
   Missirlis, YF
   Rhodes, NP
   Williams, DF
   Eloy, R
   Lemm, W
TI Influence of test protocol response to model in determining the blood
   polymers
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID THROMBOSIS; COMPATIBILITY; FLOW; SUBENDOTHELIUM; SUBCOMMITTEE;
   PARAMETERS; COMMITTEE; RHEOLOGY; SURFACES; INVIVO
AB A multi-parametric, multi-center evaluation of three polymers was performed measuring their response to blood contact. The purpose of this study was to pinpoint differences in tests performed for assessing "basic" hemocompatibility on identical materials at different centers and attempt to rationalize. Assays for platelet adhesion, activation, aggregability and activation of the coagulation system in addition to an ex vivo patency assay were performed at four centers across Europe, using protocols favored by each center for determining the blood-contacting performance of a biomaterial. Three polymers were chosen for their expected blood response spanning the range of undesirable to desirable: ethylenevinylacetate (EVA), polyvinylchloride (PVC) and PVC modified with polyethylene oxide (PEO). The assays were ranked in terms of their efficacy compared to cost and simplicity. A correlation between assays was calculated, indicating the ability of one test to correctly determine the blood response compared to another. Some assays were unable to distinguish between materials, but of the assays which could, the materials were ranked in the following order: EVA; PVC; PVC-PEO, EVA producing the most undesirable response. It is concluded that many commonly used assays for determining hemocompatibility are inappropriate, but there are simple and reliable test methods available which correlate well with the more sophisticated protocols. (C) 2002 Kluwer Academic Publishers.
C1 Univ Patras, Mech & Aer Engn Dept, Biomed Engn Lab, GR-26110 Patras, Greece.
   Univ Liverpool, Dept Clin Engn, Liverpool L69 3BX, Merseyside, England.
   Biomatech, Chasse Sur Rhone, France.
   Rudolf Virchow Clin, Dept Expt Surg, Berlin, Germany.
RP Missirlis, YF (reprint author), Univ Patras, Mech & Aer Engn Dept, Biomed Engn Lab, GR-26110 Patras, Greece.
EM misirlis@mech.upatras.gr
CR ANDERSON JM, 1987, J LAB CLIN MED, V110, P666
   AQUEY C, 1991, BIORHEOLOGY, V28, P463
   BLACK J, 1981, BIOL PERFORMANCE MAT
   BRASH JL, 1991, MODERN ASPECTS OF PROTEIN ADSORPTION ON BIOMATERIALS, P39
   BUCHANAN MJ, 1998, MED DEV DIAGN IN NOV
   CAZENAVE JP, 1993, TESTS PROCEDURES BLO, P359
   COOPER SL, 1987, ANN NY ACAD SCI, V516, P572, DOI 10.1111/j.1749-6632.1987.tb33074.x
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   COURTNEY JM, 1986, BLOOD COMPATIBLE MAT, P135
   DAVIES JA, 1986, BLOOD SURFACE INTERA
   DAWIDS S, 1986, BLOOD COMPATIBLE MAT
   Dawids S. G., 1993, TEST PROCEDURES BLOO
   DEWANJEE MK, 1987, ANN NY ACAD SCI, V516, P541, DOI 10.1111/j.1749-6632.1987.tb33073.x
   DIDISHEIM P, 1984, CONT BIOMATERIALS MA, P132
   DUDLEY B, 1976, T AM SOC ART INT ORG, V22, P538
   GALLOWAY MJ, 1984, THROMB RES, V33, P229, DOI 10.1016/0049-3848(84)90184-1
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   Hill D, 1995, Med Device Technol, V6, P14
   KAPLAN KL, 1981, BLOOD, V57, P199
   KIRKPATRICK CJ, 1998, MED DEVICE TECHNOL, V1, P38
   KLINKMANN H, 1984, CONTRIB NEPHROL
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   LEMM W, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P173
   MCEVER RP, 1984, J BIOL CHEM, V259, P9799
   Michanetzis GPA, 1996, J MATER SCI-MATER M, V7, P29, DOI 10.1007/BF00121186
   MISSIRLIS Y, 1992, REFERENCE MATERIALS OF THE EUROPEAN COMMUNITIES, P157
   MISSIRLIS YF, 1993, ROLE PLATELETS BLOOD
   MULVIHILL JN, 1993, TEST PROCEDURES BLOO, P377
   Nelson KD, 1996, ASAIO J, V42, pM884, DOI 10.1097/00002480-199609000-00119
   *NIH, 1985, NIH PUBL
   Northup SJ, 1999, INT J TOXICOL, V18, P275, DOI 10.1080/109158199225431
   NOSE Y, 1991, ARTIF ORGANS, V15, P1
   Rhodes NP, 1996, BIOMATERIALS, V17, P1995, DOI 10.1016/0142-9612(96)00018-X
   RHODES NP, 1994, BIOMATERIALS, V15, P35, DOI 10.1016/0142-9612(94)90194-5
   RISSOAN MC, 1993, TEST PROCEDURES BLOO, P461
   SAKARIASSEN KS, 1980, THROMB RES, V19, P547, DOI 10.1016/0049-3848(80)90027-4
   SALZMAN EW, 1971, BLOOD-J HEMATOL, V38, P509
   Schulze T, 1983, Life Support Syst, V1 Suppl 1, P231
   SHUMAKOV VI, 1984, T AM SOC ART INT ORG, V30, P137
   SLACK SM, 1994, THROMB HAEMOSTASIS, V72, P777
   TURITTO VT, 1979, J RHEOL, V23, P735, DOI 10.1122/1.549542
   TURITTO VT, 1975, T AM SOC ART INT ORG, V21, P593
   WILLIAMS DF, 1986, TECHNIQUES BIOCOMPAT
   Williams DF, 1981, BIOCOMPATIBILITY CLI
NR 45
TC 10
Z9 10
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2002
VL 13
IS 8
BP 757
EP 765
DI 10.1023/A:1016166807299
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 572EN
UT WOS:000176760600006
PM 15348562
DA 2018-10-19
ER

PT J
AU Yoon, SJ
   Yu, MA
   Sim, GS
   Kwon, ST
   Hwang, JK
   Shin, JK
   Yeo, IH
   Pyun, YR
AF Yoon, SJ
   Yu, MA
   Sim, GS
   Kwon, ST
   Hwang, JK
   Shin, JK
   Yeo, IH
   Pyun, YR
TI Screening and characterization of microorganisms with fibrinolytic
   activity from fermented foods
SO JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE fibrinolysis; fermented foods; Tempe; Enterococcus faecalis;
   antiplatelet activity
ID ENTEROCOCCUS-FAECALIS; ENZYME; PURIFICATION; COAGULATION; BLOOD;
   ENDOCARDITIS; NATTOKINASE; COMPLEMENT; KININ; JANG
AB Fibrinolytic microorganisms were screened from 42 samples of Korean fermented food (7 kinds of Chungook-jang, 14 kinds of commercial Doen-jang, 5 kinds of home-made Doen-jang, and 16 kinds of Jeot-gal), 15 samples of Japanese fermented food (5 kinds of home-made soybean paste, and 10 kinds of Natto), and 19 samples of Indonesian fermented food (Tempe) as well as starters of Meju (500 microflora from Korea, and 22 from China). Initially, I I isolates with strong fibrinolytic activity were selected for further characterization. The fibrinolytic activity of the I I isolates ranged from 89 to 199% of standard plasmin. Four strains, M51 from Korean fermented food (Meju), 1 1-1, 1 1-4, and 1 5-1 from Indonesian fermented food (Tempe), were chosen based on the degree of activity and reproducibility, and identified as Staphylococcus sciuri, Citrobacter or Enterobacter, Enterococcus faecalis, and Bacillus subtilis, respectively. The first two isolates are pathogenic strains while the latter two are considered as GRAS (Generally Recognized As Safe). Fibrinolytic activity of E faecalis, characterized and designated as BRCA-5, reached a maximum, when the producer was cultivated in M17 broth supplemented with 1.0% glucose for 5 h at 37degreesC with shaking at 180 rpm. Compared to commercial fibrinolytic enzymes, the cell-free culture supernatant of E. faecalis BRCA-5 showed stronger activity than plasmin and streptokinase, but similar degree of specific activity as nattokinase and urokinase, and it also demonstrated anticoagulant and antiplatelet activity ex vivo. These features of E. faecalis make it an attractive agent as a biomaterial for health-promoting foods.
C1 Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
   Yonsei Univ, Bioprod Res Ctr, Seoul 120749, South Korea.
   Yonsei Univ, Grad Program Biomat Sci & Engn, Seoul 120749, South Korea.
   Pulmuone Co Ltd, R&D Ctr, Seoul 120749, South Korea.
RP Pyun, YR (reprint author), Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
CR ASCH AS, 1985, BLOOD, V66, P926
   ASTRUP T, 1952, ARCH BIOCHEM BIOPHYS, V40, P346, DOI 10.1016/0003-9861(52)90121-5
   CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8
   Collen D, 2000, FIBRINOLYSIS PROTEOL, V14, P66, DOI 10.1054/fipr.2000.0070
   DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1
   DIMINNO G, 1983, J PHARMACOL EXP THER, V225, P57
   FURLAN M, 1988, FIBRINOGEN FIBRIN ST, P17
   GOGSTAD GO, 1982, BLOOD, V60, P664
   HOLSTROM B, 1968, APPL MICROBIOL, V16, P73
   HOLT JG, 1984, BERGEYS MANUAL SYSTE
   Hricak V, 1998, SCAND J INFECT DIS, V30, P540
   JACOBY GA, 1995, ANN INTERN MED, V122, P238, DOI 10.7326/0003-4819-122-3-199502010-00023
   Kim HK, 1997, J FERMENT BIOENG, V84, P307
   KIM JO, 1998, J KOREAN SOC FOOD SC, V27, P51
   Kim S.H., 1998, KOREAN J MICROBIOL, V34, P87
   Kim SH, 2000, BIOSCI BIOTECH BIOCH, V64, P1722, DOI 10.1271/bbb.64.1722
   Kim SH, 1998, KOREA SOYBEAN DIGEST, V15, P8
   Kim W, 1996, APPL ENVIRON MICROB, V62, P2482
   Kim Y. T., 1995, KOR J APPL MICROBIOL, V23, P1
   Lee SK, 1998, KOR J APPL MICROBIOL, V26, P226
   Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226
   Milbrandt E, 1998, CLIN CARDIOL, V21, P123, DOI 10.1002/clc.4960210211
   MURANO G, 1978, AM J HEMATOL, V4, P409, DOI 10.1002/ajh.2830040412
   NAIDU AS, 1999, CRIT REV FOOD SCI NU, V38, P13
   NIEUWENHUIS HK, 1986, BLOOD, V68, P692
   *NIH, 1985, GUIDL CAR US LAB AN
   Noh K. A., 1999, KOREAN J FOOD SCI TE, V31, P219
   OZAWA A, 1986, TOKAI J EXP CLIN M S, P65
   OZAWA K, 1983, APPL ENVIRON MICROB, V45, P1513
   RALF K, 1995, THROMB RES, V78, P161
   SAMAMA MG, 1985, THROMB HAEMOSTASIS, V154, P726
   SMYTH CJ, 1974, ACTA PATH MICRO IM B, VB 82, P860
   SUMI H, 1990, ACTA HAEMATOL-BASEL, V84, P139, DOI 10.1159/000205051
   SUMI H, 1987, EXPERIENTIA, V43, P1110, DOI 10.1007/BF01956052
   SUMI H, 1995, COMP BIOCHEM PHYS B, V112, P543, DOI 10.1016/0305-0491(95)00100-X
   SUMI H, 1998, BIOINDUSTRY, V7, P725
   SUNDSMO JS, 1983, SPRINGER SEMIN IMMUN, V6, P231
   Yoo CK, 1998, KOREAN J APPL MICROB, V26, P507
   ZWIERZINA WD, 1985, THROMB RES, V38, P91, DOI 10.1016/0049-3848(85)90010-6
NR 39
TC 9
Z9 10
U1 1
U2 5
PU KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY
PI SEOUL
PA KOREA SCI TECHNOL CENTER #507,  635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1017-7825
J9 J MICROBIOL BIOTECHN
JI J. Microbiol. Biotechnol.
PD AUG
PY 2002
VL 12
IS 4
BP 649
EP 656
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 588UQ
UT WOS:000177720400018
DA 2018-10-19
ER

PT J
AU Casaletto, MP
   Kaciulis, S
   Mattogno, G
   Mezzi, A
   Ambrosio, L
   Branda, F
AF Casaletto, MP
   Kaciulis, S
   Mattogno, G
   Mezzi, A
   Ambrosio, L
   Branda, F
TI XPS characterization of biocompatible hydroxyapatite-polymer coatings
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 9th European Conference on Applications of Surface and Interface
   Analysis
CY SEP 30-OCT 05, 2001
CL AVIGNON, FRANCE
DE XPS; biomaterial; hydroxyapatite; biomimetic method; PMMA; PHEMA
ID BIOMIMETIC PROCESS; SURFACE; APATITE; TITANIUM
AB Hydroxyapatite coatings on polymeric substrates have been prepared by treating samples of poly(methyl methacrylate) (PMMA) and poly(2-hydroxyethyl methacrylate) with a biomimetic method and by producing a mechanical mixture of polymers (PMMA and poly(butylmethyl methacrylate) and hydroxyapatite (1:1). The surface chemical composition of the samples has been studied by using X-ray photoelectron spectroscopy. Both the reference polymers and the hydroxyapatite coatings have been analyzed. The surface modifications induced by interaction of the coatings with osteoblast cells have been studied as a function of the exposure time, after in vitro treatment for 7, 15 and 21 days. Quantitative XPS analysis enabled us to compare the quality of the samples and the different response to the in vitro treatment. Copyright (C) 2002 John Wiley Sons, Ltd.
C1 CNR, Inst Mat Chem, I-00016 Monterotondo, RM, Italy.
   CNR, Inst Technol Composite Mat, I-80125 Naples, Italy.
   Univ Naples Federico II, Dept Mat & Prod Engn, I-80125 Naples, Italy.
RP Casaletto, MP (reprint author), CNR, Inst Mat Chem, POB 10, I-00016 Monterotondo, RM, Italy.
RI Mezzi, Alessio/G-5137-2010; Casaletto, Maria Pia/P-6715-2017; Kaciulis,
   Saulius/G-5252-2010
OI Casaletto, Maria Pia/0000-0002-2236-5671; Kaciulis,
   Saulius/0000-0002-9868-7626; MEZZI, ALESSIO/0000-0002-2887-520X;
   AMBROSIO, LUIGI/0000-0002-8367-2405
CR Battistoni C, 2000, SURF INTERFACE ANAL, V29, P773, DOI 10.1002/1096-9918(200011)29:11<773::AID-SIA928>3.3.CO;2-U
   BRANDA F, 2001, KEY ENGI MAT, V192, P127
   Casaletto MP, 2001, APPL SURF SCI, V172, P167, DOI 10.1016/S0169-4332(00)00844-8
   CASALETTO MP, BIOMATERIALS
   CIRILLI F, 1997, P ECASIA 97, P1063
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   Ducheyne P, 1988, SURFACE CHARACTERIZA, P175
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   Kokubo T, 1999, COMPOS PART A-APPL S, V30, P405, DOI 10.1016/S1359-835X(98)00127-4
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   Kokubo T, 1997, AN QUIM, V93, P549
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   MONTENERO A, 2000, J MATER SCI, V35, P1
   MOULDER JF, 1995, HDB XRAY PHOTOELECTR, P213
   RIMONDINI L, 1999, REPORT CNR MSTA2 FIN
   SEAH MP, 1990, PRACTICAL SURFACE AN, V1, P240
   Tanahashi M., 1992, BIOCERAMICS, P57
   WAGNER CD, 1995, HDB XRAY PHOTOELECTR, P42
   WAGNER CD, 1986, SURF INTERFACE ANAL, V2, P53
   1997, HIGH RESOLUTION XPS, P15
NR 23
TC 29
Z9 30
U1 1
U2 18
PU JOHN WILEY & SONS LTD
PI W SUSSEX
PA BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD AUG
PY 2002
VL 34
IS 1
BP 45
EP 49
DI 10.1002/sia.1249
PG 5
WC Chemistry, Physical
SC Chemistry
GA 591NC
UT WOS:000177885900010
DA 2018-10-19
ER

PT J
AU Bowen, WR
   Fenton, AS
   Lovitt, RW
   Wright, CJ
AF Bowen, WR
   Fenton, AS
   Lovitt, RW
   Wright, CJ
TI The measurement of Bacillus mycoides spore adhesion using atomic force
   microscopy, simple counting methods, and a spinning disk technique
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE adhesion; atomic force microscopy; Bacillus mycoides; hydrodynamic shear
ID FLOW DETACHMENT ASSAY; BACTERIAL ADHESION; DIRECT QUANTIFICATION;
   BIOMATERIAL SURFACES; ORAL STREPTOCOCCI; ESCHERICHIA-COLI; CEREUS
   SPORES; CELL; MODEL; CONSTANT
AB An atomic force microscope has been used to study the adhesion of Bacillus mycoides spores to a hydrophilic glass surface and a hydrophobic-coated glass surface. AFM images of spores attached to the hydrophobic-coated mica surface allowed the measurement of spore dimensions in an aqueous environment without desiccation. The spore exosporium was observed to be flexible and to promote the adhesion of the spore by increasing the area of spore contact with the surface. Results from counting procedures using light microscopy matched the density of spores observed on the hydrophobic-coated glass surface with AFM. However, no spores were observed on the hydrophilic glass surface with AFM, a consequence of the weaker adhesion of the spores at this surface. AFM was also used to quantify directly the interactions of B. mycoides spores at the two surfaces in an aqueous environment. The measurements used "spore probes" constructed by immobilizing a single spore at the apex of a tipless AFM cantilever. The data showed that stretching and sequential bond breaking occurred as the spores were retracted from the hydrophilic glass surface. The greatest spore adhesion was measured at the hydrophobic-coated glass surface. An attractive force on the spores was measured as the spores approached the hydrophobic-coated surface. At the hydrophilic glass surface, only repulsive forces were measured during the approach of the spores. The AFM force measurements were in qualitative agreement with the results of a hydrodynamic shear adhesion assay that used a spinning disk technique. Quantitatively, AFM measurements of adhesive force were up to 4 x 10(3) times larger than the estimates made using the spinning disk data. This is a consequence of the different types of forces applied to the spore in the different adhesion assays. AFM has provided some unique insights into the interactions of spores with surfaces. No other instrument can make such direct measurements for single microbiological cells. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Wales Swansea, Dept Chem & Biol Proc Engn, Ctr Complex Fluids Proc, Swansea SA2 8PP, W Glam, Wales.
RP Bowen, WR (reprint author), Univ Wales Swansea, Dept Chem & Biol Proc Engn, Ctr Complex Fluids Proc, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
OI Wright, Chris/0000-0003-2375-8159; Lovitt, robert/0000-0002-5587-2776
CR ALTMAN J, 1990, ACS SYM SER, V439, P240
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Andersson A, 1998, INT J FOOD MICROBIOL, V39, P93, DOI 10.1016/S0168-1605(97)00121-9
   ANDERSSON A, 1995, INT J FOOD MICROBIOL, V28, P144
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   BELLONFONTAINE MN, 1990, CELL BIOPHYS, V17, P93, DOI 10.1007/BF02989805
   BENTON ER, 1966, J FLUID MECH, V24, P781, DOI 10.1017/S0022112066001009
   Bowen WR, 2000, COLLOID SURFACE A, V173, P205, DOI 10.1016/S0927-7757(00)00566-5
   Bowen WR, 2000, J COLLOID INTERF SCI, V228, P428, DOI 10.1006/jcis.2000.6969
   Bowen WR, 1998, J COLLOID INTERF SCI, V197, P348, DOI 10.1006/jcis.1997.5247
   Bowen WR, 1999, J MEMBRANE SCI, V154, P205
   Bowen WR, 1998, COLLOID SURFACE A, V136, P231, DOI 10.1016/S0927-7757(97)00243-4
   Bower CK, 1999, INT J FOOD MICROBIOL, V50, P33, DOI 10.1016/S0168-1605(99)00075-6
   Brown KL, 2000, BRIT MED BULL, V56, P158, DOI 10.1258/0007142001902860
   Casey E, 2000, BIOTECHNOL BIOENG, V67, P476, DOI 10.1002/(SICI)1097-0290(20000220)67:4<476::AID-BIT11>3.3.CO;2-U
   Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P857, DOI 10.1016/S0006-3495(90)82431-0
   COZENSROBERTS C, 1990, BIOPHYS J, V58, P107, DOI 10.1016/S0006-3495(90)82357-2
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Grantham MC, 1996, GEOCHIM COSMOCHIM AC, V60, P2473, DOI 10.1016/0016-7037(96)00155-X
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   HOH JH, 1994, J CELL SCI, V107, P1105
   HUSMARK U, 1990, J APPL BACTERIOL, V69, P557, DOI 10.1111/j.1365-2672.1990.tb01548.x
   Husmark U, 1992, BIOFOULING, V5, P335
   Lele SS, 1996, BIOTECHNOL LETT, V18, P515, DOI 10.1007/BF00140195
   LUCKHAM PF, 1994, ADV COLLOID INTERFAC, V49, P341, DOI 10.1016/0001-8686(94)80019-7
   Ming F, 1998, ENZYME MICROB TECH, V22, P94, DOI 10.1016/S0141-0229(97)00136-1
   ONEILL ME, 1968, CHEM ENG SCI, V23, P1293, DOI 10.1016/0009-2509(68)89039-6
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Otto K, 1999, J BACTERIOL, V181, P5210
   PARAPURA V, 1993, J VAC SCI TECHNOL A, V11, P773
   PRATTTERPSTRA IH, 1988, CURR MICROBIOL, V16, P311, DOI 10.1007/BF01568537
   Razatos A, 1998, J BIOMAT SCI-POLYM E, V9, P1361, DOI 10.1163/156856298X00442
   ROBERTS CJ, 1993, NANOBIOLOGY, V2, P73
   RONNER U, 1990, J APPL BACTERIOL, V69, P550, DOI 10.1111/j.1365-2672.1990.tb01547.x
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   SJOLLEMA J, 1990, J ADHES SCI TECHNOL, V4, P765, DOI 10.1163/156856190X00658
   Sosa-Gomez DR, 1998, J INVERTEBR PATHOL, V71, P115, DOI 10.1006/jipa.1997.4716
   STAMATAKIS K, 1993, AICHE J, V39, P1292, DOI 10.1002/aic.690390805
   Svensson B, 1999, INT DAIRY J, V9, P903, DOI 10.1016/S0958-6946(00)00014-5
   Thoumine O, 1996, CELL MOTIL CYTOSKEL, V33, P276
   Toikka G, 1996, J COLLOID INTERF SCI, V180, P329, DOI 10.1006/jcis.1996.0311
   TURNBULL PCB, 1994, BACTERIOLOGY, P349
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   Veeramasuneni S, 1996, J COLLOID INTERF SCI, V184, P594, DOI 10.1006/jcis.1996.0656
NR 48
TC 68
Z9 68
U1 3
U2 27
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUL 20
PY 2002
VL 79
IS 2
BP 170
EP 179
DI 10.1002/bit.10321
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 564XX
UT WOS:000176339800006
PM 12115433
DA 2018-10-19
ER

PT J
AU Hodde, J
   Hiles, M
AF Hodde, J
   Hiles, M
TI Virus safety of a porcine-derived medical device: Evaluation of a viral
   inactivation method
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE small intestinal submucosa; SIS; peracetic acid; ethanol; sterilization
ID SMALL-INTESTINAL SUBMUCOSA; PERACETIC-ACID; CALCIFICATION; AUGMENTATION;
   EFFICACY; MODEL
AB The goal of this study was to evaluate the efficacy of a virus-inactivating process for use during the preparation of porcine-derived extracellular matrix biomaterials for human clinical implantation. Porcine small intestine, the source material for the tissue-engineered, small intestinal submucosa (SIS) biomaterial, was evaluated. Relevant enveloped, non-enveloped, and model viruses representative of different virus families were included in the investigation: porcine parvovirus (PPV), porcine reovirus, murine leukemia retrovirus (LRV), and porcine pseudorabies (herpes) virus (PRV). Samples of small intestine were deliberately inoculated with approximately 1 x 10(7) plaque-forming units (PFU) of virus which were thereafter exposed to a 0.18% peracetic acid/4.8% aqueous ethanol mixture for time periods ranging from 5 minutes to 2 hours. Enveloped viruses were more easily inactivated than non-enveloped viruses, but material processed for 30 minutes or longer inactivated all of the viruses. D-10 values were calculated and used to extrapolate the extent of inactivation after 2 hours. Viral titers were reduced by more than 14.0 log(10) PPV, 21.0 log(10) reovirus, 40.0 log(10) PRV, and 27.0 log(10) LRV, meeting international standards for viral sterility. These results demonstrate that treatment of porcine small intestine with a peracetic acid/ethanol solution leads to a virus-free, non-crosslinked biomaterial safe for xeno-transplantation into humans. (C) 2002 Wiley Periodicals, Inc.
C1 Cook Biotech Inc, W Lafayette, IN 47906 USA.
RP Hodde, J (reprint author), Cook Biotech Inc, 3055 Kent Ave, W Lafayette, IN 47906 USA.
CR Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   Calvano CJ, 2000, J ENDOUROL, V14, P213, DOI 10.1089/end.2000.14.213
   Cronmiller JR, 1999, GASTROINTEST ENDOSC, V50, P152, DOI 10.1016/S0016-5107(99)70217-8
   Hodde JP, 2001, WOUNDS, V13, P195
   HODDE JP, 2002, IN PRESS TISSUE ENG, V8
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   KLINE LB, 1960, AM J CLIN PATHOL, V33, P30
   Knoll LD, 2001, UROLOGY, V57, P753, DOI 10.1016/S0090-4295(00)01079-7
   KROPP BP, 1995, ADV EXP MED BIOL, V385, P229
   Li ZL, 1999, J VIROL METHODS, V81, P47, DOI 10.1016/S0166-0934(99)00064-6
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   Nimni ME, 1997, J BIOMED MATER RES, V35, P531
   Owen TJ, 1997, J SURG RES, V71, P179, DOI 10.1006/jsre.1997.5148
   Pruss A, 1999, BIOLOGICALS, V27, P195, DOI 10.1006/biol.1999.0177
   Sherr C J, 1979, Methods Enzymol, V58, P412
   WERNER HP, 1973, ZBL BAKT MIK HYG B, V157, P387
   WESLEY RD, 1988, VET MICROBIOL, V18, P197, DOI 10.1016/0378-1135(88)90087-9
   Wieler LH, 2001, J VET MED B, V48, P151, DOI 10.1046/j.1439-0450.2001.00431.x
   Wutzler P, 2000, J HOSP INFECT, V46, P304, DOI 10.1053/jhin.2000.0850
   YASUHARA H, 1989, JPN J VET SCI, V51, P337
NR 22
TC 55
Z9 61
U1 2
U2 14
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUL 20
PY 2002
VL 79
IS 2
BP 211
EP 216
DI 10.1002/bit.10281
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 564XX
UT WOS:000176339800010
PM 12115437
DA 2018-10-19
ER

PT J
AU Yuan, GL
   Kuramoto, N
   Su, SJ
AF Yuan, GL
   Kuramoto, N
   Su, SJ
TI Template synthesis of polyaniline in the presence of phosphomannan
SO SYNTHETIC METALS
LA English
DT Article
DE polyaniline; phosphomannan; aqueous solution; template polymerization
ID CHEMICAL OXIDATIVE POLYMERIZATION; CONDUCTING POLYANILINE; SUBSTITUTED
   POLYANILINE; ANILINE; ACID); SALTS
AB The synthesis of a water-soluble and conducting polyaniline (PANI)-phosphomannan (PMa) complex is presented. Chemical polymerization of aniline was carried out in the presence of PMa, a novel polymeric phosphoric acid and a kind of biomaterial. It was found that the extent of polymerization was affected greatly by initial molar ratio of aniline to PMa in reaction media. A water-soluble and conducting PANI-PMa complex has been obtained under suitable conditions and it exhibited a maximum conductivity by appropriate control of molar ratio of aniline to PMa. The synthesized PANI was characterized by UV-VIS, Fourier transform infrared spectrometer (FT-IR), thermogravimetric analysis (TGA) and inherent viscosity. TGA showed that PANI-PMa complex has highly thermal stability, which was also confirmed by conductivity measurement after exposing the casting films at high temperature. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Yamagata Univ, Grad Sch Sci & Engn, Grad Program Human Sensing & Funct Sensor ENgn, Jonan 4-3-16, Yonezawa, Yamagata 992, Japan.
RP Kuramoto, N (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Grad Program Human Sensing & Funct Sensor ENgn, Jonan 4-3-16, Yonezawa, Yamagata 992, Japan.
EM kuramoto@dip.yz.yamagata-u.ac.jp
RI Su, Shi-Jian/A-2036-2013
CR Adams PN, 1996, POLYMER, V37, P3411, DOI 10.1016/0032-3861(96)88489-8
   CAO Y, 1993, POLYMER, V34, P3139, DOI 10.1016/0032-3861(93)90381-J
   CAO Y, 1992, SYNTHETIC MET, V48, P91, DOI 10.1016/0379-6779(92)90053-L
   CHAN HSO, 1995, J AM CHEM SOC, V117, P8517, DOI 10.1021/ja00138a004
   CHEN SA, 1995, J AM CHEM SOC, V117, P10055, DOI 10.1021/ja00145a017
   Chen SA, 1996, MACROMOLECULES, V29, P3950, DOI 10.1021/ma951783p
   CHEVALIER JW, 1992, MACROMOLECULES, V25, P3325, DOI 10.1021/ma00039a001
   CHIANG JC, 1986, SYNTHETIC MET, V13, P193, DOI 10.1016/0379-6779(86)90070-6
   Davey JM, 2000, MACROMOLECULES, V33, P7044, DOI 10.1021/ma000206k
   DEARMITT C, 1993, POLYMER, V34, P158, DOI 10.1016/0032-3861(93)90299-P
   DEBERRY DW, 1985, J ELECTROCHEM SOC, V132, P1022, DOI 10.1149/1.2114008
   Geng YH, 1999, POLYMER, V40, P5723, DOI 10.1016/S0032-3861(99)00134-2
   GENIES EM, 1990, SYNTHETIC MET, V36, P139, DOI 10.1016/0379-6779(90)90050-U
   GOSPODINOVA N, 1993, POLYMER, V34, P2438, DOI 10.1016/0032-3861(93)90835-X
   GUSTAFSSON G, 1992, NATURE, V357, P477, DOI 10.1038/357477a0
   JELLE BP, 1993, J ELECTROCHEM SOC, V140, P3560, DOI 10.1149/1.2221126
   KULSZEWICZBAJER I, 1995, MACROMOLECULES, V28, P610, DOI 10.1021/ma00106a028
   Kuramoto N, 1997, POLYMER, V38, P3055, DOI 10.1016/S0032-3861(96)00861-0
   Liu W, 1999, J AM CHEM SOC, V121, P71, DOI 10.1021/ja982270b
   LUI W, 1999, J AM CHEM SOC, V121, P11345
   MACDIARMID AG, 1989, FARADAY DISCUSS, V88, P495
   Nagarajan R, 2000, MACROMOLECULES, V33, P9542, DOI 10.1021/ma000954+
   NAKAJIMA T, 1989, SYNTHETIC MET, V28, pC629
   NALWA HS, 1997, HDB ORGANIC CONDUCTI, V2, P534
   OSTERHOLM JE, 1993, SYNTHETIC MET, V55, P1034, DOI 10.1016/0379-6779(93)90195-3
   Paul RK, 1999, SYNTHETIC MET, V104, P189, DOI 10.1016/S0379-6779(99)00063-6
   SHANNON K, 1994, J CHEM SOC CHEM COMM, P643, DOI 10.1039/c39940000643
   SLODKI ME, 1972, P 4 IFS FERM TECHN T, P597
   Stejskal J, 1996, POLYMER, V37, P367, DOI 10.1016/0032-3861(96)81113-X
   Wei XL, 1996, J AM CHEM SOC, V118, P2545, DOI 10.1021/ja952277i
   Yue J., 1990, J AM CHEM SOC, V112, P2800, DOI DOI 10.1021/JA00163A051
   ZHENG WY, 1994, MACROMOLECULES, V27, P7754, DOI 10.1021/ma00104a034
NR 32
TC 32
Z9 36
U1 1
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0379-6779
J9 SYNTHETIC MET
JI Synth. Met.
PD JUL 10
PY 2002
VL 129
IS 2
BP 173
EP 178
AR PII S0379-6779(02)00049-8
DI 10.1016/S0379-6779(02)00049-8
PG 6
WC Materials Science, Multidisciplinary; Physics, Condensed Matter; Polymer
   Science
SC Materials Science; Physics; Polymer Science
GA 580GK
UT WOS:000177226700010
DA 2018-10-19
ER

PT J
AU Jones, DB
   Middelberg, APJ
AF Jones, DB
   Middelberg, APJ
TI Micromechanical testing of interfacial protein networks demonstrates
   ensemble behavior characteristic of a nanostructured biomaterial
SO LANGMUIR
LA English
DT Article
ID OIL-WATER INTERFACE; SELF-ASSEMBLED MONOLAYERS; MONTE-CARLO SIMULATION;
   LIQUID INTERFACES; MILK-PROTEINS; DILATATIONAL PROPERTIES; COMPETITIVE
   ADSORPTION; AIR/WATER INTERFACE; BETA-LACTOGLOBULIN; SHEAR PROPERTIES
AB We develop and use novel instrumentation, the Cambridge Interfacial Tensiometer (CIT), to characterize the micromechanical response of a beta-lactoglobulin network adsorbed at the air-water interface. The technique is an interfacial two-dimensional analogy of conventional materials testing methodology but is conducted with high spatial resolution and requires the measurement of micro-Newton forces. Here we characterize interfacially adsorbed networks using an elasticity modulus (Et) derived from the gradient of the stress-strain plot at low strain. Measured Et values were of order 200 mN/m at the air-water interface, consistent with a calculated ensemble average estimated using atomic force microscopy derived data on the unfolding of individual protein molecules, Hydrophobic intermolecular interactions were identified as a possible dominant mechanism by which networks transmit force laterally in the interfacial plane. Covalent disulfide linkages did not significantly contribute to network rigidity in these tests, as the addition of the reducing agent dithiothreitol did not affect force transmission. Networks demonstrated a clear ability for "repair" that is dependent on bulk protein concentration and hence the rate of transport into the interfacial region during tensile testing. Importantly, this study suggests that network mechanical response is determined by residual protein tertiary structure and that adsorbed networks should therefore be analyzed as nanostructured biomaterials. The CIT technique complements existing surface rheology approaches for the characterization of interfacial protein networks and advantageously does not require a priori assumptions about network properties and behavior.
C1 Univ Cambridge, Dept Chem Engn, Cambridge CB2 3RA, England.
RP Middelberg, APJ (reprint author), Univ Cambridge, Dept Chem Engn, Pembroke St, Cambridge CB2 3RA, England.
RI Middelberg, Anton/B-2434-2013
CR Abel AP, 1996, ANAL CHEM, V68, P2905, DOI 10.1021/ac960071+
   Anderson RE, 2000, J CHEM PHYS, V112, P9167, DOI 10.1063/1.481537
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BENJAMINS J, 1992, COLLOID SURFACE, V65, P161, DOI 10.1016/0166-6622(92)80271-3
   Best RB, 2001, BIOPHYS J, V81, P2344, DOI 10.1016/S0006-3495(01)75881-X
   BISWAS B, 1963, PROC R SOC LON SER-A, V271, P296, DOI 10.1098/rspa.1963.0019
   BOYD JV, 1973, J COLLOID INTERF SCI, V45, P478, DOI 10.1016/0021-9797(73)90163-X
   Burgess DJ, 1997, J COLLOID INTERF SCI, V189, P74, DOI 10.1006/jcis.1997.4803
   Caessens PWJR, 1999, BBA-PROTEIN STRUCT M, V1430, P73, DOI 10.1016/S0167-4838(98)00274-X
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   CLARK DC, 1994, FARADAY DISCUSS, V98, P253, DOI 10.1039/fd9949800253
   Cooper A, 2000, BIOPHYS CHEM, V85, P25, DOI 10.1016/S0301-4622(00)00136-8
   COURTHAUDON JL, 1991, COLLOID SURFACE, V56, P293, DOI 10.1016/0166-6622(91)80128-B
   DICKINSON E, 1985, J COLLOID INTERF SCI, V106, P259, DOI 10.1016/0021-9797(85)90406-0
   DICKINSON E, 1992, ADV COLLOID INTERFAC, V42, P89, DOI 10.1016/0001-8686(92)80021-O
   Dickinson E, 1997, J DAIRY SCI, V80, P2607, DOI 10.3168/jds.S0022-0302(97)76218-0
   DICKINSON E, 1991, INT J BIOL MACROMOL, V13, P26, DOI 10.1016/0141-8130(91)90006-G
   DICKINSON E, 1990, INT J BIOL MACROMOL, V12, P189, DOI 10.1016/0141-8130(90)90031-5
   DICKINSON E, 1992, INTRO FOOD COLLOIDS
   Faergemand M, 1998, J AGR FOOD CHEM, V46, P884, DOI 10.1021/jf970733b
   Faergemand M, 1997, J AGR FOOD CHEM, V45, P2514, DOI 10.1021/jf9609789
   FRAGNETO G, 1995, SCIENCE, V267, P657, DOI 10.1126/science.7839141
   GRAHAM DE, 1980, J COLLOID INTERF SCI, V76, P240, DOI 10.1016/0021-9797(80)90290-8
   GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P427, DOI 10.1016/0021-9797(79)90050-X
   GRAHAM DE, 1980, J COLLOID INTERF SCI, V76, P227, DOI 10.1016/0021-9797(80)90289-1
   GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P415, DOI 10.1016/0021-9797(79)90049-3
   Hickel A, 1999, BIOTECHNOL BIOENG, V65, P425, DOI 10.1002/(SICI)1097-0290(19991120)65:4<425::AID-BIT7>3.3.CO;2-P
   Idiris A, 2000, PROTEIN ENG, V13, P763, DOI 10.1093/protein/13.11.763
   Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6
   Jones DB, 2002, CHEM ENG SCI, V57, P1711, DOI 10.1016/S0009-2509(02)00057-X
   LOEB GI, 1968, J COLLOID INTERF SCI, V27, P38, DOI 10.1016/0021-9797(68)90007-6
   Mackie AR, 1999, J COLLOID INTERF SCI, V210, P157, DOI 10.1006/jcis.1998.5941
   Makievski AV, 1997, COLLOID SURFACE A, V122, P269, DOI 10.1016/S0927-7757(96)03857-5
   MAUGUEN Y, 1982, NATURE, V297, P162, DOI 10.1038/297162a0
   MCKENZIE HA, 1972, BIOCHEMISTRY-US, V11, P4539, DOI 10.1021/bi00774a017
   Middelberg APJ, 2000, P NATL ACAD SCI USA, V97, P5054, DOI 10.1073/pnas.080042597
   Moore WJ, 1938, J CHEM PHYS, V6, P391, DOI 10.1063/1.1750274
   Petkov JT, 2000, LANGMUIR, V16, P3703, DOI 10.1021/la991287k
   POLSON A, 1950, J PHYS COLLOID CHEM, V54, P649, DOI 10.1021/j150479a007
   TERRISSE I, 1994, COLLOID SURFACE A, V91, P121, DOI 10.1016/0927-7757(94)02790-0
   Williams A, 1996, COLLOID SURFACE A, V114, P267, DOI 10.1016/0927-7757(96)03534-0
   Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098
NR 42
TC 30
Z9 30
U1 0
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUL 9
PY 2002
VL 18
IS 14
BP 5585
EP 5591
DI 10.1021/la020090g
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 569XB
UT WOS:000176627000038
DA 2018-10-19
ER

PT J
AU Guler, M
   Kologlu, M
   Kama, NA
   Renda, N
   Gozalan, U
   Yuksek, YN
   Daglar, G
AF Guler, M
   Kologlu, M
   Kama, NA
   Renda, N
   Gozalan, U
   Yuksek, YN
   Daglar, G
TI Effect of topically applied charged particles on healing of colonic
   anastomoses
SO ARCHIVES OF SURGERY
LA English
DT Article
ID SUBCUTANEOUS AUGMENTATION; INTRAABDOMINAL SEPSIS; ELECTRICAL-CURRENT;
   BEADS; STIMULATION; WOUNDS; FIELDS; ACCELERATION; BIOMATERIAL; FRACTURES
AB Hypothesis: Various forms of electrical stimulation can improve wound healing in different tissues, but their application to gastrointestinal tract healing has not been investigated. We assumed that positively charged diethylaminoethyl cross-linked dextran bead (diethylaminoethyl Sephadex [DEAE-S]) particles would have a beneficial effect on the healing of colonic anastomoses.
   Design: Experimental animal study.
   Setting: Animal research laboratory of a university hospital.
   Animals: Forty female Wistar albino rats.
   Interventions: Right colonic transection and anastomosis was performed in 5 animal groups. The control group received no treatment; the placebo group, methylcellulose gel; and the DEAE-S group, DEAE-S in methyl cellulose gel applied topically around the anastomoses. The fecal peritonitis (FP) group underwent cecal ligation and perforation simultaneously with the anastomosis to cause FP; the FP + DEAE-S group also received DEAE-S applied around the anastomoses.
   Main Outcome Measures: After the completion of postoperative day 4, all rats were killed. Anastomotic bursting pressures and hydroxyproline concentrations in perianastomotic tissue were measured and compared.
   Results: Mean bursting pressures were 115.1 mm Hg in the control group, 113.6 mm Hg in the placebo group, 159.4 mm Hg in the DEAE-S group, 62.8 mm Hg in the FP group, and 121.1 mm Hg in the FP + DEAE-S group (P=.001, 1-way analysis of variance [ANOVA]). The differences between the control vs DEAE-S groups, placebo vs DEAE-S groups, and FP vs FP + DEAE-S groups were significant (P<.05, t test). Mean hydroxyproline concentrations were 5.2 mug/mg in the control group, 4.9 mug/mg in the placebo group, 5.6 mug/mg in the DEAE-S group, 4.5 mug/mg in the FP group, and 5.4 mug/mg in the FP + DEAE-S group (P=.09, 1-way ANOVA). The difference between the FP and FP + DEAE-S groups was significant (P=.04, t test).
   Conclusions: A positively charged particle, DEAE-S, improves healing of colonic anastomoses in healthy rats and in rats with FP. This inexpensive, nontoxic material is easily applied and deserves further evaluation in gastrointestinal tract healing.
C1 Ankara Numune Hosp, Dept Surg 4, Ankara, Turkey.
   Hacettepe Univ, Dept Biochem, TR-06100 Ankara, Turkey.
RP Kama, NA (reprint author), Uzmanlar Tip Grubu,3 Cadde,41 Sokak,No 3-1 Bahcel, TR-06500 Ankara, Turkey.
EM nak4ceranur@superonline.com
CR Ahrendt GM, 1996, AM J SURG, V171, P102, DOI 10.1016/S0002-9610(99)80082-8
   AHRENDT GM, 1994, ARCH SURG-CHICAGO, V129, P1179
   ALVAREZ OM, 1983, J INVEST DERMATOL, V81, P144, DOI 10.1111/1523-1747.ep12543498
   ASSIMACO.D, 1968, AM J SURG, V115, P683, DOI 10.1016/0002-9610(68)90101-3
   Assimacopoulos D, 1968, Am Surg, V34, P423
   BALLANTYNE GH, 1984, DIS COLON RECTUM, V27, P61, DOI 10.1007/BF02554084
   BARKER AT, 1982, AM J PHYSIOL, V242, pR358
   BARRANCO SD, 1974, CLIN ORTHOP RELAT R, P250
   BASSETT CAL, 1982, JAMA-J AM MED ASSOC, V247, P623, DOI 10.1001/jama.247.5.623
   BASSETT CAL, 1968, J CELL BIOL, V39, pA9
   BASSETT CAL, 1981, J BONE JOINT SURG AM, V63, P511, DOI 10.2106/00004623-198163040-00001
   BECKER RO, 1961, J BONE JOINT SURG AM, V43, P643, DOI 10.2106/00004623-196143050-00002
   Beech JA, 1997, BIOELECTROMAGNETICS, V18, P341, DOI 10.1002/(SICI)1521-186X(1997)18:5<341::AID-BEM1>3.0.CO;2-2
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   BIGELOW JB, 1978, ELECTRICAL PROPERTIE, P289
   BOURGUIGNON GJ, 1987, FASEB J, V1, P398
   Burgess E, 1998, PLAST RECONSTR SURG, V102, P2395, DOI 10.1097/00006534-199812000-00019
   BURR H. S., 1940, YALE JOUR BIOL AND MED, V12, P483
   CARLEY PJ, 1985, ARCH PHYS MED REHAB, V66, P443
   EPPLEY BL, 1994, ANN PLAS SURG, V32, P463, DOI 10.1097/00000637-199405000-00004
   EPPLEY BL, 1994, AESTHET PLAST SURG, V18, P413, DOI 10.1007/BF00451350
   ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296
   FALANGA V, 1987, J INVEST DERMATOL, V88, P488
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Galiano RD, 1996, ANN PLAS SURG, V36, P608, DOI 10.1097/00000637-199606000-00008
   Gault W R, 1976, Phys Ther, V56, P265
   HENDRIKS T, 1990, DIS COLON RECTUM, V33, P891, DOI 10.1007/BF02051930
   KLOTH LC, 1988, PHYS THER, V68, P503, DOI 10.1093/ptj/68.4.503
   Kologlu M, 1999, AM J SURG, V178, P293, DOI 10.1016/S0002-9610(99)00175-0
   Kologlu M, 2000, SURGERY, V128, P99, DOI 10.1067/msy.2000.107414
   KONIKOFF JJ, 1976, ANN BIOMED ENG, V4, P1, DOI 10.1007/BF02363553
   KORUDA MJ, 1990, J SURG RES, V48, P504, DOI 10.1016/0022-4804(90)90021-S
   KRUKOWSKI M, 1988, J BONE MINER RES, V3, P165
   Lechner F, 1978, Acta Orthop Belg, V44, P699
   MUSTOE TA, 1992, PLAST RECONSTR SURG, V89, P891, DOI 10.1097/00006534-199205000-00018
   ORIDA N, 1982, CELL MOTIL CYTOSKEL, V2, P243, DOI 10.1002/cm.970020305
   PESSA ME, 1987, J SURG RES, V42, P207, DOI 10.1016/0022-4804(87)90120-X
   ROWLEY BA, 1974, ANN NY ACAD SCI, V238, P543, DOI 10.1111/j.1749-6632.1974.tb26820.x
   SCHROCK TR, 1973, ANN SURG, V177, P513, DOI 10.1097/00000658-197305000-00002
   SMITH SD, 1967, ANAT REC, V158, P89, DOI 10.1002/ar.1091580110
   Taskan I, 1997, PLAST RECONSTR SURG, V100, P966
   Tawil NJ, 1999, WOUND REPAIR REGEN, V7, P389, DOI 10.1046/j.1524-475X.1999.00389.x
   WOLCOTT LE, 1969, SOUTH MED J, V62, P795, DOI 10.1097/00007611-196907000-00008
   Wu LC, 1999, J SURG RES, V85, P43, DOI 10.1006/jsre.1999.5354
NR 44
TC 3
Z9 4
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0004-0010
EI 1538-3644
J9 ARCH SURG-CHICAGO
JI Arch. Surg.
PD JUL
PY 2002
VL 137
IS 7
BP 813
EP 817
DI 10.1001/archsurg.137.7.813
PG 5
WC Surgery
SC Surgery
GA 571JU
UT WOS:000176714900013
PM 12093338
OA Bronze
DA 2018-10-19
ER

PT J
AU Schmitt, M
   Weiss, P
   Bourges, X
   del Valle, GA
   Daculsi, G
AF Schmitt, M
   Weiss, P
   Bourges, X
   del Valle, GA
   Daculsi, G
TI Crystallization at the polymer/calclum-phosphate interface in a
   sterilized injectable bone substitute IBS
SO BIOMATERIALS
LA English
DT Article
DE calcium phosphate ceramic; biomaterial; interface; cellulose ether
ID CALCIUM-PHOSPHATE; DENTAL ENAMEL; IMPLANTATION; BIOMATERIALS; COMPOSITE;
   CERAMICS; PROTEINS; POLYMER
AB Calcium phosphate (CaP) ceramics are the main raw, materials used to elaborate blocks or granules for bone substitutes. In this study injectable bone Substitutes (1BS) were developed for application,, it) orthopedic or dental surgery. Sterile, ready-to-use composite containing CaP granules (biphasic calcium phosphate. BCP) and polymer (hydroxypropylmethylcellulose, HPMC) was prepared. Steam sterilization produced ne. phenomena at the CaP polymer interface. resulting in crystal growth. These phenomena may constitute a model for the biomineralization study. Scanning electron microscopy showed that the formed crystallites organize themselves into a three-dimensional structure. Currently, the mechanisms of crystal growth are unknown and have been observed with only one combination of polymer BCP ceramics after steam sterilization. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Fac Dent, UFR Odontol, Res Ctr Mat Biol Interest, INSERM, F-44042 Nantes 01, France.
   Biomatlante ZA, F-44360 Vigneux de Bretagne, France.
RP Weiss, P (reprint author), Fac Dent, UFR Odontol, Res Ctr Mat Biol Interest, INSERM, EMI 99-03,1 Pl Alexis Ricordeau, F-44042 Nantes 01, France.
RI Weiss, Pierre/P-1372-2014; Daculsi, Guy/P-1320-2014
OI Weiss, Pierre/0000-0002-6159-8590; Daculsi, Guy/0000-0003-1030-3446
CR Aoba T, 1997, CRIT REV ORAL BIOL M, V8, P136, DOI 10.1177/10454411970080020301
   Bohic S, 2001, J MATER SCI-MATER M, V12, P201, DOI 10.1023/A:1008902829840
   Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   CHRISTIANSEN DL, 1993, CELL MATER, V3, P177
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Daculsi G, 1999, BONE, V25, P59
   DELUCAS L, 1975, CARBOHYD RES, V41, P19, DOI 10.1016/S0008-6215(00)87003-2
   Fincham AG, 1997, CIBA F SYMP, V205, P118
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Gauthier O, 2001, J MATER SCI-MATER M, V12, P385, DOI 10.1023/A:1011284517429
   GROVER JA, 1986, FOOD HYDROCOLLOIDS, V3, P121
   Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059
   LeGeros R.Z., 1991, CALCIUM PHOSPHATES O, V15
   Richard M, 1998, CALCIFIED TISSUE INT, V62, P437, DOI 10.1007/s002239900456
   Robinson C, 1996, Adv Dent Res, V10, P173
   Rohanizadeh R, 1999, CALCIFIED TISSUE INT, V64, P430, DOI 10.1007/PL00005825
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   WALSH D, 1994, SCIENCE, V264, P1576, DOI 10.1126/science.264.5165.1576
   Weiss P, 1997, J MATER SCI-MATER M, V8, P621, DOI 10.1023/A:1018519419539
   Weiss P, 1999, BONE, V25, p67S, DOI 10.1016/S8756-3282(99)00146-5
   Yokogawa Y, 1998, J MATER RES, V13, P922, DOI 10.1557/JMR.1998.0126
   YUBAO L, 1993, BIOCERAMICS, V6, P173
NR 26
TC 27
Z9 28
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2002
VL 23
IS 13
BP 2789
EP 2794
AR PII S0142-9612(02)00015-7
DI 10.1016/S0142-9612(02)00015-7
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 554DM
UT WOS:000175718600020
PM 12059030
DA 2018-10-19
ER

PT J
AU Madhan, B
   Muralidharan, C
   Jayakumar, R
AF Madhan, B
   Muralidharan, C
   Jayakumar, R
TI Study on the stabilisation of collagen with vegetable tannins in the
   presence of acrylic polymer
SO BIOMATERIALS
LA English
DT Article
DE vegetable tannins; polyphenols; acrylics; collagen; stabilisation;
   biomaterial
ID GREEN TEA; POLYPHENOLS; ACID
AB Collagen, a unique connective tissue protein finds extensive application as biocompatible biomaterial in wound healing, as drug carriers, cosmetics, etc. A study has been undertaken to stabilise, Type-I collagen of rat-tail tendon using plant polyphenol (Acacia Mollissima) in the presence of an acrylic polymer. It has been found that collagen fibres pre-treated with acrylic polymer followed by the treatment with Acacia Mollissima exhibited an increase in hydrothermal stability by 25degreesC. Infrared spectroscopic studies display the changes in the spectral characteristics of native and treated collagen films. Transmission electron microscopic and circular dichroic studies provide an insight into the understanding of the improved stabilisation of collagen, due to treatment with acrylic polymer and plant polyphenols. The study is expected to enhance the biomaterial applications of collagen tissues. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Cent Leather Res Inst, Council Sci & Ind Res, Madras 600020, Tamil Nadu, India.
RP Muralidharan, C (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Adyar, Madras 600020, Tamil Nadu, India.
RI Madhan, Balaraman/B-3136-2009
OI Madhan, Balaraman/0000-0002-4198-8452
CR BEAR RS, 1952, ADV PROTEIN CHEM, V7, P69, DOI 10.1016/S0065-3233(08)60018-2
   Borasky R., 1949, J AM LEATHER CHEM AS, V44, P830
   BRADFIELD AE, 1948, J CHEM SOC, P2249, DOI 10.1039/jr9480002249
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   GAUGLHOFER J, 1986, J SOC LEATH TECH CH, V70, P11
   GAYATRI R, 1997, P INDIAN ACAD SCI CH, V109, P145
   Gustavson K. H, 1956, CHEM TANNING PROCESS
   GUSTAVSON KH, 1954, J POLYM SCI, V12, P317, DOI 10.1002/pol.1954.120120126
   HARBORNE JB, 1959, J CHROMATOGR, V2, P581, DOI 10.1016/S0021-9673(01)86351-2
   HART GJ, 1971, BIOCHEM J, V125, P599, DOI 10.1042/bj1250599
   KOMORI A, 1993, JPN J CLIN ONCOL, V23, P186
   LAURENT TC, 1974, EUR J BIOCHEM, V43, P231, DOI 10.1111/j.1432-1033.1974.tb03404.x
   LOLLAR RM, 1977, CHEM TECHNOLOGY LEAT, V2, P1
   Madhan B, 2001, J AM LEATHER CHEM AS, V96, P120
   Madhan B, 2001, CHEM PHYS LETT, V346, P334, DOI 10.1016/S0009-2614(01)00910-1
   Nezu T, 2000, BIOMATERIALS, V21, P415, DOI 10.1016/S0142-9612(99)00204-5
   NIMMI HE, 1988, COLLAGEN, P1
   Okuda T, 1995, Fortschr Chem Org Naturst, V66, P1
   PRESTON BN, 1972, BIOPOLYMERS, V11, P1645, DOI 10.1002/bip.1972.360110811
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   RAMACHANDRAN GN, 1965, BIOCHIM BIOPHYS ACTA, V109, P314, DOI 10.1016/0926-6585(65)90119-6
   RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0
   RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1648
   Rao JR, 1999, BBA-GEN SUBJECTS, V1472, P595
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   ROUX DG, 1960, BIOCHEM J, V74, P44, DOI 10.1042/bj0740044
   ROUX DG, 1961, BIOCHEM J, V78, P834, DOI 10.1042/bj0780834
   ROUX DG, 1960, J CHROMATOGR, V4, P65, DOI 10.1016/S0021-9673(01)98371-2
   SANTAPPA M, 1982, J SCI IND RES INDIA, V41, P616
   SHARPHOUSE JH, 1989, LEATHER TECHNICIANS, P20
   SHUTTLEWORTH SG, 1952, J AM LEATHER CHEM AS, V47, P603
   Sykes R. L., 1956, J AM LEATHER CHEM AS, V51, P235
   TU ST, 1950, J AM LEATHER CHEM AS, V45, P324
   WANG ZY, 1988, DRUG METAB DISPOS, V16, P98
   WEI DQ, 1995, J SOC LEATH TECH CH, V79, P110
   WHITE T, 1952, J SOC LEATHER TRADES, V36, P148
   WHITE T, 1956, CHEM TANNING PROCESS, P1
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 38
TC 53
Z9 53
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2002
VL 23
IS 14
BP 2841
EP 2847
AR PII S0142-9612(01)00410-0
DI 10.1016/S0142-9612(01)00410-0
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 559FP
UT WOS:000176015400003
PM 12069323
DA 2018-10-19
ER

PT J
AU Noah, EM
   Chen, JS
   Jiao, XY
   Heschel, I
   Pallua, N
AF Noah, EM
   Chen, JS
   Jiao, XY
   Heschel, I
   Pallua, N
TI Impact of sterilization on the porous design and cell behavior in
   collagen sponges prepared for tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE collagen sponges; sterilization; ethylene oxide; gamma irradiation; pore
   structure; cell proliferation
ID GAMMA-IRRADIATION; PORE-SIZE; IN-VITRO; BIOMATERIAL; AERATION; POLYMERS;
   DEVICES; SHAPE
AB This study investigates the impact of different sterilization processes on structural integrity and stability of collagen sponges designed for tissue engineering. Collagen sponges with uniform pore size (20 mum) were sterilized either with ethylene oxide (EO) or gamma irradiation (2.5 Mrad). Gamma-sterilized sponges showed a dramatic decrease of resistance against enzyme degradation and severe shrinkage after cell seeding. Collapsed porosity inhibited fibroblasts and barred completely the human umbilical vein endothelial cell ingrowth into the sponges. On the contrary, the porous structure and stability of EO-sterilized sponges remained almost unaltered. Fibroblasts and endothelial cells exhibited favorable proliferation and migration within sponges with normal morphology. Tubular formation by seeded endothelial cells occurred early in the first week. Therefore, we emphasize that the impact of sterilization of biomaterials is substantial and any new procedure has to be evaluated by correlating the impact of the procedure on the porous structure with cell proliferation behavior. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Technol Univ Aachen, Dept Plast Hand & Burn Surg, D-52074 Aachen, Germany.
   Technol Univ Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
RP Noah, EM (reprint author), Technol Univ Aachen, Dept Plast Hand & Burn Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
CR BELKOFF SM, 1992, J ORTHOPAED RES, V10, P461, DOI 10.1002/jor.1100100320
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   Doillon CJ, 1997, J BIOMED MATER RES, V37, P212
   DOILLON CJ, 1994, MAT SCI ENG C-BIOMIM, V2, P43, DOI 10.1016/0928-4931(94)90028-0
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   HESCHEL I, 1997, Patent No. 9803403
   HESCHEL I, 1996, ADV CRYOGEN ENG, P13
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LIU BC, 1989, J BIOMED MATER RES, V23, P833, DOI 10.1002/jbm.820230803
   MATTHEWS IP, 1989, J BIOMED MATER RES, V23, P143, DOI 10.1002/jbm.820230202
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Moore MA, 1997, ASAIO J, V43, P23, DOI 10.1097/00002480-199701000-00006
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Schoof H., 1998, KI LUFT KAELTETECHNI, V34, P247
   Sheridan RL, 1999, BURNS, V25, P97, DOI 10.1016/S0305-4179(98)00176-4
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   VINK P, 1986, BIOMATERIALS, V7, P225, DOI 10.1016/0142-9612(86)90108-0
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
NR 22
TC 67
Z9 78
U1 2
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2002
VL 23
IS 14
BP 2855
EP 2861
AR PII S0142-9612(01)00412-4
DI 10.1016/S0142-9612(01)00412-4
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 559FP
UT WOS:000176015400005
PM 12069325
DA 2018-10-19
ER

PT J
AU Leszczyszyn, J
   Gerber-Leszczyszyn, H
   Helen, M
   Lebski, I
   Skoczylas, M
AF Leszczyszyn, J
   Gerber-Leszczyszyn, H
   Helen, M
   Lebski, I
   Skoczylas, M
TI SIS biomaterial application in treatment of fecal incontinence caused by
   anal sphincter injury - An animal study.
SO GASTROENTEROLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0016-5085
J9 GASTROENTEROLOGY
JI Gastroenterology
PD JUL
PY 2002
VL 123
IS 1
SU S
BP 11
EP 11
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 570WX
UT WOS:000176684400052
DA 2018-10-19
ER

PT J
AU Vollrath, F
   Barth, P
   Basedow, A
   Engstrom, W
   List, H
AF Vollrath, F
   Barth, P
   Basedow, A
   Engstrom, W
   List, H
TI Local tolerance to spider silks and protein polymers in vivo
SO IN VIVO
LA English
DT Article
DE spider silk; biomaterial; medical use; histology; compatibility
ID WEBS
AB Spider silks were implanted subcutaneously in pigs for a study of the tolerance against this material. Four types of spider silks of high purity and cleanliness were implanted : (i) major ampullate dragline silk reeled from the golden silk spider Nephila clavipes, (ii) native (unsterilised) silk reeled from a Brachypelma spider, (iii) native silk taken from this spider's web and (iv) its web silk thermally treated at 80degreesC. For comparison we used fibrous silk analogue protein polymers and four already marketed wound dressings (polyurethane film, collagen dressings, gauze pads). All materials were applied epicutaneously to split skin wounds. The implants were examined macroscopically as well as by light microscopy. Superficially, all sites healed rapidly. There were marked inflammatory reactions in all sites with lympho-plasmacellular infiltrations, evidence of phagocytosis and granuloma formation as indicated by the appearance of giant cells. However there was a marked absence of epitheloid cells indicating that the observed reaction was a foreign body granuloma. Furthermore, the histopathological images recorded after 14 days revealed no marked differences between the dressings. Polyurethane films, however, seemed to be superior with respect to the duration of the wound healing process.
C1 Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   LOHMANN GmbH & Co KG, D-56567 Neuwied, Germany.
   Swedish Univ Agr Sci, Fac Vet Med, Dept Pathol, S-75007 Uppsala, Sweden.
RP Vollrath, F (reprint author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.
CR Frische S, 1998, J MICROSC-OXFORD, V189, P64
   Hillyard P., 1994, BOOK SPIDER
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   MAYNES E, 1998, ADV MATER, V10, P801
   MCKINSTRY D, 1994, WILDERNESS ENV MED, V6, P228
   NEWMAN J, 1995, INT J DERMATOL, V34, P290, DOI 10.1111/j.1365-4362.1995.tb01600.x
   OBRIEN JP, 1993, TRENDS POLYM SCI, V1, P228
   RIEKEL C, 2002, UNPUB J BIOL MACROMO
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SCHILDKNECHT H, 1972, NATURWISSENSCHAFTEN, V59, P98, DOI 10.1007/BF00591781
   Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   VADLAMUDI S, 1995, PHARM RS S9, V12, P235
   VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0
   VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Vollrath F., 2000, REV MOL BIOTECHNOL, V74, P67, DOI DOI 10.1016/S1389-0352(00)00006-4)
NR 20
TC 63
Z9 64
U1 0
U2 8
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0258-851X
J9 IN VIVO
JI In Vivo
PD JUL-AUG
PY 2002
VL 16
IS 4
BP 229
EP 234
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 582ET
UT WOS:000177337300002
PM 12224131
DA 2018-10-19
ER

PT J
AU Salmons, S
AF Salmons, S
TI Electrically stimulated skeletal muscle: An adaptive, functional
   biomaterial
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 29th Conference of the European-Society-for-Artificial-Organs
CY AUG 28-31, 2002
CL VIENNA, AUSTRIA
SP European Soc Artificial Organs
ID LATISSIMUS-DORSI MUSCLE
C1 Univ Liverpool, Dept Human Anat & Cell Biol, Liverpool L69 3BX, Merseyside, England.
RP Salmons, S (reprint author), Univ Liverpool, Dept Human Anat & Cell Biol, POB 147, Liverpool L69 3BX, Merseyside, England.
CR Salmons S, 1998, J ANAT, V193, P93, DOI 10.1046/j.1469-7580.1998.19310093.x
   SALMONS S, 1981, MUSCLE NERVE, V4, P94, DOI 10.1002/mus.880040204
   SALMONS S, 1980, TRENDS NEUROSCI, V3, P134, DOI 10.1016/0166-2236(80)90050-8
   Tang ATM, 1999, ANN THORAC SURG, V68, P46, DOI 10.1016/S0003-4975(99)00313-6
   Tansey PA, 1998, SPORTS EXERC INJURY, V4, P131
   WOO EBC, 2002, IN PRESS ANN THORAC, V73
NR 6
TC 0
Z9 0
U1 0
U2 0
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD JUL
PY 2002
VL 25
IS 7
BP 625
EP 626
PG 2
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 575DL
UT WOS:000176931300016
DA 2018-10-19
ER

PT J
AU Bessho, K
   Carnes, DL
   Cavin, R
   Ong, JL
AF Bessho, K
   Carnes, DL
   Cavin, R
   Ong, JL
TI Experimental studies on bone induction using low-molecular-weight poly
   (DL-lactide-co-glycolide) as a carrier for recombinant human bone
   morphogenetic protein-2
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE bone morphogenetic protein; carrier; synthetic biomaterial;
   biodegradable polymer; poly(DL-latide-co-glycolide)
ID ACID); DEGRADATION
AB An appropriate carrier acting as a slow delivery vehicle for the BMPs is required for maximal clinical effectiveness of these bone-inductive proteins, The purpose of this study was to evaluate a low-molecular-weight PLGA copolymer as a synthetic, biodegradable carrier for rhBMP-2 implantation in vivo. Two, 10, or 50 mug of recombinant human BMP-2 were mixed with 10 mg Of a Poly (DL-lactide-co-glycolide) (PLGA) 50:50 copolymer and implanted into the calf muscles of Wistar rats. Soft X-ray analysis and histologic examination indicated that new borne formation occurred at all rhBMP-2-implanted sites within 3 weeks after implantation. Correlation of rhBMP-2 concentration with the amount of bone induction was confirmed by specific alkaline phosphatase activity and calcium content assay. In vitro analysis indicated that 78.5% of the PLGA copolymer was degraded to smaller molecular weight material after 14 days in PBS solution. It is suggested that rhBMP-2 was released in an active form at the implant site during the degradation of the copolymer, resulting in the induction of new bone formation. Thus this low-molecular-weight PLGA copolymer material represents a promising delivery vehicle for E MPs, and possibly other growth factors, around dental and orthopedic implants. (C) 2002 Wiley Periodicals, Inc.
C1 Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA.
   Dept Periodont, San Antonio, TX 78229 USA.
   Dept Restorat Dent, San Antonio, TX 78229 USA.
RP Ong, JL (reprint author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, 54 Knwahara Cho, Kyoto 6068507, Japan.
CR Bessho K, 2000, BRIT J ORAL MAX SURG, V38, P645, DOI 10.1054/bjom.2000.0533
   BESSHO K, 1989, BIOCHEM BIOPH RES CO, V165, P595, DOI 10.1016/S0006-291X(89)80008-7
   Bessho K, 1999, BRIT J ORAL MAX SURG, V37, P2, DOI 10.1054/bjom.1998.0379
   BESSHO K, 1995, ORAL ONCOL, V4, P304
   Celeste AJ, 1994, J BONE MINER RES  S1, V9, pS136
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Isobe M, 1996, J BIOMED MATER RES, V32, P433
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Witschi C, 1998, J CONTROL RELEASE, V51, P327, DOI 10.1016/S0168-3659(97)00188-0
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
NR 14
TC 51
Z9 58
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2002
VL 61
IS 1
BP 61
EP 65
DI 10.1002/jbm.10169
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 556GA
UT WOS:000175840000009
PM 12001247
DA 2018-10-19
ER

PT J
AU Muller, BP
   Ensslen, S
   Dott, W
   Hollender, J
AF Muller, BP
   Ensslen, S
   Dott, W
   Hollender, J
TI Improved sample preparation of biomaterials for in vitro genotoxicity
   testing using reference materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE in vitro genotoxicity testing; biomaterial; reference material;
   extraction; sample preparation
ID DENTIN BONDING AGENTS; IN-VITRO; COMET ASSAY; CHEMICALS; CYTOTOXICITY;
   POLYETHERURETHANES; IMPLANTATION; MUTAGENICITY; INHIBITION; RESPONSES
AB New biomaterial related reference materials with known genotoxic properties were produced in order to study the sample preparation and in vitro genotoxicity testing of biomaterials. We incorporated genotoxic substances like benzo[a]pyrene into the biomaterial Tecoflex, a polyurethane frequently used for catheters and other applications. We demonstrated that the model compound benzo[a]pyrene is sufficiently extracted by organic solvents, whereas cell culture medium only extracts very limited quantities. By changing the medium several times during extraction the extracted amount was augmented. Using higher amounts of organic solvent in relation to the reference material's surface led to a higher recovery of extracted benzo[a]pyrene. For the in vitro genotoxicity testing using the Mammalian Cell Gene Mutation Test (HPRT test), Mammalian Chromosome Aberration Test, and bacterial umu- and SOS-tests, concentration of extracts is a prerequisite because of the low sensitivity of the test systems. Often cytotoxicity interferes with the evaluation of genotoxic effects. We demonstrated that some recommendations of the ISO 10993-Part 3 and 12,(1,2) dealing with the biological evaluation of medical devices, seem to be insufficient, and new rules for the in vitro genotoxicity testing of biomaterials have to be established. (C) 2002 Wiley Periodicals, Inc.
C1 Rhein Westfal TH Aachen Klinikum, IZKF Biomat, D-52074 Aachen, Germany.
   Univ Klinikum, RWTH Aachen, Inst Hyg & Umweltmed, D-52074 Aachen, Germany.
RP Muller, BP (reprint author), Rhein Westfal TH Aachen Klinikum, IZKF Biomat, Pauwelsstr 30, D-52074 Aachen, Germany.
RI Hollender, Juliane/A-2145-2014
OI Hollender, Juliane/0000-0002-4660-274X
CR [Anonymous], 1996, 1099312 ISO 12
   Baun A, 1999, MUTAT RES-GEN TOX EN, V441, P171, DOI 10.1016/S1383-5718(99)00043-1
   Chauvel-Lebret DJ, 2001, BIOMATERIALS, V22, P1795, DOI 10.1016/S0142-9612(00)00351-3
   Ehrlichmann H, 2000, ECOTOX ENVIRON SAFE, V46, P73, DOI 10.1006/eesa.1999.1875
   Gebel T, 1999, MUTAT RES-GEN TOX EN, V444, P405, DOI 10.1016/S1383-5718(99)00111-4
   Hartmann A, 2001, FOOD CHEM TOXICOL, V39, P843, DOI 10.1016/S0278-6915(01)00031-X
   Heil J, 1996, MUTAT RES-GENET TOX, V368, P181, DOI 10.1016/S0165-1218(96)90060-9
   Henderson L, 2000, MUTAT RES-GEN TOX EN, V464, P123, DOI 10.1016/S1383-5718(99)00173-4
   Hilliard CA, 1998, ENVIRON MOL MUTAGEN, V31, P316, DOI 10.1002/(SICI)1098-2280(1998)31:4<316::AID-EM3>3.0.CO;2-G
   *ISO, 2000, 1099312 ISODIS 12
   *ISO, 1992, 109933 ISO 3
   *ISO, 2000, 100933ISODIS 3
   Kirkland D, 1998, MUTAT RES-FUND MOL M, V404, P173, DOI 10.1016/S0027-5107(98)00111-0
   KIRKLAND DJ, 1992, MUTAGENESIS, V7, P95, DOI 10.1093/mutage/7.2.95
   Kirkpatrick CJ, 2000, AM J PATHOL, V156, P1455, DOI 10.1016/S0002-9440(10)65014-6
   Leyhausen G, 1998, BIOMATERIALS, V19, P559, DOI 10.1016/S0142-9612(97)00137-3
   Lutermann C, 1998, J CHROMATOGR A, V811, P151, DOI 10.1016/S0021-9673(98)00266-0
   Muller L, 1999, MUTAT RES-REV MUTAT, V436, P195, DOI 10.1016/S1383-5742(99)00004-6
   NAKAMURA A, 1992, J BIOMED MATER RES, V26, P631, DOI 10.1002/jbm.820260506
   OBERLY TJ, 1993, CELL BIOL TOXICOL, V9, P243, DOI 10.1007/BF00755603
   Sasaki YF, 2000, CRIT REV TOXICOL, V30, P629, DOI 10.1080/10408440008951123
   Schweikl H, 1997, J BIOMED MATER RES, V36, P284, DOI 10.1002/(SICI)1097-4636(19970905)36:3<284::AID-JBM2>3.0.CO;2-A
   SCHWEIKL H, 1994, J BIOMED MATER RES, V28, P1061, DOI 10.1002/jbm.820280911
   SHELBY MD, 1993, ENVIRON MOL MUTAGEN, V21, P160, DOI 10.1002/em.2850210210
   Stea S, 1998, J BIOMED MATER RES, V40, P545, DOI 10.1002/(SICI)1097-4636(19980615)40:4<545::AID-JBM5>3.0.CO;2-F
   STEA S, 1994, J BIOMED MATER RES, V28, P319, DOI 10.1002/jbm.820280306
   Tsuchiya T, 1996, J BIOMED MATER RES, V31, P299
   TSUCHIYA T, 1993, J APPL BIOMATER, V4, P153, DOI 10.1002/jab.770040206
   TSUCHIYA T, 1995, J BIOMED MATER RES, V29, P113, DOI 10.1002/jbm.820290116
   WENING JV, 1995, BIOMATERIALS, V16, P337, DOI 10.1016/0142-9612(95)93262-C
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
NR 31
TC 5
Z9 6
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2002
VL 61
IS 1
BP 83
EP 90
DI 10.1002/jbm.10158
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 556GA
UT WOS:000175840000012
PM 12001250
DA 2018-10-19
ER

PT J
AU Gough, JE
   Scotchford, CA
   Downes, S
AF Gough, JE
   Scotchford, CA
   Downes, S
TI Cytotoxicity of glutaraldehyde crosslinked collagen/poly(vinyl alcohol)
   films is by the mechanism of apoptosis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE human osteoblasts; collagen; crosslinking; apoptosis; IGF-1; glutamic
   acid
ID BIOARTIFICIAL POLYMERIC MATERIALS; FLOW-CYTOMETRIC METHOD; DRUG-DELIVERY
   SYSTEMS; CROSS-LINKING; IN-VITRO; GROWTH-HORMONE; GLUTAMIC-ACID;
   COLLAGEN; CELLS; BONE
AB Collagen has been investigated as a potential natural biomaterial, because of its occurrence in the extracellular matrix. Collagen requires crosslinking in this context, by reagents that are often cytotoxic. Glutaraldehyde is one such agent that is potentially cytotoxic. The aim of this study was to determine the cause of poor cell attachment and growth on collagen/poly(vinyl alcohol) bioartificial composite films, when crosslinked with glutaraldehyde. Dehydrothermal crosslinking was used as a comparison. Human osteoblasts were observed to undergo apoptosis on glutaraldehyde crosslinked films dependent on concentration of collagen present. Higher collagen content resulted in higher levels of apoptosis with poor cell attachment and spreading of remaining cells. Post-treatment of films with 8% L-glutamic acid prevented the apoptotic response of osteoblasts and allowed attachment and spreading. The addition of 100 nM insulin-like growth factor-1 to the Culture medium also prevented apoptosis. Glutaraldehyde toxicity of crosslinked collagen has been demonstrated in this study, the mechanism of which is apoptosis. This study indicates that poor biocompatibility and induction of apoptosis on collagen/poly(vinyl alcohol) films crosslinked by glutaraldehyde are attributed to glutaraldehyde components on the surface of the films (not residual glutaraldehyde), whose effects can be quenched by glutamic acid, and prevented by insulin-like growth factor-1. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Nottingham, Sch Med, Sch Biomed, Queens Med Ctr, Nottingham NG7 2UH, England.
   Smith & Nephew Grp, Res Ctr, York YO10 5DF, N Yorkshire, England.
RP Gough, JE (reprint author), Univ Nottingham, Sch Med, Sch Biomed, Queens Med Ctr, E Floor, Nottingham NG7 2UH, England.
EM j.gough@ic.ac.uk
OI Scotchford, Colin/0000-0003-1937-6692
CR ARNOTT N, 1998, JOINT M BRIT ORTH RE
   BELLOC F, 1994, CYTOMETRY, V17, P59, DOI 10.1002/cyto.990170108
   Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   CASAGRANDA F, 1994, J MATER SCI-MATER M, V5, P332
   CASCONE MG, 1995, BIOMATERIALS, V16, P569, DOI 10.1016/0142-9612(95)91131-H
   CASCONE MG, 1994, J MATER SCI-MATER M, V5, P770, DOI 10.1007/BF00120374
   CHANDA J, 1994, ARTIF ORGANS, V18, P408, DOI 10.1111/j.1525-1594.1994.tb02223.x
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DISILVIO L, 1995, THESIS U COLL LONDON
   EYBL E, 1989, J BIOMED MATER RES, V23, P1355, DOI 10.1002/jbm.820231111
   EYBL E, 1992, J THORAC CARDIOV SUR, V104, P763
   Flautre B, 1996, J MATER SCI-MATER M, V7, P63, DOI 10.1007/BF00058716
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   GIUSTI P, 1993, TRENDS POLYM SCI, V1, P261
   Goissis G, 1998, ARTIF ORGANS, V22, P210, DOI 10.1046/j.1525-1594.1998.06006.x
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   GORHAM SD, 1987, UROL RES, V15, P53
   GORHAM SD, 1991, BIOMATERIALS NOVEL M, P57
   Gough JE, 2001, J BIOMED MATER RES, V57, P497, DOI 10.1002/1097-4636(20011215)57:4<497::AID-JBM1195>3.0.CO;2-U
   Grabenwoger M, 1996, ANN THORAC SURG, V62, P772
   GRIMM M, 1992, J CARDIAC SURG, V7, P58, DOI 10.1111/j.1540-8191.1992.tb00775.x
   Gudkin LR, 1997, RUSS J APPL CHEM+, V70, P782
   HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x
   Hill PA, 1997, ENDOCRINOLOGY, V138, P3849, DOI 10.1210/en.138.9.3849
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NIMNI ME, 1992, CARDIOVASCULAR BIOMA
   Norgren L, 1990, Eur J Vasc Surg, V4, P379, DOI 10.1016/S0950-821X(05)80871-0
   NORGREN L, 1985, ANGIO ARCH, V9, P39
   POHUNKOVA H, 1995, BIOMATERIALS, V16, P67, DOI 10.1016/0142-9612(95)91098-J
   Pohunkova H, 1996, BIOMATERIALS, V17, P1567, DOI 10.1016/0142-9612(95)00310-X
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   RICHARDS FM, 1968, J MOL BIOL, V37, P231, DOI 10.1016/0022-2836(68)90086-7
   RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769
   ROVIRA A, 1993, J MATER SCI-MATER M, V4, P372, DOI 10.1007/BF00122195
   RUSSELL JW, J NEUROBIOL, V36, P455
   SALGALLER ML, 1985, J BIOMED MATER RES, V19, P1, DOI 10.1002/jbm.820190103
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   SCOTCHFORD CA, 1996, P 5 WORLD BIOM C TOR
   SERRE CM, 1993, BIOMATERIALS, V14, P97, DOI 10.1016/0142-9612(93)90217-P
   SUN XM, 1992, ANAL BIOCHEM, V204, P351, DOI 10.1016/0003-2697(92)90251-2
   THANOO BC, 1993, J PHARM PHARMACOL, V45, P16, DOI 10.1111/j.2042-7158.1993.tb03671.x
   TOMITA N, 1992, BIOMATERIAL TISSUE I, V10
   Trump Benjamin F., 1998, P57
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WERGEDAL JE, 1984, P SOC EXP BIOL MED, V176, P60
   YAMAMOTO K, 1993, ARTIF ORGANS, V17, P1010, DOI 10.1111/j.1525-1594.1993.tb03183.x
   Young TH, 1996, BIOMATERIALS, V17, P2139, DOI 10.1016/0142-9612(96)00043-9
   ZUMSTEIN P, 1987, J BIOL CHEM, V262, P11252
NR 55
TC 148
Z9 152
U1 5
U2 45
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2002
VL 61
IS 1
BP 121
EP 130
DI 10.1002/jbm.10145
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 556GA
UT WOS:000175840000016
PM 12001254
DA 2018-10-19
ER

PT J
AU Lobler, M
   Sass, M
   Kunze, C
   Schmitz, KP
   Hopt, UT
AF Lobler, M
   Sass, M
   Kunze, C
   Schmitz, KP
   Hopt, UT
TI Biomaterial implants induce the inflammation marker CRP at the site of
   implantation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE biomaterial; implant; Vicryl; PHB; soft tissue; response; mRNA
   differential display
ID PROTEIN GC-GLOBULIN; EXPRESSION
C1 Univ Freiburg, Chirurg Univ Klin, D-79106 Freiburg, Germany.
   Univ Rostock, Klin & Poliklin Chirurg, D-18057 Rostock, Germany.
   Kompetenzzentrum Biomat, Inst Biomed Techn, D-18057 Rostock, Germany.
RP Lobler, M (reprint author), Univ Freiburg, Chirurg Univ Klin, Hugstetter Str 55, D-79106 Freiburg, Germany.
CR Binder R, 1999, MOL IMMUNOL, V36, P885, DOI 10.1016/S0161-5890(99)00110-8
   Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6
   HADDAD JG, 1995, J STEROID BIOCHEM, V53, P579, DOI 10.1016/0960-0760(95)00104-8
   KAPLAN E, 1989, IMMUNOL RES, V8, P118, DOI 10.1007/BF02919074
   Kishida A, 1996, BIOMATERIALS, V17, P1301, DOI 10.1016/0142-9612(96)88675-3
   Lobler M, 2002, BIOMATERIALS, V23, P577, DOI 10.1016/S0142-9612(01)00144-2
   Robitaille R, 1999, J BIOMED MATER RES, V45, P223, DOI 10.1002/(SICI)1097-4636(19990605)45:3<223::AID-JBM10>3.0.CO;2-L
NR 7
TC 13
Z9 14
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUL
PY 2002
VL 61
IS 1
BP 165
EP 167
DI 10.1002/jbm.10155
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 556GA
UT WOS:000175840000022
PM 12001260
DA 2018-10-19
ER

PT J
AU Vargas, LG
   Peng, Q
   Apple, DJ
   Escobar-Gomez, M
   Pandey, SK
   Arthur, SN
   Hoddinott, DSM
   Schmidbauer, JM
AF Vargas, LG
   Peng, Q
   Apple, DJ
   Escobar-Gomez, M
   Pandey, SK
   Arthur, SN
   Hoddinott, DSM
   Schmidbauer, JM
TI Evaluation of 3 modern single-piece foldable intraocular lenses -
   Clinicopathological study of posterior capsule opacification in a rabbit
   model
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT 19th Congress of the
   European-Society-of-Cataract-and-Refractive-Surgeons
CY SEP, 2001
CL AMSTERDAM, NETHERLANDS
SP European Soc Cataract & Refract Surgeons
ID HUMAN AUTOPSY EYES; NEODYMIUM-YAG CAPSULOTOMY; COLLAGEN TYPE-IV;
   SURGICAL PREVENTION; RETINAL-DETACHMENT; CATARACT-SURGERY; PART 1;
   FIXATION; SILICONE; ADHESION
AB Purpose: To assess the development of posterior capsule opacification (PCO) with 3 modern single-piece foldable intraocular lenses (IOLs) in a histopathological study and to compare the potential preventive effects of the IOL design and biomaterial in retarding PCO.
   Setting: Center for Research on Ocular Therapeutics and Biodevices, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, USA.
   Methods: Thirty-one rabbit eyes were randomly operated on with phacoemulsification and implantation of 3 single-piece foldable lenses: a hydrophilic acrylic design, the Rayner Centerflex(R) 570H (n = 11); a hydrophobic acrylic design, the Alcon AcrySof(R) SA30AL (n = 10); and a silicone large-hole plate design, the Staar AA-4203VF (n = 10). Central PCO (CPCO), peripheral PCO (PPCO), and Soemmering's ring formation were evaluated 3 weeks after surgery using the Miyake-Apple posterior photographic technique. Histological sections of each globe were prepared to document capsular bag status and performance of IOL geometry.
   Results: The acrylic IOLs (Centerflex and AcrySof) had lower CPCO and PPCO scores than the silicone plate IOL (P < .05). There was no significant difference in Soemmering's ring formation among the 3 models. Pathological evaluations revealed effective blockage of migrating lens epithelial cells (LECs) at the site of the truncated optic edge of the Centerflex and AcrySof IOLs, even in the presence of large amounts of retained/regenerative cortical material.
   Conclusions:, The AcrySof IOL has a hydrophobic surface and the Centerflex a hydrophilic surface, but no correlation to these characteristics could be identified. The single-piece-AcrySof optic geometry created a clear-cut barrier effect equal to that of its 3-piece predecessor. The anatomic profile of the Centerflex IOL shows the same characteristics. The optics of both acrylic lenses have square truncated edges that functionally block ingrowth of migrating LECs toward the central visual axis, leaving clear posterior capsules. The square optic edge was an appropriate geometric configuration to create a barrier effect. There was no effect of the biomaterial on PCO prevention.
C1 Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, Charleston, SC 29425 USA.
RP Apple, DJ (reprint author), Med Univ S Carolina, Dept Ophthalmol, Storm Eye Inst, Ctr Res Ocular Therapeut & Biodevices, 167 Ashley Ave,POB 250676, Charleston, SC 29425 USA.
CR AMON M, 1993, J CATARACT REFR SURG, V19, P258, DOI 10.1016/S0886-3350(13)80953-4
   Apple D J, 2000, Trans Am Ophthalmol Soc, V98, P257
   Apple D. J., 2000, FOLDABLE INTRAOCULAR
   APPLE DJ, 1990, OPHTHALMOLOGY, V97, P810
   APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   Apple DJ, 2001, OPHTHALMOLOGY, V108, P505, DOI 10.1016/S0161-6420(00)00589-3
   Apple DJ, 2000, J CATARACT REFR SURG, V26, P180, DOI 10.1016/S0886-3350(99)00353-3
   APPLE DJ, 2000, SURV OPHTHALMOL S1, V45, P70
   Auffarth GU, 1996, J CATARACT REFR SURG, V22, P1281, DOI 10.1016/S0886-3350(96)80085-X
   BLACHARSKI PA, 1988, AM J OPHTHALMOL, V105, P417, DOI 10.1016/0002-9394(88)90309-1
   Boulton M, 1998, BRIT J OPHTHALMOL, V82, P468, DOI 10.1136/bjo.82.5.468
   CHANNELL MM, 1984, ARCH OPHTHALMOL-CHIC, V102, P1024
   Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7
   Holweger RR, 1997, J CATARACT REFR SURG, V23, P115, DOI 10.1016/S0886-3350(97)80161-7
   JAVITT JC, 1992, OPHTHALMOLOGY, V99, P1487
   Kato K, 1997, J CATARACT REFR SURG, V23, P1556, DOI 10.1016/S0886-3350(97)80029-6
   Kent DG, 1997, J CATARACT REFR SURG, V23, P1371, DOI 10.1016/S0886-3350(97)80116-2
   Kent DG, 1998, J CATARACT REFR SURG, V24, P666, DOI 10.1016/S0886-3350(98)80263-0
   Kim MJ, 1999, J CATARACT REFR SURG, V25, P251, DOI 10.1016/S0886-3350(99)80135-7
   Linnola RJ, 1997, J CATARACT REFR SURG, V23, P1539, DOI 10.1016/S0886-3350(97)80026-0
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1792, DOI 10.1016/S0886-3350(00)00748-3
   Linnola RJ, 2000, J CATARACT REFR SURG, V26, P1807, DOI 10.1016/S0886-3350(00)00747-1
   Nagata T, 1998, J CATARACT REFR SURG, V24, P367, DOI 10.1016/S0886-3350(98)80325-8
   NEWLAND TJ, 1994, J CATARACT REFR SURG, V20, P527, DOI 10.1016/S0886-3350(13)80233-7
   Nishi O, 2000, J CATARACT REFR SURG, V26, P1543, DOI 10.1016/S0886-3350(00)00426-0
   Nishi O, 2001, J CATARACT REFR SURG, V27, P608, DOI 10.1016/S0886-3350(00)00644-1
   Pandey SK, 2002, J CATARACT REFR SURG, V28, P139, DOI 10.1016/S0886-3350(01)01069-0
   Peng Q, 2000, J CATARACT REFR SURG, V26, P198, DOI 10.1016/S0886-3350(99)00352-1
   Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5
   Ram J, 1999, OPHTHALMOLOGY, V106, P891, DOI 10.1016/S0161-6420(99)00506-0
   Ram J, 2001, J CATARACT REFR SURG, V27, P1039, DOI 10.1016/S0886-3350(00)00841-5
   RICKMANBARGER L, 1989, AM J OPHTHALMOL, V107, P531, DOI 10.1016/0002-9394(89)90500-X
   Schmidbauer JM, 2001, INT OPHTHALMOL CLIN, V41, P109, DOI 10.1097/00004397-200107000-00010
   Schmidbauer JM, 2001, KLIN MONATSBL AUGENH, V218, P649, DOI 10.1055/s-2001-18386
   STEINERT RF, 1991, AM J OPHTHALMOL, V112, P373, DOI 10.1016/S0002-9394(14)76242-7
   Vargas LG, 2001, INT OPHTHALMOL CLIN, V41, P1, DOI 10.1097/00004397-200107000-00003
   Werner L, 2001, OPHTHALMOLOGY, V108, P1675, DOI 10.1016/S0161-6420(01)00674-1
   Werner L, 2000, OPHTHALMOLOGY, V107, P463, DOI 10.1016/S0161-6420(99)00088-3
NR 38
TC 23
Z9 27
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD JUL
PY 2002
VL 28
IS 7
BP 1241
EP 1250
AR PII S0886-3350(02)01216-6
DI 10.1016/S0886-3350(02)01216-6
PG 10
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 573EC
UT WOS:000176815500029
PM 12106735
DA 2018-10-19
ER

PT J
AU Liu, S
   Boutrand, JP
   Bittoun, J
   Tadie, M
AF Liu, S
   Boutrand, JP
   Bittoun, J
   Tadie, M
TI A collagen-based sealant to prevent in vivo reformation of epidural scar
   adhesions in an adult rat laminectomy model
SO JOURNAL OF NEUROSURGERY
LA English
DT Article
DE dura mater; laminectomy; membrane; nerve root; epidural scar adhesion
ID LUMBAR DISKECTOMY; FOLLOW-UP; SURGERY; GRAFTS
AB Object. The authors investigated the effect of a collagen-based sealant, Gel Amidon Oxyde (GAO), in preventing the reformation of epidural scar adhesions in an adult rat model of laminectomy.
   Methods. Thirty-two adult Sprague-Dawley rats underwent a complete L5-6 laminectomy, after which the dura mater was exposed and the left adjacent L-4 and L-5 nerve roots were exposed. The surgical wound was then closed; 1 month later it was reopened. The epidural scar adhesions that developed were observed and carefully removed, leaving clean dura and nerve roots reexposed. In 16 experimental rats, GAO was placed onto the reexposed dura and around the nerve roots before it polymerized. No treatment was performed in 16 control rats. Postoperatively, all rats were healthy and without neurological deficit. The incisions healed within 1 week regardless of the treatment with the GAO. Three months after reoperation, magnetic resonance imaging revealed that important epidural adhesions were present in the control rats but not in the experimental rats. These findings were then confirmed by gross anatomical examination in which a white tissue layer was found over the dura without adhesions in the experimental animals, whereas significant epidural scar adhesions were demonstrated in the controls. Histological evaluation of the laminectomy site also showed that the peridural space in the experimental rats was larger than that in the controls.
   Conclusions. The authors found that GAO may be a safe and effective antiscarring adhesion biomaterial in vivo. When placed into the laminectomy site, GAO may prove beneficial in preventing the formation and reformation of epidural scar adhesions in humans.
C1 Hop Bicetre, Dept Neurosurg, Lab Expt Neurosurg, Assistance Publ Hop Paris, F-94275 Le Kremlin Bicetre, France.
   Univ Paris 11, CNRS, Res Unit Magnet Resonance Med, Le Kremlin Bicetre, France.
   Biomatech, Biomatech Testing Lab, Chasse Sur Rhone, France.
RP Liu, S (reprint author), Hop Bicetre, Dept Neurosurg, Lab Expt Neurosurg, Assistance Publ Hop Paris, F-94275 Le Kremlin Bicetre, France.
EM liusong986@hotmail.com
CR BARBERA J, 1978, J NEUROSURG, V49, P419, DOI 10.3171/jns.1978.49.3.0419
   BENOIST M, 1980, SPINE, V5, P432, DOI 10.1097/00007632-198009000-00007
   BODEN SC, 1992, SPINE, P1899
   BURTON CV, 1981, CLIN ORTHOP RELAT R, V157, P191
   CAUCHOIX J, 1978, Spine, V3, P256
   Dullerud R, 1998, SPINE, V23, P1464, DOI 10.1097/00007632-199807010-00007
   JACOBS RR, 1980, SPINE, V5, P223, DOI 10.1097/00007632-198005000-00004
   KELLER JT, 1978, J NEUROSURG, V49, P412, DOI 10.3171/jns.1978.49.3.0412
   Kiviluoto O, 1976, Acta Orthop Scand Suppl, P3
   LANGENSKIOLD A, 1976, CLIN ORTHOP RELAT R, V115, P92
   LAROCCA H, 1974, J BONE JOINT SURG BR, VB 56, P545
   LAWSON KJ, 1991, SPINE, V16, pS222, DOI 10.1097/00007632-199106001-00009
   LEE CK, 1984, SPINE, V9, P305, DOI 10.1097/00007632-198404000-00016
   Liu S, 2001, J NEUROSURG, V94, P61, DOI 10.3171/spi.2001.94.1.0061
   LONG DM, 1992, ATLAS SPINAL SURG, P23
   MARTINFERRER S, 1989, NEUROSURGERY, V24, P718, DOI 10.1227/00006123-198905000-00010
   MERRILD U, 1986, J BONE JOINT SURG BR, V68, P706
   NORTH RB, 1991, NEUROSURGERY, V28, P685, DOI 10.1227/00006123-199105000-00008
   Pospiech J, 1995, Eur Spine J, V4, P213, DOI 10.1007/BF00303413
   Ross JS, 1996, NEUROSURGERY, V38, P855, DOI 10.1227/00006123-199604000-00053
   SPANGFORT EV, 1972, ACTA ORTHOP SCAND S, V142, P5
NR 21
TC 15
Z9 16
U1 0
U2 1
PU AMER ASSOC NEUROLOGICAL SURGEONS
PI ROLLING MEADOWS
PA 5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA
SN 0022-3085
EI 1933-0693
J9 J NEUROSURG
JI J. Neurosurg.
PD JUL
PY 2002
VL 97
IS 1
SU S
BP 69
EP 74
DI 10.3171/spi.2002.97.1.0069
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 571RE
UT WOS:000176730200011
PM 12120654
DA 2018-10-19
ER

PT J
AU Kumar, RR
   Wang, M
AF Kumar, RR
   Wang, M
TI Functionally graded bioactive coatings of hydroxyapatite/titanium oxide
   composite system
SO MATERIALS LETTERS
LA English
DT Article
DE hydroxyapatite (HA); biomaterial; composite; functionally graded
   material; Ti6Al4V; nano-indentation
ID PLASMA
AB Hydroxyapatite powder (P81B, HA, Plasma Biotal, UK) was mixed with titanium oxide (TiO2) in different weight percentages for producing functionally graded bioactive coatings. Composite coatings were made on Ti6Al4V metal substrate. A functionally graded coating was obtained by coating titanium oxide (TiO2) powders of known particle size as the first layer, which was sintered at 900degreesC for a few minutes. Coating of subsequent layers of HA-TiO2 composites of different weight ratios (75% TiO2 and 25% HA, 50% TiO2 and 50% HA, 25% TiO2 and 75% HA, and 100% HA) were performed in sequence and these layers were sintered again at 900degreesC for a few minutes so as to ensure a good adhesion between layers. The coatings were subsequently subjected to various characterization such as X-ray diffraction (XRD), scanning electron microscopy (SEM), energy dispersive X-ray (EDX), Fourier infra-red spectroscopy (FTIR) and hardness studies. The XRD results confirmed the presence of the corresponding components in HA composites. SEM micrographs showed the surface morphology of the functionally graded layers, and the presence of elements was also identified by EDX analysis which confirms the versatility of the coating technique performed at low temperature. Nano-indentation studies revealed that RA-TiO2-Ti functionally graded coating yielded 15.1 and 0.405 GPa as the hardness and modulus values, respectively. (C) 2002 Elsevier Science B.V All rights reserved.
C1 Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
   Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Kumar, RR (reprint author), Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
RI Wang, Min/C-1584-2009
OI Wang, Min/0000-0002-6495-5637
CR BAN S, 1994, BIOCERAMICS, V7, P261
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   FILIAGGI MJ, 1991, J BIOMED MATER RES, V25, P1211, DOI 10.1002/jbm.820251004
   Gledhill HC, 1999, BIOMATERIALS, V20, P315, DOI 10.1016/S0142-9612(98)00166-5
   KUMAR RR, 1997, P IMMM, P618
   LEMONS JE, 1988, CLIN ORTHOP RELAT R, P220
   MARUNO S, 1992, NIPPON SERAM KYO GAK, V100, P362
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 8
TC 73
Z9 81
U1 2
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL
PY 2002
VL 55
IS 3
BP 133
EP 137
AR PII S0167-577X(01)00635-8
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 573VH
UT WOS:000176852000001
DA 2018-10-19
ER

PT J
AU Sanders, JE
   Malcolm, SG
   Bale, SD
   Wang, YN
   Lamont, S
AF Sanders, JE
   Malcolm, SG
   Bale, SD
   Wang, YN
   Lamont, S
TI Prevascularization of a biomaterial using a chorioallontoic membrane
SO MICROVASCULAR RESEARCH
LA English
DT Article
DE vascular remnants; angiogenesis; polyurethane; vessel ingrowth
ID ANGIOGENESIS
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RI Wang, Yak-Nam/D-4924-2011
FU NICHD NIH HHS [R01 HD038554, R01 HD038554-01, HD-38554]
CR AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9
   Buschard K, 1996, APMIS, V104, P609, DOI 10.1111/j.1699-0463.1996.tb04920.x
   CLOWES AW, 1987, AM J SURG, V153, P501, DOI 10.1016/0002-9610(87)90802-6
   Dermarchez M., 1992, TRANSPLANTATION, V54, P317
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   Medalie DA, 1996, ASAIO J, V42, pM455, DOI 10.1097/00002480-199609000-00030
   MENGER MD, 1990, EUR J CARDIO-THORAC, V4, P191, DOI 10.1016/1010-7940(90)90003-I
   POLVERINI PJ, 1989, CYTOKINES, V1, P54
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
NR 11
TC 7
Z9 8
U1 1
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0026-2862
J9 MICROVASC RES
JI Microvasc. Res.
PD JUL
PY 2002
VL 64
IS 1
BP 174
EP 178
DI 10.1006/mvre.2002.2410
PG 5
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 569YN
UT WOS:000176631000020
PM 12074644
DA 2018-10-19
ER

PT J
AU Bilek, MMM
   McKenzie, DR
   Tarrant, RN
   Lim, SHM
   McCulloch, DG
AF Bilek, MMM
   McKenzie, DR
   Tarrant, RN
   Lim, SHM
   McCulloch, DG
TI Plasma-based ion implantation utilising a cathodic arc plasma
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Workshop on Plasma-Based Ion Implantation (PBII-2001)
CY JUN 25-28, 2001
CL GRENOBLE, FRANCE
SP CNRS, Univ Joseph Fourier, Inst Natl Polytechn Grenoble, European Commiss, Minist Affaires Etrangeres, Minist Educ Natl, Minist Defense/DGA, City Grenoble, Reg Rhone Alpes, Grenoble Alps METROPOLE
DE cathodic arc; ion implantation; stress relaxatiom; adhesion; preferred
   orientation; biomaterials
ID PREFERRED ORIENTATION; VACUUM-ARC; DEPOSITION
AB Plasma-based ion implantation (PBII) is usually carried out with isotropic gaseous plasmas, such as a discharge in nitrogen. More recently. it has been applied using drifting plasmas, such as those produced by cathodic arcs, in order to allow efficient implantation of metallic species. The condensable nature of a cathodic are plasma allows for the deposition of ion-stitched thin film coatings, as well as surface modification by ion implantation. In this paper the promising results for biomaterial fabrication are discussed in light of current limitations of the technique. The use of PBII to control preferred orientation ill titanium nitride films is also discussed, together with implications for the physical mechanisms involved in the development of preferred orientations in thin films. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Sydney, Sch Phys, Appl & Plasma Phys Dept, Sydney, NSW 2006, Australia.
   RMIT Univ, Dept Appl Phys, Melbourne, Vic 3001, Australia.
RP Bilek, MMM (reprint author), Univ Sydney, Sch Phys, Appl & Plasma Phys Dept, A28, Sydney, NSW 2006, Australia.
RI McCulloch, Dougal/G-7039-2012; Lim, Sunnie/A-2827-2012
OI McKenzie, David/0000-0002-2476-1301; Bilek, Marcela/0000-0003-3363-2664
CR ANDERS A, 1994, J VAC SCI TECHNOL B, V12, P815, DOI 10.1116/1.587351
   Anders A, 2001, SURF COAT TECH, V136, P85, DOI 10.1016/S0257-8972(00)01017-3
   Bilek MMM, 2000, J APPL PHYS, V87, P4198, DOI 10.1063/1.373052
   BILEK MMM, 2000, J APPL PHYS, V89, P923
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   Howlett CR, 1999, J BIOMED MATER RES, V45, P345, DOI 10.1002/(SICI)1097-4636(19990615)45:4<345::AID-JBM9>3.0.CO;2-J
   LIEBERMAN MA, 1989, J APPL PHYS, V66, P2926, DOI 10.1063/1.344172
   Lim SH, UNPUB
   Mantese JV, 1996, MRS BULL, V21, P52
   Marks NA, 1997, PHYS REV B, V56, P2441, DOI 10.1103/PhysRevB.56.2441
   Marlo M, 2000, PHYS REV B, V62, P2899, DOI 10.1103/PhysRevB.62.2899
   McKenzie DR, 2001, THIN SOLID FILMS, V382, P280, DOI 10.1016/S0040-6090(00)01702-8
   McKenzie DR, 1999, J APPL PHYS, V86, P230, DOI 10.1063/1.370721
   MULLER KH, 1988, J VAC SCI TECHNOL A, V6, P1690
   PELLEG J, 1991, THIN SOLID FILMS, V197, P117, DOI 10.1016/0040-6090(91)90225-M
   Tarrant RN, 2001, SURF COAT TECH, V136, P188, DOI 10.1016/S0257-8972(00)01052-5
   TARRANT RN, IN PRESS SURF COAT T
   Yap E, 1998, J APPL PHYS, V83, P3404, DOI 10.1063/1.367108
NR 18
TC 75
Z9 75
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 1
PY 2002
VL 156
IS 1-3
BP 136
EP 142
AR PII S0257-8972(02)00078-6
DI 10.1016/S0257-8972(02)00078-6
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 567JB
UT WOS:000176480700024
DA 2018-10-19
ER

PT J
AU Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Chen, F
   Chu, PK
AF Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Chen, F
   Chu, PK
TI In vivo study of Ti-O thin film fabricated by PIII
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 6th International Workshop on Plasma-Based Ion Implantation (PBII-2001)
CY JUN 25-28, 2001
CL GRENOBLE, FRANCE
SP CNRS, Univ Joseph Fourier, Inst Natl Polytechn Grenoble, European Commiss, Minist Affaires Etrangeres, Minist Educ Natl, Minist Defense/DGA, City Grenoble, Reg Rhone Alpes, Grenoble Alps METROPOLE
DE in vivo study; blood compatibility; biomaterial; plasma immersion ion
   implantation (PIII)
ID BLOOD COMPATIBILITY; BIOMATERIALS; MORPHOLOGY
AB Over the past decade, much attention has been paid to anti-thrombotic materials applied in artificial organs, Surface modification has shown potential to improve the anti-coagulation of blood-contacting biomedical devices and materials [1-3]. Our in vitro study of Ti-O thin films has recently shown that Ti-O thin films Possess Superior blood compatibility to low temperature isotropic pyrolytic carbon (LTI-carbon) [1]. In this work, we have focussed our attention onto the in vivo evaluation of Ti-O thin films fabricated by plasma immersion ion implantation (PIII). The samples of titanium coated by Ti-O thin films were implanted in dogs' hearts for I month. The results of the implantation showed that no thrombus was found on the surfaces of the Ti-O thin film, although the coagulation occurred on the surfaces of LTI-carbon. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 SW Jiatong Univ, Dept Mat Engn, Inst Surface Engn Biomat, Chengdu 610031, Sichuan, Peoples R China.
   Southeast Univ, Inst Med, Dept Chest Surg, Nanjing 210000, Jiangsu, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RP Huang, N (reprint author), SW Jiatong Univ, Dept Mat Engn, Inst Surface Engn Biomat, Chengdu 610031, Sichuan, Peoples R China.
RI Chu, Paul/B-5923-2013; Leng, Yongxiang/G-5488-2010
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   BRASH JL, 1979, J POLYM SCI POL SYM, P377
   CACCIAFESTA P, 6 WORLD BIOM C T SOC, P287
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   GOODMAN SL, 1995, CELL MATER, V5, P15
   Heublein B, 1998, J ENDOVASC SURG, V5, P32, DOI 10.1583/1074-6218(1998)005<0032:SCCSCE>2.0.CO;2
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Nojiri C, 1990, ASAIO Trans, V36, pM168
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   SIT PS, 6 WORLD BIOM C T SOC, P63
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   YANGS P, 6 WORLD BIOM C SOC B, P1025
NR 14
TC 35
Z9 42
U1 1
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUL 1
PY 2002
VL 156
IS 1-3
BP 284
EP 288
AR PII S0257-8972(02)00087-7
DI 10.1016/S0257-8972(02)00087-7
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 567JB
UT WOS:000176480700051
DA 2018-10-19
ER

PT J
AU Stoll, MR
   Cook, JL
   Pope, ER
   Carson, WL
   Kreeger, JM
AF Stoll, MR
   Cook, JL
   Pope, ER
   Carson, WL
   Kreeger, JM
TI The use of porcine small intestinal submucosa as a biomaterial for
   perineal herniorrhaphy in the dog
SO VETERINARY SURGERY
LA English
DT Article; Proceedings Paper
CT Meeting of the American-College-of-Veterinary-Surgeons
CY OCT, 2001
CL CHICAGO, ILLINOIS
SP American Coll Veterinary Surg
ID PELVIC DIAPHRAGM; VASCULAR GRAFT; HERNIA; REPAIR; TRANSPOSITION; MUSCLE;
   GROWTH; MODEL
AB Objectives-To develop an in vivo perineal hernia model, to develop a technique for using small intestinal submucosa (SIS) in perineal hernia repair, to further elucidate the biological behavior of SIS, and to compare SIS herniorrhaphy with the internal obturator muscle transposition (IOT) technique.
   Study Design-Prospective evaluation comparing SIS herniorrhaphy with IOT.
   Animals-Twelve adult castrated male, large-breed dogs.
   Methods-All dogs had bilateral pelvic diaphragm defects created by complete excision of the levator am muscle. Each dog had one side repaired using SIS and the other by IOT. Pain and inflammation were subjectively scored. Dogs were killed 2 weeks (n = 4), 12 weeks (n = 4), or 16 weeks (n = 4) after surgery. Each pelvic diaphragm was biomechanically tested to failure. The pelvic diaphragms from 2 normal dogs (n = 4 sides) were also biomechanically tested. Failure site, maximum pressure, displacement at failure, and initial linear stiffness values were determined. Histologic assessment was performed. Statistical analysis was performed with significance set at P < .05
   Results-No significant postoperative complications were noted. There were no significant differences in maximum pressure to failure, displacement, or stiffness when comparing normal, SIS, and IOT at any time point. The SIS group had significantly less displacement (P = .004) at 2 weeks than at weeks 12 or 16. For all herniorrhaphy techniques, the failure site was central (n = 22) or at the suture line (n = 2). At 2 weeks, histologic evaluation of tissues from the IOT group showed inflammation, mineralization, and necrosis, which were not present in tissues from the SIS group. Histologic examination at 12 and 16 weeks showed no microscopic differences in cell population or tissue characteristics between the IOT and SIS groups.
   Conclusions-SIS herniorrhaphy was successfully performed in this in vivo model of perineal hernia in the dog.
   Clinical Relevance-This study suggests that SIS can be used as a primary means of repair, as augmentation when the internal obturator muscle is thin and friable, or as a salvage procedure in cases of recurrence in dogs with perineal hernia. (C) Copyright 2002 by The American College of Veterinary Surgeons.
C1 Univ Missouri, Dept Vet Med & Surg, Columbia, MO 65211 USA.
   Univ Missouri, Comparat Orthopaed Lab, Columbia, MO 65211 USA.
   Univ Missouri, Coll Engn, Columbia, MO 65211 USA.
RP Stoll, MR (reprint author), 379 E Campus Dr,Clydesdale Hall, Columbia, MO 65211 USA.
OI Cook, James/0000-0002-0862-995X
CR BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   BELLENGER CR, 1980, AUST VET J, V56, P434, DOI 10.1111/j.1751-0813.1980.tb02637.x
   BLAKELY CL, 1957, CANINE SURG, P458
   BOJRAB MJ, 1981, COMPEND CONTIN ED PR, V3, P8
   BURROWS CF, 1973, J SMALL ANIM PRACT, V14, P315, DOI 10.1111/j.1748-5827.1973.tb06466.x
   CALI RL, 1992, DIS COLON RECTUM, V35, P604, DOI 10.1007/BF02050544
   CHAMBERS JN, 1991, J AM VET MED ASSOC, V199, P84
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cobb MA, 1996, SURG NEUROL, V46, P389, DOI 10.1016/S0090-3019(96)00202-9
   DESAI R, 1982, J AM ANIM HOSP ASSOC, V18, P195
   Francioni G, 1999, Chir Ital, V51, P21
   FRANKLAND AL, 1986, VET REC, V119, P13, DOI 10.1136/vr.119.1.13
   HARVEY CE, 1977, J SMALL ANIM PRACT, V18, P505, DOI 10.1111/j.1748-5827.1977.tb05921.x
   HAYES HM, 1978, J AM ANIM HOSP ASSOC, V14, P703
   HILES MC, 1993, J BIOMED MATER RES, V27, P139, DOI 10.1002/jbm.820270202
   Holmes JR, 1964, VET REC, V76, P1250
   Houlton J. E. F., 1983, Veterinary Annual, V23, P209
   KRAHWINKEL DJ, 1983, VET SURG, V12, P160, DOI 10.1111/j.1532-950X.1983.tb00732.x
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   LANTZ GC, 1992, J SURG RES, V53, P175, DOI 10.1016/0022-4804(92)90031-T
   LARSEN JS, 1966, J AM VET MED ASSOC, V149, P277
   MANN FA, 1995, AM J VET RES, V56, P134
   MATTHIESEN DT, 1989, COMP CONT EDUC PRACT, V11, P797
   ORSHER RJ, 1985, COMP CONT EDUC PRACT, V7, P233
   ORSHER RJ, 1986, VET SURG, V15, P253, DOI 10.1111/j.1532-950X.1986.tb00218.x
   PETTIT GD, 1962, CORNELL VET, V52, P261
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   SJOLLEMA BE, 1993, AM J VET RES, V54, P185
   SPRUELL JSA, 1980, J SMALL ANIM PRACT, V21, P265
   Voytik-Harbin SL, 1998, TISSUE ENG, V4, P157, DOI 10.1089/ten.1998.4.157
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WALKER RG, 1965, VET REC, V77, P93
   Wallace DG, 1988, COLLAGEN BIOTECHNOLO, P118
   WEAVER AD, 1981, J SMALL ANIM PRACT, V22, P749, DOI 10.1111/j.1748-5827.1981.tb00582.x
NR 37
TC 39
Z9 41
U1 5
U2 11
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0161-3499
J9 VET SURG
JI Vet. Surg.
PD JUL-AUG
PY 2002
VL 31
IS 4
BP 379
EP 390
DI 10.1053/jvet.2002.33596
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA 568YT
UT WOS:000176573100012
PM 12094353
DA 2018-10-19
ER

PT J
AU Brodbeck, WG
   Nakayama, Y
   Matsuda, T
   Colton, E
   Ziats, NP
   Anderson, JM
AF Brodbeck, WG
   Nakayama, Y
   Matsuda, T
   Colton, E
   Ziats, NP
   Anderson, JM
TI Biomaterial surface chemistry dictates adherent monocyte/macrophage
   cytokine expression in vitro
SO CYTOKINE
LA English
DT Article
DE biocompatibility; foreign body giant cell; inflammation; macrophage;
   wound healing
ID MESSENGER-RNA EXPRESSION; GIANT-CELL FORMATION; BLOOD MONONUCLEAR-CELLS;
   MONOCYTES MACROPHAGES; ADHESION; INTERLEUKIN-4; INVITRO; FUSION; FORM
AB An in vitro human monocyte culture system was used to determine whether adherent monocyte/macrophage cytokine production was influenced by material surface chemistry. A polyethylene terephthalate (PET) base surface was modified by photograft copolymerization to yield hydrophobic, hydrophilic, anionic and cationic surfaces. Freshly isolated human monocytes were cultured onto the surfaces for periods up to 10 days in the presence or absence of interleukin-4 (IL-4). Semi-quantitative RT-PCR analysis on days 3, 7 and 10 of cell culture revealed that interleukin-10 (IL-10) expression significantly increased in cells adherent to the hydrophilic and anionic surfaces but significantly decreased in the cationic surface adherent monocytes/macrophages. Conversely, interleukin-8 (IL-8) expression was significantly decreased in cells adherent to the hydrophilic and anionic surfaces. Further analysis revealed that the hydrophilic and anionic surfaces inhibited monocyte adhesion and IL-4-mediated macrophage fusion into foreign body giant cells (FBGCs). Therefore, hydrophilic and anionic surfaces promote an anti-inflammatory type of response by dictating selective cytokine production by biomaterial adherent monocytes and macrophages. These studies contribute information necessary to enhance our understanding of biocompatibility to be used to improve the in vivo lifetime of implanted medical devices and prostheses. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Case Western Reserve Univ, Dept Pathol, Cleveland, Qld, Australia.
   Case Western Reserve Univ, Dept Biomed Engn, Cleveland, Qld, Australia.
   Natl Cardiovasc Ctr, Dept Bioengn, Osaka, Japan.
   Kyushu Univ, Dept Biomed Engn, Fukuoka 812, Japan.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Sch Med, Inst Pathol, Rm 306, Cleveland, OH 44106 USA.
EM wgb2@po.cwru.cdu
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   ANDERSON JM, 1996, BIOMATERIALS SCI, P451
   Barth S, 2000, INFLAMM RES, V49, P266, DOI 10.1007/PL00000206
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Csiszar A, 2000, CLIN EXP IMMUNOL, V122, P464, DOI 10.1046/j.1365-2249.2000.01369.x
   De Rossi M, 2000, INT IMMUNOL, V12, P1329, DOI 10.1093/intimm/12.9.1329
   DEFIFE KM, 1995, J BIOMED MATER RES, V29, P431, DOI 10.1002/jbm.820290403
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   Defife KM, 1999, J BIOMAT SCI-POLYM E, V10, P1063, DOI 10.1163/156856299X00685
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P729
   Harris PR, 2000, J INFECT DIS, V181, P783, DOI 10.1086/315257
   HASSAN NF, 1989, J IMMUNOL, V143, P2179
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KREIPE H, 1988, AM J PATHOL, V130, P232
   MAEDA M, 1986, J BIOMED MATER RES, V20, P25, DOI 10.1002/jbm.820200104
   MATSUSHIMA K, 1992, CHEM IMMUNOL, V51, P236
   MCINNES A, 1988, J EXP MED, V167, P598, DOI 10.1084/jem.167.2.598
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nakaoka R, 2000, J BIOMED MATER RES, V49, P99, DOI 10.1002/(SICI)1097-4636(200001)49:1<99::AID-JBM12>3.3.CO;2-2
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   Shimozato O, 1996, CYTOKINE, V8, P99, DOI 10.1006/cyto.1996.0013
   SUTTON JS, 1966, J CELL BIOL, V28, P303, DOI 10.1083/jcb.28.2.303
   Tanaka T, 2000, J CATARACT REFR SURG, V26, P1409, DOI 10.1016/S0886-3350(99)00469-1
   VanCoillie E, 1997, BIOCHEM BIOPH RES CO, V231, P726, DOI 10.1006/bbrc.1997.6177
   WEINBERG JB, 1984, P NATL ACAD SCI-BIOL, V81, P4554, DOI 10.1073/pnas.81.14.4554
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 32
TC 146
Z9 150
U1 1
U2 40
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD JUN 21
PY 2002
VL 18
IS 6
BP 311
EP 319
DI 10.1006/cyto.2002.1048
PG 9
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 588TH
UT WOS:000177716400003
PM 12160519
DA 2018-10-19
ER

PT J
AU Shinzato, S
   Nakamura, T
   Kokubo, T
   Kitamura, Y
AF Shinzato, S
   Nakamura, T
   Kokubo, T
   Kitamura, Y
TI Composites consisting of poly(methyl methacrylate) and alumina powder:
   An evaluation of their mechanical and biological properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE alumina; composite; crystal phase; osteoconductivity; poly(methyl
   methacrylate) (PMMA)
ID BIOACTIVE BONE-CEMENT; BEAD COMPOSITE; FILLER CONTENT; GLASS POWDER;
   IN-VITRO; OSTEOCONDUCTIVITY; INTERFACE; RESIN
AB We developed new composites consisting of comparatively high molecular weight poly(methyl methacrylate) (hPMMA) and delta-alumina powder or alpha-alumina powder (designated delta-APC and alpha-APC, respectively) that allowed direct bone formation on their surfaces in vivo. delta-Alumina powder was manufactured by the fusing and quenching of pulverized alumina powder. It was composed mainly of delta-crystal phases of alumina. The purpose of this study was to evaluate the static mechanical properties and biological properties of these composites. The hPMMA itself was used as a reference material. The bending strength and Young's modulus of both delta-APC and alpha-APC were significantly higher than those of hPMMA, and the alumina composites are believed to be strong enough for use under weight-bearing conditions. The three types of composites were packed into the intramedullary canals of rat tibiae to evaluate osteoconductivity, as determined by an affinity index. Rats were sacrificed 4 and 8 weeks after surgery. The affinity index, equal to the length of bone in direct contact with the composite surface and expressed as a percentage of the total length of the composite surface, was calculated for each composite at each interval. Histologic ally, new bone had formed along the surfaces of both delta-APC and alpha-APC within 4 weeks. The affinity indices for both delta-APC and alpha-APC increased significantly with time up to 8 weeks. At 8 weeks, the affinity index for delta-APC was significantly higher than the indices for alpha-APC and hPMMA. This study revealed that the excellent osteoconductivity of delta-APC was due to the delta-crystal phases of alumina and the high molecular weight of hPMMA. delta-APC shows promise as a base for developing a highly osteoconductive and mechanically strong biomaterial. (C) 2002 Wiley Periodicals, Inc.
C1 Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Sakyo Ku, Kyoto 6068501, Japan.
   Nippon Elect Glass Co Ltd, Otsu, Shiga 5208639, Japan.
RP Shinzato, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kawahara Cho 54, Kyoto 6068507, Japan.
CR EVANS EJ, 1994, BIOMATERIALS, V15, P713, DOI 10.1016/0142-9612(94)90170-8
   FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489
   Fujita H, 2000, J BIOMED MATER RES, V49, P273, DOI 10.1002/(SICI)1097-4636(200002)49:2<273::AID-JBM17>3.0.CO;2-Y
   HAPER EJ, 1997, P INSTRUM MECH ENG H, V212, P113
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   KAWANABE K, 1993, J APPL BIOMATER, V4, P135, DOI 10.1002/jab.770040204
   Kobayashi M, 2000, J BIOMED MATER RES, V49, P319, DOI 10.1002/(SICI)1097-4636(20000305)49:3<319::AID-JBM4>3.3.CO;2-I
   Kobayashi M, 1999, J BIOMED MATER RES, V46, P447, DOI 10.1002/(SICI)1097-4636(19990915)46:4<447::AID-JBM2>3.3.CO;2-G
   Kobayashi M, 1997, J BIOMED MATER RES, V37, P68, DOI 10.1002/(SICI)1097-4636(199710)37:1<68::AID-JBM9>3.0.CO;2-H
   Kobayashi M, 1997, J BIOMED MATER RES, V37, P554
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   Miyaji F, 1998, J BIOMED MATER RES, V42, P604, DOI 10.1002/(SICI)1097-4636(19981215)42:4<604::AID-JBM17>3.0.CO;2-G
   Mousa WF, 2000, BIOMATERIALS, V21, P2137, DOI 10.1016/S0142-9612(00)00097-1
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   NAKAMURA T, 2000, T 6 WORLD BIOM C KAM, V3, P1098
   NAKAMURA T, 2000, BIOCERAMICS, V13, P661
   Okada Y, 2000, J BIOMED MATER RES, V49, P106, DOI 10.1002/(SICI)1097-4636(200001)49:1<106::AID-JBM13>3.3.CO;2-N
   SAHA S, 1984, J BIOMED MATER RES, V18, P435, DOI 10.1002/jbm.820180411
   Shinzato S, 2001, J BIOMED MATER RES, V54, P491, DOI 10.1002/1097-4636(20010315)54:4<491::AID-JBM40>3.3.CO;2-F
   Shinzato S, 2001, J BIOMED MATER RES, V55, P277, DOI 10.1002/1097-4636(20010605)55:3<277::AID-JBM1015>3.0.CO;2-5
   Shinzato S, 1999, J BIOMED MATER RES, V46, P287, DOI 10.1002/(SICI)1097-4636(199908)46:2<287::AID-JBM19>3.0.CO;2-I
   Shinzato S, 2000, J BIOMED MATER RES, V53, P51
   Shinzato S, 2000, J BIOMED MATER RES, V51, P258, DOI 10.1002/(SICI)1097-4636(200008)51:2<258::AID-JBM15>3.0.CO;2-S
   SHINZATO S, 2000, BIOCERAMICS, V13, P665
   SHINZATO S, 2000, T 6 WORLD BIOM C KAM, V3, P1109
   Sun JS, 1998, J BIOMED MATER RES, V39, P390, DOI 10.1002/(SICI)1097-4636(19980305)39:3<390::AID-JBM7>3.0.CO;2-E
   Tamura J, 1996, J BIOMED MATER RES, V30, P85, DOI 10.1002/(SICI)1097-4636(199601)30:1<85::AID-JBM11>3.0.CO;2-P
NR 29
TC 10
Z9 10
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2002
VL 60
IS 4
BP 585
EP 591
DI 10.1002/jbm.10104
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548BE
UT WOS:000175367500009
PM 11948517
DA 2018-10-19
ER

PT J
AU Cornelius, RM
   Archambault, JG
   Berry, L
   Chan, AKC
   Brash, JL
AF Cornelius, RM
   Archambault, JG
   Berry, L
   Chan, AKC
   Brash, JL
TI Adsorption of proteins from infant and adult plasma to biomaterial
   surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE infant; plasma; protein adsorption; SDS-PAGE; immunoblots;
   thromboembolism
ID MOLECULAR-WEIGHT KININOGEN; SULFONATED POLYURETHANE SURFACES; DEEP
   VENOUS THROMBOSIS; CORD-BLOOD; THROMBOEMBOLIC COMPLICATIONS;
   RADIOIODINATION METHODS; HEMOSTATIC SYSTEM; BINARY-MIXTURES;
   SINGLE-CHAIN; FIBRINOGEN
AB The hemostatic mechanism of the newborn is immature. In general, the clotting times in screening tests are prolonged, the coagulation factors are low, and the coagulation inhibitors (with the exception of alpha-2-macroglobulin) are low. Recognizing that many of the proteins present in infant plasma are at low levels, it is of interest to determine if, following exposure to artificial surfaces, the profile of adsorbed proteins is different for infant versus adult plasma. The question of whether differences in protein profiles could lead to differences in thromboembolic episodes associated with the use of central venous catheters (or other blood-contacting devices) in infant versus adult subjects also is relevant. To address these issues, the adsorption of proteins from pooled infant plasma and pooled normal adult plasma to three different polymer surfaces (polyvinyl chloride, PVC; polymethyl methacrylate, PMMA; and polyethylene oxide-modified polyurethane, PEO-PU) was studied using SDS-PAGE and immunoblotting techniques. The total amount of protein adsorbed to each surface also was determined. It was found that the PMMA and PVC surfaces adsorbed considerably more protein than the PEO-PU surface, Furthermore, the amount of protein adsorbed to the PMMA and PVC surfaces from infant plasma was significantly less than that adsorbed from adult plasma. No such difference was seen for the protein-repellent PEO-PU surface. The immunoblot responses of proteins bound to the PMMA and PVC surfaces from infant plasma were, in general, weaker than those bound from adult plasma. It is likely that these differences were due to decreased protein levels in infant plasma. (C) 2002 Wiley Periodicals, Inc.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
   Hamilton Civ Hosp, Res Ctr, Hamilton, ON L8V 1C3, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
OI Chan, Anthony K. C./0000-0003-1551-3995
CR Andrade J.D., 1985, PROTEIN ADSORPTION
   ANDREW M, 1994, BLOOD, V83, P1251
   ANDREW M, 1987, BLOOD, V70, P165
   ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95
   ANDREW M, 1992, BLOOD, V80, P1998
   ANDREW M, 1995, THROMB HAEMOSTASIS, V74, P415
   Archambault J. G., 1998, T SOC BIOMATER, V21, P251
   BAHAKIM H, 1990, ANN SAUDI MED, V10, P149, DOI 10.5144/0256-4947.1990.149
   BRASH JL, 1996, INTERFACIAL PHENOMEN
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   COON WW, 1973, CIRCULATION, V48, P839, DOI 10.1161/01.CIR.48.4.839
   Cornelius RM, 1997, J BIOMED MATER RES, V37, P314
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   Cornelius RM, 1997, BIOMATERIALS, V18, P429, DOI 10.1016/S0142-9612(96)00148-2
   Cornelius RM, 1999, BIOMATERIALS, V20, P341, DOI 10.1016/S0142-9612(98)00174-4
   DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061
   Du YJ, 2000, COLLOID SURFACE B, V17, P59, DOI 10.1016/S0927-7765(99)00053-3
   Ehrenforth S, 1999, EUR J PEDIATR, V158, pS97, DOI 10.1007/PL00014359
   GALANAKIS DK, 1976, BLOOD, V48, P109
   GIBSON BES, 1991, FETAL NEONATAL HAEMO, P123
   HAMULYAK K, 1983, THROMB RES, V32, P301, DOI 10.1016/0049-3848(83)90165-2
   HATHAWAY W, 1991, THROMB HAEMOSTASIS, V65, P323
   Hentschel R, 1999, EUR J PEDIATR, V158, pS126, DOI 10.1007/PL00014337
   Horbett TA, 1992, STABILITY PROTEIN A, P195
   JACKSON JC, 1987, J PEDIATR-US, V110, P102
   Luck M, 1998, J BIOMED MATER RES, V39, P478
   McClung WG, 2000, J BIOMED MATER RES, V49, P409, DOI 10.1002/(SICI)1097-4636(20000305)49:3<409::AID-JBM14>3.0.CO;2-0
   MEHTA S, 1992, J PEDIATR SURG, V27, P18, DOI 10.1016/0022-3468(92)90095-O
   Monreal M, 1996, THROMB HAEMOSTASIS, V75, P251
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   Prandoni P, 1997, ARCH INTERN MED, V157, P57, DOI 10.1001/archinte.157.1.57
   RAPOZA RJ, 1990, J COLLOID INTERF SCI, V136, P480, DOI 10.1016/0021-9797(90)90395-5
   Salonvaara M, 1999, ACTA PAEDIATR, V88, P642, DOI 10.1080/08035259950169305
   Schneider DM, 1997, J PERINAT MED, V25, P55, DOI 10.1515/jpme.1997.25.1.55
   Sheardown H, 1997, COLLOID SURFACE B, V10, P29, DOI 10.1016/S0927-7765(97)00045-3
   WITT I, 1969, THROMB DIATH HAEMOST, V22, P101
   Yamazaki A, 1999, BBA-BIOMEMBRANES, V1421, P103, DOI 10.1016/S0005-2736(99)00117-0
NR 37
TC 37
Z9 37
U1 1
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 15
PY 2002
VL 60
IS 4
BP 622
EP 632
DI 10.1002/jbm.10117
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 548BE
UT WOS:000175367500013
PM 11948521
DA 2018-10-19
ER

PT J
AU Xing, SM
   Waddell, JE
   Boynton, EL
AF Xing, SM
   Waddell, JE
   Boynton, EL
TI Changes in macrophage morphology and prolonged cell viability following
   exposure to polyethylene particulate in vitro
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE cell culture; wear particulate; biomaterials; implant failure
ID IN-VITRO; WEAR DEBRIS; PARTICLES; ARTHROPLASTY; INFLAMMATION;
   PHAGOCYTOSIS; SIZE
AB The interaction of macrophages and ultra-high molecular weight polyethylene (PE) wear plays an important role in perpetuating chronic inflammation at the bone implant interface, leading to peri-implant osteolysis and mechanical failure of the implant. A model to study the interaction of human mature macrophages with orthopaedic biomaterial wear has been previously developed. With the use of the model, in this study, the mature human monocyte-derived macrophages (MDMs) were observed with light, fluorescent, and scanning electron microscopy (SEM), as well as transmission electron microscopy (TEM). The cell viability was investigated using calcein and ethidium staining. Following exposure to PE particulate, the morphology of the human MDMs was heterogeneous: rounded, flattened, and elongated. There was no morphological evidence of cytotoxicity or apoptosis. The MDM viability was not influenced by phagocytosis of PE particulate in a negative fashion. In fact, more prolonged cell viability was observed in the human MDMs exposed to PE particulate when compared to controls. (C) 2002 Wiley-Liss, Inc.
C1 Univ Toronto, Dept Surg, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A8, Canada.
   Univ Toronto, Mt Sinai Hosp, Dept Surg, Toronto, ON M5G 1X5, Canada.
RP Boynton, EL (reprint author), Univ Toronto, Dept Surg, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A8, Canada.
CR BOYNTON E, 1991, CAN J SURG, V34, P599
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   Boynton EL, 1995, CAN J SURG, V38, P507
   CAMPBELL P, 1995, J BIOMED MATER RES, V29, P127, DOI 10.1002/jbm.820290118
   FRIEDMAN RJ, 1994, AAOS INSTR COURS LEC, V43, P233
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Heidenreich S, 1997, J IMMUNOL, V159, P3178
   Howie DW, 1996, CLIN ORTHOP RELAT R, pS217
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lee AW, 2000, BIOMATERIALS, V21, P851, DOI 10.1016/S0142-9612(99)00257-4
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Morrissette Naomi, 1999, Trends in Cell Biology, V9, P199, DOI 10.1016/S0962-8924(99)01540-8
   Neale SD, 1999, ACTA ORTHOP SCAND, V70, P452, DOI 10.3109/17453679909000980
   PAPADIMITRIOU JM, 1989, ULTRASTRUCT PATHOL, V13, P343, DOI 10.3109/01913128909048488
   PETTY HR, 1981, J CELL BIOL, V89, P223, DOI 10.1083/jcb.89.2.223
   RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2
   Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308
   Sandhu J, 1998, J RHEUMATOL, V25, P1794
   Santerre JP, 2000, CAN J SURG, V43, P173
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Voronov I, 1998, J BIOMED MATER RES, V39, P40, DOI 10.1002/(SICI)1097-4636(199801)39:1<40::AID-JBM6>3.3.CO;2-Y
   XING S, 2002, IN PRESS J BIOMED MA
   XING S, 2002, IN RPESS BIOMATERIAL
NR 23
TC 12
Z9 12
U1 3
U2 9
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 1059-910X
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD JUN 15
PY 2002
VL 57
IS 6
BP 523
EP 529
DI 10.1002/jemt.10106
PG 7
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 568GW
UT WOS:000176534900012
PM 12112435
DA 2018-10-19
ER

PT J
AU Abendan, RS
   Swift, JA
AF Abendan, RS
   Swift, JA
TI Surface characterization of cholesterol monohydrate single crystals by
   chemical force microscopy
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; TAPPING MODE; ATHEROSCLEROTIC LESIONS;
   MOLECULAR ASSEMBLIES; CONTACT ANGLES; MODIFIED TIPS; PHASE IMAGES;
   FRICTION; ADHESION; GOLD
AB Atomic force microscopy (AFM) and chemical force microscopy (CFM) techniques have been used to characterize the chemical functionality of cholesterol monohydrate single-crystal surfaces in different solution environments. Both synthetic and natural crystals adopt a platelike habit in which the largest face is (001). Under aqueous and organic solution conditions, in situ contact mode topographical images reveal that the plate face is primarily terminated by bilayer molecular structures and therefore largely homogeneous. Adhesion force measurements obtained with chemically modified tips demonstrate that the functionality of the crystal surface can be altered by changes in the solution composition. The 3-hydroxyl end of cholesterol molecules is presented on the plate face in aqueous media, while alkyl tail groups terminate the surface in organic solutions. Contact angle measurements on (001) surfaces exposed to solvents of different hydrophilicity also show similar trends, providing additional support to these AFM assignments. These studies link molecular-level and macroscopic adhesion properties and demonstrate that solution environment can exert a strong influence on the surface properties of this important biomaterial.
C1 Georgetown Univ, Dept Chem, Washington, DC 20057 USA.
RP Swift, JA (reprint author), Georgetown Univ, Dept Chem, 37th & O St NW, Washington, DC 20057 USA.
EM jas2@georgetown.edu
CR ADMIRAND WH, 1968, J CLIN INVEST, V47, P1043, DOI 10.1172/JCI105794
   BABCOCK KL, DIGITAL INSTRUMENTS
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Bar G, 1997, LANGMUIR, V13, P3807, DOI 10.1021/la970091m
   Beake BD, 1999, PHYS CHEM CHEM PHYS, V1, P3345, DOI 10.1039/a809994d
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BOGREN H, 1963, BIOCHIM BIOPHYS ACTA, V75, P65, DOI 10.1016/0006-3002(63)90580-8
   Brandsch R, 1997, LANGMUIR, V13, P6349, DOI 10.1021/la970822i
   Brewer NJ, 2001, LANGMUIR, V17, P1970, DOI 10.1021/la001568o
   Burnham N. A., 1993, Nanotechnology, V4, P64, DOI 10.1088/0957-4484/4/2/002
   Chen X, 2000, SURF SCI, V460, P292, DOI 10.1016/S0039-6028(00)00574-4
   CRAVEN BM, 1976, NATURE, V260, P727, DOI 10.1038/260727a0
   Danesh A, 2000, ANAL CHEM, V72, P3419, DOI 10.1021/ac991498u
   Drelich J, 1996, LANGMUIR, V12, P1913, DOI 10.1021/la9509763
   Duwez AS, 2001, LANGMUIR, V17, P6351, DOI 10.1021/la010440j
   Eaton PJ, 2000, LANGMUIR, V16, P7887, DOI 10.1021/la000159p
   FLYNN GL, 1979, J PHARM SCI, V68, P1090, DOI 10.1002/jps.2600680908
   FRISBIE CD, 1994, SCIENCE, V265, P2071, DOI 10.1126/science.265.5181.2071
   Good RJ, 1996, J ADHESION, V59, P25, DOI 10.1080/00218469608011074
   GREEN JBD, 1995, J PHYS CHEM-US, V99, P10960, DOI 10.1021/j100027a041
   JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141
   KATZ S S, 1976, Journal of Clinical Investigation, V58, P200
   Lioubashevski O, 2001, LANGMUIR, V17, P5134, DOI 10.1021/la0105174
   LOOMIS CR, 1979, J LIPID RES, V20, P525
   Magonov SN, 1997, SURF SCI, V375, pL385, DOI 10.1016/S0039-6028(96)01591-9
   McKendry R, 1998, LANGMUIR, V14, P2846, DOI 10.1021/la970374e
   *MERCK CO, 1996, MERCK IND
   Noy A, 1998, LANGMUIR, V14, P1508, DOI 10.1021/la970948f
   NOY A, 1995, J AM CHEM SOC, V117, P7943, DOI 10.1021/ja00135a012
   Noy A, 1997, ANNU REV MATER SCI, V27, P381, DOI 10.1146/annurev.matsci.27.1.381
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   OBERDOERFER Y, WWWU MUENSTER
   OVERNEY RM, 1994, LANGMUIR, V10, P1281, DOI 10.1021/la00016a049
   PerlTreves D, 1996, CHEM BIOL, V3, P567, DOI 10.1016/S1074-5521(96)90148-9
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   SAAD HY, 1965, J PHARM SCI, V54, P1205, DOI 10.1002/jps.2600540826
   Schonherr H, 2000, CHEM MATER, V12, P3689, DOI 10.1021/cm0010351
   SEDAGHAT A, 1980, NEW ENGL J MED, V302, P1274, DOI 10.1056/NEJM198006053022302
   SHIEH HS, 1977, NATURE, V267, P287, DOI 10.1038/267287a0
   Sinniah SK, 1996, J AM CHEM SOC, V118, P8925, DOI 10.1021/ja961295c
   SMALL DM, 1974, SCIENCE, V185, P222, DOI 10.1126/science.185.4147.222
   STARY HC, 1990, EUR HEART J, V11, P3, DOI 10.1093/eurheartj/11.suppl_E.3
   Tejada F, 2001, CRYST GROWTH DES, V1, P199, DOI 10.1021/cg0102857
   Ton-That C, 2000, CHEM MATER, V12, P2106, DOI 10.1021/cm000124a
   Viswanathan R, 1997, LANGMUIR, V13, P1840, DOI 10.1021/la9607823
   WANG JL, 1992, J PHYS CHEM-US, V96, P15, DOI 10.1021/j100180a006
   WEISENHORN AL, 1992, PHYS REV B, V45, P11226, DOI 10.1103/PhysRevB.45.11226
   Woodward JT, 2000, LANGMUIR, V16, P2957, DOI 10.1021/1a991068z
   Yang ZP, 1996, LANGMUIR, V12, P1704, DOI 10.1021/la951524t
NR 49
TC 45
Z9 45
U1 0
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JUN 11
PY 2002
VL 18
IS 12
BP 4847
EP 4853
DI 10.1021/la025649r
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 560QC
UT WOS:000176091900046
DA 2018-10-19
ER

PT J
AU Anastase-Ravion, S
   Carreno, MP
   Blondin, C
   Ravion, O
   Champion, J
   Chaubet, F
   Haeffner-Cavaillon, N
   Letourneur, D
AF Anastase-Ravion, S
   Carreno, MP
   Blondin, C
   Ravion, O
   Champion, J
   Chaubet, F
   Haeffner-Cavaillon, N
   Letourneur, D
TI Heparin-like polymers modulate proinflammatory cytokine production by
   lipopolysaccharide-stimulated human monocytes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE cytokine; heparin-like; interleukin; lipopolysaccharide; monocytes
ID NECROSIS-FACTOR-ALPHA; IN-VITRO; COMPLEMENT ACTIVATION;
   ENDOTHELIAL-CELLS; DEXTRAN SULFATE; SEPSIS SYNDROME; WHOLE-BLOOD;
   ANTICOAGULANT; FUCOIDAN; PROLIFERATION
AB The search for heparin-like materials remains an intensive field of research. In this context, we studied the immunomodulatory properties of semisynthetic dextran derivatives and naturally occurring sulfated polysaccharides present in brown seaweed (fucans). In this study, we investigated the functional potencies of fucan and dextran derivatives by analyzing their effects on the release of proinflammatory cytokines by resting or lipopolysaccharide (LPS)stimulated human monocytes and their interactions on monocyte surfaces. The results showed that fucan, dextran derivatives, and heparin differentially (1) triggered interleukin-let, tumor necrosis factor alpha, interleukin-6, and interleukin-8 production by monocytes in a dose-dependent manner, (2) modulated cytokine production by LPS-stimulated monocytes, and (3) specifically inhibited the binding of biotinylated LPS to monocyte membranes. Taken together, these data indicated that fucan and dextran derivatives displayed interesting immunomodulatory effects on human blood cells that could be relevant as new drugs or biomaterial coatings. Indeed, such polysaccharides, by regulating monocyte activation, could contribute to the improved biocompatibility of implants. (C) 2002 Wiley Periodicals, Inc.
C1 X Bichat Med Sch, INSERM, ERIT M, F-75018 Paris, France.
   Univ Paris 13, Inst Galilee, LRM, F-93430 Villetaneuse, France.
   Hop Broussais, INSERM, U430, F-75014 Paris, France.
RP Letourneur, D (reprint author), X Bichat Med Sch, INSERM, ERIT M, F-75018 Paris, France.
RI Didier, letourneur/H-5268-2012; Chaubet, Frederic/L-4570-2017;
   Haeffner-Cavaillon, Nicole/A-1921-2013
OI Didier, letourneur/0000-0003-2197-9468; Chaubet,
   Frederic/0000-0001-7375-0425; Haeffner-Cavaillon,
   Nicole/0000-0002-1703-8561
CR ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934
   ANASTASERAVION S, 1999, THESIS U PARIS 13 PA
   ANDERSON JM, 1988, ASAIO, V11, P101
   Attanasio M, 1998, THROMB HAEMOSTASIS, V79, P959
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Blondin C, 1996, BIOMATERIALS, V17, P597, DOI 10.1016/0142-9612(96)88710-2
   Carr S, 1999, Biomed Sci Instrum, V35, P211
   Cavaillon JM, 1996, J ENDOTOXIN RES, V3, P471, DOI 10.1177/096805199600300605
   CAVAILLON JM, 1992, BACTERIAL ENDOTOXIC
   Chaubet F, 1995, CARBOHYD POLYM, V28, P145, DOI 10.1016/0144-8617(95)00084-4
   Chaubet F, 1999, POLYM INT, V48, P313, DOI 10.1002/(SICI)1097-0126(199904)48:4<313::AID-PI151>3.0.CO;2-H
   Chevolot L, 2001, CARBOHYD RES, V330, P529, DOI 10.1016/S0008-6215(00)00314-1
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   ELSASSERBEILE U, 1991, J IMMUNOL METHODS, V139, P191, DOI 10.1016/0022-1759(91)90188-L
   FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008
   GALLAY P, 1993, J IMMUNOL, V150, P5086
   Giraux JL, 1998, EUR J CELL BIOL, V77, P352, DOI 10.1016/S0171-9335(98)80094-0
   Guth HJ, 2000, INT J ARTIF ORGANS, V23, P675
   Heinzelmann M, 1998, INFECT IMMUN, V66, P5842
   Ingalls RR, 1999, INFECT DIS CLIN N AM, V13, P341, DOI 10.1016/S0891-5520(05)70078-7
   ITOH K, 1995, EUR SURG RES, V27, P184, DOI 10.1159/000129398
   JOHANN S, 1995, THROMB HAEMOSTASIS, V74, P998
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Kremer JP, 1996, ACTA HAEMATOL-BASEL, V95, P268
   KUENDER DY, 1996, PEDIATR INFECT DIS J, V15, P355
   LETOURNEUR D, 1993, J BIOMAT SCI-POLYM E, V4, P431, DOI 10.1163/156856293X00681
   LEY K, 1993, BLOOD, V81, P177
   Logeart D, 1997, EUR J CELL BIOL, V74, P376
   Lohmann CH, 2000, BIOMATERIALS, V21, P551, DOI 10.1016/S0142-9612(99)00211-2
   Manaster J, 1996, BRIT J HAEMATOL, V94, P48, DOI 10.1046/j.1365-2141.1996.6202063.x
   MAUZAC M, 1984, BIOMATERIALS, V5, P301, DOI 10.1016/0142-9612(84)90078-4
   McFadden G, 1997, BIOCHEM PHARMACOL, V54, P1271, DOI 10.1016/S0006-2952(97)00182-2
   Millet J, 1999, THROMB HAEMOSTASIS, V81, P391
   MYRVANG AK, 1995, THROMB RES, V80, P179
   Nardella A, 1996, CARBOHYD RES, V289, P201, DOI 10.1016/0008-6215(96)00110-3
   NELSON RM, 1993, BLOOD, V82, P3253
   Panichi V, 2000, KIDNEY INT, V58, pS96, DOI 10.1046/j.1523-1755.2000.07612.x
   Pertosa G, 2000, KIDNEY INT, V58, pS104, DOI 10.1046/j.1523-1755.2000.07613.x
   Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377
   Schumann RR, 1996, BLOOD, V87, P2805
   Senni K, 1998, J BIOMED MATER RES, V40, P164, DOI 10.1002/(SICI)1097-4636(199804)40:1<164::AID-JBM19>3.3.CO;2-4
   SOEDA S, 1995, BBA-MOL CELL RES, V1269, P85
   Solberg R, 1998, TRANSPLANT INT, V11, P252, DOI 10.1007/s001470050137
   SORIMACHI K, 1993, CELL BIOL INT, V17, P881, DOI 10.1006/cbir.1993.1151
   THOMAS H, 1995, BIOMATERIALS, V16, P1163, DOI 10.1016/0142-9612(95)93581-W
   Trindade MCD, 2001, BIOMATERIALS, V22, P253, DOI 10.1016/S0142-9612(00)00181-2
   TYRRELL DJ, 1995, TRENDS PHARMACOL SCI, V16, P198, DOI 10.1016/S0165-6147(00)89022-7
   VanOsselaer N, 1996, MEDIAT INFLAMM, V5, P346, DOI 10.1155/S0962935196000506
   Wuillemin WA, 1997, J IMMUNOL, V159, P1953
   YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1
NR 50
TC 18
Z9 19
U1 0
U2 4
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2002
VL 60
IS 3
BP 375
EP 383
DI 10.1002/jbm.10112
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536TD
UT WOS:000174717200005
PM 11920660
DA 2018-10-19
ER

PT J
AU Ohan, MP
   Weadock, KS
   Dunn, MG
AF Ohan, MP
   Weadock, KS
   Dunn, MG
TI Synergistic effects of glucose and ultraviolet irradiation on the
   physical properties of collagen
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE collagen; ultraviolet irradiation; glucose; crosslinking; enzyme
   resistance
ID CROSS-LINKING; FREE-RADICALS; IN-VITRO; GLYCATION; SUSCEPTIBILITY;
   GLYCOSYLATION; DEGRADATION; BIOMATERIAL; PROTEINS; FIBERS
AB Our objective was to strengthen and stabilize collagen films without the introduction of cytotoxic chemical crosslinkers. We hypothesized that collagen could be rapidly crosslinked with glucose with ultraviolet (UV) irradiation as a catalyst. In theory, UV-generated free radicals can expedite collagen crosslinking with glucose via the formation of reactive, linear glucose molecules. The mechanical properties of glucose-incorporated, UV-exposed collagen films and appropriate controls were determined under various conditions: (1) hydration in phosphate-buffered saline, (2) heat-denaturation, (3) incubation in a collagenase solution, and (4) incubation in a trypsin solution. Without exposure to UV, the incorporation of glucose into the films had no effect. Without glucose, exposure to UV increased the strength but caused significant denaturation. The combination of glucose and UV, however, synergistically improved the mechanical properties and enzyme resistance of collagen films, indicative of increased crosslinking without significant denaturation effects. The addition of thiourea, a potent free-radical scavenger, or aminoguanidine, an inhibitor of glucose-derived crosslinking, to the collagen films markedly hindered these synergistic effects. These data strongly suggest that free-radical-dependent, glucose-derived crosslinks provide the enhanced strength and enzyme resistance observed in glucose-incorporated, UV-exposed collagen films. Further studies are required to explore biomaterial applications of this novel collagen crosslinking method. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Orthopaed Surg, Orthopaed Res Labs, New Brunswick, NJ 08903 USA.
RP Dunn, MG (reprint author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Orthopaed Surg, Orthopaed Res Labs, New Brunswick, NJ 08903 USA.
EM dunnmg@umdnj.edu
OI Letourneur, Didier/0000-0003-2197-9468; Chaubet,
   Frederic/0000-0001-7375-0425
FU NIAMS NIH HHS [AR-42230]
CR ANGYAL SJ, 1984, ADV CARBOHYD CHEM BI, V42, P15, DOI 10.1016/S0065-2318(08)60122-5
   BAILEY AJ, 1964, RADIAT RES, V22, P606, DOI 10.2307/3571543
   BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405
   BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117
   BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669
   CARBONARE MD, 1992, J PHOTOCH PHOTOBIO B, V14, P105, DOI 10.1016/1011-1344(92)85086-A
   CHACE KV, 1991, ARCH BIOCHEM BIOPHYS, V288, P473, DOI 10.1016/0003-9861(91)90223-6
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   CHVAPIL M, 1973, INT REV CONNECTIVE T, P1
   Elgawish A, 1996, J BIOL CHEM, V271, P12964, DOI 10.1074/jbc.271.22.12964
   FU MX, 1994, DIABETES, V43, P676, DOI 10.2337/diabetes.43.5.676
   FUJIMORI E, 1989, BIOCHIM BIOPHYS ACTA, V998, P105, DOI 10.1016/0167-4838(89)90260-4
   Girton TS, 1999, J BIOMED MATER RES, V46, P87, DOI 10.1002/(SICI)1097-4636(199907)46:1<87::AID-JBM10>3.0.CO;2-K
   GORHAM SD, 1992, INT J BIOL MACROMOL, V14, P129, DOI 10.1016/S0141-8130(05)80002-9
   HANS S, 1992, ANAL BIOCHEM, V201, P336
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Koide T, 1997, Dent Mater J, V16, P1
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   KUNTZ E, 1962, RADIAT RES, V16, P568
   Miles CA, 2000, J BIOL CHEM, V275, P33014, DOI 10.1074/jbc.M002346200
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Nimni ME, 1988, COLLAGEN, VIII, P1
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   RUBIN AL, 1968, T AM SOC ART INT ORG, V14, P169
   Sajithlal GB, 1998, BBA-MOL BASIS DIS, V1407, P215, DOI 10.1016/S0925-4439(98)00043-X
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Stryer L., 1988, BIOCHEMISTRY
   VLASSARA H, 1994, LAB INVEST, V70, P138
   WEADOCK K, 1984, BIOMAT MED DEV ARTIF, V29, P1373
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WOLFF SP, 1986, BIOCHEM J, V234, P399, DOI 10.1042/bj2340399
   YANNAS AV, 1967, NATURE, V215, P509
   Yannas I. V., 1996, BIOMATERIALS SCI INT, V1, P84
NR 36
TC 51
Z9 52
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2002
VL 60
IS 3
BP 384
EP 391
DI 10.1002/jbm.10111
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536TD
UT WOS:000174717200006
PM 11920661
DA 2018-10-19
ER

PT J
AU Walboomers, XF
   Dalton, BA
   Evans, MD
   Steele, JG
   Jansen, JA
AF Walboomers, XF
   Dalton, BA
   Evans, MD
   Steele, JG
   Jansen, JA
TI Transforming growth factor-beta 1, 2, and 3 can inhibit epithelial
   tissue outgrowth on smooth and microgrooved substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE growth factor-beta; epithelial tissue outgrowth; microgrooved substrates
ID UNMODIFIED POLYSTYRENE; NEUTRALIZING ANTIBODY; CULTURE POLYSTYRENE;
   SURFACE-TOPOGRAPHY; GROOVED SUBSTRATA; CELL ATTACHMENT; FIBROBLASTS;
   MIGRATION; CHEMISTRY; POLYMER
AB In this study, we describe the influence of parallel surface microgrooves, and of TGF-beta, on the outgrowth of corneal epithelial tissue. Microgrooves (depth 1 mum, width 1-10 mum) were made in polystyrene culturing surfaces. These surfaces were left untreated, or loaded with TGF-beta 1, 2, or 3 (6.0 ng /cm(2)). Subsequently, epithelial explants from bovine corneas were placed on the experimental surfaces. After 9 days of culturing, tissue outgrowth was evaluated. Furthermore, the tissue cultures were analyzed histologically. It was shown that epithelial tissue grew from the explants over all experimental surfaces. On microgrooved surfaces outgrowth proceeded in the direction of the grooves, rather than perpendicular to the grooves. The addition of each type of TGF-beta resulted in a reduction of outgrowth. However, outgrowth remained directed by the grooves. Further, the explants had shrunk after TGF treatment. Histology showed that this shrinkage was not related to alpha-smooth muscle actin expression in the explants. We conclude that microgrooves can direct, and TGF-betas can inhibit the outgrowth of epithelial tissue. This finding could be useful in biomaterial applications where the growth of epithelial tissue needs to be discouraged. (C) 2002 Wiley Periodicals, Inc.
C1 Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   CSIRO Mol Sci, N Ryde, NSW 1670, Australia.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Walboomers, X.Frank/B-3692-2013; Evans, Margaret/B-3261-2011; Jansen,
   John/H-8055-2014
OI Evans, Margaret/0000-0003-3078-1576; 
CR ALBERTS B, 1995, MOL BIOL CELL
   BRUNET CL, 1995, INT J DEV BIOL, V39, P345
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   BRUNETTE DM, 1983, J DENT RES, V62, P1045, DOI 10.1177/00220345830620100701
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CLARK P, 1991, J CELL SCI, V99, P73
   Cordeiro MF, 1999, INVEST OPHTH VIS SCI, V40, P2225
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   Dalton BA, 1998, J BIOMAT SCI-POLYM E, V9, P781, DOI 10.1163/156856298X00154
   DALTON BA, 2000, J BIOMED MATER RES, V56, P195
   Damji A, 1996, EXP CELL RES, V228, P114, DOI 10.1006/excr.1996.0306
   Evans MDM, 2000, INVEST OPHTH VIS SCI, V41, P1674
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   GABBIANI G, 1992, KIDNEY INT, V41, P530, DOI 10.1038/ki.1992.75
   Hartsough MT, 1997, PHARMACOL THERAPEUT, V75, P21, DOI 10.1016/S0163-7258(97)00020-X
   Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   SHAH M, 1995, J CELL SCI, V108, P985
   SHAH M, 1994, J CELL SCI, V107, P1137
   SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   STEELE JG, 1993, J BIOMED MATER RES, V27, P927, DOI 10.1002/jbm.820270712
   TALIANA LT, 2000, IN PRESS INVEST OPHT
   Taya Y, 1999, DEVELOPMENT, V126, P3869
   Tseng SCG, 1999, J CELL PHYSIOL, V179, P325, DOI 10.1002/(SICI)1097-4652(199906)179:3<325::AID-JCP10>3.3.CO;2-O
   von Recum A.F., 1998, HDB BIOMATERIALS EVA
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WANATABE K, 1987, INVEST OPHTH VIS SCI, V28, P205
   Yang LJ, 1999, AM J PATHOL, V154, P105, DOI 10.1016/S0002-9440(10)65256-X
   Zicha D, 1999, J CELL SCI, V112, P447
NR 32
TC 3
Z9 4
U1 0
U2 1
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2002
VL 60
IS 3
BP 445
EP 451
DI 10.1002/jbm.1290
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536TD
UT WOS:000174717200013
PM 11920668
DA 2018-10-19
ER

PT J
AU Collier, TO
   Anderson, JM
AF Collier, TO
   Anderson, JM
TI Protein and surface effects on monocyte and macrophage adhesion,
   maturation, and survival
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH
LA English
DT Article
DE apoptosis; fibronectin; foreign-body giant cell; immunoglobulin G; human
   macrophage; RGD; vitronectin
ID GIANT-CELL FORMATION; IN-VITRO; BIOMATERIALS; FIBRONECTIN; FUSION;
   BINDING; IGG; RGD; VITRONECTIN; ATTACHMENT
AB Cell adhesion and maturation can be affected by the protein adsorption profile on the surface of an implanted biomaterial. In this study we have investigated how surface chemistry and adsorbed proteins can modulate monocyte and macrophage adhesion, IL-13-induced foreign-body giant cell formation, and apoptosis in vitro. Compared to a dimethylsilane-modified surface (DM), a surface modified with RGD peptides had no effect on adhesion density, foreign-body giant cell (FBGC) formation, or apoptosis in non-depleted serum conditions. The depletion of specific adhesive proteins affected adhesion, FBGC formation, and apoptosis. While the depletion of fibronectin and vitronectin had no overall effect compared to nondepleted serum conditions, the depletion of IgG from serum caused a significant decrease in initial adherent cell density [1000 +/- 200 compared to 2460 +/- 590 (p = 0.02)], a significant decrease in FBGC formation [2% compared to 17% (p = 0.02)], and a significant increase in the level of apoptosis [57% compared to 32% (p = 0.01)] on DM. The lowered initial adherent cell density on DM was not observed on the RGD surface, indicating that the RGD surface promotes increased initial adhesion. However, the RGD surface does not affect FBGC formation (i.e., macrophage fusion) or levels of apoptosis, which remained comparable to those on the DM surfaces at days 7 and 10. (C) 2002 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.
FU NHLBI NIH HHS [HL-55714, HL-33894]
CR Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   BLYSTONE SD, 1991, BLOOD, V78, P2900
   Brodbeck WG, 1996, J IMMUNOL, V156, P2528
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   Collier TO, 2000, J BIOMED MATER RES, V49, P141, DOI 10.1002/(SICI)1097-4636(200001)49:1<141::AID-JBM18>3.0.CO;2-A
   COLLIER TO, 2001, IN PRESS J BIOMED MA
   CRAMER AD, 1973, AM J CLIN PATHOL, V60, P148
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DeFife KM, 1999, FASEB J, V13, P823
   Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G
   DETOMA FJ, 1987, EXPT IMMUNOLOGY GUID
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P667, DOI 10.1002/jbm.820280603
   Gahmberg CG, 1998, CELL MOL LIFE SCI, V54, P549, DOI 10.1007/s000180050183
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V220, P13, DOI 10.1006/jcis.1999.6479
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jenney CR, 2000, J BIOMED MATER RES, V50, P281, DOI 10.1002/(SICI)1097-4636(20000605)50:3<281::AID-JBM1>3.0.CO;2-5
   Kao WJ, 1996, J BIOMED MATER RES, V32, P99, DOI 10.1002/(SICI)1097-4636(199609)32:1<99::AID-JBM12>3.3.CO;2-E
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   PANKOWSKY DA, 1990, J VASC SURG, V11, P599, DOI 10.1067/mva.1990.18272
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Richard CAH, 2000, BIOCHEM BIOPH RES CO, V271, P70, DOI 10.1006/bbrc.2000.2594
   ROSALES C, 1995, J LEUKOCYTE BIOL, V57, P189
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   VISSERS MCM, 1988, J IMMUNOL METHODS, V110, P203, DOI 10.1016/0022-1759(88)90104-4
   Werthen M, 2001, BIOMATERIALS, V22, P827, DOI 10.1016/S0142-9612(00)00246-5
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZIATS NP, 1988, BIOMATERIALS, V9, P5, DOI 10.1016/0142-9612(88)90063-4
NR 50
TC 51
Z9 53
U1 1
U2 8
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES
JI J. Biomed. Mater. Res.
PD JUN 5
PY 2002
VL 60
IS 3
BP 487
EP 496
DI 10.1002/jbm.10043
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536TD
UT WOS:000174717200019
PM 11920674
DA 2018-10-19
ER

PT J
AU Raitman, OA
   Katz, E
   Buckmann, AF
   Willner, I
AF Raitman, OA
   Katz, E
   Buckmann, AF
   Willner, I
TI Integration of polyaniline/poly(acrylic acid) films and redox enzymes on
   electrode supports: An in situ electrochemical/surface plasmon resonance
   study of the bioelectrocatalyzed oxidation of glucose or lactate in the
   integrated bioelectrocatalytic systems
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; DIRECT ELECTRICAL COMMUNICATION;
   QUARTZ-CRYSTAL MICROBALANCE; CHEMICALLY-MODIFIED ENZYMES;
   SURFACE-PLASMON; POLYANILINE FILMS; THIN-FILMS; AMPEROMETRIC BIOSENSORS;
   BIOFUEL CELL; METAL-ELECTRODES
AB Electropolymerization of aniline in the presence of poly(acrylic acid) on Au electrodes yields a polyaniline/poly(acrylic acid) composite film, exhibiting reversible redox functions in aqueous solutions at pH = 7.0. In situ electrochemical-SPR measurements are used to identify the dynamics of swelling and shrinking of the polymer film upon the oxidation of the polyaniline (PAn) to its oxidized state (PAn(2+)) and the reduction of the oxidized polymer (PAn(2+)) back to its reduced state (PAn), respectively. Covalent attachment of N-6-(2-aminoethyl)-flavin adenin dinucleotide (amino-FAD, 1) to the carboxylic groups of the composite polyaniline/poly(acrylic acid) film followed by the reconstitution of apoglucose oxidase on the functional polymer yields an electrically contacted glucose oxidase of unprecedented electrical communication efficiency with the electrode: electron-transfer turnover rate similar to1000 s(-1) at 30 degreesC. In situ electrochemical-SPR analyses are used to characterize the bioelectrocatalytic functions of the biomaterial-polymer interface. The current responses of the bioelectrocatalytic system increase as the glucose concentrations are elevated. Similarly, the SPR spectra of the system are controlled by the concentration of glucose. The glucose concentration controls the steady-state concentration ratio of PAn/PAn(2+) in the film composition. Therefore, the SPR spectrum of the film measured upon its electrochemical oxidation is shifted from the spectrum typical for the oxidized PAn(2+) at low glucose concentration to the spectrum characteristic of the reduced PAn at high glucose concentration. Similarly, the polyaniline/poly(acrylic acid) film acts as an electrocatalyst for the oxidation of NADH. Accordingly, an integrated bioelectrocatalytic assembly was constructed on the electrode by the covalent attachment of N-6-(2-aminoethyl)-beta-nicotinamide adenine dinucleotide (amino-NAD(+), 2) to the polymer film, and the two-dimensional cross-linking of an affinity complex formed between lactate dehydrogenase and the NAD(+)-cofactor units associated with the polymer using glutaric dialdehyde as a cross-linker. In situ electrochemical-SPR measurements are used to characterize the bioelectrocatalytic functions of the system. The amperometric responses of the system increase as the concentrations of lactate are elevated, and an electron-transfer turnover rate of 350 s(-1) between the biocatalyst and the electrode is estimated. As the PAn(2+) oxidizes the NADH units generated by the biocatalyzed oxidation of lactate, the PAn/PAn(2+) steady-state ratio in the film is controlled by the concentration of lactate, Accordingly, the SPR spectrum measured upon electrochemical oxidation of the film is similar to the spectrum of PAn(2+). at low lactate concentration, whereas the SPR spectrum resembles that of PAn at high concentrations of lactate.
C1 Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
   Gesell Biotechnol Forsch mbH, Dept Mol Struct Res, D-38124 Braunschweig, Germany.
RP Willner, I (reprint author), Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel.
EM willnea@vms.huji.ac.il
RI Raitman, Oleg/S-3960-2016
CR ANDRIEUX CP, 1978, J ELECTROANAL CHEM, V93, P163, DOI 10.1016/S0022-0728(78)80230-7
   BADIA A, 1993, J AM CHEM SOC, V115, P7053, DOI 10.1021/ja00069a001
   Badia A, 1999, SENSOR ACTUAT B-CHEM, V54, P145, DOI 10.1016/S0925-4005(98)00333-5
   Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   BARTLETT P N, 1991, Progress in Reaction Kinetics, V16, P55
   Bartlett PN, 2001, PHYS CHEM CHEM PHYS, V3, P1491, DOI 10.1039/b009377g
   Bartlett PN, 1996, J CHEM SOC FARADAY T, V92, P3123, DOI 10.1039/ft9969203123
   BARTLETT PN, 1993, ANAL CHEM, V65, P1118, DOI 10.1021/ac00056a029
   Bartlett PN, 2000, PHYS CHEM CHEM PHYS, V2, P2599, DOI 10.1039/b001107j
   Bartlett PN, 1997, J CHEM SOC FARADAY T, V93, P1951, DOI 10.1039/a700468k
   BARTLETT PN, 1994, ANAL CHEM, V66, P1552, DOI 10.1021/ac00081a031
   Bartlett PN, 1996, J CHEM SOC FARADAY T, V92, P4137, DOI 10.1039/ft9969204137
   Bechinger C, 1996, NATURE, V383, P608, DOI 10.1038/383608a0
   Beketov GV, 1998, SENSOR ACTUAT B-CHEM, V48, P432, DOI 10.1016/S0925-4005(98)00081-1
   Berger CEH, 2000, SENSOR ACTUAT B-CHEM, V63, P103, DOI 10.1016/S0925-4005(00)00307-5
   Blonder R, 1997, J AM CHEM SOC, V119, P11747, DOI 10.1021/ja972663v
   Brennan CB, 2001, SENSOR ACTUAT B-CHEM, V72, P1, DOI 10.1016/S0925-4005(00)00622-5
   Buckmann AF, 1997, METHOD ENZYMOL, V280, P360
   BUCKMANN AF, 1992, BIOTECHNOL APPL BIOC, V15, P303
   BUTTRY DA, 1992, CHEM REV, V92, P1355, DOI 10.1021/cr00014a006
   Cao TB, 2001, LANGMUIR, V17, P6034, DOI 10.1021/1a0102830
   Chegel V, 2001, CHEM COMMUN, P883, DOI 10.1039/b101243f
   COSNIER S, 1994, ANAL CHEM, V66, P3198, DOI 10.1021/ac00091a032
   Cosnier S, 1998, ELECTROANAL, V10, P521, DOI 10.1002/(SICI)1521-4109(199807)10:8<521::AID-ELAN521>3.3.CO;2-I
   Cui SY, 1999, SYNTHETIC MET, V105, P91, DOI 10.1016/S0379-6779(99)00079-X
   DEGANI Y, 1988, J AM CHEM SOC, V110, P2615, DOI 10.1021/ja00216a040
   DEGANI Y, 1987, J PHYS CHEM-US, V91, P1285, DOI 10.1021/j100290a001
   DIAZ AF, 1980, J ELECTROANAL CHEM, V111, P111, DOI 10.1016/S0022-0728(80)80081-7
   Disley DM, 1998, BIOSENS BIOELECTRON, V13, P1213, DOI 10.1016/S0956-5663(98)00059-1
   Ehler TT, 2000, J ELECTROANAL CHEM, V480, P94, DOI 10.1016/S0022-0728(99)00449-0
   EICHNER RD, 1982, METHOD ENZYMOL, V89, P359
   EMR SA, 1995, ELECTROANAL, V7, P913, DOI 10.1002/elan.1140071002
   Flatmark T, 2001, ANAL BIOCHEM, V294, P95, DOI 10.1006/abio.2001.5163
   Georgiadis R, 2000, LANGMUIR, V16, P6759, DOI 10.1021/la9917076
   GREGG BA, 1991, J PHYS CHEM-US, V95, P5970, DOI 10.1021/j100168a046
   Habermuller L, 2000, FRESEN J ANAL CHEM, V366, P560
   HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015
   HELLER A, 1990, ACCOUNTS CHEM RES, V23, P128, DOI 10.1021/ar00173a002
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9
   Iwasaki Y, 2001, ANAL CHEM, V73, P1595, DOI 10.1021/ac0012851
   JANNAKOUDAKIS PD, 1994, SYNTHETIC MET, V68, P17, DOI 10.1016/0379-6779(94)90142-2
   JIN W, 1995, BIOSENS BIOELECTRON, V10, P823, DOI 10.1016/0956-5663(95)99221-6
   JOHNSTON KS, 1995, MATER CHEM PHYS, V42, P242, DOI 10.1016/0254-0584(95)01659-I
   Kalinowski J, 1999, J PHYS D APPL PHYS, V32, pR179, DOI 10.1088/0022-3727/32/24/201
   Kambhampati DK, 1999, CURR OPIN COLLOID IN, V4, P273, DOI 10.1016/S1359-0294(99)90008-0
   Kang XF, 2001, ELECTROCHEM COMMUN, V3, P489, DOI 10.1016/S1388-2481(01)00170-9
   Katakis I, 1997, MIKROCHIM ACTA, V126, P11, DOI 10.1007/BF01242656
   Katz E, 1999, NEW J CHEM, V23, P481, DOI 10.1039/a808561g
   Katz E, 1999, J ELECTROANAL CHEM, V479, P64, DOI 10.1016/S0022-0728(99)00425-8
   KATZ E, 1994, J ELECTROANAL CHEM, V367, P59, DOI 10.1016/0022-0728(93)03010-M
   Katz E, 1999, ANAL CHIM ACTA, V385, P45, DOI 10.1016/S0003-2670(98)00688-6
   KATZ E, IN PRESS HDB FUEL CE
   Kharitonov AB, 2000, J ELECTROANAL CHEM, V487, P133, DOI 10.1016/S0022-0728(00)00178-9
   Kienle S, 1997, BIOSENS BIOELECTRON, V12, P779, DOI 10.1016/S0956-5663(97)00044-4
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   Koide S, 1999, J ELECTROANAL CHEM, V468, P193, DOI 10.1016/S0022-0728(99)00174-6
   Kruchinin AA, 1996, SENSOR ACTUAT B-CHEM, V30, P77, DOI 10.1016/0925-4005(95)01752-H
   KUMABATA S, 1995, ANAL CHEM, V67, P1684
   Lahav M, 2001, ANGEW CHEM INT EDIT, V40, P4095, DOI 10.1002/1521-3773(20011105)40:21<4095::AID-ANIE4095>3.0.CO;2-9
   MACDIARMID AG, 1985, MOL CRYST LIQ CRYST, V121, P187, DOI 10.1080/00268948508074859
   McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9
   Meyer WH, 1998, ADV MATER, V10, P439, DOI 10.1002/(SICI)1521-4095(199804)10:6<439::AID-ADMA439>3.0.CO;2-I
   Mitschke U, 2000, J MATER CHEM, V10, P1471, DOI 10.1039/a908713c
   MO D, 1993, THIN SOLID FILMS, V234, P468, DOI 10.1016/0040-6090(93)90309-D
   MORRIS DL, 1983, METHOD ENZYMOL, V92, P413
   Mullett WM, 2000, METHODS, V22, P77, DOI 10.1006/meth.2000.1039
   Oekermann T, 2001, PHYS CHEM CHEM PHYS, V3, P3387, DOI 10.1039/b101024g
   OHSAKA T, 1984, J ELECTROANAL CHEM, V161, P399, DOI 10.1016/0368-1874(84)83662-X
   Palaniappan S, 2001, EUR POLYM J, V37, P975, DOI 10.1016/S0014-3057(00)00207-X
   Raiteri R, 2001, SENSOR ACTUAT B-CHEM, V79, P115, DOI 10.1016/S0925-4005(01)00856-5
   Rao JH, 1999, J AM CHEM SOC, V121, P2629, DOI 10.1021/ja9838763
   SADOWSKI JW, 1995, OPT ENG, V34, P2581, DOI 10.1117/12.208083
   Salamon Z, 1997, BBA-REV BIOMEMBRANES, V1331, P117, DOI 10.1016/S0304-4157(97)00004-X
   Sasaki S, 1998, ANAL CHIM ACTA, V368, P71, DOI 10.1016/S0003-2670(98)00200-1
   Schlereth DD, 1998, J ELECTROANAL CHEM, V444, P231, DOI 10.1016/S0022-0728(97)00578-0
   Schlereth DD, 1999, J ELECTROANAL CHEM, V464, P198, DOI 10.1016/S0022-0728(99)00019-4
   Schmidt HL, 1996, BIOSENS BIOELECTRON, V11, P127, DOI 10.1016/0956-5663(96)83720-1
   SCHUHMANN W, 1991, J AM CHEM SOC, V113, P1394, DOI 10.1021/ja00004a048
   Shipway AN, 2001, ACCOUNTS CHEM RES, V34, P421, DOI 10.1021/ar000180h
   Sota H, 1998, ANAL CHEM, V70, P2019, DOI 10.1021/ac9713666
   Tsoi PY, 2000, LANGMUIR, V16, P6590, DOI 10.1021/la9912951
   Willner I, 1996, J AM CHEM SOC, V118, P10321, DOI 10.1021/ja9608611
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   Willner I, 1998, J CHEM SOC PERK T 2, P1817, DOI 10.1039/a801487f
   Willner I, 1997, BIOSENS BIOELECTRON, V12, P337, DOI 10.1016/S0956-5663(96)00065-6
   Willner I, 2000, ANGEW CHEM INT EDIT, V39, P1180, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1180::AID-ANIE1180>3.0.CO;2-E
   WILLNER I, 1992, J AM CHEM SOC, V114, P10965, DOI 10.1021/ja00053a045
   Willner I, 2001, PURE APPL CHEM, V73, P535, DOI 10.1351/pac200173030535
   Willner I, 1996, ANGEW CHEM INT EDIT, V35, P367, DOI 10.1002/anie.199603671
   Willner I, 1998, J PHYS ORG CHEM, V11, P546, DOI 10.1002/(SICI)1099-1395(199808/09)11:8/9<546::AID-POC49>3.0.CO;2-Q
   Willner I, 1997, ELECTROANAL, V9, P965, DOI 10.1002/elan.1140091302
   WILLNER I, 1994, J AM CHEM SOC, V116, P1428, DOI 10.1021/ja00083a031
   Yan JC, 2001, J PHYS CHEM B, V105, P8905, DOI 10.1021/jp011233v
   YANG CY, 1994, POLYMER, V35, P1142, DOI 10.1016/0032-3861(94)90004-3
NR 94
TC 222
Z9 225
U1 3
U2 92
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JUN 5
PY 2002
VL 124
IS 22
BP 6487
EP 6496
DI 10.1021/ja012680r
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 558FC
UT WOS:000175954800042
PM 12033880
DA 2018-10-19
ER

PT J
AU Chang, Y
   Tsai, CC
   Liang, HC
   Sung, HW
AF Chang, Y
   Tsai, CC
   Liang, HC
   Sung, HW
TI In vivo evaluation of cellular and acellular bovine pericardia fixed
   with a naturally occurring crosslinking agent (genipin)
SO BIOMATERIALS
LA English
DT Article
DE acellular tissue; genipin; glutaraldehyde; biocompatibility; tissue
   regeneration
ID IN-VITRO EVALUATION; CROSS-LINKING AGENT; TISSUE FIXATION; FOLLOW-UP;
   BIOMATERIAL; COLLAGEN; CALCIFICATION; CYTOTOXICITY
AB A cell extraction process was employed in the study to remove the cellular components from bovine pericardium leaving a framework of largely insoluble collagen and elastin. It was hypothesized in the literature that this process may decrease the antigenic load (or increase the biocompatibility) within the material. Additionally, acellular tissues may provide a natural microenvironment for host-cell migration to regenerate the tissue. The study was to evaluate the biocompatibility of cellular and acellular bovine pericardia fixed with a naturally occurring crosslinking agent (genipin) implanted subcutaneously in a growing rat model. Additionally, the tissue regeneration rate ill the genipin-fixed acellular tissue was investigated. The glutaraldehyde-fixed counterparts were used as controls. The results indicated that the degrees in inflammatory reaction for the genipin-fixed cellular and acellular tissues were significantly less than their glutaraldehyde-fixed counterparts. Additionally. it was noted that the inflammatory reactions for the glutaraldehyde-fixed cellular and acellular tissues lasted much longer than their genipin-fixed counterparts. The tissue regeneration rate for the genipin-fixed acellular tissue was significantly faster than its glutaraldehyde-fixed counterpart. The calcium content of each Studied group, analyzed by atomic absorption, did not change significantly until at the 52nd week, postoperatively. The differences in calcium content between the cellular and acellular tissues were insignificant for both the glutaraldehyde- and genipin-fixed groups throughout the entire course of the study. In summary, the biocompatibility of the genipin-fixed cellular and acellular tissues was superior to their glutaraldehyde-fixed counterparts. The genipin-fixed acellular tissue provided a better microenvironment for tissue regeneration than its glutaraldehyde-fixed counterpart, due to its low cytotoxicity. These results suggested that the genipin-fixed acellular tissue might be used as a tissue-engineering matrix in the clinical applications. (C) 2002 Published by Elsevier Science Ltd.
C1 Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
   Natl Yang Ming Univ, Coll Med, Taipei 112, Taiwan.
   Vet Gen Hosp, Div Cardiovasc Surg, Taichung, Taiwan.
RP Sung, HW (reprint author), Natl Tsing Hua Univ, Dept Chem Engn, Hsinchu 30013, Taiwan.
CR ARAUJO JD, 1987, J CARDIOVASC SURG, V28, P434
   CIPRIANO PR, 1982, CIRCULATION, V66, P1100, DOI 10.1161/01.CIR.66.5.1100
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   GABBAY S, 1984, J THORAC CARDIOV SUR, V88, P758
   GORHAM SD, 1990, BIOMATERIALS, V11, P113, DOI 10.1016/0142-9612(90)90125-A
   MALONE JM, 1984, J VASC SURG, V1, P181, DOI 10.1067/mva.1984.avs0010181
   MCCLAIN PE, 1972, J BIOL CHEM, V247, P692
   Nimni ME, 1988, COLLAGEN, VIII, P1
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   Noishiki Y., 1989, U. S. Patent, Patent No. [4,806,599, 4806599]
   Rosenberg D., 1978, VASCULAR GRAFTS, P261
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SEGESSER L V, 1987, Journal of Thoracic and Cardiovascular Surgery, V93, P616
   SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Sung HW, 1996, J BIOMED MATER RES, V31, P511, DOI 10.1002/(SICI)1097-4636(199608)31:4<511::AID-JBM11>3.0.CO;2-J
   Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1
   Tsai CC, 2000, J BIOMED MATER RES, V52, P58, DOI 10.1002/1097-4636(200010)52:1<58::AID-JBM8>3.0.CO;2-0
   VALENTE M, 1985, AM J PATHOL, V119, P12
   WILSON GJ, 1990, T AM SOC ART INT ORG, V36, P340
NR 22
TC 110
Z9 119
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2002
VL 23
IS 12
BP 2447
EP 2457
AR PII S0142-9612(01)00379-9
DI 10.1016/S0142-9612(01)00379-9
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 551EU
UT WOS:000175547200002
PM 12033592
DA 2018-10-19
ER

PT J
AU Krasteva, N
   Harms, U
   Albrecht, W
   Seifert, B
   Hopp, M
   Altankov, G
   Groth, T
AF Krasteva, N
   Harms, U
   Albrecht, W
   Seifert, B
   Hopp, M
   Altankov, G
   Groth, T
TI Membranes for biohybrid liver support systems - investigations on
   hepatocyte attachment, morphology and growth
SO BIOMATERIALS
LA English
DT Article
DE polymer membranes; surface properties; hepatoblastoma cells;
   cell-biomaterial interaction; biohybrid liver
ID SURFACE WETTABILITY; CYTOSKELETAL ORGANIZATION; CELL ATTACHMENT;
   ADHESION; BIOMATERIALS; FIBRONECTIN; BIOCOMPATIBILITY; MODULATION;
   TISSUE; TOPOGRAPHY
AB The biological properties of four different membranes were studied regarding their possible application in biohybrid liver support systems. Two of them, one made of polyetherimide (PEI), and a second based on polyacrylonitrile-N-vinylpyrollidone co-polymer (P(AN-NVP)), were recently developed in our lab and studied for the first time. Together with pure polyacrylonitrile (PAN) membranes, the three preparations were characterised as ultra-filtration membranes. Their ability to support cell attachment, morphology, proliferation and function of human hepatoblastoma C3A cells was studied. The role of surface morphology for the interaction with hepatocytes was highlighted using a commercial, moderately wettable polyvinylidendifluoride (PVDF) membrane with micro-filtration properties. Comparative investigations showed strongest interaction of C3A cells with PAN membranes, as the focal adhesion contacts were more expressed and cell growth was also high. However, the functional activity in terms of albumin synthesis was reduced. Very similar results were obtained with the most hydrophobic PEI membrane. In contrast, the most hydrophilic membrane P(AN-NVP) was found to provoke stronger homotypic adhesion (E-cadherin expression) of C3A cells and less substratum attachment (focal adhesions). but enhanced albumin secretion. However, proliferation of C3A cells was lowered. Micro-porous PVDF membrane showed very good initial attachment, but the resulting cell material and cell-cell interaction were relatively poor developed. Among four membranes tested, PEI seems to be the most attractive membrane for biohybrid liver devices, as it provides good surface properties for hepatocytes interaction, but in addition it is highly thermostable, which would permit steam sterilisation. No simple relationship, however, between the wettability of the membranes and their ability to support hepatocyte adhesion and function was found in this study. (C) 2002 Published by Elsevier Science Ltd.
C1 GKSS Forschungszentrum Geesthacht GmbH, Dept Membrane Res, Inst Chem, Dept Biomat, D-14513 Teltow, Germany.
   Bulgarian Acad Sci, Inst Biophys, BG-1113 Sofia, Bulgaria.
   Humboldt Univ, Fac Med Charite, Clin Dent Prosthet, D-10177 Berlin, Germany.
RP Groth, T (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Dept Membrane Res, Inst Chem, Dept Biomat, Kantstr 55, D-14513 Teltow, Germany.
RI Seifert, Barbara/K-7569-2012
OI Groth, Thomas/0000-0001-6647-9657
CR Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BADER A, 1995, ARTIF ORGANS, V19, P368, DOI 10.1111/j.1525-1594.1995.tb02343.x
   Biran R, 1999, J BIOMED MATER RES, V46, P150, DOI 10.1002/(SICI)1097-4636(199908)46:2<150::AID-JBM3>3.3.CO;2-K
   Catapano G, 1996, J BIOMAT SCI-POLYM E, V7, P1017, DOI 10.1163/156856296X00417
   Culp LA, 1998, J BIOMAT SCI-POLYM E, V9, P1161, DOI 10.1163/156856298X00703
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Evans MDM, 1999, J BIOMED MATER RES, V46, P485, DOI 10.1002/(SICI)1097-4636(19990915)46:4<485::AID-JBM6>3.0.CO;2-F
   GERLACH J, 1989, INT J ARTIF ORGANS, V12, P788
   Gerlach JC, 1996, INT J ARTIF ORGANS, V19, P645
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   GRINNELL F, 1973, BIOCHEM MED METAB B, V7, P87, DOI 10.1016/0006-2944(73)90102-6
   Groth T, 1998, BIOM HLTH R, V16, P12
   GROTH T, IN PRESS DEPENDENCE
   Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399
   Hughes RD, 1996, INT J ARTIF ORGANS, V19, P3
   IMAI Y, 1983, J BIOMED MATER RES, V17, P905, DOI 10.1002/jbm.820170602
   INGBER DE, 1997, PRINCIPLES TISSUE EN, P89
   JULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103
   KLINKMANN H, 1995, NEPHROL DIAL TRANSPL, V10, P39, DOI 10.1093/ndt/10.supp3.39
   KNEIFEL K, 1992, J MEMBRANE SCI, V65, P295, DOI 10.1016/0376-7388(92)87030-2
   Krasteva N, 2001, J BIOMAT SCI-POLYM E, V12, P613, DOI 10.1163/156856201316883449
   LEDU C, 1999, MED DEV TECHN C LOND
   Park D, 1996, J FOOD LIPIDS, V3, P1, DOI 10.1111/j.1745-4522.1996.tb00050.x
   Paul D, 1998, CHEM UNSERER ZEIT, V32, P197, DOI 10.1002/ciuz.19980320405
   Peinemann KV, 1998, POLYMER, V39, P3411, DOI 10.1016/S0032-3861(97)10067-2
   PELUSO G, 1994, J MATER SCI-MATER M, V4, P738
   Qiang S, 1997, INT J ARTIF ORGANS, V20, P119
   RICHARDSON RR, 1993, BIOMATERIALS, V14, P627, DOI 10.1016/0142-9612(93)90183-3
   Ruardy T. G., 1997, Cells and Materials, V7, P123
   Sawamoto K, 1997, IN VITRO CELL DEV-AN, V33, P569
   SEIFERT B, IN PRESS ARTIF ORGAN
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   TAGAKI M, 1997, CYTOTECHNOLOGY, V24, P39
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P667
   Te Velde Anje, 1995, Journal of Hepatology, V23, P184, DOI 10.1016/0168-8278(95)80333-5
   TSONEVA R, 2001, 15 AACH C BIOM, P84
   ULUDAG H, 1993, J BIOMED MATER RES, V27, P1213, DOI 10.1002/jbm.820271002
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VONSENGBUSCH G, 1993, ARTIF ORGANS, V17, P244
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   10030307244
NR 47
TC 56
Z9 58
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2002
VL 23
IS 12
BP 2467
EP 2478
AR PII S0142-9612(01)00381-7
DI 10.1016/S0142-9612(01)00381-7
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 551EU
UT WOS:000175547200004
PM 12033594
DA 2018-10-19
ER

PT J
AU Stephansson, SN
   Byers, BA
   Garcia, AJ
AF Stephansson, SN
   Byers, BA
   Garcia, AJ
TI Enhanced expression of the osteoblastic phenotype on substrates that
   modulate fibronectin conformation and integrin receptor binding
SO BIOMATERIALS
LA English
DT Article
DE osteoblast; fibronectin; integrin; biomaterial surface; mineralization
ID BONE CELL-CULTURES; IN-VITRO; BIOACTIVE GLASS; GENE-EXPRESSION; MC3T3-E1
   CELLS; SURFACE-CHEMISTRY; DIFFERENTIATION; ADHESION; MINERALIZATION;
   PROLIFERATION
AB Integrins represent the primary mechanism of cell-extracellular matrix interactions and control cell morphology, proliferation, and differentiation. We have previously shown that substrate-dependent modulation of adsorbed fibronectin (Fn) conformation alters alpha(5)beta(1) integrin binding to Fn and directs C2Cl2 myoblast proliferation and differentiation (Mol. Biol. Cell 10 ( 1999) 785). The model substrates used in these experiments were bacteriological (untreated) polystyrene (B), tissue culture polystyrene (T), and type-I collagen-coated T (C). In the present study, we examined MC3T3-E1 osteoblast-like cell differentiation on Fn-coated B, T, and C substrates. Immunofluorescence staining revealed substrate-dependent differences in integrin alpha(5)beta(1) binding and clustering into focal adhesions (C > T > B), consistent with our previous integrin binding analysis. Alkaline phosphatase activity and matrix mineralization showed substrate-dependent differences (C > T > B, p < 0.05). Similar trends were observed for alkaline phosphatase, osteocalcin, and bone sialoprotein gene expression. Blocking experiments with antibodies directed against Fn completely inhibited matrix mineralization on Fn-coated C, indicating that Fn is critical to expression of the osteoblastic phenotype oil this extracellular matrix component. These substrate-dependent differences in osteoblast differentiation correlated with differences in &alpha;(5)&beta;(1) binding, suggesting that these differences arise from substrate modulation of integrin-matrix interactions. Substrate-dependent modulation of cell function may provide a versatile mechanism to control cell responses in numerous biomedical applications. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Undergrad Res Scholars Program, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Sch Mech Engn, 315 Ferst Drive,Room 2314, Atlanta, GA 30332 USA.
CR ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E
   Aubin Jane E., 1996, P51
   BISCHOFF R, 1968, J CELL BIOL, V36, P111, DOI 10.1083/jcb.36.1.111
   Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.0.CO;2-A
   DAVIES JE, 1988, SCANNING MICROSCOPY, V2, P1445
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dickson G, 1984, METHODS CALCIFIED TI
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235
   FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2
   Moursi AM, 1997, J CELL SCI, V110, P2187
   PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242
   PULCO DA, 1991, J BIOMED MATER RES, V25, P711
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   SAUTIER JM, 1994, CALCIFIED TISSUE INT, V55, P458, DOI 10.1007/BF00298560
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   SHARMA SK, 1980, J CHROMATOGR, V184, P471, DOI 10.1016/S0021-9673(00)93875-5
   Simpson D, 2000, MOL VIS, V6, P178
   SODEK J, 1987, METHOD ENZYMOL, V145, P303
   SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265
   Stein Gary S., 1996, P69
   STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   VROUWENVELDER WCA, 1992, BIOMATERIALS, V13, P382, DOI 10.1016/0142-9612(92)90044-O
   WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877
   Xiao GZ, 1998, J BIOL CHEM, V273, P32988, DOI 10.1074/jbc.273.49.32988
   Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391
NR 37
TC 97
Z9 102
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2002
VL 23
IS 12
BP 2527
EP 2534
AR PII S0142-9612(01)00387-8
DI 10.1016/S0142-9612(01)00387-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 551EU
UT WOS:000175547200010
PM 12033600
DA 2018-10-19
ER

PT J
AU Hu, WJ
   Eaton, JW
   Ugarova, TP
   Tang, LP
AF Hu, WJ
   Eaton, JW
   Ugarova, TP
   Tang, LP
TI Molecular basis of biomaterial-mediated foreign body reactions (vol 98,
   pg 1231, 2001)
SO BLOOD
LA English
DT Correction
CR Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
NR 1
TC 2
Z9 2
U1 0
U2 5
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD JUN 1
PY 2002
VL 99
IS 11
BP 3908
EP 3908
PG 1
WC Hematology
SC Hematology
GA 555QL
UT WOS:000175804700005
DA 2018-10-19
ER

PT J
AU Comuzzi, L
   Ooms, E
   Jansen, JA
AF Comuzzi, L
   Ooms, E
   Jansen, JA
TI Injectable calcium phosphate cement as a filler for bone defects around
   oral implants: an experimental study in goats
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE oral implants; calcium phosphate cement; gap bone filler; animal study
ID HYDROXYAPATITE CEMENT; EXTRACTION SOCKETS; COATED IMPLANTS; TRABECULAR
   BONE; MEMBRANES; INTERFACE; COMBINATION; BIOMATERIAL; COATINGS; SITES
AB The aim of this study was to evaluate the clinical applicability and biological behavior of a newly developed injectable calcium phosphate (Ca-P) cement as bone filler for gaps around oral implants. Twenty-four step-like implants, creating gaps of 1 and 2 mm, were inserted into the trabecular bone of the medial femoral condyles of six goats. Four different situations were tested: (1) implant + gaps; (2) implant + gaps, but covered with a polylactic acid membrane; (3) implant + gaps that were filled with Ca-P cement; and (4) implant + gaps that were filled with Ca-P cement and covered with a membrane. All implants were left in place for 12 weeks. Histological and quantitative histomorphometrical measurements demonstrated that implants + gaps had generally poor bone contact at the implant base. Furthermore, fibrous encapsulation was observed in the gap part. In contrast, the presence of a membrane promoted bone ingrowth into the gap and also the bone contact at the implant base. Injection of Ca-P cement resulted in an almost complete filling of the gaps around the implant. The cement surface was completely covered by bone. Active resorption and remodeling of cement particles was observed, suggesting a pattern of slow resorption associated with full replacement with newly formed bone. Additional use of a membrane did not result in adjunctive benefits. Bone-to-implant contact at the implant base was comparable with the implants provided only with a membrane. In conclusion, the Ca-P cement used here showed excellent clinical handling proper-ties combined with a superior bone behavior. On the other hand, the degradation rate of the material was still very slow. This current characteristic can hamper the final clinical applicability of the material as gap filler for periimplant or periodontal defects.
C1 Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Periodontol, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
RI Jansen, John/H-8055-2014
CR Akimoto K, 1999, INT J ORAL MAX IMPL, V14, P351
   BECKER W, 1992, J PERIODONTOL, V63, P929, DOI 10.1902/jop.1992.63.11.929
   BECKER W, 1990, INT J PERIODONT REST, V10, P377
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   CARLSSON L, 1988, ACTA ORTHOP SCAND, V59, P272, DOI 10.3109/17453678809149361
   Clemens JAM, 1998, J BIOMED MATER RES, V40, P341, DOI 10.1002/(SICI)1097-4636(19980605)40:3<341::AID-JBM1>3.3.CO;2-V
   Clemens JAM, 1997, J BIOMED MATER RES, V36, P55, DOI 10.1002/(SICI)1097-4636(199707)36:1<55::AID-JBM7>3.0.CO;2-K
   DENISSEN HW, 1989, J PROSTHET DENT, V61, P706, DOI 10.1016/S0022-3913(89)80047-2
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   HJORTING-HANSEN E, 1990, International Journal of Oral and Maxillofacial Implants, V5, P255
   JANSEN JA, 1995, J MATER SCI-MATER M, V6, P653, DOI 10.1007/BF00123447
   Jansen JA, 1996, J INVEST SURG, V9, P463, DOI 10.3109/08941939609025864
   KLEIN CPAT, 1994, J APPL BIOMATER, V5, P369, DOI 10.1002/jab.770050413
   KLEIN CPAT, 1994, J MATER SCI-MATER M, V5, P569, DOI 10.1007/BF00120332
   KNOX R, 1991, INT J PERIODONT REST, V11, P365
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LEKHOLM U, 1993, CLIN ORAL IMPLAN RES, V4, P121, DOI 10.1034/j.1600-0501.1993.040302.x
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   MAXIAN SH, 1994, J BIOMED MATER RES, V28, P1311, DOI 10.1002/jbm.820281109
   MELLONIG JT, 1993, INT J PERIODONT REST, V13, P109
   Meraw SJ, 2000, J PERIODONTOL, V71, P8, DOI 10.1902/jop.2000.71.1.8
   Simion M, 1997, INT J ORAL MAX IMPL, V12, P159
   Soballe K, 1993, Acta Orthop Scand Suppl, V255, P1
   Szmukler-Moncler S, 1998, J BIOMED MATER RES, V43, P192, DOI 10.1002/(SICI)1097-4636(199822)43:2<192::AID-JBM14>3.0.CO;2-K
   Vercaigne S, 2000, CLIN ORAL IMPLAN RES, V11, P314, DOI 10.1034/j.1600-0501.2000.011004314.x
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Wilson TG, 1998, INT J ORAL MAX IMPL, V13, P333
   Wiskott HWA, 1999, CLIN ORAL IMPLAN RES, V10, P429, DOI 10.1034/j.1600-0501.1999.100601.x
NR 30
TC 65
Z9 68
U1 0
U2 6
PU BLACKWELL MUNKSGAARD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2002
VL 13
IS 3
BP 304
EP 311
DI 10.1034/j.1600-0501.2002.130311.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 554NM
UT WOS:000175742100011
PM 12010162
DA 2018-10-19
ER

PT J
AU Andersson, J
   Ekdahl, KN
   Larsson, R
   Nilsson, UR
   Nilsson, B
AF Andersson, J
   Ekdahl, KN
   Larsson, R
   Nilsson, UR
   Nilsson, B
TI C3 adsorbed to a polymer surface can form an initiating alternative
   pathway convertase
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID HUMAN-COMPLEMENT; MONOCLONAL-ANTIBODIES; PUTATIVE THIOESTER;
   SOLID-SURFACES; C-3 CONVERTASE; HUMAN-PLASMA; BOUND C-3; FACTOR-B;
   ACTIVATION; BINDING
AB Contact between blood and a biomaterial surface induces an immediate complement-mediated inflammatory response. Under these conditions, the alternative pathway of complement is often initiated and amplified on the biomaterial surface. Adsorption of a protein such as C3 to a polymer surface induces conformational changes in the protein. Based on the expression on adsorbed C3 of conformational neoepitopes specific for bound C3 fragments, we have hypothesized that adsorbed C3 is able to bind factor B and form a functional C3,Bb convertase. Using a quartz crystal microbalance to monitor binding of proteins to a polymer surface, we have demonstrated that a functional C3-containing alternative pathway convertase can be formed, in particular, in the presence of properdin. These data indicate that adsorption of C3 induces conformational changes that turn C3 into a Cab-like molecule that is able to participate in the functioning of the alternative convertase, and they suggest a new mechanism for complement activation on a biomaterial surface.
C1 Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, S-75185 Uppsala, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, Kalmar, Sweden.
RP Nilsson, B (reprint author), Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, S-75185 Uppsala, Sweden.
EM Bo.Nilsson@klinimm.uu.se
RI Nilsson, Bo/B-3102-2012; Nilsson Ekdahl, Kristina/B-5301-2012
OI Nilsson, Bo/0000-0003-0057-2730; 
CR ALSENZ J, 1990, CURR TOP MICROBIOL, V153, P235
   CARRENO MP, 1988, MOL IMMUNOL, V25, P165, DOI 10.1016/0161-5890(88)90064-8
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   CATANA E, 1991, J IMMUNOL METHODS, V138, P265, DOI 10.1016/0022-1759(91)90175-F
   DISCIPIO RG, 1981, BIOCHEM J, V199, P485, DOI 10.1042/bj1990485
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   FEARON DT, 1977, J IMMUNOL, V119, P1248
   FEARON DT, 1977, J EXP MED, V146, P22, DOI 10.1084/jem.146.1.22
   FISHELSON Z, 1982, J IMMUNOL, V129, P2603
   GOBEL RJ, 1987, BIOMATERIALS, V8, P285, DOI 10.1016/0142-9612(87)90116-5
   Gupta-Bansal R, 2000, MOL IMMUNOL, V37, P191, DOI 10.1016/S0161-5890(00)00047-X
   HACK CE, 1990, J IMMUNOL, V144, P4249
   HAMMER CH, 1981, J BIOL CHEM, V256, P3995
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   Jokiranta TS, 2001, INT IMMUNOPHARMACOL, V1, P495, DOI 10.1016/S1567-5769(00)00042-4
   LACHMANN PJ, 1973, LANCET, V1, P465
   LACHMANN PJ, 1975, CLIN EXP IMMUNOL, V21, P109
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAMBRIS JD, 1984, J BIOL CHEM, V259, P2685
   MARTIN A, 1976, IMMUNOCHEMISTRY, V13, P317, DOI 10.1016/0019-2791(76)90341-4
   MEDICUS RG, 1980, J IMMUNOL, V124, P602
   MINTA JO, 1978, J IMMUNOL METHODS, V19, P153, DOI 10.1016/0022-1759(78)90175-8
   NILSSON B, 1990, BIOCHEM J, V268, P55, DOI 10.1042/bj2680055
   Nilsson B, 1998, BLOOD, V92, P1661
   NILSSON B, 1986, IMMUNOL LETT, V13, P11, DOI 10.1016/0165-2478(86)90118-5
   NILSSON B, 1986, SCAND J IMMUNOL, V23, P357, DOI 10.1111/j.1365-3083.1986.tb01976.x
   NILSSON B, 1987, MOL IMMUNOL, V24, P487, DOI 10.1016/0161-5890(87)90023-X
   NILSSON B, 1989, MOL IMMUNOL, V26, P383, DOI 10.1016/0161-5890(89)90127-2
   NILSSON B, 1985, SCAND J IMMUNOL, V22, P703, DOI 10.1111/j.1365-3083.1985.tb01933.x
   NILSSON B, 1992, BIOCHEM J, V282, P715, DOI 10.1042/bj2820715
   NILSSON B, 1988, J IMMUNOL METHODS, V107, P281, DOI 10.1016/0022-1759(88)90229-3
   NILSSON UR, 1984, J IMMUNOL METHODS, V72, P49, DOI 10.1016/0022-1759(84)90432-0
   NILSSON UR, 1965, J EXP MED, V122, P277, DOI 10.1084/jem.122.2.277
   NILSSON UR, 1982, J IMMUNOL, V129, P2594
   NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L
   PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102
   PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416
   PANGBURN MK, 1983, J IMMUNOL, V131, P1930
   PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   PLATTSMI.TA, 1974, J IMMUNOL, V113, P348
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
NR 46
TC 83
Z9 86
U1 0
U2 5
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD JUN 1
PY 2002
VL 168
IS 11
BP 5786
EP 5791
DI 10.4049/jimmunol.168.11.5786
PG 6
WC Immunology
SC Immunology
GA 555WA
UT WOS:000175815200052
PM 12023380
OA Bronze
DA 2018-10-19
ER

PT J
AU Mendes, SC
   Sleijster, M
   van den Muysenberg, A
   de Bruijn, JD
   van Blitterswijk, CA
AF Mendes, SC
   Sleijster, M
   van den Muysenberg, A
   de Bruijn, JD
   van Blitterswijk, CA
TI A cultured living bone equivalent enhances bone formation when compared
   to a cell seeding approach
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MARROW STROMAL FIBROBLASTS; IN-VIVO; POROUS CERAMICS; TRANSPLANTATION;
   OSTEOGENESIS; HYDROXYAPATITE; INVITRO; GROWTH; GRAFT; RAT
AB The development of cell therapy methods to confer osteogenic potential to synthetic bone replacement materials has become common during the last years. At present, in the bone tissue engineering field, two different approaches use patient own cultured osteogenic cells in combination with a scaffold material to engineer autologous osteogenic grafts. One of the approaches consists of seeding cells on a suitable biomaterial, after which the construct is ready for implantation. In the other approach, the seeded cells are further cultured on the scaffold to obtain in vitro formed bone (extracellular matrix and cells), prior to implantation. In the present study, we investigated the in vivo osteogenic potential of both methods through the implantation of porous hydroxyapatite (HA) scaffolds coated with a layer of in vitro formed bone and porous HA scaffolds seeded with osteogenic cells. Results showed that as early as 2 days after implantation, de novo bone tissue was formed on scaffolds in which an in vitro bone-like tissue was cultured, while it was only detected on the cell seeded implants from 4 days onwards. In addition, after 4 days of implantation statistical analysis revealed a significantly higher amount of bone in the bone-like tissue containing scaffolds as compared to cell seeded ones. (C) 2002 Kluwer Academic Publishers.
C1 IsoTis NV, NL-3723 MB Bilthoven, Netherlands.
   Univ Twente, IBME, NL-7500 AE Enschede, Netherlands.
RP Mendes, SC (reprint author), IsoTis NV, Prof Bronkhorstlaan 10, NL-3723 MB Bilthoven, Netherlands.
OI van Blitterswijk, Clemens/0000-0003-2371-4615
CR AUBIN JE, 1996, PRINCIPLES BONE BIOL, P39
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DAVIES JE, 1991, CELL MATER, V1, P3
   de Bruijn J D, 1999, Adv Dent Res, V13, P74
   DEBOER HH, 1988, CLIN ORTH OP, P226
   DEBRUIJN JD, 1992, MATER RES SOC SYMP P, V252, P63
   Dennis JE, 1998, BIOMATERIALS, V19, P1323, DOI 10.1016/S0142-9612(97)00170-1
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Ishaug Riley S L, 1997, J BIOMED MATER RES, V36, P1
   Ishaug Riley SL, 1998, BIOMATERIALS, V19, P1405
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   Lennon DP, 1996, IN VITRO CELL DEV-AN, V32, P602
   Lind M, 1996, ACTA ORTHOP SCAND, V67, P407, DOI 10.3109/17453679609002342
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mendes SC, 1998, J MATER SCI-MATER M, V9, P855, DOI 10.1023/A:1008904413859
   MENDES SC, 2002, IN PRESS TISSUE ENG
   MENDES SC, 2000, BONE ENG, P505
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   OHGUSHI H, 1990, ACTA ORTHOP SCAND, V61, P431, DOI 10.3109/17453679008993556
   SCUTT A, 1992, BIOFACTORS, V4, P1
   TRIFFITT JT, 1998, ADV ORGAN BIOL SERIE, P429
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
   Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P49
NR 30
TC 20
Z9 21
U1 0
U2 2
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2002
VL 13
IS 6
BP 575
EP 581
DI 10.1023/A:1015178827323
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 542WM
UT WOS:000175068600006
PM 15348587
DA 2018-10-19
ER

PT J
AU Wang, M
   Chandrasekaran, M
   Bonfield, W
AF Wang, M
   Chandrasekaran, M
   Bonfield, W
TI Friction and wear of hydroxyapatite reinforced high density polyethylene
   against the stainless steel counterface
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID COMPOSITES
AB Hydroxyapatite (HA) reinforced high density polyethylene (HDPE) was invented as a biomaterial for skeletal applications. In this investigation, tribological properties (e.g. wear rate and coefficient of friction) of unfilled HDPE and HA/HDPE composites were evaluated against the duplex stainless steel in dry and lubricated conditions, with distilled water or aqueous solutions of proteins (egg albumen or glucose) being lubricants. Wear tests were conducted in a custom-built test rig for HDPE and HA/HDPE containing up to 40 vol % of HA. It was found that HA/HDPE composites had lower coefficients of friction than unfilled HDPE under certain conditions. HA/HDPE also exhibited less severe fatigue failure marks than HDPE. The degradation and fatigue failure of HDPE due to the presence of proteins were severe for low speed wear testing (100 rpm) as compared to high speed wear testing (200 rpm). This was due possibly to the high shear rate at the contact which could remove any degraded film instantaneously at high sliding speed, while with a low sliding speed the build-up of a degraded layer of protein could occur. The degraded protein layer would stay at the contact for a longer time and mechanical activation would induce adverse reactions, weakening the surface layer of HDPE. Both egg albumen and glucose were found to be corrosive to steel and adversely reactive for HDPE and HA/HDPE composites. The wear modes observed were similar to that of ultra-high molecular weight polyethylene. Specimens tested with egg albumen also displayed higher wear rates, which was again attributed to corrosion accelerated wear. (C) 2002 Kluwer Academic Publishers.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
   Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Wang, M (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, Nanyang Ave, Singapore 639798, Singapore.
RI Wang, Min/C-1584-2009
OI Wang, Min/0000-0002-6495-5637
CR Bonfield W, 1998, ACTA MATER, V46, P2509, DOI 10.1016/S1359-6454(98)80035-9
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   BONFIELD W, 1991, BONE-BIOMATERIAL INTERFACE, P89
   Bonfield W., 1998, BIOCERAMICS, V11, P37
   Charnley J.P., 1979, LOW FRICTION ANTHROP
   Di Silvio L, 1998, J MATER SCI-MATER M, V9, P845, DOI 10.1023/A:1008900312950
   Downes RN, 1991, BIOCERAMICS, V4, P239
   GUILD FJ, 1993, BIOMATERIALS, V14, P985, DOI 10.1016/0142-9612(93)90190-D
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   HUANG J, 1998, BIOCERAMICS, V11, P165
   Lu Z, 1997, P I MECH ENG H, V211, P101, DOI 10.1243/0954411971534728
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   Suwanprateeb J, 1997, J MATER SCI-MATER M, V8, P469, DOI 10.1023/A:1018522025474
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M, 1998, J MATER SCI-MATER M, V9, P621, DOI 10.1023/A:1008975323486
   WANG M, 1997, P 11 INT C COMP MAT, V1, P488
   WANG M, 1996, P 7 EUR C COMP MAT L, V2, P455
   Wroblewski BM, 1997, P I MECH ENG H, V211, P109, DOI 10.1243/0954411971534737
NR 19
TC 12
Z9 15
U1 0
U2 5
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2002
VL 13
IS 6
BP 607
EP 611
DI 10.1023/A:1015139213211
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 542WM
UT WOS:000175068600011
PM 15348592
DA 2018-10-19
ER

PT J
AU Brodke, DS
   Willie, BM
   Maaranen, TA
   Bloebaum, RD
AF Brodke, DS
   Willie, BM
   Maaranen, TA
   Bloebaum, RD
TI Spinal cage retrieval and assessment of biologic response
SO JOURNAL OF SPINAL DISORDERS & TECHNIQUES
LA English
DT Article; Proceedings Paper
CT 13th Annual Meeting of the North-American-Spine-Society
CY OCT 28-31, 1998
CL SAN FRANCISCO, CALIFORNIA
SP N Amer Spine Soc
DE spine; interbody fusion device; allograft; cage; pseudoarthrosis;
   corpectomy
ID HUMAN CANCELLOUS BONE; BACKSCATTERED ELECTRON IMAGES; LUMBAR INTERBODY
   FUSION; POROUS-COATED IMPLANTS; TRABECULAR BONE; MINERAL-CONTENT;
   INTERFACE; COMPONENTS; GRAYLEVELS; TITANIUM
AB Implant retrieval programs have been effective in understanding implant failure and biomaterial compatibility in joint arthroplasty; however, its application has not been extended extensively to the assessment of spinal constructs and implants. The objective of this study is to determine the efficacy of implant retrieval analysis as a standard for the assessment of explanted spinal implants. The limitations of clinical radiographic assessment of fusion through metal interbody devices are also identified. The implant analysis protocol is shown through a case report of a titanium mesh spinal fusion cage retrieved from a 54-year-old woman who had a pseudoarthrosis at the T12 cage interface. The implant analysis techniques include backscattered electron imaging, high-resolution contact radiography, histology, and fluorochrome analysis. Ail implant retrieval analysis program similar to the one discussed in the presented case study will enable an accurate assessment of outcomes of these commonly used implants and will guide future development.
C1 Univ Utah, Sch Med, Dept Orthoped, Salt Lake City, UT 84132 USA.
   Salt Lake City Vet Affairs Hlth Care Syst, Bone & Joint Res Lab, Salt Lake City, UT USA.
RP Brodke, DS (reprint author), Univ Utah, Sch Med, Dept Orthoped, 3B165,50 N Med Dr, Salt Lake City, UT 84132 USA.
RI Willie, Bettina/G-2397-2014
OI Willie, Bettina/0000-0003-2907-3580
CR Bloebaum R D, 1990, J Biomater Appl, V5, P56
   Bloebaum RD, 1997, J ARTHROPLASTY, V12, P920, DOI 10.1016/S0883-5403(97)90162-5
   Bloebaum RD, 1997, J BONE JOINT SURG AM, V79A, P1013, DOI 10.2106/00004623-199707000-00007
   Bloebaum RD, 1998, J BONE JOINT SURG AM, V80A, P518, DOI 10.2106/00004623-199804000-00008
   Bloebaum RD, 1997, BONE, V20, P485, DOI 10.1016/S8756-3282(97)00015-X
   BLOEBAUM RD, 1989, J HISTOTECHNOL, V12, P307
   BLOEBAUM RD, 1994, J BIOMED MATER RES, V28, P537, DOI 10.1002/jbm.820280503
   BLOEBAUM RD, 1991, CLIN ORTHOP RELAT R, P179
   BLOEBAUM RD, 1991, CLIN ORTHOP RELAT R, P97
   BLOEBAUM RD, 1995, T ORTHOP RES SOC, V20, P776
   BRANTIGAN JW, 1994, SPINE, V19, P1436, DOI 10.1097/00007632-199407000-00002
   BRANTIGAN JW, 1991, SPINE S, V16, P277
   Brodke DS, 1997, SPINE, V22, P26, DOI 10.1097/00007632-199701010-00005
   BRODKE DS, 1998, N AM SPIN SOC 13 ANN
   Brodsky AE, 1991, SPINE S, V16, P261
   CHOW SP, 1980, SPINE, V5, P452, DOI 10.1097/00007632-198009000-00010
   CLEVELAND M, 1948, J BONE JOINT SURG AM, V30-A, P302, DOI 10.2106/00004623-194830020-00005
   CUNNINGHAM BW, 1998, T ORTHOP RES SOC, V23, P250
   DEBOWES RM, 1984, AM J VET RES, V45, P191
   EMMANUAL J, 1987, STAIN TECHNOL, V62, P401, DOI 10.3109/10520298709108030
   FROST HM, 1983, BONE HISTOMORPHOMETR, P109
   HIBBS RA, 1929, SURG GYNECOL OBSTET, V48, P604
   Hofmann AA, 1997, ACTA ORTHOP SCAND, V68, P161, DOI 10.3109/17453679709004000
   HOFMANN AA, 1993, J ARTHROPLASTY, V8, P157, DOI 10.1016/S0883-5403(06)80056-2
   HOFMANN AA, 1992, INT ORTHOP, V16, P349
   KIMMEL DB, 1982, ANAT REC, V203, P31, DOI 10.1002/ar.1092030104
   Kuslich SD, 1998, SPINE, V23, P1267, DOI 10.1097/00007632-199806010-00019
   McAfee PC, 1999, J BONE JOINT SURG AM, V81A, P859, DOI 10.2106/00004623-199906000-00014
   MELSEN F, 1978, CALC TISS RES, V26, P99, DOI 10.1007/BF02013242
   MELSEN F, 1978, METAB BONE DIS RELAT, V1, P45, DOI 10.1016/0221-8747(78)90036-X
   Meunier P, 1977, BONE HISTOMORPHOMETR, P249
   Ray CD, 1997, SPINE, V22, P667, DOI 10.1097/00007632-199703150-00019
   RHODES DM, 1989, J HISTOTECHNOL, V13, P63
   SANDERSON C, 1994, J HISTOTECHNOL, V17, P343, DOI 10.1179/his.1994.17.4.343
   Shea JE, 2001, J ANAT, V198, P153, DOI 10.1046/j.1469-7580.2001.19820153.x
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P47, DOI 10.1002/jbm.820270107
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P57, DOI 10.1002/jbm.820270108
   THOMPSON WA, 1974, J BONE JOINT SURG AM, VA 56, P1643, DOI 10.2106/00004623-197456080-00014
   TREHARNE RW, 1979, CLIN ORTHOP RELAT R, P240
   Willie BM, 2000, J BIOMED MATER RES, V53, P137, DOI 10.1002/(SICI)1097-4636(2000)53:2<137::AID-JBM2>3.0.CO;2-Y
   WILLIE BM, 1999, TRANSCR SOC BIOM 25
   WRONSKI TJ, 1981, CALCIFIED TISSUE INT, V33, P583, DOI 10.1007/BF02409495
NR 42
TC 7
Z9 7
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1536-0652
J9 J SPINAL DISORD TECH
JI J. Spinal Disord. Tech.
PD JUN
PY 2002
VL 15
IS 3
BP 206
EP 212
DI 10.1097/00024720-200206000-00007
PG 7
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 577LQ
UT WOS:000177062700006
PM 12131421
DA 2018-10-19
ER

PT J
AU Xu, JY
   Liu, ZS
   Erhan, SZ
   Carriere, CJ
AF Xu, JY
   Liu, ZS
   Erhan, SZ
   Carriere, CJ
TI A potential biodegradable rubber-viscoelastic properties of a soybean
   oil-based composite
SO JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY
LA English
DT Article
DE biodegradable material; rheology; soybean oil; viscoelastic properties
AB Scientists are more and more interested in biodegradable materials owing to their environmental advantage. We investigated viscoelastic properties of a newly developed biomaterial made from epoxidized soybean oil (ESO). ESO crosslinked by triethylene glycol d amine exhibited viscoelastic solid properties. The storage modulus (G') was 2 x 10(4) Pa over four frequency decades. The phase angles were 14-18degrees. Stress relaxation measurements showed that there was no relaxation up to 500 s. From the plateau modulus we estimated that the MAN. of this cross-linked soybean oil was on the order of 10(5). The composites of cross-linked ESO with three different fibers had 50 times higher elasticity (G') than those without fiber. Phase shifts were the same as those of cross-linked oil without fibers, but the linear range of rheological properties was much narrower than that of the material without filers. All these results indicated that this new biopolymer made from soybean oil exhibited strong viscoelastic solid properties similar to synthetic rubbers. These rheological properties implied that this biomaterial has high potential to replace some of the synthetic rubber and/or plastics.
C1 ARS, USDA, NCAUR, Peoria, IL 60604 USA.
RP Xu, JY (reprint author), ARS, USDA, NCAUR, 1815 N Univ St, Peoria, IL 60604 USA.
EM xuj@mail.ncaur.usda.gov
CR BAGLEY EB, 1992, IFT BAS SYM, V7, P573
   Fomin V.A., 2001, PLAST MASSY, V2, P42
   LIU Z, IN PRESS J APPL POLY
   Macosko C. W., 1994, RHEOLOGY PRINCIPLES, P109
   MISHRA DP, 2000, POP PLAST PACKAG, V45, P68
   Ngai K. L., 1996, PHYSICAL PROPERTIES, P341
   Rabek J., 1980, EXPT METHODS POLYM C
   SCHROETER J, 2000, KUNSTSTOFFE, V90, P64
   SCHROETER J, 2000, KUNSTSTOFFE, V90, P68
   WEN J, 1996, PHYSICAL PROPERTIES, P371
   Wool R. P., 1998, POLYM PREP AM CHEM S, V39, P90
   Wool RP, 1999, CHEMTECH, V29, P44
   WOOL RP, 1998, 216 AM CHEM SOC NAT
   Xu JY, 2001, CEREAL CHEM, V78, P181, DOI 10.1094/CCHEM.2001.78.2.181
NR 14
TC 20
Z9 20
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0003-021X
J9 J AM OIL CHEM SOC
JI J. Am. Oil Chem. Soc.
PD JUN
PY 2002
VL 79
IS 6
BP 593
EP 596
AR UNSP J10177
DI 10.1007/s11746-002-0528-0
PG 4
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA 565WX
UT WOS:000176393400014
DA 2018-10-19
ER

PT J
AU Hutson, MS
   Hauger, SA
   Edwards, G
AF Hutson, MS
   Hauger, SA
   Edwards, G
TI Thermal diffusion and chemical kinetics in laminar biomaterial due to
   heating by a free-electron laser
SO PHYSICAL REVIEW E
LA English
DT Article
ID IRRADIATION; CONDUCTION; ABLATION; CORNEA
AB We have theoretically investigated the role of thermal diffusion and chemical kinetics as a possible dynamic explanation for the preferential ablative properties of infrared radiation from a free-electron laser (FEL). The model is based on a laminar system composed of alternating layers of protein and saline. We have compared exposure to 3 mum where water is the main absorber and 6.45 mum where both water and protein absorb. The picosecond pulses of the superpulse are treated as a train of impulses. We find that the heating rates are sufficient to superheat the outer saline layers on the nanosecond time scale, leading to explosive vaporization. We also find that competition between the layer-specific heating rates and thermal diffusion results in a wavelength-dependent separation in layer temperatures. We consider the onset of both chemical bond breaking and the helix-coil transition of protein prior to vaporization in terms of the thermal, chemical, and structural properties of the system as well as laser wavelength and pulse structure. There is no evidence for thermal bond breaking on these time scales. At 6.45 mum, but not 3 mum, there is evidence for a significant helix-coil transition. While the native protein is ductile, the denatured protein exhibits brittle fracture. This model provides a dynamic mechanism to account for the preferential ablative properties observed with FEL radiation tuned near 6.45 mum.
C1 Duke Univ, Free Electron Laser Lab, Durham, NC 27708 USA.
   Duke Univ, Dept Phys, Durham, NC 27708 USA.
RP Edwards, G (reprint author), Duke Univ, Free Electron Laser Lab, Box 90319, Durham, NC 27708 USA.
EM edwards@fel.duke.edu
CR COLE KD, 1993, J HEAT TRANS-T ASME, V115, P767, DOI 10.1115/1.2910750
   COPELAND M, 2000, INT BIOM S SPIE SAN
   CROOK AW, 1948, J OPT SOC AM, V38, P954, DOI 10.1364/JOSA.38.000954
   DAVSON H, 1972, PHYSL EYE
   EDWARDS G, 1994, NATURE, V371, P416, DOI 10.1038/371416a0
   FRANKKAMENETSKI.D, 1969, DIFFUSION HEAT TRANS, pCH6
   HECTOR LG, 1992, INT J ENG SCI, V30, P1731, DOI 10.1016/0020-7225(92)90091-T
   Joos KM, 2000, LASER SURG MED, V27, P191, DOI 10.1002/1096-9101(2000)27:3<191::AID-LSM1>3.0.CO;2-D
   Kampmeier J, 2000, CORNEA, V19, P355, DOI 10.1097/00003226-200005000-00020
   LANDAU LD, 1987, FLUID MECH, pCH5
   LIEBMAN JF, 2000, AMIDE LINKAGE, pCH5
   LIM JJ, 1974, BIOPOLYMERS, V13, P1791, DOI 10.1002/bip.1974.360130912
   MADEY JMJ, 1971, J APPL PHYS, V42, P1906, DOI 10.1063/1.1660466
   PRIVALOV PL, 1970, BIOPOLYMERS, V9, P127, DOI 10.1002/bip.1970.360090202
   SHIH OW, 1994, J APPL PHYS, V75, P4382, DOI 10.1063/1.355982
   Skripov V. P., 1988, THERMOPHYSICAL PROPE
   Sporl E, 1997, GER J OPHTHALMOL, V5, P322
   STRYER L, 1995, BIOCHEMISTRY-US, P32
   Tribble J, 1997, PHYS REV E, V55, P7385, DOI 10.1103/PhysRevE.55.7385
   VANGEMERT MJC, 1995, OPTICAL THERMAL RESP, pCH13
   Venugopalan V, 1996, BIOPHYS J, V70, P2981, DOI 10.1016/S0006-3495(96)79868-5
NR 21
TC 26
Z9 26
U1 0
U2 2
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 1539-3755
J9 PHYS REV E
JI Phys. Rev. E
PD JUN
PY 2002
VL 65
IS 6
AR 061906
DI 10.1103/PhysRevE.65.061906
PN 1
PG 6
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA 572FH
UT WOS:000176762500069
PM 12188758
DA 2018-10-19
ER

PT J
AU Schroder, K
   Meyer-Plath, A
   Keller, D
   Ohl, A
AF Schroder, K
   Meyer-Plath, A
   Keller, D
   Ohl, A
TI On the applicability of plasma assisted chemical micropatterning to
   different polymeric biomaterials
SO PLASMAS AND POLYMERS
LA English
DT Article
DE microwave plasma; ammonia; hydrogen; polymer surface; cell culture; XPS;
   fluorescence
ID NEURONAL CELL ATTACHMENT; ETHYLENE-PROPYLENE FILMS; BIOMEDICAL
   APPLICATIONS; AMMONIA PLASMA; ADHESION; SURFACES; DEPOSITION
AB A plasma process sequence has been developed to prepare chemical micropatterns on polymeric biomaterial surfaces. These patterns induce a guided localized cell layover at microscopic dimension. Two subsequent plasma steps are applied. In the first functionalization step a microwave ammonia plasma introduces amino groups to obtain areas for very good cell adhesion; the second passivation step combines pattern generation and creation of cell repelling areas. This downstream microwave hydrogen plasma process removes functional groups and changes the linkages of polymer chains' at the outermost surfaces. Similar results have been. obtained on, different polymers including polystyrene (PS), polyhydroxyethylmethacrylate (PHEMA), polyetheretherketone (PEEK), polyethleneterephthalate (PET) and polyethylenenaphthalate (PEN). Such a rather universal chemical structuring process could widen the availability of biomaterials with specific surface preparations.
C1 Inst Niedertemp Plasmaphys EV, D-17489 Greifswald, Germany.
RP Schroder, K (reprint author), Inst Niedertemp Plasmaphys EV, Friedrich Ludwig Jahn Str 19, D-17489 Greifswald, Germany.
RI Meyer-Plath, Asmus/E-4573-2011
OI Meyer-Plath, Asmus/0000-0001-9037-7706
CR BABUCKE G, 2001, P 10 BUND FACHT PLAS, P67
   Favia P, 1997, SURFACE MODIFICATION OF POLYMERIC BIOMATERIALS, P69
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   HOLLANDER A, 1993, J APPL POLYM SCI, V49, P1857, DOI 10.1002/app.1993.070491016
   KELLER D, 1997, POLYM PREPR AM CHEM, V38, P1043
   KELLER D, 1999, P 14 INT S PLASM CHE, V4, P1767
   KOONTZ SL, 1998, Patent No. 9832789
   LaRocca P, 1996, CELL LINE, V6, P1
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lhoest JB, 1996, J BIOMAT SCI-POLYM E, V7, P1039, DOI 10.1163/156856296X00534
   MATSON RS, 1994, ANAL BIOCHEM, V217, P306, DOI 10.1006/abio.1994.1123
   MEYERPLATH A, 2002, THESIS EMAU GREIFSWA
   NUZZO RG, 1984, MACROMOLECULES, V17, P1013, DOI 10.1021/ma00135a007
   Ohl A, 1999, SURF COAT TECH, V116, P1006, DOI 10.1016/S0257-8972(99)00139-5
   Ohl A, 1999, J MATER SCI-MATER M, V10, P747, DOI 10.1023/A:1008943625715
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   OHL A, 1997, INT J ART ORG, V20, P517
   OHL A, 2000, P 6 WORLD BIOM C KAM
   RANIERI JP, 1994, INT J DEV NEUROSCI, V12, P725, DOI 10.1016/0736-5748(94)90052-3
   RANIERI JP, 1993, J BIOMED MATER RES, V27, P917, DOI 10.1002/jbm.820270711
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Ratner B. D., 1997, SURFACE MODIFICATION
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Schroder K, 2001, CONTRIB PLASM PHYS, V41, P562, DOI 10.1002/1521-3986(200111)41:6<562::AID-CTPP562>3.0.CO;2-Y
   Schroder K., 2000, MAT MED ENG, P161
   Shahidzadeh N, 1996, PLASMAS POLYM, V1, P27
   SIPEHIA R, 1990, BIOMATER ARTIF CELL, V18, P643, DOI 10.3109/10731199009117333
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VARGO TG, 1992, LANGMUIR, V8, P130, DOI 10.1021/la00037a025
   VARGO TG, 1995, J BIOMED MATER RES, V29, P767, DOI 10.1002/jbm.820290613
NR 31
TC 41
Z9 42
U1 0
U2 19
PU KLUWER ACADEMIC/PLENUM PUBL
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1084-0184
J9 PLASMAS POLYM
JI Plasmas Polym.
PD JUN
PY 2002
VL 7
IS 2
BP 103
EP 125
DI 10.1023/A:1016239302194
PG 23
WC Polymer Science
SC Polymer Science
GA 627RN
UT WOS:000179948700002
DA 2018-10-19
ER

PT J
AU Gao, TJ
   Kousinioris, NA
   Wozney, JM
   Winn, S
   Uludag, H
AF Gao, TJ
   Kousinioris, NA
   Wozney, JM
   Winn, S
   Uludag, H
TI Synthetic thermoreversible polymers are compatible with osteoinductive
   activity of recombinant human bone morphogenetic protein 2
SO TISSUE ENGINEERING
LA English
DT Article
ID COLLAGEN; CARRIERS; RATS
AB Recombinant human bone morphogenetic protein 2 (rhBMP-2) is currently in clinical studies as part of an implantable device that contains a biomaterial carrier. Implant retention of rhBMP-2 by the biomaterial carrier is important for the osteoinductive activity. To control in situ retention of rhBMP-2, thermoreversible polymers were synthesized and characterized, and their compatibility with rhBMP-2-induced osteoinduction was investigated. The results indicated that polymers with a controlled "solubility <-> insolubility" transition temperature could be prepared from N-isopropylacrylamide, ethylmethacrylate, and N-acryloxysuccinimide (NASI). NASI-containing polymers were able to conjugate to rhBMP-2 without additional cross-linkers. Implantation in the rat ectopic model, where alkaline phosphatase and calcium deposition were utilized as markers of osteoinductive activity, indicated that rhBMP-2 mixed with the polymers were effective for osteoinduction. Moreover, rhBMP-2 conjugated to the chosen polymers was as effective as native rhBMP-2 in inducing ALP activity and calcium deposition. We conclude that thermoreversible polymers are compatible with rhBMP-2-induced osteogenesis and can serve as novel biomaterials for rhBMP-2 delivery.
C1 Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada.
   Genet Inst Inc, Andover, MA USA.
   Oregon Hlth Sci Univ, Dept Surg, Portland, OR 97201 USA.
RP Uludag, H (reprint author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, 526 Chem & Mat Engn Bldg, Edmonton, AB T6G 2G6, Canada.
CR Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   BESSEY OA, 1946, J BIOL CHEM, V164, P321
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   CARRINGTON JL, 1988, J CELL BIOL, V107, P1969, DOI 10.1083/jcb.107.5.1969
   CHEN JP, 1990, BIOMATERIALS, V11, P631, DOI 10.1016/0142-9612(90)90020-Q
   FEIL H, 1993, MACROMOLECULES, V26, P2496, DOI 10.1021/ma00062a016
   Friess W, 1999, INT J PHARM, V185, P51, DOI 10.1016/S0378-5173(99)00128-3
   Gao T, 2001, MATERIALWISS WERKST, V32, P953
   GAO TJ, 1996, BONE MORPHOGENETIC P, P121
   GUTOWSKA A, 1995, J BIOMED MATER RES, V29, P811, DOI 10.1002/jbm.820290705
   KESSLER G, 1964, CLIN CHEM, V10, P686
   KINLEY RA, 1993, PHARMACEUT RES, V10, P1393
   POLLAK A, 1980, J AM CHEM SOC, V102, P6324, DOI 10.1021/ja00540a026
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   SAKANO S, 1993, CLIN ORTHOP RELAT R, P337
   Sasano Y, 1997, ANAT RECORD, V247, P472, DOI 10.1002/(SICI)1097-0185(199704)247:4<472::AID-AR5>3.0.CO;2-T
   Shimizu S, 1996, ARTIF ORGANS, V20, P1232
   Takita H, 1997, EUR J ORAL SCI, V105, P588, DOI 10.1111/j.1600-0722.1997.tb00222.x
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   ULUDAG H, 2000, CONTROLLED DRUG DELI, P253
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WOZNEY J, 1988, SCIENCE, V241, P1528
NR 22
TC 21
Z9 21
U1 0
U2 2
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2002
VL 8
IS 3
BP 429
EP 440
DI 10.1089/107632702760184691
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 570UW
UT WOS:000176677800008
PM 12167229
DA 2018-10-19
ER

PT J
AU Dalby, MJ
   Di Silvio, L
   Gurav, N
   Annaz, B
   Kayser, MV
   Bonfield, W
AF Dalby, MJ
   Di Silvio, L
   Gurav, N
   Annaz, B
   Kayser, MV
   Bonfield, W
TI Optimizing HAPEX (TM) topography influences osteoblast response
SO TISSUE ENGINEERING
LA English
DT Article
ID HYDROXYAPATITE-REINFORCED POLYETHYLENE; IN-VITRO; LAMELLIPODIA
   FORMATION; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; BONE-FORMATION;
   CELLS; EXPRESSION; GUIDANCE; ACTIN
AB HAPEX(TM) (hydroxyapatite-reinforeed polyethylene composite) is a second-generation orthopedic biomaterial designed as a bone analog material, which has found clinical success. The use of topography in cell engineering has been shown to affect cell attachment and subsequent response. Thus, by combining bioactivity and enhancing osteoblast response to the implant surface, improved tissue repair and implant life span may be achieved. In this study a primary human osteoblast-like cell model has been used to study the influence of surface topography and chemistry produced by three different production methods. Scanning electron microscopy, fluorescence microscopy, and confocal scanning laser microscopy have been used to study cell adhesion; tritiated thymidine uptake has been used to observe cell proliferation; and the reverse transcriptase-polymerase chain reaction and biochemical methods have been used to study phenotypic expression. Transmission electron microscopy has also been used to look at more long-term morphology. The results show that topography significantly influences cell response, and may be a means of enhancing bone apposition on HAPEX(TM).
C1 Royal Natl Orthopaed Hosp Trust, Inst Orthopaed, IRC Biomed Mat, Stanmore, Middx, England.
RP Dalby, MJ (reprint author), Univ Glasgow, Ctr Cell Engn, Inst Biomed & Life Sci, Glasgow G12 800, Lanark, Scotland.
RI Dalby, Matthew/G-2426-2012
OI Di Silvio, Lucy/0000-0003-2554-2052; Dalby, Matthew/0000-0002-0528-3359
CR ABRAM J, 1984, PLAST RUB PROC APPL, V4, P261
   Alberts B, 1994, MOL BIOL CELL
   ALI SY, 1992, BONE BIOL SKELETAL D, P19
   ANDERSON HC, 1989, LAB INVEST, V60, P320
   ANDERSON HC, 1976, BIOCH PHYSL BONE, P135
   Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094
   BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   BONFIELD W, 1986, BIOL BIOMECHANICAL P, P153
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Christenson RH, 1997, CLIN BIOCHEM, V30, P573, DOI 10.1016/S0009-9120(97)00113-6
   COOPER GM, 1997, CELL MOL APPROACH
   Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Dalby MJ, 1999, J MATER SCI-MATER M, V10, P793, DOI 10.1023/A:1008907218330
   DALBY MJ, 2000, J MATER SCI-MATER M, V12, P805
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   DEGASNE I, 1999, CALCIFIED TISSUE INT, V64, P449
   Di Silvio L, 1998, J MATER SCI-MATER M, V9, P845, DOI 10.1023/A:1008900312950
   Di Silvio L, 2001, HUMAN CELL CULTURE, P221
   Dornhoffer JL, 1998, LARYNGOSCOPE, V108, P531, DOI 10.1097/00005537-199804000-00013
   Downes RN, 1991, BIOCERAMICS, V4, P239
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Gray C, 1996, BONE, V18, P115, DOI 10.1016/8756-3282(95)00456-4
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Gronthos S, 1997, J BONE MINER RES, V12, P1189, DOI 10.1359/jbmr.1997.12.8.1189
   Gruen TA, 1979, CLIN ORTHOP RELAT R, V141, P17, DOI DOI 10.1097/00003086-197906000-00002
   HEMACHANDRA K, 1992, THESIS U LONDON LOND
   Huang J., 1997, J MATER SCI-MATER M, V8, P1
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   KASEMO B, 1994, ENV HLTH PROSPECTS, V102, P878
   KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252
   MARIE PJ, 1995, CALCIF TISSUE INT S, V56
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   OCONNOR TP, 1993, J CELL BIOL, V123, P935, DOI 10.1083/jcb.123.4.935
   Ohgushi H, 1996, J BIOMED MATER RES, V32, P333, DOI 10.1002/(SICI)1097-4636(199611)32:3<333::AID-JBM5>3.0.CO;2-T
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   PULEO DA, 1992, BONE MINER, V18, P215, DOI 10.1016/0169-6009(92)90808-Q
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286
   SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0
   Scaife RM, 2000, J CELL SCI, V113, P215
   Schneider GB, 1999, BONE, V24, P321, DOI 10.1016/S8756-3282(99)00007-1
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   Stein Gary S., 1993, P47
   Stephenson P K, 1991, J Arthroplasty, V6, P51, DOI 10.1016/S0883-5403(06)80157-9
   Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Wang M, 2000, J MATER SCI, V35, P1023, DOI 10.1023/A:1004731315328
NR 54
TC 51
Z9 54
U1 0
U2 12
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUN
PY 2002
VL 8
IS 3
BP 453
EP 467
DI 10.1089/107632702760184718
PG 15
WC Cell & Tissue Engineering
SC Cell Biology
GA 570UW
UT WOS:000176677800010
PM 12167231
DA 2018-10-19
ER

PT J
AU Raeder, RH
   Badylak, SF
   Sheehan, C
   Kallakury, B
   Metzger, DW
AF Raeder, RH
   Badylak, SF
   Sheehan, C
   Kallakury, B
   Metzger, DW
TI Natural anti-galactose alpha 1,3 galactose antibodies delay, but do not
   prevent the acceptance of extracellular matrix xenografts
SO TRANSPLANT IMMUNOLOGY
LA English
DT Article
DE alpha 1,3-galactose; small intestinal submucosa; xenotransplantation;
   immune recognition
ID SMALL-INTESTINAL SUBMUCOSA; GAL O/O MICE; ANTI-GAL-ALPHA-1-3GAL
   ANTIBODIES; GAL-ALPHA-1,3GAL EPITOPES; COMPLEMENT; IGG; PIG;
   XENOTRANSPLANTATION; MODEL; CELLS
AB Naturally occurring antibodies to the galactose alpha1,3 galactose (alphagal) epitope expressed on xenogeneic grafts are a major barrier to organ transplantation in humans. Porcine small intestinal submucosa (SIS) expresses the agal epitope and is currently being used as a bioscaffold for tissue remodeling. To examine in detail the potential role of the alphagal epitope in immune recognition of this acellular, avascular biomaterial, we have used mice which have a genetic disruption in the alpha1,3 galactosyltransferase gene (alpha gal(-/-) mice) and thus express natural anti-alpha gal antibodies in a manner similar to humans. It was found that alpha gal(-/-) mice produced IgM anti-alpha gal antibodies in addition to IgG1 SIS-specific antibodies, which did not bind to the U gal epitope. Histological examination of implant sites demonstrated an early inflammatory response that consisted predominantly of neutrophils in both alphagal(+/+) and alphagal(-/-) mice. However, while alphagal(+/+) mice completely remodeled SIS implants by day 25, alphagal(-/-) mice still exhibited some visible SIS together with inflammatory cellular infiltrates at this time point. Nevertheless, by day 35, the implant site in alpha gal(-/-) mice appeared to be entirely remodeled although a few acute inflammatory cells were still present. Immunization of alpha gal(-/-) mice with sheep erythrocytes to enhance anti-a gal antibody levels led to a more robust early inflammatory response following implantation but did not change the ultimate fate of the graft. We conclude that, in contrast to xenotransplantation of whole organs, naturally-occurring anti-alpha gal antibodies do not influence the ability of xenogeneic extracellular matrices to serve as bioscaffolds for tissue remodeling. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.
   Med Coll Ohio, Dept Microbiol & Immunol, Toledo, OH 43699 USA.
   Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   Albany Med Ctr, Dept Pathol, Albany, NY USA.
RP Metzger, DW (reprint author), Albany Med Coll, Ctr Immunol & Microbial Dis, MC 151,47 New Scotland Ave, Albany, NY 12208 USA.
EM metzged@mail.ame.edu
OI Metzger, Dennis/0000-0002-8000-9907; Badylak,
   Stephen/0000-0003-3555-0689
FU NHLBI NIH HHS [HL60359]
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak S, 1999, CLIN ORTHOP RELAT R, pS333, DOI 10.1097/00003086-199910001-00032
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   BADYLAK SF, 1993, TISSUE ENGINEERING, P179
   GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519
   GALILI U, 1993, IMMUNOL TODAY, V14, P480, DOI 10.1016/0167-5699(93)90261-I
   Goldberg LC, 1996, TRANSPLANT P, V28, P549
   GOOD AH, 1992, TRANSPL P, V24, P559
   HAMADEH RM, 1992, J CLIN INVEST, V89, P1223, DOI 10.1172/JCI115706
   KOREN E, 1994, TRANSPLANT P, V26, P1336
   Lewin GA, 1999, J SMALL ANIM PRACT, V40, P340, DOI 10.1111/j.1748-5827.1999.tb03094.x
   McKenzie IFC, 1998, TRANSPLANTATION, V66, P754, DOI 10.1097/00007890-199809270-00010
   McKenzie IFC, 1998, J IMMUNOL, V161, P5116
   McPherson TB, 2000, TISSUE ENG, V6, P233, DOI 10.1089/10763270050044416
   Ohdan H, 2000, J IMMUNOL, V165, P5518, DOI 10.4049/jimmunol.165.10.5518
   Parker W, 1999, GLYCOBIOLOGY, V9, P865, DOI 10.1093/glycob/9.9.865
   Pearse M J, 1999, Subcell Biochem, V32, P281
   Pearse MJ, 1998, TRANSPLANTATION, V66, P748, DOI 10.1097/00007890-199809270-00009
   ROSS JR, 1993, TRANSPLANTATION, V55, P1144, DOI 10.1097/00007890-199305000-00040
   SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391
   Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358
   Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004
   THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437
   Yang YG, 1998, J EXP MED, V187, P1335, DOI 10.1084/jem.187.8.1335
   YING-ZI C, 1991, International Immunology, V3, P467, DOI 10.1093/intimm/3.5.467
   Yu PB, 1999, J CLIN IMMUNOL, V19, P116, DOI 10.1023/A:1020506617105
   Yu PB, 1996, J IMMUNOL, V157, P5163
NR 27
TC 54
Z9 59
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0966-3274
EI 2210-3384
J9 TRANSPL IMMUNOL
JI Transpl. Immunol.
PD JUN
PY 2002
VL 10
IS 1
BP 15
EP 24
AR PII S0966-3274(01)00044-2
DI 10.1016/S0966-3274(01)00044-2
PG 10
WC Immunology; Transplantation
SC Immunology; Transplantation
GA 582VZ
UT WOS:000177373000002
PM 12182460
DA 2018-10-19
ER

PT J
AU Pei, M
   Seidel, J
   Vunjak-Novakovic, G
   Freed, LE
AF Pei, M
   Seidel, J
   Vunjak-Novakovic, G
   Freed, LE
TI Growth factors for sequential cellular de- and re-differentiation in
   tissue engineering
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE tissue engineering; chondrocyte; biomaterial; bioreactor; TGF-beta 1;
   FGF-2; IGF-I
ID HUMAN ARTICULAR CHONDROCYTES; FACTOR-I; CARTILAGE EXPLANTS; IGF-I;
   DYNAMIC COMPRESSION; FACTOR-BETA; COLLAGEN; CULTIVATION; PROTEIN; MATRIX
AB A model system for the in vitro generation of cartilaginous constructs was used to study a tissue engineering paradigm whereby sequentially applied growth factors promoted chondrocytes to first de-differentiate into a proliferative state and then re-differentiate and undergo chondrogenesis. Early cultivation in medium with supplemental TGF-beta1/FGF-2 doubled cell fractions in 2-week constructs compared to unsupplemented controls. Subsequent culture with supplemental IGF-I yielded large 4-week constructs with high fractions of cartilaginous extracellular matrix (ECM) and high compressive moduli, whereas prolonged culture with supplemental FGF-2 yielded small 4-week constructs with low ECM fractions and moduli. Sequential supplementation with TGF-beta1/ FGF-2 and then lGF-I yielded 4-week constructs with type-specific mRNA expression and protein levels that were high for type II and negligible for type I collagen, in contrast to other growth factor regimens studied. The data demonstrate that structural, functional, and molecular properties of engineered cartilage can be modulated by sequential application of growth factors. (C) 2002 Elsevier Science (USA). All rights reserved.
C1 MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Freed, LE (reprint author), MIT, Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574; Freed,
   Lisa/0000-0002-0720-8432
CR Ausubel F.M., 1999, SHORT PROTOCOLS MOL
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Bonassar LJ, 2001, J ORTHOPAED RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8
   Bradham DM, 1998, CLIN ORTHOP RELAT R, P239
   BRADHAM DM, 1994, J CELL PHYSIOL, V158, P61, DOI 10.1002/jcp.1041580109
   Chen AC, 2001, J BIOMECH, V34, P1, DOI 10.1016/S0021-9290(00)00170-6
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   CURTIS AJ, 1992, BIOCHEM J, V288, P721, DOI 10.1042/bj2880721
   EVANS CH, 1999, CLIN ORTHOP S, V367, pS410
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167
   Fortier LA, 1999, J ORTHOPAED RES, V17, P467, DOI 10.1002/jor.1100170403
   FRANK EH, 1987, J BIOMECH, V20, P615, DOI 10.1016/0021-9290(87)90282-X
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   FREED LE, 1995, BIOTECHNOL BIOENG, V46, P306, DOI 10.1002/bit.260460403
   FREED LE, 1999, CLIN ORTHOP S, V367, pS46
   Gooch KJ, 2001, BIOCHEM BIOPH RES CO, V286, P909, DOI 10.1006/bbrc.2001.5486
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   HORTON WE, 1989, J CELL PHYSIOL, V141, P8, DOI 10.1002/jcp.1041410103
   Hunziker EB, 2000, BIORHEOLOGY, V37, P163
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   MADRY H, 2001, T ORTHOP RES SOC, V26, P289
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423
   Nixon AJ, 2001, J ORTHOPAED RES, V19, P26, DOI 10.1016/S0736-0266(00)00013-9
   OSBORN KD, 1989, J ORTHOP RES, V7, P35, DOI 10.1002/jor.1100070106
   Riesle J, 1998, J CELL BIOCHEM, V71, P313, DOI 10.1002/(SICI)1097-4644(19981201)71:3<313::AID-JCB1>3.0.CO;2-C
   SAH RL, 1994, ARCH BIOCHEM BIOPHYS, V308, P137, DOI 10.1006/abbi.1994.1020
   Sah RL, 1996, J ORTHOPAED RES, V14, P44, DOI 10.1002/jor.1100140109
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   Sasano Y, 1996, ANAT EMBRYOL, V194, P247
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WARDALE RJ, 1993, J CELL SCI, V105, P975
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   WROBLEWSKI J, 1995, J BONE MINER RES, V10, P735
   WU JJ, 1984, BIOCHEM BIOPH RES CO, V123, P1033, DOI 10.1016/S0006-291X(84)80237-5
   Xu C, 1996, ENDOCRINOLOGY, V137, P3557, DOI 10.1210/en.137.8.3557
   Yaeger PC, 1997, EXP CELL RES, V237, P318, DOI 10.1006/excr.1997.3781
NR 44
TC 112
Z9 118
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 31
PY 2002
VL 294
IS 1
BP 149
EP 154
AR PII S0006-291X(02)00439-4
DI 10.1016/S0006-291X(02)00439-4
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 563BU
UT WOS:000176234500025
PM 12054755
DA 2018-10-19
ER

PT J
AU Scott-Burden, T
   Bosley, JP
   Rosenstrauch, D
   Henderson, KD
   Clubb, FJ
   Eichstaedt, HC
   Eya, K
   Gregoric, I
   Myers, TJ
   Radovancevic, B
   Frazier, OH
AF Scott-Burden, T
   Bosley, JP
   Rosenstrauch, D
   Henderson, KD
   Clubb, FJ
   Eichstaedt, HC
   Eya, K
   Gregoric, I
   Myers, TJ
   Radovancevic, B
   Frazier, OH
TI Use of autologous auricular chondrocytes for lining artificial surfaces:
   A feasibility study
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID IMPERVIOUS DACRON GRAFTS; ENDOTHELIAL-CELLS; SHEAR-STRESS; TISSUE; DOG
AB Background. Auricular elastic cartilage is a potential source of autologous cells for lining the luminal surfaces of cardiovascular prostheses. We tested this potential in vitro and in vivo using a left ventricular assist device (LVAD) and a calf model.
   Methods. In vitro, auricular cartilage was harvested from the anesthetized ear of a calf, isolated, and cultured on tissue culture dishes. Primary chondrocytes were typed by immunocytochemistry, transferred into culture media, passaged twice, and seeded onto the blood-contacting luminal surfaces of four LVADs (HeartMate; Thoratec Corporation, Woburn, MA). Seeded cell linings were preconditioned under simulated flow conditions to promote cell adhesion to luminal surfaces. Seeding efficiency and cumulative cell loss under flow conditions were quantitated. In vivo, one of the four autologous chondrocyte-lined and preconditioned LVADs was implanted into the tissue-donor calf, run for 7 days; explanted; and evaluated grossly, by scanning electron microscopy, and by transmission electron microscopy.
   Results. The efficiency of seeding chondrocytes onto the luminal surfaces of the four LVADs was 95.11% +/- 4.23% (n = 4). Cumulative cell loss during preconditioning under flow conditions in vitro did not exceed 12% (n = 4). After 7 days of in vivo implantation, the luminal surfaces of the implanted LVAD demonstrated an intact, strongly adherent cellular lining.
   Conclusions. Auricular elastic cartilage is a ready and easily accessible source of chondrocytes whose ability to produce collagen 11 and other important extracellular matrix constituents allows them to adhere strongly to the luminal surfaces of LVADs. The simple method of isolating and expanding auricular chondrocytes presented here could be used to provide strongly adherent autologous cell linings for LVADs and other cardiovascular devices. If and when chondrocytes can be genetically engineered to produce antithrombogenic factors and then used to line the luminal surfaces of LVADs or other cardiovascular prostheses, they may be able to improve the hemocompatibility of the blood-biomaterial interface in such devices. Our successful feasibility study in a calf model warrants further studies of this concept in vivo.
C1 St Lukes Episcopal Hosp, Texas Heart Inst, Vasc Cell Biol Lab, Cardiovasc Surg Res Labs, Houston, TX USA.
   St Lukes Episcopal Hosp, Texas Heart Inst, Dept Cardiovasc Pathol, Houston, TX USA.
   Univ Texas, Hlth Sci Ctr Houston, Houston, TX USA.
RP Frazier, OH (reprint author), 1101 Bates Ave,Suite P357, Houston, TX 77030 USA.
FU NHLBI NIH HHS [HL 53233]
CR BERNHARD WF, 1975, J THORAC CARDIOV SUR, V70, P880
   Bordenave L, 1999, ENDOTHELIUM-J ENDOTH, V6, P267, DOI 10.3109/10623329909078494
   Fedewa MM, 1998, J ORTHOPAED RES, V16, P227, DOI 10.1002/jor.1100160210
   Fernandez P, 2001, BIOMATERIALS, V22, P649, DOI 10.1016/S0142-9612(00)00227-1
   FRAZIER OH, 1993, TEX HEART I J, V20, P78
   LISS RH, 1975, MED INSTRUM, V9, P81
   LUSCHER TF, 1990, ENDOTHELIUM MODULATO
   Megerian CA, 2000, TISSUE ENG, V6, P69, DOI 10.1089/107632700320900
   ROBINSON WJ, 1975, ANN THORAC SURG, V19, P540, DOI 10.1016/S0003-4975(10)64430-X
   SCOTTBURDEN T, 1998, CIRCULATION, V98, P339
   SHI Q, 1994, J VASC SURG, V20, P546, DOI 10.1016/0741-5214(94)90279-8
   Shi Q, 1998, ANN VASC SURG, V12, P341, DOI 10.1007/s100169900165
   Sodian R, 2000, ANN THORAC SURG, V70, P140, DOI 10.1016/S0003-4975(00)01255-8
   Tock CL, 1999, ASAIO J, V45, P172, DOI 10.1097/00002480-199905000-00013
NR 14
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD MAY
PY 2002
VL 73
IS 5
BP 1528
EP 1533
AR PII S0003-4975(01)03600-1
DI 10.1016/S0003-4975(01)03600-1
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 550QE
UT WOS:000175513100035
PM 12022544
DA 2018-10-19
ER

PT J
AU Busuttil, SJ
   Ploplis, VA
   Plow, EF
AF Busuttil, SJ
   Ploplis, VA
   Plow, EF
TI Role of the plasminogen system in the inflammatory response to
   biomaterial implants
SO ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
LA English
DT Meeting Abstract
C1 Case Western Reserve Univ, VAMC, Cleveland, OH 44106 USA.
   Univ Notre Dame, W M Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.
   Cleveland Clin Fdn, Cleveland, OH 44195 USA.
   Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1079-5642
J9 ARTERIOSCL THROM VAS
JI Arterioscler. Thromb. Vasc. Biol.
PD MAY
PY 2002
VL 22
IS 5
MA P259
BP A45
EP A45
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 550PP
UT WOS:000175511700276
DA 2018-10-19
ER

PT J
AU Kim, JH
   Kim, SC
AF Kim, JH
   Kim, SC
TI PEO-grafting on PU/PS IPNs for enhanced blood compatibility - effect of
   pendant length and grafting density
SO BIOMATERIALS
LA English
DT Article
DE blood compatibility; hydrophilic hydrophobic IPN; PEO-grafting;
   fibrinogen; platelet; protein-biomaterial interaction
ID HYDROPHOBIC POLYSTYRENE IPNS; PLASMA POLYMER SURFACES; PROTEIN
   ADSORPTION; POLYETHYLENE OXIDE; PLATELET-ADHESION; IN-VITRO; FIBRINOGEN;
   ANTITHROMBOGENICITY; RESISTANCE; INTERFACE
AB Polyurethane (PU) homopolymers and PU/polystyrene (PS) interpenetrating polymer networks (IPNs) were successfully synthesized changing the length of the pendant poly(ethylene oxide) (PEO) chains and the grafting density of PEO chains. All the PU/PS IPNs had the microphase-separated structures in which the PS-rich phase domains were dispersed in the matrix of the PU-rich phase. The domain size decreased a little, as the degree of grafting with PEO chains was increased. The water swelling ratio increased, and the interfacial energy decreased, as the length of the pendant PEO chains, and the grafting density of PEO chains of the PEO-grafted PU/PS IPNs were increased, since the mobile hydrophilic pendant PEO chains effectively induced and absorbed the water, when they were contacted with water. The hydrophilic and highly concentrated pendant PEO chains could easily prohibit the adhesion of the fibrinogens and the platelets on the surface, and the blood compatibility of IPNs was enhanced by increasing of grafting with PEO chains. The adsorption of the fibrinogens and the platelets was suppressed, as the length of pendant PEO chains, and the grafting density were increased. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Korea Adv Inst Sci & Technol, Ctr Adv Funct Polymers, Yusong Gu, Taejon 305701, South Korea.
RP Kim, SC (reprint author), Korea Adv Inst Sci & Technol, Ctr Adv Funct Polymers, Yusong Gu, 373-1 Kusong Dong, Taejon 305701, South Korea.
CR ANDRADE JD, 1979, J COLLOID INTERF SCI, V72, P488, DOI 10.1016/0021-9797(79)90350-3
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   Chen X, 1997, LANGMUIR, V13, P4106, DOI 10.1021/la970172i
   DEFLFE KM, 1999, J BIOMED MATER RES, V44, P298
   DEGENNES JH, 1979, J BIOMATER SCI POLYM
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   deGennes PG, 1979, SCALING CONCEPTS POL
   Everse SJ, 1998, THROMB HAEMOSTASIS, V80, P1
   Feng L., 1995, PROTEINS INTERFACES
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   Holmberg K, 1997, COLLOID SURFACE A, V123, P297, DOI 10.1016/S0927-7757(96)03810-1
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1996, J POLYM SCI POL CHEM, V34, P199, DOI 10.1002/(SICI)1099-0518(19960130)34:2<199::AID-POLA6>3.0.CO;2-P
   JEON SI, 1992, B KOR CHEM SOC, V13, P245
   JEON SI, 1993, B KOR CHEM SOC, V14, P352
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   Joen S. I., 1991, J COLLOID INTERF SCI, V142, P149
   Kim JH, 2000, J BIOMAT SCI-POLYM E, V11, P197, DOI 10.1163/156856200743652
   Lassen B, 1997, J COLLOID INTERF SCI, V186, P9, DOI 10.1006/jcis.1996.4529
   LEE SST, 1989, PESTIC BIOCHEM PHYS, V35, P1, DOI 10.1016/0048-3575(89)90096-5
   MALMSTEN M, 1995, J COLLOID INTERF SCI, V172, P106, DOI 10.1006/jcis.1995.1231
   Malmsten M, 1997, J COLLOID INTERF SCI, V193, P88, DOI 10.1006/jcis.1997.5039
   Marchant RE, 1997, THROMB HAEMOSTASIS, V77, P1048
   McPherson T, 1998, LANGMUIR, V14, P176, DOI 10.1021/la9706781
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   PERRIN DD, 1980, PURIFICATION LAB CHE
   Roh HW, 1999, J BIOMAT SCI-POLYM E, V10, P123, DOI 10.1163/156856299X00324
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P281
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P195
   Sugiyama K, 1999, MACROMOL CHEM PHYSIC, V200, P1439, DOI 10.1002/(SICI)1521-3935(19990601)200:6<1439::AID-MACP1439>3.0.CO;2-B
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
NR 32
TC 64
Z9 70
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 9
BP 2015
EP 2025
AR PII S0142-9612(01)00330-1
DI 10.1016/S0142-9612(01)00330-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FJ
UT WOS:000174689800013
PM 11996043
DA 2018-10-19
ER

PT J
AU dos Santos, LA
   Carrodeguas, RG
   Rogero, SO
   Higa, OZ
   Boschi, AO
   de Arruda, ACF
AF dos Santos, LA
   Carrodeguas, RG
   Rogero, SO
   Higa, OZ
   Boschi, AO
   de Arruda, ACF
TI alpha-tricalcium phosphate cement: "in vitro" cytotoxicity
SO BIOMATERIALS
LA English
DT Article
DE citotoxicity; calcium phosphate cement; bioceramic; biomaterial
ID SIMULATED BODY-FLUID; BONE CEMENTS; SETTING REACTION; SYSTEM; TCP
AB Calcium phosphate-based bioceramics have revolutionized orthopedic and dental repair of damaged parts of the bone system. Among these materials, calcium phosphate-based cements, with hydraulic setting, stand out due to their biocompatibility and in situ hardening, which allow easy manipulation and adaptation to the shape and dimensions of bone defects. An investigation was made of the in vitro cytotoxic effect of calcium phosphate cement based on a-tricalcium phosphate, immersed for different lengths of time in simulated body fluid (SBF), based on the ISO-10993 "Biological Evaluation of Medical Devices" standard. The culture medium was Chinese hamster ovary (CHO) cells in contact with diluted cement extracts. The results revealed that the calcium phosphate cement used was cytotoxic and that the material's cytotoxicity decreased the longer the cement was immersed in SBF. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Estadual Campinas, UNICAMP, FEM, CEP, BR-13081970 Campinas, SP, Brazil.
   Univ La Habana, Ctr Biomat, Havana 10600, Cuba.
   CNEN, IPEN, BR-05422970 Sao Paulo, Brazil.
   Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP dos Santos, LA (reprint author), Univ Estadual Campinas, UNICAMP, FEM, CEP, Caixa Postal 6122, BR-13081970 Campinas, SP, Brazil.
RI BOSCHI, Anselmo/K-7091-2013; Garcia Carrodeguas, Raul/E-5087-2012
OI Garcia Carrodeguas, Raul/0000-0002-4379-4598
CR BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P144, DOI 10.1007/BF00053334
   BERMUDEZ O, 1994, J MATER SCI-MATER M, V5, P160, DOI 10.1007/BF00053337
   CARRODEGUAS RG, UNPUB J MAT SCI MAT
   CARRODEGUAS RG, BIOMAT 97 C INT BIOM
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   DRIESSENS FCM, 1994, J MATER SCI-MATER M, V5, P164, DOI 10.1007/BF00053338
   Driessens FCM, 1997, AN QUIM-INT, V93, pS38
   FAMERY R, 1994, CERAM INT, V20, P327, DOI 10.1016/0272-8842(94)90050-7
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P223, DOI 10.1023/A:1008958112257
   FERNANDEZ E, 1995, J MATER SCI LETT, V14, P4, DOI 10.1007/BF02565267
   FRESA R, 1995, BIOMATERIALS, V16, P849
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   GINEBRA MP, 1998, BIOCERAMICS, V11, P243
   GRUNINGER SE, 1984, J DENT RES, V63, P200
   International Standardization Organization, 1992, 109935 ISO
   ISHIKAWA K, 1998, J DENT RES, V1446, P812
   JENKINS R, 1971, INTRO XRAY POWDER DI
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Miyamoto Y, 1999, J BIOMED MATER RES, V48, P36, DOI 10.1002/(SICI)1097-4636(1999)48:1<36::AID-JBM8>3.0.CO;2-I
   Monma H, 1984, GYPSUM LIME, V188, P11
   NAKAMURA A, 1989, P JAP AT RES I JAERI, P79
   OLIVEIRA JM, 1995, BIOMATERIALS, V16, P849, DOI 10.1016/0142-9612(95)94146-C
   Santos L.A., 1999, BONE, V25, p99S
   SANTOS L.A., 2000, ARTIF ORGANS, V24, P212
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   YU D, 1992, J PHARM SCI, V81, P529, DOI 10.1002/jps.2600810611
NR 27
TC 43
Z9 44
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 9
BP 2035
EP 2042
AR PII S0142-9612(01)00333-7
DI 10.1016/S0142-9612(01)00333-7
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FJ
UT WOS:000174689800015
PM 11996045
DA 2018-10-19
ER

PT J
AU Puleo, DA
   Kissling, RA
   Sheu, MS
AF Puleo, DA
   Kissling, RA
   Sheu, MS
TI A technique to immobilize bioactive proteins, including bone
   morphogenetic protein-4 (BMP-4), on titanium alloy
SO BIOMATERIALS
LA English
DT Article
DE protein immobilization; plasma polymerization; carbodiimide; BMP;
   biomolecular modification
ID CO-CR-MO; IN-VITRO; GROWTH-FACTOR; CHEMICAL MODIFICATION; CELL-ADHESION;
   SURFACES; BIOMATERIALS; TI-6AL-4V; MINERALIZATION; DEPOSITION
AB Immobilization of biomolecules on surfaces enables both localization and retention of molecules at the cell-biomaterial interface. Since metallic biomaterials used for orthopedic and dental implants possess a paucity of reactive functional groups, biomolecular modification of these materials is challenging. In the present work, we investigated the use of a plasma surface modification strategy to enable immobilization of bioactive molecules on a "bioinert" metal. Conditions during plasma polymerization of allyl amine on Ti-6Al-4V were varied to yield 5 ("low")- and 12 ("high")-NH2/nm(2). One- and two-step carbodiimide schemes were used to immobilize lysozyme, a model biomolecule, and bone morphogenetic protein-4 (BMP-4) on the aminated surfaces. Both schemes could be varied to control the amount of protein bound, but the one-step method destroyed the activity of immobilized lysozyme because of crosslinking. BMP-4 was then immobilized using the two-step scheme. Although BMP bound to both low- and high-NH2 surfaces was initially able to induce alkaline phosphatase activity in pluripotent C3H10T1/2 cells, only high amino group surfaces were effective following removal of weakly bound protein by incubation in cell culture medium. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Kentucky, Ctr Biomed Engn, Wenner Gren Lab 205, Lexington, KY 40505 USA.
   AST Prod, Billerica, MA 01821 USA.
RP Puleo, DA (reprint author), Univ Kentucky, Ctr Biomed Engn, Wenner Gren Lab 205, Lexington, KY 40505 USA.
CR ALBELDA SM, 1990, FASEB J, V4, P2868
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   BAIER RE, 1982, BIOMATERIALS, V3, P241, DOI 10.1016/0142-9612(82)90027-8
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Endo K, 1995, Dent Mater J, V14, P185
   GOMBOTZ WR, 1988, J APPL POLYM SCI APP, V42, P285
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   KUHL PR, 1996, NAT MED, V2, P1202
   Lee WH, 2000, J MATER SCI, V35, P593, DOI 10.1023/A:1004768125476
   Leong LM, 1996, INT J BIOCHEM CELL B, V28, P1293, DOI 10.1016/S1357-2725(96)00075-1
   LIU SQ, 1992, BIOMATERIALS, V13, P50, DOI 10.1016/0142-9612(92)90095-6
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Mikulec LJ, 1996, J BIOMED MATER RES, V32, P203, DOI 10.1002/(SICI)1097-4636(199610)32:2<203::AID-JBM8>3.0.CO;2-X
   Morra M, 1997, J BIOMED MATER RES, V37, P198, DOI 10.1002/(SICI)1097-4636(199711)37:2<198::AID-JBM8>3.0.CO;2-M
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   OKUYAMA T, 1960, J BIOCHEM-TOKYO, V47, P454, DOI 10.1093/oxfordjournals.jbchem.a127083
   Ollis D F, 1976, Methods Enzymol, V44, P444
   PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Pimentel E, 1994, HDB GROWTH FACTORS
   POGGI A, 1984, EXP CELL RES, V150, P436, DOI 10.1016/0014-4827(84)90587-1
   Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O
   Puleo DA, 1998, J BIOMED MATER RES, V41, P104, DOI 10.1002/(SICI)1097-4636(199807)41:1<104::AID-JBM13>3.0.CO;2-N
   PULEO DA, 1995, J BIOMED MATER RES, V29, P951, DOI 10.1002/jbm.820290806
   Puleo DA, 1997, J BIOMED MATER RES, V37, P222, DOI 10.1002/(SICI)1097-4636(199711)37:2<222::AID-JBM11>3.0.CO;2-G
   RATNER BD, 1992, J BIOMAT SCI-POLYM E, V4, P3
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   TAKAOKA K, 1993, CLIN ORTHOP RELAT R, P329
   TERLINGEN JGA, 1993, J BIOMAT SCI-POLYM E, V4, P165, DOI 10.1163/156856293X00500
   Thompson GJ, 1996, BIOMATERIALS, V17, P1949, DOI 10.1016/0142-9612(96)00009-9
   THOMPSON GJ, 1995, J APPL BIOMATER, V6, P249, DOI 10.1002/jab.770060406
   YUAN SM, 1994, APPL POLYM SYMP SER, V54, P77
NR 37
TC 208
Z9 216
U1 1
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 9
BP 2079
EP 2087
AR PII S0142-9612(01)00339-8
DI 10.1016/S0142-9612(01)00339-8
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 536FJ
UT WOS:000174689800020
PM 11996050
DA 2018-10-19
ER

PT J
AU Coombes, AGA
   Verderio, E
   Shaw, B
   Li, X
   Griffin, M
   Downes, S
AF Coombes, AGA
   Verderio, E
   Shaw, B
   Li, X
   Griffin, M
   Downes, S
TI Biocomposites of non-crosslinked natural and synthetic polymers
SO BIOMATERIALS
LA English
DT Article
DE collagen; polycaprolactone; bone cells; biocomposite
ID EXTRACELLULAR-MATRIX; BIOMATERIALS; SKIN
AB Biocomposite films comprising a non-crosslinked, natural polymer (collagen) and a synthetic polymer, poly(epsilon-caprolactone) (PCL). have been produced by impregnation of lyophilised collagen mats with a solution of PCL in dichloromethane followed by solvent evaporation. This approach avoids the toxicity problem, associated with chemical crosslinking. Distinct changes in film morphology, from continuous surface coating to open porous format, were achieved by variation of processing parameters such Lis collagen:PCL ratio and the weight of the starting lyophilised collagen mat. Collagenase digestion indicated that the collagen content of 1:4 and 1:8 collagen:PCL biocomposites was almost totally accessible for enzymatic digestion indicating a high degree of collagen exposure for interaction with other ECM proteins or cells contacting the biomaterial Surface. Much reduced collagen exposure (around 50%) was measured for the 1:20 collagen:PCL materials. These findings were consistent with the SEM examination of collagen:PCL biocomposites which revealed a highly porous morphology for the 1:4 and 1:8 blends but virtually complete Coverage of the collagen component by PCL in the 1:20 samples. Investigations of the attachment and spreading characteristics of human osteoblast (HOB) cells on PCL films and collagen:PCL materials respectively. indicated that HOB cells poorly recognised PCL but attachment and spreading were much improved on the biocomposites. The non-chemically crosslinked, collagen:PCL biocomposites described are expected to provide a useful addition to the range of biomaterials and matrix systems for tissue engineering. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England.
   Nottingham Trent Univ, Dept Life Sci, Nottingham NG11 8NS, England.
RP Coombes, AGA (reprint author), Aston Univ, Aston Pharm Sch, Birmingham B4 7ET, W Midlands, England.
RI Verderio, Elisabetta/H-2789-2016
OI Verderio, Elisabetta/0000-0001-9153-8997
CR BENSLIMANE S, 1988, EUR SURG RES, V20, P18
   GIUSTI P, 1993, TRENDS POLYM SCI, V1, P261
   Grzesiak JJ, 1997, BIOMATERIALS, V18, P1625, DOI 10.1016/S0142-9612(97)00103-8
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HYNES RO, 1986, SCI AM, V254, P42, DOI 10.1038/scientificamerican0686-42
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   MATSUDA K, 1993, BIOMATERIALS, V14, P1030, DOI 10.1016/0142-9612(93)90197-A
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   Verderio E, 2001, J BIOMED MATER RES, V54, P294, DOI 10.1002/1097-4636(200102)54:2<294::AID-JBM17>3.0.CO;2-Q
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 11
TC 74
Z9 75
U1 3
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 10
BP 2113
EP 2118
AR PII S0142-9612(01)00341-6
DI 10.1016/S0142-9612(01)00341-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 571HZ
UT WOS:000176713100003
PM 11962651
DA 2018-10-19
ER

PT J
AU Ronold, HJ
   Ellingsen, JE
AF Ronold, HJ
   Ellingsen, JE
TI The use of a coin shaped implant for direct in situ measurement of
   attachment strength for osseointegrating biomaterial surfaces
SO BIOMATERIALS
LA English
DT Article
DE biomaterials; attachment strength; surface roughness; tensile testing;
   bone bonding; perpendicular forces; titanium implants; animal model
ID PLASMA-SPRAYED COATINGS; EXPERIMENTAL IN-VIVO; PUSH-OUT TEST; TITANIUM
   IMPLANTS; BIOMECHANICAL CHARACTERIZATION; TENSILE-STRENGTH; COATED
   IMPLANTS; BONE; INTERFACE; HYDROXYLAPATITE
AB Most animal models currently used to study the retention of implants in bone are influenced by shear forces introduced during the retention test. This is mainly due to the implant design, which most often are cylindrical, conical or threaded. In these models interlocking between bone and implant surface will increase the effect of genuine bone bonding and thus give a false positive outcome. The purpose of the present study was to establish a model for testing functional attachment of implants in situ, with minimal influence of interlocking and shear forces, The model involves the use of flat coin shaped implant placed onto the cortical bone of rabbit tibia without mechanical fixation to the bone. The implant is passively retained on the cortical bone by a titanium band retainer. During the healing period, the contact between the coin shaped implants and the bone is restricted to the flat test surfaces. To prevent interlocking effects from lateral bone attachments a polytetrafluoroethylene (PTFE) cap covering the vertical and the upper faces of the implants were used. The tensile test was performed with a gradual, calibrated pull, perpendicular to the bone-implant interface. This pullout model makes it possible to study the kinetics and strength of bone bonding with negligible influence of shear forces or mechanical interlocking. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Oslo, Oral Res Lab, Fac Dent, Dept Prosthet & Oral Funct, N-0317 Oslo, Norway.
RP Ellingsen, JE (reprint author), Univ Oslo, Oral Res Lab, Fac Dent, Dept Prosthet & Oral Funct, POB 1109, N-0317 Oslo, Norway.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Berzins A, 1997, J BIOMED MATER RES, V34, P337
   BERZINS A, 1999, MECH TESTING BONE BO, P463
   Branemark R, 1998, J ORTHOPAED RES, V16, P61, DOI 10.1002/jor.1100160111
   Branemark R, 1997, BIOMATERIALS, V18, P969, DOI 10.1016/S0142-9612(97)00018-5
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   de Groot K, 1989, J Biomed Mater Res, V23, P1367, DOI 10.1002/jbm.820231112
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DHERT WJA, 1992, J BIOMED MATER RES, V26, P119, DOI 10.1002/jbm.820260111
   DHERT WJA, 1999, MECH TESTING BONE BO, P477
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   ELLINGSEN JE, 1995, J MATER SCI-MATER M, V6, P125, DOI 10.1007/BF00120287
   Ellingsen JE, 1995, J MATER SCI-MATER M, V6, P749, DOI 10.1007/BF00134312
   Ellingsen JE, 1998, PERIODONTOL 2000, V17, P36, DOI 10.1111/j.1600-0757.1998.tb00121.x
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   GROSS U, 1981, J BIOMED MATER RES, V15, P291, DOI 10.1002/jbm.820150302
   Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q
   KANGASNIEMI IMO, 1994, J BIOMED MATER RES, V28, P563, DOI 10.1002/jbm.820280506
   Lewis CG, 1997, J ARTHROPLASTY, V12, P451, DOI 10.1016/S0883-5403(97)90202-3
   Lin H, 1998, J BIOMED MATER RES, V43, P113, DOI 10.1002/(SICI)1097-4636(199822)43:2<113::AID-JBM5>3.0.CO;2-R
   LIN H, 1992, J BIOMED MATER RES, V26, P7
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nakashima Y, 1997, J BIOMED MATER RES, V35, P287
   Ogiso M, 1998, J BIOMED MATER RES, V39, P364
   OSBORN JF, 1989, BIOCERAMICS, V1, P388
   Pebe P, 1997, Implant Dent, V6, P259
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   STEINEMANN SG, 1986, ADV BIOMATER, V6, P409
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   TAKATSUKA K, 1995, J BIOMED MATER RES, V29, P157, DOI 10.1002/jbm.820290204
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Wennerberg A, 1996, J BIOMED MATER RES, V30, P251, DOI 10.1002/(SICI)1097-4636(199602)30:2<251::AID-JBM16>3.0.CO;2-P
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   WILKE HJ, 1990, ADV BIOMAT, V9, P309
   YOSHII S, 1988, J BIOMED MATER RES-A, V22, P327, DOI 10.1002/jbm.820221410
NR 36
TC 39
Z9 39
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2002
VL 23
IS 10
BP 2201
EP 2209
AR PII S0142-9612(01)00353-2
DI 10.1016/S0142-9612(01)00353-2
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 571HZ
UT WOS:000176713100013
PM 11962661
DA 2018-10-19
ER

PT J
AU Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
AF Duncan, AC
   Weisbuch, F
   Rouais, F
   Lazare, S
   Baquey, C
TI Laser microfabricated model surfaces for controlled cell growth
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE microfabricated; surfaces; controlled cell growth; osteoblast
ID OXYGEN-CONTAINING FILMS; EXCIMER-LASER; MICROTEXTURED SILICONE;
   IN-VITRO; MICROARCHITECTURAL DESIGN; BIOMEDICAL APPLICATIONS;
   SUBCUTANEOUS IMPLANTS; PERCUTANEOUS IMPLANTS; TITANIUM SUBSTRATA;
   BEHAVIOR INVITRO
AB The relatively recent applications of microelectronics technology into the biological sciences arena has drastically revolutionized the field. New foreseeable applications include miniaturized, multiparametric biosensors for high performance multianalyte assays or DNA sequencing, biocomputers, and substrates for controlled cell growth (i.e. tissue engineering). The objectives of this work were to investigate a new method combining microphotolithographical techniques with laser excimer beam technology to create surfaces with well defined 3-D microdomains in order to delineate critical microscopic surface features governing material-cell interaction. Another obvious application of this study pertains to the fabrication of cell-based biosensors. Microfabricated surfaces were obtained with micron resolution, by 'microsculpturing' polymer model surfaces using a laser excimer KrF beam coupled with a microlithographic projection technique. The laser beam after exiting a mask was focused onto the polymer target surface via an optical setup allowing for a 10-fold reduction of the mask pattern. Various 3-D micropatterned features were obtained at the micron level. Reproducible submicron features could also be obtained using this method. Subsequently, model osteoblast-like cells were plated onto the laser microfabricated surfaces in order to study the effects of particular surface microtopography on preferential cell deposition and orientation. Preferential cell deposition was observed on surfaces presenting 'smooth' microtopographical transitions. This system may provide an interesting model for further insights into correlations between 3-D surface microtopography and cell response with new applications in the field biosensor, biomaterial and pharmaceutical engineering sciences (e.g. new cell based biosensors, controlled synthesis of immobilized cell derived active ingredients). (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Bordeaux 2, Natl Inst Hlth & Med Res, Biomat & Tissue Repair Unit, INSERM U443, F-33076 Bordeaux, France.
   Univ Bordeaux 1, CNRS, UMR 5803, Lab Physicochim Mol, F-33405 Talence, France.
RP Duncan, AC (reprint author), CNRS, 115 Ave Docteur Albert Schweitzer, F-3360 Pessac, France.
EM aduncan65@hotmail.com
CR Amirpour ML, 2001, ANAL CHEM, V73, P1560, DOI 10.1021/ac000907f
   BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   Chehroudi B, 1997, J BIOMED MATER RES, V34, P279
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   CHEHROUDI B, 1988, J BIOMED MATER RES, V22, P459, DOI 10.1002/jbm.820220603
   CHEHROUDI B, 1995, J BIOMED MATER RES, V29, P371, DOI 10.1002/jbm.820290312
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1992, J CELL SCI, V103, P287
   COREY JM, 1991, J NEUROSCI RES, V30, P300, DOI 10.1002/jnr.490300204
   Dalton BA, 2001, J BIOMED MATER RES, V56, P195, DOI 10.1002/1097-4636(200108)56:2<195::AID-JBM1084>3.0.CO;2-7
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   denBraber ET, 1997, J BIOMED MATER RES, V37, P539, DOI 10.1002/(SICI)1097-4636(19971215)37:4<539::AID-JBM13>3.0.CO;2-3
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   ERTEL SI, 1991, J COLLOID INTERF SCI, V147, P433, DOI 10.1016/0021-9797(91)90176-9
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   HIRONO T, 1988, BRAIN RES, V446, P189, DOI 10.1016/0006-8993(88)91314-5
   Hunt JA, 1995, J MATER SCI-MATER M, V6, P813, DOI 10.1007/BF00134323
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kapur R, 1999, J BIOMECH ENG-T ASME, V121, P65, DOI 10.1115/1.2798044
   Kasemo B, 1999, Adv Dent Res, V13, P8
   LAZARE S, 1986, J PHYS CHEM-US, V90, P2124, DOI 10.1021/j100401a028
   LAZARE S, 1989, LASER CHEM, V10, P25, DOI 10.1155/1989/18750
   LAZARE S, 1990, COMMUNICATION
   LEE JS, 1994, APPL PHYS LETT, V65, P400, DOI 10.1063/1.112314
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Matsuzaka K, 2000, CLIN ORAL IMPLAN RES, V11, P325, DOI 10.1034/j.1600-0501.2000.011004325.x
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   NAKAYAMA Y, 1995, J BIOMED MATER RES, V29, P1295, DOI 10.1002/jbm.820291017
   NIINO H, 1989, APPL PHYS LETT, V54, P2159, DOI 10.1063/1.101154
   NIINO H, 1992, APPL PHYS LETT, V2697
   Pins GD, 2000, FASEB J, V14, P593
   Qu J, 1996, Oral Dis, V2, P102
   Ranucci CS, 2001, J BIOMED MATER RES, V54, P149, DOI 10.1002/1097-4636(200102)54:2<149::AID-JBM1>3.0.CO;2-O
   SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7
   SCHMIDT J, 1990, BIOMATERIALS, V12, P385
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P1059, DOI 10.1016/0142-9612(92)90138-E
   SCHMIDT JA, 1992, BIOMATERIALS, V13, P675
   SHIMO N, 1994, N-HOLLAND D, P109
   SHIMO N, 1990, MATER RES SOC SYMP P, V191, P91, DOI 10.1557/PROC-191-91
   Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
   Walboomers XF, 2000, BIOMATERIALS, V21, P629, DOI 10.1016/S0142-9612(99)00230-6
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   WALTER J, 1987, DEVELOPMENT, V101, P685
NR 53
TC 68
Z9 72
U1 0
U2 11
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAY
PY 2002
VL 17
IS 5
BP 413
EP 426
AR PII S0956-5663(01)00281-0
DI 10.1016/S0956-5663(01)00281-0
PG 14
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 539JX
UT WOS:000174867700009
PM 11888732
DA 2018-10-19
ER

PT J
AU Einmahl, S
   Savoldelli, M
   D'Hermies, F
   Tabatabay, C
   Gurny, R
   Behar-Cohen, F
AF Einmahl, S
   Savoldelli, M
   D'Hermies, F
   Tabatabay, C
   Gurny, R
   Behar-Cohen, F
TI Evaluation of a novel biomaterial in the suprachoroidal space of the
   rabbit eye
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID BIOERODIBLE POLY(ORTHO ESTER); DRUG-DELIVERY SYSTEMS; CHOROIDAL
   NEOVASCULARIZATION; MACULAR DEGENERATION; RELEASE; BIOCOMPATIBILITY;
   5-FLUOROURACIL; STERILIZATION; DEXAMETHASONE; ANGIOGENESIS
AB PURPOSE. Drug delivery to treat diseases of the posterior segment of the eye, such as choroidal neovascularization and its complications, is hampered by poor intraocular penetration and rapid elimination of the drug from the eye. The purpose of this study was to investigate the feasibility and tolerance of suprachoroidal injections of poly(ortho ester) (POE), a bio-erodible and biocompatible polymer, as a biomaterial potentially useful for development of sustained drug delivery systems.
   METHODS. After tunnelization of the sclera, different formulations based on POE were injected (100 muL) into the suprachoroidal space of pigmented rabbits and compared with 1% sodium hyaluronate. Follow-up consisted of fundus observations, echography, fluorescein angiography, and histologic analysis over 3 weeks.
   RESULTS. After injection, POE spread in the suprachoroidal space at the posterior pole. It was well tolerated and progressively disappeared from the site of injection without sequelae. No bleeding or retinal detachment occurred. Echographic pictures showed that the material was present in the suprachoroidal space for 3 weeks. Angiography revealed minor pigment irregularities at the site of injection, but no retinal edema or necrosis. Histology showed that POE was well tolerated in the choroid.
   CONCLUSIONS. POE suprachoroidal injections, an easy, controllable, and reproducible procedure, were well tolerated in the rabbit eye. POE appears to be a promising biomaterial to deliver drugs focally to the choroid and the retina.
C1 Univ Geneva, Dept Pharmaceut Technol & Biopharmaceut, Sch Pharm, CH-1211 Geneva 4, Switzerland.
   INSERM, Lab U450, Paris, France.
   Hop Hotel Dieu, Dept Ophthalmol, Paris, France.
RP Gurny, R (reprint author), Univ Geneva, Dept Pharmaceut Technol & Biopharmaceut, Sch Pharm, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.
EM robert.gurny@pharm.unige.ch
CR Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1186
   Castellarin AA, 1998, BRIT J OPHTHALMOL, V82, P480, DOI 10.1136/bjo.82.5.480
   DAMATO RJ, 1995, OPHTHALMOLOGY, V102, P1261
   DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974
   Einmahl S, 2001, INVEST OPHTH VIS SCI, V42, P695
   Einmahl S, 2000, J BIOMED MATER RES, V50, P566, DOI 10.1002/(SICI)1097-4636(20000615)50:4<566::AID-JBM12>3.0.CO;2-M
   Einmahl S, 1999, INT J PHARM, V185, P189, DOI 10.1016/S0378-5173(99)00149-0
   Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928
   FERRIS FL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1640
   FOULDS WS, 1988, BRIT J OPHTHALMOL, V72, P278, DOI 10.1136/bjo.72.4.278
   GHADIALLY FN, 1982, J SUBMICR CYTOL PATH, V14, P63
   GUYER DR, 1989, RETINA, P17
   Ishida K, 1999, INVEST OPHTH VIS SCI, V40, P1512
   Keshet E, 1999, J CLIN INVEST, V104, P1497, DOI 10.1172/JCI8849
   Martidis A, 1999, J OCUL PHARMACOL TH, V15, P425, DOI 10.1089/jop.1999.15.425
   MERKLI A, 1993, J BIOMAT SCI-POLYM E, V4, P505, DOI 10.1163/156856293X00168
   Merkli A, 1996, BIOMATERIALS, V17, P897, DOI 10.1016/0142-9612(96)83285-6
   MERKLI A, 1995, J CONTROL RELEASE, V33, P415, DOI 10.1016/0168-3659(94)00117-D
   MITTL RN, 1987, OPHTHALMIC RES, V19, P255, DOI 10.1159/000265503
   POOLE TA, 1986, OPHTHALMOLOGY, V93, P1408
   PROIA AD, 1993, EXP EYE RES, V57, P693, DOI 10.1006/exer.1993.1177
   Rothen-Weinhold A, 2001, J CONTROL RELEASE, V71, P31, DOI 10.1016/S0168-3659(00)00348-5
   Sintzel MB, 1998, INT J PHARM, V175, P165, DOI 10.1016/S0378-5173(98)00274-9
   Yasukawa T, 1999, INVEST OPHTH VIS SCI, V40, P2690
   Zignani M, 1997, J CONTROL RELEASE, V48, P115, DOI 10.1016/S0168-3659(97)00050-3
   Zignani M, 2000, BIOMATERIALS, V21, P1773, DOI 10.1016/S0142-9612(00)00065-X
   Zignani M, 1998, J BIOMED MATER RES, V39, P277
   Zignani M, 2000, EUR J PHARM BIOPHARM, V50, P251, DOI 10.1016/S0939-6411(00)00107-7
NR 28
TC 65
Z9 67
U1 0
U2 7
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD MAY
PY 2002
VL 43
IS 5
BP 1533
EP 1539
PG 7
WC Ophthalmology
SC Ophthalmology
GA 548FN
UT WOS:000175378100037
PM 11980871
DA 2018-10-19
ER

EF